<SEC-DOCUMENT>0000950170-25-054434.txt : 20250416
<SEC-HEADER>0000950170-25-054434.hdr.sgml : 20250416
<ACCEPTANCE-DATETIME>20250415203749
ACCESSION NUMBER:		0000950170-25-054434
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		105
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250416
DATE AS OF CHANGE:		20250415

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MSP Recovery, Inc.
		CENTRAL INDEX KEY:			0001802450
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
		ORGANIZATION NAME:           	06 Technology
		EIN:				844117825
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39445
		FILM NUMBER:		25841012

	BUSINESS ADDRESS:	
		STREET 1:		3150 SW 38TH AVENUE
		STREET 2:		SUITE 1100
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33146
		BUSINESS PHONE:		305.614.2222

	MAIL ADDRESS:	
		STREET 1:		3150 SW 38TH AVENUE
		STREET 2:		SUITE 1100
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33146

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lionheart Acquisition Corp. II
		DATE OF NAME CHANGE:	20200724

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lionheart Acquisition Corp.
		DATE OF NAME CHANGE:	20200205
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>mspr-20241231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-04-15T19:58:31.0027+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:mspr="http://investor.msprecovery.com/20241231" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_b323380d-1dd9-4878-be80-aabdb6a065ce" name="dei:EntityCentralIndexKey" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9">0001802450 </ix:nonNumeric><ix:nonNumeric id="F_fb03b66b-bf08-4fce-b90f-9c48a92c3f83" name="dei:DocumentFiscalPeriodFocus" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9">FY</ix:nonNumeric><ix:nonNumeric id="F_ea0775f7-3f76-484b-a25e-9c209fe1e197" name="dei:CurrentFiscalYearEndDate" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9">--12-31</ix:nonNumeric><ix:nonNumeric id="F_95ee2598-9ded-487a-b450-fb16e8eeb8a9" name="dei:AmendmentFlag" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric id="F_45f62b44-7ce5-42b4-833b-a2684d21b27e" name="dei:SecurityExchangeName" contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156" format="ixt-sec:exchnameen">NASDAQ</ix:nonNumeric><ix:nonNumeric id="F_8d6c5f74-9ddf-4376-bd12-11eb7e1ff425" name="dei:SecurityExchangeName" contextRef="C_40198a04-59e0-4db6-b71b-2e2d515a739c" format="ixt-sec:exchnameen">NASDAQ</ix:nonNumeric><ix:nonNumeric id="F_ee6b036a-077a-4fbc-a8ae-9fdf6d065041" name="dei:SecurityExchangeName" contextRef="C_0de33523-97c8-4b01-8a64-4dc4bc66ca27" format="ixt-sec:exchnameen">NASDAQ</ix:nonNumeric><ix:nonFraction id="F_40f7ef7b-5eb0-4c7b-ad84-9efbd7cf34d6" name="us-gaap:CommitmentsAndContingencies" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_b4dccdf0-8391-4f47-a8d8-62f8ba636738" name="us-gaap:CommitmentsAndContingencies" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_51bd4aa3-2e94-4fa0-8f20-4260f6251be5" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" contextRef="C_9565635a-4edf-48eb-b58e-a592cc2a6e49" unitRef="U_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">.04</ix:nonFraction><ix:nonFraction id="F_11cad189-e838-4ea3-9011-9fb880f04e08" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" contextRef="C_9565635a-4edf-48eb-b58e-a592cc2a6e49" unitRef="U_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">.04</ix:nonFraction><ix:nonFraction id="F_6dbb5636-fa51-4f4c-bb43-bb758434c2c0" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" contextRef="C_72b0b910-c912-487c-9f21-114be2b29359" unitRef="U_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">.04</ix:nonFraction><ix:nonFraction id="F_86dbe84b-548c-486d-9e3f-7db44ea29333" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" unitRef="U_USD" decimals="-4" scale="6" sign="-" format="ixt:num-dot-decimal">446.05</ix:nonFraction><ix:nonNumeric id="F_b0a040b1-eb30-4c2e-913a-8367a95bb387" name="us-gaap:LineOfCreditFacilityExpirationPeriod" contextRef="C_ef3c75c0-7dd9-4529-8a9a-8a70309613f8">P3M</ix:nonNumeric><ix:nonNumeric id="F_8b390608-14b7-4bdf-8388-0311ecd33fec" name="us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember</ix:nonNumeric><ix:nonNumeric id="F_d7c0ff4e-449b-40a5-8325-8ed41dfb3e58" name="us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" contextRef="C_5e551576-1454-4e6e-8860-e330e9e8fef2">http://fasb.org/us-gaap/2024#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember</ix:nonNumeric><ix:nonNumeric id="F_dcf042f9-2441-4111-b785-0c83a5affaab" name="us-gaap:LineOfCreditFacilityExpirationPeriod" contextRef="C_90d84360-6d32-4efa-ad4a-6a919e209aa9" format="ixt-sec:durmonth">3</ix:nonNumeric><ix:nonNumeric id="F_339a811a-2d80-47ab-9bb0-fca6e26a7e13" name="us-gaap:LineOfCreditFacilityExpirationPeriod" contextRef="C_90d84360-6d32-4efa-ad4a-6a919e209aa9" format="ixt-sec:durwordsen">three months</ix:nonNumeric><ix:nonFraction id="F_6dfc678e-53e4-4a49-b837-6bb6cde847d7" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_77a7af59-7ae1-4d3d-a7f3-5e0380c71c5d" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="4" scale="0" format="ixt:num-dot-decimal">0.0016</ix:nonFraction><ix:nonNumeric id="F_abbe20fe-8830-4413-8cd7-922975cc36b9" name="us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember</ix:nonNumeric><ix:nonNumeric id="F_1094ec3c-3994-4e86-9062-4c0d05c077e7" name="us-gaap:DebtInstrumentVariableInterestRateTypeExtensibleEnumeration" contextRef="C_1e01a200-c2e8-4634-9efe-10da04e93fb6">http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember</ix:nonNumeric><ix:nonNumeric id="F_d7edfda9-d03e-48a1-be13-3f45acb6f141" name="us-gaap:DebtInstrumentVariableInterestRateTypeExtensibleEnumeration" contextRef="C_1e01a200-c2e8-4634-9efe-10da04e93fb6">http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember</ix:nonNumeric><ix:nonNumeric id="F_4e424096-b0c4-45a8-94c2-f9386f78d00b" name="us-gaap:DebtInstrumentVariableInterestRateTypeExtensibleEnumeration" contextRef="C_0fff79a6-2fca-469c-b4ba-d88fff8a1879">http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember</ix:nonNumeric><ix:nonFraction id="F_6c011bf9-0559-4a17-8cc8-0125ab18a42f" name="mspr:ClassOfWarrantOrRightOutstandingOwnershipPercentage" contextRef="C_096f06bd-fa6c-4347-b329-d00e63925c9f" unitRef="U_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">11</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="mspr-20241231.xsd"/></ix:references><ix:resources><xbrli:context id="C_80f27fb1-52e9-4cda-90cc-c5c855c8fd29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mspr:ClassificationOfCommonStockBasedOnVotingRightsAxis">mspr:NonEconomicVotingSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_82042595-d2ec-46bd-8d33-1d9c1c5fcd8a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_83481840-3ca0-4d32-ba67-06de37b1459f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliatePayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:FundsHeldForOtherEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8396e5b3-8975-41b1-a3c5-b71482629bc6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ReservedSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8553900b-1ff0-43df-9d09-bab541f91e7e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8558b10a-b3e2-41be-8e26-98a22240201d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_859ecd69-4f84-40b2-9e61-c5f7ca8a44e9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_867693d0-bbf0-446d-b67d-8df69e448e9a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_86c39d9b-6f64-4386-b8c0-33b19e6166a7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_87af9b54-aaad-4ee8-ad42-ba6bf6f841fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_87f7ef45-9817-4e4f-b4b2-29e0e91e875b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mspr:MSPRecoveryLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mspr:SubsidiaryAxis">mspr:MaomsoRecoveryLlcSeriesFhcpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_88fe5d42-7072-4d23-aaf0-bcc6834ff66f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_89033644-94ee-4bd7-ad47-12e753cbcfce"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_89133fd7-659a-4cd9-9d0e-e1da45db1b8f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8c271ab2-9939-4c4b-a48c-af64c4e19688"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8d558395-7c90-405f-a7c4-dc8b67120549"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:OperationalCollectionFloorFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8dbd5799-d76e-43f3-b963-830f8fd31b2e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8df417e8-0685-446e-aae3-3e40048d4ae7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8ec762b9-f612-4652-b91b-9dc8a97a39c7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8faa5dec-aa23-45d8-bc7c-a3721aed1c52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_903ea2ae-ea75-475e-a44b-a70d6056fa63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-14</xbrli:startDate><xbrli:endDate>2023-11-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_909336c6-c224-484c-94a5-23ceb49463c4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_90d84360-6d32-4efa-ad4a-6a919e209aa9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_90ec9698-713b-426c-b0bb-0ec128980a66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-12</xbrli:startDate><xbrli:endDate>2025-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9268077d-b92b-434c-8a1c-d085e2f473a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:BrickellKeyInvestmentAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_92683e84-cc53-487c-a7c4-f4dbdc1db394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mspr:ProfessionalFeesLegalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9269574f-8058-4390-81dd-e7ec4e7ed960"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_936c5ddb-0e12-496d-8f55-6b4fe1ea6f11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:CanoHealthLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-07</xbrli:startDate><xbrli:endDate>2023-07-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_93c831d9-6dfd-4340-ab2a-da4af19391f3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-04</xbrli:startDate><xbrli:endDate>2025-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_948dc2cf-d2dd-4834-9c8e-109e2968c0dd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:PmpiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_94909e83-2e9e-40db-b644-8523c07ddb09"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_94b11fc0-301a-40ea-b25e-f4fc6d4b8a9f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-23</xbrli:startDate><xbrli:endDate>2022-05-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_94f5cc8c-3b7d-43d7-abe9-3622bcd0a570"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9565635a-4edf-48eb-b58e-a592cc2a6e49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-15</xbrli:startDate><xbrli:endDate>2024-11-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_95863a80-b9b0-46fb-b0ef-8af82e4c84a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_96faf7e0-a707-4cd1-84ae-926008d6d5e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_97164373-b267-4695-841a-94d63fab565c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_98ae30fc-b820-4fbe-b5f9-592ed60a472d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_998a064a-3957-4126-8109-a66c5f9a5542"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:NumberOfTenWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9996cf94-6a99-485b-acb5-c26104f11cc7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9a2ac67d-cd44-4f9e-84d7-12c88681d46c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-14</xbrli:startDate><xbrli:endDate>2023-11-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9a7a94af-f271-43a1-89d2-fb92e5b46edd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspPrincipalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-04</xbrli:startDate><xbrli:endDate>2025-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9c8844ba-74b8-4891-9bac-96c2d880ebdd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9c92dc8a-3a85-4931-89ec-6e28019c163f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:ClaimsFinancingObligationAndNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9cad53be-d2bb-4e7e-a24f-2d039319090a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9dbaa8ae-8f9d-4755-91f8-724dee794a36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9dda51d6-a0f5-455b-8398-c575ec62a1c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9f0551af-5ff4-4726-988b-01f1ae60bf7d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ReservedSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:VrmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-23</xbrli:startDate><xbrli:endDate>2022-05-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9f05eae4-c2b6-4611-89ab-2c023d2bae90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9f487c5a-0b48-49d0-b043-d8a27a0e661f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9fe75ae4-df32-424c-8f99-45879b90c2fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a1020e10-75c6-4d02-b1f3-a22f7c0f5c36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:PurchaseMoneyLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a14a72e7-94f0-4886-8c83-bd32c3ffe4e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a20e98f1-f378-4fc2-9d07-1d9c65d339f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mspr:NomuraPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-26</xbrli:startDate><xbrli:endDate>2024-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a5e2c7d9-9acb-499e-b27d-26fe7e7dce15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a64e596b-3d3c-475c-aff9-9243dbb55747"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:InvestmentInRightsToClaimRecoveryCashFlowsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMspRecoveryPartnersLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-23</xbrli:startDate><xbrli:endDate>2022-05-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a6a99836-7eb5-486a-9687-cdb21bc04965"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:CommonClassVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a819d26b-6742-4f37-b1c0-79825dc5c770"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:MonthlyVirageWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a81ca7d1-03d7-4254-97b6-cef1cc580eba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ClaimsCostRecoveryAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a848591b-1adb-44bc-b891-a50be4491f02"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a9bac2b3-ff72-451c-87fe-ebf2bc6938a2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-08-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ac30e5d6-58b4-4221-bd9f-24cd5b3365b0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_acacf35c-6921-4d48-ad39-e840756fabcf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ade22552-6404-4c28-b71c-a1780541b8a5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-14</xbrli:startDate><xbrli:endDate>2023-11-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_aeef635c-511c-48e7-bd31-2303d3add962"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:CpiaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b1695415-e4a5-4136-8a0b-0977ddf9fef4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b2b2ecfa-79d0-47aa-8ded-ad13037b27b6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b3db7d99-631c-4482-beca-74fc892d1e93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mspr:CostOfClaimsRecoveriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b40da480-7051-433e-99a9-7c5f5dd5ea4b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mspr:CostOfClaimsRecoveriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b46cfbc4-b098-4d9a-a0eb-4d949d390497"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b4bab880-e77f-42ec-81c9-310c18bf1482"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b4d69b9f-ab9d-46c5-9d48-786f9a6c9133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b56a07ac-ec0a-4021-a488-5ef64b5339af"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-28</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b7e7a2a7-5fd8-4f91-9fd5-9427aec0dbef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b8a984e0-7f94-40c6-bd5c-e7d950cd2591"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ba17b4e4-2add-4b5b-8fa4-ea5edfe1120f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ba6d251e-46b0-4175-8e53-534f56cc7116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-02</xbrli:startDate><xbrli:endDate>2024-10-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ba798111-eacc-4c32-969b-07c6da1f0336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-04</xbrli:startDate><xbrli:endDate>2025-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bc381c59-088d-4d05-9d41-0901345815e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:MonthlyVirageWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bdb33403-9b1e-41b7-92e4-eb7991db7d0f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_be1531d0-0b2e-4de3-957e-6199271373d6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_be8b70eb-d4ba-4f20-b375-143fdf4f8fe3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mspr:MSPRecoveryLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mspr:SubsidiaryAxis">mspr:MaomsoRecoveryLlcSeriesFhcpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bee1feb7-080c-486a-81cc-c38168970e45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bf132eff-e862-4432-9a3c-8ea0d6d97f66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:TaxReceivableAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bf775bb4-df03-4ad8-b1ef-bfc5c2f6dc53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspPrincipalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c070ff64-2fdb-45a2-8448-0062a4c61eaf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c1e89a5f-129c-4943-a1a7-f314ec636657"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:ClaimsFinancingObligationAndNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c23753ff-91ab-40d0-869b-679d87defcd8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c30ed3e6-e67a-4d09-9360-8226e3fc395c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c452056c-aa10-4243-85df-a94afbf6101c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c4d052d7-2f78-44e5-bfef-1e0596f96bbb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:CanoHealthLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c4e77341-1e9b-4ba5-8f65-82e4691d35db"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:OperationalCollectionFloorFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c51278ee-8240-44e0-840b-5a8e9271f685"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:TaxReceivableAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c5742b65-c220-4c54-a9c1-2dcf8313f948"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mspr:NomuraPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-15</xbrli:startDate><xbrli:endDate>2024-11-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c74b5044-7416-44a5-9669-00e2ec8bac52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c83119b4-f363-422f-942a-c73e79c98c94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c8abebaf-3c7e-4eab-8f91-5ad82e71af2b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c8ac68ca-b4ac-40c0-8ee5-21c155beaa2e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliatePayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:FundsHeldForOtherEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c8e18be5-39a5-489d-80ce-12c6054c1c18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:BrickellKeyInvestmentAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c92dc1fa-2679-4e97-b7ad-ad332c3af75f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:SpecificContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c9b18bd8-324c-46e3-8afa-33926f895ed8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:FinancingObligationsAndNotesPayableAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cacd009a-fa05-475a-b5fd-20053ae0307f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cb300f73-f574-4a36-a626-d7af3d2c40eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:CommonClassVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cb90e83b-7cd0-4ffd-8a4c-cfdf4d8ff256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cbc261d2-d131-4653-99be-97e07cea361a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:InitialVirageWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cc1f9003-7531-46fc-b9f5-b111a3ad3adf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mspr:PublicWarrantsOutstandingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cc4d14e4-5132-4152-bdd4-d68740ba0480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cecba122-eda2-4c0b-a407-e208dd46ea06"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">mspr:ClassVShareholdersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cf6558a6-9d3c-4663-9640-79620d1887bc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditFacilityCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:SecondAmendedAndRestatedFirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-22</xbrli:startDate><xbrli:endDate>2023-12-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cfa5832c-9e4b-41f3-8998-fe2d8ab4f357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mspr:WorkingCapitalCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cff61f62-d448-43e7-ae71-41198608a96b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-30</xbrli:startDate><xbrli:endDate>2025-01-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d0089042-c0e3-454a-8c16-1481457cdcac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d105a18b-9d1a-4643-bb7c-ac6ea1c98248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d114e753-e2e8-448e-8e31-cdfe137f7707"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d1561d98-416b-4bbe-bf56-1bedb1ab84d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditFacilityCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-04</xbrli:startDate><xbrli:endDate>2024-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d1d4678d-582f-4815-8271-9022cf27ca70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d28da71e-2163-4433-89d2-79d811cad1b5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d3663b7d-96ee-43d9-aad4-51ec8fb8fe14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:CanoHealthLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-07</xbrli:startDate><xbrli:endDate>2023-07-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d60db90f-4a37-413a-9383-5f9638a7dac4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d6608e57-e2af-4392-9108-161e0284de3a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:ClaimsProceedsInvestmentAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d6c4c28a-22a2-40b1-9778-e6b573c72de1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d7d3c349-08d9-4eaf-a899-c3399e98c5cb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d84f5212-815c-411b-b1b6-254a05c04b96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ReservedSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-23</xbrli:startDate><xbrli:endDate>2022-05-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d8874f5c-dad1-443d-9908-5daf18c46c70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:PmpiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d91eca92-81d8-4e73-a6df-71357a7bccc1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:CanoHealthLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-07</xbrli:startDate><xbrli:endDate>2023-07-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d9cc9699-1810-4465-8001-abc8935d5526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dba0c8eb-4e7d-4101-939e-a66a07a72a4a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-02</xbrli:startDate><xbrli:endDate>2024-10-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dbbed700-6dd7-4ab4-a4d1-5d2840f9852a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:InitialVirageWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-04</xbrli:startDate><xbrli:endDate>2024-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dc851705-b338-480f-8b51-035da6fa3959"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dc9a1a27-6e49-4cfa-9469-c027ab03a71a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_df38630e-a571-42c3-ade6-4ab4217b9d08"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e0dfe751-c423-4c59-83cb-f45bf2e04763"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e0f110ef-52d0-4fa6-963b-0050628d41b6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:FinancingObligationsAndNotesPayableAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e17c4aa1-a017-431c-a88b-5d1c628480b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e29473fa-863b-4122-a9a4-eac7411b776e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mspr:SubsidiaryAxis">mspr:UpCUnitHoldersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e330bbbd-adcb-4879-b62e-75b820d5a126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e3728ea4-48fd-4ffc-a2ed-312c25de71eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:InitialVirageWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-22</xbrli:startDate><xbrli:endDate>2024-08-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e39e346c-7b8d-4cd1-ba00-128383f3f5f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e47e8e78-3f7a-483f-be52-5d827c62b8cf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:BrickellKeyInvestmentAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e69f5703-ad7e-4186-a291-683b533d05a3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e701c51b-571e-4acd-bab5-e8a71bb9884c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:MaoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e76601ce-3711-4870-9e0a-3ab905ebdac4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e8640518-f241-41b6-ae14-29e050a44e3f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-26</xbrli:startDate><xbrli:endDate>2024-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e9e16be1-82df-4b4d-8077-c5113b5f1637"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ea41718c-eb03-4364-a84c-37e5f43f1623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eb9380b7-557e-4277-b64d-8fa02512fa54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ebf33321-45e9-493e-8b1e-d30e0e2f7a60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ec4285f4-9b93-43aa-ab90-0409cd42c969"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">mspr:UpCUnitHoldersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ecb1b45b-fbaa-4bf2-92d9-318171959c6a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryAviationLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliateReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ecedb469-0a15-457a-8825-173264a5730b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ed1639a1-0034-449c-ad1f-a852134441a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ef3c75c0-7dd9-4529-8a9a-8a70309613f8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-30</xbrli:startDate><xbrli:endDate>2025-01-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ef3df522-36ab-46ff-ba3a-3539524a7ffe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspPrincipalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f07a439f-c693-42c4-98e6-3d9e006b5525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f0fc5e6c-97d0-40e9-841d-33b02270183d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliateReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f1707b98-eb20-432a-b96a-1452ac5f9a6f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:FinancingObligationsAndNotesPayableAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f22fac30-7861-497e-b1e5-adc45046f525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f282d974-0b54-4d2a-8885-b9170aeb1b0e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mspr:SecondAmendedAndRestatedFirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-22</xbrli:startDate><xbrli:endDate>2023-12-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f39537ea-1309-4548-918f-2247de76b5db"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:BrickellKeyInvestmentAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f47d4941-5e9a-4b10-9ef9-c0cd1e17b7a2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f5366bf8-0f82-48ee-a516-2669d00a2346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mspr:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f7fd3f49-71c3-435f-9615-5ad600a0128e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f861f31f-886c-4e73-9be4-15fe686df5d1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f926d350-ede4-483e-9655-21fee4b1788c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fc307584-aef8-4d18-a952-2cc14880dd3f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-31</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fc6dbd33-7019-4991-ae2a-4323861f1f73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mspr:PublicWarrantsOutstandingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fcb3bfd4-b997-46bd-95a6-c338562ed04e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fd924673-3ac8-4110-8c0f-caed5b9b9417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fe25ee78-67ec-4d53-967e-ac07893f4a6e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0056d899-051b-43a5-b6bd-b84abe56a57e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspPrincipalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ServiceFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_00bf460d-a55a-43dc-b3bf-96f35be4b164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:FinancingObligationsAndNotesPayableAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_019f56fe-b87d-4bf1-9a97-950481da89e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_044f7093-020d-4a2c-8402-0be8ff0eb918"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:FinancingObligationsAndNotesPayableAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_045a7ff1-2fb5-4c22-bc5d-29ba574f00d7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_04ac6ccd-aacd-4024-ae81-e73dcdcaa130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mspr:OfficeAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_056857a2-ae2a-45f6-a0e9-2f2918ae0478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0583270c-f1a4-4ea8-9ef4-57cca824c658"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mspr:SecondAmendedAndRestatedFirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_05d37fc5-14e3-4592-b1a0-f0a3bb0acc27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ReservedSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_065c4f1b-82bd-4f57-8208-a41a3b157055"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mspr:ProfessionalFeesLegalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0788ee7d-2d90-4bf2-ae7b-9ebb1d14ae84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_07df6a83-0af1-46c6-adcf-ff855b251aa5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mspr:CpiaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_08ce17f4-9500-467c-ac13-d6286aef1dd5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mspr:OtherSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_096f06bd-fa6c-4347-b329-d00e63925c9f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0acb2411-d354-4e47-8f87-facfc960c807"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0b0648be-cb1d-4812-9bfd-c206264a6106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0bbf18dd-84b1-4a9c-8590-5c60d8a4eac1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0d4a0973-f818-41cd-a1c5-5c03e254d884"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mspr:LegalAccountingAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0d6f7737-1475-425e-8764-bcd96bc150b3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0db234ba-3e48-4d00-9318-17c9b2c2ecdc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0de33523-97c8-4b01-8a64-4dc4bc66ca27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0e019663-7988-47f0-9493-92a40c3ae831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0fff79a6-2fca-469c-b4ba-d88fff8a1879"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-04</xbrli:startDate><xbrli:endDate>2025-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1065a761-b9fe-4aae-899f-8f897411b778"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_108cf1ce-e085-4fcf-bec5-40d0b2f1648c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_124c16cb-bff6-4d6a-83be-6bf4a76f2445"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_125dfb7b-a596-48e9-aa73-d42dc93faea2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_12cd0c5c-e9e0-4c6d-873d-d9f0a4031377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mspr:WarrantsIssuedToVirageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_13748221-3ec6-4846-a96d-b183a19ab473"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mspr:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_13c3ccb9-b33e-456f-b270-960ccbced512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1590504a-c1dc-4f29-92cb-3b6c727c0ce3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:AdditionalReceivablesFromOtherAffiliatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:OtherAffiliatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliateReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_16e00acb-17ef-4f0e-b8a3-32f37c07b09f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:EquityMethodInvestmentInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_16f268f8-c0e0-4f58-8d27-bfb1180e5347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-05-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_171901d1-c52f-41fe-91df-db360c126e4e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1720b370-71e8-404f-b2ba-d747e1f96522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_18297503-8f58-43a0-b62e-2f8147de332e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_19dd057d-164d-4d09-aca4-862b4fbf7c68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-02</xbrli:startDate><xbrli:endDate>2024-08-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1bdb4676-b3b4-49b4-a184-8e7118c0d4af"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-31</xbrli:startDate><xbrli:endDate>2024-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1be14025-3d59-42c6-81ac-3d450aba88f4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:MonthlyVirageWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1d7e8bd6-06e5-4825-92f8-4bcc96d6e304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-14</xbrli:startDate><xbrli:endDate>2023-11-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1e01a200-c2e8-4634-9efe-10da04e93fb6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-04</xbrli:startDate><xbrli:endDate>2025-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1fc207a6-b212-4da0-b588-3744dd9baaf9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1fec80b0-38c3-4131-ada8-3af5893a5151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2007c22d-ce55-459e-b965-217365e43f85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspPrincipalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-04</xbrli:startDate><xbrli:endDate>2025-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_21918913-de21-41f4-bb8a-ff60365fc94c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-04</xbrli:startDate><xbrli:endDate>2025-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_21fdfacf-60d9-461c-b409-b9c8d8d5e297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:MonthlyVirageWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_22a3e60b-719b-4f54-9b60-4ff2fca68d03"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-31</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_23a8a03a-394f-4c24-88aa-cfe8564c686c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_23f0d6a2-3c2c-4e89-aa10-98a9a94f129d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_240c3aca-617e-45d0-80e7-144cd05885bc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mspr:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2430ad04-c84e-49df-bcbe-0fa2ab3fc260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_24ac4204-0641-451a-87a3-70ba142b0f90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryAviationLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliateReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_24c05dee-37c3-47dd-b886-8f4b407eef55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_26717c14-ec44-4c6a-8117-50449ba3aaaa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:MsoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_28b71e0a-7e6d-429a-b008-1ff060441f3d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_297dbcdf-6f51-4f4f-9dc8-a5ae170c5102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_29a25c58-bd49-4813-98cf-174eff897359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2a65b7e7-25a4-4784-a0df-3b3fc40b9b39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspPrincipalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2b6ff688-5733-44c4-adef-6460a88c6577"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2c439b10-3157-4c98-b8f8-371831d66f6f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-10</xbrli:startDate><xbrli:endDate>2025-04-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2cfffa07-7d0f-4494-b8a7-e7489ea1d410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2f3b6385-dd5e-478a-98d6-86c7576434f0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliateReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_305dc9b3-22e0-4f75-b7ee-85c8627cae64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3141ef96-8081-408d-8688-cac679df2dcc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3190b9d6-2f05-4406-add2-4c8346e46faf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_31bd9c41-8edd-4613-86e6-85b50e497f78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_32b282eb-1b22-41ce-afda-7322605f66e8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:CommonClassVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">mspr:UpCUnitHoldersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_32d5fd3f-18ff-44f6-bea9-54478be0fe12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_343a98c3-3718-4240-81dc-cca99ff09156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_349d4676-24fa-4ed0-8d02-0ac0acbd44a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mspr:NomuraPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_34c224df-e4d4-4363-a01b-1fcb9b2acaa2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mspr:CpiaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3597e466-ae9e-44f5-b5bc-782036376b71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:ForcedExpiratoryFlowSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_35dae5c1-7aae-4e29-bd11-991504d30ddb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3895f47c-684e-4e66-8154-738062424885"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mspr:NomuraPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-15</xbrli:startDate><xbrli:endDate>2024-11-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_38dbca91-c3fa-4361-8e4e-ad3d415625fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3c7a8126-415b-4641-9233-e1ab41a700c5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:PmpiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3d1f3cd4-008e-48b3-85da-f506bc8106bf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3d4f1e16-3314-456a-9834-b6faa08ca709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3e8969f2-ae97-4d3c-b1d0-74bbfc712aea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:CpiaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3f1e810b-70ff-4880-b849-ee3f4452b2d0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3f274e94-4af0-46e3-87d2-ba8533edbab8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:MinimumRequiredPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3f5e2295-148f-48ae-a6d0-b63e048ebdc3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3f7d2988-c276-41f2-9ddb-13cdccfa0680"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_40198a04-59e0-4db6-b71b-2e2d515a739c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4275f40d-714d-47ab-97d1-4eba6db92ac7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VirageRecoveryParticipationLpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_428035f8-2a73-4bf3-bd07-7c486a2b2984"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4400c0b3-2cd1-40b7-ac05-f868dde9be3a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mspr:UpCUnitHoldersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_440a05a3-a996-4acf-b096-ffc25257e6de"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4444a183-cd75-453f-82e7-94eb0d9ecda9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_47aa4785-b887-4bdc-9f4f-5f764a502283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ClaimsCostRecoveryAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_490f215f-7665-40bb-8a57-3e0bba257f4f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:ForcedExpiratoryFlowSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4957a749-8bfa-415b-9b7d-70a5bf0f2f52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4a8604ad-e380-417e-aa2c-4c0e29ad2d19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4a8f2f53-79e9-446a-aa64-4ca7f9c8dff2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4c7596be-feb0-407b-896b-01187ad8e8fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ClaimsCostRecoveryAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-23</xbrli:startDate><xbrli:endDate>2022-05-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4cf329ce-5aca-4da4-8888-8728533d3e78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4d43bce3-acbe-4666-82a1-1d40c94afa24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:MaoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_50aeca4c-0cc0-40a9-95d1-4f6f9ca8d58b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_516f8b35-03d8-4c39-9130-a23b7a95a2a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_51823262-9427-432d-a0b9-aa056efd7162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5247622b-3115-44c8-972e-3aa6f0834d88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:ClaimsProceedsInvestmentAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5252ca49-cd7d-42f1-90d0-31e55fce0385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliatePayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_540b65a1-9fe2-4515-b78b-8e298f79fa7e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_54d701f3-9c51-4703-a1c1-2c01604c2e0d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_564ee707-2109-45f7-83d2-89ed72475362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_56b72099-7c42-4ac1-9909-043db62ef97f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_57297e08-daf9-4ea8-9f0a-e30feb80ee20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryAviationLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_57d602bd-2d0a-4e61-888a-2ec5eb79b28f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_58441ed6-59f7-4eb3-8ebb-2144c6210c69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mspr:OtherSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_59b01d67-342b-4678-bb64-aa2875d5d3be"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-08</xbrli:startDate><xbrli:endDate>2024-04-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5b46d7fc-7b57-43b1-9b41-9ab104ade8c7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:PurchaseMoneyLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5be07310-661f-4b62-876e-7ad045ede894"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5cbb4b4f-b96f-4942-a566-a9743e895772"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202307Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5d819013-3703-4830-ab07-b1f1c7119714"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5e551576-1454-4e6e-8860-e330e9e8fef2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_609a7cf7-e71f-4260-af06-3fa43d842a79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:FinancingObligationsAndNotesPayableAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_61507485-2d9f-40ad-8b7b-fd6cc068d0c8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_61e6579c-7403-4590-b421-ac4ffdad7513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_62435c4d-78b1-4259-85bd-74e491eb2245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-18</xbrli:startDate><xbrli:endDate>2024-10-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6416e867-3e37-4d6c-9be5-842500520199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mspr:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6607a34a-616c-4068-a1b4-1252fffde914"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_66a14f4e-f9d4-4b7a-8ceb-e5a34a3dad44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryAviationLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_66d1760e-3b4b-4a44-adcc-7a80bfabd72f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mspr:OfficeAndComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6839411a-9365-4c82-94be-9667ed37b849"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6914b62b-8ebd-492e-9751-a059c6e34653"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:VirageTermSheetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6965b820-31a4-444e-ba96-f6ea5d589a06"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6d36e1f0-9fa4-464e-bcc8-ec43920a4389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6fc20ca9-1ab2-42c7-8e99-0cc58496a91f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_71aa315c-44f8-4147-b3c3-c4ea2d43f242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-08</xbrli:startDate><xbrli:endDate>2024-04-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_71d4c574-8d09-4451-b706-aecd0cddefa3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_72b0b910-c912-487c-9f21-114be2b29359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-12</xbrli:startDate><xbrli:endDate>2023-10-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_72c17608-1d12-4578-9b1c-a1ccd7d443c7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:VrmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_747655f3-412e-461f-8786-a873c027b7d0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_75501a7c-fddd-4767-9d6b-6669aaf3d334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:ClaimsFinancingObligationAndNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_77a7af59-7ae1-4d3d-a7f3-5e0380c71c5d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_77c0175e-530a-4d31-b2a4-dbf10318bced"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:MsoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_786664b5-9979-4e35-9243-6bdb750f8536"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_788dd740-ae7d-4599-bfa0-5e03d87f6792"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_791e8b5c-e454-490f-af98-b274119fb0c5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:CanoHealthLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_79d9f285-5c8d-4c0b-8618-a9851a277fcc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ClaimsCostRecoveryAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:PurchaseMoneyLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7a02de5d-b9d8-4bf8-9ce7-036a7202e220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7b14a4eb-0fed-4c10-be9c-613f3475755b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7ec4a520-4502-411f-9714-8faecac859f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:AdditionalReceivablesFromOtherAffiliatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:OtherAffiliatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliateReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7fafbd14-3e05-4ab0-b8db-3c7d640f612b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7fe3a456-0271-47b2-9277-1147387966fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001802450</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Days"><xbrli:measure>mspr:Days</xbrli:measure></xbrli:unit><xbrli:unit id="U_Segment"><xbrli:measure>mspr:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U_Members"><xbrli:measure>mspr:Members</xbrli:measure></xbrli:unit><xbrli:unit id="U_Tranche"><xbrli:measure>mspr:Tranche</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U_Investment"><xbrli:measure>mspr:Investment</xbrli:measure></xbrli:unit><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f" fromRefs="F_97dfeaba-1e75-43a0-ac86-c2ba64165dc6 F_9315e270-47e0-4e4e-a1cc-3186e954fd9c F_a895c9d8-b77b-49fc-bed7-f6f09c5117a3 F_127e888e-7ffb-4b96-9379-154fbd63a074 F_6a867877-52a0-4e7f-a2ee-387043ab5ed6 F_7349faec-67c3-4457-b111-13aa8b59814b F_8e88b3c9-7da4-4078-bfd3-a81f7b588a00 F_205a35fd-b126-40ae-b1a2-688dd34751c5 F_0a108fb9-2063-4b2f-a76e-eee9593bb7db F_dd4a4c78-f6f8-4e11-aab0-11a7a18e2318 F_ea8949b7-b3fb-4122-a17b-a12fec3eba2b F_5f85d3ca-1713-492b-bc89-518782029d0a F_3922abe0-69f6-4492-9c8a-1a5a120731ec F_c7ce0478-2b86-4765-abfd-d0a23db5c0b7 F_621c8126-d89e-4874-9bdd-c9eebd642153 F_6bdb6d2b-db69-4134-b692-902a552fd027 F_ea20dce6-d3f9-471b-9aee-3f6f144ce678 F_b250df4c-8239-48d4-aaf6-48db038dc64f F_ff9b0771-e0bd-4028-8ea2-970ffa0de6cd"/><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_85277ec4-535a-4590-b3e1-ed9c8021c99f" fromRefs="F_0e5f8c74-a7f3-4607-8eb1-009f6f2e19e6 F_049581b0-85bf-4cc1-856e-c1f12e8a3f2b"/><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_071ffd73-77db-4a34-b2a1-f3867369fb2f" fromRefs="F_11eab42e-5feb-4b3f-b742-4d5fa7feb23c F_ada24831-ea2f-471f-80bc-c5d0bb37a5a9"/><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_35ea91e8-3c49-4990-ba5b-48a3392a1f92" fromRefs="F_23f3c66e-3461-429c-9a94-0719426712a9 F_89672a83-8db0-4a03-8baa-589e45240c0f"/><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_9039f59d-d74a-45c2-87f9-6463d50e70ba" fromRefs="F_ffdd38b8-f4e4-4330-9852-d7d6ac99a536 F_694112ad-309c-4458-b030-ad8125036e89"/><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_cd459352-1f75-44db-a821-c46b5ea066c0" fromRefs="F_1f2aa437-b4da-460d-bf52-7edcbb42a12a F_516c8fa1-698f-44b9-91be-4fb706ccd763"/><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6" fromRefs="F_ad09f737-52d3-4889-a092-d0e79ca9c4b5 F_9a66c039-75ba-48a3-af8a-e15632e557f6 F_930ae64a-6e30-4f0f-be44-c5dff142f095 F_95951ba3-4813-4d4d-8c8d-3ce1dd308d1d F_b380e630-4fc3-442f-ba15-6a8528278443 F_67094ad7-e54b-405e-90be-9227b1870a88 F_8815d523-67e4-437e-965d-caa19cf4a4e1 F_c284a7e8-84d6-404e-8590-3871ab408ad3 F_01b50422-e877-4600-91b7-063e13cf4bf5 F_19a7307c-e905-4328-b209-d873f357833b F_7afe5ee6-3e63-4c8b-a947-6e22eba8fa9c F_9f6cf949-83d3-4966-aa38-96d7ba5d284b"/></ix:resources></ix:header></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Washington, D.C. 20549</span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2pt;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:5.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:1pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f3d663ee-b685-4222-9894-4fcaee711feb" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10-K</span></ix:nonNumeric></span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Mark One)</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:4%;box-sizing:content-box;"/>
     <td style="width:96%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_cb7d5489-dab2-4169-a591-5b340cb7fa32" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the fiscal year ended </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_99bc00a5-fcae-49c7-9d1c-7044e07e6ad0" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_17d1a794-9f3f-4037-9dd0-e24d7d0a8324" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:DocumentFiscalYearFocus"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024</span></ix:nonNumeric></span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OR</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:4%;box-sizing:content-box;"/>
     <td style="width:96%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_8b9c2f16-a804-4a2e-b757-7b3f9d9a1747" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM                      TO</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">                     </span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commission File Number: </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dd17172a-1644-4bd3-802b-eee3eba37943" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">001-39445</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><img src="img214770500_0.jpg" alt="img214770500_0.jpg" style="width:203px;height:83px;"/></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:14pt;font-family:Times New Roman;"><ix:nonNumeric id="F_96896f80-4a22-42fd-b0bd-5baa981c9534" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as specified in its Charter)</span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"/>
     <td style="width:50%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_c8e20ba6-1f5a-41b6-a628-981fb2d9236b" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9519c9dc-b6db-412f-b690-416c3039e978" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">84-4117825</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or other jurisdiction of</span></p><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">incorporation or organization)</span></p></td>
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(I.R.S. Employer</span></p><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identification No.)</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span><ix:nonNumeric id="F_3fb11ad3-5d21-4697-bef5-0dd7df92d8e8" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">3150 SW 38th Avenue</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_ce2735c6-6dd5-4027-9cd0-21e672e7b0f0" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Suite 1100</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span><ix:nonNumeric id="F_ed5a956d-aa20-45b7-b15c-74448d66dca9" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Miami</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_a95e7f9a-f3c5-4ab0-98f1-1fc897967b8d" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Florida</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_dd228b8b-f011-4f44-84c2-1ae36f54ddd2" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">33146</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registrant&#8217;s telephone number, including area code: (</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cd075438-e706-425d-b198-ff3c8a172793" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">305</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3b843241-d6fa-4e01-b014-bf1c14a2e058" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">614-2222</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:52%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:16%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:30%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title of each class</span></p></td>
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading Symbol(s)</span></p></td>
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
    </tr>
    <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_cc7dee40-b866-4d7b-8d34-0749e31c34de" contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Class A common stock, $0.0001 par value per share</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_2f9d620b-84f4-4138-985f-b97809bbec0c" contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">MSPR</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:16.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="-sec-ix-hidden:F_45f62b44-7ce5-42b4-833b-a2684d21b27e;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">Nasdaq Capital Market</span></span></span></p></td>
    </tr>
    <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_3d6bf331-c765-4850-8509-e164248f4344" contextRef="C_40198a04-59e0-4db6-b71b-2e2d515a739c" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Redeemable warrants, each lot of 625 warrants exercisable for one share of Class A common stock at an exercise price of $7,187.50 per share</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_10f2ff23-a66d-4474-bde4-d320aeccba08" contextRef="C_40198a04-59e0-4db6-b71b-2e2d515a739c" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">MSPRW</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:18pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><span style="-sec-ix-hidden:F_8d6c5f74-9ddf-4376-bd12-11eb7e1ff425;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Nasdaq Capital Market</span></span></span></p></td>
    </tr>
    <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_85a7219f-4348-4ca4-9739-ed8e70dee4ce" contextRef="C_0de33523-97c8-4b01-8a64-4dc4bc66ca27" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Redeemable warrants, each lot of 625 warrants exercisable for one share of Class A common stock at an exercise price of $0.0625 per share</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_71ddbecf-6be7-47b8-b076-3d22ac31a6a4" contextRef="C_0de33523-97c8-4b01-8a64-4dc4bc66ca27" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">MSPRZ</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:18pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><span style="-sec-ix-hidden:F_ee6b036a-077a-4fbc-a8ae-9fdf6d065041;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Nasdaq Capital Market</span></span></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(g) of the Act: </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_82a68bdc-1b20-4c0d-9abc-e53cc57d2a83" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityWellKnownSeasonedIssuer"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#9746;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.  Yes &#9744; </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_29c42d04-909a-4a84-bf7b-d4b3359b6a4d" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityVoluntaryFilers"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#9746;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d04a222e-4bb3-459a-adac-a1eaf299c54c" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityCurrentReportingStatus"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#9746; No &#9744;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).  </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0578d400-befe-42d1-b144-3aa16d345872" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityInteractiveDataCurrent"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#9746; No &#9744;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:19%;box-sizing:content-box;"/>
     <td style="width:1.14%;box-sizing:content-box;"/>
     <td style="width:55.4%;box-sizing:content-box;"/>
     <td style="width:1.04%;box-sizing:content-box;"/>
     <td style="width:20.34%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:2.08%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10.8pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Large accelerated filer</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accelerated filer</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
    </tr>
    <tr style="height:2.15pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8.5pt;"><ix:nonNumeric id="F_e3613af7-1c25-406b-8db0-e62f330775f5" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Smaller reporting company</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_d3e65866-b2da-4d0f-88ad-99012131c52c" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:2.15pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:2pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Emerging growth company</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_65784cd3-190f-4d14-96c7-b40c4361a8b8" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_73a33479-2360-44d3-85bb-3f40d840e226" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the </span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_02b0b585-cc6a-4d39-baf4-87635b068288" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ad326926-19c7-4f28-8398-d320e1b8c506" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes &#9744; No </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_057cdbda-0c7c-42be-ae2f-ec7aa04ba35b" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:EntityShellCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant based on the closing price of $11.50 for the Class A common stock, $0.0001 par value per share (&#8220;Class A Common Stock&#8221;), </span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">on the Nasdaq Stock Market on June 30, 2024, was $</span><span style="font-size:7.5pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa62216a-609d-440a-8f30-8c7b823acb1d" contextRef="C_c74b5044-7416-44a5-9669-00e2ec8bac52" name="dei:EntityPublicFloat" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">7,239,020</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The number of shares of Registrant&#8217;s Common Stock outstanding as of April 10, 2025 was </span><span style="font-size:7.5pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec184cd0-4c1a-4677-bf09-bca3f63d2597" contextRef="C_f926d350-ede4-483e-9655-21fee4b1788c" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,920,520</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock and </span><span style="font-size:7.5pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ca172b0-34dc-411c-8a64-7823342cbdee" contextRef="C_9f05eae4-c2b6-4611-89ab-2c023d2bae90" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,323,146</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class V Common Stock, $0.0001 par value per share (&#8220;Class V Common Stock&#8221; and, together with the Class A Common Stock, &#8220;Common Stock&#8221;), outstanding.</span></p><div style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_20ea3b33-d280-492f-98b7-2ab08ba78d25" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:DocumentsIncorporatedByReferenceTextBlock" escape="true"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p></ix:nonNumeric></div><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Explanatory Note Regarding Important Accounting Matters and Recent Events</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Going Concern</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As an early-stage growth company, the Company has incurred substantial net losses since inception. As of December 31, 2024, we had $12.3 million in cash and cash equivalents. The Company has incurred recurring losses and negative cash flows since inception and has an accumulated deficit of $446.1 million as of December 31, 2024. For the year ended December 31, 2024, the Company used approximately $16.1 million of cash in operations. The Company&#8217;s liquidity will depend on the ability to generate substantial Claims recovery income and Claims recovery services income in the near future, the timing of which is uncertain, as well as its ability to secure funding from capital sources. The Company&#8217;s principal liquidity needs have been working capital, debt service, and Claims financing obligations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company anticipates sources of liquidity to include up to $9.75 million in bridge loan funding to the Company under the existing Operational Collection Floor facility (in addition to the $16.0 million previously funded under the facility) in the amounts of: (i) $1.75 million for March 2025, which was funded on February 28, 2025; (ii) $1.5 million for April 2025, which was funded on April 4, 2025; (iii) $1.5 million for May 2025, to be funded on or about April 30, 2025; (iv) up to $2.0 million to fund the legal, accounting, and administrative expenses associated with the reorganization, subject to certain terms and customary conditions acceptable to Hazel, and minimum license fees of (v) $1.55 million for June 2025; and (vi) $1.55 million for July 2025, as well as the Yorkville SEPA as disclosed in more detail in Note 9, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Financing Obligations and Notes Payable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and beyond July 2025, the MSP Principals&#8217; commitment to pledge $25 million of collateral to backstop additional working capital requirements of the Company. The Company has taken several actions to address liquidity concerns, including actions enumerated in Part II, Item 7. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, Liquidity and Capital Resources, Going Concern</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. However, as discussed further herein, the Company has concluded management&#8217;s plans were not sufficient to alleviate the substantial doubt about the Company&#8217;s ability to continue as a going concern. The Company has concluded that, despite the aforementioned financing arrangements, there is substantial doubt about its ability to continue as a going concern. Unless we are successful in raising additional funds through the offering of debt or equity securities, we have concluded it is probable we will be unable to continue to operate as a going concern beyond the next twelve months. The Company has received an audit report from its independent registered public accounting firm with an emphasis of matter paragraph as to going concern in connection with the Company&#8217;s audited annual financial statements for the year ended December 31, 2024, such events resulted in an event of default in the aforementioned debt agreement, which would have resulted in the debt becoming immediately due; however, the Company has received waivers from (i) Virage and VRM and (ii) HPH and Hazel as it pertains to the year ended December 31, 2024.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Intangible Assets</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the Company&#8217;s fourth quarter review of its CCRAs, the Company identified potential impairment indicators, such as recurring operating losses and a lack of substantial revenue generated from our Claims portfolio to date, which it considered in its evaluation of its definite-lived intangible assets. As a result, the Company performed a recoverability analysis on the definite-lived CCRA intangible assets in the fourth quarter of 2024. The recoverability analysis primarily included unobservable inputs, including internally developed assumptions about the estimated market share of insurance carriers that may not have paid claims due to Assignors, undiscounted cash flows of potential estimated recoveries from those carriers, the corresponding direct costs associated with those estimated recoveries, and the Company&#8217;s ability to successfully litigate or negotiate settlements.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An asset group is impaired if the estimated undiscounted cash flows are less than the asset group&#8217;s carrying value. Impairment is measured by the amount by which the carrying value exceeds fair value. The Company performed a probability-weighted undiscounted net cash flow analyses, taking into account various scenarios of expected cash flows, some of which rendered positive results, while others rendered negative results. Given that the probability-weighted average cash flows of all scenarios were below the carrying value, the Company performed a fair value assessment to measure impairment loss.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value assessment of the intangible assets was determined using the income approach. The significant inputs and assumptions used in the estimate of fair value were primarily Level 3 inputs, and include internally developed assumptions used in the undiscounted analysis, as well as the determination of an appropriate discount rate. The Company&#8217;s estimation of the fair value of its CCRA intangible assets resulted in a non-cash impairment charge amount of $752.7 million recorded during the fourth quarter of 2024 in Impairment of intangible assets in the consolidated statement of operations for the year ended December 31, 2024. The estimation of the fair value requires significant management judgment with respect to the estimates discussed above. The estimates of the fair value are based on the best information available as of the date of the assessment. Small changes in the significant inputs and assumptions would increase or decrease estimated discounted future operating cash flows and could increase or decrease an impairment charge by a material amount. If actual results or future expectations are not consistent with the assumptions used in our estimate of fair value, it may result in the recording of additional impairment charges in the future which could be material.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restructuring Plan</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described in our Current Report on Form 8-K filed with the SEC on April 10, 2025, on April 4, 2025, Virage Recovery Master, LP (&#8220;Virage&#8221;); Virage Capital Management, LP; Hazel Partners Holdings, LLC (&#8220;HPH&#8221;); Hazel Holdings I, LLC (and together with HPH, &#8220;Hazel&#8221;); La Ley con John H. Ruiz P.A. d/b/a MSP Recovery Law Firm; MSP Recovery, LLC; MSP Law Firm PLLC; MSP</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">i</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recovery, Inc. (the &#8220;Company&#8221;), John H. Ruiz, and Frank C. Quesada (collectively, the &#8220;Parties&#8221;) entered into a term sheet (the &#8220;Term Sheet&#8221;) agreeing to certain terms and transactions that are designed to reduce costs of the Company through a servicer, deleverage the Company by converting certain debt of certain creditors into equity, provide access to $9.75 million of bridge funding to the Company (of which $6.5 million remains available through July 2025 pursuant to the Term Sheet, $2.75 million of which remains available under the Operational Collection Floor at the sole discretion of HPH) and up to $25 million of working capital for New Servicer (as defined below), and focus the Company&#8217;s operations, through the New Servicer, on the core business model of pursuing recoveries under the MSP Laws so that it can achieve its long-term recovery goals. The Company&#8217;s anticipated sources of funding include the Working Capital Credit Facility, potential distributions under our Standby Equity Purchase Agreement with YA II PN, Ltd. (the &#8220;Yorkville SEPA&#8221;), claims recovery proceeds, subject to debt obligations on certain of the claims, and beyond July 2025, the MSP Principals&#8217; commitment to pledge $25 million of collateral to backstop additional working capital funding for the Company.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These proposed transactions are subject to, among other things, further negotiation and the execution of definitive agreements, regulatory approvals, certain third-party consents and approvals, and shareholder approvals if required by the Nasdaq Stock Market. The obligation of Hazel and its affiliates to enter into definitive documents is subject to the satisfaction of various conditions precedent, at their sole discretion, including, but not limited to, satisfactory finalization of due diligence and all required internal approvals, receipt of certain third-party consents required, and finalization of documentation. Consummation of the transactions contemplated by the Term Sheet are also subject to additional fundings by other parties and certain debt concessions by other stakeholders. As a result, there can be no guarantee that the transactions contemplated by the Term Sheet will be consummated.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The proposed transactions include, but are not limited to, the following transactions:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Establishment of New Servicer</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company shall establish a new subsidiary (&#8220;New Servicer&#8221;) to provide and control recovery efforts, by way of litigation, demand letters, settlements, or other means, in connection with existing claim recovery rights (to the extent assignable), and those acquired in the future, held in special purpose vehicles (&#8220;SPV&#8221;), wholly owned by New Servicer, to hold any new claims acquired. The Company will license its intellectual property to the New Servicer in exchange for a license fee of 17.5% of New Servicer&#8217;s excess cash flow, with a minimum fee of $1.55 million paid on May 30, 2025, and June 30, 2025. New Servicer will be funded by an affiliate of Hazel (hereinafter, &#8220;Funder&#8221;), up to $25 million in funding, as set forth below, with a right of first refusal for additional funding needs. New Servicer will be independently managed and be separately governed by an independent board of directors, including a chief executive officer chosen by Funder and consented to by the Company, one director chosen by the Company, and one independent director chosen by Funder and approved by the Company. Funder&#8217;s governance rights shall terminate once all Hazel loans have been repaid in full, and Funder&#8217;s Recovery Rights Interest (as defined below) in the New Servicer is less than 10%. Virage shall have observer rights to the New Servicer board of directors until the amounts owed to Virage pursuant to the Master Transaction Agreement dated March 9, 2022, as amended (the &#8220;MTA&#8221;), which was approximately $1.1 billion as of December 31, 2024 (the &#8220;VRM Full Return&#8221;) has been repaid and Virage&#8217;s equity interest in the Company is less than 10%.</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Working Capital Funding for the New Servicer</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Funder has agreed to extend a line of credit to New Servicer of up to $25 million, funded in tranches of up to $1.75 million per month, subject to the New Servicer meeting certain milestones (which are currently being negotiated and to be agreed in definitive documentation), beginning September 2025, with a maturity date of June 30, 2027. New Servicer funding will accrue interest at the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) plus 5% per annum for one year, and SOFR plus 10% thereafter. Funder will establish a first lien on the New Servicer; the Company will not guaranty the loan to fund New Servicer.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, Funder or Hazel is entitled to receive to up to 35% of New Servicer&#8217;s excess cash flow (the &#8220;Recovery Rights Interest&#8221;). At its option, Funder may convert, in whole or part, its Recovery Rights Interest for up to 30% of the then outstanding shares of Company&#8217;s equity, measured as of the Closing and subject to dilution for stock issuance thereafter.</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Additional Bridge Financing for the Company</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, Hazel agreed to provide up to $9.75 million in bridge loan funding to the Company under the existing Operational Collection Floor facility (in addition to the $16.0 million previously funded under the facility) in the amounts of: (i) $1.75 million for March 2025, which was funded on February 28, 2025; (ii) $1.5 million for April 2025, which was funded on April 4, 2025; (iii) $1.5 million for May 2025, to be funded on or about April 30, 2025; (iv) up to $2.0 million to fund the legal, accounting, and administrative expenses associated with the reorganization, subject to certain terms and customary conditions acceptable to Hazel, and minimum license fees of (v) $1.55 million for June 2025; and (vii) $1.55 million for July 2025. Funding is conditional, in part, on an increase in the pledge of collateral and personal guaranty by $9.75 million by Messrs. Ruiz and Quesada (the &#8220;MSP Principals&#8221;). Such minimum license fee payment will be paid from the Bridge Loan.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beyond July 2025, the MSP Principals have committed to pledge $25 million of collateral to backstop additional working capital requirements of the Company, in addition to other previous sources of funding, including cash proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA, and the proceeds from claims recoveries, subject to lien repayment on certain claims. In addition, the Company&#8217;s annual costs, after currently planned cost reductions, are estimated to be reduced by $5.6 million per annum due to New Servicer operations and shall be funded by the Funder (through New Servicer).</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ii</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Term Sheet requires (and is conditioned upon) La Ley con John H. Ruiz, P.A. d/b/a MSP Recovery Law Firm and MSP Law Firm, PLLC, collectively, raising $25 million for operational funding over two years, subject to similar milestones (to be agreed upon) as per the New Servicer funding, and to be entered into at completion of the proposed transaction.</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt Restructuring</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In exchange for a 43% equity interest in the Company (inclusive of shares currently held and those shares acquired through warrant exercises pursuant to the Virage Term Sheet discussed below) Virage has agreed to waive all claims and release all liens against the Company relating to the VRM Full Return (approximately $1.1 billion as of December 31, 2024), and the Parties agree that the VRM Full Return will be paid only from: (i) a junior lien against Subrogation Holdings proceeds, (ii) claims currently owned by Virage, (iii) liens over two tranches of claims currently owned by Hazel (which Hazel shall release as part of the reorganization transaction) and (iv) a non-recourse second lien up to $100 million over 50% of the proceeds from the New Servicer and associated SPVs, to the extent that the VRM Full Return has not been repaid.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the MSP Principals have agreed to convert 100% of the Company&#8217;s debt obligation to them, totaling approximately $144 million, into shares of the Company&#8217;s Class A Common Stock, the full and final amount of the debt-to-equity conversion is subject to tax analysis and approval of the MSP Principals and the Company&#8217;s Board of Directors.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Hazel&#8217;s existing loans to Subrogation Holdings and the amount of Company&#8217;s guaranty (currently approximately $100 million) remain unchanged except that such lien shall now exclude the Company&#8217;s intellectual property. Hazel agreed, subject to obtaining third-party consents, to extend the maturity date on all outstanding obligations to November 30, 2026. To secure the repayment of the existing Hazel loans to the extent such loans have not been repaid in full, the Company shall, for a principal amount of up to $235 million with an interest rate of SOFR plus 10% per annum: (i) pledge to Hazel 50.1% of the New Servicer and associated SPV equity interests; and (ii) grant a lien over 50% of the proceeds from New Servicer and associated SPVs, once the New Servicer funding has been repaid. In addition, to the extent the VRM Full Return has not been repaid, Virage has second lien of up to $100 million over 50% of the proceeds from New Servicer and associated SPVs.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 13, 2025, the Board delegated to an independent committee of the Board of Directors (the &#8220;Independent Committee&#8221;) the power and authority to, among other things, determine on behalf of the Board and the Company whether, to the extent any conflicts or potential conflicts exist or arise in the future among the Company and Messrs. Ruiz and Quesada, certain Restructuring and Proposals are advisable and fair to, and in the best interests of, the Company and its stockholders. The Independent Committee reviewed the Term Sheet and engaged legal counsel and financial advisors that are familiar with the Company and restructuring transactions to determine if the Term Sheet is advisable and fair, and in the best interests of the Company and its stockholders. Although the Independent Committee identified material conflicts, those conflicts involve conditions precedent to the Term Sheet, and are resolvable to the satisfaction of the Independent Committee in furtherance of the Term Sheet and in the best interest of the Company; as such, the Independent Committee determined that it is advisable and in the best interests of the Company to approve the signing of the Term Sheet and subsequent entry into agreements consistent with the terms set forth therein.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Term Sheet, the parties are working to complete the definitive agreements by April 30, 2025.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Reverse Split</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described in our Current Report on Form 8-K filed with the SEC on November 18, 2024, the Company filed a Certificate of Amendment to its Second Amended and Restated Certificate of Incorporation that became effective at 11:59 PM EDT on November 15, 2024 to effect a 1-for-25 reverse stock split of the Company&#8217;s Common Stock (the &#8220;2024 Reverse Split&#8221;). The stock began trading post split on November 18, 2024. As a result of the 2024 Reverse Split, every 25 shares of the Company&#8217;s Common Stock were converted into one share of the Company&#8217;s Common Stock. Fractional shares resulting from the 2024 Reverse Split were rounded up to the nearest whole share. The 2024 Reverse Split automatically and proportionately adjusted, based on the 1-for-25 split ratio, all issued and outstanding shares of the Company&#8217;s Common Stock, as well as the terms of warrants and other derivative securities outstanding at the time of the effectiveness of the 2024 Reverse Split.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 12, 2023, we amended our Charter with the Secretary of State of the State of Delaware to effect a 1-for-25 reverse stock split (the &#8220;2023 Reverse Split&#8221;) of the Company&#8217;s common stock, effective October 13, 2023.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise stated, all share and per shares numbers (except par value) in this Annual Report on Form 10-K have been adjusted to reflect the 2024 Reverse Split and 2023 Reverse Split on a retroactive basis.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Symbol Change</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective December 9, 2024, the Company rebranded all lines of business under the MSP Recovery brand, and the Company&#8217;s Class A Common Stock, New Warrants, and Public Warrants begin trading on Nasdaq under the ticker symbols &#8220;MSPR,&#8221; &#8220;MSPRW,&#8221; and &#8220;MSPRZ,&#8221; respectively.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">iii</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;" id="toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:10.1%;box-sizing:content-box;"/>
     <td style="width:84%;box-sizing:content-box;"/>
     <td style="width:5.9%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART I</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item1"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Business</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1A.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#ii_item1a_1"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Risk Factors</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1B.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item1b"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Unresolved Staff Comments</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1C.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item1c"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Cybersecurity</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 2.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item2"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Properties</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 3.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item3"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 4.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item4"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">54</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#0563c1;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART II</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#0563c1;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 5.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item5"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 6.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item6"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">[Reserved]</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 7.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#mdna"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 7A.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item7a"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">77</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 8.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item8"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Financial Statements and Supplementary Data</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">77</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item9"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9A.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item9a"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Controls and Procedures</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9B.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item9b"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Other Information</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">115</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9C.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9c_disclosure_regarding_foreign"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">115</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#0563c1;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART III</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#0563c1;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 10.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item10"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 11.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item11"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Executive Compensation</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 12.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item12"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">124</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 13.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item13"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">126</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 14.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item14"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Principal Accounting Fees and Services</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">128</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#0563c1;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART IV</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#0563c1;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 15.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item15"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exhibits, Financial Statement Schedules</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">129</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 16</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item16"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form 10-K Summary</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">133</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">134</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">iv</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GLOSSARY OF TERMS</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise stated or unless the context otherwise requires, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and the &#8220;Company,&#8221; refer to MSP Recovery, Inc. As used in this Annual Report on Form 10-K (&#8220;Annual Report&#8221;), unless otherwise noted or the context otherwise requires, the terms below are defined as follows:</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Algorithm</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; refers to a set of instructions that perform a particular action. Our team of data scientists and medical professionals create proprietary instruction sets, or &#8220;Algorithms,&#8221; to identify recovery opportunities within the data sets of our Assignors&#8217; Claims. Our proprietary algorithms incorporate various data points within the data sets of our Assignors&#8217; Claims, which may include, but are not limited to, medical coding classification systems such as diagnosis codes (e.g., ICD-8/ICD-9/ICD-10 codes), procedure codes (e.g., CPT codes), and drug codes (e.g., NDC codes); non-medical data such as demographics and date ranges; and data from public sources such as crash reports, offense incident reports, and other reports that provide details as to an occurrence. These Algorithms are then applied to our Assignors&#8217; aggregated Claims data, filtering through the billions of lines of data from our Assignors to identify recoverable opportunities consistent with a given Algorithm&#8217;s criteria. Identified potential recoveries are then further quality reviewed by our medical team;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Amended &amp; Restated Bylaws</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the Amended and Restated Bylaws of the Company;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Annual Report</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means this Annual Report on Form 10-K for the period ending December 31, 2024.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Assignor</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means a healthcare payer, provider, or other entity that irrevocably assigned Claims to the Company or a subsidiary thereof;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ASC</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Accounting Standards Codification;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Billed Amount</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; (a/k/a the charged amount or retail price) is the full commercial value of services billed by the provider, or the full charge that the provider would ordinarily bill for the service provided. The Billed Amount for a specific procedure code is based on the provider and may vary from location to location. Where a Billed Amount is not provided in the data received from the Assignor, the Company may use paid amount or paid adjusted values, where available, to extrapolate a Billed Amount value. Where we have to extrapolate a Billed Amount to establish damages, the calculated amount may be contested by opposing parties.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">BKI</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Brickell Key Investments, LP, a Delaware limited partnership;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Board of Directors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; or &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Board</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the board of directors of the Company;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business Combination</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the transactions consummated on May 23, 2022 pursuant to the MIPA (as defined herein);</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CCRA</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Claims Cost Recovery Agreement, those agreements pursuant to which Claims are irrevocably assigned to the Company or affiliated entities;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CF</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Cantor Fitzgerald, L.P., a New York based investment bank;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Charter</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the Second Amended and Restated Certificate of Incorporation of the Company, dated May 23, 2022, as amended;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claim</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the right, title to, and/or interest in, any and all claims or potential claims, including all related reimbursement and recovery rights, which the Company has, may have had, or may have in the future assigned to it (whether or not asserted), including all rights to causes of action and remedies against any third-party, whether a primary payer or responsible party, at law or in equity. The term &#8220;Claim&#8221; includes but is not limited to: (i) claims arising under consumer protection statutes and laws; (ii) claims arising under the Medicare and Medicare Advantage secondary payer statutes, whether based in contract, tort, statutory right, or otherwise, in connection with the payment to provide healthcare services or supplies; (iii) claims arising under any state statutes and common laws irrespective of the rights that are conferred to the Company through assignment or otherwise; and (iv) all right, title, and interest to any recovery rights that may exist for any potential cause of action where a responsible party or primary payer is liable, even where it has not been established because liability is not yet proven as of the date that the Claim is identified or discovered, together with all receivables, general intangibles, payment intangibles, and other rights to payment now existing or hereafter arising and all products and proceeds of the foregoing;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Class A Common Stock</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the shares of the Company&#8217;s Class A common stock, par value $0.0001 per share, as described in more detail in Note 1, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of the Business</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, to the consolidated financial statements included elsewhere in this Annual Report;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Class B Unit</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the non-voting economic Class B Units of Opco, as described in more detail in Note 3,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Material Agreements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, to the consolidated financial statements included elsewhere in this Annual Report;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Class V Common Stock</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the shares of the Company&#8217;s Class V common stock, par value $0.0001 per share, as described in more detail in Note 1, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of the Business</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, to the consolidated financial statements included elsewhere in this Annual Report;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Closing</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the closing of the Business Combination, as defined herein;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Closing Date</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means May 23, 2022, the closing date of the Business Combination, as defined herein;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means shares of the Company&#8217;s Class A Common Stock and Class V Common Stock;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means MSP Recovery, Inc., a Delaware corporation;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CPIA Warrant</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means that warrant agreement dated September 30, 2022, whereby the Company granted to BKI the right to purchase 106,667 shares of Class A Common Stock for the purchase price of $0.0625 per share, as described in more detail in Note 9,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Claims Financing Obligations and Notes Payable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">DGCL</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the Delaware General Corporation Law, as may be amended from time to time;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exchange Act</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the Securities Exchange Act of 1934, as amended;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Existing Warrant Agreement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the Warrant Agreement dated as of August 13, 2020, by and between the Company and Continental Stock Transfer &amp; Trust Company;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Founder Shares</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the shares of the Class B Common Stock and the shares of Class A Common Stock issued upon the automatic conversion of the Class B Common Stock at the time of the Business Combination as provided in the existing Charter;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">GAAP</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means generally accepted accounting principles in the United States, as applied on a consistent basis;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">HMO</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means health maintenance organization;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hazel</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Hazel Holdings I LLC, a Delaware limited liability company, together with its affiliates;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">HPH</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Hazel Partners Holdings, LLC, a Delaware limited liability company;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">IPO</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the August 14, 2020 initial public offering by Lionheart Acquisition Company II, Inc.;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Incentive Plan</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the MSP Recovery Omnibus Incentive Plan effective May 18, 2022, a copy of which is filed as an Exhibit 10.16 to our Form S-1 Registration Statement filed on November 30, 2022;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Initial Stockholders</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means holders of the Founder Shares prior to the Business Combination;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">IPA</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Independent Physician Association;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Law Firm</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means La Ley con John H. Ruiz P.A. d/b/a MSP Recovery Law Firm and MSP Law Firm PLLC; which are owned by the Company&#8217;s Chairman of the Board and Chief Executive Officer, John H. Ruiz</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">LCAP</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Lionheart Acquisition Corporation II, the Company prior to the Closing;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">LCAP Board</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the board of directors of the Company prior to the Closing;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legacy MSP</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means MSP Recovery as it was organized in 2014 as a Medicaid and Medicare Secondary Pay Act recovery specialist;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">LLC Agreement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the first amended and restated limited liability company agreement of Opco (as defined below);</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MAO</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Medicare Advantage organization;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Members</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means members of the MSP Purchased Companies, as defined in the MIPA (as defined below);</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Members&#8217; Representative</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means John H. Ruiz, solely in his capacity as the representative of the Members;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MIPA</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the Membership Interest Purchase Agreement, dated as of July 11, 2021 (as it may be amended, supplemented or otherwise modified from time to time in accordance with its terms);</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSO</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means management service organization;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSP Act</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Medicare Secondary Payer Act;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSP Laws</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the MSP Act and associated federal regulations;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSP Principals</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the Chairman of the Board and Chief Executive Officer, John H. Ruiz, and the Director and Chief Legal Officer, Frank C. Quesada;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSP Recovery</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means MSP Recovery, LLC, a Florida limited liability company;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Near Real-Time</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; pertains to the timeliness of data or information that has been delayed by the time required for electronic communication and automatic data processing, implying that there are typically no significant delays;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Proceeds</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; is defined as the gross amount recovered on an assigned Claim, minus any costs directly traceable to such assigned Claim(s) for which recovery was made;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">New Warrants</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means 1,028,000,000 warrants, each exercisable to purchase 1/625 of one share, post 2024 Reverse Split, of Class A Common Stock (but only exercisable in lots of 625 to purchase whole shares), which were issued as a dividend to the holders of record of Class A Common Stock as of the close of business on the date of Closing;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Nomura</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Nomura Securities International, Inc.;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Nomura Note</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; refers to the promissory note issued to Nomura on May 27, 2022, as amended and restated from time to time;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Opco</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Lionheart II Holdings, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">OTC Equity Prepaid Forward Transaction</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means that certain agreement between the Company and CF dated May 16, 2022 in which CF agreed to (a) transfer to the Company for cancellation any warrants to purchase shares received as a result of being the stockholder of record of a share as of the Closing Date, pursuant to the previously announced and declared LCAP dividend, and (b) waive any redemption right that would require the redemption of the Subject Shares (as defined below) in exchange for a pro rata amount of the funds held in LCAP&#8217;s trust account;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Paid Amount</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; (a/k/a Medicare Paid Rate or wholesale price) means the amount paid to the provider from the health plan or insurer. This amount varies based on the party making payment. For example, Medicare typically pays a lower fee for service rate than commercial insurers. The Paid Amount is derived from the Claims data we receive from our Assignors. In the limited instances where the data received lacks a paid value, our team calculates the Paid Amount with a formula. The formula used provides rates for outpatient services and is derived from the customary rate at the 95th percentile as it appears from standard industry commercial rates or, where that data is unavailable, the billed amount if present in the data. These amounts are then adjusted to account for the customary Medicare adjustment to arrive at the calculated Paid Amount. Management believes that this formula provides a conservative estimate for the Medicare paid amount rate, based on industry studies which show the range of differences between private insurers and Medicare rates for outpatient services. We periodically update this formula to enhance the calculated paid amount where that information is not provided in the data received from our Assignors. Management believes this measure provides a useful baseline for potential recoveries, but it is not a measure of the total amount that may be recovered in respect of potentially recoverable Claims, which in turn may be influenced by any applicable potential statutory recoveries such as double damages or fines, as described below. This calculation accounts for an approximate 6.85% increase in the total Paid Amount. Where we have to extrapolate a Paid Amount to establish damages, the calculated amount may be contested by opposing parties;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Palantir</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Palantir Technologies, Inc., a Delaware corporation.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Public Shares</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means shares of the Company&#8217;s Class A Common Stock, traded on the Nasdaq Capital Market under symbol MSPR;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Public Stockholders</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the holders of the Public Shares, including the Sponsor (as defined below) and the Company&#8217;s management team to the extent the Sponsor and/or members of the Company&#8217;s management team purchase Public Shares; provided, that the Sponsor&#8217;s and each member of the management team&#8217;s status as a &#8220;Public Stockholder&#8221; will only exist with respect to such Public Shares;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Public Warrants</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means warrants, each exercisable to purchase 1/625 of one share, post 2024 Reverse Split, of Class A Common Stock (but only exercisable in lots of 625 to purchase whole shares), in accordance with its terms, as described in more detail in Note 1,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Description of the Business</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, to the consolidated financial statements included elsewhere in this Annual Report;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">PVPRC</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the cumulative Paid Amount value of potentially recoverable Claims. We analyze our Claims portfolio and identify potentially recoverable Claims using Algorithms that comb through historical paid Claims data and search for potential recoveries. PVPRC is a measure of the Paid Amount in respect of those potentially recoverable Claims. In the limited instances where the data received from our Assignors lacks a paid value, the adjustment formula described in the definition of Paid Amount is applied and increases PVPRC by approximately 6.32%;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recovery Proceeds</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means, with respect to any Claim, any and all gross proceeds recovered, including compensation, interest, penalties, and fees which may be paid or payable with respect to such Claim (including any and all cash, securities, instruments or other property which may be paid or issued by defendants or third parties in litigation proceedings in satisfaction of such Claim);</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Stockholders</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Nomura, the Members, the Sponsor, and certain directors and officers of the Company;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">SEC</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the U.S. Securities and Exchange Commission;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Securities Act</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the Securities Act of 1933, as amended;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Series</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Delaware series limited liability companies, formed pursuant to the Delaware law, that are used by the Company to own and segregate assets, including CCRAs;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Series MRCS</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Series MRCS, a series of MDA, Series LLC, a Delaware series limited liability company;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sponsor</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Lionheart Equities, LLC, a Delaware limited liability company;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subrogation Holdings</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Subrogation Holdings, LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Company;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Trust Account</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the trust account established by the Company for the benefit of its stockholders with Continental Stock Transfer &amp; Trust Company;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Up-C Unit</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means each pair consisting of one share of Class V Common Stock and one Class B Unit, as described in more detail in Note 1,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Description of the Business</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, to the consolidated financial statements included elsewhere in this Annual Report;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Virage</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Virage Capital Management LP, a Texas limited partnership;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Voting Rights Threshold Date</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the date on which the voting power of John H. Ruiz and his affiliates represent less than 50% of the voting power of all of the then outstanding shares of the Company generally entitled to vote;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VRM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means Virage Recovery Master LP, a Delaware limited partnership and affiliate of Virage;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VRM Full Return</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; has the meaning as set forth in Note 3,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Material Agreements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, to the consolidated financial statements included elsewhere in this Annual Report;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VRM MSP</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means VRM MSP Recovery Partners LLC, a Delaware limited liability company and joint investment vehicle of VRM and Series MRCS;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VRM Warrants</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; refers to those warrant agreements issued pursuant the Virage MTA Amendment (as defined herein), including an initial warrant (the &#8220;Initial Virage Warrant&#8221;) and monthly warrants (the &#8220;Monthly Virage Warrants&#8221;), to purchase Class A Common Stock at $0.0001 per share, which expire two years from the date of issuance.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Initial Virage Warrant, as amended, was issued effective January 1, 2024 in an amount equal to the quotient of 1% of each calendar month end balance of the Unpaid Base Amount (calculated on a cumulative basis) and the VWAP of a share of Class A Common Stock for the five-day period prior to the issuance, beginning with May 24, 2023 and ending December 31, 2023, thus entitling Virage to purchase 1,131,934 shares of Class A Common Stock at an exercise price of $0.0025 per share, with an expiration date of January 1, 2026.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Monthly Virage Warrants may be issued each calendar month, beginning with January 31, 2024 until the obligations to Virage are paid in full, in an amount equal to the quotient of 1.0% of each calendar month-end balance (which month-end balance shall be increased daily up to 20% per annum based on a formula set forth in the Virage MTA Amendment) of the amount owing to Virage as of each preceding calendar month end and the VWAP of a share of our Class A Common Stock. Until our obligations to Virage are paid in full, the Company has the option every month to pay Virage in one or a combination of: (a) cash, in an amount equal to 1.0% of each calendar month-end balance (which month-end balance shall be increased daily up to 20% per annum based on a formula set forth in the Virage MTA Amendment) of the amount owing to Virage as of each preceding calendar month end and/or (b) the issuance of subsequent Monthly Virage Warrants.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VWAP</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; is defined as the daily volume-weighted average price of the shares of common stock for such trading day on the Nasdaq Stock Market during regular trading hours as reported by Bloomberg L.P.;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Working Capital Credit Facility</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means the credit agreement as described in more detail in Note 9,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Claims Financing Obligations and Notes Payable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements included elsewhere in this Annual Report;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Yorkville</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means YA II PN, Ltd., a Cayman Islands exempt limited partnership fund managed by Yorkville Advisors Global, LP;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Yorkville Convertible Notes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means those certain convertible notes issued to Yorkville, as described in more detail in Note 9,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Claims Financing Obligations and Notes Payable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements; and</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Yorkville SEPA</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; means that certain Standby Equity Purchase Agreement by and among the Company and Yorkville, dated November 14, 2023, as amended from time to time.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless specified otherwise, amounts in this Annual Report are presented in U.S. dollars.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Defined terms in the financial statements contained in this Annual Report have the meanings ascribed to them in the financial statements.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cautionary Note Regarding Forward-Looking Statements</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain of the statements contained in this Annual Report are forward-looking and constitute forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange Act. Forward-looking statements may generally be identified by the use of words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; and &#8220;will&#8221; or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance or results, and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Although we believe that our expectations are based on reasonable assumptions within the bounds of our knowledge of our industry, business, and operations, we cannot guarantee that actual results will not differ materially from our expectations. In evaluating such forward-looking statements, you should specifically consider various factors, including the risks outlined under &#8220;Risk Factors.&#8221; Any forward-looking statement made herein by the Company speaks only as of the date made. The discussion of risks and uncertainties set forth in this Annual Report is not necessarily a complete or exhaustive list of all risks facing the Company at any particular point in time. New risks and uncertainties come up from time to time, and it is not possible for management to predict or identify all such events or to assess either the impact of all such risk factors on our business or the extent to which any individual risk factor, combination of factors, or new or altered factors, may cause results to differ materially from those contained in any forward-looking statement. The Company has no obligation, and does not intend to, update any forward-looking statements after the date hereof for any reason, even if new information becomes available in the future, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to, the Company&#8217;s substantial indebtedness and other obligations, including, but not limited to, the VRM Full Return, the Working Capital Credit Facility, the Nomura Note, the Yorkville Convertible Notes, the Company&#8217;s insufficient liquidity to satisfy these and other obligations, the Company&#8217;s ability to capitalize on its assignment agreements and recover monies that were paid by the Assignors; the inherent uncertainty surrounding settlement negotiations and/or litigation, including with respect to both the amount and timing of any such results; the validity of the assignments of Claims to the Company; the ability to successfully expand the scope of our Claims or obtain new data and Claims from the Company&#8217;s existing Assignor base or otherwise; the Company&#8217;s ability to innovate and develop new solutions, and whether those solutions will be adopted by the Company&#8217;s existing and potential Assignors; negative publicity concerning healthcare data analytics and payment accuracy; compliance with the listing standards of the Nasdaq Stock Market; and those other factors listed under &#8220;Risk Factors&#8221; below and elsewhere in this Annual Report and other reports filed by the Company with the SEC.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART I</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Business.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Industry Overview</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business is directly related to the healthcare industry and is affected by healthcare spending and complexity in the healthcare data industry. The market for healthcare data and healthcare claims recovery solutions is large and growing. We estimate that our total potentially serviceable market is over $161.5 billion annually. Our primary focus is on the Medicare and Medicaid market segments. Medicare is the third largest government program, with estimated annual expenditures during 2023 of approximately $1,029.8 billion for approximately 68.0 million enrollees. Medicaid has a combined estimated annual expenditure during 2023 of approximately $871.7 billion for approximately 88.5 million enrollees. Of the billions spent yearly by Medicare on medical expenses for its beneficiaries, we estimate that at least 10% of this was improperly paid by private Medicare plans.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our potentially serviceable market, and therefore revenue potential, is impacted by the expansion or contraction of healthcare coverage and spending, which directly affects the number of Claims available. The Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) has stated that the U.S. National Health Expenditure (&#8220;NHE&#8221;) grew 7.5% to $4.9 trillion in 2023, and accounted for 17.6% of GDP of which Medicare and Medicaid expenditures accounted for $1.9 trillion. CMS has projected that health spending will continue to grow at an average rate of 5.6% a year between 2023 and 2032. The Office of the Actuary of CMS estimates that the NHE equal 19.7% of the GDP by 2032, and is projected to grow 1.4% faster than the GDP between 2023 and 2032. We also believe reimbursement models may become more complex as healthcare payers accommodate new markets and lines of business and as advancements in medical care increase the number of testing and treatment options available. As reimbursement models grow more complex and healthcare coverage increases, the complexity and number of Claims may also increase, which could impact the demand for our solutions. Such changes could have a further impact on our results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, approximately 95.9% of our expected recoveries arise from Claims being brought under the MSP Act. While we believe the MSP Act has bipartisan support, changes to the laws on which we base our recoveries, particularly the MSP Act, can adversely affect our business. Our ability to generate future revenue is therefore significantly dependent on factors outside of our control.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Business Overview</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery is a leading healthcare reimbursement recovery and data analytics company, providing historical and Near Real-Time solutions for payers, providers, and patients. We are disrupting the antiquated healthcare reimbursement system by discovering losses and recovering improper payments for Medicare, Medicaid, and commercial health insurers, and innovating technologies and comprehensive services for multiple industries, including healthcare and legal.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Medicare and Medicaid are payers of last resort. Too often, they end up being the first and only payers, because the responsible payer is not identified or billed. As Medicare and Medicaid pay a far lower rate than what other insurers are often billed, this costs the healthcare system (and the supporting taxpayers) tens of billions of dollars a year attributable to improper billing and lost recoveries. By discovering, quantifying, and settling the billed-to-paid gap on a large-scale basis, the Company is positioned to generate meaningful annual recovery revenue at high profit margins.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our access to large volumes of data, our sophisticated data analytics platform, and advanced technology provide a unique opportunity to discover and recover improper healthcare Claims payments. We have developed Algorithms to identify waste, fraud, and abuse in the Medicare, Medicaid, and commercial health insurance sectors. Our team of experienced data scientists and medical professionals analyze historical medical Claims data to identify recoverable opportunities. Once potential recoveries are reviewed by our team, they are aggregated and pursued. Through statutory law and case law, we believe we have an established basis for future recoveries.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We differ from our competitors as we receive our recovery rights through irrevocable assignments of Claims from our Assignors. As assignees, we assume risk that our competitors do not. Rather than provide services under a third-party vendor services contract, we receive the rights to certain recovery proceeds from our Assignors&#8217; Claims. As we, or our affiliated entities, are assigned recovery rights associated with Claims, we are the plaintiff in any action filed and therefore exercise control over the direction of the litigation. By receiving Claims through assignment, we can pursue additional recoveries under numerous legal theories that our competitors cannot. Although we own the assigned Claims, for a significant portion of assigned Claims, our ability to pursue recoveries depends on our ongoing access to data associated with those Claims through data access rights granted to us. The termination of said data access rights would substantially impair our ability to generate recoveries on those Claims.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are entitled to a portion of any recovery rights associated with approximately $1,591 billion in Billed Amount (and approximately $380 billion in Paid Amount), which contains approximately $87.7 billion in Paid Value of Potentially Recoverable Claims, as of December 31, 2024. We believe it would take any competitor a significant time to amass the portfolio of Claims rights currently owned by us due to, among things, the volume of our Claims data retained and strength of our data analytics, which we believe are key to attracting counterparties willing to assign Claims to us.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our data recovery system operates across a Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) compliant IT platform incorporating the latest in business intelligence and data technology. Due to the sensitive nature of the data we receive from</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our Assignors, we ensure that our data systems comply with the security and privacy mandated by federal law. In 2023, the Company engaged a HITRUST Authorized External Assessor and AICPA member firm, which completed independent assessments of MSP Recovery&#8217;s system. These independent assessments verified that we met the healthcare industry&#8217;s highest standards in protecting healthcare information and mitigating this risk, including compliance with the HIPAA Security Rule. On October 13, 2023, HITRUST certified that the platforms, facilities, and supporting infrastructure of our organization meet the HITRUST CSF&#174; v11 Implemented, 1-year (i1) certification criteria. For our cloud computing services, we currently use Amazon Web Services (&#8220;AWS&#8221;) which is also HITRUST certified. On June 14, 2024, an Independent Service Auditor provided MSP Recovery a report opining that our data recovery system&#8217;s commitments and system requirements meet or exceed the stringent SOC 2 Type II applicable trust services criteria.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recovery Business Model</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Discover Losses/Recover Reimbursements</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We receive irrevocable assignments of health Claims recovery rights through CCRA from a variety of sources including, but not limited to, MAOs, MSOs, HMOs, hospitals, and other at-risk entities. We utilize our proprietary internal data analytics platform to review healthcare Claims and identify Claims with probable recovery paths.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once Claims are assigned, our data analysts run proprietary Algorithms to identify potential recoveries. Results are then quality checked by our internal medical team. We contract with the Law Firm and other law firms across the country to pursue recoveries through the legal system. Where appropriate, the Law Firm contacts primary payers to demand payment of amounts owed. Prior to litigation, there may be an incentive for the primary insurer to settle as, pursuant to the Medicare Secondary Payer Act, an action for damages in the case of a primary plan which fails to provide for primary payment (or appropriate reimbursement) shall be in an amount double the amount otherwise provided.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We engage with each Assignor independently. We are generally entitled to 100% of recoveries pursuant to our CCRAs; from those recoveries, we are typically obligated to pay 50% of Net Proceeds to the Assignor. In certain cases, we have purchased the Assignor&#8217;s rights to recovery proceeds in advance of any collection, thus entitling the Company to retain 100% of the Net Proceeds. In some instances, we may purchase outright an Assignor&#8217;s recovery rights; in this instance, we are entitled to the entire recovery. In some cases, we have entered into arrangements to transfer CCRAs or rights to proceeds from CCRAs to other parties. Such sales include variable consideration in the form of payments that will be made only upon achievement of certain recoveries or based on a percentage of actual recoveries. In other cases, the Company has pledged proceeds which are due to the Company to repay certain obligations, such as the Purchase Money Loan, the Working Capital Credit Facility, and the MTA. We have yet to generate substantial revenue from the recovery model.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Recovery Services</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may also recognize Claims recovery service revenue from our services to clients, assisting entities with the pursuit of Claims recovery rights by identifying recoverable Claims and providing data matching and legal services. Under our Claims recovery services model, we do not own the rights to Claims but provide our services for a fee based on budgeted expenses for the month with an adjustment for the variance between budget and actual expense from the prior month. The fees received pursuant to a Claims recovery service agreement are related to expenses incurred and are not tied to the Billed Amount or potential recovery amounts. Although we believe our future business to be highly tied to the recovery model and Chase to Pay, we may enter into these contracts as the market dictates. The Company did not recognize any Claims recovery service income during the year ended December 31, 2024.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Industry Solutions</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The MSP Ecosystem</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery has developed a comprehensive ecosystem to enhance healthcare reimbursement processes, integrating advanced data analytics, Near Real-Time insights, and technological tools to provide connectivity between property and casualty insurers, health plans, providers, patients, and stakeholders. This integrated ecosystem analyzes dates from a variety of sources to identify responsible parties, assist providers in receiving reasonable and customary rates for accident-related treatment, shorten the collection time frame, and increase revenue visibility and predictability for its users.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Chase to Pay</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Chase to Pay platform was designed to significantly improve payment accuracy in our fragmented healthcare system. Chase to Pay is a near real-time analytics driven platform that identifies the proper primary insurer at or near the point of care, helping to determine primary and secondary payers. Chase to Pay is intended to integrate with medical utilization platforms used by providers during patient care and treatment. Rather than allow a wrongful payment whereby the secondary payer needs to chase down the primary payer to collect a reimbursement, Chase to Pay helps to prevent wrongful payments in the first place, and ensures that the correct payer pays. Furthermore, as primary payers typically pay a negotiated or commercially reasonable rate, rather than the deeply discounted Medicare rate; the Company is entitled to pursue the full amount that primary payer would have been responsible to pay, had they paid in the first instance.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As Chase to Pay was designed to work at or near the point of care, it is expected to substantially improve the propriety of payments and decrease the legal costs of recovery. As a result, when implemented, Chase to Pay is expected to improve the net recovery margin as the recovery multiple grows and variable legal costs to recover decline. As a result of having already received data from property &amp;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">casualty insurance carriers we've settled with for historical claims, and based on the agreement with said carriers to receive data for one year from the date of the settlement, the Chase to Pay platform can be utilized to pursue additional recoveries by matching the insurance carrier with Claims data received from our Assignors.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we have not yet generated revenue from this platform, some Assignors send data to the Company on a monthly or quarterly basis. The Company is working to increase the number of Assignors that provide daily data outputs. We are currently in the process of determining the pricing and form of these arrangements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSP/Palantir Clearinghouse Platform</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The clearinghouse platform, created in collaboration with Palantir, was developed to identify, quantify, and resolve outstanding liens. By law, Medicare and MA Plans are payers of last resort, making no-fault insurers the primary payers, responsible to exhaust their policy limits to pay for accident-related claims before Medicare bears any responsibility. Healthcare providers often submit Claims for the payment of medical services rendered after an accident to the patient&#8217;s health insurer, either seeking &#8220;conditional payments,&#8221; pending reimbursement by a primary payer, or entirely unaware that a primary payer has payment obligations. Medicare is unable to effectively verify if and how much is owed for any particular claimant if they are not aware that there is a Primary Payer involved.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Federal law requires primary payers to maintain and report the &#8220;key identifiers&#8221; for all claimants (such as their name, Social Security number, address, etc.) used to determine a claimant&#8217;s Medicare status before settling any injury claim. These steps are required to ensure that Medicare is alerted to primary payer obligations in order to seek reimbursement. Primary payers routinely fail to fulfill these two duties, resulting in improper Medicare payments, rather than payments made by responsible parties, as required by law. The Company has proven that, in some instances, primary payers have a reporting rate as low as 2%, thus those certain primary payers have failed to comply with the law 98% of the time.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that the clearinghouse platform is a potential solution to this systemic problem, integrating advanced artificial intelligence (&#8220;AI&#8221;) tools, natural language processing (&#8220;NLP&#8221;), and machine learning (&#8220;ML&#8221;) to create a robust data analytics system capable of capturing and managing extensive healthcare data from multiple sources.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Key Features and Benefits:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Near Real-Time Data Analytics: The clearinghouse platform provides an expansive repository of data from patients, attorneys, healthcare providers, health insurers, and property and casualty insurers that can be utilized to determine payer obligations.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Enhanced Connectivity: With the ability to connect property and casualty insurers to health plans and downstream medical providers, the clearinghouse platform can address inefficiencies arising from improper payments related to accident-related injuries. This connectivity streamlines the reimbursement process, ensuring that healthcare payers and providers receive appropriate compensation, helping to reduce administrative burdens.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Advanced Data Management: The utilization of AI, NLP, and ML to process and analyze large volumes of healthcare data helps enhance the accuracy and efficiency of claims management and payment integrity.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legal Integration: The clearinghouse platform integrates legal, data, and healthcare knowledge, providing a unified ecosystem that streamlines the processing of claims reconciliation. It may also be used by primary payers to proactively resolve liens and ensure compliance with federal laws.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Through the clearinghouse platform, the Company aims to transform the healthcare reimbursement system by leveraging advanced technologies to improve data connectivity and enhance operational efficiency, leading to improved patient outcomes. Revenue generated from the clearinghouse platform has not been significant.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">EHR Platform</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery has developed a technologically advanced Electronic Health Record (&#8220;EHR&#8221;) platform (&#8220;EHR Platform&#8221;) enabling patients and their authorized third-party representatives to collect, distribute, and export their EHR securely, facilitating informed decision-making and improved health outcomes. The EHR Platform streamlines the retrieval and analysis of medical data. It also provides comprehensive insights for healthcare providers, enhancing efficiency, and monitoring outcomes and key performance indicators. The EHR Platform went live in the second quarter of 2024 and revenue generated from it has not been significant.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Medicare and the MSP Laws</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Medicare Secondary Payer Act</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the MSP Act, when another entity has the responsibility for paying before Medicare, the Medicare program does not have primary payment responsibility for its insureds. When Medicare (or an MAO) makes a payment for medical services that are the responsibility of a separate primary plan under the MSP Act, those payments are conditional. Conditional payments are made by Medicare (or an MAO) as an accommodation for its beneficiaries, but are secondary and subject to reimbursement in all situations where a primary payer was obligated to pay in the first instance.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subsequent to the initial passage of the MSP Act, Congress provided a private cause of action, authorizing private parties to recover unreimbursed payments in cases where a primary plan fails to pay or provide appropriate reimbursement in accordance with MSP Laws. We employ the MSP Laws, among others, including the double damages provision, to hold primary payers accountable.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Medicare Advantage Plans</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 1997, Congress enacted the Medicare Part C program to allow Medicare beneficiaries to receive Medicare Part A and B benefits through privately-run managed care plans. Under the Medicare Advantage program, a private insurance company contracts with CMS to provide Medicare Parts A and B benefits on behalf of Medicare beneficiaries enrolled in a Medicare Advantage Plan (&#8220;MA Plan&#8221;). Under such a contract, the MAO receives a fixed amount per enrollee (the &#8220;Capitation&#8221;) and must provide at least the same level of benefits that enrollees would receive under the fee-for-service option. The Capitation structure incentivizes MAOs to provide Medicare benefits more efficiently than under the fee-for-service model due to the competition among MAOs for enrollees as well as the savings recovered from primary payers resulting in additional benefits to enrollees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An MAO&#8217;s payment obligation under Part C is coextensive with that of the Secretary under Parts A and B. Part C includes a reference to the MSP Act and renders an MAO a &#8220;secondary payer&#8221; under the Act. In addition, the CMS regulations provide that an MAO will exercise the same rights to recovery from a primary plan, entity, or individual that the HHS Secretary exercises under the MSP regulations. The U.S. Court of Appeals for the Eleventh Circuit has accordingly recognized parity between MAOs and Medicare, as &#8220;Congress empowered (and perhaps obligated) MAOs to make secondary payments under the same circumstances as the Secretary.&#8221; MAOs, however, are merely the first layer of the Medicare Advantage program. Due to the customary practices within the MAO industry, the financial injury caused by a primary plan&#8217;s failure to reimburse conditional payments is often felt primarily by First Tier and Downstream Entities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">First-Tier and Downstream Entities</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Federal regulations recognize Medicare first-tier and downstream entities as active participants in the provision of benefits under Medicare Part C. First-tier entities are defined as &#8220;any party that enters into an acceptable written arrangement with an MA organization or contract applicant to provide administrative services or health care services for a Medicare eligible individual.&#8221; Downstream entities are those entities that enter into a similar written arrangement at a level below that of a first-tier entity. Such written arrangements continue down to the level of the ultimate provider of both health and administrative services. These contracts are both encouraged and regulated by CMS, which requires first-tier and downstream entities to furnish healthcare services in a manner consistent with the dictates of the Medicare program and an MA plan&#8217;s obligations thereunder. In this way, first-tier and downstream entities are the parties responsible for managing and providing healthcare services to Medicare beneficiaries under the Medicare Advantage program.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">First-tier entities include MSOs and IPAs. An IPA is a business entity organized and owned by a network of independent physician practices for the purpose of reducing overhead and optimizing efficiency and effectiveness in the delivery of health care to Medicare beneficiaries. Put simply, IPAs are healthcare providers who often bear the full financial risk of managing their patients&#8217; care. An MSO is a group that owns or manages multiple physician practices for the same purpose. The core business of IPAs and MSOs within the Medicare Part C infrastructure is to manage the care of patients, leverage their delivery systems, and focus on preventive health in order to create value and cost savings.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MAOs customarily pass their risk of loss onto MSOs and IPAs, who assume the role as a point of service provider and manager of a beneficiary&#8217;s care. Under these arrangements, MAOs deduct a percentage of the CMS capitation rate for its administrative costs and pays the balance to the IPA or MSO. In exchange, the provider (IPA or MSO) assumes the full financial risk for the care of the MAO&#8217;s enrollee. As such, &#8220;at-risk&#8221; IPAs and MSOs are charged with producing competition, innovation, progress, and savings in the Medicare Part C environment. In accepting the full financial risk of a Medicare beneficiary&#8217;s health care, an IPA or MSO assumes the MAO&#8217;s position within the Medicare Part C framework.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When a Medicare Advantage enrollee is injured in an accident, an IPA or MSO can meet its obligation to that enrollee in one of two ways. First, it can render the requisite care to the enrollee directly through its network of physicians, providers, or medical centers. Under this scenario, the MSO or IPA suffers the full cost of providing items and services to the Medicare beneficiary.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Alternatively, if the enrollee is treated in an emergency room or other facility outside of the MSO or IPA&#8217;s provider system, then the MSO or IPA may make conditional payments for the cost of that treatment because it is financially responsible for the enrollee&#8217;s care. Under this second scenario, the contracting MAO pays the outside provider (i.e., the emergency room) and then charges the full amount of that payment to the MSO or IPA who bears the risk of loss. In other words, the MSO or IPA must reimburse the MAO for the full amount of its payment to the outside provider (or that payment is applied as a set-off against capitated funds that the MSO or IPA would otherwise receive).</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an MAO makes a secondary payment which is later appropriately reimbursed by a primary payer, then the MAO will not charge and collect that same amount from the MSO or IPA responsible for that particular enrollee. On the other hand, if the primary payer violates the MSP Act, first-tier and downstream entities are damaged as a result. When an MSO or IPA is damaged by a primary payer, that entity may likewise turn to the MSP Act&#8217;s broadly worded private cause of action to recovery from the primary payer.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Double Damages</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under existing statutory and case law, the private cause of action under the MSP Act permits an award of double damages when a primary plan fails to provide for primary payment or appropriate reimbursement. We are entitled to pursue medical expenses paid by our Assignors that should have been paid by Primary Plans (as defined by federal law). Under the MSP Act, we are entitled to pursue double the amount that a provider charged. The private cause of action under 42 U.S.C. &#167; 1395y(b)(3)(A), works in concert with 42 U.S.C. &#167; 1395w-22(a)(4), which expressly provides MAOs with the right to &#8220;charge or authorize the provider of such services to charge, in accordance with the charges allowed under a law, plan, or policy, described in such section the insurance carrier, employer, or other entity which under such law, plan, or policy is to pay for the provision of such services&#133;&#8221; Moreover, the MSP regulations in Part 411 also support the fact that a provider may bill its full charges for services to primary payers. The statute provides the Company the ability to seek double the charged or otherwise Billed Amounts from primary plans. The payment disparity between the Paid Amount and the Billed Amount creates a free rider scenario where the primary payer is in a better financial position if it does not comply with the law. In other words, if a primary payer&#8217;s liability is capped at double the Paid Amount (an amount less than what the primary payer would have paid) then the entire purpose of the MSP Act&#8212;to make Medicare secondary&#8212;is defeated. That is why Congress set the damage amount at the amount billed by the provider; to incentivize compliance with the MSP Act.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Multiple</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the Billed Amount, the Company is entitled to pursue interest pursuant to Section 1862(b)(2)(B)(i) of the Social Security Act and 42 C.F.R. &#167; 411.24(m), which provides express authority to assess interest on Medicare Secondary Payer debts. Therefore, when recovery is pursued through litigation, we seek to recover double the amount owed for our Assignor&#8217;s accident-related medical expenses, plus accrued statutory interest due pursuant to the MSP Laws.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to federal and state laws, we believe the Company has an established basis for future recoveries, often in excess of the Paid Amount. By discovering, quantifying, and settling the gap between Paid Amount and Billed Amount on a large scale, we believe we are positioned to generate meaningful profit margins. Pursuant to the &#8220;right-to-charge&#8221; provision in the MSP Laws, an MAO may charge, or authorize providers to charge, insurance carriers for usual, customary, and reasonable charges permitted by the law, plan, or policy, such as the Billed Amount. As such laws, plans, and policies provide for payment of the providers&#8217; actual charges (the Billed Amount), rather than the reduced Medicare payments, we pursue recovery of the Billed Amount and in certain cases, as provided by law, double the Billed Amount for medical services and treatments. For additional information, see &#8220;Development of Medicare and the MSP Law&#8221; below.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Mandatory Reporting</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Medicare, Medicaid, and SCHIP Extension Act of 2007 (&#8220;MMSEA&#8221;) added mandatory reporting requirements with respect to Medicare beneficiaries who have coverage under group health plan arrangements as well as for Medicare beneficiaries who receive settlements, judgments, awards, or other payment from liability insurance (including self-insurance), no-fault insurance, or workers&#8217; compensation. Failure to comply with MMSEA may result in a civil money penalty of $1,000 for each day of non-compliance for each individual for which the information should have been submitted. This civil money penalty is in addition to any other penalties prescribed by law and in addition to any Medicare secondary payer Claim under this title with respect to an individual. Although we are not entitled to pursue MMSEA penalties on our own behalf, we have filed qui tam lawsuits on behalf of the federal government to enforce this federal law.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competitive Strengths</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Irrevocable Assignments</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We differ from competitors as we receive irrevocable assignments of recovery rights associated with certain healthcare related Claims. When we are assigned these rights, we obtain ownership in those rights that typical subrogation vendors do not. Rather than provide services under third-party vendor services contracts, we receive recovery rights to our Assignors&#8217; Claims, and therefore step into the Assignor&#8217;s shoes. As assignees, we are the plaintiff in any action filed in connection with such Claims, we maintain control over the direction of the litigation, and we can pursue additional recoveries under numerous legal theories that our competitors cannot.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Scale of Current Portfolio</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our current portfolio has scaled significantly. As of December 31, 2024, we have been assigned recovery rights on Claims valued at approximately $1,591 billion in Billed Amount (and approximately $380 billion in Paid Amount), of which approximately $87.7 billion is PVPRC.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are typically entitled to 100% of recoveries pursuant to our CCRAs. From those recoveries, we are typically contractually obligated to pay 50% of recoveries to the Assignor, plus attorneys&#8217; fees and costs associated with pursuit of the recoveries. In certain cases, we have purchased the Assignor&#8217;s rights to recovery proceeds in advance of any collection, entitling the Company to retain 100% of the recovery proceeds, net of attorneys&#8217; fees and costs. As of December 31, 2024, we were entitled to approximately 56.8% in the aggregate of the approximately $87.7 billion in PVPRC. Our recoveries would constitute a portion of the approximately $87.7 billion in PVPRC that may be recovered, after giving effect to our expenses, including any contingent fee payment payable to the Law Firm. See &#8220;Risk Factors&#8212;Risks Related to the Company&#8217;s Business and Industry.&#8221; This approximately $87.7 billion in PVPRC was identified using our Algorithms which comb through historical paid Claims data and to identify potential recoveries. As of December 31, 2024,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the approximately $87.7 billion in PVPRC and approximately $380 billion in Paid Amount included approximately $5.2 billion and approximately $24.4 billion in capitated payments, respectively. Such capitated amounts are typically based on a fixed amount per enrollee in a plan rather than amounts paid on a fee-for-service basis and, in calculating the equivalent of Paid Amount for purposes of measuring potential recoveries, in cases where payments were based on capitated amounts, MSP Recovery reviews capitated encounter data typically found in Medicare Part B payments. The Company has successfully recovered full amounts on these capitated payments in some prior settlements.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The timeline for Claims being identified as potentially recoverable Claims to actual Claims recovery revenue can vary greatly depending on the complexity of the recovery strategy and litigation, as well as the status of each Claim in the recovery process. The Company monitors the penetration status of the Claims portfolio, which categorizes the status of cases based on their progression through the recovery process in the following categories: in development, recovery process initiated, data collected and matched, resolution discussions in process, and other cases. Potentially recoverable Claims can take years to reach resolution based on a variety of factors.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Proprietary Data Analytics System</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe our access to large volumes of data, sophisticated data analytics, and proprietary leading technology platforms provide a unique opportunity to discover and recover Claims. Our Algorithms comb through historical paid Claims data to identify potential recovery opportunities. As of December 31, 2024, we estimate a PVPRC of $87.7 billion. Through data mining, we continue to identify new recovery opportunities.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Founders Have Extensive Legal Experience</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Experienced management gives us a competitive advantage. Our founder, John H. Ruiz, is recognized as one of America&#8217;s pre-eminent trial lawyers, named &#8220;2019&#8217;s DBR Florida Trailblazer&#8221; for groundbreaking work in integrating data analytics into the practice of law and for the impact it is having on healthcare recoveries. Over the course of a distinguished 33-year legal career, Mr. Ruiz has gained national recognition in class action, mass tort litigation, multi-district litigation (&#8220;MDL&#8221;) consolidated cases, medical malpractice, products liability, personal injury, real estate, and aviation disaster cases.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Chief Legal Officer, Frank C. Quesada, has extensive experience in healthcare litigation, including numerous legal wins in state and federal court, at the trial and appellate levels.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Due to our team&#8217;s extensive knowledge of the MSP Laws, and decades of experience in data analytics within the medical industry, we believe we are well positioned to recover monies owed to our Assignors under the MSP Laws, as well as other state and federal laws. We use our proprietary software and a highly trained staff including IT personnel, accountants, statisticians, physicians, data analysts and attorneys to maximize the recovery of Claims already paid.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Growth Strategies</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expansion of Assignor Claims.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> CMS has projected that health spending will continue to grow at an average rate of 5.6% a year between 2023 and 2032. We anticipate that this trend will be reflected in our own growth. We plan to expand our Assignor base by implementing new strategies to secure new Assignors and continue receiving assignments of Claims from our existing Assignors. These strategies will include a platform to educate potential Assignors about our company, making strategic business partnerships, potential mergers, acquisitions of personnel, as well as other marketing strategies.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Monetizing Existing Software Applications.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We intend to offer certain of our software applications, including our Chase to Pay, the clearinghouse platform, and the EHR Platform, as separate products.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Development of our Proprietary Data Analytics System.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We continue to develop our proprietary system and anticipate shifting to artificial intelligence and machine learning to better enhance our recovery potential. Our data analytics system will power proprietary tools such as Chase to Pay and the clearinghouse platform, thus enabling the Company to more efficiently recover on Claims, and enable us to attract more Assignors.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Services</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Recovery</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of our Claims recovery business, we pursue a number of types of recoveries, including:</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Contractual Cases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When Medicare or an MAO, as a secondary payer, makes a payment on behalf of a beneficiary for injuries related to the use, maintenance, or operation of a vehicle, that payment may be recoverable from a no-fault insurer, as a primary payer. No-fault coverage does not require an assessment of liability, and thus, when a covered medical expense is incurred, the insurer must accept primary payer responsibility. The no-fault insurer&#8217;s failure to pay or reimburse Medicare and MAOs may constitute a breach of the beneficiary&#8217;s no-fault coverage, and a violation of the MSP Laws.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Settlement Cases</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The MSP Laws allow Medicare beneficiaries, providers, and MAOs to seek reimbursement from any entity or person that has settled a dispute and failed to pay or reimburse Medicare and MAOs for an enrollee&#8217;s medical expenses related to that dispute. We review our Assignor&#8217;s Claims data and compare these records with the CMS database and court dockets to determine if any of our Assignor&#8217;s enrollees have been involved in a dispute that resulted in a settlement.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, in connection with certain of our recent settlements, settling counterparties have assigned to the Company all rights to collect additional sums from plaintiffs&#8217; attorneys and medical providers resulting from violations of the MSP Laws, including double billing and reimbursement failures.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Product Liability</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Defective or dangerous products cause thousands of injuries every year. Many product liability cases arise from instances in which an implantable medical device causes an adverse reaction due to a design or manufacturing defect. These adverse reactions may range from minor rashes to cancer and subsequent death. Where Medicare or an MAO has paid an enrollee&#8217;s medical expenses for these injuries, we may be able to pursue recoveries.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Antitrust-Pharmaceutical</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Antitrust laws, including the Sherman Antitrust Act of 1890 (the &#8220;Sherman Act&#8221;) and the Clayton Antitrust Act of 1914 (the &#8220;Clayton Act&#8221;), and analogous state unfair competition laws, prohibit business practices that unreasonably deprive consumers of the benefits of competition, resulting in higher prices for products and services. The Sherman Act also outlaws all contracts, combinations, and conspiracies that unreasonably restrain interstate and foreign trade.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our antitrust cases typically derive from one of the two following scenarios: (1) either a group of manufacturers who make similar products decide to raise product prices collectively irrespective of market fluctuations; or (2) a manufacturer of a branded pharmaceutical enters into a &#8220;pay for delay&#8221; agreement with a generic drug manufacturer so that the generic drug manufacturer delays the market launch of a cheaper competing drug. We pursue recoveries under both scenarios pursuant to the Sherman Act, the Clayton Act and state unfair competition laws to recover the differential between the actual paid amount and the price that we should have paid.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">False Claims Act</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The False Claims Act (the &#8220;FCA&#8221;) is widely regarded as an effective tool in combating waste, fraud, and abuse against the federal government. The FCA prohibits the submission of false or fraudulent Claims for payment from the government. The FCA, which imposes civil penalties, fees, and treble damages for fraudulent claims, permits private individuals to file qui tam suits on behalf of the federal government. As a relator, we have filed qui tam lawsuits to enforce the FCA on behalf of the federal government.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Mass Tort and Private Lien Resolution Programs</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When a defendant in an MDL settles its cases with the plaintiffs, the parties enter into a Master Settlement Agreement (&#8220;MSA&#8221;), which settles all pending lawsuits and provides that the defendant(s) agrees to set aside funds to settle the MDL related cases involving various conditions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSAs govern the terms of the settlement and provide for the resolution of all liens against the settlement proceeds. A lien resolution administrator assists in resolving all liens that are asserted by government payers or private payers against settlement funds and ensures that all such liens are resolved prior to settlement payments being disbursed to the settling claimants. An MSA typically provides for a Private Lien Resolution Agreement (the &#8220;PLRP Agreement&#8221;) whereby the lien resolution administrator establishes an efficient procedure to resolve liens.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon payment of the Company&#8217;s liens as provided in the PLRP Agreement, our reimbursement Claims against recoveries by claimants as defined in the MSA are resolved, and all potential liabilities related to such liens in favor of MSP Recovery are released. The only liens subject to resolution are those liens that qualify for a settlement payment pursuant to an MSA. No other Claims owned or otherwise held by the Company are encompassed in the PLRP Agreement.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conduct an analysis of the claimants in the MDL settlement and identify liens belonging to the Company arising from medical care and treatment provided to claimants for which the Company has a legal right of recovery. A lien administrator provides the list of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">claimants to us. We then provide the Claims data supporting our liens to the lien administrator, which includes the specific Billed and Paid Amount of our liens. The lien administrator reviews and verifies our data and to confirm that the Claims included in the liens are reimbursable.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Claims Portfolio</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we have received assignments to recovery rights for more than 160 Assignors in the Medicare, Medicaid, and commercial insurance segments, associated with approximately $1,591 billion in Billed Amount of health care Claims. We have been assigned Claims from all 50 states, as well as Puerto Rico.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We typically acquire recovery rights by entering into a Claims Cost Recovery Agreement (&#8220;CCRA&#8221;) with an Assignor, pursuant to which the Assignor assigns all right, title, and interest in and to certain recovery and reimbursement rights to the Company, or to an affiliated entity, partner, or investor, in exchange for deferred compensation, typically structured as 50% of any net recovery earned by and paid to us, or an up-front lump sum payment. Some of these CCRAs are &#8220;limited recovery&#8221; agreements, meaning that they are limited in time or scope as to what is assigned to us. For example, certain of our CCRAs relate specifically to claims against manufacturers, distributors, and producers of Actos, pioglitazone, metformin, glimepiride, or Duetact. Additionally, certain other CCRAs relate specifically to healthcare services rendered and paid for during a specified timeframe. In general, our CCRAs allow the Company to recover historical Claims. Under some of the CCRAs, the Company has been assigned historical Claims and the Assignor has agreed to continue assigning Claims data. The Company currently expects to generate a substantial portion of total revenue from current CCRAs through recoveries on historical Claims under our recovery model. The Company believes as it develops the Chase to Pay platform and recovery model, a significant portion of the Company&#8217;s revenue from these CCRAs will be derived through the Chase to Pay model by recovering on Claims as they occur.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the cases where we acquire recovery rights for an up-front lump sum payment, we enter into a Claims Purchase and Assignment Agreement (&#8220;CPAA&#8221;). Under a typical CPAA, an entity assigns all right, title, and interest in and to certain recovery and reimbursement rights to us, or to an affiliated entity, partner, or investor, in exchange for an up-front lump sum payment. In these arrangements, we (or our affiliated entity, partner or investor) would typically own 100% of all future net recoveries from those purchased Claims. Often, the CPAA includes a provision to continue acquiring future Claims from the Assignor.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fee Sharing Arrangements</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We enter into legal services agreements with the Law Firm and related entities that hold Claims. In this relationship, the Company (and the Claims holding entities) are the plaintiffs in any action filed, and the Law Firm serves as its counsel. The Law Firm is engaged to act as lead counsel to represent the Company and each of its subsidiaries and affiliates (or other applicable entity) as it pertains to the Assigned Claims, on a contingency basis. The Law Firm engages outside litigation counsel from around the nation as co-counsel and these arrangements are made directly between the Law Firm and other counsel. For the services provided, the Law Firm is typically entitled 40% of our 50% portion of the Gross Proceeds (i.e., 20% of the total Gross Proceeds). This contingency fee can change in the future. The Law Firm is also entitled to attorneys&#8217; fees that are awarded pursuant to any fee shifting statute, by agreement, or court award.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sales and Marketing</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our sales force is comprised of internal and external sales professionals. Our sales force identifies potential Assignors and manages relationships with existing Assignors. Among other things, our marketing strategies generate new Assignor leads by educating potential Assignor clients about our Company. The sales force is incentivized via a recovery-based commission compensation. Once we have received recoveries for Claims related to an Assignor, the applicable sales professional is compensated. This mechanism ensures low fixed costs while offering a potentially generous commission model.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Licensing and Regulation</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to federal and state laws and regulations governing privacy, security, and breaches of patient information and the conduct of certain electronic health care transactions, including, HIPAA and other health information privacy and security requirements. Some of our Assignors with which we have or may establish business relationships are &#8220;Covered Entities&#8221; that are regulated under HIPAA. We also are a &#8220;Business Associate&#8221; of our Assignors; as such, we must comply with HIPAA regulations. To provide our Covered Entity Assignors with services that involve the use or disclosure of protected health information, HIPAA requires us to enter into Business Associate agreements with our Assignors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to HIPAA, we may be subject to other federal and state laws relating to the collection, dissemination, use of, and access to, personal information. While we believe that we are in material compliance with such laws and regulations, failure to comply with these laws could expose us to lawsuits, data security incidents, regulatory enforcement, or fines.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intellectual Property and Research &amp; Development</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on trade secret laws. We use a combination of confidential agreements and licenses with our Assignors, employees, vendors, and third parties. We also rely on other security measures to control the access to our confidential information, software, and other intellectual property. For more information, see Item 1C. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cybersecurity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our research and development team uses proprietary software and a highly trained staff including IT personnel, accountants, physicians, data analysts, and attorneys to analyze data from a variety of sources. We will continue to invest resources to further develop our proprietary systems.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our intellectual property licensing agreements grant, during the term of the agreement, a non-exclusive, non-transferable, non-assignable, irrevocable, worldwide, fully paid-up license under our software and technology to use, perform, import, export, and all other rights pursuant to our software and technology solely in connection with the parties&#8217; assigned Claims and the transactions contemplated in the agreements between the parties. Nothing in these agreements affect our ownership or control in our software and technology. Except for the license, all of our other rights with respect to our software and technology are reserved.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competition</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While other entities in the industry act as vendors and pursue reactive recoveries, we aggressively pursue recoveries on our own behalf, using applicable state and federal laws. Although somewhat different in approach, we compete with in-house recovery departments, collection and financial service companies, and other companies. Some of these entities include, but are not limited to, Cotiviti Holdings, Inc.; Claritev Corp.; Encore Capital Group; Inovalon Holdings, Inc.; Optum, Inc.; Verisk Health, Inc.; McKesson Corp.; Change Healthcare Corp. (a subsidiary of Optum, Inc.); HMS Holdings Corp.; The Rawlings Group; Equian, LLC; and Trover Solutions, Inc.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Human Capital</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our employees and culture are critical components to our success and growth as a company. As of December 31, 2024, we had approximately 78 employees. We employ specialized contract or part-time employees on a temporary basis, which include highly trained IT personnel, accountants, statisticians, physicians, data analysts, and attorneys to maximize the recovery of Claims. None of our employees are covered by collective bargaining agreements or represented by a labor union. We believe that the relationships we have with our employees are positive.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We strive to attract, develop, and retain the best talent by providing competitive pay and benefits, continuous growth and development, and a diverse and inclusive workplace. Our human capital resource objectives include not only acquiring the best talent but also motivating those that drive our business forward. We aim to achieve these objectives using generous compensation programs and offering a unique employee experience. To better develop and incentivize our employees, we regularly provide employee feedback and recognition, and incentivize performance and innovation through an annual bonus program.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Seasonality</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Seasonality does not have a material impact on our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other Information about the Company</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We make available, free of charge, through our website, www.msprecovery.com, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and all amendments to those reports as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC. In addition, our website includes other items related to corporate governance matters, including, among other things, our corporate governance principles, charters of various committees of the Board of Directors, and our code of conduct applicable to all employees, officers, and directors. We intend to disclose on our internet website any amendments to or waivers from our code of business conduct and ethics as well as any amendments to its corporate governance principles or the charters of various committees of the Board of Directors.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The SEC also maintains an internet site that contains reports, proxy and information statements and other information regarding issuers that file periodic and other reports electronically with the SEC. The address of that site is www.sec.gov. The information available on or through our website is not a part of this Annual Report, and should not be relied upon.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="ii_item1a_1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1A</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Risk Factors.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RISK FACTORS SUMMARY</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business is subject to numerous risks and uncertainties, including those highlighted in the section entitled &#8220;Risk Factors&#8221; that represent challenges that we face in connection with the successful implementation of our strategy and growth of our business. The occurrence of one or more of the events or circumstances described in the section entitled &#8220;Risk Factors,&#8221; alone or in combination with other events or circumstances, may have an adverse effect on our business, cash flows, financial condition, and results of operations. Such risks include, but are not limited to:</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks Related to the Company&#8217;s Business and Industry:</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have a history of losses and no substantial revenue to date; we may not generate significant revenue, or achieve profitability.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have a limited history of actual recoveries to date; there are risks associated with estimating the revenue that we recognize.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have concluded there is a substantial doubt about our ability to continue as a going concern.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We assume the risk of failure to recover on the assigned Claims, and we may fail to make recoveries.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unfavorable court rulings, delays, and damages limitations may limit our ability to collect on judgments in our favor.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our litigation often involves complex, novel legal theories with little or no precedent on which courts can rely.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our lawsuits are brought in a diverse range of venues and jurisdictions, which may result in different outcomes on similar issues.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Counterparties in our lawsuits employ dilatory tactics that delay the resolution of litigation or settlement negotiations.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our recoveries may be limited due to legal restrictions.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our fee sharing arrangement with Law Firm materially reduces our recoveries.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Assignors may pursue recoveries directly or use other recovery agents in connection with their efforts to recover on Claims.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lawyers who we rely on to litigate may not exercise due skill and care, or have interests conflicting with those of our Assignors.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future growth depends on growth of the volume of our assigned healthcare Claims and obtaining associated data.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The positions we will typically acquire in connection with our acquisition of Claims are unsecured and may be effectively subordinated to other obligations and are at risk to fraud on the part of the Assignor of the Claim.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Internal improvements to healthcare claims and billing processes could reduce the revenue generated by our solutions.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Spending fluctuations, health care system simplification, and payment integrity initiatives may reduce the demand for our services.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our existing Assignors could prematurely terminate their agreement or materially breach their agreements.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be unable to access Assignor data or be forced to destroy data in our possession, which may impair our ability to recover.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be unable to develop new Assignor relationships.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the extent that we act as servicing agent, our clients may terminate or materially breach their agreement with us.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have long sales cycles for our data-driven solutions and may fail to close sales or experience implementation delays.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our Assignors&#8217; risk agreements change, it can have a material adverse effect on our financial condition and results of operations.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may fail to comply with those privacy regulations or adequately secure the information in our possession.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may fail to innovate and develop new solutions, or new solutions may not be adopted by existing and potential Assignors.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adverse changes could occur in the U.S. healthcare environment, or laws relating to healthcare programs and policies.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We could lose of one or more significant Assignors or experience disruptions in Assignor-payer relationships.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The inability of Assignors to maintain contracts with CMS could adversely affect our business.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The data healthcare analytics and healthcare payment markets are relatively new and unpenetrated, and may not develop, develop more slowly than we expect, or sustain negative publicity, which may adversely affect our business.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Negative publicity concerning the healthcare data analytics and payment accuracy could limit the future growth of the market.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We face significant competition, and we expect competition to increase.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success depends on our ability to protect our intellectual property rights.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable to protect our proprietary technology, information, and processes, the value of our solutions may be diminished.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to obtain, protect, and enforce our intellectual property rights is uncertain.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Qui tam litigation may be subject to Government Intervention and Dismissal pursuant to federal law.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any violation of the laws and regulations or a negative audit or investigation finding could adversely affect our business.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business depends on the integrity of our HIPAA compliant information processing systems.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have substantial indebtedness and payment obligations and may incur future indebtedness or payment obligations.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to obtain or maintain ongoing financing to fund operations would negatively impact our business.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Costs associated with, and an inability to obtain and maintain insurance could adversely affect our profit and financial condition.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our services could become subject to new, revised, or enhanced regulatory requirements in the future.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failing to accurately estimate our contract pricing may have a material adverse effect on our business.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may fail to develop widespread brand awareness, maintain our reputation, or achieve and maintain market acceptance.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to properly manage growth may impact our ability to execute plans, maintain service levels, or address challenges.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not be able to obtain additional capital to continue the development of our business.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to properly manage our growth or obtain additional financing to fund growth could negatively impact our business.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acquisitions may prove unsuccessful or change our business, financial results, and introduce new risks.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to adverse judgments or settlements in litigation, regulatory, or other dispute resolution proceedings.</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable to successfully identify and recover on future Claims, our results of operations could be adversely affected.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may fail to accurately calculate the Paid Amount and Paid Value of Potential Recoverable Claims.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our software vendors, utility providers, and network providers may fail, and we may lose access to data sources.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be sued by third parties for alleged infringement of their proprietary rights.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in, or interpretations of, tax rules and regulations may adversely affect our effective tax rates.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will be required to pay the Tax Receivable Agreement (&#8220;TRA&#8221;) Parties.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Payments under the TRA may impair our ability to consummate change of control transactions.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acceleration of payments under the TRA may impair our ability to consummate change of control transactions.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The loss of key personnel could negatively impact the operations and profitability of the Company.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business is dependent on our ability to attract and retain qualified employees.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General economic, political, and market forces beyond our control could reduce demand for our solutions.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our geographic concentration makes us sensitive to regulatory, economic, environmental, and competitive conditions.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our overall business results may suffer from an economic downturn.</span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks Related to Our Securities:</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are controlled by the Members, whose interests may conflict with our interests and the interests of other stockholders.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our stockholders will experience substantial dilution as a consequence of, among other transactions, further issuances of our stock.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our stockholders may lack corporate governance protections available to those of companies that are not controlled companies.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s management has limited experience in operating a public company.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There can be no assurance that we will be able to comply with the continued listing standards of Nasdaq.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to meet the Nasdaq listing requirements could result in the delisting of our stock and negatively impact capital raising.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our shares are delisted from Nasdaq, it will become more difficult to trade our shares.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be required to take write-downs or write-offs, restructuring, and impairment or other charges.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be subject to unanticipated changes in tax rates or adverse outcomes resulting from examination of our tax returns.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be unable to obtain additional financing to fund the operations and growth of the Company.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Anti-takeover provisions contained in our Charter and Bylaws, as well as Delaware law, could impair a takeover attempt.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Charter contains a provision renouncing our interest and expectancy in certain corporate opportunities.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may redeem unexpired warrants prior to their exercise at a time that is disadvantageous to warrant holders.</span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks Related to Ownership of our Common Stock:</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The market price of our Class A Common Stock may be significantly volatile.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A market for our securities may not continue, which would adversely affect the liquidity and price of our securities.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Company&#8217;s operating results do not meet investor expectations, the market price of our securities may decline.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If securities analysts publish negative reports or stop publishing reports about our business, the price of our stock could decline.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot predict the impact that our dual class capital structure may have on the market price of the shares of our stock.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may amend the terms of the Public Warrants in a manner that may be adverse to holders.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our stockholders may experience significant dilution as a result of future equity offerings or the exercise of options and warrants.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Charter identifying Delaware courts as an exclusive forum may discourage certain lawsuits against our directors and officers.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The JOBS Act permits &#8220;emerging growth companies&#8221; like us to take advantage of certain exemptions from reporting requirements.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to establish and maintain effective internal controls could adversely affect the accuracy and timing of our reporting.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our controls over financial reporting may be ineffective and our accountants may not be able to certify as to their effectiveness.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governmental investigations, regulatory proceedings, and litigation will result in related expenses.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s stockholders may be liable for third party claims against the Company to the extent of distributions they received.</span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks Related to the Yorkville SEPA:</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Substantial blocks of our common stock may be sold into the market, which may cause the price of our common stock to decline.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is impossible to predict the number of shares sold under the Yorkville SEPA; we may not raise the value available thereunder.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The sale and issuance of our shares of our Class A Common Stock to Yorkville will cause dilution to our existing shareholders.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While the Yorkville Convertible Notes are outstanding, we do not exercise absolute control over the issuances of our stock.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon a trigger event, we may be required to make payments that could cause us financial hardship.</span></div></div><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks Related to IT Systems and Cybersecurity</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our systems and networks may be subject to cybersecurity breaches and other disruptions that could compromise our information.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Increased cybersecurity vulnerabilities, threats, and targeted computer crime could pose a risk to our systems, solutions, and data.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain of our activities present the potential for identity theft or illegal behavior by employees, contractors, or third parties.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may fail to comply with applicable privacy, security and data laws, regulations and standards.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may fail to maintain certifications that could result in a breach of our obligations under our contract.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we fail to anticipate and adapt to the growing use of artificial intelligence in our industry could lead to decreased demand.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The use of new technologies in our business may result in spending material resources and presents risks and challenges.</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RISK FACTORS</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">An investment in our securities involves a high degree of risk. You should carefully consider the following risk factors, together with all of the other information included in this Annual Report before making an investment decision. The occurrence of one or more of the events or circumstances described in these risk factors, alone or in combination with other events or circumstances, may have an adverse effect on our business, cash flows, financial condition, and results of operations. You should also carefully consider the following risk factors in addition to the other information included in this Annual Report, including matters addressed in the section entitled &#8220;Cautionary Note Regarding Forward-Looking Statements.&#8221; We may face additional risks and uncertainties that are not presently known to us or that we currently deem immaterial, which may also impair our business or financial condition. The following discussion should be read in conjunction with the financial statements and notes to the financial statements included herein.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to the Company&#8217;s Business and Industry</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In this section &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and the &#8220;Company&#8221; refer to Legacy MSP prior to the Business Combination and to the Company following the Business Combination.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have a history of net losses and no substantial revenue to date, and we may not achieve recoveries, generate significant revenue, or achieve profitability. Our relatively limited operating history makes it difficult to evaluate our current business and future prospects, and increases the risk of your investment.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our relatively limited operating history makes it difficult to evaluate our current business and plan for our future growth. The Company started in 2014 with its first assignment from a health plan headquartered in Miami, Florida. To date, we have achieved no substantial revenue and limited actual recoveries from our assigned Claims, and there is no guarantee that we will achieve recoveries, revenue, or profitability as projected. We have encountered, and will continue to encounter, significant risks and uncertainties frequently experienced by new and growing companies in rapidly changing industries, such as determining appropriate investments for our limited resources, competition from other data analytics companies, acquiring and retaining Assignors, hiring, integrating, training, and retaining skilled personnel, unforeseen expenses, challenges in forecasting accuracy, and successfully integrating new strategies. If we are unable to achieve meaningful recoveries, increase our Assignor base, successfully manage our recovery efforts from third-party payers or successfully expand, our revenue and our ability to achieve and sustain profitability would be impaired. If our assumptions regarding these and other similar risks and uncertainties, which we use to plan our business, are incorrect or change as we gain more experience operating our business or due to changes in our industry, or if we do not address these challenges successfully, our operating and financial results could differ materially from our expectations and our business could suffer.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have a limited history of actual recoveries to date, and there are risks associated with estimating the amount of revenue that we recognize from recoveries. If our estimates of revenue are materially inaccurate, it would impact the timing and the amount of our revenue recognition and have a material adverse effect on our business, results of operations, financial condition, and cash flows.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have a limited track record of generating meaningful recoveries and related revenue from the Claims we have been assigned. There are risks associated with estimating the value of future recoveries and revenues that we may achieve under our assigned Claims. Our estimates and projections depend on significant assumptions and involve significant risks which could cause our actual results to vary materially.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Examples of material assumptions we make include, but are not limited to:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our assessment that the assigned Claims are potentially recoverable Claims;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The achievement of multiples above the Paid Amount of a given Claim; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The length (and cost) of litigation required to achieve recoveries.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any of these assumptions may prove over time to be materially inaccurate. If our estimates of revenues are materially inaccurate, it could impact the timing and the amount of our revenue recognition and have a material adverse impact on our business, results of operations, financial condition, and cash flows.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have concluded there is a substantial doubt about our ability to continue as a going concern.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described under Part II, Item 7. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, Liquidity and Capital Resources, Going Concern</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has evaluated its financial condition as of the date the accompanying consolidated financial statements are being issued (the &#8220;Filing Date&#8221;) and, based on this evaluation, the Company has determined that, as of the Filing Date, the existence of certain conditions and events raise substantial doubt about the Company&#8217;s ability to continue as a going concern within one year following the Filing Date.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s ability to meet its liquidity needs for one year following the Filing Date will largely depend on its ability to raise additional capital or generate future revenue. As of December 31, 2024, the Company had an accumulated deficit of $446.1 million  and $12.3 million in cash and cash equivalents. The Company&#8217;s ability to raise cash in the future is subject to general economic, financial, legal, legislative, regulatory, and other factors, many of which are outside of the Company&#8217;s control, including, but not limited to: (i) the execution of definitive documents to implement the Restructuring Plan, as described in more detail in Part II, Item 7. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, Recent Updates, Restructuring Plan</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, (ii) the ability of the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company to secure additional funding from lenders, if any, (iii) the Company&#8217;s ability to realize recoveries from the settlement of its claims, which to date have not been sufficient to cover the Company&#8217;s cost of operations on a yearly basis, (iv) the Company&#8217;s ability to secure new Assignor relationships and retain and obtain additional Claim assignments from existing Assignors, (v) the Company&#8217;s ability to execute on its strategic plans, (vi) the ability of the Company to manage expenses and grow the business to generate future cash flows from its operations, and (vi) the availability and terms of future financings.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on the Company&#8217;s financial projections as of the Filing Date,the Company does not believe that it will have adequate liquidity to meet its obligations for at least one year following the Filing Date. If the Company is unable to manage these risks and uncertainties, and is unable to meet its liquidity needs, its business would be jeopardized and may not be able to continue to operate. For more information, see &#8220;Part II, Item 7. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, Liquidity and Capital Resources, Going Concern</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s determination of the existence of substantial doubt as to its ability to continue as a going concern itself may have adverse consequences. In addition, the report issued by our independent registered public accounting firm in connection with the audited financial statements for the year ended December 31, 2024, included in this Annual Report includes a going concern explanatory paragraph. The public announcement of this declaration may cause or result in:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">harm to the Company&#8217;s reputation, investor confidence, relationships with the Company&#8217;s Assignors, business partners, and Lenders, and may adversely affect the willingness for third parties to do business with the Company on favorable terms, or at all, in the future;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">disruption of the Company&#8217;s business;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">distraction of the Company&#8217;s management and employees;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">difficulty in recruiting, hiring, motivating, and retaining talented and skilled employees;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">difficulty in maintaining or negotiating and consummating new business or strategic relationships or transactions;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">increased volatility in the price of the Company&#8217;s shares of Class A Common Stock; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">increased costs and advisory fees.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Company is unable to mitigate these or other potential risks related to the uncertainty caused by the Company&#8217;s determination that substantial doubt exists as to the Company&#8217;s ability to continue as a going concern, it may disrupt the Company&#8217;s business or adversely impact the Company&#8217;s prospects, reputation, revenue, operating results, and financial condition.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Under most of our agreements with Assignors, we assume the risk of failure to recover on the assigned Claims, and if we fail to make recoveries with respect to the assigned Claim receivables and therefore, are unable to generate recovery proceeds greater than or equal to the amounts paid by us to purchase the assigned Claims, it can adversely affect our business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some instances, we pay our Assignors an up-front purchase price for assignment of their recovery rights to healthcare Claims. Accordingly, there is a risk that we may not successfully recapture the up-front purchase price if we fail to make recoveries with respect to the assigned Claims. Further, our ability to identify and recover on future Claims includes risks such as:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">underperformance relative to our expectations and the price paid for the Claims;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unanticipated demands on our management and operational resources;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure to successfully recover on legal claims;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">difficulty in integrating personnel, operations, and systems;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">maintaining current customers and securing future customers;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">assumption of liabilities; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">litigation-related costs.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Finally, our potential ability to achieve recovery revenues is based largely on the Paid Value of Potentially Recoverable Claims of our portfolio and our ability to discover, quantify, and settle the gap between Billed Amount and Paid Amount on a large scale. Failure to accurately calculate the Paid Amount or the Paid Value of Potential Recoverable Claims, the recovery multiple, or perfect our recovery rights, may have a material adverse effect on our business, results of operations, financial condition, and cash flows.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Litigation outcomes are inherently risky; unfavorable court rulings, delays, damages calculations, or other limitations can adversely affect our recovery efforts, our potential to generate revenue, and our overall business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is difficult to predict litigation outcomes, particularly complex litigation of the type that forms the basis of our business. If we do not succeed in the litigation, if the damages awarded in our favor are less than what we expected, or if it is not possible to successfully enforce a favorable judgment, we could suffer a variety of adverse consequences, including the complete loss of potential revenue expected from that matter and, in some jurisdictions, liability for the adverse costs of the successful party to the litigation. Unfavorable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">litigation outcomes could, individually or in the aggregate, have a material adverse effect on our business, revenue, results of operations, and financial condition.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Typically, we must file actions in court to recover on our compensible Claims. A substantial portion of our recoveries are dependent on the courts. As such, we are subject to adverse court rulings, significant delays, differing damages calculations or other limitations, each of which can negatively impact our recovery efforts, potential to generate revenue, and the financial condition of our business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For example, from time to time, the courts dismiss our cases, or Claims pursued in our cases, with or without prejudice. When dismissal is without prejudice, we can refile the action. Accordingly, we retain the ability to bring those Claims in a recovery action. When dismissal is with prejudice, we cannot refile the action to pursue recoveries using the dismissed cause of action. We cannot guarantee that we will not receive adverse rulings in court. Historically, we have received adverse rulings or dismissal for reasons such as:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to file within the applicable statute of limitations. For example, on August 10, 2022, a federal appellate court applied a four-year statute of limitations to certain claims brought under the MSP Laws, running from the date that the action accrued. This opinion may render certain Claims held by the Company unrecoverable and may substantially reduce PVPRC and BVPRC as calculated. As our cases were filed at different times and jurisdictions, and prior to data matching with a defendant we are not able to accurately calculate the entirety of damages specific to a given defendant, we cannot calculate with certainty the impact of this ruling at this time. Although this opinion is binding only on federal courts in the Eleventh Circuit, if the application of this statute of limitations is applied to all Claims assigned to us, we estimate that the effect would be a reduction of PVPRC by approximately $9.8 billion. As set forth in our Risk Factors, PVPRC is based on a variety of factors. As such, this estimate is subject to change based on the variety of legal claims being litigated and statute of limitations tolling theories that apply.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An assignment did not include the Claim that was brought in court (or such assignment was found to be invalid).</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lack of standing to assert Claims.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lack of personal jurisdiction.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pleading deficiencies.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, in certain of our cases, our recoveries may be limited as a function of a courts&#8217; damages calculations. Adverse court rulings could also occur from:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our assignment agreements with Assignors being deemed invalid by courts. We obtain assignments of healthcare Claims from our Assignors via irrevocable assignments, which allow us to pursue those Claims that our Assignors originally owned. Enforceability of our assignment agreements is often challenged by defendants, and if a court determines an assignment agreement is invalid (due to a technical deficiency, regulatory prohibition, or otherwise), we may lose the ability to pursue recoveries related to those Claims.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our damages calculations include medical expenses paid by our Assignors that courts may deem unreasonable, unrelated, or unnecessary, and could lead to lower than anticipated recoveries. This may include, but not be limited to, the difference between Medicare, Medicaid, and commercial rates.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Claims may be subject to different interpretations of the applicable statutes of limitations.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, in antitrust matters, damages are generally limited to the difference between the price that a drug manufacturer charged for the drug and the price of the drug absent anti-competitive conduct.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The list above is not exhaustive of potentially unfavorable rulings, damages calculations, or other limitations which we have encountered or may encounter.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We generate, and expect to generate, a significant portion of our revenue by collecting on settlements and/or judgments that are granted by courts in lawsuits filed against insurers, tortfeasors, and other liable parties. A decrease in the willingness of courts to grant these judgments, a change in the requirements for filing these cases or obtaining these judgments, or a decrease in our ability to collect on these judgments could have an adverse effect on our revenue, operating results, and the financial condition of our business. As we increase our use of the legal channels for collections, there could be an increase in up-front court costs and costs related to counterclaims. We may not be able to collect on certain aged Claims because of applicable statutes of limitations, and we may be subject to adverse effects of regulatory changes.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our recoveries may be delayed due to inconsistent rulings on different cases which delay our recovery efforts. We can be subject to unfavorable rulings, damages calculations, or limitations which are not listed above. Such unfavorable rulings, damages calculations, or other limitations can negatively affect our business, results of operations, financial condition, and cash flows.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our recoveries may be limited if courts decline to compel our counterparties to data match with us, or we are otherwise unable to force responsible parties to produce data they store, which identifies the proper party to make a given payment. Among the ways we identify the proper payer for a given claim is by comparing our member data to that of our counterparties in a process called data matching. Members found in both data sets are identified and analyzed to determine if a primary payer was responsible in the first</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">instance to pay or reimburse the cost of care relating to an accident. Should a court decline to compel data matching, our recoveries against a given insurer would be limited to those members identified.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our litigation often involves complex, novel legal theories with little or no precedent on which courts can rely, which may adversely affect our ability to generate revenue and negatively impact our business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The lawsuits we file in pursuit of recoveries often involve causes of action that are entirely novel, or novel as applied to the facts alleged in our complaints. For example, while the MSP Act was enacted in 1980, its use by an assignee to pursue recoveries on its own behalf is novel. As such, courts deciding litigated issues in our cases often have limited binding precedent on which to base an opinion, and often review our cases as a matter of first impression. As a result, litigation outcomes are unpredictable, and our cases may be delayed as courts require more time to analyze the legal issues, and outcomes are difficult to accurately predict.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may employ rarely used causes of action, such as Florida&#8217;s equitable pure bill of discovery. The Company has brought numerous pure bill of discovery cases against medical device and drug manufacturers and insurance companies, seeking to identify the proper party defendant or the appropriate theory on which to base relief. As these cases do not seek money damages, success in these cases may lead to information that can be used to further pursue recoveries, but not money damages that can be recognized as revenue. These cases, in and of themselves, are an expense to the Company, and may negatively impact our business if, for any reason, they fail to yield actionable results.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our counterparties likewise often assert defenses that require complex, jurisdiction specific analysis. Litigation of these issues is often costly, time consuming, and may delay potential recoveries. The success of these defenses is difficult to predict and could result in partial or the entire dismissal of a given case, reducing or eliminating potential recoveries, and any associated recognition of revenue.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our lawsuits are brought in a diverse range of judicial venues across many jurisdictions, which may result in inconsistent outcomes on similar issues, adversely affect our recovery efforts, and limit our ability to generate revenue.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Favorable opinions from state and federal appellate courts are binding only in the jurisdiction where the opinion was published. Accordingly, appellate opinions upholding our legal position may be relied on within the issuing jurisdiction but are, at most, persuasive to other courts. Appellate courts can disagree, and we may obtain an unfavorable opinion on similar issues where another appellate court ruled in our favor. As such, we may expend substantial resources pursuing appeals to establish the validity of a legal basis for recovery, which may prove unsuccessful, thus limiting our ability to generate revenue and negatively impact our business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Counterparties in our lawsuits employ dilatory tactics that delay the resolution of litigation or settlement negotiations, increasing costs associated with recoveries and substantially delaying the outcome of our cases and any associated revenue recognition.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our counterparties employ strategies to delay proceedings and the ultimate resolution of our cases. Dilatory tactics include, but are not limited to, frivolous court filings, extended and improper discovery objections and disputes, delayed negotiations for data matching protocols, and protracted settlement negotiations that may or may not yield a settlement. While these delays do not adversely affect the value of the underlying assets, and in some cases, statutory interest continues to accrue, the costs associated with recoveries increase substantially, and our ability to successfully resolve our cases may be limited. As a result, our ability to recognize revenue is delayed and our ultimate recovery may be diminished or eliminated as a result.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In some jurisdictions, our recoveries may be limited due to legal restrictions, which may have negative consequences for the value or enforcement of our contractual agreements with our counterparties, for our ability to do business in certain jurisdictions, or for our cost of doing business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There exists in various jurisdictions prohibitions or restrictions in connection with purchasing Claims from plaintiffs (known as maintenance, and a form of maintenance, called champerty), assignment of certain kinds of Claims, and/or participation in a lawyer&#8217;s contingent fee interests. Such prohibitions and restrictions, to the extent they exist, are governed by the rules and regulations of each state and jurisdiction in the United States and vary in degrees of strength and enforcement in different states and federal jurisdictions. Some jurisdictions in the U.S. and other jurisdictions may not, for legal and professional ethics reasons, permit us to pursue certain recoveries, or the law and regulations in those jurisdictions may be uncertain, and accordingly we may not have the ability or the desire to pursue recoveries in these jurisdictions, thereby limiting the size of the potential market. If we, our counterparties, or the lawyers handling the underlying matters, were found to have violated the relevant prohibitions or restrictions in connection with certain matters, there could be a materially adverse effect on the value of the affected assets, our ability to enforce the relevant contractual agreements with our counterparties, and the amounts we would be able to recover with respect to such matters, or our costs for such matters.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our fee sharing arrangement with the Law Firm materially reduces our recoveries.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We enter into legal services agreements with the Law Firm and the various entities that hold Claims. The Law Firm is engaged to act as counsel to represent the Company and each of its subsidiaries and affiliates (or other applicable entity) on a contingency basis as it pertains to the assigned Claims. The Law Firm engages outside litigation counsel from around the U.S. as co-counsel and these arrangements are made directly between the Law Firm and other counsel. For the services provided, the Law Firm typically collects a fee equal to 40% of our 50% portion of the Net Proceeds (i.e., 20% of the total Net Proceeds), which is paid from our portion of the Net Proceeds. Co-counsel is paid from the Law Firm&#8217;s portion of the Net Proceeds. The Law Firm is also entitled to attorney&#8217;s fees that are awarded to the Law Firm pursuant to any fee shifting statute, by agreement, or court award. Any increase in attorneys&#8217; fees and costs</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">may reduce our potential net recoveries. For more information about our fee sharing arrangement, see Item 1. Business and &#8220; &#8212;Fee Sharing Arrangements.&#8221;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Assignors may pursue recovery on Claims directly or may use other recovery agents in connection with the Assignor&#8217;s efforts to recover on Claims.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to the Assignors of the assigned Claims, some of our agreements exclude from the assignment of Claims those Claims that are assigned to or being pursued by other recovery vendors of the Assignor at the time of the assignment. We have identified instances where the Assignor did not filter its data provided to us to remove such Claims. This resulted in some Claims being identified by us for purposes of our recovery estimates. This also has resulted in other recovery agents of the Assignor making collections on Claims that were assigned to us. Although we endeavor to seek appropriate clarification from Assignors to properly identify Claims that are being pursued by other recovery vendors, due to the nature and volume of data, it may not be possible to identify with precision all such Claims. While we do not believe that there is material overlap with other recovery vendors with respect to assigned Claims to be material, there can be no assurance as to the ultimate impact on our recoveries or our business. That notwithstanding, where other recovery vendors have made recoveries, the recoveries may not be the full amount of the potential recovery because it was not processed properly or against the correct responsible parties.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, plaintiffs&#8217; attorneys representing members in our Assignors data may have resolved liens as part of a third-party settlement, rendering our Claim moot and unrecoverable if paid properly.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If lawyers who we rely on to litigate Claims and defenses do not exercise due skill and care, or the interests of their clients do not align with the interests of our Assignors, there may be a material adverse effect on the value of our assets.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are particularly reliant on lawyers to litigate claims and defenses with due skill and care. If they are unable or unwilling to do this for any reason, it is likely to have a material adverse effect on the value of our assets. We may have limited experience or no prior dealings with such lawyers and there can be no guarantee that the outcome of a case will be in line with our or the lawyers&#8217; assessment of the case or that such lawyers will perform with the expected skill and care.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business and future growth depend on our ability to successfully expand the volume of our portfolio of assigned Claims and obtain data from new Assignors and healthcare Claims from our existing Assignor base.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect a significant portion of our future revenue growth to come from expanding the portfolio of Claims that we are assigned; this includes obtaining Claims and data from new Assignors as well as our existing Assignors. Our efforts to do so may not be successful. If we are unable to successfully expand the scope of healthcare Claims assigned from potential and existing Assignors, it could have a material adverse effect on our growth and on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The positions we will typically acquire in connection with our acquisition of Claims are unsecured, and may be effectively subordinated to other obligations or duplicated due to mistake, negligence, or fraud on the part of the Assignor of the Claim.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The types of Claims we invest in are typically unsecured, and therefore will be subordinated to existing or future secured obligations and may be subordinated to other unsecured obligations of the parties against which we seek recoveries. The repayment of these Claims and rights is subject to significant uncertainties. The holders of other obligations may have priority over us to collect amounts due to them and therefore would be entitled to be paid in full before assets would be available for distribution to us. Our Assignors typically provide subrogation or &#8220;carve out&#8221; lists to identify those claims that were not included in an assignment or were pursued by another recovery vendor; however, the subrogation lists may be incomplete or inaccurate, thus resulting in our pursuit of a recovery that we are either not entitled to, or that has already been recovered.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, Assignors may misrepresent or omit material information, such as the underlying beneficiary or other counterparty. For example, an Assignor may misrepresent the quality, validity, or existence of a Claim or other information provided to us, or provide duplicate Claim data, either due to unintentional negligence or intentional fraud. Although we have procedures in place to identify duplicate Claims, there is no assurance we will detect such error. Any inaccuracy, duplication, or incompleteness, if undetected, may adversely affect the valuation of one or more Claims and adversely affect our business and performance. Under certain circumstances, recoveries may be reclaimed if any such payment or distribution is later determined to have been a fraudulent conveyance.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Internal improvements to healthcare Claims and retail billing processes by our Assignors could reduce the need for, and revenue generated by, our solutions, which could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We offer solutions that help our Assignors enhance payment accuracy in an increasingly complex environment, including through our Chase to Pay platform. Over time, our work may increase compliance amongst third-party payers. If such processes continue to improve, demand for our solutions could be reduced. With enough time and investment, many of our Assignors may be able to reduce or resolve recurring payment process complexities and resulting payment inaccuracies. As the skills, experience, and resources of such technology, systems, and personnel improve, they may be able to identify payment inaccuracies before using our services, which would reduce the payment inaccuracies identified by our solutions and our ability to generate revenue, which could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, the current administration has tasked the Department of Government Efficiency subcommittee (&#8220;DOGE&#8221;) with launching a &#8220;War on Waste,&#8221; to identify and eliminate fraud, waste, and abuse in governmental spending programs, including Medicare. DOGE has committed to, among other things, improve identity verification and refine payment tracking mechanisms at the federal and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">state level to ensure that federal payments systems are protected from future abuses. Although such measures will likely have minimal impact on payments already made, they may reduce the fraud, waste, and abuse associated with future Claims assigned to the Company, thus reducing the need for our existing solutions, which could have a material adverse effect on our growth and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Healthcare spending fluctuations, simplification of the healthcare delivery and reimbursement system, and programmatic changes to the scope of benefits and limitations to payment integrity initiatives could reduce the need for our data-driven solutions, which could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our solutions improve the Assignors&#8217; ability to accurately pay healthcare Claims and prevent or recover inaccurate payments, which often are a result of complexities in the healthcare Claims payment system. Although the healthcare benefit and payment systems continue to grow in complexity due to factors such as increased regulation and increased healthcare enrollment, the need for and user adoption of our solutions and/or the scope and profitability of the solutions that we provide to our Assignors could be negatively affected by, among other things:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">simplification of the U.S. healthcare delivery and reimbursement systems, either through shifts in the commercial healthcare marketplace or through legislative or regulatory changes at the federal or state level;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reductions in the scope of private sector or government healthcare benefits (for example, decisions to eliminate coverage of certain services);</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the transition of healthcare beneficiaries from fee-for-service plans to value-based plans;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the adoption of healthcare plans with significantly higher deductibles;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limits placed on payment integrity initiatives, including the Medicare Recovery Audit Contractor (&#8220;RAC&#8221;) program; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">lower than projected growth in private health insurance or the various Medicare and Medicaid programs, including Medicare Advantage.</span></div></div><p style="margin-left:3.733%;text-indent:-3.587%;padding-left:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any of these developments could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If our existing Assignors prematurely terminate their agreement with us, or if either party materially breaches an agreement, and we can no longer receive future assignments of healthcare Claims recoveries, it could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect in the future to derive a significant portion of our revenue from our existing Assignors and, accordingly, we are reliant on the ongoing transfer and usage of data, and associated assignments, of Claims from existing Assignors. As a result, maintaining these relationships is critical to our future growth and our business, financial condition, and results of operations. We may experience significantly more difficulty than we anticipate in maintaining our existing Assignor agreements. Factors that may affect our ability to continue providing our services under such agreements for our services and our ability to sell additional solutions include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the price, performance, and functionality of our solutions;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability, price, performance, and functionality of competing solutions;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our Assignors&#8217; perceived ability to review Claims accurately using internal resources;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to develop complementary solutions;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our continued ability to access data necessary to enable us to effectively develop and deliver new solutions to Assignors;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the stability and security of our platform;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in healthcare laws, regulations, or trends; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the business environment of our Assignors.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the CCRAs with our Assignors, the Assignors may choose to discontinue one or more services under an existing contract, may exercise flexibilities within their contracts to adjust service volumes, and may breach or terminate the contract prior to its agreed upon completion date. A material breach by either party to our agreements may result in the termination of receiving future data transmissions or Claim assignments. Any such occurrences could reduce our revenue from these Assignors. Although a cancellation or termination of a contract does not revoke the original assignment from our Assignors, as such assignments are irrevocable, termination still affects future transfers of data and future assignment of Claims. Accordingly, such cancellations or terminations can constrain our growth and result in a decrease in revenue, which could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If an Assignor prematurely terminates its agreement with us, we may be precluded from accessing that Assignor&#8217;s data and/or be forced to destroy data in our possession from that Assignor, which may substantially impair our ability to recover on that Assignor&#8217;s Claims.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We enter into Claims Cost Recovery Agreements (&#8220;CCRA&#8221;) and Business Associate Agreements (&#8220;BAA&#8221;) with our Assignors. Pursuant to the CCRAs with our Assignors, we receive historical claims data, and may receive updated claims data and ongoing data transfers at agreed upon intervals. If, for any reason, a CCRA is terminated, the BAA requires us to return and/or destroy all protected health information (&#8220;PHI&#8221;) associated with that CCRA, which may substantially impair our ability to recover on that Assignor&#8217;s Claims.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to develop new Assignor relationships, it could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of our strategy, we seek to develop new Assignor relationships, principally among healthcare payers and providers. Our ability to develop new relationships depends on a variety of factors, including the quality and performance of our solutions, as well as the ability to market and sell our solutions effectively and differentiate ourselves from our competitors. We may not be successful in developing new Assignor relationships. If we are unable to develop new Assignor relationships, it could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In some events, we may act as a servicing agent for another party. If one of these parties terminates their agreement with us or if either party materially breaches an agreement, it could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may provide our services as a servicing agent to third parties. These services include, but are not limited to, identifying, processing, prosecuting, and recovering monies related to recoverable Claims. As a servicing agent, we will act as an independent contractor on behalf of a contracting party who owns the rights to certain recoverable Claims. If a party terminates such servicing agreement with us, or if either party is in default of any servicing agreement, it could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have long sales and implementation cycles for many of our data-driven solutions and may fail to close sales after expending time and resources, or experience delays in implementing the solutions, which could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Potential customers generally perform a thorough evaluation of available payment accuracy solutions and require us to expend time, effort, and money educating them as to the value of our solutions prior to entering into a contract with them. We may expend significant funds and management resources during the sales cycle and ultimately fail to close the sale. Our sales cycle may be extended due to our potential customers&#8217; budgetary constraints or for other reasons. In addition, following a successful sale, the implementation of our systems frequently involves a lengthy process, as we onboard a new customer&#8217;s healthcare data into our proprietary systems. If we are unsuccessful in closing sales after expending funds and management resources or if we experience delays in such sales or in implementing our solutions, it could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If our Assignors&#8217; risk agreements change, it can have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of our Assignors are Medicare first-tier entities, as defined federal regulations. A first-tier entity is a party that enters into a written arrangement, acceptable to CMS, with an MAO or applicant to provide administrative services or healthcare services for a Medicare eligible individual under the Medicare Advantage program. These entities enter into risk agreements with downstream entities, as defined by federal regulations. If these agreements change or include any restrictions on the assignability of Claims, it can have a material adverse effect on our recoveries, business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our use and disclosure of personally identifiable information, including PHI, is subject to federal and state privacy and security regulations, and our failure to comply with those regulations or adequately secure the information we hold could result in significant liability or reputational harm.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">State and federal laws and regulations, including HIPAA, govern the collection, dissemination, use, disclosure, creation, receipt, maintenance, transmission, privacy, confidentiality, security, availability, and integrity of personally identifiable information, including PHI. HIPAA establishes basic national privacy and security standards for protection of PHI by covered entities such as our Assignors, and the business associates with whom such entities contract for services, including us. As a business associate, we are also directly responsible for HIPAA compliance. In addition to HIPAA, we must adhere to state patient confidentiality and other laws that are not preempted by HIPAA, including those that are more stringent than HIPAA.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event of a breach of our obligations under HIPAA or other state laws, we could be subject to enforcement actions and lawsuits brought by the U.S. Department of Health and Human Services Office for Civil Rights (&#8220;OCR&#8221;), state regulators, and/or class action lawsuits brought by private plaintiffs. Mandatory penalties for HIPAA violations can be significant and OCR and state regulators may require businesses to enter into settlement or resolution agreements and corrective action plans that impose ongoing compliance requirements. If a person knowingly or intentionally obtains or discloses PHI in violation of HIPAA requirements, criminal penalties may also be imposed. In addition, state attorneys general are authorized to bring civil actions under HIPAA or relevant state laws. Courts can award damages, costs, and attorneys&#8217; fees related to violations of HIPAA or state laws in such cases. While we maintain safeguards that we believe are reasonable and appropriate to protect the privacy and security of PHI and other personally identifiable information consistent with applicable law and our contractual obligations, we cannot provide assurances regarding how these laws, regulations, and contracts will be interpreted, enforced, or applied to our operations.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to innovate and develop new solutions, or if these new solutions are not adopted by existing and potential Assignors or other users, it could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our results of operations and continued growth will depend on our ability to successfully develop and market new solutions that our existing and potential Assignors or other users are willing to adopt. We cannot provide assurance that our proposed solutions will be fully developed or released, or that new or modified solutions will be responsive to Assignor or preferences or industry changes, or that the product and service development initiatives we prioritize will yield the return on investment that we anticipate, if any.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable to predict market preferences or if our industry changes, or if we are unable to implement or modify our solutions on a timely basis, we may lose Assignors or fail to attract new ones. If existing Assignors are not willing to adopt new solutions, or if potential Assignors or other users do not value such new solutions, it could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect to make substantial investments in and changes to our operational platforms, systems, and applications to compete effectively and keep up with technological advances. We may also face difficulties in integrating new or upgraded platforms into our current technology infrastructure. In addition, significant technological changes could render our existing solutions obsolete. Although we have invested, and will continue to invest, significant resources in developing and enhancing our solutions and platforms, any failure to keep up with technological advances or to integrate upgraded operational platforms and solutions into our existing technology infrastructure could result in a negative return on investment, and have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in the United States healthcare environment, or in laws relating to healthcare programs and policies, and steps we take in anticipation of such changes or a failure to comply with such laws, particularly as they relate to the Affordable Care Act and Medicare and Medicaid programs, could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Approximately 95.9% of our expected recoveries arise from Claims being brought under the MSP Act private cause of action. This law allows us to pursue recoveries against primary payers for reimbursement of medical expenses that our Assignors paid for when primary payers (i.e., liability insurers) were responsible for payment. While we believe we have been successful at both the federal and state level in establishing a legal basis for our recoveries, changes to the laws on which we base our recoveries, particularly the MSP Act, can adversely affect our business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For example, on May 16, 2023, Senators Tim Scott (R-SC) and Maggie Hassan (D-NH) and Representatives Brad Schneider (D-IL) and Gus Bilirakis (R-FL) introduced the Repair Abuses of MSP Payments Act (S.1607/H.R.3388) (the &#8220;RAMP Act&#8221;) in the U.S. Senate and the U.S. House of Representatives, respectively, seeking to amend the private cause of action under the Medicare Secondary Payer Act, by striking &#8220;primary plan&#8221; and inserting &#8220;group health plan&#8221; (as defined in paragraph 42 U.S.C. &#167; 1395y(b)(1)(A)(v)). The 118th Congress ended on January 3, 2025 without further action on the proposal, and the RAMP Act was not enacted into law.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Medicare Secondary Payer Act&#8217;s private cause of action&#8212;a fundamental component of how the Company is able to calculate damages&#8212;incentivizes private parties, such as MSP Recovery, to pursue reimbursement of conditional payments by rewarding them with double damages. If the MSP Act is changed, it could significantly reduce the Company&#8217;s potential recoveries and have a material adverse effect on its business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The healthcare industry in the United States is subject to a multitude of changing political, economic, and regulatory influences that affect every aspect of our healthcare system. The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act (the &#8220;Affordable Care Act&#8221;), made major changes in how healthcare is delivered and reimbursed, and generally increased access to health insurance benefits to the uninsured and underinsured population of the United States. Among other things, the Affordable Care Act increased the number of individuals with Medicaid and private insurance coverage, implemented reimbursement policies that tie payment to quality, facilitated the creation of accountable care organizations that may use capitation and other alternative payment methodologies, strengthened enforcement of fraud and abuse laws, and encouraged the use of information technology. However, many of these changes require implementing regulations that have not yet been drafted or have been released only as proposed rules. In addition, there have been, and continue to be, a number of legislative and regulatory initiatives to contain healthcare costs, reduce federal and state government spending on healthcare products and services, and limit or restrict the scope of the Medicare RAC program and other program integrity initiatives.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future changes to the Affordable Care Act and to the Medicare and Medicaid programs and other federal or state healthcare reform measures may lower reimbursement rates, establish new payment models, increase or decrease government involvement in healthcare, decrease the Medicare RAC program and otherwise change the operating environment for us and our Assignors. If efforts to waive, modify, or otherwise change the Affordable Care Act, in whole or in part, are successful, if we are unable to adapt our solutions to meet changing requirements or expand service delivery into new areas, or the demand for our solutions is reduced as a result of healthcare organizations&#8217; reactions to changed circumstances and financial pressures, it could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The current administration has stated its intent to evaluate overall government spending, which could impact our business, results of operations, financial condition, and growth prospects. Future healthcare spending and program authorizations may not increase or may decrease or shift to non-healthcare related programs. Such changes in spending authorizations and budgetary priorities may occur as a result of shifts in spending priorities from healthcare-related programs as a result of competing demands for federal funds. A</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">significant decline in overall U.S. government spending, a significant shift in spending priorities, or the substantial reduction or elimination of particular healthcare-related programs could adversely affect our future revenue and limit our growth prospects.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Healthcare organizations may react to such changed circumstances and financial pressures, including those surrounding the implementation of the Affordable Care Act, by taking actions such as curtailing or deferring their retention of service providers, which could reduce the demand for our data driven solutions and, in turn, have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">A significant portion of our Claims comes from a limited number of Assignors who have relationships with key existing payers; the loss of one or more of these Assignors or disruptions in Assignor-payer relationships could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have acquired a significant portion of our Claims from and entered into agreements for new services with a limited number of large Assignors. These Assignors irrevocably assign Claims to us with different and/or staggered terms. In addition, we rely on our reputation and recommendations from key Assignors to promote our solutions to potential new Assignors.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, our ability to pursue a significant portion of our Claims depends on our arrangements pursuant to which we are granted access to health care data, which may be terminated upon the occurrence of certain events. See &#8220;Risk Factor - Failure of our software vendors, utility providers, and network providers to perform as expected, changes in our relationships with them, or losing access to data sources may adversely affect our business.&#8221; Accordingly, if any of these Assignors fail to renew or terminate their existing agreements with us, it could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our revenues and operations are dependent upon a limited number of key existing payers and our Assignors&#8217; continued relationship with those payers; disruptions in those relationships (including renegotiation, non-renewal, or termination of capitation agreements) or the inability of such payers to maintain their contracts with CMS could adversely affect our business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our operations are dependent on a concentrated number of payers with whom our Assignors contract to provide services. The loss of these contracts for our Assignors could have a material adverse effect on our business, results of operations, financial condition, and cash flows. The sudden loss of an Assignor or the renegotiation of the future rights of an Assignors&#8217; contract could adversely affect our operating results.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, our inability to maintain agreements with our Assignors with respect to their health care Claims recovery rights and data, or to negotiate favorable terms for those agreements in the future, could result in the loss of revenue and could have a material adverse effect on our profitability and business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The data healthcare analytics and healthcare payment markets are relatively new and unpenetrated, and may not develop, develop more slowly than we expect, or sustain negative publicity, which may adversely affect our business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The data healthcare analytics and healthcare payment accuracy markets are relatively new and the overall market opportunity remains relatively unpenetrated. It is uncertain whether this market will achieve and sustain high levels of demand, client acceptance, and market adoption. Our success will depend to a substantial extent on the willingness of our Assignors to use, and to increase the frequency and extent of their utilization of our solutions, as well as on our ability to demonstrate the value of data-driven solutions and payment accuracy solutions to healthcare payers and government agencies. If our Assignors or other potential customers do not perceive the benefits of our data-driven solutions, then our market may not continue to develop, or it may develop more slowly than we expect. If any of these events occur, it could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Negative publicity concerning the data healthcare analytics and healthcare payment accuracy industry or patient confidentiality and privacy could limit the future growth of the healthcare payment accuracy market.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our data-driven solutions help prevent and recover improper payments made to healthcare providers. As a result, healthcare providers, insurers, third-party payers, and others have criticized the healthcare payment accuracy industry and have hired lobbyists to discredit the reported success that payment accuracy solutions have had in improving the accuracy of payments. Further, negative publicity regarding patient confidentiality and privacy could limit market acceptance of our healthcare solutions. Many consumer advocates, privacy advocates, and government regulators believe that the existing laws and regulations do not adequately protect privacy. They have become increasingly concerned with the use of personal information. As a result, they are lobbying for further restrictions on the dissemination or commercial use of personal information to the public and private sectors. If healthcare providers, privacy advocates, or others are successful in creating negative publicity for the healthcare payment accuracy industry, government and private healthcare payers could hesitate to contract with payment accuracy providers, such as us, which could have a material adverse effect on our reputation, business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We face significant competition, and we expect competition to increase.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competition among providers of healthcare payment accuracy solutions to U.S. healthcare insurance companies is strong, and we may encounter additional competition as new competitors enter this area.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our current healthcare solutions competitors include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">other payment accuracy vendors, including vendors focused on discrete aspects of the healthcare payment accuracy process;</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">fraud, waste, and abuse Claim edit and predictive analysis companies;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">primary Claims processors;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">numerous regional utilization management companies;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in-house payment accuracy capabilities;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Medicare Recovery Audit Contractors; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">healthcare consulting firms and other third-party liability service providers.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not be able to compete successfully against existing or new competitors. In addition, we may be forced to increase the consideration we provide for assigned Claims or lower our pricing, or the demand for our data-driven solutions may decrease as a result of increased competition. Further, a failure to be responsive to our existing and potential Assignors&#8217; needs could hinder our ability to maintain or expand our Assignor base, hire and retain new employees, pursue new business opportunities, complete future acquisitions, and operate our business effectively. Any inability to compete effectively could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our success depends, in part, on our ability to protect our intellectual property rights.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success depends, in part, on our ability to protect our proprietary software, confidential information and know-how, technology and other intellectual property, and intellectual property rights. To do so, we generally rely on copyright, trademark and trade secret laws, confidentiality and invention assignment agreements with employees and third parties, and license and other agreements with consultants, vendors, and Assignors. There can be no assurance that employees, consultants, vendors, and Assignors have executed such agreements or have not breached or will not breach their agreements with us, that we will have adequate remedies for any breach, or that our trade secrets will not otherwise become known or independently developed by competitors. Additionally, we monitor our use of open-source software to avoid uses that would require us to disclose our proprietary source code or violate applicable open-source licenses, but if we engaged in such uses inadvertently, we could be required to take remedial action or release certain of our proprietary source code. These scenarios could have a material adverse effect on our business, financial condition, and results of operations. In addition, despite the protections we place on our intellectual property, a third party could, without authorization, copy or otherwise obtain and use our products or technology, or develop similar technology. In addition, agreement terms that address non-competition are difficult to enforce in many jurisdictions and might not be enforceable in certain cases.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As we begin to pursue patents, we might not be able to obtain meaningful patent protection for our technology. In addition, if any patents are issued in the future, they might not provide us with any competitive advantages or might be successfully challenged by third parties.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on unpatented proprietary technology. It is possible that others will independently develop the same or similar technology or otherwise obtain access to our unpatented technology. To protect our trade secrets and other proprietary information, we require employees, consultants, advisors, and collaborators to enter into confidentiality agreements. We cannot provide assurance that these agreements will provide meaningful protection for our trade secrets, know-how, or other proprietary information in the event of any unauthorized use, misappropriation, or disclosure of such trade secrets, know-how, or other proprietary information. Further, the theft or unauthorized use or publication of our trade secrets and other confidential business information could reduce the differentiation of our services and harm our business, and the value of our investment in development or business acquisitions could be reduced and third parties might make claims against us related to losses of their confidential or proprietary information.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on our trademarks, service marks, trade names, and brand names to distinguish our services from the services of our competitors and have registered or applied to register many of these trademarks. We cannot provide assurance that trademark applications filed by the Company will be approved. Third parties may also oppose our trademark applications or otherwise challenge our use of the trademarks. In the event that our trademarks are successfully challenged, we could be forced to rebrand our services, which could result in loss of brand recognition and could require us to devote resources to advertising and marketing new brands. Further, we cannot assure you that competitors will not infringe our trademarks or that we will have adequate resources to enforce our trademarks. Additionally, if we expand our focus to the international payment accuracy market, there is no guarantee that our trademarks, service marks, trade names, and brand names will be adequately protected.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to protect our proprietary technology, information, processes, and know-how, the value of our solutions may be diminished, which could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely significantly on proprietary technology, information, processes, and know-how that are not subject to patent or copyright protection. We seek to protect this information through trade secret or confidentiality agreements with our employees, consultants, subcontractors or other parties, as well as through other security measures. These agreements and security measures may be inadequate to deter misappropriation of intellectual property and may be insufficient to protect our proprietary information. Misappropriation of our intellectual property by third parties, or any disclosure or dissemination of our business intelligence, queries, Algorithms, and other similar information by any means, could undermine competitive advantages we currently derive or may derive therefrom. Any of these situations could result in our expending significant time and incurring expense to enforce our intellectual property rights. Although we have taken measures to protect our proprietary rights, others may compete with our business by offering solutions or services that are substantially similar to ours. If the protection of our proprietary rights is inadequate to prevent unauthorized use or appropriation by third parties or our employees, the value of our solutions, brand, and other intangible assets may be diminished and competitors may be able to more effectively offer solutions that have the same or similar functionality as our solutions, which could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our ability to obtain, protect, and enforce our intellectual property rights is subject to uncertainty as to the scope of protection, registrability, patentability, validity, and enforceability of our intellectual property rights in each applicable jurisdiction, as well as the risk of general litigation or third-party oppositions.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Existing U.S. federal and state intellectual property laws offer limited protection. If we expand our business into foreign markets, our intellectual property rights may not receive the same degree of protection as they would in the United States because of the differences in foreign trademark and other laws concerning proprietary rights. Governments may adopt regulations, and government agencies or courts may render decisions, requiring compulsory licensing of intellectual property rights. When we seek to enforce our intellectual property rights, we may be subject to claims that the intellectual property rights are invalid or unenforceable. Litigation may be necessary in the future to enforce our intellectual property rights and to protect our trade secrets. Litigation brought to protect and enforce our intellectual property rights could be costly, time consuming, and distracting to management, and could result in the impairment or loss of portions of our intellectual property rights. Furthermore, our efforts to enforce our intellectual property rights may be met with defenses, counterclaims, and countersuits attacking the validity and enforceability of our intellectual property rights. Our inability to protect our proprietary technology against unauthorized copying or use, as well as any costly litigation or diversion of our management&#8217;s attention and resources, could delay further sales or the implementation of our solutions, impair the functionality of our solutions, delay introductions of new solutions, result in our substituting inferior or more costly technologies into our solutions, or have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Qui tam litigation is subject to intervention and dismissal by the federal and state governments.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may file qui tam (whistleblower) actions on behalf of the federal government pursuant to the False Claims Act, and the states that have laws that modeled after the False Claims Act. These actions give the federal and state governments the opportunity to: (i) intervene and participate in the action, and (ii) to dismiss the action over a relator&#8217;s objection, if it is determined that the litigation does not advance the governmental interests, to preserve the government&#8217;s limited resources, or to avoid adverse precedent. Courts have stated that the federal government has an &#8220;unfettered&#8221; right to dismiss a qui tam action. As such, the Company may commit substantial resources to investigate, file, and litigate a qui tam action on behalf of a state or federal government that either opts to intervene in case or dismiss it entirely, either of which could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are subject to extensive government regulation. Any violation of the laws and regulations applicable to us or a negative audit or investigation finding, could have a material adverse effect on our business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Much of our business is regulated by the jurisdictions in which we operate. The laws and regulations governing our operations generally are intended to benefit and protect individual citizens, including government program beneficiaries, health plan members, and providers, rather than stockholders. The government agencies administering these laws and regulations have broad latitude to enforce them. These laws and regulations regulate how we do business, what services we offer, and how we interact with our Assignors, providers, other healthcare payers, and the public. Increased involvement by us in analytic or audit work that can have an impact on the eligibility of individuals for medical coverage or specific benefits could increase the likelihood and incidence of us being subjected to scrutiny or legal actions by parties other than our Assignors, based on alleged mistakes or deficiencies in our work, with significant resulting costs and strain on our resources.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, as we may receive payments from federal and state governmental agencies, we may become subject to various laws, including the federal False Claims Act and similar state statutes, which permit government law enforcement agencies to institute suits against us for violations and, in some cases, to seek double or treble damages, penalties, and assessments. In addition, private citizens, acting as whistleblowers, can sue on behalf of the federal government under the qui tam provisions of the federal False Claims Act and similar statutory provisions in many states.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The expansion of our operations into new products, services, or jurisdictions may further expose us to requirements and potential liabilities under additional statutes and legislative schemes that previously have not been relevant to our business, such as banking statutes, that may both increase demands on our resources for compliance activities and subject us to potential penalties for noncompliance with statutory and regulatory standards.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a governmental inquiry discovers improper or illegal activities in the course of audits or investigations, we may be subject to various civil and criminal penalties and administrative sanctions, which may include termination of contracts, forfeiture of profits, suspension of payments, fines and suspensions, and debarment from doing business with the government. Such risks, particularly under the Federal False Claims Act and similar state fraud statutes, have increased in recent years due to legislative changes that have (among other amendments) expanded the definition of a false claim to include, potentially, any unreimbursed overpayment received from, or other monetary debt owed to, a government agency. If we are found to be in violation of any applicable law or regulation, or if we receive an adverse review, audit or investigation, any resulting negative publicity, penalties or sanctions could have an adverse effect on our reputation in the industry, impair our ability to compete for new contracts and have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also subject to laws, regulations and rules enacted by foreign, national, regional, and local governments and Nasdaq. In particular, we are required to comply with certain SEC, Nasdaq, and other legal or regulatory requirements. Compliance with, and monitoring of, applicable laws, regulations, and rules may be difficult, time-consuming, and costly. Those laws, regulations, or rules and their interpretation and application may also change from time to time, and those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply with applicable laws, regulations, or rules, as interpreted and applied, could have a material adverse effect on our business and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business depends on effective information processing systems that are compliant with current HIPAA transaction and code set standards and the integrity of the data in, and operations of, our information systems, as well as those of other entities that provide us with data or receive data from us.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to conduct our operations and accurately report our financial results depends on the integrity of the data in our information systems and the integrity of the processes performed by those systems. These information systems and applications require continual maintenance, upgrading, and enhancement to meet our operational needs, satisfy Assignor requests, and facilitate our expansion and growth. Despite our testing and quality control measures, we cannot be certain that errors or system deficiencies will not be found, and that remediation can be done in a timeframe that is acceptable to our Assignors or that Assignor relationships will not be impaired by the occurrence of errors or the need for remediation. In addition, implementation of upgrades and enhancements may cost more, take longer, or require more testing than originally expected. Given the large amount of data we collect and manage, it is possible that hardware failures, errors, or technical deficiencies in our systems could result in data loss or corruption or cause the information that we collect, utilize, or disseminate to be incomplete or contain inaccuracies that our Assignors regard as significant.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, because we submit high volumes of monetary Claims to third parties, the efficiency and effectiveness of our own operations are to some degree dependent on the Claims processing systems of these third parties and their compliance with any new transaction and code set standards. Since October 1, 2015, health plans, commercial payers, and healthcare providers have been required to transition to the new ICD-10 coding system, which greatly expands the number and detail of diagnosis codes used for inpatient, outpatient, and physician Claims. The transition to the new transaction and code set standard is expensive, time-consuming, and may result in disruptions or delays as we and other stakeholders make necessary system adjustments to be fully compliant and capable of exchanging data.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we may experience delays in processing Claims and therefore generating revenue if the third parties with whom we work are not in full compliance with these new standards in the required timeframe. Claims processing systems failures, incapacities, or deficiencies internal to these third parties could significantly delay or obstruct our ability to obtain recoveries, and thereby interfere with our performance and our ability to generate revenue in the anticipated timeframe, which could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have a substantial amount of indebtedness and payment obligations which, together with any future indebtedness or payment obligations, could adversely affect our ability to operate our business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have substantial amounts of indebtedness and payment obligations, and we may incur substantial additional indebtedness or payment obligations in order to finance acquisitions of additional Claims assets or other costs in connection with financing our operations, and such increased leverage could adversely affect our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our indebtedness carries high compounding interest rates, which, if we are unable to generate revenues and reduce the amount of our indebtedness, will continue to increase over time by a significant amount. In addition, the terms of any of our existing or future indebtedness or payment obligations may restrict or otherwise negatively impact our ability to grow and manage our business. The maturity dates on our indebtedness are often short-term in nature, and require extensions and amendments in order to prevent such indebtedness from becoming immediately due and payable. We may not have the ability to extend the terms of our indebtedness, refinance our indebtedness, or pay such amounts when due if we do not begin generating significant revenue. Certain of our debt agreements are floating rate debt. As a result, fluctuations in interest rates can increase borrowing costs, which may directly impact the amount of interest we are required to pay. The amount of our indebtedness and payment obligations could limit our ability to obtain further financing and limit our ability to pursue our operational and strategic goals and opportunities, and adversely affect our liquidity position if the Claims we purchase do not generate proceeds at the rate we expect, if at all. The increased leverage, potential lack of access to financing, and increased expenses could have a material adverse effect on our financial condition, results of operations, and cash flows.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Failure to obtain or maintain ongoing financing to fund operations would negatively impact our business.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are currently dependent on certain limited funding sources, including the Working Capital Credit Facility, the Yorkville SEPA, and beyond July 2025, the MSP Principals&#8217; commitment to pledge $25 million of collateral to backstop additional working capital requirements of the Company.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Working Capital Credit Facility, a continued source of funding for operations, is contingent on compliance with certain covenants, which we may not meet. If we fail to comply with these covenants, continued funding may cease, substantially impairing our ability to continue our operations, including the pursuit of recoveries. During fiscal year 2023, under the Working Capital Credit Facility, HPH disbursed $20.5 million under Term Loan A and $9.0 million under Term Loan B. Under the Operational Collection Floor, during 2024 the Company received : (i) $12.3 million for working capital, and (ii) $2.0 million for the purpose of acquiring the New Claims. To date, the Company received $3.5 million of working capital for 2025. Pursuant to the Working Capital Credit Facility, HPH may, at its sole discretion, increase the Operational Collection Floor by an amount of up to $6.0 million, to be funded over a period of three to six months. On February 28, 2025 and April 4, 2025, HPH exercised that discretion and funded $1.75 million and $1.5 million, respectively, from the increase to the Operational Collection Floor. An additional $2.75 million remains available under the Operational Collection Floor, to be funded at HPH&#8217;s sole discretion. For further information on the Working Capital Credit Facility, please see Note 9, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Financing Obligations and Notes Payable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, although the Yorkville SEPA provides that we may sell up to an aggregate of $250 million of our Class A Common Stock to Yorkville, only 2.0 million shares of our common stock were registered for resale under the registration statement, which we may elect to sell to Yorkville, in our sole discretion, from time to time from and after the date of, and pursuant to, the Yorkville SEPA or that Yorkville may require that we sell pursuant to a Yorkville Advance. Even if we elect to sell to Yorkville all of the shares of Common Stock, depending on the market prices of our Class A Common Stock at the time of such sales, the actual gross proceeds from the sale of all such shares may be less than $250 million, which could materially and adversely affect our liquidity.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As we have sold substantially all of the 2.0 million shares currently registered for resale to Yorkville, we need to file with the SEC one or more additional registration statements to register under the Securities Act the resale by Yorkville of any additional shares of our common stock, and the SEC would have to declare such registration statement or statements effective before we could sell additional shares. There can be no assurances of such events occurring or the timing of such events occurring.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, although the MSP Principals committed to pledge $25 million of collateral to backstop additional working capital requirements of the Company beyond July 2025, such financing has not been secured and cannot be guaranteed, or guaranteed on terms favorable to the Company.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Costs associated with, and our ability to obtain and maintain adequate insurance, could adversely affect our profitability and financial condition.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We hold a variety of insurance policies to hedge against risks inherent in our business. If the costs of maintaining adequate insurance coverage should increase significantly in the future, our operating results could be materially adversely affected. Likewise, if any of our current insurance coverage should become unavailable to us or become economically impractical, we would be required to operate our business without indemnity from commercial insurance providers. Similarly, if we exhaust our current insurance coverage for any given policy period, we would be required to operate our business without indemnity from commercial insurance providers for any Claims made that are attributable to that policy period. Failure to maintain certain insurance policies could constitute a material breach of contract terms with certain Assignors and business partners, which may result in the termination of agreements that could have a material adverse effect on our financial condition, results of operations, and cash flows.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our services could become subject to new, revised, or enhanced regulatory requirements in the future, which could result in increased costs, delay or prevent our introduction of new solutions, or impair the function or value of our existing solutions, which could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The healthcare industry is highly regulated at the federal, state, and local levels, and is subject to changing legislative, regulatory, political, and other influences. As has been the trend in recent years, it is reasonable to assume that there will continue to be increased government oversight and regulation of the healthcare industry in the future. Changes to existing laws and regulations, or the enactment of new federal and state laws and regulations affecting the healthcare industry could create unexpected liabilities for us, could cause us or our Assignors to incur additional costs, and could restrict our or our Assignors&#8217; operations. Many healthcare laws are complex, subject to frequent change and dependent on interpretation and enforcement decisions from government agencies with broad discretion. We cannot assure our stockholders as to the ultimate content, timing, or effect of any new healthcare legislation or regulations, nor is it possible at this time to estimate the impact of potential new legislation or regulations on our business. In addition, federal and state legislatures periodically have considered programs to reform or amend the U.S. healthcare system at both the federal and state level, such as the enactment of the Affordable Care Act. It is possible that the changes to the Medicare, Medicaid, or other governmental healthcare program reimbursements may serve as precedent to possible changes in other payers&#8217; reimbursement policies in a manner adverse to us. Similarly, changes in private payer reimbursements could lead to adverse changes in Medicare, Medicaid, and other governmental healthcare programs, which could have a material adverse effect on our business, financial condition, and results of operations. Our failure to anticipate accurately the application of these laws and similar or future laws and regulations, or our failure to comply with them, could create liability for us, result in adverse publicity and have a material adverse effect on our business, financial condition, and results of operations.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we believe that we have structured our agreements and operations in material compliance with applicable healthcare laws and regulations, there can be no assurance that we will be able to successfully address changes in the current regulatory environment. We believe that our business operations materially comply with applicable healthcare laws and regulations. However, some of the healthcare laws and regulations applicable to us are subject to limited or evolving interpretations, and a review of our business or operations by a court, law enforcement, or a regulatory authority might result in a determination that could have a material adverse effect on us. Furthermore, the healthcare laws and regulations applicable to us may be amended or interpreted in a manner that could have a material adverse effect on our business, prospects, results of operations and financial condition.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our services may become subject to new or enhanced regulatory requirements and we may be required to change or adapt our services in order to comply with these regulations. If we fail to successfully implement a new regulatory framework, it could adversely affect our ability to offer services deemed critical by our Assignors, which could have a material adverse effect on our business, financial condition, and results of operations. New or enhanced regulatory requirements may render our solutions obsolete or prevent us from performing certain services. Further, new or enhanced regulatory requirements could impose additional costs on us, thereby making existing solutions unprofitable, and could make the introduction of new solutions more costly or time consuming than we anticipate, which could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Failing to accurately estimate our contract pricing may have a material adverse effect on our business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Assignor contracts are generally recovery-based. We receive a fee for such contracts based on the monies identified and ultimately recovered. Our ability to earn a profit on a performance-based agreement requires that we accurately estimate the costs involved and outcomes likely to be achieved and assess the probability of completing multiple tasks and transactions within the contracted time period.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the past, we derived a relatively small portion of our revenue on a &#8220;fee-for-service&#8221; basis whereby billing is based upon a flat fee or a fee per hour. To earn a profit on these contracts, we must accurately estimate costs involved and assess the probability of achieving certain milestones within the contracted time period. If we do not accurately estimate the costs and timing for completing projects, or if we encounter increased or unexpected costs, delays, failures, liabilities, or risks, including those outside of our control, our contracts could prove unprofitable for us or yield lower profit margins than anticipated. Although we believe that we record adequate provisions in our financial statements for losses on our fee-for-service contracts where applicable, as required under GAAP, we cannot provide assurance that contract provisions will be adequate to cover all actual future losses. The inability to accurately estimate the factors upon which we base our contract pricing could have a material adverse effect on business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to cost-effectively develop widespread brand awareness and maintain or defend our reputation, or if we fail to achieve and maintain market acceptance, our business could suffer.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that maintaining and enhancing our reputation and brand recognition is critical to our relationships with existing Assignors and ability to attract new Assignors. The promotion of our brand may require us to make substantial investments and we anticipate that, as our market becomes increasingly competitive, these marketing initiatives may become increasingly difficult and expensive. Our marketing activities may not be successful or yield increased revenue, and to the extent that these activities yield increased revenue, the increased revenue may not offset the expenses we incur and our results of operations could be harmed. In addition, any factor that diminishes our reputation or that of our management, including failing to meet expectations, or any adverse publicity or litigation involving or surrounding us, could make it substantially more difficult for us to attract new Assignors. If we do not successfully maintain and enhance our reputation and brand recognition, our business may not grow and we could lose our relationships with Assignors, which would harm our business, results of operations, and financial condition.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 11, 2022, the SEC initiated an investigation of the Company, and on March 10, 2023, the Company received a subpoena from the U.S. Attorney&#8217;s Office in connection with a grand jury investigation of the Company. See Note 12,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Commitments and Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for more information about ongoing governmental investigations. The existence of these investigations, and any negative publicity resulting from these investigations, or other governmental audits or investigations could injure our reputation.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registered or unregistered trademarks or trade names that we own or license may be challenged, infringed, circumvented, declared generic, lapsed, or determined to be infringing on or dilutive of other marks. We may not be able to protect our rights in these trademarks and trade names, which we need in order to build name recognition with Assignors, payers, and other partners. In addition, third parties may in the future file for registration of trademarks similar or identical to our trademarks. If they succeed in registering or developing common law rights in such trademarks, and if we are not successful in challenging such third-party rights, we may not be able to use these trademarks to promote our business in certain relevant jurisdictions. If we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively and our brand recognition, reputation and results of operations may be adversely affected.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our ability to execute on business plans, maintain high levels of service, or adequately address competitive challenges will be negatively impacted if we fail to properly manage our growth, which could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that our business operations will continue to grow and expand into new areas within the healthcare industry; however, such growth and expansion carries costs and risks that, if not properly managed, could have a material adverse effect on our business, financial condition, and results of operations. To effectively manage our business plans, we must continue to improve our operations, while remaining competitive. We must also be flexible and responsive to our Assignors&#8217; needs and to changes in the political, economic, and regulatory environment in which we operate. The greater size and complexity of our expanding business puts additional strain on our administrative, operational, and financial resources and makes the determination of optimal resource allocation more difficult. A failure to anticipate or properly address the demands that our growth and diversification may have on our resources and existing infrastructure may result in unanticipated costs and inefficiencies, and could adversely impact our ability to execute on our business plans and growth goals, which could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may require significant capital expenditures and the allocation of valuable management resources to grow and change in these areas. We may need to increase our headcount and must continue to effectively train and manage our employees. We will need to continue to hire, train and manage additional qualified information technology, operations, and marketing staff, and improve and maintain our technology and information systems to properly manage our growth. If our new hires perform poorly, or if we are unsuccessful in hiring, training, managing, and integrating these new employees, or if we are not successful in retaining our existing employees, our business may be adversely affected. We will be unable to manage our business effectively if we are unable to alleviate the strain on resources caused by growth in a timely and successful manner. If we fail to effectively manage our anticipated growth and change, the quality of our services may suffer, which could negatively affect our brand and reputation and harm our ability to attract and retain Assignors and employees.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have encountered, and will continue to encounter, risks and difficulties frequently experienced by growing companies in rapidly changing industries, including increasing expenses as we continue to grow our business. We expect our operating expenses to increase significantly over the next several years as we continue to hire additional personnel, expand our operations and infrastructure, and continue to expand to reach more Assignors. In addition to the expected costs to grow our business, we also expect to incur additional legal, accounting, investor relations, and other expenses as a public company. These investments may be more costly than we expect, and if we do not achieve the benefits anticipated from these investments, or if the realization of these benefits is delayed, they may not result in increased revenue or growth in our business. If our growth rate were to decline significantly or become negative, it could adversely affect our financial condition and results of operations. If we are not able to achieve or maintain positive cash flow in the long term, we may require additional financing, which may not be available on favorable terms or at all and/or which could be dilutive to our stockholders. Our failure to achieve or maintain profitability could negatively impact the value of our Common Stock.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may require additional financing to fund our operations or growth. See &#8220;Risk Factor - Failure to obtain or maintain ongoing financing to fund operations would negatively impact our business.&#8221;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be able to obtain additional capital to continue the development of our business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There can be no assurance that our future proposed operations and Claims recovery will be implemented successfully or that we will ever have profits. If we are unable to continue pursuing recoveries or successfully recover on Claims, holders of our Common Stock may lose their entire investment. We face all of the risks inherent in a new business and a new public company, including the expenses, difficulties, complications, and delays frequently encountered in connection with conducting operations, including the need for significant additional capital requirements and management&#8217;s potential underestimation of initial and ongoing costs. In evaluating our business and future prospects, these difficulties should be considered. If we are not effective in addressing these risks, we may not be able to implement our business strategy and our results of operations would be adversely affected. To date, the Company&#8217;s sources of liquidity to fund working capital have been through funds from servicing agreements, member contributions, loans, and investments from other third parties. Our ability to obtain necessary financing may be impaired by factors such as the health of, and access to, capital markets, our limited track record, or a future doubt about our ability to continue as a going concern.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Failure to properly manage our growth or obtain additional financing to fund growth could negatively impact our business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In order to implement our business plan and achieve and favorable results, we expect to expand our business operations and hire additional sales and support personnel. We may not have sufficient resources to do so. If we hire additional personnel and invest in additional infrastructure, we may not be effective in expanding our operations and our systems, procedures, or controls may not be adequate to support any such expansion. Failure to properly manage our growth could have a material adverse effect on our business and our operating results. Failure to obtain financing, or obtain financing on favorable terms, could have a material adverse effect on future operating prospects, could require us to significantly reduce operations, and could result in a decrease in our stock price.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may make acquisitions of businesses or Claim recovery interests that prove unsuccessful, and any mergers, acquisitions, dispositions, or joint venture activities may change our business and financial results and introduce new risks.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may make acquisitions of, or otherwise invest in, other companies that could complement our business, including the acquisition of entities in diverse geographic regions and entities offering greater access to businesses and markets that we do not currently serve. The acquisitions we make may be unprofitable or may take some time to achieve profitability. In addition, we may not successfully operate the businesses that we acquire, or may not successfully integrate these businesses with our own, which</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">may result in our inability to maintain our goals, objectives, standards, controls, policies, culture, or profitability. Through acquisitions, we may enter markets in which we have limited or no experience. Any acquisition may result in a potentially dilutive issuance of equity securities, and the incurrence of additional debt which could reduce our profitability. We also pursue dispositions and joint ventures from time to time. Any such transactions could change our business lines, geographic reach, financial results, or capital structure. Our company could be larger or smaller after any such transactions and may have a different investment profile.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may also invest in certain Claim recovery interests, as well as Assignor interests in Claims with the intent to expand our portfolio of recoverable Claims and add to our potential revenue streams by selling these Claims at a higher rate than that paid by the Company. These purchases may prove unprofitable or may take some time to achieve profitability. These purchases may also adversely affect our liquidity and cash positions if we use our cash in order to purchase new Claims, or if we finance such purchase with debt that we are ultimately not able to repay. If we do not realize the anticipated benefits of any such acquisition, it would have a material effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Adverse judgments or settlements in litigation, regulatory, or other dispute resolution proceedings could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are currently party to, and may in the future become party to, lawsuits and other claims against us that arise from time to time in the ordinary course of our business, including the governmental investigations disclosed elsewhere in this Annual Report. See Note 12, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Commitments and Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for more information about ongoing governmental investigations. These may include lawsuits and claims related to, for example, contracts (including CCRAs), subcontracts, protection of confidential information or trade secrets, wage and benefits, employment of our workforce, or compliance with any of a wide array of state and federal statutes, rules and regulations that pertain to different aspects of our business. We also may be required to initiate expensive litigation or other proceedings to protect our business interests. In addition, because of the payments we may receive from potential future governmental Assignors, we may become subject to unexpected inquiries, investigations, legal actions, or enforcement proceedings pursuant to the False Claims Act, healthcare fraud, waste, and abuse laws, or similar legislation. Any investigations, settlements, or adverse judgments stemming from such legal disputes or other claims may result in significant monetary damages or injunctive relief against us, as well as reputational injury that could adversely affect us. In addition, litigation and other legal claims are subject to inherent uncertainties, and management&#8217;s view of currently pending legal matters may change in the future. Those uncertainties include, but are not limited to, costs of litigation, unpredictable judicial or jury decisions and the differing laws and judicial proclivities regarding damage awards among the states in which we operate. Unexpected outcomes in such legal proceedings, or changes in management&#8217;s evaluation or predictions of the likely outcomes of such proceedings (possibly resulting in changes in established reserves) could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to successfully identify and recover on future Claims, our results of operations could be adversely affected.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a part of our business plan, we have acquired the right to pursue recoveries and we intend to continue to pursue the acquisition of additional Claims to support our business strategy. These recoveries can involve a number of risks and challenges, any of which could cause significant operating inefficiencies and adversely affect our growth and profitability. Such risks and challenges include:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">underperformance relative to our expectations and the price paid for the Claims;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unanticipated demands on our management and operational resources;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure to successfully recover on legal Claims;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">difficulty in integrating personnel, operations, and systems;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">maintaining current customers and securing future customers of the combined businesses;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">assumption of liabilities; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">litigation-related charges.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Profits derived from Claim recoveries may take considerable time, and certain recoveries may fall short of expected returns. If our recoveries are not successful, we may record impairment charges. Our ability to grow our capital will depend upon our success at identifying and recovering legal Claims, which requires substantial judgment in assessing their values, strengths, weaknesses, liabilities, and potential profitability, as well as the availability of capital.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to accurately calculate the Paid Amount and Paid Value of Potential Recoverable Claims, it can have a material adverse effect on our business, results of operations, financial condition, and cash flows.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Typically, we identify recoverable Claims using our proprietary Algorithms which analyze historical paid Claims data to identify potential recovery opportunities. Our potential ability to achieve recovery revenues is based largely on our ability to discover, quantify, and settle the gap between Billed Amount and Paid Amount on a large scale. A failure to accurately calculate the Paid Amount or the Paid Value of Potential Recoverable Claims, the recovery multiple, or the amount we are entitled to pursue for recovery, may have a material adverse effect on our business, results of operations, financial condition, and cash flows.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Failure of our software vendors, utility providers, network providers, and third-party data providers to perform as expected, changes in our relationships with them, or losing access to data sources may adversely affect our business.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to deliver and implement solutions requires that we work with certain third-party providers, including software vendors, utility providers, data providers, and network providers, and depends on such third parties meeting our expectations in both timeliness and quality. We might incur significant additional liabilities if the services provided by these third parties do not meet our expectations, if they terminate or refuse to renew their relationships with us, or if they were to offer their services to us on less advantageous terms, which could have a material adverse effect on our business, financial condition, and results of operations. In addition, while there are backup systems in many of our operating facilities, an extended outage of utility or network services supplied by these vendors or providers could impair our ability to deliver our solutions, which could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to service our Assignors and deliver and implement solutions requires that we use several data sources when identifying recoveries. If we were to lose access to those data sources, including as a result of any termination of our data access arrangements, it could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be sued by third parties for alleged infringement of their proprietary rights.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our competitors, as well as a number of other entities and individuals, may own or claim to own intellectual property relating to our industry. In the future, such third parties may claim that we are infringing their intellectual property rights, and we may be found to be infringing such rights. Any claims or litigation could cause us to incur significant expenses and, if successfully asserted against us, could require that we pay substantial damages or ongoing royalty payments, prevent us from offering our services, or require that we comply with other unfavorable terms. Even if we were to prevail in such a dispute, any litigation could be costly and time-consuming and divert the attention of our management and key personnel from our business operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in, or interpretations of, tax rules and regulations may adversely affect our effective tax rates.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have offices in the United States and in Puerto Rico. Accordingly, we are subject to taxation in jurisdictions with increasingly complex tax laws, the application of which can be uncertain.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unanticipated changes in our tax rates could affect our future financial condition and results of operations. Our future effective tax rates could be unfavorably affected by changes in the tax rates in jurisdictions where our income is earned and taxed, by changes in, or our interpretation of, tax rules and regulations in the jurisdictions in which we do business, by increases in expenses not deductible for tax purposes including impairments of goodwill, by changes in GAAP or other applicable accounting standards or by changes in the valuation of our deferred tax assets and liabilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we are subject to the continual examination of our income tax returns by the U.S. Internal Revenue Service (&#8220;IRS&#8221;) and other domestic and international tax authorities. Tax authorities in various jurisdictions may disagree with and subsequently challenge the amount of profits taxed in their state or country, which may result in increased tax liability, including accrued interest and penalties, which would cause our tax expense to increase. There can be no assurance that the final determination of any of these examinations will not have a material adverse effect on our financial condition and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We will be required to pay the Tax Receivable Agreement (&#8220;TRA&#8221;) Parties (as defined in the TRA) for most of the benefits relating to, among other things, an increase in tax attributes as a result of the Company&#8217;s direct and indirect allocable share of existing tax basis acquired in the Business Combination, and the Company&#8217;s increase in its allocable share of existing tax basis and anticipated tax basis adjustments we receive in connection with sales or exchanges of Up-C Units after the Business Combination.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Business Combination, we entered into a TRA with the TRA Parties (as defined in the TRA) that provides for the payment by the Company to such TRA Parties of 85% of the benefits, if any, that the Company is deemed to realize (calculated using certain assumptions) as a result of: (i) the Company&#8217;s direct and indirect allocable share of existing tax basis acquired in the Business Combination, (ii) increases in the Company&#8217;s allocable share of existing tax basis and tax basis adjustments that will increase the tax basis of the tangible and intangible assets of Opco as a result of the Business Combination and as a result of sales or exchanges of Up-C Units for cash or shares of the Company&#8217;s Class A Common Stock, and (iii) certain other tax benefits related to entering into the TRA, including tax benefits attributable to payments under the TRA. These increases in existing tax basis and tax basis adjustments generated over time may reduce the amount of tax that the Company would otherwise be required to pay in the future, although the IRS may challenge all or part of the validity of that tax basis, and a court could sustain such a challenge. Actual tax benefits realized by the Company may differ from tax benefits calculated under the TRA as a result of the use of certain assumptions in the TRA, including the use of an assumed weighted-average state and local income tax rate to calculate tax benefits. The payment obligation under the TRA is an obligation of the Company and not of Opco. While the amount of existing tax basis, the anticipated tax basis adjustments, and the actual amount and utilization of tax attributes, as well as the amount and timing of any payments under the TRA, will vary depending upon a number of factors, including the timing of exchanges of Up-C Units for shares of the Company&#8217;s Class A Common Stock, the applicable tax rate, the price of shares of the Company&#8217;s Class A Common Stock at the time of exchanges, the extent to which such exchanges are taxable and the amount and timing of our income, we expect that as a result of the size of the transfers and increases in the tax basis of the tangible and intangible assets of Opco and our possible utilization of tax attributes, including existing tax basis acquired at the time of the Business Combination, the payments that the Company may make under the TRA will be substantial. The payments under the TRA are not conditioned on the exchanging holders of Opco Units or other TRA Parties continuing to hold ownership interests in us. To the extent payments are due to the TRA Parties under the TRA, the payments are generally required to be made within five business days after the tax benefit schedule (which sets forth the Company&#8217;s realized tax benefits covered by the TRA for the relevant taxable year) is finalized. The Company is required to deliver such a tax benefit schedule to the TRA Parties&#8217;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Representative (as defined in the TRA), for its review, within 90 calendar days after the due date (including extensions) of the Company&#8217;s federal corporate income tax return for the relevant taxable year.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Payments under the TRA may be accelerated and/or significantly exceed the actual tax benefits the Company realizes under the TRA, and such accelerations may impair our ability to consummate change of control transactions.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s payment obligations under the TRA will be accelerated in the event of certain changes of control or its election to terminate the TRA early. The accelerated payments will relate to all relevant tax attributes then allocable to the Company in the case of an acceleration upon a change of control, and to all relevant tax attributes allocable or that would be allocable to the Company (in the case of an election by the Company to terminate the TRA early, assuming all Up-C Units were then exchanged). The accelerated payments required in such circumstances will be calculated by reference to the present value (at a specified discount rate determined by reference to LIBOR) of all future payments that holders of Up-C Units or other recipients would have been entitled to receive under the TRA, and such accelerated payments and any other future payments under the TRA will utilize certain valuation assumptions, including that the Company will have sufficient taxable income to fully utilize the deductions arising from the increased tax deductions and tax basis and other benefits related to entering into the TRA. In addition, recipients of payments under the TRA will not reimburse us for any payments previously made under the TRA if such tax basis and the Company&#8217;s utilization of certain tax attributes is successfully challenged by the IRS (although any such detriment would be taken into account in future payments under the TRA). The Company&#8217;s ability to achieve benefits from any existing tax basis, tax basis adjustments or other tax attributes, and the payments to be made under the TRA, will depend upon a number of factors, including the timing and amount of our future income. As a result, even in the absence of a change of control or an election to terminate the TRA, payments under the TRA could be in excess of 85% of the Company&#8217;s actual cash tax benefits.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accordingly, it is possible that the actual cash tax benefits realized by the Company may be significantly less than the corresponding TRA payments or that payments under the TRA may be made years in advance of the actual realization, if any, of the anticipated future tax benefits. There may be a material negative effect on our liquidity if the payments under the TRA exceed the actual cash tax benefits that the Company realizes in respect of the tax attributes subject to the TRA and/or distributions to the Company by Opco are not sufficient to permit the Company to make payments under the TRA after it has paid taxes and other expenses. We may need to incur additional indebtedness to finance payments under the TRA to the extent our cash resources are insufficient to meet our obligations under the TRA as a result of timing discrepancies or otherwise, and these obligations could have the effect of delaying, deferring or preventing certain mergers, asset sales, other forms of business combinations or other changes of control.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The acceleration of payments under the Tax Receivable Agreement in the case of certain changes of control may impair our ability to consummate change of control transactions or negatively impact the value of our Common Stock.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the case of a &#8220;Change of Control&#8221; under the TRA (which is defined to include, among other things, a 50% change in control of the Company, the approval of a complete plan of liquidation or dissolution of the Company, or the disposition of all or substantially all of the Company&#8217;s direct or indirect assets), payments under the TRA will be accelerated and may significantly exceed the actual benefits the Company realizes in respect of the tax attributes subject to the TRA. We expect that the payments that we may make under the TRA (the calculation of which is described in the immediately preceding risk factor) in the event of a change of control will be substantial. As a result, our accelerated payment obligations and/or the assumptions adopted under the TRA in the case of a change of control may impair our ability to consummate change of control transactions or negatively impact the value received by owners of our Common Stock in a change of control transaction.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our success is dependent upon the efforts of our key personnel. The loss of key personnel could negatively impact the operations and profitability of the Company, and its financial condition could suffer as a result.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success depends largely upon the continued services of our senior management team and other key employees. We rely on our leadership team in the areas of operations, information technology and security, marketing, compliance, and general and administrative functions. From time to time, there may be changes in our executive management team resulting from the hiring or departure of executives, which could disrupt our business. The loss of one or more of the members of our senior management team, or other key employees, could negatively impact the operations and profitability of the Company. In particular, the loss of the services of our founder and Chief Executive Officer, John H. Ruiz, could significantly delay or prevent the achievement of our strategic objectives. Changes in our executive management team may also cause disruptions in, and harm to, our business. The Company does not maintain key-man life insurance on any of its officers. The services of such personnel may not continue to be available to the Company. We anticipate that some or all of the management of the Company will remain in place.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business is dependent on our ability to attract and retain qualified employees.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to operate our business and provide our solutions is dependent on our ability to recruit, employ, train, and retain the skilled personnel who have relevant experience in the healthcare and data analytics industries as well as information technology professionals who can design, implement, operate, and maintain complex information technology systems. For example, certain of our employees in our company must either have, or rapidly develop, a significant amount of technical knowledge with regard to medical insurance coding and procedures. In addition, certain of our retrospective data-driven solutions rely on a team of trained registered nurses or medical coding professionals to review medical information and provide feedback with respect to the medical appropriateness of care provided. Innovative, experienced, and technologically proficient professionals, such as qualified nurses and experienced medical coding professionals, are in great demand and are likely to remain a limited resource. Our ability to recruit and retain such individuals</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">34</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">depends on a number of factors, including the competitive demands for employees having, or able to rapidly develop, the specialized skills we need and the level and structure of compensation required to hire and retain such employees. We may not be able to recruit or retain the personnel necessary to efficiently operate and support our business. Even if our recruitment and retention strategies are successful, our labor costs may increase significantly. In addition, our internal training programs may not be successful in providing inexperienced personnel with the specialized skills required to perform their duties. If we are unable to hire, train, and retain sufficient personnel with the requisite skills without significantly increasing our labor costs, it could have a material adverse effect on our business, financial condition and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General economic, political, and market forces and dislocations beyond our control could reduce demand for our solutions and our overall business may suffer from an economic downturn.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The demand for our data-driven solutions may be impacted by factors that are beyond our control, including macroeconomic, political, and market conditions, the availability of short-term and long-term funding and capital, the level and volatility of interest rates, currency exchange rates, and inflation. Domestic and global economic environments may prove less favorable than those of prior years. Any one or more of these factors may contribute to reduced activity and prices in the securities markets generally and could result in a reduction in demand for our solutions, which could have a material adverse effect on our business, results of operations, and financial condition.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are concentrated in certain geographic regions, which makes us sensitive to regulatory, economic, environmental, and competitive conditions in those regions.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Due to the concentration of our operations in Florida, our business may be adversely affected by economic conditions that disproportionately affect Florida as compared to other states. In addition, our exposure to many of the risks described herein are not mitigated by the diverse geographic locations of our Assignors.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, regions in and around the southeastern United States commonly experience hurricanes and other extreme weather conditions. As a result, our offices, located in Florida and Puerto Rico, are susceptible to physical damage and business interruption from an active hurricane season or a single severe storm. Moreover, global climate change could increase the intensity of individual hurricanes or the number of hurricanes that occur each year. Even if our facilities are not directly damaged, we may experience considerable disruptions in our operations due to property damage or electrical outages experienced in storm-affected areas by our employees. Additionally, long-term adverse weather conditions, whether caused by global climate change or otherwise, could cause an out-migration of people from the communities where our offices are located. If any of the circumstances described above occurs, there could be a harmful effect on our business, and our results of operations could be adversely affected.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our overall business results may suffer from an economic downturn.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During periods of high unemployment, governmental entities often experience budget deficits as a result of increased costs and lower than expected tax collections. These budget deficits affect federal, state, and local government entities, and may result in reductions in spending for health and human service programs, including Medicare, Medicaid, and similar programs, which represent significant payer sources for our Assignors.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">High inflation may adversely affect our financial results.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. economy is currently experiencing increasing levels of inflation, which creates a heightened level of risk for the Company. Rising inflation may decrease the fair value of the Company&#8217;s investment in its portfolio of Claims as the Paid Amount and PVPRC, set at the date of the Claim was paid, become less valuable in relation to the present value of the dollar, leading to an effective decrease in their potential real return. Furthermore, rising inflation may increase our operating expenses, including the cost to hiring or retaining employees.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. government and Federal Reserve may be slow to approve rate changes or adopt measures to attempt to control inflation, which could affect the Company&#8217;s ability to generate profits and cash flow. There can be no assurance that inflation rates will not continue to escalate in the future or that measures adopted or that may be adopted by the U.S. government or the Federal Reserve to control inflation will be effective or successful. Significant increases in inflation can have an adverse impact on our business, financial condition, and results of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Securities</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In this section, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company,&#8221; and other similar terms refer to Legacy MSP prior to the Business Combination and to the Company following the Business Combination.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are controlled by the Members, including John H. Ruiz and Frank C. Quesada, whose interests may conflict with our interests and the interests of other stockholders. Further, our status as a &#8220;controlled company&#8221; on Nasdaq removes certain corporate governance protections.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of April 8, 2025, the Members (or their designees) hold a majority of our issued and outstanding Class V Common Stock, controlling approximately 85.44% of the combined voting power of our outstanding Class V Common Stock, and John H. Ruiz and Frank C. Quesada (collectively, the &#8220;MSP Principals&#8221;), as a group, control approximately 47.16% of the combined voting power of our Common Stock. They effectively have the ability to determine all corporate actions requiring stockholder approval, including the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">35</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">election and removal of directors, any amendment to our Charter or Amended &amp; Restated Bylaws, or the approval of any merger or other significant corporate transaction, including a sale of substantially all of our assets. This could have the effect of delaying or preventing a change in control or otherwise discouraging a potential acquirer from attempting to obtain control of the Company, which could cause the market price of our Class A Common Stock to decline or prevent stockholders from realizing a premium over the market price for Class A Common Stock. The Members&#8217; interests may conflict with our interests as a company or the interests of our other stockholders.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our stockholders will experience substantial dilution as a consequence of, among other transactions, future issuances of Common Stock.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of April 14, 2025, the following securities are convertible into, or allow the purchase of, our Class A Common Stock, including: (i) 3,323,146 outstanding or designated Up-C Units that may each be exchanged for one share of Class A Common Stock; (ii) 2,950,157 Public Warrants outstanding, each exercisable to purchase 1/625th of one share of our Class A Common Stock (but only exercisable in lots of 625 to purchase whole shares); (iii) 894,754,824 New Warrants outstanding, each exercisable to purchase 1/625th of one share of our Class A Common Stock (but only exercisable in lots of 625 to purchase whole shares); (iv) the CPIA Warrant exercisable to purchase up to 106,667 shares of our Class A Common Stock; (v) the VRM Warrants, entitling VRM to purchase 19,361,939 shares of Class A Common Stock; each warrant expiring two years from the date of issuance, of which 9,751,339 and 9,610,600 are exercisable for $0.0025 per share and $0.0001 per share, respectively; and (vi) the VRP Warrant, entitling VRP to purchase 100,000 shares of Class A Common Stock at a purchase price of $0.0025 per shares for a period of two years from issuance, exercisable on a cashless basis.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 18, 2025, the Company entered into a binding term sheet agreement with Virage to amend the MTA, as amended, whereby Virage agreed to exercise the VRM Warrants to receive 33 1/3% of the then issued and outstanding Class A Common Stock, and surrender to the Company any remaining unexercised VRM Warrants, or portions thereof, for termination, subject to certain consents and approvals. Contemporaneous with the warrant exercise, Virage will terminate its agreement to hold no more than 9.99% of the outstanding Common Stock of the Company. These proposed transactions are subject to, among other things, further negotiation and the execution of definitive agreements, regulatory approvals, certain third-party consents and approvals, and shareholder approvals if required by the Nasdaq Stock Market. As a result, there can be no guarantee that the transactions thereby will be consummated.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company also has the ability to issue up to 153,721 shares of Class A Common Stock pursuant to awards under the Incentive Plan. The shares of Class A Common Stock reserved for future issuance under the Incentive Plan will become eligible for sale in the public market once those shares are issued, subject to provisions relating to various vesting agreements, lock-up agreements and, in some cases, limitations on volume and manner of sale applicable to affiliates under Rule 144, as applicable. The aggregate number of shares that may be issued pursuant to awards under the Incentive Plan will be subject to an annual increase on January 1 of each calendar year (commencing with January 1, 2023 and ending on and including January 1, 2031) equal to the lesser of: (i) a number of shares equal to 3% of the total number of shares actually issued and outstanding on the last day of the preceding fiscal year or (ii) a number of shares as determined by the Board. The Company filed one or more registration statements on Form S-8 under the Securities Act to register shares of Class A Common Stock or securities convertible into or exchangeable for shares of Class A Common Stock issued pursuant to the Incentive Plan. Any such Form S-8 registration statements automatically become effective upon filing. Accordingly, shares registered under such registration statements will be available for sale in the open market.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depending upon market liquidity at the time, sales of shares of our Class A Common Stock under the Yorkville SEPA and the Yorkville Convertible Notes may cause the trading price of our Class A Common Stock to decline. After Yorkville has acquired shares under the Yorkville SEPA, it may sell all, some, or none of those shares. Sales to Yorkville by us pursuant to the Yorkville SEPA may result in substantial dilution to the interests of other holders of our Class A Common Stock. The sale of a substantial number of shares of our Class A Common Stock to Yorkville, or anticipation of such sales, could make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect sales.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The sale of substantial amounts of shares of our Class A Common Stock or warrants, or the perception that such sales could occur, could cause the prevailing market price of shares of our Class A Common Stock and warrants to decline significantly. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. We believe the likelihood that warrant holders will exercise their warrants is dependent upon the market price of our Class A Common Stock.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We qualify as a &#8220;controlled company&#8221; within the meaning of the Nasdaq listing standards and, as a result, our stockholders may not have certain corporate governance protections that are available to stockholders of companies that are not controlled companies.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">So long as more than 50% of the voting power for the election of directors is held by an individual, group, or another company, we will qualify as a &#8220;controlled company&#8221; under the Nasdaq listing requirements. John H. Ruiz and Frank C. Quesada (collectively, the &#8220;MSP Principals&#8221;) control more than a majority of the voting power of our outstanding capital stock. As a result, we qualify as a &#8220;controlled company&#8221; under the Nasdaq listing standards, and will not be subject to the requirements that would otherwise require us to have: (i) a majority of &#8220;independent directors,&#8221; as defined under the listing standards of Nasdaq; (ii) a nominating and corporate governance committee comprised solely of independent directors; and (iii) a compensation committee comprised solely of independent directors. In addition, the Members, including the MSP Principals, have the ability to control matters requiring stockholder approval, including the election and removal of directors, any amendment to our Charter or Amended &amp; Restated Bylaws, or the approval of any</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">merger or other significant corporate transaction, including a sale of substantially all of our assets. See &#8220;We are controlled by the Members, including the MSP Principals, whose interests may conflict with our interests and the interests of other stockholders.&#8221;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Members, including the MSP Principals, may have their interest in the Company diluted due to future equity issuances, repurchases under the LLC Agreement from the MSP Principals in connection with the exercise of New Warrants or Members or their designees selling shares of Class A Common Stock, in each case, which could result in a loss of the &#8220;controlled company&#8221; exemption under the Nasdaq listing rules. We would then be required to comply with those provisions of the Nasdaq listing requirements.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Company&#8217;s management has limited experience in operating a public company.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s executive officers have limited experience in the management of a publicly traded company. The Company is subject to significant regulatory oversight and reporting obligations under federal securities laws. Management&#8217;s limited experience in dealing with the increasingly complex laws pertaining to public companies could be a significant disadvantage in that it is likely that an increasing amount of their time may be devoted to these activities which will result in less time being devoted to the management and growth of the Company. The Company may not have adequate personnel with the appropriate level of knowledge, experience, and training in the accounting policies, practices or internal controls over financial reporting required of publicly traded companies. The development and implementation of the standards and controls necessary for the Company to achieve the level of accounting standards required of a publicly traded company may require costs greater than expected. It is possible that the Company will be required to expand its employee base and hire additional employees to support its operations as a public company, which will increase its operating costs in future periods.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">There can be no assurance that we will be able to comply with the continued listing standards of Nasdaq.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Class A Common Stock, Public Warrants, and New Warrants are currently listed on Nasdaq. If Nasdaq delists our Class A Common Stock, Public Warrants, or New Warrants from trading on its exchange for failure to meet the listing standards, we and our stockholders could face significant material adverse consequences including:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a limited availability of market quotations for our securities;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reduced liquidity for our securities;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a determination that the Class A Common Stock is a &#8220;penny stock&#8221; which will require brokers trading in the Class A Common Stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a limited amount of news and analyst coverage; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a decreased ability to issue additional securities or obtain additional financing in future.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The National Securities Markets Improvement Act of 1996, a federal statute, prevents or preempts states from regulating the sale of certain securities, which are referred to as &#8220;covered securities.&#8221; To the extent our Class A Common Stock, Public Warrants, and New Warrants are listed on Nasdaq, they are covered securities. Although the states are preempted from regulating the sale of our securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. See also &#8220;Risk Factor - Failure to meet the continued listing requirements of Nasdaq could result in the delisting of our Class A Common Stock, thus negatively impacting the price of our Class A Common Stock and negatively impacting our ability to raise additional capital.&#8221;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Failure to meet the continued listing requirements of Nasdaq could result in the delisting of our Class A Common Stock, thus negatively impacting the price value of our Class A Common Stock and negatively impacting our ability to raise additional capital.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 7, 2024, the Company was notified by Nasdaq Listing Qualifications staff (the &#8220;Staff&#8221;) that the Company was non-compliant with Nasdaq&#8217;s Bid Price Requirement as the closing bid price for the Company&#8217;s Class A Common Stock had fallen below $1.00 per share for 30 consecutive business days (April 25, 2024 through June 6, 2024). Pursuant to Nasdaq Marketplace Rule 5810(c)(3)(A), the Company was provided with a compliance cure period of 180 calendar days, or until December 4, 2024, to regain compliance with the Bid Price Requirement. On September 25, 2024, stockholders holding at least a majority of our outstanding voting capital stock, including our Class A Common Stock and Class V Common Stock, approved by written consent a resolution authorizing the Board of Directors to amend the Company&#8217;s Charter, to effect a reverse stock split (the &#8220;2024 Reverse Split&#8221;) of the Company&#8217;s Common Stock at a reverse stock split ratio ranging from 1:3 to 1:30, and to authorize the Company&#8217;s Board of Directors to determine, at its discretion, the timing of the amendment and the specific ratio of the 2024 Reverse Split. On November 12, 2024, the Board determined to proceed with the 2024 Reverse Split at a ratio of 1:25, which was effectuated on the open of business on November 18, 2024.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 3, 2024, the Company received correspondence from Nasdaq stating that the Company&#8217;s previously disclosed bid price deficiency had been cured, and that the Company had regained compliance with Listing Rule 5450(a)(1). The Company&#8217;s Class A common stock continued to be listed and traded on Nasdaq, subject to continued compliance with applicable Nasdaq listing standards. On December 6, 2024, the Company received notification from the Staff that the Company&#8217;s application to transfer the listing of its common stock from the Nasdaq Global Market to the Nasdaq Capital Market was approved. The Company&#8217;s securities transferred to the Nasdaq Capital Market at the opening of business on December 10, 2024, and continue to trade under the symbol &#8220;MSPR.&#8221; The</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">37</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market, and listed companies must meet certain financial requirements and comply with Nasdaq&#8217;s corporate governance requirements.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2023, the Staff notified the Company of non-compliance with Nasdaq&#8217;s Bid Price Requirement and Nasdaq&#8217;s Listing Rules as a result of having not timely filed periodic reports; however, by October 27, 2023, the Company had regained compliance with all applicable listing standards.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If in the future we fail to comply with Nasdaq&#8217;s continued listing requirements, including the Reporting Rule and Minimum Bid Requirement, our Class A Common Stock will be subject to delisting. In the event we receive notice that our Class A Common Stock is being delisted, Nasdaq rules permit us to appeal any delisting determination by the Nasdaq staff to a Hearings Panel. If our Class A Common Stock were to be delisted by Nasdaq, our Class A Common Stock would be subject to rules that impose additional sales practice requirements on broker-dealers who sell our securities. The additional burdens imposed upon broker-dealers by these requirements could discourage broker-dealers from effecting transactions in our Class A Common Stock. This would adversely affect the ability of investors to trade our Class A Common Stock and would adversely affect the value of our Class A Common Stock. These factors could contribute to lower prices and larger spreads in the bid and ask prices for our Class A Common Stock. The delisting of our common stock from Nasdaq would also adversely affect our ability to complete future financing.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If our shares are delisted from Nasdaq and become subject to the penny stock rules, it will become more difficult to trade our shares.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or authorized for quotation on certain automated quotation systems, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system. If we do not retain our listing on Nasdaq and if the price of our Class A Common Stock is less than $5.00, it will be deemed a penny stock. The penny stock rules require a broker-dealer, before a transaction in a penny stock not otherwise exempt from those rules, to deliver a standardized risk disclosure document containing specified information. In addition, the penny stock rules require that, before effecting any transaction in a penny stock not otherwise exempt from those rules, a broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive: (i) the purchaser&#8217;s written acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement to transactions involving penny stocks; and (iii) a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for our Class A Common Stock, and therefore stockholders may have difficulty selling their shares.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be required to take write-downs or write-offs, or restructuring, impairment, or other charges that could have a significant negative effect on our financial condition, results of operations, and our stock price, and which could adversely affect the value of our securities.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot assure you that our due diligence will surface all material issues that may be present in our business, and it is likely not possible to uncover all material issues through a customary amount of due diligence, or factors outside of our control which may arise. As a result of these factors, we may be forced to write-down or write-off assets, restructure our operations, or incur impairment or other charges that could result in reporting losses. Even if our due diligence successfully identifies certain risks, unexpected risks may arise, and previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though these charges may be non-cash items and not have an immediate impact on our liquidity, the fact that we report charges of this nature could contribute to negative market perceptions about us or our securities. In addition, charges of this nature may cause us to violate net worth or other covenants to which we may be subject to as a result of assuming pre-existing debt held by virtue of our obtaining debt financing to partially finance business operations. Accordingly, stockholders could suffer a reduction in the value of their shares. Such stockholders are unlikely to have a remedy for such reduction in value.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Unanticipated changes in effective tax rates or adverse outcomes resulting from examination of our income or other tax returns could adversely affect our financial condition and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will be subject to federal and state income taxes in the United States and potentially in other jurisdictions. Our future effective tax rates could be subject to volatility or adversely affected by a number of factors, including:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in the valuation of our deferred tax assets and liabilities;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expected timing and amount of the release of any tax valuation allowances;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tax effects of stock-based compensation;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in tax laws, regulations, or interpretations thereof; or</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">lower than anticipated future earnings in jurisdictions where we have lower statutory tax rates and higher than anticipated future earnings in jurisdictions where we have higher statutory tax rates.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we may be subject to audits of our income, sales, and other transaction taxes by taxing authorities. Outcomes from these audits could have an adverse effect on our financial condition and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be unable to obtain additional financing to fund the operations and growth of the Company.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We require financing to fund the operations or growth of the Company. Failure to secure additional financing would have a material adverse effect on the continued operations or growth of the Company. None of our officers, directors or stockholders is required to provide any financing to us. See &#8220;Risk Factor - Failure to obtain or maintain ongoing financing to fund operations would negatively impact our business.&#8221;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anti-takeover provisions contained in our Charter and Amended &amp; Restated Bylaws, as well as provisions of Delaware law, could impair a takeover attempt.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Charter contains provisions that may discourage unsolicited takeover proposals that stockholders may consider to be in their best interests. We are also subject to anti-takeover provisions under Delaware law, which could delay or prevent a change of control. Together, these provisions may make the removal of management more difficult and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for our securities. These provisions include:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">no cumulative voting in the election of directors, which limits the ability of minority stockholders to elect candidates to serve as a director of the Board;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a classified board of directors with three-year staggered terms, which could delay the ability of stockholders to change the membership of a majority of the Board;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the requirement that, at any time from and after the date on which the voting power of John H. Ruiz and his affiliates represent less than 50% of the voting power of all of the then outstanding shares entitled to vote (&#8220;Voting Rights Threshold Date&#8221;), directors elected by the stockholders generally entitled to vote may be removed from the Board solely for cause and only by affirmative vote of the holders of at least 66 2/3% of the voting power of the then outstanding shares entitled to vote, voting together as a single class;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the exclusive right of the Board to fill newly created directorships and vacancies with respect to directors elected by the stockholders generally entitled to vote, which prevents stockholders from being able to fill vacancies on the Board;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the prohibition on stockholder action by written consent from and after the Voting Rights Threshold Date, which forces stockholder action from and after the Voting Rights Threshold Date to be taken at an annual or special meeting of stockholders;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the requirement that special meetings of stockholders may only be called by the Chairperson of the Board, the Chief Executive Officer of the Company or the Board, which may delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the requirement that, from and after the Voting Rights Threshold Date, amendments to certain provisions of the Charter and Amended &amp; Restated Bylaws must be approved by the affirmative vote of the holders of at least 66 2/3% in voting power of the then outstanding shares of the Company generally entitled to vote;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our authorized but unissued shares of Common Stock and preferred stock are available for future issuances without stockholder approval and could be utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans; the existence of authorized but unissued and unreserved shares of Common Stock and preferred stock could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger, or otherwise;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">advance notice procedures set forth in the Amended &amp; Restated Bylaws that stockholders must comply with in order to nominate candidates to the Board or to propose other matters to be acted upon at a meeting of stockholders, which may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#8217;s own slate of directors or otherwise attempting to obtain control of the Company;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an exclusive forum provision which provides that, unless the Company consents in writing to the selection of an alternative forum, (i) any derivative action brought on behalf of the Company, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer, or employee of the Company to the Company or the Company&#8217;s stockholders, (iii) any action asserting a claim; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">arising pursuant to any provision of the DGCL, the Charter or the Amended &amp; Restated Bylaws, or (iv) any action asserting a claim governed by the internal affairs doctrine of the State of Delaware, in each case, will be required to be filed in the Court of Chancery of the State of Delaware (or, if the Court of Chancery of the State of Delaware lacks jurisdiction over any such action or proceeding, then a state court located within the State of Delaware or the federal district court for the District of Delaware).</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Charter contains a provision renouncing our interest and expectancy in certain corporate opportunities.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Charter provides that the Company will have no interests or expectancy in, or being offered an opportunity to participate in any corporate opportunity, to the fullest extent permitted by applicable law, with respect to any lines of business or business activity or business venture conducted by any holder of Common Stock, any affiliate of such holder or any director, officer or stockholder of such holder or any affiliate thereof (&#8220;Relevant Persons&#8221;) as of the date of the filing of the Charter with the Secretary of State of the State of Delaware or received by, presented to or originated by the Relevant Persons after the date of the filing of the Charter with the Secretary</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">39</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of State of the State of Delaware in such person&#8217;s capacity as a Relevant Person (and not in his, her or its capacity as a director, officer or employee of the Company). These provisions of the Charter create the possibility that a corporate opportunity of ours may be used for the benefit of the Relevant Persons.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may redeem unexpired Public Warrants and New Warrants prior to their exercise at a time that is disadvantageous to warrant holders, thereby making such warrants worthless.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have the ability to redeem outstanding Public Warrants and New Warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant; provided that the last reported sales price of our Class A Common Stock equals or exceeds $11,250.00 per share (or as otherwise adjusted pursuant to the Existing Warrant Agreement or New Warrant Agreement, as applicable) for any 20 trading days within a 30 trading-day period ending on the third trading day prior to the date on which we give proper notice of such redemption to the warrant holders and provided certain other conditions are met. During the most recent 60-day trading period, the price of our Class A Common Stock has remained below the threshold that would allow us to redeem the Public Warrants and New Warrants. If and when the Public Warrants and New Warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of the outstanding Public Warrants and New Warrants could force the warrant holders: (i) to exercise their Public Warrants or New Warrants and pay the exercise price therefor at a time when it may be disadvantageous for them to do so; (ii) to sell their Public Warrants or New Warrants at the then-current market price when they might otherwise wish to hold their Public Warrants or New Warrants; or (iii) to accept the nominal redemption price which, at the time the outstanding New Warrants are called for redemption, is likely to be substantially less than the market value of their New Warrants. Pursuant to the terms of the Existing Warrant Agreement, the exercise price of the Public Warrants has increased to $0.0625 after giving effect to the issuance of the New Warrants.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has no obligation to notify holders of the Public Warrants or the New Warrants that they have become eligible for redemption. However, in the event the Company determined to redeem the Public Warrants or the New Warrants, holders of the Public Warrants and the New Warrants, as applicable, would be notified of such redemption as described in the Existing Warrant Agreement and the New Warrant Agreement, as applicable. Specifically, in the event that the Company elects to redeem all of the redeemable warrants as described above, the Company shall fix a date for the redemption (the &#8220;Redemption Date&#8221;). Notice of redemption shall be mailed by first class mail, postage prepaid, by the Company not less than 30 days prior to the Redemption Date to the registered holders of the redeemable warrants to be redeemed at their last addresses as they appear on the registration books. Any notice mailed in the manner provided in the Existing Warrant Agreement and the New Warrant Agreement shall be conclusively presumed to have been duly given whether or not the registered holder received such notice. In addition, beneficial owners of the redeemable warrants will be notified of such redemption via the Company&#8217;s posting of the redemption notice to DTC.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Ownership of Our Common Stock</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In this section, unless otherwise noted or the context otherwise requires, &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to the Company.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The market price of our Class A Common Stock may be significantly volatile.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The market price for our Class A Common Stock may be significantly volatile and subject to wide fluctuations of price and volume in response to factors including the following:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">actual or anticipated fluctuations in our quarterly or annual operating results;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in financial or operational estimates or projections;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">conditions in markets generally;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in legislation that may affect our business;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in the economic performance or market valuations of companies similar to ours;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">naked short selling of our common stock and stock price manipulation; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">general economic or political conditions in the United States or elsewhere.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we fail to reach an important recovery milestone or result by a publicly expected deadline, even if by only a small margin, there could be significant impact on the market price of our Class A Common Stock. Additionally, as we approach the announcement of anticipated significant information and as we announce such information, we expect the price of our Class A Common Stock to be particularly volatile, and negative results would have a substantial negative impact on the price of our Class A Common Stock.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, following periods of volatility in the market price of a company&#8217;s securities, stockholders have often instituted class action securities litigation against those companies. Such litigation, if instituted, could result in substantial costs and diversion of management attention and resources, which could significantly harm our business operations and reputation.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">40</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">A market for our securities may not continue, which would adversely affect the liquidity and price of our securities.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The price of our securities may fluctuate significantly due to the market&#8217;s reaction to the perceived or actual condition of the Company&#8217;s business, and general market and economic conditions. An active trading market for our securities may never develop or, if developed, it may not be sustained. In addition, the price of our securities can vary due to general economic conditions and forecasts, our general business condition, and the release of our financial reports. Additionally, if our securities are not listed on, or become delisted from, Nasdaq for any reason, and are quoted on the OTC Bulletin Board, an inter-dealer automated quotation system for equity securities that is not a national securities exchange, the liquidity and price of our securities may be more limited than if we were quoted or listed on Nasdaq or another national securities exchange. You may be unable to sell your securities unless a market can be established or sustained.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If the Company&#8217;s operating results do not meet the expectations of investors, stockholders, or financial analysts, the market price of our securities may decline.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our operating results could fluctuate due to a number of factors, including changes in our accounting estimates; litigation and claim-related expenditures; an increase in the number and type of competitors; changes in competitors&#8217; product offerings; and other matters. Similarly, our future operating results may vary significantly from quarter to quarter or year to year due to these and other factors, many of which are beyond our control. If our operating results or projections of future operating results do not meet the expectations of securities analysts or investors in future periods, our stock price may fall.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading price of our Class A Common Stock is highly volatile and is subject to wide fluctuations in response to various factors, some of which are beyond our control, including limited trading volume. In addition to the factors discussed in this &#8220;Risk Factors&#8221; section and elsewhere in this Annual Report, these factors include:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">research and reports that industry or securities analysts may publish about us, our business, our market, or our competitors,</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our dual class structure could make us ineligible for inclusion in certain indices, and as a result, mutual funds, exchange-traded funds and other investment vehicles that attempt to passively track those indices will not be investing in our stock,</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our status as an &#8220;emerging growth company&#8221; allows us exemptions from certain reporting requirements including: (i) the exemption from the auditor attestation requirements with respect to internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act of 2002 (&#8220;SOX&#8221;); (ii) the exemptions from say-on-pay, say-on-frequency and say-on-golden parachute voting requirements; (iii) reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements; and (iv) delayed adoption of certain accounting standards. The attractiveness of our Class A Common Stock as a result of these exemptions cannot be predicted.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In such circumstances, the trading price of our securities may not recover and may experience a further decline.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If securities analysts publish negative evaluations of our stock or stop publishing research or reports about the Company, our peers, or our industry, the price of our stock could decline.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading market for our Class A Common Stock relies in part on the research and reports that industry or financial analysts publish about us or our business. We currently have limited research coverage by financial analysts. Securities analysts may discontinue coverage or downgrade their evaluation of our stock. If any of the analysts who continue to cover or cover us in the future downgrade their evaluation of our Class A Common Stock or publishes inaccurate or unfavorable research about our business, our Class A Common Stock price may decline. If additional analysts cease to cover our stock, we could lose visibility in the market for our stock, which in turn could cause our stock price to decline.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">41</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We cannot predict the impact our dual class capital structure may have on the market price of the shares of Class A Common Stock.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot predict whether our dual class structure, combined with the concentrated control of the Company, will result in a lower or more volatile market price of the Class A Common Stock, adverse publicity, or other adverse consequences. For example, certain index providers have announced restrictions on including companies with multiple-class share structures in certain of their indices. Under any such announced policies or future policies, our dual class capital structure could make us ineligible for inclusion in certain indices, and as a result, mutual funds, exchange-traded funds, and other investment vehicles that attempt to passively track those indices will not be investing in our stock. It is unclear what effect, if any, these policies will have on the valuations of publicly traded companies excluded from such indices, but it is possible that they may depress valuations as compared to similar companies that are included. As a result, the market price of shares of the Company&#8217;s Class A Common Stock could be adversely affected.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may amend the terms of the Public Warrants in a manner that may be adverse to holders with the approval by the holders of at least 50% of the then-outstanding Public Warrants. As a result, the exercise price of a holder&#8217;s Public Warrants could be increased, the exercise period could be shortened and the number of shares of our Class A Common Stock purchasable upon exercise of a Public Warrant could be decreased, all without the approval of that warrant holder.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Public Warrants were issued in registered form under the Existing Warrant Agreement. The Existing Warrant Agreement provides that the terms of the Public Warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision or provide for the delivery of Alternative Issuance (as defined in the Existing Warrant Agreement) but requires the approval by the holders of at least 65% of the then-outstanding Public Warrants to make any other change, including any change that adversely affects the interests of the registered holders. Accordingly, we may amend the terms of the Public Warrants in a manner adverse to a holder if holders of at least 65% of the then-outstanding Public Warrants approve of such amendment. Although our ability to amend the terms of the Public Warrants with the consent of at least 65% of the then-outstanding Public Warrants is unlimited, examples of such amendments could be amendments to, among other things, changes to the exercise price, exercise period, or number of shares of stock purchasable upon exercise of a Public Warrant.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our stockholders will experience significant dilution as a result of future equity offerings or issuances and exercise of outstanding options and warrants.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In order to raise additional capital or pursue strategic transactions, we may in the future offer, issue, or sell additional shares of our Class A Common Stock or other securities convertible into or exchangeable for our Class A Common Stock, including the issuance of stock in relation to our Incentive Plan. Our stockholders may experience significant dilution as a result of future equity offerings, issuances, or the exercising of warrants. Investors purchasing shares or other securities in the future could have rights superior to existing stockholders.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of April 14, 2025, the following securities are convertible into, or allow the purchase of, our Class A Common Stock, including: (i) 3,323,146 Up-C Units that may each be exchanged for one share of Class A Common Stock; 2,950,157 Public Warrants outstanding, which are exercisable in lots of 625 with an exercise price of $0.0625 per whole share; (ii) 894,754,824 New Warrants outstanding, which are exercisable in lots of 625 with an exercise price of $7,187.50 per whole share; (iii) the CPIA Warrant exercisable to purchase up to 106,667 shares of our Class A Common Stock; (iv) the VRM Warrants, entitling VRM to purchase 19,361,939 shares of Class A Common Stock; each warrant expiring two years from the date of issuance, of which 9,751,339 and 9,610,600 are exercisable on a cashless basis for $0.0025 per share and $0.0001 per share, respectively; and (v) the VRP Warrant, entitling VRP to purchase 100,000 shares of Class A Common Stock at a purchase price of $0.0025 per share for a period of two years from issuance, exercisable on a cashless basis only. In addition, 153,721 shares of Class A Common Stock are reserved for future issuance under our stock incentive plan.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 18, 2025, the Company entered into a binding term sheet agreement with Virage to amend the MTA, as amended, whereby Virage agreed to exercise the VRM Warrants to receive 33 1/3% of the then issued and outstanding Class A Common Stock, and surrender to the Company any remaining unexercised VRM Warrants, or portions thereof, for termination, subject to certain consents and approvals. Contemporaneous with the warrant exercise, Virage will terminate its agreement to hold no more than 9.99% of the outstanding Common Stock of the Company. These proposed transactions are subject to, among other things, further negotiation and the execution of definitive agreements, regulatory approvals, certain third-party consents and approvals, and shareholder approvals if required by the Nasdaq Stock Market. As a result, there can be no guarantee that the transactions thereby will be consummated.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, pursuant to the terms of the LLC Agreement, at least twice a month, to the extent any New Warrants have been exercised in accordance with their terms, the Company is required to purchase from the MSP Principals, proportionately, the number of Up-C Units or shares of Class A Common Stock owned by such MSP Principal equal to the Aggregate Exercise Price divided by the Warrant Exercise Price in exchange for the Aggregate Exercise Price. Notwithstanding the foregoing, the shares of Class A Common Stock issuable upon exercise of our warrants will result in dilution to the then existing holders of Class A Common Stock of the Company and increase the number of shares eligible for resale in the public market. Sales of substantial numbers of such shares in the public market could adversely affect the market price of our Class A Common Stock.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">42</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The provision of our Charter requiring exclusive forum in the courts in the State of Delaware for certain types of lawsuits may have the effect of discouraging lawsuits against our directors and officers.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Charter requires that, unless the Company consents in writing to the selection of an alternative forum, (i) any derivative action brought on behalf of the Company; (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer, or employee of the Company to the Company or the Company&#8217;s stockholders; (iii) any action asserting a claim arising pursuant to any provision of the DGCL, the Charter or Amended &amp; Restated Bylaws; or (iv) any action asserting a claim governed by the internal affairs doctrine of the State of Delaware, in each case, is to be filed in the Court of Chancery of the State of Delaware (or, if the Court of Chancery of the State of Delaware lacks jurisdiction over any such action or proceeding, then a state court located within the State of Delaware or the federal district court for the District of Delaware). The exclusive forum provision described above does not apply to actions arising under the Securities Act or the Exchange Act. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder, and Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. The Charter provides that the federal district courts of the United States of America will, to the fullest extent permitted by law, be the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the federal securities laws, including the Securities Act and the rules and regulations thereunder. Our decision to adopt such a federal forum provision followed a decision by the Supreme Court of the State of Delaware holding that such provisions are facially valid under Delaware law. While there can be no assurance that federal or state courts will follow the holding of the Delaware Supreme Court or determine that our federal forum provision should be enforced in a particular case, application of our federal forum provision means that suits brought by our stockholders to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder must be brought in federal court and cannot be brought in state court. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all claims brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Accordingly, actions by our stockholders to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder must be brought in federal court. Our stockholders will not be deemed to have waived our compliance with the federal securities laws and the regulations promulgated thereunder.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we believe that these exclusive forum provisions benefit us by providing greater consistency in the application of Delaware law, the exclusive forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable in disputes with us or any of our directors, officers or stockholders, which may discourage lawsuits with respect to such claims. Further, in the event a court finds the exclusive forum provision contained in the Charter to be unenforceable or inapplicable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, operating results, financial condition, and the market for our Class A Common Stock.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The JOBS Act permits &#8220;emerging growth companies&#8221; like us to take advantage of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently qualify as an &#8220;emerging growth company&#8221; as defined in Section 2(a)(19) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (&#8220;JOBS Act&#8221;). As such, we take advantage of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies for as long as we continue to be an emerging growth company, including: (i) the exemption from the auditor attestation requirements with respect to internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act of 2002 (&#8220;SOX&#8221;); (ii) the exemptions from say-on-pay, say-on-frequency and say-on-golden parachute voting requirements; and (iii) reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. As a result, our stockholders may not have access to certain information they deem important. We will remain an emerging growth company until the earliest of the last day of the fiscal year: (a) following August 18, 2025, the fifth anniversary of our IPO; (b) in which we have total annual gross revenue of at least $1.07 billion; or (c) in which we are deemed to be a large accelerated filer, which means the market value of our Class A Common Stock that is held by non-affiliates exceeds $700 million as of the last business day of our prior second fiscal quarter, and the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the exemption from complying with new or revised accounting standards provided in Section 7(a)(2)(B) of the Securities Act as long as it is an emerging growth company. An emerging growth company can therefore delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies, but any such election to opt out is irrevocable. We have elected to avail ourselves of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot predict if investors will find our Class A Common Stock less attractive because we rely on these exemptions. If some investors find our Class A Common Stock less attractive as a result, there may be a less active trading market for our Class A Common Stock and our stock price may be more volatile.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">43</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Failure to establish and maintain effective internal controls could have a material adverse effect on the accuracy and timing of our financial reporting in future periods.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a publicly traded company, we are subject to the Exchange Act and the Sarbanes-Oxley Act of 2002 (&#8220;Sarbanes-Oxley Act&#8221; or &#8220;SOX&#8221;). The Sarbanes-Oxley Act requires that we maintain effective disclosure controls and procedures and internal control over financial reporting. The standards required for a public company under Section 404 of SOX are significantly more stringent than those required of MSP as a privately held company. Further, as an emerging growth company, our independent registered public accounting firm is not required to formally attest to the effectiveness of our internal controls over financial reporting pursuant to Section 404 of SOX until the date we are no longer an emerging growth company. Our independent registered public accounting firm may issue a report that is adverse in the event that it is not satisfied with the level at which the controls of the Company are documented, designed or operating.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any failure to maintain effective internal controls, including the recommendations of the Special Committee, could adversely impact our ability to report our financial results on a timely and accurate basis, or may result in a restatement of our financial statements for prior periods. Any such failures could have a material adverse effect on our financial results and investor confidence and the market for our Class A Common Stock.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our internal controls over financial reporting may not be effective, which could have a significant and adverse effect on our business and reputation.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a public company, we are required to comply with the SEC&#8217;s rules implementing Sections 302 and 404 of SOX, which require management to certify financial and other information in our quarterly and annual reports and provide an annual management report on the effectiveness of internal controls over financial reporting. To comply with the requirements of being a public company, the Company is required to provide the management report on internal controls on Form 10-K for year ended December 31, 2024. The standards required for a public company under Section 404 of SOX are significantly more stringent than those required as a privately held company. Further, as an emerging growth company, our independent registered public accounting firm is not required to formally attest to the effectiveness of our internal controls over financial reporting pursuant to Section 404 of SOX until the date we are no longer an emerging growth company. Our independent registered public accounting firm may issue a report that is adverse in the event that it is not satisfied with the level at which the controls of the Company are documented, designed or operating.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Testing and maintaining these controls can divert our management&#8217;s attention from other matters that are important to the operation of our business. If we identify material weaknesses in the internal control over financial reporting of the Company or are unable to comply with the requirements of Section 404 of SOX or assert that our internal control over financial reporting is effective, or if our independent registered public accounting firm is unable to express an opinion as to the effectiveness of our internal controls over financial reporting when we no longer qualify as an emerging growth company, investors may lose confidence in the accuracy and completeness of our financial reports and we could become subject to further investigations by the SEC or other regulatory authorities, which could require additional financial and management resources, and negatively impact the market price of our Class A Common Stock.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Matters relating to or arising from the Special Committee investigation, including governmental investigations, regulatory proceedings, litigation matters, and potential additional expenses, may adversely affect our business and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As previously disclosed, on August 11, 2022, the SEC initiated an investigation of the Company, and requested documents relating to, among other matters, the Business Combination transaction with Lionheart Acquisition Corporation II consummated on May 23, 2022, certain historical and projected financial results, investor agreements, and data analytic platforms and Algorithms. The Company received a subpoena dated March 1, 2023 from the SEC regarding the aforementioned subject matter, and subsequently received a subpoena on May 10, 2023, in connection with the investigation relating to, among other matters, the Company&#8217;s projections and the accounting and valuation of certain assets that were the basis for the Company&#8217;s determination that its quarterly financial statements for the periods ended June 30, 2022 and September 30, 2022 require restatements and should no longer be relied upon, as disclosed in the Company&#8217;s Form 8-K on April 14, 2023. On August 16, 2023, the Company received an additional subpoena from the SEC regarding certain funding sources of the Company prior to the Business Combination, various statements and disclosures by the Company in connection with, and following, the Business Combination, certain historical and projected financial results, and data analytic platforms and Algorithms used to identify potential recoveries.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, on March 10, 2023, the Company received a subpoena from the U.S. Attorney&#8217;s Office (&#8220;USAO&#8221;) in connection with a grand jury investigation in the U.S. District Court for the Southern District of Florida requesting certain information concerning the Company, which requested documents relating to, among other matters, the Company&#8217;s proprietary Algorithms and other software used to identify potentially recoverable claims, the drop in the price of the Company&#8217;s common stock following the Business Combination, and certain marketing materials and investment agreements presented to potential investors. On July 18, 2024, the Company received an additional subpoena from the USAO, requesting documents related to a Company press release. To the best of the Company&#8217;s knowledge, the Department of Justice has not issued any target letters to anyone associated with the Company as a result of this investigation. (The United States Attorney&#8217;s Manual states that a &#8220;target&#8221; is a person as to whom the prosecutor or the grand jury has substantial evidence linking him or her to the commission of a crime and who, in the judgment of the prosecutor, is a putative defendant.)</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has cooperated, and will continue to cooperate, fully with these inquiries. On April 16, 2023, a special committee of the Board of Directors was formed, which along with external advisors retained thereby, reviewed matters related to the preparation and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">44</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">filing of the 2022 Annual Report on Form 10-K and the subject matter of information requests related to the foregoing subpoenas received prior to June 2023. Based on that review, and the nature of the documents requested in the subsequent subpoena, the Company believes that the investigations will be resolved without any material developments; however, there can be no assurance as to the outcome or future direction thereof.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have incurred significant expenses related to legal, accounting, and other professional services in connection with the Special Committee review and related matters. The expenses incurred, and expected to be incurred, have adversely affected, and could continue to adversely affect, our business, financial condition, and results of operations or cash flows.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the resulting impact of our delayed filing of periodic reports on the confidence of investors, employees, and customers, and the diversion of the attention of the management team that has occurred, and is expected to continue, has adversely affected, and could continue to adversely affect, our business, financial condition, and results of operations or cash flows.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the matters reported above, we are exposed to greater risks associated with litigation, regulatory proceedings, and government enforcement actions. Any future investigations or additional lawsuits may adversely affect our business, financial condition, results of operations and cash flows, and negatively impact the market price of our Class A Common Stock.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Company&#8217;s stockholders may be held liable for claims by third parties against the Company to the extent of distributions received by them.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Company is forced to file a bankruptcy case or an involuntary bankruptcy case is filed against the Company that is not dismissed, any distributions received by stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a &#8220;preferential transfer&#8221; or a &#8220;fraudulent conveyance.&#8221; As a result, a bankruptcy court could seek to recover all amounts received by the Company&#8217;s stockholders. Furthermore, because the Company distributed the proceeds held in the Public Shares to the Company&#8217;s Public Stockholders in connection with the Closing, this may be viewed or interpreted as giving preference to the Company&#8217;s Public Stockholders over any potential creditors with respect to access to or distributions from the Company&#8217;s assets. Furthermore, the LCAP Board may be viewed as having breached their fiduciary duties to the Company&#8217;s creditors and/or may have acted in bad faith, and thereby exposing itself and the Company to claims of punitive damages, by paying Public Stockholders from the Trust Account prior to addressing the claims of creditors. The Company cannot assure you that claims will not be brought against it for these reasons.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We completed a 1-for-25 reverse stock split of our shares of common stock, which may have adverse effects on the trading of our Class A Common Stock.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 7, 2024, the Company was notified by Nasdaq Listing Qualifications staff (the &#8220;Staff&#8221;) that the Company was non-compliant with Nasdaq&#8217;s Bid Price Requirement as the closing bid price for the Company&#8217;s Class A Common Stock had fallen below $1.00 per share for 30 consecutive business days (April 25, 2024 through June 6, 2024). On September 25, 2024, stockholders holding at least a majority of our outstanding voting capital stock, including our Class A Common Stock and Class V Common Stock, approved by written consent a resolution authorizing the Board of Directors to amend the Company&#8217;s Charter, to effect a reverse stock split (the &#8220;2024 Reverse Split&#8221;) of the Company&#8217;s Common Stock at a reverse stock split ratio ranging from 1:3 to 1:30, and to authorize the Company&#8217;s Board of Directors to determine, at its discretion, the timing of the amendment and the specific ratio of the 2024 Reverse Split. On November 12, 2024, the Board determined to proceed with the 2024 Reverse Split at a ratio of 1:25, which was effectuated on the open of business on November 18, 2024. On December 3, 2024, the Company received correspondence from Nasdaq stating that the Company&#8217;s previously disclosed bid price deficiency had been cured, and that the Company had regained compliance with Listing Rule 5450(a)(1). The effect that the 2024 Reverse Split will have on the market price of our Class A Common Stock cannot be predicted with certainty. There can be no assurance that the per share price of our Class A Common Stock will continue to meet the price criteria or other requirements for continued listing of our common stock on the Nasdaq.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to the Yorkville SEPA</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In this section &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and other similar terms refer to Legacy MSP Recovery prior to the Business Combination and to the Company following the Business Combination.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Substantial blocks of our common stock may be sold into the market as a result of the shares sold to Yorkville under the Yorkville SEPA, which may cause the price of our common stock to decline.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The price of our common stock could decline if there are substantial sales of shares of our common stock, if there is a large number of shares of our common stock available for sale, or if there is the perception that these sales could occur. On November 14, 2023, we entered into the Yorkville SEPA, pursuant to which the Company agreed to issue and sell to Yorkville, from time to time, and Yorkville agreed to purchase from the Company, up to $250 million of the Company&#8217;s Class A Common Stock for a 36-month period.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We generally have the right to control the timing and amount of any sales of our shares of Class A Common Stock to Yorkville under the Yorkville SEPA, except with respect to Class A Common Stock issued upon conversion of Yorkville Convertible Notes. Sales of our shares of Class A Common Stock, if any, to Yorkville under the Yorkville SEPA will depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to Yorkville all, some, or none of the shares of Class A Common Stock that may be available for us to sell to Yorkville pursuant to the Yorkville SEPA. However, to the extent that there is a balance outstanding pursuant to the Yorkville Convertible Notes, Yorkville may, at its discretion, deliver a notice under the Yorkville SEPA requiring the issuance and sale of shares of Class A Common Stock to Yorkville at a price per share equivalent to the Conversion Price as determined</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">45</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in accordance with the Yorkville Convertible Notes in consideration of an offset to the Yorkville Convertible Notes; Yorkville, in its sole discretion, may select the amount of any such conversion, provided that the number of shares issued does not cause Yorkville to exceed certain limitations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">It is not possible to predict the actual number of shares we will sell under the Yorkville SEPA to Yorkville, or the actual gross proceeds resulting from those sales. Further, we may not have access to the full amount available under the Yorkville SEPA with Yorkville.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The number of shares of Class A Common Stock ultimately offered for sale by Yorkville is dependent upon the number of shares of Class A Common Stock, if any, we ultimately elect to sell to Yorkville under the Yorkville SEPA.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Yorkville SEPA provides that, during the term of the agreement, and subject to issuance and effective registration of the shares, we may, at our discretion, from time to time direct Yorkville to purchase our shares of Class A Common Stock from us in one or more purchases under the agreement, for a maximum aggregate purchase price of up to $250 million. However, because the market prices of our shares of Class A Common Stock may fluctuate from time to time and, as a result, the actual purchase prices to be paid by Yorkville for our shares of Class A Common Stock that we direct it to purchase under the Yorkville SEPA, if any, also may fluctuate because they will be based on such fluctuating market prices of our shares of Class A Common Stock, it is possible that we would need to issue, register, and sell additional shares of our Class A Common Stock to Yorkville under the Yorkville SEPA in order to receive aggregate gross proceeds equal to Yorkville&#8217;s $250 million total aggregate purchase commitment under the Yorkville SEPA.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Yorkville SEPA, the Company shall not affect any sales under the Yorkville SEPA, and Yorkville shall not have any obligation to purchase shares of our Class A Common Stock under the Yorkville SEPA, to the extent that after giving effect to such purchase and sale: (i) Yorkville would beneficially own more than 9.99% of the Company&#8217;s outstanding voting Common Stock at the time of such issuance (the &#8220;Ownership Limitation&#8221;), or (ii) the aggregate number of shares of Class A Common Stock issued under the Yorkville SEPA together with any shares of Common Stock issued in connection with any other related transactions that may be considered part of the same series of transactions, would exceed 19.99% of the aggregate number of shares of outstanding voting Common Stock as of November 14, 2023 (the &#8220;Exchange Cap&#8221;). However, on December 6, 2024, stockholders holding at least a majority of our outstanding voting capital stock, including our Class A Common Stock and Class V Common Stock, approved by written consent as required by Nasdaq Rule 5635(d), the issuance of shares of common stock of the Company in excess of the Exchange Cap set forth in the Yorkville SEPA. Effective January 8, 2025, the Exchange Cap was effectively lifted, allowing the Company to issue shares to Yorkville pursuant to the Yorkville SEPA and the Yorkville Convertible Notes in excess of the Exchange Cap.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We generally have the right to control the timing and amount of any sales of our shares of Class A Common Stock to Yorkville under the Yorkville SEPA, except with respect to a Yorkville Advance (as defined herein). Sales of our shares of Class A Common Stock, if any, to Yorkville under the Yorkville SEPA will depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to Yorkville all, some, or none of the shares of Class A Common Stock that may be available for us to sell to Yorkville pursuant to the Yorkville SEPA. In addition, to the extent that there is a balance outstanding pursuant to the Yorkville Convertible Notes, Yorkville may, at its discretion, deliver a notice under the SEPA requiring a Yorkville Advance. Yorkville, in its sole discretion, may select the amount of any Yorkville Advance, provided that the number of shares issued does not cause Yorkville to exceed the Ownership Limitation, does not exceed the Exchange Cap, or the number of shares of common stock that are registered. As a result of a Yorkville Advance, the amounts payable under the Yorkville Convertible Notes will be offset by such amount subject to each Yorkville Advance.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Yorkville SEPA, and subject to the condition set forth therein, Yorkville agreed to advance to the Company in the form of convertible promissory notes (the &#8220;Yorkville Convertible Notes&#8221;) an aggregate principal amount of $15.0 million. In 2023, the Company issued two Convertible Notes to Yorkville for a combined principal amount of $10 million, resulting in net proceeds of $9.48 million, and in 2024 the Company issued a third Convertible Note to Yorkville in the principal amount of $5.0 million, resulting in net proceeds to us of $4.75 million.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville may convert the Yorkville Convertible Notes into shares of our Class A Common Stock at a conversion price equal to the lower of: (A)(i) with respect to the initial Convertible Note issued on November 15, 2023, $200.5625, (ii) with respect to the second Convertible Note issued on December 11, 2023, $92.84, and (iii) with respect to the third Convertible Note issued on April 8, 2024, $37.625, or (B) 95% of the lowest daily VWAP during the seven consecutive trading days immediately preceding the conversion (the &#8220;Conversion Price&#8221;), which in no event may the Conversion Price be lower than $3.75 (the &#8220;Floor Price&#8221;) (as reduced by the Yorkville Letter Agreement). Yorkville, at its discretion, and providing that there is a balance remaining outstanding under the Yorkville Convertible Notes, may deliver a notice under the Yorkville SEPA requiring the issuance of shares of Class A Common Stock to Yorkville at a price per share equivalent to the Conversion Price as determined in accordance with the Yorkville Convertible Notes; Yorkville, in its sole discretion, may select the amount of any such conversion, provided that the number of shares issued is subject to certain limitations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the purchase price per share to be paid by Yorkville for the shares of Class A Common Stock that we may elect to sell to Yorkville under the Yorkville SEPA, if any, will fluctuate based on the market prices of our shares of Class A Common Stock at the time we elect to sell shares to Yorkville pursuant to the Yorkville SEPA, if any, it is not possible for us to predict the number of shares of Class A Common Stock that we will sell to Yorkville under the Yorkville SEPA, the purchase price per share that Yorkville will pay for shares purchased from us under the Yorkville SEPA, or the aggregate gross proceeds that we will receive from those purchases by Yorkville under the Yorkville SEPA.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">46</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, although the Yorkville SEPA provides that we may sell up to an aggregate of $250 million of our Class A Common Stock to Yorkville, only 2.0 million shares of our common stock were registered for resale under the registration statement, which we may elect to sell to Yorkville, in our sole discretion, from time to time from and after the date of, and pursuant to, the Yorkville SEPA or that Yorkville may require that we sell pursuant to a Yorkville Advance. Even if we elect to sell to Yorkville all of the shares of Common Stock, depending on the market prices of our Class A Common Stock at the time of such sales, the actual gross proceeds from the sale of all such shares may be substantially less than $250 million, which could materially and adversely affect our liquidity.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As we have sold substantially all of the 2.0 million shares currently registered for resale to Yorkville, we need to file with the SEC one or more additional registration statements to register under the Securities Act the resale by Yorkville of any additional shares of our common stock, and the SEC would have to declare such registration statement or statements effective before we could sell additional shares. There can be no assurances of such events occurring or the timing of such events occurring.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Third Virage MTA Amendment, 25% of the Company&#8217;s portion of any net proceeds from the Yorkville SEPA would be used to pay down the VRM Full Return after the Yorkville Convertible Notes are fully satisfied. Pursuant to a letter agreement dated November 15, 2024, Nomura agreed to forego payments of up to $4.0 million due under the Nomura Note from proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA until March 31, 2025. Moreover, on April 10, 2025, Yorkville agreed to waive Volume Threshold and Maximum Advance Amount limitations set forth in the Yorkville SEPA.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The sale and issuance of our shares of our Class A Common Stock to Yorkville will cause dilution to our existing shareholders, and the sale of the shares acquired by Yorkville, or the perception that such sales may occur, could cause the price of our Class A Common Stock to fall.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The purchase price for the shares that we may sell to Yorkville under the Yorkville SEPA will fluctuate based on the price of our shares of Common Stock. Depending on a number of factors, including market liquidity, sales of such shares may cause the trading price of our Common Stock to fall. If and when we do sell shares to Yorkville or when Yorkville requires a Yorkville Advance, Yorkville may resell all, some, or none of those shares at its sole discretion, subject to the terms of the Yorkville SEPA. Therefore, sales to Yorkville by us could result in substantial dilution to the interests of other holders of our shares of Common Stock. Additionally, the sale of a substantial number of shares of Common Stock to Yorkville, or the anticipation of such sales, could make it more difficult for us to sell equity or equity-related securities in the future at a desirable time and price. The resale of shares of Common Stock by Yorkville in the public market or otherwise, or the perception that such sales could occur, could also harm the prevailing market price of our shares of Common Stock.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Following these issuances described above and as restrictions on resale end and registration statements are available for use, the market price of our shares of Common Stock could decline if the holders of restricted shares sell them or are perceived by the market as intending to sell them. As such, sales of a substantial number of shares of Common Stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our shares of Common Stock.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">While there is an outstanding remaining balance pursuant to one or more of the Yorkville Convertible Notes, we do not exercise absolute control over the timing and amount of the issuance of our Class A Common Stock to Yorkville and, accordingly, it is not possible to predict the actual number of shares we will issue pursuant to the conversion of a Convertible Note, at any one time or in total.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While there is an outstanding remaining balance pursuant to one or more of the Yorkville Convertible Notes, we do not have absolute control over the timing and amount of any issuances of our shares of Class A Common Stock to Yorkville upon conversion of a Yorkville Convertible Note. Sales of our shares of Class A Common Stock, if any, to Yorkville under the Yorkville SEPA will depend upon market conditions and other factors, and the discretion of Yorkville. We may ultimately decide to sell to Yorkville all, some, or none of the shares of Class A Common Stock that may be available for us to sell to Yorkville pursuant to the Yorkville SEPA.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the purchase price per share to be paid by Yorkville for the shares of Class A Common Stock that we may elect to sell to Yorkville under the Yorkville SEPA, if any, will fluctuate based on the market prices of our shares of Class A Common Stock, if any, it is not possible for us to predict, prior to any such sales, the number of shares of Class A Common Stock that we will sell to Yorkville under the Yorkville SEPA, the purchase price per share that Yorkville will pay for shares purchased from us under the Yorkville SEPA, or the aggregate gross proceeds that we will receive from those purchases by Yorkville under the Yorkville SEPA, if any.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Upon a trigger event, we may be required to make payments that could cause us financial hardship.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Yorkville SEPA, and subject to the conditions set forth therein, Yorkville has agreed to advance us an amount of up to $15.0 million, evidenced by the Yorkville Convertible Notes to be issued to Yorkville at a purchase price equal to 95.0% of the principal amount of each Convertible Note. In 2023, the Company issued two Convertible Notes to Yorkville for a combined principal amount of $10 million, resulting in net proceeds of $9.48 million, and in 2024 the Company issued a third Convertible Note to Yorkville in the principal amount of $5.0 million, resulting in net proceeds to us of $4.75 million.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest accrues on the outstanding balance of any Convertible Note at an annual rate equal to 5.0%, subject to an increase to 18% upon an event of default as described in the Yorkville Convertible Notes. The maturity date of each Convertible Note will be September 30, 2025 (as extended pursuant to the Yorkville Letter Agreement, defined below), and may be extended at the option of Yorkville. Yorkville may convert the Yorkville Convertible Notes into shares of our Class A Common Stock at a conversion price equal to the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">47</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">lower of: (A)(i) with respect to the initial Convertible Note issued on November 15, 2023, $200.5625, (ii) with respect to the second Convertible Note issued on December 11, 2023, $92.84, and (iii) with respect to the third Convertible Note issued on April 8, 2024, $37.625, or (B) 95% of the lowest daily VWAP during the seven consecutive trading days immediately preceding the conversion (the &#8220;Conversion Price&#8221;), which in no event may the Conversion Price be lower than $3.75 (the &#8220;Floor Price&#8221;) (as reduced by the Yorkville Letter Agreement).</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Yorkville SEPA, if any time on or after November 14, 2023, (i) the daily VWAP is less than the Floor Price for ten consecutive trading days (&#8220;Floor Price Trigger&#8221;), (ii) the Company has issued substantially all of the shares available under the Exchange Cap (as defined below) (&#8220;Exchange Cap Trigger&#8221;) or (iii) Company is in material breach of the Registration Rights Agreement, dated as of the date hereof, by and between Yorkville and the Company (the &#8220;Registration Rights Agreement&#8221;) and such breach remains uncured for a period of twenty trading days, or the occurrence of an &#8220;Event&#8221; (as defined in the Registration Rights Agreement) (&#8220;Registration Event Trigger&#8221; and collectively with the Floor Price Trigger and the Exchange Cap Trigger, the &#8220;Trigger&#8221;), are triggered then the Company shall make monthly payments to Yorkville beginning on the seventh trading day after the Trigger and continuing monthly in the amount of $1,500,000 plus an 5.0% premium and accrued and unpaid interest.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 8, 2024, the Company and Yorkville reached an agreement (the &#8220;Yorkville Letter Agreement&#8221;) to: (1) reduce the Floor Price from $32.00 to $25.00; (2) waive the first monthly payment due to the Floor Price Trigger, thereby curing the Floor Price Trigger; and (3) extend the maturity date of the Yorkville Convertible Notes to September 30, 2025. In addition, the parties agreed that the third Convertible Note for $5.0 million would be issued on April 8, 2024. On April 12, 2024, Yorkville further agreed that, to the extent that it holds Class A Common Stock in such quantities that would prevent the Company from utilizing the SEPA solely due to the Ownership Limitation, Yorkville commits to fund an additional advance in the principal amount of $13.0 million on the same terms and conditions as the previous advances pursuant to the Yorkville SEPA. On May 2, 2024, the Company and Yorkville reached an agreement to reduce the Floor Price under the Yorkville SEPA from $25.00 to $12.50. On July 11, 2024, the daily VWAP for our Class A Common Stock had been below the Floor Price for ten consecutive trading days, resulting in a Floor Price Trigger. On July 12, 2024, Yorkville agreed to extend the due date for the first Monthly Payment, due as a result of a Floor Price Trigger, to September 11, 2024. On August 13, 2024, the Company and Yorkville reached an agreement to reduce the Floor Price under the Yorkville SEPA from $12.50 to $3.75, thereby curing the Floor Price Trigger pursuant to the terms of the Yorkville SEPA. On December 6, 2024, stockholders holding at least a majority of our outstanding voting capital stock, including our Class A Common Stock and Class V Common Stock, approved by written consent as required by Nasdaq Rule 5635(d), the issuance of shares of common stock of the Company in excess of the Exchange Cap set forth in the Yorkville SEPA. Effective January 8, 2025, the Exchange Cap was effectively lifted, allowing the Company to issue shares to Yorkville pursuant to the Yorkville SEPA and the Yorkville Convertible Notes in excess of the Exchange Cap. On January 24, 2025, the Company and Yorkville agreed that Monthly Payments resulting from a Floor Price Trigger would be due no sooner than April 30, 2025, and that the Company would initiate Advance Notices weekly to issue and sell shares remaining under an existing effective registration statement. On April 10, 2025, Yorkville further agreed to: (i) extend the due date for the first Monthly Payment to November 30, 2026, (ii) extend the maturity date of the Convertible Notes to November 30, 2026, and (iii) to waive Volume Threshold and Maximum Advance Amount limitations set forth in the Yorkville SEPA.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to IT Systems and Cybersecurity</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In this section &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and other similar terms refer to Legacy MSP Recovery prior to the Business Combination and to the Company following the Business Combination.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We obtain and process a large amount of sensitive data. Our systems and networks may be subject to cybersecurity breaches and other disruptions that could compromise our information. Any real or perceived improper use of, disclosure of, or access to such data could harm our reputation as a trusted brand, as well as have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on IT networks and systems to process and store electronic information. We collect and store sensitive data, including PHI on our IT networks. Our systems may be vulnerable to physical break-ins, viruses, hackers, and other potential sources of security breaches or incidents. We may not be able to prevent incidents of inappropriate use or disclosure or unauthorized access to or acquisition. Despite the implementation of security measures, our information technology networks and systems have been, and in the future may be, vulnerable to disruptions and shutdowns due to attacks by hackers or breaches due to malfeasance by contractors, employees, and others who have access to our networks and systems. The occurrence of any of these cybersecurity events could compromise our networks and the information stored on our networks could be accessed. Any such access could disrupt our operations, adversely affect the willingness of existing or potential Assignors to do business with us or result in legal claims, liability, reputational damage, or regulatory penalties under laws protecting the privacy of personal information, any of which could adversely affect our business, financial condition, and operating results.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely heavily on technology to communicate internally and efficiently perform our services. We have implemented measures that are designed to mitigate the potential adverse effects of a disruption, relocation, or change in operating environment; however, we cannot provide assurance that the situations we plan for and the amount of insurance coverage that we maintain will be adequate in any particular case. In addition, despite system redundancy and security measures, our systems and operations are vulnerable to damage or interruption from, among other sources:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">power loss, transmission cable cuts, and telecommunications failures;</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">48</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">damage or interruption caused by fire, earthquakes, and other natural disasters;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">attacks by hackers or nefarious actors;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">human error;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">computer viruses and other malware or software defects; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">physical break-ins, sabotage, intentional acts of vandalism, terrorist attacks, and other events beyond our control.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we encounter a business interruption, if we fail to effectively maintain our information systems, if it takes longer than we anticipate to complete required upgrades, enhancements, or integrations, or if our business continuity plans and business interruption insurance do not effectively compensate on a timely basis, we could suffer operational disruptions, disputes with Assignors, civil or criminal penalties, regulatory problems, increases in administrative expenses, loss of our ability to produce timely and accurate financial and other reports or other adverse consequences, any of which could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As we collect and manage large amounts of data, it is possible that hardware failures or errors in our systems could result in data loss or corruption or cause the information that we collect to be incomplete or contain inaccuracies that our partners regard as significant. If our data were found to be inaccurate or unreliable due to fraud or other error, or if we, or any of the third-party service providers we engage, were to fail to maintain information systems and data integrity effectively, we could experience operational disruptions that may hinder our ability to provide services, establish appropriate pricing for services, retain and attract Assignors, establish reserves, timely report financial results, and accurately and maintain regulatory compliance, among other things. Additionally, as Assignors maintain their own supporting documentation, data, and records, it is possible that they may provide us with erroneous or inaccurate data. The occurrence of any of these events could cause our solutions to be perceived as vulnerable, cause our Assignors to lose confidence in our solutions, negatively affect our ability to attract new Assignors, and cause existing Assignors to terminate or not renew our solutions. If the information is lost, improperly disclosed, or threatened to be disclosed, we could incur significant liability and be subject to regulatory scrutiny and penalties. Furthermore, we could be forced to expend significant resources in response to a security breach, including investigating the cause of the breach, repairing system damage, increasing cyber-security protection costs by deploying additional personnel and protection technologies, notifying and providing credit monitoring to affected individuals, paying regulatory fines and litigating and resolving legal Claims and regulatory actions, all of which could increase our expenses and divert the attention of our management and key personnel away from our business operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, if our own confidential business information were improperly disclosed, our business could be materially adversely affected. A core aspect of our business is the reliability and security of our technology platform. Any perceived or actual breach of security could have a significant impact on our reputation as a trusted brand, cause us to lose existing Assignors, prevent us from obtaining new Assignors, require us to expend significant funds to remedy problems caused by breaches and to implement measures to prevent further breaches and expose us to legal risk and potential liability. Any security breach at a third-party vendor providing services to us could have similar effects. Any breach or disruption of any systems or networks on which we rely could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our information technology strategy and execution are critical to our continued success. We expect to continue to invest in long-term solutions that will enable us to continue being a differentiator in the market and to protect against cybersecurity risks and threats. Our success is dependent, in large part, on maintaining the effectiveness of existing technology systems and continuing to deliver and enhance technology systems that support our business processes in a cost-efficient and resource-efficient manner. Increasing regulatory and legislative changes will place additional demands on our information technology infrastructure that could have a direct impact on resources available for other projects tied to our strategic initiatives. In addition, recent trends toward greater patient engagement in health care require new and enhanced technologies, including more sophisticated applications for mobile devices. Connectivity among technologies is becoming increasingly important. We must continue to develop our systems to meet market standards and keep pace with continuing changes in information processing technology, evolving industry and regulatory standards and patient needs. Failure to do so may present compliance challenges and impede our ability to deliver services in a competitive manner. Further, because system development projects are long-term in nature, they may be more costly than expected to complete and may not deliver the expected benefits upon completion. Our failure to effectively invest in, implement improvements to, and properly maintain the uninterrupted operation and data integrity of our information technology and other business systems could adversely affect our results of operations, financial position, and cash flow.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any of our employees or contractors take, convert, or misuse confidential business information, or we experience a data breach creating a risk of identity theft, we could be liable for damages and our business reputation could be damaged. In addition, we could be perceived to have facilitated or participated in illegal misappropriation of documents or data and, therefore, be subject to civil or criminal liability. In addition, federal and state regulators may take the position that a data breach or misdirection of data constitutes an unfair or deceptive act or trade practice. We also may be required to notify individuals affected by any data breaches. Further, a data breach or similar incident could impact the ability of our Assignors that are creditors to comply with the federal &#8220;red flags&#8221; rules, which require the implementation of identity theft prevention programs to detect, prevent, and mitigate identity theft in connection with Assignor accounts, which could be costly. If data utilized in our solutions are misappropriated for the purposes of identity theft or similar illegal behavior, it could have a material adverse effect on our reputation, business, financial condition, and results of operations.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">49</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Increased cybersecurity requirements, vulnerabilities, threats, and more sophisticated and targeted computer crime could pose a risk to our systems, networks, products, solutions, services, and data.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the perpetrators of cyberattacks become more capable, as cybercrime becomes commoditized, and as critical infrastructure is increasingly becoming digitized, the risks in this area continue to grow. While we attempt to mitigate these risks by employing certain physical, administrative, and technical measures, including, but not limited to, employee training, logical access controls, monitoring and testing, and maintenance of protective systems and contingency plans, we remain potentially vulnerable to additional known or unknown threats, and we cannot assure that the impact from such threats will not be material.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We regularly assess external and internal cybersecurity-related risks and identify potential improvements to our cybersecurity program, including its staffing, processes, and technology. When potential improvements are identified, we weigh the costs and benefits of such improvements and, if selected, the improvements are added to an agenda for possible implementation. We have incurred, and expect to continue to incur, significant costs implementing additional security measures to protect against existing and emerging cybersecurity threats, which may adversely affect our results of operations, financial position, and cash flow.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Certain of our activities present the potential for identity theft or similar illegal behavior by employees, contractors, or third parties, which could have a material adverse effect on our business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our solutions involve the use and disclosure of PHI that, in some cases, could be used to impersonate third parties or otherwise improperly gain access to their data or funds. If an employee or contractor were to take, convert, or misuse such information, or we experience a data breach creating a risk of identity theft, we could be liable for damages and our business reputation could be damaged. In addition, we could be perceived to have facilitated or participated in illegal misappropriation of documents or data and, therefore, be subject to civil or criminal liability. In addition, federal and state regulators may take the position that a data breach or misdirection of data constitutes an unfair or deceptive act or trade practice. We also may be required to notify individuals affected by any data breaches. Further, a data breach or similar incident could impact the ability of our Assignors, those of whom are creditors, to comply with the federal &#8220;red flags&#8221; rules, which require the implementation of identity theft prevention programs to detect, prevent and mitigate identity theft in connection with Assignor accounts, which could be costly. If data utilized in our solutions are misappropriated for the purposes of identity theft or similar illegal behavior, it could have a material adverse effect on our reputation, business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to comply with applicable privacy, security, and data laws, regulations and standards, including with respect to third-party service providers that utilize sensitive personal information on our behalf, it could have a material adverse effect on our reputation, business, financial condition, and results of operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have Assignors throughout the United States and Puerto Rico, and may expand our business into foreign markets. Our solutions may contain PHI of patients located domestically and abroad. Therefore, we may be subject to the privacy laws of each such jurisdiction, which may vary and, in some cases, can impose more restrictive requirements than federal law. Where state laws are more protective, we have to comply with the stricter provisions. In addition to fines and penalties imposed upon violators, some of these state laws also afford private rights of action to individuals who believe their personal information has been misused. California&#8217;s patient privacy laws, for example, provide for penalties of up to $250,000 and permit injured parties to sue for damages. The interplay of federal and state laws may be subject to varying interpretations by courts and government agencies, creating complex compliance issues for us and our Assignors and potentially exposing us to additional expense, adverse publicity, and liability. Further, as regulatory focus on privacy issues continues to increase, and laws and regulations concerning the protection of personal information expand and become more complex, these potential risks to our business could intensify. Changes in laws or regulations associated with the enhanced protection of certain types of sensitive data, such as PHI or personally identifiable information, along with increased customer demands for enhanced data security infrastructure, could greatly increase the cost of providing our services, decrease demand for our services, reduce our revenue, and/or subject us to additional liabilities.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following legal and regulatory developments also could have a material adverse effect on our business, financial condition, and results of operations:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amendment, enactment, or interpretation of laws and regulations that restrict the access and use of personal information and reduce the supply of data available to Assignors;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in cultural and consumer attitudes to favor further restrictions on information collection and sharing, which may lead to regulations that prevent full utilization of our solutions;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure of our solutions to comply with current laws and regulations; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure of our solutions to adapt to changes in the regulatory environment in an efficient, cost-effective manner.</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">50</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In the event we fail to maintain our SOC 2, HITRUST or other certifications, we could be in breach of our obligations under our contracts; fines and other penalties could result, we may suffer reputational harm, and our business could be damaged, limiting our ability to generate revenue.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to government regulations and securities laws, we are subject to self-regulatory standards and industry certifications that may legally or contractually apply to us. These include Security Organization Control 2 (&#8220;SOC 2&#8221;), with which we are currently compliant. In the event we fail to maintain our SOC 2 compliance or fail to receive recertification from HITRUST, we could be in breach of our obligations under Assignor agreements and other contracts, fines, and other penalties could result, and we may suffer reputational harm and damage to our business. Further, our Assignors may expect us to comply with more stringent privacy and data security requirements than those imposed by laws, regulations, or self-regulatory requirements, and we may be obligated contractually to comply with additional or different standards relating to our handling or protection of data.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any failure or perceived failure by us to comply with laws or regulations, industry standards, or other legal obligations, or any actual or suspected privacy or security incident, whether or not resulting in unauthorized access to, or acquisition, release or transfer of PHI or other data, may result in governmental enforcement actions and prosecutions, private litigation, fines and penalties, or adverse publicity and could cause our Assignors to lose trust in us, which could have an adverse effect on our reputation and business. We may be unable to make such changes and modifications in a commercially reasonable manner or at all, and our ability to pursue recoveries could be limited. Any of these developments could harm our business, financial condition, and results of operations. Privacy and data security concerns may inhibit retention of our systems by existing Assignors or onboarding onto or, in the case of our Chase to Pay services, adoption of our systems by new Assignors. For more information on Chase to Pay services, please see the section entitled &#8220;Business - Chase to Pay.&#8221;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to anticipate and adapt to the growing use of artificial intelligence in our industry, other competing products and services that do so more effectively could surpass us and lead to decreased demand for our platform and products.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The use of artificial intelligence applications is pervasive in the data analytics industry, and we expect its use to grow. If our vendors and business partners adopt new artificial intelligence platforms, we may need to develop integrations and functionalities related to these new networks and platforms to remain competitive. These development efforts may require significant costs, including compliance expenses, research and development costs, and/or licensing fees, all of which could adversely affect our business, cash flow, and operating results.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The use of new and evolving technologies, such as artificial intelligence, in our business may result in spending material resources and presents risks and challenges, which may expose the Company to reputational harm and liability that could have a material adverse effect on our revenue, earnings, and the value of our publicly traded securities.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The rapid evolution of artificial intelligence will require the application of significant resources to design, develop, test, and maintain our products and services to help ensure that artificial intelligence is implemented in accordance with applicable law and regulation to minimize any real or perceived unintended harmful impacts.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our vendors may incorporate artificial intelligence tools into their services, and the providers of these artificial intelligence tools may not meet existing or rapidly evolving regulatory or industry standards, including with respect to privacy and data security.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, bad actors around the world use increasingly sophisticated methods, including the use of artificial intelligence, to engage in illegal activities involving the theft and misuse of personal information, confidential information, and intellectual property. Any of these effects could damage our reputation, result in the loss of valuable property and information, cause us to breach applicable laws and regulations, and adversely impact our business and operating results.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item1b"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1B</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Unresolved Staff Comments.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p><div><ix:nonNumeric id="F_b03677fd-f244-426b-bbb0-2ae5c76caf93" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" escape="true" continuedAt="F_b03677fd-f244-426b-bbb0-2ae5c76caf93_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item1c"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. Cybers</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ecurity.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company maintains robust processes for assessing, identifying, and managing material risks from cybersecurity threats. We are subject to federal and state laws and regulations governing privacy, security, and breaches of patient information and the conduct of certain electronic health care transactions, including, the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) and other health information privacy and security requirements. We rely on information technology networks and systems to process and store electronic information. We collect and store sensitive data, including PHI on our information technology networks. As we collect and manage large quantities of data, it is possible that hardware failures or errors in our systems could result in data loss or corruption or cause the information that we collect to be incomplete or contain inaccuracies that our partners regard as significant. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2047d019-e6e6-4128-8615-64dd122ef92f" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" escape="true" continuedAt="F_2047d019-e6e6-4128-8615-64dd122ef92f_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Increased global cybersecurity vulnerabilities, threats, computer viruses, ransomware and phishing attacks, and more sophisticated and targeted cyber-related attacks, as well as cybersecurity failures resulting from human error and technological errors, pose a risk to the security of the Company&#8217;s systems and networks and the confidentiality, availability, and </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_028ae83e-f8ae-4766-97a2-136e39dea512" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">integrity</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">data on these products, systems, and networks. We have implemented security measures designed to prevent disruptions and shutdowns of our information technology networks due to attacks by hackers or breaches due to malfeasance by contractors, employees and others who have access to our networks and systems. </span></ix:nonNumeric></span><span style=""></span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">51</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_b03677fd-f244-426b-bbb0-2ae5c76caf93_1" continuedAt="F_b03677fd-f244-426b-bbb0-2ae5c76caf93_2"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_2047d019-e6e6-4128-8615-64dd122ef92f_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expect to continue to invest in long-term solutions to protect against cybersecurity risks and threats.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Except as otherwise provided herein, this Item 1C reflects the Company&#8217;s cybersecurity policies and procedures as of December 31, 2024.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2024, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2bb15d9f-3849-4231-a6ba-1d34d37f7e70" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we did not identify any cybersecurity threats that would have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or financial condition</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. However, despite our efforts, we cannot eliminate all risks from cybersecurity threats, or provide assurances that we have not experienced undetected cybersecurity incidents. For additional information about these risks, see Part I, Item 1A, &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors&#8201;&#8212;&#8201;Risks Related to IT Systems and Cybersecurity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; in this Annual Report.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risk Management and Strategy</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Company employs an IT Security Team that is responsible for assessing and managing cybersecurity risks.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has a designated IT Security Team to maintain its cybersecurity program and oversee third-party service providers that provide cybersecurity protection. The IT Security Team is tasked with the prevention, detection, mitigation, and remediation of cybersecurity incidents through a variety of technical and operational measures, and reports to our DevOPS/Security Manager. The team is comprised of personnel with a broad range of experience across the business and information technology industries, including our DevOPS/Security Manager, and employees in senior legal and administrative roles. The IT Security Team relies on the advice of the Manager DevOPS/Security related to the security of our data and any mitigation steps necessary.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our DevOPS/Security Manager leads our cybersecurity program and is tasked with supporting our security functions of identifying, preventing, detecting, responding to, and recovering from cybersecurity threats and incidents. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_91d9de8b-cef6-4bd8-8649-345cb1c3cbf7" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The DevOPS/Security Manager has 28 years of experience in IT networking, administration, and security related roles, including nine years at the Company. Prior to joining the Company, our DevOPS/Security Manager served for 15 years in a senior leadership role in the IT department of a large, publicly traded Fortune 500 company.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The DevOPS/Security Manager reports directly to the Company&#8217;s Chief Technology Officer, and provides quarterly updates to the Cybersecurity Subcommittee on the Company&#8217;s cybersecurity program, including cybersecurity risks, incidents, and mitigation strategies.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The identification of cybersecurity risks is a continuous and evolving assessment. As a data company, we are subject to cybersecurity risks. We have identified certain cybersecurity risks specific to our business, which are identified above in Part I, Item 1A, &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors&#8201;&#8212;&#8201;Risks Related to IT Systems and Cybersecurity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; in this Annual Report.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b64e5ecf-f544-476c-9bb6-515df06cd735" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" escape="true"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Company has established processes for assessing, identifying, and managing material risks from cybersecurity threats.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company utilizes a hybrid platform consisting of a local and cloud environment. Our local environment connects to the cloud environment via an encrypted virtual private network (&#8220;VPN&#8221;) connection. Our Site-to-Site connection consists of a firewall in our local environment which responds to a connection from a firewall in our cloud. Our networks have segregated subnets, and only allow designated staff access to our cloud environment, which is only accessible from one of our local office segments. All firewalls are configured with intrusion detection systems and intrusion prevention systems, strict firewall rules, denial of service, spoof protection, advanced threat protection, and zero-day protection. Our firewalls are configured to receive definition updates as they are released, and firmware updates are automatically installed when available. We secure our local network by not utilizing any wireless access points connected to any of our networks or firewalls, enabling port security on switches, following a principle of least privilege policy, and implementing Security Information &amp; Event Management (&#8220;SIEM&#8221;) to capture all network traffic &amp; security events from both networking equipment, endpoints, and servers. We enforce a strict password policy with multi-factor authentication.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All computers and servers utilized by the Company are protected by endpoint protection, which provides real-time protection of local and network files, internet activity, and utilizes ransomware protection, application protection, malicious behavior protection, anti-malware scan interface protection, file integrity monitoring, and data loss prevention. Our endpoint protection software updates immediately upon definition releases. This endpoint has live protection and performs a deep system scan daily. Our endpoint protection products are managed by our IT Security Team via a dashboard that provides our team with immediate alerts, device isolation, and investigation features, and also contracted the use of a Managed Detection and Response (&#8220;MDR&#8221;) service. The MDR service monitors our protected endpoints, servers, and network equipment at all times. This service also investigates, eliminates, and mitigates any critical alerts, while notifying our IT Security Team issues identified. All endpoints and servers are updated with security patches and application updates to our systems from a Patch Management system.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our IT Security Team reviews security logs daily, and performs quarterly audits of device access, building access, outages, application access, and IT &amp; Development tickets. We employ data loss prevention policies to enforce HIPAA rules and also use stringent encryption controls. In addition, a Vulnerability Scanning system performs vulnerability detection on a quarterly basis. An independent third-party company conducts annual penetration and vulnerability detection as well.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our offices are physically secured with key card access controls for parking and floor access. In addition, security guards monitor building reception areas and parking garages, and receptionists are located in our lobbies to greet visitors.</span></p></ix:nonNumeric></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Company engages assessors, consultants, auditors, or other third parties in connection with its cybersecurity processes.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9a7b7174-e788-41f4-b760-f6274b12c1a2" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">engages</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> third </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">party vendors in connection with our cybersecurity processes, including penetration and vulnerability scanning, auditing of our information security management program (ISMP); and a provider of products and services to secure users, networks, and endpoints against ransomware, malware, exploits, phishing and the wide range of other cyberattacks. In addition, the Company engaged national accounting and advisory services firms to audit the operating effectiveness of our security program, which</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">52</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_b03677fd-f244-426b-bbb0-2ae5c76caf93_2"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">incorporates </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cybersecurity in our processes. On an annual basis, the Company conducts a SOC 2 Type II audit and a HITRUST assessment.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SOC 2 Type II audits assess risks from interactions with the Company&#8217;s systems, particularly information about system controls that the Company has designed, implemented, and operated to provide reasonable assurance that its service commitments and system requirements were achieved based on the SOC 2 trust services criteria.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A HITRUST assessment address the need for a continuously relevant cybersecurity assessment that incorporates best practices and leverages the latest threat intelligence to maintain applicability with information security risks and emerging cyber threats, such as ransomware and phishing. HITRUST assessments also provide a level of assurance that delivers full transparency, accuracy, consistency, and integrity.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2023, the Company engaged a HITRUST Authorized External Assessor and AICPA member firm	`, which completed independent assessments of MSP Recovery&#8217;s system. These independent assessments verified that we met the healthcare industry&#8217;s highest standards in protecting healthcare information and mitigating this risk, including compliance with the HIPAA Security Rule. On October 13, 2023, HITRUST certified that the platforms, facilities, and supporting infrastructure of our organization meet the HITRUST CSF&#174; v11 Implemented, 1-year (i1) certification criteria. For our cloud computing services, we currently use Amazon Web Services (&#8220;AWS&#8221;) which is also HITRUST certified. On June 14, 2024, an Independent Service Auditor provided MSP Recovery a report opining that our data recovery system&#8217;s commitments and system requirements meet or exceed the stringent SOC 2 Type II applicable trust services criteria.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Company has processes to oversee and identify risks from cybersecurity threats associated with its use of third-party service providers.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_06e903a0-e3b0-4203-942c-ccb8ae9f5b38" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company maintains specific policies and practices governing our third-party security risks, including our third-party assessment (&#8220;TPA&#8221;) process. Under our TPA process, we gather information from certain third parties who contract with the Company and share or receive data, or have access to or integrate with our systems, in order to help us assess potential risks associated with their security controls. We also generally require third parties to, among other things, utilize encrypted secure file transfer protocols to exchange data. We require counterparties to enter into Business Associate Agreements and Non-Disclosure Agreements that, among other things, require them to maintain security controls to protect our confidential information and data, and notify us of material data breaches that may impact our data.</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_45e7c49c-0272-467d-870a-4bc397316b46" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governance</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Board has established a Cybersecurity Subcommittee of the Audit Committee responsible for the oversight of risks from cybersecurity threats.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 7, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_090581bf-dbf0-4937-b7fa-a4545451c4d8" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Board established the Cybersecurity Subcommittee of the Audit Committee (the &#8220;Cybersecurity Subcommittee&#8221;) to assist the Board in fulfilling its oversight responsibilities with respect to assessing and mitigating the Company&#8217;s cybersecurity risks.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bb7d453e-0bd9-4a80-b4b7-aa5e18c4ddb7" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0d4c15e6-3d5d-42ca-9fcc-3672b3aa84ca" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s management, under the guidance of the IT Security Team, is responsible for the preparation, presentation, and self-assessment of the Company&#8217;s cybersecurity policies and practices.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a9940c0a-b665-4456-b32d-db7a72c891c0" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Cybersecurity Subcommittee shall be comprised of at least one independent director, and is tasked with reviewing and providing high level guidance on cybersecurity-related issues of importance to the Company.</span></ix:nonNumeric></span></ix:nonNumeric></span></p><div><ix:nonNumeric id="F_deedd04a-cf4a-4f6b-a044-a096f74b4621" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_206b514a-7f83-493b-8b2f-bc3310fe49a5" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The IT Security Team reports to the Cybersecurity Subcommittee on a quarterly basis to inform the committee about and monitoring, prevention, detection, mitigation, and remediation of cybersecurity incidents</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and is tasked with notifying the Cybersecurity Subcommittee of a cybersecurity incident upon discovery. The Cybersecurity Subcommittee held three meetings during the year ended December 31, 2024.</span></p></ix:nonNumeric></div></ix:nonNumeric></div></ix:continuation></div><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Properties.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We lease our corporate headquarters and maintain our executive offices in an office building located at 3150 SW 38th Avenue, Suite 1100, Miami, Florida 33146. We also lease office space in Puerto Rico. We believe that our existing facilities are adequate for our current and planned levels of operation.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item3"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 3</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Legal Proceedings.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. Regardless of outcome, such proceedings or claims can have an adverse impact on us because of defense and settlement costs, diversion of resources and other factors and there can be no assurances that favorable outcomes will be obtained.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investigations</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 11, 2022, the Securities and Exchange Commission (the &#8220;SEC&#8221;) initiated an investigation of the Company, and requested documents relating to, among other matters, the Business Combination transaction with Lionheart Acquisition Corporation II consummated on May 23, 2022, certain historical and projected financial results, investor agreements, and data analytic platforms and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">53</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Algorithms. The Company received a subpoena dated March 1, 2023 from the SEC regarding the aforementioned subject matter, and subsequently received a subpoena on May 10, 2023, in connection with the investigation relating to, among other matters, the Company&#8217;s projections and the accounting and valuation of certain assets that were the basis for the Company&#8217;s determination that its quarterly financial statements for the periods ended June 30, 2022 and September 30, 2022 require restatements and should no longer be relied upon, as disclosed in the Company&#8217;s Form 8-K on April 14, 2023. On August 16, 2023, the Company received an additional subpoena from the SEC regarding certain funding sources of the Company prior to the Business Combination, various statements and disclosures by the Company in connection with, and following, the Business Combination, certain historical and projected financial results, and data analytic platforms and Algorithms used to identify potential recoveries.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, on March 10, 2023, the Company received a subpoena from the U.S. Attorney&#8217;s Office (&#8220;USAO&#8221;) in connection with a grand jury investigation in the U.S. District Court for the Southern District of Florida requesting certain information concerning the Company, which subpoena requests documents relating to, among other matters, the Company&#8217;s proprietary Algorithms and other software used to identify potentially recoverable claims, the drop in the price of the Company&#8217;s common stock following the Business Combination, and certain marketing materials and investment agreements presented to potential investors. On July 18, 2024, the Company received an additional subpoena from the USAO, requesting documents related to a Company press release. To the best of the Company&#8217;s knowledge, the Department of Justice has not issued any target letters to anyone associated with the Company as a result of this investigation. (The United States Attorney&#8217;s Manual states that a &#8220;target&#8221; is a person as to whom the prosecutor or the grand jury has substantial evidence linking him or her to the commission of a crime and who, in the judgment of the prosecutor, is a putative defendant.)</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has cooperated, and will continue to cooperate, fully with these inquiries. On April 16, 2023, a special committee of the Board of Directors was formed, which along with external advisors retained thereby, reviewed matters related to the preparation and filing of the 2022 Annual Report on Form 10-K and the subject matter of information requests related to the foregoing subpoenas received prior to June 2023. Based on that review, and the nature of the documents requested in the subsequent subpoena, the Company believes that the investigations will be resolved without any material developments; however, there can be no assurance as to the outcome or future direction thereof.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cano Health</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 7, 2023, the Company issued 318,401 shares of Class A Common Stock to Cano Health, LLC (&#8220;Cano&#8221;) as payment for $61.7 million in deferred compensation related to the following agreements, which the Company had the option to pay in cash or in stock and has elected to pay in stock, of which (i) 129,033 shares of Class A Common Stock were issued as deferred consideration for the assignment of certain claims pursuant to that certain Purchase Agreement, effective as of September 30, 2022, as amended to date, by and between the Company and Cano (&#8220;Cano Purchase Agreement&#8221;), and (ii) 189,368 shares of Class A Common Stock were issued as deferred consideration for the assignment of certain claims pursuant to that certain Amended and Restated Claims Recovery and Assignment Agreement effective as of December 31, 2021, as amended to date, by and between the Company and Cano (&#8220;Cano CCRA&#8221;).</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 10, 2023, the Company sued Cano in the Circuit Court of the Eleventh Judicial Circuit in and for Miami-Dade County, Florida for declaratory relief and anticipatory breach of the Cano CCRA, Cano Purchase Agreement, and a Service Agreement (collectively, the &#8220;Cano Agreements&#8221;) between the parties. On the same day, Cano sued the Company in the same court, alleging fraud in the inducement, breach of contract, tortious interference, and unjust enrichment relating to the Cano Agreements. The Company has a $5.0 million receivable outstanding from Cano; however, due to Cano&#8217;s Quarterly Report on Form 10-Q filings for the periods ending June 30, 2023 and September 30, 2023, which include a substantial doubt about Cano&#8217;s ability to continue as a going concern, and Cano&#8217;s subsequent filing of voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code on February 4, 2024, the Company established a reserve for the balance due under such receivable during 2023. These matters were automatically stayed as a result of Cano&#8217;s bankruptcy filing. As of June 28, 2024, the Debtors&#8217; Plan has been confirmed and declared effective. The automatic stay of litigation has been lifted and the parties anticipate the ongoing litigation to re-commence under a new scheduling order.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 4, 2024, Cano sued Simply Healthcare Plans, Inc. (&#8220;Simply&#8221;) and the Company and affiliated entities seeking a declaratory judgment to determine whether the Cano Purchase Agreement should be rescinded, and whether Cano or the Company have standing to recover on claims assigned to the Company against Simply under the Cano Purchase Agreement. Cano also sought damages from Simply relating to the claims assigned to the Company under the Cano Purchase Agreement. Effective March 4, 2025, Cano voluntarily dismissed their case against Simply without prejudice.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company intends to vigorously assert its position in all Cano related litigation.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item4"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 4</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Mine Safety Disclosures.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">54</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART II</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="item5"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 5</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Market for our Common Stock and Warrants</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Class A Common Stock is traded on the Nasdaq Stock Market under the ticker symbol &#8220;MSPR.&#8221;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Class V Common stock is not listed on any stock exchange nor traded on any public market.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Public Warrants are traded on the Nasdaq Stock Market under the ticker symbol &#8220;MSPRZ.&#8221;</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our New Warrants are traded on the Nasdaq Stock Market under the ticker symbol &#8220;MSPRW.&#8221;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Record Holders</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, there were approximately 84 stockholders of record of our Class A Common Stock and the closing price of our Class A Common Stock was $2.27 per share as reported on the Nasdaq Stock Market; there was approximately one holder of record of our Public Warrants, and there were approximately eight holders of record of our New Warrants. As many of our publicly traded securities are held by brokers and other institutions in street name on behalf of beneficial owners, we are unable to estimate the total number of holders for our securities that are represented by these record holders.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dividend Policy</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have never declared or paid any cash dividends on our common stock. We currently anticipate that we will retain all of our future earnings for use in the operation of our business and to fund future growth and do not anticipate paying any cash dividends in the foreseeable future. Any future determination to declare cash dividends will be made at the discretion of our Board of Directors, subject to applicable law, and will depend on our financial condition, results of operations, capital requirements, general business conditions and other factors that our Board of Directors may deem relevant.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unregistered Sales of Equity Securities</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Palantir</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the fiscal year ending December 31, 2024, the Company issued 305,133 unregistered shares of Class A Common Stock to Palantir, in exchange for services provided in reliance on Section 4(a)(2) of the U.S. Securities Act of 1933.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">John H. Ruiz</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to a purchase agreement dated March 4, 2024, and as disclosed on his Form 4 dated March 4, 2024, the Company issued 17,544 unregistered shares of Class A Common Stock to Virage in satisfaction of certain obligations of the Company, which shares were subsequently purchased from Virage by Mr. Ruiz.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VRP</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In partial satisfaction of amounts owed by the Company pursuant to that certain Services Agreement dated May 20, 2022 between Virage and the Company, on May 23, 2024 the Company issued, among other things, 20,000 shares of the Company&#8217;s Class A Common Stock to VRP.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Yorkville</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During 2024, the Company sold 1,108,071 shares of Class A Common Stock to Yorkville pursuant to investor and/or advance notices delivered under the Yorkville SEPA at prices between $1.78 and $21.09 per share. The proceeds therefrom were used to: (i) reduce amounts owed under Yorkville Note #1 by $2.8 million and $0.2 million of principal and interest, respectively, for fiscal year 2024, (ii) $0.5 million to fund operations of the Company, and (iii) $2.6 million of payment to reduce amounts owed under the Nomura Note for fiscal year 2024.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Issuer Purchases of Equity Securities</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;" id="item6"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 6</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. [Reserved]</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">55</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="mdna"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The following discussion and analysis provides information that management believes is relevant to an assessment and understanding of the Company&#8217;s consolidated results of operations and financial condition. This Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with our Consolidated Financial Statements and related Notes included elsewhere in this Annual Report on Form 10-K (the &#8220;Annual Report&#8221;). Unless the context otherwise requires, all references in this subsection to &#8220;we,&#8221; or &#8220;the Company&#8221; refers to Legacy MSP prior to the Business Combination and the Company after the Business Combination. This discussion may contain forward-looking statements based upon the Company&#8217;s current expectations, estimates, and projections that involve risks and uncertainties. Actual results could differ materially from those anticipated in these forward-looking statements due to, among other considerations, the matters discussed under &#8220;Risk Factors&#8221; and &#8220;Cautionary Note Regarding Forward-Looking Statements.&#8221;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Business</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery is a leading healthcare reimbursement recovery and data analytics company, providing historical and Near Real-Time solutions for payers, providers, and patients. We focus on discovering losses and recovering improper payments for Medicare, Medicaid, and commercial health insurers, disrupting the antiquated healthcare reimbursement system. We also provide innovative technology and comprehensive services for multiple industries including healthcare and legal.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Medicare and Medicaid are payers of last resort. Too often, they end up being the first and only payers, because the responsible payer is not identified or billed. As Medicare and Medicaid pay a far lower rate than what other insurers are often billed, this costs the healthcare system (and the supporting taxpayers) tens of billions of dollars a year attributable to improper billing and lost recoveries. By discovering, quantifying, and settling the billed-to-paid gap on a large-scale basis, the Company is positioned to generate meaningful annual recovery revenue at high profit margins.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our access to large volumes of data, sophisticated data analytics platforms, and advanced technology provide a unique opportunity to discover and recover improper healthcare Claims payments. We have developed Algorithms to identify waste, fraud, and abuse in the Medicare, Medicaid, and commercial health insurance sectors. Our team of experienced data scientists and medical professionals analyze historical medical Claims data to identify recoverable opportunities. Once potential recoveries are reviewed by our team, they are aggregated and pursued. Through statutory law and case law, we believe we have an established basis for future recoveries.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We differ from our competitors as we receive our recovery rights through irrevocable assignments of Claims. When we are assigned these rights by our clients, we assume risk that our competitors do not. Rather than provide services under a third-party vendor services contract, we receive the rights to certain recovery proceeds from our Assignors&#8217; Claims (and, in most cases, take assignment of the Claims themselves, allowing us to step into the Assignor clients&#8217; shoes). As we, or our affiliated entities, are assigned the recovery rights associated with Claims, we are the plaintiff in any action filed and therefore exercise control over the direction of the litigation. By receiving Claims through assignment, we can pursue additional recoveries under numerous legal theories that our competitors cannot. Although we own the assigned Claims, for a significant portion of assigned Claims, our ability to pursue recoveries depends on our ongoing access to data associated with those Claims through data access rights granted to us. The termination of said data access rights would substantially impair our ability to generate recoveries on those Claims.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are entitled to a portion of any recovery rights associated with approximately $1,591 billion in Billed Amount (and approximately $380 billion in Paid Amount), which contains approximately $87.7 billion in Paid Value of Potentially Recoverable Claims, as of December 31, 2024. We believe it would take any competitor significant time to amass the portfolio of Claims rights currently owned by us due to, among things, the volume of our Claims data retained and strength of our data analytics, which we believe are key to attracting new clients that are willing to assign Claims to us.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Healthcare Industry</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business is directly related to the healthcare industry and is affected by healthcare spending and complexity in the healthcare industry. We estimate that our total potentially serviceable market is over $161.5 billion annually. Our primary focus is on the Medicare and Medicaid market segments. Medicare is the second largest government program, with annual expenditures during 2023 of approximately $1,029.8 billion for approximately 68.0 million enrollees. Medicaid has a combined estimated annual expenditure during 2023 of approximately $871.7 billion for approximately 88.5 million enrollees. Of the billions spent yearly by Medicare on medical expenses for its beneficiaries, we estimate that at least 10% of this was improperly paid by private Medicare plans.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our potentially serviceable market is impacted by the expansion or contraction of healthcare coverage and spending, which directly affects the number of Claims available. The Centers for Medicare &amp; Medicaid Services has projected that health spending will continue to grow at an average rate of 5.6% a year between 2023 and 2032. We also believe reimbursement models may become more complex as healthcare payers accommodate new markets and lines of business and as advancements in medical care increase the number of testing and treatment options available. As reimbursement models grow more complex and healthcare coverage increases, the complexity and number of Claims may also increase, which could impact the demand for our solutions. Such changes could have a further impact on our results of operations.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">56</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, approximately 95.9% of our expected recoveries arise from Claims being brought under the Medicare Secondary Payer Act. While we believe the MSP Act has bipartisan support, changes to the laws on which we base our recoveries, particularly the MSP Act, can adversely affect our business. Our ability to generate future revenue is therefore significantly dependent on factors outside our control.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Business Model</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Discover Losses/Recover Reimbursements</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We receive irrevocable assignments of health Claims recovery rights through CCRAs from a variety of sources including, but not limited to, MAOs, MSOs, HMOs, hospitals, and other at-risk entities. We utilize our proprietary internal data analytics platforms to review healthcare Claims and identify Claims with probable recovery paths.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once Claims have been assigned, our data analysts run proprietary Algorithms to identify potential recoveries. Results are then quality checked by our internal medical team. We contract with the Law Firm and other law firms across the country to pursue recoveries through the legal system. Where appropriate, the Law Firm contacts primary payers to demand payment of amounts owed. Prior to litigation, there may be an incentive for the primary insurer to settle as, pursuant to the Medicare Secondary Payer Act, an action for damages in the case of a primary plan which fails to provide for primary payment (or appropriate reimbursement) shall be in an amount double the amount otherwise provided.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We engage with each Assignor independently. We are generally entitled to 100% of recoveries pursuant to our CCRAs; from those recoveries, we are typically obligated to pay 50% of Net Proceeds to the Assignor. In certain cases, we have purchased the Assignor&#8217;s rights to recovery proceeds in advance of any collection; therefore, entitling the Company to retain 100% of the Net Proceeds. In some instances, we may purchase outright an Assignor&#8217;s recovery rights; in this instance, we are entitled to the entire recovery. In some cases, we have entered into arrangements to transfer CCRAs or rights to proceeds from CCRAs to other parties. Such sales include variable consideration in the form of payments that will be made only upon achievement of certain recoveries or based on a percentage of actual recoveries. In other cases, the Company has pledged proceeds which are due to the Company to repay certain obligations, such as the Purchase Money Loan, the Working Capital Credit Facility, and the MTA. We have yet to generate substantial revenue from the recovery model.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Recovery Services</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may also recognize Claims recovery service revenue from our services to clients, assisting entities with the pursuit of Claims recovery rights by identifying recoverable Claims and providing data matching and legal services. Under our Claims recovery services model, we do not own the rights to Claims but provide our services for a fee based on budgeted expenses for the month with an adjustment for the variance between budget and actual expense from the prior month. The fees received pursuant to a Claims recovery service agreement are related to expenses incurred and are not tied to the Billed Amount or potential recovery amounts. Although we believe our future business to be highly tied to the Recovery model and Chase to Pay, we may enter into these contracts as the market dictates. The Company did not recognize any Claims recovery service income during the year ended December 31, 2024.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Industry Solutions</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The MSP Ecosystem</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery has developed a comprehensive ecosystem to enhance healthcare reimbursement processes, integrating advanced data analytics, Near Real-Time insights, and technological tools to provide connectivity between property and casualty insurers, health plans, providers, patients, and stakeholders. This integrated ecosystem analyzes data from various sources to identify responsible parties, assists providers in receiving reasonable and customary rates for accident-related treatment, shortens the company&#8217;s collection time frame, and increases revenue visibility and predictability for its users.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Chase to Pay platform was designed to significantly improve payment accuracy in our fragmented healthcare system. Chase to Pay is a near real-time analytics driven platform that identifies the proper primary insurer at or near the point of care, helping to determine primary and secondary payers. Chase to Pay is intended to integrate with medical utilization platforms used by providers during patient care and treatment. Rather than allow a wrongful payment whereby the secondary payer needs to chase down the primary payer to collect a reimbursement, Chase to Pay helps to prevent wrongful payments in the first place, and ensures that the correct payer pays. Furthermore, as primary payers typically pay a negotiated or commercially reasonable rate, rather than the deeply discounted Medicare rate; the Company is entitled to pursue the full amount that primary payer would have been responsible to pay, had they paid in the first instance.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As Chase to Pay was designed to work at or near the point of care, it is expected to substantially improve the propriety of payments and decrease the legal costs of recovery. As a result, when implemented, Chase to Pay is expected to improve the net recovery margin as the recovery multiple grows and variable legal costs to recover decline. As a result of having already received data from property &amp; casualty insurance carriers we've settled with for historical claims, and based on the agreement with said carriers to receive data for one year from the date of the settlement, the Chase to Pay platform can be utilized to pursue additional recoveries by matching the insurance carrier with Claims data received from our Assignors.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">57</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we have not yet generated revenue from this platform, some Assignors send data to the Company on a monthly or quarterly basis. The Company is working to increase the number of Assignors that provide daily data outputs. We are currently in the process of determining the pricing and form of these arrangements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSP/Palantir Clearinghouse Platform</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The clearinghouse platform, created in collaboration with Palantir, was developed to identify, quantify, and resolve outstanding liens. By law, Medicare and MA Plans are payers of last resort, making no-fault insurers the primary payers, responsible to exhaust their policy limits to pay for accident-related claims before Medicare bears any responsibility. Healthcare providers often submit Claims for the payment of medical services rendered after an accident to the patient&#8217;s health insurer, either seeking &#8220;conditional payments,&#8221; pending reimbursement by a primary payer, or entirely unaware that a primary payer has payment obligations. Medicare is unable to effectively verify if and how much is owed for any particular claimant if they are not aware that there is a Primary Payer involved.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Federal law requires primary payers to maintain and report the &#8220;key identifiers&#8221; for all claimants (such as their name, Social Security number, address, etc.) used to determine a claimant&#8217;s Medicare status before settling any injury claim. These steps are required to ensure that Medicare is alerted to primary payer obligations in order to seek reimbursement. Primary payers routinely fail to fulfill these two duties, resulting in improper Medicare payments, rather than payments made by responsible parties, as required by law. The Company has proven that, in some instances, primary payers have a reporting rate as low as 2%, thus those certain primary payers have failed to comply with the law 98% of the time.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that the clearinghouse platform is a potential solution to this systemic problem, integrating advanced artificial intelligence (&#8220;AI&#8221;) tools, natural language processing (&#8220;NLP&#8221;), and machine learning (&#8220;ML&#8221;) to create a robust data analytics system capable of capturing and managing extensive healthcare data from multiple sources.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Key Features and Benefits:</span></p><div class="item-list-element-wrapper" style="margin-left:0.25in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.85964186330392%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Near Real-Time Data Analytics: The clearinghouse platform provides an expansive repository of data from patients, attorneys, healthcare providers, health insurers, and property and casualty insurers that can be utilized to determine payer obligations.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.25in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.85964186330392%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Enhanced Connectivity: With the ability to connect property and casualty insurers to health plans and downstream medical providers, the clearinghouse platform can address inefficiencies arising from improper payments related to accident-related injuries. This connectivity streamlines the reimbursement process, ensuring that healthcare payers and providers receive appropriate compensation, helping to reduce administrative burdens.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.25in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.85964186330392%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Advanced Data Management: The utilization of AI, NLP, and ML to process and analyze large volumes of healthcare data helps enhance the accuracy and efficiency of claims management and payment integrity.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.25in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.85964186330392%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legal Integration: The clearinghouse platform integrates legal, data, and healthcare knowledge, providing a unified ecosystem that streamlines the processing of claims reconciliation. It may also be used by primary payers to proactively resolve liens and ensure compliance with federal laws.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Through the clearinghouse platform, the Company aims to transform the healthcare reimbursement system by leveraging advanced technologies to improve data connectivity and enhance operational efficiency, leading to improved patient outcomes.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">EHR Platform</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery has developed an Electronic Health Record (&#8220;EHR&#8221;) platform (the &#8220;EHR Platform&#8221;), enabling patients and their authorized third-party representatives to collect, distribute, and export their EHR securely, facilitating informed decision-making and improved healthcare outcomes. The EHR Platform streamlines the retrieval and analysis of medical data. It also provides comprehensive insights for healthcare providers, enhancing efficiency, and monitoring outcomes and key performance indicators. The use of blockchain technology tokenization helps improve accuracy in patient care and treatment while minimizing errors in billing and payment. This aims to prevent fraud and abuse while supporting proactive, patient-centered care.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Updates</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Reverse Stock Split</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective 11:59 PM EDT on November 15, 2024, the Company filed a Certificate of Amendment to its Second Amended and Restated Certificate of Incorporation filed with the Secretary of State of the State of Delaware to effect a 1-for-25 reverse stock split of the Company&#8217;s Common Stock (the &#8220;2024 Reverse Split&#8221;). The stock began trading post split on November 18, 2024 under the same symbol. As a result of the 2024 Reverse Split, every 25 shares of the Company&#8217;s Common Stock were converted into one share of the Company&#8217;s new Common Stock. Fractional shares resulting from the 2024 Reverse Split were rounded up to the nearest whole number. The 2024 Reverse Split automatically and proportionately adjusted, based on the 1-for-25 split ratio, all issued and outstanding shares of the Company&#8217;s Common Stock, as well as the terms of warrants and other derivative securities outstanding at the time of the effectiveness of the 2024 Reverse Split. Proportionate adjustments were made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options and warrants to purchase shares of Common Stock.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Primary Market Transfer</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">58</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 6, 2024, the Company received notification from the Staff that the Company&#8217;s application to transfer the listing of its Class A Common Stock and publicly traded warrants from the Nasdaq Global Market to the Nasdaq Capital Market was approved. The Company&#8217;s securities transferred to the Nasdaq Capital Market at the opening of business on December 10, 2024. The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market, and listed companies must meet certain financial requirements and comply with Nasdaq&#8217;s corporate governance requirements.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Symbol Change</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective December 9, 2024, the Company consolidated all lines of business under the MSP Recovery brand, and the Company&#8217;s Class A Common Stock, New Warrants, and Public Warrants began trading on Nasdaq under the ticker symbols &#8220;MSPR,&#8221; &#8220;MSPRW,&#8221; and &#8220;MSPRZ,&#8221; respectively. Prior to this change, the Company was known as LifeWallet.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Going Concern</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has assessed its ability to continue as a going concern. Refer to the &#8220;Going Concern&#8221; section within </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Liquidity and Capital Resources</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> below for analysis and conclusion.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Intangible Assets</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the Company&#8217;s fourth quarter review of its CCRAs, the Company identified potential impairment indicators, such as recurring operating losses, and a lack of substantial revenue generated from our Claims portfolio to date, which it considered in its evaluation of its definite-lived intangible assets. As a result, the Company performed a recoverability analysis on the definite-lived CCRA intangible assets in the fourth quarter of 2024. The recoverability analysis primarily included unobservable inputs, including internally developed assumptions about the estimated market share of insurance carriers that may not have paid claims due to Assignors, undiscounted cash flows of potential estimated recoveries from those carriers, the corresponding direct costs associated with those estimated recoveries, and the Company&#8217;s ability to successfully litigate or negotiate settlements.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An asset group is impaired if the estimated undiscounted cash flows are less than the asset group&#8217;s carrying value. Impairment is measured by the amount by which the carrying value exceeds fair value. The Company performed a probability-weighted undiscounted net cash flow analyses, taking into account various scenarios of expected cash flows, some of which rendered positive results, while others rendered negative results. Given that the probability-weighted average cash flows of all scenarios were below the carrying value, the Company performed a fair value assessment to measure impairment loss.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value assessment of the intangible assets was determined using the income approach. The significant inputs and assumptions used in the estimate of fair value were primarily Level 3 inputs, and include internally developed assumptions used in the undiscounted analysis, as well as the determination of an appropriate discount rate. The Company&#8217;s estimation of the fair value of its CCRA intangible assets resulted in a non-cash impairment charge amount of $752.7 million recorded during the fourth quarter of 2024 in Impairment of intangible assets in the consolidated statement of operations for the year ended December 31, 2024. The estimation of the fair value requires significant management judgment with respect to the estimates discussed above. The estimates of the fair value are based on the best information available as of the date of the assessment. Small changes in the significant inputs and assumptions would increase or decrease estimated discounted future operating cash flows and could increase or decrease an impairment charge by a material amount. If actual results or future expectations are not consistent with the assumptions used in our estimate of fair value, it may result in the recording of additional impairment charges in the future which could be material.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">2024 Settlements</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal year 2024, the Company entered into comprehensive settlements with property and casualty insurers (the &#8220;P&amp;C Insurers&#8221;) on March 1, 2024, April 18, 2024, July 16, 2024, and November 11, 2024. Although the identity of the parties and terms of settlement are confidential, the settlement terms include:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Agreements to provide historical data for claimants and also assist the Company in reconciling its relevant current and future assigned Medicare claims (applicable to all settlements);</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The P&amp;C Insurers&#8217; Implementation of the Company&#8217;s coordination of benefits clearinghouse platform (applicable to the March 1, July 16, and November 11 settlements);</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Agreements to resolve cooperatively, or through binding mediation, relevant Medicare claims (liens) that MSP Recovery owns today and in the future (applicable to all settlements);</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Agreements that the P&amp;C Insurers are primary payers for any unreimbursed Medicare lien that the Company identifies from data sharing, and the P&amp;C Insurers&#8217; agreement to assign all rights to collect against other third parties that either failed to pay liens or collected twice from Medicare funds and the P&amp;C Insurers (applicable to all settlements); and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash payments from the P&amp;C Insurers to settle existing historical claims (applicable to all settlements).</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Company entered into confidential settlement agreements with certain pharmaceutical manufacturers, medical device manufacturers, and patient assistant organizations:</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">59</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 19, 2024, the Company announced a $3.1 million cash settlement with a pharmaceutical manufacturer in a case where the Company alleged that the manufacturer increased the price of a drug in violation of antitrust laws.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 11, 2024, the Company entered into a confidential settlement agreement with a medical device manufacturer totaling $760,000, where the Company alleged that the manufacturer increased the price of a medical device in violation of antitrust laws.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 21, 2024, the Company reached a preliminary settlement totaling $2.0 million where the Company alleged violations of the Racketeer Influenced and Corrupt Organizations Act, and violation of various state consumer protection laws and unjust enrichment laws. The terms of the settlement are a combination of monetary and non-monetary consideration, with the non-monetary consideration involving the Company&#8217;s acquisition of prescription drug claims data that may assist the Company to identify and recover against other responsible parties, including other pharmaceutical manufacturers and distributors.</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Yorkville Amendments</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the close of Primary Market trading on October 18, 2024, the daily VWAP for MSP Recovery, Inc.&#8217;s (the &#8220;Company&#8221;) Class A Common Stock was below the Floor Price (which is $3.75), as defined in the Exchangeable Promissory Notes (&#8220;Notes&#8221;) issued to YA II PN, Ltd. (&#8220;Yorkville&#8221;) pursuant to the Standby Equity Purchase Agreement dated November 14, 2023, as amended (the &#8220;SEPA&#8221;), by and between Yorkville and the Company, for ten consecutive Trading Days, resulting in a Floor Price Trigger pursuant to the Notes. Upon the occurrence of a Trigger Event, the Company shall make monthly payments (&#8220;Monthly Payments&#8221;) beginning on the 7th Trading Day after the date of the Trigger Event and continuing on the same day of each successive month.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 10, 2025, Yorkville agreed: (i) that the first Monthly Payment, as set forth in Section (1)(c) of the Notes, would be due from the Company no sooner than November 30, 2026, (ii) the maturity date of the Convertible Notes is extended to November 30, 2026, and (iii) to waive Volume Threshold and Maximum Advance Amount limitations set forth in the Yorkville SEPA.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Capitalized but undefined terms have the same meaning as set forth in the Yorkville SEPA and the Notes.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">LSA Amendment</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 14, 2025, Lionheart II Holdings, LLC (&#8220;Lionheart&#8221;), a wholly owned subsidiary of the Company, executed Amendment No. 1 to its Legal Services Agreement with La Ley con John H. Ruiz, P.A. d/b/a MSP Recovery Law Firm (&#8220;La Ley&#8221;), and MSP Law Firm, PLLC (collectively with La Ley, &#8220;Law Firm&#8221;) which, effective December 31, 2024: (i) terminates any obligation by the Company or its subsidiaries to provide further advances to fund the Law Firm, and provides that any Compensation earned by the Law Firm will be first used to repay the Advance Balance to Lionheart.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restructuring Plan</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described in our Current Report on Form 8-K filed with the SEC on April 10, 2025, on April 4, 2025, Virage Recovery Master, LP (&#8220;Virage&#8221;); Virage Capital Management, LP; Hazel Partners Holdings, LLC (&#8220;HPH&#8221;); Hazel Holdings I, LLC (and together with HPH, &#8220;Hazel&#8221;); La Ley con John H. Ruiz P.A. d/b/a MSP Recovery Law Firm; MSP Recovery, LLC; MSP Law Firm PLLC; MSP Recovery, Inc. (the &#8220;Company&#8221;), John H. Ruiz, and Frank C. Quesada (collectively, the &#8220;Parties&#8221;) entered into a term sheet (the &#8220;Term Sheet&#8221;) agreeing to certain terms and transactions that are designed to reduce costs of the Company through a servicer, deleverage the Company by converting certain debt of certain creditors into equity, provide access to $9.75 million of bridge funding to the Company (of which $6.5 million remains available through July 2025 (of which $6.5 million remains available through July 2025 pursuant to the Term Sheet, $2.75 million of which remains available under the Operational Collection Floor at the sole discretion of HPH) and up to $25 million of working capital for New Servicer (as defined below), and focus the Company&#8217;s operations, through the New Servicer, on the core business model of pursuing recoveries under the MSP Laws so that it can achieve its long-term recovery goals. Beyond July 2025, the Company&#8217;s anticipated sources of funding include the MSP Principals&#8217; commitment to pledge $25 million of collateral to backstop additional working capital funding for the Company, potential distributions under our Standby Equity Purchase Agreement with YA II PN, Ltd. (the &#8220;Yorkville SEPA&#8221;), and claims recovery proceeds, subject to debt obligations on certain of the claims.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These proposed transactions are subject to, among other things, further negotiation and the execution of definitive agreements, regulatory approvals, certain third-party consents and approvals, and shareholder approvals if required by the Nasdaq Stock Market. The obligation of Hazel and its affiliates to enter into definitive documents is subject to the satisfaction of various conditions precedent, at their sole discretion, including, but not limited to, satisfactory finalization of due diligence and all required internal approvals, receipt of certain third-party consents required, and finalization of documentation. Consummation of the transactions contemplated by the Term Sheet are also subject to additional fundings by other parties and certain debt concessions by other stakeholders. As a result, there can be no guarantee that the transactions contemplated by the Term Sheet will be consummated.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The proposed transactions include, but are not limited to, the following transactions:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Establishment of New Servicer</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company shall establish a new subsidiary (&#8220;New Servicer&#8221;) to provide and control recovery efforts, by way of litigation, demand letters, settlements, or other means, in connection with existing claim recovery rights (to the extent assignable), and those acquired in the future, held in special purpose vehicles (&#8220;SPV&#8221;), wholly owned by New Servicer, to hold any new claims acquired. The</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">60</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company will license its intellectual property to the New Servicer in exchange for a license fee of 17.5% of New Servicer&#8217;s excess cash flow, with a minimum fee of $1.55 million paid on May 30, 2025, and June 30, 2025. New Servicer will be funded by an affiliate of Hazel (hereinafter, &#8220;Funder&#8221;), up to $25 million in funding, as set forth below, with a right of first refusal for additional funding needs. New Servicer will be independently managed and be separately governed by an independent board of directors, including a chief executive officer chosen by Funder and consented to by the Company, one director chosen by the Company, and one independent director chosen by Funder and approved by the Company. Funder&#8217;s governance rights shall terminate once all Hazel loans have been repaid in full, and Funder&#8217;s Recovery Rights Interest (as defined below) in the New Servicer is less than 10%. Virage shall have observer rights to the New Servicer board of directors until the amounts owed to Virage pursuant to the Master Transaction Agreement dated March 9, 2022, as amended (the &#8220;MTA&#8221;), which was approximately $1.1 billion as of December 31, 2024 (the &#8220;VRM Full Return&#8221;) has been repaid and Virage&#8217;s equity interest in the Company is less than 10%.</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Working Capital Funding for the New Servicer</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Funder has agreed to extend a line of credit to New Servicer of up to $25 million, funded in tranches of up to $1.75 million per month, subject to the New Servicer meeting certain milestones (which are currently being negotiated and to be agreed in definitive documentation), beginning September 2025, with a maturity date of June 30, 2027. New Servicer funding will accrue interest at the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) plus 5% per annum for one year, and SOFR plus 10% thereafter. Funder will establish a first lien on the New Servicer; the Company will not guaranty the loan to fund New Servicer.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, Funder or Hazel is entitled to receive to up to 35% of New Servicer&#8217;s excess cash flow (the &#8220;Recovery Rights Interest&#8221;). At its option, Funder may convert, in whole or part, its Recovery Rights Interest for up to 30% of the then outstanding shares of Company&#8217;s equity, measured as of the Closing and subject to dilution for stock issuance thereafter.</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Additional Bridge Financing for the Company</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, Hazel agreed to provide up to $9.75 million in bridge loan funding to the Company under the existing Operational Collection Floor facility (in addition to the $16.0 million previously funded under the facility) in the amounts of: (i) $1.75 million for March 2025, which was funded on February 28, 2025; (ii) $1.5 million for April 2025, which was funded on April 4, 2025; (iii) $1.5 million for May 2025, to be funded on or about April 30, 2025; (iv) up to $2.0 million to fund the legal, accounting, and administrative expenses associated with the reorganization, subject to certain terms and customary conditions acceptable to Hazel, and minimum license fees of (v) $1.55 million for June 2025; and (vii) $1.55 million for July 2025. Funding is conditional, in part, on an increase in the pledge of collateral and personal guaranty by $9.75 million by Messrs. Ruiz and Quesada (the &#8220;MSP Principals&#8221;). Such minimum license fee payment will be paid from the Bridge Loan.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beyond July 2025, the MSP Principals have committed to pledge $25 million of collateral to backstop additional working capital requirements of the Company, in addition to other previous sources of funding, including cash proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA, and the proceeds from claims recoveries, subject to lien repayment on certain claims. In addition, the Company expects  annual costs reductions due to New Servicer operations and shall be funded by the Funder (through New Servicer).</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Term Sheet requires (and is conditioned upon) La Ley con John H. Ruiz, P.A. d/b/a MSP Recovery Law Firm and MSP Law Firm, PLLC, collectively, raising $25 million for operational funding over two years, subject to similar milestones (to be agreed upon) as per the New Servicer funding, and to be entered into at completion of the proposed transaction.</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt Restructuring</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In exchange for a 43% equity interest in the Company (inclusive of shares currently held and those shares acquired through warrant exercises pursuant to the Virage Term Sheet discussed below) Virage has agreed to waive all claims and release all liens against the Company relating to the VRM Full Return (approximately $1.1 billion as of December 31, 2024), and the Parties agree that the VRM Full Return will be paid only from: (i) a junior lien against Subrogation Holdings proceeds, (ii) claims currently owned by Virage, (iii) liens over two tranches of claims currently owned by Hazel (which Hazel shall release as part of the reorganization transaction) and (iv) a non-recourse second lien up to $100 million over 50% of the proceeds from the New Servicer and associated SPVs, to the extent that the VRM Full Return has not been repaid.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the MSP Principals have agreed to convert 100% of the Company&#8217;s debt obligation to them, totaling approximately $144 million, into shares of the Company&#8217;s Class A Common Stock, the full and final amount of the debt-to-equity conversion is subject to tax analysis and approval of the MSP Principals and the Company&#8217;s Board of Directors.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Hazel&#8217;s existing loans to Subrogation Holdings and the amount of Company&#8217;s guaranty (currently approximately $100 million) remain unchanged except that such lien shall now exclude the Company&#8217;s intellectual property. Hazel agreed, subject to obtaining third-party consents, to extend the maturity date on all outstanding obligations to November 30, 2026. To secure the repayment of the existing Hazel loans to the extent such loans have not been repaid in full, the Company shall, for a principal amount of up to $235 million with an interest rate of SOFR plus 10% per annum: (i) pledge to Hazel 50.1% of the New Servicer and associated SPV equity interests; and (ii) grant a lien over 50% of the proceeds from New Servicer and associated SPVs, once the New Servicer funding has been repaid. In addition, to the extent the VRM Full Return has not been repaid, Virage has second lien of up to $100 million over 50% of the proceeds from New Servicer and associated SPVs.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">61</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 13, 2025, the Board delegated to an independent committee of the Board of Directors (the &#8220;Independent Committee&#8221;) the power and authority to, among other things, determine on behalf of the Board and the Company whether, to the extent any conflicts or potential conflicts exist or arise in the future among the Company and Messrs. Ruiz and Quesada, certain Restructuring and Proposals are advisable and fair to, and in the best interests of, the Company and its stockholders. The Independent Committee reviewed the Term Sheet and engaged legal counsel and financial advisors that are familiar with the Company and restructuring transactions to determine if the Term Sheet is advisable and fair, and in the best interests of the Company and its stockholders. Although the Independent Committee identified material conflicts, those conflicts involve conditions precedent to the Term Sheet, and are resolvable to the satisfaction of the Independent Committee in furtherance of the Term Sheet and in the best interest of the Company; as such, the Independent Committee determined that it is advisable and in the best interests of the Company to approve the signing of the Term Sheet and subsequent entry into agreements consistent with the terms set forth therein.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Term Sheet, the parties expect to enter into one or more definitive agreements by April 30, 2025.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VRM Warrant Issuance and Restructuring</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the first Amendment to the Master Transaction Agreement, dated April 11, 2023 (the &#8220;First Amendment&#8221;), for each calendar month beginning with January 31, 2024 and ending when the VRM Full Return (as defined in the Master Transaction Agreement dated March 9, 2022 (as amended, the &#8220;MTA&#8221;)) is paid in full, the Company is required to either: (i) pay in cash or (ii) issue a warrant to purchase a number of shares of Class A Common Stock of the Company, or some combination thereof, to Virage Recovery Master LP (&#8220;VRM&#8221;) equal to the quotient of 1% of the calendar month-end balance of the Unpaid Base Amount (as defined in the MTA) (the &#8220;Required Monthly Issuance&#8221;). On April 14, 2025, the Company issued VRM Monthly Warrants for November 2024 and December 2024, for 3,277,808 and 6,332,792 shares respectively, exercisable at a purchase price of $0.0001 per share for a period of two years from the original issuance date, exercisable on a cashless basis only. To date, the Company has issued 12 warrants to VRM pursuant to the First Amendment, entitling Virage to purchase 19,361,939 shares of Class A Common Stock.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with negotiations to restructure the Company&#8217;s obligations under the MTA, on February 18, 2025, the Company entered into a term sheet agreement with Virage (the &#8220;Virage Term Sheet&#8221;) to amend the MTA, whereby Virage and the Company agreed, subject to certain conditions, which have not been met as of the date of this Annual Report on Form 10-K, to enter into definitive documentation at a later date to: (i) exercise the VRM Warrants to purchase that number of shares that would result in Virage owning 33 1/3% of the then issued and outstanding Common Stock (the &#8220;Warrant Exercise&#8221;), (ii) surrender to the Company any remaining unexercised VRM Warrants, or portions thereof, for termination, (iii) contemporaneous with the Warrant Exercise, terminate its agreement to hold no more than 9.99% of the outstanding Common Stock of the Company, (iv) subject to certain conditions, grant proxy voting rights to the MRCS Principals over an amount of shares of Common Stock issuable to Virage from the Warrant Exercise such that the MRCS Principals will have voting control over 51% of the total outstanding Parent Class A Common Stock, and (v) terminate any obligation of the Company to satisfy the Required Monthly Issuance. These proposed transactions under the Virage Term Sheet are subject to, among other things, further negotiation and the execution of definitive agreements, regulatory approvals, and shareholder approvals if required by the Nasdaq Stock Market; as a result, there can be no guarantee that the transactions thereby will be consummated.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">62</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Key Factors Affecting Our Results</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Claims Portfolio</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We differ from our competitors because we obtain our recovery rights through irrevocable assignments. When we are assigned these rights, we take on the risk that such Claims may not be recoverable. We are entitled to pursue a portion of any recovery rights associated with approximately $1,591 billion in Billed Amount (and approximately $380 billion in Paid Amount), which contained approximately $87.7 billion in Paid Value of Potentially Recoverable Claims, as of December 31, 2024. We are typically entitled to 100% of recovery rights pursuant to our CCRAs, but contractually obligated to pay 50% of gross recoveries to the Assignor. In certain cases, we have purchased from our Assignors the rights to 100% of the recovery. By discovering, quantifying, and settling the gap between Billed Amount and Paid Amount on a large scale, we believe we are positioned to generate substantial annual recovery revenue at high profit margins for our assigned Claims. In litigation, our experienced management and legal teams provide us with a competitive advantage. While our model of being assigned the Claim rights allows us the flexibility to direct the litigation and potentially generate higher margins, we have, on an opportunistic basis, paid the Assignor an up-front purchase price for these rights.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, we have not generated substantial revenue from our Claims portfolio, and our business model is dependent of achieving revenue from this model in the future. If we are unable to recover the up-front purchase price from the assigned Claims or the investments we have made in pursuing recoveries, it would have an adverse effect on our profitability and business.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our potential Claims recovery income in a given period will be impacted by the amount of Claims we review and ultimately pursue. The number of Claims that we review is driven by the Claims we receive through assignment. As we are assigned more Claims, we can review the Claims and identify additional recoveries. To expand our Assignor base and obtain more Claims, we plan to implement new strategies to secure new Assignors. These strategies will include a platform to educate potential Assignors about our company, making strategic business partnerships, potential mergers, as well as other marketing strategies. Our Assignors have grown from 32 Assignors in 2015 to over 160 Assignors to date. If we are unable to continue to attract new Assignors to our platform, this could adversely affect future profitability.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to obtaining new Claims, our ability to collect on identified Claims at our estimated multiples is key to our future profitability. Pursuant to the MSP Laws, we believe we are entitled to pursue reasonable and customary rates. Under existing statutory and case law, the private cause of action under the MSP Act permits the pursuit of double damages when a primary plan fails to provide for primary payment or appropriate reimbursement. In addition to double damages, federal law and regulations provide express authority to pursue statutory interest from primary payers on any amounts owed.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result, we may pursue double damages and statutory interest in our MSP Act-related recoveries. We seek to recover these amounts under either the recovery model or the Chase to Pay platform. Federal law also expressly provides MAOs with the right to charge providers for the Billed Amount when accident-related liability exists. Per the terms of various legal services agreements that MSP Recovery has with the Law Firm, for legal services provided, the Law Firm would receive a percentage of the total Claim recovery which would include double damages and additional penalties.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Claims recovery revenue is typically recognized upon reaching a binding settlement or arbitration with a counterparty or when the legal proceedings, including any appellate process, are resolved. A decrease in the willingness of courts to grant these judgments, a change in the requirements for filing these cases or obtaining these judgments, or a decrease in our ability to collect on these judgments could have an adverse effect on our business, financial condition, and operating results. Of the Claims identified as potentially recoverable, relating to our accident-related cases as of December 31, 2024, approximately 86.8% of claims are already in the recovery process, which are claims where either the recovery process has been initiated, data has been collected and matched, or resolution discussions are in process.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Key Performance Indicators</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To evaluate our business, key trends, risks and opportunities, prepare projections, make strategic decisions, and measure our performance, we track several key performance indicators (&#8220;KPIs&#8221;). As our company has yet to achieve significant revenues and the drivers of expected revenues require significant lead time before revenue can be generated, management utilizes KPIs to assist in tracking progress, and believes such KPIs are useful in evaluating the performance of our business, in addition to our financial results prepared in accordance with GAAP. The KPIs are Total Paid Amount, Paid Value of Potentially Recoverable Claims, Billed Value of Potentially Recoverable Claims, Recovery Multiple, and Penetration Status of Portfolio.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total Paid Amount</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: The term Paid Amount is defined in the Glossary of Terms section above. As we continue to expand, we anticipate our revenue growth will be greatly dependent on our ability to increase the total Paid Amount and, correspondingly, the Paid Value of Potentially Recoverable Claims, in our portfolio. Management believes this metric is a useful measure to investors and is useful in managing or monitoring company performance because we view an increase in Paid Amount as a positive indicator as it should provide the Company with the ability to increase the Paid Value of Potentially Recoverable Claims. Conversely, a decrease would produce a diminishing expectation of the Paid Value of Potentially Recoverable Claims.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Paid Value of Potentially Recoverable Claims (&#8220;PVPRC&#8221;)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: The term PVPRC is defined in the Glossary of Terms section above. We analyze our Claims portfolio and identify potentially recoverable Claims using our Algorithms to comb through historical paid Claims data and search for potential recoveries. PVPRC is a measure of the Paid Amount that has been paid to providers in respect of those potentially recoverable Claims. Management believes this measure provides a useful metric for potential recoveries, but it is not</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">63</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a measure of the actual amount that may be recovered with respect to potentially recoverable Claims, which in turn may be higher or lower based on a variety of factors. As non-compliance with Section 111 reporting requirements is commonplace, responsible reporting entities (RRE) routinely fail to report their responsibility to make primary payments; for this reason, data matching is often required to determine which reporting entity is responsible to reimburse a given potentially recoverable Claim. Our ability to generate future Claims recovery income is largely dependent on our ability to accurately identify potentially recoverable Claims through our data analytics and ultimately recover on these Claims. Management believes this metric is a useful measure to investors and in managing or monitoring company performance because we view an increase in PVPRC as a positive indicator as it should provide the Company with the ability to increase Claims recovery income and otherwise shows growth.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Billed Value of Potentially Recoverable Claims (&#8220;BVPRC&#8221;)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: BVPRC represents the cumulative Billed Amount of potentially recoverable Claims. We analyze our Claims portfolio and identify potentially recoverable Claims using Algorithms to comb through historical paid Claims data and search for potential recoveries. For a majority of our Claims, the Company believes it has the ability to recover in excess of the Paid Amount by pursuing the Billed Amount plus interest plus double damages under applicable law. Under existing statutory and case law, the private cause of action under the Medicare Secondary Payer Act permits an award of double damages when a primary plan fails to provide for primary payment or appropriate reimbursement. We believe federal law expressly provides MAOs with the right to charge, or authorize the provider of such services to charge, in accordance with the charges allowed under a law, plan, or primary plan policy. We believe our ability to generate future Claim recovery income is largely dependent on our ability to accurately identify potentially recoverable Claims through our data analytics and ultimately recover on these Claims. Management believes this metric is a useful measure to investors and in managing or monitoring company performance because we view an increase in BVPRC as a positive indicator as it should provide the Company with the ability to increase Claims recovery income and otherwise shows growth.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recovery Multiple</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: The vast majority of our recoveries are sought pursuant to the MSP Laws; however, some recoveries are sought under product liability, antitrust, and other various causes of action. For recoveries sought pursuant to the MSP Laws, we generally pursue amounts in excess of the Paid Amount; in other cases, such as antitrust or product liability, the cause of action will dictate the amount pursued. The Recovery Multiple is the amount of any generated Claims recovery income obtained by the Company in respect to any Claims as compared to the Paid Amount of those Claims (e.g., if a given Claim had a Paid Amount of $100, a $300 recovery would represent a Recovery Multiple of 3x). For these purposes, we record values under the Recovery Multiple once we have recorded Claims recovery income, either through the receipt of cash or recognition of accounts receivable on the Claims. Management believes this metric is useful to investors to manage or monitor the Company&#8217;s performance because the Recovery Multiple provides a measure of our ability to recover on Claims recovery rights. A Recovery Multiple above 1x would illustrate the Company&#8217;s ability to recover amounts in excess of the Paid Amount. As actual recoveries have been limited to date, this measure has limited utility for historical periods. However, management believes this measure will become more meaningful during the next 12 months and beyond to the extent the Company begins to report substantive recoveries.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company has obtained settlements where the Recovery Multiple was or would be in excess of the Paid Amount, settlements at or below the paid amount, and settlements where the Recovery Multiple cannot be calculated with certainty on the settlement date, as these settlements include, in addition to cash payments, non-cash consideration, including, but not limited to agreements: (i) to assign Claims for the Company to pursue recoveries against plaintiffs&#8217; attorneys and medical providers, (ii) to provide historical data and assistance in reconciling current and future Medicare claims; (iii) to implement the clearinghouse platform; and (iv) to resolve cooperatively, or through binding mediation, recoverable Medicare Claims that the Company owns today and/or obtains in the future.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Penetration Status of Portfolio</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Penetration Status of Portfolio provides a measure of the Company&#8217;s recovery efforts by taking into account the current stages of recovery of Claims in the portfolio and tying it in with the estimated market share of the related primary payers. The total percentage represents the estimated aggregate market share for the respective primary payers in which the Company is in some stage of recovery. As the Company initiates additional recovery efforts against additional primary payers, the Company expects this number to increase. These stages of recovery include where (1) the recovery process has been initiated, (2) data has been collected and matched, or (3) potential resolution discussions are in process. The Company uses third-party sources to estimate the aggregate market share of those primary payers in the property and casualty auto insurance market with whom the Company is engaged in one of these stages of recovery. Management believes this metric is useful to investors and in managing or monitoring company performance because it provides insight as to the estimated share of the market that is covered by existing recovery efforts. We estimate that cases that are in the potential resolution discussions and/or data matching are closer to generating potential future Claims recovery income.</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:42.749%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15.843%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.86%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15.843%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.86%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15.843%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">$ in billions</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2022</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Paid Amount</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">380.4</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">369.8</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">374.8</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Paid Value of Potentially Recoverable Claims</span><span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">87.7</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">88.9</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89.6</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Billed Value of Potentially Recoverable Claims</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">375.3</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">373.5</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">377.8</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Recovery Multiple</span><span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.08</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Penetration Status of Portfolio</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86.8</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86.8</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85.8</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
   </table><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, the Company received gross recoveries of $18.1 million, of which the Recovery Multiple for recoveries obtained pursuant to the MSP Laws was 1.32 times the Paid Amount, and the Recovery Multiple for </span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">64</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">recoveries obtained pursuant to non-MSP Laws, including antitrust and unfair trade practice laws, was 0.04 times the Paid Amount. During the years ended December 31, 2023 and 2022, recoveries were not meaningful, and so no multiple is provided.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 10, 2022, the United States Court of Appeals, Eleventh Circuit held that a four-year statute of limitations period applies to certain claims brought under the Medicare Secondary Payer Act&#8217;s private cause of action, and that the limitations period begins to run on the date that the cause of action accrued. This opinion may render certain Claims held by the Company unrecoverable and may substantially reduce PVPRC and BVPRC as calculated. As our cases were filed at different times and in various jurisdictions, and prior to data matching with a defendant we are not able to accurately calculate the entirety of damages specific to a given defendant, we cannot calculate with certainty the impact of this ruling at this time. However, the Company has deployed several legal strategies (including but not limited to seeking to amend existing lawsuits in a manner that could allow claims to relate back to the filing date as well as asserting tolling arguments based on theories of fraudulent concealment) that would apply to tolling the applicable limitations period and minimizing any material effect on the overall collectability of its claim rights. In addition, the Eleventh Circuit decision applies only to district courts in the Eleventh Circuit. Many courts in other jurisdictions have applied other statutes of limitations to the private cause of action, including borrowing the three-year statute of limitations applicable to the government&#8217;s cause of action; and borrowing from the False Claims Act&#8217;s six-year period. The most recent decision on the issue from the District Court of Massachusetts, for example, applies the same statute of limitations as Eleventh Circuit, but expressly disagrees with the Eleventh Circuit&#8217;s application of the &#8220;accrual&#8221; rule and instead adopted the notice-based trigger that the company has always argued should apply. This would mean that the limitations period for unreported claims has not even begun to accrue. This is a complex legal issue that will continue to evolve in jurisdictions across the country. Nevertheless, if the application of the statute of limitations as determined by the Eleventh Circuit was applied to all Claims assigned to us, we estimate that the effect would be a reduction of PVPRC by approximately $9.8 billion. As set forth in our Risk Factors, PVPRC is based on a variety of factors. As such, this estimate is subject to change based on the variety of legal claims being litigated and statute of limitations tolling theories that apply.</span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Key Components of Sales and Expenses</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following represent the components of our results of operations.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Recovery Income</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our primary income-producing activities are associated with the pursuit and recovery of proceeds related to Claims recovery rights that the Company obtains through CCRAs, which are irrevocably assigned to us. As such, this income is not generated from the transfer of control of goods or services to customers, but through the proceeds realized from perfection of Claims recoveries from rights we own. We recognize Claims recovery income based on a gain contingency model; that is, when the amounts are reasonably certain of collection. This typically occurs upon reaching a binding settlement or arbitration with the counterparty or when the legal proceedings, including any appellate process, are resolved.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, we would owe an additional payment to the original Assignor in connection with the realized value of the recovery right. Claims recovery income is recognized on a gross basis, as we are entitled to the full value of recovery proceeds and make payment to the original Assignor similar to a royalty arrangement. Such payments to our Assignors are recognized as cost of Claims recovery in the same period the Claims recovery income is recognized.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Recovery Service Income</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the past, we have recognized Claims recovery service income for our services to a related party and a third party to assist those entities with pursuit of Claims recovery rights. We have determined we have a single performance obligation for the series of daily activities that comprise Claims recovery services, which are recognized over time using a time-based progress measure. We enter into Claims recovery service contracts with third parties. Amounts payable for services to third parties are typically based on budgeted expenses for the current month with an adjustment for the variance between budget and actual expenses from the prior month.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company did not recognize any claims recovery service income during the year ended December 31, 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Revenue</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other revenue consists of fee revenue generated by the Company&#8217;s new electronic health records (&#8220;EHR&#8221;) platform, which went live in the second quarter of 2024. Other revenue was not significant for the year ended December 31, 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating Expenses</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Costs of Claim Recoveries</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Costs of recoveries consist of all directly attributable costs specifically associated with Claims processing activities, including contingent payments payable to Assignors (i.e., settlement expenses), and any other revenue generating activity.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">65</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Amortization Expense</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims Amortization Expense consists of the amortization of CCRA intangible assets for those CCRAs in which we made up-front payments or commitments in order to acquire Claims recovery rights.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Expenses</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses consist primarily of personnel-related expenses for employees involved in general corporate, sales, and marketing functions, including executive management and administration, legal, human resources, accounting, finance, tax, and information technology. Personnel-related expenses primarily include wages and bonuses. General and administrative expenses also consist of rent, IT costs, insurance, and other office expenses.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Allowance for Credit Losses</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Allowance for credit losses consists of a specific reserve in 2023 for a receivable amount due from Cano Health, LLC (see Note 12, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Commitments and Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), which was subsequently written-off in 2024. Due to its material nature, it is included separately in the consolidated statement of operations.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Professional Fees</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Professional Fees consist of consulting, accounting, and other professional fees that are charged for services provided by third-party vendors.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Professional Fees &#8211; Legal</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Professional fees </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#8211;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> legal consist of payments for the expenses of the Law Firm covered by a certain Legal Services Agreement and other legal professional services from third-party providers, including payments to co-counsel.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Intangible Assets</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consists of a non-cash impairment charge of the CCRA intangible assets recognized during the fourth quarter of 2024 as a result of the fourth quarter 2024 impairment review.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Depreciation and Amortization</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation and amortization expense consist of depreciation and amortization of property and equipment related to our investments in leasehold improvements, office and computer equipment, and internally generated capitalized software development costs. We provide for depreciation and amortization using the straight-line method to allocate the cost of depreciable assets over their estimated useful lives.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Expense</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest expense includes interest paid on the Nomura Note, Hazel Working Capital Credit Facility and Purchase Money Loan, Virage transactions (see Note 3,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Material Agreements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), Yorkville Advances, and Loans from related parties.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income (Expense)</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other income consists of equity investment earnings, some affiliate related income, mark-to-market gain (loss) for payments due in stock, settlement income, and interest income. Other expenses consist of bank service charges, airing fees, tax penalties, settlement expense, political contributions and donations, and some affiliate related expenses.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in Fair Value of Warrant and Derivative Liabilities</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.707%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in fair value of warrants and derivative liabilities consists of the mark-to-market of warrant liabilities due to Public Warrants and Virage Warrants as noted in Note 3, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Material Agreements.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net (Income) Loss Attributable to Non-Controlling Members</span></p><p style="text-indent:3.707%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net (income) loss attributable to non-controlling members consists of income or loss attributable to Class V Common Stock shareholders.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Tax Benefit</span></p><p style="text-indent:3.707%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the Business Combination, the Company became the sole managing member of MSP Recovery, which is treated as a partnership for U.S. federal, state, and local income tax purposes. As a partnership, MSP Recovery is not subject to U.S. federal and certain state and local income taxes. Any taxable income or loss generated by MSP Recovery is passed through to and included in the taxable income or loss of its partners, including MSP Recovery, Inc. The Company is subject to U.S. federal income taxes, in addition to state and local income taxes, with respect to the Company&#8217;s allocable share of income of MSP Recovery. The Company&#8217;s deferred tax balances reflect the impact of temporary differences between the carrying amount of assets and liabilities and the Company&#8217;s tax basis. The balances are stated at the tax rates in effect when the temporary differences are expected to be recovered or settled. The Company reviewed the anticipated future realization of the tax benefit of the Company&#8217;s existing deferred tax assets and concluded that it is more likely than not that all of the deferred tax assets will not be realized in the future.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">66</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Results of Operations</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Year ended December 31, 2024 versus year ended December 31, 2023</span></p><p style="text-indent:3.707%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth a summary of our consolidated results of operations for the years ended December 31, 2024 and 2023.</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50.54%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.8%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.8%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:8.44%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.44%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:3.98%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="13" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands, except for percentages)</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$ Change</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="4" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">% Change</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims recovery income</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,122</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,207</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,915</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">151</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims recovery service income</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">498</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(498</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(100</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">127</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">127</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total Revenue</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">18,249</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">7,705</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">10,544</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">137</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of revenues</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,607</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,145</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,462</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">348</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims amortization expense</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">484,076</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">476,492</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,584</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,231</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,508</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(4,277</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(16</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,131</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,766</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(8,635</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(38</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees &#8211; legal</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,519</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34,401</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(24,882</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(72</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment of intangible assets</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">752,697</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">752,697</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Allowance for credit losses</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(5,000</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(100</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">277</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">263</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,292,538</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">567,575</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">724,963</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">128</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating Loss</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(1,274,289</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(559,870</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(714,419</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">128</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(420,032</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(289,169</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(130,863</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income (expense), net</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">542</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,290</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(8,748</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(94</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant and derivative liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">136,934</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,604</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">132,330</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,874</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net loss before provision for income taxes</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(1,556,845</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(835,145</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(721,700</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">86</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income tax expense</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(1,556,845</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(835,145</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(721,700</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">86</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Net (income) loss attributable to non-controlling interests</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,196,346</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">778,797</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">417,549</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">54</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net loss attributable to MSP Recovery, Inc.</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(360,499</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(56,348</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(304,151</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">540</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
   </table><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Recovery Income. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims recovery income increased by $10.9 million for the year ended December 31, 2024 compared to the year ended December 31, 2023 driven by increased settlements during the period.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Recovery Service Income. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims recoveries service income decreased by $0.5 million to zero for the year ended December 31, 2024 from $0.5 million for the year ended December 31, 2023, driven by third-party service fees related to a contract that expired during 2023 and did not renew.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Revenue.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Other revenue was $0.1 million for the year ended December 31, 2024. The increase is related to a new service introduced in the second quarter of 2024.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cost of Claims Recoveries. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cost of Claims recoveries increased by $7.5 million to $9.6 million for the year ended December 31, 2024 from $2.1 million for the year ended December 31, 2023, driven by assignor and law firm costs, which are directly correlated to the increase in claims recovery income.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Amortization Expense. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims amortization expense increased by $7.6 million, to $484.1 million for the year ended December 31, 2024 from $476.5 million for the year ended December 31, 2023, primarily driven by increased amortization due to the acquisition of CCRAs.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative decreased by $4.3 million, or 16%, to $22.2 million for the year ended December 31, 2024 from $26.5 million for the year ended December 31, 2023, primarily driven by a decrease in marketing and promotions of $3.9 million, salaries, benefits and payroll expenses and taxes of $0.3 million, and insurance of $0.4 million, offset primarily by an increase in rent expense of $0.3 million and information technology expenses of $0.1 million, mainly data storage, among others.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Professional Fees. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Professional fees decreased by $8.6 million, or 38%, to $14.1 million for the year ended December 31, 2024 from $22.8 million for the year ended December 31, 2023, primarily driven by a $5.5 million reduction in consulting fees, $6.6 million management fees in 2023 that did not reoccur in 2024, a $1.5 million reduction in other professional fees, and $0.2 million reduction in professional accounting fees, offset by an increase of $5.1 million in corporate legal fees.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Professional Fees </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Georgia',serif;font-kerning:none;min-width:fit-content;">&#8211;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Legal. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Professional Fees </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Georgia',serif;font-kerning:none;min-width:fit-content;">&#8211;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Legal decreased by $24.9 million, or 72%, to $9.5 million for the year ended December 31, 2024, from $34.4 million for the year ended December 31, 2023, primarily due to fees incurred for outsourced law firms in 2023 being managed by the Law Firm in 2024, as well the difference in amortization of the advance to the Law Firm, discussed within &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSP Principals Promissory Note&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in Sources of Liquidity further below, which completed its amortization early in 2024.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">67</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Intangible Assets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> A non-cash impairment of intangible assets of $752.7 million was recorded for the year ended December 31, 2024. As discussed in Note 6,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Intangible Assets, Net</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K, the Company recorded a non-cash impairment amounting to $752.7 million as part the annual impairment review over intangible assets. Refer to discussion in &#8220;Recent Updates&#8221; above and in Note 6, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Intangible Assets, Net</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Allowance for Credit Losses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Allowance for credit losses for year ended December 31, 2023 was $5.0 million, entirely related to an amount due from Cano which has been reserved considering Cano&#8217;s bankruptcy proceeding, and subsequently written-off. No such allowance occurred during 2024.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Depreciation and Amortization.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Depreciation and amortization expense remained consistent for year ended December 31, 2024 in comparison with year ended December 31, 2023.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Expense. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest expense increased by $130.9 million, or 45%, to $420.0 million for the year ended December 31, 2024 from $289.2 million for the year ended December 31, 2023, primarily driven by an increase due to the guaranty obligation, the Hazel Working Credit Facility and Purchase Money Loan, as well as increases in the basis for which interest is incurred on our Claims financing obligations and accrued interest on the related party loan.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income, Net. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other income decreased by $8.7 million, to $0.5 million for the year ended December 31, 2024 from $9.3 million for the year ended December 31, 2023 primarily due to a $4.6 million gain on sale of CCRAs during 2023 that did not reoccur in 2024, a $3.9 million reduction in the mark-to-market gain on liability payable in stock, and $0.2 million reduction in Other miscellaneous income and expense.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Change in Fair Value of Warrant and Derivative Liabilities. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in fair value of warrant and derivative liabilities increased $132.3 million to $136.9 million for the year ended December 31, 2024 from $4.6 million to the same period in the prior year. For the year ended December 31, 2024, $136.9 million gain in 2024 related to a mark-to-market adjustment to the fair value of Public Warrants and Virage Warrants. For the year ended December 31, 2023, the $4.6 million gain in 2023 related to a mark-to-market adjustment to the fair value of Public Warrants.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">68</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Non-GAAP Financial Measures</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the financial measures prepared in accordance with GAAP, this Annual Report also contains non-GAAP financial measures. We consider &#8220;adjusted net loss&#8221; and &#8220;adjusted operating loss&#8221; as non-GAAP financial measures and important indicators of performance and useful metrics for management and investors to evaluate the Company&#8217;s ongoing operating performance on a consistent basis across reporting periods. We believe these measures provide useful information to investors. Adjusted net loss represents net loss adjusted for certain non-cash and non-recurring expenses, and adjusted operating loss items represent operating loss adjusted for certain non-cash and non-recurring expenses. A reconciliation of these non-GAAP measures to their most relevant GAAP measure is included below:</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:97.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:59%;box-sizing:content-box;"/>
     <td style="width:2.1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:16.4%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:2.1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:16.4%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">GAAP Operating Loss</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,274,289</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(559,870</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees paid in stock</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,072</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">830</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims amortization expense</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">484,076</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">476,492</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment of intangible assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">752,697</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Allowance for credit losses</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Adjusted Operating Loss</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(35,444</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(77,548</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">GAAP Net Loss</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,556,845</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(835,145</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees paid in stock</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,072</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">830</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims amortization expense</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">484,076</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">476,492</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment of intangible assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">752,697</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Allowance for credit losses</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">413,648</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">204,287</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant and derivative liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(136,934</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(4,604</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Adjusted Net Loss</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(41,286</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(153,140</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:1.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) Interest expense included above excludes any interest expense payments made in cash during the year ended December 31, 2024.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">69</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Liquidity and Capital Resources</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Going Concern</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As an early-stage growth company, the Company has incurred substantial net losses since inception. As of December 31, 2024, we had $12.3 million in cash and cash equivalents. The Company has incurred recurring losses and negative cash flows since inception and has an accumulated deficit of $446.1 million as of December 31, 2024. For the year ended December 31, 2024, the Company used approximately $16.1 million of cash in operations. The Company&#8217;s liquidity will depend on the ability to generate substantial Claims recovery income and Claims recovery services income in the near future, the timing of which is uncertain, as well as its ability to secure funding from capital sources. The Company&#8217;s principal liquidity needs have been working capital, debt service, and Claims financing obligations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company anticipates sources of liquidity to include up to $9.75 million in bridge loan funding to the Company under the existing Operational Collection Floor facility (in addition to the $16.0 million previously funded under the facility) in the amounts of: (i) $1.75 million for March 2025, which was funded on February 28, 2025; (ii) $1.5 million for April 2025, which was funded on April 4, 2025; (iii) $1.5 million for May 2025, to be funded on or about April 30, 2025; (iv) up to $2.0 million to fund the legal, accounting, and administrative expenses associated with the reorganization, subject to certain terms and customary conditions acceptable to Hazel, and minimum license fees of (v) $1.55 million for June 2025; and (vi) $1.55 million for July 2025, as well as the Yorkville SEPA as disclosed in more detail in Note 9, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Financing Obligations and Notes Payable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and beyond July 2025, the MSP Principals&#8217; commitment to pledge $25 million of collateral to backstop additional working capital requirements of the Company. The Company has taken several actions to address liquidity concerns, including actions enumerated below. However, as discussed further below, the Company has concluded management&#8217;s plans were not sufficient to alleviate the substantial doubt about the Company&#8217;s ability to continue as a going concern:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 29, 2023, the Company&#8217;s subsidiary, Subrogation Holdings, LLC and its parent, MSP Recovery, entered into the Working Capital Credit Facility consisting of commitments to fund up to $48 million in proceeds. Certain terms were amended to the Working Capital Credit Facility, which were memorialized in the Second Amended and Restated First Lien Credit Agreement dated November 10, 2023. See summary in &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hazel Working Capital Credit Facility and Hazel Purchase Money Loan</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; in Note 9,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Claims Financing Obligations and Notes Payable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements. On August 2, 2024, HPH agreed to, among other things, (i) extend the period for the Company draw up to $14 million for working capital, accessible in eight tranches of $1.75 million, that can be drawn at least one month apart, until September 2025 and (ii) provide for a $2.0 million loan to be funded by August 31, 2024 for the purpose of acquiring the New Claims. On January 30, 2025, the Company drew the final $1.75 million tranche for working capital. Pursuant to the OCF Amendment, HPH may, at its sole discretion, increase the Operational Collection Floor by an amount of up to $6.0 million, to be funded over a period of three to six months. On February 28, 2025 and April 4, 2025, HPH exercised that discretion and funded $1.75 million and $1.5 million, respectively, from the increase to the Operational Collection Floor; said payments are considered part of the bridge loan, as set forth in the proposed reorganization Term Sheet discussed in Note 18, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Events</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. An additional $2.75 million remains available under the Operational Collection Floor, to be funded at HPH&#8217;s sole discretion.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 13, 2023, the Company entered into the MTA Amendment No. 2 and Amendment to the Amended and Restated Security Agreement (&#8220;Second Virage MTA Amendment&#8221;), which extended the due date for the payment obligations to Virage to December 31, 2024. See summary in Note 3, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Material Agreements </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements. On April 1, 2024, the Company entered into the MTA Amendment No. 3 and Amendment No. 2 to the Amended and Restated Security Agreement (&#8220;Third Virage MTA Amendment&#8221;), which: (i) extended the VRM Full Return payment due date to September 30, 2025, subject to acceleration upon certain triggering events; (ii) the Company agreed that, after the Yorkville Convertible Notes are fully satisfied, 25% of the Company&#8217;s portion of any net proceeds from the Yorkville SEPA would be used to pay down the VRM Full Return; and (iii) commence the sale of certain reserved shares of Messrs. John H. Ruiz and Frank C. Quesada, and the delivery of the resulting net cash proceeds thereof to VRM. The VRM Full Return guaranty obligation became current on September 30, 2024, and the Company does not currently have available liquidity to satisfy said obligation.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 13, 2023, the Company entered into the Second Amended and Restated Nomura Note (defined in Note 3, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business Combination </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements), which extended the maturity date of the Nomura Note to December 31, 2024. See summary in Note 9, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Financing Obligations and Notes Payable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements. On March 26, 2024, the Company entered into the Third Amended and Restated Nomura Promissory Note, which extended the maturity date of the Nomura Note to September 30, 2025. The note became current on September 30, 2024, and the Company does not currently have available liquidity to satisfy said obligation. Pursuant to a letter agreement dated November 15, 2024, Nomura agreed to forego payments of up to $4.0 million due under the Third Amended and Restated Nomura Note from proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA until March 31, 2025.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 14, 2023, the Company entered into the Yorkville SEPA, which included the issuance of Yorkville Convertible Notes to Yorkville having aggregate principal amounts of up to $15.0 million in connection with the purchase of Class A Common Stock. See summary in &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Committed Equity Facility</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; within Note 9,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Claims Financing Obligations and Notes Payable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements. On April 8, 2024, the maturity date of the Yorkville Convertible Notes was extended to September 30, 2025. On April 12, 2024, Yorkville agreed that, to the extent that it holds Class A Common Stock in such </span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">70</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">quantities that would prevent the Company from utilizing the SEPA solely due to the Ownership Limitation, Yorkville commits to fund an additional advance in the principal amount of $13.0 million on the same terms and conditions as the previous advances pursuant to the Yorkville SEPA. On April 10, 2025, Yorkville further agreed to: (i) extend the due date for the first Monthly Payment to November 30, 2026, (ii) extend the maturity date of the Convertible Notes to November 30, 2026, and (iii) to waive Volume Threshold and Maximum Advance Amount limitations set forth in the Yorkville SEPA. As we have sold substantially all of the 2.0 million shares currently registered for resale to Yorkville, we need to file with the SEC one or more additional registration statements to register under the Securities Act the resale by Yorkville of any additional shares of our common stock, and the SEC would have to declare such registration statement or statements effective before we could sell additional shares. There can be no assurances of such events occurring or the timing of such events occurring.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has concluded that, despite the aforementioned financing arrangements, there is substantial doubt about its ability to continue as a going concern. Unless we are successful in raising additional funds through the offering of debt or equity securities, we have concluded it is probable we will be unable to continue to operate as a going concern beyond the next twelve months. The Company has received a report from its independent registered public accounting firm with an emphasis of matter paragraph as to going concern in connection with the Company&#8217;s audited annual financial statements for the year ended December 31, 2024, which resulted in an event of default in the aforementioned debt agreement, which would have resulted in the debt becoming immediately due; however, the Company has received waivers from (i) Virage and VRM and (ii) HPH and Hazel as it pertains to the year ended December 31, 2024.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sources of Liquidity</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Working Capital Credit Facility</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 6, 2023, Subrogation Holdings entered into a credit agreement (as amended on March 29, 2023; November 10, 2023; and October 1, 2024; the &#8220;Working Capital Credit Facility&#8221;) with HPH providing for funding of up to $80 million (with a 40% original issue discount), consisting of a Term Loan A commitment to fund up to $30 million (in multiple installments) in proceeds and a Term Loan B Commitment to fund up to $18 million (in multiple installments) in proceeds.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Loans under the Working Capital Credit Facility accrue interest at a Term Secured Overnight Financing Rate for 12-month interest period, plus an applicable margin of 10% per annum. Accrued interest on the Working Capital Credit Facility is payable in kind and are capitalized. The Working Capital Credit Facility has a stated maturity date of March 31, 2026, and HPH may extend for up to one year in its sole discretion. The Purchase Money Loan accrues interest at a rate of 20% per annum, payable in kind or in cash at the Company&#8217;s discretion. The Purchase Money Loan has a maturity date of March 31, 2026, extendable up to one year in Hazel&#8217;s sole discretion.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal year 2023, HPH disbursed $20.5 million under Term Loan A and $9.0 million under Term Loan B. During fiscal year 2024, HPH disbursed $4.5 million under Term Loan B on January 25, 2024. On August 2, 2024, Subrogation Holdings entered into a letter agreement to amend the Working Capital Credit Facility (the &#8220;HPH Letter Agreement&#8221;) with HPH, which, among other things: (i) extended the period to draw up to $23.3 million (with a 40% original issue discount) remaining under Term Loan B for working capital, accessible in eight tranches of $1.75 million, that can be drawn at least one month apart, until September 2025, and (ii) provided for a $3.3 million loan (subject to a 40% original issue discount) funded by August 31, 2024 to acquire additional Claims (the &#8220;New Claims&#8221;) that collateralize the Working Capital Credit Facility (collectively, (i) and (ii) the &#8220;Operational Collection Floor&#8221;). The parties formalized the terms of the HPH Letter Agreement in Amendment No. 3 to the Working Capital Credit Facility dated October 1, 2024 (the &#8220;OCF Amendment&#8221;). On October 2, 2024, the Company acquired the recovery rights to additional Medicare Secondary Payer Claims from an existing Assignor consisting of more than 450,000 Medicare members, as documented by the Assignor.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Operational Collection Floor, the Company received during 2024: (i) $12.3 million for working capital, and (ii) $2.0 million for the purpose of acquiring the New Claims. To date, the Company received $3.5 million of working capital for 2025. Pursuant to the Working Capital Credit Facility, HPH may, at its sole discretion, increase the Operational Collection Floor by an amount of up to $6.0 million, to be funded over a period of three to six months. On February 28, 2025 and April 4, 2025, HPH exercised that discretion and funded $1.75 million and $1.5 million, respectively, from the increase to the Operational Collection Floor. An additional $2.75 million remains available under the Operational Collection Floor, to be funded at HPH&#8217;s sole discretion.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts borrowed and obligations under the Working Capital Credit Facility are secured by a pledge of proceeds from certain Claims in the Company&#8217;s Claims portfolio, with the lien securing the Purchase Money Loan being subordinated and junior to the lien securing the Working Capital Credit Facility. Pursuant to the Second Amended and Restated First Lien Credit Agreement, and in order to secure those additional advances of Term Loan B beginning in January 2024, the following was provided as additional collateral: (i) a pledge of proceeds from certain Claims in the Company&#8217;s Claims portfolio, up to $14 million; (ii) a pledge of the equity interests in an Affiliate of Messrs. John H. Ruiz and Frank C. Quesada; and (iii) a personal guaranty by Messrs. John H. Ruiz and Frank C. Quesada, as primary obligors, guaranteeing those additional advances of Term Loan B beginning in January 2024. On December 22, 2023, our Board approved the Company's payment of certain costs and fees (including legal fees) on behalf of John H. Ruiz and Frank C. Quesada, associated with a mortgage granted in connection with said guaranty, totaling $0.1 million. On April 1, 2025, in connection with the increased funding under the Operational Collection Floor, the pledge and personal guaranty in (ii) and (iii) above was increased by $3.25 million to $17.25 million.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSP Principals Promissory Note</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 16, 2022, the MSP Principals provided cash to the Company to finance operations in an aggregate amount of $112.8 million. The Company issued the MSP Principals Promissory Note to the MSP Principals in an aggregate principal amount of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">71</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$112.8 million that has an annual interest rate of 4%, payable in kind, and matures on the day that is the four-year anniversary of the issuance. On the maturity date, the Company is required to pay the MSP Principals an amount in cash equal to the outstanding principal amount, plus accrued and unpaid interest. The promissory note is prepayable by the Company at any time, without prepayment penalties, fees or other expenses. In addition to the amounts in the Promissory Note, at the merger date with LCAP, the MSP Principals contributed $13.0 million through funds that had been loaned to VRM MSP to cover related service fees. A portion of the proceeds under the MSP Principals Promissory Note in an amount equal to $36.5 million was advanced to the Law Firm for certain operating expenses as contemplated by the Legal Services Agreement. The MSP Principals Promissory Note contains customary events of default that would allow the MSP Principals to declare the MSP Principals Promissory Note immediately due and payable or the MSP Principals Promissory Note will immediately and automatically become due and payable without notice, presentment, demand, protest or other request of any kind. In addition, the MSP Principals Promissory Note may be accelerated by the MSP Principals if the Board of Directors of the Company (excluding the MSP Principals) terminates the Legal Services Agreement. For the years ended December 31, 2024 and 2023, approximately $7.7 million and $19.2 million, respectively, of the $36.5 million advanced by the Company to the Law Firm has been incurred for expenses pursuant to the legal services agreement.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023, the Company received a $4.95 million loan from the Law Firm, evidenced by an unsecured promissory note, to provide general operational funding. The aggregate unpaid principal amount of this promissory note is due 24 months from the date of the last advance from the Working Capital Credit Facility is made. This promissory note is payable by the Company at any time, without prepayment penalties, fees, or other expenses. The note does not carry any interest and can be repaid at any time or from time to time without a prepayment penalty. On March 4, 2024, the Board authorized the partial repayment of the Law Firm Loan in the amount of $0.4 million, which funds were to be used for the express purpose of paying property taxes on real property owned and pledged by the MSP Principals to HPH as collateral in connection with the Working Capital Credit Facility.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Nomura Note</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 27, 2022, the Company issued an unsecured promissory note to Nomura (as amended on April 12, 2023, November 13, 2023, and March 26, 2024, the &#8220;Nomura Note&#8221;). The Nomura Note carries a principal amount of approximately $30.0 million related to advisory fees and deferred underwriting fees and expenses that became due and payable by the Company to Nomura, in connection with the consummation of the Business Combination. The Nomura Note is payable in kind or in cash, at the Company&#8217;s discretion, accrues interest at 16% per annum, and matures on September 30, 2025. Upon two days prior written notice to Nomura, the Company may prepay all or any portion of the then outstanding principal amount under the Nomura Note together with all accrued and unpaid interest thereon. The balance of the unsecured Nomura Note and related interest are included within Claims financing obligations and notes payable in the consolidated balance sheet. The Nomura Note became current on September 30, 2024, and the Company does not currently have available liquidity to satisfy said obligation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Nomura Note, 50% of the aggregate proceeds under the Yorkville SEPA will be used to pay amounts outstanding under the Amended and Restated Nomura Promissory Note (first towards accrued and unpaid interest, if any, then towards principal) and the remaining 50% of such proceeds will be used to pay amounts due under the Convertible Notes, if any, or be paid to the Company after the Convertible Notes are fully repaid. Pursuant to a letter agreement dated November 15, 2024, Nomura agreed to forego payments of up to $4.0 million due under the Nomura Note from proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA until March 31, 2025.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Yorkville SEPA</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 14, 2023, the Company entered into a standby equity purchase agreement (the &#8220;Yorkville SEPA&#8221;) with YA II PN, Ltd., a Cayman Island exempted company (&#8220;Yorkville&#8221;), pursuant to which Yorkville committed to purchase up to $250.0 million in shares of Class A Common Stock, subject to certain limitations and conditions set forth therein, during the term thereof. Sales of Class A Common Stock under the Yorkville SEPA, and the timing of any such sales, are at the Company&#8217;s option, and the Company is under no obligation to sell any shares of Class A Common Stock to Yorkville under the Yorkville SEPA except in connection with notices that may be submitted by Yorkville, in certain circumstances as described below.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the terms and conditions set forth in the Yorkville SEPA, the Company has the right, but not the obligation, from time to time at its discretion until the Yorkville SEPA is terminated to direct Yorkville to purchase a specified number of shares of Class A Common Stock (&#8220;Advance&#8221;) by delivering written notice to Yorkville (&#8220;Advance Notice&#8221;). While there is no mandatory minimum amount for any Advance, it may not exceed an amount equal to 100% of the average of the daily traded amount during the five consecutive trading days immediately preceding an Advance Notice.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The shares of Class A Common Stock purchased pursuant to an Advance Notice will be purchased at a price equal to: (i) 98% of the VWAP of the shares of Class A Common Stock on the applicable date of delivery of the Advance Notice during regular trading hours on such date, or (ii) 97% of the lowest daily VWAP of the shares of Class A Common Stock during the three consecutive trading days commencing on the date of the delivery of the Advance Notice, other than the daily VWAP on a day in which the daily VWAP is less than a minimum acceptable price as stated by the Company in the Advance Notice or there is no VWAP on the subject trading day. The Company may establish a minimum acceptable price in each Advance Notice, below which the Company will not be obligated to make any sales to Yorkville.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Yorkville SEPA, and subject to the conditions set forth therein, Yorkville agreed to advance to the Company in the form of convertible promissory notes (the &#8220;Yorkville Convertible Notes&#8221;) an aggregate principal amount of $15.0 million. In</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">72</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2023, the Company issued two Convertible Notes to Yorkville for a combined principal amount of $10 million, resulting in net proceeds of $9.48 million, and in 2024 the Company issued a third Convertible Note to Yorkville in the principal amount of $5.0 million, resulting in net proceeds to us of $4.75 million.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Yorkville Convertible Notes, Yorkville has the option, subject to certain limitations, of exchanging on one or more occasions all or part of the then outstanding balance under a given note for shares of our Class A Common Stock at a conversion price equal to the lower of: (i) a fixed price equaling 120% of VWAP the day prior to the date of the closing of each tranche (the &#8220;Fixed Price&#8221;), or (ii) a variable price equaling 95% of the lowest daily VWAP during the seven consecutive trading days immediately preceding the exchange (the &#8220;Variable Price&#8221;), but in no event may the variable price be lower than $3.75 per share (the &#8220;Floor Price&#8221;). With respect to the initial Convertible Note issued on November 15, 2023, the Fixed Price equals $200.5625 per share, with respect to the second Convertible Note issued on December 11, 2023, the Fixed Price equals $92.84 per share, and with respect to the third Convertible Note issued on April 8, 2024, the Fixed Price equals $37.625 per share.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As required pursuant to the Second Amended and Restated Nomura Promissory Note, 50% of the aggregate proceeds under the Yorkville SEPA will be used to repay amounts outstanding under the Nomura Note (first towards accrued and unpaid interest, if any, then towards principal) and the remaining 50% of such proceeds will be used to repay amounts due under the Convertible Notes, if any, or be paid to the Company after the Convertible Notes are fully repaid. Pursuant to a letter agreement dated November 15, 2024, Nomura agreed to forego payments of up to $4.0 million due under the Nomura Note from proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA until March 31, 2025. Pursuant to the Third Virage MTA Amendment, 25% of the Company&#8217;s portion of any net proceeds from the Yorkville SEPA would be used to pay down the VRM Full Return after the Convertible Notes are fully satisfied.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon the occurrence and during the continuation of an event of default, the Yorkville Convertible Notes shall become immediately due and payable, and the Company shall pay to Yorkville the principal and interest due thereunder. Events of default include, among others: (i) termination of quotation or listing of the Class A Common Stock on any primary market for a period of 10 consecutive trading days (the Company is currently quoted and listed for trading on Nasdaq) and (ii) failure to timely file any periodic report with the SEC on or before the due date of such filing as established by the SEC, including extensions under Rule 12b-25 under the Exchange Act. In no event shall Yorkville be allowed to effect a conversion if such conversion, along with all other shares of Common Stock beneficially owned by Yorkville and its affiliates would exceed 9.99% of the outstanding shares of the Common Stock of the Company. If any time on or after November 14, 2023: (i) the daily VWAP is less than the Floor Price for ten consecutive trading days (&#8220;Floor Price Trigger&#8221;), (ii) the Company has issued substantially all of the shares available under the Exchange Cap (as defined below) (&#8220;Exchange Cap Trigger&#8221;), or (iii) the Parent is in material breach of the Registration Rights Agreement, and such breach remains uncured for a period of twenty trading days, or the occurrence of an &#8220;Event&#8221; (as defined in the Registration Rights Agreement) (&#8220;Registration Event Trigger&#8221; and collectively with the Floor Price Trigger and the Exchange Cap Trigger, the &#8220;Trigger&#8221;), then the Company shall make monthly payments to Yorkville beginning on the seventh trading day after the Trigger and continuing monthly in the amount of $1.5 million plus a 5.0% premium and accrued and unpaid interest. On December 6, 2024, stockholders holding at least a majority of our outstanding voting capital stock approved by written consent as required by Nasdaq Rule 5635(d), the issuance of shares of common stock of the Company in excess of the Exchange Cap set forth in the Yorkville SEPA. Effective January 8, 2025, the Exchange Cap was effectively lifted, allowing the Company to issue shares to Yorkville pursuant to the Yorkville SEPA and the Yorkville Convertible Notes in excess of the Exchange Cap. In addition, on April 10, 2025, Yorkville agreed to waive Volume Threshold and Maximum Advance Amount limitations set forth in the Yorkville SEPA.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville, at its discretion and providing that there is a balance remaining outstanding under the Yorkville Convertible Notes, may deliver a notice under the Yorkville SEPA requiring the issuance and sale of shares of Class A Common Stock to Yorkville at the Conversion Price in consideration of an offset of the Yorkville Convertible Notes (&#8220;Investor Notice&#8221;). Yorkville, in its sole discretion, may select the amount of any Investor Notice, provided that the number of shares issued does not cause Yorkville to exceed the 9.99% ownership limitation or the amount of shares of Class A Common Stock that are registered. As a result of an Investor Notice, the amounts payable under the Yorkville Convertible Notes will be offset by such amount subject to each Investor Notice.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will control the timing and amount of any sales of shares of Class A Common Stock to Yorkville, except with respect to the conversion of the Yorkville Convertible Notes. Actual sales of shares of Class A Common Stock to Yorkville as an Advance under the Yorkville SEPA will depend on a variety of factors to be determined by the Company from time to time, which may include, among other things, market conditions, the trading price of the Company&#8217;s Class A Common Stock, and determinations by the Company as to the appropriate sources of funding for our business and operations.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Yorkville SEPA will automatically terminate on the earliest to occur of: (i) the first day of the month following the 36-month anniversary of the date of the Yorkville SEPA, or (ii) the date on which Yorkville shall have made payment of Advances pursuant to the Yorkville SEPA for shares of Class A Common Stock equal to $250.0 million. The Company has the right to terminate the Yorkville SEPA at no cost or penalty upon five trading days&#8217; prior written notice to Yorkville, provided that there are no outstanding Advance Notices for which shares of Class A Common Stock need to be issued, and the Company has paid all amounts owed to Yorkville pursuant to the Yorkville Convertible Notes. The Company and Yorkville may also agree to terminate the Yorkville SEPA by mutual written consent. Neither the Company nor Yorkville may assign or transfer the Company&#8217;s respective rights and obligations under the Yorkville SEPA, and no provision of the Yorkville SEPA may be modified or waived by the Company or Yorkville other than by an instrument in writing signed by both parties.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">73</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Yorkville SEPA contains customary representations, warranties, conditions and indemnification obligations of the parties. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The net proceeds under the Yorkville SEPA to the Company will depend on the frequency and prices at which the Company sells its shares of Class A Common Stock to Yorkville. The Company expects that any proceeds received from such sales to Yorkville will be used for working capital and general corporate purposes.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 12, 2024, Yorkville agreed that, to the extent that it holds Class A Common Stock in such quantities that would prevent the Company from utilizing the Yorkville SEPA solely due to the Ownership Limitation, Yorkville committed to fund an additional advance in the principal amount of $13.0 million on the same terms and conditions as the Yorkville Convertible Notes pursuant to the Yorkville SEPA.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During 2024, the Company sold 1,108,071 shares of Class A Common Stock to Yorkville, respectively, pursuant to investor and/or advance notices delivered under the Yorkville SEPA at prices between $1.78 and $21.09 per share. The proceeds therefrom were used to: (i) reduce amounts owed under Yorkville Note #1 by $2.8 million and $0.2 million of principal and interest, respectively for fiscal year 2024, (ii) $0.5 million to fund operations of the Company, and (iii) $2.6 million of payment to reduce amounts owed under the Nomura Note for fiscal year 2024. As we have sold substantially all of the 2.0 million shares currently registered for resale to Yorkville, we need to file with the SEC one or more additional registration statements to register under the Securities Act the resale by Yorkville of any additional shares of our common stock, and the SEC would have to declare such registration statement or statements effective before we could sell additional shares. There can be no assurances of such events occurring or the timing of such events occurring.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Assignment and Sale of Proceeds Agreement</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 30, 2022, the Company entered into an Assignment and Sale of Proceeds Agreement (the &#8220;Assignment Agreement&#8221;) and a Recovery Services Agreement (the &#8220;Services Agreement&#8221; and collectively, the &#8220;Agreements&#8221;) with the Prudent Group (&#8220;Prudent&#8221;) in order to monetize up to $250 million of the value of the Company&#8217;s net recovery interest in Claim demand letters that the Company has commenced sending to insurers who admitted they had primary payer responsibility for the underlying accidents to the federal government (&#8220;Net Recovery Proceeds&#8221;). Pursuant to the Agreements, at the Company&#8217;s sole and absolute discretion, the Company has the right to direct Prudent to acquire, on a non-recourse basis, a percentage of Net Recovery Proceeds, up to an aggregate of $250 million, at a purchase price of 90% of Net Recovery Proceeds of such Claim.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Agreements that the Company entered into on June 30, 2022 with Prudent have been terminated effective August 13, 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Financing Obligations</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 29, 2023, the Company acquired a controlling interest in nine legal entities, whose sole assets are CCRAs, from Hazel. This is referred to as the &#8220;Claims Purchase.&#8221; The purchase price for the Claims Purchase was funded by (i) a purchase money loan between Hazel, as a lender, and the Company, as a borrower, in the amount of $250 million (the &#8220;Purchase Money Loan&#8221;) and (ii) proceeds from the sale of certain, separate CCRAs in the Claims Sale. See Note 3,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Material Agreements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in the consolidated financial statements included elsewhere in this Annual Report.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 20, 2015, a subsidiary of the Company entered into a Claims Proceeds Investment Agreement (&#8220;CPIA&#8221;) with a third-party investor to invest directly and indirectly in Claims, disputes, and litigation and arbitration Claims. For such investment, the Company assigned to the investor a portion of the future proceeds of certain Claims, albeit the Company remained the sole owner and assignee of rights to Claims because the investor was only acquiring rights to a portion of the proceeds of the Claims. The investor return was based on its investment ($23 million between the original and amended agreements) and an internal rate of return of 30% calculated from the Closing Date.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2022, the Company finalized an Amendment to the CPIA and a Warrant Agreement with the third-party, pursuant to which the parties have agreed to amend the original CPIA and required payment terms. See Note 9, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Financing Obligations and Notes Payable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, to our consolidated financial statements included elsewhere in this Annual Report for a description of the Claims financing obligations and details on the amendment.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Tax Receivable Agreement</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the terms of the TRA, we generally will be required to pay to the Members, and to each other person from time to time that becomes a &#8220;TRA Party&#8221; under the TRA, 85% of the tax savings, if any, that we are deemed to realize in certain circumstances as a result of certain tax attributes that exist following the Business Combination and that are created thereafter, including as a result of payments made under the TRA. The term of the TRA will continue until all such tax benefits have been utilized or expired unless we exercise our right to terminate the TRA for an amount representing the present value of anticipated future tax benefits under the TRA or certain other acceleration events occur. Any payments made by us under the TRA will generally reduce the amount of overall cash flow that might have otherwise been available to us, and, to the extent that we are unable to make payments under the TRA for any reason, the unpaid amounts generally will be deferred and will accrue interest until paid by us.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">74</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flows</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our cash flows for the periods indicated:</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:68.28%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:13.860000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:2.4%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.46%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
     <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
     <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in operating activities</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(16,121</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(40,023</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash (used in) provided by investing activities</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2,725</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,558</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,541</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29,017</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase (decrease) in cash</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">695</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3,448</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash at beginning of year</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,633</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,081</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash at end of period</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,328</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,633</span></p></td>
     <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flows Used in Operating Activities</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in operating activities decreased by $23.9 million to $16.1 million for the year ended December 31, 2024 compared to net cash used in operating activities of $40.0 million for the year ended December 31, 2023. During the year ended December 31, 2024, net cash used in operating activities was impacted by our net loss and non-cash adjustments primarily related to $752.7 million impairment of intangible assets, $484.1 million of claims amortization expense, $278.8 million of paid-in-kind interest, $2.1 million of professional fees paid in stock, and an increase of $160.3 million of changes in working capital, partially offset by a change in fair value of warrant liability of $137.3 million, and a mark-to-market gain on liability payable in stock of $0.5 million.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023, net cash used in operating activities was impacted primarily by our net loss and non-cash adjustments primarily related to $476.5 million of claims amortization expense, $289.1 million of paid-in-kind interest, allowance for credit losses $5.0 million, $2.7 million of professional fees paid in stock, and an increase of $34.2 million of changes in working capital, partially offset by a change in fair value of warrant liability of $4.8 million, gain on sale of intangible $4.6 million and a mark-to-market gain on liability payable in stock of $4.4 million.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flows (Used in) Provided by Investing Activities</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash used in investing activities fluctuated by $10.3 million to $2.7 million for the year ended December 31, 2024 compared to cash provided by investing activities $7.6 million for the year ended December 31, 2023. During the year ended December 31, 2024, our cash used in investing activities related to the acquisition of additional CCRAs amounting to $2.2 million and $0.5 million of additions to property, plant, and equipment.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023, our cash provided by investing activities was primarily $10.0 million proceeds from the sale of CCRAs, which are included in Intangible assets, offset by cash used in investing activities related to the acquisition of additional CCRAs amounting to $0.7 million and $1.7 million of additions to property, plant, and equipment.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flows Provided by Financing Activities</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities decreased by $9.5 million to $19.5 million for the year ended December 31, 2024 compared to $29.0 million net cash provided by financing activities for the year ended December 31, 2023. During the year ended December 31, 2024, our net cash provided by financing activities was primarily due to borrowings of $23.5 million from the Working Capital Credit Facility and Yorkville Convertible Notes, and proceeds from the issuance of stock of $3.1 million, which are offset by $6.6 million repayments of the claims financing obligation and $0.4 million of payment on related party loan.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2023, our net cash provided by financing activities was primarily due to borrowings from the New Money Loan of $39.0 million and proceeds from the related party loan of $4.95 million, which are offset by $11.4 million restricted cash payment related to the FEF shares to CF, $2.6 million repayments of the claims financing obligation, $0.7 million of debt issuance costs and $0.3 million payment of deferred financing costs.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Contractual Obligations, Commitments and Contingencies</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on Claims financing obligations and notes payable agreements, as of December 31, 2024 and 2023, the present value of amounts owed under these obligations were $673.6 million and $556.3 million, respectively, including unpaid interest to date of $1.6 million and $0.8 million, respectively. In addition, as of December 31, 2024 and 2023, the Company has $12.2 million and $10.0 million advances from Yorkville, respectively. The weighted average interest rate is 15.0% based on the current book value of $685.7 million with rates that range from 0.0% to 20.00%. The Company is expected to repay these obligations from cash flows from Claim recovery income.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the minimum required payments on these agreements are $818.7 million. Certain of these agreements have priority of payment regarding any proceeds until full payment of the balance due is satisfied. The maturity of the commitments range from the date sufficient claims recoveries are received to cover the required return or in some cases by 2031.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company has $1,126.5 million of guaranty obligations. On April 12, 2023, we entered into the Virage MTA Amendment pursuant to which the payment date was extended from May 23, 2023 until September 30, 2024, subject to acceleration upon certain triggering events. On November 13, 2023, the maturity date was extended to December 31, 2024. Under the Virage MTA Amendment, Virage will receive a first priority lien on all sources of revenue of the company not otherwise encumbered as of the date of the Virage MTA Amendment, to the extent in excess of the amount of revenues necessary to establish and maintain an</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">75</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">operating reserve of $70 million for overhead expenses and applicable taxes. On July 24, 2023, the operating reserve was adjusted to $47.5 million and pursuant to the Second Virage MTA Amendment, the operating reserve was changed from $47.5 million to the budget of the Company (plus applicable taxes) plus 10%. On April 1, 2024, the Company entered into the Third Virage MTA Amendment which: (i) extended the VRM Full Return payment due date to September 30, 2025, subject to acceleration upon certain triggering events; (ii) the Company agreed that, after the Yorkville Convertible Notes are fully satisfied, 25% of the Company&#8217;s portion of any net proceeds from the Yorkville SEPA would be used to pay down the VRM Full Return; and (iii) commence the sale of certain reserved shares of Messrs. John H. Ruiz and Frank C. Quesada, and the delivery of the resulting net cash proceeds thereof to VRM.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Accounting Estimates</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our consolidated financial statements and the related notes thereto included elsewhere in this Annual Report are prepared in accordance with GAAP. The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts and related disclosures in our financial statements and accompanying notes. We base our estimates on historical experience and on various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions due to the inherent uncertainty involved in making those estimates and any such differences may be material.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that the following accounting policies involve a high degree of judgment and complexity. Accordingly, these are the policies we believe are the most critical to aid in fully understanding and evaluating our consolidated financial condition and results of our operations. See Note 2,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, to our consolidated financial statements appearing elsewhere in this Annual Report for a description of our other significant accounting policies.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Intangible Assets</span></p><p style="text-indent:3.707%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We evaluate long-lived assets, such as property and equipment, and finite-lived intangibles, such as Claims recovery rights and capitalized software costs, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset or asset group may not be recoverable. If the estimated future cash flows (undiscounted and without interest charges) from the use of an asset group are less than the carrying value, a write-down would be recorded to reduce the related asset group to its estimated fair value.</span></p><p style="text-indent:3.707%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the CCRA intangibles, we will also assess the intangible assets recognized for CCRAs for impairment in accordance with ASC 350-30-35-14, whereby an impairment loss shall be recognized if the carrying amount of the intangible asset is not recoverable and its carrying amount exceeds its fair value based on the model for long-lived assets to be held and used under ASC 360-10. ASC 360-10 requires entities to evaluate long-lived assets (including finite-lived intangible assets) when indicators are present. Impairment indicators would result only when the potential recoveries under the Claim paths of all remaining Claims suggests the unamortized carrying value is not recoverable. As up-front payments for CCRAs are typically a fraction of the potential recoveries, it would typically take a substantial negative event (such as an unfavorable court ruling upheld on appeal or a change in law/statute with retroactive effect) to suggest an impairment may be triggered.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the Company&#8217;s fourth quarter review of its CCRAs, the Company identified potential impairment indicators, such as recurring operating losses, and a lack of substantial revenue generated from our Claims portfolio to date, which it considered in its evaluation of its definite-lived intangible assets. As a result, the Company performed a recoverability analysis on the definite-lived CCRA intangible assets in the fourth quarter of 2024. The recoverability analysis primarily included unobservable inputs, including internally developed assumptions about the estimated market share of insurance carriers that may not have paid claims due to Assignors, undiscounted cash flows of potential estimated recoveries from those carriers, the corresponding direct costs associated with those estimated recoveries, and the Company&#8217;s ability to successfully litigate or negotiate settlements.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An asset group is impaired if the estimated undiscounted cash flows are less than the asset group&#8217;s carrying value. Impairment is measured by the amount by which the carrying value exceeds fair value. The Company performed a probability-weighted undiscounted net cash flow analyses, taking into account various scenarios of expected cash flows, some of which rendered positive results, while others rendered negative results. Given that the probability-weighted average cash flows of all scenarios were below the carrying value, the Company performed a fair value assessment to measure impairment loss.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value assessment of the intangible assets was determined using the income approach. The significant inputs and assumptions used in the estimate of fair value were primarily Level 3 inputs, and include internally developed assumptions used in the undiscounted analysis, as well as the determination of an appropriate discount rate. The Company&#8217;s estimation of the fair value of its CCRA intangible assets resulted in a non-cash impairment charge amount of $752.7 million recorded during the fourth quarter of 2024 in Impairment of intangible assets in the consolidated statement of operations for the year ended December 31, 2024. The estimation of the fair value requires significant management judgment with respect to the estimates discussed above. The estimates of the fair value are based on the best information available as of the date of the assessment. Small changes in the significant inputs and assumptions would increase or decrease estimated discounted future operating cash flows and could increase or decrease an impairment charge by a material amount. For example, if estimated recoveries were accelerated by one year, the non-cash impairment charge would decrease by $141.6 million, while if estimated recoveries were extended by a year, then the non-cash impairment charge would increase by $128.3 million. In addition, a hypothetical 1% change in the discount rate assumption would increase or decrease the impairment charge by approximately $39.0 million. If actual results or future expectations are not consistent with the assumptions used in our estimate of fair value, it may result in the recording of additional impairment charges in the future which could be material.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">76</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item7a"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7A</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Quantitative and Qualitative Disclosures About Market Risk.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;" id="item8"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 8</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Financial Statements and Supplementary Data.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">77</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:92.92%;box-sizing:content-box;"/>
     <td style="width:7.08%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#auditor_report"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm (PCAOB ID: </span><span><ix:nonNumeric id="F_0d5e7f36-5e0b-47f1-a5f8-67b7691b7ac6" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:AuditorFirmId"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">34</span></ix:nonNumeric></span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">)</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#balance_sheets"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Balance Sheets as of December 31, 2024 and 2023</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#statementofoperations"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Operations for the Years ended December 31, 2024 and 2023</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#statementsofchangesinequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Stockholders&#8217; Equity for the Years ended December 31, 2024 and 2023</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#statementsofcashflows"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Cash Flows for the Years ended December 31, 2024 and 2023</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">83</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#footnotes"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">78</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="auditor_report"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rep</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ort of Independent Registered Public Accounting Firm</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the shareholders and the Board of Directors of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc. and Subsidiaries:</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a08b4f9f-d8fc-4768-be0f-908ba397cc93" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:AuditorOpinionTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of MSP Recovery, Inc. and Subsidiaries (the "Company") as of December 31, 2024 and 2023, the related consolidated statements of operations, changes in equity, and cash flows, for each of the two years in the period ended December 31, 2024, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.</span></p></ix:nonNumeric></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emphasis of matter</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in Note 6 to the financial statements, the Company identified potential impairment indicators with respect to its claims cost recovery agreement (&#8220;CCRA&#8221;) definite-lived intangible assets during 2024. The Company performed an undiscounted cash flow analysis and determined the carrying value was not recoverable. The Company performed a fair value assessment to measure the impairment and recorded an impairment loss of $752.7 million during 2024.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Going Concern</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has incurred recurring net losses and negative cash flows that raise substantial doubt about its ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">/s/ </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a3d8eb9a-f2dd-4aef-9397-db8eba8403b2" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:AuditorName"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Deloitte &amp; Touche LLP</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c7efe285-37de-426e-b1d5-c4478d7a4583" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="dei:AuditorLocation"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Miami, Florida</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">April 15, 2025</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have served as the Company&#8217;s auditor since 2021.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">79</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:-26.093%;padding-left:20.693%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:-26.093%;padding-left:20.693%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP RECOVERY, INC. and Subsidiaries</span></p><p style="text-indent:-26.093%;padding-left:20.693%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="balance_sheets"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Bala</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nce Sheets</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:67.407%;box-sizing:content-box;"/>
     <td style="width:1.56%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.737%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.56%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.737%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ASSETS</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bda987b0-f554-4743-b164-f481d8abeaef" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:Cash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,328</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e599351a-be0d-4a7a-8f4b-6e2219374d56" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:Cash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,633</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts receivable</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9c59423-a860-4945-9c2a-1a88cf8cffd5" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">295</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b24ca8d5-cc12-4022-bc5b-12c486323b4b" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">217</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Affiliate receivable (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea8949b7-b3fb-4122-a17b-a12fec3eba2b" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="mspr:AffiliateReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,204</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_127e888e-7ffb-4b96-9379-154fbd63a074" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="mspr:AffiliateReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,188</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f85d3ca-1713-492b-bc89-518782029d0a" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,647</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd4a4c78-f6f8-4e11-aab0-11a7a18e2318" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,908</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total current assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71d1d8bb-e701-480f-8898-7afb573ab77c" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,474</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6810b38-31b5-4670-aa9b-a07f67970f96" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,946</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_036a0355-9236-40d5-aae1-d391c56cea19" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,159</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_524966d4-4541-4cf2-97fb-b05cf9a868da" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,911</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets, net (2)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0e5f8c74-a7f3-4607-8eb1-009f6f2e19e6" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,898,223</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_049581b0-85bf-4cc1-856e-c1f12e8a3f2b" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,132,796</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b1f690a-9b80-4541-bebd-d9420bc3deea" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">227</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de0f27e5-3fbd-430d-8b25-c0138ce07b55" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">342</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd476432-8f15-4710-ac9a-e389de9761d3" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,919,083</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4315a12d-c77b-4587-8d79-7bd75143f9bd" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,159,995</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIABILITIES AND EQUITY</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current liabilities:</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8e13ac0-c8a7-4830-bb66-b6bfca1dc13e" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,971</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ac85195-8bb5-43f6-8814-a7106fce2274" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,244</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Affiliate payable (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7349faec-67c3-4457-b111-13aa8b59814b" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="mspr:AffiliatePayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,664</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a895c9d8-b77b-49fc-bed7-f6f09c5117a3" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="mspr:AffiliatePayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,822</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commission payable</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d55a56d-9335-49c7-a5e3-be726408b6f4" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="mspr:CommissionPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,342</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d789c86d-6905-42b9-8b2b-e0116b51f33a" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="mspr:CommissionPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">821</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Derivative liability</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_412c3429-23c5-4d01-96c7-59b9f33c9466" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:DerivativeLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">211</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_379bef79-b669-432d-b2ef-b7281b917d73" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:DerivativeLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liability (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b250df4c-8239-48d4-aaf6-48db038dc64f" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="mspr:WarrantLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,373</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3922abe0-69f6-4492-9c8a-1a5a120731ec" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="mspr:WarrantLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">268</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Guaranty obligation (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7ce0478-2b86-4765-abfd-d0a23db5c0b7" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="mspr:GuarantyObligationCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,126,490</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims financing obligation and notes payable (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a867877-52a0-4e7f-a2ee-387043ab5ed6" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="mspr:ClaimsFinancingObligationNotesPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,200</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest payable (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97dfeaba-1e75-43a0-ac86-c2ba64165dc6" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:InterestPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,298</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current liabilities (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea20dce6-d3f9-471b-9aee-3f6f144ce678" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:OtherLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,765</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6bdb6d2b-db69-4134-b692-902a552fd027" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:OtherLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,314</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total current liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6ad9eda-0ac3-4ff8-876f-146a86504eb6" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,265,314</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44781b55-45f4-42ca-9540-2df23f41f4b1" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,506</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Guaranty obligation (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9f90372-fc27-416e-aab7-d587cf41cece" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="mspr:GuarantyObligationNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">941,301</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims financing obligation and notes payable (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_205a35fd-b126-40ae-b1a2-688dd34751c5" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="mspr:ClaimsFinancingObligationNotesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">633,026</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9315e270-47e0-4e4e-a1cc-3186e954fd9c" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="mspr:ClaimsFinancingObligationNotesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">548,276</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5fda4b9b-e925-405b-88da-51da2f21f7fa" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">102</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3144712f-c1e9-47cd-b212-52cbd61c9692" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">235</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loan from related parties (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e88b3c9-7da4-4078-bfd3-a81f7b588a00" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="mspr:LoanFromRelatedPartiesNonCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">130,328</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff9b0771-e0bd-4028-8ea2-970ffa0de6cd" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="mspr:LoanFromRelatedPartiesNonCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">130,709</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest payable (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_621c8126-d89e-4874-9bdd-c9eebd642153" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="mspr:InterestPayableNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,828</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a108fb9-2063-4b2f-a76e-eee9593bb7db" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="mspr:InterestPayableNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">73,839</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other long-term liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7e2d0e8-95b4-4f61-9aac-9f651017cdcb" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,894</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4cf53cfc-c544-4024-9ac2-78be92713b02" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,047,492</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ac74836-4594-4de5-bfa0-c0b21e1d09ac" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,740,866</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;"><span style="-sec-ix-hidden:F_40f7ef7b-5eb0-4c7b-ad84-9efbd7cf34d6;"><span style="-sec-ix-hidden:F_b4dccdf0-8391-4f47-a8d8-62f8ba636738;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Commitments and contingencies</span></span></span></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">&#160;(Note 12)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stockholders&#8217; Equity:</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">Class A common stock, $</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78ac3d88-3247-4a50-947a-097068fef34d" contextRef="C_9996cf94-6a99-485b-acb5-c26104f11cc7" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_9cb2d57f-2052-40b7-98e5-0257017df878" contextRef="C_056857a2-ae2a-45f6-a0e9-2f2918ae0478" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">&#160;par value; </span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03b8ed82-5799-4d69-a53e-2d31e40a0179" contextRef="C_9996cf94-6a99-485b-acb5-c26104f11cc7" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ed5c82cc-3d53-4ec7-a82d-db4b920336d7" contextRef="C_056857a2-ae2a-45f6-a0e9-2f2918ae0478" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,500,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">&#160;shares authorized; </span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6c449ac-b7f0-4ffa-a84a-aa014b0d2c75" contextRef="C_9996cf94-6a99-485b-acb5-c26104f11cc7" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_50917e60-cdac-49e6-a468-4702e3f43892" contextRef="C_9996cf94-6a99-485b-acb5-c26104f11cc7" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,184,958</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3edb958d-9e7b-4630-ad39-82a31a2621fa" contextRef="C_056857a2-ae2a-45f6-a0e9-2f2918ae0478" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_6117dd02-2989-4572-a4bc-4c9548b0b4d1" contextRef="C_056857a2-ae2a-45f6-a0e9-2f2918ae0478" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">586,393</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">&#160;issued and outstanding as of December 31, 2024 and 2023, respectively</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">Class V common stock, $</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_601ddd58-54f2-4e79-b2c4-13698076069c" contextRef="C_cb300f73-f574-4a36-a626-d7af3d2c40eb" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_3d54d126-a6f1-434d-b1a1-cf98252b584d" contextRef="C_a6a99836-7eb5-486a-9687-cdb21bc04965" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">&#160;par value; </span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb331d80-3e93-45ea-9f84-7739bad74f6e" contextRef="C_cb300f73-f574-4a36-a626-d7af3d2c40eb" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a6fa1160-583c-4aaa-b2b7-241d09ddb3b4" contextRef="C_a6a99836-7eb5-486a-9687-cdb21bc04965" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,250,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">&#160;shares authorized; </span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_945c245c-c314-4542-a539-9153cd930f80" contextRef="C_cb300f73-f574-4a36-a626-d7af3d2c40eb" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b2f06aed-fbde-4e6a-946d-af75a54d55e3" contextRef="C_cb300f73-f574-4a36-a626-d7af3d2c40eb" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,962,704</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9a13ac5-f3f2-453e-8d86-e75eb1153936" contextRef="C_a6a99836-7eb5-486a-9687-cdb21bc04965" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_3608c88f-73e4-4e44-a56c-0ea90ac14046" contextRef="C_a6a99836-7eb5-486a-9687-cdb21bc04965" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,965,296</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">&#160;issued and outstanding as of December 31, 2024 and 2023, respectively</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7cccfd6f-cd3c-4ebc-b69e-7453d51c9699" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">546,635</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee1c88c8-5ef6-4dfb-bee4-3e6f9aeb734c" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">357,941</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated deficit</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d7b3ef7-3712-4cfb-bbea-4d42d2a433ef" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">446,050</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9384447a-14c4-464b-9c23-f876790ab466" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">85,551</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_51d0bd27-56fb-44cd-9989-09fe2cdb0e89" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100,585</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0fedd86d-3f99-4827-88d7-a911005a0d77" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">272,390</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-controlling interest</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91ba0355-461c-4f46-acbe-8169fc2aa9f3" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:MinorityInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">228,994</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e2fa33f-aaf8-4e5d-b40b-259e977f2ab4" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:MinorityInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,146,739</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total equity</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d0155496-8374-468c-98cf-9d8e0761610c" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">128,409</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a48d69a3-7934-48cb-8acc-bc49c1493110" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,419,129</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:25pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:25pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total liabilities and equity</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3f31d3a-ff80-4d36-a6e6-c992df27d38f" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,919,083</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5147e9b4-144e-4e53-99b6-aae07804b455" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,159,995</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><ix:footnote id="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of December 31, 2024 and 2023, total affiliate receivable, affiliate payable, warrant liability, guaranty obligation and loan from related parties balances are with related parties. In addition, the prepaid expenses and other current assets, claims financing obligation and notes payable, other current liabilities, and interest payable include balances with related parties. See Note 14, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Party Transactions, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for furthe</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">r details.</span></ix:footnote></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><ix:footnote id="FNT_85277ec4-535a-4590-b3e1-ed9c8021c99f" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, intangible assets, net included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36c91bc8-c5e9-4489-9823-2cda6a1fe2af" contextRef="C_ea41718c-eb03-4364-a84c-37e5f43f1623" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="9" decimals="-8" format="ixt:num-dot-decimal">1.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a64d663-7010-4670-9eeb-1bb6839c3024" contextRef="C_ba17b4e4-2add-4b5b-8fa4-ea5edfe1120f" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="9" decimals="-8" format="ixt:num-dot-decimal">2.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, related to a consolidated VIE. See Note 8,</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Variable Interest Entities</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for further details.</span></ix:footnote></div></div><p style="margin-left:8%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">80</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP RECOVERY, INC. and Subsidiaries</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="statementofoperations"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated State</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ments of Operations</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:62.12%;box-sizing:content-box;"/>
     <td style="width:1.82%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15.12%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.82%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15.12%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims recovery income</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94b8d356-3a27-4492-aa41-6b8d871b0d44" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:ClaimsRecoveryIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,122</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_244de9e0-7790-4280-95e7-c57d5abf208a" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:ClaimsRecoveryIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,207</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims recovery service income</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_468371b6-a944-4c4d-a66a-40f0f01253df" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:ClaimsRecoveryServiceIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">498</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_40ee0357-3c37-43fb-8c1b-b31245e165f7" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:OtherClaimsRecoveryRevenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">127</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total Revenues</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c1c9f722-f78e-496f-805b-9cf1fb530474" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:TotalClaimsRecovery" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,249</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca5e14a1-d0c8-4a39-8cfa-f54902b39e21" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:TotalClaimsRecovery" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,705</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of revenues (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11eab42e-5feb-4b3f-b742-4d5fa7feb23c" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:CostOfClaimRecoveries" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,607</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ada24831-ea2f-471f-80bc-c5d0bb37a5a9" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:CostOfClaimRecoveries" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,145</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims amortization expense</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23a74459-6685-4fc1-a5c8-06a285c45345" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:ClaimsAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">484,076</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21cd5fa4-faba-455f-b6f7-f88dc4864da6" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:ClaimsAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">476,492</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative (2)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23f3c66e-3461-429c-9a94-0719426712a9" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,231</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89672a83-8db0-4a03-8baa-589e45240c0f" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,508</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4c42070-b3b6-4a0e-9455-78490b6eef55" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ProfessionalFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,131</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_952dd24c-f9aa-4afc-b0cb-ef2981386621" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:ProfessionalFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,766</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees &#8211; legal (3)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_694112ad-309c-4458-b030-ad8125036e89" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:LegalFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,519</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ffdd38b8-f4e4-4330-9852-d7d6ac99a536" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:LegalFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,401</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment of intangible assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bed12f23-a898-4bce-b62c-13f87396b0bc" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">752,697</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Allowance for credit losses</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04683025-ea1a-4e69-beb7-0e6d435c6423" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:AllowanceForCreditLosses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,000</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1012f7ac-e265-4afa-b4eb-f41d7c1eaeea" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">277</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70ec9fe3-a255-430b-b697-d8f6aaf72491" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">263</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_777c43df-4de3-43b6-a578-f117be4b4a7b" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,292,538</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0081aba8-371c-4f83-b25b-f18d999caa5c" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">567,575</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:25pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:25pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating Loss</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d342194c-3f49-4d54-a117-3830fa065cf2" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,274,289</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_054d9bde-9a41-4fd3-a09a-5e57f47e1a60" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">559,870</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:30pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense (4)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f2aa437-b4da-460d-bf52-7edcbb42a12a" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">420,032</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_516c8fa1-698f-44b9-91be-4fb706ccd763" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">289,169</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income (expense), net</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3202478b-2efd-46f7-8041-a359ee0c9646" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">542</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4bb1a7f8-3d06-425a-8b7a-d814e1979f66" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,290</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant and derivative liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd54a7f7-fcd9-4aa4-9e1f-1ac8a1c76eee" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:ChangeInFairValueOfWarrantAndDerivativeLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">136,934</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e2b895f-a7cd-4970-8d28-a4d1a5d2a02b" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:ChangeInFairValueOfWarrantAndDerivativeLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,604</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net loss before provision for income taxes</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a6b7e3cb-ef1d-4144-91eb-b1fed618dbca" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,556,845</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38ad261b-c970-4ed7-ac05-5ad47477f37d" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">835,145</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income tax expense</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1c11b6b-01ae-49a1-9652-d114ac7d76a5" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,556,845</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f257151-a134-43a1-ad28-9597abeaf0bd" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">835,145</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Net loss attributable to non-controlling interests</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6984eabf-8b14-4ecd-a988-396d2023b0f7" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,196,346</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_abd7fd90-a0ae-4f89-b9c2-51cc6300b14f" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">778,797</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net loss attributable to MSP Recovery, Inc.</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e759957d-9ebe-4def-a0e3-811bcf4c1680" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">360,499</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82f41da1-51e8-4344-a8e8-4e63a72b8fd8" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">56,348</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Basic and diluted weighted average shares outstanding, Class A Common Stock</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1654bf83-caea-47da-9288-d43c15badebb" contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4c48d164-22c8-4f6b-afd4-a427dbb46d70" contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,001,525</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8652c3dd-6477-4b92-8492-b8881866a79c" contextRef="C_1720b370-71e8-404f-b2ba-d747e1f96522" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_5026c220-35ea-43a6-ad29-2937c96ff8bb" contextRef="C_1720b370-71e8-404f-b2ba-d747e1f96522" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">356,591</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Basic and diluted net loss per share, Class A Common Stock</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29e11530-007e-4115-85f5-5d10b9370acf" contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_220506d7-50fb-4327-ae05-5daf1fdb4a8f" contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">359.95</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e9664009-d1bd-4d7e-a52f-22d535782b91" contextRef="C_1720b370-71e8-404f-b2ba-d747e1f96522" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_6ea52bb7-e3f3-4d72-aa48-bd0b9d809282" contextRef="C_1720b370-71e8-404f-b2ba-d747e1f96522" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">158.02</ix:nonFraction></ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><ix:footnote id="FNT_071ffd73-77db-4a34-b2a1-f3867369fb2f" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, cost of Claim recoveries included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_92917827-7757-4e9a-bfbd-12685c6a429a" contextRef="C_b7e7a2a7-5fd8-4f91-9fd5-9427aec0dbef" name="us-gaap:OperatingCostsAndExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dec14e83-d033-44b9-ba26-210adfe46403" contextRef="C_5d819013-3703-4830-ab07-b1f1c7119714" name="us-gaap:OperatingCostsAndExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of related party expenses, respectively. This relates to contingent legal expenses earned from Claims recovery income pursuant to legal service agreements with the La Ley con John H. Ruiz P.A., d/b/a MSP Recovery Law Firm (the &#8220;Law Firm&#8221;). See Note 14, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for further details.</span></ix:footnote></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><ix:footnote id="FNT_35ea91e8-3c49-4990-ba5b-48a3392a1f92" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, general and administrative expenses included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88478178-c219-4e68-b995-563014fb16ce" contextRef="C_fe25ee78-67ec-4d53-967e-ac07893f4a6e" name="us-gaap:OperatingCostsAndExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e55f5c6-3d79-4c36-b323-2ba82d337bff" contextRef="C_5be07310-661f-4b62-876e-7ad045ede894" name="us-gaap:OperatingCostsAndExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of related party expenses, respectively</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></ix:footnote></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</span><div style="width:100%;display:inline;"><ix:footnote id="FNT_9039f59d-d74a-45c2-87f9-6463d50e70ba" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024 and 2023, Professional Fees - Legal included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11035ae1-0aca-461f-aa66-0d71863ed7e2" contextRef="C_c452056c-aa10-4243-85df-a94afbf6101c" name="us-gaap:OperatingCostsAndExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2cb27973-b952-4220-b55b-a09f745dfe11" contextRef="C_94909e83-2e9e-40db-b644-8523c07ddb09" name="us-gaap:OperatingCostsAndExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">19.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of related party expenses related to the Law Firm. See Note 14, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for further details.</span></ix:footnote><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</span><div style="width:100%;display:inline;"><ix:footnote id="FNT_cd459352-1f75-44db-a821-c46b5ea066c0" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024 and 2023, Interest expense included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9508de49-0fd8-4f10-b86d-a4e7715861c9" contextRef="C_fe25ee78-67ec-4d53-967e-ac07893f4a6e" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">318.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93ebfcf7-3243-4db0-9e4d-c2080b82362b" contextRef="C_5be07310-661f-4b62-876e-7ad045ede894" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">226.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of interest expense to related parties.</span></ix:footnote></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">81</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP RECOVERY, INC. and Subsidiaries</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="statementsofchangesinequity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Statements of Cha</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nges in Equity</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Years Ended December 31, 2024, and 2023</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:27.714%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.459%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:2.939%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.279%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:3.379%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:7.119%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:7.119%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:7.119%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:7.299%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Class A Common Stock</span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="border-top:0.5pt solid #000000;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Class V Stock</span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands except shares)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Additional Paid-in Capital</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated Deficit</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-Controlling <br/>Interests</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total Equity</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at December 31, 2022</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_172c2378-ad5c-4409-8734-a173e540677d" contextRef="C_d1d4678d-582f-4815-8271-9022cf27ca70" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">119,369</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_45c83dea-835e-478a-8abd-0a2071753827" contextRef="C_89133fd7-659a-4cd9-9d0e-e1da45db1b8f" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,036,768</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68823bd3-dce5-4e61-af5d-bc751afe5b8c" contextRef="C_d9cc9699-1810-4465-8001-abc8935d5526" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">137,082</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49c4b944-a389-4360-861b-cec22fca8808" contextRef="C_867693d0-bbf0-446d-b67d-8df69e448e9a" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">29,203</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d1e728a-6aa0-4f43-84ff-69c04ff02ba8" contextRef="C_fcb3bfd4-b997-46bd-95a6-c338562ed04e" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,077,586</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f02bf800-1274-49f1-a3c9-328fc2f71e42" contextRef="C_8dbd5799-d76e-43f3-b963-830f8fd31b2e" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,185,465</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Conversion of Warrants</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2d91421-10a2-41c5-a065-8abd52c5ba19" contextRef="C_13c3ccb9-b33e-456f-b270-960ccbced512" name="mspr:StockIssuedDuringPeriodSharesConversionOfWarrants" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">591</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_adc2eb04-c108-4a69-a0ae-1fc142fd44e2" contextRef="C_6839411a-9365-4c82-94be-9667ed37b849" name="mspr:StockIssuedDuringPeriodValueConversionOfWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">458</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa9241c7-fa6f-4575-834b-b93928d3851b" contextRef="C_8553900b-1ff0-43df-9d09-bab541f91e7e" name="mspr:StockIssuedDuringPeriodValueConversionOfWarrants" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">200</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce2ae544-15e3-4943-b7f4-3680a2fa3c2b" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:StockIssuedDuringPeriodValueConversionOfWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">258</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Class A Issuances</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b258f7fe-e14b-497e-b7c0-5fa338abee61" contextRef="C_13c3ccb9-b33e-456f-b270-960ccbced512" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">466,433</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4510ea1-9251-4fdd-ad98-8c3177876b0a" contextRef="C_6965b820-31a4-444e-ba96-f6ea5d589a06" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">71,472</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09768ef0-96c7-4152-99a2-1a3adc7c0927" contextRef="C_6839411a-9365-4c82-94be-9667ed37b849" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">220,401</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8ab55c0-273a-47ac-9db1-022e2207158a" contextRef="C_8553900b-1ff0-43df-9d09-bab541f91e7e" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">151,850</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b25fd665-d511-42a4-a12b-e2be5f1b32e4" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,551</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc4f6f1c-8730-48d0-af0c-e9382b36b9e0" contextRef="C_87af9b54-aaad-4ee8-ad42-ba6bf6f841fb" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">56,348</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3d16cf6e-b52c-4cfe-a722-633c903ef244" contextRef="C_8553900b-1ff0-43df-9d09-bab541f91e7e" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">778,797</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf5e8216-655a-4828-9823-441a366c41c1" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">835,145</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6b19e78-17b1-477e-8f1b-92fc23c0d7f2" contextRef="C_1fec80b0-38c3-4131-ada8-3af5893a5151" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">586,393</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19ee8de6-d5ae-4bfe-835c-004cc39da64c" contextRef="C_0b0648be-cb1d-4812-9bfd-c206264a6106" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,965,296</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f343b3a6-30e5-44fc-a285-f7b822d27720" contextRef="C_89033644-94ee-4bd7-ad47-12e753cbcfce" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">357,941</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ee32284-08ea-4390-a076-6191016ed453" contextRef="C_e39e346c-7b8d-4cd1-ba00-128383f3f5f5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">85,551</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4dcc6013-2eec-4912-b857-d672c1db9702" contextRef="C_564ee707-2109-45f7-83d2-89ed72475362" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,146,739</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c27cf1ff-6ba1-482f-8ad9-56fe8aa83dd2" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,419,129</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Class A Issuances</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d65ac83c-66f8-48d1-b7e3-be100ad3b4e6" contextRef="C_95863a80-b9b0-46fb-b0ef-8af82e4c84a4" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,598,565</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2f77234c-dfc6-4b6a-8587-68ce5f478a60" contextRef="C_4957a749-8bfa-415b-9b7d-70a5bf0f2f52" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">2,592</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19371993-fbfa-4afd-a9ac-b72dbd2d6839" contextRef="C_ebf33321-45e9-493e-8b1e-d30e0e2f7a60" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">188,694</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07bdaef7-0fcf-4a0d-b3ec-ee50d679a469" contextRef="C_31bd9c41-8edd-4613-86e6-85b50e497f78" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">179,387</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1def1e94-985d-448a-bfbc-8483f81b296a" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,307</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_880a65c1-5a53-45b5-93d8-29c465d92bf4" contextRef="C_3d1f3cd4-008e-48b3-85da-f506bc8106bf" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">360,499</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6c2f820-cfc8-4486-9670-d647af24f6ca" contextRef="C_31bd9c41-8edd-4613-86e6-85b50e497f78" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,196,346</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a7199d4-2c4a-440a-a278-9d52921d1861" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,556,845</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_65d754f2-d01d-4c9e-a4ef-ddc55bc1cf87" contextRef="C_8ec762b9-f612-4652-b91b-9dc8a97a39c7" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,184,958</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e64ebbc5-8b15-44ec-b447-f4d9db47d24b" contextRef="C_4444a183-cd75-453f-82e7-94eb0d9ecda9" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,962,704</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ddde5ab-ff6e-4227-8c35-4e6fd069cd7b" contextRef="C_8558b10a-b3e2-41be-8e26-98a22240201d" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">546,635</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1394c0e5-8509-407d-b07e-f428a4675d2e" contextRef="C_e17c4aa1-a017-431c-a88b-5d1c628480b4" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">446,050</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd4dc406-5009-4f18-b38e-e6bad7df8d01" contextRef="C_516f8b35-03d8-4c39-9130-a23b7a95a2a6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">228,994</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:8.5pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8d85a97-08da-42df-8c37-b27318a781b2" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">128,409</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">82</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP RECOVERY, INC. and Subsidiaries</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="statementsofcashflows"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Statements of C</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ash Flows</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:66.993%;box-sizing:content-box;"/>
     <td style="width:1.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.923%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.923%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from operating activities:</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67094ad7-e54b-405e-90be-9227b1870a88" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,556,845</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b380e630-4fc3-442f-ba15-6a8528278443" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">835,145</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d769b8f8-bb2d-4aa5-87fc-9b1cd2de455f" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">277</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_581fcdd9-85ef-4aad-9db3-f415df4cbef2" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">263</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims amortization expense</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_60b4976c-7905-4617-a963-58072b52097f" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:ClaimsAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">484,076</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7e5e455e-1b0a-4c25-a16b-82638c7f2df6" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:ClaimsAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">476,492</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Paid-in-kind interest (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7afe5ee6-3e63-4c8b-a947-6e22eba8fa9c" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:PaidInKindInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">278,800</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95951ba3-4813-4d4d-8c8d-3ce1dd308d1d" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:PaidInKindInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">214,380</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment of intangible assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_edff83bc-d5b6-40a4-bb82-3372d865326a" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">752,697</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce8e4777-fc85-4685-bc36-6865ee59ed6e" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Allowance for credit losses</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_959634c0-63d7-4032-bc53-1a943b08b590" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:AllowanceForCreditLosses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_192b7237-0b20-4513-8dbd-bc56d2071202" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:AllowanceForCreditLosses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,000</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liability</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad932ba7-0b55-4bc1-af54-440b89105e26" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">137,095</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_513dffc8-d1c2-4734-af40-ac978c2a8dd0" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,785</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of derivatives</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3d366071-a7f9-4056-8797-8679361404be" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:ChangeInFairValueOfDerivatives" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">161</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f87c6285-924c-4097-86f0-ddd12a6585ea" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:ChangeInFairValueOfDerivatives" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">181</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain on sale of intangibles</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97a53cd4-5aec-40b0-95d4-490f47bdf126" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10ef6ded-4feb-4559-801c-b555ff55f759" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,599</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share based compensation</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2770c71e-6840-4ea3-b3cf-78fce79b0364" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8790d5ab-7081-4a42-b631-b72778d7d2d4" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">830</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Mark-to-market gain on liability payable in stock</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c14ab74-7eee-48e3-8729-2565d09ceb35" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:MarkToMarketGainOnLiabilityPayableInStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">545</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a430292c-6823-4920-b101-04052f9cdcc6" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:MarkToMarketGainOnLiabilityPayableInStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,431</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees settled in shares</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_746cf6b0-5ca3-43f4-bcb4-60bc1f391020" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:ProfessionalFeesSettledInShares" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,072</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_743b71a3-27eb-42f1-b5a7-10bf95c052da" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:ProfessionalFeesSettledInShares" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,745</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-cash lease expense</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_87a91b6c-1754-4260-9950-26ddd2fb57a4" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4eeec56b-6606-4568-b4ea-e56a3b210655" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:15pt;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in operating assets and liabilities:</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts receivable</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0282c2a5-2c49-44ba-9c91-22117c33de3a" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a596ca5-7184-47b8-bd50-fee4fc9d1fe2" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">542</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f02dc4e6-433d-4853-be83-9eacfc5dc07a" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7,261</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d26365c-1f34-4de0-8975-6a4dbf52940a" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">18,999</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Affiliate receivable (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f6cf949-83d3-4966-aa38-96d7ba5d284b" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:IncreaseDeceaseInAffiliatesReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01b50422-e877-4600-91b7-063e13cf4bf5" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:IncreaseDeceaseInAffiliatesReceivable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,238</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Affiliate payable (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad09f737-52d3-4889-a092-d0e79ca9c4b5" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:IncreaseDeceaseInAffiliatesPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,842</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19a7307c-e905-4328-b209-d873f357833b" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:IncreaseDeceaseInAffiliatesPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable, commission payable and accrued liabilities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_65f2c33a-55bd-4494-8867-3c660b813aaf" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,100</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_812beb5f-cb26-478b-ad0f-8c6a82648e4f" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,513</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest Payable</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_66b985b1-bf1c-48cb-b975-b9c48ee0c744" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:IncreaseDecreaseInInterestPayableNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">141,167</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15148547-8c79-4f81-8e20-cf182816130c" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:IncreaseDecreaseInInterestPayableNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74,752</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:25pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:25pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net cash used in operating activities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2e5ed20-98c4-4eaf-b804-a335ab27687f" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">16,121</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_612859a8-8ca5-4b7a-9fd5-bd62c73929ed" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">40,023</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:35pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:35pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from investing activities:</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of property and equipment</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71951754-1bf1-4333-96b1-5c9659a89609" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">525</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_390fce61-8729-4dc3-a96f-c15d1a499e09" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,742</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of intangible assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae680be0-9e6d-4381-9537-b31932b5dfc1" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:PaymentsToAcquireIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,200</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_520b2837-d3bf-4724-8852-01edc4596c28" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:PaymentsToAcquireIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">700</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from sale of intangible assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09c1468e-9770-4f23-9877-54354dd2bc6a" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ProceedsFromSaleOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e266d31-6217-4730-91b2-152181f635e1" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:ProceedsFromSaleOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,000</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:25pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:25pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net cash (used in) provided by investing activities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ec1fcef-2d50-439d-87dc-75b9b15b1239" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,725</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93e12e8a-d5d2-462f-abe0-2a19657cd249" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,558</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:40pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:40pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from financing activities:</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from debt financing</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0493f88-37dd-459f-98e0-3bd7ad8372f5" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,500</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35ccca58-c4c0-44f3-b732-e3b4e07bcd93" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,000</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred financing costs</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8568705-8cfb-4f9b-9f9c-11eed6ac15ce" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:PaymentsOfDeferredFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf14fe9d-1751-457f-8064-7cea7f966e03" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:PaymentsOfDeferredFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">250</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Debt issuance costs</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5a625dfa-004a-48d2-a3cb-1124cbda09e0" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:PaymentsOfDebtIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38b48923-380f-438f-ae81-f8bd20fc840b" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:PaymentsOfDebtIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">708</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payments on related party loan (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_930ae64a-6e30-4f0f-be44-c5dff142f095" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:PaymentsOnRelatedPartyLoan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">382</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8815d523-67e4-437e-965d-caa19cf4a4e1" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:PaymentsOnRelatedPartyLoan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds on related party loan (1)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a66c039-75ba-48a3-af8a-e15632e557f6" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ProceedsFromRelatedPartyDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c284a7e8-84d6-404e-8590-3871ab408ad3" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:ProceedsFromRelatedPartyDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,950</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Release of temporary equity</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e153c2fa-f8fb-485c-a8b2-e10e1e3fb819" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:ReleaseOfTemporaryEquityForPayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63f0835b-cbc2-4079-8bbf-9b5431653a16" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:ReleaseOfTemporaryEquityForPayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,420</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Repayment of the Claims financing obligation</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9de4fe0a-6f6f-4385-8a59-d924f5c18041" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:RepaymentOfTheClaimsFinancingObligation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,640</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85b1c1d5-5001-401c-8384-6d5ae4527fac" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:RepaymentOfTheClaimsFinancingObligation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,555</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from the issuance of common stock</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8154c682-b649-4f68-b006-dab8b63de37a" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,063</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_058c0697-639d-457c-9de9-4f7435e8d783" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:25pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:25pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18ae87f2-d704-4949-9400-90f649e6c23b" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,541</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_388303c4-427d-47dd-83d7-079072e33c22" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,017</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:35pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:35pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase (decrease) in cash</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18326b3b-1fae-4c67-9ba0-92dcb754a147" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">695</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e3fc2ff-3963-4157-8dbb-1e1e3f0b89cb" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,448</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash at beginning of year</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7214458-23aa-429c-b2b8-21208179b15e" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,633</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2590ac1-62a4-4d60-a1be-3d138b711f12" contextRef="C_8dbd5799-d76e-43f3-b963-830f8fd31b2e" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,081</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash at end of period</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f6bf50eb-0420-47df-add3-b6f60e9fa71c" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,328</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c73a54c-0ef3-4d3e-9782-7b7d9d6673f7" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,633</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:2.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><ix:footnote id="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Balances include related party transactions.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> See Note 14,</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, f</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or further details.</span></ix:footnote></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">83</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP RECOVERY, INC. and Subsidiaries</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consolidated Statements of Cash Flows (continued)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:66.993%;box-sizing:content-box;"/>
     <td style="width:1.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.923%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.58%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.923%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental disclosure of non-cash investing and financing activities:</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sale of intangible assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_560147cb-0dcf-4b18-8ac1-47d50ea14627" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:SaleOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_34b11072-b00e-41fc-9dfd-dff8b29c710d" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:SaleOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,987</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase of intangible asset financed by note payable</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c566f6d6-425f-4008-9a89-20e0e09c6e42" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:IntangibleAssetsFinancedByNotePayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a75c6acf-6f4b-4f93-b6bc-e8d9e0ce6d67" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:IntangibleAssetsFinancedByNotePayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">250,000</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Release of temporary equity</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_942f816f-88ba-4b43-8359-fd9394fe5f8e" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:ReleaseOfTemporaryEquityDuringNonCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb3427da-9055-4074-a4ed-439b030e5406" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:ReleaseOfTemporaryEquityDuringNonCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,807</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Original issue discount</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c51734bd-59e6-486f-ae13-c766a057f141" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:OriginalIssueDiscountOfNonCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,750</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63eb2886-5bc5-4a90-9218-71e33e198f06" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:OriginalIssueDiscountOfNonCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,167</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase of intangible asset through issuance of Class A common stock</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a9650a3b-d511-40c3-8e53-75c295fd00ad" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08945d0b-e2d9-4c83-a611-94135a9f9fa8" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">833</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of shares in settlement of debt</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01ff08c6-fe0b-4cec-9d6a-290c4572074c" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:StockIssued1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,063</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e75061a-0482-4047-b97d-4d78a5f6f97e" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:StockIssued1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payment of professional fees through issuance of Class A common stock</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d31e469b-66bc-4b87-87fa-38907c5f3ebb" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,072</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aba1fe40-f49e-41a1-9ff9-4b713052b208" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,745</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-cash lease liabilities arising from obtaining right-of-use assets</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ebf2abd1-966d-49f4-824e-c3567df0a7ab" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd5c4001-abbf-4593-9a63-56ebe70367fa" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">376</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payment of Cano Health payment in shares</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15f1e09c-262e-4502-b1da-7f6c2486f073" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2cff6a2c-301f-44f7-ada7-c18e3dd6093b" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,690</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant conversions on a cashless basis</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2f099a0-965f-4e49-b316-0036707af240" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:WarrantConversionsOnACashlessBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b99866bf-0374-436d-8031-8cf106d92764" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:WarrantConversionsOnACashlessBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">258</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash paid during the period for:</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00e897fd-6bc2-4663-bff2-0477da7912e7" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,384</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88e9c93e-3224-4e7a-b540-d89c195e30ab" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37</ix:nonFraction></span></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">84</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:nonNumeric id="F_73e07322-c9ea-4374-b248-8be27a3a4015" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:NatureOfOperations" escape="true" continuedAt="F_73e07322-c9ea-4374-b248-8be27a3a4015_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="footnotes"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 1. DESCRIPTION OF THE BUSINESS</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 23, 2022 (the &#8220;Closing Date&#8221;), MSP Recovery, Inc., a Delaware corporation (formerly known as Lionheart Acquisition Corporation II (&#8220;LCAP&#8221;)) consummated the previously announced business combination pursuant to that certain Membership Interest Purchase Agreement, dated as of July 11, 2021, as amended (the &#8220;MIPA&#8221;), by and among the Company, Lionheart II Holdings, LLC, a wholly owned subsidiary of the Company, MSP Recovery, LLC and combined and consolidated subsidiaries (&#8220;Legacy MSP&#8221;), the members of Legacy MSP (the &#8220;Members&#8221;), and John H. Ruiz, in his capacity as the representative of the Members (the &#8220;Members&#8217; Representative&#8221;). Pursuant to the MIPA, the Members sold and assigned all of their membership interests in Legacy MSP to the Company in exchange for non-economic voting shares of Class V common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_acaab098-c78d-4152-8a98-0ebd3afa2741" contextRef="C_80f27fb1-52e9-4cda-90cc-c5c855c8fd29" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, of the Company (&#8220;Class V Common Stock&#8221;) and non-voting economic Class B Units of Opco (&#8220;Class B Units,&#8221; and each pair consisting of one share of Class V Common Stock and one Class B Unit, an &#8220;Up-C Unit&#8221;) (such transaction, the &#8220;Business Combination&#8221;).</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">T</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">he Company is organized in an &#8220;Up-C&#8221; structure in which all of the business of Legacy MSP and its subsidiaries is held directly or indirectly by the Company, the Company is the managing member, consolidates Legacy MSP and the Company owns all of the voting economic Class A Units and the Members and their designees own all of the non-voting economic Class B Units in accordance with the terms of the first amended and restated limited liability company agreement of the Company. Each Up-C Unit may be exchanged for either, at the Company&#8217;s option, (a) cash or (b) one share of Class A common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2dc528af-6cf2-4905-b80d-3e0aa02b957a" contextRef="C_bee1feb7-080c-486a-81cc-c38168970e45" name="us-gaap:BusinessAcquisitionSharePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, of the Company (&#8220;Class A Common Stock&#8221;), subject to the provisions set forth in the LLC Agreement. The aggregate consideration paid to the Members (or their designees) at the Closing consisted of: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94396d02-31b7-4dab-9a45-092d2db205c5" contextRef="C_94b11fc0-301a-40ea-b25e-f4fc6d4b8a9f" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,200,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Units and (ii) rights to receive payments under the Tax Receivable Agreement (&#8220;TRA&#8221;), discussed in more detail below.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legacy MSP was organized in 2014 as a Medicaid and Medicare Secondary Payer Act recovery specialist. The Company utilizes its proprietary internal data analytics platform to review health Claims assigned by secondary payers such as health plans, MSOs, providers of medical services, and independent physicians associations. This platform allows the Company to identify Claims cost recovery rights with potential recovery paths where Claims either should not have been paid by the secondary payers or should have been reimbursed by third-party entities.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery is assigned recovery rights to Claims by secondary payers via CCRAs. Prior to executing a CCRA, MSP Recovery utilizes its proprietary internal data analytics platform to review the set of Claims of a prospective Assignor to identify Claims with probable recovery paths. MSP Recovery&#8217;s assets are these irrevocable broad assignments of health Claims recovery rights that are supported by federal and state laws and regulations. MSP Recovery&#8217;s offices are located in the U.S. and Puerto Rico.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrants</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Public Warrants</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the terms of the Existing Warrant Agreement, and after giving effect to the issuance of the New Warrants, as defined below, the exercise price of the Public Warrants increased to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ccd686a-708c-4cfc-9ac5-8e30aadf481f" contextRef="C_94b11fc0-301a-40ea-b25e-f4fc6d4b8a9f" name="us-gaap:WarrantExercisePriceIncrease" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.0625</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share of Class A Common Stock, on a cashless basis, in lots of 625. During the period from the Closing Date to December 31, 2024, approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_87265a44-8a8e-46c7-ac82-f0e9862c36c4" contextRef="C_9996cf94-6a99-485b-acb5-c26104f11cc7" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million war</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">rants of the orig</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inal </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ac6ac58-e160-45b5-88b1-562545de5821" contextRef="C_9996cf94-6a99-485b-acb5-c26104f11cc7" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">11.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">warrants had been exercised. For the years ended December 31, 2024 and 2023, the fair value of the remaining unexercised warrants decreased resulting in other income</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_695b1feb-9354-4a67-b792-45031db45043" contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9f8e7f3-7f58-4a1f-b13b-2db3bf01779e" contextRef="C_1720b370-71e8-404f-b2ba-d747e1f96522" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">4.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, which is recorded within change in fair value of warrant and derivative liabilities in the consolidated statements of operations.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">New Warrants</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, in connection with the Business Combination, the Company declared</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the New Warrant Dividend comprising approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_86e1f928-4b80-4bf3-a6f1-d72f9a4d4fa1" contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156" name="mspr:DividendComprisingNumberOfNewWarrantsPayableHolders" unitRef="U_shares" scale="6" decimals="-6" format="ixt:num-dot-decimal">1,028</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million New Warrants payable to the holders of record of the Class A Common Stock as of the close of business on the Closing Date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The New Warrants expire on the fifth anniversary of the Closing Date or upon earlier redemption. The Company determined that the New Warrants instruments meet the equity scope exception in ASC 815 to be </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">classified in stockholders&#8217; equity, and as the repurchase right noted above has a mirrored value designed to offset the New Warrants, if exercised would be an equity only transaction. The New Warrants are each exercisable in lots of 625 for one whole share of Class A Common Stock at a reverse split adjusted exercise price $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1bbc35bf-52b3-420a-9ab3-7e878731b898" contextRef="C_9996cf94-6a99-485b-acb5-c26104f11cc7" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">7,187.50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per whole share. The New Warrants are subject to certain anti-dilution adjustments.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Public Warrants and New Warrants are currently listed on Nasdaq under the symbols &#8220;MSPRZ&#8221; and &#8220;MSPRW,&#8221; respectively.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Tax Receivable Agreement</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Business Combination, the Company also entered into a Tax Receivable Agreement (the &#8220;TRA&#8221;). Pursuant to the TRA, the Company is required to pay the sellers </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44cc443d-49fc-4523-94df-3f4f791597b5" contextRef="C_bf132eff-e862-4432-9a3c-8ea0d6d97f66" name="mspr:PercentageOfPaySellersToAmountOfTaxBenefit" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">85</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the amount of tax benefits that the Company actually realizes as a result of (i) the Company&#8217;s direct and indirect allocable share of existing tax basis acquired in the Business Combination, (ii) increases in the Company&#8217;s allocable share of existing tax basis and tax basis adjustments that will increase the tax basis of the tangible and intangible assets of the Company as a result of the Business Combination and as a result of sales or exchanges of Up-C Units for cash or shares of Class A Common Stock, and (iii) certain other tax benefits related to entering into the TRA, including tax benefits attributable to payments under the TRA.</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">85</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_73e07322-c9ea-4374-b248-8be27a3a4015_1" continuedAt="F_73e07322-c9ea-4374-b248-8be27a3a4015_2"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended December 31, 2024 and 2023, the Company&#8217;s TRA liability associated with the allocable share of existing tax basis acquired in the Business Combination would give rise to a TRA liability of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3224a2a8-4059-4ec0-8962-4bb3e6e45ad5" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:IncreaseInTaxReceivableAgreementLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_deb6d26f-f3af-4af2-bfc1-c70b31445641" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:IncreaseInTaxReceivableAgreementLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">11.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. The Company has not recognized such liabilities under the TRA after concluding it was not probable that the Company will be able to realize the remaining tax benefits based on estimates of future taxable income. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78b3ae5b-c39b-4606-8d68-d759dfb1adde" contextRef="C_bf132eff-e862-4432-9a3c-8ea0d6d97f66" name="mspr:PaymentsToContinuingEquityOwnersAndBlockerShareholders" unitRef="U_USD" scale="6" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_5596e581-750d-4692-bfef-a3943c4981cc" contextRef="C_c51278ee-8240-44e0-840b-5a8e9271f685" name="mspr:PaymentsToContinuingEquityOwnersAndBlockerShareholders" unitRef="U_USD" scale="6" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> payments were made to the Continuing Equity Owners and Blocker Shareholders (as defined in the TRA) pursuant to the TRA during the years ended December 31, 2024, or 2023. The estimation of liability under the tax receivable agreement is by its nature imprecise and subject to significant assumptions regarding the amount, character, and timing of the taxable income of MSP Recovery, Inc. in the future. We may incur additional liabilities under the TRA when Lionheart II Holdings, LLC are exchanged in the future. If the valuation allowance recorded against the deferred tax assets applicable to the tax attributes subject to the TRA is released in a future period, the relating TRA liability may be considered probable at that time and recorded within earnings.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has assessed the realizability of the net deferred tax assets and, in that analysis, has considered the relevant positive and negative evidence available to determine whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The Company has recorded a full valuation allowance against the deferred tax assets as of December 31, 2024 and 2023, which will be maintained until there is sufficient evidence to support the reversal of all or some portion of these allowances. As the tax benefits associated with the TRA have not be recognized, based on estimates of future taxable income, the Company has concluded it is not probable to recognize any tax receivable agreement liability. If the valuation allowance recorded against the deferred tax assets is released in a future period, the Tax Receivable Agreement liability may be considered probable at that time and recorded within earnings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Non-Controlling Interest</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company reflects non-controlling interests due to the Up-C structure. The Company holds all of the voting Class A Units of Opco, whereas the Members (or their designees) hold all of the non-voting economic Class B Units of Opco (these Class B Units represent the non-controlling interest in the Company). The ownership percentage of Class V Common Stock held in the Company by the Members (or their designees) will be equivalent to the number of Class B Units held in the Company, and as such, reflects non-controlling interest in the Company, which is equivalent to the Class V Common Stock ownership percentage. See Note 11, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Noncontrolling Interest</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for more information on ownership interests in the Company</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reverse Stock Splits</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective at 11:59 PM EDT on November 15, 2024, the Company amended its Charter filed with the Secretary of State of the State of Delaware to effect a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_51bd4aa3-2e94-4fa0-8f20-4260f6251be5;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1-for-25</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reverse stock split of the Company&#8217;s common stock (the &#8220;2024 Reverse Split&#8221;). The Company&#8217;s Class A Common Stock began trading post split on November 18, 2024. As a result of the 2024 </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_acd4b75b-e7f9-4f7b-b139-5fc7a5bb115c" contextRef="C_9565635a-4edf-48eb-b58e-a592cc2a6e49" name="us-gaap:StockholdersEquityReverseStockSplit"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reverse Split, every 25 shares of the Company&#8217;s old common stock were converted into one share of the Company&#8217;s new common stock. </span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fractional shares resulting from the 2024 Reverse Split were rounded up to the nearest whole number. The 2024 Reverse Split automatically and proportionately adjusted, based on the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_11cad189-e838-4ea3-9011-9fb880f04e08;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1-for-25</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> split ratio, all issued and outstanding shares of the Company&#8217;s common stock, as well as the terms of warrants and other derivative securities outstanding at the time of the effectiveness of the 2024 Reverse Split. Proportionate adjustments were made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options and warrants to purchase shares of common stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 12, 2023, we amended our Charter with the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Secretary of State of the State of Delaware to effect a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_6dbb5636-fa51-4f4c-bb43-bb758434c2c0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1-for-25</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reverse stock split (the &#8220;2023 Reverse Split&#8221;) of the Company&#8217;s common stock, effective October 13, 2023.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise stated, all share and per shares numbers (except par value) in this Annual Report on Form 10-K have been adjusted to reflect the 2024 Reverse Split and 2023 Reverse Split.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Primary Market Change</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 6, 2024, the Company received notification from the Staff that the Company&#8217;s application to transfer the listing of its common stock from the Nasdaq Global Market to the Nasdaq Capital Market was approved. The Company&#8217;s securities transferred to the Nasdaq Capital Market at the opening of business on December 10, 2024, and continue to trade under the symbol &#8220;MSPR.&#8221; The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market, and listed companies must meet certain financial requirements and comply with Nasdaq&#8217;s corporate governance requirements.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Symbol Change</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective December 9, 2024, the Company rebranded all lines of business under the MSP Recovery brand, and the Company&#8217;s Class A Common Stock, New Warrants, and Public Warrants begin trading on Nasdaq under the ticker symbols &#8220;MSPR,&#8221; &#8220;MSPRW,&#8221; and &#8220;MSPRZ,&#8221; respectively. Prior to this change, the Company was known as LifeWallet.</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Going Concern</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As an early-stage growth company, the Company has incurred substantial net losses since inception. As of December 31, 2024, the Company had unrestricted cash and cash equivalents totaling </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3af1293-227c-4487-b63c-9c2388ac34a6" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:Cash" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company has incurred recurring losses and negative cash flows since inception and has an accumulated deficit of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_86dbe84b-548c-486d-9e3f-7db44ea29333;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">446.1 </span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of December 31, 2024. For the year ended December 31,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">86</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_73e07322-c9ea-4374-b248-8be27a3a4015_2" continuedAt="F_73e07322-c9ea-4374-b248-8be27a3a4015_3"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024, the Company used approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c8d0850-a4c9-4d86-bf99-eedee68005b6" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">16.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of cash in operations. The Company&#8217;s liquidity will depend on the ability to generate substantial Claims recovery income and Claims recovery services income in the near future, the timing and amount of which is uncertain, as well as its ability to secure funding from capital sources. The Company&#8217;s principal liquidity needs have been working capital, debt service, and Claims financing obligations.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company anticipates sources of liquidity to include up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_940b9948-c171-44ed-8c5d-e1fb7abbb964" contextRef="C_8d558395-7c90-405f-a7c4-dc8b67120549" name="us-gaap:BridgeLoan" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">9.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in bridge loan funding to the Company under the existing Operational Collection Floor facility (in addition to the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_45e7fdc0-9844-4eea-9af4-cdf102cd743f" contextRef="C_71d4c574-8d09-4451-b706-aecd0cddefa3" name="mspr:AdditionalBridgeLoan" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">16.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million previously funded under the facility) in the amounts of: (i) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a93180b-8092-458a-90d5-de68b08f31ef" contextRef="C_88fe5d42-7072-4d23-aaf0-bcc6834ff66f" name="us-gaap:BridgeLoan" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">1.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for March 2025, which was funded on February 28, 2025; (ii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_627cbc70-110e-467e-98d5-a2a22c628328" contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688" name="us-gaap:BridgeLoan" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for April 2025, which was funded on April 4, 2025; (iii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_51e32426-d6ad-40bd-a56b-0cc55bd817d6" contextRef="C_a14a72e7-94f0-4886-8c83-bd32c3ffe4e1" name="us-gaap:BridgeLoan" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for May 2025, to be funded on or about April 30, 2025; (iv) up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7e518435-551d-4b2a-85ca-a278f5292dc9" contextRef="C_0d4a0973-f818-41cd-a1c5-5c03e254d884" name="us-gaap:BridgeLoan" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to fund the legal, accounting, and administrative expenses associated with the reorganization, subject to certain terms and customary conditions acceptable to Hazel, and minimum license fees of (v) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f3b6415-d208-4edf-aea5-75ca269bcc5c" contextRef="C_c23753ff-91ab-40d0-869b-679d87defcd8" name="us-gaap:BridgeLoan" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">1.55</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for June 2025; and (vi) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_90055722-3d4a-42e4-a738-7567a05b0e8f" contextRef="C_82042595-d2ec-46bd-8d33-1d9c1c5fcd8a" name="us-gaap:BridgeLoan" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">1.55</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for July 2025, as well as the Yorkville SEPA as disclosed in more detail in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Note 9,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Claims Financing Obligations and Notes Payable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and beyond July 2025, the MSP Principals&#8217; commitment to pledge $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28df29dd-3f64-40d8-913e-46077daaea00" contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688" name="us-gaap:OtherCommitment" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of collateral to backstop additional working capital requirements of the Company. The Company </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">has taken several actions to address liquidity concerns, including actions enumerated below. However, as discussed further below, the Company has concluded management&#8217;s plans were not sufficient to alleviate the substantial doubt about the Company&#8217;s ability to continue as a going concern:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 29, 2023, the Company&#8217;s subsidiary, Subrogation Holdings, LLC and its parent, MSP Recovery, entered into the Working Capital Credit Facility consisting of commitments to fund up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_beb2f9de-56a1-4344-9ea6-304c0994f20a" contextRef="C_f7fd3f49-71c3-435f-9615-5ad600a0128e" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">48</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in proceeds. Certain terms were amended to the Working Capital Credit Facility, which were memorialized in the Second Amended and Restated First Lien Credit Agreement dated November 10, 2023. See summary in &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hazel Working Capital Credit Facility and Hazel Purchase Money Loan</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; in Note 9,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Claims Financing Obligations and Notes Payable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements. On August 2, 2024, HPH agreed to, among other things, (i) extend the period for the Company draw up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f28af631-0a60-4270-953d-04662a61a084" contextRef="C_f22fac30-7861-497e-b1e5-adc45046f525" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">14</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for working capital, accessible in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bdd1897c-4a9e-4478-a80d-64b548e23f73" contextRef="C_a9bac2b3-ff72-451c-87fe-ebf2bc6938a2" name="mspr:NumberOfTranches" unitRef="U_Tranche" decimals="INF" format="ixt-sec:numwordsen">eight</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> tranches of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ee334f8-167a-43c3-9916-af9b3480a50b" contextRef="C_f22fac30-7861-497e-b1e5-adc45046f525" name="mspr:LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">1.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, that can be drawn at least one month apart, until September 2025 and (ii) provide for a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5587596b-7f2c-40a1-be4f-bed5814da5bc" contextRef="C_f22fac30-7861-497e-b1e5-adc45046f525" name="mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million loan to be funded by August 31, 2024 for the purpose of acquiring the New Claims. On January 30, 2025, the Company drew the final $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58f43b07-a839-408f-849b-631f2a011f60" contextRef="C_788dd740-ae7d-4599-bfa0-5e03d87f6792" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">1.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million tranche for working capital. Pursuant to the OCF Amendment, HPH may, at its sole discretion, increase the Operational Collection Floor by an amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_037c831d-837c-4939-abd2-650b1a75ad88" contextRef="C_cff61f62-d448-43e7-ae71-41198608a96b" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, to be funded over a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_b0a040b1-eb30-4c2e-913a-8367a95bb387;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3ba70a15-dfd6-4cf3-92ec-f9390251ddbf" contextRef="C_cff61f62-d448-43e7-ae71-41198608a96b" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">six months</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 28, 2025 and April 4, 2025, HPH exercised that discretion and funded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e832759e-dbf6-4f70-bab6-b30af4394821" contextRef="C_b56a07ac-ec0a-4021-a488-5ef64b5339af" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">1.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c581579-97e1-469f-a6d9-138dd823d894" contextRef="C_21918913-de21-41f4-bb8a-ff60365fc94c" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, from the increase to the Operational Collection Floor; said payments are considered part of the bridge loan, as set forth in the proposed reorganization term sheet. An additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cab4dad-f327-47ee-a156-da180eb3f82a" contextRef="C_bdb33403-9b1e-41b7-92e4-eb7991db7d0f" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">2.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million remains available under the Operational Collection Floor, to be funded at HPH&#8217;s sole discretion.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 13, 2023, the Company entered into the MTA Amendment No. 2 and Amendment to the Amended and Restated Security Agreement (&#8220;Second Virage MTA Amendment&#8221;), which extended the due date for the payment obligations to Virage to December 31, 2024. See summary in Note 3,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Material Agreements </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements. On April 1, 2024, the Company entered into the MTA Amendment No. 3 and Amendment No. 2 to the Amended and Restated Security Agreement (&#8220;Third Virage MTA Amendment&#8221;), which: (i) extended the VRM Full Return payment due date to September 30, 2025, subject to acceleration upon certain triggering events; (ii) the Company agreed that, after the Yorkville Convertible Notes are fully satisfied, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8de2df1-eaf8-4278-906d-45258dd5afaf" contextRef="C_72c17608-1d12-4578-9b1c-a1ccd7d443c7" name="mspr:PercentageOfProceedsFromRepaymentOfDebt" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the Company&#8217;s portion of any net proceeds from the Yorkville SEPA would be used to pay down the VRM Full Return; and (iii) commence the sale of certain reserved shares of Messrs. John H. Ruiz and Frank C. Quesada, and the delivery of the resulting net cash proceeds thereof to VRM. The VRM Full Return guaranty obligation became current on September 30, 2024, and the Company does not currently have available liquidity to satisfy said obligation.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 13, 2023, the Company entered into the Second Amended and Restated Nomura Note (defined in Note 3, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business Combination </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements), which extended the maturity date of the Nomura Note to December 31, 2024. See summary in Note 9, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Financing Obligations and Notes Payable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements. On March 26, 2024, the Company entered into the Third Amended and Restated Nomura Promissory Note, which extended the maturity date of the Nomura Note to September 30, 2025. The note became current on September 30, 2024, and the Company does not currently have available liquidity to satisfy said obligation. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to a letter agreement dated November 15, 2024, Nomura agreed to forego payments of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_738f056b-9d5c-46b3-8208-0b705abbef6e" contextRef="C_3895f47c-684e-4e66-8154-738062424885" name="mspr:AggregateAmountOutstandingUnderCashProceeds" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million due under the Third Amended and Restated Nomura Note from proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA until March 31, 2025.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 14, 2023, the Company entered into the Yorkville SEPA, which included the issuance of Yorkville </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes to Yorkville having aggregate principal amounts of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c77af1a-6532-4fd9-9d64-432c93cc9b44" contextRef="C_35dae5c1-7aae-4e29-bd11-991504d30ddb" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in connection with the purchase of Class A Common Stock. See summary in &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Committed Equity Facility</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; within Note 9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, Claims Financing Obligations and Notes Payable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements. On April 8, 2024, the maturity date of the Yorkville </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes was extended to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_01396f50-ecc3-4d1d-aeb4-e462b33a3f4e" contextRef="C_59b01d67-342b-4678-bb64-aa2875d5d3be" name="mspr:DebtInstrumentsExtendedMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 30, 2025</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. On April 12, 2024, Yorkville agreed that, to the extent that it holds Class A Common Stock in such quantities that would prevent the Company from utilizing the SEPA solely due to the Ownership Limitation, Yorkville commits to fund an additional advance in the principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8b38c58-7ad6-479b-a4bd-44a7a70d4520" contextRef="C_8df417e8-0685-446e-aae3-3e40048d4ae7" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">on the same terms and conditions as the previous </span></div></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">87</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_73e07322-c9ea-4374-b248-8be27a3a4015_3"><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">advances </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pursuant to the Yorkville SEPA. On April 10, 2025, Yorkville further agreed to: (i) extend the due date for the first Monthly Payment to November 30, 2026, (ii) extend the maturity date of the Convertible Notes to November 30, 2026, and (iii) to waive Volume Threshold and Maximum Advance Amount limitations set forth in the Yorkville SEPA. As we have sold substantially all of the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d105f09-6a3b-4fef-bcdd-404192373138" contextRef="C_2c439b10-3157-4c98-b8f8-371831d66f6f" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" scale="0" decimals="1" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares currently registered for resale to Yorkville, we need to file with the SEC one or more additional registration statements to register under the Securities Act the resale by Yorkville of any additional shares of our common stock, and the SEC would have to declare such registration statement or statements effective before we could sell additional shares. There can be no assurances of such events occurring or the timing of such events occurring.</span></div></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has concluded that, despite the aforementioned financing arrangements, there is substantial doubt about its ability to continue as a going concern. Unless we are successful in raising additional funds through the offering of debt or equity securities, we have concluded it is probable we will be unable to continue to operate as a going concern beyond the next twelve months. The Company has received a report from its independent registered public accounting firm with an emphasis of matter paragraph as to going concern in connection with the Company&#8217;s audited annual financial statements for the year ended December 31, 2024, which resulted in an event of default in the aforementioned debt agreement, which would have resulted in the debt becoming immediately due; however, the Company has received waivers from (i) Virage and VRM and (ii) HPH and Hazel as it pertains to the year ended December 31, 2024.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_2bc3053c-8495-4a41-b4b6-723d3baa0f92" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" escape="true" continuedAt="F_2bc3053c-8495-4a41-b4b6-723d3baa0f92_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a41683c3-5401-42f6-b4da-7eff32aa3233" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of presentation</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These statements have been prepared pursuant to the rules and regulations of the SEC and in accordance with GAAP. In the opinion of management, the consolidated financial statements reflect all adjustments, which consist only of normal recurring adjustments, necessary to state fairly the results of operations, financial condition and cash flows for the periods presented herein. Prior to the Business Combination, the consolidated financial statements reflect Legacy MSP. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All intercompany transactions and balances are eliminated from the consolidated financial statements.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_80ba22bd-9bc5-46b8-9c74-ac1ccc7aedcf" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ConsolidationPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Principles of consolidation</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company consolidates all entities that it controls through a majority voting interest or otherwise and the accompanying financial statements include the accounts of the Company&#8217;s wholly owned subsidiaries and these entities for which the Company has a controlling interest in. The Company also consolidates all entities that it controls as the primary beneficiary of a variable interest entity (&#8220;VIE&#8221;). Under the VIE model, management first assesses whether the Company has a variable interest in an entity, which would include an equity interest. If the Company has a variable interest in an entity, management further assesses whether that entity is a VIE, and if so, whether the Company is the primary beneficiary under the VIE model. Generally, entities that are organized similar to a limited partnership, in which a general partner (or managing member) make the most relevant decisions that affect the entity&#8217;s economic performance, are considered to be VIEs which would require consolidation, unless the limited partners have substantive kickout or participating rights. Entities that do not qualify as VIEs are assessed for consolidation under the voting interest model.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the VIE model, an entity is deemed to be the primary beneficiary of a VIE if it holds a controlling financial interest. A controlling financial interest is defined as (a) the power to direct the activities of a VIE that most significantly affect the entity&#8217;s economic performance and (b) the obligation to absorb losses of the entity or the right to receive benefits from the entity that could potentially be significant to the VIE. Management determines whether the Company is the primary beneficiary of a VIE at the time it becomes involved with a VIE and reconsiders that conclusion at each reporting date. This analysis includes an evaluation of the Company&#8217;s control rights, as well as the economic interests that the Company holds in the VIE, including indirectly through related parties. As a result of the Business Combination, the Company consolidates MSP Recovery under the VIE model.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9f164af0-313d-4c19-a1e0-af3a5b8afe86" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:UseOfEstimates" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Estimates and Assumptions</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting periods. Actual results could differ from the Company&#8217;s estimates. Estimates are periodically reviewed considering changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Significant estimates and assumptions reflected in these consolidated financial statements include but are not limited to recoverability of long-lived assets.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_08dd13fc-175f-46bd-a373-5b777be1bb15" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain reclassifications have been made to the prior year statement of cash flows to conform to classifications used in the current year. These reclassifications had no impact on net loss, shareholders&#8217; equity or total cash flows as previously reported.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_e667066a-9eb5-4e5d-a9ec-7441825ff997" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true" continuedAt="F_e667066a-9eb5-4e5d-a9ec-7441825ff997_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Segments</span></p></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">88</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_2bc3053c-8495-4a41-b4b6-723d3baa0f92_1" continuedAt="F_2bc3053c-8495-4a41-b4b6-723d3baa0f92_2"><div><ix:continuation id="F_e667066a-9eb5-4e5d-a9ec-7441825ff997_1"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are defined as components of an entity for which separate financial information (including profit and/or loss) is available and regularly reviewed by the chief operating decision maker (&#8220;CODM&#8221;). The Company manages its operations as a single segment for the purposes of assessing performance and making decisions. The Company&#8217;s CODM is its </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_8b390608-14b7-4bdf-8388-0311ecd33fec;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company has determined that it operates in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_002a03ca-eed4-4409-a369-94762ead54fb" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:NumberOfOperatingSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating segment and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f2ca362-8748-4619-afcc-46fc1f976cb2" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:NumberOfReportableSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. In addition, all of the Company&#8217;s revenues and long-lived assets are attributable primarily to operations in the United States and Puerto Rico for all periods presented.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4128e570-c514-43ed-a534-d23ccad03f1b" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ConcentrationRiskCreditRisk" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Concentration of credit risk and Off-Balance Sheet Risk</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and affiliate receivable are financial instruments that are potentially subject to concentrations of credit risk. See Note 14,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, fo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">r disclosure of affiliate receivables. The Company&#8217;s cash and restricted cash are deposited in accounts at large financial institutions, and amounts may exceed federally insured limits. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash and cash equivalents are held. The Company has no other financial instruments with off-balance-sheet risk of loss.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_41e455a9-8b77-436b-9a50-91f28ccd89c0" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers all highly liquid investments purchased with original maturities of three months or less to be cash equivalents. There are </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_adb03ff9-1c13-456d-b62d-573d316a085f" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:CashEquivalentsAtCarryingValue" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_5ebf5d55-4f7a-4026-bfa3-dc3d3e914e06" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:CashEquivalentsAtCarryingValue" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> cash equivalents as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 or 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_871e37b5-118c-4e55-9d9c-01136c923366" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company applies the provisions of ASC 820, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for fair value measurements of financial assets and financial liabilities and for fair value measurements of non-financial items that are recognized or disclosed at fair value in the financial statements on a recurring basis. The Company also applied the provisions of the subtopic to fair value measurements of non-financial assets and non-financial liabilities that are recognized or disclosed at fair value in the financial statements on a non-recurring basis. The subtopic defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The subtopic also establishes a framework for measuring fair value and expands disclosures about fair value measurements. The fair value framework requires the Company to categorize certain assets and liabilities into three levels, based upon the assumptions used to price those assets or liabilities. The three levels are defined as follows:</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1: Quoted prices in active markets for identical assets or liabilities.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2: Quoted prices for similar assets and liabilities in active markets or inputs that are observable.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3: Unobservable inputs reflecting management&#8217;s own assumptions about the inputs used in pricing the asset or liability.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has determined the estimated fair value of its financial instruments based on appropriate valuation methodologies; however, for Level 2 and Level 3 inputs considerable judgment is required to develop these estimates. Accordingly, these estimated fair values are not necessarily indicative of the amounts the Company could realize in a current market exchange. The estimated fair values can be materially affected by using different assumptions or methodologies. The methods and assumptions used in estimating the fair values of financial instruments are based on carrying values and future cash flows. As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20ad384c-87e8-454e-b526-e23ab06df68f" contextRef="C_e9e16be1-82df-4b4d-8077-c5113b5f1637" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t hold any Level 2 or Level 3 assets. See </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 13,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for additional information on Level 2 and Level 3 liabilities as of December 31, 2024.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash is stated at cost, which approximates their fair value. The carrying amounts reported in the consolidated balance sheets for affiliate receivable, accounts payable, affiliate payable and accrued liabilities approximate fair value, due to their short-term maturities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Outstanding borrowings that qualify as financial instruments are carried at cost, which approximates their fair value as of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, due to their short duration.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_1e2506b0-ca87-4064-856c-3517da6369a1" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:EquityMethodInvestmentsPolicy" escape="true" continuedAt="F_1e2506b0-ca87-4064-856c-3517da6369a1_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity Method Investments</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity investments that are not consolidated, but over which the Company exercises significant influence, are accounted for in accordance with ASC 323, &#8220;Investments&#8212;Equity Method and Joint Ventures&#8221; (&#8220;ASC 323&#8221;). Wh</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ether or not the Company exercises significant influence with respect to an investee company depends on an evaluation of several factors including, among others, representation on the investee company&#8217;s board of directors and ownership level. An entity is presumptively assumed to have significant influence in a corporation when it holds </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a0080e2-0228-45de-b77b-017f8a12305f" contextRef="C_16e00acb-17ef-4f0e-b8a3-32f37c07b09f" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">20</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or more of the voting stock of the investee company, or at a lower level (e.g., </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78259e20-392e-4c16-9343-5e1bcda72692" contextRef="C_0788ee7d-2d90-4bf2-ae7b-9ebb1d14ae84" name="mspr:EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b416822d-b561-4b48-8719-6a1331316612" contextRef="C_3f5e2295-148f-48ae-a6d0-b63e048ebdc3" name="mspr:EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%) for entities that track separate members capital accounts.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the equity method of accounting, an investee company&#8217;s accounts are not reflected within the Company&#8217;s consolidated balance sheets and statements of operations; however, the Company&#8217;s share of the earnings or losses of the investee company is reflected in the caption &#8220;Other income&#8221; in the consolidated statements of operations. The Company&#8217;s carrying value in equity method investee companies is not reflected in the Company&#8217;s consolidated balance sheets as of December 31, 2024 or 2023 as the carryin</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">g </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">value is de</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">89</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_2bc3053c-8495-4a41-b4b6-723d3baa0f92_2" continuedAt="F_2bc3053c-8495-4a41-b4b6-723d3baa0f92_3"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_1e2506b0-ca87-4064-856c-3517da6369a1_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">minimis. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When the Company&#8217;s carrying value in an equity method investee company is reduced to zero, no further losses are recorded in the Company&#8217;s consolidated financial statements unless the Company has guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_ba52adc6-fa2a-4848-9303-7700c5ca061a" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and Equipment</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are stated at historical cost less accumulated depreciation and accumulated impairment losses, if any. Major expenditures for property and equipment and those that substantially increase useful lives are capitalized. When assets are sold or otherwise disposed of, costs and related accumulated depreciation are removed from the financial statements and any resulting gains or losses are included in general and administrative expenses within our consolidated statements of operations.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4cbcdbbc-7082-417b-9188-be3f9783cca0" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock" escape="true" continuedAt="F_4cbcdbbc-7082-417b-9188-be3f9783cca0_1"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company provides for depreciation and amortization on property and equipment using the straight-line method to allocate the cost of depreciable assets over their estimated lives as follows:</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:67.54%;box-sizing:content-box;"/>
           <td style="width:32.46%;box-sizing:content-box;"/>
          </tr>
          <tr style="height:8.45pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office and Computer Equipment</span></p></td>
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_0ddedd76-7c62-460a-b5af-7eb149c9aae7" contextRef="C_66d1760e-3b4b-4a44-adcc-7a80bfabd72f" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
          </tr>
          <tr style="height:11.9pt;white-space:pre-wrap;word-break:break-word;">
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and Fixtures</span></p></td>
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_dda656a3-f2ff-4813-935c-d23e9b021a05" contextRef="C_9dbaa8ae-8f9d-4755-91f8-724dee794a36" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
          </tr>
          <tr style="height:1pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold Improvements</span></p></td>
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="-sec-ix-hidden:F_d7c0ff4e-449b-40a5-8325-8ed41dfb3e58;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lesser of lease term or estimated life</span></span></span></p></td>
          </tr>
         </table></ix:nonNumeric></div></ix:nonNumeric></div><div><ix:continuation id="F_4cbcdbbc-7082-417b-9188-be3f9783cca0_1"></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cda1621b-13f7-4e87-9455-a47a63f52589" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:InternalUseSoftwarePolicy" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Internal Use Software</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Internal-use software development costs incurred in the preliminary project stage are expensed as incurred; costs incurred in the application and development stage, which meet the capitalization criteria, are capitalized and amortized on a straight-line basis over the estimated useful life of the asset and costs incurred in the post-implementation/operations stage are expensed as incurred. The estimated useful life for development costs capitalized as of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_29b8dde9-7560-4287-8300-8e96d3ef6afe" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:DevelopmentCostsCapitalizedUsefulLife" format="ixt-sec:durwordsen"><ix:nonNumeric id="F_3b5ea9ae-a1d1-4906-a6ce-d0ad30f909ed" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:DevelopmentCostsCapitalizedUsefulLife" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five years</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Further, internal and external costs incurred in connection with upgrades or enhancements are also evaluated for capitalization. If the software upgrade results in an additional functionality, costs are capitalized; if the upgrade only extends the useful life, it is expensed as occurred.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a4c9737e-797d-4407-9498-46eb58ae4219" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intangible assets</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In certain of its CCRAs, the Company makes up-front payments to acquire Claims recovery rights from secondary payers, such as health plans, managed service organizations, providers or medical services and independent physicians&#8217; associations. The Company recognizes intangible assets for costs incurred up front to acquire Claims recovery rights from various Assignors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CCRA assets are held at cost. Historically, the Company amortized capitalized costs associated with CCRAs over </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_11275084-7385-4f31-a71c-a18d07e3d50e" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">eight years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, based on the expected timing to pursue recovery through litigation, including through potential appeals. As part of the annual reassessment of useful lives as of December 31, 2024, the Company updated the estimated useful life of the CCRAs to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7cc78fdd-429d-4066-804e-557136b0eddd" contextRef="C_4a8604ad-e380-417e-aa2c-4c0e29ad2d19" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seven years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> beginning January 1, 2025.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the Business Combination, the Company acquired rights to Claims recovery cash flows. As a result of this purchase and the guaranty obligation as noted in Note 8, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Variable Interest Entities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company consolidated the entity which holds these Claim rights. Upon consolidation, these Claims rights were accounted for under ASC 350. As such these assets are held at cost, net of amortization.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates these assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. If the estimated future cash flows (undiscounted and without interest charges) from the use of an asset group are less than the carrying value, a write-down would be recorded to reduce the related asset group to its estimated fair value.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_c003c5f7-0205-4360-a699-ada048b1fd34" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:DerivativesPolicyTextBlock" escape="true" continuedAt="F_c003c5f7-0205-4360-a699-ada048b1fd34_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Derivative Instruments</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates its convertible debt, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 480, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Distinguishing Liabilities from Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ASC 815, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Derivatives and Hedging</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The result of this accounting treatment is that the fair value of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability. The change in fair value is recorded in the statements of operations as a component of other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, combined derivative instrument.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">90</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_2bc3053c-8495-4a41-b4b6-723d3baa0f92_3" continuedAt="F_2bc3053c-8495-4a41-b4b6-723d3baa0f92_4"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_c003c5f7-0205-4360-a699-ada048b1fd34_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">will </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">be classified in the consolidated balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_85287e80-3d76-46be-bd01-ed5785d81caa" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:NonControllingInterestsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Non-Controlling Interests</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the Business Combination and described in Note 1, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of the Business</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company became the managing member of MSP Recovery, which is consolidated as the Company controls the operating decisions of MSP Recovery. The non-controlling interest relates to the Up-C Units that are convertible into Class A Common Stock of the Company at the discretion of the holder of the Up-C Unit. The Up-C Unit holders retained approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c258b911-120a-4980-a8a2-49dd1e7dfb2b" contextRef="C_ec4285f4-9b93-43aa-ab90-0409cd42c969" name="us-gaap:MinorityInterestOwnershipPercentageByParent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">99.76</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the economic ownership percentage of the Company as of the Closing Date. The non-controlling interest is classified as permanent equity within</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the consolidated balance sheet of the Company. As of December 31, 2024, based on the Class A common stock issuances during the period, the non-controlling interest of Class V shareholders was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59b255d7-389a-4dae-97b8-c5a439fe04d5" contextRef="C_cecba122-eda2-4c0b-a407-e208dd46ea06" name="us-gaap:MinorityInterestOwnershipPercentageByParent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">69.43</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in the Company&#8217;s ownership interest in MSP Recovery, due to Class V shareholders converting their shares to Class A, are accounted for as equity transactions. Each issuance of the Company&#8217;s Class A Common Stock requires a corresponding issuance of MSP Recovery units to the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company. The issuance would result in a change in ownership and would reduce the balance of non-controlling interest and increase the balance of additional paid-in capital.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_35deb694-43ea-4761-8d66-63b53de796ba" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates long-lived assets, such as property and equipment, including capitalized software costs, and finite-lived intangibles such as Claims recovery rights, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset or asset group may not be recoverable. If the estimated future cash flows (undiscounted and without interest charges) from the use of an asset group are less than the carrying value, a write-down would be recorded to reduce the related asset group to its estimated fair val</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ue.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_7501e508-1912-406f-ba59-a492c6b16e0f" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:RevenueRecognitionPolicyTextBlock" escape="true" continuedAt="F_7501e508-1912-406f-ba59-a492c6b16e0f_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims Recovery</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s primary income-producing activities are associated with the pursuit and recovery of proceeds related to Claims recovery rights that the Company obtains through CCRAs, in which it becomes the owner of those rights. As a result, such income is not generated from the transfer of control of goods or services to customers, but from the proceeds realized from perfection of Claims recoveries from rights the Company holds outright. The Company may also generate future revenue by providing Claims recovery services to other entities outside of the Company.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims recovery income</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes Claims recovery income based on a gain contingency model&#8212;that is, when the amounts are reasonably certain of collection. This typically occurs upon reaching a binding settlement or arbitration with the counterparty or when the legal proceedings, including any appellate process, are resolved.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, the Company owes an additional payment to the original Assignor in connection with the realized value of the recovery right. Claims recovery income is recognized on a gross basis, as the Company is entitled to the full value of recovery proceeds, and makes a payment to the original Assignor similar to a royalty arrangement. Such payments to prior owners are recognized as cost of Claims recovery in the same period the Claims recovery income is recognized.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When the Company becomes entitled to recovery proceeds from the settlement of a Claim recovery pursuit or proceeding that meets the requirements under ASC 450, it recognizes the amount in accounts receivable.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims recovery service income, ASC 606, Revenue from Contracts with Customers</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The guidance under ASC 606, Revenue from Contracts with Customers, provides that an entity should apply the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, the entity satisfies a performance obligation.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company derives revenues from contracts with customers primarily from Claims recovery services arrangements (&#8220;Claims recovery services&#8221;). Claims recovery services include services to related parties or third parties to assist those entities with pursuit of Claims recovery rights. The Company has determined it has a single performance obligation for the series of daily activities that comprise Claims recovery services, which are recognized over time using a time-based progress measure and are typically based on (1) budgeted expenses for the current month with an adjustment for the variance between budget and actual expenses from the prior month or (2) on a contingent basis dependent on actual settlements or resolved litigation. Amounts estimated and recognized, but not yet fully settled or resolved as part of litigation are recognized as contract assets. There were no contract assets as of December 31, 2024 or 2023, as amounts associated with unresolved litigation were fully constrained.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">91</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_2bc3053c-8495-4a41-b4b6-723d3baa0f92_4" continuedAt="F_2bc3053c-8495-4a41-b4b6-723d3baa0f92_5"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_7501e508-1912-406f-ba59-a492c6b16e0f_1"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims recovery services are generally paid in advance on a monthly basis. The Company did not recognize any material revenue for the years ended December 31, 2024 or 2023 for performance obligations that were fully satisfied in previous periods. For the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company also recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1224e06-09c2-4944-a995-5a5e2528bedb" contextRef="C_c92dc1fa-2679-4e97-b7ad-ad332c3af75f" name="mspr:ClaimsRecoveryServiceIncome" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of servicing income related to a specific contract where the performance obligations were completed during the year.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company does not have material unfulfilled performance obligation balances for contracts with an original length greater than one year in any years presented. Additionally, the Company does not have material costs related to obtaining a Claims recovery service contract with amortization periods greater than one year for any period presented.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company applies ASC 606 utilizing the following allowable exemptions or practical expedients:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exemption to not disclose the unfulfilled performance obligation balance for contracts with an original length of one year or less.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Practical expedient to recognize the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Election to present revenue net of sales taxes and other similar taxes, if any.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Practical expedient not requiring the entity to adjust the promised amount of consideration for the effects of a significant financing component if the entity expects, at contract inception, that the period between when the entity transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.</span></div></div></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d55b46a3-d243-46ef-ba9d-0646b3595a03" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfers of Claims Cost Recovery Rights to Others</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, the Company has entered into arrangements to transfer CCRAs or rights to proceeds from CCRAs to other parties. The Company evaluates whether such transfers are sales of nonfinancial assets, sales of future revenues treated as debt, in-kind contributions to equity method investees, or other types of arrangements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When they are treated as sales of nonfinancial assets, the Company recognizes a gain on the sale when control transfers to the counterparty based on the difference between the fair value of consideration (including cash) received and the recognized carrying value of the CCRAs. In some cases, such sales include variable consideration in the form of payments that will be made only upon achievement of certain recoveries or based on a percentage of actual recoveries. The Company estimates and constrains the amounts that will ultimately be realized based on these variable payment terms and includes those amounts in the determination of gain or loss; the gain or loss is subsequently updated based on changes in those estimates.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In other cases, such transfers are considered to be sales of future revenue that are debt-like in nature. These arrangements are recognized as debt based on the proceeds received, and are imputed an interest rate based on the expected timing and amount of payments to achieve contractual hurdles. These are subject to revisions of estimates of that timing and amount based on the contractual provisions and the Company&#8217;s assumptions from changes in facts and circumstances. Such changes are reflected through revision of the imputed interest rate on a cumulative catch-up basis.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6f12421b-26b4-496f-a50a-045213b1e4b3" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:CostOfClaimRecoveriesPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cost of Claims Recoveries</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Costs of Claims recoveries consist of all directly attributable costs specifically associated with Claims processing activities, including contingent payments to Assignors (i.e., settlement expenses).</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e997aecf-15b9-4cab-90f3-8aacbb73a8f5" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:ClaimsAmortizationExpensePolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims amortization expense</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims amortization expense includes amortization of CCRAs acquired as part of the business combination, shown as Intangibles, net in the consolidated balance sheets, and CCRA intangible assets for which the Company made up-front payments for Claims recovery rights. For further details on CCRAs see Note 6, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Intangible Assets, Net</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_59ea7cf9-9b46-4bd3-b3b1-628260d56389" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true" continuedAt="F_59ea7cf9-9b46-4bd3-b3b1-628260d56389_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our income tax expense, deferred tax assets and liabilities, and reserves for unrecognized tax benefits reflect management&#8217;s best assessment of estimated current and future taxes to be paid. As a result of the Business Combination, the Company became the sole managing member of MSP Recovery, which is treated as a partnership for U.S. federal, state and local income tax purposes. As a partnership, MSP Recovery is not subject to U.S. federal and certain state and local income taxes. Any taxable income or loss generated by MSP Recovery is passed through to and included in the taxable income or loss of its partners, including MSP Recovery, Inc. The Company is subject to U.S. federal income taxes, in addition to state and local income taxes, with respect to the Company&#8217;s allocable share of income of MSP Recovery, LLC.</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">92</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_2bc3053c-8495-4a41-b4b6-723d3baa0f92_5"><div><ix:continuation id="F_59ea7cf9-9b46-4bd3-b3b1-628260d56389_1"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s deferred tax balances reflect the impact of temporary differences between the carrying amount of assets and liabilities and the Company&#8217;s tax basis. The balances are stated at the tax rates in effect when the temporary differences are expected to be recovered or settled. The Company reviewed the anticipated future realization of the tax benefit of the Company&#8217;s existing deferred tax assets and concluded that it is more likely than not that all of the deferred tax assets will not be realized in the future and recorded a full valuation allowance at December 31, 2024 and 2023.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4968d868-b57d-44b0-b1b7-bdd06a6601a8" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive Income (Loss)</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has no components of other comprehensive income (loss). As such, net loss equates to comprehensive income (loss) for all periods presented in this report.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_74801a7b-e712-4ec3-b9f4-542c58af08fd" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New Accounting Pronouncements Recently Adopted</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2024, we </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5999613d-4d57-4137-92d8-cbec97b25f0e" contextRef="C_5cbb4b4f-b96f-4942-a566-a9743e895772" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-07, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, on a retrospective basis. The amendments are intended to increase reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. Refer to Note 15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, Segment Information</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for further information.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New Accounting Pronouncements Issued but Not Yet Adopted</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASU 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Among other requirements, this update adds specific disclosure requirements for income taxes, including: (1) disclosing specific categories in the rate reconciliation and (2) providing additional information for reconciling items that meet quantitative thresholds. The guidance is effective for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company is currently evaluating the provisions of this guidance and assessing the potential impact on the Company&#8217;s financial statement disclosures.</span></p><p style="text-indent:21.6pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU 2024-03, &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40) Disaggregation of Income Statement Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;. The guidance in ASU 2024-03 does not change the expense line items presented on the face of the financial statements, but instead, it requires additional disaggregation of specific expense captions</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the notes to the financial statements, among other things, specific information about certain costs and expenses including purchases of inventory; employee compensation; and depreciation, amortization and depletion expenses for each caption on the income statement where such expenses are included. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted, and the amendments may be applied prospectively to reporting periods after the effective date or retrospectively to all periods presented in the financial statements. The Company is currently evaluating the provisions of this guidance and assessing the potential impact on the Company&#8217;s financial statement disclosures.</span></p></ix:nonNumeric></div></ix:continuation></div><div><ix:nonNumeric id="F_f0d35edd-e822-4075-a7ae-9f92fc21f045" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:MaterialAgreementsDisclosureTextBlock" escape="true" continuedAt="F_f0d35edd-e822-4075-a7ae-9f92fc21f045_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 3. MATERIAL AGREEMENTS</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Virage</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 23, 2022 as part of the Closing of the Business Combination, the Company acquired assets through the issuance of Up-C Units. In exchange for approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f246f7c5-6bc2-49c1-a822-043d4f5599de" contextRef="C_a64e596b-3d3c-475c-aff9-9243dbb55747" name="mspr:NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired" unitRef="U_shares" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million Up-C Units, the Company acquired the rights to receive the distributable net proceeds (the &#8220;Proceeds&#8221;) of a portfolio of Claims owned by VRM MSP, a Delaware limited liability company and joint investment vehicle of VRM and Series MRCS. Under this asset acquisition structure, the Company determined that the arrangements to acquire the rights to proceeds from certain Claims recovery rights along with the guarantee of the VRM Full Return (noted and defined below) result in the Company consolidating the Series. Upon consolidation, the Company included the value of the Up-C Units provided and the value of the guarantee as Intangible Assets, net in the consolidated balance sheet. These are held at cost and treated as finite life intangible assets under ASC 350, and have a useful life of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d47c78e3-59ae-4012-b111-5ccc1b16cbd4" contextRef="C_4c7596be-feb0-407b-896b-01187ad8e8fd" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seven years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with such transaction the Company agreed to pay Virage an amount equal to the contributions by Virage to VRM MSP plus an annual rate of return of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e249bc34-d9b7-4816-bc10-fd0e1b78e9f1" contextRef="C_d84f5212-815c-411b-b1b6-254a05c04b96" name="mspr:AnnualCompoundedReturnOnContributionPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">20</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% (the &#8220;VRM Full Return&#8221;). Pursuant to the terms of the agreement with Virage, such amount is payable exclusively by any of the following means (or any combination thereof): (a) the Proceeds, net of expenses related to claim settlement, (b) a sale of certain reserved shares of Messrs. John H. Ruiz and Frank C. Quesada, and the delivery of the resulting net cash proceeds thereof to VRM, or (c) a sale of shares by the Company and delivery of the net cash proceeds thereof to VRM. The amount of the VRM Full Return was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_481979ae-2906-4aa4-ab6f-443cbcd2d46f" contextRef="C_8396e5b3-8975-41b1-a3c5-b71482629bc6" name="mspr:ValueOfFullReturn" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1,126.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3be63cd-743b-4a17-a336-badcbc48b8e7" contextRef="C_05d37fc5-14e3-4592-b1a0-f0a3bb0acc27" name="mspr:ValueOfFullReturn" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">941.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the Company incurred debt related to the VRM Full Return as included in the guaranty obligation within the consolidated balance sheet, this value was included in the purchase price and is included in Intangible Assets, net, in the consolidated balance sheet for the full value of the VRM Full Return at the acquisition date. Any subsequent interest accrual is reflected within interest expense in the consolidated statement of operations.</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">93</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_f0d35edd-e822-4075-a7ae-9f92fc21f045_1" continuedAt="F_f0d35edd-e822-4075-a7ae-9f92fc21f045_2"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Virage MTA dated March 9, 2022 (as amended on April 12, 2023, November 13, 2023, and April 1, 2024, the &#8220;Virage MTA&#8221;), the VRM Full Return payment due date is September 30, 2025. The payment methods for the VRM Full Return are as follows, and in the following order of priority: (a) a first priority lien on all sources of revenue of the Company not otherwise encumbered as of April 12, 2023 to the extent such revenues and liquidity exceed the amount of net of revenues necessary to establish and maintain an operating reserve (&#8220;Operating Reserve&#8221;) of to the budget of the Company (plus applicable taxes) plus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3e1f698-2be1-496d-a339-fe3bf2e6bd95" contextRef="C_acacf35c-6921-4d48-ad39-e840756fabcf" name="mspr:MinimumCashAvailableForDistributionsPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, (b) a sale of certain reserved shares of Messrs. John H. Ruiz and Frank C. Quesada, and the delivery of the resulting net cash proceeds thereof to VRM, (c) Parent&#8217;s sale of additional shares and delivery of proceeds to VRM, subject to certain anti-dilution provisions, and (d) if the VRM Full Return is not satisfied by the foregoing, a sale by Messrs. Ruiz and Quesada of other shares of Common Stock that they hold, and the delivery of the resulting net cash proceeds thereof to VRM; provided that if the VRM Full Return is not fully paid by September 30, 2025 the VRM Full Return shall be payable by any of such payment methods in any order of priority. In addition, Messrs. Quesada and Ruiz agreed to certain transfer restrictions applicable to their Common Stock.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Company agreed to make a one-time, lump sum payment to Virage for the period starting May 24, 2023 and ending December 31, 2023, in one or a combination of: (a)</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_99cb377f-9bcb-442d-b273-9c6aff19f9e9" contextRef="C_acacf35c-6921-4d48-ad39-e840756fabcf" name="mspr:DescriptionOfCashPaymentsMadeToCounterParty"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> cash, in an amount equal to 1.0% of each calendar month-end balance (which month-end balance shall be increased daily up to 20.0% per annum based on a formula set forth in the Virage MTA) of the amount owing to Virage as of each preceding calendar month end</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and/or (b) </span><span><ix:nonNumeric id="F_941bf0e4-9e87-490c-977e-399e1049876e" contextRef="C_540b65a1-9fe2-4515-b78b-8e298f79fa7e" name="us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees" continuedAt="F_941bf0e4-9e87-490c-977e-399e1049876e_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">issue to VRM a warrant to purchase a number of shares of Class A Common Stock of Parent equal to the quotient of 1.0% of each calendar month end balance of the Unpaid Base Amount (calculated on a cumulative basis) and the VWAP of a share of Class A Common Stock for the five-day period prior to the issuance, beginning with May 24, 2023 and ending December 31, 2023, which warrant will have an exercise price (payable in cash) of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01238f20-5400-4da7-b323-eec6f1e9ff1f" contextRef="C_9c8844ba-74b8-4891-9bac-96c2d880ebdd" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0025</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share (the &#8220;Initial Virage Warrant&#8221;); provided that the Initial Virage Warrant will expire on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0d0c6319-8394-4f07-90a5-dbfe4279e842" contextRef="C_9c8844ba-74b8-4891-9bac-96c2d880ebdd" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 1, 2026</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></ix:nonNumeric></span></p><div><ix:continuation id="F_941bf0e4-9e87-490c-977e-399e1049876e_1"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Initial Virage Warrant, as amended, was issued effective January 1, 2024, entitling Virage to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_806bc548-275c-4fd8-b363-b8b7a01fcb48" contextRef="C_cbc261d2-d131-4653-99be-97e07cea361a" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,131,934</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_023a825f-b37c-491b-8dc6-e33c29e04287" contextRef="C_cbc261d2-d131-4653-99be-97e07cea361a" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0025</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, with an expiration date of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ca0a25b5-d384-4e0a-b5d2-ff221c2e3806" contextRef="C_cbc261d2-d131-4653-99be-97e07cea361a" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 1, 2026</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fea741a1-7670-4354-acf3-807912d4662d" contextRef="C_fd924673-3ac8-4110-8c0f-caed5b9b9417" name="mspr:WarrantPaymentDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, for each calendar month-end beginning with January 31, 2024, and continuing until the VRM Full Return is paid in full, the Company agreed to issue to VRM a warrant to purchase a number of shares of Class A Common Stock of Parent equal to the quotient of 1% of the calendar month-end balance of the Unpaid Base Amount and the VWAP (each, a &#8220;Monthly Virage Warrant&#8221;), which warrant will have an exercise price (payable in cash) of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_afe57484-a602-4046-baf9-16d71ab46ba9" contextRef="C_bc381c59-088d-4d05-9d41-0901345815e7" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and expire on the second anniversary of its issuance.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bcb3d576-ac32-472f-a448-489f2cf7a4f8" contextRef="C_21fdfacf-60d9-461c-b409-b9c8d8d5e297" name="mspr:NumberOfWarrantsIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Monthly Virage Warrants, entitling Virage to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4fe7138-e370-42b4-bdfc-b9a826ff150c" contextRef="C_21fdfacf-60d9-461c-b409-b9c8d8d5e297" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">8,619,405</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock, each warrant expiring </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8fcca2dd-9802-4b82-82d6-83f89adc4a95" contextRef="C_21fdfacf-60d9-461c-b409-b9c8d8d5e297" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">two years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date of issuance, which are exercisable for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70c6088f-23f8-4d8e-9e01-2dba9c8df879" contextRef="C_21fdfacf-60d9-461c-b409-b9c8d8d5e297" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0025</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. Furthermore, on April 14, 2025, the Company issued two additional warrants for November 2024 and December 2024, each warrant exercisable for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a04e865-60df-4588-8812-8298925b199c" contextRef="C_a819d26b-6742-4f37-b1c0-79825dc5c770" name="mspr:NumberOfSharesExercisable" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,277,808</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ff75c05-c40d-4955-98cc-4106a2f48846" contextRef="C_1be14025-3d59-42c6-81ac-3d450aba88f4" name="mspr:NumberOfSharesExercisable" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,332,792</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, respectively, both which are exercisable for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8b0af90-db0c-4486-8e0c-6d6213086e8e" contextRef="C_a819d26b-6742-4f37-b1c0-79825dc5c770" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a50fad66-1db9-4136-be8a-c64592e001f5" contextRef="C_1be14025-3d59-42c6-81ac-3d450aba88f4" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and expiring two years from the date of issuance.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fda161e6-85b8-4357-9f2b-70af3a08999b" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:VRMFullPaymentDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company also agreed that, after the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes are fully satisfied, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12cfa4ab-39f4-43b7-93a9-83bcaace255a" contextRef="C_98ae30fc-b820-4fbe-b5f9-592ed60a472d" name="mspr:PercentageOfProceedsFromRepaymentOfDebt" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the Company&#8217;s portion of any net proceeds from the Yorkville SEPA would be used to pay down the VRM Full Return</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and that Messrs. John H. Ruiz and Frank C. Quesada would commence the sale of certain of their reserved shares, and deliver the resulting net cash proceeds thereof to VRM.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has received a report from its independent registered public accounting firm with an emphasis of matter paragraph as to going concern in connection with the Company&#8217;s audited annual financial statements for the year ended December 31, 2024; however on September 6, 2024, Virage agreed to waive a provision of the Virage MTA Amendment that would otherwise accelerate the payment of amounts due to Virage in such event.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hazel Purchase Money Loan</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 29, 2023, the Company acquired a controlling interest in nine legal entities, whose sole assets are CCRAs, from Hazel. This is referred to as the &#8220;Claims Purchase.&#8221; The purchase price for the Claims Purchase was funded by (i) a purchase money loan between Hazel, as a lender, and the Company, as a borrower, in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c08b1db2-bac5-4873-82ed-e514c8e522aa" contextRef="C_28b71e0a-7e6d-429a-b008-1ff060441f3d" name="mspr:PurchaseMoneyLoan" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">250</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the &#8220;Purchase Money Loan&#8221;) and (ii) proceeds from the sale of certain, separate CCRAs in the Claims Sale (as defined below).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Also, on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f40ea2e0-81b0-4fb5-8e6a-53aa2bccbc7b" contextRef="C_e0dfe751-c423-4c59-83cb-f45bf2e04763" name="mspr:AgreementDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 29, 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company sold a controlling interest in three legal entities whose sole assets are CCRAs to Hazel. The agreement provided that the Company and Hazel would share in the recovery proceeds therefrom, in accordance with an agreed waterfall after Hazel had realized the first $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62f9be89-8122-4349-9868-d862bf00b618" contextRef="C_e0dfe751-c423-4c59-83cb-f45bf2e04763" name="mspr:RealizedClaimRecoveries" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">150</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in claims recoveries. This transaction is referred to as the &#8220;Claims Sale,&#8221; and together with the Claims Purchase, the &#8220;Claims Transactions.&#8221;</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the Claims Transactions were negotiated together in contemplation of one another, they have been combined for accounting purposes. The Company analyzed the Claims Sale and determined that this transaction would be treated as the sale of in-substance nonfinancial assets, in exchange for noncash consideration in the form of the CCRAs from the Claims Purchase measured at fair value. The variable consideration related to future recoveries is fully constrained, because, at this time, it is not probable that any amounts will be owed above the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa676569-350e-4723-9df1-e40176b801fd" contextRef="C_47aa4785-b887-4bdc-9f4f-5f764a502283" name="mspr:RealizedClaimRecoveries" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">150</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million recovery threshold that would trigger additional payments. The Company analyzed the Claims Purchase and determined it results in the initial consolidation of variable interest entities that are not businesses. The acquired CCRAs held by those entities are recognized at fair value.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">94</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_f0d35edd-e822-4075-a7ae-9f92fc21f045_2"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of the assets sold in the Claims Sale was determined to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81e3ebf6-1dbd-4d70-bd83-9b4ef0bcc762" contextRef="C_28b71e0a-7e6d-429a-b008-1ff060441f3d" name="us-gaap:AssetsSoldUnderAgreementsToRepurchaseMarketValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">45.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company&#8217;s carrying value of those CCRAs surrendered was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2fd08d59-9e9c-4b5c-8375-63af41d88fad" contextRef="C_a81ca7d1-03d7-4254-97b6-cef1cc580eba" name="us-gaap:AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">40.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Because there are no other observable prices for such transactions, the Company determined the fair value by reference to the purchase price for those CCRAs in a recent transaction. The fair value of the acquired CCRAs was determined to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a3330a8-2a6f-4fab-800d-0a3b84368a6a" contextRef="C_47aa4785-b887-4bdc-9f4f-5f764a502283" name="us-gaap:AssetAcquisitionPriceOfAcquisitionExpected" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">285.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and the Company recognized the Purchase Money Loan recognized at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58cf3ae4-df06-49ae-a040-75d2225139a5" contextRef="C_79d9f285-5c8d-4c0b-8618-a9851a277fcc" name="us-gaap:AssetAcquisitionPriceOfAcquisitionExpected" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">250</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, as any implicit discount or premium to current market rates at the time of issuance were insignificant.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This resulted in a gain on the Claims Transactions of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f572531-50be-445f-98a1-9b00f9727c7e" contextRef="C_47aa4785-b887-4bdc-9f4f-5f764a502283" name="mspr:NetGainOfTheAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which largely corresponds to the previously recognized amortization of the CCRAs that were sold in the Claims Sale.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, under the Operational Collection Floor, HPH agreed to extend up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b818dc3-d04a-44a0-8f1a-05b8e19139ab" contextRef="C_ac30e5d6-58b4-4221-bd9f-24cd5b3365b0" name="mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (with a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89dc0580-d344-4dee-9fef-63576b69afca" contextRef="C_b46cfbc4-b098-4d9a-a0eb-4d949d390497" name="mspr:DebtInstrumentOriginalIssueDiscount" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">40</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% original issue discount) to fund the acquisition of additional Claims, which further collateralize the Working Capital Credit Facility. On October 2, 2024, the Company acquired the recovery rights to additional Medicare Secondary Payer Claims from an existing Assignor consisting of more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4ba74d7-f3b9-4225-bbea-958178bae3b9" contextRef="C_dba0c8eb-4e7d-4101-939e-a66a07a72a4a" name="mspr:NumberOfMedicareMembers" unitRef="U_Members" decimals="INF" format="ixt:num-dot-decimal">450,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Medicare members, as documented by the Assignor.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts borrowed and obligations under the Purchase Money Loan and the Working Capital Credit Facility (See Note 9,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Claims Financing Obligations and Notes Payable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">are secured by a pledge of proceeds from specific Claims in the Company&#8217;s Claims portfolio, with the lien securing the Purchase Money Loan being subordinated and junior to the lien securing the Working Capital Credit Facility. Pursuant to the Purchase Money Loan and the Working Capital Credit Facility, the Company entered into a collateral administrative agreement between the Company and Hazel, which sets forth certain arrangements between the Company and Hazel in relation to Claims owned by the Company, the proceeds of which are due to the Company were pledged to Hazel to secure the Purchase Money Loan and the Working Capital Credit Facility.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hazel Working Capital Credit Facility</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5cc00db7-c300-47ec-9f96-d110f54248ca" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:AgreementDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 6, 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, Subrogation Holdings entered into a credit agreement (as amended on March 29, 2023; November 10, 2023; and October 1, 2024; the &#8220;Working Capital Credit Facility&#8221;) with HPH providing for funding of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_660b9db3-1221-43bd-b957-34d7910e0f3c" contextRef="C_6416e867-3e37-4d6c-9be5-842500520199" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">80</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (with a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fdda453a-27b2-4849-bd71-516e642cc8dd" contextRef="C_13748221-3ec6-4846-a96d-b183a19ab473" name="mspr:DebtInstrumentOriginalIssueDiscount" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">40</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% original issue discount), consisting of a Term Loan A commitment to fund up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_213516d8-3d36-4261-8a0e-8701e5f29f30" contextRef="C_f5366bf8-0f82-48ee-a516-2669d00a2346" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">30</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (in multiple installments) in proceeds and a Term Loan B Commitment to fund up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_188c43f3-c0a5-4526-8a80-ba60d7a3b503" contextRef="C_240c3aca-617e-45d0-80e7-144cd05885bc" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">18</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (in multiple installments) in proceeds. During fiscal year 2023, HPH disbursed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6bc38299-a024-4e7b-ae68-b92b7312126a" contextRef="C_94f5cc8c-3b7d-43d7-abe9-3622bcd0a570" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million under Term Loan A and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94a2c504-7164-4bc8-8e55-eba3172e460e" contextRef="C_6d36e1f0-9fa4-464e-bcc8-ec43920a4389" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million under Term Loan B.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal year 2024, HPH disbursed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c90c8aa8-05ba-4c6b-a400-fa8f2fde21ff" contextRef="C_3f7d2988-c276-41f2-9ddb-13cdccfa0680" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million under Term Loan B on January 25, 2024. On August 2, 2024, Subrogation Holdings entered into a letter agreement to amend the Working Capital Credit Facility (the &#8220;HPH Letter Agreement&#8221;) with HPH, which, among other things: (i) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_891b4274-3919-403d-bc20-ce4b18b645f0" contextRef="C_d114e753-e2e8-448e-8e31-cdfe137f7707" name="us-gaap:LineOfCreditFacilityDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">extended the period to draw up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_834c8a94-0fa5-41c7-867a-7f165bbcdd2f" contextRef="C_2b6ff688-5733-44c4-adef-6460a88c6577" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">23.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (with a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d0c8f86-99e5-4d08-992e-f6381ed7bf4e" contextRef="C_19dd057d-164d-4d09-aca4-862b4fbf7c68" name="mspr:DebtInstrumentOriginalIssueDiscount" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">40</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% original issue discount) remaining under Term Loan B for working capital, accessible in eight tranches of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e9e4362-308f-422a-abc9-4ab8bfc18692" contextRef="C_2b6ff688-5733-44c4-adef-6460a88c6577" name="mspr:LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">1.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, that can be drawn at least one month apart, until September 2025</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and (ii) provided for a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1175668-3b25-468d-b26f-32e1a2e11b11" contextRef="C_2b6ff688-5733-44c4-adef-6460a88c6577" name="mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million loan (subject to a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c46dbef-76aa-4391-82ea-023cd3cfc1a6" contextRef="C_19dd057d-164d-4d09-aca4-862b4fbf7c68" name="mspr:DebtInstrumentOriginalIssueDiscount" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">40</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% original issue discount) funded by August 31, 2024 to acquire additional Claims (the &#8220;New Claims&#8221;) that collateralize the Working Capital Credit Facility (collectively, (i) and (ii) the &#8220;Operational Collection Floor&#8221;). The parties formalized the terms of the HPH Letter Agreement in Amendment No. 3 to the Working Capital Credit Facility dated October 1, 2024 (the &#8220;OCF Amendment&#8221;). On October 2, 2024, the Company acquired the recovery rights to additional Medicare Secondary Payer Claims from an existing Assignor consisting of more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d146a150-9bb4-4d1d-aa27-3854dd23648d" contextRef="C_ba6d251e-46b0-4175-8e53-534f56cc7116" name="mspr:AssignorConsistingNumberOfMedicareMembers" unitRef="U_Members" decimals="INF" format="ixt:num-dot-decimal">450,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Medicare members, as documented by the Assignor.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Operational Collection Floor, the Company received during 2024: (i) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b0e7221-0d07-4ecc-99e0-c1cbbf7937dc" contextRef="C_f47d4941-5e9a-4b10-9ef9-c0cd1e17b7a2" name="us-gaap:ProceedsFromLongTermLinesOfCredit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for working capital, and (ii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2ca59df-b0b1-4126-940f-21e90e912553" contextRef="C_e69f5703-ad7e-4186-a291-683b533d05a3" name="mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the purpose of acquiring the New Claims. To date, the Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf0752df-083b-467e-878c-e67e87b18c39" contextRef="C_859ecd69-4f84-40b2-9e61-c5f7ca8a44e9" name="us-gaap:ProceedsFromLongTermLinesOfCredit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of working capital for 2025. Pursuant to the Working Capital Credit Facility, HPH may, at its sole discretion, increase the Operational Collection Floor by an amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9807bfc1-a32a-44fe-b117-fa3b04939d42" contextRef="C_0bbf18dd-84b1-4a9c-8590-5c60d8a4eac1" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, to be funded over a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_dcf042f9-2441-4111-b785-0c83a5affaab;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e363690d-f5b1-4a01-ae7f-9e9ab4ccd13e" contextRef="C_0bbf18dd-84b1-4a9c-8590-5c60d8a4eac1" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">six months</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. On February 28, 2025 and April 4, 2025, HPH exercised that discretion and funded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_860ec9a3-7e90-4318-af2b-59433b62327b" contextRef="C_b56a07ac-ec0a-4021-a488-5ef64b5339af" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">1.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb1f8288-9cbd-4fef-a4e1-6864ec1ed16b" contextRef="C_21918913-de21-41f4-bb8a-ff60365fc94c" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, from the increase to the Operational Collection Floor. An additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_643be868-3487-48ad-b6f4-5cf52c01a7ca" contextRef="C_bdb33403-9b1e-41b7-92e4-eb7991db7d0f" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">2.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million remains available under the Operational Collection Floor, to be funded at HPH&#8217;s sole discretion.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_5caad33f-1cfc-4f65-9da6-18428c5fc7fb" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" escape="true" continuedAt="F_5caad33f-1cfc-4f65-9da6-18428c5fc7fb_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 4. INVESTMENT IN EQUITY METHOD INVESTEES</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company holds </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c7c31a3-5dc4-444e-a3a1-8cde84f2f90c" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="mspr:NumberOfHoldingInvestments" unitRef="U_Investment" decimals="INF" format="ixt-sec:numwordsen">four</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> investments which are accounted for using the equity method</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: MAO-MSO Recovery II LLC Series PMPI (&#8220;Series PMPI&#8221;), MAO-MSO Recovery LLC, MAO-MSO Recovery II LLC (both collectively the &#8220;MAO-MSO entities&#8221;) and VRM MSP.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Series PMPI is a series of MAO-MSO Recovery II LLC. The Company exercises significant influence over the operating and financial activities of Series PMPI, but does not exercise control of the entity. In accordance with Series PMPI&#8217;s operating agreement, the controlling member is entitled to a preferred return of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41b34a39-f3a2-4cf3-8930-31fd0accd9ec" contextRef="C_948dc2cf-d2dd-4834-9c8e-109e2968c0dd" name="mspr:PercentageOfPreferredReturnForTheControlling" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">20</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Preferred Return&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Once the Preferred Return has been met, the controlling member is entitled to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4f5b3b0-25ba-4ed2-8d21-449e360df778" contextRef="C_948dc2cf-d2dd-4834-9c8e-109e2968c0dd" name="mspr:PercentageOfRecoveryClaimsForTheControlling" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of Claim</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s recoveries by PMPI. The noncontrolling member is allocated </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b27ee73e-827d-4822-9fd7-9149d9434604" contextRef="C_948dc2cf-d2dd-4834-9c8e-109e2968c0dd" name="mspr:PercentageOfCostsAllocatedToNonControlling" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the costs of PMPI. Since the Preferred Return exceeds the total members&#8217; equity of PMPI as of both </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, the value of the equity method investment in the consolidated balance sheet is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67b173cf-fab2-4572-9514-25be84b5eafa" contextRef="C_3c7a8126-415b-4641-9233-e1ab41a700c5" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b9275708-4496-44db-850a-876c8bbd7910" contextRef="C_d8874f5c-dad1-443d-9908-5daf18c46c70" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">0</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The MAO-MSO entities are Delaware limited liability companies formed as master series entities whose central operations are to form other series legal entities that will hold and pursue Claims recovery rights. The MAO-MSO entities are not designed to hold or pursue Claims recoveries themselves. The Company holds a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83a1e637-da3f-4aaa-8ec4-29644a691454" contextRef="C_4d43bce3-acbe-4666-82a1-1d40c94afa24" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="F_330b819a-38ed-4628-b202-1d5efa0f095d" contextRef="C_26717c14-ec44-4c6a-8117-50449ba3aaaa" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">economic interest in both entities, and has significant influence through</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">95</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_5caad33f-1cfc-4f65-9da6-18428c5fc7fb_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">its </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">equity investment, but does not control either entity. As equity method investments, the Company recognizes its proportionate share of net earnings or losses as equity earnings in Other income. The activity of these entities has been insignificant for the years ended December 31, 2024 and 2023. Since the Company did not make a contribution to the MAO-MSO entities and the entities have recorded losses, the value of the equity method investment in the consolidated balance sheets is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f03c279-a126-4e17-b257-927a6c920262" contextRef="C_26717c14-ec44-4c6a-8117-50449ba3aaaa" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d639a4b8-4025-4e15-b307-17de55d19f86" contextRef="C_77c0175e-530a-4d31-b2a4-dbf10318bced" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_c9cdbaf4-245f-4990-9323-500f7b475280" contextRef="C_4d43bce3-acbe-4666-82a1-1d40c94afa24" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_81c42503-c3f5-405a-82d7-3a0e4feca0e5" contextRef="C_e701c51b-571e-4acd-bab5-e8a71bb9884c" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of both December 31, 2024 and 2023.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_928db263-b006-409f-b9fe-27e1184c6a4f" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock" escape="true"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Summary financial information for equity accounted investees, not adjusted for the percentage ownership of the Company is as follows:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:15%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:16%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Year Ended December 31,</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32dd08c3-f402-455e-9c31-b6504fc4b24b" contextRef="C_1fc207a6-b212-4da0-b588-3744dd9baaf9" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">354</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e759e584-3221-47d8-bce5-a34090ba03ec" contextRef="C_8faa5dec-aa23-45d8-bc7c-a3721aed1c52" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">8</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd235a17-eef8-425b-9bc2-3bc643ea2cc9" contextRef="C_1fc207a6-b212-4da0-b588-3744dd9baaf9" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,167</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1877a3af-dd6b-4a01-8f82-ff20a1e10bd9" contextRef="C_8faa5dec-aa23-45d8-bc7c-a3721aed1c52" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,000</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e40f8b27-daf0-42dc-af53-ca13370d8834" contextRef="C_1fc207a6-b212-4da0-b588-3744dd9baaf9" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b61cde7-ccd7-4ee3-9979-04a797906cec" contextRef="C_8faa5dec-aa23-45d8-bc7c-a3721aed1c52" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0d1106c-ff73-43eb-815a-d829fc7de1b2" contextRef="C_1fc207a6-b212-4da0-b588-3744dd9baaf9" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">840</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_107cfb98-0f8b-4528-9a4d-7d6fe7e821c5" contextRef="C_8faa5dec-aa23-45d8-bc7c-a3721aed1c52" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,038</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.013%;box-sizing:content-box;"/>
         <td style="width:1.04%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:15.403%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:15.543%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total Assets</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b4bcacf-2ed7-4cb5-9cd0-02f8ab8d0b9b" contextRef="C_b4bab880-e77f-42ec-81c9-310c18bf1482" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">928</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1dd687a6-0805-4bbe-bf9a-37ce3827d7ef" contextRef="C_56b72099-7c42-4ac1-9909-043db62ef97f" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,403</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total Liabilities</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c1ee48a-ccfe-4bdc-be49-a3b2d06cd6cd" contextRef="C_b4bab880-e77f-42ec-81c9-310c18bf1482" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">762</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6baa9a98-3faf-458b-8629-f10fa808c52b" contextRef="C_56b72099-7c42-4ac1-9909-043db62ef97f" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">399</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2023, in connection with an amendment to the VRM MSP structure, the Company became a direct investor in VRM MSP, which controls MSP Recovery Claims, Series LLC, and recognizes this investment as an equity method investment. However, the Company previously consolidated and continues to consolidate the underlying Series of MSP Recovery Claims, Series LLC, which hold investments in CCRAs that the Company controls as primary beneficiary under the VIE model. As such, other than the Series, which were already consolidated, the investment in VRM MSP includes only administrative activities that are not otherwise consolidated, and any costs are allocable to the other investors. As a result, the Company has no significant equity earnings or exposure to losses or obligations to fund this investment.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a9875462-2255-4341-930f-49be712eebff" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 5. PROPERTY AND EQUIPMENT, NET</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c73f46ba-b263-44d8-be28-1897f21af753" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment, net consist of the following:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:65.52%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.52%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.44%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.52%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office and computer equipment</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e9930fc-9ed2-4d9b-a930-0dffbfaac968" contextRef="C_66d1760e-3b4b-4a44-adcc-7a80bfabd72f" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">459</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f59eec1-5a17-40ba-8a17-601d9e122ffb" contextRef="C_04ac6ccd-aacd-4024-ae81-e73dcdcaa130" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">434</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84184696-8cf0-474b-8a05-89284b777fa8" contextRef="C_5e551576-1454-4e6e-8860-e330e9e8fef2" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">701</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5fab5ef0-b165-4d80-a464-a7c3367f19e3" contextRef="C_ecedb469-0a15-457a-8825-173264a5730b" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">113</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Internally developed software</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d3cbf6c-b5e5-4cab-8897-5425b709961c" contextRef="C_29a25c58-bd49-4813-98cf-174eff897359" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,588</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_799f6f36-d9fb-4854-a2d5-b7c75c434665" contextRef="C_b4d69b9f-ab9d-46c5-9d48-786f9a6c9133" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,789</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other software</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8530920-e15c-4ad6-a493-5d13366d74c9" contextRef="C_58441ed6-59f7-4eb3-8ebb-2144c6210c69" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">67</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9caec4d9-f433-4211-b987-79640f910d26" contextRef="C_08ce17f4-9500-467c-ac13-d6286aef1dd5" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">67</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Property and equipment, gross</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e1288763-3026-4599-8e8c-3dbc48ebe30c" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,815</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_281cc5e4-54f9-4c3e-8276-d30b0a82ced0" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,403</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: accumulated depreciation and amortization of software</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67c72925-afd9-43b3-a0be-d9cdf23697fc" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,656</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1404f9d1-74c6-4ae1-9e84-8b6a20ea8ff3" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,492</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84d8e9e8-686b-4b64-b978-641d4242bf33" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,159</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd75d65c-1e51-4172-8b52-f6630f7ef2cb" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,911</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended December 31, 2024 and 2023, depreciation expense and amortization expense was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e176d83-9af7-4d82-87d9-3f42027842e0" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7217235-78ae-45b6-ac2d-4cee86fb78db" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_a7c2de14-36d7-4554-a49f-911004230564" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:IntangibleAssetsDisclosureTextBlock" escape="true" continuedAt="F_a7c2de14-36d7-4554-a49f-911004230564_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 6. INTANGIBLE ASSETS, NET</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company holds CCRAs held by Series MRCS, which were acquired through the issuance of equity as part of the Business Combination in 2022 and acquisitions of additional CCRAs from the Closing Date through 2024.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ae12e070-87f3-4312-86e4-9431b0063817" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" escape="true"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intangible assets, net consists of the following:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:65.987%;box-sizing:content-box;"/>
         <td style="width:1.56%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.177%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.56%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.717%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets, gross</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54d992de-8248-4374-83fc-d9220ab97f60" contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5" name="us-gaap:FiniteLivedIntangibleAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,121,859</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f003419a-aa6d-4038-9ecb-6db04d902b3b" contextRef="C_125dfb7b-a596-48e9-aa73-d42dc93faea2" name="us-gaap:FiniteLivedIntangibleAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,872,356</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated amortization</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b168000-401e-47a5-a359-cd273d08b5a2" contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,223,636</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd064645-2397-47b2-b120-1dac5ebaa276" contextRef="C_125dfb7b-a596-48e9-aa73-d42dc93faea2" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">739,560</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e64bc70-dbc8-492d-8859-eaa9bd1f382d" contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,898,223</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06d82de1-02c4-431a-a573-95ac4ec3f5b2" contextRef="C_125dfb7b-a596-48e9-aa73-d42dc93faea2" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,132,796</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, the Company purchased </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f522baee-e3fd-4cc8-864b-3308472e89ee" contextRef="C_e76601ce-3711-4870-9e0a-3ab905ebdac4" name="us-gaap:PaymentsToAcquireBusinessesGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CCRAs included in Intangible assets, net, which were paid in cash. During the year ended December 31, 2023, the Company purchased $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4bafacd3-81fc-4ab4-8c33-1c08f61cbd20" contextRef="C_23f0d6a2-3c2c-4e89-aa10-98a9a94f129d" name="mspr:AdditionalFiniteLivedIntangibleAssetsAcquired" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">287.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of CCRAs included in Intangible assets, net, of whic</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">h </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67a81912-9623-45b2-80f4-d25179044e04" contextRef="C_d6c4c28a-22a2-40b1-9778-e6b573c72de1" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">285.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was through the Hazel transaction (See Note 3,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Material Agreements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c55e33e-26c5-4719-930f-52281ed4b695" contextRef="C_51823262-9427-432d-a0b9-aa056efd7162" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was through a Class A Common Stock and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e22444f8-b332-4dbb-9bf4-3ea73cd12ed2" contextRef="C_23f0d6a2-3c2c-4e89-aa10-98a9a94f129d" name="us-gaap:PaymentsToAcquireBusinessesGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was paid in cash.</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">96</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_a7c2de14-36d7-4554-a49f-911004230564_1"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended December 31, 2024 and 2023, Claims amortization expense was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_50923188-2f50-40e0-ad4f-e2014dca3052" contextRef="C_4a8604ad-e380-417e-aa2c-4c0e29ad2d19" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">484.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a375adf7-a850-4b9e-b29b-e8a2e4c00290" contextRef="C_a5e2c7d9-9acb-499e-b27d-26fe7e7dce15" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">476.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8a54746e-a04f-4cd6-9a15-2109f1495334" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" escape="true"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future amortization for CCRAs is expected to be as follows:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:78.82%;box-sizing:content-box;"/>
         <td style="width:1.86%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:17.32%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">CCRAs Amortization</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_79c90ef7-6d0c-4386-9241-88faec77f83c" contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">474,556</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9fe16a0-c962-464b-acda-e510b5503159" contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">474,556</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be5bc9a3-ab2b-4ab7-9e28-f6967e9a0d49" contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">474,556</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7e59f19-1e86-4593-a960-9f2f284bba6d" contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">474,555</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc3b0458-7ed6-4ec6-a740-920c32a2eca7" contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,898,223</ix:nonFraction></span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company monitors intangible assets for potential impairment indicators, including, but not limited to, assumptions regarding the amount and timing of future collections derived from its CCRAs. The Company continues to pursue recoveries from various parties under rights held through its CCRAs; however, extended delays may result in future impairment of the Company&#8217;s intangible assets.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the Company&#8217;s fourth quarter review of its CCRAs, the Company identified potential impairment indicators, such as recurring operating losses, and a lack of substantial revenue generated from our Claims portfolio to date, which it considered in its evaluation of its definite-lived intangible assets. As a result, the Company performed a recoverability analysis on the definite-lived CCRA intangible assets in the fourth quarter of 2024. The recoverability analysis primarily included unobservable inputs, including internally developed assumptions about the estimated market share of insurance carriers that may not have paid claims due to Assignors, undiscounted cash flows of potential estimated recoveries from those carriers, the corresponding direct costs associated with those estimated recoveries, and the Company&#8217;s ability to successfully litigate or negotiate settlements.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An asset group is impaired if the estimated undiscounted cash flows are less than the asset group&#8217;s carrying value. Impairment is measured by the amount by which the carrying value exceeds fair value. The Company performed a probability-weighted undiscounted net cash flow analyses, taking into account various scenarios of expected cash flows, some of which rendered positive results, while others rendered negative results. Given that the probability-weighted average cash flows of all scenarios were below the carrying value, the Company performed a fair value assessment to measure impairment loss.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value assessment of the intangible assets was determined using the income approach. The significant inputs and assumptions used in the estimate of fair value were primarily Level 3 inputs, and include internally developed assumptions used in the undiscounted analysis, as well as the determination of an appropriate discount rate. The Company&#8217;s estimation of the fair value of its CCRA intangible assets resulted in a non-cash impairment charge amount of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de1f8726-fef0-44d0-94d1-70b7a513b66e" contextRef="C_7fe3a456-0271-47b2-9277-1147387966fe" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">752.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> recorded during the fourth quarter of 2024 in Impairment of intangible assets in the consolidated statement of operations for the year ended December 31, 2024. The estimation of the fair value requires significant management judgment with respect to the estimates discussed above. The estimates of the fair value are based on the best information available as of the date of the assessment. Small changes in the significant inputs and assumptions would increase or decrease estimated discounted future operating cash flows and could increase or decrease an impairment charge by a material amount. For example, if estimated recoveries were accelerated by one year, the non-cash impairment charge would decrease by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab678c3c-d583-460a-a465-91e6000109b2" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">141.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, while if estimated recoveries were extended by a year, then the non-cash impairment charge would increase by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae17066b-bd05-4ff1-bc3e-6f5d840a0d01" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">128.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In addition, a hypothetical </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad53a73a-b1f7-44b0-9073-8ebe5881d408" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:GoodwillMeasurementInputIncreaseDecrease" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% change in the discount rate assumption would increase or decrease the impairment charge by approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe4117cc-b5be-4611-baf5-1d5d04235116" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:IncreaseDecreaseInImpairmentCharges" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">39.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. If actual results or future expectations are not consistent with the assumptions used in our estimate of fair value, it may result in the recording of additional impairment charges in the future which could be material.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f442e20b-7792-45c1-8b49-ee30347f3c8c" contextRef="C_4a8604ad-e380-417e-aa2c-4c0e29ad2d19" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" escape="true"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the changes in the Company&#8217;s intangibles assets for </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:65.987%;box-sizing:content-box;"/>
         <td style="width:1.6%;box-sizing:content-box;"/>
         <td style="width:16.137%;box-sizing:content-box;"/>
         <td style="width:1.56%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.717%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Intangible Assets</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2022</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8fbdbd2-c65a-4c7f-aa47-9022e248b624" contextRef="C_124c16cb-bff6-4d6a-83be-6bf4a76f2445" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,363,156</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquisitions of CCRAs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98a7a192-340e-4b1d-b8da-2d77bae0709d" contextRef="C_a5e2c7d9-9acb-499e-b27d-26fe7e7dce15" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">287,029</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8cc1f43-bb4e-45cf-b7a6-98786c18506d" contextRef="C_a5e2c7d9-9acb-499e-b27d-26fe7e7dce15" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">476,492</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sale of CCRAs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85756e9d-59e5-487c-a3a1-8bedbea3118a" contextRef="C_a5e2c7d9-9acb-499e-b27d-26fe7e7dce15" name="mspr:SaleOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,897</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9fb1233-7a2d-4036-a98d-a2c7cd86524b" contextRef="C_125dfb7b-a596-48e9-aa73-d42dc93faea2" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,132,796</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquisitions of CCRAs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cff9ec14-9fe6-4cce-8d64-dba42c509112" contextRef="C_4a8604ad-e380-417e-aa2c-4c0e29ad2d19" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,200</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eec4078d-78d2-4f8f-90fe-29f7936282dc" contextRef="C_4a8604ad-e380-417e-aa2c-4c0e29ad2d19" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">484,076</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96c19d0f-4312-43a3-a79f-72d5f122f625" contextRef="C_4a8604ad-e380-417e-aa2c-4c0e29ad2d19" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">752,697</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17a50813-5967-43a0-b354-96ef380fe616" contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,898,223</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><ix:nonNumeric id="F_eb31242e-acf9-4930-af83-4f744adacb52" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true" continuedAt="F_eb31242e-acf9-4930-af83-4f744adacb52_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 7. INCOME TAX</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company holds an economic interest in MSP Recovery, LLC and consolidates its financial position and results. The remaining ownership of MSP Recovery, LLC not held by the Company is considered a noncontrolling interest. MSP Recovery, LLC is treated as a partnership for income tax reporting and its members, including the Company, are liable for federal, state, and local income taxes based on their share of the LLC&#8217;s taxable income.</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">97</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_eb31242e-acf9-4930-af83-4f744adacb52_1"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_659e69c4-68bb-478f-909b-ea9c17255aae" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_b20fb039-83dc-4aab-a7a2-2e685aaeb4fc" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> provision for income tax for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5016e1df-5984-4ce8-b23d-36dc532d8e2c" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the United States statutory income tax rate to the Company&#8217;s effective tax rate for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 is as follows for the years indicated:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:56.249%;box-sizing:content-box;"/>
         <td style="width:1.8%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:18.556%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.8%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:17.597%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Year Ended December 31,</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal Statutory rate</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d63a4d08-f972-4ac9-9609-281c2d279f92" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">21.00</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33b322a3-bde4-44d8-a680-20ae06625b43" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">21.00</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncontrolling interests/effect of pass-through entities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">-</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9977a8b0-0026-4a93-9cc2-f4fd158a0b64" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities" unitRef="U_pure" scale="-2" decimals="4" sign="-" format="ixt:num-dot-decimal">16.14</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">-</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_92fea579-d819-4009-b01b-00fcf2be93ce" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities" unitRef="U_pure" scale="-2" decimals="4" sign="-" format="ixt:num-dot-decimal">19.59</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">-</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_afedeb5b-1f87-47e6-a445-200ca121dab5" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="4" sign="-" format="ixt:num-dot-decimal">8.47</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">-</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c073ed2a-bb1e-4ba1-8b57-164a5882af24" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="4" sign="-" format="ixt:num-dot-decimal">1.73</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liability</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6744dc0b-4e5d-4751-8cc8-5e8030e2e812" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">1.85</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_660c7891-9682-4a92-80e0-517fc9cc7cc8" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.00</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State Taxes</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fadcedd0-85de-4e44-8cee-93467cc982fa" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">1.76</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ddb92287-61b7-4b49-ac0b-6558e805f8aa" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.37</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6885a70f-f824-4e65-9674-ac9bcf32c7c1" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.00</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">-</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_64d99560-52f5-4aac-aa87-0ab9a1c4be79" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="4" sign="-" format="ixt:num-dot-decimal">0.05</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Effective Income tax rate</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb0e5f4e-9413-4738-9b38-302abf9614a8" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.00</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_762f7145-fa13-46d4-9433-c4b43b9e763a" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.00</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e457e5d9-5c4b-4cb6-b301-cbf63b0765cc" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true" continuedAt="F_e457e5d9-5c4b-4cb6-b301-cbf63b0765cc_1"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Details of the Company&#8217;s deferred tax assets and liabilities at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 are as follows for the years indicated:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:50.44%;box-sizing:content-box;"/>
         <td style="width:2.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:20.14%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:2.64%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:20.14%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">in thousands</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforward</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12055e2a-73fc-4e0c-9499-a617201b3cc7" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,613</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1526eade-9946-4c5b-9d5d-02b650abd687" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,126</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment in MSP Recovery, LLC</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c25bb46-d219-4c12-a086-25b7292a46ee" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="mspr:DeferredTaxAssetsInvestmentInMspRecoveryLlc" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,668</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bbdabde5-2e2d-4ec2-b316-cec7cf999a00" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="mspr:DeferredTaxAssetsInvestmentInMspRecoveryLlc" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,385</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Start-up Costs</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b17082ef-6e92-4bd8-bae9-1a2a65bace9c" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="mspr:DeferredTaxAssetsOrganizationalCostsAndStartupExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">791</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba997579-bbad-44eb-b866-5e61709d20d2" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="mspr:DeferredTaxAssetsOrganizationalCostsAndStartupExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">854</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Transaction Costs</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95fb6564-66e5-4246-98ff-1e0797588c5b" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="mspr:DeferredTaxAssetsTransactionCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,699</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e658d1ac-f429-4275-b2e9-93aa905451cd" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="mspr:DeferredTaxAssetsTransactionCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,962</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest Expense &#8212; 163j</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3afe63b0-96c2-49d3-84b0-fffdcb43fad2" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:DeferredTaxAssetInterestCarryforward" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,863</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e99fd9f-58b4-44a0-9a25-11183bdf546c" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:DeferredTaxAssetInterestCarryforward" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,065</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03748bcb-1c3e-4e48-b81b-8628fc20ea27" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,634</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db513d06-a6dc-4139-95a4-83d370a1de70" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,392</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation Allowance</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62d63ceb-dd37-4d50-bbb6-5ed8bc5012e1" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,634</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1b01d0e0-3179-478a-a8b1-df3d8b989b95" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,392</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets (liability)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span><ix:continuation id="F_e457e5d9-5c4b-4cb6-b301-cbf63b0765cc_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has a deferred tax asset for the difference between the financial reporting and the tax basis of its investment in MSP Recovery, LLC. The deferred tax asset above does not consider the iterative impact of the TRA liability as the entire liability has not been recorded as of</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 the Company had </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04e8565f-f855-44af-a5f3-2000e5fd7bd4" contextRef="C_0db234ba-3e48-4d00-9318-17c9b2c2ecdc" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">17.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad817bfe-70c0-4367-a2dd-226bd3722510" contextRef="C_f07a439f-c693-42c4-98e6-3d9e006b5525" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">17.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of U.S. gross federal and state net operating loss carryovers available to offset future taxable income, respectively. As of December 31, 2023, the Company had </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7b2fcac-d97c-4703-a6b3-2ce1ce4801ec" contextRef="C_d105a18b-9d1a-4643-bb7c-ac6ea1c98248" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0de07c75-7f5e-449d-9976-6d58023661d1" contextRef="C_045a7ff1-2fb5-4c22-bc5d-29ba574f00d7" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of U.S. gross federal and state net operating loss carryovers available to offset future taxable income, respectively.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e57da7ad-0d8c-41e3-9277-3e753a715706" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_9326c398-add0-467e-8bbf-0d96b772fe1d" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t recorded any unrecognized tax benefits. The Company files income tax returns in the U.S. federal jurisdiction and Florida which remain open and subject to examination by the various taxing authorities. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_124e6392-d4c2-47c8-be83-9a085b7ae7a6" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:IncomeTaxExaminationDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company&#8217;s federal and state and local income tax years </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a2e197ee-5a0a-4070-8e0f-73271dcdeee8" contextRef="C_54d701f3-9c51-4703-a1c1-2c01604c2e0d" name="us-gaap:OpenTaxYear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2021</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> through </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_82e43e61-7615-4007-bc0a-b45c24beadc3" contextRef="C_7a02de5d-b9d8-4bf8-9ce7-036a7202e220" name="us-gaap:OpenTaxYear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> remain open and are subject to examination. </span></ix:nonNumeric></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p></ix:continuation></div><div><ix:nonNumeric id="F_21fa6d91-d1b6-4a8b-8deb-e1381766e191" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:VariableInterestEntityDisclosureTextBlock" escape="true" continuedAt="F_21fa6d91-d1b6-4a8b-8deb-e1381766e191_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 8. VARIABLE INTEREST ENTITIES</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments in consolidated Variable Interest Entities</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates its ownership, contractual, and other interests in entities to determine if they are VIEs, if the Company has a variable interest in those entities, and the nature and extent of those interests. These evaluations are highly complex and involve management judgment and the use of estimates and assumptions based on available historical information, among other factors. Based on its evaluations, if the Company determines it is the primary beneficiary of such VIEs, it consolidates such entities into its financial statements. VIEs information below is presented on aggregate basis based on similar risk and reward characteristics and the Company&#8217;s involvement with the VIEs.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company includes a number of entities that are determined to be VIEs and for which the common control group can direct the use of the entities&#8217; assets and resources for other purposes. The Company only consolidates those VIEs for which the Company is the primary beneficiary.</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">98</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_21fa6d91-d1b6-4a8b-8deb-e1381766e191_1"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The assets of the consolidated VIEs may only be used to settle obligations of these VIEs and to settle any investors&#8217; ownership liquidation requests. There is no recourse to the Company for the consolidated VIEs&#8217; liabilities. The assets of the consolidated VIEs are not available to the Company&#8217;s creditors.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total assets and liabilities included in its consolidated balance sheets for these VIEs were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2dda366d-2505-494e-93fe-9c86f6679fa4" contextRef="C_ea41718c-eb03-4364-a84c-37e5f43f1623" name="us-gaap:Assets" unitRef="U_USD" scale="9" decimals="-8" format="ixt:num-dot-decimal">1.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31d6173c-f3f0-4d3a-9c27-661b18fcabf3" contextRef="C_ea41718c-eb03-4364-a84c-37e5f43f1623" name="us-gaap:Liabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, at December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59712ec3-043b-41eb-bc71-9bfec29dae79" contextRef="C_ba17b4e4-2add-4b5b-8fa4-ea5edfe1120f" name="us-gaap:Assets" unitRef="U_USD" scale="9" decimals="-8" format="ixt:num-dot-decimal">2.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f01c5339-b955-4046-abd6-70f16ef7ddee" contextRef="C_ba17b4e4-2add-4b5b-8fa4-ea5edfe1120f" name="us-gaap:Liabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, at December 31, 2023. The assets at December 31, 2024 and 2023 include the Intangible Assets, net included in the Series of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2aff6da5-0bba-4e8b-9e47-0f798fc6a08f" contextRef="C_ea41718c-eb03-4364-a84c-37e5f43f1623" name="mspr:IntangibleAssetsHeldBeCertainSpecificSubsidiaries" unitRef="U_USD" scale="9" decimals="-8" format="ixt:num-dot-decimal">1.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06cd4233-6943-40c4-abfb-707dc6f2887d" contextRef="C_ba17b4e4-2add-4b5b-8fa4-ea5edfe1120f" name="mspr:IntangibleAssetsHeldBeCertainSpecificSubsidiaries" unitRef="U_USD" scale="9" decimals="-8" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments in unconsolidated Variable Interest Entities</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is involved with VIEs in which it has investments in equity but does not consolidate because it does not have the power to direct the activities that most significantly impact their economic performance and thus is not considered the primary beneficiary of the entities. Those VIEs are reflected as equity method investments and are reflected at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15e2ab1c-3982-4a95-9cf9-192569f778ec" contextRef="C_305dc9b3-22e0-4f75-b7ee-85c8627cae64" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> on the Company&#8217;s consolidated balance sheet.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total assets and liabilities for these VIEs were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0d13b51-bad5-4f58-a289-852e43ced142" contextRef="C_305dc9b3-22e0-4f75-b7ee-85c8627cae64" name="us-gaap:Assets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80fcd8cb-36e2-49ee-a498-7dde88a7d8df" contextRef="C_305dc9b3-22e0-4f75-b7ee-85c8627cae64" name="us-gaap:Liabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, at December 31, 2024 and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7aebe43-136e-4976-baa4-9800f376c03e" contextRef="C_96faf7e0-a707-4cd1-84ae-926008d6d5e3" name="us-gaap:Assets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f3b31cc-1643-4c02-82db-511849e201b5" contextRef="C_96faf7e0-a707-4cd1-84ae-926008d6d5e3" name="us-gaap:Liabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, at December 31, 2023.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Generally, MSP&#8217;s exposure is limited to its investment in those VIEs (see Note 4, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investment in Equity Method Investees</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">). For MAO-MSO Recovery II, LLC and Series PMPI, MSP may be exposed to providing additional recovery services at its own cost if recovery proceeds allocated to it are insufficient to recover the costs of those services. MSP does not have any other exposures or any obligation to provide additional funding.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VRM MSP</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 4,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Investment in Equity Method Investees</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company became a member of VRM MSP through the contribution of certain Series (holding certain CCRAs) by MSP Recovery into VRM MSP. The Company determined, based on analysis of the rights to cash flows from the Series and the related guaranty obligation, that the Company is the primary beneficiary of the Series entities, and therefore should consolidate as of the transaction date. The contribution is considered a common control transaction, as the Company controls and consolidated the Series before and after such contribution. The Company consolidates the Series held within VRM MSP, however does not consolidate VRM MSP itself.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to Note 4,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Investment in Equity Method Investees</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for additional information on this VRM MSP transaction.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_53f7c84d-6ceb-4653-8f30-00d293b81ffa" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:DebtDisclosureTextBlock" escape="true" continuedAt="F_53f7c84d-6ceb-4653-8f30-00d293b81ffa_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 9. CLAIMS FINANCING OBLIGATIONS AND NOTES PAYABLE</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on claims financing obligations and notes payable agreements, as of December 31, 2024 and 2023, the present value of amounts owed under these obligations were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16be53b0-b745-498a-9484-dacd0d387afa" contextRef="C_c9b18bd8-324c-46e3-8afa-33926f895ed8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">673.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_061f10bb-48aa-4a92-ab0d-84a260a782ee" contextRef="C_f1707b98-eb20-432a-b96a-1452ac5f9a6f" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">556.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, including capitalized interest. In addition, as of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6913da0f-361c-4749-8c82-d223a6af8581" contextRef="C_9f487c5a-0b48-49d0-b043-d8a27a0e661f" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_004eaceb-e44f-4672-b377-053daa5e61be" contextRef="C_428035f8-2a73-4bf3-bd07-7c486a2b2984" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of advances from Yorkville, respectively. The weighted average interest rate is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_575a18a9-e1da-46a6-a40f-0751fff9f401" contextRef="C_c9b18bd8-324c-46e3-8afa-33926f895ed8" name="us-gaap:DebtWeightedAverageInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_082cc81e-e356-4031-8930-58253716b649" contextRef="C_f1707b98-eb20-432a-b96a-1452ac5f9a6f" name="us-gaap:DebtWeightedAverageInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">15.0</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> based on the current book value of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e13da600-59f7-4026-a751-6bf63ead028e" contextRef="C_f1707b98-eb20-432a-b96a-1452ac5f9a6f" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_e6287a8a-13f9-48b6-92db-915bfbd6006c" contextRef="C_f1707b98-eb20-432a-b96a-1452ac5f9a6f" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">685.7</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> with rates that range from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16cad5f8-6ea3-4f61-8daa-593aa7ce3f89" contextRef="C_609a7cf7-e71f-4260-af06-3fa43d842a79" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4d82d33d-217f-48bc-b6b2-eb77e4ea1a7d" contextRef="C_e0f110ef-52d0-4fa6-963b-0050628d41b6" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.0</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2f21e6e5-7ab5-429d-81e7-2c500c7d9281" contextRef="C_044f7093-020d-4a2c-8402-0be8ff0eb918" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal"><ix:nonFraction id="F_28640c9a-6f76-4853-b83e-63ece78e3c38" contextRef="C_00bf460d-a55a-43dc-b3bf-96f35be4b164" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">20.0</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company is expected to repay these obligations from cash flows from claim recovery income or potentially for the renegotiated debt through class A common stock issuances.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the minimum required payments on these agreements are </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d714133f-903d-4538-8d6a-efadd4f87ce3" contextRef="C_3f274e94-4af0-46e3-87d2-ba8533edbab8" name="us-gaap:RepaymentsOfLinesOfCredit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">818.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Certain of these agreements have priority of payment regarding any proceeds until full payment of the balance due is satisfied. The maturity of the commitments range from the date sufficient claims recoveries are received to cover the required return or in some cases by 2031.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Brickell Key Investments, LP</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2015, the Company entered into a Claims Proceeds Investment Agreement (as amended, the &#8220;CPIA&#8221;) with Brickell Key Investments LP (the &#8220;Holder&#8221;). On October 12, 2022, the Company entered into an Amendment to the CPIA (the &#8220;Amendment&#8221;) and a Warrant Agreement (the &#8220;Warrant Agreement&#8221;) with the Holder, pursuant to which the parties agreed to amend the original CPIA and required payment terms.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the CPIA, as amended, the Company granted to the Holder the right to purchase Class A common shares in the Company (the &#8220;Class A Shares&#8221;) up to a maximum amount of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88790463-8780-42c7-a1ac-1e5e0c1675e7" contextRef="C_c8e18be5-39a5-489d-80ce-12c6054c1c18" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">106,667</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Amount&#8221;) for a purchase price equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25f14334-aaf7-4836-92d1-690f0f87fdee" contextRef="C_c8e18be5-39a5-489d-80ce-12c6054c1c18" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="0" decimals="2" format="ixt:num-dot-decimal">6,666.67</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ($</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cb4e3794-f9fb-43e1-8190-52dce2426958" contextRef="C_c8e18be5-39a5-489d-80ce-12c6054c1c18" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.0625</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per Class A Share), and is payable in cash. This Warrant (the &#8220;Warrant&#8221;) will expire at 5:00 p.m. (Eastern Time), on September 30, 2027 and may be exercised in whole or in part by Holder at any time prior to such date. The Holder can only sell a maximum of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce3a7ca4-f7ad-45cc-84e9-53ac2a1e1b58" contextRef="C_5247622b-3115-44c8-972e-3aa6f0834d88" name="mspr:PercentageOfSharesObtainedThroughWarrant" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per month of the Class A Shares obtained through the Warrant. In exchange for the Company issuing the Warrant, the amounts owed to the Holder pursuant to CPIA are amended to equal $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b81ad0e-7dff-4055-a749-79aa29853d0a" contextRef="C_9268077d-b92b-434c-8a1c-d085e2f473a4" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">80</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In exchange for the Company issuing the Warrant, the amounts owed to the Holder pursuant to CPIA was reduced from approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_371a265a-2d98-4f20-8119-75b5ae856a86" contextRef="C_c30ed3e6-e67a-4d09-9360-8226e3fc395c" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">143</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to equal $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_65a9f82d-178b-4eb8-8aa7-70d90e9b1095" contextRef="C_5247622b-3115-44c8-972e-3aa6f0834d88" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">80</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the &#8220;Reduced Obligation&#8221;), and no further interest will accrue. The Holder has the right to receive the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2f9d108-25ba-48cb-9c76-1f4536e07ed0" contextRef="C_5247622b-3115-44c8-972e-3aa6f0834d88" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">80</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">owed through (1) proceeds as outlined in the CPIA, (2) cash paid by the Company or (3) monetization of the Warrant (through the sale of the Warrant or sale of the underlying Class A Shares). If the Holder monetizes the Warrant, the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">99</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_53f7c84d-6ceb-4653-8f30-00d293b81ffa_1" continuedAt="F_53f7c84d-6ceb-4653-8f30-00d293b81ffa_2"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amount </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">owed will be reduced at a measure of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7f83b8d-267e-48ce-9274-8d5eb8222541" contextRef="C_d6608e57-e2af-4392-9108-161e0284de3a" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">750.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per Class A Share (five-day volume weighted average price as of September 30, 2022).</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Amendment and Warrant Agreement, the Holder also executed a Stock Pledge Agreement (the &#8220;Pledge Agreement&#8221;) with Legacy MSP founders, John H. Ruiz and Frank C. Quesada (the &#8220;Founders&#8221;). As part of the Pledge Agreement, the Founders agreed to pledge </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5cb2cdb5-9baf-4107-a15f-9e6bdea58cf6" contextRef="C_e47e8e78-3f7a-483f-be52-5d827c62b8cf" name="mspr:SharesPledgedUnderAgreement" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">80</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> thousand shares to secure payment of the original principal amount of the CPIA; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided, that if any any time prior to September 30, 2024, if the pledge agreement had not terminated, and the per share price of the pledged shares dropped below $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07a69ed3-967e-4bba-8fa0-5aeb3a33abd0" contextRef="C_f39537ea-1309-4548-918f-2247de76b5db" name="us-gaap:SharePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.60</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (before 2023 and 2024 Reverse stock splits), then additional shares were required to be pledged by the Founders to bring the number of pledged shares to a value based on the value on that date to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ac70ea8b-0b2f-43df-a40d-d4ddd1f35561" contextRef="C_f39537ea-1309-4548-918f-2247de76b5db" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">36.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (minus amounts received in satisfaction of the obligation)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Holder has raised a dispute relating to the total number of shares that the Founders were required to pledge under the Pledge Agreement; however, before any pledged shares may be transacted upon, Holder must have monetized the CPIA Warrant. As of the date of this report, Holder has not monetized the CPIA Warrant.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As the Company has an obligation to pay this indebtedness through cash proceeds from certain purchased claims recovery rights, the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca88bb0d-1c4c-4880-aac6-7e52b90ac44b" contextRef="C_75501a7c-fddd-4767-9d6b-6669aaf3d334" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">80.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of amounts owed as of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> December 31, 2024 was included as Claims financing obligation and notes payable on the consolidated balance sheet.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Founders did not exercise the option to repurchase the CPIA Warrant on or before June 30, 2023. The Company recognizes the CPIA Warrant at fair value which, considering the price of the Company&#8217;s common stock was below $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_768ab56c-eedb-452f-912e-c076e4e5af4b" contextRef="C_4cf329ce-5aca-4da4-8888-8728533d3e78" name="mspr:PriceOfCommonStock" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">750.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, was determined to be </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09a4f21f-0e0d-4ba1-954b-1bd091ed9163" contextRef="C_22a3e60b-719b-4f54-9b60-4ff2fca68d03" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hazel Working Capital Credit Facility and Purchase Money Loan</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Working Capital Credit Facility</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9d62fec9-4bee-4675-b7aa-f29320c91b04" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:AgreementDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 6, 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, Subrogation Holdings entered into a credit agreement (as amended on March 29, 2023; November 10, 2023; and October 1, 2024; the &#8220;Working Capital Credit Facility&#8221;) with HPH providing for funding of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad0d7913-647a-4f93-8e6a-8e61321b5681" contextRef="C_6416e867-3e37-4d6c-9be5-842500520199" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">80</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (with a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef8cae7a-c9fb-4388-a0e9-81943561d5d0" contextRef="C_13748221-3ec6-4846-a96d-b183a19ab473" name="mspr:DebtInstrumentOriginalIssueDiscount" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">40</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% original issue discount), consisting of a Term Loan A commitment to fund up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c5ab2be-7c10-4270-838c-0aec38bb0ade" contextRef="C_f5366bf8-0f82-48ee-a516-2669d00a2346" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">30</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (in multiple installments) in proceeds and a Term Loan B Commitment to fund up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc02f9c7-7829-43bd-b216-8ee47ef0b6bf" contextRef="C_240c3aca-617e-45d0-80e7-144cd05885bc" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">18</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (in multiple installments) in proceeds. During fiscal year 2023, HPH disbursed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8fe79457-5f33-486b-b5e3-bd34ec08474d" contextRef="C_94f5cc8c-3b7d-43d7-abe9-3622bcd0a570" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million under Term Loan A and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f7d0c67-37f1-4fd1-a901-eb7b530a2520" contextRef="C_6d36e1f0-9fa4-464e-bcc8-ec43920a4389" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million under Term Loan B.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal year 2024, HPH disbursed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0e7bbdd-add8-46b6-a65f-7c52bead0f02" contextRef="C_3f7d2988-c276-41f2-9ddb-13cdccfa0680" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million under Term Loan B on January 25, 2024. On August 2, 2024, Subrogation Holdings entered into a letter agreement to amend the Working Capital Credit Facility (the &#8220;HPH Letter Agreement&#8221;) with HPH, which, among other things: (i) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_35852166-a7e8-461c-83d7-d4a6d8e2175b" contextRef="C_d114e753-e2e8-448e-8e31-cdfe137f7707" name="us-gaap:LineOfCreditFacilityDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">extended the period to draw up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3f2d6f9-f518-4b8e-8533-3ba2b352aaeb" contextRef="C_2b6ff688-5733-44c4-adef-6460a88c6577" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">23.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (with a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cef429fd-116e-46db-b7db-7655bdfff3b1" contextRef="C_19dd057d-164d-4d09-aca4-862b4fbf7c68" name="mspr:DebtInstrumentOriginalIssueDiscount" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">40</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% original issue discount) remaining under Term Loan B for working capital, accessible in eight tranches of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6863c05-9183-4618-a339-01054ffa44e3" contextRef="C_2b6ff688-5733-44c4-adef-6460a88c6577" name="mspr:LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">1.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, that can be drawn at least one month apart, until September 2025</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and (ii) provided for a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ecaef37-4ca8-4ec7-bd75-7f69ca77adc9" contextRef="C_2b6ff688-5733-44c4-adef-6460a88c6577" name="mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million loan (subject to a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd39b72d-9516-497e-8fa8-b59aa79586d7" contextRef="C_19dd057d-164d-4d09-aca4-862b4fbf7c68" name="mspr:DebtInstrumentOriginalIssueDiscount" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">40</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% original issue discount) funded by August 31, 2024 to acquire additional Claims (the &#8220;New Claims&#8221;) that collateralize the Working Capital Credit Facility (collectively, (i) and (ii) the &#8220;Operational Collection Floor&#8221;). The parties formalized the terms of the HPH Letter Agreement in Amendment No. 3 to the Working Capital Credit Facility dated October 1, 2024 (the &#8220;OCF Amendment&#8221;). On October 2, 2024, the Company acquired the recovery rights to additional Medicare Secondary Payer Claims from an existing Assignor consisting of more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9cfa7c23-392c-4bfc-a9f6-adb65a49038a" contextRef="C_ba6d251e-46b0-4175-8e53-534f56cc7116" name="mspr:AssignorConsistingNumberOfMedicareMembers" unitRef="U_Members" decimals="INF" format="ixt:num-dot-decimal">450,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Medicare members, as documented by the Assignor.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Operational Collection Floor, the Company received during 2024: (i) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d8a0c4a-7bc7-4e84-b175-e48790984038" contextRef="C_f47d4941-5e9a-4b10-9ef9-c0cd1e17b7a2" name="us-gaap:ProceedsFromLongTermLinesOfCredit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for working capital, and (ii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cc8b1d6-3afa-47bf-b885-f7f237629324" contextRef="C_e69f5703-ad7e-4186-a291-683b533d05a3" name="mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the purpose of acquiring the New Claims. To date, the Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd824c34-5ee9-42d2-a27b-ebaf186654d7" contextRef="C_859ecd69-4f84-40b2-9e61-c5f7ca8a44e9" name="us-gaap:ProceedsFromLongTermLinesOfCredit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of working capital for 2025. Pursuant to the Working Capital Credit Facility, HPH may, at its sole discretion, increase the Operational Collection Floor by an amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa95743f-45a9-49d4-a8f7-10f9152a889c" contextRef="C_0bbf18dd-84b1-4a9c-8590-5c60d8a4eac1" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, to be funded over a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_339a811a-2d80-47ab-9bb0-fca6e26a7e13;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_932af136-b7f1-4cf1-98b1-dd8698efc64f" contextRef="C_0bbf18dd-84b1-4a9c-8590-5c60d8a4eac1" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">six months</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. On February 28, 2025 and April 4, 2025, HPH exercised that discretion and funded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21e7d174-2aac-40bb-9cb7-e52d2d80a66f" contextRef="C_b56a07ac-ec0a-4021-a488-5ef64b5339af" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">1.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c5c75f7-3cd0-421c-91c3-c39df969c322" contextRef="C_21918913-de21-41f4-bb8a-ff60365fc94c" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, from the increase to the Operational Collection Floor. An additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a9a83c5-0fcd-403b-878b-d8b93f235519" contextRef="C_bdb33403-9b1e-41b7-92e4-eb7991db7d0f" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">2.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million remains available under the Operational Collection Floor, to be funded at HPH&#8217;s sole discretion.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Purchase Money Loan</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 29, 2023, the Company acquired a controlling interest in nine legal entities, whose sole assets are CCRAs, from Hazel. This is referred to as the &#8220;Claims Purchase.&#8221; The purchase price for the Claims Purchase was funded by (i) a purchase money loan between Hazel, as a lender, and the Company, as a borrower, in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17c47db5-0bcd-4a07-9d8e-cf98c8d6b1f3" contextRef="C_28b71e0a-7e6d-429a-b008-1ff060441f3d" name="mspr:PurchaseMoneyLoan" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">250.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the &#8220;Purchase Money Loan&#8221;) </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">as discussed in Note 3,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Material Agreements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and (ii) proceeds from the sale of certain, separate CCRAs in the Claims Sale (as defined below).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Also, on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5fbc6244-96f7-4dbf-9582-01abddf7bf91" contextRef="C_e0dfe751-c423-4c59-83cb-f45bf2e04763" name="mspr:AgreementDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 29, 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company sold a controlling interest in three legal entities whose sole assets are CCRAs to Hazel. The agreement provided that the Company and Hazel would share in the recovery proceeds therefrom, in accordance with an agreed waterfall after Hazel had realized the first $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea102158-24d8-46d8-add5-d3093291bb4c" contextRef="C_e0dfe751-c423-4c59-83cb-f45bf2e04763" name="mspr:RealizedClaimRecoveries" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">150</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in claims recoveries. This transaction is referred to as the &#8220;Claims Sale,&#8221; and together with the Claims Purchase, the &#8220;Claims Transactions.&#8221;</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts borrowed and obligations under the Purchase Money Loan and the Working Capital Credit Facility are secured by a pledge of proceeds from specific Claims in the Company&#8217;s Claims portfolio, with the lien securing the Purchase Money Loan being subordinated and junior to the lien securing the Working Capital Credit Facility. Pursuant to the Second Amended and Restated First Lien Credit Agreement, and in order to secure those additional advances of Term Loan B beginning in January 2024, the following was provided as additional collateral: (i) a pledge of proceeds from certain Claims in the Company&#8217;s Claims portfolio, up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09ca6628-1ee3-498d-b7b4-09dd01d73be7" contextRef="C_0583270c-f1a4-4ea8-9ef4-57cca824c658" name="us-gaap:DebtInstrumentCollateralAmount" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">14</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ii)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">100</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_53f7c84d-6ceb-4653-8f30-00d293b81ffa_2" continuedAt="F_53f7c84d-6ceb-4653-8f30-00d293b81ffa_3"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pledge of the equity interests in an Affiliate of Messrs. John H. Ruiz and Frank C. Quesada; and (iii) a personal guaranty by Messrs. John H. Ruiz and Frank C. Quesada, as primary obligors, guaranteeing those additional advances of Term Loan B beginning in January 2024. On December 22, 2023, our Board approved the Company's payment of certain costs and fees (including legal fees) on behalf of John H. Ruiz and Frank C. Quesada, associated with a mortgage granted in connection with said guaranty, totaling $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_919f5f98-7258-4f6f-9193-4dfee3f3c542" contextRef="C_f282d974-0b54-4d2a-8885-b9170aeb1b0e" name="mspr:PaymentOfCertainCostsAndFees" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. On April 1, 2025, in connection with the increased funding under the Operational Collection Floor, the pledge and personal guaranty in (ii) and (iii) above was increased by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef9c9dbd-504f-4cd3-b907-66e05a01afab" contextRef="C_fc307584-aef8-4d18-a952-2cc14880dd3f" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">3.25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80de4159-277e-47e7-8145-ebb6f299fcda" contextRef="C_2cfffa07-7d0f-4494-b8a7-e7489ea1d410" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">17.25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Loans under the Working Capital Credit Facility accrue interest at a Term Secured Overnight Financing Rate for 12-month interest period, plus an applicable margin of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8fb0bb7e-a188-414e-86ff-d2d288cd1c04" contextRef="C_cfa5832c-9e4b-41f3-8998-fe2d8ab4f357" name="mspr:InterestPeriodPlusAnApplicableMargin" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum. Accrued interest on the Working Capital Credit Facility is payable in kind and are capitalized. The Working Capital Credit Facility has a stated maturity date of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c7dc4813-f1c4-43f5-b42f-e06890a7e31f" contextRef="C_cfa5832c-9e4b-41f3-8998-fe2d8ab4f357" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2026</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and HPH may extend for up to one year in its sole discretion. The Purchase Money Loan accrues interest at a rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f724279-0057-4108-bb54-6d14855ec8ff" contextRef="C_e0dfe751-c423-4c59-83cb-f45bf2e04763" name="mspr:PurchaseMoneyLoanAccruesInterest" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">20</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum, payable in kind or in cash at the Company&#8217;s discretion. The Purchase Money Loan has a maturity date of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_233b327e-610f-47c3-bd23-8f5d408fcc79" contextRef="C_5b46d7fc-7b57-43b1-9b41-9ab104ade8c7" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2026</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, extendable up to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fec88da3-12d5-4b3a-8972-8978905dcbfe" contextRef="C_a1020e10-75c6-4d02-b1f3-a22f7c0f5c36" name="mspr:DebtInstrumentExtendedMaturityYear" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in Hazel&#8217;s sole discretion.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is permitted to prepay the loans under the Working Capital Credit Facility from time to time without prepayment premium. Prepayment of the Purchase Money Loan will be permitted after the prepayment or repayment of loans under the Working Capital Credit Facility, and such prepayment of the Purchase Money Loan may be subject to prepayment penalty, as applicable.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Purchase Money Loan and the Working Capital Credit Facility, the Company entered into a collateral administrative agreement between the Company and HPH, which sets forth certain arrangements between the Company and HPH in relation to the management of the litigation of certain Claims owned by the Company, the proceeds of which are due to the Company, and were pledged to Hazel and HPH to secure the Purchase Money Loan and the Working Capital Credit Facility, respectively.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Purchase Money Loan and the Working Capital Credit Facility contain certain representations, warranties, and covenants of the Company and its subsidiaries, including restrictions on debt incurrence, liens, investments, affiliate transactions, distributions and dividends, fundamental changes, certain debt prepayments, and Claim settlement.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Nomura Promissory Note</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 27, 2022, the Company issued an unsecured promissory note to Nomura (as amended on April 12, 2023, November 13, 2023, and March 26, 2024, the &#8220;Nomura Note&#8221;). The Nomura Note carries a principal amount of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38ec8f3c-5dc1-4e42-a0be-ec961aab421e" contextRef="C_349d4676-24fa-4ed0-8d02-0ac0acbd44a4" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million related to advisory fees and deferred underwriting fees and expenses that became due and payable by the Company to Nomura, in connection with the consummation of the Business Combination. The Nomura Note is payable in kind or in cash, at the Company&#8217;s discretion, accrues interest at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7275b831-e84e-48ab-be6a-c1179bc061b9" contextRef="C_a20e98f1-f378-4fc2-9d07-1d9c65d339f5" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">16</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum, and matures on September 30, 2025. Upon two days prior written notice to Nomura, the Company may prepay all or any portion of the then outstanding principal amount under the Nomura Note together with all accrued and unpaid interest thereon. The balance of the unsecured Nomura Note and related interest are included within Claims financing obligations and notes payable in the consolidated balance sheet. The Nomura Note became current on September 30, 2024, and the Company does not currently have available liquidity to satisfy said obligation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Nomura Note, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a3f00ef-68f7-497a-8df1-7b25853136d0" contextRef="C_e8640518-f241-41b6-ae14-29e050a44e3f" name="mspr:PercentageOfAggregateProceedsToPayOutstandingAmount" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the aggregate proceeds under the Yorkville SEPA will be used to pay amounts outstanding under the Amended and Restated Nomura Promissory Note (first towards accrued and unpaid interest, if any, then towards principal) and the remaining </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a29314fb-573e-42da-8939-56a6a10729bb" contextRef="C_e8640518-f241-41b6-ae14-29e050a44e3f" name="mspr:PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of such proceeds will be used to pay amounts due under the Convertible Notes, if any, or be paid to the Company after the Convertible Notes are fully repaid. Pursuant to a letter agreement dated November 15, 2024, Nomura agreed to forego payments of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb384b03-8ccc-49ae-968f-da4a89c5c1a6" contextRef="C_c5742b65-c220-4c54-a9c1-2dcf8313f948" name="mspr:AggregateAmountOutstandingUnderCashProceeds" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million due under the Nomura Note from proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA until March 31, 2025.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Yorkville Standby Equity Purchase Agreement</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 14, 2023, the Company entered into a standby equity purchase agreement (the &#8220;Yorkville SEPA&#8221;) with YA II PN, Ltd., a Cayman Island exempted company (&#8220;Yorkville&#8221;), pursuant to which Yorkville committed to purchase up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12a9be84-2c10-4c93-97b2-09357c3aa8a5" contextRef="C_903ea2ae-ea75-475e-a44b-a70d6056fa63" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">250.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in shares of Class A Common Stock, subject to certain limitations and conditions set forth therein, during the term thereof. Sales of Class A Common Stock under the Yorkville SEPA, and the timing of any such sales, are at the Company&#8217;s option, and the Company is under no obligation to sell any shares of Class A Common Stock to Yorkville under the Yorkville SEPA except in connection with notices that may be submitted by Yorkville, in certain circumstances as described below.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the terms and conditions set forth in the Yorkville SEPA, the Company has the right, but not the obligation, from time to time at its discretion until the Yorkville SEPA is terminated to direct Yorkville to purchase a specified number of shares of Class A Common Stock (&#8220;Advance&#8221;) by delivering written notice to Yorkville (&#8220;Advance Notice&#8221;). While there is no mandatory minimum amount for any Advance, it may not exceed an amount equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_45b64dc3-2561-46ca-993a-914b04d10999" contextRef="C_ade22552-6404-4c28-b71c-a1780541b8a5" name="mspr:PercentageOfMandatoryMinimumAmountForAnyAdvance" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the average of the daily traded amount during the five consecutive trading days immediately preceding an Advance Notice.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The shares of Class A Common Stock purchased pursuant to an Advance Notice will be purchased at a price equal to: (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8be27245-6f26-4c53-956f-e7543ec5012a" contextRef="C_ade22552-6404-4c28-b71c-a1780541b8a5" name="mspr:PercentageOfStockPurchasePrice" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">98</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the VWAP of the shares of Class A Common Stock on the applicable date of delivery of the Advance Notice during regular trading hours on such date, or (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d868363-d3f6-49c8-be8b-5541fa7cbf15" contextRef="C_ade22552-6404-4c28-b71c-a1780541b8a5" name="mspr:PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">97</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the lowest daily VWAP of the shares of Class A Common Stock during the three consecutive trading</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">101</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_53f7c84d-6ceb-4653-8f30-00d293b81ffa_3" continuedAt="F_53f7c84d-6ceb-4653-8f30-00d293b81ffa_4"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">days </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">commencing on the date of the delivery of the Advance Notice, other than the daily VWAP on a day in which the daily VWAP is less than a minimum acceptable price as stated by the Company in the Advance Notice or there is no VWAP on the subject trading day. The Company may establish a minimum acceptable price in each Advance Notice, below which the Company will not be obligated to make any sales to Yorkville.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Yorkville SEPA, and subject to the conditions set forth therein, Yorkville agreed to advance to the Company in the form of convertible promissory notes (the &#8220;Yorkville Convertible Notes&#8221;) an aggregate principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_516af340-1a83-4747-940c-c3896d7df5c1" contextRef="C_e330bbbd-adcb-4879-b62e-75b820d5a126" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In 2023, the Company issued two Convertible Notes to Yorkville for a combined principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_392e82f9-10ad-4cc3-aa04-ca63def9714a" contextRef="C_a848591b-1adb-44bc-b891-a50be4491f02" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, resulting in net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48338401-3968-48fd-b58b-ae418dae2185" contextRef="C_86c39d9b-6f64-4386-b8c0-33b19e6166a7" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">9.48</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and in 2024 the Company issued a third Convertible Note to Yorkville in the principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a40fef93-12cf-45f5-aa71-425ff7660b2e" contextRef="C_0acb2411-d354-4e47-8f87-facfc960c807" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, resulting in net proceeds to us of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49aff1fb-f553-44fa-b038-bd6a4c253025" contextRef="C_71aa315c-44f8-4147-b3c3-c4ea2d43f242" name="us-gaap:ProceedsFromIssuanceOfDebt" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">4.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Yorkville </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes, Yorkville has the option, subject to certain limitations, of exchanging on one or more occasions all or part of the then outstanding balance under a given note for shares of our Class A Common Stock at a conversion price equal to the lower of: (i) a fixed price equaling </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_92bc3cad-51dc-4306-8e1a-fdffd48559a7" contextRef="C_9a2ac67d-cd44-4f9e-84d7-12c88681d46c" name="mspr:PercentageOfVwapOfSharesDuringPriorDate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">120</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of VWAP the day prior to the date of the closing of each tranche (the &#8220;Fixed Price&#8221;), or (ii) a variable price equaling </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed503fee-0f5e-42cd-810d-f154cf2cd1fe" contextRef="C_9a2ac67d-cd44-4f9e-84d7-12c88681d46c" name="mspr:PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">95</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the lowest daily VWAP during the seven consecutive trading days immediately preceding the exchange (the &#8220;Variable Price&#8221;), but in no event may the variable price be lower than $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82d93742-c6b5-403f-9528-fabe72e8c60e" contextRef="C_35dae5c1-7aae-4e29-bd11-991504d30ddb" name="mspr:MinimumVariablePricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">3.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share (the &#8220;Floor Price&#8221;). With respect to the initial Convertible Note issued on November 15, 2023, the Fixed Price equals $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_121d0b29-f890-43cc-84d4-df449222fd18" contextRef="C_297dbcdf-6f51-4f4f-9dc8-a5ae170c5102" name="mspr:FixedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">200.5625</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, with respect to the second Convertible Note issued on December 11, 2023, the Fixed Price equals $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6126cac-fc56-4ada-8039-81a2842bf492" contextRef="C_b8a984e0-7f94-40c6-bd5c-e7d950cd2591" name="mspr:FixedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">92.84</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and with respect to the third Convertible Note issued on April 8, 2024, the Fixed Price equals $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6279cb65-3f53-48c4-a284-4294c90db7af" contextRef="C_df38630e-a571-42c3-ade6-4ab4217b9d08" name="mspr:FixedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">37.625</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As required pursuant to the Second Amended and Restated Nomura Promissory Note, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fea5d85d-4bea-468f-9405-c90ce54b5a20" contextRef="C_1d7e8bd6-06e5-4825-92f8-4bcc96d6e304" name="mspr:PercentageOfAggregateProceedsToPayOutstandingAmount" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the aggregate proceeds under the Yorkville SEPA will be used to repay amounts outstanding under the Nomura Note (first towards accrued and unpaid interest, if any, then towards principal) and the remaining </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49d079d5-ca34-4d8f-ab2a-5e5f271f484a" contextRef="C_1d7e8bd6-06e5-4825-92f8-4bcc96d6e304" name="mspr:PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of such proceeds will be used to repay amounts due under the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville Convertible Notes, if any, or be paid to the Company after the Yorkville </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes are fully repaid. Pursuant to a letter agreement dated November 15, 2024, Nomura agreed to forego payments of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b42bcd8d-d0d2-4426-b225-4c8abf332a62" contextRef="C_c5742b65-c220-4c54-a9c1-2dcf8313f948" name="mspr:AggregateAmountOutstandingUnderCashProceeds" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million due under the Nomura Note from proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA until March 31, 2025. Pursuant to the Third Virage MTA Amendment, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf4ac771-09f7-461a-8008-f1f4a6f69495" contextRef="C_98ae30fc-b820-4fbe-b5f9-592ed60a472d" name="mspr:PercentageOfProceedsFromRepaymentOfDebt" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the Company&#8217;s portion of any net proceeds from the Yorkville SEPA would be used to pay down the VRM Full Return after the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville Convertible Notes are fully satisfied.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon the occurrence and during the continuation of an event of default, the Yorkville </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes shall become immediately due and payable, and the Company shall pay to Yorkville the principal and interest due thereunder. Events of default include, among others: (i) termination of quotation or listing of the Class A Common Stock on any primary market for a period of 10 consecutive trading days (the Company is currently quoted and listed for trading on Nasdaq) and (ii) failure to timely file any periodic report with the SEC on or before the due date of such filing as established by the SEC, including extensions under Rule 12b-25 under the Exchange Act. In no event shall Yorkville be allowed to effect a conversion if such conversion, along with all other shares of Common Stock beneficially owned by Yorkville and its affiliates would exceed </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_869b293c-d10d-4062-bcef-6e7ddbe347df" contextRef="C_9a2ac67d-cd44-4f9e-84d7-12c88681d46c" name="mspr:PercentageOfPaymentOfAggregatePurchasePriceOfShares" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding shares of the Common Stock of the Company. If any time on or after November 14, 2023: (i) the daily VWAP is less than the Floor Price for ten consecutive trading days (&#8220;Floor Price Trigger&#8221;), (ii) the Company has issued substantially all of the shares available under the Exchange Cap (as defined below) (&#8220;Exchange Cap Trigger&#8221;), or (iii) the Parent is in material breach of the Registration Rights Agreement, and such breach remains uncured for a period of twenty trading days, or the occurrence of an &#8220;Event&#8221; (as defined in the Registration Rights Agreement) (&#8220;Registration Event Trigger&#8221; and collectively with the Floor Price Trigger and the Exchange Cap Trigger, the &#8220;Trigger&#8221;), then the Company shall make monthly payments to Yorkville beginning on the seventh trading day after the Trigger and continuing monthly in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_828f82b0-fce6-49e1-82be-ae113a58d657" contextRef="C_9a2ac67d-cd44-4f9e-84d7-12c88681d46c" name="us-gaap:DebtInstrumentPeriodicPayment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million plus a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2d407e7-d70c-49ac-8b52-78e6480b5d27" contextRef="C_9a2ac67d-cd44-4f9e-84d7-12c88681d46c" name="mspr:PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% premium and accrued and unpaid interest. On December 6, 2024, stockholders holding at least a majority of our outstanding voting capital stock approved by written consent as required by Nasdaq Rule 5635(d), the issuance of shares of common stock of the Company in excess of the Exchange Cap set forth in the Yorkville SEPA. Effective January 8, 2025, the Exchange Cap was effectively lifted, allowing the Company to issue shares to Yorkville pursuant to the Yorkville SEPA and the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville Convertible Notes in excess of the Exchange Cap. In addition, on April 10, 2025, Yorkville agreed to waive Volume Threshold and Maximum Advance Amount limitations set forth in the Yorkville SEPA.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville, at its discretion and providing that there is a balance remaining outstanding under the Yorkville Convertible Notes, may deliver a notice under the Yorkville SEPA requiring the issuance and sale of shares of Class A Common Stock to Yorkville at the Conversion Price in consideration of an offset of the Yorkville </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes (&#8220;Investor Notice&#8221;). Yorkville, in its sole discretion, may select the amount of any Investor Notice, provided that the number of shares issued does not cause Yorkville to exceed the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d776b38-4b98-4715-a825-dddbd5a473c4" contextRef="C_9a2ac67d-cd44-4f9e-84d7-12c88681d46c" name="mspr:PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% ownership limitation or the amount of shares of Class A Common Stock that are registered. As a result of an Investor Notice, the amounts payable under the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville Convertible Notes will be offset by such amount subject to each Investor Notice.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will control the timing and amount of any sales of shares of Class A Common Stock to Yorkville, except with respect to the conversion of the Yorkville Convertible Notes. Actual sales of shares of Class A Common Stock to Yorkville as an Advance under the Yorkville SEPA will depend on a variety of factors to be determined by the Company from time to time, which may include, among other things, market conditions, the trading price of the Company&#8217;s Class A Common Stock, and determinations by the Company as to the appropriate sources of funding for our business and operations.</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">102</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_53f7c84d-6ceb-4653-8f30-00d293b81ffa_4" continuedAt="F_53f7c84d-6ceb-4653-8f30-00d293b81ffa_5"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Yorkville SEPA will automatically terminate on the earliest to occur of: (i) the first day of the month following the 36-month anniversary of the date of the Yorkville SEPA, or (ii) the date on which Yorkville shall have made payment of Advances pursuant to the Yorkville SEPA for shares of Class A Common Stock equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73be5f06-4315-474d-a60f-5d927955907d" contextRef="C_35dae5c1-7aae-4e29-bd11-991504d30ddb" name="mspr:PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">250.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company has the right to terminate the Yorkville SEPA at no cost or penalty upon five trading days&#8217; prior written notice to Yorkville, provided that there are no outstanding Advance Notices for which shares of Class A Common Stock need to be issued, and the Company has paid all amounts owed to Yorkville pursuant to the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville Convertible Notes. The Company and Yorkville may also agree to terminate the Yorkville SEPA by mutual written consent. Neither the Company nor Yorkville may assign or transfer the Company&#8217;s respective rights and obligations under the Yorkville SEPA, and no provision of the Yorkville SEPA may be modified or waived by the Company or Yorkville other than by an instrument in writing signed by both parties.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Yorkville SEPA contains customary representations, warranties, conditions and indemnification obligations of the parties. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The net proceeds under the Yorkville SEPA to the Company will depend on the frequency and prices at which the Company sells its shares of Class A Common Stock to Yorkville. The Company expects that any proceeds received from such sales to Yorkville will be used for working capital and general corporate purposes.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 12, 2024, Yorkville agreed that, to the extent that it holds Class A Common Stock in such quantities that would prevent the Company from utilizing the Yorkville SEPA solely due to the Ownership Limitation, Yorkville committed to fund an additional advance in the principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_083f3630-7965-40a9-ae53-085cda522f91" contextRef="C_8df417e8-0685-446e-aae3-3e40048d4ae7" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million on the same terms and conditions as the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville Convertible Notes pursuant to the Yorkville SEPA.</span></p></ix:continuation></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:continuation id="F_53f7c84d-6ceb-4653-8f30-00d293b81ffa_5"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During 2024, the Company sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98a26bd2-81d1-49ac-b040-4f435b25af05" contextRef="C_6607a34a-616c-4068-a1b4-1252fffde914" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,108,071</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock to Yorkville, respectively, pursuant to investor and/or advance notices delivered under the Yorkville SEPA at prices between $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_059c6fd7-14dd-4c12-9e15-de50f5bf77b6" contextRef="C_cacd009a-fa05-475a-b5fd-20053ae0307f" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">1.78</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dbff0342-5cdb-46d2-8b7b-159e18a06e69" contextRef="C_61507485-2d9f-40ad-8b7b-fd6cc068d0c8" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">21.09</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The proceeds therefrom were used to: (i) reduce amounts owed under Yorkville Note #1 by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4b5a1d6-73b2-4130-be0a-efbd5b2fdcde" contextRef="C_6607a34a-616c-4068-a1b4-1252fffde914" name="mspr:ReductionInDebtPrincipalOwing" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6af7094c-3ba2-41db-bb3a-eba3b563b12b" contextRef="C_6607a34a-616c-4068-a1b4-1252fffde914" name="mspr:ReductionInInterestAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of principal and interest, respectively for fiscal year 2024, (ii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae31fbf7-7008-4650-94ff-a0244a7d8443" contextRef="C_6607a34a-616c-4068-a1b4-1252fffde914" name="mspr:PaymentToFundOperations" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to fund operations of the Company, and (iii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0a47917-e7e5-489d-9068-62cfbb5259d8" contextRef="C_6607a34a-616c-4068-a1b4-1252fffde914" name="mspr:PaymentToReduceAmountsOwedUnderNomuraNote" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of payment to reduce amounts owed under the Nomura Note for fiscal year 2024. As we have sold substantially all of the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ccade26-580c-41a0-bc80-c098c5925d9e" contextRef="C_6607a34a-616c-4068-a1b4-1252fffde914" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares currently registered for resale to Yorkville, we need to file with the SEC one or more additional registration statements to register under the Securities Act the resale by Yorkville of any additional shares of our common stock, and the SEC would have to declare such registration statement or statements effective before we could sell additional shares. </span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There can be no assurances of such events occurring or the timing of such events occurring.</span></p><div><ix:nonNumeric id="F_efcf43d7-b107-43a4-b78c-e6f62f283c62" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:WarrantLiabilityTextBlock" escape="true" continuedAt="F_efcf43d7-b107-43a4-b78c-e6f62f283c62_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. WARRANT LIABILITY</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When the Company issues warrants, it evaluates the proper balance sheet classification of the warrant to determine whether it should be classified as equity or as a derivative liability on the consolidated balance sheets. In accordance with ASC 815-40, &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Derivatives and Hedging-Contracts in the Entity&#8217;s Own Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; (&#8220;ASC 815-40&#8221;), the Company classifies a warrant as equity so long as it is &#8220;indexed to the Company&#8217;s equity&#8221; and several specific conditions for equity classification are met. A warrant is not considered indexed to the Company&#8217;s equity, in general, when it contains certain types of exercise contingencies or adjustments to the exercise price. If a warrant is not indexed to the Company&#8217;s own common stock or it has net cash settlement that results in the warrants to be accounted for under ASC 480, &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Distinguishing Liabilities from Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;, or ASC 815-40, it is classified as a derivative liability which is carried on the consolidated balance sheet at fair value with any changes in its fair value recognized currently in the consolidated statement of operations.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 17, 2022, the Company and CF Principal Investments LLC (&#8220;CF&#8221;) entered into an agreement for an OTC Equity Prepaid Forward Transaction (the &#8220;Prepaid Forward&#8221;). Pursuant to the terms of the Prepaid Forward, CF agreed to, among other things, transfer to MSP for cancellation any New Warrants received as a result of being the stockholder of record of any shares of Class A Common Stock as of the close of business on the closing date of the Business Combination, in connection with the New Warrant Dividend, On January 12, 2024, CF transferred </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e98b6ea-f11b-4620-a77e-542a58983013" contextRef="C_90ec9698-713b-426c-b0bb-0ec128980a66" name="mspr:ClassOfNewWarrantOrRightTransferredDuringPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">133,291,502</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> New Warrants to the Company, which were canceled upon receipt.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had recognized a warrant liability for the following securities which are convertible into, or allow the purchase of, our Class A Common Stock, including: (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12e2d015-ea89-4e2f-8ef8-0755ad6b3021" contextRef="C_77a7af59-7ae1-4d3d-a7f3-5e0380c71c5d" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,950,157</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Public Warrants outstanding, each exercisable to purchase </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_6dfc678e-53e4-4a49-b837-6bb6cde847d7;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1/625</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th of one share of our Class A Common Stock (but only exercisable in lots of 625 to purchase whole shares); (ii) the CPIA Warrant, exercisable to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8bd6607-be80-43c2-9d38-aeb36de0f151" contextRef="C_aeef635c-511c-48e7-bd31-2303d3add962" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">106,667</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock at a purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_decc36c7-2aa8-44c6-b7d4-19d4be086601" contextRef="C_3e8969f2-ae97-4d3c-b1d0-74bbfc712aea" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0625</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share; (iii) the VRM Warrants, of which 10 are exercisable to purchase a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ddec5226-c13e-4d89-8b42-802a39ae71a8" contextRef="C_998a064a-3957-4126-8109-a66c5f9a5542" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">9,751,339</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock at a purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83b748ae-b00f-45d5-8e42-e948320b19c3" contextRef="C_998a064a-3957-4126-8109-a66c5f9a5542" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0025</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share; and (iv) warrants to Virage Recovery Participation, LP, exercisable to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a4df70b-26de-4ed8-919f-3a4dc06500a3" contextRef="C_4275f40d-714d-47ab-97d1-4eba6db92ac7" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">100,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock at a purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c94020a8-e972-4df9-bfd8-26376bf249bd" contextRef="C_4275f40d-714d-47ab-97d1-4eba6db92ac7" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0025</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The warrant liability includes the mark-to-market fair value of the warrants discussed above. The fair value of the warrant liability is derived considering the potential shares issuable for each warrant and using the price of the Company&#8217;s Class A Common Stock as of the most recent balance sheet date, which is a quoted price in active markets.</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">103</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_efcf43d7-b107-43a4-b78c-e6f62f283c62_1"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_240cc23c-0093-4009-ad77-a8139dc62510" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock" escape="true"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The table below presents a roll-forward of the warrant liability from </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023 to December 31, 2024:</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:55.82%;box-sizing:content-box;"/>
         <td style="width:2.26%;box-sizing:content-box;"/>
         <td style="width:20.68%;box-sizing:content-box;"/>
         <td style="width:2.22%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:17.02%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Warrant Liability</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c0425b8-2009-460a-ba63-cf52b92a13a5" contextRef="C_dc9a1a27-6e49-4cfa-9469-c027ab03a71a" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">268</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97edf9c4-dcea-4095-8eff-6ff3b2779507" contextRef="C_786664b5-9979-4e35-9243-6bdb750f8536" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">159,200</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of outstanding warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f13516d-69ec-4823-9f30-7aa9484cbc19" contextRef="C_786664b5-9979-4e35-9243-6bdb750f8536" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">137,095</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4dff5cd2-c7fa-435e-9f82-62de1207e740" contextRef="C_4cf329ce-5aca-4da4-8888-8728533d3e78" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,373</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6dd00bd4-4d30-41ce-a05e-331750bee466" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" escape="true"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A summary of activity of the shares underlying the warrants from December 31, 2022 through December 31, 2024:</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:55.82%;box-sizing:content-box;"/>
         <td style="width:1.74%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:19.2%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:2.22%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:17.02%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"># of Shares</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise Price</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2022</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec45dc93-4745-423d-92db-64a958df9756" contextRef="C_8dbd5799-d76e-43f3-b963-830f8fd31b2e" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">111,978</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_072487f0-3524-477e-adad-c1a58bb3a172" contextRef="C_8dbd5799-d76e-43f3-b963-830f8fd31b2e" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0625</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Converted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f988c6d-5d23-438a-9b47-d4a7ece015a1" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:ClassOfWarrantConvertedDuringPeriod" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">590</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8b1a4fd-4285-497c-8009-e2cfec828e14" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:ClassOfWarrantsOrRightConvertedExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0625</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a0c9a45-3dec-4caa-9bc7-a9cafdbfd5c2" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">111,388</ix:nonFraction></span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0fa23a7c-6d9d-4e02-9c2a-c3b3476ea00a" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0625</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issued</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c1dd6c0-d534-4c02-a11f-aaa96814f1ba" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:ClassOfWarrantOrRightIssuedDuringPeriod" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">9,851,339</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4485b32d-38f0-4337-948c-fd405f243eea" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:ClassOfWarrantsOrRightIssuedExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0025</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96f34709-bc93-422a-a740-cf4ce335cce4" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">9,962,727</ix:nonFraction></span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ba48ca1-7c71-4a4a-a9ee-32058631e49e" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0032</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to Note 1, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of the Business</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for discussion of the terms of the Public Warrants and New Warrants, to Note 3,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Material Agreements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for discussion of the terms of the VRM Warrants, and to Note 9, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Financing Obligations and Notes Payable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for discussion of the terms of the CPIA Warrant.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_7124f71f-5e6e-44bf-9088-4cdb1f2c80bd" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:MinorityInterestDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 11. NONCONTROLLING INTEREST</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The non-controlling interest balance primarily represents the Up-C Units of the Company held by the Members. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_27f4035a-1581-4a83-ba5d-d307ee9a5a2e" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:ScheduleOfOwnershipInterestsTableTextBlock" escape="true" continuedAt="F_27f4035a-1581-4a83-ba5d-d307ee9a5a2e_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the ownership of Units in the Company as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024:</span></ix:nonNumeric></span></p><div style="font-size:9pt;font-family:Times New Roman;"><ix:continuation id="F_27f4035a-1581-4a83-ba5d-d307ee9a5a2e_1">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.347%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.537%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:19.116%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Ownership Percentage</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Ownership of Class A Common Stock</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4bf6494-4e5d-4acf-83b7-a5a68e659cda" contextRef="C_ec4285f4-9b93-43aa-ab90-0409cd42c969" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,184,958</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b18e6241-54bf-45de-8c31-db5dc3f40528" contextRef="C_ec4285f4-9b93-43aa-ab90-0409cd42c969" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">30.6</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Ownership of Class V Common Stock</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_45e399bf-7529-45bd-9ac4-59298baf3dea" contextRef="C_32b282eb-1b22-41ce-afda-7322605f66e8" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,962,704</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58f60cc0-f3ea-48a7-8887-0d8b0307b09e" contextRef="C_32b282eb-1b22-41ce-afda-7322605f66e8" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">69.4</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at end of period</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0dc1a7b4-9872-44e6-89f6-6bffe05e42c9" contextRef="C_4400c0b3-2cd1-40b7-ac05-f868dde9be3a" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,147,662</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd4cb926-0cd7-4a61-9514-5c84d160e947" contextRef="C_4400c0b3-2cd1-40b7-ac05-f868dde9be3a" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">100.0</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table></ix:continuation></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The non-controlling interest holders have the right to exchange Up-C Units, at the Company&#8217;s option, for (i) cash or (ii) one share of Class A Common Stock, subject to the provisions set forth in the LLC Agreement. As such, future exchanges of Up-C Units by non-controlling interest holders will result in a change in ownership and reduce or increase the amount recorded as non-controlling interest and increase or decrease additional paid-in-capital or retained earnings when the Company has positive or negative net assets, respectively. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b31eeda-bdd9-4589-bdea-4507cb793b79" contextRef="C_e29473fa-863b-4122-a9a4-eac7411b776e" name="mspr:CommonUnitExchangeValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Up-C Units had been exchanged into Class A shares.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the non-controlling interest related to Up-C Units, the Company also has non-controlling interests related to the Series as noted in Note 8, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Variable Interest Entities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and MAO-MSO Recovery LLC Series FHCP (&#8220;FHCP&#8221;), which is a non-wholly owned subsidiary of MSP Recovery, LLC. In accordance with FHCP&#8217;s operating agreement, the noncontrolling member is entitled to a preferred return of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_51466ba1-06d3-4c45-9d2d-964b3d89ef35" contextRef="C_be8b70eb-d4ba-4f20-b375-143fdf4f8fe3" name="mspr:PercentageOfEntitledPreferredReturnByNonControllingMembers" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">20</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum (the &#8220;Preferred Return&#8221;). Once the Preferred Return has b</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">een met, the noncontrolling member is entitled to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e348c267-f1b5-4d95-90f0-007be47442a8" contextRef="C_be8b70eb-d4ba-4f20-b375-143fdf4f8fe3" name="mspr:EntitledClaimsRecoverPercentageByNonControllingMembers" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">80</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of Claims recoveries by FHCP. The controlling member is allocated </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc79e47c-29e9-4b00-a6ed-0a8fa8cfce4e" contextRef="C_be8b70eb-d4ba-4f20-b375-143fdf4f8fe3" name="mspr:PercentageOfNonControllingMemberAllocatedCost" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the costs of FHCP. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since the Preferred Return exceeds the total members&#8217; equity of FHCP as of both December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the non-controlling interest also includes $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a65d7d6-a807-4210-8005-7d262cf13286" contextRef="C_be8b70eb-d4ba-4f20-b375-143fdf4f8fe3" name="us-gaap:MinorityInterest" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_df11dd7d-0859-4b1b-a9a7-89f2d6d2f73e" contextRef="C_87f7ef45-9817-4e4f-b4b2-29e0e91e875b" name="us-gaap:MinorityInterest" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.4</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million representing the entire members&#8217; equity of FHCP.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_25a06344-be2c-473f-b56b-704e99e8e51c" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true" continuedAt="F_25a06344-be2c-473f-b56b-704e99e8e51c_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 12. COMMITMENTS AND CONTINGENCIES</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to certain legal proceedings, claims, investigations, and administrative proceedings in the ordinary course of its business. The Company records a provision for a liability when it is both probable that the liability has been incurred and the amount of the liability can be reasonably estimated. These provisions, if any, are reviewed and adjusted to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case. Depending on the nature and timing of any such proceedings that may arise, an unfavorable resolution of a matter could materially affect the Company&#8217;s future results of operations, cash flows or financial position in a particular period.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company pursues claims recoveries through settlement, arbitration and legal proceedings. The accounting policy for these activities is discussed under Claims recovery income in Note 2, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A significant majority of the Company&#8217;s expected recoveries arise from Claims brought pursuant to the private cause of action under the Medicare Secondary Payer Act (&#8220;MSP Act&#8221;). This law allows the Company to pursue recoveries against primary payers for reimbursement of medical expenses that the Company&#8217;s Assignors paid for when primary payers (i.e., liability insurers) were responsible for payment.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investigations</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">104</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_25a06344-be2c-473f-b56b-704e99e8e51c_1"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 11, 2022, the Securities and Exchange Commission (the &#8220;SEC&#8221;) initiated an investigation of the Company, and requested documents relating to, among other matters, the Business Combination transaction with Lionheart Acquisition Corporation II consummated on May 23, 2022, certain historical and projected financial results, investor agreements, and data analytic platforms and Algorithms. The Company received a subpoena dated March 1, 2023 from the SEC regarding the aforementioned subject matter, and subsequently received a subpoena on May 10, 2023, in connection with the investigation relating to, among other matters, the Company&#8217;s projections and the accounting and valuation of certain assets that were the basis for the Company&#8217;s determination that its quarterly financial statements for the periods ended June 30, 2022 and September 30, 2022 require restatements and should no longer be relied upon, as disclosed in the Company&#8217;s Form 8-K on April 14, 2023. On August 16, 2023, the Company received an additional subpoena from the SEC regarding certain funding sources of the Company prior to the Business Combination, various statements and disclosures by the Company in connection with, and following, the Business Combination, certain historical and projected financial results, and data analytic platforms and Algorithms used to identify potential recoveries.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, on March 10, 2023, the Company received a subpoena from the U.S. Attorney&#8217;s Office (&#8220;USAO&#8221;) in connection with a grand jury investigation in the U.S. District Court for the Southern District of Florida requesting certain information concerning the Company, which subpoena requests documents relating to, among other matters, the Company&#8217;s proprietary Algorithms and other software used to identify potentially recoverable claims, the drop in the price of the Company&#8217;s common stock following the Business Combination, and certain marketing materials and investment agreements presented to potential investors. On July 18, 2024, the Company received an additional subpoena from the USAO, requesting documents related to a Company press release. To the best of the Company&#8217;s knowledge, the Department of Justice has not issued any target letters to anyone associated with the Company as a result of this investigation. (The United States Attorney&#8217;s Manual states that a &#8220;target&#8221; is a person as to whom the prosecutor or the grand jury has substantial evidence linking him or her to the commission of a crime and who, in the judgment of the prosecutor, is a putative defendant.)</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has cooperated, and will continue to cooperate, fully with these inquiries. On April 16, 2023, a special committee of the Board of Directors was formed, which along with external advisors retained thereby, reviewed matters related to the preparation and filing of the 2022 Annual Report on Form 10-K and the subject matter of information requests related to the foregoing subpoenas received prior to June 2023. Based on that review, and the nature of the documents requested in the subsequent subpoena, the Company believes that the investigations will be resolved without any material developments; however, there can be no assurance as to the outcome or future direction thereof.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cano Health, LLC</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 7, 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a67efc7-ee82-41d7-b430-5e17940c069f" contextRef="C_d3663b7d-96ee-43d9-aad4-51ec8fb8fe14" name="us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">318,401</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> unregistered shares of Class A Common Stock </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(after giving effect to the Reverse Split) </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to Cano Health, LLC (&#8220;Cano&#8221;) as payment for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e83e7e49-eff5-4f0d-a8d6-a1e59b2c7c22" contextRef="C_c4d052d7-2f78-44e5-bfef-1e0596f96bbb" name="us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">61.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in deferred compensation related to the following agreements, which the Company had the option to pay in cash or in stock and elected to pay in stock, of which (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_39cbce9a-8ee0-4c3d-a963-d168b834b17f" contextRef="C_936c5ddb-0e12-496d-8f55-6b4fe1ea6f11" name="us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">129,033</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock were issued as a deferred consideration for the assignment of certain claims pursuant to that certain Purchase Agreement, effective as of September 30, 2022, as amended to date, by and between MSP Recovery and Cano, and (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b0ab7bb-319f-4659-aaf5-13dc3a1f128e" contextRef="C_d91eca92-81d8-4e73-a6df-71357a7bccc1" name="us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">189,368</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock were issued as deferred consideration for the assignment of certain claims pursuant to that certain Amended and Restated Claims Recovery and Assignment Agreement effective as of December 31, 2021, as amended to date, by and between MSP Recovery and Cano.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 10, 2023, the Company sued Cano in the Circuit Court of the Eleventh Judicial Circuit in and for Miami-Dade County, Florida for declaratory relief and anticipatory breach of the Cano CCRA, Cano Purchase Agreement, and a Service Agreement (collectively, the &#8220;Cano Agreements&#8221;) between the parties. On the same day, Cano sued the Company in the same court, alleging fraud in the inducement, breach of contract, tortious interference, and unjust enrichment relating to the Cano Agreements. The Company has a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6adfd698-2708-4530-a9d4-ee66c72977cf" contextRef="C_791e8b5c-e454-490f-af98-b274119fb0c5" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million receivable outstanding from Cano; however, due to Cano&#8217;s Quarterly Report on Form 10-Q filings for the periods ending June 30, 2023 and September 30, 2023, which include a substantial doubt about Cano&#8217;s ability to continue as a going concern, and Cano&#8217;s subsequent filing of voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code on February 4, 2024, the Company established a reserve for the balance due under such receivable during 2023. These matters were automatically stayed as a result of Cano&#8217;s bankruptcy filing. As of June 28, 2024, the Debtors&#8217; Plan has been confirmed and declared effective. The automatic stay of litigation has been lifted and the parties anticipate the ongoing litigation to re-commence under a new scheduling order.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 4, 2024, Cano sued Simply Healthcare Plans, Inc. (&#8220;Simply&#8221;) and the Company and affiliated entities seeking a declaratory judgment to determine whether the Cano Purchase Agreement should be rescinded, and whether Cano or the Company have standing to recover on claims assigned to the Company against Simply under the Cano Purchase Agreement. Cano also seeks damages from Simply relating to the claims assigned to the Company under the Cano Purchase Agreement. Effective March 4, 2025, Cano voluntarily dismissed their case against Simply without prejudice.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company intends to vigorously assert its position in all Cano related litigation.</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">105</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:nonNumeric id="F_d87506d1-7e19-4b59-a62c-787c3ec1541a" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:FairValueDisclosuresTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 13. FAIR VALUE MEASUREMENTS</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has no assets that are measured at fair value on a recurring basis as of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span><ix:nonNumeric id="F_7180efaf-82fa-4e90-899e-9de59d3f097f" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" escape="true" continuedAt="F_7180efaf-82fa-4e90-899e-9de59d3f097f_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Liabilities measured at fair value on a recurring basis as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, are summarized as follows:</span></ix:nonNumeric></span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:continuation id="F_7180efaf-82fa-4e90-899e-9de59d3f097f_1">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:47.359%;box-sizing:content-box;"/>
         <td style="width:1.441%;box-sizing:content-box;"/>
         <td style="width:1.681%;box-sizing:content-box;"/>
         <td style="width:14.106%;box-sizing:content-box;"/>
         <td style="width:1.441%;box-sizing:content-box;"/>
         <td style="width:1.701%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.565%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.441%;box-sizing:content-box;"/>
         <td style="width:1.701%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.565%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Level</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Derivative liability</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74b0c95e-ecbd-4017-98b3-1a20e97252c1" contextRef="C_dc851705-b338-480f-8b51-035da6fa3959" name="us-gaap:DerivativeLiabilities" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">211</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99c5f241-69cb-498c-9055-c6c510bd19c4" contextRef="C_171901d1-c52f-41fe-91df-db360c126e4e" name="us-gaap:DerivativeLiabilities" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">37</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liability</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc21b7cc-015e-45da-8a4e-6ba583648bba" contextRef="C_cb90e83b-7cd0-4ffd-8a4c-cfdf4d8ff256" name="mspr:FinancialLiabilitiesFairValueWarrants" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">22,373</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7f97c04-a8b3-499b-bcb0-41e103b9a899" contextRef="C_1065a761-b9fe-4aae-899f-8f897411b778" name="mspr:FinancialLiabilitiesFairValueWarrants" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">268</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a8f389e-b5a7-46c9-8e48-6c1c8ccbc78f" contextRef="C_38dbca91-c3fa-4361-8e4e-ad3d415625fe" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">22,584</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1497a238-99b2-4ec7-85b7-07e35ad2656d" contextRef="C_0e019663-7988-47f0-9493-92a40c3ae831" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">305</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cdbd1b28-163f-4017-ad4c-e0e6def45339" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" escape="true"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table details the roll-forward of the Level 3 liabilities during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:74.3%;box-sizing:content-box;"/>
         <td style="width:2.26%;box-sizing:content-box;"/>
         <td style="width:2.18%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:19.26%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Derivative liability</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cec0e35b-36d9-43af-88e1-d4124dc389c7" contextRef="C_c83119b4-f363-422f-942a-c73e79c98c94" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of derivative liability</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71f27aa5-e0ce-4266-9aeb-38aa1b85fcda" contextRef="C_9dda51d6-a0f5-455b-8398-c575ec62a1c3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">161</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of note</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a230ff63-1aba-4802-855f-d6b3eea8be87" contextRef="C_9dda51d6-a0f5-455b-8398-c575ec62a1c3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f7eea90b-5857-44f1-b10c-ee356fd4e419" contextRef="C_ed1639a1-0034-449c-ad1f-a852134441a4" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">211</ix:nonFraction></span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the beneficial conversion feature within the Yorkville SEPA is treated as an embedded derivative liability and changes in the fair value were recognized in the change in fair value of warrant and derivative liabilities in the consolidated statements of operations. </span><span><ix:nonNumeric id="F_05014204-c4d7-4fb0-9d3a-1bfaa4ba79e5" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock" escape="true" continuedAt="F_05014204-c4d7-4fb0-9d3a-1bfaa4ba79e5_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The embedded derivative liability was valued at each of the respective issuance dates and at year-end using the following market-based inputs:</span></ix:nonNumeric></span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:continuation id="F_05014204-c4d7-4fb0-9d3a-1bfaa4ba79e5_1" continuedAt="F_05014204-c4d7-4fb0-9d3a-1bfaa4ba79e5_2">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:57.563%;box-sizing:content-box;"/>
         <td style="width:1.761%;box-sizing:content-box;"/>
         <td style="width:1.581%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:15.587%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.761%;box-sizing:content-box;"/>
         <td style="width:2.161%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:15.587%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Price of Common Stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7128d925-71d7-458c-ba1d-e47a2f60d769" contextRef="C_9cad53be-d2bb-4e7e-a24f-2d039319090a" name="us-gaap:EmbeddedDerivativeLiabilityMeasurementInput" unitRef="U_pure" scale="0" decimals="2" format="ixt:num-dot-decimal">2.27</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_620aa17f-62e6-4b31-9a6d-ae2f2093c42b" contextRef="C_440a05a3-a996-4acf-b096-ffc25257e6de" name="us-gaap:EmbeddedDerivativeLiabilityMeasurementInput" unitRef="U_pure" scale="0" decimals="2" format="ixt:num-dot-decimal">56.75</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Volatility</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af0f6579-5b8b-4f2c-82ff-3b605f1ca079" contextRef="C_c070ff64-2fdb-45a2-8448-0062a4c61eaf" name="us-gaap:EmbeddedDerivativeLiabilityMeasurementInput" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">60</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f0a55d7-ef89-433f-ad84-4e747633cbf9" contextRef="C_d7d3c349-08d9-4eaf-a899-c3399e98c5cb" name="us-gaap:EmbeddedDerivativeLiabilityMeasurementInput" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">40</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Market Risk Spread</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_626b5ea8-ed10-42b5-9d2c-0b431e5b8b04" contextRef="C_108cf1ce-e085-4fcf-bec5-40d0b2f1648c" name="us-gaap:EmbeddedDerivativeLiabilityMeasurementInput" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.56</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b1159f98-fdf6-4b0d-9edf-6fe6b1ef9a62" contextRef="C_4a8f2f53-79e9-446a-aa64-4ca7f9c8dff2" name="us-gaap:EmbeddedDerivativeLiabilityMeasurementInput" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">12.37</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected Term (in years)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_8aac89bd-f875-4f04-9c7d-5a6f68b2d4c5" contextRef="C_9fe75ae4-df32-424c-8f99-45879b90c2fd" name="mspr:EmbeddedDerivativeLiabilitiesMeasurementTerm" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.75</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_152e60ff-908a-4dc0-957d-a05d28c77420" contextRef="C_18297503-8f58-43a0-b62e-2f8147de332e" name="mspr:EmbeddedDerivativeLiabilitiesMeasurementTerm" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.25</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:continuation></div></ix:nonNumeric></div><div><ix:continuation id="F_05014204-c4d7-4fb0-9d3a-1bfaa4ba79e5_2"></ix:continuation></div><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><ix:nonNumeric id="F_af42b370-447a-49ec-a508-b45361ab81fe" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" escape="true" continuedAt="F_af42b370-447a-49ec-a508-b45361ab81fe_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 14. RELATED PARTY TRANSACTIONS</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loans from Related Parties</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2022, the Company issued an unsecured promissory note in an aggregate principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f3dba98f-9815-477a-8ef7-422b44f88493" contextRef="C_ef3df522-36ab-46ff-ba3a-3539524a7ffe" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">112.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the &#8220;Promissory Note&#8221;) to John H. Ruiz and Frank C. Quesada, the Company&#8217;s Chief Executive Officer and director and Chief Legal Officer and director, respectively (collectively, the &#8220;MSP Principals&#8221;), in exchange for the MSP Principals agreeing to provide cash to pay transaction costs related to the Merger, pay down affiliate payable balances, and provide operating cash to the Company. In addition to the amounts in the Promissory Note, at the merger date with LCAP, the MSP Principals contributed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d76245f-96e3-4c79-ac59-6231e8dafbdd" contextRef="C_0056d899-051b-43a5-b6bd-b84abe56a57e" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million through funds that had been loaned to VRM MSP to cover related service fees. The Promissory Note as well as the amount contributed at the merger date bears interest at an annual rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c9d19ac-73b1-4a24-8d64-48279c2e2e3a" contextRef="C_ef3df522-36ab-46ff-ba3a-3539524a7ffe" name="mspr:DebtInstrumentPaymentInKindAnnualInterestRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, payable in kind, and will mature on the </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ff0a7a37-522c-4c6b-b366-1cf9aec9dcd8" contextRef="C_bf775bb4-df03-4ad8-b1ef-bfc5c2f6dc53" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">four-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> anniversary of the issuance. The Promissory Note is payable by the Company at any time, without prepayment penalties, fees, or other expenses. The Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3a9bdb5-984b-4b3b-83ec-b77d425ec4e9" contextRef="C_3190b9d6-2f05-4406-add2-4c8346e46faf" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d8cd389c-3efe-40fc-8bfd-5ab4f606dc75" contextRef="C_7fafbd14-3e05-4ab0-b8db-3c7d640f612b" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of interest expense related to the Promissory Note for each of the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A portion of the proceeds under the Promissory Note in an amount equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4e38b9b-c75f-4736-a7f5-2185f66253fe" contextRef="C_f861f31f-886c-4e73-9be4-15fe686df5d1" name="us-gaap:ProceedsFromNotesPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">36.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was advanced to the Law Firm, an affiliate of certain Members, for certain operating expenses pursuant to a legal services agreement. During the three months ended September 30, 2024, the Company amortized all remaining advances to the Law Firm. This amount is reflected in prepaid expenses and other current assets within the consolidated balance sheets and had a balance of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3f6add1b-6582-4d9d-b378-1f221ee4c641" contextRef="C_2430ad04-c84e-49df-bcbe-0fa2ab3fc260" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0007e669-e265-47d8-8745-c9789af7bc84" contextRef="C_c8abebaf-3c7e-4eab-8f91-5ad82e71af2b" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of December 31, 2024 and 2023, respectively. The advances of Law Firm expenses are reflected in Professional fees - legal within the consolidated statement of operations. The advances are expensed as incurred, as the Company does not have recourse to any amounts incurred should Law Firm fail to secure recoveries, although it does have recourse to any amounts advanced that have not been incurred as an expense.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the legal services agreement, Company shall advance certain of Law Firm&#8217;s monthly expenses, including payroll and overhead; however, should Law Firm earn fees under the legal service agreements (the &#8220;Existing LSAs&#8221;) noted below, net of pre-existing obligations including payments to co-counsel sufficient to cover its monthly expenses, Company is entitled to reimbursement of the advance of said monthly expenses. Further, to the extent that Law Firm earns a surplus of fees in excess of its monthly expenses, said surplus shall be used to reimburse past amounts of Law Firm&#8217;s monthly expenses that Company advanced. For the years ended December 31, 2024 and 2023, approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2f5c13e-b95d-46c2-961b-231f26d6a5f4" contextRef="C_747655f3-412e-461f-8786-a873c027b7d0" name="mspr:AdvancePaymentIncurredForExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e9c0895a-9fe5-4d7a-a6b6-97aaa31f52aa" contextRef="C_57d602bd-2d0a-4e61-888a-2ec5eb79b28f" name="mspr:AdvancePaymentIncurredForExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">19.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, of the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a178293-d82c-4ff8-ad93-18286e0fb969" contextRef="C_f861f31f-886c-4e73-9be4-15fe686df5d1" name="us-gaap:ProceedsFromNotesPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">36.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million advanced by the Company to the Law Firm has been incurred for expenses pursuant to the legal services agreement.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Founders&#8217; Pledge - Claims Proceeds Investment Agreement</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">106</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_af42b370-447a-49ec-a508-b45361ab81fe_1" continuedAt="F_af42b370-447a-49ec-a508-b45361ab81fe_2"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As disclosed in Note 9,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Claims Financing Obligations and Notes Payable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements, the Founders pledged </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e57ad81-6a64-429e-acdc-e7d339ef0e52" contextRef="C_e47e8e78-3f7a-483f-be52-5d827c62b8cf" name="mspr:SharesPledgedUnderAgreement" unitRef="U_shares" scale="3" decimals="-3" format="ixt:num-dot-decimal">80</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> thousand shares to secure payment of the original principal amount of the CPIA.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Services &#8211; Law Firm</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain Company entities have previously entered into the Existing LSAs with the Law Firm, an affiliate of certain Members, for the recovery of Claims. Pursuant to the terms of the Existing LSAs, the Law Firm provides the Company with investigation, case management, research and legal services in the pursuit of recovery of Claims in exchange for a portion of the recovered proceeds relating to such Claims. The Existing LSAs also provide that the Law Firm serves as lead counsel or co-lead counsel for any litigation relating to such Claims.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company has a payable to the Law Firm amounting to </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7aaa9c4f-7d33-4f38-9eae-392c4431a815" contextRef="C_5252ca49-cd7d-42f1-90d0-31e55fce0385" name="us-gaap:OtherLiabilitiesCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. For the years ended December 31, 2024 and 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f109ca4-4593-41f3-90d9-d08840d94f43" contextRef="C_92683e84-cc53-487c-a7c4-f4dbdc1db394" name="mspr:OperatingCostsAndExpenses1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dab5ac58-9d5c-416f-be79-90d0fb7cf4ed" contextRef="C_065c4f1b-82bd-4f57-8208-a41a3b157055" name="mspr:OperatingCostsAndExpenses1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">19.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, was included in Professional fees - legal for expenses related to the Law Firm in the consolidated statements of operations.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, during fiscal year 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company issued an unsecured promissory note in an aggregate principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d797262-fcf1-4a04-869f-e19e798d891e" contextRef="C_9269574f-8058-4390-81dd-e7ec4e7ed960" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">4.95</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to the Law Firm, to provide general operational funding (the &#8220;Law Firm Loan&#8221;). The aggregate unpaid principal amount of this promissory note is due </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_947529ac-7d14-40f1-84e7-e08f738543da" contextRef="C_b1695415-e4a5-4136-8a0b-0977ddf9fef4" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months from the date of the last advance from the Second Amended and Restated First Lien Credit Agreement is made. This promissory note does not carry interest and is payable by the Company at any time, without prepayment penalties, fees, or other expenses. On March 4, 2024, the Board authorized the partial repayment of the Law Firm Loan in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42786803-1aa1-4ba6-bb5b-2a2a1a09ffcf" contextRef="C_d1561d98-416b-4bbe-bf56-1bedb1ab84d5" name="mspr:PartialRepaymentOfDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which funds were to be used for the express purpose of paying property taxes on real property owned and pledged by the MSP Principals to HPH as collateral in connection with the Working Capital Credit Facility.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended December 31, 2024 and 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0fd61de-6c7c-428f-b202-3f4b1bf35db8" contextRef="C_b40da480-7051-433e-99a9-7c5f5dd5ea4b" name="mspr:OperatingCostsAndExpenses1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5e62d9a-0c60-45ff-9e8f-e2d955c33862" contextRef="C_b3db7d99-631c-4482-beca-74fc892d1e93" name="mspr:OperatingCostsAndExpenses1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, were included in cost of Claims recoveries for expenses related to the Law Firm in the consolidated statements of operations.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Law Firm may also collect and/or hold cash on behalf of the Company in the ordinary course of business. As of December 31, 2024 and 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b48cf71-2ec0-46a4-8b4e-238993fe7139" contextRef="C_2f3b6385-dd5e-478a-98d6-86c7576434f0" name="us-gaap:OtherReceivablesNetCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd5b0a86-ce6a-40d6-99ac-c70f70418a2c" contextRef="C_f0fc5e6c-97d0-40e9-841d-33b02270183d" name="us-gaap:OtherReceivablesNetCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, was due from the Law Firm and included in the consolidated balance sheets in Affiliate Receivable. In addition, the Company rents office space from the Law Firm.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSP Recovery Aviation, LLC</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company may make payments related to operational expenses on behalf of its affiliate, MSP Recovery Aviation, LLC (&#8220;MSP Aviation&#8221;). The Company has made payments in the periods of the financial statements only related to specifically billed flights. As of both December 31, 2024 and 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ae13e08-2aeb-400a-a350-3e1a9398fd05" contextRef="C_ecb1b45b-fbaa-4bf2-92d9-318171959c6a" name="us-gaap:OtherReceivablesNetCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_309ce0a3-adfe-4caf-a179-cb1a036678da" contextRef="C_24ac4204-0641-451a-87a3-70ba142b0f90" name="us-gaap:OtherReceivablesNetCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was due from MSP Aviation and included in the consolidated balance sheets in Affiliate Receivable. For the years ended December 31, 2024 and 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5b47643-15cc-49f7-a754-872cad109f72" contextRef="C_57297e08-daf9-4ea8-9f0a-e30feb80ee20" name="us-gaap:OperatingCostsAndExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bda61174-14a3-4157-b044-b3c577b4f17a" contextRef="C_66a14f4e-f9d4-4b7a-8ceb-e5a34a3dad44" name="us-gaap:OperatingCostsAndExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, was included in General and Administrative expenses related to MSP Aviation in the consolidated statements of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Funds Held for Other Entities</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company may collect and/or hold cash on behalf of its affiliates in the ordinary course of business. As of both December 31, 2024 and 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca6dc896-1940-4787-9d30-223d30d1f434" contextRef="C_83481840-3ca0-4d32-ba67-06de37b1459f" name="us-gaap:OtherLiabilitiesCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ba1325de-3320-4992-92a5-ba33f83221e8" contextRef="C_c8ac68ca-b4ac-40c0-8ee5-21c155beaa2e" name="us-gaap:OtherLiabilitiesCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">19.8</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was due to affiliates of the Company and included in the consolidated balance sheets in Affiliate Payable. These amounts were primarily due to Series MRCS, and will be repaid either through excess cash flows from operations or other financing. During the year ended December 31, 2021, the Company also entered into a note payable with Series MRCS as outlined in Note 6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, Intangible Assets, Net</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of both December 31, 2024 and 2023, the balance of the note payable was</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74c3f7c6-2aeb-49c4-841f-2c080e79e01f" contextRef="C_c1e89a5f-129c-4943-a1a7-f314ec636657" name="us-gaap:LongTermNotesPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_0f17969f-0d75-469b-9b4e-b91f5f18d42e" contextRef="C_9c92dc8a-3a85-4931-89ec-6e28019c163f" name="us-gaap:LongTermNotesPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and included in the consolidated balance sheets in Claims financing obligation and notes payable.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, there were additional receivables from other affiliates of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94d92676-c9a8-4205-9253-5497d251cbc2" contextRef="C_7ec4a520-4502-411f-9714-8faecac859f6" name="us-gaap:OtherReceivablesNetCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6fec9d4f-ecab-40f7-b213-4853322be3c3" contextRef="C_1590504a-c1dc-4f29-92cb-3b6c727c0ce3" name="us-gaap:OtherReceivablesNetCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. These were included in the consolidated balance sheets in Affiliate Receivable.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VRM MSP</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company concluded that VRM MSP is a related party due to ownership interests in the entity held by the MSP Recovery and Series MRCS. For the year ended December 31, 2024, the Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8860abda-2f54-4f19-95ad-1a3f2261ff0a" contextRef="C_7b14a4eb-0fed-4c10-be9c-613f3475755b" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">188.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_003fbced-c82f-4621-a760-b783bbb82cc7" contextRef="C_3d4f1e16-3314-456a-9834-b6faa08ca709" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">124.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for interest expense related to the VRM Full Return and Virage MTA Amendment, and for the year ended December 31, 2023, the Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_128d68aa-fa20-46ab-8233-b669ab9f47c7" contextRef="C_be1531d0-0b2e-4de3-957e-6199271373d6" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">156.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07c5b987-28bf-4adf-9ca6-d76d37bef480" contextRef="C_61e6579c-7403-4590-b421-ac4ffdad7513" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">65.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for interest expense related to the VRM Full Return and Virage MTA Amendment, respectively.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Virage</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in Note 3, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Material Agreements </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements, the Initial Virage Warrant, as amended, was issued effective January 1, 2024. Until our obligations to Virage are paid in full, the Company has the option every month to continue to pay Virage in one or a combination of: (a) cash, in an amount equal to 1.0% of each calendar month-end balance (which month-end balance shall be increased daily up to 20% per annum based on a formula set forth in the Virage MTA Amendment) of the amount owing to Virage as of each preceding calendar month end and/or (b) the issuance of subsequent Monthly Virage Warrants.</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">107</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_af42b370-447a-49ec-a508-b45361ab81fe_2"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to Note 3, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Material Agreements </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements, for the listing of warrants issued during the year ended December 31, 2024.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to purchase agreements dated March 4, 2024 and August 22, 2024, and as disclosed on Form 4 filings by Mr. John H. Ruiz, the Company&#8217;s Chief Executive Officer, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fecc0c97-699f-4eb4-90a9-bb96d25bc7f6" contextRef="C_dbbed700-6dd7-4ab4-a4d1-5d2840f9852a" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">17,544</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e31408bd-fe8d-4c61-a732-65a192fa5d63" contextRef="C_e3728ea4-48fd-4ffc-a2ed-312c25de71eb" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">14,425</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, of unregistered shares of Class A Common Stock to Virage in satisfaction of certain obligations of the Company, which shares were subsequently purchased from Virage by Mr. Ruiz.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Founder&#8217;s Up-C Units &#8211; VRM Full Return</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As disclosed in Note 3, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Material Agreements </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements, in connection with the MTA Amendment, the Company agreed to pay Virage an amount equal to the contributions by Virage to VRM MSP plus an annual rate of return of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e49829ee-8f0a-42d1-9417-54244331c830" contextRef="C_9f0551af-5ff4-4726-988b-01f1ae60bf7d" name="mspr:AnnualCompoundedReturnOnContributionPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">20</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% (the &#8220;VRM Full Return&#8221;). Pursuant to the terms of the agreement with Virage, such amount may be payable by a sale of certain reserved shares of Messrs. John H. Ruiz and Frank C. Quesada, and the delivery of the resulting net cash proceeds thereof to VRM.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Working Capital Credit Facility Collateral</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Second Amended and Restated First Lien Credit Agreement, and in order to secure those additional advances of Term Loan B beginning in January 2024, the Company approved for Messrs. John H. Ruiz and Frank C. Quesada to provide, as additional collateral, the following: (i) a pledge of the equity interests in an Affiliate of Messrs. John H. Ruiz and Frank C. Quesada; (ii) a mortgage on real property owned by an Affiliate of Messrs. John H. Ruiz and Frank C. Quesada, and (iii) a personal guaranty by Messrs. John H. Ruiz and Frank C. Quesada, as primary obligors, guaranteeing those additional advances of Term Loan B beginning in January 2024. On December 22, 2023, our Board approved the Company's payment of certain costs and fees (including legal fees) on behalf of John H. Ruiz and Frank C. Quesada, associated with the mortgage granted in connection with said guaranty, totaling $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_567c67da-7e28-4a6c-a3e2-4db3d42ea124" contextRef="C_cf6558a6-9d3c-4663-9640-79620d1887bc" name="mspr:PaymentOfCertainCostsAndFees" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. On March 4, 2024, the Board authorized the partial repayment of the Law Firm Loan in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3afa240d-3a74-4201-b956-b954c5bf0b09" contextRef="C_d1561d98-416b-4bbe-bf56-1bedb1ab84d5" name="mspr:PartialRepaymentOfDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which funds were to be used for the express purpose of paying property taxes on real property owned and pledged by the MSP Principals to HPH as collateral in connection with the Working Capital Credit Facility.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_edcbda42-9549-460f-818a-74449180df80" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:SegmentReportingDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. SEGMENT INFORMATION</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are defined as components of an entity for which separate financial information is available and regularly reviewed by the chief operating decision maker (&#8220;CODM&#8221;). The Company manages its operations, as described in Note 1, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of the Business</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, as a single reportable segment for the purposes of assessing performance and making decisions. The accounting policies of the reportable segment are those included in this Note 2, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company&#8217;s CODM is its </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_abbe20fe-8830-4413-8cd7-922975cc36b9;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6b88191d-f40d-4764-9bc5-b2813148e90c" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:SegmentReportingExpenseInformationUsedByCodmDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has determined that it operates in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_774c616a-6e79-46ac-9591-c38dacf88157" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:NumberOfOperatingSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating segment and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d74de64f-7cae-4888-80db-4a11405293db" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:NumberOfReportableSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment, as the CODM reviews financial information presented on a consolidated basis, using the operating expenses and interest expense, as presented on the face of the income statement, for purposes of making operating decisions, allocating resources, and evaluating financial performance.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The measure of segment assets is reported on the consolidated balance sheet as total consolidated assets. In addition, all of the Company&#8217;s revenues and long-lived assets are attributable primarily to operations in the United States and Puerto Rico for all periods presented.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant expenses regularly provided to the CODM are Claims Amortization Expense, Interest Expense, General &amp; Administrative, and Professional Fees as reported on the face of the income statement. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1ec21296-09be-4ee6-a424-ef5a28c73e13" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" escape="true" continuedAt="F_1ec21296-09be-4ee6-a424-ef5a28c73e13_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The table below presents the Company&#8217;s significant segment expenses and a reconciliation of Significant Segment expenses and other segment items to Net Loss, the CODM&#8217;s primary measure of performance:</span></ix:nonNumeric></span></p><div style="font-size:9pt;font-family:Times New Roman;"><ix:continuation id="F_1ec21296-09be-4ee6-a424-ef5a28c73e13_1">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:65.52%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.52%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.44%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:14.52%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total Revenues</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_375d5ef2-f8ee-4bfe-8322-21ea1de1e929" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:TotalClaimsRecovery" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,249</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df2538fc-1c86-4a16-b51d-a722f7c73394" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:TotalClaimsRecovery" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,705</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less:</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Significant Expenses:</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims amortization expense</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5565d19f-7d71-44ed-a427-474f5f0106aa" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:ClaimsAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">484,076</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72bcf323-9df6-450b-bdc3-93fdaa77c32c" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:ClaimsAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">476,492</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca1a0ed3-e4f8-4efe-a22a-6a6a01f0b139" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,231</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0e480b3-f6e9-4d89-92c4-02cea1825e95" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,508</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c1047646-2664-482b-961c-ae6425196c2e" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ProfessionalFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,131</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70816971-00f3-414b-be38-f2c3957528cd" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:ProfessionalFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,766</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees &#8211; legal</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8283251e-e531-4c4d-928b-52d3e8988d93" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:LegalFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,519</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f53b3e4c-6410-4913-94b5-25f717171e55" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:LegalFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,401</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment of intangible assets</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a54cdf2-68e1-4c47-8b7a-df26a23949e8" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">752,697</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4fb56340-ad75-46c3-97de-c16302b9b7f0" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">420,032</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ce5249f-5b6c-4f58-8f40-b5ee68e4de56" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">289,169</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Significant Expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8862fc78-066f-45cf-a4f6-85cc7bb6f0e2" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="mspr:SignificantExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,702,686</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47c43b89-8ae1-49f0-bb04-fcbc7f74d97f" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="mspr:SignificantExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">849,336</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other Segment Items (1)</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dff60589-bc3a-46a2-b9d3-b986d22eeb78" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:SegmentReportingOtherItemAmount" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">127,592</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_51d18894-4a00-48af-9882-6574aff6e215" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:SegmentReportingOtherItemAmount" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">6,486</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net Loss</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2aed189d-63ba-4872-a0b6-f3d918294f8d" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,556,845</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_277361e9-53e9-476e-95df-a70ac5044b06" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">835,145</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes Cost of revenues, Allowance for credit losses, Depreciation and amortization, Change in fair value of warrant and derivative liabilities, and Other income (expense), net, as reported in our consolidated statements of operations.</span></div></div></ix:continuation></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">108</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_93d47858-57cb-409a-bf28-a69abf4695d0" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 16. N</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ET LOSS PER COMMON SHARE</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic earnings per share of Class A common stock is computed by dividing net income attributable to common shareholders by the weighted-average number of shares of Class A common stock outstanding during the period. Diluted earnings per share of Class A common stock is computed by dividing net income attributable to common shareholders adjusted for the assumed exchange of all potentially dilutive securities, by the weighted-average number of shares of Class A common stock outstanding adjusted to give effect to potentially dilutive elements. Diluted loss per share for all period presented is the same as basic loss per share as the inclusion of the potentially issuable shares would be anti-dilutive.
</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dbf74cb8-d272-49e1-ae85-40e2fa149b56" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth the computation of basic and diluted earnings per share of Class A common stock:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.587%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:15.317%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.78%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:15.317%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Numerator - basic and diluted:</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5ef4efb-b5d8-4ec6-8710-cce029971c1f" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,556,845</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3066991a-69f8-48cf-899a-ee3cc88cd81e" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">835,145</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Net loss attributable to the non-controlling interests</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25076080-1974-4465-9392-bd342016497d" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,196,346</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b4300c2-147b-4cd8-9e92-ad935cafccdc" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">778,797</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss attributable to MSP Recovery, Inc.</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a13837fc-f8be-404c-957f-6c80a5f221a9" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">360,499</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_625e740d-4c0c-4af2-8d63-2b067fcf2c6f" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">56,348</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Denominator &#8211; basic and diluted:</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares of Class A common stock outstanding &#8211; basic</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2960f945-71a3-4ad0-b244-f5117f736af6" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,001,525</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6df5c2c2-4e58-4050-a166-3739759d6bf2" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">356,591</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares of Class A common stock outstanding &#8211; dilutive</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bcd9e6a5-be9b-4ce5-b880-1b33992f7601" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,001,525</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9c0117d-ec81-49f1-bfc0-fa8438d5ac58" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">356,591</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Earnings per share of Class A common stock &#8211; basic</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8641101b-76af-4954-b4c9-b58585cda6bd" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">359.95</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_149448c5-9dc1-4a84-93e0-b95d869a8f4a" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">158.02</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Earnings per share of Class A common stock &#8211; diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0c9f18d-86b6-4688-9e4a-cb964c31b92e" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">359.95</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18eee7e8-469e-41a5-bba7-7ac0c9072283" contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">158.02</ix:nonFraction></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Shares of the Company&#8217;s Class V common stock do not participate in the earnings or losses of the Company and are therefore not participating securities. As such, separate presentation of basic and diluted earnings per share of Class V common stock under the two-class method has not been presented.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the calculation for earnings per share for the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company excluded from the calculation of diluted earnings per share </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4dd4a197-24cc-4be7-92c4-3b58664949e6" contextRef="C_d60db90f-4a37-413a-9383-5f9638a7dac4" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">4,962,704</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class V common stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b484b591-9df5-4bbe-a295-6a4cce38b7d5" contextRef="C_cc1f9003-7531-46fc-b9f5-b111a3ad3adf" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,950,157</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Public Warrants outstanding, the CPIA Warrant exercisable for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49045f5c-cc6b-45a1-b83b-65c415693907" contextRef="C_34c224df-e4d4-4363-a01b-1fcb9b2acaa2" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">106,667</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6cbc4c8e-7052-442d-950b-47ef59d58540" contextRef="C_909336c6-c224-484c-94a5-23ceb49463c4" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">894,754,824</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> New Warrants outstanding and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32f084cf-1b1c-4f56-8ddf-422d8f51feac" contextRef="C_12cd0c5c-e9e0-4c6d-873d-d9f0a4031377" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">9,851,339</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants issued to Virage, as their effect would have been anti-dilutive.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the calculation for earnings per share for the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company excluded from the calculation of diluted earnings per share </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8890c9c5-edc3-4016-b620-4417b5512f05" contextRef="C_0d6f7737-1475-425e-8764-bcd96bc150b3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">4,965,296</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class V common stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e6eb46b-9631-4a99-bb07-9fa107fa9258" contextRef="C_fc6dbd33-7019-4991-ae2a-4323861f1f73" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,950,157</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Public Warrants outstanding, the CPIA Warrant exercisable for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fec875d8-7861-4dfc-a033-1305f6112585" contextRef="C_07df6a83-0af1-46c6-adcf-ff855b251aa5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">106,667</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42a43462-dd17-4749-ba8f-3e83e8c51dda" contextRef="C_3f1e810b-70ff-4880-b849-ee3f4452b2d0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">894,754,824</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> New Warrants outstanding because their effect would have been anti-dilutive.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_40d6c5cf-7469-4c5b-97da-8c5b867319a1" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" escape="true" continuedAt="F_40d6c5cf-7469-4c5b-97da-8c5b867319a1_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 17. DERIVATIVE LIABILITY</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes of determining whether certain instruments are derivatives for accounting treatment, the Company follows the accounting standard that provides guidance for determining whether an equity-linked financial instrument, or embedded feature, is indexed to an entity&#8217;s own stock. The standard applies to any freestanding financial instruments or embedded features that have the characteristics of a derivative, and to any freestanding financial instruments that are potentially settled in an entity&#8217;s own common stock.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Yorkville SEPA</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As disclosed previously, the beneficial conversion feature within the Yorkville SEPA is treated as an embedded derivative liability and changes in the fair value are recognized in the change in fair value of warrant and derivative liabilities in the consolidated statements of operations.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, the derivative liability associated with the beneficial conversion feature within the Yorkville SEPA amounted to </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35d3072d-b960-48a0-bece-f2918157e59b" contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c" name="us-gaap:DerivativeLiabilitiesCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1fdf7420-a775-4092-9223-983be90d4406" contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9" name="us-gaap:DerivativeLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.0 thousand</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to Note 9,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Claims Financing Obligations and Notes Payable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for additional information on the Yorkville SEPA and Note 13, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for fair value measurements disclosures related to the embedded derivative in the Yorkville SEPA.</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">109</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_40d6c5cf-7469-4c5b-97da-8c5b867319a1_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">OTC Equity Prepaid Forward Transaction</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and CF entered into an agreement for an OTC Equity Prepaid Forward Transaction (the &#8220;Transaction&#8221;). Pursuant to the terms of the Transaction, CF agreed to (a) transfer to the Company for cancellation any warrants to purchase shares received as a result of being the stockholder of record of a share as of the close of business on the closing date of the Business Combination, pursuant to the previously announced and declared LCAP dividend and (b) waive any redemption right that would require the redemption of the Subject Shares (as defined below) in exchange for a pro rata amount of the funds held in LCAP&#8217;s trust account.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At closing of the Business Combination, the Company transferred from the trust account to an escrow account an amount equal to (a) the aggregate number of such Subject Shares (approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_259cbcd2-51f4-44d4-9a14-ff189262627b" contextRef="C_490f215f-7665-40bb-8a57-3e0bba257f4f" name="mspr:AggregateNumberOfSharesTransferredToEscrowAccount" unitRef="U_shares" scale="3" decimals="-2" format="ixt:num-dot-decimal">1.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> thousand shares), multiplied by (b) the per share redemption price for shares out of the trust account, as a prepayment to CF of the amount to be paid to CF in settlement of the Transaction for the number of shares owned by CF at the closing of the Business Combination (the &#8220;FEF Shares&#8221;). CF may sell the Subject Shares at its sole discretion in one or more transactions, publicly or privately. Any such sale shall constitute an optional early termination of the Transaction upon which (a) CF will receive from the escrow account an amount equal to the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">positive excess, if any, of (x) the product of the redemption price and the aggregate number of shares over (y) an amount equal to the proceeds received by CF in connection with sales of the shares, and (b) the Company will receive from the escrow account the amount set forth in (y) above.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company concluded that the instrument includes an embedded derivative for the change in value of the Company&#8217;s Class A common stock and as such, at the end of each period the Company will mark to market the shares through booking a derivative liability/asset. The calculation of the derivative liability/asset would be the difference between the restricted cash and current fair value of the outstanding FEF shares (number of FEF shares multiplied by market price of the Company&#8217;s Class A common stock as of period end).</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 6, 2023, the Company and CF entered into an Omnibus Fee Amendment Agreement (&#8220;Fee Amendment Agreement&#8221;). Pursuant to the terms of the Fee Amendment Agreement, in satisfaction of the deferred underwriting commissions under a previous agreement, the Company and CF agreed to release from escrow the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b17e5552-7687-46da-8b48-0add63891905" contextRef="C_3597e466-ae9e-44f5-b5bc-782036376b71" name="us-gaap:RestrictedCashCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">11.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of restricted cash and release the FEF shares previously held as Class A Common Stock subject to possible redemption within temporary equity. Prior to the Fee Amendment Agreement, CF had not sold any FEF shares.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the Fee Amendment Agreement and termination of the OTC Forward Transaction, as of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company no longer has any restricted cash, Class A Common Stock subject to possible redemption, or derivative liability in the consolidated balance sheets related to the OTC Forward Transaction.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_d41d7044-890b-4eea-b914-30ed7406c2da" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="us-gaap:SubsequentEventsTextBlock" escape="true" continuedAt="F_d41d7044-890b-4eea-b914-30ed7406c2da_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 18. SUBSEQUENT EVENTS</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restructuring Plan</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described in our Current Report on Form 8-K filed with the SEC on April 10, 2025, on April 4, 2025, Virage Recovery Master, LP (&#8220;Virage&#8221;); Virage Capital Management, LP; Hazel Partners Holdings, LLC (&#8220;HPH&#8221;); Hazel Holdings I, LLC (and together with HPH, &#8220;Hazel&#8221;); La Ley con John H. Ruiz P.A. d/b/a MSP Recovery Law Firm; MSP Recovery, LLC; MSP Law Firm PLLC; MSP Recovery, Inc. (the &#8220;Company&#8221;), John H. Ruiz, and Frank C. Quesada (collectively, the &#8220;Parties&#8221;) entered into a term sheet (the &#8220;Term Sheet&#8221;) agreeing to certain terms and transactions that are designed to reduce costs of the Company through a servicer, deleverage the Company by converting certain debt of certain creditors into equity, provide access to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35bf780f-c04c-41d7-ace8-bbc1ecbe4296" contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688" name="mspr:ConvertingCertainDebtOfCertainCreditorsIntoEquity" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">9.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of bridge funding to the Company (of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26f14b12-4071-45ca-b314-06f437a82670" contextRef="C_82042595-d2ec-46bd-8d33-1d9c1c5fcd8a" name="mspr:ConvertingCertainDebtOfCertainCreditorsIntoEquity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million remains available through July 2025 pursuant to the Term Sheet, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_424680a5-4f7c-4ff3-b31c-a45a4bcb2965" contextRef="C_c4e77341-1e9b-4ba5-8f65-82e4691d35db" name="mspr:ConvertingCertainDebtOfCertainCreditorsIntoEquity" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">2.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of which remains available under the Operational Collection Floor at the sole discretion of HPH) and up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97267c4c-c680-4286-96ef-11301d0caa6a" contextRef="C_1e01a200-c2e8-4634-9efe-10da04e93fb6" name="us-gaap:ProceedsFromLongTermLinesOfCredit" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of working capital for New Servicer (as defined below), and focus the Company&#8217;s operations, through the New Servicer, on the core business model of pursuing recoveries under the MSP Laws so that it can achieve its long-term recovery goals. Beyond July 2025, the Company&#8217;s anticipated sources of funding include the MSP Principals&#8217; commitment to pledge $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3b37006-b035-4350-8e62-958ac11e2205" contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688" name="us-gaap:OtherCommitment" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of collateral to backstop additional working capital funding for the Company, potential distributions under our Standby Equity Purchase Agreement with YA II PN, Ltd. (the &#8220;Yorkville SEPA&#8221;), and claims recovery proceeds, subject to debt obligations on certain of the claims.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These proposed transactions are subject to, among other things, further negotiation and the execution of definitive agreements, regulatory approvals, certain third-party consents and approvals, and shareholder approvals if required by the Nasdaq Stock Market. The obligation of Hazel and its affiliates to enter into definitive documents is subject to the satisfaction of various conditions precedent, at their sole discretion, including, but not limited to, satisfactory finalization of due diligence and all required internal approvals, receipt of certain third-party consents required, and finalization of documentation. Consummation of the transactions contemplated by the Term Sheet are also subject to additional fundings by other parties and certain debt concessions by other stakeholders. As a result, there can be no guarantee that the transactions contemplated by the Term Sheet will be consummated.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The proposed transactions include, but are not limited to, the following transactions:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Establishment of New Servicer</span></div></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company shall establish a new subsidiary (&#8220;New Servicer&#8221;) to provide and control recovery efforts, by way of litigation,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">110</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_d41d7044-890b-4eea-b914-30ed7406c2da_1" continuedAt="F_d41d7044-890b-4eea-b914-30ed7406c2da_2"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">demand </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">letters, settlements, or other means, in connection with existing claim recovery rights (to the extent assignable), and those acquired in the future, held in special purpose vehicles (&#8220;SPV&#8221;), wholly owned by New Servicer, to hold any new claims acquired. The Company will license its intellectual property to the New Servicer in exchange for a license fee of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5c461bc-17f1-453f-9ce1-050fc9e3eb9f" contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688" name="mspr:LicenseFeePercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">17.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of New Servicer&#8217;s excess cash flow, with a minimum fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3d2f1ea4-0d6c-47d0-afb3-4f0e343f85dd" contextRef="C_16f268f8-c0e0-4f58-8d27-bfb1180e5347" name="mspr:MinimumFeePaid" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal"><ix:nonFraction id="F_195d1308-bb2d-4972-bc68-5ea91b5ded17" contextRef="C_c23753ff-91ab-40d0-869b-679d87defcd8" name="mspr:MinimumFeePaid" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">1.55</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million paid on May 30, 2025, and June 30, 2025. New Servicer will be funded by an affiliate of Hazel (hereinafter, &#8220;Funder&#8221;), up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68c824a6-2edd-4e42-b426-4432956986fb" contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688" name="mspr:FundedForAdditionalClaims" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in funding, as set forth below, with a right of first refusal for additional funding needs. New Servicer will be independently managed and be separately governed by an independent board of directors, including a chief executive officer chosen by Funder and consented to by the Company, one director chosen by the Company, and one independent director chosen by Funder and approved by the Company. Funder&#8217;s governance rights shall terminate once all Hazel loans have been repaid in full, and Funder&#8217;s Recovery Rights Interest (as defined below) in the New Servicer is less than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4fb79c0-8b7a-43dc-8a2b-d3b09e30bdd8" contextRef="C_d0089042-c0e3-454a-8c16-1481457cdcac" name="mspr:LoansRepaymentPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%. Virage shall have observer rights to the New Servicer board of directors until the amounts owed to Virage pursuant to the Master Transaction Agreement dated March 9, 2022, as amended (the &#8220;MTA&#8221;), which was approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c53c4c8-4a3e-42cd-aa69-45694d267a7c" contextRef="C_24c05dee-37c3-47dd-b886-8f4b407eef55" name="mspr:AmountsReceivedToToTheMasterTransactionAgreement" unitRef="U_USD" scale="9" decimals="-8" format="ixt:num-dot-decimal">1.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;VRM Full Return&#8221;) has been repaid and Virage&#8217;s equity interest in the Company is less than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f2452483-eca0-47a7-9a3f-dc72c3c78449" contextRef="C_97164373-b267-4695-841a-94d63fab565c" name="mspr:LoansRepaymentPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Working Capital Funding for the New Servicer</span></div></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Funder has agreed to extend a line of credit to New Servicer of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c0600fd-fbb6-4656-9017-3b8fda5aef8d" contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="INF" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, funded in tranches of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_46356be8-5271-4f7e-bed1-fbbe9ac0da2c" contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688" name="mspr:LineOfCreditFundedInTranchesPerMonth" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">1.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million per month, subject to the New Servicer meeting certain milestones (which are currently being negotiated and to be agreed in definitive documentation), beginning September 2025, with a maturity date of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2d897482-fb94-40a5-a5c5-4ad01541f079" contextRef="C_1e01a200-c2e8-4634-9efe-10da04e93fb6" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2027</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. New Servicer funding will accrue interest at the Secured Overnight Financing Rate (&#8220;</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1094ec3c-3994-4e86-9062-4c0d05c077e7;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SOFR</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;) plus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b48d703-ed95-43c1-932a-ec7ab76eac30" contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688" name="mspr:AccruedInterestPercentageInYearOne" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum for one year, and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_d7edfda9-d03e-48a1-be13-3f45acb6f141;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SOFR</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> plus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dcc4fe97-8bd0-4207-9aee-3a9101f18792" contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688" name="mspr:AccruedInterestPercentageAfterOneYear" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% thereafter. Funder will establish a first lien on the New Servicer; the Company will not guaranty the loan to fund New Servicer.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, Funder or Hazel is entitled to receive to up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_313aa4a2-c997-4976-ae4c-7a0a1f0592c2" contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688" name="mspr:RecoveryRightsInterestExcessCashFlowPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">35</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of New Servicer&#8217;s excess cash flow (the &#8220;Recovery Rights Interest&#8221;). At its option, Funder may convert, in whole or part, its Recovery Rights Interest for up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ee09995-2dc9-40ca-b726-bdc5b1ec52dc" contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688" name="mspr:RecoveryRightsInterest" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">30</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the then outstanding shares of Company&#8217;s equity, measured as of the Closing and subject to dilution for stock issuance thereafter.</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Additional Bridge Financing for the Company</span></div></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, Hazel agreed to provide up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd2c3bfa-431b-4f16-88a5-9e22b0aca234" contextRef="C_8d558395-7c90-405f-a7c4-dc8b67120549" name="us-gaap:BridgeLoan" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">9.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in bridge loan funding to the Company under the existing Operational Collection Floor facility (in addition to the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8bdfaa9e-e024-4086-a4c0-c9962df5c96c" contextRef="C_8d558395-7c90-405f-a7c4-dc8b67120549" name="mspr:AdditionalBridgeLoan" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">16.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million previously funded under the facility) in the amounts of: (i) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_383718bd-1384-4cd1-89d8-8aaf82bac955" contextRef="C_88fe5d42-7072-4d23-aaf0-bcc6834ff66f" name="us-gaap:BridgeLoan" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">1.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for March 2025, which was funded on February 28, 2025; (ii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b697473-88b5-4394-bf50-66aa6d957477" contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688" name="us-gaap:BridgeLoan" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for April 2025, which was funded on April 4, 2025; (iii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3c6d451-9f87-473d-ae19-7c4557c1b0e4" contextRef="C_23a8a03a-394f-4c24-88aa-cfe8564c686c" name="us-gaap:BridgeLoan" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for May 2025, to be funded on or about April 30, 2025; (iv) up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e757fbc-2296-473f-83e8-bddab94ba74a" contextRef="C_0d4a0973-f818-41cd-a1c5-5c03e254d884" name="us-gaap:BridgeLoan" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to fund the legal, accounting, and administrative expenses associated with the reorganization, subject to certain terms and customary conditions acceptable to Hazel, and minimum license fees of (v) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_107b0200-a9a4-4d47-9c1f-5f8e49fb275b" contextRef="C_c23753ff-91ab-40d0-869b-679d87defcd8" name="us-gaap:BridgeLoan" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">1.55</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for June 2025; and (vii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37fe2928-01ca-4274-9524-a3f9bf52b7af" contextRef="C_82042595-d2ec-46bd-8d33-1d9c1c5fcd8a" name="us-gaap:BridgeLoan" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">1.55</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for July 2025. Funding is conditional, in part, on an increase in the pledge of collateral and personal guaranty by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e80918e-95f4-428d-850d-c9ca44b5f08a" contextRef="C_2a65b7e7-25a4-4784-a0df-3b3fc40b9b39" name="us-gaap:BridgeLoan" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">9.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million by Messrs. Ruiz and Quesada (the &#8220;MSP Principals&#8221;). Such minimum license fee payment will be paid from the Bridge Loan.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beyond July 2025, the MSP Principals have committed to pledge $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_394b1780-5ff6-4702-a34b-46051454ef6c" contextRef="C_2a65b7e7-25a4-4784-a0df-3b3fc40b9b39" name="us-gaap:OtherCommitment" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of collateral to backstop additional working capital requirements of the Company, in addition to other previous sources of funding, including cash proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA, and the proceeds from claims recoveries, subject to lien repayment on certain claims. In addition, the Company expects annual costs reductions due to New Servicer operations and shall be funded by the Funder (through New Servicer).</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Term Sheet requires (and is conditioned upon) La Ley con John H. Ruiz, P.A. d/b/a MSP Recovery Law Firm and MSP Law Firm, PLLC, collectively, raising $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91ba6499-7ac5-429b-80f5-54f8f2ba67a0" contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688" name="mspr:OperationalFunding" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for operational funding over two years, subject to similar milestones (to be agreed upon) as per the New Servicer funding, and to be entered into at completion of the proposed transaction.</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt Restructuring</span></div></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In exchange for a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe643977-af12-4ea7-90c2-23e587f5041b" contextRef="C_6914b62b-8ebd-492e-9751-a059c6e34653" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">43</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest in the Company (inclusive of shares currently held and those shares acquired through warrant exercises pursuant to the Virage Term Sheet discussed below) Virage has agreed to waive all claims and release all liens against the Company relating to the VRM Full Return (approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7018eaf2-bf8d-4d51-abe2-345b393a3789" contextRef="C_24c05dee-37c3-47dd-b886-8f4b407eef55" name="mspr:AmountsReceivedToToTheMasterTransactionAgreement" unitRef="U_USD" scale="9" decimals="-8" format="ixt:num-dot-decimal">1.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), and the Parties agree that the VRM Full Return will be paid only from: (i) a junior lien against Subrogation Holdings proceeds, (ii) claims currently owned by Virage, (iii) liens over two tranches of claims currently owned by Hazel (which Hazel shall release as part of the reorganization transaction) and (iv) a non-recourse second lien up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7ad43cd-b555-48fe-a872-f39686e26ab5" contextRef="C_93c831d9-6dfd-4340-ab2a-da4af19391f3" name="mspr:Non-RecourseDebtSecondLienAmount" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million over </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_437ed781-28f8-4894-a542-de15134f386c" contextRef="C_ba798111-eacc-4c32-969b-07c6da1f0336" name="mspr:PercentageOfGrantProceedsToExtentFullReturnNotRepaid" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the proceeds from the New Servicer and associated SPVs, to the extent that the VRM Full Return has not been repaid.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the MSP Principals have agreed to convert </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c6fba2d-7c49-4de8-82ae-3cb02a865437" contextRef="C_9a7a94af-f271-43a1-89d2-fb92e5b46edd" name="us-gaap:DebtConversionConvertedInstrumentRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the Company&#8217;s debt obligation to them, totaling approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d16e745-1dbb-45ac-bf0d-270620f81b2d" contextRef="C_2007c22d-ce55-459e-b965-217365e43f85" name="us-gaap:DebtConversionConvertedInstrumentAmount1" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">144</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, into shares of the Company&#8217;s Class A Common Stock, the full and final amount of the debt-to-equity conversion is subject to tax analysis and approval of the MSP Principals and the Company&#8217;s Board of Directors.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Hazel&#8217;s existing loans to Subrogation Holdings and the amount of Company&#8217;s guaranty (currently approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4938ebf3-5bb1-421a-8408-a687c104832b" contextRef="C_cc4d14e4-5132-4152-bdd4-d68740ba0480" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million) remain unchanged except that such lien shall now exclude the Company&#8217;s intellectual property. Hazel agreed, subject to obtaining third-party consents, to extend the maturity date on all outstanding obligations to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8a551566-3ad5-43d4-bf18-443c01743cef" contextRef="C_0fff79a6-2fca-469c-b4ba-d88fff8a1879" name="mspr:DebtInstrumentsExtendedMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 30, 2026</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To secure the repayment of the existing</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">111</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_d41d7044-890b-4eea-b914-30ed7406c2da_2" continuedAt="F_d41d7044-890b-4eea-b914-30ed7406c2da_3"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Hazel </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">loans to the extent such loans have not been repaid in full, the Company shall, for a principal amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_912ff67c-66bd-4b1b-a985-1d3fc05b418e" contextRef="C_019f56fe-b87d-4bf1-9a97-950481da89e1" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">235</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million with an interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_4e424096-b0c4-45a8-94c2-f9386f78d00b;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SOFR</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> plus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d9ac644-9561-4616-bb13-624c2c9e406c" contextRef="C_cc4d14e4-5132-4152-bdd4-d68740ba0480" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum: (i) pledge to Hazel </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2518ebad-92f1-4a60-a27c-1d2ae9c6e609" contextRef="C_0fff79a6-2fca-469c-b4ba-d88fff8a1879" name="mspr:PercentageOfPledge" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">50.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the New Servicer and associated SPV equity interests; and (ii) grant a lien over </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed2eb785-3afe-4d13-aa71-8adeec82009a" contextRef="C_1e01a200-c2e8-4634-9efe-10da04e93fb6" name="mspr:PercentageOfProceedsFromGrantLien" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the proceeds from New Servicer and associated SPVs, once the New Servicer funding has been repaid. In addition, to the extent the VRM Full Return has not been repaid, Virage has second lien of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d5f2859-505d-43cb-bcdb-e25f2bef1e07" contextRef="C_93c831d9-6dfd-4340-ab2a-da4af19391f3" name="mspr:Non-RecourseDebtSecondLienAmount" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million over </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f96c8e7-8879-4550-b4f2-20e4ef011ff7" contextRef="C_ba798111-eacc-4c32-969b-07c6da1f0336" name="mspr:PercentageOfGrantProceedsToExtentFullReturnNotRepaid" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the proceeds from New Servicer and associated SPVs.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 13, 2025, the Board delegated to an independent committee of the Board of Directors (the &#8220;Independent Committee&#8221;) the power and authority to, among other things, determine on behalf of the Board and the Company whether, to the extent any conflicts or potential conflicts exist or arise in the future among the Company and Messrs. Ruiz and Quesada, certain Restructuring and Proposals are advisable and fair to, and in the best interests of, the Company and its stockholders. The Independent Committee reviewed the Term Sheet and engaged legal counsel and financial advisors that are familiar with the Company and restructuring transactions to determine if the Term Sheet is advisable and fair, and in the best interests of the Company and its stockholders. Although the Independent Committee identified material conflicts, those conflicts involve conditions precedent to the Term Sheet, and are resolvable to the satisfaction of the Independent Committee in furtherance of the Term Sheet and in the best interest of the Company; as such, the Independent Committee determined that it is advisable and in the best interests of the Company to approve the signing of the Term Sheet and subsequent entry into agreements consistent with the terms set forth therein.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Term Sheet, the parties are working to complete the definitive agreements by April 30, 2025.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VRM Warrant Issuance and Restructuring</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the first Amendment to the Master Transaction Agreement, dated April 11, 2023 (the &#8220;First Amendment&#8221;), for each calendar month beginning with January 31, 2024 and ending when the VRM Full Return (as defined in the Master Transaction Agreement dated March 9, 2022 (as amended, the &#8220;MTA&#8221;)) is paid in full, the Company is required to either: (i) pay in cash or (ii) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4469199e-744e-4ec9-9e70-879d98bc8912" contextRef="C_1bdb4676-b3b4-49b4-a184-8e7118c0d4af" name="us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">issue a warrant to purchase a number of shares of Class A Common Stock of the Company, or some combination thereof, to Virage Recovery Master LP (&#8220;VRM&#8221;) equal to the quotient of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d07d47c4-768a-416a-8e0e-309c9ace6a57" contextRef="C_1bdb4676-b3b4-49b4-a184-8e7118c0d4af" name="mspr:PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the calendar month-end balance of the Unpaid Base Amount (as defined in the MTA) (the &#8220;Required Monthly Issuance&#8221;).</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> On Apri</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">l 14,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 2025, the Company issued VRM Monthly Warrants for November 2024 and December 2024, for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e64cf72d-eb3d-41f6-9f06-bd98c1aafba3" contextRef="C_b2b2ecfa-79d0-47aa-8ded-ad13037b27b6" name="mspr:NumberOfWarrantsIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,277,808</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2383030c-f3ac-4d66-919c-f650f1da1086" contextRef="C_50aeca4c-0cc0-40a9-95d1-4f6f9ca8d58b" name="mspr:NumberOfWarrantsIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,332,792</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares respectively, exercisable at a purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_24e7cec7-1e8d-475b-aa13-93443024eef0" contextRef="C_eb9380b7-557e-4277-b64d-8fa02512fa54" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_82a81d4e-732e-4940-9689-f0d46c9b4bbf" contextRef="C_eb9380b7-557e-4277-b64d-8fa02512fa54" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">two years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the original issuance date, exercisable on a cashless basis only. To date, the Company has issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c19c3814-7f9c-4cba-b7cf-9f8f38691853" contextRef="C_eb9380b7-557e-4277-b64d-8fa02512fa54" name="mspr:NumberOfWarrantsIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">12</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants to VRM pursuant to the First Amendment, entitling Virage to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98dbb897-30c5-46e9-96ae-cfdcaf6fcdd2" contextRef="C_eb9380b7-557e-4277-b64d-8fa02512fa54" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">19,361,939</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with negotiations to restructure the Company&#8217;s obligations under the MTA, on February 18, 2025, the Company entered into a term sheet agreement with Virage (the &#8220;Virage Term Sheet&#8221;) to amend the MTA, whereby Virage and the Company agreed, subject to certain conditions, which have not been met as of the date of this Annual Report on Form 10-K, to enter into definitive documentation at a later date to: (i) exercise the VRM Warrants to purchase that number of shares that would result in Virage owning </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_6c011bf9-0559-4a17-8cc8-0125ab18a42f;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33 1/3</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the then issued and outstanding Common Stock (the &#8220;Warrant Exercise&#8221;), (ii) surrender to the Company any remaining unexercised VRM Warrants, or portions thereof, for termination, (iii) contemporaneous with the Warrant Exercise, terminate its agreement to hold no more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3942b4e5-062b-469f-83aa-3cfea6954d01" contextRef="C_096f06bd-fa6c-4347-b329-d00e63925c9f" name="mspr:ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding Common Stock of the Company, (iv) subject to certain conditions, grant proxy voting rights to the MRCS Principals over an amount of shares of Common Stock issuable to Virage from the Warrant Exercise such that the MRCS Principals will have voting control over </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4a6d719-1098-4a18-83d9-f17d31975f18" contextRef="C_3141ef96-8081-408d-8688-cac679df2dcc" name="mspr:ClassOfWarrantOrRightOutstandingVotingPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">51</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total outstanding Parent Class A Common Stock, and (v) terminate any obligation of the Company to satisfy the Required Monthly Issuance. These proposed transactions under the Virage Term Sheet are subject to, among other things, further negotiation and the execution of definitive agreements, regulatory approvals, and shareholder approvals if required by the Nasdaq Stock Market; as a result, there can be no guarantee that the transactions thereby will be consummated.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Yorkville Amendments</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the close of Primary Market trading on October 18, 2024, the daily VWAP for MSP Recovery, Inc.&#8217;s (the &#8220;Company&#8221;) Class A Common Stock was below the Floor Price (which is $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f07a6886-b0fc-4cea-bbe6-140b64a22599" contextRef="C_32d5fd3f-18ff-44f6-bea9-54478be0fe12" name="mspr:FloorPriceOfACommonStock" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), as defined in the Exchangeable Promissory Notes (&#8220;Notes&#8221;) issued to YA II PN, Ltd. (&#8220;Yorkville&#8221;) pursuant to the Standby Equity Purchase Agreement dated November 14, 2023, as amended (the &#8220;SEPA&#8221;), by and between Yorkville and the Company, for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_542a1eba-99bc-4882-acf5-7dc8c5c3ba38" contextRef="C_62435c4d-78b1-4259-85bd-74e491eb2245" name="mspr:NumberOfConsecutiveTradingDays" unitRef="U_Days" decimals="0" format="ixt-sec:numwordsen">ten</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> consecutive Trading Days, resulting in a Floor Price Trigger pursuant to the Notes.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon the occurrence of a Trigger Event, the Company shall make monthly payments (&#8220;Monthly Payments&#8221;) beginning on the 7th Trading Day after the date of the Trigger Event and continuing on the same day of each successive month.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 10, 2025, Yorkville agreed: (i) that the first Monthly Payment, as set forth in Section (1)(c) of the Notes, would be due from the Company no sooner than November 30, 2026, (ii) the maturity date of the Convertible Notes is extended to November 30, 2026, and (iii) to waive Volume Threshold and Maximum Advance Amount limitations set forth in the Yorkville SEPA.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Capitalized but undefined terms have the same meaning as set forth in the Yorkville SEPA and the Notes.</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">112</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_d41d7044-890b-4eea-b914-30ed7406c2da_3"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">LSA Amendment</span></p><p style="text-indent:36pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 14, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2025, Lionheart II Holdings, LLC (&#8220;Lionheart&#8221;), a wholly owned subsidiary of the Company, entered into Amendment No. 1 to its Legal Services Agreement with La Ley con John H. Ruiz, P.A. d/b/a MSP Recovery Law Firm (&#8220;La Ley&#8221;), and MSP Law Firm, PLLC (collectively with La Ley, &#8220;Law Firm&#8221;), which: (i) terminates any obligation by the Company or its subsidiaries to provide further advances to fund the Law Firm, and provides that any Compensation earned by the Law Firm will be first used to repay the Advance Balance to Lionheart.</span></p></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">113</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item9"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item9a"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9A</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Controls and Procedures.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Evaluation of Disclosure Controls and Procedures</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We maintain disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act that are designed to ensure that information required to be disclosed by us in reports that we file under the Exchange Act is recorded, processed, summarized and reported as specified in the SEC&#8217;s rules and forms and that such information required to be disclosed by us in reports that we file under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. We evaluated the effectiveness of our disclosure controls and procedures and based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the Company&#8217;s disclosure controls and procedures were effective as of December 31, 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Report on Internal Control over Financial Reporting</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Exchange Act Rules 13a-15(f) and 15d-15(f). These internal controls are designed to provide reasonable assurance that the reported financial information is presented fairly, that disclosures are adequate and that the judgments inherent in the preparation of financial statements are reasonable. There are inherent limitations in the effectiveness of any system of internal controls including the possibility of human error and overriding of controls. Consequently, an effective internal control system can only provide reasonable, not absolute, assurance with respect to reporting financial information.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our internal control over financial reporting includes policies and procedures that: (i) pertain to maintaining records that, in reasonable detail, accurately and fairly reflect our transactions; (ii) provide reasonable assurance that transactions are recorded as necessary for preparation of our financial statements in accordance with generally accepted accounting principles and that the receipts and expenditures of company assets are made in accordance with our management and directors authorization; and (iii) provide reasonable assurance regarding the prevention of or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on our financial statements.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the supervision of management, including our Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and subsequent guidance prepared by the Commission specifically for smaller public companies as of December 31, 2024. Based on that evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that our internal controls over financial reporting were effective as of December 31, 2024.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Remediation of Material Weaknesses Previously Reporting</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As disclosed in Item 9A. Controls and Procedures in our Annual Report on Form 10-K for the year ended December 31, 2023, we identified material weaknesses in internal control related to the ineffective design and operation of controls in the human resources and payroll process and the accounting for contract terminations. Following the identification of the material weaknesses, we commenced remediation efforts that continued during 2024 to enhance our control environment.</span></p><div class="item-list-element-wrapper" style="margin-left:0.34027777777777773in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.793752553345275%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Key steps in our remediation efforts over the deficiencies noted in our human resources and payroll processes included:</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.55in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.87804720126906%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Implementing additional compensating controls to mitigate user access conflicts within the payroll system.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.55in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.87804720126906%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Utilizing a third-party payroll services processer for fiscal year 2024 that undergoes System and Organization Controls (SOC) audit processes and reviewing their SOC report.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.55in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.87804720126906%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Enhancing the design and operation of controls over the review and approval of payroll entries and payroll processing.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.34027777777777773in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.793752553345275%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Key steps in our remediation efforts over the deficiency noted in our accounting for contract terminations process included:</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.55in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:2.87804720126906%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">o</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Implementing process enhancements and controls to facilitate timely communications between the legal and accounting departments to ensure proper accounting treatment for new, amended, and terminated contracts.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management has concluded that the new and redesigned controls are operating effectively and have operated for a sufficient period of time to consider the material weaknesses reported as of December 31, 2023 remediated.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Form 10-K does not include an attestation report of our independent registered public accounting firm due to an exemption established by the JOBS Act for &#8220;emerging growth companies.&#8221;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">114</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While our independent registered public accounting firm is not required to audit the effectiveness of our internal control over financial reporting until after we are no longer an &#8220;emerging growth company&#8221; as defined in the JOBS Act, a failure to design, implement or maintain effective internal control over financial reporting could adversely affect the results of annual independent registered public accounting firm audit reports regarding the effectiveness of the Company&#8217;s internal control over financial reporting that we will eventually be required to include in reports that will be filed with the SEC. If one or more material weaknesses in the Company&#8217;s internal control over financial reporting exist, this could have a material and adverse effect on our business, results of operations and financial condition, and it could cause a decline in the trading price of the Company&#8217;s Class A common stock.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in Internal Control Over Financial Reporting</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other than the remediation of the material weaknesses discussed above, there were no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item9b"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9B</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Other Information.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Yorkville Letter Agreement</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 12, 2024, Yorkville agreed that, to the extent that it holds Class A Common Stock in such quantities that would prevent the Company from utilizing the SEPA solely due to the Ownership Limitation, Yorkville commits to fund an additional advance in the principal amount of $13.0 million on the same terms and conditions as the previous advances pursuant to the Yorkville SEPA.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exchange Act Rule 10b5-1</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_757dabb5-ba0e-403a-bd7a-e3bc38d93a3a" contextRef="C_6fc20ca9-1ab2-42c7-8e99-0cc58496a91f" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_91a3288a-abbc-424e-b5fd-9a31078a3e34" contextRef="C_6fc20ca9-1ab2-42c7-8e99-0cc58496a91f" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_b0ba318a-f959-4484-8a3f-7ee92cb749b6" contextRef="C_6fc20ca9-1ab2-42c7-8e99-0cc58496a91f" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_34ba0c4a-9a11-4e36-811b-1ddbec5a3abb" contextRef="C_6fc20ca9-1ab2-42c7-8e99-0cc58496a91f" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">no</span></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> officer or director of the Company adopted or terminated any contract, instruction, or written plan for the purchase or sale of securities of the Company&#8217;s common stock that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) or any non-Rule 10b5-1 trading arrangement as defined in 17 CFR &#167; 229.408(c).</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9c_disclosure_regarding_foreign"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9C. Disclosure Regarding Fo</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reign Jurisdiction that Prevent Inspections.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">115</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART III</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;" id="item10"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 10</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Directors, Executive Officers and Corporate Governance.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management and Board of Directors</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following sets forth certain information, as of April 8, 2025, concerning the persons who serve as executive officers and members of the Board following.</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:46.44%;box-sizing:content-box;"/>
     <td style="width:14.68%;box-sizing:content-box;"/>
     <td style="width:38.88%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Directors</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Age</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Position</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">John H. Ruiz</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Class III Director</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Frank C. Quesada</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Class III Director</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Ophir Sternberg</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">54</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Class III Director</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Beatriz Maria Assapimonwait</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">62</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Class I Director</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Michael Arrigo</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">66</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Class II Director</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thomas Hawkins</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Class II Director</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Roger Meltzer</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Class I Director</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Executive Officers</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Position</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">John H. Ruiz</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Frank C. Quesada</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Legal Officer</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Ricardo Rivera</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Operating Officer</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Alexandra Plasencia</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General Counsel</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Francisco Rivas-V&#225;squez</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information about Executive Officers and Directors</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Directors</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">John H. Ruiz</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Experience</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: John H. Ruiz is a founder of MSP Recovery, and has served as Chief Executive Officer since the Company&#8217;s inception (in 2014 as MSP Recovery). Mr. Ruiz was named one of Lawyers of Distinction&#8217;s &#8220;2023 Power Lawyers,&#8221; for his accomplishments in healthcare law. He was also named &#8220;2019&#8217;s DBR Florida Trailblazer,&#8221; for his work in integrating data analytics into the practice of law, and for its positive impact on healthcare recoveries across the mainland U.S. and Puerto Rico. Over the course of his 30-year legal career, Mr. Ruiz has gained national recognition in class action, mass tort litigation, MDL consolidated cases, medical malpractice, products liability, personal injury, real estate, and aviation disaster cases. Recently, Mr. Ruiz led the legal strategy in the landmark victory handed down by the U.S. Court of Appeals for the Eleventh Circuit, in MSP Recovery Claims Series v. Ace American (11th Cir.). In addition, he has certified more than 100 class actions and led MSP&#8217;s participation in Humana v. Western Heritage (11th Cir.), MSP Recovery v. Allstate (11th Cir.), and MSPA Claims 1, LLC v. Kingsway Amigo Ins. Co. (11th Cir.). Mr. Ruiz has been involved as counsel in cases that have totaled more than $20 billion in settlements. These class actions resulted in some of the largest awards in Florida against major insurance companies. In total, Mr. Ruiz has certified class actions against major car insurers in the State of Florida, resulting in the current and potential redistribution of billions of dollars in improperly paid claims spanning a period of more than 10 years. Starting as early as 1996, Mr. Ruiz filed class-action lawsuits on behalf of more than 30,000 Miami-Dade County residents against the Florida Department of Agriculture for trespassing onto the private properties of homeowners and chopping down their citrus trees without any compensation. The case was ultimately certified, and the Department of Agriculture directly compensated all members of the aggrieved class. In 2001, Mr. Ruiz represented consumers in a class action lawsuit against Firestone that resulted in dozens of fatalities and thousands of serious blowouts. Mr. Ruiz was also hired as local counsel by numerous out of state law firms that had pending cases in Florida courts. The cases in aggregate settled for more than $30 million. Mr. Ruiz also represented the families of crash victims in a wrongful death suit against Chalk&#8217;s International Ocean Airway. Mr. Ruiz was the first lawyer to file a limited fund class action. The case settled for a confidential agreed amount. Mr. Ruiz is licensed to practice before the Court of Appeals for the Fourth Circuit, the US Court of Appeals for the Second Circuit, the US Court of Appeals for the Third Circuit, and the Florida Supreme Court.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Skills &amp; Expertise</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Mr. Ruiz brings to the Board leadership, legal, strategic, operational, brand management, and data analytics expertise from his expansive legal career, business background, and use of technology in his law practice. He has experience formulating legal strategy and case development from his work leading La Ley con John H. Ruiz. Mr. Ruiz has vast leadership and business strategy experience having founded or led companies across a variety of sectors, including legal, media, aviation, and manufacturing companies. Mr. Ruiz designed and developed information systems that streamlined his law practice and algorithms that analyze terabytes of data to identify and pursue recoveries in a variety of lawsuits. Mr. Ruiz&#8217;s mastery of brand development is evidenced by his pioneering of panel format television and radio to reach audiences, and his development of programs to raise brand awareness through college athlete spokespersons.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">116</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Frank C. Quesada</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Experience</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Frank C. Quesada is a founding member of MSP Recovery, and has served as Chief Legal Officer since its inception. Mr. Quesada is also a Partner at MSP Recovery Law Firm. With over 16 years of healthcare and complex commercial litigation experience, Mr. Quesada oversees the Company&#8217;s in-house attorneys and several nationally recognized law firms that assist MSP Recovery Law Firm in their recovery efforts. Additionally, he develops legal strategies and spearheads execution. Notably, Mr. Quesada led the execution of federal appellate strategies in MSP Recovery cases resulting in landmark legal victories and new Medicare Secondary Payer Act precedent benefitting Medicare entities across the country. These legal victories include </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSP Recovery v. Allstate</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (11th Cir.), </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSPA Claims 1 v. Tenet</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (11th Cir.), </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSPA Claims 1 v. Kingsway Amigo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (11th Cir.), and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSP Recovery Claims Series v. Ace American</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (11th Cir.). Mr. Quesada currently serves on the Board of Directors of USA Water Polo, Inc.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Skills &amp; Expertise</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Mr. Quesada brings to the Board leadership, legal, strategic, operational, governmental, business development, and data analytics expertise. Mr. Quesada brings a depth of legal and strategic experience from years of complex commercial litigation. Having served in elected office, Mr. Quesada leverages years of experience navigating the political landscape, creating and influencing policy. This experience carries over to the business world, making Mr. Quesada an effective communicator and advocate on behalf of the Company with bankers and potential clients. Prior to the Company and MSP Recovery Law Firm, Mr. Quesada managed his own law firm, overseeing attorneys with a substantial case load in the hospitality industry.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ophir Sternberg</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Experience</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Ophir Sternberg is a Board Member of the Company, and was previously the Chairman, President and Chief Executive Officer of Lionheart Acquisition Corporation II, the SPAC through which MSPR became a publicly traded company. Mr. Sternberg is the Founder and Chief Executive Officer of Miami/Fort Lauderdale based Lionheart Capital, founded in 2010. Mr. Sternberg began his career assembling, acquiring, and developing properties in emerging neighborhoods in New York City, which established his reputation for identifying assets with unrealized potential and combining innovative partnerships with efficient financing structures to realize above average returns. Mr. Sternberg came to the United States in 1993 after completing three years of military service within an elite combat unit for the Israeli Defense Forces. In March 2020, Mr. Sternberg became Chairman of Nasdaq-listed OPES, and on June 30, 2020, announced the SPAC&#8217;s initial business combination with BurgerFi, a fast-casual &#8220;better burger&#8221; concept that consists of approximately 120 restaurants nationally and internationally. The OPES-BurgerFi business combination closed on December 16, 2020 and Mr. Sternberg is the Executive Chairman of the post-combination Nasdaq-listed company, BurgerFi International, Inc. On October 11, 2021, BurgerFi, led by Ophir Sternberg as Executive Chairman, announced the acquisition of Anthony&#8217;s Coal Fired Pizza &amp; Wings, creating a multi-brand platform of premium casual restaurant concepts. With the acquisition of Anthony&#8217;s, BurgerFi now has 180 systemwide restaurant locations across the country through its two premium casual dining brands, with 61 Anthony&#8217;s locations and 119 BurgerFi locations. Mr. Sternberg is also the Chairman, President, and Chief Executive Officer of Lionheart III Corp, a SPAC that was originally formed for a $100 million raise, but on November 8, 2021, closed on its initial public offering at an upsized $125 million. Lionheart III Corp, under the ticker symbol LION, was welcomed into the Nasdaq family. On July 26, 2022, Lionheart III announced its business combination agreement with Security Matters Limited (&#8220;SMX&#8221;) (ASX:SMX), a publicly traded company on the Australian Securities Exchange, bringing the expected combined entity value to $360M. SMX creates a sustainable system within the current supply chain, designed for the 21st century economy. The SMX business combination closed on March 8, 2023.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Skills &amp; Expertise</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Mr. Sternberg brings to the Board leadership, strategic, operational, finance and business structuring, and capital markets experience. Mr. Sternberg is qualified to serve as a director due to his extensive experience in both the public and private company sectors. Having successfully launched a number of public companies, Mr. Sternberg is intimately familiar with the capital markets and large-scale financing. Mr. Sternberg serves on the board of several public companies, and has led successful corporate growth strategies. Mr. Sternberg&#8217;s leadership qualities are demonstrated in his leadership positions over a variety of business sectors, including healthcare, hospitality, and technology.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beatriz Assapimonwait</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Experience</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Beatriz (Betty) Assapimonwait has over 40 years of experience in the managed health care industry. Ms. Assapimonwait was, up until August 2021, Regional President for the South Florida region at Humana Inc. (NYSE:HUM) (&#8220;Humana&#8221;), one of the largest private insurance health insurers in the U.S. with a focus on administering Medicare Advantage plans. In her role at Humana, Ms. Assapimonwait was responsible for developing market strategies and leading all market operations for all Medicare lines of business, including HMOs and PPOs for the South Florida region. Prior to her role at Humana, she served as CEO of Family Physicians of Winter Park, Inc., until its acquisition by Humana, where from December 2016 to July 2019, she led the strategic and operational efforts of a global risk MSO with 22 primary clinics in the Central Florida Region. Additionally, she served as the Vice President of Medicare Advantage Prescription Drug Plans at Aetna, Inc. from November 2014 to November 2016; Chief Operations Officer at Innovacare Health, from January 2014 to October 2014; Founder and President of Seven Stars Quality Healthcare, from July 2013 to December 2013; and Regional President for the North Florida region at Humana, from January 2009 to June 2013. Ms. Assapimonwait was appointed to serve on the board of directors of CareMax, Inc. (Nasdaq:CMAX) and also serves as the Chair of the Strategy and Operations Committee since September 2021. She earned her Bachelor of Arts degree from Florida International University</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">117</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in 1983, and is certified in Healthcare Compliance by the Health Care Compliance Association and in HIPAA Compliance from Kennesaw State University. She has won several awards and commendations, including being a Stevie Award Finalist of the American Business Awards for Best Customer Service Organization in 2004 and appointed Preceptor and Clinical Adjunct Faculty for the Healthcare Administration Program in 1997 at the University of Houston-Clear Lake.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Skills &amp; Expertise</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Ms. Assapimonwait brings to the Board leadership, strategic, operational, and healthcare industry experience. A proven effective leader, Ms. Assapimonwait has served in director and officer positions for large-scale healthcare companies, leading strategy and operations initiatives. Ms. Assapimonwait has relevant experience in the pharmaceutical industry and with Medicare Advantage drug plans.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Michael F. Arrigo</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Experience</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Michael F. Arrigo is a co-founder and the chief executive officer of No World Borders, Inc., a healthcare data, regulations, and economics firm with clients in the pharmaceutical, medical device, hospital, surgical center, physician group, diagnostic imaging, laboratory and genetic testing, health information technology, and health insurance markets. In his role at No World Borders, Inc., Mr. Arrigo advises MAOs who provide health insurance under Part C of the Medicare Act and serves as an expert witness regarding medical coding and medical billing, fraud damages, HIPAA privacy, and Electronic Health Record software. Prior to his current role, Mr. Arrigo served as Vice President at First American Financial (NYSE: FAF) from October 2002 to February 2007, overseeing eCommerce and regulatory compliance technology initiatives for top mortgage banks; Vice President of Fidelity National Financial (NYSE: FNF) from 2002 to 2003; chief executive officer of one of the first cloud-based billing software companies, Erogo, from 2000 to 2002; Vice President of Marketing for an email encryption and security software company until its acquisition by a company that merged into Axway Software SA (Euronext: AXW.PA) from 1999 to 2000; CEO of LeadersOnline, an online recruiting venture of Heidrick &amp; Struggles from 1997 to 1999; management consultant to Hewlett Packard, Oracle, and Symantec from 1994 to 1997; Vice President of Marketing for a software company acquired by a company that merged into Cincom Systems from 1992 to 1994; Product Manager at Ashton-Tate from 1987 to 1992 responsible for database software products including Microsoft/Sybase SQL Server. Mr. Arrigo earned his Bachelor of Science in Business Administration from the University of Southern California in 1981. His post-graduate studies include biomedical ethics at Harvard Medical School, biomedical informatics at Stanford Medical School, blockchain and crypto-economics at the Massachusetts Institute of Technology, and training as a Certified Professional Medical Auditor (CPMA).</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Skills &amp; Expertise</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Mr. Arrigo brings to the Board leadership, strategic, regulatory, information technology, finance, and Medicare Advantage industry experience. Mr. Arrigo has broad business experience. A data specialist, Mr. Arrigo is intimately familiar with data management and analysis and across the healthcare industry spectrum. He is admitted as an expert in court in healthcare privacy and cybersecurity (commonly known as HIPAA and the companion regulations such as the ARRA HITECH Act) and led the Sarbanes Oxley internal audit for a public Fortune 100 firm in compliance with the Public Company Accounting Oversight Board (PCAOB) Standards. He qualifies as a financial expert as defined in Item 407(d)(5) of Regulation S-K promulgated under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Mr. Arrigo has also been admitted by courts as an expert in fair market value physician compensation and corporate governance. Having served in senior leadership positions at variety of information technology and finance companies, Mr. Arrigo is a proven valuable advisor and strategist.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Thomas W. Hawkins</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Experience</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Since March 2023, Thomas Hawkins has served on the board of directors of SMX (Security Matters) Public Limited Company, a technology company that enables materials to carry a history that can be authenticated through organization, use, recycle, and multiple reuse cycles; he is also a member of the company&#8217;s Risk and Audit Committee. Mr. Hawkins previously served as a Management Consultant for MEDNAX, Inc. from February 2014 to December 2017, after serving as General Counsel and Board Secretary from April 2003 to August 2012. Prior to that, Mr. Hawkins worked for New River Capital Partners as a Partner from January 2000 to March 2003; AutoNation, Inc. as Senior Vice President of Corporate Development from May 1996 to December 1999; Viacom, Inc. as Executive Vice President from September 1994 to May 1996; and Blockbuster Entertainment Corporation as Senior Vice President, General Counsel, and Secretary from October 1989 to September 1994. Mr. Hawkins currently serves on the board of directors of the Alumni Association of the University of Michigan, holding the position of Treasurer and thus leading the Finance Committee of the board. Mr. Hawkins received his Juris Doctor from Northwestern University in 1986 and his A.B. in Political Science from the University of Michigan in 1983.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Skills &amp; Expertise</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Mr. Hawkins brings to the Board leadership, finance, business, legal, and finance experience. Mr. Hawkins led companies across a variety of industries, including finance, entertainment, information technology, and retail sales. An experienced advisor, Mr. Hawkins is qualified to serve as a director due to his experience as a senior executive and chief legal officer at several public companies (including his experience acquiring companies and in finance) and with counseling and serving on boards of directors.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">118</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Roger Meltzer</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Experience</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Mr. Meltzer practiced law at DLA Piper LLP from 2007 and held various roles: Global Co-Chairman (2015 through 2020), and currently as Chairman Emeritus; Americas Co-Chairman (2013 through 2020); Member, Office of the Chair (2011 through 2020); Member, Global Board (2008 through 2020); Co-Chairman, U.S. Executive Committee (2013 through 2020); Member, U.S. Executive Committee (2007 through 2020); and Global Co-Chairman, Corporate Finance Practice (2007 through 2015). Prior to joining DLA Piper LLP, Mr. Meltzer practiced law at Cahill Gordon &amp; Reindel LLP from 1977 to 2007 where he was a member of the Executive Committee from 1987 through 2007, Co-Administrative Partner and Hiring Partner from 1987 through 1999, and Partner from 1984 through 2007. Mr. Meltzer currently serves on the Advisory Board of Harvard Law School Center on the Legal Profession (May 2015&#8212;Present); and the Board of Trustees, New York University Law School (September 2011&#8212;Present); and previously served on the Corporate Advisory Board, John Hopkins, Carey Business School (January 2009&#8212;December 2012). He has previously served on the board of directors of: Lionheart II Corp (March 2021 to May 2022), Lionheart III Corp (March 2021 to August 2022), Haymaker Acquisition Corp. III (February 2021 to July 2022), certain subsidiaries of Nordic Aviation Capital (December 2021 to April 2022), The Legal Aid Society (November 2013 to January 2020), Hain Celestial Group, Inc. (December 2000 to February 2020), American Lawyer Media (January 2010 to July 2014) and The Coinmach Service Corporation (December 2009 to June 2013). Mr. Meltzer has also received several awards and honors and has been actively involved in philanthropic activity throughout his career. Mr. Meltzer received his Juris Doctor degree in law from New York University School of Law and an A.B. from Harvard College. In February 2021, Mr. Meltzer joined the board of directors of Haymaker Acquisition Corp. 4, a special purpose acquisition company focused on identifying and implementing value creation initiatives within the consumer and consumer-related products and services industries. In February 2021, Mr. Meltzer joined the board of directors of Ubicquia LLC, a smart solutions infrastructure company. In May 2022, Mr. Meltzer joined the board of directors of MSP Recovery, Inc. following its business combination with Lionheart Acquisition Corp. II. In June 2022, Mr. Meltzer joined the board of directors of Aearo Holding LLC and affiliated entities. In August 2022, Mr. Meltzer joined the board of directors of Empatan Public Limited Company (&#8220;SMX&#8221;) following its business combination with Lionheart III Corp, Security Matters Limited and Aryeh Merger Sub Inc. In January 2023, Mr. Meltzer joined the board of directors of AID Holdings II (&#8220;Enlivant&#8221;), a senior living facility provider and portfolio company of TPG Capital L.P. In February 2023, Mr. Meltzer joined the board of directors of Klein Hersh, an executive recruitment firm that spans the life sciences continuum and healthcare industry. In April 2023, Mr. Meltzer joined the board of directors of Cyxtera Technologies, Inc., a company specializing in colocation and interconnection services, with a footprint of more than 60 data centers in over 30 markets. In May 2023, Mr. Meltzer joined the board of directors of John C. Heath, Attorney at Law PC d/b/a/ Lexington Law, an industry leader specializing in credit repair services.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Skills &amp; Expertise</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Mr. Meltzer brings to the Board legal, finance, business, and leadership experience. Mr. Meltzer is qualified to serve as a director due to his experience representing clients on high-profile, complex, and cross-border matters and his leadership qualities in managing a large international organization. During his tenure, DLA Piper was subject to a large-scale cybersecurity infiltration, and Mr. Meltzer was a leader of a small group of senior executives that managed the firm through that cyberattack.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Executive Officers</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">John H. Ruiz</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> - See &#8220;-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management and Board of Directors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.&#8221;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Frank C. Quesada </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">- See &#8220;-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management and Board of Directors</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.&#8221;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Alexandra Plasencia</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Alexandra Plasencia serves as the General Counsel of MSP Recovery, Inc. Prior to becoming General Counsel, Ms. Plasencia served as the Company&#8217;s Chief Compliance Officer and Corporate Counsel. Ms. Plasencia is a corporate and healthcare attorney who focuses her practice on complex business transactions, contracting, and healthcare and organizational compliance. Ms. Plasencia utilizes her comprehensive healthcare background to advise the Company on a full spectrum of legal and regulatory business issues. Prior to her role at the Company, Alexandra was General Counsel and Corporate Secretary for Conviva Care Solutions, a management services organization overseeing 300,000 patients, throughout 300 practices and 800 clinicians throughout Florida and Texas. In that role, Ms. Plasencia worked closely with and advised the board of directors, developed the organization&#8217;s legal strategy and oversaw legal affairs, including acquisitions, regulatory compliance &amp; oversight, corporate governance, litigation oversight, and provider, payor, and physician contracting. Ms. Plasencia has extensive experience in managed care and full-risk arrangements. Prior to her role with Conviva, Ms. Plasencia was the General Counsel for MCCI Medical Group where she developed a legal team and oversaw the company&#8217;s legal and organizational strategy. During her tenure, Ms. Plasencia handled various multi-million-dollar acquisitions, corporate financing, and successfully integrated various physician practices into MCCI. Most notably, Ms. Plasencia represented MCCI in its sale to Humana and played a pivotal role in the structure, development and creation of Conviva Care Solutions and Conviva Physician Group. Ms. Plasencia earned her Juris Doctor and MBA in 2011 from the University of Miami, where she also received her BBA from the School of Business. Ms. Plasencia has supported and contributed her time to Kristi House, the Leadership Learning Center, Amigos for Kids, and the Friends of St. Jude.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">119</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ricardo Rivera</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ricardo Rivera serves as Chief Operating Officer of MSP Recovery, Inc. Mr. Rivera joined the Company in September 2019, and from September 2019 until July 2021, Mr. Rivera served as the Chief of Staff. Over the past 25 years Mr. Rivera has held positions as COO &amp; CFO at various private corporations in the U.S. and internationally. Before joining the Company, Mr. Rivera was COO &amp; CFO of Transatlantic Power Fund Management, LLC, a subsidiary of Transatlantic Power Holdings LLC. Mr. Rivera has a Master&#8217;s in Professional Accounting and a BBA in Accounting from the University of Miami.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Francisco Rivas-V&#225;squez</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Francisco Rivas-V&#225;squez currently serves as Chief Financial Officer of MSP Recovery, Inc. Mr. Rivas-Vasquez joined the Company in November 2023. Prior to his appointment as CFO of MSP Recovery, Inc., Mr. Rivas-Vasquez served as Transaction Advisory Services Managing Director at BDO USA LLP since 2022. Mr. Rivas-Vasquez served as Deal Advisory Director for KPMG LLP from 2010 to 2022, and Manager/Senior Associate for KPMG LLP from 2005 to 2010. From 2002 to 2005, Mr. Rivas-Vasquez served as Audit Senior/Staff Accountant for Ernst &amp; Young LLP. Mr. Rivas-Vasquez received a Master of Science in Accountancy from the University of Notre Dame and a Bachelor&#8217;s degree in Business Administration from the University of Miami.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Family Relationships</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are no family relationships between any of our directors or executive officers.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Involvement in Certain Legal Proceedings</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the past 10 years, none of our current directors, nominees for directors, or current executive officers has been involved in any legal proceeding identified in Item 401(f) of Regulation S-K that would be material to an evaluation of the ability or integrity of any director, person nominated to become a director or executive officer of the Company.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporate Governance Principles and Code of Ethics</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board is committed to sound corporate governance principles and practices. In order to clearly set forth our commitment to conduct our operations in accordance with our high standards of business ethics and applicable laws and regulations, our Board adopted Corporate Governance Guidelines applicable to our directors, executive officers and employees that complies with the rules and regulations of Nasdaq. A copy of our Corporate Governance Guidelines is available on our corporate website at https://investors.msprecovery.com, in the &#8220;Documents &amp; Charters&#8221; section in the &#8220;Corporate Governance&#8221; tab. The information on our website shall not be deemed incorporated by reference in this Annual Report. You also may obtain without charge a printed copy of the Corporate Governance Guidelines by sending a written request to: MSP Recovery General Counsel, 3150 SW 38th Avenue, Suite 1100, Miami, Florida 33146.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Board of Directors</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The business and affairs of the Company are managed by or under the direction of the Board. The Board is currently composed of seven members.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Board held 6 meetings and acted by written consent without a meeting on 6 occasions during the year ended December 31, 2024. In 2024, each person serving as a director attended at least 75% of the total number of meetings of our Board and any Board committee on which he or she served.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Board Committees</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to our Amended &amp; Restated Bylaws, our Board may establish one or more committees of the Board however designated, and delegate to any such committee the full power of the Board, to the fullest extent permitted by law.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The standing committees of our Board currently include an Audit Committee, Cybersecurity Subcommittee of the Audit Committee, Compensation Committee, and the Nominating and Corporate Governance Committee. Each of the committees reports to the Board as such committee deems appropriate and as the Board may request. The composition, duties, and responsibilities of these committees are as follows:</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s corporate governance guidelines and the charters of the audit committee, compensation committee, and nominating and corporate governance committee of the Board of Directors are available on the Company&#8217;s website, https://investors.msprecovery.com, in the &#8220;Documents &amp; Charters&#8221; section in the &#8220;Corporate Governance&#8221; tab. The Company shall provide to any person without charge, upon request, a copy of any of the foregoing materials. Any such request must be made in writing to the General Counsel of the Company, c/o MSP Recovery, Inc., 3150 SW 38th Avenue, Suite 1100, Miami, Florida 33146.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">120</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9d1a96bb-f757-48c0-92bc-2d2686d2bd11" contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> an Insider Trading Policy governing the purchase, sale, and other dispositions of the Company&#8217;s securities that applies to all officers, directors, and employees of the Company and its affiliated entities. We believe that our Insider Trading Policy is reasonably designed to promote compliance with insider trading laws, rules, and regulations, as well as applicable listing standards. A copy of the Company&#8217;s Insider Trading Policy is filed as Exhibit 19.1 to this Annual Report.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item11"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 11</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Executive Compensation.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Summary Compensation Table</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents information regarding the total compensation awarded to, earned by, and paid to the named executive officers of MSP Recovery for services rendered to the Company in all capacities for the years indicated.</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:25.68%;box-sizing:content-box;"/>
     <td style="width:5.86%;box-sizing:content-box;"/>
     <td style="width:9%;box-sizing:content-box;"/>
     <td style="width:7%;box-sizing:content-box;"/>
     <td style="width:5.98%;box-sizing:content-box;"/>
     <td style="width:6.92%;box-sizing:content-box;"/>
     <td style="width:10.04%;box-sizing:content-box;"/>
     <td style="width:10.28%;box-sizing:content-box;"/>
     <td style="width:10.16%;box-sizing:content-box;"/>
     <td style="width:9.08%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Summary Compensation Table</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name and Principal Position</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">Salary<br/>($) </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Bonus<br/>($)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">Stock Awards<br/>($) </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">6</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">Option Awards ($) </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">6</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">Non-Equity Incentive Plan Compensation ($) </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">6</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change in Pension Value and Nonqualified Deferred Compensation Earnings ($)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-kerning:none;min-width:fit-content;">All Other<br/>Compensation<br/>($) </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">2</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total<br/>($)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">John H. Ruiz </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">3</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$1,800,000</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$7,880</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$1,807,880</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;Chief Executive Officer</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$917,500</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$97,108</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$1,014,608</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Frank C. Quesada </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$600,000</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$5,055</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$605,055</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;Chief Legal Officer</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$600,000</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$11,873</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$611,873</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Ricardo Rivera </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">5</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$600,000</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$7,835</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$607,835</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;Chief Operating Officer</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2023</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$600,000</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$75,000</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$7,665</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$682,665</span></p></td>
    </tr>
   </table><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The salary amounts represent the actual amounts paid during the fiscal year. For Mr. Ruiz, his salary represents what was paid from January 1, 2023, until June 26, 2023, at which point Mr. Ruiz voluntarily reduced his salary to $35,000. On April 12, 2024 the Board of Directors voted to reinstate Mr. Ruiz&#8217;s salary retroactively from January 1, 2024 in accordance with the terms of his employment agreement.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts reported in the &#8220;All Other Compensation&#8221; column reflect amounts paid to our named executive officers by the Law Firm for their services to the Company. The relationship between the Company and the Law Firm, which is an entity that is not part of the Business Combination, is fully described in &#8220;Related Party Transactions&#8212;Legal Services-Law Firm.&#8221; Except as detailed below, in 2024 and 2023, the total amount of perquisites and personal benefits for each of the NEOs was less than $10,000.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All Other Compensation includes the cost of employee benefit plan premiums and other insurance benefits, and for 2023, $89,832 per year paid by the Law Firm for life insurance premiums.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All Other Compensation includes the cost of employee benefit plan premiums and other insurance benefits, and for 2024 and 2023, $5,055 per year paid by the Law Firm for life insurance premiums.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All Other Compensation includes the cost of employee benefit plan premiums and other insurance benefits.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years 2024 and 2023, the named executive officers did not receive stock awards, option awards, non-equity incentive plan compensation, or non-qualified deferred compensation earnings.</span></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Narrative Disclosure to Summary Compensation Table</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For 2024 and 2023, the principal elements of compensation provided to the named executive officers were base salaries, bonuses, and broad-based employee benefits.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Base Salary</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During 2024, each of our named executive officers received an annual base salary from the Company as a fixed component of compensation. See the &#8220;Summary Compensation Table.&#8221; Base salaries were either determined when the named executive officers entered into their employment agreements or were determined by the Compensation Committee, and are intended to attract and retain individuals with superior talent commensurate with their relative expertise and experience. Considerations in determining base salary amounts include the executive&#8217;s performance, level of responsibility, experience, and comparative salaries in the marketplace.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">121</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash Bonus Compensation</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company paid a cash performance bonus to Mr. Rivera during the fiscal year ended December 31, 2023.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity Compensation</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company did not issue any equity compensation to named executive officers during the fiscal year ended December 31, 2024. The Company intends to issue equity awards under the Incentive Plan, a copy of which is filed as an Exhibit 10.16 to our Form S-1 Registration Statement filed on November 30, 2022.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Outstanding Equity Awards at Fiscal Year-End</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the named executive officers did not have any outstanding equity awards.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fiscal Year 2024 Director Compensation Table</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides information regarding the total compensation that was earned by or paid to each of our non-employee directors during the fiscal year ended December 31, 2024. Other than as set forth in the table and described below, we did not pay any compensation, make any equity awards or non-equity awards to, or pay any other compensation to any of the non-employee members of our Board of Directors. John H. Ruiz, our Chief Executive Officer, and Frank C. Quesada, our Chief Legal Officer, did not receive any compensation for their service as members of our Board of Directors during 2024. To the extent applicable, we reimburse non-employee directors for travel expenses incurred in attending meetings of our Board of Directors or any committee thereof.</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:19.224%;box-sizing:content-box;"/>
     <td style="width:13.463%;box-sizing:content-box;"/>
     <td style="width:13.463%;box-sizing:content-box;"/>
     <td style="width:13.463%;box-sizing:content-box;"/>
     <td style="width:13.463%;box-sizing:content-box;"/>
     <td style="width:13.463%;box-sizing:content-box;"/>
     <td style="width:13.463%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="7" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024 Non-Employee Director Compensation Table</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fees Earned or<br/>Paid in Cash<br/>($)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stock Awards ($)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Option Awards ($)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-Equity Incentive Plan Compensation ($)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">All Other Compensation ($)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total Compensation<br/>($)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Ophir Sternberg</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$71,100</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$165,900</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$237,000</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Beatriz Assapimonwait</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$90,100</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$165,900</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$256,000</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Michael Arrigo</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$121,100</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$165,900</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$287,000</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thomas Hawkins</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$106,100</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$165,900</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$272,000</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Roger Meltzer</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$96,100</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$165,900</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$262,000</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Narrative Disclosure to Director Compensation Table</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the fiscal year ended December 31, 2024, the Compensation Committee and the Board determined that each non-employee director was entitled to receive a $237,000 retainer per year regardless of committee services, paid in 30% cash and 70% equity. In addition to the $237,000 retainer for each non-employee director, some directors received additional payment as follows:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$35,000 cash retainer per year for the chairman of the audit committee or $25,000 cash retainer per year for each other member of the audit committee; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$25,000 cash retainer per year for the chairman of the compensation committee or $19,000 cash retainer per year for each other member of the compensation committee.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation for our non-employee directors is not limited to the payments determined by our compensation policies. Our non-employee directors remain eligible to receive equity awards and cash or other compensation as may be provided from time to time at the discretion of our Board. No such awards or payments were made in 2024.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company Executive Officer and Director Compensation</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following disclosures concern employment agreements with the Company&#8217;s executive officers:</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employment Agreements.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have entered into Employment Agreements with John H. Ruiz and Frank C. Quesada.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employment Agreement with John H. Ruiz</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Ruiz serves as our Chief Executive Officer. Under the terms of his employment agreement, he will earn a base salary of not less than $1,800,000, subject to annual review for potential increase (but not decrease) by the Board. In addition, Mr. Ruiz is eligible to receive an annual cash performance bonus of up to 100% of his base salary, based upon the achievement of individual and Company performance objectives and subject to Board approval. In addition, Mr. Ruiz is entitled to: (i) participate in and be granted awards under the MSP Recovery Omnibus Incentive Plan effective as of May 18, 2022 at the discretion of the Board, (ii) participate in the employee benefit plans, including pension, medical, disability and life insurance offered by the Company, and (iii) reimbursement for all reasonable and necessary out-of-pocket business, entertainment and travel expenses.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">122</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the term of Mr. Ruiz&#8217;s employment agreement, he will be bound by non-competition and non-solicitation obligations. Upon a termination of Mr. Ruiz&#8217;s employment without Cause (as defined in his employment agreement) or the resignation by Mr. Ruiz for Good Reason (as defined in his employment agreement), Mr. Ruiz will be entitled to receive all accrued, determined and unpaid compensation, a pro-rata bonus payment for the fiscal year of termination based on actual performance results for the full annual performance period and a severance payment of Mr. Ruiz&#8217; base salary for a period of six months after the date of termination.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective June 26, 2023, Mr. Ruiz voluntarily reduced his salary to $35,000. On April 12, 2024 the Board of Directors voted to reinstate Mr. Ruiz&#8217;s salary retroactively from January 1, 2024 in accordance with the terms of his employment agreement.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employment Agreement with Frank C. Quesada</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Quesada serves as our Chief Legal Officer. Under the terms of his employment agreement, he will earn a base salary of not less than $600,000, subject to annual review for potential increase (but not decrease) by the Board. In addition, Mr. Quesada is eligible to receive an annual cash performance bonus of up to 100% of his base salary, based upon the achievement of individual and Company performance objectives and subject to Board approval. In addition, Mr. Quesada is entitled to: (i) participate in and be granted awards under the MSP Recovery Omnibus Incentive Plan effective as of May 18, 2022 at the discretion of the Board, (ii) participate in the employee benefit plans, including pension, medical, disability and life insurance offered by the Company, and (iii) reimbursement for all reasonable and necessary out-of-pocket business, entertainment and travel expenses.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the term of Mr. Quesada&#8217;s employment agreement, he will be bound by non-competition and non-solicitation obligations. Upon a termination of Mr. Quesada&#8217;s employment without Cause (as defined in his employment agreement) or the resignation by Mr. Quesada for Good Reason (as defined in his employment agreement), Mr. Quesada will be entitled to receive all accrued, determined and unpaid compensation, a pro-rata bonus payment for the fiscal year of termination based on actual performance results for the full annual performance period and a severance payment of Mr. Quesada&#8217;s base salary for a period of six months after the date of termination.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">123</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item12"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 12</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth information known by us regarding the beneficial ownership of the Common Stock as of April 8, 2025, by:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">each person who is known by us to be the beneficial owner of more than 5% of the outstanding shares of Common Stock;</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">each of our current Named Executive Officers and directors; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all of our current executive officers and directors as a group.</span></div></div><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The percentage of beneficial ownership is based on 4,920,520 shares of Class A Common Stock issued and outstanding as of April 8, 2025, and 3,323,146 shares of Class V Common Stock issued and outstanding as of April 8, 2025, as applicable, the only outstanding classes of the Company&#8217;s common stock. Unless otherwise indicated, the address for each of the persons listed in the table below is c/o MSP Recovery, Inc., 3150 SW 38th Avenue, Suite 1100, Miami, Florida 33146.</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:44.88%;box-sizing:content-box;"/>
     <td style="width:17.92%;box-sizing:content-box;"/>
     <td style="width:9.64%;box-sizing:content-box;"/>
     <td style="width:17.92%;box-sizing:content-box;"/>
     <td style="width:9.64%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="5" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Beneficial Stock Ownership Table</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Class A Common Stock </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Class V Common Stock </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Beneficial Owner Name</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Shares</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Shares</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Named Executive Officers &amp; Directors</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">John H. Ruiz </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(3)(4)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,434,188</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38.53%</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,397,098</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42.04%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Frank C. Quesada </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(5)(6)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,454,078</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22.85%</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,442,226</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43.40%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Ricardo Rivera </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(7)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Alexandra Plasencia </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(8)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">58</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Michael F. Arrigo</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">944</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Beatriz Assapimonwait</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Roger Meltzer </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(9)(10)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,838</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thomas W. Hawkins</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">&#160;(9)(11)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,772</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Ophir Sternberg </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(9)(12)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,012,211</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.09%</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Francisco Rivas-V&#225;squez</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">All directors and officers as a group (10 individuals)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,910,164</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55.99%</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,839,324</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85.44%</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">5% Stockholders</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Mayra C. Ruiz</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">&#160;(13)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,029,477</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.72%</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">297,998</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.97%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Palantir Technologies, Inc. </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(14)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">593,438</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.06%</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series MRCS </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(15)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">661,565</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.85%</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">661,565</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.91%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Virage Recovery Master LP </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(16)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">543,757</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.99%</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">149,599</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.50%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">YA II PN, Ltd. </span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(17)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">508,381</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.99%</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
   </table><p style="text-indent:-3.878%;padding-left:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">       Less than one percent (1%)</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes shares of Class A Common Stock issuable pursuant to derivatives (including Up-C Units and warrants) exercisable within 60 days of April 8, 2025, and New Warrants exercisable to purchase 1/625 of one share of Class A Common Stock, but only exercisable in lots of 625 to purchase whole shares.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Shares of Class V Common Stock are non-economic voting shares of the Company.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 71,657 shares of Class A Common Stock directly held by Mr. Ruiz. In addition to securities directly held by Mr. Ruiz in his individual capacity, includes shares held by the following entities Jocral Family LLLP and Series MRCS, a series of MDA, Series LLC, a Delaware series limited liability company (&#8220;Series MRCS&#8221;), including shares held by Series MRCS for the benefit of Jocral Holdings LLC. Reported figures do not include securities held by John Ruiz II, Mr. Ruiz&#8217;s son, in his capacity as a Member, or by Alex Ruiz, Mr. Ruiz&#8217;s son, of which Mr. Ruiz disclaims beneficial ownership.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reported figures do not include any attributed ownership based on Mr. Ruiz&#8217;s investment in VRM, which have been transferred to affiliated trusts of Mr. Ruiz and of which Mr. Ruiz disclaims beneficial ownership. Messrs. Ruiz and Quesada together invested in VRM, which investment represented a 1.14% ownership interest in VRM. Mr. Ruiz is entitled to 70% of such investment, and Mr. Quesada is entitled to 30% of such investment. As a result, the indirect beneficial ownership attributable to such affiliated trusts would be 0.8% of VRM. Reported figures do not include any attributed ownership based on Mr. Ruiz&#8217;s investment in VRM, which </span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">124</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">have been transferred to affiliated trusts of Mr. Ruiz and of which Mr. Ruiz disclaims beneficial ownership. Messrs. Ruiz and Quesada together invested in VRM, which investment represented a 1.14% ownership interest in VRM. Mr. Ruiz is entitled to 70% of such investment, and Mr. Quesada is entitled to 30% of such investment. As a result, the indirect beneficial ownership attributable to such affiliated trusts would be 0.8% of VRM.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 11,212 shares of Class A Common Stock and 640 shares of Class A Common Stock underlying New Warrants directly held by Mr. Quesada. In addition to securities directly held by Mr. Quesada in his individual capacity, includes shares held by Quesada Group Holdings LLC and Series MRCS.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reported figures do not include any attributed ownership based on Mr. Quesada&#8217;s investment in VRM, which have been transferred to affiliated trusts of Mr. Quesada and of which Mr. Quesada disclaims beneficial ownership. Messrs. Ruiz and Quesada together invested in VRM, which investment represented a 1.14% ownership interest in VRM. Mr. Ruiz is entitled to 70% of such investment, and Mr. Quesada is entitled to 30% of such investment. As a result, the indirect beneficial ownership attributable to such affiliated trusts would be 0.3% of VRM.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 59 shares of Class A Common Stock and 16 shares of Class A Common Stock underlying New Warrants directly held by Mr. Rivera.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consists of 58 shares of Class A Common Stock held by the spouse of Alexandra Plasencia.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The business address for each of these individuals is c/o, Lionheart Equities LLC, 4218 NE 2nd Avenue, Miami, Florida 33137.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">10.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Roger Meltzer has been a member of the Board since 2021. Beneficial ownership includes 950 shares of Class A Common Stock and 1,888 shares of Class A Common Stock underlying New Warrants.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Thomas Hawkins has been a member of the Board since 2021. Beneficial ownership includes (i) 1,980 shares of Class A Common Stock and 1,888 shares of Class A Common Stock underlying New Warrants held in an individual capacity and (ii) 16 shares of Class A Common Stock and 1,888 shares of Class A Common Stock underlying New Warrants held by the Estate of Steven R. Berrard. Thomas Hawkins holds sole voting and investment control over the shares held by the Estate of Steven R. Berrard as the personal representative.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes: (i) 934 shares of Class A Common Stock held in an individual capacity; (ii) 932 shares of Class A Common Stock and 188,800 shares of Class A Common Stock underlying New Warrants owned by Lionheart Investments, LLC; (iii) 1,600 shares of Class A Common Stock and 188,800 shares of Class A Common Stock underlying New Warrants owned by Star Mountain Equities, LLC; (iv) 3,897 shares of Class A Common Stock and 436,848 shares of Class A Common Stock underlying New Warrants owned by Sponsor; and (v) 1,600 shares of Class A Common Stock and 188,800 shares of Class A Common Stock underlying New Warrants owned by the 2022 OS Irrevocable Trust. Mr. Sternberg holds sole voting and investment control over the shares held by each of Lionheart Investments, LLC, Star Mountain Equities, LLC, and Sponsor as the sole manager. Mr. Sternberg&#8217;s spouse holds sole voting and investment control over the shares owned by the 2022 OS Irrevocable Trust as its trustee and as a result, Mr. Sternberg may be deemed to have beneficial ownership of the shares owned by the 2022 OS Irrevocable Trust.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 320,000 shares of Class A Common Stock and 1,354 shares of Class A Common Stock underlying New Warrants held in an individual capacity. In addition to securities directly held by Ms. Ruiz in an individual capacity, includes shares 297,998 Up-C Units and 410,125 shares of Class A Common Stock held by Ruiz Group Holdings Limited, LLC, over which Ms. Ruiz has sole voting and investment control over.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">14.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beneficial ownership includes 593,438 shares of Class A Common Stock.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">15.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 198,470 Up-C Units held by Series MRCS that are beneficially owned by Frank C. Quesada and 463,096 shares beneficially owned by John H. Ruiz (including through his affiliate, Jocral Holdings, LLC).</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">16.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beneficial ownership includes 1,260 shares of Class A Common Stock, and 542,497 shares of Class A Common Stock that VRM may acquire within 60 days, including 149,599 shares of Class A Common Stock issuable upon exchange of the Up-C Units, and 392,898 shares of Class A Common Stock issuable upon exchange of VRM Warrants. VRM Class A Common Stock holdings are subject to a 9.99% ownership limitation, based on 4,920,520 shares of Class A Common Stock outstanding as of April 8, 2025, and the additional 542,497 shares of Class A Common Stock that may be acquired within 60 days. The sole general partner of Virage Recovery Master LP is Virage Recovery, LLC, a Texas limited liability company. The sole members of Virage Recovery, LLC are Edward Ondarza and Martin Shellist.</span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.2798611111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.731%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">17.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beneficial ownership includes 508,381 shares of Class A Common Stock that YA II PN, Ltd. may acquire under the SEPA or the Convertible Notes within 60 days (based on 320,000 shares of Class A Common Stock outstanding as of April 8, 2025, and the additional 168,381 shares of Class A Common Stock that may be acquired within 60 days, and subject to the 9.99% ownership limitations).</span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">125</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item13"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 13</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Certain Relationships and Related Transactions, and Director Independence.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Advances and Promissory Notes</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to a loan agreement dated May 20, 2022, John H. Ruiz and Frank C. Quesada provided a cash loan to the Company in the amount of $13.0 million in order to satisfy the Service Fee Account condition as described in the Membership Interest Purchase Agreement dated July 11, 2021 (the &#8220;Closing Loan&#8221;). The Closing Loan has an annual interest rate of 4% and was set to mature on November 23, 2022; however, the maturity date of the Closing Loan may be extended, at the option of the Company, for up to three successive six-month periods (for a total of 24 months). The Company exercised this right and extended the maturity date of the Closing Loan. This loan agreement was ratified by the Audit Committee on June 15, 2022.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to a loan agreement dated June 16, 2022, La Ley con John H. Ruiz d/b/a MSP Recovery Law Firm and MSP Law Firm, PLLC (collectively, &#8220;Law Firm&#8221;) made a cash loan to the Company in the amount of approximately $112.8 million (the &#8220;New Loan&#8221;) in order to: (i) to fund the obligations to pay costs and expenses incurred in connection with the SPAC transaction undertaken by Lionheart II Holdings, LLC, and (ii) to fund operating expenses and other obligations of MSP Recovery, Inc., including repayment of certain funds that had been previously advanced to the Company by John H. Ruiz and Frank C. Quesada of approximately $24.0 million. The New Loan has an annual interest rate of 4%, paid-in-kind, and will mature four years from the effective date of the New Loan, with no prepayment penalty. This loan agreement was approved by the Audit Committee on June 15, 2022.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the New Loan, the Law Firm advanced an additional $4.95 million to the Company to cover certain expenses (the &#8220;Bridge Loan&#8221;). The Bridge Loan does not accrue interest on the unpaid balance and becomes due and payable upon funding of a credit facility that was being negotiated, but had not closed, at the end of fiscal year 2022, as set forth in Note 18,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Subsequent Events</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Company&#8217;s 2022 Annual Report on Form 10-K. Company can repay the Bridge Loan at any time, without prepayment penalties, fees, or other expenses.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Services Agreement</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the closing of the business combination between the Company and Lionheart Acquisition Corporation II, the Company entered into a Legal Services Agreement (&#8220;LSA&#8221;) with La Ley con John H. Ruiz, P.A. d/b/a MSP Recovery Law Firm and MSP Law Firm, PLLC (collectively the &#8220;Law Firm&#8221;), dated May 23, 2022. Pursuant to the LSA, the Company engaged the Law Firm to act as its exclusive lead counsel to represent the Company, and each of its subsidiaries, as it pertains to certain assigned Claims, causes of actions, proceeds, products, and distribution. Under the LSA, the Company will pay the Law Firm all of the Law Firm&#8217;s documented costs related to representation of the Company or its subsidiaries approved in accordance with an agreed budget. For the services described in the LSA, the Law Firm will be entitled to: (i) any attorneys&#8217; fees that are awarded to the Law Firm pursuant to a fee shifting statute by agreement or court award in such case, and (ii) an amount, if greater than zero, equal to the difference between 40% of the recovery proceeds due to the Company or its subsidiaries for recovered Claims, less any amount due to the Law Firm under the foregoing clauses ((i) and (ii) together, the &#8220;Compensation&#8221;).</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The LSA also contains an advance provision, whereby the Company will advance to the Law Firm a monthly amount equal to: (x) $1,000,000 of the Compensation due to the Law Firm to fund certain resources necessary to provide services by the Law Firm, plus (y) overhead costs (i.e., salaries rent, utilities, and similar expenses; provided that any compensation paid to John H. Ruiz or Frank C. Quesada by the Law Firm shall not be included in such overhead costs) (collectively, the &#8220;Law Firm Advance&#8221;) to operate the Law Firm in an amount necessary to pay such overhead costs reasonably anticipated by the Law Firm to become due in such month. This Advance shall be offset from the Compensation, and in the event that the Legal Services Agreement is terminated, certain additional fees may become payable to the Law Firm pursuant to the terms of the Legal Services Agreement. The LSA was ratified by the Audit Committee on June 15, 2022.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The LSA was amended on April 14, 2025 to terminate the Company&#8217;s obligation to fund the Law Firm Advance effective December 31, 2024.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSP Recovery Aviation, LLC</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company may make payments related to operational expenses on behalf of its affiliate, MSP Recovery Aviation, LLC (&#8220;MSP Aviation&#8221;). The Company has made payments in the periods of the financial statements only related to specifically billed flights. As of both December 31, 2024 and 2023, $0.2 million was due from MSP Aviation and included in the consolidated balance sheets in Affiliate Receivable. For the years ended December 31, 2024 and 2023, $0.2 million and $0.2 million, respectively, was included in General and Administrative expenses related to MSP Aviation in the consolidated statements of operations.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">126</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Funds held for other entities</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company may collect and/or hold cash on behalf of its affiliates in the ordinary course of business. As of both December 31, 2024 and 2023, $19.8 million was due to affiliates of the Company and included in the consolidated balance sheets in Affiliate Payable. These amounts were primarily due to Series MRCS, and will be repaid either through excess cash flows from operations or other financing. During the year ended December 31, 2022, the Company also entered into a note payable with Series MRCS as outlined in Note 6,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Intangible Assets, Net</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, Net. As of both December 31, 2024 and 2023, the balance of the note payable was $0.5 million and included in the consolidated balance sheets in Claims financing obligation and notes payable.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, there were additional receivables from other affiliates of $0.2 million and $0.2 million, respectively. These were included in the consolidated balance sheets in Affiliate Receivable.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VRM MSP</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company concluded that VRM MSP is a related party due to ownership interests in the entity held by MSP Recovery and Series MRCS. For the 12 months ended December 31, 2024 and 2023, the Company recorded $188.0 million and $124.7 million, and $156.2 million and $65.3 million, respectively, for interest expense related to the VRM Full Return and Virage MTA Amendment.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Working Capital Credit Facility Collateral</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Second Amended and Restated First Lien Credit Agreement, and in order to secure those additional advances of Term Loan B beginning in January 2024, the Company approved for Messrs. John H. Ruiz and Frank C. Quesada to provide, as additional collateral, the following: (i) a pledge of the equity interests in an Affiliate of Messrs. John H. Ruiz and Frank C. Quesada; and (ii) a personal guaranty by Messrs. John H. Ruiz and Frank C. Quesada, as primary obligors, guaranteeing those additional advances of Term Loan B beginning in January 2024. On December 22, 2023, our Board approved the Company's payment of certain costs and fees (including legal fees) on behalf of John H. Ruiz and Frank C. Quesada, associated with a mortgage granted in connection with said guaranty, totaling $0.1 million.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Registration Rights</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has entered into the Registration Rights Agreement August 13, 2020 with the Holders (as defined therein). Pursuant to the terms of the Amended and Restated Registration Rights Agreement, (i) the Founder Shares and the shares of Class A common stock issued or issuable upon the conversion of any Founder Shares, (ii) the Units (as defined therein), (iii) the shares of Class A common stock included in such Units, (iv) the Original Warrants included in such Units (including any shares of Class A common stock issued or issuable upon the exercise of any such Original Warrants), (v) the New Warrants (including any shares of Class A common stock issued or issuable upon the exercise of any such New Warrants), (vi) the equity securities that Nomura purchased from the Company pursuant to that certain Forward Purchase Agreement described in the section entitled &#8220;Business &#8211; Company History.&#8221; (the &#8220;Forward Purchase Shares&#8221;), (vii) any outstanding share of the Class A common stock or any other equity security (including the shares of Class A common stock issued or issuable upon the exercise or conversion of any other equity security) of the Company held by a Holder as of the date of the Registration Rights Agreement, (viii) any shares of the Company issued or to be issued to any Additional Holders (as defined in the Registration Rights Agreement) in connection with the Business Combination and (ix) any other equity security of the Company issued or issuable with respect to any of the securities described in the foregoing clauses (i) - (ix) by way of a stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization will be entitled to certain registration rights, subject to the terms and conditions set forth in the Registration Rights Agreement.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The foregoing summary of the Registration Rights Agreement is not complete and is qualified in its entirety by reference to the complete text of the Registration Rights Agreement as set forth in an exhibit to the registration statement.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Director Independence</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board has determined that five of our directors, Michael F. Arrigo, Beatriz Assapimonwait, Thomas Hawkins, Ophir Sternberg, and Roger Meltzer, qualify as &#8220;independent&#8221; directors within the meaning of the independent director guidelines of Nasdaq and applicable SEC rules. The Nasdaq independence definition includes a series of objective tests regarding a director&#8217;s independence and requires that the Board make an affirmative determination that a director has no relationship with us that would interfere with such director&#8217;s exercise of independent judgment in carrying out the responsibilities of a director. As part of the Board&#8217;s determination, among other factors, the Board considered certain relationships of directors, including employment by MSP Recovery.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">127</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item14"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 14</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Principal Accounting Fees and Services.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is a summary of the fees billed to us by Deloitte &amp; Touche LLP (&#8220;Deloitte&#8221;) for professional services rendered for the fiscal year ending December 31, 2024 and 2023.</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:55.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:36.022%;box-sizing:content-box;"/>
     <td style="width:1.808%;box-sizing:content-box;"/>
     <td style="width:1.808%;box-sizing:content-box;"/>
     <td style="width:27.125%;box-sizing:content-box;"/>
     <td style="width:3.617%;box-sizing:content-box;"/>
     <td style="width:1.808%;box-sizing:content-box;"/>
     <td style="width:27.812%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="7" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accounting Fees and Services</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fee Category</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Audit Fees</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,692,287</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,475,236</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Audit-Related Fees</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">208,790</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">226,895</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax Fees</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">All Other Fees</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total Fees</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,901,077</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #4472c4;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,702,131</span></p></td>
    </tr>
   </table><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Audit Fees. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aggregate audit fees (inclusive of out-of-pocket expenses) billed by Deloitte were for professional services rendered for the audit of our annual financial statements and review of financial statements included in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the SEC, and for services that are normally provided by the independent registered certified public accountants in connection with such filings, including amendments, or engagements for the fiscal year ended December 31. Audit Fees for 2024 include $171,000 of 2023 Audit Fees billed subsequent to the filing of the 2023 Annual Report on Form 10-K.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Audit Related Fees. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This category consists of assurance and related services by the independent registered public accounting firm that are reasonably related to the performance of the audit or review of our financial statements and are not reported above under &#8220;Audit Fees.&#8221; The services for the fees that would normally be disclosed under this category include consultation regarding our correspondence with the SEC and other accounting consulting.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Tax Fees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> This category consists of professional services rendered by our independent registered public accounting firm for tax compliance, tax advice and tax planning. The services for the fees that would normally be disclosed under this category include tax return preparation and technical tax advice.</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">All Other Fees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> This consists of fees billed for products and services other than those described above.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">128</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART IV</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item15"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 15</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Exhibits, Financial Statement Schedules.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1. FINANCIAL STATEMENTS</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is a list of the consolidated financial statements of MSP Recovery, Inc. filed with this Annual Report on Form 10-K, together with the reports of our independent registered public accountants and Management&#8217;s Report on Internal Control over Financial Reporting:</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial Statements</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:92%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:7%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#auditor_report"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm (PCAOB ID No 34).</span></a></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#balance_sheets"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Balance Sheets as of December 31, 2024 and 2023</span></a></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#statementofoperations"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Operations for the Years Ended December 31, 2024 and 2023</span></a></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#statementsofchangesinequity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Equity for the Years Ended December 31, 2024 and 2023</span></a></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#statementsofcashflows"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Cash Flows for the Years Ended December 31, 2024 and 2023</span></a></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">83</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:3pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#footnotes"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2. FINANCIAL STATEMENT SCHEDULES</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All financial statement schedules are omitted because the information is inapplicable or presented in the notes to the Consolidated Financial Statements.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3. EXHIBITS</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following documents are included as exhibits to this report:</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:8%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:53%;box-sizing:content-box;"/>
     <td style="width:5.64%;box-sizing:content-box;"/>
     <td style="width:10%;box-sizing:content-box;"/>
     <td style="width:7%;box-sizing:content-box;"/>
     <td style="width:15.36%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="4" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Incorporated by Reference</span></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Form</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">File No.</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Filing</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1802450/000114036122017042/ny20000825x14_s4a.htm#tANXA"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Membership Interest Purchase Agreement</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.2+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1802450/000114036122017042/ny20000825x14_s4a.htm#aANNEXA2"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment No. 1 to Membership Interest Purchase Agreement</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.2</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.3+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1802450/000114036122017042/ny20000825x14_s4a.htm#aANNEXA3"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment No. 2 to Membership Interest Purchase Agreement</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.3</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.4+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1802450/000114036122017042/ny20000825x14_s4a.htm#aANNEXA4"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment No. 3 to Membership Interest Purchase Agreement</span></a><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.5+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312522162422/d535105dex25.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment No. 4 to Membership Interest Purchase Agreement</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.5</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312522162422/d535105dex31.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Second Amended and Restated Certificate of Incorporation of the Company</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312522162422/d535105dex32.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Bylaws of the Company</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.3+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024044197/lifw-ex3_3.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certificate of Amendment of Second Amended and Restated Certificate of Incorporation of the Company</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.3</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.4+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024127963/lifw-ex3_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certificate of Amendment to Second Amended and Restated Certificate of Incorporation</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">November 18, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000110465920091561/tm207455d8_ex4-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Specimen Unit Certificate of the Registrant</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000110465920091561/tm207455d8_ex4-2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Specimen Class A Common Stock Certificate of the Registrant</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000110465920091561/tm207455d8_ex4-3.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Specimen Warrant Certificate of the Registrant</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000110465920096910/tm2028964d1_ex4-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Warrant Agreement, dated August 13, 2020, by and between the Registrant and Continental Stock Transfer &amp; Trust Company, LLC</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312522162422/d535105dex45.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">New Warrant Agreement</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.6+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000114036122017042/ny20000825x14_s4a.htm#tANXM2"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of New Warrant Certificate</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.6</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.7+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017022024524/mspr-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">CPIA Warrant Agreement dated September 30, 2022</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">November 10, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.8+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024044197/lifw-ex4_8.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">VRM Initial Warrant dated January 1, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.8</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.9+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024105221/lifw-ex4_9.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">VRM Monthly Warrant dated February 1, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1/A</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-279958</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.9</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 10, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.10+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024105221/lifw-ex4_10.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">VRM Monthly Warrant dated March 1, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1/A</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-279958</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.10</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 10, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.11+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024105221/lifw-ex4_11.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">VRM Monthly Warrant dated April 1, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1/A</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-279958</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.11</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 10, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.12+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024105221/lifw-ex4_12.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">VRM Monthly Warrant dated May 1, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1/A</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-279958</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.12</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 10, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.13+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024070594/lifw-ex10_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">VRM Monthly Warrant dated June 1, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">June 7, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.14+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024097154/lifw-ex10_14.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">VRM Monthly Warrant dated July 1, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.14</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 14, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.15+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024097154/lifw-ex10_15.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">VRM Monthly Warrant dated August 1, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.15</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 14, 2024</span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">129</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:8%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:53%;box-sizing:content-box;"/>
     <td style="width:5.64%;box-sizing:content-box;"/>
     <td style="width:10%;box-sizing:content-box;"/>
     <td style="width:7%;box-sizing:content-box;"/>
     <td style="width:15.36%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.16+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024117405/lifw-ex4_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">VRM Monthly Warrant dated September 1, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 25, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.17+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024117405/lifw-ex4_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">VRM Monthly Warrant dated October 1, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 25, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.18*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="mspr-ex4_18.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">VRM Monthly Warrant dated November 1, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.19*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="mspr-ex4_19.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">VRM Monthly Warrant dated December 1, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.20+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024064540/lifw-ex10_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">VRP Warrant dated May 23, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 24, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.21+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024093889/lifw-ex4_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Note by and between Subrogation Holdings, LLC and Hazel Partners Holdings, LLC dated August 2, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 8, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.22+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017023063845/lifw-ex10_12.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Yorkville Convertible Debt</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">November 14, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000110465920096910/tm2028964d1_ex10-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Letter Agreement, dated August 13, 2020, by and among the Registrant and its officers, directors, Nomura and the Sponsor</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6770</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 29, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000110465920096910/tm2028964d1_ex10-2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Investment Management Trust Agreement, dated August 13, 2020, by and between the Registrant and Continental Stock Transfer &amp; Trust Company, LLC</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6770</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 29, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000110465920096910/tm2028964d1_ex10-3.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Registration Rights Agreement, dated August 13, 2020, by and among the Registrant and certain security holders</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 29, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000110465920096910/tm2028964d1_ex10-4.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Securities Purchase Agreement, dated July 27, 2020, by and between the Sponsor and Nomura</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 29, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000110465920096910/tm2028964d1_ex10-5.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Private Placement Unit Subscription Agreement, dated August 13, 2020, by and between the Registrant and the Sponsor</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6770</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 29, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000110465920096910/tm2028964d1_ex10-6.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Private Placement Unit Subscription Agreement, dated August 13, 2020, by and between the Registrant and Nomura</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6770</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 29, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000110465920096910/tm2028964d1_ex10-7.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Indemnification Agreement</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6770</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 29, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.8+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000110465920096910/tm2028964d1_ex10-8.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Administrative Support Agreement, dated August 13, 2020, by and between the Registrant and the Sponsor</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6770</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.8</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 29, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.9+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000110465920096910/tm2028964d1_ex10-9.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Forward Purchase Agreement, dated August 13, 2020, by and between the Company and Nomura</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6770</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.9</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 29, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000114036122017042/ny20000825x14_s4a.htm#tANXD"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Limited Liability Agreement of Opco</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6770</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 29, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312522162422/d535105dex103.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Registration Rights Agreement</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312522162422/d535105dex104.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Tax Receivable Agreement</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000114036122017042/ny20000825x14_s4a.htm#tANXG"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Sponsor Agreement</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6770</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 29, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.14+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312522162422/d535105dex105.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement, entered into as of May 23, 2022 by and between John H. Ruiz and Lionheart II Holdings, LLC</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.14+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312522162422/d535105dex106.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement, entered into as of May 23, 2022 by and between Frank C. Quesada and Lionheart II Holdings, LLC</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.15+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312522162422/d535105dex107.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Escrow Agreement, entered into as of May 23, 2022, by and among MSP Recovery, Inc., f/k/a &#8220;Lionheart Acquisition Corporation II,&#8221; Lionheart II Holdings, LLC, John H. Ruiz, as the representative of the Members and Continental Stock Transfer &amp; Trust Company.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.16+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312522204988/d334485dex991.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc. 2022 Omnibus Incentive Plan.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-266374</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 28, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.17+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312522162422/d535105dex109.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Lock-Up Agreement</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.9</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.18+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312522162422/d535105dex1010.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Legal Services Agreement, entered into as of May 23, 2022, by and between Lionheart II Holdings, LLC, La Ley con John H. Ruiz P.A., d/b/a MSP Recovery Law Firm and MSP Law Firm.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.19+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1802450/000114036122017042/ny20000825x14_s4a.htm#tANXN"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Side Letter Agreement, entered into as of July 11, 2021, by and between John H. Ruiz and Lionheart Acquisition Corporation II and Lionheart I.I Holdings, LLC</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.20+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1802450/000114036122017042/ny20000825x14_s4a.htm#tANXO"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Virage Side Letter Agreement, dated as of July 11, 2021, by and among John H. Ruiz, Frank C. Quesada, Lionheart Acquisition Corporation II and Lionheart II Holdings, LLC.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 27, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.21+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000114036122017042/ny20000825x14_s4a.htm#tANXP"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">VRM Full Return Guaranty Agreement</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6770</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.21</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 29, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.22+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000114036122008991/ny20000825x6_ex10-22.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Asset and Interest Transfer Agreement in relation to the Series MRCS Asset Acquisition</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6770</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.22</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 29, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.23+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000114036122008991/ny20000825x6_ex10-23.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Transfer Agreement in relation to the VRM MSP Asset Acquisition</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6770</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.23</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 29, 2022</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.24+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000114036122008991/ny20000825x6_ex10-24.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Master Transaction Agreement in relation to the VRM MSP Asset Acquisition</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-4</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6770</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.24</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 29, 2022</span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">130</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:8%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:53%;box-sizing:content-box;"/>
     <td style="width:5.64%;box-sizing:content-box;"/>
     <td style="width:10%;box-sizing:content-box;"/>
     <td style="width:7%;box-sizing:content-box;"/>
     <td style="width:15.36%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.25+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017023000723/mspr-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Common Stock Purchase Agreement, dated January 6, 2023, between MSP Recovery, Inc. and YA II PN, Ltd.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 12, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.26+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017023000723/mspr-ex10_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Registration Rights Agreement, dated January 6, 2023, between MSP Recovery, Inc. and YA II PN, Ltd.</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 12, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.27+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312523012155/d427435dex1027.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Second Amended and Restated Claims Proceeds Investment Agreement, dated January 24, 2019, between MSPA Claims 1, LLC and Brickell Key Investments LP</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1/A</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-268616</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.27</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 20, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.28+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312523012155/d427435dex1028.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment to Claim Proceeds Investment Agreement, dated September 30, 2022, between MSP Recovery, Inc. and Brickell Key Investments LP</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">S-1/A</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">333-268616</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.28</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 20, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.29+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312523102832/d491048dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">MTA Amendment and Binding Term Sheet, by and between Virage Recovery Master LP, Series MRCS, a series of MDA, Series LLC, John H. Ruiz, Frank C. Quesada, Virage Capital Management LP, MSP Recovery, LLC, La Ley con John H. Ruiz, MSP Recovery, Inc. and Lionheart II Holdings, LLC, dated April 12, 2023</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 17, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.30+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000119312523102832/d491048dex102.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Secured Promissory Note,</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001802450/000119312523102832/d491048d8k.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">dated April 12, 2023 by and between the Company and Nomura</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001802450/000119312523102832/d491048d8k.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Securities International, Inc.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 17, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.31+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017023034839/mspr-ex10_31.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Membership Interest Purchase Agreement, dated March 29, 2023, by and among MSP Recovery LLC, MSP Recovery Claims, Series, LLC and Hazel</span><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;"> </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Holdings I LLC</span><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.31</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 27, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.32+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017023034839/mspr-ex10_32.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Membership Interest Purchase Agreement, dated March 29, 2023 by and among MSP Recovery, LLC, MSP Recovery Claims Series 44, LLC, MSP Recovery Holding Series 01, LLC and Hazel Holdings I LLC</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.32</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 27, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.33+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017023034839/mspr-ex10_33.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Credit Agreement, dated March 29, 2023 by and between Subrogation Holdings LLC, MSP Recovery, LLC, MSP Recovery Claims, Series LLC - Series 15-09-321 and Hazel Holdings I LLC</span></a><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.33</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 27, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.34+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017023034839/mspr-ex10_34.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Credit Agreement, dated March 29, 2023 by and between Subrogation Holdings LLC, MSP Recovery, LLC, MSP Recovery Claims, Series LLC - Series 15-09-321 and Hazel Holdings I LLC</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.34</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 27, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.35+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024044197/lifw-ex10_35.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Collateral Administration Agreement, dated March 29, 2023, by and between Hazel Partners Holdings LLC, Subrogation Holdings, LLC and MSP Recovery LLC</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.35</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.36+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017023063845/lifw-ex10_8.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">MTA Amendment No. 2 and Amendment to the Amended and Restated Security Agreement dated November 13, 2023 by and between Virage Recovery Master LP, Series MRCS, John H. Ruiz, Frank C. Quesada, Virage Capital Management LP, MSP Recovery, LLC, La Ley con John H. Ruiz, MSP Recovery, Inc. and Lionheart II Holdings, LLC</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.08</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">November 14, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.37+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017023063845/lifw-ex10_9.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Second Amended and Restated Credit Agreement, dated November 10, 2023 by and between Subrogation Holdings LLC, MSP Recovery, LLC, JRFQ Holdings, LLC, 4601 Coral Gables Property, LLC, Hazel Partners Holdings LLC and MSP Recovery Claims, Series LLC - Series 15-09-321</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.09</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">November 14, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.38+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017023063845/lifw-ex10_10.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Standby Equity Purchase Agreement dated November 14, 2023 by and between YA II PN, LTD. and MSP Recovery, Inc.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">November 14, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.39+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017023063845/lifw-ex10_11.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Registration Rights Agreement dated November 14, 2023 by and between YA II PN, LTD. and MSP Recovery, Inc.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">November 14, 2023</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.40+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024044197/lifw-ex10_40.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Promissory Note dated March 26, 2024 by and between the MSP Recovery, Inc. and Nomura Securities International, Inc.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.40</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.41+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024044197/lifw-ex10_41.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">MTA Amendment No. 3 and Amendment No. 2 to the Amended and Restated Security Agreement dated March 26, 2024 by and between Virage Recovery Master LP, Series MRCS, a series of MDA, Series LLC, John H. Ruiz, Frank C. Quesada, Virage Capital Management</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.41</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2024</span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">131</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:8%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:53%;box-sizing:content-box;"/>
     <td style="width:5.64%;box-sizing:content-box;"/>
     <td style="width:10%;box-sizing:content-box;"/>
     <td style="width:7%;box-sizing:content-box;"/>
     <td style="width:15.36%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024044197/lifw-ex10_41.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">LP, MSP Recovery, LLC, La Ley con John H. Ruiz, MSP Recovery, Inc. and Lionheart II Holdings, LLC</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.42+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024044153/lifw-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Yorkville SEPA Side Letter dated April 8, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 12, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.43+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024044197/lifw-ex10_42.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Yorkville SEPA Side Letter dated April 12, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.42</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.44+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024052875/lifw-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Yorkville SEPA Side Letter dated May 2, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 3, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.45+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024084572/lifw-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Yorkville SEPA Side Letter dated July 12, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 18, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.46+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024093889/lifw-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Letter Agreement by and between Subrogation Holdings, LLC; MSP Recovery, LLC; JRFQ Holdings, LLC; 4601 Coral Gables Property, LLC; MSP Recovery Claims, Series LLC - Series 15-09-321; and Hazel Partners Holdings, LLC dated August 2, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 8, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.47+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024097154/lifw-ex10_13.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Yorkville SEPA Side Letter executed August 13, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">August 14, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.48+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024105194/lifw-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Letter agreement by Virage Recovery Master LP and Virage Capital Management LP dated September 6, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">September 10, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.49+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024113229/lifw-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment No. 3 to Second Amended and Restated Credit Agreement dated October 2, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">October 2, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.50+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024127034/lifw-ex10_7.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Yorkville SEPA Side Letter executed November 7, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10-Q</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">November 14, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.51+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017024127963/lifw-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Nomura Letter Agreement dated November 12, 2024</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">November 18, 2024</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.52+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017025011070/mspr-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Yorkville Letter Agreement dated January 24, 2025</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 30, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.53+</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1802450/000095017025052906/mspr-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Yorkville Letter Agreement dated April 10, 2025</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8-K</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">001-39445</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 10, 2025</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.54*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="mspr-ex10_54.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">LSA Termination</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14.1*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="mspr-ex14_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Code of Ethics</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.1*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="mspr-ex19_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Insider Trading Policy</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.1*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="mspr-ex21_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Subsidiaries of the Company</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.1*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="mspr-ex23_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consent of Deloitte &amp; Touche LLP</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.1*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="mspr-ex31_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.2*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="mspr-ex31_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.1#</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="mspr-ex32_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.2#</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="mspr-ex32_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97.1#</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="mspr-ex97_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Executive Officer Incentive Compensation Recovery Policy</span></a></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.INS*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">XBRL Instance Document</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.SCH*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104*</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:86.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*	Filed herewith.</span></p><p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">#	Furnished herewith.</span></p><p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">+	Previously filed.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">132</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item16"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 16</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Form 10-K Summary</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">133</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="signatures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:45.46%;box-sizing:content-box;"/>
     <td style="width:2%;box-sizing:content-box;"/>
     <td style="width:3%;box-sizing:content-box;"/>
     <td style="width:49.54%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2025</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ John H. Ruiz</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">John H. Ruiz</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2025</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Francisco Rivas-V&#225;squez</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Francisco Rivas-V&#225;squez</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Principal Financial Officer and Principal Accounting Officer)</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:30%;box-sizing:content-box;"/>
     <td style="width:50%;box-sizing:content-box;"/>
     <td style="width:20%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:1.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:1.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:1.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ John H. Ruiz</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer and Chairman of the Board of Directors</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2025</span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">John H. Ruiz</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Francisco Rivas-V&#225;squez</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Financial Officer and Principal Accounting Officer)</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2025</span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Francisco Rivas-V&#225;squez</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Frank C. Quesada</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2025</span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Frank C. Quesada</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Ophir Sternberg</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2025</span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Ophir Sternberg</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Beatriz Assapimonwait</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2025</span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Beatriz Assapimonwait</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Michael Arrigo</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2025</span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Michael Arrigo</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Thomas W. Hawkins</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2025</span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Thomas W. Hawkins</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Roger Meltzer</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">April 15, 2025</span></p></td>
    </tr>
    <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.009722222222222222in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Roger Meltzer</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">134</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.18
<SEQUENCE>2
<FILENAME>mspr-ex4_18.htm
<DESCRIPTION>EX-4.18
<TEXT>
<html>
 <head>
  <title>EX-4.18</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.074%;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Execution Version</font></p><p style="font-size:10pt;margin-top:0.35pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><h1 style="margin-left:25.227%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:23.593%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP RECOVERY, INC.</font></h1><p style="margin-left:25.227%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:23.593%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CLASS A COMMON STOCK WARRANT</font></p><p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:2.773%;text-indent:6.932%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.056%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">THIS WARRANT (THE &#x201c;WARRANT&#x201d;) AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#x201c;ACT&#x201d;), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SECURITIES IS EFFECTIVE UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE COMPANY REQUESTS, AN OPINION SATISFACTORY TO THE COMPANY TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.</font></p><p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:61.653%;font-size:10pt;margin-top:4.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrant Certificate No.:	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</font></p><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:45.38%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Original Issue Date: November 1, 2024 <br>Reissuance Date, if any:</font></p><p style="margin-left:2.773%;text-indent:6.933%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FOR VALUE RECEIVED, MSP Recovery, Inc. d/b/a LifeWallet (formerly known as Lionheart Acquisition Corporation II), a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), hereby certifies that Virage Recovery Master LP, a Delaware limited partnership, or its registered assigns (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) is entitled to purchase from the Company 3,277,808 duly authorized, validly issued, fully paid and nonassessable shares of Common Stock, at a purchase price per share of $0.0001 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Strike Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), all subject to the terms, conditions and adjustments set forth below in this Warrant.</font></p><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;" id="x__definitions"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Definitions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As used in this Warrant, the following terms have the respective meanings set forth below:</font></div></div><p style="margin-left:2.773%;text-indent:6.934%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.083%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Affiliate</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is under common control with, such Person, it being understood for purposes of this definition that &#x201c;control&#x201d; of a Person means the power directly or indirectly to direct or cause the direction of the management and policies of such Person whether by contract or otherwise.</font></p><p style="margin-left:2.773%;text-indent:6.934%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.083%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Aggregate Strike Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means an amount equal to the product of (a) the number of Warrant Shares in respect of which this Warrant is then outstanding, multiplied by (b) the Strike Price.</font></p><p style="margin-left:2.773%;text-indent:6.934%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.083%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Business Day</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any day, except a Saturday, Sunday or legal holiday, on which banking institutions in the State of New York are authorized or obligated by law or executive order to close.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:2.773%;text-indent:6.933%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Capital Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, collectively, the Common Stock and the Class V Common Stock, par value $0.0001 per share, of the Company.</font></p><p style="margin-left:2.773%;text-indent:6.935%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.102%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Class A Common Stock, par value $0.0001 per share, of the Company, and any capital stock into which such Common Stock shall have been converted, exchanged or reclassified following the date hereof.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in the preamble.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:22.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dilutive Issuance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(iii)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:22.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Distribution</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(iv)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="margin-left:2.773%;text-indent:6.933%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Excluded Issuances</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any issuance of (a) shares of any equity securities (including warrants or other convertible securities) pursuant to an employee stock option plan, management incentive plan, restricted stock plan, stock purchase plan or stock, ownership plan or similar benefit plan or similar program, or any compensatory arrangement or agreement approved by the Board of Directors or shareholders of the Company, (b) shares of any equity securities issuable upon exercise of any warrants or upon conversion, exercise or redemption of other securities outstanding as of the date of this Warrant which have been disclosed in the Company&#x2019;s reports filed with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934 (as amended, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), (c) shares of Common Stock or securities convertible into Common Stock, as applicable, issued by the Company upon exercise of this Warrant or pursuant to any of the other Transaction Agreements, (d) any equity-linked securities to be issued pursuant to any obligations existing at the time of this Warrant, (e) securities issued pursuant to acquisitions or strategic transactions and the payment of contractor invoices in the ordinary course of business approved by a majority of the disinterested directors of the Company, and (f) securities issued upon the exercise or exchange of or conversion of any securities, and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock in each case issued and outstanding on the date of this Warrant, provided that such securities have not been amended since the date of this Warrant to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with share splits or combinations) or to extend the term of such securities.</font></p><p style="margin-left:2.773%;text-indent:6.933%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, for any given exercise of this Warrant, the date on which the conditions to such exercise as set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shall have been satisfied at or prior to 5:00 p.m., New York City, NY time, on a Business Day.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:29.62%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:29.62%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in the preamble.</font></p><p style="margin-left:2.773%;text-indent:6.935%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.093%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MTA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means that certain Master Transaction Agreement among the Company, Holder and certain other parties named therein, dated as of March 9, 2022, as amended by that certain (i) Amendment, dated as of April 11, 2023, (ii) Amendment No. 2, dated as of November 13, 2023, and (iii) Amendment No. 3, dated as of March 26, 2024.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notice of Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Original Issue Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the first date hereabove written.</font></p><p style="margin-left:2.773%;text-indent:6.935%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.093%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any individual, sole proprietorship, partnership, limited liability company, corporation, joint venture, trust, incorporated organization or government or department or agency thereof.</font></p><p style="margin-left:2.773%;text-indent:6.933%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Strike Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in the preamble, subject to adjustments in accordance with the terms of this Warrant.</font></p><p style="margin-left:2.773%;text-indent:6.932%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.056%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subsidiary</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means a corporation association, company (including limited liability company), joint-stock company, business trust or other similar entity more than 50% of the outstanding voting stock of which is owned, directly or indirectly, by the Company or by one or more other Subsidiaries, or by the Company and one or more other Subsidiaries. For purposes of this definition, &#x201c;voting stock&#x201d; means stock which ordinarily has voting power for the election of directors, whether at all times or only so long as no senior class of stock has such voting power by reason of any contingency.</font></p><p style="margin-left:2.773%;text-indent:6.934%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.083%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trading Market</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, the OTC Bulletin Board, the OTCQB, or the OTCQX (or any successors to any of the foregoing).</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:5.287%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transaction Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means each of the MTA and this Warrant/other warrants.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:5.287%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(ii)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="margin-left:2.773%;text-indent:6.933%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">VWAP</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the OTC Bulletin Board is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the OTC Bulletin Board, (c) if the Common Stock is not then listed or quoted for trading on the OTC Bulletin Board and if prices for the Common Stock are then reported on the OTCQX, OTCQB or OTC Pink Marketplace maintained by the OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the volume weighted average price of the Common Stock on the first such facility (or a similar organization or agency succeeding to its functions of reporting prices), or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company. For purposes of calculating VWAP over any multiple-day period, the number of shares of Common Stock shall be adjusted for any stock splits, stock combinations, reclassifications or similar transaction.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:2.773%;text-indent:6.935%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.093%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means this Warrant and all warrants issued upon division or combination of, or in substitution for, this Warrant.</font></p><p style="margin-left:2.773%;text-indent:6.933%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.074%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrant Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the shares of Common Stock or other capital stock of the Company then purchasable upon exercise of this Warrant in accordance with the terms of this Warrant.</font></p><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;" id="x__term_of_warrant"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Term of Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Subject to the terms and conditions hereof, at any time or from time to time after the Original Issue Date and prior to 5:00 p.m., New York City, NY time, on the second anniversary of the Original Issue Date or, if such day is not a Business Day, on the next preceding Business Day (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the Holder of this Warrant may exercise this Warrant for all or any part of the Warrant Shares purchasable hereunder (subject to adjustment as provided herein).</font></div></div><div class="item-list-element-wrapper" style="margin-left:9.463%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.363840197930127%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;" id="x__exercise_of_warrant"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise of Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;" id="xa__exercise_procedure___this_warrant_ma"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise Procedure</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Warrant may be exercised from time to time on any Business Day during the Exercise Period, for all or any part of the unexercised Warrant Shares, upon: surrender of this Warrant to the Company at the address for notices in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> below (or an indemnification undertaking with respect to this Warrant in the case of its loss, theft or destruction), together with duly completed and executed exercise notice in the form attached hereto as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notice of Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).</font></div></div><div class="item-list-element-wrapper" style="margin-left:16.13%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.94920710623584%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;" id="xb__reserved_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RESERVED</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;" id="xc__delivery_of_warrant_shares_upon_exer"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delivery of Warrant Shares Upon Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In accordance with and subject to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> hereof, the Company shall, as promptly as practicable, and in any event within three (3) Business Days after surrender of this Warrant, instruct the transfer agent (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) for the Common Stock to record the issuance of the Warrant Shares purchased hereunder to the Holder in book-entry form pursuant to the Transfer Agent&#x2019;s regular procedures. The Warrant Shares shall be registered in the name of the Holder or, subject to compliance with </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 5</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> below, such other Person&#x2019;s name as shall be designated. This Warrant shall be deemed to have been exercised in whole or in part, and such certificate or certificates of Warrant Shares shall be deemed to have been issued, and the Holder or any other Person so designated to be named therein shall be deemed to have become a holder of record of such Warrant Shares for all purposes, as of the applicable Exercise Date.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;" id="xd__delivery_of_new_warrant___unless_the"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delivery of New Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Unless the purchase rights represented by this Warrant shall have expired or shall have been fully exercised, the Company shall, at the time of delivery of the Warrant Shares being issued in accordance with </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3(c)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> hereof, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unexpired and unexercised Warrant Shares called for by this Warrant. Such new Warrant shall in all other respects be identical to this Warrant.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;" id="xe__reservation_of_shares___during_the_e"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reservation of Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. During the Exercise Period, the Company shall at all times reserve and keep available out of its authorized but unissued Common Stock or other securities constituting Warrant Shares, solely for the purpose of issuance upon the exercise of this Warrant, the maximum number of Warrant Shares issuable upon the exercise of this Warrant, and </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:2.796%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the par value per Warrant Share shall at all times be less than or equal to the applicable Strike Price. The Company shall not increase the par value of any Warrant Shares receivable upon the exercise of this Warrant above the Strike Price then in effect, and shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;" id="xf__exercise_restriction___notwithstandi"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise Restriction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Notwithstanding anything herein to the contrary, the Company shall not effect the exercise of any portion of this Warrant, and the Holder shall not have the right to exercise any portion of this Warrant, and any such exercise shall be null and void and treated as if never made, to the extent, and only to the extent, that:</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;" id="xi__after_giving_effect_to_such_exercise"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">after giving effect to such exercise, the number of Warrant Shares then beneficially owned by the Holder and its Affiliates and any other Persons or entities whose beneficial ownership of Common Stock or other Capital Stock that is convertible or exercisable into Common Stock, for purposes of Section 13(d) of the Exchange Act, would be aggregated with the Holder&#x2019;s (including any shares held by any &#x201c;group&#x201d; of which the Holder is a member, but excluding shares beneficially owned by virtue of the ownership of securities or rights to acquire securities that have limitations on the right to exchange, convert, exercise or purchase similar to the limitation set forth herein) would exceed 9.99% of the total number of Common Stock issued and outstanding; except that Holder may increase such threshold upon 61 days&#x2019; notice to the Company; </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that if any Warrant Shares otherwise due to Holder pursuant to an exercise of this Warrant are not delivered as a result of the limitation in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3(f)(i)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Excess Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) then the Company&#x2019;s obligation to deliver such Excess Shares will not be extinguished, and the Company will deliver such Excess Shares as soon as reasonably practicable after the Holder provides written confirmation to the Company that such delivery will not contravene the limitation in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3(f)(i)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">; or</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;" id="xii__such_issuance__when_aggregated_with"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such issuance, when aggregated with any other Capital Stock theretofore or simultaneously therewith issued (including all of the transactions as contemplated under the Transaction Agreements) to or otherwise beneficially owned by the Holder and its Affiliates and any other Persons or entities whose beneficial ownership of Capital Stock would be aggregated with the Holder&#x2019;s for purposes of Section 13(d) of the Exchange Act (including any shares held by any &#x201c;group&#x201d; of which the Holder is a member) would result in a &#x201c;change of control&#x201d; of the Company within the meaning of Nasdaq Listing Rule 5635(b) or otherwise require shareholder approval under Nasdaq Listing Rule 5635(d); except that such limitation under this clause (ii) shall not apply in the event that the Company obtains all necessary shareholder approvals for such exchange in accordance with the Nasdaq Listing Rules. The Company shall use its commercially reasonable efforts to obtain any such necessary shareholder approval as soon as commercially practicable.</font></div></div><p style="margin-left:2.507%;text-indent:6.914%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes hereof, &#x201c;group&#x201d; has the meaning set forth in Section 13(d) of the Exchange Act and applicable regulations of the Securities and Exchange Commission, and the percentage held by the Holder shall be determined in a manner consistent with the provisions of Section 13(d) of the Exchange Act.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:9.463%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.363840197930127%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;" id="x__mandatory_cashless_exercise__adjustme"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mandatory Cashless Exercise; Adjustments</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="margin-left:16.13%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.94920710623584%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;" id="xa__reserved_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RESERVED</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;" id="xb__cashless_exercise___upon_the_exercis"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cashless Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Upon the exercise of the Warrant in whole or in part, the Company will settle such exercise by paying or delivering, as applicable and as provided in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, shares of Common Stock, together, if applicable, with cash in lieu of fractional shares in the amounts set forth herein. The Warrant shall only be settled in shares of Common Stock, other than any cash payments in lieu of fractional shares, and shall not be settled in cash. The consideration due upon settlement of the exercise of each Warrant will consist of the following:</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;" id="xi__a_number_of_shares_of_common_stock_e"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A number of shares of Common Stock equal to the greater of (x) zero and (y) the quotient obtained by dividing (VP-SP) * (WS) by (VP), where:</font></div></div><p style="margin-left:13.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.102%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WS = the number of Warrant Shares being exercised, subject to any adjustments as set forth in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">;</font></p><p style="margin-left:13.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.083%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">VP = the average of the VWAPs of each of the 5 days ending as of the market close on the trading day immediately preceding the applicable Exercise Date; and</font></p><p style="margin-left:13.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.083%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SP = the Strike Price in effect immediately after the close of business on such Exercise Date.</font></p><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;" id="xii__additionally__if_the_calculation_se"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, if the calculation set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(b)(i)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> results in the issuance of fractional shares of Common Stock, in lieu of delivering any fractional share of Common Stock otherwise due upon exercise of any Warrant, the Company will round to the nearest non-fractional share.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;" id="xc__strike_price_and_warrant_share_adjus"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Strike Price and Warrant Share Adjustments</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Each of the Strike Price and the Warrant Shares will be adjusted from time to time as follows:</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;" id="xi__adjustment_upon_stock_dividends__cer"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Adjustment Upon Stock Dividends, Certain Issuances, Subdivisions or Combinations of Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If the Company, at any time while this Warrant is outstanding:</font></div></div><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.056%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(A) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock, (B) subdivides outstanding shares of Common Stock into a larger number of shares, (C) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (D) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Strike Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of Warrant Shares shall be proportionately adjusted such that the Aggregate Strike Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(i)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re&#x2011;classification.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;" id="xii__changes_in_common_stock___in_case_o"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In case of any reclassification or reorganization of the outstanding shares of Common Stock (other than a change under subsection 4(c)(i) hereof or that solely affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of the Company with or into another entity or conversion of the Company as another entity (other than a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding shares of Common Stock), or in the case of any sale or conveyance to another entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved (any of the foregoing being herein called a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the holders of the Warrant shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Warrants would have received if such holder had exercised his, her or its Warrant(s) immediately prior to such event (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Alternative Issuance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; ); </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided, however,</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> that in connection with the closing of any such consolidation, merger, sale or conveyance, the successor or purchasing entity shall execute an amendment hereto providing for delivery of such Alternative Issuance; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided, further</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that (i) if the holders of the Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets constituting the Alternative Issuance for which the Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of the Common Stock in such consolidation or merger that affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Common Stock (other than a tender, exchange or redemption offer made by the Company in connection with redemption rights held by stockholders of the Company as provided for in the Company&#x2019;s amended and restated certificate of incorporation) under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act (or any successor rule)) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act (or any successor rule)) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act (or any successor rule)) more than 50% of the outstanding shares of Capital Stock, the holder of a Warrant shall be entitled to receive as the Alternative Issuance, the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder if such Warrant holder had exercised the Warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the Common Stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in this Section 4; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided, further</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that if less than 70% of the consideration receivable by the holders of Capital Stock in the applicable event is payable in the form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the Holder properly exercises the Warrant within thirty (30) days following the public disclosure of the consummation of such applicable event by the Company </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:2.796%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pursuant to a Current Report on Form 8-K filed with the Commission, the Strike Price shall be reduced by an amount (in dollars) (but in no event less than zero) equal to the difference of (i) the Strike Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) minus (B) the Black-Scholes Warrant Value (as defined below). The &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Black-Scholes</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrant Value</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the value of a Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bloomberg</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). For purposes of calculating such amount, (1) Section 6 of this Agreement shall be taken into account, (2) the price of each share of Common Stock shall be the volume weighted last reported average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event, (3) the assumed volatility shall be the 90 day volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately prior to the day of the announcement of the applicable event, and (4) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining term of the Warrant. &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Per Share Consideration</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means (i) if the consideration paid to holders of the Common Stock consists exclusively of cash, the amount of such cash per share of Common Stock, and (ii) in all other cases, the amount of cash per share of Common Stock, if any, plus the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event. If any reclassification or reorganization also results in a change in shares of Common Stock covered by subsection 4(c)(i), then such adjustment shall be made pursuant to subsection 4(c)(i) and this Section 4(c)(ii). The provisions of this subsection shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no event will the Strike Price be reduced to less than the par value per share issuable upon exercise of the Warrant.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;" id="xiii__common_stock_and_convertible_secur"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock and Convertible Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If the Company, at any time while this Warrant is outstanding, sells or grants any shares of Common Stock, or any securities convertible into or exercisable for Common Stock (such issuances collectively, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dilutive Issuance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), at a price per share of Common Stock, or at the exercise price per share for securities convertible into Common Stock, that is at a more than a 10% discount to the Fair Market Value (as defined below), then simultaneously with the consummation of each Dilutive Issuance,</font></div></div><div class="item-list-element-wrapper" style="margin-left:22.796%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:8.635562924200817%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(A)</font><div style="width:100%;display:inline;" id="xa__the_strike_price_in_effect_immediate"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Strike Price in effect immediately prior to such Dilutive Issuance will immediately be reduced to the price determined by multiplying the Strike Price in effect immediately prior to such Dilutive Issuance by a fraction, (x) the numerator of which shall be the sum of (1) the product obtained by multiplying the Common Stock Deemed Outstanding (as defined below) prior to such issuance or sale by the Fair Market Value of the Common Stock immediately prior to such Dilutive Issuance, plus (2) the aggregate consideration, if any, received by the Company for the total number of such additional shares of Common Stock or securities convertible into or exercisable for Common Stock, and (y) the denominator of which shall be the product obtained by multiplying (1) the number of shares of Common Stock outstanding immediately after such Dilutive Issuance by (2) the Fair Market Value of the shares of Common Stock immediately prior to such Dilutive Issuance;</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:22.796%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:8.635562924200817%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(B)</font><div style="width:100%;display:inline;" id="xb__the_number_of_warrant_shares_issuabl"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number of Warrant Shares issuable upon the exercise of this Warrant shall be adjusted to a number equal to the quotient obtained by dividing: (i) the product of (A) the Strike Price in effect immediately prior to any such Dilutive Issuance multiplied by (B) the number of Warrant Shares issuable upon exercise of this Warrant immediately prior to such Dilutive Issuance; by (ii) the Strike Price resulting from such adjustment (as set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(iii)(A)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">); and</font></div></div><div class="item-list-element-wrapper" style="margin-left:22.796%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:8.635562924200817%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(C)</font><div style="width:100%;display:inline;" id="xc__for_purposes_of_this_section_4_c__ii"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(iii)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, &#x201c;Common Stock Deemed Outstanding&#x201d; shall mean the total number of shares of common stock outstanding as of such date, expressed on a fully-diluted basis and &#x201c;Fair Market Value&#x201d; shall mean the 10-day VWAP prior to the date of the Dilutive Issuance.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;" id="xiv__other_distributions___during_such_t"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Distributions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) other than any such dividend or distribution that is subject to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(i)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> hereof (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Distribution</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), at any time after the issuance of this Warrant, then, in each such case, the Strike Price shall be adjusted by multiplying the Strike Price in effect immediately prior to the record date fixed for determination of stockholders entitled to receive such Distribution by a fraction of which the denominator shall be the closing price on the record date mentioned above, and of which the numerator shall be such closing price on such record date less the then per share fair market value at such record date of the portion of such assets or evidence of indebtedness so distributed applicable to one outstanding share of the Common Stock as determined by the Board of Directors in good faith, and the number of Warrant Shares shall be proportionately adjusted such that the Aggregate Strike Price of this Warrant shall remain unchanged. In either case the adjustments shall be described in a statement provided to the Holder of the portion of assets or evidences of indebtedness so distributed or such subscription rights applicable to one share of Common Stock. Such adjustment shall be made whenever any such distribution is made and shall become effective immediately after the record date mentioned above.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(v)</font><div style="width:100%;display:inline;" id="xv__repurchases___unless_otherwise_adjus"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Repurchases</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Unless otherwise adjusted pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(i)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> through (x) hereof, if, at any time while this Warrant is outstanding, the Company effects any Repurchases, then, following the completion of the Repurchase, the Strike Price shall be reduced to the price determined by multiplying the Strike Price in effect immediately prior to the date of the Repurchase by a fraction of which the numerator shall be (a) the product of (1) the number of shares of Common Stock outstanding immediately prior to the date of the Repurchase and (2) the closing price of the Common Stock on the trading day immediately preceding the Company&#x2019;s first public disclosure of its intent to effect such Repurchases, minus (b) the Assumed Payment Amount (as defined below), and of which the denominator shall be the product of (X) the number of shares of Common Stock outstanding immediately prior to the date of the Repurchase minus the number of shares of Common Stock so repurchased and (Y) the closing price of the Common Stock on the trading day immediately preceding the Company&#x2019;s first public disclosure of its intent to effect such Repurchases. In such event, the number of Warrant Shares issuable upon the exercise of this </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:2.796%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrant shall be increased to the number obtained by multiplying such number of Warrant Shares by the quotient of (A) the Strike Price in effect immediately prior to the date of the Repurchases divided by (B) the new Strike Price determined in accordance with the immediately preceding sentence. For purposes of the foregoing, the &#x201c;Assumed Payment Amount&#x201d; with respect to any Repurchases shall mean the closing price as of the date of such Repurchases, of the aggregate consideration paid to effect such Repurchases and &#x201c;Repurchases&#x201d; means any transaction or series of related transactions to purchase Common Stock of the Company for a purchase price greater than the closing price on the trading day immediately prior to such transactions pursuant to any tender offer or exchange offer.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(vi)</font><div style="width:100%;display:inline;" id="xvi__exceptions_to_adjustment_upon_issua"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exceptions to Adjustment Upon Issuance of Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Notwithstanding anything herein to the contrary herein, there shall be no adjustment to the number of Warrant Shares issuable upon exercise of this Warrant or the Strike Price with respect to any Excluded Issuance.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;" id="xd__notices___whenever_the_strike_price_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Whenever the Strike Price or the Warrant Shares are adjusted pursuant to any provision of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company shall mail to the Holder a notice setting forth the adjusted Strike Price or the Warrant Shares and a brief statement of the facts requiring such adjustment. In the event the Company shall consummate any Transaction then, unless the Company has made a filing with the Securities and Exchange Commission, including pursuant to a Current Report on Form 8-K, which filing discloses such Transaction, the Company shall give to each Holder of a warrant certificate a written notice of such Transaction.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;" id="x__transfer_of_warrant"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer of Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Subject to the transfer conditions referred to in the legend endorsed hereon, this Warrant and all rights hereunder are transferable, in whole or in part, by the Holder without charge to the Holder, upon surrender of this Warrant to the Company at the address for notices in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> below (email being sufficient) with a properly completed and duly executed assignment in the form set forth on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit B</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and any other documentation as may be reasonably requested from the Company. Upon such compliance, surrender and delivery and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees and in the denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant, if any, not so assigned and this Warrant shall promptly be cancelled.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;" id="x__holder_not_deemed_a_stockholder__limi"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holder Not Deemed a Stockholder; Limitations on Liability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Other than as set forth herein, prior to the issuance to the Holder of the Warrant Shares to which the Holder is then entitled to receive upon the due exercise of this Warrant, the Holder shall not be entitled to vote or be deemed the holder of shares of capital stock of the Company for any purpose (other than for tax purposes), nor shall anything contained in this Warrant be construed to confer upon the Holder, as such, any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise) or receive notice of meetings. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:9.463%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.363840197930127%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;" id="x__replacement_on_loss__division_and_com"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Replacement on Loss; Division and Combination</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;" id="xa__replacement_of_warrant_on_loss___upo"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Replacement of Warrant on Loss</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and upon delivery of an indemnity reasonably satisfactory to it (it being understood that a written indemnification agreement or affidavit of loss of the Holder shall be a sufficient indemnity) and, in case of mutilation, upon surrender of such Warrant for cancellation to the Company, the Company at its own expense shall execute and deliver to the Holder, in lieu hereof, a new Warrant of like tenor and exercisable for an equivalent number of Warrant Shares as the Warrant so lost, stolen, mutilated or destroyed; provided, that, in the case of mutilation, no indemnity shall be required if this Warrant in identifiable form is surrendered to the Company for cancellation.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;" id="xb__division_and_combination_of_warrant_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Division and Combination of Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Subject to compliance with the applicable provisions of this Warrant as to any transfer or other assignment which may be involved in such division or combination, this Warrant may be divided or, following any such division of this Warrant, subsequently combined with other Warrants, upon the surrender of this Warrant or Warrants to the Company at its then principal executive offices, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the respective Holders or their agents or attorneys, along with any other documentation that the Company may reasonably request. Subject to compliance with the applicable provisions of this Warrant as to any transfer or assignment which may be involved in such division or combination, the Company shall at its own expense execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants so surrendered in accordance with such notice. Such new Warrant or Warrants shall be of like tenor to the surrendered Warrant or Warrants and shall be exercisable in the aggregate for an equivalent number of Warrant Shares as the Warrant or Warrants so surrendered in accordance with such notice.</font></div></div><div class="item-list-element-wrapper" style="margin-left:9.463%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.363840197930127%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.</font><div style="width:100%;display:inline;" id="x__compliance_with_the_act"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compliance with the Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;" id="xa__restrictive_legend___the_holder__by_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restrictive Legend</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Holder, by acceptance of this Warrant, agrees to comply in all respects with the provisions of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 8</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and the restrictive legend requirements set forth on the face of this Warrant and further agrees that such Holder shall not offer, sell or otherwise dispose of this Warrant or any Warrant Shares to be issued upon exercise hereof except under circumstances that will not result in a violation of the Act. This Warrant and all Warrant Shares issued upon exercise of this Warrant (unless registered under the Act) shall be stamped or imprinted with a legend in substantially the following form:</font></div></div><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:7.741%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#x201c;ACT&#x201d;), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SECURITIES IS EFFECTIVE UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:7.741%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE COMPANY REQUESTS, AN OPINION SATISFACTORY TO THE COMPANY TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.&#x201d;</font></p><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;" id="xb__removal_of_restrictive_legend___the_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Removal of Restrictive Legend</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company agrees, upon request of the Holder or permitted assignee, to take all steps reasonably necessary to promptly effect the removal of any restrictive legend from the certificates representing Warrant Shares or the book- entry account of such Warrant Shares, and the Company shall bear all costs associated therewith, regardless of whether the request is made in connection with a sale or otherwise, so long as the Holder, its permitted assigns or its broker provides to the Company a certification as to the length of time the such Warrant Shares have been held and a certification that the Holder is not an affiliate of the Company. The Company shall cooperate with the Holder to effect the removal of the legend at any time such legend is no longer appropriate.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">9.</font><div style="width:100%;display:inline;" id="x__warrant_register"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrant Register</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company shall keep and properly maintain at its principal executive offices books for the registration of the Warrant and any transfers thereof. The Company may deem and treat the Person in whose name the Warrant is registered on such register as the Holder thereof for all purposes, and the Company shall not be affected by any notice to the contrary, except any assignment, division, combination or other transfer of the Warrant effected in accordance with the provisions of this Warrant.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">10.</font><div style="width:100%;display:inline;" id="x0__notices"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed to have been given: (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by e-mail of a PDF document (with confirmation of transmission); or (d) on the third day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must be sent to the respective parties at the addresses indicated below (or at such other address for a party as shall be specified in a notice given in accordance with this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">).</font></div></div><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If to the Company:	MSP Recovery, Inc.</font></p><p style="margin-left:29.467%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:32.037%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3150 SW 38th Avenue</font></p><p style="margin-left:29.467%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:32.037%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Suite 1100</font></p><p style="margin-left:29.467%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:32.037%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Miami, Florida 33146</font></p><p style="margin-left:29.467%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Attention:	Alexandra Plasencia</font></p><p style="margin-left:29.467%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">E-mail:	aplasencia@msprecovery.com</font></p><p style="margin-left:9.467%;text-indent:-29.298%;padding-left:20%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.269%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If to the Holder:	To such Holder at the address of such Holder as listed in the stock record books of the Company.</font></p><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">11.</font><div style="width:100%;display:inline;" id="x1__cumulative_remedies"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cumulative Remedies</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Except to the extent expressly provided to the contrary, the rights and remedies provided in this Warrant are cumulative and are not exclusive of, and are in addition to and not in substitution for, any other rights or remedies available at law, in equity or otherwise.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">12.</font><div style="width:100%;display:inline;" id="x2__equitable_relief"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equitable Relief</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Each of the Company and the Holder acknowledges that a breach or threatened breach by such party of any of its obligations under this Warrant would give rise to irreparable harm to the other party hereto for which monetary damages would not be an adequate </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:2.796%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">remedy and hereby agrees that in the event of a breach or a threatened breach by such party of any such obligations, the other party hereto shall, in addition to any and all other rights and remedies that may be available to it in respect of such breach, be entitled to equitable relief, including a restraining order, an injunction, specific performance and any other relief that may be available from a court of competent jurisdiction.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">13.</font><div style="width:100%;display:inline;" id="x3__entire_agreement"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Entire Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Warrant, together with the Transaction Agreements, constitutes the sole and entire agreement of the parties to this Warrant with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings and agreements, both written and oral, with respect to such subject matter. In the event of any inconsistency between the statements in the body of this Warrant and any of the Transaction Agreements, the statements in the body of this Warrant shall control.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">14.</font><div style="width:100%;display:inline;" id="x4__successor_and_assigns"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Successor and Assigns</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Warrant and the rights evidenced hereby shall be binding upon and shall inure to the benefit of the parties hereto and the successors of the Company and the successors and permitted assigns of the Holder. Such successors and/or permitted assigns of the Holder shall be deemed to be a Holder for all purposes hereunder.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">15.</font><div style="width:100%;display:inline;" id="x5__no_third_party_beneficiaries"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Third-Party Beneficiaries</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Warrant is for the sole benefit of the Company and the Holder and their respective successors and, in the case of the Holder, permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other Person any legal or equitable right, benefit or remedy of any nature whatsoever, under or by reason of this Warrant.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">16.</font><div style="width:100%;display:inline;" id="x6__headings"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Headings</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The headings in this Warrant are for reference only and shall not affect the interpretation of this Warrant.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">17.</font><div style="width:100%;display:inline;" id="x7__amendment_and_modification__waiver"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amendment and Modification; Waiver</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Except as otherwise provided herein, this Warrant may only be amended, modified or supplemented by an agreement in writing signed by each party hereto. No waiver by the Company or the Holder of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any party shall operate or be construed as a waiver in respect of any failure, breach or default not expressly identified by such written waiver, whether of a similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay in exercising, any rights, remedy, power or privilege arising from this Warrant shall operate or be construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">18.</font><div style="width:100%;display:inline;" id="x8__severability"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Severability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If any term or provision of this Warrant is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other term or provision of this Warrant or invalidate or render unenforceable such term or provision in any other jurisdiction.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">19.</font><div style="width:100%;display:inline;" id="x9__governing_law"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governing Law</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Warrant shall be governed by and construed in accordance with the internal laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of laws of any jurisdiction other than those of the State of Delaware.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">20.</font><div style="width:100%;display:inline;" id="x0__submission_to_jurisdiction"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Submission to Jurisdiction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Any legal suit, action or proceeding arising out of or based upon this Warrant or the transactions contemplated hereby may be instituted in the federal courts of the United States of America or the Chancery Court of the State of Delaware in each case located in the city of Wilmington, and each party irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action or proceeding. Service of process, summons, notice or other document by certified or registered mail to such party&#x2019;s address set forth herein shall be effective service of process for any suit, action or other proceeding brought in any such court. The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or any proceeding in such courts and irrevocably waive and agree not to plead or claim in any such court that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">21.</font><div style="width:100%;display:inline;" id="x1__waiver_of_jury_trial"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Waiver of Jury Trial</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Each party acknowledges and agrees that any controversy which may arise under this Warrant is likely to involve complicated and difficult issues and, therefore, each such party irrevocably and unconditionally waives any right it may have to a trial by jury in respect of any legal action arising out of or relating to this Warrant or the transactions contemplated hereby.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">22.</font><div style="width:100%;display:inline;" id="x2__counterparts"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Counterparts</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Warrant may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this Warrant delivered by facsimile, e-mail or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Warrant.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">23.</font><div style="width:100%;display:inline;" id="x3__no_strict_construction"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Strict Construction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Warrant shall be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting an instrument or causing any instrument to be drafted.</font></div></div><p style="margin-left:25.227%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:23.583%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[SIGNATURE PAGE FOLLOWS]</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.94in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:25.227%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:23.583%;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:2.773%;text-indent:6.857%;font-size:10pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF, the Company has duly executed this Warrant as of the Original Issue Date.</font></p><p style="font-size:10pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0.05pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:41.833%;border-spacing:0;table-layout:auto;width:43.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:20.8%;box-sizing:content-box;"></td>
     <td style="width:79.2%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:33.1pt;word-break:break-word;white-space:pre-wrap;">
     <td colspan="2" style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">MSP RECOVERY, INC.</font></p></td>
    </tr>
    <tr style="height:33.85pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:1.853%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:1.853%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:13.7pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font></p></td>
     <td style="padding-top:0in;text-indent:1.95pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:0.36%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Robert Strongarone</font></p></td>
    </tr>
    <tr style="height:13.7pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:</font></p></td>
     <td style="padding-top:0in;text-indent:1.95pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:0.36%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Authorized Representative</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:0.991%;border-spacing:0;table-layout:auto;width:52.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:17.22%;box-sizing:content-box;"></td>
     <td style="width:82.78%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:19.45pt;word-break:break-word;white-space:pre-wrap;">
     <td colspan="2" style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ACKNOWLEDGED AND AGREED:</font></p></td>
    </tr>
    <tr style="height:52.55pt;word-break:break-word;white-space:pre-wrap;">
     <td colspan="2" style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">VIRAGE RECOVERY MASTER LP</font></p><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:	Virage Recovery LLC, its general partner</font></p></td>
    </tr>
    <tr style="height:33.1pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">___________________________</font></p></td>
    </tr>
    <tr style="height:13.7pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font></p></td>
     <td style="padding-top:0in;text-indent:2.05pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:0.373%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Edward Ondarza</font></p></td>
    </tr>
    <tr style="height:13.7pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:</font></p></td>
     <td style="padding-top:0in;text-indent:2.05pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:0.373%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Manager</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.49in;min-height:0.63in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.94in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h1 style="margin-left:34%;text-indent:18.502%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:32.13%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT A</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> NOTICE OF EXERCISE</font></h1><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To:	MSP RECOVERY, INC.</font></p><p style="margin-left:2.773%;text-indent:6.935%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.093%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reference is made to that certain Class A Common Stock Warrant (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) issued by MSP Recovery, Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) on November 1, 2024. Capitalized terms used but not otherwise defined herein shall have the respective meanings given thereto in the Warrant.</font></p><div class="item-list-element-wrapper" style="margin-left:2.537%;text-indent:7.192%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.235453454131312%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The undersigned Holder of the Warrant hereby elects to exercise the Warrant for number of Warrant Shares, subject to tender of Warrant Shares pursuant to the cashless </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">exercise provisions of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Warrant.</font></div></div><p style="margin-left:2.773%;text-indent:6.934%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.083%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The undersigned Holder hereby instructs the Company to issue the applicable net number of shares of Common Stock issuable upon exercise of the Warrant pursuant to the cashless exercise provisions of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Warrant, in the name of the undersigned Holder. The Holder&#x2019;s calculation of such net number shall be provided to the Company upon request.</font></p><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The undersigned Holder hereby represents and warrants to the Company that, as of the date hereof:</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Experience; Accredited Investor Status</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Holder (i) is an accredited investor as that term is defined in Rule 501 of Regulation D promulgated under the Securities Act, is capable of evaluating the merits and risks of its investment in the Company, (ii) has the capacity to protect its own interests, and (iii) has the financial ability to bear the economic risk of its investment in the Company.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company Information</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Holder has been provided access to all information, including through the Company&#x2019;s publicly available documents and filing, regarding the business and financial condition of the Company, its expected plans for future business activities, material contracts, intellectual property, and the merits and risks of its purchase of the Warrant Shares, which it has requested or otherwise needs to evaluate an investment in the Warrant Shares. It has had an opportunity to discuss the Company&#x2019;s business, management and financial affairs with directors, officers and management of the Company and has had the opportunity to review the Company&#x2019;s operations and facilities. It has also had the opportunity to ask questions of, and receive answers from, the Company and its management regarding the terms and conditions of this investment and all such questions have been answered to its satisfaction.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Holder has not been formed solely for the purpose of making this investment and is acquiring the Warrant Shares for investment for its own account, not as a nominee or agent, and not with the view to, or for resale in connection with, any distribution of any part thereof. It understands that the Warrant Shares have not been registered under the Securities Act or applicable state and other securities laws and are being issued by reason of a specific exemption from the registration provisions of the Securities Act and applicable state and other securities laws, the availability of which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of its representations as expressed herein.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.94in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:16.13%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.94920710623584%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer Restrictions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Holder acknowledges and understands that:</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:1.7869634994444676%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">this Warrant, and the Warrant Shares, are &#x201c;restricted securities&#x201d; and may only be transferred pursuant to an exemption, or exclusion, from registration requirements under U.S. federal securities laws,</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:1.7869634994444676%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">it may have to bear the economic risk of this investment for an indefinite period of time unless the Warrant Shares are subsequently registered under the Securities Act and applicable state and other securities laws or unless an exemption from such registration is available, and</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:1.7869634994444676%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the legend described in Section 8 of the Warrant may only be removed once the Warrant Shares are no longer &#x201c;restricted securities.&#x201d;</font></div></div><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Name of Registered Owner: _______________________________________________________</font></p><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Signature of Authorized Signatory of Registered Owner: ________________________________</font></p><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Name of Authorized Signatory: ____________________________________________________</font></p><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Title of Authorized Signatory: _____________________________________________________</font></p><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date: ______________________________________</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.94in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.18</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h1 style="margin-left:34.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:33.333%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT B</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ASSIGNMENT FORM</font></h1><p style="margin-left:2.8%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.269%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</font></p><p style="margin-left:2.8%;text-indent:6.859%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</font></p>
   <table style="border-spacing:0;table-layout:auto;width:62.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:13.7pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">   </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:20.15pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Please Print)</font></p></td>
    </tr>
    <tr style="height:20.15pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Address:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:20.15pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Please Print)</font></p></td>
    </tr>
    <tr style="height:25.9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dated:   </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">_________________________________</font></p></td>
    </tr>
    <tr style="height:26.65pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:5.95pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Holder&#x2019;s Signature: ________________________</font></p></td>
    </tr>
    <tr style="height:20.15pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:6.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Holder&#x2019;s Address:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.19
<SEQUENCE>3
<FILENAME>mspr-ex4_19.htm
<DESCRIPTION>EX-4.19
<TEXT>
<html>
 <head>
  <title>EX-4.19</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.074%;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Execution Version</font></p><p style="font-size:10pt;margin-top:0.35pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><h1 style="margin-left:25.227%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:23.593%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP RECOVERY, INC.</font></h1><p style="margin-left:25.227%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:23.593%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CLASS A COMMON STOCK WARRANT</font></p><p style="font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:2.773%;text-indent:6.932%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.056%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">THIS WARRANT (THE &#x201c;WARRANT&#x201d;) AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#x201c;ACT&#x201d;), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SECURITIES IS EFFECTIVE UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE COMPANY REQUESTS, AN OPINION SATISFACTORY TO THE COMPANY TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.</font></p><p style="font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:61.653%;font-size:10pt;margin-top:4.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrant Certificate No.:	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</font></p><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:45.38%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Original Issue Date: December 1, 2024 <br>Reissuance Date, if any:</font></p><p style="margin-left:2.773%;text-indent:6.933%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FOR VALUE RECEIVED, MSP Recovery, Inc. d/b/a LifeWallet (formerly known as Lionheart Acquisition Corporation II), a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), hereby certifies that Virage Recovery Master LP, a Delaware limited partnership, or its registered assigns (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) is entitled to purchase from the Company 6,332,792 duly authorized, validly issued, fully paid and nonassessable shares of Common Stock, at a purchase price per share of $0.0001 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Strike Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), all subject to the terms, conditions and adjustments set forth below in this Warrant.</font></p><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;" id="x__definitions"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Definitions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As used in this Warrant, the following terms have the respective meanings set forth below:</font></div></div><p style="margin-left:2.773%;text-indent:6.934%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.083%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Affiliate</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is under common control with, such Person, it being understood for purposes of this definition that &#x201c;control&#x201d; of a Person means the power directly or indirectly to direct or cause the direction of the management and policies of such Person whether by contract or otherwise.</font></p><p style="margin-left:2.773%;text-indent:6.934%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.083%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Aggregate Strike Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means an amount equal to the product of (a) the number of Warrant Shares in respect of which this Warrant is then outstanding, multiplied by (b) the Strike Price.</font></p><p style="margin-left:2.773%;text-indent:6.934%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.083%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Business Day</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any day, except a Saturday, Sunday or legal holiday, on which banking institutions in the State of New York are authorized or obligated by law or executive order to close.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:2.773%;text-indent:6.933%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Capital Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, collectively, the Common Stock and the Class V Common Stock, par value $0.0001 per share, of the Company.</font></p><p style="margin-left:2.773%;text-indent:6.935%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.102%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Class A Common Stock, par value $0.0001 per share, of the Company, and any capital stock into which such Common Stock shall have been converted, exchanged or reclassified following the date hereof.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in the preamble.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:22.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dilutive Issuance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(iii)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:22.463%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Distribution</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(iv)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="margin-left:2.773%;text-indent:6.933%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Excluded Issuances</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any issuance of (a) shares of any equity securities (including warrants or other convertible securities) pursuant to an employee stock option plan, management incentive plan, restricted stock plan, stock purchase plan or stock, ownership plan or similar benefit plan or similar program, or any compensatory arrangement or agreement approved by the Board of Directors or shareholders of the Company, (b) shares of any equity securities issuable upon exercise of any warrants or upon conversion, exercise or redemption of other securities outstanding as of the date of this Warrant which have been disclosed in the Company&#x2019;s reports filed with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934 (as amended, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), (c) shares of Common Stock or securities convertible into Common Stock, as applicable, issued by the Company upon exercise of this Warrant or pursuant to any of the other Transaction Agreements, (d) any equity-linked securities to be issued pursuant to any obligations existing at the time of this Warrant, (e) securities issued pursuant to acquisitions or strategic transactions and the payment of contractor invoices in the ordinary course of business approved by a majority of the disinterested directors of the Company, and (f) securities issued upon the exercise or exchange of or conversion of any securities, and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock in each case issued and outstanding on the date of this Warrant, provided that such securities have not been amended since the date of this Warrant to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with share splits or combinations) or to extend the term of such securities.</font></p><p style="margin-left:2.773%;text-indent:6.933%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, for any given exercise of this Warrant, the date on which the conditions to such exercise as set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shall have been satisfied at or prior to 5:00 p.m., New York City, NY time, on a Business Day.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:29.62%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:29.62%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in the preamble.</font></p><p style="margin-left:2.773%;text-indent:6.935%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.093%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MTA</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means that certain Master Transaction Agreement among the Company, Holder and certain other parties named therein, dated as of March 9, 2022, as amended by that certain (i) Amendment, dated as of April 11, 2023, (ii) Amendment No. 2, dated as of November 13, 2023, and (iii) Amendment No. 3, dated as of March 26, 2024.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notice of Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Original Issue Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the first date hereabove written.</font></p><p style="margin-left:2.773%;text-indent:6.935%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.093%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any individual, sole proprietorship, partnership, limited liability company, corporation, joint venture, trust, incorporated organization or government or department or agency thereof.</font></p><p style="margin-left:2.773%;text-indent:6.933%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Strike Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in the preamble, subject to adjustments in accordance with the terms of this Warrant.</font></p><p style="margin-left:2.773%;text-indent:6.932%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.056%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subsidiary</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means a corporation association, company (including limited liability company), joint-stock company, business trust or other similar entity more than 50% of the outstanding voting stock of which is owned, directly or indirectly, by the Company or by one or more other Subsidiaries, or by the Company and one or more other Subsidiaries. For purposes of this definition, &#x201c;voting stock&#x201d; means stock which ordinarily has voting power for the election of directors, whether at all times or only so long as no senior class of stock has such voting power by reason of any contingency.</font></p><p style="margin-left:2.773%;text-indent:6.934%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.083%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trading Market</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, the OTC Bulletin Board, the OTCQB, or the OTCQX (or any successors to any of the foregoing).</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:5.287%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transaction Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means each of the MTA and this Warrant/other warrants.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:5.287%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(ii)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="margin-left:2.773%;text-indent:6.933%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">VWAP</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a trading day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the OTC Bulletin Board is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the OTC Bulletin Board, (c) if the Common Stock is not then listed or quoted for trading on the OTC Bulletin Board and if prices for the Common Stock are then reported on the OTCQX, OTCQB or OTC Pink Marketplace maintained by the OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the volume weighted average price of the Common Stock on the first such facility (or a similar organization or agency succeeding to its functions of reporting prices), or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company. For purposes of calculating VWAP over any multiple-day period, the number of shares of Common Stock shall be adjusted for any stock splits, stock combinations, reclassifications or similar transaction.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:2.773%;text-indent:6.935%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.093%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means this Warrant and all warrants issued upon division or combination of, or in substitution for, this Warrant.</font></p><p style="margin-left:2.773%;text-indent:6.933%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.074%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrant Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the shares of Common Stock or other capital stock of the Company then purchasable upon exercise of this Warrant in accordance with the terms of this Warrant.</font></p><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;" id="x__term_of_warrant"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Term of Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Subject to the terms and conditions hereof, at any time or from time to time after the Original Issue Date and prior to 5:00 p.m., New York City, NY time, on the second anniversary of the Original Issue Date or, if such day is not a Business Day, on the next preceding Business Day (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the Holder of this Warrant may exercise this Warrant for all or any part of the Warrant Shares purchasable hereunder (subject to adjustment as provided herein).</font></div></div><div class="item-list-element-wrapper" style="margin-left:9.463%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.363840197930127%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;" id="x__exercise_of_warrant"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise of Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;" id="xa__exercise_procedure___this_warrant_ma"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise Procedure</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Warrant may be exercised from time to time on any Business Day during the Exercise Period, for all or any part of the unexercised Warrant Shares, upon: surrender of this Warrant to the Company at the address for notices in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> below (or an indemnification undertaking with respect to this Warrant in the case of its loss, theft or destruction), together with duly completed and executed exercise notice in the form attached hereto as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notice of Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).</font></div></div><div class="item-list-element-wrapper" style="margin-left:16.13%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.94920710623584%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;" id="xb__reserved_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RESERVED</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;" id="xc__delivery_of_warrant_shares_upon_exer"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delivery of Warrant Shares Upon Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In accordance with and subject to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3(a)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> hereof, the Company shall, as promptly as practicable, and in any event within three (3) Business Days after surrender of this Warrant, instruct the transfer agent (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) for the Common Stock to record the issuance of the Warrant Shares purchased hereunder to the Holder in book-entry form pursuant to the Transfer Agent&#x2019;s regular procedures. The Warrant Shares shall be registered in the name of the Holder or, subject to compliance with </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 5</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> below, such other Person&#x2019;s name as shall be designated. This Warrant shall be deemed to have been exercised in whole or in part, and such certificate or certificates of Warrant Shares shall be deemed to have been issued, and the Holder or any other Person so designated to be named therein shall be deemed to have become a holder of record of such Warrant Shares for all purposes, as of the applicable Exercise Date.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;" id="xd__delivery_of_new_warrant___unless_the"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delivery of New Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Unless the purchase rights represented by this Warrant shall have expired or shall have been fully exercised, the Company shall, at the time of delivery of the Warrant Shares being issued in accordance with </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3(c)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> hereof, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unexpired and unexercised Warrant Shares called for by this Warrant. Such new Warrant shall in all other respects be identical to this Warrant.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(e)</font><div style="width:100%;display:inline;" id="xe__reservation_of_shares___during_the_e"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reservation of Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. During the Exercise Period, the Company shall at all times reserve and keep available out of its authorized but unissued Common Stock or other securities constituting Warrant Shares, solely for the purpose of issuance upon the exercise of this Warrant, the maximum number of Warrant Shares issuable upon the exercise of this Warrant, and </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:2.796%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the par value per Warrant Share shall at all times be less than or equal to the applicable Strike Price. The Company shall not increase the par value of any Warrant Shares receivable upon the exercise of this Warrant above the Strike Price then in effect, and shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(f)</font><div style="width:100%;display:inline;" id="xf__exercise_restriction___notwithstandi"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise Restriction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Notwithstanding anything herein to the contrary, the Company shall not effect the exercise of any portion of this Warrant, and the Holder shall not have the right to exercise any portion of this Warrant, and any such exercise shall be null and void and treated as if never made, to the extent, and only to the extent, that:</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;" id="xi__after_giving_effect_to_such_exercise"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">after giving effect to such exercise, the number of Warrant Shares then beneficially owned by the Holder and its Affiliates and any other Persons or entities whose beneficial ownership of Common Stock or other Capital Stock that is convertible or exercisable into Common Stock, for purposes of Section 13(d) of the Exchange Act, would be aggregated with the Holder&#x2019;s (including any shares held by any &#x201c;group&#x201d; of which the Holder is a member, but excluding shares beneficially owned by virtue of the ownership of securities or rights to acquire securities that have limitations on the right to exchange, convert, exercise or purchase similar to the limitation set forth herein) would exceed 9.99% of the total number of Common Stock issued and outstanding; except that Holder may increase such threshold upon 61 days&#x2019; notice to the Company; </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that if any Warrant Shares otherwise due to Holder pursuant to an exercise of this Warrant are not delivered as a result of the limitation in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3(f)(i)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Excess Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) then the Company&#x2019;s obligation to deliver such Excess Shares will not be extinguished, and the Company will deliver such Excess Shares as soon as reasonably practicable after the Holder provides written confirmation to the Company that such delivery will not contravene the limitation in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3(f)(i)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">; or</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;" id="xii__such_issuance__when_aggregated_with"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such issuance, when aggregated with any other Capital Stock theretofore or simultaneously therewith issued (including all of the transactions as contemplated under the Transaction Agreements) to or otherwise beneficially owned by the Holder and its Affiliates and any other Persons or entities whose beneficial ownership of Capital Stock would be aggregated with the Holder&#x2019;s for purposes of Section 13(d) of the Exchange Act (including any shares held by any &#x201c;group&#x201d; of which the Holder is a member) would result in a &#x201c;change of control&#x201d; of the Company within the meaning of Nasdaq Listing Rule 5635(b) or otherwise require shareholder approval under Nasdaq Listing Rule 5635(d); except that such limitation under this clause (ii) shall not apply in the event that the Company obtains all necessary shareholder approvals for such exchange in accordance with the Nasdaq Listing Rules. The Company shall use its commercially reasonable efforts to obtain any such necessary shareholder approval as soon as commercially practicable.</font></div></div><p style="margin-left:2.507%;text-indent:6.914%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes hereof, &#x201c;group&#x201d; has the meaning set forth in Section 13(d) of the Exchange Act and applicable regulations of the Securities and Exchange Commission, and the percentage held by the Holder shall be determined in a manner consistent with the provisions of Section 13(d) of the Exchange Act.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:9.463%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.363840197930127%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;" id="x__mandatory_cashless_exercise__adjustme"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mandatory Cashless Exercise; Adjustments</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="margin-left:16.13%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.94920710623584%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;" id="xa__reserved_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RESERVED</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;" id="xb__cashless_exercise___upon_the_exercis"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cashless Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Upon the exercise of the Warrant in whole or in part, the Company will settle such exercise by paying or delivering, as applicable and as provided in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(b)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, shares of Common Stock, together, if applicable, with cash in lieu of fractional shares in the amounts set forth herein. The Warrant shall only be settled in shares of Common Stock, other than any cash payments in lieu of fractional shares, and shall not be settled in cash. The consideration due upon settlement of the exercise of each Warrant will consist of the following:</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;" id="xi__a_number_of_shares_of_common_stock_e"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A number of shares of Common Stock equal to the greater of (x) zero and (y) the quotient obtained by dividing (VP-SP) * (WS) by (VP), where:</font></div></div><p style="margin-left:13.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.102%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WS = the number of Warrant Shares being exercised, subject to any adjustments as set forth in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">;</font></p><p style="margin-left:13.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.083%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">VP = the average of the VWAPs of each of the 5 days ending as of the market close on the trading day immediately preceding the applicable Exercise Date; and</font></p><p style="margin-left:13.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.083%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SP = the Strike Price in effect immediately after the close of business on such Exercise Date.</font></p><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;" id="xii__additionally__if_the_calculation_se"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, if the calculation set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(b)(i)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> results in the issuance of fractional shares of Common Stock, in lieu of delivering any fractional share of Common Stock otherwise due upon exercise of any Warrant, the Company will round to the nearest non-fractional share.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;" id="xc__strike_price_and_warrant_share_adjus"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Strike Price and Warrant Share Adjustments</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Each of the Strike Price and the Warrant Shares will be adjusted from time to time as follows:</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;" id="xi__adjustment_upon_stock_dividends__cer"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Adjustment Upon Stock Dividends, Certain Issuances, Subdivisions or Combinations of Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If the Company, at any time while this Warrant is outstanding:</font></div></div><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.056%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(A) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock, (B) subdivides outstanding shares of Common Stock into a larger number of shares, (C) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (D) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Strike Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of Warrant Shares shall be proportionately adjusted such that the Aggregate Strike Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(i)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re&#x2011;classification.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;" id="xii__changes_in_common_stock___in_case_o"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In case of any reclassification or reorganization of the outstanding shares of Common Stock (other than a change under subsection 4(c)(i) hereof or that solely affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of the Company with or into another entity or conversion of the Company as another entity (other than a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding shares of Common Stock), or in the case of any sale or conveyance to another entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved (any of the foregoing being herein called a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the holders of the Warrant shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Warrants would have received if such holder had exercised his, her or its Warrant(s) immediately prior to such event (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Alternative Issuance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; ); </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided, however,</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> that in connection with the closing of any such consolidation, merger, sale or conveyance, the successor or purchasing entity shall execute an amendment hereto providing for delivery of such Alternative Issuance; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided, further</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that (i) if the holders of the Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets constituting the Alternative Issuance for which the Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of the Common Stock in such consolidation or merger that affirmatively make such election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Common Stock (other than a tender, exchange or redemption offer made by the Company in connection with redemption rights held by stockholders of the Company as provided for in the Company&#x2019;s amended and restated certificate of incorporation) under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act (or any successor rule)) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act (or any successor rule)) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act (or any successor rule)) more than 50% of the outstanding shares of Capital Stock, the holder of a Warrant shall be entitled to receive as the Alternative Issuance, the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder if such Warrant holder had exercised the Warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the Common Stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in this Section 4; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided, further</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that if less than 70% of the consideration receivable by the holders of Capital Stock in the applicable event is payable in the form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the Holder properly exercises the Warrant within thirty (30) days following the public disclosure of the consummation of such applicable event by the Company </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:2.796%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pursuant to a Current Report on Form 8-K filed with the Commission, the Strike Price shall be reduced by an amount (in dollars) (but in no event less than zero) equal to the difference of (i) the Strike Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) minus (B) the Black-Scholes Warrant Value (as defined below). The &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Black-Scholes</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrant Value</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the value of a Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bloomberg</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). For purposes of calculating such amount, (1) Section 6 of this Agreement shall be taken into account, (2) the price of each share of Common Stock shall be the volume weighted last reported average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event, (3) the assumed volatility shall be the 90 day volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately prior to the day of the announcement of the applicable event, and (4) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining term of the Warrant. &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Per Share Consideration</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means (i) if the consideration paid to holders of the Common Stock consists exclusively of cash, the amount of such cash per share of Common Stock, and (ii) in all other cases, the amount of cash per share of Common Stock, if any, plus the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event. If any reclassification or reorganization also results in a change in shares of Common Stock covered by subsection 4(c)(i), then such adjustment shall be made pursuant to subsection 4(c)(i) and this Section 4(c)(ii). The provisions of this subsection shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no event will the Strike Price be reduced to less than the par value per share issuable upon exercise of the Warrant.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;" id="xiii__common_stock_and_convertible_secur"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock and Convertible Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If the Company, at any time while this Warrant is outstanding, sells or grants any shares of Common Stock, or any securities convertible into or exercisable for Common Stock (such issuances collectively, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dilutive Issuance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), at a price per share of Common Stock, or at the exercise price per share for securities convertible into Common Stock, that is at a more than a 10% discount to the Fair Market Value (as defined below), then simultaneously with the consummation of each Dilutive Issuance,</font></div></div><div class="item-list-element-wrapper" style="margin-left:22.796%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:8.635562924200817%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(A)</font><div style="width:100%;display:inline;" id="xa__the_strike_price_in_effect_immediate"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Strike Price in effect immediately prior to such Dilutive Issuance will immediately be reduced to the price determined by multiplying the Strike Price in effect immediately prior to such Dilutive Issuance by a fraction, (x) the numerator of which shall be the sum of (1) the product obtained by multiplying the Common Stock Deemed Outstanding (as defined below) prior to such issuance or sale by the Fair Market Value of the Common Stock immediately prior to such Dilutive Issuance, plus (2) the aggregate consideration, if any, received by the Company for the total number of such additional shares of Common Stock or securities convertible into or exercisable for Common Stock, and (y) the denominator of which shall be the product obtained by multiplying (1) the number of shares of Common Stock outstanding immediately after such Dilutive Issuance by (2) the Fair Market Value of the shares of Common Stock immediately prior to such Dilutive Issuance;</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:22.796%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:8.635562924200817%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(B)</font><div style="width:100%;display:inline;" id="xb__the_number_of_warrant_shares_issuabl"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number of Warrant Shares issuable upon the exercise of this Warrant shall be adjusted to a number equal to the quotient obtained by dividing: (i) the product of (A) the Strike Price in effect immediately prior to any such Dilutive Issuance multiplied by (B) the number of Warrant Shares issuable upon exercise of this Warrant immediately prior to such Dilutive Issuance; by (ii) the Strike Price resulting from such adjustment (as set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(iii)(A)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">); and</font></div></div><div class="item-list-element-wrapper" style="margin-left:22.796%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:8.635562924200817%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(C)</font><div style="width:100%;display:inline;" id="xc__for_purposes_of_this_section_4_c__ii"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(iii)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, &#x201c;Common Stock Deemed Outstanding&#x201d; shall mean the total number of shares of common stock outstanding as of such date, expressed on a fully-diluted basis and &#x201c;Fair Market Value&#x201d; shall mean the 10-day VWAP prior to the date of the Dilutive Issuance.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;" id="xiv__other_distributions___during_such_t"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Distributions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) other than any such dividend or distribution that is subject to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(i)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> hereof (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Distribution</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), at any time after the issuance of this Warrant, then, in each such case, the Strike Price shall be adjusted by multiplying the Strike Price in effect immediately prior to the record date fixed for determination of stockholders entitled to receive such Distribution by a fraction of which the denominator shall be the closing price on the record date mentioned above, and of which the numerator shall be such closing price on such record date less the then per share fair market value at such record date of the portion of such assets or evidence of indebtedness so distributed applicable to one outstanding share of the Common Stock as determined by the Board of Directors in good faith, and the number of Warrant Shares shall be proportionately adjusted such that the Aggregate Strike Price of this Warrant shall remain unchanged. In either case the adjustments shall be described in a statement provided to the Holder of the portion of assets or evidences of indebtedness so distributed or such subscription rights applicable to one share of Common Stock. Such adjustment shall be made whenever any such distribution is made and shall become effective immediately after the record date mentioned above.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(v)</font><div style="width:100%;display:inline;" id="xv__repurchases___unless_otherwise_adjus"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Repurchases</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Unless otherwise adjusted pursuant to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4(c)(i)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> through (x) hereof, if, at any time while this Warrant is outstanding, the Company effects any Repurchases, then, following the completion of the Repurchase, the Strike Price shall be reduced to the price determined by multiplying the Strike Price in effect immediately prior to the date of the Repurchase by a fraction of which the numerator shall be (a) the product of (1) the number of shares of Common Stock outstanding immediately prior to the date of the Repurchase and (2) the closing price of the Common Stock on the trading day immediately preceding the Company&#x2019;s first public disclosure of its intent to effect such Repurchases, minus (b) the Assumed Payment Amount (as defined below), and of which the denominator shall be the product of (X) the number of shares of Common Stock outstanding immediately prior to the date of the Repurchase minus the number of shares of Common Stock so repurchased and (Y) the closing price of the Common Stock on the trading day immediately preceding the Company&#x2019;s first public disclosure of its intent to effect such Repurchases. In such event, the number of Warrant Shares issuable upon the exercise of this </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:2.796%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrant shall be increased to the number obtained by multiplying such number of Warrant Shares by the quotient of (A) the Strike Price in effect immediately prior to the date of the Repurchases divided by (B) the new Strike Price determined in accordance with the immediately preceding sentence. For purposes of the foregoing, the &#x201c;Assumed Payment Amount&#x201d; with respect to any Repurchases shall mean the closing price as of the date of such Repurchases, of the aggregate consideration paid to effect such Repurchases and &#x201c;Repurchases&#x201d; means any transaction or series of related transactions to purchase Common Stock of the Company for a purchase price greater than the closing price on the trading day immediately prior to such transactions pursuant to any tender offer or exchange offer.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:20.803%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.530677749886836%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(vi)</font><div style="width:100%;display:inline;" id="xvi__exceptions_to_adjustment_upon_issua"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exceptions to Adjustment Upon Issuance of Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Notwithstanding anything herein to the contrary herein, there shall be no adjustment to the number of Warrant Shares issuable upon exercise of this Warrant or the Strike Price with respect to any Excluded Issuance.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;" id="xd__notices___whenever_the_strike_price_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Whenever the Strike Price or the Warrant Shares are adjusted pursuant to any provision of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company shall mail to the Holder a notice setting forth the adjusted Strike Price or the Warrant Shares and a brief statement of the facts requiring such adjustment. In the event the Company shall consummate any Transaction then, unless the Company has made a filing with the Securities and Exchange Commission, including pursuant to a Current Report on Form 8-K, which filing discloses such Transaction, the Company shall give to each Holder of a warrant certificate a written notice of such Transaction.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;" id="x__transfer_of_warrant"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer of Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Subject to the transfer conditions referred to in the legend endorsed hereon, this Warrant and all rights hereunder are transferable, in whole or in part, by the Holder without charge to the Holder, upon surrender of this Warrant to the Company at the address for notices in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> below (email being sufficient) with a properly completed and duly executed assignment in the form set forth on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit B</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and any other documentation as may be reasonably requested from the Company. Upon such compliance, surrender and delivery and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees and in the denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant, if any, not so assigned and this Warrant shall promptly be cancelled.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">6.</font><div style="width:100%;display:inline;" id="x__holder_not_deemed_a_stockholder__limi"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holder Not Deemed a Stockholder; Limitations on Liability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Other than as set forth herein, prior to the issuance to the Holder of the Warrant Shares to which the Holder is then entitled to receive upon the due exercise of this Warrant, the Holder shall not be entitled to vote or be deemed the holder of shares of capital stock of the Company for any purpose (other than for tax purposes), nor shall anything contained in this Warrant be construed to confer upon the Holder, as such, any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise) or receive notice of meetings. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:9.463%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.363840197930127%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.</font><div style="width:100%;display:inline;" id="x__replacement_on_loss__division_and_com"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Replacement on Loss; Division and Combination</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;" id="xa__replacement_of_warrant_on_loss___upo"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Replacement of Warrant on Loss</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and upon delivery of an indemnity reasonably satisfactory to it (it being understood that a written indemnification agreement or affidavit of loss of the Holder shall be a sufficient indemnity) and, in case of mutilation, upon surrender of such Warrant for cancellation to the Company, the Company at its own expense shall execute and deliver to the Holder, in lieu hereof, a new Warrant of like tenor and exercisable for an equivalent number of Warrant Shares as the Warrant so lost, stolen, mutilated or destroyed; provided, that, in the case of mutilation, no indemnity shall be required if this Warrant in identifiable form is surrendered to the Company for cancellation.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;" id="xb__division_and_combination_of_warrant_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Division and Combination of Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Subject to compliance with the applicable provisions of this Warrant as to any transfer or other assignment which may be involved in such division or combination, this Warrant may be divided or, following any such division of this Warrant, subsequently combined with other Warrants, upon the surrender of this Warrant or Warrants to the Company at its then principal executive offices, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the respective Holders or their agents or attorneys, along with any other documentation that the Company may reasonably request. Subject to compliance with the applicable provisions of this Warrant as to any transfer or assignment which may be involved in such division or combination, the Company shall at its own expense execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants so surrendered in accordance with such notice. Such new Warrant or Warrants shall be of like tenor to the surrendered Warrant or Warrants and shall be exercisable in the aggregate for an equivalent number of Warrant Shares as the Warrant or Warrants so surrendered in accordance with such notice.</font></div></div><div class="item-list-element-wrapper" style="margin-left:9.463%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.363840197930127%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.</font><div style="width:100%;display:inline;" id="x__compliance_with_the_act"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compliance with the Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;" id="xa__restrictive_legend___the_holder__by_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restrictive Legend</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Holder, by acceptance of this Warrant, agrees to comply in all respects with the provisions of this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 8</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and the restrictive legend requirements set forth on the face of this Warrant and further agrees that such Holder shall not offer, sell or otherwise dispose of this Warrant or any Warrant Shares to be issued upon exercise hereof except under circumstances that will not result in a violation of the Act. This Warrant and all Warrant Shares issued upon exercise of this Warrant (unless registered under the Act) shall be stamped or imprinted with a legend in substantially the following form:</font></div></div><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:7.741%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#x201c;ACT&#x201d;), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SECURITIES IS EFFECTIVE UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE QUALIFICATION</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:7.741%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE COMPANY REQUESTS, AN OPINION SATISFACTORY TO THE COMPANY TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL.&#x201d;</font></p><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;" id="xb__removal_of_restrictive_legend___the_"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Removal of Restrictive Legend</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company agrees, upon request of the Holder or permitted assignee, to take all steps reasonably necessary to promptly effect the removal of any restrictive legend from the certificates representing Warrant Shares or the book- entry account of such Warrant Shares, and the Company shall bear all costs associated therewith, regardless of whether the request is made in connection with a sale or otherwise, so long as the Holder, its permitted assigns or its broker provides to the Company a certification as to the length of time the such Warrant Shares have been held and a certification that the Holder is not an affiliate of the Company. The Company shall cooperate with the Holder to effect the removal of the legend at any time such legend is no longer appropriate.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">9.</font><div style="width:100%;display:inline;" id="x__warrant_register"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrant Register</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company shall keep and properly maintain at its principal executive offices books for the registration of the Warrant and any transfers thereof. The Company may deem and treat the Person in whose name the Warrant is registered on such register as the Holder thereof for all purposes, and the Company shall not be affected by any notice to the contrary, except any assignment, division, combination or other transfer of the Warrant effected in accordance with the provisions of this Warrant.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">10.</font><div style="width:100%;display:inline;" id="x0__notices"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed to have been given: (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by e-mail of a PDF document (with confirmation of transmission); or (d) on the third day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must be sent to the respective parties at the addresses indicated below (or at such other address for a party as shall be specified in a notice given in accordance with this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 10</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">).</font></div></div><p style="margin-left:9.44%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If to the Company:	MSP Recovery, Inc.</font></p><p style="margin-left:29.467%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:32.037%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3150 SW 38th Avenue</font></p><p style="margin-left:29.467%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:32.037%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Suite 1100</font></p><p style="margin-left:29.467%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:32.037%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Miami, Florida 33146</font></p><p style="margin-left:29.467%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Attention:	Alexandra Plasencia</font></p><p style="margin-left:29.467%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">E-mail:	aplasencia@msprecovery.com</font></p><p style="margin-left:9.467%;text-indent:-29.298%;padding-left:20%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.269%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If to the Holder:	To such Holder at the address of such Holder as listed in the stock record books of the Company.</font></p><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">11.</font><div style="width:100%;display:inline;" id="x1__cumulative_remedies"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cumulative Remedies</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Except to the extent expressly provided to the contrary, the rights and remedies provided in this Warrant are cumulative and are not exclusive of, and are in addition to and not in substitution for, any other rights or remedies available at law, in equity or otherwise.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">12.</font><div style="width:100%;display:inline;" id="x2__equitable_relief"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equitable Relief</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Each of the Company and the Holder acknowledges that a breach or threatened breach by such party of any of its obligations under this Warrant would give rise to irreparable harm to the other party hereto for which monetary damages would not be an adequate </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:2.796%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">remedy and hereby agrees that in the event of a breach or a threatened breach by such party of any such obligations, the other party hereto shall, in addition to any and all other rights and remedies that may be available to it in respect of such breach, be entitled to equitable relief, including a restraining order, an injunction, specific performance and any other relief that may be available from a court of competent jurisdiction.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">13.</font><div style="width:100%;display:inline;" id="x3__entire_agreement"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Entire Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Warrant, together with the Transaction Agreements, constitutes the sole and entire agreement of the parties to this Warrant with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings and agreements, both written and oral, with respect to such subject matter. In the event of any inconsistency between the statements in the body of this Warrant and any of the Transaction Agreements, the statements in the body of this Warrant shall control.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">14.</font><div style="width:100%;display:inline;" id="x4__successor_and_assigns"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Successor and Assigns</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Warrant and the rights evidenced hereby shall be binding upon and shall inure to the benefit of the parties hereto and the successors of the Company and the successors and permitted assigns of the Holder. Such successors and/or permitted assigns of the Holder shall be deemed to be a Holder for all purposes hereunder.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">15.</font><div style="width:100%;display:inline;" id="x5__no_third_party_beneficiaries"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Third-Party Beneficiaries</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Warrant is for the sole benefit of the Company and the Holder and their respective successors and, in the case of the Holder, permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other Person any legal or equitable right, benefit or remedy of any nature whatsoever, under or by reason of this Warrant.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">16.</font><div style="width:100%;display:inline;" id="x6__headings"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Headings</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The headings in this Warrant are for reference only and shall not affect the interpretation of this Warrant.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">17.</font><div style="width:100%;display:inline;" id="x7__amendment_and_modification__waiver"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amendment and Modification; Waiver</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Except as otherwise provided herein, this Warrant may only be amended, modified or supplemented by an agreement in writing signed by each party hereto. No waiver by the Company or the Holder of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any party shall operate or be construed as a waiver in respect of any failure, breach or default not expressly identified by such written waiver, whether of a similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay in exercising, any rights, remedy, power or privilege arising from this Warrant shall operate or be construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">18.</font><div style="width:100%;display:inline;" id="x8__severability"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Severability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If any term or provision of this Warrant is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other term or provision of this Warrant or invalidate or render unenforceable such term or provision in any other jurisdiction.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">19.</font><div style="width:100%;display:inline;" id="x9__governing_law"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governing Law</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Warrant shall be governed by and construed in accordance with the internal laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of laws of any jurisdiction other than those of the State of Delaware.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.94in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">20.</font><div style="width:100%;display:inline;" id="x0__submission_to_jurisdiction"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Submission to Jurisdiction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Any legal suit, action or proceeding arising out of or based upon this Warrant or the transactions contemplated hereby may be instituted in the federal courts of the United States of America or the Chancery Court of the State of Delaware in each case located in the city of Wilmington, and each party irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action or proceeding. Service of process, summons, notice or other document by certified or registered mail to such party&#x2019;s address set forth herein shall be effective service of process for any suit, action or other proceeding brought in any such court. The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or any proceeding in such courts and irrevocably waive and agree not to plead or claim in any such court that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">21.</font><div style="width:100%;display:inline;" id="x1__waiver_of_jury_trial"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Waiver of Jury Trial</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Each party acknowledges and agrees that any controversy which may arise under this Warrant is likely to involve complicated and difficult issues and, therefore, each such party irrevocably and unconditionally waives any right it may have to a trial by jury in respect of any legal action arising out of or relating to this Warrant or the transactions contemplated hereby.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">22.</font><div style="width:100%;display:inline;" id="x2__counterparts"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Counterparts</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Warrant may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this Warrant delivered by facsimile, e-mail or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Warrant.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">23.</font><div style="width:100%;display:inline;" id="x3__no_strict_construction"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Strict Construction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Warrant shall be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting an instrument or causing any instrument to be drafted.</font></div></div><p style="margin-left:25.227%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:23.583%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[SIGNATURE PAGE FOLLOWS]</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Page </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.94in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:25.227%;font-size:10pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;margin-right:23.583%;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:2.773%;text-indent:6.857%;font-size:10pt;margin-top:3.95pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF, the Company has duly executed this Warrant as of the Original Issue Date.</font></p><p style="font-size:10pt;margin-top:0.4pt;font-family:Times New Roman;margin-bottom:0.05pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:41.833%;border-spacing:0;table-layout:auto;width:43.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:20.8%;box-sizing:content-box;"></td>
     <td style="width:79.2%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:33.1pt;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">MSP RECOVERY, INC.</font></p></td>
    </tr>
    <tr style="height:33.85pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:1.853%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0.55pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:1.853%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font></p></td>
     <td style="padding-top:0in;text-indent:1.95pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:0.36%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Robert Strongarone</font></p></td>
    </tr>
    <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:</font></p></td>
     <td style="padding-top:0in;text-indent:1.95pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:0.36%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Authorized Representative</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:0.991%;border-spacing:0;table-layout:auto;width:52.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:17.22%;box-sizing:content-box;"></td>
     <td style="width:82.78%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:19.45pt;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ACKNOWLEDGED AND AGREED:</font></p></td>
    </tr>
    <tr style="height:52.55pt;white-space:pre-wrap;word-break:break-word;">
     <td colspan="2" style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">VIRAGE RECOVERY MASTER LP</font></p><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:	Virage Recovery LLC, its general partner</font></p></td>
    </tr>
    <tr style="height:33.1pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">___________________________</font></p></td>
    </tr>
    <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font></p></td>
     <td style="padding-top:0in;text-indent:2.05pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:0.373%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Edward Ondarza</font></p></td>
    </tr>
    <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:</font></p></td>
     <td style="padding-top:0in;text-indent:2.05pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:0.373%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Manager</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.49in;min-height:0.63in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.94in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h1 style="margin-left:34%;text-indent:18.502%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:32.13%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT A</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> NOTICE OF EXERCISE</font></h1><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To:	MSP RECOVERY, INC.</font></p><p style="margin-left:2.773%;text-indent:6.935%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.093%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reference is made to that certain Class A Common Stock Warrant (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Warrant</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) issued by MSP Recovery, Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) on December 1, 2024. Capitalized terms used but not otherwise defined herein shall have the respective meanings given thereto in the Warrant.</font></p><div class="item-list-element-wrapper" style="margin-left:2.537%;text-indent:7.192%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.935%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.235453454131312%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The undersigned Holder of the Warrant hereby elects to exercise the Warrant for number of Warrant Shares, subject to tender of Warrant Shares pursuant to the cashless </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">exercise provisions of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Warrant.</font></div></div><p style="margin-left:2.773%;text-indent:6.934%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.083%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The undersigned Holder hereby instructs the Company to issue the applicable net number of shares of Common Stock issuable upon exercise of the Warrant pursuant to the cashless exercise provisions of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Warrant, in the name of the undersigned Holder. The Holder&#x2019;s calculation of such net number shall be provided to the Company upon request.</font></p><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:6.934%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.255997695568084%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The undersigned Holder hereby represents and warrants to the Company that, as of the date hereof:</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Experience; Accredited Investor Status</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Holder (i) is an accredited investor as that term is defined in Rule 501 of Regulation D promulgated under the Securities Act, is capable of evaluating the merits and risks of its investment in the Company, (ii) has the capacity to protect its own interests, and (iii) has the financial ability to bear the economic risk of its investment in the Company.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company Information</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Holder has been provided access to all information, including through the Company&#x2019;s publicly available documents and filing, regarding the business and financial condition of the Company, its expected plans for future business activities, material contracts, intellectual property, and the merits and risks of its purchase of the Warrant Shares, which it has requested or otherwise needs to evaluate an investment in the Warrant Shares. It has had an opportunity to discuss the Company&#x2019;s business, management and financial affairs with directors, officers and management of the Company and has had the opportunity to review the Company&#x2019;s operations and facilities. It has also had the opportunity to ask questions of, and receive answers from, the Company and its management regarding the terms and conditions of this investment and all such questions have been answered to its satisfaction.</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;text-indent:13.869%;font-size:0;margin-top:12pt;justify-content:flex-start;margin-bottom:0;margin-right:1.065%;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:2.06164355376322%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Holder has not been formed solely for the purpose of making this investment and is acquiring the Warrant Shares for investment for its own account, not as a nominee or agent, and not with the view to, or for resale in connection with, any distribution of any part thereof. It understands that the Warrant Shares have not been registered under the Securities Act or applicable state and other securities laws and are being issued by reason of a specific exemption from the registration provisions of the Securities Act and applicable state and other securities laws, the availability of which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of its representations as expressed herein.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.94in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:16.13%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.94920710623584%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer Restrictions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Holder acknowledges and understands that:</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:1.7869634994444676%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">this Warrant, and the Warrant Shares, are &#x201c;restricted securities&#x201d; and may only be transferred pursuant to an exemption, or exclusion, from registration requirements under U.S. federal securities laws,</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:1.7869634994444676%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">it may have to bear the economic risk of this investment for an indefinite period of time unless the Warrant Shares are subsequently registered under the Securities Act and applicable state and other securities laws or unless an exemption from such registration is available, and</font></div></div><div class="item-list-element-wrapper" style="margin-left:2.796%;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:1.7869634994444676%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the legend described in Section 8 of the Warrant may only be removed once the Warrant Shares are no longer &#x201c;restricted securities.&#x201d;</font></div></div><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Name of Registered Owner: _______________________________________________________</font></p><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Signature of Authorized Signatory of Registered Owner: ________________________________</font></p><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Name of Authorized Signatory: ____________________________________________________</font></p><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Title of Authorized Signatory: _____________________________________________________</font></p><p style="margin-left:2.773%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.065%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date: ______________________________________</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.94in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.19</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h1 style="margin-left:34.933%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:33.333%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid #000000;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT B</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ASSIGNMENT FORM</font></h1><p style="margin-left:2.8%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.269%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</font></p><p style="margin-left:2.8%;text-indent:6.859%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</font></p>
   <table style="border-spacing:0;table-layout:auto;width:62.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:13.7pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">   </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:20.15pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Please Print)</font></p></td>
    </tr>
    <tr style="height:20.15pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Address:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:20.15pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Please Print)</font></p></td>
    </tr>
    <tr style="height:25.9pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dated:   </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">_________________________________</font></p></td>
    </tr>
    <tr style="height:26.65pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:5.95pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Holder&#x2019;s Signature: ________________________</font></p></td>
    </tr>
    <tr style="height:20.15pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.853%;text-indent:0;font-size:12pt;margin-top:6.05pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Holder&#x2019;s Address:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.55in;min-height:0.68in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:0.187%;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.54
<SEQUENCE>4
<FILENAME>mspr-ex10_54.htm
<DESCRIPTION>EX-10.54
<TEXT>
<html>
 <head>
  <title>EX-10.54</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="padding-top:0.3in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.54</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AMENDMENT NO. 1 TO LEGAL SERVICES AGREEMENT</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This AMENDMENT NO. 1 TO LEGAL SERVICES AGREEMENT (this &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), effective as of December 31, 2024 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Effective Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), by and between Lionheart II Holdings, LLC, a Delaware limited liability company (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Client</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), La Ley con John H. Ruiz, P.A. d/b/a MSP Recovery Law Firm, a Florida corporation, and MSP Law Firm, PLLC, a Florida professional limited liability company (either or both entities, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Law Firm</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). Client and Law Firm may be referred to each as a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Party</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; and together, as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Parties</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preliminary Statements</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Client and the Law Firm entered into that certain Legal Services Agreement dated as of May 23, 2022 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), pursuant to which the Client engaged the Law Firm to act as its exclusive lead counsel to represent the Client and each of its subsidiaries on the terms and conditions set forth therein.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Parties wish to amend certain terms of the Agreement, including those related to certain obligations of Client to provide compensation advances to the Law Firm.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 5.6 of the Agreement, no amendment or modification of the terms of the Agreement will be valid and binding unless set forth in a written instrument signed by all the Parties.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOW THEREFORE, in consideration of these premises and the mutual covenants and agreements contained herein, the receipt and sufficiency of which are hereby acknowledged, the Parties agree that the Agreement is amended as follows, effective immediately as of the Effective Date.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Capitalized terms used and not otherwise defined shall have the same meanings as set forth in the Agreement.</font></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes of Section 2.3 of the Agreement, the Parties acknowledge and agree as follows:</font></div></div><p style="margin-left:10%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.407777777777778%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Client made a prepaid Advance to the Law Firm that amounts to $36,480,000 for the initial 36-month period of the Agreement (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Advance Balance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).</font></div></div><p style="margin-left:16.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.407777777777778%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of the Effective Date, the Client shall not have any obligation to provide any Advances to the Law Firm in excess of the Advance Balance, and such obligation is hereby terminated.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.407777777777778%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Advance Balance shall be offset exclusively from the Compensation and reimbursed only after payment of all pre-existing obligations of the Law Firm as of the Effective Date and arrangements with co-counsel. Except as otherwise provided, any Compensation earned by the Law Firm will be first used to repay the Advance Balance.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Representations and Warranties</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each Party hereby represents and warrants to the other Party as follows:</font></div></div><p style="margin-left:10%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.407777777777778%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It has full power and authority to execute, deliver and perform its obligations under this Amendment;</font></div></div><p style="margin-left:16.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.407777777777778%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Its execution, delivery and performance of this Amendment has been duly authorized by all appropriate corporate action and this Amendment constitutes a valid, binding and enforceable obligation of such Party, and will not result, in a breach or violation of any provision of (A) </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.3in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.407777777777778%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such Party&#x2019;s organizational documents, (B) statute, law, writ, order, rule or regulation of any governmental authority, (C) any judgement, injunction, decree or determination applicable to such Party, or (D) any contract, indenture, mortgage, loan agreement, note, lease or other agreement, document or instrument to which such Party may be a party, may be bound or to which any of such Party&#x2019;s assets are subject.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Client hereby represents and warrants to the Law Firm as follows:</font></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:10%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:7.407777777777778%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It has obtained the required approvals by MSP Recovery, Inc.&#x2019;s &#x201c;Independent Directors&#x201d; (as such term is defined in Nasdaq Listing Rule 5605(2)(2)) to execute, deliver and perform the Amendment set forth herein.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date of Effectiveness</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Amendment will be deemed effective as of the Effective Date. Except as expressly provided in this Amendment, all terms and provisions of the Agreement are and will remain in full force and effect and are ratified and confirmed by the Parties.  Without limiting the generality of the foregoing, the amendments contained here will not be construed as an amendment to or waiver of any other provision of the Agreement or as a waiver of or consent to any further or future action on the part of either Party that would require the waiver or consent of the other Party. On and after the Effective Date, each reference in the existing agreement to &#x201c;this Agreement&#x201d;, &#x201c;the Agreement&#x201d;, &#x201c;hereunder&#x201d;, &#x201c;hereof&#x201d;, &#x201c;herein&#x201d;, or words of like import, and each reference to the Agreement in any other agreements, documents, or instruments executed and delivered pursuant to, or in connection with the Agreement will mean and be a reference to the Agreement as amended by this Amendment.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Counterparts</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  This Amendment may be executed in two or more counterparts, all of which shall be deemed an original, but all which together shall constitute one and the same instrument, an DocuSign, facsimile or portable document format (pdf) transmission shall be deemed to be an original signature for all purposes under this Amendment.</font></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Signature Page Follows</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">]</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.3in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Parties have caused this Amendment to be duly executed and delivered as of the Effective Date.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:29.245%;box-sizing:content-box;"></td>
     <td style="width:32.653%;box-sizing:content-box;"></td>
     <td style="width:38.102%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">LIONHEART II HOLDINGS, LLC</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:_________________</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:Alexandra M. Plasencia</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:Authorized Representative</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">La Ley con John H. Ruiz, P.A. d/b/a MSP Recovery Law Firm</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:_________________</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:John H. Ruiz</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:President</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">MSP Law Firm, PLLC</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:_________________</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:John H. Ruiz</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:Manager</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-14.1
<SEQUENCE>5
<FILENAME>mspr-ex14_1.htm
<DESCRIPTION>EX-14.1
<TEXT>
<html>
 <head>
  <title>EX-14.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 14.1</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><img src="img41968384_0.jpg" alt="img41968384_0.jpg" style="width:178px;height:73px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP RECOVERY, INC.<br>CODE OF CONDUCT AND BUSINESS ETHICS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Integrity, honesty and sound judgment are fundamental to the reputation and success of MSP Recovery, Inc. and its subsidiaries (collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). We must comply with laws, rules and regulations and hold ourselves to high standards of ethical business conduct in every aspect of our business dealings. The policies outlined in this Code of Conduct and Business Ethics (this &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Code</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) are designed to set forth the basic guidelines that we all must follow.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Code is not intended to reduce or limit the other obligations that you may have to the Company, including with respect to the policies and procedures set forth in our Insider Trading Policy, Regulation FD Policy, Related Person Transaction Policy and Whistleblower Reporting Policy as well as in our Employee Handbook, which supplement and are in addition to this Code. You should refer to such policy documents for specific policies and procedures. If you are a member of the Board of Directors, you should also refer to the Corporate Governance Guidelines for additional policies that specifically govern the conduct of directors.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WHO MUST FOLLOW OUR CODE?</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Code applies to all directors, officers (including the principal executive officer, principal financial officer, principal accounting officer, controller and persons performing similar functions) and employees of the Company, including contract employees and employees of contractors performing services on behalf of Company.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SPEAKING UP</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Code serves as a guide for what to do when faced with legal or ethical questions, and it is your responsibility to read the Code carefully and understand it. The Code is not all-inclusive, however, and it does not answer every possible question that may come up in the course of conducting business. We expect you to use your own reasonable judgment at all times to follow the high ethical standards to which the Company is committed.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you are concerned about an ethical situation or are not sure whether specific conduct meets the Company&#x2019;s standards, you are responsible for asking your manager and, where appropriate, the Company&#x2019;s human resources or the General Counsel, any question that you feel is necessary to understand the Company&#x2019;s expectations of you. All references to General Counsel used herein shall mean the General Counsel or his or her designee.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you believe that actions have taken place, may be taking place or may be about to take place that violate or would violate this Code, the policies referenced herein or in the Company&#x2019;s Handbook, or any applicable legal or regulatory requirement, or that relate to complaints and concerns regarding accounting, internal accounting controls and auditing (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accounting Concerns</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), you are expected to bring the matter to the attention of the Company. You are encouraged to talk to</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">your manager about actual or suspected illegal or unethical behavior and when in doubt about the best course of action in a particular situation.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any manager who receives a report of a potential violation of this Code, the policies referenced herein or any other applicable legal or regulatory requirement or that are Accounting Concerns must report such matter immediately to the Company&#x2019;s General Counsel as provided below.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following resources are available to you to ask questions or raise concerns:</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Report to a Manager or Human Resources</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The most direct way to raise any concern is to discuss it with a manager or human resources. Managers and human resources representatives will forward Accounting Concerns to the General Counsel for review.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use the Hotline</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#x2019;s Hotline is available at 833-246-0139 or through the Hotline web intake site at </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">msprecovery.ethicspoint.com</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and mobile intake site at </font><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">msprecovery.navexone.com</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Hotline is staffed by an outside, independent service provider and allows any employee or other interested party to submit a concern on an anonymous and confidential basis.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Report to the General Counsel</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The General Counsel may be reached by email, telephone, or regular mail as follows:</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:13.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Alexandra M. Plasencia</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:13.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General Counsel, MSP Recovery, Inc.<br>aplasencia@msprecovery.com<br>2701 South LeJeune Road, Floor 10</font></p><p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:13.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Coral Gables, Florida 33134</font></p><p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:13.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">305-614-2222</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Report Accounting Concerns to the Audit Committee</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Audit Committee may be reached by email or regular mail as follows:</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;margin-right:13.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chair of the Audit Committee<br>MSP Recovery, Inc.<br>corporatesecretary@msprecovery.com</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No form is required to submit a question or concern, but you are encouraged to provide as much factual information and detail as possible so that the concern can be properly investigated. It is recommended that you report any concerns as soon as reasonably possible after becoming aware of the concern. You may report your concerns anonymously and confidentially; however, you are encouraged to supply contact information with your submission to facilitate follow-up, clarification, and assistance with any investigation, if necessary.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regardless of the method that you use or whether you raise a concern anonymously, it is important to provide us with as much information as possible so that we can review and seek to address your concern.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NO RETALIATION</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Retaliation against anyone who raises a concern in good faith, or who assists the Company, the Board of Directors or the Audit Committee of the Board of Directors or any governmental, regulatory or law enforcement body in reviewing or otherwise helping to resolve a concern, is prohibited and is a violation of this Code. If you believe someone has retaliated against you, you should immediately report it to your manager, human resources, the General Counsel or his or her designee, or any of the other resources listed in this Code. You may also report retaliation through the Hotline referenced above. See &#x201c;Speaking Up&#x201d; above. Any person who retaliates against another individual for making any report pursuant to this Code will be subject to disciplinary action up to and including termination.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we encourage you to seek to address concerns through the methods provided in this Code or in any other agreement or policy of the Company, nothing in this Code prohibits or interferes with your ability, without notice to or authorization of the Company, to communicate in good faith with any governmental agency for the purpose of reporting a possible violation of law, or to participate in any investigation or proceeding that may be conducted by any governmental agency, including providing documents or other information.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any use of these reporting procedures in bad faith or in a false or frivolous manner will be considered a violation of this Code.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DIVERSITY AND INCLUSION</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Creating an inclusive, equitable, and diverse environment is key to our success as a business. We are committed to promoting diversity and inclusion both inside and outside of the office. An inclusive and diverse work environment promotes respect and understanding, fosters creativity and innovation, and is a competitive business advantage.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Company provides equal opportunities for employment. We base employment decisions on merit, considering qualifications and achievement. We strictly prohibit discrimination based on race, creed, color, religion, sex, gender, age, national origin, alienage or citizenship status, sexual orientation, gender identity or expression, marital, partnership or familial status, disability, genetic information, veteran/military status, domestic violence victim status, or any other characteristic protected by law.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COMPLIANCE WITH LAWS, RULES AND REGULATIONS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obeying the law, both in letter and in spirit, is one of the foundations on which the Company's ethical standards are built. In conducting the business of the Company, you must respect and obey the laws of the jurisdictions in which we operate. Although you are not expected to know every detail of every law that might apply to the Company, it is important to know enough about the applicable local, state and national laws to determine when to seek advice from the Company&#x2019;s General Counsel or other appropriate personnel. If a law conflicts with any Company policy or this Code, you must comply with the law. There are serious consequences for failing to follow any applicable laws, rules and regulations, including termination of service and potential criminal and civil penalties.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONFLICTS OF INTEREST</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is the Company&#x2019;s policy that you avoid any conflict between your personal interests and those of the Company. The purpose of this policy is to ensure that the Company&#x2019;s honesty and integrity, and therefore its reputation, are not compromised. The fundamental principle guiding this policy is that no one should have, or appear to have, personal interests or relationships that actually or potentially conflict with the best interests of the Company. Conflicts of interest may not always be clear cut, so if you have a question, you should err on the side of disclosure and consult with your manager and, where appropriate, the Company&#x2019;s General Counsel.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Conflicts of interest can arise when your personal interests or activities:</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Improperly influence your judgment when acting on behalf of our Company;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Result in your competing with our Company or diverting business or assets from our Company;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Diminish the efficiency, effectiveness, or objectivity with which you perform your duties;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Result in your receiving improper personal benefits due to your position with our Company; or</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Harm or impair our Company&#x2019;s reputation.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is not possible to give an exhaustive list of situations that might involve violations of this policy. However, the situations that would constitute a conflict in most cases include but are not limited to:</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holding an interest in or accepting free or discounted goods from any organization that does, or is seeking to do, business with the Company, by anyone who is in a position to directly or indirectly influence either the Company&#x2019;s decision to do business, or the terms upon which business could be done with such organization;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Profiting personally, e.g., through commissions, loans, expense reimbursements or other payments, from any organization seeking to do business with the Company;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Engaging in any business competing with the Company;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holding any material interest in a competitor of the Company;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Being employed by (including as a consultant) or seeking to do personal business with a competitor to the Company; or</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Taking part in a Company business decision that involves a company with which you or your family members have a personal affiliation or a Company decision that involves hiring or supervising a family member.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A conflict of interest could also exist when a member of an employee's immediate family is involved in situations such as those above. Each individual&#x2019;s situation is different, and in evaluating your own situation, you will have to consider many factors.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you become aware of a conflict or potential conflict involving an employee, you should promptly bring it to the attention of a manager. Any manager who receives a report of a conflict or potential conflict will report it immediately to the General Counsel. An actual or potential conflict of interest involving a member of senior management, other than an executive officer, should be disclosed directly to the General Counsel, who will disclose such conflict of interest to the Board, and actual or potential conflicts of interest involving an executive officer or director should be disclosed directly to the Board. Alternatively, you may utilize the notification procedures described above under &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Speaking Up</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CORPORATE OPPORTUNITIES</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You owe a duty to the Company to advance the Company&#x2019;s legitimate business interests when the opportunity to do so arises. You are prohibited from:</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Diverting to yourself or to others any opportunities that are discovered through the use of the Company&#x2019;s property or information or as a result of your position with the Company;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Using the Company&#x2019;s property or information or your position for improper personal gain; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competing with the Company.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">BRIBERY AND CORRUPTION</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We strictly prohibit bribery and corrupt conduct in any form as it harms the communities we operate in and violates the anti-bribery and corruption laws of the jurisdictions where we conduct business. No person or entity representing our Company may (either directly or indirectly) offer, promise, or give or receive money or anything of value for a business favor, or favorable decision or advantage. This prohibition applies to our employees, officers, directors, and third persons or entities acting on behalf of our Company.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is against this Code to offer or provide anything of value to facilitate a government process or to influence a government official. Items of value include, among other things: gifts, entertainment, charitable donations, and work opportunities. You must consult with the General Counsel in advance if you are unsure of whether a gift, engagement, or other transaction or arrangement may violate Company policies or the law.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a government or regulatory representative contacts you for non-routine information or inspection, you must inform your manager immediately. You must also consult with the General Counsel if you are unsure whether an individual is a government official.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">GIFTS AND ENTERTAINMENT</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While modest gifts and entertainment that serve a legitimate business purpose are part of maintaining positive business relationships, they must be given and accepted in a way that keeps our business relationships fair, honest, and objective and avoids conflicts of interest or the appearance of conflicts of interest. Gifts may never be in the form of cash or the equivalent of cash (e.g., gift cards), loans or guarantees, or offers of employment or internships that deviate from our normal competitive recruitment process. Gifts, entertainment, or favors that would likely result in a feeling or expectation of personal obligation should be avoided. No employee, officer, or director or family member of these individuals may give or accept gifts from a competitor.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When considering whether giving or accepting a gift is permissible and appropriate, consider the following:</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Is the gift given on a nontraditional occasion?</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Is the gift more than modest?</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Does the giver regularly give gifts?</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Would the gift potentially influence business objectivity?</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Would the gift result in someone receiving an improper personal benefit due to his or her position?</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Would public disclosure of the gift harm your or the Company&#x2019;s reputation?</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you can answer yes to any of the questions above, you should seek guidance from your manager or the General Counsel before accepting or giving the gift. If you are offered a gift or gratuity by a client or contracted provider, you must report this to your manager immediately.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONFIDENTIAL INFORMATION</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the course of your work for the Company, you may obtain or have access to non-public information (about the Company, its clients, employees or other constituents) that might be of use to competitors, or harmful to the Company or the other source of such information, if disclosed. Such information may have been or may be provided in written or electronic form or orally. All such information, from whatever source obtained and regardless of the Company&#x2019;s connection to the information, is referred to herein as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Confidential Information.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is strongly committed to protecting Confidential Information, whether generated within the Company or obtained from some other source. The Company is also strongly committed to avoiding the misuse, or the appearance of misuse, of such information, whether in connection with the trading of securities or otherwise.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You must maintain the confidentiality of Confidential Information, except when disclosure is either expressly authorized by the Company or required by law.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding the foregoing, and notwithstanding any other confidentiality or non-disclosure agreement (whether in writing or otherwise, including without limitation as part of an employment agreement, separation agreement or similar employment or compensation arrangement) applicable to current or former employees, this Code does not restrict any current or former employee, from communicating, cooperating or filing a complaint with any U.S. federal, state or local governmental or law enforcement branch, agency or entity (collectively, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governmental Entity</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) with respect to possible violations of any U.S. federal, state or local law or regulation, or otherwise making disclosures to any Governmental Entity, in each case, that are protected under the whistleblower provisions of any such law or regulation, provided that (i) in each case such communications and disclosures are consistent with applicable law and (ii) the information subject to such disclosure was not obtained by the current or former employee through a communication that was subject to the attorney-client privilege, unless such disclosure of that information would otherwise be permitted by an attorney pursuant to 17 CFR 205.3(d)(2), applicable state attorney conduct rules, or otherwise. Any agreement in conflict with the foregoing is hereby deemed amended by the Company to be consistent with the foregoing.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COMPETITION AND FAIR DEALING</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We seek to outperform our competitors fairly and honestly. We seek competitive advantages through superior performance, never through unethical or illegal business practices. Stealing proprietary information, possessing trade secret information that was obtained without the owner&#x2019;s consent, or inducing such disclosures by past or present employees of other companies, is prohibited. You should endeavor to respect the rights of and deal fairly with the Company&#x2019;s customers, suppliers, vendors, competitors, and employees. No one should take unfair advantage of others through manipulation, concealment, abuse of privileged information, misrepresentation of material facts, or any other intentional unfair-dealing practice.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PROTECTION AND PROPER USE OF COMPANY ASSETS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Theft, carelessness and waste have a direct impact on the Company&#x2019;s profitability. You have a duty to safeguard Company assets and ensure their efficient use. Company assets should be used only for legitimate business purposes and you should take measures to ensure against their theft, damage, or misuse.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company assets include tangible property, intellectual property such as patents, trademarks, trade secrets, business and proprietary information such as new products, salary information, and any unpublished financial data and reports. Unauthorized use or distribution of this information is a violation of this Code.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Those who have access to proprietary and confidential information are obligated to safeguard it from unauthorized access in accordance with the Company&#x2019;s policy on Confidential Information described above.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INAPPROPRIATE TRADING</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The federal securities laws prohibit any person who is in possession of &#x201c;material, non-public information&#x201d; from engaging in securities transactions on the basis of such information and from communicating such information to any other person for such use. Transacting in securities of the</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company, or any other company, while you possess material, nonpublic information is known as &#x201c;insider trading.&#x201d; &#x201c;Tipping,&#x201d; which is also prohibited, means communicating such material, non-public information to another for his or her or its use. Any of these actions may amount to &#x201c;insider trading&#x201d; and are strictly prohibited.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You are prohibited from:</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">directly or indirectly buying or selling the Company&#x2019;s securities if you are aware of material non-public information about the Company; </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">trading, taking advantage of, or sharing information about another company&#x2019;s securities if, in the course of working for the Company, you learn of material non-public information about that other company, until the information becomes public or is no longer material; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">communicating or passing material, non-public information about the Company to any other person, including spouses, relatives, friends, co-habitants or business associates, who then trades on the basis of the information.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, during Blackout Periods throughout the year, designated individuals are prohibited from trading in the Company&#x2019;s securities and must receive preclearance from our General Counsel before trading in Company securities. The Company has also adopted an Insider Trading Policy, which supplement this Code and apply to directors, executive officers and employees of the Company as well as family members and entities controlled by such persons. You should read such policy in its entirety and periodically refer to it for additional guidance.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you have any doubts as to the propriety of any transaction, you should seek advice from the General Counsel before undertaking the sale or purchase of any of the Company&#x2019;s or other&#x2019;s securities.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PROTECTING PRIVACY</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the normal course of business, you may be required to collect and store certain personal information. The Company is committed to respecting the privacy of our employees and those with whom we conduct business, subject to the terms and condition specified in the Employee Handbook.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">What constitutes personal information may vary, but it generally means information that identifies or relates to an individual person. Examples of personal information include: names, contact information (e.g., business and personal email addresses and mobile telephone numbers), dates of birth, health information, skin types/conditions, biometric data, racial or ethnic origin, government issued ID information, photos, usernames, IP addresses, purchase history, payment card information, and social media information.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you suspect any loss, theft, or unauthorized access, use, or disclosure of personal information (including loss or theft of a Company-owned device or laptop or any device or laptop with personal information), you must contact the General Counsel.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SPEAKING FOR THE COMPANY</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Only specifically designated Authorized Spokespersons are permitted to speak publicly on behalf of our Company. The Company engages in communications with investors, securities analysts, and the financial press. It is against the law &#x2013; specifically Regulation FD &#x2013; as well as this Code &#x2013; for any person acting on behalf of the Company to selectively disclose material non-public information to certain market participants (e.g., research analysts, brokers, dealers, investment advisers and certain institutional investment managers and investment companies and hedge funds, and retail (non-institutional) holders or potential holders of the Company&#x2019;s securities) where it is reasonably foreseeable that the recipient may be likely to trade on the basis of such information, unless the information has first or simultaneously been disclosed to the public.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has adopted a Regulation FD Policy, which supplements this Code. The purpose of such policy is also to ensure the timely public disclosure of material, non-public information about the Company is disclosed only by Authorized Spokespersons and through the appropriate means of communication as required by Regulation FD.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COMMUNICATING RESPONSIBLY ON SOCIAL MEDIA AND OTHER ELECTRONIC COMMUNICATIONS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When using social media, we all have a responsibility to communicate in a manner that is consistent with our Company&#x2019;s values. Use of personal social media channels by directors, officers, employees, agents or other persons, including the Authorized Spokespersons, to communicate material non-public Company information is prohibited.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ACCURACY OF RECORDS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is the Company&#x2019;s policy to make full, fair, accurate, timely and understandable disclosures in compliance with applicable laws and regulations in all reports and documents that the Company files with, or submits to, the U.S. Securities and Exchange Commission, state agencies, and in all other public communications made by the Company.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The integrity, reliability and accuracy in all material respects of the Company&#x2019;s books, records and financial statements are fundamental to the Company&#x2019;s continued and future business success. In addition, as a company whose stock is publicly traded, the Company is subject to a number of laws and regulations that govern our business records, including U.S. securities laws. The Company must record its financial activities in compliance with all applicable laws and accounting practices and provide current, complete and accurate information to any and all government agencies. You may not cause the Company to enter into a transaction with the intent to document or record it in a deceptive or unlawful manner. In addition, you may not create any false or artificial documentation or book entry for any transaction entered into by the Company. Similarly, those who have responsibility for accounting and financial reporting matters have a responsibility to accurately record all funds, assets and transactions on the Company&#x2019;s books and records.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADMINISTRATION</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Board of Directors</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Board of Directors, through the Audit Committee, will help ensure this Code is properly administered. The Audit Committee is responsible for the periodic review of the compliance procedures in place to implement this Code and will recommend clarifications or necessary changes to this Code to the Board for approval.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Officers and Managers</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. All officers and managers are responsible for reviewing this Code with employees under the supervision or management, as applicable, and ensuring that all individual subject to this Code have signed the attached certification. Officers and managers are also responsible for the diligent review of practices and procedures in place to help ensure compliance with this Code.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">VIOLATIONS AND WAIVERS OF THE CODE</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to comply with the Code may be subject to disciplinary action, including termination of employment. The following are examples of conduct that may result in discipline:</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Actions that violate any Company policy;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Requesting others to violate any Company policy;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to promptly disclose a known or suspected violation of any Company policy;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to cooperate in Company investigations of possible violations of any Company policy;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Retaliation against others for reporting a good faith integrity concern; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Failure to demonstrate the leadership and diligence needed to ensure compliance with Company policies and applicable law.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is also important to understand that a violation of this Code and certain Company policies may subject the Company and you to civil liability and damages, regulatory sanction, and/or criminal prosecution.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any request for a waiver of any provision of this Code by or on behalf of an executive officer or senior financial officer or member of the Board of Directors of the Company must be reviewed by the Audit Committee of the Company and will be promptly disclosed as required by applicable securities law and/or stock exchange rules.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Last updated August 2023.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ACKNOWLEDGMENT AND CERTIFICATION</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I hereby acknowledge I have received the MSP Recovery, Inc. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) Code of Conduct and Business Ethics (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Code</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) and understand that it is my responsibility to read and comply with all provisions contained within the Code.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information described in this Code is intended to replace and supersede any previously existing information or policy. Further, I understand that the Company reserves the right to modify any or all of the provisions of the Code at any time, for any reason, with or without notice.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Name: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">				</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">				</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>6
<FILENAME>mspr-ex19_1.htm
<DESCRIPTION>EX-19.1
<TEXT>
<html>
 <head>
  <title>EX-19.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exhibit 19.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><img src="img184519493_0.jpg" alt="img184519493_0.jpg" style="width:477px;height:196px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#595959;white-space:pre-wrap;font-size:48pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Contents</font></p>
     <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
      <tr style="visibility:collapse;">
       <td style="width:7.441%;box-sizing:content-box;"></td>
       <td style="width:89.258%;box-sizing:content-box;"></td>
       <td style="width:3.301%;box-sizing:content-box;"></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td style="padding-top:0in;text-indent:36pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.</font></p></td>
       <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Introduction</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td style="padding-top:0in;text-indent:36pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.</font></p></td>
       <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Who is subject to this Policy?</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td colspan="2" style="padding-top:0in;text-indent:72pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Company Personnel</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td colspan="2" style="padding-top:0in;text-indent:72pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Family Members and Others Living in Your Household</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td colspan="2" style="padding-top:0in;text-indent:72pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Controlled Entities</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td colspan="2" style="padding-top:0in;text-indent:72pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Designated Persons</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td style="padding-top:0in;text-indent:36pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.</font></p></td>
       <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Individual Responsibility</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td style="padding-top:0in;text-indent:36pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.</font></p></td>
       <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">What Is Insider Trading?</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td style="padding-top:0in;text-indent:36pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.</font></p></td>
       <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">What Securities are Subject to this Policy?</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td style="padding-top:0in;text-indent:36pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.</font></p></td>
       <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Policy Prohibiting Insider Trading</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td style="padding-top:0in;text-indent:36pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.</font></p></td>
       <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">What is Material, Non-Public Information?</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td style="padding-top:0in;text-indent:36pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.</font></p></td>
       <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">When is Information Considered &#x201c;Public&#x201d;?</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td style="padding-top:0in;text-indent:36pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.</font></p></td>
       <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Blackout Periods</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td style="padding-top:0in;text-indent:36pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.</font></p></td>
       <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Insider Trading Compliance Committee</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td style="padding-top:0in;text-indent:36pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.</font></p></td>
       <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Certain Additional Restrictions</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td colspan="2" style="padding-top:0in;text-indent:72pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Designated Persons</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td colspan="2" style="padding-top:0in;text-indent:72pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-Clearance</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td colspan="2" style="padding-top:0in;text-indent:72pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prohibited and Special Transactions</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td colspan="2" style="padding-top:0in;text-indent:72pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Transactions under Company Plans</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td colspan="2" style="padding-top:0in;text-indent:72pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Planned Trading Programs</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td colspan="2" style="padding-top:0in;text-indent:72pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:6.667%;text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Post-Termination Transactions</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td style="padding-top:0in;text-indent:36pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.</font></p></td>
       <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consequences of Violation</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td colspan="2" style="padding-top:0in;text-indent:36pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Appendix A</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td colspan="2" style="padding-top:0in;text-indent:36pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Appendix B</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11</font></p></td>
      </tr>
      <tr style="height:12pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
       <td colspan="2" style="padding-top:0in;text-indent:36pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-7.143%;padding-left:6.667%;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Appendix C</font></p></td>
       <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</font></p></td>
      </tr>
     </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ii</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><h1 style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1.	</font><font style="text-transform:uppercase;color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INTRODUCTION</font></h1><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In order to take a proactive role in the prevention of insider trading violations by its officers, directors, employees, consultants, advisors, and other related individuals, the management of MSP Recovery, Inc. has adopted the policies and procedures set forth in this revised Insider Trading Policy (the &#x201c;Policy&#x201d;).</font></p><h1 style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.	</font><font style="text-transform:uppercase;color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Who is subject to this Policy?</font></h1><h2 style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Company Personnel</font></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy applies to all directors, officers and employees of the Company and its subsidiaries and designated consultants (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company Personnel</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). The use of &#x201c;you&#x201d; throughout this Policy speaks directly to Company Personnel. The term &#x201c;directors&#x201d; refers only to the members of the Board of Directors of the Company (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Board</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), and not to members of the board of directors of any subsidiary or affiliate entities or employees with the functional job title &#x201c;director.&#x201d;</font></p><h2 style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Family Members and Others Living in Your Household</font></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy applies to: (a) anyone who lives in the household of Company Personnel (whether or not family members) and (b) any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, and includes adoptive relationships, whose transactions are subject to your influence or control (collectively referred to as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Family Members</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). You are responsible for the transactions of Family Members and therefore should inform your Family Members of the need to confer with you before they trade in Company Securities.</font></p><h2 style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Controlled Entities</font></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy applies to any entities or accounts, including corporations, partnerships, or trusts, that are under your influence or control, or are a beneficiary of you or your Family Members (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Controlled Entities</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). Transactions by such Controlled Entities should be treated as if they were for your account or that of a Family Member for the purposes of this Policy and applicable securities laws.</font></p><h2 style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Designated Persons</font></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, Designated Persons (as defined below) are subject to additional restrictions relating to the prohibition of purchases and sales of Company Securities.</font></p><h1 style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3.	</font><font style="text-transform:uppercase;color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Individual Responsibility</font></h1><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You are responsible for compliance with this Policy, including the determination of whether you are aware of material non-public information. You could be subject to severe legal penalties and disciplinary action by the Company for any conduct prohibited by this Policy or violation of applicable securities laws, as described below in more detail under the heading &#x201c;Consequences of Violation.&#x201d;</font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Questions about this Policy or any proposed transaction should be directed to the General Counsel. All references to General Counsel used herein shall mean the General Counsel or a designee thereof.</font></p><h1 style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4.	</font><font style="text-transform:uppercase;color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">What Is Insider Trading?</font></h1><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider trading occurs when a person who is aware of material non-public information about a company buys or sells that company&#x2019;s securities or provides material non-public information to another person who may trade on the basis of that information. Insider trading is illegal and prohibited by federal and state securities laws and this Policy.</font></p><h1 style="text-indent:-6.188%;padding-left:5.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5.	</font><font style="text-transform:uppercase;color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">What Securities are Subject to this Policy?</font></h1><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy applies to purchases or sales of the Company&#x2019;s securities (e.g., common stock, as well as warrants, options, puts, calls or other derivatives, whether or not issued by the Company) or any other type of securities that the Company may issue, such as preferred stock, debt, convertible debentures and warrants (collectively, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company Securities</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). This Policy also prohibits trading in the securities of another company if you become aware of material non-public information about that company as a result of your affiliation with the Company.</font></p><h1 style="text-indent:-6.188%;padding-left:5.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6.	</font><font style="text-transform:uppercase;color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Policy Prohibiting Insider Trading</font></h1><p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Trading on Material Non-Public Information.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you are aware of material non-public information about the Company, you may not, directly or indirectly, buy or sell Company Securities.</font></p><p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Tipping.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you are aware of material non-public information about the Company, you may not communicate or pass (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tip</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) that information on to others outside the Company, including Family Members and friends. The federal securities laws impose liability on any person who &#x201c;tips&#x201d; or communicates material non-public information (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tipper</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) to another person or entity (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tippee</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), who then trades on the basis of the information. Penalties may apply regardless of whether the tipper derives any benefits from the tippee&#x2019;s trading activities.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, in the course of working for the Company, if you learn of material non-public information about a company with which the Company does business, including a client, vendor, supplier, or subcontractor of the Company, you may not trade in, take advantage of, or share information about that company&#x2019;s securities until the information becomes public or is no longer material.</font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><h1 style="text-indent:-6.188%;padding-left:5.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.	</font><font style="text-transform:uppercase;color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">What is Material, Non-Public Information?</font></h1>
     <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
      <tr style="visibility:collapse;">
       <td style="width:100%;box-sizing:content-box;"></td>
      </tr>
      <tr style="height:12pt;background-color:#595959;word-break:break-word;white-space:pre-wrap;text-align:right;">
       <td style="border-top:3pt solid #4f81bd;padding-top:0in;border-right:3pt solid #4f81bd;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:3pt solid #4f81bd;border-left:3pt solid #4f81bd;padding-right:0.075in;"><p style="font-size:12pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#ffffff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">You should consider material information as any information that a reasonable investor would consider important in making a decision to buy, hold, or sell securities. Any information that could be expected to affect a company&#x2019;s stock price, whether it is positive or negative, should be considered material. There is no bright-line standard for assessing materiality; rather, materiality is based on an assessment of all of the facts and circumstances, and you should carefully consider how a transaction may be construed by enforcement authorities who will have the benefit of hindsight.</font></p></td>
      </tr>
     </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While it is not possible to define all categories of material information, some examples of information that could be regarded as material are:</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A proposed acquisition, sale, joint venture, merger, tender offer or spin-off;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Plans to enter a new line of business or discontinue a line of business;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Plans to engage in a new marketing strategy or other major marketing changes;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Large contracts, renewals and terminations;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Projected future earnings, profits or losses;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adjustments to reported earnings;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes to sales or earnings guidance or projections, if any;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A significant expansion or cutback of operations;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Purchases, sales or revaluations of Company assets;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant changes to vendor or supplier pricing;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Extraordinary management or business developments;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in executive management;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Major lawsuits, legal settlements, or regulatory matters;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Material cyber-security incidents or privacy breaches;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The commencement or results of regulatory proceedings;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The gain or loss of a major customer, supplier, licensee/licensor or vendor;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company restructuring;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Borrowing activities (other than in the ordinary course), including contemplated financings and refinancings or defaults;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A change in dividend policy, the declaration of a stock split, or an offering of additional securities;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The establishment, actual purchases, or the anticipated timing of purchases of a repurchase program for Company Securities;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A change in pricing or cost structure;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Major marketing changes;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A change in auditors or notification that the auditor&#x2019;s reports may no longer be relied upon;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commercialization of a significant new product, process, or service;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The imposition of a ban on trading in Company Securities or the securities of another company;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant transactions in Company Securities;</font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Material weakness in internal controls of financial reporting; or</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Impending bankruptcy or the existence of severe liquidity problems.</font></p><p style="margin-left:10%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><h1 style="text-indent:-6.188%;padding-left:5.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8.	</font><font style="text-transform:uppercase;color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When is Information Considered &#x201c;Public&#x201d;?</font></h1><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information that has not been disclosed to the public is generally considered to be non-public information. In order to establish that the information has been disclosed to the public, it may be necessary to demonstrate that the information has been widely disseminated. The following are considered methods of public dissemination:</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A Form 8-K or other document filed with, or submitted to, the U.S. Securities and Exchange Commission (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEC</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;);</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A press release; or</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A conference call or webcast of such a call that is open to the public at large, and has been the subject of adequate advance notice within the meaning of Regulation FD, as promulgated under the Securities Exchange Act of 1934, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).</font></p><p style="margin-left:10%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By contrast, material non-public information is generally not considered to be publicly disseminated if it is:</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">only provided to the Company&#x2019;s employees, or if it is only available to a select group of analysts, brokers, and institutional investors; or</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">only communicated through internet forums, blogs, or social media (e.g., Twitter, Facebook or LinkedIn) or the Company&#x2019;s website.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once information is widely disseminated, it is still necessary to afford the investing public with sufficient time to absorb the information. As a general rule, information should not be considered fully absorbed by the marketplace until after one full trading day has elapsed since the day on which the information is released. Depending on the particular circumstances, the Company may determine that a longer or shorter period should apply to the release of specific material non-public information.</font></p><h1 style="text-indent:-6.188%;padding-left:5.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9.	</font><font style="text-transform:uppercase;color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Blackout Periods</font></h1><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless pursuant to a properly established Rule 10b5-1 Plan (as defined below), in order to prevent inadvertent violations of the securities laws and to avoid even the appearance of trading on the basis of material non-public information, Company Personnel, their Family Members, and their Controlled Entities may not conduct transactions (for their own or related accounts) involving the purchase or sale of Company Securities during the following periods (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Blackout Periods</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;):</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The period in any fiscal quarter commencing after the close of trading on the 15th day prior to the end of that quarter and ending after the first full trading day after public disclosure of the financial results for such fiscal quarter or year. If public disclosure occurs on a trading day after the markets open, then such date of disclosure shall not be considered the first full trading day with respect to such public disclosure. For example, trading would be</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">permissible on a Tuesday following a Monday release before trading hours and on a Wednesday following a Monday release during or after trading hours.</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any other period designated in writing by the General Counsel.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The occurrence of an event-specific Blackout Period could itself be, or otherwise imply the existence of, material non-public information. If you are made aware of the existence of an event-specific Blackout Period, you should not disclose the existence of such Blackout Period to any other person.</font></p>
     <table style="border-spacing:0;table-layout:auto;width:99.0%;border-collapse:separate;">
      <tr style="visibility:collapse;">
       <td style="width:100%;box-sizing:content-box;"></td>
      </tr>
      <tr style="height:12pt;background-color:#595959;word-break:break-word;white-space:pre-wrap;text-align:right;">
       <td style="border-top:3pt solid #4f81bd;padding-top:0in;border-right:3pt solid #4f81bd;padding-left:0.075in;vertical-align:middle;padding-bottom:0in;border-bottom:3pt solid #4f81bd;border-left:3pt solid #4f81bd;padding-right:0.075in;"><p style="font-size:12pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#ffffff;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">If you have any question as to whether information is material or is publicly available, please err on the side of caution and direct an inquiry to the General Counsel.</font></p></td>
      </tr>
     </table><h1 style="text-indent:-6.188%;padding-left:5.84%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10.	</font><font style="text-transform:uppercase;color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INSIDER TRADING COMPLIANCE COMMITTEE</font></h1><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has established an Insider Trading Compliance Committee (the &#x201c;Insider Trading Compliance Committee&#x201d;), consisting of three corporate attorneys, including General Counsel, Deputy General Counsel, and a third attorney to be designated annually. The duties of the Insider Trading Compliance Committee (in cooperation with the Company Personnel) shall include the following:</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">administer this Policy and enforce compliance with Policy provisions;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">respond to inquiries relating to this Policy and its procedures;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">administer, monitor, and enforce compliance with federal and state insider trading laws;</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">revise this Policy as needed to reflect changes in federal and state insider trading laws; and</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">fulfill other responsibilities described herein.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No member of the Insider Trading Compliance Committee may trade in the Company&#x2019;s securities unless the trade(s) have been approved by the other members of the Insider Trading Compliance Committee.</font></p><h1 style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11.	</font><font style="text-transform:uppercase;color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTAIN ADDITIONAL RESTRICTIONS</font></h1><h2 style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Designated Persons</font></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All Designated Persons are subject to Pre-Clearance restrictions described herein. Designated Persons may not give trading advice of any kind about the Company, whether or not such Designated Person is aware of material non-public information.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following are &#x201c;Designated Persons&#x201d;:</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All directors and executive officers of the Company as designated by the Board.</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Family Members and Controlled Entities of directors and executive officers of the Company.</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Persons holding the offices listed on </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Appendix A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to this Policy, and their Family Members and Controlled Entities.</font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Employees of Controlled Entities that participate in, or have non-public knowledge of: (i) pre-litigation due diligence; (ii) litigation and settlement strategies, and (iii) litigation and settlement communications and status.</font></p><p style="margin-left:3.333%;text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Such other persons as may be designated from time to time by the Company&#x2019;s Legal Department (designated individuals will be identified and contacted by the General Counsel), and their Family Members and Controlled Entities.</font></p><p style="margin-left:10%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><h2 style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pre-Clearance</font></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All Designated Persons must clear purchases or sales in Company Securities with the Insider Trading Compliance Committee before the trade may occur.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designated Persons seeking to pre-clear a trade in Company Securities must notify the General Counsel in writing by submitting a Pre-Clearance Form (attached hereto as </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Appendix B</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) requesting approval to transact in Company Securities at least two (2) business days before the date of the proposed transaction. Designated Persons should be prepared to provide the dates on which the proposed transactions are expected to occur and to identify the broker-dealer or any other investment professional responsible for executing the trade.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Insider Trading Compliance Committee will review Pre-Clearance Forms using the predetermined review criteria set forth in </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Appendix C</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, attached hereto, and either approve or reject the request to transact in Company Securities. The Insider Trading Compliance Committee shall be under no obligation to approve a transaction submitted for pre-clearance, and may determine not to permit the transaction.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General Counsel will inform the requesting individual of a decision with respect to the request as soon as possible after considering all the circumstances relevant to their determination. If General Counsel has not responded to a request for pre-clearance, do not trade in the Company&#x2019;s Securities. If approved, the transaction must occur within five (5) business days after receipt of approval (not including the day of receipt of such approval), so long as the transaction is not during a Blackout Period. If a pre-clearance request is rejected, refrain from transacting in Company Securities, and do not inform any other person of the rejection. Requests to transact in Company Securities during a Blackout Period will not be approved.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designated Persons must also clear gifts to charities or other persons and other transfers of Company Securities with the Insider Trading Compliance Committee before the gift or other transfer is made.</font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;">
     <table style="border-spacing:0;table-layout:auto;width:99.0%;border-collapse:separate;">
      <tr style="visibility:collapse;">
       <td style="width:100%;box-sizing:content-box;"></td>
      </tr>
      <tr style="height:12pt;background-color:#595959;word-break:break-word;white-space:pre-wrap;text-align:right;">
       <td style="border-top:3pt solid #4f81bd;padding-top:0in;border-right:3pt solid #4f81bd;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:3pt solid #4f81bd;border-left:3pt solid #4f81bd;padding-right:0.075in;"><p style="font-size:12pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#ffffff;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Even if approval to trade pursuant to the pre-clearance process is obtained in writing, or pre-clearance is not required for a particular transaction, Designated Persons may not trade in Company Securities if they are aware of material, non-public information about the Company. This Policy does not require pre-clearance of transactions in any other company&#x2019;s securities unless otherwise indicated in writing by the General Counsel. In all cases, the responsibility for complying with this Policy, including whether an individual is in possession of material nonpublic information, rests with that individual, and any action on the part of the Company, the Company&#x2019;s General Counsel or any other employee or director pursuant to this Policy (or otherwise) does not in any way constitute legal advice or insulate an individual from liability under applicable securities laws.</font></p></td>
      </tr>
     </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><h2 style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Prohibited and Special Transactions</font></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the other restrictions and prohibitions contained in this Policy, Designated Persons may not:</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Short-Term Trading:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Sell any Company Securities of the same class during the six months following a purchase of any Company Securities of that class (or vice versa). Shares purchased through the Company&#x2019;s equity plans and transactions with the Company are not subject to this restriction.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Short Sales:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Engage in short sales (selling securities that you do not own, with the intention of buying the securities at a lower price in the future) of Company Securities. In addition, Section 16(c) of the Exchange Act prohibits directors and officers from engaging in short sales.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Publicly Traded Options:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Engage in puts, calls, or other derivative securities, on an exchange or in any other organized market.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pledging:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pledge, hypothecate, or otherwise encumber shares of Company Securities as collateral for indebtedness without approval from the Board. This includes but is not limited to holding such shares in a margin account or any other account that could cause Company Securities to be subject to a margin call or otherwise be available as collateral for a margin loan.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hedging:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Purchase a financial instrument or entering into any transaction that is designed to hedge, establish downside price protection, or otherwise offset declines in the market value of Company Securities, including puts, calls, prepaid variable forward contracts, equity swaps, collars, exchange funds (excluding broad-based index funds), and other financial instruments that are designed to or have the effect of hedging or offsetting any decrease in the market value of Company Securities.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Standing and Limit Orders:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Place standing or limit orders on Company Securities outside of a properly established Rule 10b5-1 Plan (as defined below).</font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><h2 style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Transactions under Company Plans</font></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The limitations of this Policy do not apply to the following, except as specifically noted:</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Option Exercises: </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise of an employee stock option acquired pursuant to the Company&#x2019;s plans, or the exercise of a tax withholding right pursuant to which a person has elected to have the Company withhold shares subject to an option to satisfy tax withholding requirements. However, this Policy </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">does apply</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to any sale of the underlying stock or to a cashless exercise of the option through a broker, as this entails selling a portion of the underlying stock to cover the cost of exercise.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Stock Awards:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Vesting of restricted stock, or the exercise of a tax withholding right pursuant to which the Company withholds shares of stock to satisfy tax withholding requirements upon the vesting of any restricted stock. However, the Policy </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">does apply</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to any market sale of restricted stock.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Stock Unit: </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The delivery of shares upon the payment or settlement of restricted stock unit awards, or the exercise of a tax withholding right pursuant to which the Company withhold shares of stock to satisfy tax withholding requirements upon the vesting, payment or settlement of any restricted stock unit.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">401(k) Plan:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Purchases of Company Securities in the Company&#x2019;s 401(k) plan, if any, resulting from periodic contribution of compensation to the plan pursuant to standard payroll deduction elections.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employee Stock Purchase Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: Purchases of Company Securities under an employee stock purchase plan (or any sub-plan of such plan), if any, that may be adopted by, the Company resulting from periodic contribution of money to the plan pursuant to the election made at the time of enrollment in the plan. This Policy also does not apply to purchases of Company Securities or the exercise of an option to purchase Company Securities, as applicable, resulting from lump sum contributions to the plan, provided that elections to participate by lump sum payment were made at the beginning of the applicable enrollment period. However, the Policy </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">does apply</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to elections to participate in the plan for any enrollment period, and to sales of Company Securities purchased pursuant to the plans.</font></p><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Similar Transactions: </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any other similar purchase of Company Securities from the Company or sales of Company Securities to the Company are not subject to this Policy. In addition, the exercise of a tax withholding right relating to any other equity awards under the Company&#x2019;s equity compensation plans pursuant to which the Company withholds Company Securities to satisfy tax withholding requirements is not subject to this Policy.</font></p><h2 style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Planned Trading Programs</font></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rule 10b5-1 under the Exchange Act provides an affirmative defense, under certain conditions, against allegations that an insider traded in the Company&#x2019;s securities while aware of material non-public information. In order to be eligible to rely on this defense, a person subject to this Policy must enter into a trading plan for transactions in Company Securities that meets certain conditions specified in Rule 10b5-1 (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rule 10b5-1 Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). If the plan meets the requirements of Rule</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10b5-1, Company Securities may be purchased or sold without regard to certain insider trading restrictions, including blackout and pre-clearance requirements.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In general, a Rule 10b5-1 Plan must be entered into at a time when the person entering into the plan is not aware of material non-public information and not during a Blackout Period. Once the plan is adopted, the person must not exercise any influence over the amount of securities to be traded, the price at which they are to be traded, or the date of the trade. The plan must either specify the amount, pricing, and timing of transactions in advance or delegate discretion on these matters to an independent third party. Generally, any Rule 10b5-1 Plan must be submitted to the General Counsel for approval two weeks prior to the entry into the Rule 10b5-1 Plan. If you are interested in setting up a 10b5-1 Plan, consult with our General Counsel to confirm the proposed 10b5-1 Plan complies with the requirements of Rule 10b5-1 under the Exchange Act and this Policy.</font></p><h2 style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Post-Termination Transactions</font></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Policy continues to apply to transactions in Company Securities even after your service with the Company has ended (other than the pre-clearance and trading prohibitions during a Blackout Period, which will cease to apply upon the expiration of any Blackout Period pending at the time of the termination of service). If you are aware of material non-public information when your employment terminates, you may not purchase or sell Company Securities until that information has become public or is no longer material.</font></p><h1 style="text-indent:-6.188%;padding-left:5.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12.	</font><font style="text-transform:uppercase;color:#4f81bd;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consequences of violation</font></h1><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider trading is a serious crime. There are no thresholds or limits on the size of a transaction that will trigger insider trading liability. Insider trading violations are pursued vigorously by the SEC and can be detected using advanced technologies. In the past, relatively small trades have resulted in investigations by the SEC or the Department of Justice and lawsuits.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Individuals found liable for insider trading (and tipping) face penalties of up three (3) times the profit gained or loss avoided, a criminal fine of up to $5 million, and up to twenty (20) years in jail. In addition to the potential criminal and civil liabilities, in certain circumstances the Company may be able to recover all profits made by an insider who traded illegally plus collect other damages. Furthermore, the Company (and its executive officers and directors) could face penalties the greater of $1 million or three (3) times the profit gained or loss avoided as a result of an employee&#x2019;s violation and/or criminal penalty of up to $25 million.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any violation of this Policy should be brought to the attention of the General Counsel. Without regard to civil or criminal penalties that may be imposed by others, violation of this Policy and its procedures may constitute grounds for dismissal from the Company.</font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.4in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><h1 style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Appendix A</font></h1><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Head and Members of the IR Team</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Head and Members of the Audit Department</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Head and Members of the Finance Department</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Head and Members of Accounting Department</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Head and Members of the Corporate Legal Department</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Treasurer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Executive Assistants</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Head and Members of the Medical Audit Department</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Head and Members of the Data Analysis Department</font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Appendix A</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><h1 style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Appendix B</font></h1><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-Clearance Request Form &#x2013; Application to Transact in Company Securities</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any Designated Person who wants to buy or sell securities of the Company must pre-clear the proposed transaction by completing this form. Hand deliver or email as an attachment the completed and signed form to General Counsel at </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">aplasencia@msprecovery.com</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In addition to preclearing all trades, Designated Persons are prohibited from buying or selling Company Securities during Blackout Periods. If you have questions about this form or your proposed trade, contact General Counsel.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DO NOT EXECUTE THE PROPOSED TRADE UNLESS AND UNTIL YOU HAVE RECEIVED WRITTEN NOTICE OF APPROVAL IN RESPONSE TO THIS PRECLEARANCE REQUEST FROM GENERAL COUNSEL.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Name: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Title: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Proposed Trade Date: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Type of Security to be Traded: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Type of Trade (i.e. Purchase/Sale/Gift/Option Exercise/Transfer): </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Number of Shares to be Traded: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If Relating to an Employee Benefit Plan, Provide Name: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other Information on Proposed Trade: </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I certify that I am not in possession of any &#x201c;material non-public information&#x201d; about the Company. I understand that &#x201c;material non-public information&#x201d; is material information about the Company that: (i) is not generally known to the public and (ii) if publicly known, would be likely to affect either the market price of Company Securities or a person&#x2019;s decision to buy, sell, or hold the Company Securities. I understand that, in all cases, the responsibility for complying with this Policy, including whether an individual is in possession of material nonpublic information, rests with that individual, and any action on the part of the Company, the Company&#x2019;s General Counsel or any other employee or director pursuant to this Policy (or otherwise) does not in any way constitute legal advice or insulate an individual from liability under applicable securities laws. I understand that if I trade while in possession of such information, I may be subject to severe civil or criminal penalties and may be subject to discipline by the Company up to and including termination.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br>Applicant Signature		Date</font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-Clearance Request Form</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><h1 style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Appendix C</font></h1><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Compliance Committee</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-Clearance Transaction Review Criteria Form</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Company&#x2019;s Insider Trading Policy, as revised on November 20, 2024, the Insider Trading Compliance Committee (the &#x201c;Committee&#x201d;) is tasked with reviewing Pre-Clearance Transaction Forms submitted by Designated Individuals intending to transact in Company Securities. Based upon a good faith review of the information available to it at the time of review, the Committee has determined as follows:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Requestor Name: 	________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date on Pre-Clearance</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Request Form: 	________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-Clearance Transaction Review Criteria Form</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Review Criteria</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Is the Requestor subject to a scheduled Blackout Period?</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Is the Requestor subject to an event-specific Blackout Period?</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Did the Requestor certify that they are not in possession of MNPI?</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon reasonable review, does Requestor have knowledge of material non-public litigation status updates or settlement negotiations?</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon reasonable review, does Requestor have knowledge of material non-public contracts or negotiation of contracts?</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon reasonable review, does Requestor have knowledge of material non-public financial data or corporate events?</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Is the contemplated trade a hedging transaction as defined in the Insider Trading Policy?</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any answer above is yes, the above reference Pre-Clearance Request Form must be rejected. Is the above referenced Pre-Clearance Request Form approved?</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General Counsel: 	________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deputy General Counsel:	________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporate Counsel: 	________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date of determination: 	________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-Clearance Transaction Review Criteria Form</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div class="page-border" style="margin-left:0.0pt;margin-right:0.0pt;border-top:1pt solid #4F81BD;border-right:1pt solid #4F81BD;border-left:1pt solid #4F81BD;border-bottom:1pt solid #4F81BD;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="padding-top:0.3in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revised on November 20, 2024</font></p></div></div><div class="main-content-container" style="z-index:5;position:relative;"><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:18pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">____</font></p></div></div><div class="page-border-spacing" style="padding-left:7.0%;padding-right:7.0%;"><div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.3in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-Clearance Transaction Review Criteria Form</font></p></div></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>7
<FILENAME>mspr-ex21_1.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html>
 <head>
  <title>EX-21.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 21.1</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="text-indent:3.733%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SUBSIDIARIES OF THE REGISTRANT</font></p><p style="text-indent:3.733%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following is a list of all subsidiaries of and partnership interests of MSP Recovery, Inc., the percentage of ownership and the state or other jurisdiction of organization or incorporation as of December 31, 2024. Ownership may include ownership held through one or more subsidiaries.</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:39%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:45.76%;box-sizing:content-box;"></td>
     <td style="width:14.24%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #0070c0;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of Entity</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #0070c0;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Jurisdiction</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lionheart II Holdings, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Florida</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP National, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Productions, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LifeWallet, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LifeWallet Federal, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LifeWallet Health, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LifeWallet Lawyer Referral Information Services, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LifeWallet Legal, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LifeWallet Schools, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MAO-MSO Recovery LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series FHCP</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MAO-MSO Recovery, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MAO-MSO Recovery II, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series PMPI</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MAO-MSO Recovery II, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MDA, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery Claims CAID, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery Claims COM, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery Claims HOSP, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery Claims HP, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP WB, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Subrogation Holdings, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-09-321</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims RR, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Florida</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP National, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Florida</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Productions, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Florida</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery Claims CAID, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 19-10-1128</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims CAID, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery Claims COM, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 19-04-1014</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims COM, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-12-1645</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims COM, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery Claims HOSP, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series-21-05-1576</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims HOSP, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series-21-05-1568</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims HOSP, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series-21-05-1569</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims HOSP, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series-21-05-1570</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims HOSP, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series-21-05-1578</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims HOSP, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery Claims HP, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series-22-05-1716</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims HP, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-09-136</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 19-10-1123</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 20-06-1374</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 20-09-1483</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-01-1517</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-02-1521</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-02-1532</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-03-1544</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-03-1546</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-03-1547</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-03-1548</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-03-1549</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-03-1550</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-03-1551</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-03-1552</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:39%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:45.76%;box-sizing:content-box;"></td>
     <td style="width:14.24%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-03-1554</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-04-1561</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-06-1565</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-05-1571</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-06-1588</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-09-1617</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-09-1623</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 21-10-1632</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 22-01-1658</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 22-01-1660</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 22-01-1661</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 22-01-1662</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 22-02-1667</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 22-11-1874</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 23-05-1895</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims PROV, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-09-32</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 18-01-812</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 17-12-674</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 19-05-1023</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-11-392</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-12-404</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-08-14</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-08-17</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 19-05-1042</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-12-406</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-03-441</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-03-444</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-11-386</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-02-437</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-02-427</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-05-455</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-11-378</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-10-358</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-02-438</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-11-376</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-12-397</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-08-24</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 19-02-982</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 18-11-949</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 18-03-848</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-12-407</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-04-448</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-08-26</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-10-357</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 17-03-620</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-09-281</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-09-284</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-03-442</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-10-359</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-08-15</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-08-16</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-11-373</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-12-403</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-11-372</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-11-375</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-11-377</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-02-429</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-02-428</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-11-374</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-08-27</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-09-273</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-02-426</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:39%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:45.76%;box-sizing:content-box;"></td>
     <td style="width:14.24%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-08-19</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 18-05-872</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-09-242</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-09-288</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-12-402</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-12-400</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-08-12</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-02-436</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-02-433</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-12-399</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-09-330</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 17-02-565</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-12-398</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-12-401</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-08-18</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 17-03-584</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-11-524</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-01-409</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-09-293</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-10-362</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-12-396</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-10-504</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-02-425</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-05-457</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-04-454</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-02-435</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 17-07-642</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-08-21</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-01-413</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 18-01-811</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-11-383</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-03-440</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-01-410</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-02-439</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-08-23</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-11-380</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-07-481</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-10-361</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 16-01-420</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 18-04-859</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-08-10</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-11-387</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-09-250</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-11-385</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-11-371</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-09-30</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-08-25</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 19-06-1054</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 15-09-108</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 19-06-1058</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 19-01-977</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 23-05-1941</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 23-05-1942</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 23-05-1940</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 23-05-1947</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series 23-05-1948</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">,</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a designated series of MSP Recovery Claims, Series LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery Services LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Florida</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Florida</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSPA Claims 1, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Florida</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">MSP Recovery of Puerto Rico LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Puerto Rico</font></p></td>
    </tr>
    <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">NY Claims Holdings, LLC</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</font></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>8
<FILENAME>mspr-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 23.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consent to the incorporation by reference in Registration Statement No. 333-266374 on Form S-8 of our report dated April 15, 2025, relating to the financial statements of MSP Recovery, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2024.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Deloitte &amp; Touche LLP<br></font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Miami, Florida</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">April 15, 2025</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>9
<FILENAME>mspr-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.1</font></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, John H. Ruiz, certify that:</font></p><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this Form 10-K of MSP Recovery, Inc.;</font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP;</font></p><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></p><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></p><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></p><p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:45.46%;box-sizing:content-box;"></td>
     <td style="width:5.04%;box-sizing:content-box;"></td>
     <td style="width:3.04%;box-sizing:content-box;"></td>
     <td style="width:46.46%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: April 15, 2025</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ John H. Ruiz</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">John H. Ruiz</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Executive Officer</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>10
<FILENAME>mspr-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.2</font></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Francisco Rivas-V&aacute;squez, certify that:</font></p><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this Form 10-K of MSP Recovery, Inc.;</font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP;</font></p><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d)	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></p><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></p><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></p><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:45.46%;box-sizing:content-box;"></td>
     <td style="width:5.04%;box-sizing:content-box;"></td>
     <td style="width:3.04%;box-sizing:content-box;"></td>
     <td style="width:46.46%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: April 15, 2025</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Francisco Rivas-V&aacute;squez</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Francisco Rivas-V&aacute;squez</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>11
<FILENAME>mspr-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 32.1</font></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Annual Report of MSP Recovery, Inc. (the &#x201c;Company&#x201d;) on Form 10-K for the period ending December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</font></p><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></p><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></p><p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:45.46%;box-sizing:content-box;"></td>
     <td style="width:5.04%;box-sizing:content-box;"></td>
     <td style="width:3.04%;box-sizing:content-box;"></td>
     <td style="width:46.46%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: April 15, 2025</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ John H. Ruiz</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">John H. Ruiz</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Executive Officer</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>12
<FILENAME>mspr-ex32_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html>
 <head>
  <title>EX-32.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 32.2</font></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Annual Report of MSP Recovery, Inc. (the &#x201c;Company&#x201d;) on Form 10-K for the period ending December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</font></p><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></p><p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></p><p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:45.46%;box-sizing:content-box;"></td>
     <td style="width:5.04%;box-sizing:content-box;"></td>
     <td style="width:3.04%;box-sizing:content-box;"></td>
     <td style="width:46.46%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: April 15, 2025</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Francisco Rivas-V&aacute;squez</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Francisco Rivas-V&aacute;squez</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>13
<FILENAME>mspr-ex97_1.htm
<DESCRIPTION>EX-97.1
<TEXT>
<html>
 <head>
  <title>EX-97.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 97.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><img src="img3963835_0.jpg" alt="img3963835_0.jpg" style="width:179px;height:73px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP RECOVERY, INC.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Executive Officer Incentive Compensation Recovery Policy</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PURPOSE</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Board of Directors (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Board</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) of MSP Recovery, Inc., a Delaware Corporation, (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), has adopted this policy (this &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Policy</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) which requires the recovery of certain executive compensation in the event that the Company is required to prepare an Accounting Restatement (as defined below). References herein to the Company also include all of its consolidated direct and indirect subsidiaries. This Policy is designed to comply with Section 10D of the Securities Exchange Act of 1934, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), Rule 10D-1 thereunder, The Nasdaq Stock Market (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nasdaq</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) Listing Rule 5608 (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rule 5608</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) and will be interpreted and applied accordingly.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADMINISTRATION</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy will be administered by the Board of Directors (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Committee</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). The Committee is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy. Any determinations made by the Committee will be final and binding on all affected individuals.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">COVERED PERSONS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy applies to the Company&#x2019;s current and former executive officers, as determined pursuant to Rule 16a-1(f) promulgated under the Exchange Act and including executive officers identified under Item 401(b) of Regulation S-K (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Executive Officers</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#x201d; and together with any former Executive Officer, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Covered Persons</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). Each Executive Officer shall be required to sign and return to the Company the Acknowledgement Form attached hereto as </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> pursuant to which such Executive Officer will agree to be bound by the terms and comply with this Policy.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RECOUPMENT UPON AN ACCOUNTING RESTATEMENT</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Company is required to prepare an Accounting Restatement, the Company will recover reasonably promptly all Erroneously Awarded Compensation from each Covered Person, unless the Committee determines in accordance with Section VI below that such recovery is impracticable.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes of the foregoing:</font></p><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.3780291282799726%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accounting Restatement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means an accounting restatement of any of the Company's financial statements due to the Company's material noncompliance with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or to correct an error that is not material to previously issued financial statements, but would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period, within the meaning of Rule 10D-1 and Rule 5608.  For the avoidance of doubt, an Accounting Restatement will not be deemed to occur in the event of a restatement of the Company&#x2019;s financial statements due to an out-of-period adjustment or due to a retrospective (i) application of a change in accounting principles; (ii) revision to reportable segment information due to a change in the structure of the Company&#x2019;s internal organization; (iii) reclassification due to a discontinued operation; (iv) application of a change in reporting entity, such as from a reorganization of entities under common control; or (v) revision for stock splits, reverse stock splits, stock dividends, or other changes in capital structure.</font></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.3780291282799726%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Covered Incentive Compensation</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means Incentive Compensation Received on or after October 2, 2023 by a person: (i) after beginning service as an Executive Officer, (ii) who served as an Executive Officer at any time during the performance period for that Incentive Compensation, and (iii) while the Company has a class of securities listed on a national securities exchange or a national securities association, and (iv) during the three completed fiscal years immediately preceding the date that the Company is required to prepare the Accounting Restatement (or such longer period as required under Rule 5608 in the event the Company changes its fiscal year).  The date that the Company is required to prepare the Accounting Restatement will be the earlier of (x) the date the Board concluded or reasonably should have concluded that the Accounting Restatement is required, and (y) the date a court, regulator or other authorized body directs the Company to prepare the Accounting Restatement. </font></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.3780291282799726%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Erroneously Awarded Compensation</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the amount of Covered Incentive Compensation that was Received by each Covered Person in excess of the Covered Incentive Compensation that would have been Received by the Covered Person had such Covered Incentive Compensation been determined based on the restated Financial Reporting Measure following an Accounting Restatement, computed without regard to taxes paid.  For this purpose, if the amount of Covered Incentive Compensation that is Received by a Covered Person was based on the Company's stock price or total shareholder return and is not subject to mathematical recalculation directly from the Accounting Restatement, the amount to be recovered as Erroneously Awarded Compensation shall be based on a reasonable estimate of the effect of the Accounting Restatement on the Financial Reporting Measure upon which the Covered Incentive Compensation was Received.  The Company's Corporate Secretary shall, on behalf of the Committee, obtain and maintain all documentation of the determination of any such reasonable estimate and provide such documentation to Nasdaq when required.</font></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.3780291282799726%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial Reporting Measure</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means (i) any measure that is determined and presented in accordance with the accounting principles used in preparing the Company&#x2019;s financial </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.3780291282799726%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">statements and any measure that is derived wholly or in part from any such measure, and (ii) the Company&#x2019;s stock price and the total stockholder return of the Company. A measure, however, need not be presented within the financial statements or included in a filing with the U.S. Securities and Exchange Commission (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEC</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) to constitute a Financial Reporting Measure.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.3780291282799726%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Incentive Compensation</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure.  For the avoidance of doubt, Incentive Compensation shall also be deemed to include any amounts which were determined based on (or were otherwise calculated by reference to) Incentive Compensation (including, without limitation, any amounts under any long-term disability, life insurance or supplemental retirement plan or any notional account that is based on Incentive Compensation, as well as any earnings accrued thereon).</font></div></div><div class="item-list-element-wrapper" style="margin-left:1.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.3780291282799726%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Received</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; - Incentive Compensation is deemed &#x201c;Received&#x201d; in the Company's fiscal period during which the Financial Reporting Measure specified in such Incentive Compensation is attained.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recoupment of Erroneously Awarded Compensation pursuant to this Policy is made on a &#x201c;no fault&#x201d; basis, without regard to whether any misconduct occurred or whether any Covered Person has responsibility for the noncompliance that resulted in the Accounting Restatement.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">METHOD OF RECOUPMENT</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Committee will determine, in its sole discretion, the method for recouping Erroneously Awarded Compensation hereunder, which may include, without limitation, any of the following:</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Requiring reimbursement of cash Incentive Compensation previously paid;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Seeking recovery of any gain realized on or since the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Offsetting the recouped amount from any compensation otherwise owed by the Company to the Covered Person (including, without limitation, any severance otherwise payable by the Company to the Covered Person);</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Making a deduction from the Covered Person&#x2019;s salary;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Requiring the Covered Person to transfer back to the Company any shares he or she received pursuant to an equity award;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Surrendering to the Company any shares being held pursuant to stock ownership guidelines;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cancelling, or reducing the number of shares subject to, or the value of, outstanding vested or unvested equity awards; and/or</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Taking any other remedial and recovery action permitted by law, as determined by the Committee.</font></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Committee will consider Section 409A of the U.S. Internal Revenue Code of 1986, as amended, prior to offsetting recouped amounts against future payments of deferred compensation. In addition, the Committee may, in its sole discretion, determine whether and to what extent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">additional action is appropriate to address the circumstances surrounding the noncompliance so as to minimize the likelihood of any recurrence.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IMPRACTICABILITY</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Committee will recover any Erroneously Awarded Compensation in accordance with this Policy unless the Committee determines that such recovery would be impracticable because (i) the direct expense paid to a third party to assist in enforcing the Policy would exceed the amount to be recovered, (ii) recovery would violate an applicable home country law adopted prior to November 28, 2022, or (iii) recovery would likely cause an otherwise tax-qualified, broad-based retirement plan of the Company to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and regulations thereunder.  Before concluding that it would be impracticable to recover any Erroneously Awarded Compensation based on the expense of enforcement, the Company shall make a reasonable attempt to recover such Erroneously Awarded Compensation, and the Company Secretary, on behalf of the Committee, shall document such reasonable attempt(s) to recover and provide that documentation to Nasdaq when required. Before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on violation of law, the Committee shall engage legal counsel experienced and qualified to practice law in the applicable jurisdiction (if such counsel is acceptable to Nasdaq) to render an opinion that recovery would result in a violation of law and shall provide such opinion to Nasdaq. The Company shall provide funding for the fees and expenses of such legal counsel as approved by the Committee.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NO INDEMNIFICATION OR INSURANCE</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Neither the Company nor any of its subsidiaries or affiliates shall indemnify any Covered Person against the loss of any Erroneously Awarded Compensation. Further, neither the Company nor any of its subsidiaries or affiliates shall pay or reimburse any Covered Person for any insurance policy entered into by a Covered Person that provides for full or partial coverage of any recoupment obligation under this Policy.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AMENDMENT; TERMINATION</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Board or the Committee may amend this Policy from time to time in its discretion in any manner consistent with applicable law and regulation. The Board or Committee may terminate this Policy at any time when the Company does not have a class of securities listed on a national securities exchange or a national securities association.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OTHER RECOUPMENT RIGHTS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Board intends that this Policy will be applied to the fullest extent of the law. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company (a) under applicable law, regulation or rule, (b) pursuant to the terms of any similar policy or recoupment provision in any employment agreement, severance agreement, equity award agreement, bonus plan, or similar agreement or plan, and (c) any other legal remedies available to the Company. Further, the provisions of this Policy are in</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">addition to (and not in lieu of) any rights to repayment the Company may have under Section 304 of the Sarbanes-Oxley Act of 2002.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SUCCESSORS</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Policy shall be binding and enforceable against all Covered Persons and their beneficiaries, heirs, executors, administrators, or other legal representatives.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DISCOLSURE</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The circumstances of any recoupment pursuant to this Policy will be publicly disclosed where required by Rule 10D-1, Item 402 of Regulation S-K and Rule 5608. In accordance with Rule 10D-1, the Policy shall be filed with the SEC as an exhibit to the Company&#x2019;s Form 10-K, as provided in Item 601(b) of Regulation S-K.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CHANGE OF LISTING</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event that the Company lists its securities on any national securities exchange or national securities association other than Nasdaq, all references to Nasdaq in this Policy shall mean each national securities exchange or national securities association upon which the Company has a class of securities then listed.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">[Remainder of Page Intentionally Left Blank. Signature Page Follow.]</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit A</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Executive Officer Incentive Compensation Recovery Policy Acknowledgment Form</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">By signing below, the undersigned acknowledges and confirms that the undersigned has received and reviewed a copy of MSP Recovery, Inc. Executive Officer Incentive Compensation Recovery Policy. Capitalized terms used but not otherwise defined in this Acknowledgement Form (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acknowledgement Form</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) shall have the meanings ascribed to such terms in the Policy. By signing this Acknowledgement Form, the undersigned acknowledges and agrees that the undersigned is and will continue to be subject to the Policy and that the Policy will apply both during and after the undersigned&#x2019;s employment with the Company. Further, by signing below, the undersigned agrees to abide by the terms of the Policy, including, without limitation, by returning any Erroneously Awarded Compensation to the Company to the extent required by, and in a manner permitted by, the Policy.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:46.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">________________________________ Signature</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:46.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:46.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">________________________________</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:46.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Print Name</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:46.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:46.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">________________________________</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:46.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img3963835_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img3963835_0.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "0 5\# 2(  A$! Q$!_\0
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ME)^TDKR;D[6CI=MNP4445YYV","58*VUBI"M@-M)!PV#P<'G!X.,&OQ>\;?
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M/A+QVFD:A8KK'A?X<>*-/U1=&NWMO[1MA<3:<JBWG:.V\Y =S;5 XW5]A_\
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MI8C#8C#U(5J&(H5H1J4:]"M3E*G5HU:<HU*52G*4*D)1G&3BTW_,3_P</?\
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M<>./#]I_PGOPWDV%Y!XQ\+0W%W;Z='M1Y!_PD>F/J?AIC&-R#5Q*5D$1C?\
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M:0:?I.C:=9:3I=A;(L5M9:=IUM%9V5I;QJ L<%M;0Q0Q(H"I&BJ  !7\W_\
MP<._\@[]E'WOOC'V)_Y=_AL>HZ?4\=NI%5A*LJV8PJRWG.;]%[.:2^227R)Q
M%-4L%*FMHJ"OW?M(MOYMM_,_F;A_UL7_ %T3_P!"%?Z5UO\ \>\'_7&+_P!
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MZ2<>/_W>7^*'YGY=?L;_ /)W_P"RC_V<M\!__5J>%*_T**_SF/@?KOB_PO\
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MDN[*)+N*WN[6:2!I$BN()"LJ^(DY-);MI+U;LCTV[)M[)-_<>E45\8_\$_\
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M ";/^T3_ -D+^+?_ *@'B"O=*\+_ &H?^39_VB?^R%_%O_U /$%>-3_B4_\
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M=K\5OA>6M;@ ?$?P+DF"4 ?\53I7).W 'O7]*/\ P<#_ /(B_LU?]C1\2O\
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M (=)7W_1;+3_ ,(F;_YHJ/\ B.'AC_T4C_\ #3G?_P [O/\ /LP_XED\;?\
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M:/XMT&[T"YOM%T[2=0TQ+C5+>WU"YE@%_="T69(&DBF021-8^V?M*?\ 0N?
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M8%NK?3&M[9K6VMOH'[9^TI_T+GP._P#"U\>__,#1]L_:4_Z%SX'?^%KX]_\
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M0:)HVI>&/$>I:1%->>%;M+G6-+\5/9:C8HVD:E;6]C>^*?M'Z-?_  T_;/\
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83W^7F45S6J2C>+22M%)1:=W=IZ)IR__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>img41968384_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img41968384_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "0 5\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W7_A\+_P4
M*_Z+I!_X;7X6?_,91_P^%_X*%?\ 1=(/_#:_"S_YC*_,JBOL?JN&_P"@>A_X
M*A_\CY?GW9\Y[>O_ ,_JO_@R?^9^FO\ P^%_X*%?]%T@_P##:_"S_P"8RC_A
M\+_P4*_Z+I!_X;7X6?\ S&5^95%'U7#?] ]#_P %0_\ D?+\^[#V]?\ Y_5?
M_!D_\S]-?^'PO_!0K_HND'_AM?A9_P#,91_P^%_X*%?]%T@_\-K\+/\ YC*_
M,JBCZKAO^@>A_P""H?\ R/E^?=A[>O\ \_JO_@R?^9^FO_#X7_@H5_T72#_P
MVOPL_P#F,H_X?"_\%"O^BZ0?^&U^%G_S&5^95%'U7#?] ]#_ ,%0_P#D?+\^
M[#V]?_G]5_\ !D_\S^EC_@E5_P %"/VM?VD_VK+?X:?&3XGP^+/!<OP[\8ZX
M^D+X,\#Z&_\ :NDMI)L+H:AH'AW3+]1"+B8&$7 AD#GS4?"@?TP5_&=_P0V_
MY/GLO^R3?$+^>AU_9C7SV90A3Q+C3A&$?9P?+"*BKZZV22N^KZGKX&4IT6YR
ME)^TDKR;D[6CI=MNP4445YYV","58*VUBI"M@-M)!PV#P<'G!X.,&OQ>\;?
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M/A+QVFD:A8KK'A?X<>*-/U1=&NWMO[1MA<3:<JBWG:.V\Y =S;5 XW5]A_\
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MI8C#8C#U(5J&(H5H1J4:]"M3E*G5HU:<HU*52G*4*D)1G&3BTW_,3_P</?\
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M<>./#]I_PGOPWDV%Y!XQ\+0W%W;Z='M1Y!_PD>F/J?AIC&-R#5Q*5D$1C?\
M@SDBEADDAGBD@GAD>&:&9#'+#-$QCEAEC8!HY8I%9)$8!D=65@""*]/+JRQ&
M%]E.TG37LI)_:@U[K].7W?\ MV_4X<93=&OSQT4VJD6OLS33E;S4K2\N96V/
M](SP/XR\/?$7P=X6\>^$K]-3\,>,M TKQ+H-_'MVW6E:S90W]E*0K.$D,$Z"
M6/<QBE#QL=RFNIK\"_\ @A'^T^/'/P@\5?LR^([_ '^(?@[._B3P2MQ*7N+_
M .'OBK5+NXO[. NQ=T\*^*+F:-EP%M]/\1:1;09AM]D/[Z5\_7HRH5ITI?8E
MH_YHO6,OG%I^3NNA[%&HJM.%1?:6J[26DE\G?Y685_/O_P %X_VG9/!_PR\$
M_LP^&KXIJ_Q5G?Q?\0#;7+QRV?@?PO?VC:'I-U'&5$D?BCQ*IN]DC,BVWA6=
M)H2M[;R#]]M:UC3/#VCZMK^M7MOIVCZ'IM_K&K:A=RI#:V&F:9:RWM_>W,TC
M+'%;VMK!+/-+(RI''&SLP4$U_$U:0^(/^"I?_!25WD34?^$/\?>-VN+E@A1_
M"GP*\"0K'&DAB#Q6EU<>&]/@M5):-+CQ7X@4F19KQI*ZLOI)U95ZG\+#1=63
M_O)-P2\TTY+SBEU.?&U'&G&E#XZ\E!?X6TI??=1]&WT/WC_X(I_LPGX+?LQ'
MXK^(M.^S^.?V@+RU\5H\RIY]C\.;*W\GP/8#Y?,C&I";4_%$H9E+Q:W80R1*
M]GO?Y#_X.'?^0=^RCR!F^^,?7J?]'^&QP.1SQGOP#QW'](&D:3IV@Z3IFAZ/
M:0:?I.C:=9:3I=A;(L5M9:=IUM%9V5I;QJ L<%M;0Q0Q(H"I&BJ  !7\W_\
MP<._\@[]E'WOOC'V)_Y=_AL>HZ?4\=NI%5A*LJV8PJRWG.;]%[.:2^227R)Q
M%-4L%*FMHJ"OW?M(MOYMM_,_F;A_UL7_ %T3_P!"%?Z5UO\ \>\'_7&+_P!
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MZ2<>/_W>7^*'YGY=?L;_ /)W_P"RC_V<M\!__5J>%*_T**_SF/@?KOB_PO\
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MDN[*)+N*WN[6:2!I$BN()"LJ^(DY-);MI+U;LCTV[)M[)-_<>E45\8_\$_\
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M ";/^T3_ -D+^+?_ *@'B"O=*\+_ &H?^39_VB?^R%_%O_U /$%>-3_B4_\
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M=K\5OA>6M;@ ?$?P+DF"4 ?\53I7).W 'O7]*/\ P<#_ /(B_LU?]C1\2O\
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M (=)7W_1;+3_ ,(F;_YHJ/\ B.'AC_T4C_\ #3G?_P [O/\ /LP_XED\;?\
MHC5_X?\ AK_Y\>?Y]F?C=17[(_\ #I*^_P"BV6G_ (1,W_S14?\ #I*^_P"B
MV6G_ (1,W_S14?\ $</#'_HI'_X:<[_^=WG^?9A_Q+)XV_\ 1&K_ ,/_  U_
M\^//\^S/QNHK]D?^'25]_P!%LM/_  B9O_FBH_X=)7W_ $6RT_\ ")F_^:*C
M_B.'AC_T4C_\-.=__.[S_/LP_P")9/&W_HC5_P"'_AK_ .?'G^?9GZ ?L3?\
MFM?!S_L6#_Z<KZOF]?V0?VBC^VD/VS)OB?\ !]M8'P[7X6Q_#Q?!7B\:/#X4
M#F=I!XA'B9=0EUG[=)/J NY-.%MF46/V(0HDX^X/@?\ #63X/_"KP9\-I=53
M7)/">F-IK:K':M9)>C[5<3K,+5IIV@RLP!C,TFU@0'888X;WO[2P=@GAKX&,
M@9@C/XW\?([)D[69!\/I C$8+*'<*<@.P&3_  KQ!C:6-XBX@QV"J1J87'YQ
MFF(H590</:X7%8^M6I34*L8SA[2G.$FI1C4BG:2BTT?ZD<(Y?B<MX1X3RS,*
M4J..RSAS(<%BZ*G&I[#&8+*\)A\13<Z4ITJGLJU.I#FA.=.=G*$I1<6_GC]J
MK]C'6?C-\1_A%^T'\&/B%9?!+]H[X27QMK;Q^- EU[2_%7@V\BFCU'P;XMT>
M*_TU]9TK_2;R.TCN)_\ CRU/5;&4[+N&6T^R? D?Q B\.VT?Q-NO!][XL2:=
M;N[\#66LZ;X?N+<,/LTL%AKU_J>HVL[)DW$+ZA=QJ^/*E*G \\%[^TQD9\,_
M H#/)'CGQ^2!WP/^%>#)]LC/J*?]L_:4_P"A<^!W_A:^/?\ Y@:\:4IRC"$I
M1:AI%OEYDGKR\RU<4VVHMM)WLE?7Z*,8J4I1C).;3EO9NT8WLW9.R2;23:6M
M[(]QK\Q_CC^QW^T)\5OVK?A-^U!H?Q4^$?A>\^!MGKND>!/"6H^ _%NOV>JZ
M9K%SJIFF\6:A!XOT6X>]N;'4(;>6/1TLX;22V,UO)(92%^Q_MG[2G_0N? [_
M ,+7Q[_\P-'VS]I3_H7/@=_X6OCW_P"8&E"4J;<HN*;C*+ORR]V2M)6::U3:
MOO:]G>P3C&:2DI63C*R;6L7&46VFGH[/?1I]CPSQ_P#"_P#;;^)?A;4O VI?
M&KX$>"-!\31IH_B;6_A[\,O']KXT'AB_FCMO$=EX;U37?B1JMEHFKW^BR7]G
M8:TMA-=Z9=317EFT%Q#'/%]I:-I&F^'M'TK0-&LX-/TC0]-L=(TJPM8TAMK'
M3=-M8K*QL[>&-5CB@MK6"*&*.-51(T554* !Y!]L_:4_Z%SX'?\ A:^/?_F!
MH^V?M*?]"Y\#O_"U\>__ # T-RDDFX))MI)16KM=NR3>W6]K.UKZM))M^\VT
MEJV]%;:[:6]W:UVG>]D>XU^?GQO_ &)]:USXZ:=^U7^S9\4%^!?Q_CTQ="\9
MR7WAX>*/AS\7_#T<%I9V^D_$3PW#?Z5=27%E:6ENEIK5C=/>1_8=-80"[L+&
M_M/I+[9^TI_T+GP._P#"U\>__,#1]L_:4_Z%SX'?^%KX]_\ F!HA*=-MQE%7
M3C)/E:E%VO&47=->33U5UJD$HQFDI)Z--/5--6::::::OT>W,G=73\VTWP=^
MU_XWMY?#_P 6/B%\'/ GABX'D:Q>_ O0O'!\=ZW8$+'=:?I7B3QGK;67@==3
MB>59M8T_1=9U_3XP!HE[I>H-#J]I]2Z%H>C^&-%TKP[X?TZUTC0]#T^TTK2-
M+L8A#:6&GV,*6]I:6\2\)%##&B+DEB!EF9B2?(_MG[2G_0N? [_PM?'O_P P
M-'VS]I3_ *%SX'?^%KX]_P#F!I-N6EX);V5DOG;>UWJ[O>W2XDETDW:UY:OI
M]V^MNS?0]QKXR_: _9&MOB9\3O 7[17PL\8-\(_VC_AI;R:7HWCF/1TUWP]X
MS\(SBY-[\/OB7X<6[TV;7O#-[]KN%M[NSU*QUC1))WN;&>;RX[8>N?;/VE/^
MA<^!W_A:^/?_ )@:/MG[2G_0N? [_P +7Q[_ /,#1%R@[QDDVFGJFFFK--.Z
M::>J::=O0)*,U:46U=-;IIIIIIIIIIZW3NK,\,\?_"G]KKXY>%=0^&7CSXC_
M  E^$G@3Q);2:/XZU[X,:=XTU7XD>(O#ES&8=6T?PQJ?BVYL=(\!+K]J\UC=
M:DUGXLU.QM)Y!92K,/-D^H_A7\+? OP5^'WA;X7?#70;7PUX+\':7!I.B:5:
MY;RX8LM-=7=PY,U]J5_</+>ZEJ%R\EU?WT\]U<2/+*S'C_MG[2G_ $+GP._\
M+7Q[_P#,#1]L_:4_Z%SX'?\ A:^/?_F!IN4I14;Q44^;EC9+F:2N[;M+17OR
MJZC9/4C&*?-:3DTE>3;:6FBN]%=W=K7:N[V1[C17AWVS]I3_ *%SX'?^%KX]
M_P#F!H^V?M*?]"Y\#O\ PM?'O_S U/+YQ^]?U_PS\KU?R?W>G^?X/L>'^-/V
M)/!/C']MSX:?MBW,EG%J/@?X>:SX;U70#;.S:_XMMKN"/P)XHE=-D!E\.Z1J
M?B.WGEN#+.UQ9>$OLT:IITLB?<->'?;/VE/^A<^!W_A:^/?_ )@:/MG[2G_0
MN? [_P +7Q[_ /,#52<I<JE)/DBH1NUI%-M+T3D_ZM>8J,>9QBUSRYI:;R:B
MF_N2OZ,]QKP;]I'X?_$3XL?"/QQ\+OA_KG@[PT_Q'\'>+O FOZ]XMTO6=9.E
M:/XMT&[T"YOM%T[2=0TQ+C5+>WU"YE@%_="T69(&DBF021-8^V?M*?\ 0N?
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M8%NK?3&M[9K6VMOH'[9^TI_T+GP._P#"U\>__,#1]L_:4_Z%SX'?^%KX]_\
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M0:)HVI>&/$>I:1%->>%;M+G6-+\5/9:C8HVD:E;6]C>^*?M'Z-?_  T_;/\
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83W^7F45S6J2C>+22M%)1:=W=IZ)IR__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img184519493_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img184519493_0.jpg
M_]C_X  02D9)1@ ! @$ W #<  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '#!$@# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^C/\ X?\
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M5A/Y:G_@;_R_J[\K'U_$=X?^ K^O^'?E;^O/_A_U^QU_T37]I?\ \([X6_\
MSY:/^'_7['7_ $37]I?_ ,([X6__ #Y:_D,HH_LK"?RU/_ W_E_5WY6/K^([
MP_\  5_7_#ORM_7G_P /^OV.O^B:_M+_ /A'?"W_ .?+1_P_Z_8Z_P"B:_M+
M_P#A'?"W_P"?+7\AE%']E83^6I_X&_\ +^KORL?7\1WA_P" K^O^'?E;^O/_
M (?]?L=?]$U_:7_\([X6_P#SY:/^'_7['7_1-?VE_P#PCOA;_P#/EK^0RBC^
MRL)_+4_\#?\ E_5WY6/K^([P_P# 5_7_  [\K?UY_P##_K]CK_HFO[2__A'?
M"W_Y\M?N+7^:/7^EQ7EYCA:.&]C[)27/[3FYI<WP^SM;M\3N=V#KU*_M/:-/
MEY+65OBYKW_\!7XA1117F'<%%%% !1110 4444 %%%% !1110!\__M!_M2?
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MD]/C@]U9_$<5>MBH3DJ5%3@DK2Y92;T5_ADMGIL?T/\ _#X/_@G1_P!'$?\
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MU;VND7D]^+#XD>&K.UT._P!:U+68+*ST31]5\"^%-&@M]1EDU?QC;C33-?\
M].U%=5+&XFBURU9-+[$VYQMVM*]O^W;/S,)X:A4^*G%/O%<K^^-K_.Y_G7?&
MW]G;XW_LX>)E\)?&_P"&GB?X=ZS.9QIS:S:1RZ+KJ6D5E+>S^&/%&FS7WACQ
M5:V(U&RBO[OPYK&J6MC=7"V=W-#=AX5\8K_1^^)'PR^'OQ@\'ZMX ^*'@[P_
MX[\&ZY"8M1\/^)--M]2L9&"L(+RW$RF6PU2Q=OM&F:OI\MKJNE7B17VFWEI>
M0Q3I_,[^W;_P1(UWP3!JWQ1_8X36/&7A6UM=<UOQ'\%=8OVU7QQHB17L^I0P
M?"V]^R)=^-M(L]'EDL+3PGK5U=_$-FT6U33=8^(VN^)%L-+]G"YI3JN,*R5*
MH].:_P"[;]6[POT4KK^]=V/-KX&=-.5-NI%=+>^EZ+XOE9^1_/'12D%258%6
M4D,I!!!!P00>00>"#R#25ZIP!1110!_7G_P0%_Y,Z^)7_9R_C'_U5OP:K]Q:
M_#K_ (("_P#)G7Q*_P"SE_&/_JK?@U7[BU\EC_\ >Z_^/_VU'T.&_P!WI?X$
M%%%%<AN%%%% !1110 5^9G[>O_!,OX/?MD>'M<\3Z+IVC_#K]HE+>"YT+XI6
M5H]M;^)[G3+ 6%EX=^)]G81O_P )#HEY8P6.F1>(Q:7/B_PK%INC2:3=7^A:
M;?>#]>_3.BM*56=&:J4Y.,H[-=5V:V:?5/1D3A"I%PG%2B^C_-=FNC6JZ'^<
M#\3?AGXY^#?C_P 5?"_XE^'-0\)^.?!>K3:-XAT+4HPL]K=1*DT%Q;S1L]MJ
M.E:G936NJZ)K.GS7.E:YHU[8:SI%Y>:9?6EU-PM?O]_P7^^#FD>%_C7\%_C9
MI7]GVMW\6O!/B#PIXETZQT"WL9[K7/A5?:,UKXLUK7H+DOKVIZSX=\=Z)X6@
MCO;"*ZTK1_ .FV\>HW]G+;66C?@#7UN&K>WH4ZNSG'5*]E)-QDE?HI)V\NKW
M/GZU/V56=.]^5Z/KRM)QOYV:OYA1116YD%%%?U0?\$,_@9\$_B!^S'XT\<^/
M/@_\+O&_C70/VCO$5GH7B_Q?X \*>)?$^B6FE?#WX3:MI=MH^O:SI-[JFF0:
M=JM_?:E9165U EK?W=S>0A+B:21N?$XA8:DZKBYI-*R=G[SMNTS:A1=>?(FH
MNS=W=Z+T/YI?A[\'OBW\7)]2M?A1\+?B-\3KG1HK>?6+?X>^"/$WC2?28+MY
M([6;4H?#>F:E)8Q7+PS);R72Q),\4BQEC&P'UIX%_P""7/[??Q$T;^W= _9I
M\::?8_:)K;R/'6I^#_A?K/F0-M=O^$<^)?B3PEXA^SL>8;O^R_LMPOSV\TJ?
M-7]WU%>//.*K^"C3C_CE*?Y>S/1CET%\52;W^%*/IOS?/OY'\.O_  Y\_P""
MB_\ T;O_ .9;^!?_ ,\VN;\6_P#!*;_@H)X+T*^\1:Q^S;XDO-/T^-9;BW\)
M^*?AWX^UV16ECB L?"_@7QCXC\3:G('E4M%IND7<J1"29D6&*61/[KJ*A9QB
M;ZTZ%NMHU$[>OM';UL_0IY=1Z3JW\W!_AR+\S_."\?\ PM^)OPHU2UT3XI?#
MGQW\-=9O;0:A9:1X_P#"'B#P=JEW8&1X1>VMAXBT_3KNXM#-')$+F*)X3(CH
M'W*P'"5_I0Z_X?T'Q7HFJ^&?%.B:1XE\.:[87.EZWX?U_3;+6=$UG3+R)H;O
M3M5TK48;FPU&PNH7:*YM+NWFMYXF:.6-E)!_)G]IG_@BY^R=\<(K[6?AI8W/
M[.7CVYGFN1JO@&R74? -[/<3:0C+JWPLO;^QT:SL['3["^ATJR^'^J?#R"/4
M-7N-3U@:X((;*NNCF].32K4W3_OQ?/'U<;*27ISO].>IETXJ].:G_=:Y7\G=
MQ;]>5'\8E%?97[6?[!G[1O[&>I6:_%WPQ97?A#5KVWTSP_\ $_P7>7.O?#S7
M=6GTE-6?1X-4NM/TG5M&UF&--3@CTCQ7H?A[4M5.@ZYJ&@VNK:%8-JS_ !K7
MK0G"I%3A)3B]I1=U_P !KJGJGH]3@E&4&XRBXR6Z:L_Q[]'U"I(9IK>:*XMY
M9()X)$F@GA=HIH9HF#QRQ2(5>.2-U5T=&#(P#*00#4=%42?M5^QU_P %I_CQ
M\#I]-\(?'\ZO^T'\,?/M[=]8U;5 WQ?\+VMQJL,VH:AI_BS4C)_PGRVMC/JL
M\'A[QO=1ZAJ%Y_9.FVGC[PMHEB;=_P"JGX$_M _"#]I;P#:?$OX*^-=.\;>$
M[F\N],N+BUCN[#4]&UBQ<+>:-XAT'5+>RUK0-5A1X;N.SU:PM)+[2KS3M;T[
M[9HNJ:9J%W_G65[Q^SI^TI\7OV5_B5H_Q1^#OB>XT/6M.GA75M&N7N;GPGXT
MT8,WVOPQXVT&&ZM8==T&^BDE0QM+;ZEI-V8-<\.:GHGB/3M*UFQ\S%Y;2K)S
MHI4JNKLM*<W_ 'DOA;_FCY\R=[KNP^-G3:C4O4AMKK./HWNO)^5FM4_]$"BO
MA[]B;]O;X._MN>#I]3\%O+X5^(GA^RM9_'?PJUN]@N=>\.//Y<+ZCI5]'%:1
M^*?";WK&ULO$EI964FY[6/6](T#4+R#3F^X:^=G"=.3A.+C*+LXO=?YI[IK1
MK5'L1E&<5*+4HM737]:/NGJGH]0HHHJ"C_-'HHHK[@^7"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O\ 2XK_ #1Z
M_P!+BO#SG_F&_P"XW_N(]3+?^7W_ '#_ /<@4445X9Z@4444 %%%% !1110
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M^"=>J_M5^'+)&USX4?M/>)? /Q'D5X(WN?ASXK\#_!M/">JRRWVM6ZE?"GQ
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MSV<!5YZ;IM^]3>G^![?<[KR5CMZ***\H[PHHHH **** "BBB@ HHHH ****
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M\8_^JM^#5?R&5_7G_P $!?\ DSKXE?\ 9R_C'_U5OP:KTLT_W27^.G_Z4<>
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M5;_EZM?6"T^5OQ/(S%/VE-].1KYJ3O\ F@HHHKUSSCTKX-?%#7?@I\6?AO\
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MW3>K?K!J]NSEN['=@:ZIS=.3M&HU9]IK1?*5[-]&ELKL_JDHHHKYP]H****
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M)_ZO3X95_#K7]Q7_  6#_P"4='[1'_=)/_5Z?#*OX=:^CR?_ ':I_P!?Y?\
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M !7\./\ P5^_Y2*_M$_]=/A5_P"J1^&M?W'5_#C_ ,%?O^4BO[1/_73X5?\
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MJO!E&46XR3C).SC)---;IIZI^3/534DFFFFKIK5-/9IA1112&%%%% !1110
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MI>2TE_=L??M%%%<)U!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M?FC_ ,%@_P#E'1^T1_W23_U>GPRK^'6O[BO^"P?_ "CH_:(_[I)_ZO3X95_#
MK7T>3_[M4_Z_R_\ 3=(\;,?X\/\ KU'_ -+F%%%%>J< 5_7G_P $!?\ DSKX
ME?\ 9R_C'_U5OP:K^0ROZ\_^" O_ "9U\2O^SE_&/_JK?@U7G9I_NDO\=/\
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M=,N[:YCTBSO9BOE<QK*MBJC3O&G:E%_X+\WJN=RL^JL]CWL'3=.A%/>=YO\
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M_J35/]T.'O\ D09'_P!B?+/_ %"H!1117G'L!1110 5_#C_P5^_Y2*_M$_\
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M^(FDVX76YC<^)?"R+9^%_'*?:9O#NDQ7&D2^!=4TK1+#5-8U >/?$-TEO/\
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M  58_P""K'A[QUX>\2_LP_LQ>([K4-#U"ZO=!^+?Q8T6YBCT7Q-HD<7V?4?
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M(X(/!'!I:* /X%O^"@7[-3?LI_M5_$_X7:?ILVG>![C4_P#A-/A:&35#:O\
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MCPOXET:Z:5;;5M \0:=<Z3K.F7#020SK!?Z==W-K,T,L4HCE8QR(X5A_GO\
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M*** "BBB@ HHHH **** "BBB@ HHHH **** /E+]I_\ 8I_9T_:\T$Z9\9/
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M #*U+#^Q1^V1<2I"G[)_[22NY(4S? _XEVT0(!/SSW'AF*&,8'!DD4$X4')
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M?#'_ *5GY_G1^T6_W?PB_P"OW'?_ *1P@9-%%%?V@?YBA1110 4444 %%%%
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MEH^\7K&7SBT_)W70^CHU%5IPJ+[2U7:2TDOD[_*S"OYEO^"^'[4,%U=_#O\
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MJ(B@*JJJ@!54 !5     &!3J**^2/H HHHH **** "OY#/\ @OU_R>+\-?\
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M_6"O#SG_ )AO^XW_ +B/T#@7_F:?]R/_ +N!1117AGZ %%%% !1110 4444
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M2;TDN>/^):27JXV?I$_7"BBBO /6"BBB@ HHHH **** "BBB@ HHHH ****
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MU@HHHKE-PHHHH **** /S1_X+!_\HZ/VB/\ NDG_ *O3X95_#K7]Q7_!8/\
MY1T?M$?]TD_]7I\,J_AUKZ/)_P#=JG_7^7_IND>-F/\ 'A_UZC_Z7,****]4
MX K^O/\ X("_\F=?$K_LY?QC_P"JM^#5?R&5_7G_ ,$!?^3.OB5_V<OXQ_\
M56_!JO.S3_=)?XZ?_I1VX#_>/^W)?H?N+1117S![84444 %%%% !1110 444
M4 %%%% !1110 4444 ?YH]%%%?<'RX4444 %%%% !1110 5_H0_L6_\ )G7[
M)O\ V;1\"/\ U5OA6O\ />K_ $(?V+?^3.OV3?\ LVCX$?\ JK?"M>-G/\.A
M_CG_ .DH]'+OXE3_  +_ -*1]+U_F^Z__P AW6O^PMJ/_I9-7^D%7^;[K_\
MR'=:_P"PMJ/_ *635_5/T1_XO'W_ %[X8_\ 2L_/\Z/VBW^[^$7_ %^X[_\
M2.$#)HHHK^T#_,4**** "BBB@ HHHH **** "BBB@ HHHH *_6"OR?K]8*\/
M.?\ F&_[C?\ N(_0.!?^9I_W(_\ NX%%%%>&?H 4444 %%%% !1110 4444
M?US? W_DBGP>_P"R6_#[_P!1/2*]2KRWX&_\D4^#W_9+?A]_ZB>D5ZE7^6&<
M?\C;-/\ L8XW_P!2:I_NAP]_R(,C_P"Q/EG_ *A4 HHHKSCV HHHH *_@U_X
M*;^,D\=?MZ?M-:VDME,+'X@CP:7T])XX _PZT#1?A])%(MQ+-(;V"3PPT.I.
MKB"348[J2VB@MFBAC_O*K_/<_;/97_;#_:P=&5T?]I7XZLCJ0RLK?%'Q2596
M!(96!!!!((((.*]?)U^^JRZJE;[YQ?\ [:CSLQ?[NFN\V_NBU^K/FJOZ\_\
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M5;F7PSXK\.ZRHC,B?9-6M27$A=$]+*O][]*<[_\ DJ_,X\?_ +N_.4;???\
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M])\2>'-:L7,EEJ^A:[86^J:1JEG(RJ7M=0T^ZM[NW<JI:&9&*@G%;=?QQ_\
M!+3_ (*;WO[*VKV_P4^-6J:GJO[.GB'4FETG4&6XU.\^"^NZG=23W^L:/:11
MSWUSX&UJ]N'OO%GAFQ69K#4GNO%WAJQ.LWWB;3_%O]A6C:SH_B/1])\0^'M6
MTW7M U[3;'6=#US1KZUU31]9T?5+6*^TS5M)U.QEGLM1TW4;*>"\L;ZSGFM;
MNUFBN+>62*1'/R>*PL\+4<)7<'=TYVLIK])*]I+H]=4TW[]"O"O"ZTDOCAU3
M_6+Z/Y.S31I4445RFX4444 %%%% !1110 4444 %8'BOQ3H'@;PMXE\:^+-3
M@T7PMX/T#6?%/B76;E9GMM)T#P_IUSJVLZG<);Q37#P6&G6ES=2K!#+,T<3"
M**1RJG?K^?7_ (+@_MKZ;X.\ Q?LA_#OQ!I]UXW^("VNH_&=M+U*Z_M/P1X%
MMGTS6- \*WXM+=;:UU3XCSO#?WED^KKJ-KX(TN2+6/#\VA_$30M2?;#T98BM
M"E%/WG[S7V8+XI/IHMK[NR6K2,JU54:<JCZ+1=Y/1+YO?LKOH?S)?%OXA7_Q
M<^*OQ,^*VJV%KI6I_$WX@>,OB!J&EV,DTUEIE[XR\1:CXBNM/LI;@M<26EE-
MJ+VML\Y,K011F0ER:\^HHK[%)12BE9)))=DE9+[CYUMMMO5MMM^;W"O?/V7/
M@7J_[2_[0?PH^!NC236\GQ \66NGZMJ%M)I\=SHWA/38+C7O&_B"U35+FSL[
MNZ\/>#=*UW7+73FG$^J3Z?'IME%<7MU;V\O@=?UL?\$1/V+YOA+\,;S]JCQS
M:2V_CSXW>'AI/@+39CK=G<>'?@\^J6NIB]U"PNDL-/N;OXDZMHNB^)]-N1::
MQ#%X-TKPEJ>AZY;_ /"4^(M+3FQF(6&H3G?WVN6FN\VG9^D=9/NE;=HVPU%U
MJL8_97O3_P *:NO5[+S=]DS]S]'T?2/#ND:5X?\ #^E:;H6@Z%IMCH^B:)H]
MC:Z9I&CZ1IEK%9:;I6E:;9106>GZ;I]G!#:6-C:0PVMI:PQ6]O%'%&B#1HHK
MY'?<^A"BBB@ HHHH **** /S+_X+$7-O!_P3K_: BFGAADO)OA-;6D<LJ1O=
M7"_&SX<W;06R.P:>9;2UN;EHH@SBWMIYBHCAD9?X>Z_L/_X+R:_>Z/\ L5^'
M-.M7D2#Q7\>_ V@:DJ321+)96WA+XB>*(TF1/EN8QJ/ANPD$,O[M98XK@?O8
M(Z_CPKZ3*5;"R?\ -6F__)81_P#;3Q<P=ZZ7\M.*?WRE^304445ZAPA7]>?_
M  0%_P"3.OB5_P!G+^,?_56_!JOY#*_J/_X-ZO&E[??#W]ICX=R6T2Z=X6\9
M_#KQI:WBR.9Y[WQ[HGB?0[^VDB(\M(K6#X;Z;+#(A+R/>7"R +%&3Y^:)O!S
M:Z2IM^G.E^;1V8%VQ$5_-&:7W<WY)G]%-%%%?+GN!1110 4444 %%%% !111
M0 4444 %%%% !1110!_FCT445]P?+A1110 4444 %%%% !7^A#^Q;_R9U^R;
M_P!FT? C_P!5;X5K_/>K_0A_8M_Y,Z_9-_[-H^!'_JK?"M>-G/\ #H?XY_\
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M[K_@E7_P3LG_ &N/'C?%'XG6UW8_L]_#;6K0ZG;K 4E^*GBRS>VOXO -G<R
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M#FJW\%_;Z9<:J\U_%XC\5^$[>*S-O;.BR6]U=3&8HIMU0F1?SZ_X?]?L=?\
M1-?VE_\ PCOA;_\ /EK[&_X*"_L+_P##=G@+P'X(_P"%H_\ "K/^$)\7W7BK
M^T_^$)_X3C^T_M.C76D?8/L7_"7>$/L6S[3]H^U?:[O=L\K[.N[S5_*+_B'<
M_P"KP/\ S7[_ /';3PT<N=*+Q%2<:MY<R2J6M?W?A@UMY]7UVZZTL8JC]C"+
MIZ6;<+[*_P 4D][K;]#U/X@_\'!OP3TVUL'^%7P ^*?C.]DN9%U2W^(.O^$O
MAE:V=H(@89["\\.3?%J74KEY\QR6MQ8Z5%%$!,MY,Y\@?E3^TI_P6*_:^_:!
MT_5_"NAZWI'P-\!:G-J4$NC?"N._L/%6I:)-JMIJ&DV&O_$34;R\\2?;M/M;
M*/3=2O/!#> =,\36EYJ]IK.@S:3J/]E6_P"@?_$.Y_U>!_YK]_\ CMH_XAW/
M^KP/_-?O_P =M=E*>44FI1:E);2G"M/7H[2@XIKHU%/KN<TXYC45FFDU9J,Z
M<;][M2N[]4W;RL?S1T5_2Y_Q#N?]7@?^:_?_ ([:/^(=S_J\#_S7[_\ ';79
M_:6"_P"?W_E.K_\ *SG^I8G_ )]?^3T__DS^:.BOZ7/^(=S_ *O _P#-?O\
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M)K^TO_X1WPM_^?+7Z7?MA?L[?\-7_LY_$3X _P#"8?\ " _\)]_PB7_%6?\
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MF3/2Z_S?=?\ ^0[K7_86U'_TLFK_ $@J_@IUG]F/S=8U67_A-]OF:E?2;?\
MA&L[=]U*V,_V^,XSC.!GK@5_57T3<31P]7CSVT^3GI\,\ONSE?EEGU_AC*UK
MK>WD?YX_M!\KQV94/"98*A[=T:W'#J?O:-/E52'"7)_&J4[WY)?#>UM;75_C
MVBOK#_AE_P#ZGC_RVO\ \(*/^&7_ /J>/_+:_P#P@K^R?[2P7_/[_P IU?\
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M!O\ R13X/?\ 9+?A]_ZB>D5ZE7EOP-_Y(I\'O^R6_#[_ -1/2*]2K_+#./\
MD;9I_P!C'&_^I-4_W0X>_P"1!D?_ &)\L_\ 4*@%%%%><>P%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?_#\_'?_ .=31_P[_P#^"SO_ $?EX=_\/S\=_P#YU-?T=45Y?U^K_P ^\/\
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M3QC%\)/A;'\0]+_L3Q_'\.?!">.=%^VZ7J7]D>,4\,Z8OB;2_P"T=#)T6_\
ML&M"]M/MNCDZ7=>5Y^GDVDD-&(K1KT:$N6E"I"56%14XJ/,FJ;A/E71I23Z*
M2=DDTD4:<J56I'FG*G*,)0<VY6:<E*-]K[/NU;>S/1:***XCI"BBB@ HHHH
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MGT8Z6(UNK+X7_$OPGX\\4:E=66DZ5X9U6[T[3)Z_,[]MK_@KG\4OVKO@E!\
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M3.OAK_V<OX._]5;\9:_<6OPZ_P""_7_)G7PU_P"SE_!W_JK?C+6&"_WO#_\
M7Q?J>AB_]WJ_X?U1^:/_  0%_P"3Q?B5_P!FT>,?_5I?!JOZ\Z_B;_X)"?M(
M_!;]EW]I3QOX_P#CKXS_ .$&\(ZQ\#O$O@_3M6_X1WQ7XF^T>(]0\>_#36K3
M3OL'@_0O$&IP^=IGA_5[G[7/916$?V3R9;I+BXM8IOW8^('_  7+_8=\'W@M
M/#,_Q8^*Z/!YBZGX(\ KI.EQS&/<MO<GXF:U\/\ 5T(D(BEEM]'NT4AGC\Y0
MI;MS##UZN+DZ=*I.+A"TE%\NBU7-;ENNUSFP=:E3H6G4A%\\G9R7-;37EW_
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M_P#TZ:76M#^/1_Z^T_\ TN)%3^'4_P $O_26?QA_L6_\GB_LF_\ 9R_P(_\
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M*224FI7;^S:VITSQ<.:G"',Y3J4XW<)17*YQYOB2;O%VT7VKW/Z\J***\X[
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M/#^#_IN?PO#3_KYQ?_Z3PP4:***_K,_@<**** "BBB@ HHHH **** "BBB@
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M*** /Y5?^#@[_DLW[/G_ &3'Q+_ZE0KT[_@W<_YO _[M^_\ >VUYC_P<'?\
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M2O&&J^+_ (7> _#OC?X@^*K;1(/^%>>%+GQ=<0-X7\"ZKX@DU%+^/QYKVA7
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M_M,>H_$1/ *Q[7;;/\5M$UCX76MQA"K?Z)=>,(;K<3L7R=T@:,,I_LL_;4^
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MQTZ]]YJ7&2BI--1DY*+[N-KV]+K7:^FZ95TVTGJK-KM>]K^MF%%%%2,****
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M&G.1?\&\EC#)'-#^USJ,4T3I+%+%\$88Y(I(V#))&Z_%H,CHP#(ZD,K $$$
MU[;KX)X)81XFSY8IS5&J[-34VU%Q5U>ZW6GR/,]EB5B7B/87U;Y74IK1P<-[
MOIKM_F?TET5_.7_PX$U#_H]3Q1_X:.?_ .?#56[_ .#?9[^-8;[]LC7KV%7$
MJQ7?P<-S&LBJRB14F^+SJ'"NZAP P5V .&(/G^PP?_0=_P"6M7R_O>;^[S.O
MVN)_Z!/_ "O3_P O7^GI^B7_  4 _P""DOPM_8R\&ZKHV@ZCX;^(7[1&HJ^F
M^%_A;!JL5Z/"U[<:;9:E!XK^*]OI=Y'J?AOPO9Z?JNF:IIVBS3:7XB^(#7=I
MIWAJ6QTD^(/&7A/S'_@C5\,==TW]G7QC^T=\0'74OBK^UK\3O%'Q0\4>(9[.
M[TS5M2T.PUG5]+T1-5TSR;+1H3>^)I_'WC?3+K0M.MK*\T?QS8%)9;:&S@M/
MBO\ XAW]-_Z.UOO_  Q]O_\ /:K^B'P#X)T#X:>!?!7PY\*6\]KX6\ >$O#G
M@GPU:W5U->W-MH'A71[/0M&M[B\N&:>[GATZPMHY;J9FFGD5I9&+NQJJT\-2
MPZHX:HZLZDDZU1PE"\8:Q@E)*T>9IV3>L6Y/X14XUYUO:5H*$81:IQ4HRLY:
M.3:;N^56;TT>BW.MHHHK@.L**** "BBB@#\@_P#@J=_P3<_X;%\.6?Q7^%LI
MM/VBOA]X<&A:-I5_J:6OAWXF^#K/4-2UB/P1=RZC<PZ7X:\2V&HZOK&H>$?$
M^^RTV[N]1O/#OC.3^RKW1_$W@7^9/]DO]K3XV?L"?&W4=>T+3M2ABAU)O"?Q
MG^#'BQ=1T"V\3VN@ZC=6NH>']?L+JU>]\*^.?"UZVIQ^'O$,FERZQX0UB34;
M&^T[5= U3Q3X6U[^^BOB']JK_@GE^R[^U^K:E\3_  5-HWCT1Q0V_P 5OA]<
MVOA?XAQP1S:*&@U+4'T_4M#\70C3=#M]#L(_'7A_Q2OA[2;S4T\+#0KV]DOA
MZ>$QT84WA\3%U*$E9/>4$^EFU>*>JLU*#UC?1+BQ&%<YJM1DH54TW?:36SOK
M9VT>C4NMM6^T_9D_;4_9R_:YT1=1^#/Q"T_4M?M]/74->^'6N;-!^)/A>..V
MT274&U?PE>2F[N],TJ[\0Z9HUWXM\.2:]X&N-<DFTS2?%&I7%O*%^JJ_EJ^)
M/_!OG\4-,-K=?!C]HCP-XHF?4[AYK'XD^&/$/P\.D:8I:2P>UUOPI-\3&UO4
MXV\N&XW:%X<MR5:[A9"5LU[K3/\ @F9_P5YMFT^Q?]OHZ9H]N;2T9=,_::_:
M<F;3]-B,<)&GZ:?!NG6LIM+52+2Q-Y86[F..W-S:QGS4F>&P<GS4L;",7>T:
MD)*4=M+V3?7[*TZO5CC7Q"5JF&DY*VL)1:?RN[:/^9]=K.W]&7C/QSX)^''A
MV]\7?$/QAX6\!^$]->UCU'Q/XS\0:3X7\/6$E]=0V-C'>:UK=W8Z;:O>7UQ;
MV=HD]RC7-W/#;PAYI41OQ,\0_$SQC_P5[\>/\(/A!I_B#P9^P+\._&-C-\=_
MBOKUC-I&I?'C4?#>KZ?KNB?#OP+I[^3JFGV^H&RTWQ"&NI[#5_#&CZEH_BSQ
MOINAZZGA#P+XJZ7P+_P15\$:SXW?X@?M@?M%?%S]KG6+>"UL].L?$E_XA\)6
M4VG16&J6LFG>)=<N/&_C3Q]JUK9W5[9:GH*>'?&?@N+3[O3GBU"WUFPU"XL4
M_9OPUX8\->#-!TOPMX/\/:'X3\,:):K9:+X<\-:38:%H.D62,SI::7I&EV]K
MI^GVJN[LMO:6\42LS,$!8DX\U##ZT9.O6M[M5P<*=)M;PC+WIS3ORRDHJ+LU
M&36FG+5K:5(JE3O[T%)2G-+6SE'W8P?5)R<E=-I/6SHNBZ-X:T;2?#OAW2=,
MT#P_H&F6&BZ%H6BV%KI>C:+HVE6L5CI>DZ3IEC%!9:=IFG64$%G86%G!#:V=
MK#%;V\4<,:(-.BBN3?<Z HHHH **** "OYR_^"M/_!+C6_'>MZA^TW^R_P"!
MQJ7B?4EOM1^-'PT\,0!=2\3ZDBRWLOQ'\):#'@:GXHU-1+%XPT+1$_M3Q3JG
MV/Q#I^D:IXIU3Q/>ZK_1I16^'Q%3#5%4IO7:47?EE%[J25O5=4TFC*M1A6@X
M36FZ:WB^Z>OS[H_D^_X)"_\ !2[PW\#+:V_9<^/VK0Z)\+]7U^XO/AA\1]0N
M)H],^'>N>(KOSM4\+^+YI[AK+2? &N:S-)K-EXCBM[2V\(^(]5U[4?%ES+X9
MUJ?6O!?]8-?FC^U=_P $I?V5/VIKG5O%<WAVX^$GQ5U-M0OI_B)\,HK'23KN
MM7G]NWO]H>.O",UM)X:\6O>^(-;.N>)-8CM=$\?>(FLK33Y?'=G9(J+\/^%O
M^"9__!23]F>;0=)_9-_;ST6[\&:9I>I6T?AOXEV_BGP]X2\/SZIJ5SJ-[#X?
M^%^H:3\>O 96]N[N[U2XUA+;1M174[N[F2!I;B:[DZZWU3%R=6%58>K/6=.K
M&3@Y=9*I!22N][KWGK:+O?GI?6,/'V<X.M35E"5-KF2TT<9--I=-=+6;M:W]
M!U?BI_P5"_X*@>"OV?\ P5XE^!WP0\2:;XM_: \7Z7KOAG6-7\-:Z\EG\"K&
M?[;H.K:OJNKZ!?17-I\5[6>.\A\)>%+>^MM2\+ZE;)XP\7K:6%GX>\/>._,_
M$G["?_!6_P".M_8>'?CY^WKX,\._#V:QUC3=>E^#\WB32]0O-/U+3KFWET[4
M_!?@WX=? W1/&EAJ3.FGWUKXF\4K!;:?<W4L,5V4^P7/O?[+O_!&#]E?X"36
M'B3XC07'[1OCZU64_;?B%I%C:_#BRF9]9MEGTCX5)/JNEW)FTC4[.WO(_'FM
M>/XH=7TFV\0>'D\.WACBMXIT\)0DJE:NJ\HVE&C1C)J3Z<U2:@K)ZN.C\FM'
M4Y8BJG"G3=)/1U*KBI):7Y81<G=IZ/9=T]5^3W_!+/\ X);>*_BYXL\'?M#_
M +0W@Z/3/@3I4=EXK\&>#O%=DLEU\8KQMEUX>N[SPY=H0WPRQY6MW,^N0BP\
M<V/]F:?8:;KGA76]2U"#^MVBBL<3B:F*J<\[))6A!;17E?=O>3ZOLDDM:%"%
M"'+'5O64GO)VM\EV6RN]VVV4445S&P4444 %%%% !1110!\7?\%!/V:!^U=^
MRI\3?A=IVG07_CFUT]?&OPLWIIPN$^(WA*.>_P!"T^QO-7U#2M,TF;Q=:MJ?
M@*[UF_O[>TTK2?%FI7L[-'"RM_"[\(?A=XJ^-OQ1\ _"/P1!%/XJ^(OBO1?"
M>C/=1ZC)IUC<:Q>Q6LNL:R^DZ?JNH6OA_0K9Y]9\0ZC;:;>MI>B6&H:B]O)'
M:NM?Z.=?DS\"_P#@FA9_"/\ X*$?&7]KRXU'PU>^!/$ \1Z]\)/"\-YKD_BS
MPUX_^)=O9O\ $;7]66+3M#\/Z?I5H^H^/M!\*Z)!-XH@E\.^+;66Z;2]5\/V
MLMSZF!QJP]&O"3VBZE+SJ.T>7T;Y9>2C-ZW.'%89UJE*45U4*C3M[E[\WJES
M+NVXKH?IQX \#^'?AEX$\&?#CPC:RV/A7P#X5\/^#/#=G/<2WD]MH7AC2;31
M=)AN+R=FN+RXCL;*!;B[N'>>ZF#SS.TLCL>NHHKS&VVVW=MMMO=MZMOU.U))
M)+1)62[)!1112&%%%% !1110 5^?7_!5/Q!#X:_X)_?M)ZC/;RW27/A;P[X?
M6.)U1UF\6>/O"7A6WN"7X,5I<:S%=S(/F>&&1$P[+7U[\7/#'Q!\9?#SQ!X;
M^%?Q/D^#/CS4O[)_L+XDQ>#- ^(+^&_L>N:;?ZIM\(>*'CT+5_[8T:UU'03]
MN<?8!JAU.VS>65N#^1GQ[_X)0?M"_M//9K\<_P#@HMXX\=:;I\MC<V/AJ3X(
MZ-X>\%VNHZ=#JEM9ZU#X&\)_$O0O!R>(8K36M4LCXC&A_P!NRV%[+8S:C):;
M(5Z<,J2J4ZE6M&G&%2,G%QJRE)1<9:<D'%*6JOSW5F^7:^-=U.2<*=.4Y2@T
MI*5.,4Y)K7FDG=;VY6GHK[V_F&_9(UK1O#?[5O[,GB+Q%JVF:!X?T#]H3X+Z
MUKNNZU?VNE:-HNC:5\2/#5]J>K:MJ=]+!9:=IFFV4$]Y?W]Y/#:V=K#+<7$L
M<,;NO^AI7\V/_$._IO\ T=K??^&/M_\ Y[5:EO\ \&_<]G"EO:?MF>(K6WCW
M>7!;_!YX(8][M(^R*+XOJB[G9G;:HW.S,<DDGT<94P6+E3E]:=/D35O859WN
MT[[1M;7O?RZ\6&AB</&47A^=2:=_:TXM='U=]/3\=/Z.J\T^+/QD^%GP)\&W
MWQ ^,'CSPU\/?"-@+E&U?Q)J4-D-0O;;3-1UG^Q=!L,OJ?B7Q+>:=I.I7&E>
M%_#UEJGB+6C9S0:1I=[<J(3^"W_#@34/^CU/%'_AHY__ )\-8O\ Q#OZ;_T=
MK??^&/M__GM5QQH8&ZYL<VNJ6&J)VTO9MM+KK9[;;'2ZN*L[86SZ-UJ;2?FE
M9OTNO4J_L]_'C7O^"IG_  4N\!>/=0\+QZ#^SY^R7H?BSXA_#KPCK5A-<:DU
M_+=Z1I'AOQ#XFUK2Y9[&U^(VN>-&\)^.8-#BU&3PYHVB_#D:!IA\0WFF:YXI
M\3?TL5^?'_!/S]@#PO\ L&^%?B+I.G>.;GXD^*/B5X@T;4-;\6S^'YO":+H/
MAC3KFV\,^'8_#X\3^)[(-I6HZUXLU.36(+BVNM1&OQV5W"T.CV3G]!ZSQ=2G
M.HHT-*%*$84E9K3XI-IZWE.4FV]7HV7AX3A!NK_%G)SGJGKM%75U912LEHMD
M%%%%<IN%%%% !7!?%7Q_I_PH^%_Q(^*6KVEQ?Z5\-? 7C#Q_J=C:,J75[I_@
M[P]J/B*]M+9V5U6XN+;3I8869'59'4E6 (.SXRTOQ#K?A#Q5HOA+Q0W@CQ7J
M_AO7-+\,^-%T:P\1MX0\0W^EW5IHOBA?#VJLNEZ\V@:E+;:L-&U)EL-4-H+&
M\86\\AK\F/CG_P $W/VKOVDO"J>!OC'_ ,%)/%WB?P:9EGO/#&F?L[^"O!&B
M:R\5W8:A:KXET[P%XY\,6WBB'3]1TO3]2TJW\1QZI;Z3J5K'J&FQ6MYNG;:C
M"G*2]K5C3@I+F3C4E)QZ\JA"2^^4?F9U)3BGR4Y3DT[6E"*3Z7<I)_<F?QI5
M_I0^']?T3Q7H.B>*/#6JV&N^'/$FD:;K_A_6]+N8KW3-9T36+.'4=*U73KR!
MGAN[#4+"Y@N[.YA=HI[>:.6-F1P3_.1_Q#OZ;_T=K??^&/M__GM5]G_!3_@G
M9^UQ^SQX-B^'OPD_X*3^*_#_ (+M;F6YT[P]JW[.'@/QQ8Z,9SOFM?#_ /PG
MOC3Q/-X>TR6=I;R72-$ET_2GU"XN]1:S-]>75Q-Z>/K87%JE[/$1C*FY:3IU
MDFI\E]8TY--<O;77ROP82G7P[GST9.,U'6,Z3:<;VT=1*SYG?7HC]?Z_FQ_X
M+7_L!7.I&[_;,^#WAR]O;V&WBC_:(T;3[M[IAINF6-AIF@_%+3=$D1IHX=+L
M+./1?B"-(N)((-/AT/Q>^A6L%E\0?%,G])U9FM:+H_B31]6\.^(M)TS7O#^O
M:9?Z+KNA:U86NJ:/K6CZI:RV.IZ3JVF7T4]EJ.F:C93SV=_87D$UK>6LTMO<
M120R.A\W#5Y8:K&K'6VDH])0=N:+^Y-=I).SL=U:E&M3<)==8OK&2V:_)]TV
MKJY_&#_P2P_X*(0_L:>.]5\"?$TZE>_L_?$[5+&Y\1W-C]OO[SX9^*XXH].A
M^(6F:%;>?_:NF7=@EIIGC[3-,LV\1W^C:7HFJZ(=5U#PK:>$_$O]F_AWQ)X=
M\8:'I?B?PEKVB^*/#6N6<6HZ)XA\.ZI8ZWH>L:?.-T%]I>K:9/=6&H6<R\Q7
M-I<302#E'85_/MXZ_P"#?7P'KOC/Q3K?@?\ :(U/P%X0U?7=3U+PWX(F^&$G
MBT^$M'O;N6XLO#L?B74?B?9:EKEMH\,BV%IJ.IP'4[FU@A?4;B\O3/=S^F?!
MG_@C]\<_V>;N"Y^"W_!1?XE_#ZVBU?\ M^;0-$^%SMX.U36/LD=B;_Q!X&O_
M (N7G@WQ+,UG#!;,/$&A:G&T5O;*R$6T'E]^+E@<3+VM.O[*JTN=2I57&3LD
MKN,7RR2T;CS)V^;Y,.L517LYTN>"?NM5*=XJ^MKR5UU2?*U??HOW7HKF_!NE
M^(=$\(>%=%\6^*&\;^*](\-Z'I?B;QH^C6'AQO%_B&PTNUM-:\4-X>TIFTO0
M6U_4HKG5CHVFLUAI9NS8V;&W@C-=)7DO=ZW\U>S\]4G]Z3\CT%MM;R=KKR=F
MU]S:\PHHHH **** "BBOF_\ :#^&/[07Q'_X1'_A1/[3\_[-_P#8W]O_ /"5
M>3\&O /Q<_X3/^T?[%_L/=_PG$T/_"/_ /"._8=8V_V7N_M;^W3]MQ_9MIFH
MI2DDY1@GO*2DXK3KR1G+7;2+U>NEV*3:3:BY-?9CRIO7IS2C'3?5K3:[T/PB
M_P"#A_5])GU;]DS0(=4TZ;7=-T[XVZOJ.BQ7MM)JVGZ3KES\*K+1=4O=.24W
MEKIVKWGA[7[32[V>&.VU"YT/5X+26:73;U(/'O\ @W\\1BU_:5^,WA(V@<ZY
M\#I?$(OS<[/LY\+^/?!^G?8A:>0WGF^'BXW'GBYB^RC33'Y%P+HR6OU]\3/^
M"&?C7XS>+]3\??%7]NKQAX]\8:N[M>:[XE^$7]I7:PF>>XBT^Q27XN?9]*T:
MR>YF33-#TN&ST?2;=A::98VEJD<*YG@C_@@SXB^&GBG2/''P\_;@\7^"/&.@
MRW$VC>)_"OPFGT+7=,>[L[C3KT6FIZ;\8+>[ABOM-O+S3;^!9?)OM.O+NPNX
MYK2YGAD]I5\&L#]4>(7-RM<_LJUN9S]IMR)V4G;O97L]GYCI8EXKZPJ+2YD^
M7VE._*HJ#^U:[2_X/4_HCHKY+^ WP=_:C^'OB_4M:^-O[8US^T+X4NO#=YI>
MG^"YO@!\,OA4NF>(9M4T>[M/% \0^"[B75+QK+3;+5M)&C7"BPN!K1OI6%QI
MUJ#]:5XLHJ+LIQFK+WHJ:7I[\82NNONV[-GI1;DKN,H/M)Q;]?<E)?C?R"BB
MBI*"BBB@ HHHH **** "BBB@ HHHH *_C5U3_D):C_U_7?\ Z425_957\:NJ
M?\A+4?\ K^N__2B2OZM^C!_$XV_P<._^E9X?P?\ 3<_A>&G_ %\XO_\ 2>&"
MC1117]9G\#A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% ']<WP-_P"2*?![_LEOP^_]1/2*]2KRWX&_\D4^#W_9+?A]
M_P"HGI%>I5_EAG'_ "-LT_[&.-_]2:I_NAP]_P B#(_^Q/EG_J%0"BBBO./8
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV_\ !4S_ *%G]@'_ ,+G]HK_ .=Y7W]15>U7_/JC_P" R_\ D_ZN_*R]F_\
MGY4^]>7]WR_%]SX!^V_\%3/^A9_8!_\ "Y_:*_\ G>4?;?\ @J9_T+/[ /\
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M ,+G]HK_ .=Y1]M_X*F?]"S^P#_X7/[17_SO*^_J*/:K_GU1_P# 9?\ R?\
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M .?E3[UY?W?+\7W/@'[;_P %3/\ H6?V ?\ PN?VBO\ YWE'VW_@J9_T+/[
M/_A<_M%?_.\K[^HH]JO^?5'_ ,!E_P#)_P!7?E8]F_\ GY4^]>7]WR_%]SX!
M^V_\%3/^A9_8!_\ "Y_:*_\ G>4?;?\ @J9_T+/[ /\ X7/[17_SO*^_J*/:
MK_GU1_\  9?_ "?]7?E8]F_^?E3[UY?W?+\7W/@'[;_P5,_Z%G]@'_PN?VBO
M_G>4?;?^"IG_ $+/[ /_ (7/[17_ ,[ROOZBCVJ_Y]4?_ 9?_)_U=^5CV;_Y
M^5/O7E_=\OQ?<^ ?MO\ P5,_Z%G]@'_PN?VBO_G>4?;?^"IG_0L_L _^%S^T
M5_\ .\K[^HH]JO\ GU1_\!E_\G_5WY6/9O\ Y^5/O7E_=\OQ?<^ ?MO_  5,
M_P"A9_8!_P#"Y_:*_P#G>4?;?^"IG_0L_L _^%S^T5_\[ROOZBCVJ_Y]4?\
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M]JO^?5'_ ,!E_P#)_P!7?E8]F_\ GY4^]>7]WR_%]SX!^V_\%3/^A9_8!_\
M"Y_:*_\ G>4?;?\ @J9_T+/[ /\ X7/[17_SO*^_J*/:K_GU1_\  9?_ "?]
M7?E8]F_^?E3[UY?W?+\7W/@'[;_P5,_Z%G]@'_PN?VBO_G>4?;?^"IG_ $+/
M[ /_ (7/[17_ ,[ROOZBCVJ_Y]4?_ 9?_)_U=^5CV;_Y^5/O7E_=\OQ?<^ ?
MMO\ P5,_Z%G]@'_PN?VBO_G>4?;?^"IG_0L_L _^%S^T5_\ .\K[^HH]JO\
MGU1_\!E_\G_5WY6/9O\ Y^5/O7E_=\OQ?<^ ?MO_  5,_P"A9_8!_P#"Y_:*
M_P#G>4?;?^"IG_0L_L _^%S^T5_\[ROOZBCVJ_Y]4?\ P&7_ ,G_ %=^5CV;
M_P"?E3[UY?W?+\7W/@'[;_P5,_Z%G]@'_P +G]HK_P"=Y1]M_P""IG_0L_L
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M_P!7?E8]F_\ GY4^]>7]WR_%]SX!^V_\%3/^A9_8!_\ "Y_:*_\ G>4?;?\
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M/[17_P [ROOZBCVJ_P"?5'_P&7_R?]7?E8]F_P#GY4^]>7]WR_%]SX!^V_\
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M%HTNH+</81:K)X:^)^IIITE\EI=O9I=F%KE;6X:$.()2OI'_  \H_P"K!/\
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M8)[R_OKN:&UM+6&6XN)8XHW<?&G_  3N_::?]J_]E#X;?$O5KV*[\>Z5;2^
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M?^'YM6DLIM1ET35/!D>N7RZ!;W=K:W_BK2_#%]<>9)IL*-\N_P#!'/\ :/\
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M/Q-INI?VLMQ8Z7K5]I]Q?>&_^$B\,M>VFE7\B67B"\AEM+BUGGA?[!K\H?V
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M=T8J"\DVZCCHW>TIR2=]MM-#JI.,H^TBK>T?._-V44^GV8KH%?FC_P %@_\
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M=/:[4GZ._4****\\[ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNI9MEV-3^'OC#2=)L+"TB.%G2ZL?B+K-Y<@$RQKI<3JIC\YD_K"K^0#]H_\
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MM^,M=6"_WO#_ /7Q?J<^+_W>K_A_5'9?\$+?^3'Y/^RR^/\ _P!-WA6OUO\
M&'@_PM\0/"^N^"O&V@:5XI\)^)M.N-)U_P /ZW9Q7^EZKIUTNV:VN[6=61U/
MRO&X"RP3)'/ \<T4<B_C_P#\$(M7TV__ &+-9TZTNXIK[1/C;XVMM5M1N6:S
MEO-!\&ZC:>8CJI:*XL[J*2&XBWP.XG@64W%K<Q0_M)1C+K%UWJFJLFGLUK=-
M?FF/#V>'I;->SBGU6UFOT9\V_L@?!WQ-^S_^S1\'O@UXROM"U/Q1\/O"B:%K
M-_X9NM0O-!N;M=0OKLR:9=:KIFBZA-;>7=1J'N]+LI=X<>3M"LWTE7Y,?&?]
ML_P]\=_VF_@I^Q)^S3X[76KG6O'>E^-/V@OBO\/_ !'X@CTWPG\._A@8/B-J
M_P -O#WC'P)>V$PUOXBIH4?@KQ+XCTKQ+#IOA>/53X+OX]1UOQ'JEKX7_6>L
MZT)Q:G47+.MS5.5JS492=I-=%)\UD];)/:2+IRBTXPUC3M3O>ZO%*ZOUY4TF
M^]UNF%?AU_P7Z_Y,Z^&O_9R_@[_U5OQEK]Q:_#?_ (+]R1C]C[X9Q&1!*_[2
MGA&1(BRB1XXOA?\ &!99%0G<R1M-$LC %4:6,,074'3!?[WA_P#KXOU,\7_N
M]7_#^J.,_P""1O[+7[-WQM_8:DO/BQ\"_A7X[UG7O&WQ*\-7_BG7O!&@7'C9
M-'FCLK)(-+\<QV,7C#0KFQ@NIFTC4M#US3M3T2Y9+[1[RQO8HKA/S#\$>)?B
MY_P1E_;IO/"?BS5=;\6_"G58].F\8:?X7$5A8?&+X/ZQ_:T'A;QG8:%KVZRM
MO&G@G4WU*XL[4:C9O9>*]#\6^ K+QV?!_B+6=<U?]E/^"$&O_P!L?L3ZUIWV
M3[-_PBGQU\=:!YWG^=]O^T^&O 7BC[7Y?DQ?9=G_  DGV'R-]SN^Q?:O.7[3
M]G@^J/\ @HK^Q1H_[:_P)N?"MG+9:/\ %;P--?>*_A)XFN;*SE$>O?86BO\
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MPU5-)-WNDW=\OJEJ^UTM[VOU^:/_  6#_P"4='[1'_=)/_5Z?#*OTNK\T?\
M@L'_ ,HZ/VB/^Z2?^KT^&5&%_P!YP_\ U_H_^G(A7_@5O^O53_TB1^0W_!"#
MX+?!SXO_ /#5'_"V?A-\,_BC_P (]_PH_P#L#_A8G@3PMXV_L/\ M;_A;_\
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MI6,Z-6'*YTY1YXJ4;K>+V>GJM]=32-2G+F49Q?*^65GL^Q^F]%%%9EA1110
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M\="_S444X5)TW>G.<'WA)Q?WQ:?5_>$H0FK3C&2[2BI+\4^R^XE^'G_!-_\
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1V27^T/HO^?=)_FV_5M[L_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>img214770500_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img214770500_0.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" A\%* # 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***\]^(OQ;^%
MGPATJ+7/BK\1_ WPXTB?[0+74/''BK1/"]M>R6HB:>#3WUF]L_[0N4\^!?LM
MD)[EI+BWB2)I)XE=I-M))MO9)7;]$A-I*[:26[;LE\V>A45^3'Q6_P""U'[#
M7PW^TVWA_P 6>+_B_JMOOC-E\-O"%Z;-;D9"(VO>-)?!^B7-L24>6\T>]U>-
M(BWDI<7"&VK\T?BM_P '!7Q'U'[3:?!3X">$/"L7SQ0:W\2?$.K>,[R5&R!=
M+H7AU/!EGIURBM^Z@FUG7;994668W$3-:CKIX#%U+6HRBGUG:"MZ2LW\DSGG
MB\/"]ZBDUTA>7XJZ^]K[S^I6LS6-:T;P[IMSK'B#5M,T+2+/R?M>JZQ?VNF:
M;:_:)XK6W^TWU[+!:P>?=3PVT/FRKYL\T4*;I)$4_P ,_P 3?^"JO[>/Q1>:
M/4/CYXA\'Z=)$\,.E_#*QTCX>):)-#917!AUGPS8V7BJ:662R6Z2>^\07DUC
M-<WJ:9)8VEU);'X<\7>._&_Q U-]:\>>,O%7C;6));J>35O%WB'5_$FIO-?7
M#7=[,]_K-Y>W32WET[W-U(TI>XN'::4O(Q8]M/)ZC_B5H1\H1<WZ7?(D_O7J
M<TLQ@O@IRE_B:C^7-^A_>9\0O^"@7[%7PO2Y_P"$N_:8^$HN+*74(+W3/"_B
M>V\?ZW8W6E316]_9WN@^ 5\3:U9WT,\PA6QN;"*[GDBNTMX96LKP0?'WCC_@
MN-^PMX3EDCT'4OBK\342YMH%G\#_  \DL(IHI[,W4M[&OQ)U?X>SBVLYP-.N
M4EABO&O&#VEI=:?NOU_C*HKJAE&'5N>=6;ZZQC%_)1;_ /)MGWU,)9C6?PQI
MQ7HY/[[I?@?U#>*?^#ACP1:30KX*_9@\5>(+=I;P7$OBGXGZ1X/FBA1XA820
MP:3X-\<)<2W*-.UY"]S;)8O'$D,^H"9Y+?YD\1?\' G[2ES]C_X1/X,? W1-
MGVC^T/\ A(HO'OBC[3N\C[+]C_LWQCX0^P^3MN?M'G_VC]I\V#R_LGV>3[3^
M"E%=$<NP<?\ ERF^\I3E^#E;\#%XS$O_ )>->D8K\4K_ (_AH?KAXE_X+;_M
MYZ[%JD>E^+?A[X+>_NFN+2?PU\-M!NI=$B:\6Z%EI8\8_P#"60RVJ0*=.5]:
MAU>\-F[.UVVH!+]/$O$/_!5'_@H!XGFMY]2_:4\5VSVL3PQ+X>\/^ _",+([
M[R;BV\*>%-%M[R4'A)[N*>:-/W:2*GRU^?E%;1PN&CM0H^OLXM_>TW^)FZ]=
M[U:G_@<DON32/J[7/V[?VTO$-^VHW_[5?[0%O<-%'"8]#^*WC/PQ8!(@0I72
MO#>KZ3IB2D$^9.MFLTQP9I'(!'GOB']I;]HWQ=-;W/BOX_\ QL\3W%G$\%I/
MXA^*OCO6IK6&1_,>&WEU+7KEX(G?YWCB949_F()YKQ.BM%2I1VITU;:T(JWW
M(ASF]YR?763>O?<]+_X71\8O^BL?$O\ \+OQ3_\ +6N>\0^._&_BV&WMO%?C
M+Q5XFM[25I[2#Q#XAU?6H;69T\MYK>+4KRY2&5T^1I(U5V3Y22.*Y6BFHQ6J
MC%/NDO\ (7-)Z-MKM=^7^2^Y!7>Z;\5?BAHMA:Z5H_Q(\>Z3IEC$(++3M-\8
M>(;"PLX021#:V=KJ,5O;Q L2(XHT0$D@9)K@J*;2>Z3]4G^8)M;-KT=CTO\
MX71\8O\ HK'Q+_\ "[\4_P#RUKT>#]LO]K^VAAMK;]JS]I*WM[>*."""#XY_
M$^*&"&)!'%##%'XH5(XHT54CC151$4*H  %?-M%2Z<'O"#]8I_H-3FMI27I)
M_P"?DON/MW2_^"DG[=>D0Z=!:?M/?%&5-+BM(;9M4U6UUN:5+)(TA.HW&M6-
M_<:O*XB4W<VK2WLU^YDDOY+EY96?VW0/^"S/_!0C1KR6ZU'XPZ'XL@DMG@33
MM?\ A9\,+:SAE:6&1;V)_"WA/PUJ!N8TB>!$FOI;,Q7,QDM))UMYH/RUHK-X
M;#RWH47_ -PX7^^URU7K1VJU%_V_*WW7L?N+X/\ ^"^'[6^B_P!G6WBWP#\#
MO&ME;?:_[0N_^$?\7^'/$>I^=]JDM/\ B8:9XTE\/V?V.:6VB_<>$F^T6%IY
M$F+V>34Q])>"_P#@X8G#6MM\1/V8(G1I;HWVL^"_B>\310^3(UE':^&=<\&S
M"XE-PL4%U--XMMD$,DEU% SP+9W'\U%%92R_!RO>A%?X7*/X1DE^!I'%XB.U
M5O\ Q*,OS3?3O?=[L_L!\&_\%Z/V/=>2*'Q5X1^-O@6]%BUS=2WOA?PUK^B"
M[6:*,:=8WV@>,+O6+J62.5KB.XN_#FF6OEV\Z2R13?9HKGZ]\"_\%1/V"?B$
M\$.C_M(^"](N)I8+=H?'5IXD^'*6]Q/#YWESWWCO1/#VEB*$ Q3W\5]+ID<R
M^6+UBR;_ .$&BN>>4X:5^656#Z6DFONE%M_^!+<UCF%=;J$O6+3?W-+\/D?Z
M1/A#XA> ?B%9G4? /CCPAXXT];:PO3?>$/$NB^);,6>JQ23Z7=FZT6]O8!;:
ME!#--83E_*O(HI)+=Y$1B.OK_-5TS5-3T6_M=5T?4;[2=3L91-9:CIEW<6%_
M:3 %1-:WEK)%<6\H5F DBD1P"1G!-?5WPW_;[_;/^$_V=/!7[2?Q5M[.T^RB
MSTGQ%XDF\=:#9QV?VGR8+/P]X[3Q)H=I:DW<S7%K;Z?';7C"!KN*=K6U,/+/
M)I+^'7B_*<''UUBY?^D^7F;QS*/VZ37G&2E^#4?S/[_**_D'^&W_  7G_:R\
M+O;VWQ"\&_"7XH:<DOF75S)HVK^#/%$Z>3:PB"#5- U=_#=M%N@GN27\&7,Q
MN;R;$RVD5M:0_H;\+/\ @OW^SUXC\JV^+/PC^)GPPO9M_P#I7AV]T3XE^'+;
MR_[0D_TS4/\ BBO$"^=#!IL=O]B\)W^;[4)X+G[+96']I7?'4RW%PU]GSKO"
M49?^2W4O_)3IAC<//[?*^TTU^.L?Q/WKHKXT^&'_  4,_8H^,,R6O@;]H_X<
M2W\TIAMM+\5:A>?#G6+V8.4\G3]'^(MCX4U/4)2062.QM+AWB5ID#0J7'V77
M'.$Z;M.$H/M.+B_N:3.B,HS5XRC)=XM-?>FPHHHJ2@HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKP3]J7XNQ_ 7
M]G3XS_%_S/+O/ GP]\1ZQHOS6R^=XG:QDL?"EIOO+6^M4^V^);O2K/?<6-]"
MGG[I+&\4&VEJ,7.48QUE*2BEW<G9?BQ-J*<GM%-OT2NS^&S]N+XE2?%W]KW]
MHKQ\9;J:UU3XJ^*=-TB2\FN9KEO#WA6^;PEX:$GVMY)K?9X?T/3$2Q#>1IT:
MII]JJ6UM"B_*M%%?:0BH0C!;0C&*](I)?@CYF3<I2D]Y-M^K=V%%%%4(_<7_
M (("_P#)XOQ*_P"S:/&/_JTO@U7]>=?R&?\ ! 7_ )/%^)7_ &;1XQ_]6E\&
MJ_KSKYC-/][E_@I_^DGMX#_=_P#M^7Z!1117G':%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]7_G]3_\!E_7?^GHO[1A_P ^Y_>OZ[_T]/\ 0AHK_/>_X;2_;%_Z.R_:7_\
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M,OZ[_P!/0_M&'_/N?WK^N_\ 3T_T(:*_SWO^&TOVQ?\ H[+]I?\ \/O\4O\
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M:JC^QZO_ #^I_P#@,OZ[_P!/0_M&'_/N?WK^N_\ 3T_T(:*_SWO^&TOVQ?\
MH[+]I?\ \/O\4O\ YJJ/^&TOVQ?^CLOVE_\ P^_Q2_\ FJH_L>K_ ,_J?_@,
MOZ[_ -/0_M&'_/N?WK^N_P#3T_T(:*_SWO\ AM+]L7_H[+]I?_P^_P 4O_FJ
MH_X;2_;%_P"CLOVE_P#P^_Q2_P#FJH_L>K_S^I_^ R_KO_3T/[1A_P ^Y_>O
MZ[_T]/\ 0AHK_/>_X;2_;%_Z.R_:7_\ #[_%+_YJJ/\ AM+]L7_H[+]I?_P^
M_P 4O_FJH_L>K_S^I_\ @,OZ[_T]#^T8?\^Y_>OZ[_T]/]"&BO\ />_X;2_;
M%_Z.R_:7_P##[_%+_P":JC_AM+]L7_H[+]I?_P /O\4O_FJH_L>K_P _J?\
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M(:*_SWO^&TOVQ?\ H[+]I?\ \/O\4O\ YJJ/^&TOVQ?^CLOVE_\ P^_Q2_\
MFJH_L>K_ ,_J?_@,OZ[_ -/0_M&'_/N?WK^N_P#3T_T(:*_SWO\ AM+]L7_H
M[+]I?_P^_P 4O_FJH_X;2_;%_P"CLOVE_P#P^_Q2_P#FJH_L>K_S^I_^ R_K
MO_3T/[1A_P ^Y_>OZ[_T]/\ 0AHK_/>_X;2_;%_Z.R_:7_\ #[_%+_YJJ/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?Y^?Y]F'UK#_ //V'WO_ "\_S[,_<6BOPZ_X?]?L=?\ 1-?VE_\ PCOA;_\
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M?Y^?Y]F'UK#_ //V'WO_ "\_S[,_<6BOPZ_X?]?L=?\ 1-?VE_\ PCOA;_\
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M?Y^?Y]F'UK#_ //V'WO_ "\_S[,_<6BOPZ_X?]?L=?\ 1-?VE_\ PCOA;_\
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M['7_ $37]I?_ ,([X6__ #Y:/J.+_P"?%3[E_GY_GV8?6L/_ ,_8?>_\O/\
M/LS]Q:*_#K_A_P!?L=?]$U_:7_\ ".^%O_SY:/\ A_U^QU_T37]I?_PCOA;_
M //EH^HXO_GQ4^Y?Y^?Y]F'UK#_\_8?>_P#+S_/LS]Q:*_#K_A_U^QU_T37]
MI?\ \([X6_\ SY:/^'_7['7_ $37]I?_ ,([X6__ #Y:/J.+_P"?%3[E_GY_
MGV8?6L/_ ,_8?>_\O/\ /LS]Q:*_#K_A_P!?L=?]$U_:7_\ ".^%O_SY:/\
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M['7_ $37]I?_ ,([X6__ #Y:/J.+_P"?%3[E_GY_GV8?6L/_ ,_8?>_\O/\
M/LS]Q:*_#K_A_P!?L=?]$U_:7_\ ".^%O_SY:/\ A_U^QU_T37]I?_PCOA;_
M //EH^HXO_GQ4^Y?Y^?Y]F'UK#_\_8?>_P#+S_/LS]Q:*_#K_A_U^QU_T37]
MI?\ \([X6_\ SY:/^'_7['7_ $37]I?_ ,([X6__ #Y:/J.+_P"?%3[E_GY_
MGV8?6L/_ ,_8?>_\O/\ /LS]Q:*_#K_A_P!?L=?]$U_:7_\ ".^%O_SY:/\
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M['7_ $37]I?_ ,([X6__ #Y:/J.+_P"?%3[E_GY_GV8?6L/_ ,_8?>_\O/\
M/LS]Q:*_#K_A_P!?L=?]$U_:7_\ ".^%O_SY:/\ A_U^QU_T37]I?_PCOA;_
M //EH^HXO_GQ4^Y?Y^?Y]F'UK#_\_8?>_P#+S_/LS]Q:*_#K_A_U^QU_T37]
MI?\ \([X6_\ SY:/^'_7['7_ $37]I?_ ,([X6__ #Y:/J.+_P"?%3[E_GY_
MGV8?6L/_ ,_8?>_\O/\ /LS]Q:*_#K_A_P!?L=?]$U_:7_\ ".^%O_SY:/\
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M['7_ $37]I?_ ,([X6__ #Y:/J.+_P"?%3[E_GY_GV8?6L/_ ,_8?>_\O/\
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MUK#_ //V'WO_ "\_S[,_<6BOPZ_X?]?L=?\ 1-?VE_\ PCOA;_\ /EH_X?\
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MUK#_ //V'WO_ "\_S[,_<6BOPZ_X?]?L=?\ 1-?VE_\ PCOA;_\ /EH_X?\
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MUK#_ //V'WO_ "\_S[,_<6BOPZ_X?]?L=?\ 1-?VE_\ PCOA;_\ /EH_X?\
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MUK#_ //V'WO_ "\_S[,_<6BOPZ_X?]?L=?\ 1-?VE_\ PCOA;_\ /EH_X?\
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MA3PSXGMUBC/[MQ=SVLQ?E(73YZ3PF*7_ ##UOE3F_P E_7R8_K%#_G]3_P#
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MW"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!_G)?&C_DL7Q8_[*7X[_\ 4IU6O-*]+^-'_)8OBQ_V4OQW
M_P"I3JM>:5]M#X(_X8_DCYB6[]7^844450@HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#^XK_@CY_RCH_9W_[JW_ZO3XFU^EU?FC_P1\_Y1T?L[_\ =6__
M %>GQ-K]+J^.Q7^\XC_K_6_].2/HZ'\"C_UZI_\ I$0HHHK U"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "OY5_\ @X._Y+'^SU_V3/Q/_P"I3'7]
M5%?RK_\ !P=_R6/]GK_LF?B?_P!2F.O0RO\ WRG_ (:G_I#.3'?[M/UA_P"E
MH_GOHHHKZ@\(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG7Q*_P"SE_&/_JK?@U7[BU\EC_\ >Z_^/_VU'T.&_P!WI?X$%%%%<AN%%%%
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MFNOS;"BBBNHP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M47&2WC)-->J=FCM34E>+37=--?>@HHHI#"BBB@ HHHH **** "BBB@ HHHH
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MP**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX>E_V[!1_P#2;%K$UUM6J?.3?YW/Z-O#O_!PSXRM?MG_  EO[+OAG6]_V?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!_<5_P1\_Y1T?L[_\ =6__
M %>GQ-K]+J_-'_@CY_RCH_9W_P"ZM_\ J]/B;7Z75\=BO]YQ'_7^M_Z<D?1T
M/X%'_KU3_P#2(A1116!J%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%?RK_P#!P=_R6/\ 9Z_[)GXG_P#4ICK^JBOY5_\ @X._Y+'^SU_V3/Q/_P"I
M3'7H97_OE/\ PU/_ $AG)CO]VGZP_P#2T?SWT445]0>$%%%% !1110 4444
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MFK-:-/=/LSZ%--)K5-73[IA1110,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ:+XR2V5[VUA^U2:$EL;B7[,LIN$DC3_ #WJ*X:F48>6M.4Z3[7YX_=*TO\
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MG3G3?+4A*$NTHN+_ !2NO/8[(SC-<T)1DN\6FOPV?EN%%%%04%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '^
M<E\:/^2Q?%C_ +*7X[_]2G5:\TKTOXT?\EB^+'_92_'?_J4ZK7FE?;0^"/\
MAC^2/F);OU?YA1115""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /[BO\
M@CY_RCH_9W_[JW_ZO3XFU^EU?FC_ ,$?/^4='[.__=6__5Z?$VOTNKX[%?[S
MB/\ K_6_].2/HZ'\"C_UZI_^D1"BBBL#4**** "BBB@ HHHH **** "BBB@
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M;O?\?;Z=^US_ ,_#V%K>_ K_ 'S:V]W?P?&#_<CN+N'3O[\T=ET@JEF>#?\
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MO+B\TGX6^#_#NJS7/F-*\DFM>'M)TO5V\Z1V>X0WWEW+$FX66OG;QI_P1_\
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MW:<)1?2ZT?H]G\F5J***U("BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBBBN0Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /\ .2^-'_)8OBQ_V4OQW_ZE.JUYI7I?QH_Y+%\6/^RE^.__ %*=5KS2
MOMH?!'_#'\D?,2W?J_S"BBBJ$%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M ?W%?\$?/^4='[.__=6__5Z?$VOTNK\T?^"/G_*.C]G?_NK?_J]/B;7Z75\=
MBO\ ><1_U_K?^G)'T=#^!1_Z]4__ $B(4445@:A1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_=^;84445T&(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWABXM/!MQ;2I-=)YD?Q&%REQ:>6UF;>XCNA_6WH'A[0/"FCV/A[POH>C^&]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 ?W%?\$?/^4='[.__ '5O_P!7I\3:
M_2ZOS1_X(^?\HZ/V=_\ NK?_ *O3XFU^EU?'8K_><1_U_K?^G)'T=#^!1_Z]
M4_\ TB(4445@:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P!NG%CJOLZ/(OBJWC_VZK<S_%+YGRK1117TQX@4444 %%%% !1110 4444
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M>,?UEN]E9;^'BL5*N^6-XTT]%UD_YI?HNGF]BBBBO0.0**** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_<5_P1\_Y
M1T?L[_\ =6__ %>GQ-K]+J_-'_@CY_RCH_9W_P"ZM_\ J]/B;7Z75\=BO]YQ
M'_7^M_Z<D?1T/X%'_KU3_P#2(A1116!J%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M  %<WFXI=3LP57V=9)_#4]Q^M_=?WZ>C9_8I1117RY[@4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% 'XY_\ !:K]IO\ X4M^RU/\*_#VL?8/'G[0=U<^#EBMC_IUO\-[
M)(9_B'=Y$JK#:ZQ:7.G>"[D3PSB[T_Q/JD=LB36[75I_&G7Z$?\ !3O]I_\
MX:F_:U\<^)=)G\WP#\/L_"OX<878MWX<\)ZCJ/V[Q ?EC,O_  E7B>]U[Q!8
MRW%O!?P:#?:+I5ZGFZ6,?GO7U> H>PP\$U:<_P!Y/NG)*T7_ (596Z.YX&+J
M^UK2:=XQ]V/HMW\W=^ENP4445VG,%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%?9?[ '[.Z?M0?M8?"?X6ZE8RW
MOA!M8D\5_$+;YRV\?@;PC VM:U;7D\$,[VL6OO;V?A2VGV*HU/7[")I[;S?M
M$4SG&G"4Y.T81<I/R2N_GV75E1BYRC&.KDU%>K=D?TR_\$;/V0+#X!?LZV/Q
M@\4:'%!\6_CU8V?B*ZO;R$G4] ^&KD77@KPS;&;)L(M8MV7QCK26RVTNH7&I
MZ-9ZPMQ)X8TL6G[$5%!!#;0PVUM#%;V]O%'!!!!&D4,$,2".*&&*,*D<4:*J
M1QHJHB*%4  "I:^.K595ZLZL_BF[^BV27DDDEZ'T5*FJ5.-..T4EZOJ_5N[?
MJ%%%%9&@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR%=Z::3333U33NFNZ:W.-IK1JS[,****8!1110 4444 %%%% !1110 4444
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M-/<HD5Q?>&_$%E):>(/"^IS11K ^J>'-4TO46@W0&Z\EW1OP!_:L_P""#/\
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M7Q8_[*7X[_\ 4IU6O-*^VA\$?\,?R1\Q+=^K_,****H04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!_<5_P1\_Y1T?L[_]U;_]7I\3:_2ZOS1_X(^?\HZ/
MV=_^ZM_^KT^)M?I=7QV*_P!YQ'_7^M_Z<D?1T/X%'_KU3_\ 2(A1116!J%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNH;07HU>7_;QX>.J^TK.*?NT_=79R^T_O]WY!1117HG&%%%% !1110 4444
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MBBBO/.P**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0?S7,OOE%(Y,;'FP\WUBXR7_ ($D_P &S^6JBBBOJ3P@HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH _2[_@CY_P I%_V=_P#NK?\
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MC1_R6+XL?]E+\=_^I3JM>:5]M#X(_P"&/Y(^8EN_5_F%%%%4(**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH _N*_P""/G_*.C]G?_NK?_J]/B;7Z75^:/\
MP1\_Y1T?L[_]U;_]7I\3:_2ZOCL5_O.(_P"O];_TY(^CH?P*/_7JG_Z1$***
M*P-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /G_P#:M^')^+G[,_Q[
M^&T5I+?7_B_X2^.])T2W@COYYCXD;P[?S^&)H;73'2^O9;7Q#!IEU'I\'F?V
M@\(LI(+F*>2WE_SQZ_TN*_SJOVB/ J_##X_?&[X<1016UOX$^+7Q$\)6<5O!
M-;6OV#0/%NK:98264%Q^^2QGLK:">QWEB]I)"X=U8.?<R:?\>G_@FOQC+\HG
MEYE'^%+_ !Q;_P# 6O\ VX\<HHHKW#RPHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *]9^!'Q@\2? #XQ_#CX
MS^$DBGUWX=>*],\1V]C<.8K75[2VE\O5] O95CEDAL?$.CS7^B7T\"_:H+34
M)I;5XKE(I$\FHI2BI1<9*\9)Q:>S35FGZH:;333LTTT^S6J9_H__  R^(OA7
MXN_#SP5\4/ ]_P#VEX1\?>&='\5^'[M@B3G3M:LH;V&"^@227['J=EYK66JZ
M?)(9].U*WNK"Y"W%O*B]S7\_'_!!W]J"Y\9_#;QK^R]XFOOM&K_"G?XV^'YG
MN(VN9? 'B'5!#X@TJ*%Y/M#6WACQ=?V]T+@(\4<?C*UL2T,=K:QR?T#U\?B:
M+P]:I2?V7[K[Q:4HO[FK^=T?14:JK4H5%U7O+M):27I>]NZL%%%%8&H4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /W*_X('>"TUO\
M:Q^(7C*ZM8I[7P/\$M;2RG-U-#-9>(/$_BSPCIUE/';0R1I=Q2Z!:^*;687*
MS6\#W$$HA^U"UG@_KNK^:S_@WF\(;;/]J/Q[<6=JWGW/PK\(:1?^9F\A^R1>
M.=9\1V?E#'EVMU]M\+3>8V[SI;3:NWR'W_TIU\MF<N;&5%NHJG%?^ 1D_P 9
M/MKYGNX&/+AX/^9RE_Y,TOP2^04445P'6%%%% !1110 4444 %%%% !1110
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M"":YFAMK:&6XN+B6.""""-Y9IYI7$<4,,489Y)9'94CC16=W8*H)(%?VH_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ K\E/\ @MGX-7Q1^P3XSUMHK&0_#GQ]\-?&2/=M,MQ
MU]XCB^'IETL112(]\4\=O!(MR\$(TR;4765KA(()OUKKXY_X*$^%_P#A+OV(
M/VI=)WVR?9/@OXU\4;KN'SXC_P (1I<OC38B8.VYD_L#R[*;'^C7C07&1Y61
MOAI<F(H2[5:=_3F5_P +F5:/-1JQ[TYI>O*[?B?P&T445]B?.!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^EW_!'S_E(O\ L[_]
MU;_]47\3:_N*K^'7_@CY_P I%_V=_P#NK?\ ZHOXFU_<57SF<?[S3_Z\1_\
M3E4]G+OX$_\ K[+_ -(@%%%%>4=X4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^XK_@
MCY_RCH_9W_[JW_ZO3XFU^EU?FC_P1\_Y1T?L[_\ =6__ %>GQ-K]+J^.Q7^\
MXC_K_6_].2/HZ'\"C_UZI_\ I$0HHHK U"BBB@ HHHH **** "BBB@ HHHH
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M=O\ NG7Y._\ !%/0[_2?V!/A_?WBQ+;^)_&GQ,US2C'()'>PM_%^H>&I&G4
M&&4:IX>U)!&V285AFSB4 ?K%7R.-ES8O$/\ Z>2C_P" ^[^A]#AE:A27_3N+
M^]7_ %"BBBN4W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*^3;;;;;;;NV]6V]VWU;/?2222T25DNR04444AA1110 4444 %%%% !1110
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MJ<;*:TJ0OK&7SM>+W3VW6Z9X.(H2H3Y7K%ZPE_,O\ULU^C1%111748!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?U%_\
M!&O_ (*+2>*[/2/V0_CAXA\SQ+I=L;;X(>+];O[F:Z\1Z5:Q-(/AIJ-U/#(O
M]IZ%:0S2^$+J\OU%_HT:>%K:*.ZTK1X-4_ETJ]I>J:GHFIZ=K6BZC?:1K&D7
MUIJFDZMI=W<6&IZ7J=A<1W=AJ.G7]I)%=65]97445S:7=M+%<6UQ%'-#(DB*
MPY\3AX8FDZ<]'O"5KN$NC7ET:ZKY-:T:TJ%13CMM*/24;ZKU[/H_N?\ I545
M^8?_  3"_;RTS]L?X/Q:+XMOK&T^/7PUL;;3_B!I*O;VK^)],CD^R:5\0M$L
M'O[J]N+'4H39VWBB58H+?3/%LMQ"EM9Z;J>A+<?IY7R=6E.C4E3J*THNS7XI
MI]4U9I]4SZ"G.-2$9Q=XR5_3NGYIZ/S"BBBLRPHHHH **** /\Y+XT?\EB^+
M'_92_'?_ *E.JUYI7I?QH_Y+%\6/^RE^._\ U*=5KS2OMH?!'_#'\D?,2W?J
M_P PHHHJA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ']Q7_!'S_E'1^SO
M_P!U;_\ 5Z?$VOTNK\T?^"/G_*.C]G?_ +JW_P"KT^)M?I=7QV*_WG$?]?ZW
M_IR1]'0_@4?^O5/_ -(B%%%%8&H4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG$,4G]ZL$$-M##;6T,5O;V\4<$$$$:10P0Q((XH88HPJ1Q1HJI'&BJB(H50
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M4WKOK!/4^:J*U2:[3DONDT%%%%:D!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'Z7?\$?/^4B_[.__ '5O_P!47\3:_N*K^'7_ ((^?\I%
M_P!G?_NK?_JB_B;7]Q5?.9Q_O-/_ *\1_P#3E4]G+OX$_P#K[+_TB 4445Y1
MWA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7\P7_!9W_@G@F@W6M?MC_!
M?1(DT?5+Y;CX\>$M)M)O-L=;U2[O)KCXO6\8G>%K'6;V>TL?&]M9VUO):ZQ/
M;^+98KV/5O%.I:5_3[5'5-+TS6],U'1=:TZQU?1]7L;O2]6TG5+2WO\ 3-4T
MR_MY+2_T[4;"[CEM;VQO;666VN[2YBEM[FWEDAFC>-V4]&&Q$\-552&JVG'I
M.+>J?9]4^C2>JNGC7HQKP<):/>,NL7W_ $:ZKY'^:K17Z0?\%+_V&[_]C#XV
M20^&[2^G^"'Q&EU#6?A7J]U<"\DT]+8VTNN>!M0N)+FXOY+[PE+J%I#9WVI8
MFUG1+G3KXW%WJ":NMK^;]?6TZD*L(U(.\9JZ?7S371IZ-=&?/SA*G.4)*THN
MS_1KR:U3ZIIA1115DA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH _N*_X(^?\HZ/V=_\ NK?_ *O3XFU^EU?FC_P1\_Y1
MT?L[_P#=6_\ U>GQ-K]+J^.Q7^\XC_K_ %O_ $Y(^CH?P*/_ %ZI_P#I$0HH
MHK U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_#K_ (+]?\F=?#7_
M +.7\'?^JM^,M?N+7Y ?\%PH89?V%-8DEABD>V^*/PZFMWDC1WMYFNM2MVFA
M9@3%*UO<3P&2,JYAFFB)V2.K=.#=L5A_^OL%][M^IAB5?#U5_<;^[7]#^,:B
MBBOKSYX**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH _2G_@E1^U+#^S!^U?X7N?$-Y%9_#GXK11
M?#'QY/<,B6^E0ZU?VTGAOQ-)*^%MXM \216#ZE<NP2#P_>:VVUI#&5_N/K_-
M'K^[3_@F5^U+-^U?^RAX+\6Z_>RWGQ&\#2O\,?B=/<,[W&I>*?#%AI\EMXFD
MEDVM=2^+O#=_H?B+4KF*&&S3Q#?ZYIEHICTPFO#S?#ZPQ$5O^[J>OV)/\8M^
M44>IE]7XJ+?]^'Y27Y-+_$S]!****\,]0**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ K^#S_@I/^TW_ ,-3?M8_$+QEI&L?VO\
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M2K $$5_I9U_)'_P6F_893X/_ !"7]I[X::-%;?#3XJ:PUOX]TG2[.9;;P?\
M$N[66ZGUB41A[>UT?QZ5GOE;]U%;^)XM3A;RQJ^EV]>UE>+L_JU1Z.[I-]'N
MX>CU<?.ZZI'F8_#W7MX+5:5$NJV4OEM+RL]+-GX1T445[QY04444 %%%% !1
M110 4444 %%%% '[B_\ ! 7_ )/%^)7_ &;1XQ_]6E\&J_KSK^0S_@@+_P G
MB_$K_LVCQC_ZM+X-5_7G7S&:?[W+_!3_ /23V\!_N_\ V_+] HHHKSCM"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _
MAG_X*Y:98:3_ ,%#_P!HRUTVUBL[>6^^'&IR10@A'O\ 6O@]\/=9U6Z())\V
M^U2_O+V<YP9KB0J%!"C\WZ_4'_@LEH^HZ9_P4-^-U[?6WD6WB'3/A3K&CR^=
M!)]LTZ#X2>"- EN=D,LDEOMU?0]4M/)ND@G;[+YZQ&VGMIIOR^K['"N^&P^M
M_P!Q2^_DC?\ '<^<KJU>MI;][4^[F=OP"BBBMS(**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH _2[_@CY_RD7_9W_[JW_ZHOXFU_<57\.O_
M  1\_P"4B_[._P#W5O\ ]47\3:_N*KYS./\ >:?_ %XC_P"G*I[.7?P)_P#7
MV7_I$ HHHKRCO"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YC_:_
M_9A\'_M>? ?Q?\&/%K16%QJ<2ZQX*\3FTAO+GP7X]TJ"Y_X1SQ/:Q2+O>*![
MFYTO6[6UFL[O5?"^JZ[HL&H6!U(W</\  O\ $;X?>+?A/X]\7_#3QWI4NB>,
M? OB'5/#'B/2Y7246VJ:1=R6EP;>YA9[>^L9VC%SIVHVDDUEJ5A-;7]C//:7
M,,S_ .D)7\Z__!<O]B]/$?AO3?VP/A_I,LGB'PK%9>&?C-96-K-<2:KX2/EV
MOACQO((7Q#+X2N!_8.MSFVG>ZT35=(N9[BQL?"LIN?5RO%>RJ>PF_P!W5?NM
M_9J.R7RG:W^*VVIY^.H<\/:Q7O07O=Y0_P X[^E^R1_+?1117T9XX4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_9%
M_P $;?VT_P#AH?X(M\%O&]_<W'Q<^!.F6&GO?ZA>?:[GQI\-Y939^&O$ FF;
M[7+J?AUEC\*>(DE6X CB\-ZQ+J-S>>(KJTT[]EJ_SQOV7?V@_%O[+GQU^'_Q
MK\'RRM=^$M80ZUI*L@M_$WA+45;3_%/AF\297@:+6-%N+NWMKB6-WTO4_L&L
MV1AU'3;.XA_T!?AS\0?"7Q8\!>$/B7X$U:+7/!WCKP]I?B?PYJD2/$;G2]7M
M([NW%Q;2A+BQOH!(;;4=-NXX;W3;^&YL+Z""[MIH4^9S+"^PK>T@K4ZMVDMH
MS5N:/DG?FCZM)6B>W@J_M:?))^_327^*.T7YM6L_D]V=I1117FG:%%%% '^<
ME\:/^2Q?%C_LI?CO_P!2G5:\TKTOXT?\EB^+'_92_'?_ *E.JUYI7VT/@C_A
MC^2/F);OU?YA1115""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /[BO^"/
MG_*.C]G?_NK?_J]/B;7Z75^:/_!'S_E'1^SO_P!U;_\ 5Z?$VOTNKX[%?[SB
M/^O];_TY(^CH?P*/_7JG_P"D1"BBBL#4**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOD74A*G.4);Q?WIZIKR::84445H0%%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /[BO^"/G_*.
MC]G?_NK?_J]/B;7Z75^:/_!'S_E'1^SO_P!U;_\ 5Z?$VOTNKX[%?[SB/^O]
M;_TY(^CH?P*/_7JG_P"D1"BBBL#4**** "BBB@ HHHH **** "BBB@ HHHH
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M9VOPH^,4%K:6EK D<%M:VT$:0V]O"B10Q(D<:*B@#F?^"$7[+]MX(^$/BO\
M:>\16./%GQ>N;KPCX*DGMY(Y=+^&?AG4U&J7%K-)'"Y_X3'QE8NU]$%N;5K/
MP7X<N[2Y5[J]@3K_ /@OU_R9U\-?^SE_!W_JK?C+7AUJ_M<SH4T_<HU%%><W
MK-_)I1_[=\STX4O9X&K-KWJL5+_MVZY5\[N7S\C^0RBBBO</,"BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS6R[I'\.M%%%?5'@A1110 4444 %%%% !1110!^XO_! 7_D\7XE?]FT>,?\
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MM_\ JB_B;7]Q5?PZ_P#!'S_E(O\ L[_]U;_]47\3:_N*KYS./]YI_P#7B/\
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MH04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!_<5_P1\_Y1T?L[_P#=6_\
MU>GQ-K]+J_-'_@CY_P HZ/V=_P#NK?\ ZO3XFU^EU?'8K_><1_U_K?\ IR1]
M'0_@4?\ KU3_ /2(A1116!J%%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^'7_@J
MQ^RG_P ,O?M4^)/^$?TW[%\,?BW]K^(_P^\B+R['3O[2O'_X2OPI;[0(HO\
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MVA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 ?Q@?\%OO^3[_ !!_V33X<_\ IMNZ_(:OUY_X+??\GW^(/^R:?#G_ --M
MW7Y#5]?@_P#=</\ ]>H?D?/8G_>*O^-A111728!1110 4444 %%%% !1110
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _N*_X(^?\
M*.C]G?\ [JW_ .KT^)M?I=7YH_\ !'S_ )1T?L[_ /=6_P#U>GQ-K]+J^.Q7
M^\XC_K_6_P#3DCZ.A_ H_P#7JG_Z1$****P-0HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "OS1_X+!_\HZ/VB/^Z2?^KT^&5?I=7YH_\%@_^4='[1'_
M '23_P!7I\,JWPO^\X?_ *_T?_3D3*O_  *W_7JI_P"D2/X=:***^Q/G HHH
MH **** "BBB@ HHHH _T;/@K_P D<^$W_9,_ ?\ ZBVE5Z97F?P5_P"2.?";
M_LF?@/\ ]1;2J],KXB6[]7^9]/'9>B_(_%;_ (+=?LOVWQ=_9JA^.&@V._QY
M^SW<OJURUM;R2W6L_#/Q#=V&G^+M/D6WC#2_\(Y>+I/C*"[O93:Z/HVE>+1;
MQK/K,KG^/"O]*76M&TKQ'HVK>'M=L+;5=#U[3+_1M9TN]B$UGJ6E:I:RV.HV
M%W"WRRVUY:3S6\\3<212.AX-?Y]G[7?[/FM_LN_M%?%#X+ZQ%*;7POXAN)_"
MFHNL@CUSP-K(&K>#=9BD=I4DENM N[*/4XHKF[73M;@U32);J:ZTZX:O>RBO
MS0GAY/6%YPO_ "-KF2_PR=_^WO(\K,*5I1K):2]V7^)+1OUCI_V[YGS;1117
MLGFA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_47
M_P $$_VH+G7/"GCW]E#Q/?>;/X(^T?$CX7&>XC\Q?#.MZDD/CGPU;0/)&4M=
M)\3W]EXGLDMX;F:XN?%_B6:[FMX+.SCD_HMK_.]_9F^._B3]FCXZ_#?XV>%S
M++>^"/$-O>ZCIL<IA37O#=VKZ=XH\.SOG8L6N:!=ZAIPE=6%K-/#>1CSK>)E
M_P!";PQXET'QIX:\/>,?"VJ6VM^&/%FAZ3XE\.:U9,S6>KZ#KMA;ZII&J6C.
MJ.UM?Z?=6]W SHC&*5"RJ20/FLTH>RK^UBO=K7>G2<;<]_\ %=2\VWV/:P%;
MGI.#=Y4[)?X'\/W6<?))=S<HHHKS#N"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4D[J233[IJZ?S1\ZTTVGHTVFO-;A1113$%%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<YA[M"?:4X/_ +>46O\ TEGI9=+WJL.\8R7_ &ZVG_Z4CZ]HHHKP3U@HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\J^.7PD\/?'GX/?$GX-
M^*CY6B?$?PAK7A:YOEM8+R?1[G4;21-+\06-M<D02ZGX=U5;+7=+$Q$:ZCIU
MJ[$!<UZK133<6I)V<6FGV:=T_DQ-)IIJZ:::[IZ-'^;1XN\+:WX&\5^)_!/B
M:RETWQ)X/\0ZUX6\0:=.DD<UAK?A_4KG2=5LIHYDBFCEM;^TN()$EBCD1XRK
MHC J.>K]@_\ @ME\!X_A-^V'>>/=(T_['X8^//AFP\=QO"MM'8IXSTPCPYXW
ML[>*)(YQ=7$]CI'BW5)K@3"YU#Q?--'=.6EM;/\ 'ROLJ%55J-.JOMP3?D]I
M+Y2NOD?-U8.G4G!_9DUZKH_FK,****U("BBB@ HHHH _<7_@@+_R>+\2O^S:
M/&/_ *M+X-5_7G7\AG_! 7_D\7XE?]FT>,?_ %:7P:K^O.OF,T_WN7^"G_Z2
M>W@/]W_[?E^@4445YQVA1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 ?Q@?\ !;[_ )/O\0?]DT^'/_IMNZ_(:OUY_P""
MWW_)]_B#_LFGPY_]-MW7Y#5]?@_]UP__ %ZA^1\]B?\ >*O^-A111728!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Z7?\$?/^4B_[.__
M '5O_P!47\3:_N*K^'7_ ((^?\I%_P!G?_NK?_JB_B;7]Q5?.9Q_O-/_ *\1
M_P#3E4]G+OX$_P#K[+_TB 4445Y1WA1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7\W?\ P<$?!9[K1/@1^T)IFF1$Z3?:W\(_&.J1
MQPFZ:UU6.3Q;X!MYV4BZ^PV5U8>/\2.LMI#=ZQ#%OM;B]C2]_I$KX8_X*4_"
M!/C7^Q+\?O"T5G+>:QH?@NZ^(OAR.V6:2_;6_AO)'XSBM=-AM['4IKF^UBRT
M>^T"&RBM#)?C5GLH[G3Y+A-1M.G!U?8XFC.^G.HR_P ,_=?W)W]488F'M*%2
M/7E<EZQ]Y??:WHS^"ZBBBOKSYX**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH _9;_@AM\78_ '[9C> ;Z3&F_&OX>^)
M?"5LC-;0Q0^)O#:P^/-&O99Y+66=LZ5X<\2Z-;V45U9PW=YKEL\OVFYMK*!O
M[(J_SK_V<OB9)\&OC[\&OBJMU]C@\ _$OP9XGU&4K<R1OHNF:]8SZ[:SQV<-
MQ>26U[HPO[*ZCLX)KN2VN)4MHVG:,'_10KYW-Z?+7A42_B0L_.4'9_\ DKBC
MV,OG>E*'6$[KR4E=?BI/^F?YR7QH_P"2Q?%C_LI?CO\ ]2G5:\TKTOXT?\EB
M^+'_ &4OQW_ZE.JUYI7T$/@C_AC^2/(EN_5_F%%%%4(**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH _N*_X(^?\HZ/V=_\ NK?_ *O3XFU^EU?FC_P1\_Y1
MT?L[_P#=6_\ U>GQ-K]+J^.Q7^\XC_K_ %O_ $Y(^CH?P*/_ %ZI_P#I$0HH
MHK U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[[<Z^+[]'YMOS.5HHHKU#A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M HHHH **** "BBB@#^XK_@CY_P HZ/V=_P#NK?\ ZO3XFU^EU?FC_P $?/\
ME'1^SO\ ]U;_ /5Z?$VOTNKX[%?[SB/^O];_ -.2/HZ'\"C_ ->J?_I$0HHH
MK U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_-'_@L'_RCH_:(_[I
M)_ZO3X95^EU?FC_P6#_Y1T?M$?\ =)/_ %>GPRK?"_[SA_\ K_1_].1,J_\
M K?]>JG_ *1(_AUHHHK[$^<"BBB@ HHHH **** "BBB@#_1L^"O_ "1SX3?]
MDS\!_P#J+:57IE>9_!7_ )(Y\)O^R9^ _P#U%M*KTROB);OU?YGT\=EZ+\@H
MHHI#"OY+?^"ZO[+4/PZ^,OAC]I7PM916_AGXVQ'1/&T%NJ1QZ?\ $[PQI\,<
M>I&)?*BBB\9>%8+6X$=M#+)+K?AGQ-J^IW'VG6H!+_6E7R9^W%^SC9_M4_LQ
M_%#X1_8K:Z\3WVAW&O?#F>YFBM%L/B1X=@FU#PA*;^9733[;4-03^P-7N]I*
M:#K&JQX(D(KKP5?ZOB(3;M!ODJ=N26EW_A=I?(Y\32]M1E%*\E[T/\2Z+U5X
M_,_S^J*LWME>:;>7>G:C:7-AJ%A<SV5]8WL$MK>65Y:RO!=6EW:SI'/;7-M/
M&\,\$R)+#*CQR(KJ0*U?6GSX4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %?W)_\ !*K]J"Y_:>_9*\*:AXBOOMGQ"^%MS_PJSQU+
M/<1RW^J7/A_3M/G\/>)[B,R-=/\ \)!X:O--:\U"=$COO$=CXB6!G^RRA/X;
M*_6+_@CG^TY-\ ?VM-$\&:UJD5C\.?C]%;?#KQ0EY.\-E:>*4:ZN?AIKVU5"
MO?0>)+F7PE%)<RQV=II?C;6KR;,D$#)P9CA_;X>3BKSI?O(]VDO>BO6.J75I
M(ZL'5]E65W[L_<EV5W[K^3Z]$V?VK4445\L>\%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M\0_\%$/VF7_91_94^(?Q*TNXB@\;:I%!X#^&PDDA1_\ A.?%<-W!I]_"DSJ+
MJ7PWI=KK'BTVB)*US#X?EC=!"998_P""6OVR_P""X/[3?_"V?VD-,^"7AO6/
MM?@CX!:9-IVJV]L<6MU\5/$#1W/BR:26*7R[[^P-(M_#WAN&.XB\[1=9M?%E
MO ZKJ-TK?B;7U&6T/8X=2DO?K-5'IJHVM"+^5Y>3DT>%C:OM*S2=XT_=7:_V
MFO5Z>:2"BBBO0.0**** "BBB@ HHHH ***^T/^"?W[--Y^U7^U1\,_AF]A]L
M\'V&IQ>.?BA)(DK6MM\-_"=Y97GB"VNW@=)[?_A)IY=.\$Z?=1AQ;:SXGTR:
M9?LZ3,LSG&G"4Y.T81<I/R2O]_9=7H5&+G*,(J\I-12\V[?)=WT6I_47_P $
M>?V7[;]GW]D[0_&.KV/D_$3X_P#]G_$CQ1--;R07=EX8:WGC^''AHF6."5[;
M3_#]Y/XD9)[=)K;6O&.NVBS7-G#9S']7:B@@AMH8;:VABM[>WBC@@@@C2*&"
M&)!'%##%&%2.*-%5(XT541%"J  !4M?&U:DJU2=67Q3DY/R71+RBK)>2/HZ<
M%3A&"VC%+U?5_-W?S"BBBLRPK\.O^"_7_)G7PU_[.7\'?^JM^,M?N+7X=?\
M!?K_ ),Z^&O_ &<OX._]5;\9:ZL%_O>'_P"OB_4Y\7_N]7_#^J/Y#****^N/
MGPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _TN**
M**^'/J HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^XK_@CY_R
MCH_9W_[JW_ZO3XFU^EU?FC_P1\_Y1T?L[_\ =6__ %>GQ-K]+J^.Q7^\XC_K
M_6_].2/HZ'\"C_UZI_\ I$0HHHK U"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *_-'_@L'_P HZ/VB/^Z2?^KT^&5?I=7YH_\ !8/_ )1T?M$?]TD_
M]7I\,JWPO^\X?_K_ $?_ $Y$RK_P*W_7JI_Z1(_AUHHHK[$^<"BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#^,#_@M]_R??X@_[)I\.?\ TVW=?D-7Z\_\%OO^3[_$'_9-/AS_ .FV
M[K\AJ^OP?^ZX?_KU#\CY[$_[Q5_QL****Z3 **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH _2[_ ((^?\I%_P!G?_NK?_JB_B;7]Q5?PZ_\
M$?/^4B_[._\ W5O_ -47\3:_N*KYS./]YI_]>(_^G*I[.7?P)_\ 7V7_ *1
M****\H[PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?W%?\$?/
M^4='[.__ '5O_P!7I\3:_2ZOS1_X(^?\HZ/V=_\ NK?_ *O3XFU^EU?'8K_>
M<1_U_K?^G)'T=#^!1_Z]4_\ TB(4445@:A1110 4444 %%%% !1110 4444
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M\%6U.79-M<DOE+1OI%R9R8RE[6BVE[U.\X^B^)?-:^J1_%=1117U)X04444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M** "BBB@ HHHH **** "BBB@#^,#_@M]_P GW^(/^R:?#G_TVW=?D-7Z\_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA;_\RM'_  Q;^QU_T:;^S1_X8CX6_P#S*T?VQ2_Y\U/_  */]=_Z>A_9T_\
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M ,"C_7?^GH?V=/\ Y^0^Y_UW_IZ?Y[U%?Z$/_#%O['7_ $:;^S1_X8CX6_\
MS*T?\,6_L=?]&F_LT?\ AB/A;_\ ,K1_;%+_ )\U/_ H_P!=_P"GH?V=/_GY
M#[G_ %W_ *>G^>]17^A#_P ,6_L=?]&F_LT?^&(^%O\ \RM'_#%O['7_ $:;
M^S1_X8CX6_\ S*T?VQ2_Y\U/_ H_UW_IZ']G3_Y^0^Y_UW_IZ?Y[U%?Z$/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %?FC_P6#_Y1T?M$?]TD_P#5Z?#*OTNK\T?^"P?_ "CH_:(_[I)_ZO3X
M95OA?]YP_P#U_H_^G(F5?^!6_P"O53_TB1_#K1117V)\X%%%% !1110 4444
M %%%% '^C9\%?^2.?";_ +)GX#_]1;2J],KS/X*_\D<^$W_9,_ ?_J+:57IE
M?$2W?J_S/IX[+T7Y!1112&%%%% !44\$-S#-;7,,5Q;W$4D$\$\:2PSPRH8Y
M89HI R212(S))&ZLCHQ5@02*EHH _@-_;T_9@O/V1_VG/B#\)T@NAX/DNE\7
M_"^_NFEE;4OAOXEGNI_#X-U.?/OKK0)[?4?!VKZA(D0O=>\-:K<PQBWDA+?'
M-?UR_P#!=#]F.'XC? 70OVB/#VERS^,?@A?0Z?XDFLH$EN+[X8^*+^*TNVNU
M5A<SQ>%O$UQINIV[11S)IFFZMXGO[A(K075W;?R-5];@J_UC#PFW><?<J=^:
M-M?^WDU+YGS^)I>QK2BE[K]Z'^%]/D[KY!11176<X4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5W'PS^(OBKX1?$/P5\4/ ]__9GB[P#X
MFT?Q7X?NV#R0+J6BWL-[!!?6Z21?;-,O/*-GJFGR.(-1TZXNK&Y#V]Q*C</1
M2:3335TTTT]FGHT_4$VFFM&G=/LT?Z+WP'^,/AO]H#X.?#CXS^$DE@T+XB^%
M-,\1V]C</YMUI%W<Q>5J^@7DHCBCGOO#VL0W^B7T\"?99[O3YI;1Y;9XI']:
MK^;'_@@A^TY-=VGQ#_90\3ZI$PTN*?XH?"Z&[G99A:7%U;V/C[P]8>8HA>*&
M]N=(\36FG02BZ+7WBK4E@FMXKR:T_I.KY#%4'AZ]2ET3O%]X2UB_N=GYIGT5
M"JJU*$^K5I+M):2_'5>304445SFP4444 %%%% !1110 4444 %%%% !1110
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M^<;<FV]6VVWYMW84444Q!1110 4444 %%%% !7]%O_!!3]E^VUWQ9X]_:O\
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M*=5KS2IA\$?\,?R0Y;OU?YA1115""BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH _TN****^'/J HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\IQM_P"V?+YGDYC&TZ<_YHN/_@+O_P"W?U8HT445[)YH4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 2P3S6TT-S;32V]Q;RQSP3P2
M/%-!-$XDBFAEC*O'+&ZJ\<B,KHZAE((!K^L3_@E=_P %48?C-#H/[.'[1^O1
M6_Q>MXH-*^'7Q%U6=(H?BI#$@BM?#OB.ZE*I'\1XT58M/U"5E3QTBB&9AXO
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M_P#JB_B;7]Q5?.9Q_O-/_KQ'_P!.53V<N_@3_P"OLO\ TB 4445Y1WA1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *_-'_@L'_P HZ/VB/^Z2?^KT^&5?I=7YH_\ !8/_ )1T?M$?]TD_
M]7I\,JWPO^\X?_K_ $?_ $Y$RK_P*W_7JI_Z1(_AUHHHK[$^<"BBB@ HHHH
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M HHHH **** "BBB@ HHHH **** "BBB@#_2XHHHKX<^H"BBB@ HHHH ****
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7]#_ /P3-_X*\S>
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5^:/_!8/_E'1^T1_W23_ -7I\,J_2ZOS1_X+!_\ *.C]HC_NDG_J]/AE
M6^%_WG#_ /7^C_Z<B95_X%;_ *]5/_2)'\.M%%%?8GS@4444 %%%% !1110
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MHM[^_#U7Q+YJS[:/JS]2J***\(]4**** "BBB@ HHHH **** "BBB@ HHHH
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MG9^6W;L?K]1117F'<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)->C5T?,M6;79M?<%%%%,1^XO_! 7_D\7XE?]FT>,?\ U:7P:K^O.OY#/^"
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MAM_X&ZC_ /*VC_AY'^PO_P!',_#;_P #=1_^5M>Q_J5QE_T27$__ (8<U_\
MF3S7WGS?_$4?#/\ Z.)P+_XEV0?_ #P/MVBOB+_AY'^PO_T<S\-O_ W4?_E;
M1_P\C_87_P"CF?AM_P"!NH__ "MH_P!2N,O^B2XG_P###FO_ ,R>:^\/^(H^
M&?\ T<3@7_Q+L@_^>!]NT5\1?\/(_P!A?_HYGX;?^!NH_P#RMH_X>1_L+_\
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ML+_]',_#;_P-U'_Y6T?\/(_V%_\ HYGX;?\ @;J/_P K:/\ 4KC+_HDN)_\
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M!_\ / ^W:*^(O^'D?["__1S/PV_\#=1_^5M'_#R/]A?_ *.9^&W_ (&ZC_\
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M7_Q+L@_^>!]NT5\1?\/(_P!A?_HYGX;?^!NH_P#RMH_X>1_L+_\ 1S/PV_\
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M#;_P-U'_ .5M'^I7&7_1)<3_ /AAS7_YD\U]X?\ $4?#/_HXG O_ (EV0?\
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M^'D?["__ $<S\-O_  -U'_Y6T?ZE<9?]$EQ/_P"&'-?_ )D\U]X?\11\,_\
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M5'_#9G[+G_1:_!G_ ($WG_R%1_JCQ7_T3'$/_AES+_YF#_B(' ?_ $6W"/\
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M$WG_ ,A4?\-F?LN?]%K\&?\ @3>?_(5'^J/%?_1,<0_^&7,O_F8/^(@<!_\
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M1_JCQ7_T3'$/_AES+_YF#_B(' ?_ $6W"/\ XDF3?_-I]-T5\R?\-F?LN?\
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MMPC_ .))DW_S:?3=%?,G_#9G[+G_ $6OP9_X$WG_ ,A4?\-F?LN?]%K\&?\
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M+NGYH^<J0E3G*$MXNWKV?HU9KR84445H0%%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M][P__7Q?J<^+_P!WJ_X?U1_(91117UQ\^%%%% !1110 4444 %%%% !1110
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MH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHHHK(T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=5KS2O2_C1_R6+XL?]E+\=_^I3JM>:5VP^"/^&/Y(Y9;OU?YA1115""BBB@
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M?P$?ZOA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG.5G+_P%)1ZV?-W/9P%+DINHU:53:_\ (MOO=WYJWJ%%%%>6=X4444 %%%%
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M%%%>N>>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#*M\+_O.'_Z_T?\ TY$RK_P*W_7JI_Z1(_AUHHHK[$^<"BBB@ HHHH ****
M"BBB@#_1L^"O_)'/A-_V3/P'_P"HMI5>F5YG\%?^2.?";_LF?@/_ -1;2J],
MKXB6[]7^9]/'9>B_(****0PHHHH **** "BBB@ HHHH *_&[_@M=^S'-\:_V
M7?\ A:OAG2XKSQQ^SU?7?C*=XH'DU&]^&-];"V^(5C R,B+%HR0:/XYNIKIG
MCM=)\*:S':QFZO@LG[(U6O;*SU*SN].U&TM=0T_4+6XLK^PO;>*ZL[VSNHG@
MNK2[M9TD@N;6Y@D>&XMYD>*:)WCD1D8@ZT:LJ-6%6.\))V[KK%^35U\R*M-5
M:<J<MI*U^SW3^32?R/\ -0HKZJ_;4_9LU7]D_P#:0^(OP<O$N9-#TO4SK/@/
M5+D$MK?@#7FDOO"]^9B MQ<V]H6T;5Y8QY:Z]I6JP)Q#7RK7V,)QG&,XN\9Q
M4HONFKH^;E%QDXR5G%M-=FG9A1115""BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "OWO\ ^"$W[4LW@/XP^)/V7O$=[+_PBOQFBN_%/@9'
M9VM])^)WA?1I+G5(44;(+:+QCX)TJ:.]O+AY))-3\&^%M+LH1)J4S-^"%=5X
M%\:^)/AOXT\*?$#P=J,ND>*O!7B'2/%'A[4H<[[/6-$OH-1L)BF0)8EN+=!/
M ^8KB$R02JT4CJ<<11C7HSI2^TM'_+):QE\G:_=774THU'2J0J+[+U7>+TDO
MFK_.S/\ 2.HKQ+]F_P"->B?M&? KX7_&SP_'%;V'Q"\*V6LW%A%<1W2:1K<3
M2Z;XFT$W$3NLLN@>)+'5=%G8D2>=82":.*4/$GMM?'2BXR<9*THMQ:>Z:=FG
MZ,^C34DI+:237HU=!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !115:]O;/
M3;.[U'4;NUT_3]/M;B]O[^]N(K6SLK.UB>>ZN[NZG>."VM;:"-YKBXF=(H8D
M>21U120 ?A7_ ,%U?VG)OAU\#O#'[.WA?5(K;Q+\;KXZGXR2WG==0M/ACX6N
MX;EK4K$JR6D7BSQ5'IUF+K[2J7VDZ!XFT66UN[:_NFM_Y)*^N/VY_P!H^;]J
MK]I_XG_%V"YOIO"M]K#:!\.[:_#1RV/P]\.%]-\,J+-XXCILNJV\<OB/4=.(
M=K36-;U&.2>ZDWW,OR/7UN"H?5\/"#5IR]^IWYY)77_;JM'Y'S^)J^VK2DG[
MJ]V'^%=?^WG>7S"BBBNLYPHHHH **** "BBB@ KK_A_X&\0_$WQUX.^'7A*T
M^W>)_'/B;1/">@VI6<QRZKKVHV^F67GFV@N9X[:.>Y22ZFC@F,%LDLWEL(R*
MY"OWY_X(/?LQS>-/BYXR_:<\1Z7%-X5^$UC<^#? T]W [I=_$[Q+9V\FJ7VG
MRAF@,OA#P3=30ZA#<1B1)O'F@WME)YEI,8\<165"C4JO[*]U=Y/2*^;?W7?0
MTHTW5J0IK[3U?:*UD_DK]M=#^F'X!?!CPK^SQ\&?AS\%?!:?\4_\//#-EH4-
MVT"6T^LZEF2]\0>)+ZWB>2*'4_%'B"[U3Q'JB0-Y"ZCJET(%2'8B^O445\<V
MY-RDVW)MMO=MN[;\V]3Z-))))622279+1(****0PHHHH **** "BBB@ HHHH
M *_#K_@OU_R9U\-?^SE_!W_JK?C+7[BU^'7_  7Z_P"3.OAK_P!G+^#O_56_
M&6NK!?[WA_\ KXOU.?%_[O5_P_JC^0RBBBOKCY\**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /]+BBBBOASZ@**** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZRCSO_M]N2^Z+2^1\_BY\^(J/HGRK_MU*+_%,****[#G"BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %>GPRK]+J_-'_@L'_RCH_:(_P"Z2?\ J]/AE6^%_P!YP_\ U_H_^G(F5?\
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MB](>_4_Q27NKY1;?_;R['K9?2M&59[RO"/\ A3O)_.22^7F%%%%>,>D%%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '\
M8'_!;[_D^_Q!_P!DT^'/_IMNZ_(:OUY_X+??\GW^(/\ LFGPY_\ 3;=U^0U?
M7X/_ '7#_P#7J'Y'SV)_WBK_ (V%%%%=)@%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 ?I=_P1\_Y2+_L[_P#=6_\ U1?Q-K^XJOX=?^"/
MG_*1?]G?_NK?_JB_B;7]Q5?.9Q_O-/\ Z\1_].53V<N_@3_Z^R_](@%%%%>4
M=X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M HHHH _TN****^'/J HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_/1?='F?D['!F%3EI*FMZCU_PQLW][Y?E<\.HHHKZ,\8**** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /T(^!W_ "2[PO\ ]QO_ -2+
M5Z]8KR?X'?\ )+O"_P#W&_\ U(M7KUBOCL5_O.(_Z_UO_3DC]PRG_D599_V+
M\%_ZC4@HHHK ] **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *_<_\ X),?\D\^+?\ V.>A_P#ICDK\,*_<_P#X
M),?\D\^+?_8YZ'_Z8Y*_'/'K_DVF<?\ 87D__JSPI_1/T5_^3T\._P#8!Q#_
M .J3''ZTT445_ 1_J^%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %?FC_P6#_Y1T?M$?\ =)/_
M %>GPRK]+J_-'_@L'_RCH_:(_P"Z2?\ J]/AE6^%_P!YP_\ U_H_^G(F5?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>K_A_5'\AE%%%?7'SX4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ?Z7%%%%?#GU 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'Y _\ !:;]I!_@I^R7>_#K1-0EL?&G[0U]
M<> ;)[6ZA@NX/ U@MG?_ !)NA#(6DNK'4='N;'P3J<<<15;7QJ6::"7R"_\
M&+7Z0?\ !5+]IR']IO\ :W\9:EX?U274?AW\,HE^%_@)DG233KNT\.W=TWB+
MQ!8)"J021>(O%%QJUW::B?-NK[0H=#2:X-O:6=M:_F_7U> H>PPT$U:=3]Y/
MNG)*T?\ MV-DUWYGU/ Q=7VM:33O&/NQ[66[7J[OTL%%%%=IS!1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /T(^!W_ "2[PO\ ]QO_ -2+5Z]8KR?X'?\ )+O"_P#W&_\ U(M7KUBO
MCL5_O.(_Z_UO_3DC]PRG_D599_V+\%_ZC4@HHHK ] **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_<_\ X),?
M\D\^+?\ V.>A_P#ICDK\,*_<_P#X),?\D\^+?_8YZ'_Z8Y*_'/'K_DVF<?\
M87D__JSPI_1/T5_^3T\._P#8!Q#_ .J3''ZTT445_ 1_J^%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %?FC_P6#_Y1T?M$?\ =)/_ %>GPRK]+J_-'_@L'_RCH_:(_P"Z2?\
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M=[K=+U5UZV['\'%%%%?6'@!1110 4444 %%%% !1110 4444 %%%% !1110
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ME%V:_)KNFM4PHHHJR0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"6">:VF
MAN;::6WN+>6.>">"1XIH)HG$D4T,L95XY8W57CD1E='4,I! -?LC^Q[_ ,%G
M/C]\ ?[*\&_&1+GX^_"Z*YMX9+G7]4N1\5/#>F_N;=_[ \77DMQ!K]M8P>;=
MQ:%XMMKJ>^FCM]-L_%7AJQ9Y4_&FBLJM&E7CR58*:Z7W7G&2LT_1J_4NG4G2
MES4Y.+ZVV:[-;->I_H,?LS_MC_L]_M;Z#<:Q\%O'5KK6H:;:V]UXA\&ZI ^B
M^-_#"W#>6AUKP]=GS_LOG_Z,NKZ9+J6@W%P##::K<."*^H*_S8_#7B?Q+X+U
M[2_%/@[Q#KGA/Q/HETM[HOB/PUJU_H6O:1>(K(MWI>KZ7<6NH6%TJ.ZK<6EQ
M%*JNRAP&(/\ 0'^R'_P77\9>&IM/\'?M=Z%+XX\/+%':P?%/P1I.GV?C:QEW
M1113^*?#*76EZ!X@L44L]Y?Z$FC:Q;P1/*NE^([Z41-X>)RJI"\L._:1WY'9
M5%Y)Z*??[+Z)-GJ4<?&5HUER2_G7POU6\?Q7H?U,T5Y?\(OC5\*/CUX/L/'O
MP>\>>'O'_A74(H9$U'0KSS)K*6>)9UL-;TJY2WUCP[K$4; W6B:_I^FZQ9/F
M.\L8)59!ZA7DM.+<9)QDG9IIII]FGJGZGH)II---/5-.Z:[IK<****0PHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%%%<1TA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC^0RBBBOKCY\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /\ 2XHHHKX<^H"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% 'J'PB^-7Q7^ OC"P\>_![QYXA\
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M=XIHG22-V1@39KS3M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M /XP/^"WW_)]_B#_ +)I\.?_ $VW=?D-7Z\_\%OO^3[_ !!_V33X<_\ IMNZ
M_(:OK\'_ +KA_P#KU#\CY[$_[Q5_QL****Z3 **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH _2[_@CY_P I%_V=_P#NK?\ ZHOXFU_<57\.
MO_!'S_E(O^SO_P!U;_\ 5%_$VO[BJ^<SC_>:?_7B/_IRJ>SEW\"?_7V7_I$
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MZ]KM_;Z7I&EVBNR(UU?ZA=6]I;JSHIEE0,R@DC^_?]C']FC1_P!DK]G7X?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M91?PU+1?^+[+^]V]&?UU4445\P>X%%%% !1110 4444 %%%% !1110 4444
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M>G4A5A&I3DI1DKIK\FMTUU3LT]&CPYPE3DX33C);I_UJGNGU044459(4444
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ME>#VQ-1?]>8O[G4:_"'SE;X6>7CL1O0@_P#KXU]ZC^LON[A1117N'EA1110
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M?CO_ -2G5:\TK[:'P1_PQ_)'S$MWZO\ ,****H04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% '^EQ1117PY]0%%%% !1110 4444 %?Q&_\
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MC_L+R?\ ]6>%/Z)^BO\ \GIX=_[ .(?_ %28X_6FBBBOX"/]7PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K\T?\ @L'_ ,HZ/VB/^Z2?^KT^&5?I=7YH_P#!8/\ Y1T?M$?]
MTD_]7I\,JWPO^\X?_K_1_P#3D3*O_ K?]>JG_I$C^'6BBBOL3YP**** "BBB
M@ HHHH **** /]&SX*_\D<^$W_9,_ ?_ *BVE5Z97F?P5_Y(Y\)O^R9^ _\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MET?GJGNFUJ>'5I3HRY9JW9])+NG^?5=;!1116QF%%%% !1110 4444 %%%%
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M\U='K5%%%<QN%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME7\1O_!7G_E(A^T)_P!TF_\ 5'?#2OZ9^BI_R</.?^R,S'_U><.G\,?M O\
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M445[QY04444 %%%% !1110 4444 ?K%_P1S_ &8YOC]^UIHGC/6M+BOOAS\
M8K;XB^*'O('FLKOQ2[75M\--!W*Q5+Z?Q);2^+8H[F*2SN]+\$ZU9S8DG@5_
M[5J_-;_@E'^S,W[-7[(G@Z#6;>*/QU\6I8_BUXS;RH3<63>)=+TY/#/AU[E%
M\]HM#\+VFEFXLY)9(;3Q!?\ B&2V"K=R-)^E-?*9AB/;XB33O"G^[AV:3]Z7
M_;TKN_:RZ'O82E[*C&Z]Z?OR[ZK1?)6T[W[A1117$=04444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7X=?\ !?K_ ),Z^&O_ &<OX._]5;\9:_<6
MOPZ_X+]?\F=?#7_LY?P=_P"JM^,M=6"_WO#_ /7Q?J<^+_W>K_A_5'\AE%%%
M?7'SX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?Z
M7%%%%?#GU 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %?B;_ ,%#O^"1/@G]HN/7
M_B_\ HM,^'OQS%K+J&I^&8H;>Q\#_%:ZMK;:+:ZC$MK:>#_%]ZL48@\2VZ?V
M-JMZI3Q/8QW&IW7BS3?VRHK6C7J4)J=*3C+9]5)=I+9I_ANK-)F=2E"K%QG%
M-=.Z?>+W3]/1W5T?YO?Q"^'7CGX3^,-<\ ?$?PMK'@[QCX;OKC3M8T'6[5K:
M[MKBWFDA:2)LO;WUC.T;2V&J6$UUIFI6K1WFGW=U:313OQ=?WR?ME?L(?!#]
MM7PDFF?$+3I=!\=Z-8S6W@KXJ>'8+5/%OAE]\MS!871F3R?$?A5[V:674/#&
MIL(72ZOYM%OM UJY36K?^-C]KK]B7XY?L9^,_P#A'?BCH/VKPOJMS.G@KXE:
M$LEWX,\96L09P+2\QYND:Y!$K'4O#&M)9ZS9F-KN"&^T6?3M8O\ Z7"8^EB4
MHNU.MU@WI*V[@^JZ\OQ+7=+F?BXC"SH-M7E3OI)+5>4ET[7V?EL?(5%%%=QR
MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7I?PI^,
MOQ4^!OBJV\;?"+Q[XF^'WB>VV+_:?AO4IK+[9 CB3[#JUEE]/UK3)' ,VEZQ
M:7VG7'2>UD'%>:44FE)-22:>C32::[-/1C3:::;36J:=FGW36Q_4K^R%_P %
MV/"GB7['X-_:]\/6O@;6?]%MK/XL>!M.U*]\(:BQW0N_BWPDCZEK?ANZ 2":
M;5?#\NO:5?7-W<L=$\*V%E&)_P"@?PUXG\->--!TOQ3X.\0Z'XL\,:W;+>Z+
MXC\-:M8:[H.KV;,R+=Z7J^EW%UI]_;,Z.BSVEQ+$61E#DJ0/\V.OJ#]F?]L?
M]H/]DC7KC6/@MXZN=%T_4[FWN?$7@[5($UKP3XG:W7RT.M>'KL^1]I\C-NNK
MZ9+INO6]N3#::K;H2*\G$Y53G>6':IRWY'=P>VSU<.O\RULE%'?1Q\XVC67/
M'^964UZ[*7X/NV?Z#%%?CG^R%_P6:_9X_: ^Q^$_B[]E_9[^)DGV6WBC\3:Q
M%<_#?Q+<R[HB^A>-YX+"+1;J26/SI=&\7VNE1VPO+*QTK7_$]RMU+#^QE>'5
MHU:,N2K"4'TNM';K&2TDM=TVCU*=6G57-3DI+K;=>36Z?J@HHHK(T"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /XP/^"WW_)]_B#_ +)I\.?_ $VW=?D-7Z\_\%OO^3[_ !!_V33X<_\
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MF%%%%4(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110!_&!_P6^_Y/O\ $'_9-/AS_P"FV[K\AJ_7G_@M]_R??X@_[)I\.?\
MTVW=?D-7U^#_ -UP_P#UZA^1\]B?]XJ_XV%%%%=)@%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 ?I=_P $?/\ E(O^SO\ ]U;_ /5%_$VO
M[BJ_AU_X(^?\I%_V=_\ NK?_ *HOXFU_<57SF<?[S3_Z\1_].53V<N_@3_Z^
MR_\ 2(!1117E'>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7YV_MY?\%%_A-^Q/X8DT
MVYDM?&WQPUS3%O?!?PKM+F:*06L\TEM'XG\9:E;P3Q>'?#-O+%,;>*9EUGQ+
M<P26.A6K6\&L:QH?Q-^W_P#\%F?"/PC_ +7^%'[*E[H?Q!^)D>ZSUGXH)+9Z
MW\/O \_^@3^7X?6)+O3?'^N-;37MK,\=U'X>\/ZC%&MVVOW,-_HMM_*GXL\6
M^*/'?B36?&/C3Q!K'BKQ5XBOIM3UWQ#K^H7.J:QJU_.1YEU?7]Y)+<7$I"JB
MEW(CB2.*,+%&B+ZV"RV56U7$)QIZ.,-I5.NO6,'\I-;65I'GXG&J%X46I3V<
M]'&/ITE+_P E3WOJCT+X]?'KXG?M*?$[Q!\6OBUX@EU_Q7K\H1$0/!H^@:/
M\K:;X9\,Z:TLR:1X>TA)I([&QCDEEDEDN=1U&YO]7O\ 4=1N_'***^AC%12C
M%*,8I))*R26B22T22/(;;;;;;;NV]VPHHHIB"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *_J9_X)'?\$P[_P"'<VB_M4?M
M%^'8H/&5S8QWOPA^&>NV :[\$I<O;W-I\0_$]G<J#9>-)+="OA?1)XO.\*6M
MW)K&I1Q>+'TZ#PKY#_P2A_X)6S:[-X5_:F_:5T"6WT&WEL?$?P>^%NK0/%-K
M\T3QWFD>/_&ME*%>/P]&ZPWWA7PY<(K^(W6#6]7C'AL6-GXE_I]KP\QQZ:EA
MZ+NM55FOQA%_A)_]NKJ>I@\)M6JKLZ<7^$I+\8KYOH%%%%>&>H%%%% !1110
M 4444 %%%% '^<E\:/\ DL7Q8_[*7X[_ /4IU6O-*]+^-'_)8OBQ_P!E+\=_
M^I3JM>:5]M#X(_X8_DCYB6[]7^844450@HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** /]+BBBBOASZ@**** "BBB@ HHHH *_B-_X*\_\I$/
MVA/^Z3?^J.^&E?VY5_$;_P %>?\ E(A^T)_W2;_U1WPTK^F?HJ?\G#SG_LC,
MQ_\ 5YPZ?PQ^T"_Y,UPS_P!G-R;_ -97C,_-FBBBO[_/\?@HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 4444 %%%% '^C9\%?\ DCGPF_[)GX#_ /46TJO3*\S^"O\ R1SX3?\ 9,_
M?_J+:57IE?$2W?J_S/IX[+T7Y!1112&%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 ?(_[<_P"SA#^U5^S!\3_A%!;6,WBJ^T=O$'P[N;\I
M'%8_$+PX'U+PR1>/+$NFQ:K<1R^'-0U$LZVFD:WJ,DD%U%OMIOX"+VRO--O+
MO3M1M+FPU"PN9[*^L;V"6UO+*\M97@NK2[M9TCGMKFVGC>&>"9$EAE1XY$5U
M('^E?7\8/_!9S]F#_A1'[5%Y\1]$@\OP1^T;_;?Q"L/FS]D\>6]Y:?\ "S-.
M^8F1_/U?6--\5^:0(U_X2W[%%\MD:]K**]I3P\GI*]2'^))*45ZQM+RY9=SS
M,PI7C&LEK'W9V[/X6_1Z?-(_(6BBBO>/*"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#ZN_8D_:/U/]E3]I;X:?%ZVN98M T_6(M"
M\?V:"X>/4_A[X@DBT_Q5;2V]M%--=2V5DRZYID*0S,-;TC2YUAE>%4;_ $ ;
M*]L]2L[34=.N[74-/U"UM[VPO[*XBNK.]L[J))[6[M+J!Y(+FUN8)$FM[B%W
MBFB=)(W9&!/^:A7]EG_!%7]IO_A=/[+4'PK\0ZQ]O\>?L^75MX.:*Y/^G7'P
MWO4FG^'EWDRLLUKH]I;:CX+MA!# +33_  QI<=RCS7"W5WXV;T+PAB(K6'N5
M/\,G[K?I)V_[>78]++ZUI2HMZ2]Z'^)+5?-*_P#VZ^K/V,HHHKP#U@HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OYB_P#@O?\ M.37>L?#
MO]E#PQJD0L-)B@^*'Q1AM)W,TNL7<5S8^ ?#]_Y:QB&*PTN;5_$UWITTMS%?
M/K/A74FM[672K.:X_H[^)OQ%\*_"+X>>-?BAXXO_ .S?"/@'PSK'BOQ!=J$>
M<:=HME->S06,#R1?;-3O?*6RTK3XY!/J.I7%K86P:XN(D;_/5^.7Q;\0_'GX
MP_$CXR>*AY6N?$;Q?K7BFYLEN9[R#1[;4;MWTSP_8W-S_I$NF>'=*6RT+2O.
M D73M.M48 K7JY50]I6=:2]VBM+[.I*]O_ 5>7D^5]C@Q]7DIJFGK4W[J*LW
M][LO-77IY51117T9XP4444 %%%% !1110 4444 ?4O[%W[.=_P#M5?M)?#/X
M,P/+;:/KNL'4_&>HPN(Y=,\#:!$VK>*KJ"0\)?3Z7;2Z;I)(93J]_8)(!&SL
MO^@5965GIMG::=IUI:Z?I^GVMO96%A96\5K9V5G:Q)!:VEI:P)'!;6MM!&D-
MO;PHD4,2)'&BHH _!3_@A%^R_;>"/A#XK_:>\16./%GQ>N;KPCX*DGMY(Y=+
M^&?AG4U&J7%K-)'"Y_X3'QE8NU]$%N;5K/P7X<N[2Y5[J]@3]]*^9S.O[7$>
MS3]RC>*\YNSF_O2C_P!N^9[>!I>SI<[7O5;2_P"W?LK\7+Y^04445YIVA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7X=?\%^O^3.OAK_
M -G+^#O_ %5OQEK]Q:_#K_@OU_R9U\-?^SE_!W_JK?C+75@O][P__7Q?J<^+
M_P!WJ_X?U1_(91117UQ\^%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% '^EQ1117PY]0%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% 'A/[0G[-GP<_:B\!WGP\^,O@^Q\2Z3)%>MH^I^7%!XD\(ZI>6
MCV@U_P ):WY4MQHVL6P9)$D19K*\,,=MJUCJ-@9;.7^1_P#;F_X)-?&S]D]]
M9\>^!UOOC%\![>6\O&\6:1IY/BWP+I44)O<?$?P[9B1H+&QMTNHIO&VB+/X:
ME33SJ&MP^#9]4TW1&_M6HKKPN-K85VB^:FW>5.3?+YN+WC+S6C^TI61SU\-3
MKKWERS6TUOZ/^9>3U[-'^:/17]>?[<G_  1?^%WQO_M;XC?LV'0_@S\59MEU
M?>$/L[V7PF\:3IO2X?\ L[3;>:7P!KEQ$T,G]H^'K&Y\/7LUEMO_  O#J>L:
MEXIA_E7^+?P;^*/P'\;ZE\.?B_X(USP%XRTK+W&C:Y;HGVFT-Q<VL6JZ/J%M
M)<Z5K^AW<]I=1Z?K^A7VHZ+J/V>9K"_N4C9A]'AL71Q4;PE::7O4Y64X]W;[
M4?[RTU5[/0\:MAZE!VFKQ>TUK%_/H_)V?:ZU/-****ZC **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKVEG=7\?S^)RZO0O**]K3WYHKWHK^_'5KU5XVU;6QZU#&4ZUHR_=S?1O1O\
MNRZW[.S[7W/U4HHHKSSL"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\BK+/^Q?@O\ U&I!1116!Z 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5^Y__  28_P"2>?%O_L<]#_\ 3')7
MX85^Y_\ P28_Y)Y\6_\ L<]#_P#3')7XYX]?\FTSC_L+R?\ ]6>%/Z)^BO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6_&6OW%K\.O^"_7_ "9U\-?^SE_!W_JK?C+75@O][P__ %\7ZG/B_P#=ZO\
MA_5'\AE%%%?7'SX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 ?Z7%%%%?#GU 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO-*^VA\$?\,?R1\Q+=^K_,****H04444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% '^EQ1117PY]0%%%% !1110 4444 %?Q&_\%>?^4B'[0G_=
M)O\ U1WPTK^W*OXC?^"O/_*1#]H3_NDW_JCOAI7],_14_P"3AYS_ -D9F/\
MZO.'3^&/V@7_ "9KAG_LYN3?^LKQF?FS1117]_G^/P4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
MH1\#O^27>%_^XW_ZD6KUZQ7D_P #O^27>%_^XW_ZD6KUZQ7QV*_WG$?]?ZW_
M *<D?N&4_P#(JRS_ +%^"_\ 4:D%%%%8'H!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7[G_\$F/^2>?%O_L<
M]#_],<E?AA7[G_\ !)C_ ))Y\6_^QST/_P!,<E?CGCU_R;3./^PO)_\ U9X4
M_HGZ*_\ R>GAW_L XA_]4F./UIHHHK^ C_5\**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_-'
M_@L'_P HZ/VB/^Z2?^KT^&5?I=7YH_\ !8/_ )1T?M$?]TD_]7I\,JWPO^\X
M?_K_ $?_ $Y$RK_P*W_7JI_Z1(_AUHHHK[$^<"BBB@ HHHH **** "BBB@#_
M $;/@K_R1SX3?]DS\!_^HMI5>F5YG\%?^2.?";_LF?@/_P!1;2J],KXB6[]7
M^9]/'9>B_(****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH _(__@LK^R_<_'_]E>Z\<>&['[9X\_9^N=2^(.E0Q6\<UYJ'@R>S
MA@^(FD6TGEM<1XTJQT_Q2T4#YO9?"5O:>5+-+;F+^+>O]*^]LK/4K.[T[4;2
MUU#3]0M;BRO["]MXKJSO;.ZB>"ZM+NUG22"YM;F"1X;BWF1XIHG>.1&1B#_
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M\.MIMYXYO ^)(H[K6I;_ $+PE;V]U$!=Z5KGB.\LIXKW1D9?V?K^#S_@I/\
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M)>6DMVXI:GCU\+5HW=N:'\\>G^);Q]=O.^A\34445VG,%%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH _C _X+??\GW^(/\ LFGPY_\ 3;=U^0U?KS_P6^_Y
M/O\ $'_9-/AS_P"FV[K\AJ^OP?\ NN'_ .O4/R/GL3_O%7_&PHHHKI, HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKO?!OQ5^*'PY>*3X>_$CQ[X$D@OFU2!_!OC#Q#X8>'4WABMGU&)M$U&Q:.^>
MW@@@:[0K<-##%$9"D:*."HI-)JS2:[-77W,$VMFUZ:'W9X'_ ."FO[>?P]BC
MAT']IKXA7Z16MS:*?'!T+XG2F*ZO%OY7DG^).C>+)I;I9U"6U[+(]Y9V>[3K
M2X@T]FM3]7>%O^"['[;GA^&>+5K'X)^.7EBLXX[CQ3X"UJTFMGMDF6::!?!7
MC/P?;M+J!D22\%S!<0H]O"+"&Q1ITG_&6BL)87#3^*A2;[J$4_FTDW_7=FL:
M]:/PU9I=N9M?<[H_I \+_P#!PSXE@WIXT_9=T+5?,NH?+NO"_P 5+_0/LEGP
M+C?8:MX'\2_VA=#F2';J.F1' A?;N,Z_2_A?_@O_ /LQWV]/%_PB^./AR5KJ
M&*WDT2T\"^*;,6TF!+=7TUSXQ\,WEOY#'<8+/3]2DDB5FC)EVP-_)116$LLP
M<MJ;CYQJ3_\ ;I27X=398W$K[:EZQC^B3_$_MI\/?\%G?^"?6M0W$NI?%KQ#
MX1>"5(XK;Q#\+?B1<S7B,FXSV[>%/#/B>W6*,_NW%W/:S%^4A=/GKZ)\/_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Z$
M? [_ ))=X7_[C?\ ZD6KUZQ7D_P._P"27>%_^XW_ .I%J]>L5\=BO]YQ'_7^
MM_Z<D?N&4_\ (JRS_L7X+_U&I!1116!Z 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^Y_P#P28_Y)Y\6_P#L
M<]#_ /3')7X85^Y__!)C_DGGQ;_['/0__3')7XYX]?\ )M,X_P"PO)__ %9X
M4_HGZ*__ ">GAW_L XA_]4F./UIHHHK^ C_5\**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_-
M'_@L'_RCH_:(_P"Z2?\ J]/AE7Z75^:/_!8/_E'1^T1_W23_ -7I\,JWPO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '^EQ1117PY]0%%%%
M!1110 4444 %?Q&_\%>?^4B'[0G_ '2;_P!4=\-*_MRK^(W_ (*\_P#*1#]H
M3_NDW_JCOAI7],_14_Y.'G/_ &1F8_\ J\X=/X8_:!?\F:X9_P"SFY-_ZRO&
M9^;-%%%?W^?X_!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-%.*5OG*.OFXR9[&7U>:$J3>L'>/^!]/^W9?FE;0]>HHHKR#T HHHH ****
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MGK]B+^5Y-><7T/4R^E\59KO"'X.37X*_^)=0HHHKQ#U HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\T?VQ/\ @EC^S?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?6?[)_[:GQV
M_8Y\7CQ'\*/$?F:#?W2S^*OASK[WM[X$\8*MM+:(^KZ1;7=G+!J=K%*'L-;T
MNZL=5M9(88GN;C3C<Z?<_)E%3.$:D7"<5*,E9QDKI_U^'0<92BU*+<6M4T[-
M']X?[%7_  4.^!O[:N@PP>%;S_A#/BO8Z8^H>*OA!KU]'<:]I<5LUK#>ZGH&
MIK;6-MXO\,Q7-W#%%K-C:V=Y$LL!UK1-#GN(;9OO6O\ -C\,^)O$/@OQ%HGB
MWPEK>I^&_$_AO4[/6=!U[1KR?3]5TC5=/G2YLK^PO;9XY[:YMIXTDBEC<$,.
MX)!_J,_X)\_\%G=!\??V!\'?VN+_ $SPIXW?[#HWAKXQK UAX5\77#?V9IEC
M9^.H8O.MO"_B:_N9+J]O/$Z+IG@F=-_VN'PRT,1U'P,9EDJ=ZF'3G36LJ=[S
MA_AZSBOG)=>;5KU\/CE.T*UHSV4]HR?GTBW_ . M[6T1_0A144$\-S##<VTT
M5Q;W$4<\$\$B2PSPRH)(IH98RR212(RO'(C,CHP9200:EKR#T HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#^,#_@M]_R??X@_[)I\.?\ TVW=?D-7Z\_\%OO^3[_$'_9-
M/AS_ .FV[K\AJ^OP?^ZX?_KU#\CY[$_[Q5_QL****Z3 **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **]Q_9N^ /C']J+XT^#/@5X U+PS
MH_B[QS_PD7]DZCXPO-4T_P .6_\ PC/A37?&%_\ VC=Z+HWB#4X?.TSP_>P6
MGV;2+OS+^6UBF^SV[RW4/U[\3/\ @D3^WG\--T__  IO_A/]+7*_VK\,_$FA
M>*]TH^WOY2Z!]LL/&!S;V'VD7'_"-BS/VVPLOM/]J7/V!,IUJ-.2A.K"$VN9
M1E)1;3;2:NU?5-?(N-*I./-&$I13LW%-V:L[.U^Z/S1HKO?'/PJ^*'PPN_[/
M^)?PW\>_#R_$J0&R\<^#_$/A*[\Z6UBOHX?LVOZ=I\WFR64\%XD>S>]K-%<*
M#%(CG@JT34E=--/9IIK[T0TT[--/L]&%%%%, HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBO5?A9\#/C)\;]5?1?A#\,/'/Q'U"'F\3PC
MX;U36;;38]T2F?5]0M+=]/T>V#SP(UUJEU:6RR7$$9E#SQ*Z;44W)J*6[;22
M]6]$-)MI)-M[)*[?HD>545^\WP%_X(*_'[QDEEJ_Q[\?>%/@QI;RV\EQX8T)
M8?B/XY\F.:3[9:7<NEZA9>"=)EN(4B6QU&P\3^*TB:=Y[K2R;5;2\_;?]GS_
M ()4_L8?L^?8-3L?AC:_$SQE9>1(/&?Q<:'QK>)=P?998KO3?#MU;P^"M%N;
M:]MC>V&H:;X:AUJSEE95U:1(H!%P5LSPM*ZC)U9=J:]WYS=HV_P\QUT\%7J6
M;2IKO/1_^ J[OZV]3^1K]GS]A7]J?]IUXKCX3?"3Q#J'AQY5BD\<Z]&GA7P-
M$6A:X(B\3:\UE8:K+%$(WGL]";5;^%;JR:6T1;RV:7]]/V;_ /@@E\,/"Z:?
MKW[3OQ!OOB?K'E6LUWX"\ OJ7A+P-:W23![JQNO%;26WC3Q/8SQ(L:7EA;?#
MZ[B6:8" R)#<+_0/!!#;0PVUM#%;V]O%'!!!!&D4,$,2".*&&*,*D<4:*J1Q
MHJHB*%4  "I:\FMFF)JW4&J,?[FLWZS>J]8J/9W.^E@:,+.=ZDE_-\-_**W7
ME)R7D<-\.OAE\//A%X5L/ _PO\%>&? /A'3<M:>'_"FCV6BZ<)W2-)[Z>&RA
MB^VZG>>5')J&JWK7&I:C.#<W]U<7#/*W<T45YS;;;;;;U;;NV^[;W.U))62L
MEHDMDNP4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^\X?_K_1_P#3D3*O_ K?]>JG_I$C^'6BBBOL3YP**** "BBB@ HHHH ****
M/]&SX*_\D<^$W_9,_ ?_ *BVE5Z97F?P5_Y(Y\)O^R9^ _\ U%M*KTROB);O
MU?YGT\=EZ+\@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *_EF_P""]7[,<V@^/O W[5?AK2XDT7QU8V/P[^),]I X
M=/&N@6MR_A+7M4EW/YDNN^$+4>&XY L4%M#X'TZ%LSWR&3^IFOG;]K']G_1_
MVHOV>?BA\#M7GBL9/&OAYTT#5YO-$6A^,-'NK?7?!VM3_9U:Y>QT[Q-INESZ
MM:VVR;4='&H:8'5+US73A*[P]>%3[-^6?^"32EZV^)+ND88BE[:C*"^+>/\
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MM-/=-:-/T/H4TTFM4U=/NF%%%%(84444 %%%% !1110 4444 %%%% !1110
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M44 %%%% !1110 4444 %%%% !1110 4444 %?AU_P7Z_Y,Z^&O\ V<OX._\
M56_&6OW%K\.O^"_7_)G7PU_[.7\'?^JM^,M=6"_WO#_]?%^ISXO_ '>K_A_5
M'\AE%%%?7'SX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.,HNSBU9I]FF>Q&2DE*+335TULT%%%%2,**** "BBB@ HHHH **** "BBB@
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M::[K5&336ZMZA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDU>HK@J5:E5WJ5)S?3FDW;T3=EZ*QUPIPIJT(1BO[J2^^V_S"BBBLRPHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH _P Y+XT?\EB^+'_92_'?_J4ZK7FE>E_&C_DL7Q8_[*7X[_\ 4IU6O-*^
MVA\$?\,?R1\Q+=^K_,****H04444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% '^EQ1117PY]0%%%% !1110 4444 %?Q&_\%>?^4B'[0G_=)O\
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M'9>B_(****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK.25HU/>79/[2^_6W121%1117HG&%%%% !1110 4444 %%%% !1110 4444
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M64U\])>LGV/;P-7GI<C?O4]/-Q?P_=\/DDNYIT445YAVA1110 4444 %%%%
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M@Z%86^EZ1I=HKL[K;6&GVMO:0*[NPBB0,S$$GQ\VK\M.-"+UJ>]/_!%^ZO\
MMZ6O_;OF>CE]+FG*JUI#W8_XFM7\HO\ \FN;E%%%?/GKA1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]N[_ *-B^)G_ ( :?_\ +&O[UJ*?]L5_^?5'[I__ "?K_2U/[.I?SU/OC_\
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M%L;-$1+6T"BWMT15BC0* .THHK%MMW;;?=ZLT22V27IH%%%%(84444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH _0CX'?\DN\+_P#<;_\ 4BU>O6*\G^!W_)+O"_\ W&__ %(M
M7KUBOCL5_O.(_P"O];_TY(_<,I_Y%66?]B_!?^HU(****P/0"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OW/
M_P""3'_)//BW_P!CGH?_ *8Y*_#"OW/_ ."3'_)//BW_ -CGH?\ Z8Y*_'/'
MK_DVF<?]A>3_ /JSPI_1/T5_^3T\._\ 8!Q#_P"J3''ZTT445_ 1_J^%%%%
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M_;LK(****P-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% '^EQ1117PY]0%%%% !1110 4444 %?Q&_P#!7G_E(A^T
M)_W2;_U1WPTK^W*OXC?^"O/_ "D0_:$_[I-_ZH[X:5_3/T5/^3AYS_V1F8_^
MKSAT_AC]H%_R9KAG_LYN3?\ K*\9GYLT445_?Y_C\%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Z
M$? [_DEWA?\ [C?_ *D6KUZQ7D_P._Y)=X7_ .XW_P"I%J]>L5\=BO\ ><1_
MU_K?^G)'[AE/_(JRS_L7X+_U&I!1116!Z 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^Y_\ P28_Y)Y\6_\
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M*^(EN_5_F?3QV7HOR"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH ****
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MHK[&G"-.$*<=(PBHKT2M=^;W;ZO4^<E)SE*4G=R;;?FPHHHJR0HHHH ****
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M6^EW]TPD?38[^U3[2?BNO]*K5-+TS6],U'1=:TZQU?1]7L;O2]6TG5+2WO\
M3-4TR_MY+2_T[4;"[CEM;VQO;666VN[2YBEM[FWEDAFC>-V4_A/^V1_P0_\
MA9\3DU3QS^RWJ%C\'?'31&XE^'>H_:9_A1XCN1,SR#3I(DNM8^'U]/'-(0=.
MBUOPPWV.PT^T\,Z"MQ?:R/;PV:QE:&(2A+1>TC\#?]Y;Q\VKQ\HI'EU\!*-Y
M46Y+=PE;F7H]%+TT?JS^2VBO:/CG^SS\9OV;/&<_@/XU> =<\#Z\GF26#ZA
M)M%\06<8B+:GX6\0V;7&B>)=,4SQ137NBW]Y%9W9DT^^-KJ-O<VD/B]>Q&49
MQ4HM2C)74HM--=TUHSSVFFTTTUNFK->J84444Q!1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% '^<E\:/^2Q?%C_LI?CO_P!2G5:\TKTOXT?\EB^+'_92_'?_ *E.
MJUYI7VT/@C_AC^2/F);OU?YA1115""BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MSPI_1/T5_P#D]/#O_8!Q#_ZI,<?K31117\!'^KX4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]"/@=_R2[PO_
M -QO_P!2+5Z]8KR?X'?\DN\+_P#<;_\ 4BU>O6*^.Q7^\XC_ *_UO_3DC]PR
MG_D599_V+\%_ZC4@HHHK ] **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX[+T7Y!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7(?$'P-X>^)W@7QC\.O%MI]N\,>.?#.M^$]>M0
ML!DETK7M.N-,O3 ;F"Y@CNHX+EY;6:2WF6"Y2*;RV,8%=?133:::=FFFFMTU
MJG\@:3335T]&GLUV9_G2_'WX,>*OV>/C-\1O@KXT3_BH/AYXFO="FNU@>V@U
MG3L1WOA_Q)8P2N\T6F>*/#]WI?B/2DG;SQINJ6OGJDV]%\AK^ES_ (+W?LP?
M\D__ &L_#D'_ #Y?"OXE0JW_ %_ZCX%\0+&6_P"POX?U24?]2U&B?Z^2OYHZ
M^OPM=8BA3J?::M-=IQTEZ7>J\FCYVO2]C5G#HG>+[Q>J^[9^:84445T&(444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 59LKV\TV\M-1TZ[
MN;#4+"Y@O;&^LIY;6\LKRUE2>UN[2Z@>.>VN;:>-)H)X726&5$DC=74$5J*
M/] 7]AW]HZS_ &J?V8_A?\7/MMM=>)[[0[?0?B-!;0Q6BV'Q(\.P0Z?XOB%A
M"SII]MJ&H)_;^D6FXE-!UC2I,D2 U]9U_)1_P0I_:@MOAQ\:_%7[./BB^\CP
M[\<;:#5O!<US<2+:Z=\3/"5C>SG3XXWDCLK7_A-/"QO;::[D+75YK/A?PEHM
MG')-J( _K7KY'&T/J^(G!*T'[]/_  2V2_PN\?D?08:K[:C&3^)>[+_%'=_-
M6E\PHHHKE.@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBOG']K7]H?0?V6/V>_B5\;=<6UNI_">AR)X7T6ZD95\2>-]6=-+\'^
M'RL,B7;6M_KMU9G5YK(2W&FZ##JNL>4T&G3%:C&4Y1A%7E)J,4NK;LE]XI24
M4Y2=E%-MOHEJV?S!?\%OOVG)OBU^TG9?!'P_JD5QX%^ %C+IE[#93O);W_Q.
M\0QVUWXNNKMD6**:7P_80Z-X6M[65;I]'U*Q\3^3=(VKWMK#^*5:>M:SJOB/
M6=6\0Z[?W.JZYKVIW^LZSJE[*9KS4M5U2ZEOM1O[N9OFEN;R[GFN)Y6YDED=
MSR:S*^QH4HT*5.E':$4F^\MY2_[>DV_F?.5:CJU)5'O)WMV71?)604445J9A
M1110 4444 %%%% !7ZQ?\$<_V8YOC]^UIHGC/6M+BOOAS\ 8K;XB^*'O('FL
MKOQ2[75M\--!W*Q5+Z?Q);2^+8H[F*2SN]+\$ZU9S8DG@5_R=K^X_P#X)1_L
MS-^S5^R)X.@UFWBC\=?%J6/XM>,V\J$W%DWB72].3PSX=>Y1?/:+0_"]II9N
M+.262&T\07_B&2V"K=R-)P9CB/88>2B[3J_NX]TFO>DO2.B?1M,ZL'2]K65U
M[L/?EV=G[J^;Z=4F?I31117RQ[P4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7X=?\ !?K_ ),Z^&O_
M &<OX._]5;\9:_<6OPZ_X+]?\F=?#7_LY?P=_P"JM^,M=6"_WO#_ /7Q?J<^
M+_W>K_A_5'\AE%%%?7'SX4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 ?Z7%%%%?#GU 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>O6*^.Q7^\XC_K_6_P#3DC]PRG_D599_V+\%_P"HU(****P/0"BBB@ HHHH
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MWA2]R-MF_MR^<M+]5%,]W!4O944VK2J>^^]FO=3]%K;HVTPHHHKSSK"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *_#K_@OU_R9U\-?^SE_!W_JK?C+7[BU^'7_  7Z_P"3.OAK_P!G
M+^#O_56_&6NK!?[WA_\ KXOU.?%_[O5_P_JC^0RBBBOKCY\**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** /]+BBBBOASZ@**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI,ORRVUY:3PW$$J\212(XX-:=?)[;GT&^P4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!_&!_P6^_Y/O\0?]DT^'/\ Z;;NOR&K]>?^
M"WW_ "??X@_[)I\.?_3;=U^0U?7X/_=</_UZA^1\]B?]XJ_XV%%%%=)@%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?I=_P1\_Y2+_ +._
M_=6__5%_$VO[BJ_AU_X(^?\ *1?]G?\ [JW_ .J+^)M?W%5\YG'^\T_^O$?_
M $Y5/9R[^!/_ *^R_P#2(!1117E'>%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 ?YR7QH_Y+%\6/\ LI?C
MO_U*=5KS2O2_C1_R6+XL?]E+\=_^I3JM>:5]M#X(_P"&/Y(^8EN_5_F%%%%4
M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_2XHHHKX<^H"
MBBB@ HHHH **** "OXC?^"O/_*1#]H3_ +I-_P"J.^&E?VY5_$;_ ,%>?^4B
M'[0G_=)O_5'?#2OZ9^BI_P G#SG_ +(S,?\ U><.G\,?M O^3-<,_P#9S<F_
M]97C,_-FBBBO[_/\?@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH _0CX'?\DN\+_]QO\ ]2+5Z]8K
MR?X'?\DN\+_]QO\ ]2+5Z]8KX[%?[SB/^O\ 6_\ 3DC]PRG_ )%66?\ 8OP7
M_J-2"BBBL#T HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME+D;]ZG9>;C]E_+X?DNYN4445YIVA1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% '^<E\:/^2Q?%C_ +*7X[_]2G5:\TKT
MOXT?\EB^+'_92_'?_J4ZK7FE?;0^"/\ AC^2/F);OU?YA1115""BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH _TN****^'/J HHHH **** "
MBBB@ K^(W_@KS_RD0_:$_P"Z3?\ JCOAI7]N5?Q&_P#!7G_E(A^T)_W2;_U1
MWPTK^F?HJ?\ )P\Y_P"R,S'_ -7G#I_#'[0+_DS7#/\ V<W)O_65XS/S9HHH
MK^_S_'X**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** /T(^!W_)+O"__<;_ /4BU>O6*\G^!W_)+O"_
M_<;_ /4BU>O6*^.Q7^\XC_K_ %O_ $Y(_<,I_P"15EG_ &+\%_ZC4@HHHK ]
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '^
M<E\:/^2Q?%C_ +*7X[_]2G5:\TKTOXT?\EB^+'_92_'?_J4ZK7FE?;0^"/\
MAC^2/F);OU?YA1115""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH _TN****^'/J HHHH **** "BBB@ K^(W_@KS_RD0_:$_P"Z3?\ JCOA
MI7]N5?Q&_P#!7G_E(A^T)_W2;_U1WPTK^F?HJ?\ )P\Y_P"R,S'_ -7G#I_#
M'[0+_DS7#/\ V<W)O_65XS/S9HHHK^_S_'X**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /T(^!W_)
M+O"__<;_ /4BU>O6*\G^!W_)+O"__<;_ /4BU>O6*^.Q7^\XC_K_ %O_ $Y(
M_<,I_P"15EG_ &+\%_ZC4@HHHK ] **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKS7QU:E*C5G2EO"5O5;Q?SBT_F?1TJBJTX5%M))^CV:^3NGZ!1116184444
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M2"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\5?\;"BBBNDP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/TN_X(^?\I%_V=_^ZM_^J+^)M?W%5_#K_P $?/\ E(O^SO\ ]U;_ /5%_$VO
M[BJ^<SC_ 'FG_P!>(_\ IRJ>SEW\"?\ U]E_Z1 ****\H[PHHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_
M #DOC1_R6+XL?]E+\=_^I3JM>:5Z7\:/^2Q?%C_LI?CO_P!2G5:\TK[:'P1_
MPQ_)'S$MWZO\PHHHJA!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ?Z7%%%%?#GU 4444 %%%% !1110 5_$;_P5Y_Y2(?M"?]TF_P#5'?#2
MO[<J_B-_X*\_\I$/VA/^Z3?^J.^&E?TS]%3_ ).'G/\ V1F8_P#J\X=/X8_:
M!?\ )FN&?^SFY-_ZRO&9^;-%%%?W^?X_!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^A'P._Y)=X
M7_[C?_J1:O7K%>3_  ._Y)=X7_[C?_J1:O7K%?'8K_><1_U_K?\ IR1^X93_
M ,BK+/\ L7X+_P!1J04445@>@%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %?N?_P28_Y)Y\6_^QST/_TQR5^&
M%?N?_P $F/\ DGGQ;_['/0__ $QR5^.>/7_)M,X_["\G_P#5GA3^B?HK_P#)
MZ>'?^P#B'_U28X_6FBBBOX"/]7PHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\T?^"P?_ "CH
M_:(_[I)_ZO3X95^EU?FC_P %@_\ E'1^T1_W23_U>GPRK?"_[SA_^O\ 1_\
M3D3*O_ K?]>JG_I$C^'6BBBOL3YP**** "BBB@ HHHH **** /\ 1L^"O_)'
M/A-_V3/P'_ZBVE5Z97F?P5_Y(Y\)O^R9^ __ %%M*KTROB);OU?YGT\=EZ+\
M@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?H1\#O^27>%_P#N-_\ J1:O
M7K%>3_ [_DEWA?\ [C?_ *D6KUZQ7QV*_P!YQ'_7^M_Z<D?N&4_\BK+/^Q?@
MO_4:D%%%%8'H!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKIKU1\XTTVGHT[-=F@HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%%
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M117PY]0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI;:[M+F**XMKB*2&:-)$911KZ0\4**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _P!"']C3XF?\+B_93_9]^(TC;K[Q
M%\*O"']ML#N0^)=(TJ#0O%'D%K_4YC:_\)%I>J"U^UWT]_\ 9O*_M'RK[[1#
M']+U^,G_  0K^(3^+?V*KGPC<7,37'PK^+7C3PO:6)U"&YNH=$UZVT3Q]:WI
ML%BAGTVQO=:\6>([:U$QN8[N[TW4[B&[)\ZSLOV;KXW$T_95ZU/I&I)+TO>/
M?HT?1T9<]*G+O"+?K;7\;A1116)J%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 ?Q@?\%OO^3[_ !!_V33X<_\ IMNZ_(:OUY_X+??\GW^(/^R:?#G_ --M
MW7Y#5]?@_P#=</\ ]>H?D?/8G_>*O^-A111728!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'Z7?\ !'S_ )2+_L[_ /=6_P#U1?Q-K^XJ
MOX=?^"/G_*1?]G?_ +JW_P"J+^)M?W%5\YG'^\T_^O$?_3E4]G+OX$_^OLO_
M $B 4445Y1WA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% '^<E\:/\ DL7Q8_[*7X[_ /4IU6O-*]+^-'_)
M8OBQ_P!E+\=_^I3JM>:5]M#X(_X8_DCYB6[]7^844450@HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /]+BBBBOASZ@**** "BBB@ HHHH *
M_B-_X*\_\I$/VA/^Z3?^J.^&E?VY5_$;_P %>?\ E(A^T)_W2;_U1WPTK^F?
MHJ?\G#SG_LC,Q_\ 5YPZ?PQ^T"_Y,UPS_P!G-R;_ -97C,_-FBBBO[_/\?@H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\X%%%% !1110 4444 %%%% '^C9\%?\ DCGPF_[)GX#_ /46TJO3*\S^"O\
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M!=6EW:SI'/;7-M/&\,\$R)+#*CQR(KJ0*U?6GSX4444 %%%% !1110 4444
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M4!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?D+_P %O_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /\Y+XT?\EB^+'_ &4O
MQW_ZE.JUYI7I?QH_Y+%\6/\ LI?CO_U*=5KS2OMH?!'_  Q_)'S$MWZO\PHH
MHJA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?Z7%%%%?#G
MU 4444 %%%% !1110 5_$;_P5Y_Y2(?M"?\ =)O_ %1WPTK^W*OXC?\ @KS_
M ,I$/VA/^Z3?^J.^&E?TS]%3_DX><_\ 9&9C_P"KSAT_AC]H%_R9KAG_ +.;
MDW_K*\9GYLT445_?Y_C\%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'Z$? [_ ))=X7_[C?\ ZD6K
MUZQ7D_P._P"27>%_^XW_ .I%J]>L5\=BO]YQ'_7^M_Z<D?N&4_\ (JRS_L7X
M+_U&I!1116!Z 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5^Y_P#P28_Y)Y\6_P#L<]#_ /3')7X85^Y__!)C
M_DGGQ;_['/0__3')7XYX]?\ )M,X_P"PO)__ %9X4_HGZ*__ ">GAW_L XA_
M]4F./UIHHHK^ C_5\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *_-'_@L'_RCH_:(_P"Z2?\
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M/AC>70S)_P (AH-ZC^--:T]3$8Q:ZSXKM+?PZMT)_M*7/@S5[4P06TWF7O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P 0?]DT^'/_ *;;NOR&KZ_!_P"ZX?\ Z]0_(^>Q/^\5?\;"BBBNDP"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /TN_X(^?\ *1?]G?\
M[JW_ .J+^)M?W%5_#K_P1\_Y2+_L[_\ =6__ %1?Q-K^XJOG,X_WFG_UXC_Z
M<JGLY=_ G_U]E_Z1 ****\H[PHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#_.2^-'_ "6+XL?]E+\=_P#J
M4ZK7FE>E_&C_ )+%\6/^RE^._P#U*=5KS2OMH?!'_#'\D?,2W?J_S"BBBJ$%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_I<4445\.?4!11
M10 4444 %%%% !7\1O\ P5Y_Y2(?M"?]TF_]4=\-*_MRK^(W_@KS_P I$/VA
M/^Z3?^J.^&E?TS]%3_DX><_]D9F/_J\X=/X8_:!?\F:X9_[.;DW_ *RO&9^;
M-%%%?W^?X_!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!^A'P._Y)=X7_ .XW_P"I%J]>L5Y/\#O^
M27>%_P#N-_\ J1:O7K%?'8K_ 'G$?]?ZW_IR1^X93_R*LL_[%^"_]1J04445
M@>@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %?N?_ ,$F/^2>?%O_ +'/0_\ TQR5^&%?N?\ \$F/^2>?%O\
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MU2[6/^UX0?[IJ_'S_@M#^R_;?&_]EJ^^*>BV/F>/OV>?M_C:TG@MY)KF_P#
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M"V_9?_9*\=ZKIU]]G^(?Q,MKKX6?#>&"XD@OK;6O%.G7D&L>)[>2WD6ZM?\
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M% !1110 4444 %%%% !1110 4444 %%%% !7Y"_\%O\ _DQ'7_\ LIGPY_\
M3A>U^O5?D+_P6_\ ^3$=?_[*9\.?_3A>UT83_>L/_P!?J?\ Z6C'$?P*W_7N
M?_I+/XP:***^P/G0HHHH *_;?_@@_P#%%_"/[7'B7X<W-U%'IWQ;^%^N6=M:
M27,-N]UXG\%7=IXJTN6&*:56O9;7PW!XS!M+:.6Y6&>:]^2TL[MJ_$BOI?\
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M=W=U.\D]S=7,\CS7%Q,[RS2N\DCL[$GP\Y6F'?\ U]7_ *;/4RUZUE_U[?\
MZ6>A4445X9Z@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_&!_P6^_Y/O\
M0?\ 9-/AS_Z;;NOR&K]>?^"WW_)]_B#_ +)I\.?_ $VW=?D-7U^#_P!UP_\
MUZA^1\]B?]XJ_P"-A111728!1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% 'Z7?\$?/^4B_[._\ W5O_ -47\3:_N*K^'7_@CY_RD7_9W_[J
MW_ZHOXFU_<57SF<?[S3_ .O$?_3E4]G+OX$_^OLO_2(!1117E'>%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 ?YR7QH_Y+%\6/^RE^._\ U*=5KS2O2_C1_P EB^+'_92_'?\ ZE.JUYI7
MVT/@C_AC^2/F);OU?YA1115""BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH _TN****^'/J HHHH **** "BBB@ K^(W_ (*\_P#*1#]H3_ND
MW_JCOAI7]N5?Q&_\%>?^4B'[0G_=)O\ U1WPTK^F?HJ?\G#SG_LC,Q_]7G#I
M_#'[0+_DS7#/_9S<F_\ 65XS/S9HHHK^_P _Q^"BBB@ HHHH **** "BBB@
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M#_\ 7^C_ .G(F5?^!6_Z]5/_ $B1_#K1117V)\X%%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7X=?\ !?K_ ),Z^&O_ &<O
MX._]5;\9:_<6OPZ_X+]?\F=?#7_LY?P=_P"JM^,M=6"_WO#_ /7Q?J<^+_W>
MK_A_5'\AE%%%?7'SX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 ?Z7%%%%?#GU 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7Y"_P#!;_\ Y,1U_P#[*9\.?_3A>U^O5?D+_P %O_\ DQ'7_P#L
MIGPY_P#3A>UT83_>L/\ ]?J?_I:,<1_ K?\ 7N?_ *2S^,&BBBOL#YT****
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M^>.C;_Q*TOF?/8FE[*M."5HWYH_X9:I+TUCZH****ZC **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *_T;/@K_ ,D<^$W_ &3/P'_ZBVE5
M_G)U_HV?!7_DCGPF_P"R9^ __46TJO$SG;#^M7\J9Z>6[UO2'YR/3****\(]
M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH _C _P""WW_)]_B#_LFGPY_]
M-MW7Y#5^O/\ P6^_Y/O\0?\ 9-/AS_Z;;NOR&KZ_!_[KA_\ KU#\CY[$_P"\
M5?\ &PHHHKI, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#]+O^"/G_*1?]G?_ +JW_P"J+^)M?W%5_#K_ ,$?/^4B_P"SO_W5O_U1?Q-K
M^XJOG,X_WFG_ ->(_P#IRJ>SEW\"?_7V7_I$ HHHKRCO"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /\Y+
MXT?\EB^+'_92_'?_ *E.JUYI7I?QH_Y+%\6/^RE^._\ U*=5KS2OMH?!'_#'
M\D?,2W?J_P PHHHJA!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 ?Z7%%%%?#GU 4444 %%%% !1110 5_$;_P %>?\ E(A^T)_W2;_U1WPT
MK^W*OXC?^"O/_*1#]H3_ +I-_P"J.^&E?TS]%3_DX><_]D9F/_J\X=/X8_:!
M?\F:X9_[.;DW_K*\9GYLT445_?Y_C\%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Z$? [_DEWA?_
M +C?_J1:O7K%>3_ [_DEWA?_ +C?_J1:O7K%?'8K_><1_P!?ZW_IR1^X93_R
M*LL_[%^"_P#4:D%%%%8'H!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7[G_\ !)C_ ))Y\6_^QST/_P!,<E?A
MA7[G_P#!)C_DGGQ;_P"QST/_ -,<E?CGCU_R;3./^PO)_P#U9X4_HGZ*_P#R
M>GAW_L XA_\ 5)CC]::***_@(_U?"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OS1_P""P?\
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M+:YY2DB#^W?#&I:1K'V<DM;?;O(?YXVK_1'K^;K_ (+W_LQPW>D?#O\ :O\
M#&ERB_TF6#X7_%*:T@0PRZ1=RW%]X!\0W_EM&89;#4YM7\,WFHSQW,M\FL>%
M=-:>UBTJSAN/4RJO[.O[*3]RLK+RJ+6+^:O'S;78X<?2YZ2J+XJ>K\XR:3^Y
MV>NROW/YC****^D/%"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$3:=X4_<AV:7Q27^*5WZ6/>PE+V5&-U[T_?EWU6B^2MIWOW"BBBN(Z@HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K\A?\ @M__ ,F(Z_\ ]E,^'/\ Z<+VOUZK\A?^"W__ "8CK_\ V4SX
M<_\ IPO:Z,)_O6'_ .OU/_TM&.(_@5O^O<__ $EG\8-%%%?8'SH4444 %%%%
M '[-?\$-?C&_P^_;%F^'-[=2IHOQP\!>(/#,=J9H8+0>+?"<1\<>']3N7>WD
MDEEAT?1O%NAV-LES:)-=>)$+&XGCM;>3^QZO\Y?X)?$[4_@M\8OA=\6](666
M_P#AOX]\*>-([2.>XMQJ4/A[6K/4KS1[A[6YLYGL=9LK>XTK4;=;J!+NPO+F
MUED$4SU_HM:7J=AK6F:=K.E745]I>K6-IJ>FWL!)AO+"_MX[JSNH2P4F*XMY
M8Y8R5!*."0#Q7SN;TN6M"JEI5A9_XJ=E_P"DN*^7W>QET[TYP>\)77^&2_S4
MG\_OO4445Y)Z 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% 'D/Q^^$&@_'[X+?$WX->)!MTKXA^$-7\.FY#LDFF:
ME<6YET/6X&59!]IT'7(=.UFU62&X@>YL(EN;6ZMVEMY?\[SQ#H&L>%-?USPO
MXAL9=+U_PWK&IZ!KFFSM$\VG:QH][/IVIV,SPR2PM+:7MM/;R-%+)$SQDQR.
MA#'_ $H:_B1_X+%?!6/X/_MP>/\ 4M.L/L/A_P",.F:/\7=)6.VMH;9]0\0B
MYTSQE(DMK/*L]S>>-]$\1:Q>-<PV-\)-61Y[6:&6VU34O9RBM:=2@]IQ]I'_
M !1LI)>;BT_2!YN8T[QA42^%N,GY2U7W-/\ \"/RUHHHKWSR0HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ K_1L^"O_)'/A-_V3/P'_P"H
MMI5?YR=?Z4'A[0[#PQH&A^&M*65-+\/:/IFAZ:D\AFF6PTFR@L+-9IF ,LJV
M]O&))" 9'!8@$UXF<[8=>=7\/9_YGIY;O6](?^WFQ1117A'JA1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% '\8'_!;[_D^_Q!_V33X<_P#IMNZ_(:OUY_X+
M??\ )]_B#_LFGPY_]-MW7Y#5]?@_]UP__7J'Y'SV)_WBK_C84445TF 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^EW_!'S_E(O\ L[_]
MU;_]47\3:_N*K^'7_@CY_P I%_V=_P#NK?\ ZHOXFU_<57SF<?[S3_Z\1_\
M3E4]G+OX$_\ K[+_ -(@%%%%>4=X4444 %%%% !1110 4444 %%%% !1110
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MK31117\!'^KX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?D+_P %O_\
MDQ'7_P#LIGPY_P#3A>U^O5?D+_P6_P#^3$=?_P"RF?#G_P!.%[71A/\ >L/_
M -?J?_I:,<1_ K?]>Y_^DL_C!HHHK[ ^="BBB@ HHHH *_N8_P""3?QF'QF_
M89^#L]Q/%+K7PQL;CX,ZXD1L-EL?AXMOI_A> QV,A>*4^ +CP?<3C4+>TOYI
MIY+J2.Z@N+?4K_\ AGK^A[_@@#\<GT?XC?&+]GC5+N7[!XU\/6/Q,\)P2+"+
M6W\0^$IXM$\3VT#@K<M?:[H6LZ/>,CI-;K:>#IF22TE+)?>=FE+VF%E)*\J4
ME-=^7X9?))\S_P )V8&IR5TGM43A\]''\5;YG]35%%%?,'N!1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?SW?\
M' OPF_MCX2? [XUV5EON? WCG6O &MW-K;;K@Z-X^TA=8TVYU2:'399#IFE:
MOX)>RL9KO5;2UL=2\4M;6]E>7.N&6T_H1KX._P""G'PVM?BA^PG^T=HT]M%-
M<>'/ 5U\2=.N&^R)<6%U\,+NU\>SW-G<7=K="WEGTO0-1TVY^S+#=WFF7]_I
M<%U;&_,R].#J>SQ5"?\ T\C%_P"&?N2_"3,<1#GH58]7%M>L?>7XH_@XHHHK
MZ\^="BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .O\ A]H%
MGXL\>^"/"VHRW,.G^)?%_AK0+Z:R>*.\BL]9UFRTZZEM))X;F".YC@N7>!YK
M>>)90C20RH"C?Z1-?Y\?[%7A]O%'[8/[+FB?V5%K=O=?'_X1RZGI=Q;PW=K=
MZ)8>.M#U'7EO+6Y5H+FQBT6TOY[Z"9'CEM(ID>.0,4;_ $'*\'.7[]"/:,W;
M_$XK\>7\/(];+5[E67>45]R;_P#;OQ"BBBO%/2"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** /XP/\ @M]_R??X@_[)I\.?_3;=U^0U?KS_ ,%OO^3[_$'_
M &33X<_^FV[K\AJ^OP?^ZX?_ *]0_(^>Q/\ O%7_ !L****Z3 **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH _2[_@CY_RD7_9W_P"ZM_\
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M:5Z7\:/^2Q?%C_LI?CO_ -2G5:\TK[:'P1_PQ_)'S$MWZO\ ,****H04444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH *_#K_@OU_P F=?#7_LY?P=_ZJWXRU^XM?AU_P7Z_Y,Z^&O\
MV<OX._\ 56_&6NK!?[WA_P#KXOU.?%_[O5_P_JC^0RBBBOKCY\**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /]+BBBBOASZ@****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\A?\ @M__ ,F(Z_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /XP/^"WW_)]_B#_ +)I\.?_ $VW=?D-7Z\_\%OO
M^3[_ !!_V33X<_\ IMNZ_(:OK\'_ +KA_P#KU#\CY[$_[Q5_QL****Z3 ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _2[_@CY_P I%_V=
M_P#NK?\ ZHOXFU_<57\.O_!'S_E(O^SO_P!U;_\ 5%_$VO[BJ^<SC_>:?_7B
M/_IRJ>SEW\"?_7V7_I$ HHHKRCO"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** /\Y+XT?\ )8OBQ_V4OQW_
M .I3JM>:5Z7\:/\ DL7Q8_[*7X[_ /4IU6O-*^VA\$?\,?R1\Q+=^K_,****
MH04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '^EQ1117PY]0
M%%%% !1110 4444 %?Q&_P#!7G_E(A^T)_W2;_U1WPTK^W*OXC?^"O/_ "D0
M_:$_[I-_ZH[X:5_3/T5/^3AYS_V1F8_^KSAT_AC]H%_R9KAG_LYN3?\ K*\9
MGYLT445_?Y_C\%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M75^:/_!8/_E'1^T1_P!TD_\ 5Z?#*M\+_O.'_P"O]'_TY$RK_P "M_UZJ?\
MI$C^'6BBBOL3YP**** "BBB@ HHHH **** /]&SX*_\ )'/A-_V3/P'_ .HM
MI5>F5YG\%?\ DCGPF_[)GX#_ /46TJO3*^(EN_5_F?3QV7HOR"BBBD,****
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M%%%>4=X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ?H1\#O^27>%_P#N-_\ J1:O7K%>3_ [_DEWA?\ [C?_ *D6KUZQ7QV*
M_P!YQ'_7^M_Z<D?N&4_\BK+/^Q?@O_4:D%%%%8'H!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBBB@ HHHH _T;/@K_P D<^$W_9,_ ?\ ZBVE5Z97F?P5_P"2.?";_LF?@/\
M]1;2J],KXB6[]7^9]/'9>B_(****0PHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#\OO^"N'[,G_#17[(OBW4]!T?\ M/XC_!?S?B=X
M+\@?Z=<Z;I42_P#"?:%;[(IKBZ_M/P?'J&H6>D6L;3ZOXCT+P[:1#S3'7\1%
M?Z7%?P<?\%(OV8YOV5_VK_B'X,T_2XM,\ >++ZX^(GPN2S@>'38/!7BF_O+F
MWT&P5FD*1>#]3CU+PDL;RO.UOHUM>2?)>Q,_NY17NIX>3VO4I^CLIQ7H[22\
MY/H>5F%*SC62W]R?JOA?W77R1\'4445[9Y@4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '7_  _\#>(?
MB;XZ\'?#KPE:?;O$_CGQ-HGA/0;4K.8Y=5U[4;?3++SS;07,\=M'/<I)=31P
M3&"V26;RV$9%?Z%?P"^#'A7]GCX,_#GX*^"T_P"*?^'GAFRT*&[:!+:?6=2S
M)>^(/$E];Q/)%#J?BCQ!=ZIXCU1(&\A=1U2Z$"I#L1?YH_\ @@[^S)_PFGQ6
M\:_M-^)='\_P[\)[5_!W@&\NAFVN/B1XDL ^MW=DOE2)-=>%/!MXD=T)I(#;
M2>-M'NK5+B:-I++^KJOGLVK\]6-"+]VEK+71SDE;YQCIY.4D>QE]+EA*JUK-
MVC_@77_MZ7Y)WU"BBBO(/0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "OPZ_X+]?\F=?#7_LY?P=_ZJWXRU^XM?AU_P %^O\ DSKX
M:_\ 9R_@[_U5OQEKJP7^]X?_ *^+]3GQ?^[U?\/ZH_D,HHHKZX^?"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_2XHHHKX<^H"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_(7_@M__P F(Z__
M -E,^'/_ *<+VOUZK\A?^"W_ /R8CK__ &4SX<_^G"]KHPG^]8?_ *_4_P#T
MM&.(_@5O^O<__26?Q@T445]@?.A1110 4444 %%%% !7]C/_  1%_:4_X6[^
MR]-\']=NO-\8?L]:FGAV!YKO[1=:G\//$<U_JW@V\=99C.G]BSIK?A"*WAMT
MLK/1M \/[)Y+FZGCA_CFK]&_^"6/[3?_  S+^UUX&U/6]8_LOX<?$O?\,?B-
MYYS8PZ;XBEB_X1S7;CS)4M[/_A'/&$&A:A>:NT<D]GX</B*TA*1:E<[N+'T/
M;X::2O.'[R'>\=TO\4>9)=VNQTX2K[*M%MVC+W)7[2:U\K-)W[7/[G:***^4
M/?"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*** "BBB@ HHHH **** /TN_X(^?\I%_V=_^ZM_^J+^)M?W%5_#K_P $?/\
ME(O^SO\ ]U;_ /5%_$VO[BJ^<SC_ 'FG_P!>(_\ IRJ>SEW\"?\ U]E_Z1 *
M***\H[PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#_ #DOC1_R6+XL?]E+\=_^I3JM>:5Z7\:/^2Q?%C_L
MI?CO_P!2G5:\TK[:'P1_PQ_)'S$MWZO\PHHHJA!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 ?Z7%%%%?#GU 4444 %%%% !1110 5_$;_P5
MY_Y2(?M"?]TF_P#5'?#2O[<J_B-_X*\_\I$/VA/^Z3?^J.^&E?TS]%3_ ).'
MG/\ V1F8_P#J\X=/X8_:!?\ )FN&?^SFY-_ZRO&9^;-%%%?W^?X_!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!^A'P._Y)=X7_[C?_J1:O7K%>3_  ._Y)=X7_[C?_J1:O7K%?'8
MK_><1_U_K?\ IR1^X93_ ,BK+/\ L7X+_P!1J04445@>@%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQDK.+::[-.S"BBBJ$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPSMY-7VE&/)1I0_EIPC_ . Q2_0^:J2YISE_-.4OO;84445H0%%%% !1110
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MJ_AU_P""/G_*1?\ 9W_[JW_ZHOXFU_<57SF<?[S3_P"O$?\ TY5/9R[^!/\
MZ^R_](@%%%%>4=X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2OZ9^BI_R</.?^R,S'_U><.G\,?M O\ DS7#/_9S<F_]97C,_-FBBBO[_/\
M'X**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** /T(^!W_)+O"__ '&__4BU>O6*\G^!W_)+O"__ '&_
M_4BU>O6*^.Q7^\XC_K_6_P#3DC]PRG_D599_V+\%_P"HU(****P/0"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "OW/_X),?\ )//BW_V.>A_^F.2OPPK]S_\ @DQ_R3SXM_\ 8YZ'_P"F.2OQ
MSQZ_Y-IG'_87D_\ ZL\*?T3]%?\ Y/3P[_V <0_^J3''ZTT445_ 1_J^%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?2^*LUWA#\')K\%?_$NH4445XAZ@4444 %%%% !1110 4444 %%%% !1110
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Y"_\%O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /\
MY+XT?\EB^+'_ &4OQW_ZE.JUYI7I?QH_Y+%\6/\ LI?CO_U*=5KS2OMH?!'_
M  Q_)'S$MWZO\PHHHJA!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 ?Z7%%%%?#GU 4444 %%%% !1110 5_$;_P5Y_Y2(?M"?\ =)O_ %1W
MPTK^W*OXC?\ @KS_ ,I$/VA/^Z3?^J.^&E?TS]%3_DX><_\ 9&9C_P"KSAT_
MAC]H%_R9KAG_ +.;DW_K*\9GYLT445_?Y_C\%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ*__ ">GAW_L XA_]4F./UIHHHK^ C_5\**** "BBB@ HHHH **** "BBB@
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M **** /]&SX*_P#)'/A-_P!DS\!_^HMI5>F5Y5\"+VSU+X'_  ;U'3KNVO\
M3[_X5?#R]L;ZRGBNK.]L[KPCH\]K=VEU \D%S;7,$B303PN\4T3I)&[(P)]5
MKXB6[]7^9]/'9>B_(****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;0GNX^2E\4?FEL>W@J_M8<DG[]-)?XH[)^;6S^3ZGK5%%%>8=H4444 %%%%
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M*#?_ &]+W8_AS._E\UPYA4Y:*@MZDDO^W8VD_P >5?/Y/Y:HHHKZ0\4****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC+OX,U_T\?XQA_D%%%%>2>@%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 ?YR7QH_Y+%\6/^RE^._\ U*=5
MKS2O2_C1_P EB^+'_92_'?\ ZE.JUYI7VT/@C_AC^2/F);OU?YA1115""BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _TN****^'/J HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *_<__ (),?\D\^+?_ &.>A_\ ICDK\,*_<_\ X),?\D\^+?\
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Y"_\ !;__ ),1U_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% '^<E\:/^2Q?%C_ +*7X[_]2G5:\TKTOXT?\EB^+'_92_'?
M_J4ZK7FE?;0^"/\ AC^2/F);OU?YA1115""BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH _TN****^'/J HHHH **** "BBB@ K^(W_@KS_RD
M0_:$_P"Z3?\ JCOAI7]N5?Q&_P#!7G_E(A^T)_W2;_U1WPTK^F?HJ?\ )P\Y
M_P"R,S'_ -7G#I_#'[0+_DS7#/\ V<W)O_65XS/S9HHHK^_S_'X**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** /T(^!W_)+O"__<;_ /4BU>O6*\G^!W_)+O"__<;_ /4BU>O6*^.Q
M7^\XC_K_ %O_ $Y(_<,I_P"15EG_ &+\%_ZC4@HHHK ] **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7\:?_!:K]F3_A2O[4L_Q4\/:/\
M8/ ?[0=M=>,5EMAFQM_B19/#!\0[3 B5H;K6+RYT_P :7)GFF-WJ'B?4WMG2
M&W:UM/[+*^ /^"F/[+]S^U5^R=XZ\'^'K'[;\1/!WE_$CX:P1V\=Q=ZAXF\+
MV]W)<^&K0&,S&Z\7>'[G6?#>GI'<6D*ZUJ.DW5[,UG:30R=F K_5\1"3=H3_
M '<[[*,FO>_[=:3]+G-BZ7MJ,DE><?>CW;6Z^:NO6Q_"-1117UAX 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 445Z7\&OA3XJ^.7Q4\!
M?"+P3;?:?$_Q!\3:;X;TS<CO!9_;9A]MU:^\L%TTS1=/2[U?5)@#]GTZQNIS
MQ&:3:BG)NR2;;>R25VWZ(:3;22NVTDENV]$OF?TE?\$$_P!F3^PO _CW]JGQ
M-H_EZEXYNKCX>?#&\NAF3_A$-!O4?QIK6GJ8C&+76?%=I;^'5NA/]I2Y\&:O
M:F""VF\R]_HCKSWX2_#7P]\&_AA\/_A1X3B\OP[\._"&@>#]*9H8(9[NVT'3
M;?3SJ5\MND<4FIZK+!)J6JW.WS+S4KNZNYF>::1V]"KX_$UGB*]2J]I2]U=H
M+2*^Y*_=W?4^BH4E1I0@MTKR?>3UD_OV[*R"BBBL#4**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^6'_@X1O;R3XK_
M +.>G/=W3Z?:_#SQE>VM@]Q*UG;7FH>)-.@O[NWM2Y@ANKV#3=.AN[B-%EN8
MM/LHYG=+6 1_U/5_(/\ \%]-4AO/VQ/A_I]OJ,5T-'_9V\(P7EE#=I.-+U.[
M^(?Q3OI(;JV21A97UUI<VD7CQRI%<36$NFW#!K>2U<^CE:OBX/\ EA4?_DMO
MU./'.V&DN\H+_P F3_0_#^BBBOISPPHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH _NF_X).Z_>>)?^">_[-^HWT5M%/;:'XTT!$M$
MECB-GX3^)_C?PMITKK--.YN9M/T:UFO7#K%)>23R00VT#1V\7Z)5^3'_  1/
MUC4M3_8'\#65]<^?:^'?'/Q+T?1XO)@B^QZ;/XINO$$MMOABCDN-VKZ[JMWY
MUT\\Z_:OLZRBU@MH8?UGKX[%+EQ.(7_3ZI;T<VU^#/HZ#O1HO_IW#_TE!111
M6!J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Y"_P#!;_\ Y,1U
M_P#[*9\.?_3A>U^O5?D+_P %O_\ DQ'7_P#LIGPY_P#3A>UT83_>L/\ ]?J?
M_I:,<1_ K?\ 7N?_ *2S^,&BBBOL#YT**** "BBB@ HHHH **** "BBB@ HH
MHH V/#WB#6_">OZ'XJ\,ZK?:%XD\-:QIGB#P_K>EW$EIJ>C:WHU[!J.E:KIU
MW"RRVM]I]_;6]W:7$3+)!<0QRHP90:_MD_X)G?\ !031/VT/AJ/#_BJ>+3OV
M@?AWH]F/B+I*6D=E9>)[ 2I86OQ"\.I;*ED+'5IC!'KVEV\=J?#^OW#VL=C#
MHU[H5Q>?Q!UZ/\)/BW\0O@9\0O#7Q2^%OB6^\*>-O"E\M]I.K6+*005,5WI^
MH6DH>UU/1]3M7EL=6TF^BGL-2L)Y[2[@EAE93R8S"1Q5/ET52-W3F^CZIV3?
M++KV=FMK/HP^(E0G?5P>DX]UW73F73OLS_1QHKXA_84_;<^'O[:OPEL/%.B7
M=CI7Q+\.V.F6/Q8^'ZEK>[\,^));;;/J&EVEQ=WEU=>"]=NH+NY\+ZL;J[+V
MJR:9J,\6NZ;JEI;_ &]7RM2$Z4Y4YQ<9Q=FGT_S36J:T:::T/>C*,XJ46G%J
MZ:_K?NMT]&%%%%04%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\T?M>?M)
M^&?V3O@#X]^,_B)[:>\T33)[#P7H=R9MOBKQ_J=M<Q>$O#9%N1<K:WVI1K-J
M]S;YET[0;75=4"NMBRGZ7K^/3_@M1^V)#\<_CC;? CP5J45Y\-O@+?7MIJ5_
M87J7.G^*?B=>VEM#XAO!Y0"-%X*0S^#K7?O>'5D\5RP2R65_;N>O!8=XFO&#
M3Y(^]4?]U=+]Y.T5ZM]&<^)K>QI2DK<S]V"?\SZV\E=]M+=3\:?$.OZQXKU_
M7/%'B&^EU37_ !)K&IZ_KFI3K$DVHZQK%[/J.IWTR0QQ0K+=WMS/<2+%%'$K
MR$1QH@"C(HHKZW;8^?"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK]
M//\ @E3^QM-^U?\ M&Z7J7BK1(K_ ."_PBEL?&7Q&;4K1[C1_$-W#<!O"WP^
M='@FM+V7Q-J4+7>K:?=^7:S^$='\1I),MS-86UY%6I&E3G4F[1A%M^?9+S;L
MDNK:14(2J3C".\FDO*_5^26K\D?T&?\ !'?]D>Y_9Q_9LA\>>,=)_L_XH_'K
M^RO&FL0W*1_VAH?@=+1Y/ 'ARY +/:W+Z??W?B?5+*7R;VROO$/]D:K;PWVB
MM##^N%%%?'5JLJU2=6?Q3=WV2M9)>2227DCZ.G3C2A&G':*MYM]6_-N[?J%%
M%%9EA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?Y^/[=&L:
MCKG[9_[5E[JES]JN8/VA/B[H\4ODP0;=.\/>.=;T#1[;9;10QM]CTC3+&T\Y
MD,]QY'GW4L]S)--)\JUZS\?-3O\ 6OCK\:=9U6ZEOM4U;XL_$;4]2O9R#->7
M]_XPUFZO+J8J%!EN+B6260A0"[D@ <5Y-7VM)<M.G'^6$%IMI%(^9F[RD^\I
M/7?5O<****LD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MZKP)XAA\)>-_!OBNYMY;NW\,>*O#WB&>T@9$FNH=%U>SU*6WA>3Y$EG2V:.-
MG^178%N :_TCJ_S1Z_TB?A[X@O/%G@'P/XJU&*UAU#Q+X/\ #7B"_ALDECLX
MKS6=%LM1NHK2.>:YGCM8Y[ETMTFN)Y5B"+)-*X+MX><K_=W_ -?4_P#RFU^I
MZF6O^,O\#7_DR?Z'7T445X9Z@4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!_G)?&C_ )+%\6/^RE^._P#U
M*=5KS2O2_C1_R6+XL?\ 92_'?_J4ZK7FE?;0^"/^&/Y(^8EN_5_F%%%%4(**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_2XHHHKX<^H"BBB
M@ HHHH **** "OXC?^"O/_*1#]H3_NDW_JCOAI7]N5?Q&_\ !7G_ )2(?M"?
M]TF_]4=\-*_IGZ*G_)P\Y_[(S,?_ %><.G\,?M O^3-<,_\ 9S<F_P#65XS/
MS9HHHK^_S_'X**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%X<^*6A:/9WOQ$^%6H32-K'AN:6=K&74=(NYH+:'Q/X4GO40VFMZ8'>SBO\
M2[7Q%::)JU]#I[?<]?+U*<Z4Y0J1<9Q=G%[K]&FM4U=-:IM'N0G&<5*#4HM7
M37Y>36S6Z>CU"BBBH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBOO7<]#+G^]FN]._W2C_ )GZ74445\\>P%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?YR7QH_Y+%\6/\
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MZ]8KR?X'?\DN\+_]QO\ ]2+5Z]8KX[%?[SB/^O\ 6_\ 3DC]PRG_ )%66?\
M8OP7_J-2"BBBL#T HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ K]S_ /@DQ_R3SXM_]CGH?_ICDK\,*_<__@DQ
M_P D\^+?_8YZ'_Z8Y*_'/'K_ )-IG'_87D__ *L\*?T3]%?_ )/3P[_V <0_
M^J3''ZTT445_ 1_J^%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !7Y"_\ !;__ ),1U_\ [*9\.?\ TX7M?KU7Y"_\%O\ _DQ'7_\ LIGPY_\
M3A>UT83_ 'K#_P#7ZG_Z6C'$?P*W_7N?_I+/XP:***^P/G0HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** /1_A)\6_B%\#/B%X:^*7PM\2WWA3QMX
M4OEOM)U:Q92""IBN]/U"TE#VNIZ/J=J\MCJVDWT4]AJ5A//:7<$L,K*?[(O^
M"=W_  4U^'O[9&B:;X#\7/8^"/VC-*T>2?7/"1W6^B>-X],CSJ'B3X>W$\TI
MN(C;J-2U3PK<S'6]#C-Z]O\ VSHFF7&N#^):KVEZIJ>B:GIVM:+J-]I&L:1?
M6FJ:3JVEW=Q8:GI>IV%Q'=V&HZ=?VDD5U97UE=117-I=VTL5Q;7$4<T,B2(K
M#DQ6#IXJ-I>[47PU$DVO*6W-'ROINFG>_1A\1.A+3WH/XH-Z/S7:7G\FF?Z5
M5%?SW?\ !.[_ (+*:-\0/["^#'[7&KZ9X;\=/C3_  U\9[D6NC^%?%CC['!8
MZ9XX2)8M/\,^)KAWNG'B)$T_PKJ211P7<>C:EY3ZQ_0C7S%?#U<//DJQL]TU
MK&2[Q?5?<ULTGH>W2JPK1YH._==8OLU_2?2X4445B:A1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %?QZ?\ !7K_ (*#I^TAXY7X"_"76I7^"'PTUBX;7=6LFFAM_B=X^LV-K+J#
MF18WN/"OA!UNM/\ #:*D=KJVI3ZIXC=M3M#X6N-.^WO^"Q?_  4@B\,Z=K_[
M(OP*\06MQXCUBUDTSXV^-M"U2\2Z\)6?GQFZ^&NDW=@8(#KFL0(UIXWE2]NH
MM*T:>\\)W=F=6U'4QH?\NE>[EF"Y>7$U5JU>E%]$_P#EXUW:^#LO>W<6O*QN
M)O>C3>FU22ZO^1/R^UYZ=&%%%%>V>8%%%% !1110 4444 %%%% !1110 444
M4 %%%% !7W9_P3X_8OU[]M3X[:=X,,ESI?PS\(_8/$WQ<\2VQ6.YL/"HO1&F
MA:/+(KQ)XF\6RPSZ3HLLD=PFFQC4/$$UEJ%MHEQ87/R9\,_AOXS^+_C_ ,(_
M##X>:)<^(O&GCC7+'P]X>TBU #7%]?2A/.NIWQ!8:980";4-7U6\>'3](TJU
MO-4U&XMK"SN)X_[Q_P!B;]DOPE^QI\!_#OPF\/S1:MX@EED\1_$7Q<J/')XN
M\<ZE#;QZGJ$4<@5K71].M[:ST+P[8B.)K?1-,LI;X7.LW.JZA?<&/Q:PU*T6
MO;5$U!=8KK-KLMH]Y=TI6Z\)A_;5+R7[N#3E_>?2*]>O9>J/J#P]X?T3PGH&
MA^%?#.E6.A>&_#6CZ9X?\/Z)I=O'::;HVB:-90:=I6E:=:0JL5K8Z?86UO:6
MEO$JQP6\,<2*%4"MBBBOEM]SW=M@HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!_G)?&C_DL7Q8_[*7X[_P#4IU6O-*]+^-'_ "6+XL?]E+\=_P#J
M4ZK7FE?;0^"/^&/Y(^8EN_5_F%%%%4(**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#_2XHHHKX<^H"BBB@ HHHH **** "OXC?\ @KS_ ,I$
M/VA/^Z3?^J.^&E?VY5_$;_P5Y_Y2(?M"?]TF_P#5'?#2OZ9^BI_R</.?^R,S
M'_U><.G\,?M O^3-<,_]G-R;_P!97C,_-FBBBO[_ #_'X**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#ZL\*?T3]%?_D]/#O_ & <0_\ JDQQ^M-%%%?P$?ZOA1110 4444 %%%%
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M4C[GHHHKP3U0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% '^<E\:/^2Q?%C_LI?CO_P!2G5:\TKTOXT?\EB^+'_92_'?_ *E.
MJUYI7VT/@C_AC^2/F);OU?YA1115""BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MSPI_1/T5_P#D]/#O_8!Q#_ZI,<?K31117\!'^KX4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[79\W.3G.4WO*3D_F[V^6P44459(4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 5^Y__  28_P"2>?%O_L<]#_\ 3')7X85^Y_\
MP28_Y)Y\6_\ L<]#_P#3')7XYX]?\FTSC_L+R?\ ]6>%/Z)^BO\ \GIX=_[
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M%10!9HHKY$^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?WA_P#!-?\
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MH **** "BBB@ HHHH *_(7_@M_\ \F(Z_P#]E,^'/_IPO:_7JOR%_P""W_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '^<E\:/\
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M,4K))=$>)*3DW*3;;=VWNV%%%%4(**** "BBB@ HHHH **** "BBB@ HHHH
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MHTT;-'B[L=,\*Z=J%HZ2'RO&&FRL8I)$?^E.OF\UK^TKJE%^[133\YRLY?\
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MQ!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'P]/#4U3IK3>4G\4Y=9/]%LEHCPJU:=:;G-^22VBNR_5[MZL****W,@HHHH
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MKFE7,5[I>LZ-?W6EZKIMY"VZ&[L-1L98+NSN8F^:*>WFCEC;E7!K]EOV7_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Y"_\%O\
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M ()ZZM8+>7_QGUCPQ<-+)&=*USX5_%6XOT2,@+.TGAKP=XATLQ3 [HPFI-,
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M"BBBK)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY%66?]B_!?\ J-2"BBBL#T HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW+@WES:6RRW$?\2-%:PR>@K<]2I+R7+%/;RD[;[.^VNEWG+,:K^&$(^MY/\
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M76B_E._KO%?J?Z-M%?YR7_"Z/C%_T5CXE_\ A=^*?_EK1_PNCXQ?]%8^)?\
MX7?BG_Y:TO[&G_S_ (_^"W_\D']I1_Y]2_\  U_\CZ_T]/\ 1MHK_.2_X71\
M8O\ HK'Q+_\ "[\4_P#RUH_X71\8O^BL?$O_ ,+OQ3_\M:/[&G_S_C_X+?\
M\D']I1_Y]2_\#7_R/K_3T_T;:*_SDO\ A='QB_Z*Q\2__"[\4_\ RUH_X71\
M8O\ HK'Q+_\ "[\4_P#RUH_L:?\ S_C_ ."W_P#)!_:4?^?4O_ U_P#(^O\
M3T_T;:*_%;_@A+XG\2^+/V1OB+J/BGQ#KGB74(?VCO%UE#?:_JU_K-Y%9Q_#
M+X0SQVD5UJ-Q<SQVT<]S<3) CB)99YI%0/*Y;]J:\JO2=&K.DY<S@[<R5KZ)
M[7=M^YZ%*?M*<)VMS).U[VOYV7Y!1116184444 %%%% !1110 4444 %%%%
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MI1_Y]2_\#7_R/K_3T_T;:*_SDO\ A='QB_Z*Q\2__"[\4_\ RUH_X71\8O\
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M)+WQ[9^!M$N/MQEE:RN+75I[-X[2=Y[FW62S-U_%)16T<GH+XZE67DN6*?\
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M5_G)?\+H^,7_ $5CXE_^%WXI_P#EK1_PNCXQ?]%8^)?_ (7?BG_Y:T?V-/\
MY_Q_\%O_ .2#^TH_\^I?^!K_ .1]?Z>G^C;17^<E_P +H^,7_16/B7_X7?BG
M_P"6M'_"Z/C%_P!%8^)?_A=^*?\ Y:T?V-/_ )_Q_P#!;_\ D@_M*/\ SZE_
MX&O_ )'U_IZ?Z-M%?BM_P0E\3^)?%G[(WQ%U'Q3XAUSQ+J$/[1WBZRAOM?U:
M_P!9O(K./X9?"&>.TBNM1N+F>.VCGN;B9($<1++/-(J!Y7+?M37E5Z3HU9TG
M+F<';F2M?1/:[MOW/0I3]I3A.UN9)VO>U_.R_(****R+"BBB@ HHHH ****
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M 4444 %%%% !1110 4444 %%%?G)_P %:]:UGP]_P3Y_: UC0-6U/0]7L_\
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MYR7_  NCXQ?]%8^)?_A=^*?_ ):T?\+H^,7_ $5CXE_^%WXI_P#EK1_8T_\
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M/C%_T5CXE_\ A=^*?_EK1_PNCXQ?]%8^)?\ X7?BG_Y:T?V-/_G_ !_\%O\
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MO-*]+^-'_)8OBQ_V4OQW_P"I3JM>:5]M#X(_X8_DCYB6[]7^844450@HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /\ 2XHHHKX<^H"BBB@
MHHHH **** "OXC?^"O/_ "D0_:$_[I-_ZH[X:5_;E7\1O_!7G_E(A^T)_P!T
MF_\ 5'?#2OZ9^BI_R</.?^R,S'_U><.G\,?M O\ DS7#/_9S<F_]97C,_-FB
MBBO[_/\ 'X**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** /T(^!W_)+O"__ '&__4BU>O6*\G^!W_)+
MO"__ '&__4BU>O6*^.Q7^\XC_K_6_P#3DC]PRG_D599_V+\%_P"HU(****P/
M0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "OW/_X),?\ )//BW_V.>A_^F.2OPPK]S_\ @DQ_R3SXM_\ 8YZ'
M_P"F.2OQSQZ_Y-IG'_87D_\ ZL\*?T3]%?\ Y/3P[_V <0_^J3''ZTT445_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH _KS_X("_\F=?$K_LY?QC_ .JM^#5?N+7X=?\ ! 7_ ),Z
M^)7_ &<OXQ_]5;\&J_<6ODL?_O=?_'_[:CZ'#?[O2_P(****Y#<**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ K\A?\ @M__ ,F(Z_\ ]E,^'/\
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M2!6KK.<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBBB@ HHHH _SDOC1_P EB^+'_92_'?\ ZE.JUYI7I?QH_P"2Q?%C_LI?CO\
M]2G5:\TK[:'P1_PQ_)'S$MWZO\PHHHJA!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 ?Z7%%%%?#GU 4444 %%%% !1110 5_$;_ ,%>?^4B
M'[0G_=)O_5'?#2O[<J_B-_X*\_\ *1#]H3_NDW_JCOAI7],_14_Y.'G/_9&9
MC_ZO.'3^&/V@7_)FN&?^SFY-_P"LKQF?FS1117]_G^/P4444 %%%% !1110
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MO_PE_"W_ ,=H_M3!_P#/R7_@N?\ D'U'$?RQ_P# X_Y_U9^5_P"5BBOZI_\
MB'P^#O\ T<+\2_\ PE_"W_QVC_B'P^#O_1POQ+_\)?PM_P#':/[4P?\ S\E_
MX+G_ )!]1Q'\L?\ P./^?]6?E?\ E8HK^J?_ (A\/@[_ -'"_$O_ ,)?PM_\
M=H_XA\/@[_T<+\2__"7\+?\ QVC^U,'_ ,_)?^"Y_P"0?4<1_+'_ ,#C_G_5
MGY7_ )6**_JG_P"(?#X._P#1POQ+_P#"7\+?_':/^(?#X._]'"_$O_PE_"W_
M ,=H_M3!_P#/R7_@N?\ D'U'$?RQ_P# X_Y_U9^5_P"5BBOZI_\ B'P^#O\
MT<+\2_\ PE_"W_QVC_B'P^#O_1POQ+_\)?PM_P#':/[4P?\ S\E_X+G_ )!]
M1Q'\L?\ P./^?]6?E?\ E8HK^J?_ (A\/@[_ -'"_$O_ ,)?PM_\=H_XA\/@
M[_T<+\2__"7\+?\ QVC^U,'_ ,_)?^"Y_P"0?4<1_+'_ ,#C_G_5GY7_ )6*
M*_JG_P"(?#X._P#1POQ+_P#"7\+?_':/^(?#X._]'"_$O_PE_"W_ ,=H_M3!
M_P#/R7_@N?\ D'U'$?RQ_P# X_Y_U9^5_P"5BBOZI_\ B'P^#O\ T<+\2_\
MPE_"W_QVC_B'P^#O_1POQ+_\)?PM_P#':/[4P?\ S\E_X+G_ )!]1Q'\L?\
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ME?\ E8HK^J?_ (A\/@[_ -'"_$O_ ,)?PM_\=H_XA\/@[_T<+\2__"7\+?\
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M7\+?_':/^(?#X._]'"_$O_PE_"W_ ,=H_M3!_P#/R7_@N?\ D'U'$?RQ_P#
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M<+\2_P#PE_"W_P =H_XA\/@[_P!'"_$O_P )?PM_\=KL_M3!_P#/R7_@N?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5_&!_P %OO\ D^_Q!_V33X<_^FV[K^S^OR3_ &P_^"2O
MP[_;#^-%]\:/$GQ<\:>#M3OO#V@>'GT70]#T._L(X= MY;>&X6XOW6X,MPLI
M:1"-BD +Q7=E]>GAZ[J56XQ]G*-TF]6XVT2;Z,YL72G5I<D%>7-%ZM+17N[O
M_AS^+.BOZI_^(?#X._\ 1POQ+_\ "7\+?_':/^(?#X._]'"_$O\ \)?PM_\
M':]K^U,'_P _)?\ @N?^1Y?U'$?RQ_\  X_Y_P!6?E?^5BBOZI_^(?#X._\
M1POQ+_\ "7\+?_':/^(?#X._]'"_$O\ \)?PM_\ ':/[4P?_ #\E_P""Y_Y!
M]1Q'\L?_  ./^?\ 5GY7_E8HK^J?_B'P^#O_ $<+\2__  E_"W_QVC_B'P^#
MO_1POQ+_ /"7\+?_ !VC^U,'_P _)?\ @N?^0?4<1_+'_P #C_G_ %9^5_Y6
M**_JG_XA\/@[_P!'"_$O_P )?PM_\=H_XA\/@[_T<+\2_P#PE_"W_P =H_M3
M!_\ /R7_ (+G_D'U'$?RQ_\  X_Y_P!6?E?^5BBOZI_^(?#X._\ 1POQ+_\
M"7\+?_':/^(?#X._]'"_$O\ \)?PM_\ ':/[4P?_ #\E_P""Y_Y!]1Q'\L?_
M  ./^?\ 5GY7_E8HK^J?_B'P^#O_ $<+\2__  E_"W_QVC_B'P^#O_1POQ+_
M /"7\+?_ !VC^U,'_P _)?\ @N?^0?4<1_+'_P #C_G_ %9^5_Y6**_JG_XA
M\/@[_P!'"_$O_P )?PM_\=H_XA\/@[_T<+\2_P#PE_"W_P =H_M3!_\ /R7_
M (+G_D'U'$?RQ_\  X_Y_P!6?E?^5BBOZI_^(?#X._\ 1POQ+_\ "7\+?_':
M/^(?#X._]'"_$O\ \)?PM_\ ':/[4P?_ #\E_P""Y_Y!]1Q'\L?_  ./^?\
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M?PM_\=H_XA\/@[_T<+\2_P#PE_"W_P =H_M3!_\ /R7_ (+G_D'U'$?RQ_\
M X_Y_P!6?E?^5BBOZI_^(?#X._\ 1POQ+_\ "7\+?_':/^(?#X._]'"_$O\
M\)?PM_\ ':/[4P?_ #\E_P""Y_Y!]1Q'\L?_  ./^?\ 5GY7_E8HK^J?_B'P
M^#O_ $<+\2__  E_"W_QVC_B'P^#O_1POQ+_ /"7\+?_ !VC^U,'_P _)?\
M@N?^0?4<1_+'_P #C_G_ %9^5_Y6**_JG_XA\/@[_P!'"_$O_P )?PM_\=H_
MXA\/@[_T<+\2_P#PE_"W_P =H_M3!_\ /R7_ (+G_D'U'$?RQ_\  X_Y_P!6
M?E?^5BBOZI_^(?#X._\ 1POQ+_\ "7\+?_':/^(?#X._]'"_$O\ \)?PM_\
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MG_XA\/@[_P!'"_$O_P )?PM_\=H_XA\/@[_T<+\2_P#PE_"W_P =H_M3!_\
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MOX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\
M@<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)
M?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/
M_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?
MDO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$
MOX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\
M@<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)
M?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/
M_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?
MDO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$
MOX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\
M@<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)
M?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/
M_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?
MDO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$
MOX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\
M@<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)
M?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/
M_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?
MDO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$
MOX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\
M@<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)
M?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/
M_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?
MDO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$
MOX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\
M@<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)
M?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/
M_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?
MDO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$
MOX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\
M@<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)
M?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/
M_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?
MDO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$
MOX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\
M@<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)
M?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/
M_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?
MDO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$
MOX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\
M@<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)
M?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/
M_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?
MDO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$
MOX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\
M@<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)
M?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/
M_P 0^'P=_P"CA?B7_P"$OX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?
MDO\ P7/_ "#ZCB/Y8_\ @<?\_P"K/RO_ "L45_5/_P 0^'P=_P"CA?B7_P"$
MOX6_^.T?\0^'P=_Z.%^)?_A+^%O_ ([1_:F#_P"?DO\ P7/_ "#ZCB/Y8_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '^EQ1117PY]0%%%% !1110
M4444 %?Q&_\ !7G_ )2(?M"?]TF_]4=\-*_MRK^(W_@KS_RD0_:$_P"Z3?\
MJCOAI7],_14_Y.'G/_9&9C_ZO.'3^&/V@7_)FN&?^SFY-_ZRO&9^;-%%%?W^
M?X_!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!^A'P._Y)=X7_P"XW_ZD6KUZQ7D_P._Y)=X7_P"X
MW_ZD6KUZQ7QV*_WG$?\ 7^M_Z<D?N&4_\BK+/^Q?@O\ U&I!1116!Z 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5^Y__  28_P"2>?%O_L<]#_\ 3')7X85^Y_\ P28_Y)Y\6_\ L<]#_P#3
M')7XYX]?\FTSC_L+R?\ ]6>%/Z)^BO\ \GIX=_[ .(?_ %28X_6FBBBOX"/]
M7PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM]^2/.TSQC#>^)[GRR%$>WQM;_(9!+YKLDD7H4\WH2LJD*E-]6K3BOFK2_\
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M(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 ?YR7QH_Y+%\6/^RE^._\ U*=5KS2O2_C1_P EB^+'
M_92_'?\ ZE.JUYI7VT/@C_AC^2/F);OU?YA1115""BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH _TN****^'/J HHHH **** "BBB@ K^(W_
M (*\_P#*1#]H3_NDW_JCOAI7]N5?Q&_\%>?^4B'[0G_=)O\ U1WPTK^F?HJ?
M\G#SG_LC,Q_]7G#I_#'[0+_DS7#/_9S<F_\ 65XS/S9HHHK^_P _Q^"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#]"/@=_R2[PO_ -QO_P!2+5Z]8KR?X'?\DN\+_P#<;_\ 4BU>
MO6*^.Q7^\XC_ *_UO_3DC]PRG_D599_V+\%_ZC4@HHHK ] **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_<__
M (),?\D\^+?_ &.>A_\ ICDK\,*_<_\ X),?\D\^+?\ V.>A_P#ICDK\<\>O
M^3:9Q_V%Y/\ ^K/"G]$_17_Y/3P[_P!@'$/_ *I,<?K31117\!'^KX4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#_ #DOC1_R6+XL?]E+\=_^I3JM>:5Z7\:/^2Q?%C_LI?CO_P!2G5:\TK[:
M'P1_PQ_)'S$MWZO\PHHHJA!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 ?Z7%%%%?#GU 4444 %%%% !1110 5_$;_P5Y_Y2(?M"?]TF_P#5
M'?#2O[<J_B-_X*\_\I$/VA/^Z3?^J.^&E?TS]%3_ ).'G/\ V1F8_P#J\X=/
MX8_:!?\ )FN&?^SFY-_ZRO&9^;-%%%?W^?X_!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^A'P._
MY)=X7_[C?_J1:O7K%>3_  ._Y)=X7_[C?_J1:O7K%?'8K_><1_U_K?\ IR1^
MX93_ ,BK+/\ L7X+_P!1J04445@>@%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %?N?_P28_Y)Y\6_^QST/_TQ
MR5^&%?N?_P $F/\ DGGQ;_['/0__ $QR5^.>/7_)M,X_["\G_P#5GA3^B?HK
M_P#)Z>'?^P#B'_U28X_6FBBBOX"/]7PHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#_ #DOC1_R6+XL?]E+\=_^I3JM
M>:5Z7\:/^2Q?%C_LI?CO_P!2G5:\TK[:'P1_PQ_)'S$MWZO\PHHHJA!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 ?Z7%%%%?#GU 4444 %%
M%% !1110 5_$;_P5Y_Y2(?M"?]TF_P#5'?#2O[<J_B-_X*\_\I$/VA/^Z3?^
MJ.^&E?TS]%3_ ).'G/\ V1F8_P#J\X=/X8_:!?\ )FN&?^SFY-_ZRO&9^;-%
M%%?W^?X_!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!^A'P._Y)=X7_[C?_J1:O7K%>3_  ._Y)=X
M7_[C?_J1:O7K%?'8K_><1_U_K?\ IR1^X93_ ,BK+/\ L7X+_P!1J04445@>
M@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %?N?_P28_Y)Y\6_^QST/_TQR5^&%?N?_P $F/\ DGGQ;_['/0__
M $QR5^.>/7_)M,X_["\G_P#5GA3^B?HK_P#)Z>'?^P#B'_U28X_6FBBBOX"/
M]7PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^A
M'P._Y)=X7_[C?_J1:O7K%>3_  ._Y)=X7_[C?_J1:O7K%?'8K_><1_U_K?\
MIR1^X93_ ,BK+/\ L7X+_P!1J04445@>@%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %?N?_P28_Y)Y\6_^QST
M/_TQR5^&%?N?_P $F/\ DGGQ;_['/0__ $QR5^.>/7_)M,X_["\G_P#5GA3^
MB?HK_P#)Z>'?^P#B'_U28X_6FBBBOX"/]7PHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^;-%%%?W^?X_!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!^A'P._Y)=X7_[C?_J1:O7K%>3_  ._
MY)=X7_[C?_J1:O7K%?'8K_><1_U_K?\ IR1^X93_ ,BK+/\ L7X+_P!1J044
M45@>@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %?N?_P28_Y)Y\6_^QST/_TQR5^&%?N?_P $F/\ DGGQ;_['
M/0__ $QR5^.>/7_)M,X_["\G_P#5GA3^B?HK_P#)Z>'?^P#B'_U28X_6FBBB
MOX"/]7PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#_ #DOC1_R6+XL?]E+\=_^I3JM>:5Z7\:/^2Q?%C_LI?CO_P!2
MG5:\TK[:'P1_PQ_)'S$MWZO\PHHHJA!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 ?Z7%%%%?#GU 4444 %%%% !1110 5_$;_P5Y_Y2(?M"
M?]TF_P#5'?#2O[<J_B-_X*\_\I$/VA/^Z3?^J.^&E?TS]%3_ ).'G/\ V1F8
M_P#J\X=/X8_:!?\ )FN&?^SFY-_ZRO&9^;-%%%?W^?X_!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!^A'P._Y)=X7_[C?_J1:O7K%>3_  ._Y)=X7_[C?_J1:O7K%?'8K_><1_U_
MK?\ IR1^X93_ ,BK+/\ L7X+_P!1J04445@>@%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?N?_P28_Y)Y\6_
M^QST/_TQR5^&%?N?_P $F/\ DGGQ;_['/0__ $QR5^.>/7_)M,X_["\G_P#5
MGA3^B?HK_P#)Z>'?^P#B'_U28X_6FBBBOX"/]7PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_ #DOC1_R6+XL?]E+
M\=_^I3JM>:5Z7\:/^2Q?%C_LI?CO_P!2G5:\TK[:'P1_PQ_)'S$MWZO\PHHH
MJA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?Z7%%%%?#GU
M 4444 %%%% !1110 5_$;_P5Y_Y2(?M"?]TF_P#5'?#2O[<J_B-_X*\_\I$/
MVA/^Z3?^J.^&E?TS]%3_ ).'G/\ V1F8_P#J\X=/X8_:!?\ )FN&?^SFY-_Z
MRO&9^;-%%%?W^?X_!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!^A'P._Y)=X7_[C?_J1:O7K%>3_
M  ._Y)=X7_[C?_J1:O7K%?'8K_><1_U_K?\ IR1^X93_ ,BK+/\ L7X+_P!1
MJ04445@>@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %?N?_P28_Y)Y\6_^QST/_TQR5^&%?N?_P $F/\ DGGQ
M;_['/0__ $QR5^.>/7_)M,X_["\G_P#5GA3^B?HK_P#)Z>'?^P#B'_U28X_6
MFBBBOX"/]7PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#_ #DOC1_R6+XL?]E+\=_^I3JM>:5Z7\:/^2Q?%C_LI?CO
M_P!2G5:\TK[:'P1_PQ_)'S$MWZO\PHHHJA!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 ?Z7%%%%?#GU 4444 %%%% !1110 5_$;_P5Y_Y2
M(?M"?]TF_P#5'?#2O[<J_B-_X*\_\I$/VA/^Z3?^J.^&E?TS]%3_ ).'G/\
MV1F8_P#J\X=/X8_:!?\ )FN&?^SFY-_ZRO&9^;-%%%?W^?X_!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\5O$__!"7]D;Q
M9XE\0^*=1^(O[1T.H>)=<U;7[Z&R\7?#*.SBO-9O[C4;J*TCG^$-S/';1SW+
MI DUQ/*L019)I7!=L/\ X<"_L=?]%*_:7_\ "Q^%O_SFJ_<6BNI8W%I)*O.R
MT6JZ6\O+\^[,/JN'_P"?4/N?^?\ 6O=GX=?\.!?V.O\ HI7[2_\ X6/PM_\
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M?=GX=?\ #@7]CK_HI7[2_P#X6/PM_P#G-4?\.!?V.O\ HI7[2_\ X6/PM_\
MG-5^XM%'U[%_\_ZGWK_+R_/NP^JX?_GU#[G_ )^7Y]V?AU_PX%_8Z_Z*5^TO
M_P"%C\+?_G-4?\.!?V.O^BE?M+_^%C\+?_G-5^XM%'U[%_\ /^I]Z_R\OS[L
M/JN'_P"?4/N?^?E^?=GX=?\ #@7]CK_HI7[2_P#X6/PM_P#G-4?\.!?V.O\
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MM+_^%C\+?_G-5^XM%'U[%_\ /^I]Z_R\OS[L/JN'_P"?4/N?^?E^?=GX=?\
M#@7]CK_HI7[2_P#X6/PM_P#G-4?\.!?V.O\ HI7[2_\ X6/PM_\ G-5^XM%'
MU[%_\_ZGWK_+R_/NP^JX?_GU#[G_ )^7Y]V?AU_PX%_8Z_Z*5^TO_P"%C\+?
M_G-4?\.!?V.O^BE?M+_^%C\+?_G-5^XM%'U[%_\ /^I]Z_R\OS[L/JN'_P"?
M4/N?^?E^?=GX=?\ #@7]CK_HI7[2_P#X6/PM_P#G-4?\.!?V.O\ HI7[2_\
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M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
M[1__ )14?\,V>!?^@KXL_P# [1__ )15]"44?7L7_P _ZGWK_+R_/NP_U?R;
M_H78?_P&7_R1\]_\,V>!?^@KXL_\#M'_ /E%1_PS9X%_Z"OBS_P.T?\ ^45?
M0E%'U[%_\_ZGWK_+R_/NP_U?R;_H78?_ ,!E_P#)'SW_ ,,V>!?^@KXL_P#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5^Y__!)C_DGGQ;_['/0__3')7X85^Y__  28_P"2>?%O_L<]#_\ 3')7
MXYX]?\FTSC_L+R?_ -6>%/Z)^BO_ ,GIX=_[ .(?_5)CC]::***_@(_U?"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *_F5_P""A'_)WWQ=_P"Y!_\ 58>"J_IJK^97_@H1
M_P G??%W_N0?_58>"J_H3Z-G_)=9M_V2>._]7&1'\D?3,_Y-?D/_ &7N5_\
MK/<4GQC1117]N'^9P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^Y_P#P
M28_Y)Y\6_P#L<]#_ /3')7X85^Y__!)C_DGGQ;_['/0__3')7XYX]?\ )M,X
M_P"PO)__ %9X4_HGZ*__ ">GAW_L XA_]4F./UIHHHK^ C_5\**** "BBB@
MHHHH **** "BBO*OB%\=O@A\)+S3M.^*WQD^%7PRU#5[66]TFP^(7Q#\(^"[
MS5+."7R)KO3K7Q)K&FSWMK#.1#+<6R2Q1RGRW</Q32<G:*;?9)M_<A-I*[:2
M[MV7;\SU6BOFC_AM+]CK_H[+]FC_ ,/O\+?_ )JJ/^&TOV.O^CLOV:/_  ^_
MPM_^:JK]E5_Y]U/_  "7^7FOO)]I#^>'_@2_S\U]Y]+T5\T?\-I?L=?]'9?L
MT?\ A]_A;_\ -51_PVE^QU_T=E^S1_X??X6__-51[*K_ ,^ZG_@$O\O-?>'M
M(?SP_P# E_GYK[SZ7HKYH_X;2_8Z_P"CLOV:/_#[_"W_ .:JC_AM+]CK_H[+
M]FC_ ,/O\+?_ )JJ/95?^?=3_P  E_EYK[P]I#^>'_@2_P _-?>?2]%?-'_#
M:7['7_1V7[-'_A]_A;_\U5'_  VE^QU_T=E^S1_X??X6_P#S54>RJ_\ /NI_
MX!+_ "\U]X>TA_/#_P "7^?FOO/I>BOFC_AM+]CK_H[+]FC_ ,/O\+?_ )JJ
M/^&TOV.O^CLOV:/_  ^_PM_^:JCV57_GW4_\ E_EYK[P]I#^>'_@2_S\U]Y]
M+T5\T?\ #:7['7_1V7[-'_A]_A;_ /-51_PVE^QU_P!'9?LT?^'W^%O_ ,U5
M'LJO_/NI_P" 2_R\U]X>TA_/#_P)?Y^:^\^EZ*^:/^&TOV.O^CLOV:/_  ^_
MPM_^:JC_ (;2_8Z_Z.R_9H_\/O\ "W_YJJ/95?\ GW4_\ E_EYK[P]I#^>'_
M ($O\_-?>?2]%>+Z!^TA^SOXLLY=1\+?'OX+^)=/AN7LIK[0/BEX'UFSBO(X
MH9Y+26ZT[7;F".YC@N;>9X'<2K%/#(R!)4+=?H_Q/^&GB+4K;1_#_P 0_ VN
MZO>>=]DTK1_%N@:GJ5U]G@ENKC[-8V6H3W4_D6L$US-Y43>5!#+,^V.-V$N,
ME>\9*V]TU;UT\U]Y2E%[23OM9IW.YHHHJ1A1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !117AWC#]IW]FOX>>(]1\'^/\ ]H7X'>!O
M%VC_ &3^UO"WC#XL^ O#/B/2_P"T+&UU2P_M'1-:U^RU.R^VZ9>V6HVGVFUB
M^TV-W:W<.^WN(I'<8RD[1BY/>T4V[7M>R\VEZL3:6K:2VNVEKVU/<:*^:/\
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M_8Z_Z.R_9H_\/O\ "W_YJJ/^&TOV.O\ H[+]FC_P^_PM_P#FJH]E5_Y]U/\
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M-?X5*7YJ/G_3TR>8T^E.;]7%?JS_ $.:*_SDO^%T?&+_ **Q\2__  N_%/\
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M\/:0_GA_X$O\_-?>?2]%?-'_  VE^QU_T=E^S1_X??X6_P#S54?\-I?L=?\
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M_P!'9?LT?^'W^%O_ ,U5'_#:7['7_1V7[-'_ (??X6__ #557LJO_/NI_P"
M2_R\U]XO:0_GA_X$O\_-?>?2]%?-'_#:7['7_1V7[-'_ (??X6__ #54?\-I
M?L=?]'9?LT?^'W^%O_S54>RJ_P#/NI_X!+_+S7WA[2'\\/\ P)?Y^:^\^EZ*
M^:/^&TOV.O\ H[+]FC_P^_PM_P#FJH_X;2_8Z_Z.R_9H_P##[_"W_P":JCV5
M7_GW4_\  )?Y>:^\/:0_GA_X$O\ /S7WGTO17S1_PVE^QU_T=E^S1_X??X6_
M_-51_P -I?L=?]'9?LT?^'W^%O\ \U5'LJO_ #[J?^ 2_P O-?>'M(?SP_\
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M/^&TOV.O^CLOV:/_  ^_PM_^:JC_ (;2_8Z_Z.R_9H_\/O\ "W_YJJ/95?\
MGW4_\ E_EYK[P]I#^>'_ ($O\_-?>?2]%?-'_#:7['7_ $=E^S1_X??X6_\
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M_8Z_Z.R_9H_\/O\ "W_YJJ/^&TOV.O\ H[+]FC_P^_PM_P#FJH]E5_Y]U/\
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M  )?Y^:^\^EZ*^:/^&TOV.O^CLOV:/\ P^_PM_\ FJH_X;2_8Z_Z.R_9H_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "OYE?^"A'_ "=]\7?^Y!_]5AX*K^FJOYE?^"A'_)WWQ=_[D'_U
M6'@JOZ$^C9_R76;?]DGCO_5QD1_)'TS/^37Y#_V7N5_^L]Q2?&-%%%?VX?YG
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG=;-)GI4JU.M'FIR3[K:2\FGJO79]&T6:***Q- HHHH **** "BBB@ HHHH
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M/M:7_/RG_P"!Q_S\U]X_9S_DG_X"_P#+S7WGS117TO\ \,6_MB_]&F_M+_\
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M]#? W_!.7]ACX>6GV+0/V7OA+J$/E/#O\<^'A\3[O9)=2WC'[?\ $N?Q;?\
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MK3JQYJ<DUU75/LUT?X/HV%%%%8F@4444 %%%% !1110 4444 %%%% !1110
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M75]J7C/PS8/9>(/"&G6Y1OM/C?P<]S>7ME8I"TLL^OZ#=:]H5E;V=Q=Z[=:
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MZ7/&4N9M2Y6M$MN5I[=UZG'B<+]8<9*?*XJUG&Z>M][JWW,_S<J*_MR^.?\
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M2"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEJHR:VNDWKIIHO-?>CYHHKZ7_P"&+?VQ?^C3?VE__#$?%+_YE:/^&+?VQ?\
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M9O[5G_!"OX0_$/\ M+Q7^S#XC_X4QXNF\VY_X03Q'+J>O_"O5+I\MY=G>?\
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M371)[=EOY:^A0P<:$U451R:333BDG=6[MK[V%%%%>:=H4444 %%%% !1110
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MN)?&_@!I&D22STVWOYD3QOHMK&IFMY=2OM7\9W/E?99/L,LT%P;W^>#]I?\
M8Q_:*_9*UB/3_C1\/[[1]'O;YM/T+QSI3C6_ 7B.X$4]Q'#I/B:S7[*E]-:V
MUQ=IHFJIIGB!+2":XN-)@CC=E_T$ZY[Q9X2\+^//#>L^#O&GA_1_%7A7Q%8R
MZ9KOA[7]/MM4T?5K"?'F6M]87D<MO<1%E5U#H3'*D<L926-'7T,/F=>DTJC]
MM#KS/WUZ3W?I*]^ZW..K@:51-P7LY=.7X7ZQ_P#D;?,_S:**_=W_ (*1_P#!
M(?5O@5#J?QJ_9@TKQ#XN^$2RW=[XL^'4*:CXC\4_"RR5&N7U;3;IGO=8\3^
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M6_\ U1?Q-K^XJOG,X_WFG_UXC_Z<JGLY=_ G_P!?9?\ I$ HHHKRCO"BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2YMN:_\ V\DW'_R:Q_511117R9] %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOZ7/^#=S_F\#_NW[_P![;7\T=?TN?\&[G_-X'_=OW_O;:X<R_P!RK?\ </\
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M#'_J4R5_517!F2_VVMYJF_\ RE!?H=>"_P!VI^3G_P"ER?ZA1117 =84444
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M(86O]6T.QO[QH85)$437%Q(8XP2(T(4$@5VE?)/1M=CZ!:I/N%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!_"#_ ,%1M#O_  ]^WW^TO8:DL2W%QXTTW7(Q#()4
M-AXG\(>&_$NE,6  $KZ7JUF\\?6&9I(6),9)^!:_2[_@L'_RD7_:(_[I)_ZH
MOX95^:-?8X;7#8=]Z%+_ --Q/G*^E:LNU6I_Z6PHHHK<R"O[BO\ @CY_RCH_
M9W_[JW_ZO3XFU_#K7]Q7_!'S_E'1^SO_ -U;_P#5Z?$VO*SC_=J?_7^/_INJ
M=^7?QY_]>I?^EP/TNHHHKYP]D**** "BBB@ HHHH Y#Q]X!\&?%+P9XC^'GQ
M#\.:9XM\%^+=,FTCQ#X>U>$SV.HV,Y5]K;&CGMKFVGCAO-/U"SFM]0TS4+>U
MU'3KJUO[6WN(OX7?^"@'[%WB3]BGXX7?@J>>76?AWXLBN_$OPK\4O'Y;ZGX;
M^U>7<:-J2^;.(_$/A6XEBTO5@)/]-A;3==CAM+?68+2#^]&OB'_@H)^R1IG[
M8G[.7BOX>006,/Q$T.*7Q;\)];NH;</8>-=*MY)+;1Y;Z9X38Z/XPMQ+X9UF
MX,K06,-_!K<EI?7&C6ENW=@,4\-52D_W-1J,UTBWHJG_ &[UMO&^[2MR8O#J
MM3;2_>03<>[ZN+]>G9^K/X):*LWME>:;>7>G:C:7-AJ%A<SV5]8WL$MK>65Y
M:RO!=6EW:SI'/;7-M/&\,\$R)+#*CQR(KJ0*U?5'A!1110 5_9/_ ,$=OVWK
M_P#:6^#E[\(OB1J\NH_&+X(V.F6/]J7KB2_\;?#1HH-.\.^)+VZDG:ZU+Q#H
MEU"_A[Q7>S0F6Z#>&];U#4-1UGQ#J3P_QL5]+_L>_M!:K^R_^TA\*OC/I]S<
MQ:;X9\36EOXRL[9#.VL> -:;^R/&^E"T,D<-U<W'AV\OYM(%QYD=EKUOI6J)
M&;FP@9>3&X98FA*-OWD4Y4WU4ET]))<K^3W2.C#5G1JJ7V9>[-?W6]_6.Z^:
MV;/]"&BJ.EZG8:UIFG:SI5U%?:7JUC::GIM[ 28;RPO[>.ZL[J$L%)BN+>6.
M6,E02C@D \5>KY(^@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^*_V\OV/O#'
M[9GP'UWX?WT5C8>/=$BNO$'PK\6S6EM)=^'_ !;;PAX[![R5#<6_A[Q2L$.C
M>);>&54DM6M=2\J:^T?3FB^U**J$Y4YQG!VE!J47YK].C6S5T]"91C.+C)7C
M)6:\C_-H\6^$_$G@3Q1X@\%^,=&OO#OBKPKK&H:!XAT+4X3!?Z3K&EW,EG?V
M-U'E@);>XB="R,\4@ DBDDB=';GJ_J&_X+>_L,VNM>'_ /ALCX8Z-%!KGAN*
MQTCXY:3IEG:1'6_#\UQ%I^@_$=DMQ!=76L:!=7%MX?\ $\QCU*XN_#=QHNIR
M'2],\':I<7G\O-?787$1Q-&-2.CVG'^6:M=>FJ:?5-7L[I?/5Z,J-1P>V\7_
M #1>S_1^:84445T&05[C^S5\<->_9M^._P ,?C?X<B^TZA\/O$T&IW%AN5/[
M7T&]MKG1O%.A^:P(@_MWPQJ6KZ/]H +6WV[ST^>-:\.HI2BI1<9*\9)Q:>S3
M5FGZH:;BU).S3336Z:=TUZ,_TCO OC7PW\2/!?A3X@>#M1BU?PKXU\/:1XH\
M/:E#C9>:/K=C!J-A,4R3%*UO<()X'Q+;S"2"55EC=1U5?SB?\$*_VR'U?1]:
M_8Z\>:I++J.@1:EXS^"EU=&$B7P^\KWOC7P*LVZ*5I=(OYW\7Z!"T5]<3V&I
M^+HY;NST[0-(LF_H[KX_$T)8>M.E+6SO%_S1>L7]VC[--=#Z*A55:E&:W:M)
M=I+XE]^J[II]0HHHK U"BBB@ HHHH **** "BBB@ HHHH ***\O^-7Q=\'_
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M &:F][.JUVW4/GO+RLMFT=V P]_W\UHG:FGW6\_EM'SN[;,****\(]4****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "OYE?^"A'_)WWQ=_[D'_ -5AX*K^FJOYE?\
M@H1_R=]\7?\ N0?_ %6'@JOZ$^C9_P EUFW_ &2>._\ 5QD1_)'TS/\ DU^0
M_P#9>Y7_ .L]Q2?&-%%%?VX?YG!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7[G_\$F/^2>?%O_L<]#_],<E?AA7[G_\ !)C_ ))Y\6_^QST/_P!,<E?C
MGCU_R;3./^PO)_\ U9X4_HGZ*_\ R>GAW_L XA_]4F./UIHHHK^ C_5\****
M "BBB@ HHHH **** "BBB@ HHHH **** /YH_P#@XC_YL_\ ^[@?_>)5_-'7
M]+G_  <1_P#-G_\ W<#_ .\2K^:.OJLM_P!RH_\ <3_T[4/!QO\ O-7_ +<_
M]-P"BBBNXY0K^ES_ (-W/^;P/^[?O_>VU_-'7]+G_!NY_P W@?\ =OW_ +VV
MN',O]RK?]P__ $[3.K!?[S2_[?\ _3<S^ERBBBOE3W@HHHH **** "BBB@ H
MHHH _F0_X. O@-;6>I?!;]I/1].MH&UC[?\ "'QS>Q+)#+=ZA9P7?BGP!-,D
M:&VNKI]-A\<6=S>SM'?"RTO1[(/=VEK FG?S;5_<[_P5F^'\7Q!_8'^/%N(?
M,U#PEIGA[X@:5-B\?[)+X/\ %6C:IJTWD6<B";SO#"Z]89O$GL[7[9_:$L:/
M9Q7$'\,5?3974=3"J+WI3E#SY=)K[N9Q7E$\3'PY*[:VG%2^>L7^5WZA1117
MI'$%%%% ']/'_!OM\8KF[\/?'OX":C>[X-$U/P]\5?"=D_ELZQZY _A;QLR.
M5$Z6T$^C^"'CMP\ELMSJ-Y.D5O/<7$EY_2!7\6__  1(\<2^$_V\_"6@QR7*
M)\3?A[\2? \ZP6UG/%-%8:$/B2L=[+=$3V=L)_A[#*ESIP:\:\BM+-Q_9]U?
MLO\ :17R^:4^3%S:T52,*GX<K^]Q;?FV>Y@9N6'2>O)*4/DK27W*5@HHHKSS
ML"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_JB_B;7]Q5?.9Q_O-/\ Z\1_].53V<N_@3_Z^R_](@%%%%>4=X4444 %%%%
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MCSL=0G4E3E3@Y-*496Z*Z<?Q<O0_IO\ V8?$7_"7_LU_L]>+/L?]G?\ "4?
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MTIV^7-8^APT^>A2EUY>5^L6X_H%%%%<IN%%%% !1110 4444 %%%% !1110
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M6]&O9].U72M1M)E66UOM/O[:XM+NWE59(+B&2)U#*16/7U6^QX(4444 =?X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P!N?^FX!1117<<H5_2Y_P &[G_-X'_=OW_O;:_FCK^ES_@W<_YO _[M^_\
M>VUPYE_N5;_N'_Z=IG5@O]YI?]O_ /IN9_2Y1117RI[P4444 %%%% !1110
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M<,2X/1J,XM>::OOYH_?"BBBOFCV@HHHH **** "BBB@ HHHH **** "BBB@
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M_DK?S2/Y!Z***^I/""BBB@#]9_\ @C[^UK>?LZ_M.:+\/=;NL?#']H+4]#\
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M'^W](N/#WB2&2XE\[6M9NO%EQ C+IUTR_P!@U? O_!2W]F.;]J?]DOX@^#-
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M:SMMGEU/P)/=6.E;I#(]SX>O-&*F233-1F/[L5_G)?!OXM^-_@/\4?!'Q?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ K]S_\ @DQ_R3SXM_\ 8YZ'_P"F.2OPPK]S_P#@DQ_R3SXM
M_P#8YZ'_ .F.2OQSQZ_Y-IG'_87D_P#ZL\*?T3]%?_D]/#O_ & <0_\ JDQQ
M^M-%%%?P$?ZOA1110 4444 %%%% !1110 4444 %%%% !1110!_-'_P<1_\
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M??%)A1117 =84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_#K_ ,%@_P#E
M(O\ M$?]TD_]47\,J_-&OTN_X+!_\I%_VB/^Z2?^J+^&5?FC7V.%_P!VP_\
MUXH_^FXGSE?^/6_Z^U/_ $N04445N9!7]GW_  1 _P"3$= _[*9\1O\ TX65
M?Q@U_9]_P1 _Y,1T#_LIGQ&_].%E7F9M_NJ_Z^P_*1W9?_'?_7N7_I43]>J*
M**^:/:"BBB@ HHHH **** "BBB@ HHHH _(;]OW_ (*K?\,-?&/PU\)O^%#_
M /"T?^$A^&>C?$3^W_\ A:'_  A/V/\ M;Q3XR\-?V/_ &5_PKOQ=]H^S_\
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M^'?U"BBBN$Z@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;/H,-2]E1A"UI6YI?XI:N_I\/R"BBBN8W"BBB@ HHHH **** "BBB@ HHHH
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M7^RD%%%%>8=H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_#K_ ,%@_P#E
M(O\ M$?]TD_]47\,J_-&OTN_X+!_\I%_VB/^Z2?^J+^&5?FC7V.%_P!VP_\
MUXH_^FXGSE?^/6_Z^U/_ $N04445N9!7]Q7_  1\_P"4='[._P#W5O\ ]7I\
M3:_AUK^XK_@CY_RCH_9W_P"ZM_\ J]/B;7E9Q_NU/_K_ !_]-U3OR[^//_KU
M+_TN!^EU%%%?.'LA1110 4444 %%%% !1110!^$__!?CQS'HW[+OPO\  <%W
M=6^H>./C18ZI-#$;86U]X>\&^$O$TFI6UT'G%VWEZ[K_ (4O(/L]M) 'M2;F
MYMG^S0WG\C]?MW_P7;^.-M\0OVI?"_PCTB_^UZ1\"/ T-GJT)@D1;3Q_\07M
M?$OB".WNOM$EO>VP\(VWP[BD>*""6UU6#5;"Y:62U"0_B)7U674W3PE.^\[U
M'I;23]W_ ,E47<\'&34\1-K51M'_ ,!5G_Y-<****[CE"BBB@#^J/_@WO\!O
MI_PC_:)^)Q>4Q^+_ (C^$O :H;B%H5?X<^&;OQ [QVJP+<0RNOQ2C$UQ+<S0
MW*1PQP06[VMS)=?T*U\)_P#!-3X*2? ;]BOX'>$;Z'RO$&O>&5^(WB@&:YDD
M36OB),_BI;&>.?;';7.AZ1J.E>'KJ"SBCM/M.D2S(]W---?W?W97R&,J*KB:
MTULYM)]U!*"?S4;H^BP\.2A2CLU!-KLY>\_Q;"BBBN8V"BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^97_@H1_P G??%W_N0?_58>
M"J_IJK^97_@H1_R=]\7?^Y!_]5AX*K^A/HV?\EUFW_9)X[_U<9$?R1],S_DU
M^0_]E[E?_K/<4GQC1117]N'^9P4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5^Y_\ P28_Y)Y\6_\ L<]#_P#3')7X85^Y_P#P28_Y)Y\6_P#L<]#_ /3'
M)7XYX]?\FTSC_L+R?_U9X4_HGZ*__)Z>'?\ L XA_P#5)CC]::***_@(_P!7
MPHHHH **** "BBB@ HHHH **** "BBB@ HHHH _FC_X.(_\ FS__ +N!_P#>
M)5_-'7]+G_!Q'_S9_P#]W _^\2K^:.OJLM_W*C_W$_\ 3M0\'&_[S5_[<_\
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M+2U]'F,5# R@MH^RBO2,HI?@CQL$W+%*3U<E-OU:;?XG]"-%%%?,GMA1110
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M****P-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH S-:T;2O$>C:MX>UVPMM5T/7M,O\
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M. J\])TV_>IO3_ ]ON=UY*QT-%%%>6=X4444 %%%% !1110 4444 %?PQ?\
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M?^DH****\8]$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT?\ #_K]CK_HFO[2_P#X1WPM_P#GRT?4<7_SXJ?<O\_/\^S#ZUA_^?L/O?\
MEY_GV9^XM%?AU_P_Z_8Z_P"B:_M+_P#A'?"W_P"?+1_P_P"OV.O^B:_M+_\
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MW]H7_LI?A?\ ]1:6OY6*_JG_ .#?#_DCO[0O_92_"_\ ZBTM&:?[G4_Q4_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW-?*P4445P'6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7E7QR^$GA[X\_![XD_!OQ4
M?*T3XC^$-:\+7-\MK!>3Z/<ZC:2)I?B"QMKDB"74_#NJK9:[I8F(C74=.M78
M@+FO5:*:;BU).SBTT^S3NG\F)I---73337=/1H_S=OB!X&\0_#+QUXQ^'7BV
MT^P^)_ WB;6_">O6H6<1Q:KH.HW&F7OD&Y@MIY+:2>V>2UFD@A,]L\4WEJ)
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ME(]++OX=3_&O_24%%%%>,>B%%%% !1110 4444 %%%% !1110 4444 %%%%
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M5I-'\&RB2)&OD\2WUCJ-K9S17<&EWIGM(+K^5S]M+_@IK\?OVR+FXT"_N?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MII=^5M+U:NE\SXYHHHK<R"OZI_\ @WP_Y([^T+_V4OPO_P"HM+7\K%?U3_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *_,/_@JC^Q7#^UQ^S]=ZEX3
MT>6]^-_PDBU#Q/\ #1K)D6\\0VDJ0-XJ\ 3))^ZNHO$EA9PW>CH?*NH?%.D:
M(D%[;:?>ZU;:A^GE%:4JDJ-2%2#M*#379]T_)K1KJF14A&I"4)*\9*S[^37F
MG9KS1_FF3P36TTUM<PRV]Q;RR03P3QO%-!-$YCEAFBD"O'+&ZLDD;JKHZE6
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+U74O[5_X3C_ (3#[)]C_LQE\G[#_P (A<_://SYGVR#R_\ 5R5^>]?TN?\
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M4E^\-%%%>$>J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6;(),2:GI.G7H"E3YUI$<[05/\?U?2Y2K85^=6;_  @OT/$Q[OB+=H17YO\
M4****],X@HHHH _=/_@@#IE_+^UG\5=8CM97TRP_9V\0Z9>7H \FWO\ 5OB5
M\+KK3K60YW"6[M]%U66(!2"EC/D@A0W]<M?R\?\ !O1X>FN?''[3_BM;B);?
M1?"GPQ\/2VA1S-/-XGU?QEJ4%Q&X^18K5/"-S%,C?.[WD!3B.2OZAZ^7S-WQ
ME1?RQIK_ ,DC+]3W,"K8>+_FE-_^3-?H%%%%>>=@4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWK65.A%[_O)KR6D%\WS-KRBS?+J6LZK6B]R/KHY/Y*ROYM$M%%%>$>J%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7YH_P#!8/\ Y1T?M$?]TD_]
M7I\,J_2ZOS1_X+!_\HZ/VB/^Z2?^KT^&5;X7_></_P!?Z/\ Z<B95_X%;_KU
M4_\ 2)'\.M%%%?8GS@4444 ?I=_P1\_Y2+_L[_\ =6__ %1?Q-K^XJOX=?\
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M/0A.E)1DZL8MM*7NN$VU9IK>*UW.O!TH5JLHU%=*FY)7:U4HK=-=&S\.O^'
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M[O0-=LED,$_V:Y"O#>6-R%9K/4]-NX[?4M*O45I++4;2UNXP7A45_ 1^T_\
MLZ>.?V5?C9XT^"WCV"5]0\-7QET37A9M9Z?XR\)7Q>;PYXOT=?/NXOL.M6 5
MY[:*^O7T;5H=3\/:A.-6T?4((?\ 0YK\G?\ @K+^PRG[6'P3;QQX"T:*X^/'
MP=L=0U?PFMG9S2ZKXZ\) &\\1?#@_8@]Q?7TZQMK?@F&6UU!XO$MO-HFGC2X
M/&6MZBOHY=B_J]7DF_W55I.^T)[1GY+I+;2S?PV.+&T/:T^>*_>4TVN\H[N/
M=M;Q\[I:R/XJ:***^G/$"BBB@ HHK]$O^"9_[&=[^V+^T/IFD:W97/\ PI_X
M<?8O%_Q;U2-94AFTT2S_ /"/>"X;D6\MNNI^.-5LI++R)9[2=?#.G^+-7L)9
M+O1H[:>*E2-*$JDW:,$Y-_HN[;T2ZMI=2H0E4G&$5>4G9?YOR6[?1:G[6_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *_<__ (),?\D\^+?_ &.>A_\ ICDK\,*_<_\ X),?\D\^+?\ V.>A_P#I
MCDK\<\>O^3:9Q_V%Y/\ ^K/"G]$_17_Y/3P[_P!@'$/_ *I,<?K31117\!'^
MKX4444 %%%% !1110 4444 %%%% !1110 4444 ?S1_\'$?_ #9__P!W _\
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MF7^T_G5&?_@3C+]3Q<)'DQ;C_+[2/W77Z']"-%%%?-'M!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!X3^U)X>F\6_LR_M%^%+>XBL[CQ/\"?B[X>@NYD>2&UFUKX?^(=
M-BN)DCP[Q0/<K+(B?.R*0O)%?YWM?Z7%?YO_ ,3O!ES\./B5\0_AY>+=+>>
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MOES]RI'JII_^!*W_ +:PHHHKQCT0HHHH **** "BBB@ HHHH **** "BBB@
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M%%%%<QL%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]7I\,JWPO^\X?_K_ $?_ $Y$RK_P*W_7JI_Z1(_AUHHHK[$^<"BBB@#]+O\
M@CY_RD7_ &=_^ZM_^J+^)M?W%5_#K_P1\_Y2+_L[_P#=6_\ U1?Q-K^XJOG,
MX_WFG_UXC_Z<JGLY=_ G_P!?9?\ I$ HHHKRCO"BBB@ HHHH **** "BBB@
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M-?8X7_=L/_UXH_\ IN)\Y7_CUO\ K[4_]+D%%%%;F05_<5_P1\_Y1T?L[_\
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MY.6%H.3;;IQNWJW;35]=%N?/8F*C7JJ*LE+1+S2?YL****Z3 *_JG_X-\/\
MDCO[0O\ V4OPO_ZBTM?RL5_5/_P;X?\ )'?VA?\ LI?A?_U%I:\_-/\ <ZG^
M*G_Z6CLP'^\1_P ,_P C^A&BBBOESW HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K^97_ (*$?\G??%W_ +D'_P!5AX*K^FJO
MYE?^"A'_ "=]\7?^Y!_]5AX*K^A/HV?\EUFW_9)X[_U<9$?R1],S_DU^0_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %?PS_\ !6?X7/\ "[]O'XVPQ6L5MI7CR^T?XHZ.\-M#:)=IXWTBUO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#Q+]I3X9/\ &?\ 9\^-?PI@@BGO_'_PO\;^%]&$
MR0R)!XAU3P]?P>'+T1W-[IULTNGZZ=.OX!<ZA96YFMH_/N[>+?*O^=I7^EQ7
M\#?_  42^#)^ _[9WQ[\!V\$L.BS^-+CQKX89A?O;MX;^(=M;^-M,M;.\U&-
M+C48M#779?#=S>&2[W:GHU_;R7UY/;S3O[>3U-:U%]5&I'Y>[+\X?<SS,QAI
M3J+HW!_/6/Y2/BNBBBO=/*"BBB@#]1?^"-_CI/!7[??PGM+B>*VL/'FD>/?
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MG"<9QWA*,E?:\6FK_-"DE*+B]I)I^C5F?QS?LQ?\$K/V]/AY^TI^SUX_\8?
MC^Q_"/@;XX_";QAXIU;_ (6?\&M0_LOPYX9\>Z!K6MZC]@TOXAWNIWOV+3+*
MZN?LFG65W?W/E>3:6MQ</'$_]C-%%;XG%U,5*,JD81<$TN122LW?7FE+\+&5
M"A"A&48.34G=\S3=[6TLD%%%%<QL%%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^97_@H1_R=]\7?^Y!_P#5
M8>"J_IJK^97_ (*$?\G??%W_ +D'_P!5AX*K^A/HV?\ )=9M_P!DGCO_ %<9
M$?R1],S_ )-?D/\ V7N5_P#K/<4GQC1117]N'^9P4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5^Y__!)C_DGGQ;_['/0__3')7X85^Y__  28_P"2>?%O
M_L<]#_\ 3')7XYX]?\FTSC_L+R?_ -6>%/Z)^BO_ ,GIX=_[ .(?_5)CC]::
M***_@(_U?"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^:/\ X.(_^;/_
M /NX'_WB5?S1U_2Y_P '$?\ S9__ -W _P#O$J_FCKZK+?\ <J/_ '$_].U#
MP<;_ +S5_P"W/_3< HHHKN.4*_I<_P"#=S_F\#_NW[_WMM?S1U_2Y_P;N?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWH[2BBBOGCV HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?[S3_P"O$?\ TY5/9R[^!/\ Z^R_](@%%%%>4=X4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?PZ_\%@_
M^4B_[1'_ '23_P!47\,J_-&OTN_X+!_\I%_VB/\ NDG_ *HOX95^:-?8X7_=
ML/\ ]>*/_IN)\Y7_ (];_K[4_P#2Y!1116YD%?W%?\$?/^4='[.__=6__5Z?
M$VOX=:_N*_X(^?\ *.C]G?\ [JW_ .KT^)M>5G'^[4_^O\?_ $W5._+OX\_^
MO4O_ $N!^EU%%%?.'LA1110 4444 <SXS\'>&/B'X1\3> _&FCVOB#PCXQT/
M4_#?B31+PS+;:IHNLV<MAJ-E));RP7,'GVT\B)<VL\%W;2%;BUG@N(XY4_A+
M_;[_ &-_$G[%OQXU;P#<_;M4^'OB.*3Q/\*?%]Q:F*'7?"UQ.4FTNXF2>ZA_
MX2'PC>LVAZ[;/-%>3(FF>(FL+'3/$FD++_>U7QS^W+^R%X5_;.^!.N_#+5WM
M=*\7Z=Y_B'X8^+9D16\->-K6RN(].-[<K8ZA>+X9UAI%TSQ5:6=O)<7&E2M<
M6B#5+'39H.[ 8MX:K:3?L9V4U_*^DTN\>O>-U9M1MR8O#^WA>*_>0UB^ZZQ?
MD]UV?JS^ VBNO\?^ _%7PO\ &WBKX=^.-(N="\7>#-<U'P[X@TJ[C>.6TU+3
M+A[>8(75/.MIM@N+*[C!@O;.6"\MGDMYXI&Y"OJ4TTFG=-)IK9IZI_,\)IIM
M-6:T:>Z?9A1113 _2#_@FA^W)?\ [&'QLCF\27=]/\$/B-+I^C?%32+6W%Y)
MIZ6QN8M#\<Z?;QVUQ?R7WA*74+N:\L=-Q-K.B7.HV(M[O4$TAK7^XK2]4TS6
M],T[6M%U&QU?1]7L;35-)U;2[NWO],U33+^WCN[#4=.O[226UO;&]M98KFTN
M[:66WN;>6.:&1XW5C_FJU_3+_P $4?V^Y+O[-^QQ\7_$&98+9Y_@'XAUBYN9
M9;B.WWR:E\*[G4+N\F5/LUH$U'X?68MK>VBL[/6O#J7GFCPII$WCYIA.>+Q-
M->_%+VJ2^**LE/U@M'O>-MN77T<#B.5^QF_=D_<?:3^SZ2Z?WO4_I3HHHKY\
M]<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH _D,_X+]?\ )XOPU_[-H\'?^K2^,M?AU7[B_P#!?K_D\7X:_P#9
MM'@[_P!6E\9:_#JOKL%_NF'_ .O:_4^?Q?\ O%7_ !?H@HHHKJ.<*_JG_P"#
M?#_DCO[0O_92_"__ *BTM?RL5_5/_P &^'_)'?VA?^RE^%__ %%I:\_-/]SJ
M?XJ?_I:.S ?[Q'_#/\C^A&BBBOESW HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K^97_@H1_R=]\7?^Y!_P#58>"J_IJK^97_
M (*$?\G??%W_ +D'_P!5AX*K^A/HV?\ )=9M_P!DGCO_ %<9$?R1],S_ )-?
MD/\ V7N5_P#K/<4GQC1117]N'^9P4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5^Y__!)C_DGGQ;_['/0__3')7X85^Y__  28_P"2>?%O_L<]#_\ 3')7
MXYX]?\FTSC_L+R?_ -6>%/Z)^BO_ ,GIX=_[ .(?_5)CC]::***_@(_U?"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#^:/\ X.(_^;/_ /NX'_WB5?S1
MU_2Y_P '$?\ S9__ -W _P#O$J_FCKZK+?\ <J/_ '$_].U#P<;_ +S5_P"W
M/_3< HHHKN.4*_I<_P"#=S_F\#_NW[_WMM?S1U_2Y_P;N?\ -X'_ ';]_P"]
MMKAS+_<JW_</_P!.TSJP7^\TO^W_ /TW,_I<HHHKY4]X**** "BBB@ HHHH
M^#O^"A'[%/AO]M;X(7OA7;8Z9\5/!D6J^(/@_P"++I B:9XDGM8OM7AS5+I$
M>XA\*>-!86&F>(#"DYLIK;2/$26.HW7A^TL9_P"%3Q-X9\0^"_$6M^$O%NB:
MGX;\3^&]3O-&U[0=9LY]/U72-5T^=[:]L+^RN4CGMKFVGC>.6*1 0P[@@G_2
M<K^=?_@M5^P'#XFT34/VQ_A/I,4/B3PU8QK\=="M(T7_ (2'PW9QVUGIOQ#M
M(T"G^V/#%O&NG^*EQ-_:/AL6&K V+>&=2?6?7RS&>SDL/4?[N;_=M_8F_L^4
M9OY*6OVI,\['8?G3K07O17OK^:*Z^L5]Z]$?RWT445]">0%%%% ']5G_  15
M_;U3Q]X7T_\ 9 ^*>M1'QMX(T>0?!74KZ68W?BOP-HUM<WEYX+DN;N[F%SK'
M@32X3)H%E:10+_P@6GM;PVR0^$[FYN/Z#*_S;?!GC'Q/\//%WAGQYX+UBZ\/
M^+O!VN:9XD\-ZW9B%KG2]:T:\BO].O8X[B*>VG\BY@C=[:Z@GM+F,/;W4$]O
M))$_]VG[ G[9'AO]M+X#Z3X^MOL.E_$+PY+'X8^*WA"WNA+-H7BFW@#PZI;P
MO!:S?\(]XNLE77-"N4AELX7?4_#JW]]J?AO5VB^>S/">SF\137[N;]]+:$WU
M\HS_  E?NDO8P.(YX^QF_>@O=;^U%:6]8_C'T;/MZBBBO(/0"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#^'7_@L'_RD7_:(_P"Z2?\ JB_AE7YH
MU^EW_!8/_E(O^T1_W23_ -47\,J_-&OL<+_NV'_Z\4?_ $W$^<K_ ,>M_P!?
M:G_I<@HHHK<R"O[/O^"('_)B.@?]E,^(W_IPLJ_C!K^S[_@B!_R8CH'_ &4S
MXC?^G"RKS,V_W5?]?8?E([LO_CO_ *]R_P#2HGZ]4445\T>T%%%% !1110 4
M444 %%%% !1110 4444 %%%% !7CG[0/QN\'_LY_!SQ_\9_'-S%'H7@7P]?:
MLMBUU#9W7B'6%B:+0?"NERSJ\?\ ;'B?6'LM$TS>C1)=WL<MQLMHII$]CK^3
MO_@N)^V3;?$KXB:3^RMX#U#[1X1^$FIMK7Q*O[:>00:O\47M[FRM_#WEB-8Y
M;7P)I%U.ES<)<2I/XBU[5-/GM;>X\,PW%UTX3#O$UXT[/E3YJC[035]>C?PK
MS9AB*RHTI3TYMH)]9/\ R6K\D?D+\0/VG_CY\2O&_BKQ]XC^*OCB+7/%^N:C
MK^I0:+XHU[1=&M;G4;AYVM-)TBQU&*STW3+-66VL+*W01VUK%%$"Q4NW]Q7[
M#'PC\2_!+]E7X.^!?&^I:YJWCQ?#*>)/'-[XDO\ 4-1UI/%7BZYG\2:II-[<
M:FJ7@_X1MM3C\,V\$L:/!::/!'+YLRRSR_QG_P#!/#X&I^T+^V+\$/A]?6D5
MYX<@\5P^-/&4-PTR6D_A+P'%)XKU?3KN2V4W"1>(%TN'PU&T!C?[5K-N/M-F
MI:\@_ODKT<VG&/LJ$%&-ESR226GPP6G_ &]IZ,X\OC*7M*LFWKR*[OKHY/\
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M=2>XBU;Q;I8;S-.\:>)G7^TKW6_#]_9ZYH%M/!X5L]>U#1K&=M4]4_X+&_\
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M;9G(4445Z1Q!7VS_ ,$[_P!H7_AF?]KKX1_$/4-5MM(\'ZAKD7@7XBW=^/\
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M%YYFD?!SPS'XB\4PH=N/'GQ M[;4;>SGC:W5G_LOP1#X<O[2X2ZDC;_A*;V
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MSPPHHHH _?[_ ((._M-_\(7\5O&O[,GB76/(\._%BU?QCX!L[HXMK?XD>&[
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_-'_ (+!_P#*.C]H
MC_NDG_J]/AE7Z75^:/\ P6#_ .4='[1'_=)/_5Z?#*M\+_O.'_Z_T?\ TY$R
MK_P*W_7JI_Z1(_AUHHHK[$^<"BBB@#]+O^"/G_*1?]G?_NK?_JB_B;7]Q5?P
MZ_\ !'S_ )2+_L[_ /=6_P#U1?Q-K^XJOG,X_P!YI_\ 7B/_ *<JGLY=_ G_
M -?9?^D0"BBBO*.\**** "BBB@ HHHH **** "BBB@ HHHH **** "OY@O\
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MOT04445U'.%?U3_\&^'_ "1W]H7_ +*7X7_]1:6OY6*_JG_X-\/^2._M"_\
M92_"_P#ZBTM>?FG^YU/\5/\ ]+1V8#_>(_X9_D?T(T445\N>X%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?S*_\ !0C_ ).^
M^+O_ '(/_JL/!5?TU5_,K_P4(_Y.^^+O_<@_^JP\%5_0GT;/^2ZS;_LD\=_Z
MN,B/Y(^F9_R:_(?^R]RO_P!9[BD^,:***_MP_P S@HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ K]S_P#@DQ_R3SXM_P#8YZ'_ .F.2OPPK]S_ /@DQ_R3
MSXM_]CGH?_ICDK\<\>O^3:9Q_P!A>3_^K/"G]$_17_Y/3P[_ -@'$/\ ZI,<
M?K31117\!'^KX4444 %%%% !1110 4444 %%%% !1110 4444 ?S1_\ !Q'_
M ,V?_P#=P/\ [Q*OYHZ_H[_X.&O$,-SXL_99\*+;RK<:+X>^+/B&6[+H89X?
M$^I> --@MXT'SK+:OX1N99G;Y'2\@"<QR5_.)7U66JV"HW_Z>/[ZLVOP/!QO
M^\U?^W/PA$****[CE"OZ7/\ @W<_YO _[M^_][;7\T=?TN?\&[G_ #>!_P!V
M_?\ O;:X<R_W*M_W#_\ 3M,ZL%_O-+_M_P#]-S/Z7****^5/>"BBB@ HHHH
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M6EQ8:GI>IV%Q):7^G:C87<<5U97UE=12VUW:7,45Q;7$4D,T:2(RBC7],/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7[G_\ !)C_ ))Y
M\6_^QST/_P!,<E?AA7[G_P#!)C_DGGQ;_P"QST/_ -,<E?CGCU_R;3./^PO)
M_P#U9X4_HGZ*_P#R>GAW_L XA_\ 5)CC]::***_@(_U?"BBB@ HHHH ****
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M_-W?S"BBBLC0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:0M'JFE76J:=_:2Z'^L]?+5:52C-TZD7&2^YKHT]FGT:_,]ZG4A5BIP=XO\
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M9TX27+B*3VNW'UYHM+\6OF?UYT445\H>^%%%% !1110 4444 %%%% !1110
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MEQ/Y\\'BJ?Q4*GK&/.OOAS+\3LCB*$[6JPUZ-J+^Z5G_ %Y'Z&T5R'@?XA>
M?B=H,?BGX;>./"'Q"\,2W5S91>(_ _B71?%F@RWEFRI=VD>KZ#>W^GO=6KLJ
MW-NMP98&95E120*Z^N=IIV:::W3T:^1LFFKIW3U36S7<****0!1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'K&/OS]+_"O6\O1G)4S"FM*<7-]Y>['_ .2?I9>I_0M^V+_P76^V6WB'X?\
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M?_MYZ1^Y7?JD?1-%%%?-'M!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%<SXP\:>#OAYX<U'QAX_\ %GAGP-X1T?[)_:WBGQAKVE^&?#FE
M_P!H7]KI=A_:.MZU=66F67VW4[VRTZT^TW47VF_N[6TAWW%Q%&_AW_#:7['7
M_1V7[-'_ (??X6__ #55483DKQA*2O:\8MJ^FETM]5]Z[DN44[.44^S:3[=?
M/0^EZ*^3/$'[>?[%7AJSBO\ 4?VJO@)<P3726B)X?^)_A+Q9>"62*:97ET[P
MKJ>LZA#:A+=P][-:QV<<K0P27"SW-O'+\ ?&G_@NQ^R9X$L[B'X1Z-XY^.VN
MC'V$V>EWOPX\(2XBLY7^WZ]XSTV/Q/9<W,]M#]D\ ZION=/N_-\BTDL+N]UI
MX7$5':%&H_-Q<8Z]Y2M%?-HB=>C!7E4@O^WDV_1*[?R3/V6\3>)O#W@OP]K?
MBWQ;K>F>&_#'AO3+S6=>U[6;R#3]*TC2M/@>YO;^_O;EXX+:VMH(WDEED<
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M<.^WN(I'<8RD[1BY/>T4V[7M>R\VEZL3:6K:2VNVEKVU/<:*^:/^&TOV.O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K]S_\ @DQ_R3SXM_\
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M/^&+?VQ?^C3?VE__  Q'Q2_^96O]"&BO2_MBK_SYI_\ @4OZ[_TM>+^SH?\
M/R?W+^N_]+7_ #WO^&+?VQ?^C3?VE_\ PQ'Q2_\ F5H_X8M_;%_Z--_:7_\
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M[2__ (8CXI?_ #*T?\,6_MB_]&F_M+_^&(^*7_S*U_H0T5O_ &Q5_P"?-/\
M\"E_7?\ I:Y?V=#_ )^3^Y?UW_I:_P">]_PQ;^V+_P!&F_M+_P#AB/BE_P#,
MK1_PQ;^V+_T:;^TO_P"&(^*7_P RM?Z$-%']L5?^?-/_ ,"E_7?^EJ?V=#_G
MY/[E_7?^EK_GO?\ #%O[8O\ T:;^TO\ ^&(^*7_S*T?\,6_MB_\ 1IO[2_\
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MF_M+_P#AB/BE_P#,K7^A#11_;%7_ )\T_P#P*7]=_P"EJ?V=#_GY/[E_7?\
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M:;^TO_X8CXI?_,K7^A#11_;%7_GS3_\  I?UW_I:G]G0_P"?D_N7]=_Z6O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M);F?4-MU;7:P0Q6MF#82V5Y.PU%?E7Q/_P &_'[1%IL_X0SXW?!?7\W4R/\
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M/"/PQO=8FO\ 3 ZM>QIJVL^,M#32+Z1 \-K,VBZW;PNRW,L,X0VDGV7\,_\
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MM/JK'5A*3I44I*TI/GDGNF]D_1)771W"BBBN(Z@HHHH **** "BBB@ HHHH
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M_/FG_P"!2_KO_2U/[.A_S\G]R_KO_2U_SWO^&+?VQ?\ HTW]I?\ \,1\4O\
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M $M3^SH?\_)_<OZ[_P!+7_/>_P"&+?VQ?^C3?VE__#$?%+_YE:/^&+?VQ?\
MHTW]I?\ \,1\4O\ YE:_T(:*/[8J_P#/FG_X%+^N_P#2U/[.A_S\G]R_KO\
MTM?\][_ABW]L7_HTW]I?_P ,1\4O_F5H_P"&+?VQ?^C3?VE__#$?%+_YE:_T
M(:*/[8J_\^:?_@4OZ[_TM3^SH?\ /R?W+^N_]+7_ #WO^&+?VQ?^C3?VE_\
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M^TO_ .&(^*7_ ,RM'_#%O[8O_1IO[2__ (8CXI?_ #*U_H0T4?VQ5_Y\T_\
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M7^A#11_;%7_GS3_\"E_7?^EJ?V=#_GY/[E_7?^EK_GO?\,6_MB_]&F_M+_\
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M\8T445_;A_F<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?N?_P $F/\
MDGGQ;_['/0__ $QR5^&%?N?_ ,$F/^2>?%O_ +'/0_\ TQR5^.>/7_)M,X_[
M"\G_ /5GA3^B?HK_ /)Z>'?^P#B'_P!4F./UIHHHK^ C_5\**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K^97_@H1_R=]\7?^Y!_P#58>"J_IJK^97_ (*$?\G??%W_ +D'
M_P!5AX*K^A/HV?\ )=9M_P!DGCO_ %<9$?R1],S_ )-?D/\ V7N5_P#K/<4G
MQC1117]N'^9P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^Y__!)C_DGG
MQ;_['/0__3')7X85^Y__  28_P"2>?%O_L<]#_\ 3')7XYX]?\FTSC_L+R?_
M -6>%/Z)^BO_ ,GIX=_[ .(?_5)CC]::***_@(_U?"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ*__ ">GAW_L XA_]4F./UIHHHK^ C_5\**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5^Y_\ P28_Y)Y\6_\ L<]#_P#3')7X85^Y_P#P
M28_Y)Y\6_P#L<]#_ /3')7XYX]?\FTSC_L+R?_U9X4_HGZ*__)Z>'?\ L XA
M_P#5)CC]::***_@(_P!7PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OYE?^"A'_)WWQ=_[
MD'_U6'@JOZ:J_F5_X*$?\G??%W_N0?\ U6'@JOZ$^C9_R76;?]DGCO\ U<9$
M?R1],S_DU^0_]E[E?_K/<4GQC1117]N'^9P4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5^Y__  28_P"2>?%O_L<]#_\ 3')7X85^Y_\ P28_Y)Y\6_\
ML<]#_P#3')7XYX]?\FTSC_L+R?\ ]6>%/Z)^BO\ \GIX=_[ .(?_ %28X_6F
MBBBOX"/]7PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "OYE?^"A'_)WWQ=_[D'_ -5AX*K^
MFJOYE?\ @H1_R=]\7?\ N0?_ %6'@JOZ$^C9_P EUFW_ &2>._\ 5QD1_)'T
MS/\ DU^0_P#9>Y7_ .L]Q2?&-%%%?VX?YG!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7[G_\$F/^2>?%O_L<]#_],<E?AA7[G_\ !)C_ ))Y\6_^QST/
M_P!,<E?CGCU_R;3./^PO)_\ U9X4_HGZ*_\ R>GAW_L XA_]4F./UIHHHK^
MC_5\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(7@O_P );0__ )!H_P"%;_#O_H0O!?\ X2VA_P#R#1_Q,[@?^B0Q?_AYH_\
MSN#_ (DFS3_HX67_ /B.XC_Y[^O]/3^/NBO[!/\ A6_P[_Z$+P7_ .$MH?\
M\@T?\*W^'?\ T(7@O_PEM#_^0:/^)G<#_P!$AB__  \T?_G<'_$DV:?]'"R_
M_P 1W$?_ #W]?Z>G\?=%?V"?\*W^'?\ T(7@O_PEM#_^0:/^%;_#O_H0O!?_
M (2VA_\ R#1_Q,[@?^B0Q?\ X>:/_P [@_XDFS3_ *.%E_\ XCN(_P#GOZ_T
M]/X^Z*_L$_X5O\._^A"\%_\ A+:'_P#(-'_"M_AW_P!"%X+_ /"6T/\ ^0:/
M^)G<#_T2&+_\/-'_ .=P?\239I_T<++_ /Q'<1_\]_7^GI_'W17]@G_"M_AW
M_P!"%X+_ /"6T/\ ^0:/^%;_  [_ .A"\%_^$MH?_P @T?\ $SN!_P"B0Q?_
M (>:/_SN#_B2;-/^CA9?_P"([B/_ )[^O]/3^/NBO[!/^%;_  [_ .A"\%_^
M$MH?_P @T?\ "M_AW_T(7@O_ ,);0_\ Y!H_XF=P/_1(8O\ \/-'_P"=P?\
M$DV:?]'"R_\ \1W$?_/?U_IZ?Q]T5_8)_P *W^'?_0A>"_\ PEM#_P#D&C_A
M6_P[_P"A"\%_^$MH?_R#1_Q,[@?^B0Q?_AYH_P#SN#_B2;-/^CA9?_XCN(_^
M>_K_ $]/X^Z*_L$_X5O\._\ H0O!?_A+:'_\@T?\*W^'?_0A>"__  EM#_\
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M.XC_ .>_K_3T_C[HK^P3_A6_P[_Z$+P7_P"$MH?_ ,@T?\*W^'?_ $(7@O\
M\);0_P#Y!H_XF=P/_1(8O_P\T?\ YW!_Q)-FG_1PLO\ _$=Q'_SW]?Z>G\?=
M%?V"?\*W^'?_ $(7@O\ \);0_P#Y!H_X5O\ #O\ Z$+P7_X2VA__ "#1_P 3
M.X'_ *)#%_\ AYH__.X/^))LT_Z.%E__ (CN(_\ GOZ_T]/X^Z*_L$_X5O\
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M?U_IZ?Q]T5_8)_PK?X=_]"%X+_\ "6T/_P"0:/\ A6_P[_Z$+P7_ .$MH?\
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MW_T(7@O_ ,);0_\ Y!H_X5O\._\ H0O!?_A+:'_\@T?\3.X'_HD,7_X>:/\
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M (5O\._^A"\%_P#A+:'_ /(-'_$SN!_Z)#%_^'FC_P#.X/\ B2;-/^CA9?\
M^([B/_GOZ_T]/X^Z*_L$_P"%;_#O_H0O!?\ X2VA_P#R#1_PK?X=_P#0A>"_
M_"6T/_Y!H_XF=P/_ $2&+_\ #S1_^=P?\239I_T<++__ !'<1_\ /?U_IZ?Q
M]T5_8)_PK?X=_P#0A>"__"6T/_Y!H_X5O\._^A"\%_\ A+:'_P#(-'_$SN!_
MZ)#%_P#AYH__ #N#_B2;-/\ HX67_P#B.XC_ .>_K_3T_C[HK^P3_A6_P[_Z
M$+P7_P"$MH?_ ,@T?\*W^'?_ $(7@O\ \);0_P#Y!H_XF=P/_1(8O_P\T?\
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M ,/-'_YW!_Q)-FG_ $<++_\ Q'<1_P#/?U_IZ?Q]T5_8)_PK?X=_]"%X+_\
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M[@_XDFS3_HX67_\ B.XC_P">_K_3T_C[HK^P3_A6_P ._P#H0O!?_A+:'_\
M(-'_  K?X=_]"%X+_P#"6T/_ .0:/^)G<#_T2&+_ /#S1_\ G<'_ !)-FG_1
MPLO_ /$=Q'_SW]?Z>G\?=%?V"?\ "M_AW_T(7@O_ ,);0_\ Y!H_X5O\._\
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MOZ_T]/X^Z*_L$_X5O\._^A"\%_\ A+:'_P#(-'_"M_AW_P!"%X+_ /"6T/\
M^0:/^)G<#_T2&+_\/-'_ .=P?\239I_T<++_ /Q'<1_\]_7^GI_'W17]@G_"
MM_AW_P!"%X+_ /"6T/\ ^0:/^%;_  [_ .A"\%_^$MH?_P @T?\ $SN!_P"B
M0Q?_ (>:/_SN#_B2;-/^CA9?_P"([B/_ )[^O]/3^/NBO[!/^%;_  [_ .A"
M\%_^$MH?_P @T?\ "M_AW_T(7@O_ ,);0_\ Y!H_XF=P/_1(8O\ \/-'_P"=
MP?\ $DV:?]'"R_\ \1W$?_/?U_IZ?Q]T5_8)_P *W^'?_0A>"_\ PEM#_P#D
M&C_A6_P[_P"A"\%_^$MH?_R#1_Q,[@?^B0Q?_AYH_P#SN#_B2;-/^CA9?_XC
MN(_^>_K_ $]/X^Z*_L$_X5O\._\ H0O!?_A+:'_\@T?\*W^'?_0A>"__  EM
M#_\ D&C_ (F=P/\ T2&+_P##S1_^=P?\239I_P!'"R__ ,1W$?\ SW]?Z>G\
M?=?N?_P28_Y)Y\6_^QST/_TQR5^FO_"M_AW_ -"%X+_\);0__D&MW2/#^@Z!
M'-#H.B:1HD-PZRW$6D:;9Z;'/(J[5DF2SAA65U7Y5=PS!> 0.*^*\0?''"\;
M<+XWAVEP[B,OGBZV"JK%5,RIXB,%A,52Q+BZ4<'1<N=4^1/VBY6[V=K/])\)
M?HQX_P -..,MXOK\7X3-Z> P^8T'@:63UL'.J\?@:^#4E7GF&(C%4W6]HTZ4
MN91Y4XMW6O1117\\G]=A1110 4444 %%%% !1110 445^5?_  5[_:1^-/[+
MO[-?@CQ_\"O&?_"#>+M8^./AKP?J.K?\([X4\3?:/#FH> OB7K5WIWV#QAH7
MB#3(?.U/P_I%S]K@LHK^/[)Y,5TEO<744VE*G*M4A2BTI3DHIRNDF^]DW;T3
M(J35.$JDDVHJ[2M?>VEVE^)^JE%?PZ_\/@_^"B__ $<1_P"8D^!?_P [*C_A
M\'_P47_Z.(_\Q)\"_P#YV5>C_8^)_GH?^!5/_E1Q_P!HT/Y:O_@,/_DS^XJB
MOX=?^'P?_!1?_HXC_P Q)\"__G94?\/@_P#@HO\ ]'$?^8D^!?\ \[*C^Q\3
M_/0_\"J?_*@_M&A_+5_\!A_\F?W%45_#K_P^#_X*+_\ 1Q'_ )B3X%__ #LJ
M/^'P?_!1?_HXC_S$GP+_ /G94?V/B?YZ'_@53_Y4']HT/Y:O_@,/_DS^XJBO
MX=?^'P?_  47_P"CB/\ S$GP+_\ G94?\/@_^"B__1Q'_F)/@7_\[*C^Q\3_
M #T/_ JG_P J#^T:'\M7_P !A_\ )G]Q5%?PZ_\ #X/_ (*+_P#1Q'_F)/@7
M_P#.RH_X?!_\%%_^CB/_ #$GP+_^=E1_8^)_GH?^!5/_ )4']HT/Y:O_ (##
M_P"3/[BJ*_AU_P"'P?\ P47_ .CB/_,2? O_ .=E1_P^#_X*+_\ 1Q'_ )B3
MX%__ #LJ/['Q/\]#_P "J?\ RH/[1H?RU?\ P&'_ ,F?W%45_#K_ ,/@_P#@
MHO\ ]'$?^8D^!?\ \[*C_A\'_P %%_\ HXC_ ,Q)\"__ )V5']CXG^>A_P"!
M5/\ Y4']HT/Y:O\ X##_ .3/[BJ*_AU_X?!_\%%_^CB/_,2? O\ ^=E1_P /
M@_\ @HO_ -'$?^8D^!?_ ,[*C^Q\3_/0_P# JG_RH/[1H?RU?_ 8?_)G]Q5%
M?PZ_\/@_^"B__1Q'_F)/@7_\[*C_ (?!_P#!1?\ Z.(_\Q)\"_\ YV5']CXG
M^>A_X%4_^5!_:-#^6K_X##_Y,_N*HK^'7_A\'_P47_Z.(_\ ,2? O_YV5'_#
MX/\ X*+_ /1Q'_F)/@7_ /.RH_L?$_ST/_ JG_RH/[1H?RU?_ 8?_)G]Q5%?
MPZ_\/@_^"B__ $<1_P"8D^!?_P [*C_A\'_P47_Z.(_\Q)\"_P#YV5']CXG^
M>A_X%4_^5!_:-#^6K_X##_Y,_N*HK^'7_A\'_P %%_\ HXC_ ,Q)\"__ )V5
M'_#X/_@HO_T<1_YB3X%__.RH_L?$_P ]#_P*I_\ *@_M&A_+5_\  8?_ "9_
M<517\.O_  ^#_P""B_\ T<1_YB3X%_\ SLJ/^'P?_!1?_HXC_P Q)\"__G94
M?V/B?YZ'_@53_P"5!_:-#^6K_P" P_\ DS^XJBOX=?\ A\'_ ,%%_P#HXC_S
M$GP+_P#G94?\/@_^"B__ $<1_P"8D^!?_P [*C^Q\3_/0_\  JG_ ,J#^T:'
M\M7_ ,!A_P#)G]Q5%?PZ_P##X/\ X*+_ /1Q'_F)/@7_ /.RH_X?!_\ !1?_
M *.(_P#,2? O_P"=E1_8^)_GH?\ @53_ .5!_:-#^6K_ . P_P#DS^XJBOX=
M?^'P?_!1?_HXC_S$GP+_ /G94?\ #X/_ (*+_P#1Q'_F)/@7_P#.RH_L?$_S
MT/\ P*I_\J#^T:'\M7_P&'_R9_<517\.O_#X/_@HO_T<1_YB3X%__.RH_P"'
MP?\ P47_ .CB/_,2? O_ .=E1_8^)_GH?^!5/_E0?VC0_EJ_^ P_^3/[BJ*_
MAU_X?!_\%%_^CB/_ #$GP+_^=E1_P^#_ ."B_P#T<1_YB3X%_P#SLJ/['Q/\
M]#_P*I_\J#^T:'\M7_P&'_R9_<517\.O_#X/_@HO_P!'$?\ F)/@7_\ .RH_
MX?!_\%%_^CB/_,2? O\ ^=E1_8^)_GH?^!5/_E0?VC0_EJ_^ P_^3/[BJ*_A
MU_X?!_\ !1?_ *.(_P#,2? O_P"=E1_P^#_X*+_]'$?^8D^!?_SLJ/['Q/\
M/0_\"J?_ "H/[1H?RU?_  &'_P F?W%45_#K_P /@_\ @HO_ -'$?^8D^!?_
M ,[*C_A\'_P47_Z.(_\ ,2? O_YV5']CXG^>A_X%4_\ E0?VC0_EJ_\ @,/_
M ),_N*HK^'7_ (?!_P#!1?\ Z.(_\Q)\"_\ YV5'_#X/_@HO_P!'$?\ F)/@
M7_\ .RH_L?$_ST/_  *I_P#*@_M&A_+5_P# 8?\ R9_<517\.O\ P^#_ ."B
M_P#T<1_YB3X%_P#SLJ/^'P?_  47_P"CB/\ S$GP+_\ G94?V/B?YZ'_ (%4
M_P#E0?VC0_EJ_P#@,/\ Y,_N*HK^'7_A\'_P47_Z.(_\Q)\"_P#YV5'_  ^#
M_P""B_\ T<1_YB3X%_\ SLJ/['Q/\]#_ ,"J?_*@_M&A_+5_\!A_\F?W%45_
M#K_P^#_X*+_]'$?^8D^!?_SLJ/\ A\'_ ,%%_P#HXC_S$GP+_P#G94?V/B?Y
MZ'_@53_Y4']HT/Y:O_@,/_DS^XJBOX=?^'P?_!1?_HXC_P Q)\"__G94?\/@
M_P#@HO\ ]'$?^8D^!?\ \[*C^Q\3_/0_\"J?_*@_M&A_+5_\!A_\F?W%45_#
MK_P^#_X*+_\ 1Q'_ )B3X%__ #LJ/^'P?_!1?_HXC_S$GP+_ /G94?V/B?YZ
M'_@53_Y4']HT/Y:O_@,/_DS^XJBOX=?^'P?_  47_P"CB/\ S$GP+_\ G94?
M\/@_^"B__1Q'_F)/@7_\[*C^Q\3_ #T/_ JG_P J#^T:'\M7_P !A_\ )G]Q
M5%?PZ_\ #X/_ (*+_P#1Q'_F)/@7_P#.RH_X?!_\%%_^CB/_ #$GP+_^=E1_
M8^)_GH?^!5/_ )4']HT/Y:O_ (##_P"3/[BJ*_AU_P"'P?\ P47_ .CB/_,2
M? O_ .=E1_P^#_X*+_\ 1Q'_ )B3X%__ #LJ/['Q/\]#_P "J?\ RH/[1H?R
MU?\ P&'_ ,F?W%45_#K_ ,/@_P#@HO\ ]'$?^8D^!?\ \[*C_A\'_P %%_\
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M#_P*I_\ *@_M&A_+5_\  8?_ "9_<517\.O_  ^#_P""B_\ T<1_YB3X%_\
MSLJ/^'P?_!1?_HXC_P Q)\"__G94?V/B?YZ'_@53_P"5!_:-#^6K_P" P_\
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M #LJ/['Q/\]#_P "J?\ RH/[1H?RU?\ P&'_ ,F?W%45_#K_ ,/@_P#@HO\
M]'$?^8D^!?\ \[*C_A\'_P %%_\ HXC_ ,Q)\"__ )V5']CXG^>A_P"!5/\
MY4']HT/Y:O\ X##_ .3/[BJ*_AU_X?!_\%%_^CB/_,2? O\ ^=E1_P /@_\
M@HO_ -'$?^8D^!?_ ,[*C^Q\3_/0_P# JG_RH/[1H?RU?_ 8?_)G]Q5%?PZ_
M\/@_^"B__1Q'_F)/@7_\[*C_ (?!_P#!1?\ Z.(_\Q)\"_\ YV5']CXG^>A_
MX%4_^5!_:-#^6K_X##_Y,_N*HK^'7_A\'_P47_Z.(_\ ,2? O_YV5'_#X/\
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M?_!1?_HXC_S$GP+_ /G94?\ #X/_ (*+_P#1Q'_F)/@7_P#.RH_L?$_ST/\
MP*I_\J#^T:'\M7_P&'_R9_<517\.O_#X/_@HO_T<1_YB3X%__.RH_P"'P?\
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MN*HK^'7_ (?!_P#!1?\ Z.(_\Q)\"_\ YV5'_#X/_@HO_P!'$?\ F)/@7_\
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M .=E1_P^#_X*+_\ 1Q'_ )B3X%__ #LJ/['Q/\]#_P "J?\ RH/[1H?RU?\
MP&'_ ,F?W%45_#K_ ,/@_P#@HO\ ]'$?^8D^!?\ \[*C_A\'_P %%_\ HXC_
M ,Q)\"__ )V5']CXG^>A_P"!5/\ Y4']HT/Y:O\ X##_ .3/[BJ*_AU_X?!_
M\%%_^CB/_,2? O\ ^=E1_P /@_\ @HO_ -'$?^8D^!?_ ,[*C^Q\3_/0_P#
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MA_X%4_\ E0?VC0_EJ_\ @,/_ ),_N*HK^'7_ (?!_P#!1?\ Z.(_\Q)\"_\
MYV5'_#X/_@HO_P!'$?\ F)/@7_\ .RH_L?$_ST/_  *I_P#*@_M&A_+5_P#
M8?\ R9_<517\.O\ P^#_ ."B_P#T<1_YB3X%_P#SLJ/^'P?_  47_P"CB/\
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M^CB/_,2? O\ ^=E1_8^)_GH?^!5/_E0?VC0_EJ_^ P_^3/[BJ*_AU_X?!_\
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M0_EJ_P#@,/\ Y,_N*HK^'7_A\'_P47_Z.(_\Q)\"_P#YV5'_  ^#_P""B_\
MT<1_YB3X%_\ SLJ/['Q/\]#_ ,"J?_*@_M&A_+5_\!A_\F?W%45_#K_P^#_X
M*+_]'$?^8D^!?_SLJ/\ A\'_ ,%%_P#HXC_S$GP+_P#G94?V/B?YZ'_@53_Y
M4']HT/Y:O_@,/_DS^XJBOX=?^'P?_!1?_HXC_P Q)\"__G94?\/@_P#@HO\
M]'$?^8D^!?\ \[*C^Q\3_/0_\"J?_*@_M&A_+5_\!A_\F?W%45_#K_P^#_X*
M+_\ 1Q'_ )B3X%__ #LJ/^'P?_!1?_HXC_S$GP+_ /G94?V/B?YZ'_@53_Y4
M']HT/Y:O_@,/_DS^XJBOX=?^'P?_  47_P"CB/\ S$GP+_\ G94?\/@_^"B_
M_1Q'_F)/@7_\[*C^Q\3_ #T/_ JG_P J#^T:'\M7_P !A_\ )G]Q5%?PZ_\
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MH/[1H?RU?_ 8?_)G]Q5%?PZ_\/@_^"B__1Q'_F)/@7_\[*C_ (?!_P#!1?\
MZ.(_\Q)\"_\ YV5']CXG^>A_X%4_^5!_:-#^6K_X##_Y,_N*HK^'7_A\'_P4
M7_Z.(_\ ,2? O_YV5'_#X/\ X*+_ /1Q'_F)/@7_ /.RH_L?$_ST/_ JG_RH
M/[1H?RU?_ 8?_)G]Q5%?PZ_\/@_^"B__ $<1_P"8D^!?_P [*C_A\'_P47_Z
M.(_\Q)\"_P#YV5']CXG^>A_X%4_^5!_:-#^6K_X##_Y,_N*HK^'7_A\'_P %
M%_\ HXC_ ,Q)\"__ )V5'_#X/_@HO_T<1_YB3X%__.RH_L?$_P ]#_P*I_\
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M_#X/_@HO_P!'$?\ F)/@7_\ .RH_L?$_ST/_  *I_P#*@_M&A_+5_P# 8?\
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M^8D^!?\ \[*C^Q\3_/0_\"J?_*@_M&A_+5_\!A_\F?W%45_#K_P^#_X*+_\
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MQ)\"_P#YV5']CXG^>A_X%4_^5!_:-#^6K_X##_Y,_N*HK^'7_A\'_P %%_\
MHXC_ ,Q)\"__ )V5'_#X/_@HO_T<1_YB3X%__.RH_L?$_P ]#_P*I_\ *@_M
M&A_+5_\  8?_ "9_<517\.O_  ^#_P""B_\ T<1_YB3X%_\ SLJ/^'P?_!1?
M_HXC_P Q)\"__G94?V/B?YZ'_@53_P"5!_:-#^6K_P" P_\ DS^XJBOX=?\
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M8D^!?_SLJ/['Q/\ /0_\"J?_ "H/[1H?RU?_  &'_P F?W%45_#K_P /@_\
M@HO_ -'$?^8D^!?_ ,[*C_A\'_P47_Z.(_\ ,2? O_YV5']CXG^>A_X%4_\
ME0?VC0_EJ_\ @,/_ ),_N*HK^'7_ (?!_P#!1?\ Z.(_\Q)\"_\ YV5'_#X/
M_@HO_P!'$?\ F)/@7_\ .RH_L?$_ST/_  *I_P#*@_M&A_+5_P# 8?\ R9_<
M517\.O\ P^#_ ."B_P#T<1_YB3X%_P#SLJ/^'P?_  47_P"CB/\ S$GP+_\
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M_P "J?\ RH/[1H?RU?\ P&'_ ,F?W%45_#K_ ,/@_P#@HO\ ]'$?^8D^!?\
M\[*C_A\'_P %%_\ HXC_ ,Q)\"__ )V5']CXG^>A_P"!5/\ Y4']HT/Y:O\
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M"_\ YV5']CXG^>A_X%4_^5!_:-#^6K_X##_Y,_N*HK^'7_A\'_P47_Z.(_\
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M ,%%_P#HXC_S$GP+_P#G94?\/@_^"B__ $<1_P"8D^!?_P [*C^Q\3_/0_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/^'('["/_0 ^)G_AQM0_^0Z_7JBCZYBO^@BM_P"!R_S\OS[L/J]#_GS3_P#
M%_D?D+_PY _81_Z 'Q,_\.-J'_R'1_PY _81_P"@!\3/_#C:A_\ (=?KU11]
M<Q7_ $$5O_ Y?Y^7Y]V'U>A_SYI_^ +_ "/R%_X<@?L(_P#0 ^)G_AQM0_\
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M?\.0/V$?^@!\3/\ PXVH?_(=?KU11]<Q7_016_\  Y?Y^7Y]V'U>A_SYI_\
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M4/\ Y#K]>J*/KF*_Z"*W_@<O\_+\^[#ZO0_Y\T__  !?Y'Y"_P##D#]A'_H
M?$S_ ,.-J'_R'1_PY _81_Z 'Q,_\.-J'_R'7Z]44?7,5_T$5O\ P.7^?E^?
M=A]7H?\ /FG_ . +_(_(7_AR!^PC_P! #XF?^'&U#_Y#H_X<@?L(_P#0 ^)G
M_AQM0_\ D.OUZHH^N8K_ *"*W_@<O\_+\^[#ZO0_Y\T__ %_D?D+_P .0/V$
M?^@!\3/_  XVH?\ R'1_PY _81_Z 'Q,_P##C:A_\AU^O5%'US%?]!%;_P #
ME_GY?GW8?5Z'_/FG_P" +_(_(7_AR!^PC_T /B9_X<;4/_D.C_AR!^PC_P!
M#XF?^'&U#_Y#K]>J*/KF*_Z"*W_@<O\ /R_/NP^KT/\ GS3_ / %_D?D+_PY
M _81_P"@!\3/_#C:A_\ (='_  Y _81_Z 'Q,_\ #C:A_P#(=?KU11]<Q7_0
M16_\#E_GY?GW8?5Z'_/FG_X O\C\A?\ AR!^PC_T /B9_P"'&U#_ .0Z/^'(
M'["/_0 ^)G_AQM0_^0Z_7JBCZYBO^@BM_P"!R_S\OS[L/J]#_GS3_P# %_D?
MD+_PY _81_Z 'Q,_\.-J'_R'1_PY _81_P"@!\3/_#C:A_\ (=?KU11]<Q7_
M $$5O_ Y?Y^7Y]V'U>A_SYI_^ +_ "/R%_X<@?L(_P#0 ^)G_AQM0_\ D.C_
M (<@?L(_] #XF?\ AQM0_P#D.OUZHH^N8K_H(K?^!R_S\OS[L/J]#_GS3_\
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M-J'_ ,AU^O5%'US%?]!%;_P.7^?E^?=A]7H?\^:?_@"_R/R%_P"'('["/_0
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M?_@"_P C\A?^'('["/\ T /B9_X<;4/_ )#H_P"'('["/_0 ^)G_ (<;4/\
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MJ'_R'1_PY _81_Z 'Q,_\.-J'_R'7Z]44?7,5_T$5O\ P.7^?E^?=A]7H?\
M/FG_ . +_(_(7_AR!^PC_P! #XF?^'&U#_Y#H_X<@?L(_P#0 ^)G_AQM0_\
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M^'('["/_ $ /B9_X<;4/_D.OUZHH^N8K_H(K?^!R_P _+\^[#ZO0_P"?-/\
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M:A_\AU^O5%'US%?]!%;_ ,#E_GY?GW8?5Z'_ #YI_P#@"_R/R%_X<@?L(_\
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MQM0_^0Z_7JBCZYBO^@BM_P"!R_S\OS[L/J]#_GS3_P# %_D?D+_PY _81_Z
M'Q,_\.-J'_R'1_PY _81_P"@!\3/_#C:A_\ (=?KU11]<Q7_ $$5O_ Y?Y^7
MY]V'U>A_SYI_^ +_ "/R%_X<@?L(_P#0 ^)G_AQM0_\ D.C_ (<@?L(_] #X
MF?\ AQM0_P#D.OUZHH^N8K_H(K?^!R_S\OS[L/J]#_GS3_\  %_D?D+_ ,.0
M/V$?^@!\3/\ PXVH?_(='_#D#]A'_H ?$S_PXVH?_(=?KU11]<Q7_016_P#
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M'US%?]!%;_P.7^?E^?=A]7H?\^:?_@"_R/R%_P"'('["/_0 ^)G_ (<;4/\
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MP^KT/^?-/_P!?Y'Y"_\ #D#]A'_H ?$S_P .-J'_ ,AT?\.0/V$?^@!\3/\
MPXVH?_(=?KU11]<Q7_016_\  Y?Y^7Y]V'U>A_SYI_\ @"_R/R%_X<@?L(_]
M #XF?^'&U#_Y#H_X<@?L(_\ 0 ^)G_AQM0_^0Z_7JBCZYBO^@BM_X'+_ #\O
MS[L/J]#_ )\T_P#P!?Y'Y"_\.0/V$?\ H ?$S_PXVH?_ "'1_P .0/V$?^@!
M\3/_  XVH?\ R'7Z]44?7,5_T$5O_ Y?Y^7Y]V'U>A_SYI_^ +_(_(7_ (<@
M?L(_] #XF?\ AQM0_P#D.C_AR!^PC_T /B9_X<;4/_D.OUZHH^N8K_H(K?\
M@<O\_+\^[#ZO0_Y\T_\ P!?Y'Y"_\.0/V$?^@!\3/_#C:A_\AT?\.0/V$?\
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MN8K_ *"*W_@<O\_+\^[#ZO0_Y\T__ %_D?D+_P .0/V$?^@!\3/_  XVH?\
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MU>A_SYI_^ +_ "/R%_X<@?L(_P#0 ^)G_AQM0_\ D.C_ (<@?L(_] #XF?\
MAQM0_P#D.OUZHH^N8K_H(K?^!R_S\OS[L/J]#_GS3_\  %_D?D+_ ,.0/V$?
M^@!\3/\ PXVH?_(='_#D#]A'_H ?$S_PXVH?_(=?KU11]<Q7_016_P# Y?Y^
M7Y]V'U>A_P ^:?\ X O\C\A?^'('["/_ $ /B9_X<;4/_D.C_AR!^PC_ - #
MXF?^'&U#_P"0Z_7JBCZYBO\ H(K?^!R_S\OS[L/J]#_GS3_\ 7^1^0O_  Y
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MPY _81_Z 'Q,_P##C:A_\AU^O5%'US%?]!%;_P #E_GY?GW8?5Z'_/FG_P"
M+_(_(7_AR!^PC_T /B9_X<;4/_D.C_AR!^PC_P! #XF?^'&U#_Y#K]>J*/KF
M*_Z"*W_@<O\ /R_/NP^KT/\ GS3_ / %_D?D+_PY _81_P"@!\3/_#C:A_\
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MO_#D#]A'_H ?$S_PXVH?_(='_#D#]A'_ * 'Q,_\.-J'_P AU^O5%'US%?\
M016_\#E_GY?GW8?5Z'_/FG_X O\ (_(7_AR!^PC_ - #XF?^'&U#_P"0Z/\
MAR!^PC_T /B9_P"'&U#_ .0Z_7JBCZYBO^@BM_X'+_/R_/NP^KT/^?-/_P
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MVH?_ "'7Z]44?7,5_P!!%;_P.7^?E^?=A]7H?\^:?_@"_P C\A?^'('["/\
MT /B9_X<;4/_ )#H_P"'('["/_0 ^)G_ (<;4/\ Y#K]>J*/KF*_Z"*W_@<O
M\_+\^[#ZO0_Y\T__  !?Y'Y"_P##D#]A'_H ?$S_ ,.-J'_R'1_PY _81_Z
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M  Y _81_Z 'Q,_\ #C:A_P#(=?KU11]<Q7_016_\#E_GY?GW8?5Z'_/FG_X
MO\C\A?\ AR!^PC_T /B9_P"'&U#_ .0Z/^'('["/_0 ^)G_AQM0_^0Z_7JBC
MZYBO^@BM_P"!R_S\OS[L/J]#_GS3_P# %_D?D+_PY _81_Z 'Q,_\.-J'_R'
M1_PY _81_P"@!\3/_#C:A_\ (=?KU11]<Q7_ $$5O_ Y?Y^7Y]V'U>A_SYI_
M^ +_ "/R%_X<@?L(_P#0 ^)G_AQM0_\ D.C_ (<@?L(_] #XF?\ AQM0_P#D
M.OUZHH^N8K_H(K?^!R_S\OS[L/J]#_GS3_\  %_D?D+_ ,.0/V$?^@!\3/\
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M_P#P!?Y'Y"_\.0/V$?\ H ?$S_PXVH?_ "'1_P .0/V$?^@!\3/_  XVH?\
MR'7Z]44?7,5_T$5O_ Y?Y^7Y]V'U>A_SYI_^ +_(_(7_ (<@?L(_] #XF?\
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M<O\ /R_/NP^KT/\ GS3_ / %_D?D+_PY _81_P"@!\3/_#C:A_\ (='_  Y
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MZ_7JBCZYBO\ H(K?^!R_S\OS[L/J]#_GS3_\ 7^1^0O_  Y _81_Z 'Q,_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH _GN_XB#_ (._]&]?$O\ \*CP
MM_\ &J/^(@_X._\ 1O7Q+_\ "H\+?_&J^X_^'/G_  3H_P"C=_\ S+?QT_\
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M\TE^!_I5:9JFF:U86NJZ-J-CJVEWT0GLM2TR[M[^PO(22HFM;RUDEM[B(E6
MDBD="00#D&KU?YO?@KXD?$3X;7[:K\.O'OC3P#JCRVT[ZEX*\4ZYX5OVFLQ<
M+9S->:%?6%PTMJ+NZ%M(9"\ N;@1%!-)N_1;X._\%C/VY?A1<V46J_$33/B]
MX?M/E?P_\5?#]EK$D\;1M%([>*]%_L#QO)<JI66WDO/$E[;17,,4DMG<0O=6
M]URU,GJQNZ=6$_*2<&_):R7WM&\,QIO2=.4?.+4E\_A=O1-G]MU%?A/^SK_P
M7=_9_P#B#<VF@_'WP?KGP)U>2UA4^*;*:\^('@"ZOHXREP+E]'TBW\7>'_MU
MQY3Z? _AW7M/LXY9DU;Q%;QV:WM[^UW@KQUX+^)'AO3O&/P_\5^'O&OA75XO
M.TWQ#X7U>QUO1[Q,#>(;_3I[BW:6(G9/ 7$UO*&BGCCE5D'FUL/6H.U6G*'9
MM7B_22O%^=G==3MIUJ=57IS4NK6TEZQ=FO6UCJJ***Q- HHHH **** "BBB@
M HHHH **** "BBB@ K^>[_B(/^#O_1O7Q+_\*CPM_P#&J_H1K\T?^'/G_!.C
M_HW?_P RW\=/_GFUU8:6$CS_ %JG5G?EY/9M*WQ<W-><-_=MOL]NN%98A\OL
M)0C:_-SK?;EM[LO.^V_W?#G_ !$'_!W_ *-Z^)?_ (5'A;_XU1_Q$'_!W_HW
MKXE_^%1X6_\ C5>[?%+_ ((8?L8^-+74'^'[_$?X.:K+$3I9\/\ BRY\6^'[
M*Z%I%;QF_P!)\>KX@UK4K$SQO?W%K;^*]*NY+B>6.#4[6S$%K#^ 7[;7_!,?
MX\?L7))XLU.6Q^)?P:FOK:PL_BEX7M)[)--N;^::WT^Q\<>%[BXO+_PC?7DL
M*)!<Q7VN^%Y9KW3=.A\43:U>#2X_2H4LJQ$E"*G&;VA4G.+?DGS.+?DI7?1,
MXJL\?23E)QE%;RA&+2VW5E)+SM;7?M^P_P#Q$'_!W_HWKXE_^%1X6_\ C5'_
M !$'_!W_ *-Z^)?_ (5'A;_XU7\K%%=G]EX/_GW+_P &3_S.;Z]B/YH_^ 1_
MR_J[\K?U3_\ $0?\'?\ HWKXE_\ A4>%O_C5'_$0?\'?^C>OB7_X5'A;_P"-
M5_*Q4L$$US-#;6T,MQ<7$L<$$$$;RS3S2N(XH88HPSR2R.RI'&BL[NP5020*
M/[+P?_/N7_@R?^8?7L1_-'_P"/\ E_5WY6_JB_XB#_@[_P!&]?$O_P *CPM_
M\:H_XB#_ (._]&]?$O\ \*CPM_\ &J^<OV1_^"$OB/QYX>TGQW^U7XVUSX;:
M?KFF)?Z?\+/ D-C'\1+&*]@+V4GC#Q#XDTK5=#\*ZG 1'/=>%[;PYXEO!;W*
M6NIZKX>UFVO=+@_5C0_^"-/_  3UTFP6SO\ X,:QXGN%EDD.JZY\5/BK;W[I
M(05@:/PUXQ\/:6(H0-L9335F()\Z:4X(\^K_ &33DXJ-6HUNZ<I-)_XI3BGZ
MIM>9V4_[0G%2YJ<$]4IQ2?3HHMKT=GJ_(B_8A_X*D^ OVW?BMX@^%/A;X6>+
M_ ^H>'_A[JWQ"FU;7]9T;4;.XL]*\2>$_#<FG10:<BSI<RS^++>Y25SY2Q6D
MR,-[I7ZEU\A? ']@W]E']EWQCJ7C_P"!7PJ_X0;Q=K'AF\\'ZCJW_"<_$CQ-
M]H\.:AJNC:U=Z=]@\8>,/$&F0^=J?A_2+G[7!917\?V3R8KI+>XNHIOKVO-K
MNBZC>'C.%.RLIZRO;7[4M+[:G;2550M6E&4[O6&UNG2.O?0****Q- HHHH *
M*** "BBB@ HHHH ***\<^/7QZ^&/[-?PQ\0?%KXM>((M \*:!$$1$"3ZQK^L
M3I*VF^&?#.FM+"^K^(=7>&2.QL8Y(HHXH[G4=1N;#2+#4=1M'&+DU&*<I2:2
M25VV]$DEJVV)M13;:22NV]$DMVV>M7M[9Z;9W>HZC=VNGZ?I]K<7M_?WMQ%:
MV=E9VL3SW5W=W4[QP6UK;01O-<7$SI%#$CR2.J*2/QW_ &F?^"V'[+OP2O[C
MPU\+K>^_:-\6V<LL5[)X*U:VT7X=6,D0<&!OB-=6.K6^M2S,;=[:Z\&Z%XJT
M22![@RZS!>6PLIOP!_;E_P""FGQL_;&UC4O#MM>WWPX^!D-\S:%\,M'OV2;5
MK>.*.&.^^(&KV:VS^)[Z=T>\CTJ11X?T9YD@L[.ZN[9]9O?S6KW,-E,;*>);
M;>OLHNR7E.:U;[J+2723/+KY@[N-%66WM)*[?^&.R]97O_*C]?OB_P#\%M_V
MU_B,]Y:^#-7\%_!71;F)K5;?P+X7L]5UMK22&^AF%QXC\;CQ-<07TPO8V&I^
M'[3P]=6DFG:?-IIL9UOIK[X<\5_MJ?M>^-FU+_A)OVG/CM?VNL110:EI,7Q2
M\9:9X?N88H88%A;PWI6KV.@1Q.D$;SQPZ;&ES<>9=W ENIIII.5^!_[-7QW_
M &DM>E\.?!#X8^)OB#J%MC[?<:9!;66@Z1O4M%_;GBG6;G3?#&A>> 1;_P!L
M:O8_:6^2#S'^6OV1^%O_  ;^?&OQ!8"\^+OQQ\!?#.XEBED@TKPEX;U;XH7\
M#@V@MX-3DNM5^'NEV\L@?4&G;3=2UB& 6]CY4MT;^X&F=TG@,)I)4*;73E4J
MG1JZ2E-]&F_)G-'ZWB-4ZLUWYFH7]6U&Y^)'_"Z/C%_T5CXE_P#A=^*?_EK7
MJOA#]MG]K_P)]C3PO^TU\<;&ST^UDL['2;GXE^*]8T&TMI.L=OX?UK4]1T2+
M:26B=-/$D#,S0M&S,3_0%#_P;W_"-88EN/VB?B-+<+%&)Y8?"/AFWADF" 2R
M1027=R\,3ON:.%[BX>-"$::4J9&\%\:_\&]7Q$L+!9/AU^TOX+\5:F8KDO9^
M-?AYKG@&P69#;_8XUU'0O$OQ)N'BG#71N9CI2/:&&W$4%Z+F0VF:QV7S]URC
MKTG2E9_^2-+YV*^JXN.J4O\ MVHKK;^\G]U]O0^6OA/_ ,%O?VV? %S"GC?5
MO WQHTA=T<MKXS\(:9H.JQVWEV21K9:U\/X_"F+J#[)*R7FLZ?KLDQU&_:]2
M[D^P26'ZU_ '_@NY^S;\0IK#1?C=X3\5? C6KB*43Z\/,^(7P]2XC8I#')JN
M@Z=:^+[*74<Q/"LO@FXTS3V>>/4=<C@MEO[G^?WX\?\ !-?]LO\ 9XCU'4O&
M?P:UW7_">G;I)?''PY*>/?#"V<=L]S/J=\V@"XUOP[IEN(I8I[WQ9HF@11S(
MH),=S9R7/PG3E@L#B8\T(P7]^A)*WRC>%_6-Q+$XJB^63EI]FK%O\7:5O1G^
MD)X!^(_P_P#BKX;MO&/PR\;>%/B!X5O)9;>W\0^#M?TSQ'H[W5N$^TV37^DW
M-U;Q7UH9$2]L972[LY6\JZABE!0=I7^<E\+OC-\6/@GKW_"3?"3XB>+_ (=Z
MXWEBXOO">NW^D?;HX5G2*#5+:VF2TU6VC6ZN0EKJ5O=6R^?*1%EV)_2K3?\
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M-,\&)?1W+Q36]YXW\1BR@N+801FXAU3PGH_B_3[DS6L<,[![J6S_ "4^*?\
MP7J_:F\533V_PP\#?"_X3Z2\LLEM--8ZEX_\5PHSZBD,$VL:U=:=X9N(H[:X
MT]Y&3P/;S2ZEIINEFAT^]ETA/PUK[Q_9O_X)K_M>?M0V&G^(O /PTET#P'J4
MMJMK\1?B->#P9X2NK6[(V:II O(9_$?BK1XU$K3ZGX.\/>(K2)X);5I/MOEV
MLGJ1P.!PT>:JHNV\ZTKJ_91TCZ+E;Z:G"\5BJTN6%U_=I1?WMZR]7=+T*OC3
M_@IA^WCX]6Z37/VG/B/8B\BM89CX+N-(^&[(EG-'/$;5_AWI7A9[&5WB5;J>
MQ:WFOH3);7LEQ;S2Q/X)XA_:6_:-\736]SXK^/\ \;/$]Q9Q/!:3^(?BKX[U
MJ:UAD?S'AMY=2UZY>")W^=XXF5&?YB">:_?GX:_\&]UF+:*Y^,'[1ES)>/Y/
MG:+\-?!D4-M;[9$:?RO$_BC49Y;SSHO,BAW^$;'[/($N'^U*6ME^K_#W_!!_
M]BC19KB74M<^.WBU)XDCBM_$/CKPQ;0V;J^XS6[>%/ /ABX:60?NW%W/=0A!
ME(4?+U+QV74](1B[?\^Z*2Z+2ZBMOR]+M87&3LY-K_'4;??HY/S[_,_DV_X7
M1\8O^BL?$O\ \+OQ3_\ +6O7_#O[<_[9GA6Y@N='_:F^/?\ HMJ;.WM-5^*7
MC#Q#I4-MY:Q)''HWB'5M4TA?)C14MW%EYELH MVCK^F77_\ @@W^Q5K-Y%=:
M=XC^/?A.".V2!].T#QSX2N;.:599I&O97\4_#OQ+J N9$E2!TAOHK,16T)CM
M(YVN)I_E7XE?\&]UF;:6Y^#_ .T9<QWB>=Y.B_$KP9%-;7&Z1V@\WQ/X7U&"
M6S\F+RXIMGA&^^T2%[A/LJA;9FLPP$]))1OTG2NM>_*I+UZ>8/"8N&L6W_@J
M6?3NX_TO0^!?A=_P6M_;H^'SVD/B+Q7X+^+NEVL5M:K8_$/P3I<-T+2WABM\
M#6_ C>"]8N[YHXS(VIZU>:Q=3W;M<WQO2SQO^I7P-_X+[_!SQ*]II7Q]^%7B
MKX87\LK0R>*/!5W%X^\)*JPB47VHZ=+#H?BK2(I)!+;+9Z78>,)E<6\SS^5/
M.;'\2?V@/^"8G[9?[.=MJ6L^+/A5=>+/!NE_:Y+CQU\,;M/&_AY+.RD1)M3O
M+.QBA\6:#IGER17"WOB?PSH<1@=V8J]K>QVWP!6CPF!Q,>:$:>OVZ$E&S\U'
MW;^4HMWW1"Q&*H/EE*>GV:J;_&6MO1V['^B]\'OCQ\'/V@/#;^+?@Q\1_"GQ
M%T*"5+>^N/#FIQ7-WH]U+YAAL]?TB7R=8\/7T\<3SP6.MV&GW<]KLNXH7MI8
MY7]:K_-_^'7Q,^(?PB\56'CCX7^-?$W@'Q=IF5M/$'A36+W1=26"1XWN+&>:
MRFB^V:9>>4D>H:7>"XT[48 ;:^M;BW=XF_HD_8P_X+HW,]SHOP^_;)TNV/VB
MZBL8/CGX3TR.QC@CDC14N?B!X)TJW^R_\?/FM=:[X)M;*V@MI+6$>#!]GN]4
MG\O$955IIRHOVT5O&UJB]%M/Y6?:+.ZCCZ<[1JKV<GIS?8?SWC\[KNS^ERBN
M>\)^+?"_CSPWHWC'P7X@T?Q5X5\16,6IZ%XAT#4+;5-'U:PGSY=U8W]G)+;W
M$1961BCDQRI)%($EC=%Z&O*::;35FM&GNGV9W[[!1110 4444 %%%% !1110
M 4444 %%%% 'Y:?MO?\ !4GP%^Q%\5O#_P *?%/PL\7^.-0\0?#W2?B%#JV@
M:SHVG6=O9ZKXD\6>&X].E@U%&G>YBG\)W%R\J'RFBNX44;T>OCG_ (B#_@[_
M -&]?$O_ ,*CPM_\:K]/?VF_^"?7[+O[7'B+3_&?QF\%ZQJ7C;2?#VG>$M-\
M5Z'XR\4Z#?VGAG3-6UK6[;1UTRSU0^&9HCJ7B'5[B2]NM!GU5Q="$7ZPP6T<
M/Y5_&;_@WY^']_:3WO[/_P ;_%7AO4TB,D7A_P"+.GZ9XJT>]NGNI"T$?B7P
MIIWAC4M!L8;22-8#/X=\67;RVI6:9Q>>=9^G0>62A"-:-2-2R4Y-RY'+NN23
MLO5+TL<558U2DZ3A*%_=C[O-;3?F27?JW^!K_P#$0?\ !W_HWKXE_P#A4>%O
M_C5'_$0?\'?^C>OB7_X5'A;_ .-5_/+^TG^RA\<OV3O&;^"_C/X-NM$EFS)H
M?B6P,FI^#/%5K@L+KPWXDCACL[[:HS<Z?,+76=.)5-4TVQE94/SE7IQR[ SB
MI0BY1:NI1JR::]4SA>-Q46XR:36C3A%-;;JW]7]+?U3_ /$0?\'?^C>OB7_X
M5'A;_P"-4?\ $0?\'?\ HWKXE_\ A4>%O_C5?RL457]EX/\ Y]R_\&3_ ,R?
MKV(_FC_X!'_+^KORM_5/_P 1!_P=_P"C>OB7_P"%1X6_^-4?\1!_P=_Z-Z^)
M?_A4>%O_ (U7\K%?>O[&7_!.KX_?MJW.H:IX%M-,\(_#;1+F2PUKXH>,7N;?
MP\NKQQPS'0-!L[.&XU7Q+KBP3I<W4.G6PTO28##_ &YJ^ESZAI$&HQ4R_ 4H
MN=1.$5NY5)I>F^K?1*[?1%PQ>+G)1@U*3V2A'\=-%W;LE=[:6_;+_B(/^#O_
M $;U\2__  J/"W_QJON?]AC_ (*4^"/VY?%GCKPIX4^&GBKP+<>!?#VG>(;N
M[\0ZOI&I0W\.HZDVFI;VZ::BO'+&Z^:SRY0IP.:^0_AS_P $ _V<-"AM)OB;
M\6_BU\0M3MY8Y)X_#R>&?A[X;OT5'$L-QI4FF^,M?CBD<JZ&S\7VLT83:9I
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M_HWKXE_^%1X6_P#C5'_$0?\ !W_HWKXE_P#A4>%O_C5?RL45K_9>#_Y]R_\
M!D_\S/Z]B/YH_P#@$?\ +^KORM_5/_Q$'_!W_HWKXE_^%1X6_P#C5'_$0?\
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M"W_QJOY6**K^R\'_ ,^Y?^#)_P"9/U[$?S1_\ C_ )?U=^5OZI_^(@_X._\
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ME)TE4BZT92IIOGC'XFK.UM8];=4144W"2IN*GIRN7PK57OH^E^A^.7_$0?\
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M_A'?"W_Y\M?S,_\ #'?[7/V/^T?^&6?VCO[/^R_;?M__  I#XF_8_L?E>?\
M:_M7_",>1]E\C]]]HW^5Y7[S?LYKQ?Q%X+\8^$/L?_"6>$_$WA?^T?M']G_\
M)%H.J:)]N^R>1]J^Q_VE:VWVG[-]IMOM'D;_ "?M$'F;?-CW0LNP,G:-V^T:
MK;[]WT_!ORL_KF*CO;YT[=O);_KZ']A>@?\ !<K]AG6+2QN=1N_BUX4FNY6C
MN+#7_AZMS=Z6BW4EN)[Y_"^N^)+"2)XD6^4:;>ZC,+66-'A6]$MG']'>$?\
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ML_7S3Z-73Z,[X3C.*E"2E%[-._\ PS75/5/1JX4445!04444 %%%% !1110
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M*7E_=_J_H?T(?\1!_P '?^C>OB7_ .%1X6_^-4?\1!_P=_Z-Z^)?_A4>%O\
MXU7\]_\ PQ;^V+_T:;^TO_X8CXI?_,K1_P ,6_MB_P#1IO[2_P#X8CXI?_,K
M1]0R_O'_ ,'/_P"2\U]X?6\9V?\ X*7E_=_J_H?T(?\ $0?\'?\ HWKXE_\
MA4>%O_C5'_$0?\'?^C>OB7_X5'A;_P"-5_/?_P ,6_MB_P#1IO[2_P#X8CXI
M?_,K1_PQ;^V+_P!&F_M+_P#AB/BE_P#,K1]0R_O'_P '/_Y+S7WA];QG9_\
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MYI7U5TO=?R.^BL7S)UI0Y+.\5R\U[:;1MOKH_P#(^CJ***\\ZPHHHH ****
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M]?$O_P *CPM_\:H_XB#_ (._]&]?$O\ \*CPM_\ &J_E8HK3^R\'_P ^Y?\
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M/Z$/^(@_X._]&]?$O_PJ/"W_ ,:H_P"(@_X._P#1O7Q+_P#"H\+?_&J_GO\
M^&+?VQ?^C3?VE_\ PQ'Q2_\ F5H_X8M_;%_Z--_:7_\ #$?%+_YE:/J&7]X_
M^#G_ /)>:^\/K>,[/_P4O+^[_5_0_H0_XB#_ (._]&]?$O\ \*CPM_\ &J/^
M(@_X._\ 1O7Q+_\ "H\+?_&J_GO_ .&+?VQ?^C3?VE__  Q'Q2_^96C_ (8M
M_;%_Z--_:7_\,1\4O_F5H^H9?WC_ .#G_P#)>:^\/K>,[/\ \%+R_N_U?T/Z
M$/\ B(/^#O\ T;U\2_\ PJ/"W_QJC_B(/^#O_1O7Q+_\*CPM_P#&J_G.\0_L
MN?M->$8;>Y\5_LZ?';PQ;WDKP6D_B'X1?$#18;J:-/,>&WEU+P];)/*B?.\<
M3,ZI\Q '->'3P36TTUM<PRV]Q;RR03P3QO%-!-$YCEAFBD"O'+&ZLDD;JKHZ
ME6 ((JEEV!E\,7+TJR?Y2)>-Q2W:7K!+MY?U?T/ZHO\ B(/^#O\ T;U\2_\
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M/F<9*#2G9\K>RETOH]+[Z,_$S_B(/^#O_1O7Q+_\*CPM_P#&J/\ B(/^#O\
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M/!'B":SGM=/\8>#]0NH)GTCQ#I#S>;!/%_H]_;_:-(U>WU#1-0U'3KO^$_\
M:R_9A\>_LA_&SQ)\&/'S17]QID5KK'AGQ/9VEW9Z3XT\'ZJ9_P"QO$^E17B[
MTBG>VO-+U2UCFO(=*\1:5K6BKJ%^=-:[F^DP..6*BX32C6BKM+::VYH]M?BC
MTNFKIZ>+BL*Z#YHW=-O1O>+_ )9?H^NSUW^;:_KS_P"" O\ R9U\2O\ LY?Q
MC_ZJWX-5_(97]>?_  0%_P"3.OB5_P!G+^,?_56_!JEFG^Z2_P =/_THK ?[
MQ_VY+]#]Q:***^8/;"BBB@ HHHH **** "BBB@ HHHH **** "BBOYA_^"LO
M_!4N\U.\\7_LH?LY:S<V&DV%SJ7A;XT?$NP>6UO-9O+6673];^'7A"X7RY[;
M0[:>.XT[Q=K\127Q!*EQH6E.OAQ;Z\\2[X?#U,345.FO.4GM"/5O]%NWIW:R
MK5H4(.<WY1BMY/LOU>R1ZA_P4/\ ^"S-KX,NM<^"_P"R!JMCJWBBTEN]*\6?
M&Y;>TU/1/#U[:7<$<^F_#FWO8KS3/$M\1#?65]XHO+2XT"UC>.7PV-8GFBU;
M3/Y@M9UK6?$>JW^N^(=6U/7M<U6YEO=4UG6;^ZU35=2O)FW37=_J-]+/=WES
M*WS2SW$TDLC<LY-9E%?4X?#4L-#DIK7[4W;FF^[?;M%:+HKW;\&M6J5Y<TWI
M]F*ORQ7DN_=[O[@K]6?V#O\ @E/\8/VOTTCXB>*KF7X5? "6^(;QE>6\=QXH
M\;V]E--'J-G\.]!F8"6);BW_ ++G\7ZX+?P_87,\TVEV_BZ]T75M C]G_P""
M27_!-V']HS7X/V@_C?H$5[\!O"U]<P>%/#E[<(L?Q/\ &NDWL"20ZCIPAE>\
M\!>'G2Y76XYYK*#7M;2TT)1JFE6WBBRC_KJTO2],T33-.T71=.L=(T?2+&TT
MO2=)TNTM[#3-+TRPMX[2PT[3K"TCBM;*QLK6**VM+2VBBM[:WBCAAC2-%4<&
M/S%T6Z-!IU%I.=DU#^[%;.?>]U':SE?EZ\+@_:)5*MU!ZQAJG+S;Z1?2VKWN
MEO\ /?[.7[(W[/W[*?AN/P_\%?AYH_ARZEL8++7?&%U$FJ>/?%GE"*22;Q+X
MNO$?5;Z*>\C;4$T:WEL_#>F7<TPT+1-*M2ELGTE117@2E*<G*<G*3U<I-MOU
M;U/7C&,4HQ2BELDDDOD@HHHJ1A1110 5^=/[7G_!,/\ 9E_:WAU#7=3\.Q?#
M+XL74LEVOQ6\ 6%EI^L:G>2++O;QMHJK#H_CB*XD:![F^U6.'Q2L5G;6>F^*
M--LS<P7'Z+45=.I4I24Z<Y0DNL7;Y/HUW3NGU1,X0J1<9Q4D^C7Y=4_-69_G
M[?M8_L9?&_\ 8W\:IX4^+.A1-I.J2W \(>/]!-U>>"O&EO:P6EQ=-HFI7-K9
MW$5]IRWUO#JNCZE:66IV,YW_ &>:PFLK^[^4*_T5?CU\!?AC^TI\,?$'PE^+
M7A^+7_"FOQ!T="D&L:!K$"2KIOB;PSJ313/I'B'2'FDDL;Z..6*2*2YT[4;:
M_P!(O]1TZ[_AU_;>_8N^(7[$WQ;D\ ^++B+7_"FOQ7FL?#7QW:1K!:>+_#<%
MRL#O<V0EF?2/$.D/-!:>(=%EDD%G=2PW-E<W^D7^FZC>?28''K$KV=2T:T5?
M32-1+>4?[W64>VJTNH^+BL*Z#YX7E2?5ZN#[2\GT?R>MF_C2OZ1/^#>+7+"W
MU_\ :N\-2-*-4U;1_@UKEF@C)A:P\/7OQ,L-2:2;.(Y5N/$^E"&,@F5'G8$"
M%L_S=U^^G_!OQK]G;?M$?&[PL\5R=0UGX+PZ_:S(D1LX[/PUXY\-Z=?13R&9
M9UN99_%FG/:)';RQ210WK330/' ESIF*O@ZZ\H/[JD'^A&#=L32?FU]\9+\;
MV/ZQ****^4/?"BBB@ HHHH **** "BBB@ HHHH ***Y#Q]X^\&?"WP9XC^(?
MQ#\1Z9X2\%^$M,FU?Q#XAU>8P6.G6,!5-S;%DGN;FYGDAL]/T^SAN-0U/4+B
MUT[3K6ZO[JWMY6DVTDFVW9):MM[)+JV#:2;;LEJV]DN[#Q]X^\&?"WP9XC^(
M?Q#\1Z9X2\%^$M,FU?Q#XAU>8P6.G6,!5-S;%DGN;FYGDAL]/T^SAN-0U/4+
MBUT[3K6ZO[JWMY?X^?\ @H)_P5C^)'[4]SK'PT^$<VN?##]G]O,LKJQ2Z-AX
MS^)4!COK2YE\:7FFW!6S\,ZE:78B;P';75[ITPB6YUV\U:5K6VTOP[_@H/\
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M->TJ+JX*S\E+56^:^X^\:***^?/7"BBB@ HHHH **** "BBB@ K^1'_@NS\
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MU7FE)VJU$KMNR4FDE?9):+R/HZ,8JE3LDKTX-V25VXJ[=@HHHK U/CGXY_L
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MOP\O;"_LKB6UO+*\M?%VD3VMW:74#QSVUU;3QI-;W$+I+#*B21NKJ"/[;_\
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M+S3;_38[^VGL/"7A748KP7$.OZG;ZCJVHQ6CP:;X>BLM3L_$UK[M_P $F_\
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M]I4W_P"3Q7ZCP+MB(K^:,U_Y*W^A_1W1117RY[@4444 %%%% !1110 4444
M%%%% !117CGQZ^/7PQ_9K^&/B#XM?%KQ!%H'A30(@B(@2?6-?UB=)6TWPSX9
MTUI87U?Q#J[PR1V-C')%%'%'<ZCJ-S8:18:CJ-HXQ<FHQ3E*3222NVWHDDM6
MVQ-J*;;225VWHDENVP^/7QZ^&/[-?PQ\0?%KXM>((M \*:!$$1$"3ZQK^L3I
M*VF^&?#.FM+"^K^(=7>&2.QL8Y(HHXH[G4=1N;#2+#4=1M/XS_V\O^"D_P 7
M?VS?$.I^'[6\U/P'\!+'4Y6\+_#.RO&MY-9M+>>REL-9^)$MC.;;Q+KGVG3X
M-5L].E:YT7PK<R&WT87-U%<ZYJ?E_P"V]^V]\3OVV?B=)XL\622Z!X$T"6\M
M/AK\-;2\>?1_"&CSNH>YN7"PIJ_BO5TA@E\0^(98(Y;R6*&RLH;#1;#3=-L_
MBJOI,#E\:"52JE*L]5UC3\ET<UUETVCI=R\7%8N59N$&XTEIU3GYO^[VC\WK
MHBO8_@+\!?B=^TI\3O#_ ,)?A+X?EU_Q7K\I=W<O!H^@:/ \2ZEXF\3:DL4R
M:1X>TA)HY+Z^DCEEDEDMM.TZVO\ 5[_3M.N^9^%WPR\:_&;XA>$OA;\.=%E\
M0>-O&VL0:)X?TF.:"V%Q=S*\LDMQ=W4D5K96-E:Q7%]J-_=2Q6MC86US=W,B
M0PNP_NG_ &(?V(?AC^Q-\,8_"?A..+7_ !WK\5G=_$KXE7=FD&L>+]8@1BEM
M;(6F?2/"FD/-/%X>\/13R16<4LU[>S7^M7^I:E>;8W&1PL%:TJLT^2'1='*7
M:*Z+>35EM)K/#8:5>6MU3BUS2[_W8Z6YK?<M7ND_%_V(?^"6OP'_ &1;#2/%
M>LZ?8_%?XZQQ)<WOQ'\2:=!<6'AC4&,$AM_AIH%TDUOX9BLFA$</B67[5XRO
M#-J).L:=I&I#P[8_IY117S%2K4K2<ZDW.3ZM[+LELDNB5DCW(4X4XJ$(J,5T
M75]V]VWU;U"BBBLRPHHHH BG@AN89K:YABN+>XBD@G@GC26&>&5#'+#-%(&2
M2*1&9)(W5D=&*L""17X?_MV?\$9OA=\:[/6/B-^S19Z'\(?BX/.U&]\(6\+V
M/PR^(,XB57M%TZ!_LGP^UR98TDMM3T"Q7P[?7:RKK>A1WFK7?BFP_<6BM:->
MK0FITIN+ZK>,EVE'9I_>MTTTF9U*4*L7&<4UT?6+[Q>Z?IOL[K0_S=O'W@'Q
MG\+?&?B/X>?$/PYJ?A+QIX2U.;2/$/A[5X1!?:=?0!7VML:2"YMKF"2&\T_4
M+.:XT_4]/N+74=.NKJPNK>XEY"O[;O\ @IE_P3O\/?MC_#NZ\6^!]*TS3?VC
M_!6F#_A"=>>Y@TB#QEI5M<?:;KP#XKO7@D@N;:Y@DO9/"E_?/;#0?$,T/F:I
MIV@ZEKXG_B?U32]3T34]1T76M.OM(UC2+Z[TO5M)U2TN+#4]+U.PN)+2_P!.
MU&PNXXKJROK*ZBEMKNTN8HKBVN(I(9HTD1E'U&$Q<,53YE[LXV52'9O9KO&5
MG9^33U1X>(P\J$[/6$KN$NZ[/^\NOR?4_4O_ ()[_P#!4+XG?LB:WHO@/QU?
M:Q\0OV<[J^6'4O"-U</J&M_#^WNY&-SK/PUN+RX06,4%Q(VI7_@V6:/P_K$C
M7[VJ:+K>J7.N'^QCX2?%OX>_'/X>^&OBE\+?$MCXK\$^*[%;[2=6L68$$,8K
MO3]0M)0EUIFL:9=)+8ZMI-]%!?Z;?P3VEW!%-$RC_..K] _V ?V_OB%^Q#\0
MC/ +[Q7\&?%=];?\+(^&_P!I4"<!8[8>+?"1N9$M=,\::9:HB([O!8>)+""/
M1-;DB6+2-7T+FQV7QK)U:*4:RU<591J=[Z:3[2V;TE_,ML+BW2:IU&W3V3W<
M/S;BNW3==G_=K17%_#KXA>#_ (L>!O"WQ'\ :Y8^)/!WC'1[76]!UC3KB&XM
M[FTN5.Z*1H9)%@OK&X2:PU2PE876FZG:W>GWD<-W:SQ)VE?.---IIIIV:>C3
M6Z:Z-'LIII-:IJZ?=,****0PHHHH **** "BBB@ HHHH **** /E']L3]D/X
M8_MD?"74OAUX_P!/B@UNQBO=1^'GC>VC1-=\#>*9+8)!J%C=>5(\VCW[Q6UM
MXFT.0/9ZUIT:96#5+'1]3TW^"GXC?#[Q;\)_'OB_X:>.]*ET3QCX%\0ZIX8\
M1Z7*Z2BVU32+N2TN#;W,+/;WUC.T8N=.U&TDFLM2L)K:_L9Y[2YAF?\ TA*_
MEJ_X+U_LR?V%XX\!?M4^&='\O3?'-K;_  \^)UY:C,?_  E^@V3OX+UK4%$1
M<7.L^$[2?PZUR9_LR6W@S2+800W,_F7OKY5B7"I]7E+W*EW"[^&:ULNRDKW7
M627=GG8^BI0]M%>]"RE;[46TDWYQ=ODW?1*W\[E%%%?0GD'0^$=#A\3>*_#'
MANXU&+1[?Q#XAT70Y]7FC2:'2X=6U*VL)=1FADN+1)8K%+AKF2-[NU1TB*M<
M0@F1?]''P7X/\/?#[PCX9\#>$M,MM&\,>$-#TSPYH.EV<$%M;6.E:19Q6-E!
M'#;10P)L@A3>8XHP\A=]H+&O\VVO]%7]GCXH0_&KX$?!_P"+44D3O\0OAQX0
M\57Z0A%2UUC5M$L[C7-/*Q@1I+IFL-?:?.D68DFM9%C9D"L?$SE2Y:#UY4ZB
M:Z<S4&O5M*7I9VW9Z>6M7JK[5HM=[)M/[FU]_H>QT445X1ZH4444 %%%% !1
M110 4444 %?Q!_\ !77]G?PE^SI^V/XATSP)8V.C>$OBCX5TCXPZ5X=TW>EE
MX<N/$^L^)-$\0:9:6QAA@TZQE\4>%]<U73-)L"^F:1I>IV6FZ<MK9VL-A9_V
M^5_#/_P5G^*5A\5/V\?C;=:28GTKP-?:/\+;658C%<2W_@+2+31O%(O"+R[B
MEEM_&B>)+*VEA%J&TVVL!/9PWBW)?U<HY_K$[-J/LGSKH_>BHW\TV[/>UULV
M<&8<OL8W7O<Z47U6CYOE9:^=NQ^;]?KA_P $I/\ @GY%^U[\1-0^(?Q-TZY?
M]G_X8:G;6VOVZSWFGM\0/&+6\>I6?@>ROH+8JVF6-I)9:EXY-I?V6J6FE:IH
MEE9R6\OB"+4K#\Q_AG\.O%7Q=^(?@KX7^![#^T_%WC[Q-H_A3P_:,7C@;4M:
MO8;*">^N$CE^QZ99^:;S5-0D0P:=IUO=7UR4M[>5U_T#_P!FWX#^%?V9O@C\
M/?@EX/?[5I7@;0XK&ZU=[1+*Y\1Z]=2RZAXC\37EJDUR+>ZU_6[J^U-[7[5=
M+8QW$=A#<2P6L35Z.98IX>DH0=JM6Z33LX15KR36S=[1?>[6QQ8/#JM-RFKT
MX:M=)2Z1?=;M_)/1GL>EZ7IFB:9IVBZ+IUCI&CZ18VFEZ3I.EVEO8:9I>F6%
MO':6&G:=86D<5K96-E:Q16UI:6T45O;6\4<,,:1HJB]117S)[@4444 %%%%
M!1110 4444 %%%% !7P5_P %.?A/I7Q>_8;_ &@]*U"&U-YX+\#:G\6-"O;A
MA'+IFJ_"ZWE\93364QLK\Q76HZ'I>L^'V58(S=6>LW=B;W3ENFU"U^]:\X^,
M>ES:W\(OBIHMMITNKW&K_#CQQI<&DP6CW\VJ37_AC5+2+3H;"..5[V6]DE6V
MCM$BE>Y>40K&Y<*=*4G"K3FG9QG&2UMM)/<F<5.$XM74HM=]T?YQU%%%?:'S
M(5_>K_P34_Y,0_9B_P"R:67_ *<M2K^"JO[U?^":G_)B'[,7_9-++_TY:E7D
M9Q_ I?\ 7W_VR1Z&7?Q9_P#7M_\ I43[CHHHKYX]@**** "BBB@ KP#XY?LL
M_L_?M(:)=Z'\9?A9X4\9"ZB6.+6[C3TL/%NFO'&T4$^C^+M,-GXDTN6!6PHM
M-3CAD0>3<0SVY:%O?Z*J,I0DI1DXR3NI1;33\FM1.,9)J24D]TTFGZIZ'\5/
M_!1__@F+XM_8UU/_ (6'X GUCQU^SUK=\MM;Z_=P)-K_ ,.M4O+@QV/A[QN]
MG'';SV-\7B@T+Q=#;65EJ%ZQT?4;/3-4?2_[<_)VO]'OXI?#3P?\9?AUXT^%
M?C_2XM9\'>//#VI>&]>L76$R_9-1@:);VPEFAG6RUC2[CR=4T35(HS=:3K%G
M8ZG9M'=VD$B?YY_QF^%VO?!/XL?$3X2>)OFUSX=^+]=\)WUP(UACOO[(OYK:
MVU2"))[I8[;5;1+?4K5!<S[;:ZB!E<Y8_29=BY8B$H5'>K3MK_/!Z*37=/25
MM-8O=L\7&8>-&490TA.^G\LE;2_9WNNNCZ6/[P_V%]8TW7?V+_V4[W2KG[5:
MP?L]_"/1Y9?)G@VZEX=\#:)X?UBVV7,4,C?8]7TR^M/.5#!<>1]HM99[66&:
M3ZJKX<_X)J?\F(?LQ?\ 9-++_P!.6I5]QU\[65JU5+I4FONDT>O2UI4WWIP_
M])04445F:!1110 4444 %%%% !1110 4444 ?CE_P6[^!NG?$O\ 8[N_B9#I
M7VOQ;\!O$VC^)]+O[=)Y-1A\*^*]4TOPEXTTV**"RO/-TR7[9X?\2ZQO?3TM
M8/"$6IRZBEO83V.H?QJ5_H"_MY^'[/Q+^Q5^U5IU_+=106WP$^)_B!'M'BCE
M-YX3\):GXJTZ)VFAG0VLVH:-:PWJ!%EDLY+B.":VG:.XB_S^J^CRB;EAYP>J
MA4?+Y*44[+YW?JV>-F$4JL9+[4-?6+:O]UE\@HHHKU3@/[H?V&?V4OV9]'_9
MA_9R\;V?P$^$K^-/%_P)^$WBKQ'XNU'P)X=UGQ/JFN^)_AMX6O=?NY=?UBPO
MM5ABU2\:2[N;"UNX-.^TS7$Z6B2W,[R?H=965GIMG::=IUI:Z?I^GVMO96%A
M96\5K9V5G:Q)!:VEI:P)'!;6MM!&D-O;PHD4,2)'&BHH ^<?V+?^3.OV3?\
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M)\Y7_C5O^OM3_P!+D%?U3_\ !OA_R1W]H7_LI?A?_P!1:6OY6*_JG_X-\/\
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MDNM,?PG#;>+;=+G$UGJ/C+6+; 15)_5VO-S"O[;$SL[PI_NX_P#;OQ/YRO\
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M<D-_HGB#3;;5M*O8I(7EBDBNK"[MYXWBDDC9) R.ZD,?\VBO[OO^"7/C6_\
M'W[ G[-.NZDLJ7%AX+U/P5&)KD73FP^&WC#Q)\.M*82BWM@L3Z7X5LW@MO+8
MV<+1V;7%V8#=3>+G%-<E&KU4G3;[J2<H_=RRMZL]++IOFJ4[Z./.EYIJ+?SN
MON/OJBBBO!/6"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF3U7^]HO96JQ\MHR^_W?Q/+S&FOW=1+5WA)]^L?_ &[\#Y'HHHKW#RS]7?\
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M#"EO#8>#_$[1>+?!EI##&J1)%;^%==T>*,Q1QPLBAXHHHV6-?]!.OQ@_;?\
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MC[4K2SELK+XF^%?!'Q&MXVC2.WEFO-(/A35[RS*LSRQ7NO\ A'5KNYDEVO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *_@I_X*5?\GW?M._]E,O_ /TWZ=7]ZU?P4_\
M!2K_ )/N_:=_[*9?_P#IOTZO6R?_ 'BI_P!>7_Z7 \_,?X4/^OB_])D?#M%%
M%?1'CG]4_P#P;X?\D=_:%_[*7X7_ /46EK^A&OY[O^#?#_DCO[0O_92_"_\
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M1![Z^TOQ_#IUO=7.J7MQ=6'AV.TCM+&WTE)+W[G_ ." O_)G7Q*_[.7\8_\
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M&76_!]W#=2W%H++?K=C:V%[<?:[>.32KW4+.\>2PNKN";^.O_@EUK.I^$/\
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M*^4/?"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_ #WOVTO^3Q?VLO\
MLY?X[_\ JTO%5?-%?2_[:7_)XO[67_9R_P =_P#U:7BJOFBOM*/\*E_U[A_Z
M2CYF?QR_Q2_-A7]GW_!$#_DQ'0/^RF?$;_TX65?Q@U_9]_P1 _Y,1T#_ +*9
M\1O_ $X65<&;?[JO^OL/RD=F7_QW_P!>Y?\ I43]>J***^:/:"BBB@ HHHH
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MPG_[*7X$_P#4ITJO3G\$O\,OR9Q0^./^*/YH_P!&VBBBOB3Z8**** "BBB@
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MFUNH[R?RBF_D9UJGLJ<ZG\L6TGLWM%/U;2/Y7/C[\9_%7[0_QF^(WQJ\:/\
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MO/\ A(_!\^NZ?9Z0DD<%[XC7P[=S!Y--MMO\,5?Z7%?P<?\ !2;]FN']EO\
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M0 4444 ?YH]%%%?<'RX5_>K_ ,$U/^3$/V8O^R:67_IRU*OX*J_O5_X)J?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]6:7I%N,?P2/HZ$>6C27_3N%_5Q3?XMA1117.:A1110 4444 %%%% !1110
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M;+^]6OZ*/&?C'PQ\//"/B;QYXTUBU\/^$?!VAZGXD\2:W>"9K;2]%T:SEO\
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M_I43[CHHHKYX]@**** "BBB@ K^2/_@OI\3K3Q+^TK\,?AC87LMVGPO^%_\
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MZIJVK:I=V]AIFEZ986\EW?ZCJ-_=R16ME8V5K%+<W=W<RQ6]M;Q2332)&C,
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M 4444 %%%% !7YH_\%@_^4='[1'_ '23_P!7I\,J_2ZOS1_X+!_\HZ/VB/\
MNDG_ *O3X95OA?\ ></_ -?Z/_IR)E7_ (%;_KU4_P#2)'\.M%%%?8GS@5_7
MG_P_Z_8Z_P"B:_M+_P#A'?"W_P"?+7\AE?2__#%O[8O_ $:;^TO_ .&(^*7_
M ,RM<N)P^'K^S]N[<G-R>^H7YG'F]=HKROYHWH5JU+F]DK\W+S>[S;-VVVW:
M\S^ES_A_U^QU_P!$U_:7_P#".^%O_P ^6C_A_P!?L=?]$U_:7_\ ".^%O_SY
M:_FC_P"&+?VQ?^C3?VE__#$?%+_YE:/^&+?VQ?\ HTW]I?\ \,1\4O\ YE:Y
M/[/R_P#G_P#*R\OZ^?H='UO%_P O_E-^7]?/T/Z7/^'_ %^QU_T37]I?_P (
M[X6__/EH_P"'_7['7_1-?VE__".^%O\ \^6OYH_^&+?VQ?\ HTW]I?\ \,1\
M4O\ YE:/^&+?VQ?^C3?VE_\ PQ'Q2_\ F5H_L_+_ .?_ ,K+R_KY^@?6\7_+
M_P"4WY?U\_0_HV\1_P#!P)^S7:_8_P#A$O@Q\<=;W_:/[0_X2./P%X6^R[?(
M^R?8_P"S/&'C#[=YVZY^T>?_ &=]E\J#R_M?VB3[+\F?%?\ X.!_B?K%MJ&G
M_!?X#^$/ [2?;;6S\1>/?$NI>/-06!Y)H[358-#TBP\&:;IVII;-%<+8WE]X
METZVOEV3MJUFK1S?BWXA_9<_::\(PV]SXK_9T^.WABWO)7@M)_$/PB^(&BPW
M4T:>8\-O+J7AZV2>5$^=XXF9U3YB .:\.G@FMIIK:YAEM[BWED@G@GC>*:":
M)S'+#-%(%>.6-U9)(W571U*L 016M/+\"M8P53UJ2DO6RE9_=8SGC,5:SDX7
M[047LMFU?L]._:R/2_C#\:?BG\?O'.H_$GXQ>-=8\>>--4BAMY]8U9K:)+:R
MMVE>VTS2=+TZWLM'T+1[:2>XEMM'T33]/TNWFN;F:&TCEN9WD\OHHKO244HQ
M222LDDDDELDEHDNR.5MMMMMMZMMW;?=M[G^EQ1117Q!].%%%% !1110 4444
M %%%% !1110 4444 ?P;_P#!3OQ2_C#]O;]IG5GO;&_:T\?1>%A/ISPR6\:>
M!O#FA>"8[*1H'D07VFQ^'UT[5$9A-'J=K=QW*17"RQI\'U]+_MI?\GB_M9?]
MG+_'?_U:7BJOFBOLZ"Y:%%+94J:^Z"1\U4?-4J-]9R?WR;"MSPQH%YXL\2^'
MO"VG2VT.H>)=<TG0+&:]>6.SBO-9O[?3K66[D@AN9X[:.>Y1YWAMYY5B#M'#
M*X"-AUZ7\%_^2Q?"?_LI?@3_ -2G2JTD[1DUNDVODB8J\HI[-I/YL_T;:***
M^(/IPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K_-C\3Z_>>+/$OB'Q3J,5M#J'B77-6U^^ALDECLXKS6;^XU&ZBM
M(YYKF>.VCGN72!)KB>58@BR32N"[?Z3E?YH]>YDRUQ+ZKV*^_P!K?\D>7F7_
M "Y_[B?^V!1117N'EGV7_P $\=#L/$/[</[+EAJ2RM;V_P 8_"&N1B*0Q.+_
M ,,WP\2:4Q8 DQ)J>DV;S1])H5DA8A7)']]M?P4_\$U?^3[OV8O^RF6'_IOU
M&O[UJ^>SC^-2_P"O7_M\O\E]Q[&7?PI_]?/_ &V(4445Y!Z 4444 %%%% !1
M110 4444 %%%% !7^:A>V5YIMY=Z=J-I<V&H6%S/97UC>P2VMY97EK*\%U:7
M=K.D<]M<VT\;PSP3(DL,J/'(BNI _P!*^O\ .2^-'_)8OBQ_V4OQW_ZE.JU[
M>3/7$+NJ3^YU/\SS,RVHOSJ?CR?Y'FE%%%>Z>4?7'[ _B&;PQ^VO^RMJ4%O%
M=/<_';X;>'FBF=T18?%OB?3_  I<7 *<F6SM]:ENX4/R2301I)A&8U_H 5_G
MO?L6_P#)XO[)O_9R_P "/_5I>%:_T(:\#.$O:T7U=.2^2EI^;/7R[^'4_P ?
M_MJ_R"BBBO&/1"BBB@ HHHH **** "BBB@ HHHH **** /YJ/^"^_P"S>AA^
M%W[5'A_3XE=)8OA'\19+2UF\Z59$U37O FNW[0!K<16YB\0^'[O5+Q(YF:Y\
M*Z2;J9%T^VM_YGJ_T2_VD/@IHG[1GP*^*'P3\0216]A\0O"M[HUO?S6\=TFD
M:W$T6I>&=>%O*CK++H'B2QTK6H5 $GG6$9ADBE"2I_GJ^+O"VM^!O%?B?P3X
MFLI=-\2>#_$.M>%O$&G3I)'-8:WX?U*YTG5;*:.9(IHY;6_M+B"1)8HY$>,J
MZ(P*CZ3*J_M*#I-^]1=EWY):Q^YW7DDCQ<?2Y*JJ)>[45WV4E9/[U9^;OV9S
MU>C_  @^)_B3X*_%+P!\6O"#Q)XD^'OBO1O%6E)<#=:W4VDWD5S)I]XH!+6.
MI6ZS:??(N'>TN9E1E8AAYQ17IM*2<6KIIII[--6:?JCB3:::=FFFFMTUJG\C
M_1_^&7Q%\*_%WX>>"OBAX'O_ .TO"/C[PSH_BOP_=L$2<Z=K5E#>PP7T"22_
M8]3LO-:RU73Y)#/IVI6]U87(6XMY47N:_ ;_ ((/?M.0^-/A'XR_9C\2:I+-
MXJ^$U]<^,O T%W.KO=_#'Q+>V\>J6.GQ!6F,7A#QM=33:A-<2A%A\>:#964?
ME6<PC_?FOCL11="M4I/[,O=?>+UB_FFK^=SZ*C456E":^TE?RDM)+Y._RLPH
MHHK$U"BBJ.J:G8:+IFHZSJMU%8Z7I-C=ZGJ5[.2(;.PL+>2ZO+J8J&(BM[>*
M260A20B$@$\4 ?S?_P#!?S]HA(;#X2?LN:%?2K<7LK_&'XA0PF:)!86YU/PS
M\/M,EN(9A#=Q75Z/&.KZEI-U$3;3:5X4U15)EM9$_F>LK*\U*\M-.TZTN;_4
M+^Y@LK&QLH);J\O;RZE2"UM+2U@22>YN;F>1(8((4>6:5TCC1G8 _1/[7WQ[
MO_VF_P!I+XN?&J[>7[!XO\5W2^%;:: 6LNG^!M#CBT#P/I\]LCO%%?6WA73-
M)&K/$56\UAM0OW42W<F?LO\ X(W_ +.LGQQ_;&\+^*]3M/-\&_ .V7XKZU++
M#<F"X\3:==1V?PZTN&Z@(CMM33Q9-;>+;=+G,-YIO@W6+?!=DQ]71C'!8).2
MLX4W4GW=22NX_P#@34$^R1X%23Q.)TVG-0CY06B?W)R:[MV/ZNOV,?@!9_LQ
M?LS?";X.Q6=M;:SX>\,V][XSFMQ$S7_CS7V;6_&%W-=17%V+W9K=]=6%E<?:
M[B./2K+3[.S>.PM;2"'ZAHHKY:<I3E*<G>4Y.4GW;=W^+/>C%1C&*VBE%>B5
ME^""BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% '^:/1117W!\N%?
MTR_LB?\ !9O]E_X!?LU?!WX-^,? ?Q[U+Q/\/?"%OH&M7_AKPO\ #V\T&ZO(
M;N[G:72[K5/BEHVH36Q2X0*]WI=E*6# P@ ,W\S5>]^&OV5?VH/&F@Z7XI\'
M?LW_ ![\6>&-;MEO=%\1^&O@_P#$+7=!U>S9F1;O2]7TOP[=:??VS.CHL]I<
M2Q%D90Y*D#GQ-"C7C&-=VBI77O<GO6:WZZ-Z&U"K5I2<J2NVK/W7+2Z>R[M)
M']/'_#_K]CK_ *)K^TO_ .$=\+?_ )\M'_#_ *_8Z_Z)K^TO_P"$=\+?_GRU
M_-'_ ,,6_MB_]&F_M+_^&(^*7_S*T?\ #%O[8O\ T:;^TO\ ^&(^*7_S*UQ?
MV?E_\_\ Y67E_7S]#I^MXO\ E_\ *;\OZ^?H?TN?\/\ K]CK_HFO[2__ (1W
MPM_^?+1_P_Z_8Z_Z)K^TO_X1WPM_^?+7\T?_  Q;^V+_ -&F_M+_ /AB/BE_
M\RM'_#%O[8O_ $:;^TO_ .&(^*7_ ,RM']GY?_/_ .5EY?U\_0/K>+_E_P#*
M;\OZ^?H?TDZQ_P %_P#]E*#3;F7P_P#"?]H34]77R?LECK&B?#C0M-GW3Q+<
M?:=5LOB5XBNK7RK4S30^5H]YY\\<5L_V>.9[J#YM^)/_  <):G+:W%I\(/V;
M[&RO3%FTU_XD^.+C5+6.9K2Z3R[CPCX8T?1Y98H+]K*?SHO&\+W5I#=6GD6<
MUU%>VGX=:G^R#^UGHMA=:KK/[+W[1.DZ78Q&>]U+4_@G\2K"PLX00IFNKRZ\
M,Q6]O$"R@R2R(@) )R17ANN>'M?\,7[:5XDT/6/#VII%'.VG:YIE[I-^L,P)
MAF:SOX+>X6*4 F.0QA' )4D UI3R_ WO&*J6[U7)+;I&23^=UKZ$3QF*MJ^2
M_:"5_FT_73\CZ)_:8_;'_:#_ &M]>M]8^-/CJYUK3],N;BY\.^#M+@31?!/A
MAKA?+<Z+X>M#Y'VGR,6[:OJ<NI:]<6X$-WJMP@ KY?HHKOC",(J,(J,5HHQ2
M27R1R2E*3<I-R;W;;;?S9_<5_P $?/\ E'1^SO\ ]U;_ /5Z?$VOTNK\T?\
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M4\!VWAKPWJ$2-IEI<1QWFESI%>"XOHPMY>WL]Q<,HQ$FN>=."ZZN4ON22?\
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MGZ5;/+#IUDUW:V<^MZ[?D"RT'P]I\U[;?VGKNJSVFEZ>DT;75S'YD8;^PO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "OX*?\ @I5_R?=^T[_V4R__ /3?
MIU?WK5_!3_P4J_Y/N_:=_P"RF7__ *;].KULG_WBI_UY?_I<#S\Q_A0_Z^+_
M -)D?#M%%%?1'CG]4_\ P;X?\D=_:%_[*7X7_P#46EK^A&OY[O\ @WP_Y([^
MT+_V4OPO_P"HM+7]"-?)YA_OE?\ Q1_](B?083_=Z7^']6%%%%<9T!1110 4
M444 %%%% !1110!^47_!:CQ!>:-^P%\1M.M8K62#Q9XP^&/A_47N$E:6&SMO
M&VE>*DELFCFB2.Z.H>&;"%WG2YB-G-=QB%9Y(;BW_BDK^OS_ (+U^+_[$_9
M\%^%[>\M8[SQK\<?#%M<V,L>^YNM!T'PIXUUJ^N+4GB+['K<'AE)Y0=WEW@A
M"E9G9/Y Z^ERE-85O^:K-KS5H1_.+/$S!WKV_EA%/RUE+\F@HHHKTSB/Z1/^
M#>+0["XU_P#:N\2R+*=4TG1_@UH=FXD(A6P\0WOQ,O\ 4EDAQB25KCPQI1AD
M)!B1)U (F;'].E?S\?\ !OGX0^Q?!#X_>/?L=JG_  DOQ5T+PA]O23-[<_\
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M%%%?+GN!1110 4444 %%%% !1110 4444 %%%% !1110 4444 > ?M!_LN_
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MX]HU'_X$X+_VT]7+5[M67>4%]RD__;@HHHKQ3TPHHHH **** "BBB@ HHHH
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M37NA:KY(,C:=J-TB@EJ_T-/A]XY\/?$[P+X.^(OA*[^W>&/'/AG1/%F@W1:
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M]>X?^DH^9G\<O\4OS85_9]_P1 _Y,1T#_LIGQ&_].%E7\8-?V??\$0/^3$=
M_P"RF?$;_P!.%E7!FW^ZK_K[#\I'9E_\=_\ 7N7_ *5$_7JBBBOFCV@HHHH
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M&_\ 3A95^O5>7C/]ZQ'_ %]G^9W8?^!1_P"O</\ TE!1117,;!1110 4444
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M*6Z_97L+WXW_  /O-8\3_ RXU>"VUWPWJ,=WJGBCX5RZH9VMIKO5;>T,.K>
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M$KR!6DE>,DMVFE\T3%VE%O9--_)G^DO1117Q!].%%%% !1110 4444 %%%%
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M;V\4<48+$A$ ))YKT<WKVA"@GK/WY_X8OW4_65W_ -NHX\NI7E.JUI%<D?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5_!3_ ,%*O^3[OVG?^RF7_P#Z;].K^]:OX*?^"E7_
M "?=^T[_ -E,O_\ TWZ=7K9/_O%3_KR__2X'GYC_  H?]?%_Z3(^':***^B/
M'/ZI_P#@WP_Y([^T+_V4OPO_ .HM+7]"-?SW?\&^'_)'?VA?^RE^%_\ U%I:
M_H1KY/,/]\K_ .*/_I$3Z#"?[O2_P_JPHHHKC.@**** "BBB@ HHHH ****
M/Y@O^#A+XC0W/BO]F_X1VMW*MQHOA[QQ\1M<L!(AAGA\3ZEH_AGPK=R0[/,6
M6U?PCXRABDW['2\F4)NC)K^<2OT2_P""JWQBMOC/^W+\:M5TN]^W>'_ ^IV'
MPJT%QYACCC^'UE'HOB)8)'5%FM9O&Z>*;VUN(%^S3VUU%+;R7,3I=3_G;7UV
M"I^RPM&#T?(I/O>;<VGYKFM\CY[$S]I7JR6W-RKTBE%->3M?YA117<_#'X?Z
M]\5_B-X#^&/A>'S_ !%\0?%_AWP9HJ$+Y8U'Q)JUII-K+.TDD,45M;RW:SW4
M\TT$%O;1RSSSPPQO*G2VDFV[))MM[)+5M^A@DVTEJV[)=VS^TS_@D'\-G^'/
M[!/P=:ZMY;;5?'\OBKXDZI')Y.QT\2^(]0B\.W$!CM;:4Q77@O3?#-R?M3W<
MPFEF6.Z-F+6"#],ZYGP5X2T;P#X-\)>!/#L/V;P_X*\,Z#X2T*W\NUA^SZ-X
M<TJTT?3(?)L;:SLHO*LK."/R[.SM+5-NVWMH(0D2=-7QE6?M:M2H_MSE+TYF
MVE\EH?2TX\E.$/Y81CZV25_G8****S+"BBB@ HHHH **** "BBB@ HHHH _A
MU_X+!_\ *1?]HC_NDG_JB_AE7YHU^EW_  6#_P"4B_[1'_=)/_5%_#*OS1K[
M'"_[MA_^O%'_ --Q/G*_\>M_U]J?^ER"OZI_^#?#_DCO[0O_ &4OPO\ ^HM+
M7\K%?U3_ /!OA_R1W]H7_LI?A?\ ]1:6N;-/]SJ?XJ?_ *6C? ?[Q'_#/\C^
MA&BBBOESW HHHH **** "BBB@ HHHH **** "BBB@ HKXTU'_@H+^R%I/QOC
M_9PU'XOQ6?QFE\::9\/(_!\W@?XDA'\9:U=6ECI6B#Q(/!Q\)>;?7E_9VT%W
M_;W]GF:XCC-VK$@?9=5*$X<O/"4>9<T>:+CS1>THW2NGW5T3&497Y91ERNSY
M6G9]G9Z/R>H4445)04444 %13P0W,,UM<PQ7%O<1203P3QI+#/#*ACEAFBD#
M))%(C,DD;JR.C%6!!(J6B@#\3?VRO^"+'P4^./\ :_C?]G^;3/@5\4;K^T=1
MN-(C@OIOA7XNU>XS-$NHZ+;-=3^!/-G"POJ'@O3Y-+M89)KE_!NIWSM*_P#+
M5\??V</C-^S'XVF\ _&CP3J?A#6C]IFTJ[F47.@^)M-MKAK8ZQX8URWWZ?K6
MF2.%S+:S&>T:1+?4;>RO!);)_HCUY+\:?@7\*/VA? VI_#KXP>"]'\:>%]3B
MD46^HP;;_2KIE CU3P_J\!BU30-8MR 8-3TFZM+M #$TCP22Q/Z>%S*K1:A5
M;JTMM7><5_=D]TOY9>B:.&O@J=2\J=J<_)>X_5+9^:6KU:;/\Z&BOU4_X*)?
M\$QO'_[&VJWWQ!\(277CC]G;6-<:TT7Q*HEN/$/@-KYH3IF@_$6&*T@MH//N
M9Y-*T;Q38L^E:W/:P)?Q:!K&J:?HUQ^5=?0TJL*T(U*<E*,NO5/JFNC75,\B
M=.=.3A-.,E^/FGU3Z-!6QX>\0:WX3U_0_%7AG5;[0O$GAK6-,\0>'];TNXDM
M-3T;6]&O8-1TK5=.NX666UOM/O[:WN[2XB99(+B&.5&#*#6/16F^Y&VQ_H$_
ML2_M+Z9^UI^S;\._C+;1Q6>NZG8S:%X[T>-K?.C>/?#DO]F>)+98K>>X6WL=
M1N(XO$.@PS2"[/AO6M&FNX;>YEE@C^KZ_E<_X(!_'*_T?XI?%O\ 9YU&[B_L
M#QKX43XF>'8)E >W\6^$KS3=$UFVL71E9I==\-ZS#>7L<Z3(L/@ZW>VDM'-R
ME_\ U1U\CC*"P^(J4U\-^:'^&6J7_;KO'Y'T.&J^UHPF_BMRR_Q1T;^>C^84
M445RFX4444 %%%% !1110 4444 ?RD_\'!?@:[T_XZ_ 7XEOYOV#Q;\)=7\#
M6Q+VIA^U_#SQCJ&OWOEQI*;U)1#\3]/\Y[B".UD0P+9RS2Q7R0?S^U_8-_P7
M=^%/_"9?LBZ#\2;2VWZA\'/B9H6HWMWLW_9_"OC>*;P=J<.0 8_M/B>]\$MY
MA8I_H_E&-GEC>+^/FOJ<MJ<^$IKK3<J;^3NO_)91/"QL>7$3[249+YI)_BF%
M%%%=YR']W/\ P2U\:?\ "=_L#?LWZJUS=7$^D^$-2\%SB]OOM]U;?\(#XJU_
MP9:VSN9)'M[5-/T.S?2K%RGV+1I-.MXXT@2):^_Z_![_ ((#_$R/Q#^S;\5?
MA?<77GZE\-?BJ-<MX=MM']B\,_$/P_92:7!MAACFE\SQ%X4\8W7VF[DN)G^T
M?9HY$MK2&&/]X:^0QD/9XJO#_IY*2])^^OPDCZ+#RYZ%*5[^Y%-^<5RO\4PH
MHHKF-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "OXZ_P#@NQ\/7\*_MFZ9XRAMHELOBA\)?".NRWD.GPV8FUOPY>:SX+OK
M2YN8Y9)-6OK31]!\.3O?W$<$D5A?Z;I:(\.G1RO_ &*5^ /_  < ?"G^WO@?
M\&?C%:6WF7?P[^(6I^#M3DB3$D>@_$71A>"[NG  >UM-;\%:590!V9H;G7#Y
M"!;FZ:N_+:GL\73OM44J;_[>5U]\HI')C8\V'GWBXR7R:3_!L_E%HHHKZD\(
M*_T+_P!D3QDGQ"_97_9R\9B6QEN/$'P2^&5[J8TQ9DL+?6QX/TBWUZQM8[B6
M>>.+3M:AO[ 1S7%Q)&;8H\\Y4RO_ )Z%?VO_ /!&#XFI\1/V#O 6DR32W.H_
M"GQ7XX^&6J3S/,[L]KJX\::-"!)96D4<5AX5\;>']-A2UFU&'R;.-I+U;MKF
MQLO(SB%Z-.:7P5+/R4XO7[XQ7S^[T,NE:K./\T+^KC)?HV?JS1117SQ[ 444
M4 %%%% !1110 4444 %%%% !7^;W\2/$T/C7XB>/?&5N;XV_BWQIXI\30'5"
MAU,PZ]KE]JL1U$QW%VAOBEVINREU<H;CS-MQ,,2-_H'?M0_$)/A/^S?\=OB1
M]IEM+CP;\)?'VN:9);ZA-I-U)K=IX9U(Z!:66JV\4\^FWU]K36%E8W\,,LEI
M=W$,Z(QC K_.]KW<FCI7GT;A%?)2;_.)Y>9/6E'K[[?SY4OR84445[9Y9^I7
M_!&WX9R?$7]O/X9W\EK]KTKX8Z'XS^)FL1[KF/RH]+T*?PYH-UYMK- Z?8_&
M7BGPQ<[9&>VN?*^QW4,UO<R1-_;=7\W_ /P;[?!VYM/#WQ[^/>HV6R#6]3\/
M?"KPG>OY:NT>AP/XI\;*B%C.]M//K'@A([@)';-<Z=>0)+<3V]Q'9_T@5\QF
ME3GQ<HIW5.,8+M>W-+YIR:?6ZMT/<P,.6@FU9SE*7RTBOPC=>H4445YQV!11
M10 4444 %%%% !1110 4444 %%%% !1110!_'S_P7!_9D_X5-^TAIGQM\-Z/
M]D\$?'W3)M1U6XMAFUM?BIX?:.V\60R111>78_V_I%QX>\20R7$OG:UK-UXL
MN($9=.NF7\3:_N^_X*6_LQS?M3_LE_$'P9H&EQ:G\1O"<47Q%^&*"!Y[Z?Q3
MX566YN=!TU8V1GOO&'AN37/"5A'+*EFNJ:SIUY=_N[(,O\(-?49;7]MAU%N\
MZ+]F^[C;W)?->[ZQ9X6-I>SK-I6C4]Y=K_:7R>MNB:"OLO\ 8"_:/F_99_:K
M^%OQ0N+F*W\)3:Q'X-^(XN YMS\/?%TT&E>(KZ011R7#R^&U>U\76$,!B:ZU
M/P]96D\ALY[F.3XTHKNG"-2$H25XSBXR7DU9_/L^C.:,G"491T<6I+U3NC_2
MS@GAN88;FVFBN+>XBCG@G@D26&>&5!)%-#+&622*1&5XY$9D=&#*2"#4M?EK
M_P $A?VEO^&@OV0O"FAZU?VUSX\^!OV7X4^)(D?%W/H.C642_#[6[FW9 Z_;
MO"<=KH\]Z\UTVK:UX<UO4))EGFFMK?\ 4JOC:M.5*I.E+>$G%^=MFO)JS7DS
MZ.G-5(1FMI13^_=>J=T_-'!?%/XC>&_A!\-O'?Q2\7W<5EX9^'_A37/%FL32
MR",O::)I\]\;2W^61YKZ_DA2PTZT@BGNKV_N;:SM+>XN9XH9/\\'XI_$;Q)\
M7_B3X[^*7B^[EO?$OQ \5ZYXLUB:63S EWK>H3WS6EOA(XX;&P29+'3K2"*"
MULK"VMK2TM[>V@BAC_J0_P""\'[2G_""_!3P9^SAH%UM\0?&?4SXB\7-!=[)
M=/\ AYX*OK2XMK.ZMHIHKA?^$L\7/8?8;AUGLI;/PCXCLIX#+-;RP_R95[N4
MT.2E*M)>]5?+'_!'K_V]*]_**?4\K,*O-4C36T%=_P"*6NOHK?>S]X?^"#_[
M.L?COX[^,OV@==M/-T/X*Z&-'\,"2&VDBG\?^.+>[L1=J\QDD_XD/A.'6]Z0
M01RI>Z[I-TE]"+9[:\_K7KX<_P""<W[.?_#,/[(OPK^'^I:1_9'C?6M,_P"%
MA?$R&:W^RZE_PGGC2*WU&_T[6(Q++&VI^$](31/ LLL+".6#PM;N S%I'^XZ
M\G'5_;XFI-.\(ODA_ACI=>4G>7S/0PM+V5&$6K2DN>7^*71^:5H_(****Y#H
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _SWOVTO\ D\7]K+_L
MY?X[_P#JTO%5?-%?2_[:7_)XO[67_9R_QW_]6EXJKYHK[2C_  J7_7N'_I*/
MF9_'+_%+\V%?V??\$0/^3$= _P"RF?$;_P!.%E7\8-?V??\ !$#_ ),1T#_L
MIGQ&_P#3A95P9M_NJ_Z^P_*1V9?_ !W_ ->Y?^E1/UZHHHKYH]H**** "BBB
M@ K^>#_@X0\ B^^%_P"SM\4DM9<^&/'OB[P#<WL<MA'"1XZ\/6GB*QM;N!T_
MM2ZE7_A7>H2Z=+;R?8+!&U1+Q/M&HV+5_0_7E_Q;^"GPH^//A>#P7\8O ?A[
MXA^%[76+3Q!::-XCL_M=K::W8VU[96NJVA1XIK6^ALM2U&S6XMY8Y#:7]Y:N
MS07,T;[X:M["O3JM-J#=TMVFG%I7:6SZF5>FZM*=--)R2LWLFFG^A^:O_!$#
M_DQ'0/\ LIGQ&_\ 3A95^O5><?"OX0_#3X(>$H? GPG\':/X%\(6]]>ZG#H&
MAQS16$=_J+K)?72I/-/)YMRZ(TA,A!*C %>CU->HJM:K42:4YRDD]TF[ZVTN
M.E!PIP@VFXQC%M;72MI>P4445D:!1110 4444 %%%% !1110 4444 %%%% !
M7^:/7^EQ7^:/7N9-_P Q/_<'_P!RGEYE_P N?^XG_N,****]P\L_O5_X)J?\
MF(?LQ?\ 9-++_P!.6I5]QU\.?\$U/^3$/V8O^R:67_IRU*ON.OC*_P#'K?\
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M3G2E\,XN+\K[->:=FO-&-.;ISC-;QDGZVW3\FM'ZG^EG17Q[^P9^T;#^U/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;16]U%/#=165ZS:[J<+P3*-$TC5)VAE2%D;ZOK^/G_@M9^V%9_'+XW:?\"?
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M4 %%%% !1110 4444 ?PZ_\ !8/_ )2+_M$?]TD_]47\,J_-&OTN_P""P?\
MRD7_ &B/^Z2?^J+^&5?FC7V.%_W;#_\ 7BC_ .FXGSE?^/6_Z^U/_2Y!7]4_
M_!OA_P D=_:%_P"RE^%__46EK^5BOZI_^#?#_DCO[0O_ &4OPO\ ^HM+7-FG
M^YU/\5/_ -+1O@/]XC_AG^1_0C1117RY[@4444 %%%% !1110 4444 %%%%
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ME?\ "4?:[#QQ#<7DRS:IK.L^+(K*!;31&V?C!7V-"K&O2IU8[3BFUVEM*/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ?FC_ ,%@_P#E'1^T1_W23_U>GPRK^'6O[BO^"P?_ "CH
M_:(_[I)_ZO3X95_#K7T>3_[M4_Z_R_\ 3=(\;,?X\/\ KU'_ -+F%>E_!?\
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M+MD5W6VL-/M;B[G9$=A%$Y56( /^<O\ #CQ]XD^%7Q \$_$SP==16?BKX?\
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M[^0D8'Z2_P#!$7]G6/XO?M73?%/6K7[1X3_9XT-/%I62&VN+6Z\?^)OM^A^
MK*[CF/FP_8XH/$_C#3[VV!EMM9\'Z:C8CG8U^--?W%?\$FOV<_\ AGG]CGP'
M_:^D?V9XZ^+6?BQXR^TVWDZI'_PDUK;?\(GI-[YDLUQ;_P!D^#[?1?,TJ7[-
M_9NKWNL^=86FI76I>;UYA56'PGLX:.:5&"[12M)_*"Y;]'),Y\)3=;$*4M5%
MNI)OJ[Z?-R=_1,_2ZBBBOF#W HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#_-'HHHK[@^7"O[U?^":G_)B'[,7_9-++_TY:E7\%5?WJ_\
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M^P]^USXM_8T^/'ASXGZ-)?:AX/O)8M!^*/@^V9'C\7>!KR91J,$%O/<VEO\
M\)#HK$:YX4O)+NS6WUNRM[6]N6T/4-9L;[^\CX?^//"OQ0\$>%?B)X'U>UUW
MPCXST/3O$/A_5;21)(KO3M2MTN(2X1G\FZAWM;WMI(1/97D-Q9W*1W$$L:_Y
MNU?O-_P1C_;Y3X/^,(?V5_BKK$J?#3XD^(8'^&6LZA<S2VW@;XAZS,EFWAY4
M6TN9;?P]X_OY+%5S=VND:#XH1]4>WB'B?Q#JD7EYG@_:P]O35ZE->\DM9P7Y
MRANNKC=:M11W8+$>SE[*;]R;T;VC)_DGUZ)Z]V?UI4445\X>R%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5_!3_P %*O\ D^[]IW_LIE__ .F_3J_O6K^"G_@I5_R?=^T[_P!E,O\
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MVG/:]^L8ZJ/=MO5<MO:P6&=*/M)JTYJR7\L7K9^;T;[:+>X4445Y9W!1110
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M=-/=0@ONBD?,RUE)_P!Y_F%?V??\$0/^3$= _P"RF?$;_P!.%E7\8-?V??\
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M=HKT>LEY2"BBBO-.T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML/57^*+A_P"E\HGB</'>K#Y2YO\ TFY^\-<-\1?B;\//A%X5O_''Q0\:^&?
M/A'3<+=^(/%>L66BZ<)W21X+&":]FB^VZG>>5)'I^E62W&I:C.!;6%K<7#)$
MW\HOQD_X+R?M2^-?M=C\(O!_P]^"6E3>6]KJ'V1_B3XVM)%^U+(G]L^)[>T\
M&W%M*DUJ_ER?#D7*7%IYBWAM[B2U'X^?$KXM?$_XR>(9?%GQ7^('B_XB>(I/
M.5=5\8>(-2UZYM()IWN&L=.&H7$\6EZ9'+(WV;2]-CM=.LX]L-I:PPHD:]M'
M**TFG6G&E'K&/OS]-/<7:_-+T:WYJF84XZ4XN;[OW8__ "3]++U/WT_;4_X+
ME:EXBL[_ .'_ .QU8:GX:L;C[99:M\9/%6FP0:]=6LL30 ^ O#=PUQ_87F;V
MFB\0^(8SK,:E/LN@Z->Q1WP_G7U35-3UO4]1UK6M1OM7UC5[Z[U35M6U2[N+
M_4]4U._N)+N_U'4;^[DENKV^O;J66YN[NYEEN+FXEDFFD>1V8T:*]JAAZ6'C
MRTHVO\4GK*3_ +TMWY+1+HE<\RK6J5G>I)NVRVBO1;+S>[ZMA4L$$US-#;6T
M,MQ<7$L<$$$$;RS3S2N(XH88HPSR2R.RI'&BL[NP5020*_1O]FO_ ()5_M@?
MM(S:9J=KX!E^%O@"\E;S_'_Q5$_ABS%O"Z&5](\+R0R^--?EN(C*-,N++0$\
M/W5U%]GO?$.F(QN$_IO_ &-_^"6_[.7[(J:7XF73(OBQ\8[*(&3XI^,]*M]^
MEW@F687/@7PI+<ZKIG@B6,1I'#J=M=:GXICA>[M6\326-[/:-AB,PP^'37,J
ME3^2#3L_[TM5'SWEVBS6CA*M:SMR0T]Z2:NO[L=Y>6R\T?CO_P $\_\ @C3X
MA^(LFB_&3]K;2]3\)?#X_8M5\+?"!II]*\9^,3%<VUVESX]B>U^T^%?"%[;*
M]L-$AN++QGJXFFEF?PM:6UE<:[_5'I>EZ9HFF:=HNBZ=8Z1H^D6-II>DZ3I=
MI;V&F:7IEA;QVEAIVG6%I'%:V5C96L45M:6EM%%;VUO%'##&D:*HO45\[B<3
M5Q,^:H]%?D@OA@GV75NRO)ZOT22]BC0IT(\L%J[<TG\4K=WV[+97"BBBN<V"
MBBB@ HHHH **** "BBB@ HHHH **** "BBOS,_X**_\ !0WX:?LA_#KQ+X4T
M?Q'8ZQ^T5XD\/7-OX$\#Z?YM]=>'I=4@,%OXS\8R6<T">'](TR.<7^EVMW>6
MVL>)+N."'1K.?3XM7U32=*5*=:<:=.+E*3LDE>RZM]DMVWHEJR)SC3BYS:44
MKMO\EW;Z+=L_D5_;3\:)\0_VN?VE?%\%U%?6&J_&WXCIHUY#:S6277A_3/%.
MI:1X=G-K<QPW,,LFA6&G-.+F&&X:8R//#%*SQK\R445]E"*A",%M",8KII%)
M+\CYN3<I2D]Y-M^K=V%?T@?\&\GB"SMO$O[57A5XKHZAK.A?"#Q!:S(D1LX[
M/PSJ'Q%TZ_BN)#,LZW4T_BS3GM$CMY8I(H;UIIK=XX$N?YOZ^P?V%_VL=8_8
MT_:$\.?%^STV77/#L]C=^#_B%X?MC$M[K?@+7+S3KK6+?3))I;>%-8T^]TK2
M]>T=;BXM[2XU32+2TOIXK&XN77#&4I5L-5IQUE**<5W<91FETWY;=M=37#U%
M3K4YR^%.S?923BW\D[NVNFFI_?O17B_P,_:&^#/[2?@R#QY\%?'VA^.=!?RX
M[]-.N##K7A^\D,H73/%/AV\6WUSPUJ;""66&RUJPLY;RT$>H6(NM.N+:[F]H
MKY&491;C).,EHU)--/LT]4?0IJ24HM--733NFO)A1112&%%%% !1110 4444
M %%%% !1110!_!3_ ,%*O^3[OVG?^RF7_P#Z;].KX=K[B_X*5?\ )]W[3O\
MV4R__P#3?IU?#M?98?\ W>A_UYI?^D1/FZW\6K_U\G_Z4SZJ_9"_:]^*G[&O
MQ4L_B/\ #B\^V:9>?9M/\>> ]0N9HO#GC[PY%,TC:9J:QK+]CU.S\V>?P[XB
M@@EO]!OY9'2.\TR\U?2-4_MD_9/_ &R/@E^V-X#'C/X3Z_MU.PVQ>+?A]KLV
MGVOCSP5=/)+% ->T6TOKW&F:EY,DNBZ]9376C:M&D\$%VNIV&JZ=I_\ GXUU
M_@/Q_P"-OA?XJTCQQ\._%6N>#/%VA7,=WI7B#P[J-QIFI6DL;JY036[IYUM-
ML$=W97 EL[V O;7D$]O))$W-C,##%+F3Y*J5E.UU)=IKK;HUJO-:&V'Q4Z'N
MOWJ;>L;[=W%]'Y;/R>I_I$T5_+Q^RS_P7J\3:)#9>%_VM_ TOC.UBB6%/BG\
M,;'2M+\4NZIA9?$W@2XN=)\+ZI+<3N7N=2\+ZAX2AT^S@6.V\*:M=.TA_<_X
M1_MY?L?_ !OL+>\^'_[0/PXN+J>*24^'O$FNP>!_%L(@+K<^9X4\9_V#K[Q6
MSQL);RWL)[!D,5Q!=S6MQ;3S>!6P>(H-J=.3C_/!.4'\TM/223\CUZ>)HU5[
MLU?^67NR7R>_RNCZXHHHKE-PHJCJ>J:9HMA=:KK.HV.DZ78Q&>]U+4[NWL+"
MSA!"F:ZO+J2*WMX@64&261$!(!.2*_,S]I;_ (*X_LA?L^6=_8Z+XSMOCAX\
M@WPVWA#X4W]EKFG)=B))%&M^.HGG\)Z7;1O(MO>K8WFMZU9SK- ="EGMKB*+
M2G2J59<M.$IO^ZF[>KV2\VTB)U(4US3DHKS?Y+=^B3/OKXM_%OX>_ SX>^)?
MBE\4O$MCX4\$^%+%K[5M6OF8DDL(K33]/M(@]UJ>L:G=/%8Z3I-C%/?ZE?SP
M6EI!+-*JG^%G]NK]K[Q)^V?\>-<^)VH07VC>#=.B_P"$<^&?A"[N#(?#?@^S
MGD>V>\ABN+BR3Q#KLSOK'B.6SDFA-_<+86]S<:?INGLNG^VC^WM\;/VV/%-O
M>^/+R+PY\/="OI+WP3\*M!F+>&_#<TMG%8RZC>7;06U[XG\0SPI,9-;UD.]D
M+_4;70;31=,OI]/;XAKZ+ 8%89>TJ6E6DK::JG%VO%/K)_:DM/LK2[EX^*Q7
MMGR0NJ:=]=')]VK[+HOF];)%?<?[ 7[&7B?]M/XY:;X(MC<Z7\.O#'V7Q#\6
M/%L*0O\ V'X8$DWV;3+-);NT:77/%EW:MH>CK;FXFLO-O->EL[G3]$OHSPW[
M(7[(7Q4_;*^*EG\./AQ9_8],L_LVH>//'FH6TTOASP#X<EF:-M3U-HVB^V:G
M>>5/!X=\.P3Q7^O7\4B))9Z99ZOJ^E_W ?LK_LP_#?\ 9*^#WASX2_#G3K94
ML+:VNO%GBC[&+75_'GB][2"'6?%VN%KB]G%SJ4\/^AZ>U]=6VA:6EEH>FNNG
MV%N@>/QL</!TX.]>2T2_Y=I_:EY_RKJ]7INL+A76DIR5J47J_P"=K[*ZV[M;
M;+7;W;P]X?T3PGH&A^%?#.E6.A>&_#6CZ9X?\/Z)I=O'::;HVB:-90:=I6E:
M=:0JL5K8Z?86UO:6EO$JQP6\,<2*%4"MBBBOF-]SW-M@HHHH **** "BBB@
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MC_A]_P#L(_\ 0?\ B9_X;G4/_DRE]3Q7_0/6_P# )?Y>?Y]F/ZQ0_P"?U/\
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M'3-4TS6K"UU71M1L=6TN^B$]EJ6F7=O?V%Y"25$UK>6LDMO<1$JP$D4CH2"
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MWIY9BZC5X*G%[RG*.G_;J;E?Y+71M:F4\;AXIVDYOM%/7YM)?C\C]]/V_O\
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M*ME>(IMNG:M#HXM*=K]8MZO_  MGJ4L?1FDIWIR\[N+?DTM/^WDO4_HVHKX
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M/FE)Z]DNB2Z)+1+]3U:=.-*"A!6BOO?=M]6^K"BBBLRPHHHH **** "BBB@
MHHHH **** "HIX(;F&:VN88KBWN(I()X)XTEAGAE0QRPS12!DDBD1F22-U9'
M1BK @D5+10!_*3_P4\_X)*ZQ\-;_ ,1?M!_LM^&)=4^%DD5_X@^(GPPT<1-?
M_#,Q!KK4?$'A#3C(MQJ?@)P9+F]T+3H[F_\ !06:XM+:3P<DO_"*_P _M?Z7
M%?@-^WW_ ,$7O"_Q3FU;XL?LFV^C^!/B)=2R7OB'X4W$UMH_P]\6S.YDEO?"
MDHA2W\#^(96:3S]/=U\'ZHPMC%%X6N(]0O\ 5O<P69I)4L2]K*%5_E4;?_D_
M_@763\O%8+>I17G*FOSA^L?_  'L?R@5^\W_  2C_P""HD/P*.A_LT_M ZG%
M%\&KN^FM_A[X_NMD9^%VIZO?S7D^D>)9@ 9O 6J:G>7%TFKS;KCP??W4TE[)
M+X6G>7PS^)'CSP!XV^%_BK5_ _Q$\*ZYX,\7:%<R6FJ^'_$6G7&F:E:2QNR!
MS#<(GG6TVPR6E[;F6SO8"ES9SSV\D<K<A7K5J-+$TG":4HR2<9)ZI])1??\
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M';&74]=\0Z_J%MI>CZ3808\RZOK^\DBM[>(,RHI=P9)7CBC#RR(C?EA^T?\
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M3+S6=:U2Y6&6XDCLM.L(I[F?R+:">ZN72,QVUI!/=3M';PRR)_9%_P $S?\
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MJLS!3[9//#;0S7-S-%;V]O%)////(D4,$,2&26::60JD<4:*SR2.RHB*68@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /Y!IO^"J7_
M  53EAFBC\&RVSR121I<0_L^ZBTUN[H56:);BPN+=I8B1)&)X)H2Z@2PR)N1
MO!?'7[;O_!5GXC:)/X>\2^-_CM!I=S%/!<+X2^$^G_#V_FAN8_*GADUCX?\
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M1_9L?^?LO_ %_P#)>O\ 2U_SDO\ A2_QB_Z)/\2__"$\4_\ RJH_X4O\8O\
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M622-U5T=2K $$5_9A_P15_9PN?@K^R=#\1/$&E_V=XP_:$U.U\>RB:.-;Y?
M%A;S67PWAN'6!':VU#3[K5O&.EK]INXAI_C&"4&VN)KJVC_/#]J7_@G=\!=3
M_:Y^(EK9W_CWPYIOB_Q]I&MWFD^'M5\-VNFZ9=^/;71O$.NQ:';7GA*__L^Q
M34]=OY-,L"\]KIUNT%G;QBTMXH5_I_T71M*\.:-I/A[0K"VTK0]!TRPT;1M+
MLHA#9Z;I6EVL5CIUA:0K\L5M9VD$-O!$O$<4:(.!7M9EBN?#T8132K6G*]MH
MJ,E'=_:DG_VZCS<%0Y:M24FFZ?NJU]Y7N]NR:^;\F:=%%%>&>H%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!Y#^T'XK\5>!/@)\;_''@6#[5XW\
M&_"#XE>*_!MM_9[ZM]H\5>'?!FM:OX>@_LJ,-)J?G:O9V<?]GHI>]W?9E!:4
M"OY5M8_X*C_\%6]3TZYL;+0=3\/7,_D^5K&C_L\K/J-GY<\4S_9XM?\ #^N:
M0WVB.-[6;[7I=UM@GE:#R+D0W,/]@]%=6'Q%.BI*>&IUVY)IS^S9;6<7==3"
MM2G4:<:TZ22::AUUO>]U9VT[^?0_A3^+G[2W_!2SXY6%QI/Q)\5_M$:GHMY%
M'#?Z#H/@W5_ ?A_4H8BC1PZIH'@#PUX8T?5(EDCCG\O4+*Y0W$<=RP,\:2#X
M^_X4O\8O^B3_ !+_ /"$\4__ "JK_1MHKNAFWLURPPM.$>T)<J^Y02.667\[
MO.O.3[R5W][D_/\ I:_YR7_"E_C%_P!$G^)?_A">*?\ Y54?\*7^,7_1)_B7
M_P"$)XI_^55?Z-M%5_;,_P#GQ'_P8_\ Y$G^S8_\_9?^ +_Y+U_I:_YR7_"E
M_C%_T2?XE_\ A">*?_E51_PI?XQ?]$G^)?\ X0GBG_Y55_HVT4?VS/\ Y\1_
M\&/_ .1#^S8_\_9?^ +_ .2]?Z6O^<E_PI?XQ?\ 1)_B7_X0GBG_ .55'_"E
M_C%_T2?XE_\ A">*?_E57^C;11_;,_\ GQ'_ ,&/_P"1#^S8_P#/V7_@"_\
MDO7^EK_G)?\ "E_C%_T2?XE_^$)XI_\ E51_PI?XQ?\ 1)_B7_X0GBG_ .55
M?Z-M%']LS_Y\1_\ !C_^1#^S8_\ /V7_ ( O_DO7^EK_ )R7_"E_C%_T2?XE
M_P#A">*?_E51_P *7^,7_1)_B7_X0GBG_P"55?Z-M%']LS_Y\1_\&/\ ^1#^
MS8_\_9?^ +_Y+U_I:_YR7_"E_C%_T2?XE_\ A">*?_E51_PI?XQ?]$G^)?\
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M6S3O9_+FMW^_RU_SDO\ A2_QB_Z)/\2__"$\4_\ RJH_X4O\8O\ HD_Q+_\
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MI?XQ?]$G^)?_ (0GBG_Y55_HVT5K_;,_^?$?_!C_ /D3/^S8_P#/V7_@"_\
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M5?Z-M%']LS_Y\1_\&/\ ^1#^S8_\_9?^ +_Y+U_I:_YR7_"E_C%_T2?XE_\
MA">*?_E51_PI?XQ?]$G^)?\ X0GBG_Y55_HVT4?VS/\ Y\1_\&/_ .1#^S8_
M\_9?^ +_ .2]?Z6O^<E_PI?XQ?\ 1)_B7_X0GBG_ .55'_"E_C%_T2?XE_\
MA">*?_E57^C;11_;,_\ GQ'_ ,&/_P"1#^S8_P#/V7_@"_\ DO7^EK_G)?\
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1-J_)%7M>UKMM+OHEZWZ'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>18
<FILENAME>mspr-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-04-15T19:58:31.9507+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://investor.msprecovery.com/20241231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:mspr="http://investor.msprecovery.com/20241231" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd" namespace="http://xbrl.sec.gov/ecd-sub/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" namespace="http://fasb.org/srt/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2024-01-31"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" namespace="http://xbrl.sec.gov/cyd/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" namespace="http://xbrl.sec.gov/ecd/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2023/calculation-1.1.xsd" namespace="https://xbrl.org/2023/calculation-1.1"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage" id="CoverPage">
        <link:definition>100000 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets" id="StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations" id="StatementConsolidatedStatementsOfOperations">
        <link:definition>100030 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical" id="StatementCondensedConsolidatedStatementsOfOperationsParenthetical">
        <link:definition>100040 - Statement - Condensed Consolidated Statements of Operations (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity" id="StatementConsolidatedStatementsOfChangesInEquity">
        <link:definition>100050 - Statement - Consolidated Statements of Changes in Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100060 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance" id="DisclosureCyberSecurityRiskManagementStrategyAndGovernance">
        <link:definition>100070 - Disclosure - Cyber Security Risk Management, Strategy, and Governance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness1" id="DisclosureDescriptionOfTheBusiness1">
        <link:definition>995457 - Disclosure - Description of the Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies" id="DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies">
        <link:definition>995467 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreements" id="DisclosureMaterialAgreements">
        <link:definition>995477 - Disclosure - Material Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvestees" id="InvestmentInEquityMethodInvestees">
        <link:definition>995487 - Disclosure - Investment In Equity Method Investees</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNet" id="DisclosurePropertyAndEquipmentNet">
        <link:definition>995497 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNet4" id="DisclosureIntangibleAssetsNet4">
        <link:definition>995507 - Disclosure - Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTax" id="DisclosureIncomeTax">
        <link:definition>995517 - Disclosure - Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntities" id="VariableInterestEntities">
        <link:definition>995527 - Disclosure - Variable Interest Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayable" id="ClaimsFinancingObligationsAndNotesPayable">
        <link:definition>995537 - Disclosure - Claims Financing Obligations and Notes Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiability1" id="DisclosureWarrantLiability1">
        <link:definition>995547 - Disclosure - Warrant Liability</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterest1" id="DisclosureNoncontrollingInterest1">
        <link:definition>995557 - Disclosure - Noncontrolling Interest</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>995567 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurements" id="DisclosureFairValueMeasurements">
        <link:definition>995577 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactions" id="DisclosureRelatedPartyTransactions">
        <link:definition>995587 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecurities" id="InvestmentsInEquitySecuritiesAndObligationsToDeliverSecurities">
        <link:definition>995597 - Disclosure - Investments in Equity Securities and Obligations to Deliver Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformation" id="DisclosureSegmentInformation">
        <link:definition>995607 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShare1" id="DisclosureNetLossPerCommonShare1">
        <link:definition>995617 - Disclosure - Net Loss Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiability" id="DisclosureDerivativeLiability">
        <link:definition>995627 - Disclosure - Derivative Liability</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEvents1" id="DisclosureSubsequentEvents1">
        <link:definition>995637 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" id="DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>995647 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentatonAndSummaryOfSignificantAccountingPoliciesTables" id="DisclosureBasisOfPresentatonAndSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>995657 - Disclosure - Basis of Presentaton and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesTables" id="InvestmentInEquityMethodInvesteesTables">
        <link:definition>995667 - Disclosure - Investment In Equity Method Investees (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables" id="DisclosurePropertyAndEquipmentNetTables">
        <link:definition>995677 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables" id="DisclosureIntangibleAssetsNetTables">
        <link:definition>995687 - Disclosure - Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxTables" id="DisclosureIncomeTaxTables">
        <link:definition>995697 - Disclosure - Income Tax (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityTables" id="DisclosureWarrantLiabilityTables">
        <link:definition>995707 - Disclosure - Warrant Liability (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestTables" id="DisclosureNoncontrollingInterestTables">
        <link:definition>995717 - Disclosure - Noncontrolling Interest (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables" id="DisclosureFairValueMeasurementsTables">
        <link:definition>995727 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationTables" id="DisclosureSegmentInformationTables">
        <link:definition>995737 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareTables" id="DisclosureNetLossPerCommonShareTables">
        <link:definition>995747 - Disclosure - Net Loss Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail" id="DisclosureDescriptionOfTheBusinessAdditionalInformationDetail">
        <link:definition>995757 - Disclosure - Description of the Business - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness2024ReverseStockSplitAdditionalInformationDetail" id="DisclosureDescriptionOfTheBusiness2024ReverseStockSplitAdditionalInformationDetail">
        <link:definition>995767 - Disclosure - Description of the Business - 2024 Reverse Stock Split - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail" id="DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail">
        <link:definition>995777 - Disclosure - Description of the Business - Going Concern - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" id="DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>995787 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail" id="DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail">
        <link:definition>995797 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Summary of Depreciation and Amortization on Property and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail" id="DisclosureMaterialAgreementsAdditionalInformationDetail">
        <link:definition>995807 - Disclosure - Material Agreements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail" id="InvestmentInEquityMethodInvesteesAdditionalInformationDetail">
        <link:definition>995817 - Disclosure - Investment In Equity Method Investees - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail" id="InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail">
        <link:definition>995827 - Disclosure - Investment In Equity Method Investees  - Summary of Financial Information For Equity Accounted Investees (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail" id="DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail">
        <link:definition>995837 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetail" id="DisclosurePropertyAndEquipmentNetAdditionalInformationDetail">
        <link:definition>995847 - Disclosure - Property and Equipment, Net - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail" id="DisclosureIntangibleAssetsNetAdditionalInformationDetail">
        <link:definition>995857 - Disclosure - Intangible Assets, Net - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail" id="DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail">
        <link:definition>995867 - Disclosure - Intangible Assets, Net - Summary of Intangible Assets Net (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail" id="DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail">
        <link:definition>995877 - Disclosure - Intangible Assets, Net - Schedule of Expected Future Amortization Expense of Intangible Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail" id="DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail">
        <link:definition>995887 - Disclosure - Intangible Assets, Net - Summary of Changes in the Company's Intangibles Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail" id="DisclosureIncomeTaxAdditionalInformationDetail">
        <link:definition>995897 - Disclosure - Income Tax - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail" id="DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail">
        <link:definition>995907 - Disclosure - Income Tax - Schedule of Reconciliation Statutory Income Tax Rate to the Company's Effective Tax Rate (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail" id="DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail">
        <link:definition>995917 - Disclosure - Income Tax - Schedule of Company's Deferred Tax Assets and Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail" id="VariableInterestEntitiesAdditionalInformationDetail">
        <link:definition>995927 - Disclosure - Variable Interest Entities - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail" id="ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail">
        <link:definition>995937 - Disclosure - Claims Financing Obligations and Notes Payable - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail" id="DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail">
        <link:definition>995947 - Disclosure - Claims Financing Obligations and Notes Payable - Brickell Key Investments, LP - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail" id="DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail">
        <link:definition>995957 - Disclosure - Claims Financing Obligations and Notes Payable - Hazel Working Capital Credit Facility and Purchase Money Loan - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail" id="DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail">
        <link:definition>995967 - Disclosure - Claims Financing Obligations and Notes Payable - Nomura Promissory Note - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail" id="DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail">
        <link:definition>995977 - Disclosure - Claims Financing Obligations and Notes Payable - Yorkville Standby Equity Purchase Agreement - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail" id="DisclosureWarrantLiabilityAdditionalInformationDetail">
        <link:definition>995987 - Disclosure - Warrant Liability - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail" id="DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail">
        <link:definition>995997 - Disclosure - Warrant Liability - Schedule of Roll-forward of the Warrant Liability (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilitySummaryOfActivityOfSharesUnderlyingWarrantsDetail" id="DisclosureWarrantLiabilitySummaryOfActivityOfSharesUnderlyingWarrantsDetail">
        <link:definition>996007 - Disclosure - Warrant Liability - Summary of Activity of Shares Underlying Warrants (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail" id="DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail">
        <link:definition>996017 - Disclosure - Noncontrolling Interest - Summary of Ownership Units (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail" id="DisclosureNoncontrollingInterestAdditionalInformationDetail">
        <link:definition>996027 - Disclosure - Noncontrolling Interest - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" id="DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
        <link:definition>996037 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" id="DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails">
        <link:definition>996047 - Disclosure - Fair Value Measurements - Schedule of Liabilities Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails" id="DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails">
        <link:definition>996057 - Disclosure - Fair Value Measurements - Fair Value Measurements within the Fair Value Hierarchy of Derivative Liabilities Using Level 3 Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails" id="DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails">
        <link:definition>996067 - Disclosure - Fair Value Measurements - Embedded Derivative Liability Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail" id="DisclosureRelatedPartyTransactionsAdditionalInformationDetail">
        <link:definition>996077 - Disclosure - Related Party Transactions - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesAdditionalInformationDetail" id="InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesAdditionalInformationDetail">
        <link:definition>996087 - Disclosure - Investments in Equity Securities and Obligations to Deliver Securities - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetail" id="DisclosureSegmentInformationAdditionalInformationDetail">
        <link:definition>996097 - Disclosure - Segment Information - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails" id="DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails">
        <link:definition>996107 - Disclosure - Segment Information - Schedule of Other Segment Items (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail" id="DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail">
        <link:definition>996117 - Disclosure - Net Loss Per Common Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail" id="DisclosureNetLossPerCommonShareAdditionalInformationDetail">
        <link:definition>996127 - Disclosure - Net Loss Per Common Share - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail" id="DisclosureDerivativeLiabilityAdditionalInformationDetail">
        <link:definition>996137 - Disclosure - Derivative Liability - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" id="DisclosureSubsequentEventsAdditionalInformationDetail">
        <link:definition>996147 - Disclosure - Subsequent Events - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage" xlink:href="mspr-20241231.xsd#CoverPage" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="mspr-20241231.xsd#StatementConsolidatedBalanceSheets" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="mspr-20241231.xsd#StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="mspr-20241231.xsd#StatementConsolidatedStatementsOfOperations" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:href="mspr-20241231.xsd#StatementCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity" xlink:href="mspr-20241231.xsd#StatementConsolidatedStatementsOfChangesInEquity" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="mspr-20241231.xsd#StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance" xlink:href="mspr-20241231.xsd#DisclosureCyberSecurityRiskManagementStrategyAndGovernance" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness1" xlink:href="mspr-20241231.xsd#DisclosureDescriptionOfTheBusiness1" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:href="mspr-20241231.xsd#DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreements" xlink:href="mspr-20241231.xsd#DisclosureMaterialAgreements" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvestees" xlink:href="mspr-20241231.xsd#InvestmentInEquityMethodInvestees" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNet" xlink:href="mspr-20241231.xsd#DisclosurePropertyAndEquipmentNet" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNet4" xlink:href="mspr-20241231.xsd#DisclosureIntangibleAssetsNet4" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTax" xlink:href="mspr-20241231.xsd#DisclosureIncomeTax" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntities" xlink:href="mspr-20241231.xsd#VariableInterestEntities" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayable" xlink:href="mspr-20241231.xsd#ClaimsFinancingObligationsAndNotesPayable" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiability1" xlink:href="mspr-20241231.xsd#DisclosureWarrantLiability1" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterest1" xlink:href="mspr-20241231.xsd#DisclosureNoncontrollingInterest1" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/CommitmentsAndContingencies" xlink:href="mspr-20241231.xsd#CommitmentsAndContingencies" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurements" xlink:href="mspr-20241231.xsd#DisclosureFairValueMeasurements" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactions" xlink:href="mspr-20241231.xsd#DisclosureRelatedPartyTransactions" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecurities" xlink:href="mspr-20241231.xsd#InvestmentsInEquitySecuritiesAndObligationsToDeliverSecurities" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformation" xlink:href="mspr-20241231.xsd#DisclosureSegmentInformation" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShare1" xlink:href="mspr-20241231.xsd#DisclosureNetLossPerCommonShare1" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiability" xlink:href="mspr-20241231.xsd#DisclosureDerivativeLiability" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEvents1" xlink:href="mspr-20241231.xsd#DisclosureSubsequentEvents1" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="mspr-20241231.xsd#DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentatonAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="mspr-20241231.xsd#DisclosureBasisOfPresentatonAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesTables" xlink:href="mspr-20241231.xsd#InvestmentInEquityMethodInvesteesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables" xlink:href="mspr-20241231.xsd#DisclosurePropertyAndEquipmentNetTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables" xlink:href="mspr-20241231.xsd#DisclosureIntangibleAssetsNetTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxTables" xlink:href="mspr-20241231.xsd#DisclosureIncomeTaxTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityTables" xlink:href="mspr-20241231.xsd#DisclosureWarrantLiabilityTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestTables" xlink:href="mspr-20241231.xsd#DisclosureNoncontrollingInterestTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables" xlink:href="mspr-20241231.xsd#DisclosureFairValueMeasurementsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationTables" xlink:href="mspr-20241231.xsd#DisclosureSegmentInformationTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareTables" xlink:href="mspr-20241231.xsd#DisclosureNetLossPerCommonShareTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureDescriptionOfTheBusinessAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness2024ReverseStockSplitAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureDescriptionOfTheBusiness2024ReverseStockSplitAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail" xlink:href="mspr-20241231.xsd#DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureMaterialAgreementsAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#InvestmentInEquityMethodInvesteesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail" xlink:href="mspr-20241231.xsd#InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail" xlink:href="mspr-20241231.xsd#DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosurePropertyAndEquipmentNetAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureIntangibleAssetsNetAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail" xlink:href="mspr-20241231.xsd#DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail" xlink:href="mspr-20241231.xsd#DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail" xlink:href="mspr-20241231.xsd#DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureIncomeTaxAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail" xlink:href="mspr-20241231.xsd#DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail" xlink:href="mspr-20241231.xsd#DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#VariableInterestEntitiesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureWarrantLiabilityAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail" xlink:href="mspr-20241231.xsd#DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilitySummaryOfActivityOfSharesUnderlyingWarrantsDetail" xlink:href="mspr-20241231.xsd#DisclosureWarrantLiabilitySummaryOfActivityOfSharesUnderlyingWarrantsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail" xlink:href="mspr-20241231.xsd#DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureNoncontrollingInterestAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:href="mspr-20241231.xsd#DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails" xlink:href="mspr-20241231.xsd#DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails" xlink:href="mspr-20241231.xsd#DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureRelatedPartyTransactionsAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureSegmentInformationAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails" xlink:href="mspr-20241231.xsd#DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail" xlink:href="mspr-20241231.xsd#DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureNetLossPerCommonShareAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureDerivativeLiabilityAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" xlink:href="mspr-20241231.xsd#DisclosureSubsequentEventsAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd#eedm1" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentPaymentInKindAnnualInterestRate" xlink:label="mspr_DebtInstrumentPaymentInKindAnnualInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OriginalIssueDiscountOfNonCash" xlink:label="mspr_OriginalIssueDiscountOfNonCash"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AdditionalBridgeLoan" xlink:label="mspr_AdditionalBridgeLoan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_GuarantyObligationNoncurrent" xlink:label="mspr_GuarantyObligationNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc" xlink:label="mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CpiaWarrantMember" xlink:label="mspr_CpiaWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AnnualCompoundedReturnOnContributionPercentage" xlink:label="mspr_AnnualCompoundedReturnOnContributionPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfNonControllingMemberAllocatedCost" xlink:label="mspr_PercentageOfNonControllingMemberAllocatedCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_StandbyEquityPurchaseAgreementMember" xlink:label="mspr_StandbyEquityPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RealizedClaimRecoveries" xlink:label="mspr_RealizedClaimRecoveries"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:label="us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount" xlink:label="us-gaap_SegmentReportingOtherItemAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AllowanceForCreditLosses" xlink:label="mspr_AllowanceForCreditLosses"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ProfessionalFeesLegalMember" xlink:label="mspr_ProfessionalFeesLegalMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_GoodwillMeasurementInputIncreaseDecrease" xlink:label="mspr_GoodwillMeasurementInputIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentToReduceAmountsOwedUnderNomuraNote" xlink:label="mspr_PaymentToReduceAmountsOwedUnderNomuraNote"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfPreferredReturnForTheControlling" xlink:label="mspr_PercentageOfPreferredReturnForTheControlling"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MinimumRequiredPaymentMember" xlink:label="mspr_MinimumRequiredPaymentMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers" xlink:label="mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ScheduleOfOwnershipInterestsTableTextBlock" xlink:label="mspr_ScheduleOfOwnershipInterestsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MinimumVariablePricePerShare" xlink:label="mspr_MinimumVariablePricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsLineItems" xlink:label="dei_EntityListingsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance" xlink:label="mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OperationalFunding" xlink:label="mspr_OperationalFunding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommonStockPurchaseAgreementMember" xlink:label="mspr_CommonStockPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MspPrincipalsMember" xlink:label="mspr_MspPrincipalsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfTranches" xlink:label="mspr_NumberOfTranches"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NonControllingInterestsPolicyTextBlock" xlink:label="mspr_NonControllingInterestsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AnnualCostsAfterCurrentlyPlannedCostReductions" xlink:label="mspr_AnnualCostsAfterCurrentlyPlannedCostReductions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OfficeAndComputerEquipmentMember" xlink:label="mspr_OfficeAndComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:label="us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReductionInDebtPrincipalOwing" xlink:label="mspr_ReductionInDebtPrincipalOwing"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ParentMember" xlink:label="us-gaap_ParentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SaleOfIntangibleAssets" xlink:label="mspr_SaleOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsAmortizationExpense" xlink:label="mspr_ClaimsAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentExtendedMaturityYear" xlink:label="mspr_DebtInstrumentExtendedMaturityYear"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReleaseOfTemporaryEquityForPayments" xlink:label="mspr_ReleaseOfTemporaryEquityForPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantExercisePriceIncrease" xlink:label="us-gaap_WarrantExercisePriceIncrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeMember" xlink:label="us-gaap_OtherIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OperatingCostsAndExpenses1" xlink:label="mspr_OperatingCostsAndExpenses1"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EquityMethodInvestmentInvesteeMember" xlink:label="mspr_EquityMethodInvestmentInvesteeMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentFloorPriceTrigger" xlink:label="mspr_DebtInstrumentFloorPriceTrigger"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LoanFromRelatedPartiesNonCurrent" xlink:label="mspr_LoanFromRelatedPartiesNonCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DescriptionOfCashPaymentsMadeToCounterParty" xlink:label="mspr_DescriptionOfCashPaymentsMadeToCounterParty"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_UnsecuredPromissoryNotesMember" xlink:label="mspr_UnsecuredPromissoryNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="us-gaap_AssetAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OptionToSellMaximumSharesValueUnderPurchaseAgreement" xlink:label="mspr_OptionToSellMaximumSharesValueUnderPurchaseAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAffiliatesMember" xlink:label="us-gaap_OtherAffiliatesMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VirageRecoveryParticipationLpMember" xlink:label="mspr_VirageRecoveryParticipationLpMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FundsHeldForOtherEntitiesMember" xlink:label="mspr_FundsHeldForOtherEntitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfMedicareMembers" xlink:label="mspr_NumberOfMedicareMembers"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember" xlink:label="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:label="us-gaap_LineOfCreditFacilityExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion" xlink:label="mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_GuarantyObligationCurrent" xlink:label="mspr_GuarantyObligationCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationAndNotesPayableMember" xlink:label="mspr_ClaimsFinancingObligationAndNotesPayableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FinancialLiabilitiesFairValueWarrants" xlink:label="mspr_FinancialLiabilitiesFairValueWarrants"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock" xlink:label="mspr_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WarrantPaymentDescription" xlink:label="mspr_WarrantPaymentDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IntangibleAssetsNetTable" xlink:label="mspr_IntangibleAssetsNetTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets" xlink:label="mspr_NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VariableInterestEntityDisclosureAbstract" xlink:label="mspr_VariableInterestEntityDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DividendComprisingNumberOfNewWarrantsPayableHolders" xlink:label="mspr_DividendComprisingNumberOfNewWarrantsPayableHolders"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsRecoveryIncome" xlink:label="mspr_ClaimsRecoveryIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IntangibleAssetsNetLineItems" xlink:label="mspr_IntangibleAssetsNetLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:label="us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AccruedInterestPercentageInYearOne" xlink:label="mspr_AccruedInterestPercentageInYearOne"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations" xlink:label="mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseMoneyLoan" xlink:label="mspr_PurchaseMoneyLoan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock" xlink:label="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseMoneyLoanAccruesInterest" xlink:label="mspr_PurchaseMoneyLoanAccruesInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantConvertedDuringPeriod" xlink:label="mspr_ClassOfWarrantConvertedDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OtherSoftwareMember" xlink:label="mspr_OtherSoftwareMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfMinimumVariablePriceEqualingOfVwap" xlink:label="mspr_PercentageOfMinimumVariablePriceEqualingOfVwap"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TermLoanBMember" xlink:label="mspr_TermLoanBMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfAggregateProceedsToPayOutstandingAmount" xlink:label="mspr_PercentageOfAggregateProceedsToPayOutstandingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CashPaidDuringThePeriodAbstract" xlink:label="mspr_CashPaidDuringThePeriodAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AffiliateReceivable" xlink:label="mspr_AffiliateReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain" xlink:label="us-gaap_RestructuringPlanDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestLineItems" xlink:label="us-gaap_MinorityInterestLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MarkToMarketGainOnLiabilityPayableInStock" xlink:label="mspr_MarkToMarketGainOnLiabilityPayableInStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ProfessionalFeesSettledInShares" xlink:label="mspr_ProfessionalFeesSettledInShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AdvancePaymentIncurredForExpenses" xlink:label="mspr_AdvancePaymentIncurredForExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration" xlink:label="us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsWarrantLiabilityPercent" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsWarrantLiabilityPercent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AdditionalFiniteLivedIntangibleAssetsAcquired" xlink:label="mspr_AdditionalFiniteLivedIntangibleAssetsAcquired"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ValueOfSharesToCoverShortPosition" xlink:label="mspr_ValueOfSharesToCoverShortPosition"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PmpiMember" xlink:label="mspr_PmpiMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ForcedExpiratoryFlowSharesMember" xlink:label="mspr_ForcedExpiratoryFlowSharesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MembershipInterestPurchaseAgreementMember" xlink:label="mspr_MembershipInterestPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CostOfClaimRecoveriesPolicyTextBlock" xlink:label="mspr_CostOfClaimRecoveriesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfMinimumFixedPriceEqualingOfVwap" xlink:label="mspr_PercentageOfMinimumFixedPriceEqualingOfVwap"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid" xlink:label="mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries" xlink:label="mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AccruedInterestPercentageAfterOneYear" xlink:label="mspr_AccruedInterestPercentageAfterOneYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfWarrantsIssuedAndExercisable" xlink:label="mspr_NumberOfWarrantsIssuedAndExercisable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AgreementDate" xlink:label="mspr_AgreementDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SubsidiaryAxis" xlink:label="mspr_SubsidiaryAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WarrantLiabilityCurrent" xlink:label="mspr_WarrantLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_YaIiPnLtdMember" xlink:label="mspr_YaIiPnLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalUseSoftwarePolicy" xlink:label="us-gaap_InternalUseSoftwarePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="us-gaap_EquityMethodInvestmentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RecoveryRightsInterest" xlink:label="mspr_RecoveryRightsInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InterestPayableNoncurrent" xlink:label="mspr_InterestPayableNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfCashProceedsFromSaleOfStock" xlink:label="mspr_PercentageOfCashProceedsFromSaleOfStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember" xlink:label="us-gaap_ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:label="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IntangibleAssetsFinancedByNotePayable" xlink:label="mspr_IntangibleAssetsFinancedByNotePayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AdditionalReceivablesFromOtherAffiliatesMember" xlink:label="mspr_AdditionalReceivablesFromOtherAffiliatesMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelPartnersHoldingsLlcLetterAgreementMember" xlink:label="mspr_HazelPartnersHoldingsLlcLetterAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryRightsMember" xlink:label="mspr_ClaimsCostRecoveryRightsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvesteeMember" xlink:label="us-gaap_EquityMethodInvesteeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WarrantsIssuedToVirageMember" xlink:label="mspr_WarrantsIssuedToVirageMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WorkingCapitalCreditAgreementMember" xlink:label="mspr_WorkingCapitalCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FixedPricePerShare" xlink:label="mspr_FixedPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WorkingCapitalCreditFacilityMember" xlink:label="mspr_WorkingCapitalCreditFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BridgeLoan" xlink:label="us-gaap_BridgeLoan"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfVwapOfSharesDuringPriorDate" xlink:label="mspr_PercentageOfVwapOfSharesDuringPriorDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MsoMember" xlink:label="mspr_MsoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReductionInInterestAmount" xlink:label="mspr_ReductionInInterestAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote" xlink:label="mspr_PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities" xlink:label="mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis" xlink:label="mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WarrantConversionsOnACashlessBasis" xlink:label="mspr_WarrantConversionsOnACashlessBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202309Member" xlink:label="us-gaap_AccountingStandardsUpdate202309Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfPaySellersToAmountOfTaxBenefit" xlink:label="mspr_PercentageOfPaySellersToAmountOfTaxBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MspRecoveryAviationLlcMember" xlink:label="mspr_MspRecoveryAviationLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SpecificContractMember" xlink:label="mspr_SpecificContractMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassVShareholdersMember" xlink:label="mspr_ClassVShareholdersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AccountingPoliciesLineItems" xlink:label="mspr_AccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfRecoveryClaimsForTheControlling" xlink:label="mspr_PercentageOfRecoveryClaimsForTheControlling"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FinancingObligationsAndNotesPayableAgreementsMember" xlink:label="mspr_FinancingObligationsAndNotesPayableAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims" xlink:label="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_StockIssuedDuringPeriodSharesConversionOfWarrants" xlink:label="mspr_StockIssuedDuringPeriodSharesConversionOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommonClassVMember" xlink:label="mspr_CommonClassVMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod" xlink:label="mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TermSheetMember" xlink:label="mspr_TermSheetMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts" xlink:label="mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IssuanceOfSharesPurchaseTerm" xlink:label="mspr_IssuanceOfSharesPurchaseTerm"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage" xlink:label="mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCollateralAmount" xlink:label="us-gaap_DebtInstrumentCollateralAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="us-gaap_BusinessAcquisitionSharePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MinimumFeePaid" xlink:label="mspr_MinimumFeePaid"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VRMFullPaymentDescription" xlink:label="mspr_VRMFullPaymentDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202307Member" xlink:label="us-gaap_AccountingStandardsUpdate202307Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:label="us-gaap_LineOfCreditFacilityDescription"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired" xlink:label="mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentsExtendedMaturityDate" xlink:label="mspr_DebtInstrumentsExtendedMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationNotesPayable" xlink:label="mspr_ClaimsFinancingObligationNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PublicWarrantsOutstandingMember" xlink:label="mspr_PublicWarrantsOutstandingMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain" xlink:label="mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AffiliatePayable" xlink:label="mspr_AffiliatePayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseDeceaseInAffiliatesReceivable" xlink:label="mspr_IncreaseDeceaseInAffiliatesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="us-gaap_DerivativeLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RestructuringPlanMember" xlink:label="mspr_RestructuringPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:label="us-gaap_SegmentReportingInformationProfitLossAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MonthlyVirageWarrantsMember" xlink:label="mspr_MonthlyVirageWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfSharesExercisable" xlink:label="mspr_NumberOfSharesExercisable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest" xlink:label="mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TaxReceivableAgreementMember" xlink:label="mspr_TaxReceivableAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities" xlink:label="mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelTransactionsMember" xlink:label="mspr_HazelTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses" xlink:label="mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LegalAccountingAndAdministrativeExpenseMember" xlink:label="mspr_LegalAccountingAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CreditAgreementMember" xlink:label="mspr_CreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember" xlink:label="mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantsOrRightConvertedExercisePrice" xlink:label="mspr_ClassOfWarrantsOrRightConvertedExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtWeightedAverageInterestRate" xlink:label="us-gaap_DebtWeightedAverageInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SignificantExpenses" xlink:label="mspr_SignificantExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" xlink:label="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationNotesPayableCurrent" xlink:label="mspr_ClaimsFinancingObligationNotesPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseInTaxReceivableAgreementLiability" xlink:label="mspr_IncreaseInTaxReceivableAgreementLiability"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MaterialAgreementsDisclosureTextBlock" xlink:label="mspr_MaterialAgreementsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseDecreaseInImpairmentCharges" xlink:label="mspr_IncreaseDecreaseInImpairmentCharges"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitment" xlink:label="us-gaap_OtherCommitment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfEquitySharesAcquiredToCoverTheShortPosition" xlink:label="mspr_NumberOfEquitySharesAcquiredToCoverTheShortPosition"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LicenseFeePercentage" xlink:label="mspr_LicenseFeePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember" xlink:label="mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfConsecutiveTradingDays" xlink:label="mspr_NumberOfConsecutiveTradingDays"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EmbeddedDerivativeLiabilityMeasurementTerm" xlink:label="mspr_EmbeddedDerivativeLiabilityMeasurementTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfWarrantsIssued" xlink:label="mspr_NumberOfWarrantsIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ValueOfFullReturn" xlink:label="mspr_ValueOfFullReturn"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock" xlink:label="mspr_ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InterestPeriodPlusAnApplicableMargin" xlink:label="mspr_InterestPeriodPlusAnApplicableMargin"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AggregateAmountOutstandingUnderCashProceeds" xlink:label="mspr_AggregateAmountOutstandingUnderCashProceeds"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReleaseOfTemporaryEquityDuringNonCash" xlink:label="mspr_ReleaseOfTemporaryEquityDuringNonCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:label="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantOrRightCancellationDuringPeriod" xlink:label="mspr_ClassOfWarrantOrRightCancellationDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice" xlink:label="mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionPriceOfAcquisitionExpected" xlink:label="us-gaap_AssetAcquisitionPriceOfAcquisitionExpected"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="us-gaap_AssetAcquisitionDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_Non-RecourseDebtSecondLienAmount" xlink:label="mspr_Non-RecourseDebtSecondLienAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_UpCUnitHoldersMember" xlink:label="mspr_UpCUnitHoldersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DeferredTaxAssetsTransactionCosts" xlink:label="mspr_DeferredTaxAssetsTransactionCosts"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NetGainOfTheAsset" xlink:label="mspr_NetGainOfTheAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DevelopmentCostsCapitalizedUsefulLife" xlink:label="mspr_DevelopmentCostsCapitalizedUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AccountingPoliciesTable" xlink:label="mspr_AccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WorkingCapitalCreditFacilityCollateralMember" xlink:label="mspr_WorkingCapitalCreditFacilityCollateralMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LoansRepaymentPercentage" xlink:label="mspr_LoansRepaymentPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable" xlink:label="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SharesPledgedUnderAgreement" xlink:label="mspr_SharesPledgedUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FloorPriceOfACommonStock" xlink:label="mspr_FloorPriceOfACommonStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RealizedLossOnInvestmentsToCoverShortPosition" xlink:label="mspr_RealizedLossOnInvestmentsToCoverShortPosition"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ForegoPayments" xlink:label="mspr_ForegoPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentToFundOperations" xlink:label="mspr_PaymentToFundOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfProceedsFromGrantLien" xlink:label="mspr_PercentageOfProceedsFromGrantLien"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfHoldingInvestments" xlink:label="mspr_NumberOfHoldingInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetInterestCarryforward" xlink:label="us-gaap_DeferredTaxAssetInterestCarryforward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock" xlink:label="mspr_PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ProceedsFromSaleOfStockMonthlyPaymentAmount" xlink:label="mspr_ProceedsFromSaleOfStockMonthlyPaymentAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WarrantLiabilityTextBlock" xlink:label="mspr_WarrantLiabilityTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VirageTermSheetMember" xlink:label="mspr_VirageTermSheetMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RelatedPartyLegalExpense" xlink:label="mspr_RelatedPartyLegalExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NewClassOfWarrantOrRightOutstanding" xlink:label="mspr_NewClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanAxis" xlink:label="us-gaap_RestructuringPlanAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock" xlink:label="mspr_TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AffiliateReceivableMember" xlink:label="mspr_AffiliateReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AmendedAndRestatedCreditAgreementMember" xlink:label="mspr_AmendedAndRestatedCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfSharesObtainedThroughWarrant" xlink:label="mspr_PercentageOfSharesObtainedThroughWarrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantsOrRightIssuedExercisePrice" xlink:label="mspr_ClassOfWarrantsOrRightIssuedExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentsOfDeferredFinancingCosts" xlink:label="mspr_PaymentsOfDeferredFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfPledge" xlink:label="mspr_PercentageOfPledge"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember" xlink:label="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfTenWarrantMember" xlink:label="mspr_NumberOfTenWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_BrickellKeyInvestmentAmendmentMember" xlink:label="mspr_BrickellKeyInvestmentAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="us-gaap_VariableInterestEntityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentsOnRelatedPartyLoan" xlink:label="mspr_PaymentsOnRelatedPartyLoan"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ExistingLegalServicesAgreementsMember" xlink:label="mspr_ExistingLegalServicesAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PriceOfCommonStock" xlink:label="mspr_PriceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MaomsoRecoveryLlcSeriesFhcpMember" xlink:label="mspr_MaomsoRecoveryLlcSeriesFhcpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EarningsPerSharesBasicAndDilutedAbstract" xlink:label="mspr_EarningsPerSharesBasicAndDilutedAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InitialVirageWarrantMember" xlink:label="mspr_InitialVirageWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders" xlink:label="mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfStockPurchasePrice" xlink:label="mspr_PercentageOfStockPurchasePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentRate" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember" xlink:label="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EntitledClaimsRecoverPercentageByNonControllingMembers" xlink:label="mspr_EntitledClaimsRecoverPercentageByNonControllingMembers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestTable" xlink:label="us-gaap_MinorityInterestTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TotalClaimsRecovery" xlink:label="mspr_TotalClaimsRecovery"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries" xlink:label="mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable" xlink:label="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReservedSharesMember" xlink:label="mspr_ReservedSharesMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MaoMember" xlink:label="mspr_MaoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PartialRepaymentOfDebt" xlink:label="mspr_PartialRepaymentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember" xlink:label="mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes" xlink:label="mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassVCommonStockMember" xlink:label="mspr_ClassVCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseMoneyLoanMember" xlink:label="mspr_PurchaseMoneyLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ChangeInFairValueOfDerivatives" xlink:label="mspr_ChangeInFairValueOfDerivatives"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFundedInTranchesPerMonth" xlink:label="mspr_LineOfCreditFundedInTranchesPerMonth"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:label="us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMspRecoveryPartnersLlcMember" xlink:label="mspr_VrmMspRecoveryPartnersLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock" xlink:label="mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfTwoWarrantMember" xlink:label="mspr_NumberOfTwoWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm" xlink:label="mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CanoHealthLlcMember" xlink:label="mspr_CanoHealthLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmbeddedDerivativeLiabilityMeasurementInput" xlink:label="us-gaap_EmbeddedDerivativeLiabilityMeasurementInput"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AmountsReceivedToToTheMasterTransactionAgreement" xlink:label="mspr_AmountsReceivedToToTheMasterTransactionAgreement"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsRecoveryServiceIncome" xlink:label="mspr_ClaimsRecoveryServiceIncome"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares" xlink:label="mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentOriginalIssueDiscount" xlink:label="mspr_DebtInstrumentOriginalIssueDiscount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommissionPayable" xlink:label="mspr_CommissionPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember" xlink:label="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable" xlink:label="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MinimumCashAvailableForDistributionsPercentage" xlink:label="mspr_MinimumCashAvailableForDistributionsPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OperationalCollectionFloorFacilityMember" xlink:label="mspr_OperationalCollectionFloorFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsTable" xlink:label="dei_EntityListingsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription" xlink:label="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionTable" xlink:label="us-gaap_AssetAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NomuraPromissoryNoteMember" xlink:label="mspr_NomuraPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AggregateNumberOfSharesTransferredToEscrowAccount" xlink:label="mspr_AggregateNumberOfSharesTransferredToEscrowAccount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries" xlink:label="mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RepaymentOfTheClaimsFinancingObligation" xlink:label="mspr_RepaymentOfTheClaimsFinancingObligation"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OtherClaimsRecoveryRevenues" xlink:label="mspr_OtherClaimsRecoveryRevenues"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ServiceFeesMember" xlink:label="mspr_ServiceFeesMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseDeceaseInAffiliatesPayable" xlink:label="mspr_IncreaseDeceaseInAffiliatesPayable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity" xlink:label="mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RecoveryRightsInterestExcessCashFlowPercentage" xlink:label="mspr_RecoveryRightsInterestExcessCashFlowPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfProceedsFromRepaymentOfDebt" xlink:label="mspr_PercentageOfProceedsFromRepaymentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantOrRightOutstandingVotingPercentage" xlink:label="mspr_ClassOfWarrantOrRightOutstandingVotingPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NonEconomicVotingSharesMember" xlink:label="mspr_NonEconomicVotingSharesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MSPRecoveryLLCMember" xlink:label="mspr_MSPRecoveryLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FundedForAdditionalClaims" xlink:label="mspr_FundedForAdditionalClaims"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NatureOfOperationsTable" xlink:label="mspr_NatureOfOperationsTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AmendedAndRestatedNomuraPromissoryNoteMember" xlink:label="mspr_AmendedAndRestatedNomuraPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentOfCertainCostsAndFees" xlink:label="mspr_PaymentOfCertainCostsAndFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SeriesMrcsLlcMember" xlink:label="mspr_SeriesMrcsLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CantorFitzgeraldMember" xlink:label="mspr_CantorFitzgeraldMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VirageAmendmentMember" xlink:label="mspr_VirageAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdsAndLeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember" xlink:label="mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock" xlink:label="mspr_ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfCostsAllocatedToNonControlling" xlink:label="mspr_PercentageOfCostsAllocatedToNonControlling"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TermLoanAMember" xlink:label="mspr_TermLoanAMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsProceedsInvestmentAgreementMember" xlink:label="mspr_ClaimsProceedsInvestmentAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_StockIssuedDuringPeriodValueConversionOfWarrants" xlink:label="mspr_StockIssuedDuringPeriodValueConversionOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock" xlink:label="mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SubsidiaryDomain" xlink:label="mspr_SubsidiaryDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AffiliatePayableMember" xlink:label="mspr_AffiliatePayableMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient" xlink:label="mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CostOfClaimRecoveries" xlink:label="mspr_CostOfClaimRecoveries"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AssignorConsistingNumberOfMedicareMembers" xlink:label="mspr_AssignorConsistingNumberOfMedicareMembers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsAmortizationExpensePolicyTextBlock" xlink:label="mspr_ClaimsAmortizationExpensePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryAgreementsMember" xlink:label="mspr_ClaimsCostRecoveryAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseInProceedsFromLongTermLinesOfCredit" xlink:label="mspr_IncreaseInProceedsFromLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommonUnitExchangeValue" xlink:label="mspr_CommonUnitExchangeValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="mspr_NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:label="mspr_ClassOfWarrantOrRightIssuedDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MspRecoveryLawFirmMember" xlink:label="mspr_MspRecoveryLawFirmMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CostOfClaimsRecoveriesMember" xlink:label="mspr_CostOfClaimsRecoveriesMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock" xlink:label="mspr_PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" xlink:label="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NatureOfOperationsLineItems" xlink:label="mspr_NatureOfOperationsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredOvernightFinancingRateSofrMember" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrMember"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DebtInstrumentPaymentInKindAnnualInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument, payment in kind, annual interest rate.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DebtInstrumentPaymentInKindAnnualInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Payment in Kind, Annual Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DebtInstrumentPaymentInKindAnnualInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest rate, payable in kind</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate During Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest rate of promissory note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OriginalIssueDiscountOfNonCash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Original issue discount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OriginalIssueDiscountOfNonCash_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Original Issue Discount Of Non Cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OriginalIssueDiscountOfNonCash_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Original issue discount of non cash.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AdditionalBridgeLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Bridge Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AdditionalBridgeLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional Bridge Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AdditionalBridgeLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional bridge loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Accounts receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_GuarantyObligationNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Guaranty obligation noncurrent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_GuarantyObligationNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Guaranty Obligation Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_GuarantyObligationNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Guaranty obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets investment in MSP recovery, LLC.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Investment in MSP Recovery, LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment in MSP Recovery, LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CpiaWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">CPIA warrant.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CpiaWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">CPIA Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Activity of Shares Underlying Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AnnualCompoundedReturnOnContributionPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Annual compounded return on contribution percentage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AnnualCompoundedReturnOnContributionPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Annual Compounded Return on Contribution Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AnnualCompoundedReturnOnContributionPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual compounded return on contribution percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AnnualCompoundedReturnOnContributionPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Annual compounded return percentage on contribution</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfNonControllingMemberAllocatedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of non-controlling member allocated cost.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfNonControllingMemberAllocatedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Non-controlling Member Allocated Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfNonControllingMemberAllocatedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of non-controlling member allocated cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_StandbyEquityPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Standby Equity Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_StandbyEquityPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Standby Equity Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_StandbyEquityPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Standby equity purchase agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale of Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of operating segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Operating Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Tranch One [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche One [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RealizedClaimRecoveries_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized claim recoveries</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RealizedClaimRecoveries_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Realized Claim Recoveries</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RealizedClaimRecoveries_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Realized claim recoveries.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reverse stock split description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity, Reverse Stock Split</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at beginning of period, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at end of period, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gain on sale of intangibles</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Disposition of Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OpenTaxYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Open Tax Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OpenTaxYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Open tax year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingOtherItemAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Other Segment Item, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingOtherItemAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Segment Items</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingOtherItemAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Other Segment Items</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AllowanceForCreditLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allowance for credit losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AllowanceForCreditLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Allowance for Credit Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AllowanceForCreditLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Allowance for credit losses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ProfessionalFeesLegalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Professional fees - legal.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ProfessionalFeesLegalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Professional Fees - Legal [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ProfessionalFeesLegalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Professional Fees Legal [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_GoodwillMeasurementInputIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill measurement input increase (decrease)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_GoodwillMeasurementInputIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill, Measurement Input Increase (Decrease)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_GoodwillMeasurementInputIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Goodwill measurement input increase (decrease).</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentToReduceAmountsOwedUnderNomuraNote_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment to Reduce Amounts Owed Under Nomura Note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentToReduceAmountsOwedUnderNomuraNote_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment to reduce amounts owed under nomura note.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentToReduceAmountsOwedUnderNomuraNote_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment to reduce nomura note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfPreferredReturnForTheControlling_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Preferred Return For The Controlling Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfPreferredReturnForTheControlling_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of preferred return for the controlling member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfPreferredReturnForTheControlling_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of preferred return for the controlling member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Examination, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax examination, description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements within the Fair Value Hierarchy of Derivative Liabilities Using Level 3 Inputs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derivative Instruments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivatives, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation, Depletion and Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Depletion and Amortization, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MinimumRequiredPaymentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum Required Payment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MinimumRequiredPaymentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Required Payment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MinimumRequiredPaymentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum Required Payment Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of entitled preferred return by non-controlling members.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Entitled Preferred Return by Non-Controlling Members</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of entitled preferred return by non-controlling member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ScheduleOfOwnershipInterestsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of ownership interests table text block.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ScheduleOfOwnershipInterestsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Ownership Interests Table Text Block</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ScheduleOfOwnershipInterestsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Ownership Units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MinimumVariablePricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MinimumVariablePricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Variable Price Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MinimumVariablePricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum variable price per share.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityListingsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Listings [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Mandatory minimum amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Mandatory Minimum Amount For Any Advance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of mandatory minimum amount for any advance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OperationalFunding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operational funding.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OperationalFunding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operational funding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CommonStockPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock purchase agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CommonStockPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CommonStockPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MspPrincipalsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">MSP principals.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MspPrincipalsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">MSP Principals [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MspPrincipalsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">MSP Principals [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfTranches_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Tranches</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfTranches_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number Of Tranches</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfTranches_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of tranches</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility, maximum remaining borrowing capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Line of credit facility, remaining borrowing capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NonControllingInterestsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-controlling interests.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NonControllingInterestsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non-controlling Interests [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NonControllingInterestsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-controlling Interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Finite lived intangible assets useful lives</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AnnualCostsAfterCurrentlyPlannedCostReductions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Annual Costs, After Currently Planned Cost Reductions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AnnualCostsAfterCurrentlyPlannedCostReductions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Annual costs, after currently planned cost reductions.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AnnualCostsAfterCurrentlyPlannedCostReductions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual costs, after currently planned cost reductions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents, at Carrying Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash Equivalents, at Carrying Value, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">New Warrants Outstanding [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Opinion [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Opinion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OfficeAndComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Office and computer equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OfficeAndComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Office And Computer Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OfficeAndComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Office And Computer Equipment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in operating assets and liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net proceeds from debt issuance amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from debt financing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCompensationShareBasedPaymentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Deferred Compensation, Share-Based Payments [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCompensationShareBasedPaymentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Compensation, Share-Based Payments [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCompensationShareBasedPaymentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Option to Pay in Cash or in Stock and Elected to Pay in Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ReductionInDebtPrincipalOwing_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reduction in principal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ReductionInDebtPrincipalOwing_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reduction In Debt Principal Owing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ReductionInDebtPrincipalOwing_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reduction in debt principal owing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address State Or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss before provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ParentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Parent [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ParentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Members' Deficit [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Note payable related party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Notes Payable, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Notes Payable, Noncurrent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Claims Financing Obligations and Notes Payable [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Claims Financing Obligations and Notes Payable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SaleOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SaleOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Sale of CCRAs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SaleOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SaleOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sale of intangible assets.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Investment In Equity Method Investees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Claims amortization expense.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Claims amortization expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Claims amortization expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Claims amortization expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DebtInstrumentExtendedMaturityYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Extended Maturity Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DebtInstrumentExtendedMaturityYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument extended maturity year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DebtInstrumentExtendedMaturityYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument extended maturity year.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ReleaseOfTemporaryEquityForPayments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Release of temporary equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ReleaseOfTemporaryEquityForPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Release Of Temporary Equity For Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ReleaseOfTemporaryEquityForPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Release of temporary equity for payments.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant, Exercise Price, Increase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant, exercise price, increase per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Debt issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Debt Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earnings per share of common stock - basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Basic net loss per common share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Income [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OperatingCostsAndExpenses1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Costs and Expenses 1</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OperatingCostsAndExpenses1_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating costs and expenses 1.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OperatingCostsAndExpenses1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related party expenses 1</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EquityMethodInvestmentInvesteeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Method Investment Investee [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EquityMethodInvestmentInvesteeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment Investee [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EquityMethodInvestmentInvesteeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity method investment investee.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DebtInstrumentFloorPriceTrigger_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Floor price trigger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DebtInstrumentFloorPriceTrigger_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Floor Price Trigger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DebtInstrumentFloorPriceTrigger_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument floor price trigger.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Acquisitions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business combination units issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LoanFromRelatedPartiesNonCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan from related parties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LoanFromRelatedPartiesNonCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loan From Related Parties Non Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LoanFromRelatedPartiesNonCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Loan From Related Parties Non Current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DescriptionOfCashPaymentsMadeToCounterParty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Description of cash payments made to counter party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DescriptionOfCashPaymentsMadeToCounterParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Description of Cash Payments Made to Counter Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DescriptionOfCashPaymentsMadeToCounterParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of cash payments made to counter party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_UnsecuredPromissoryNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unsecured promissory notes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_UnsecuredPromissoryNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unsecured Promissory Notes [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_UnsecuredPromissoryNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unsecured Promissory Notes [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Acquisition [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Interest Entities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments, Debt and Equity Securities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derivative Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OptionToSellMaximumSharesValueUnderPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Option to sell maximum shares value under purchase agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OptionToSellMaximumSharesValueUnderPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Option to Sell Maximum Shares Value under Purchase Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OptionToSellMaximumSharesValueUnderPurchaseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Option to sell maximum shares value under purchase agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Increase (Decrease), Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Line of Credit Facility, Increase (Decrease), Net, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in credit facility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAffiliatesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Affiliates [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAffiliatesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Affiliates [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VirageRecoveryParticipationLpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Virage Recovery Participation LP [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VirageRecoveryParticipationLpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Virage Recovery Participation LP [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VirageRecoveryParticipationLpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">VRP [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FundsHeldForOtherEntitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Funds Held For Other Entities Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FundsHeldForOtherEntitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Funds Held For Other Entities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FundsHeldForOtherEntitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Funds Held For Other Entities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfMedicareMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Medicare Members</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfMedicareMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of medicare members.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfMedicareMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Medicare Members</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Warrants, Each Lot of 25 Warrants is Exercisable for One Share of Class A Common Stock at an Exercise Price of $0.0025 Per Share [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Redeemable warrants, each lot of 25 warrants is exercisable for one share of class a common stock at an exercise price of $0.0025 per share.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable Warrants, each Lot of 25 Warrants is Exercisable for One Share of Class A Common Stock at an Exercise Price of $287.50 Per Share [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in credit facility expiration period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Expiration Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">VWAP seven consecutive trading days</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of WAP of Shares During Seven Consecutive Trading Days Immediately Preceding the Conversion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of WAP of shares during seven consecutive trading days immediately preceding the conversion.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash in operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_GuarantyObligationCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Guaranty obligation current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_GuarantyObligationCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Guaranty Obligation Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_GuarantyObligationCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Guaranty obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of shares in settlement of debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of stock value for purchase of assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsFinancingObligationAndNotesPayableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Claims Financing Obligation and Notes Payable [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsFinancingObligationAndNotesPayableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Claims Financing Obligation and Notes Payable [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsFinancingObligationAndNotesPayableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Claims financing obligation and notes payable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Compensation Arrangement with Individual, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred compensation arrangement shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Debt instrument, maturity term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryovers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FinancialLiabilitiesFairValueWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Liabilities Fair Value Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FinancialLiabilitiesFairValueWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Financial liabilities fair value warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FinancialLiabilitiesFairValueWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Summary of Depreciation and Amortization on Property and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure In Tabular Form Of Useful Lives Of Property Plant And Useful Lives [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure in tabular form of useful lives of property plant and useful lives.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfRestructuringDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Type of Restructuring [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Recurring [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock par or stated value per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock, par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WarrantPaymentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Virage warrants payment description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WarrantPaymentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Payment description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WarrantPaymentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant Payment description.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IntangibleAssetsNetTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets, Net [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IntangibleAssetsNetTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Intangible assets, net.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible Assets, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash lease liabilities arising from obtaining right-of-use assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non-cash Lease Liabilities Arising from Obtaining Right-of-use Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-cash lease liabilities arising from obtaining right-of-use assets.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VariableInterestEntityDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VariableInterestEntityDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Variable interest entity disclosure.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DividendComprisingNumberOfNewWarrantsPayableHolders_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Dividend comprising number of new warrants payable holders.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DividendComprisingNumberOfNewWarrantsPayableHolders_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividend Comprising Number of New Warrants Payable Holders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DividendComprisingNumberOfNewWarrantsPayableHolders_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend comprising number of new warrants payable holders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Equity Method Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity method investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of derivative liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Change in fair value of outstanding warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsRecoveryIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Claims recovery income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsRecoveryIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Claims recovery income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsRecoveryIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Claims recovery income.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Company issued warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IntangibleAssetsNetLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets, Net [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IntangibleAssetsNetLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Intangible assets, net.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment in equity securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Securities, FV-NI</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Equity Securities, FV-NI, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Computation of Basic and Diluted Earnings Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AccruedInterestPercentageInYearOne_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest percentage in year one</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AccruedInterestPercentageInYearOne_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Interest Percentage in Year one</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AccruedInterestPercentageInYearOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued interest percentage in year one.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Asset, Finite-Lived [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of advance for shares of common stock in event of termination</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment Of Advance For Shares Of Common Stock In Event Of Terminations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment of advance for shares of common stock in event of terminations.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseMoneyLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase money loan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseMoneyLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Money Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseMoneyLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase money loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summarized Financial Information of Equity Method Investees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure In Tabular Form Of Summarized Financial Information Of Equity Method Investees [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure in tabular form of summarized financial information of equity method investees.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseMoneyLoanAccruesInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase Money Loan accrues interest.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseMoneyLoanAccruesInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Money Loan Accrues Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseMoneyLoanAccruesInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase Money Loan accrues interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Line of credit facility, Maximum borrowing capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility, maximum borrowing capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantConvertedDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant Converted During Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantConvertedDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant converted during period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantConvertedDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantConvertedDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Converted (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OtherSoftwareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other software</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OtherSoftwareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Software [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OtherSoftwareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other Software.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfMinimumVariablePriceEqualingOfVwap_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable price equaling</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfMinimumVariablePriceEqualingOfVwap_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of minimum Variable price equaling of vwap</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfMinimumVariablePriceEqualingOfVwap_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of minimum variable price equaling of vwap.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments in Equity Securities and Obligations to Deliver Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TermLoanBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan B.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TermLoanBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan B [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TermLoanBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term Loan B [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss) Attributable to Noncontrolling Interest, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: Net loss attributable to non-controlling interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Less: Net loss attributable to the non-controlling interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfAggregateProceedsToPayOutstandingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentag of aggregate proceeds used to pay amounts outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfAggregateProceedsToPayOutstandingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Aggregate Proceeds To Pay Outstanding Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfAggregateProceedsToPayOutstandingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of aggregate proceeds to pay outstanding amount.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Operating lease liability, non-current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability, non-current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CashPaidDuringThePeriodAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid during the period for:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CashPaidDuringThePeriodAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Paid During The Period [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CashPaidDuringThePeriodAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash paid during the period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AffiliateReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Affiliate receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AffiliateReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Affiliate receivable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringPlanDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Plan [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Price Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of stock, price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss attributable to MSP Recovery, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related party expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Costs and Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Costs and Expenses, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MarkToMarketGainOnLiabilityPayableInStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Mark to Market Gain on liability payable in stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MarkToMarketGainOnLiabilityPayableInStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Mark to market Gain on liability payable in stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MarkToMarketGainOnLiabilityPayableInStock_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Mark-to-market gain on liability payable in stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Financial Statement Error Correction [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Financial Statement Error Correction [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">General and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Income (Expense), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense), net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture and Fixtures [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ProfessionalFeesSettledInShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Professional fees settled in shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ProfessionalFeesSettledInShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Professional Fees Settled In Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ProfessionalFeesSettledInShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Professional fees settled in shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AdvancePaymentIncurredForExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Advance payment incurred for expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AdvancePaymentIncurredForExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Advance Payment Incurred For Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AdvancePaymentIncurredForExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Advance payment incurred for expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss (1)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Net Income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsWarrantLiabilityPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsWarrantLiabilityPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Warrant Liability Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsWarrantLiabilityPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective income tax rate reconciliation change in deferred tax assets warrant liability percent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AdditionalFiniteLivedIntangibleAssetsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional purchase of intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AdditionalFiniteLivedIntangibleAssetsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Finite-Lived Intangible Assets Acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AdditionalFiniteLivedIntangibleAssetsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional finite-Lived intangible assets acquired.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ValueOfSharesToCoverShortPosition_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of securities to cover short position</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ValueOfSharesToCoverShortPosition_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Value Of Shares To Cover Short Position</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ValueOfSharesToCoverShortPosition_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Value of shares to cover short position.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Aggregate purchase price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PmpiMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">PMPI [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PmpiMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">PMPI.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PmpiMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">PMPI [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Acquisitions of CCRAs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets Acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of Intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ForcedExpiratoryFlowSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Forced expiratory flow shares [Member].</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ForcedExpiratoryFlowSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Forced Expiratory Flow Shares [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ForcedExpiratoryFlowSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">FEF Shares [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Remaining amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MembershipInterestPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Membership Interest Purchase Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MembershipInterestPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">membership interest purchase agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MembershipInterestPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Membership interest purchase agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CostOfClaimRecoveriesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cost of Claims Recoveries</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CostOfClaimRecoveriesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Claim Recoveries [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CostOfClaimRecoveriesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cost of claim recoveries.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfMinimumFixedPriceEqualingOfVwap_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Minimum Fixed Price Equaling Of Vwap</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfMinimumFixedPriceEqualingOfVwap_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of minimum fixed price equaling of vwap.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfMinimumFixedPriceEqualingOfVwap_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fixed price equaling</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Price of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Share Price [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Grant Proceeds To Extent Full Return Not Repaid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of grant proceeds to extent full return not repaid.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of grant proceeds to extent full return not repaid.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Payment of Cano Health payment in shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Compensation Arrangement with Individual, Recorded Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred compensation arrangement recorded liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Intangible Assets Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Shares, Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Shares, Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility, Current borrowing capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Current Borrowing Capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non-Cash Impairment Charge Would Increase Estimated Recoveries</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-cash impairment charge would increase estimated recoveries.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash impairment charge would increase estimated recoveries</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Components of Income Tax Provision</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AccruedInterestPercentageAfterOneYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued interest percentage after year one.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AccruedInterestPercentageAfterOneYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued interest percentage after one year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite life intangible assets acquired useful life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfWarrantsIssuedAndExercisable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Warrants Issued and Exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfWarrantsIssuedAndExercisable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of warrants issued and exercisable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfWarrantsIssuedAndExercisable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of warrants exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AgreementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Agreement date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AgreementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Agreement Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AgreementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit facility, agreement date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repayments of lines of credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayments of Lines of Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Ownership interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary, Ownership Percentage, Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-controlling interests ownership percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SubsidiaryAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SubsidiaryAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Subsidiary.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WarrantLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Liability Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WarrantLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant liability current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WarrantLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Cash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Cash_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cash in operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Cash_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrestricted cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_YaIiPnLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">YA II PN, Ltd</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_YaIiPnLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">YA II PN, Ltd.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_YaIiPnLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">YA II PN, Ltd [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_YaIiPnLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">YA II PN, Ltd [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InternalUseSoftwarePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Internal Use Software</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InternalUseSoftwarePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Internal Use Software, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Equity Method Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RecoveryRightsInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Recovery Rights Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RecoveryRightsInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Recovery rights interest.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RecoveryRightsInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recovery rights interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_InterestPayableNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Payable Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_InterestPayableNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest payable noncurrent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_InterestPayableNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash at beginning of year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transactions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective income tax rate reconciliation at noncontrolling interests effect of pass through entities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation at Noncontrolling Interests Effect of Pass Through Entities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncontrolling interests/effect of pass-through entities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2029</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfCashProceedsFromSaleOfStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Cash Proceeds From Sale Of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfCashProceedsFromSaleOfStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of cash proceeds from sale of stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfCashProceedsFromSaleOfStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of cash proceeds from sale of stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Tranche Three [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Third Pre-Paid Advance [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trance Three [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Assets at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Assets, Fair Value Disclosure, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Debt [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Future Amortization Expense [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Finite lived intangible assets future amortization expense.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Finite-Lived Intangible Assets, Gross, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible assets, gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IntangibleAssetsFinancedByNotePayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of intangible asset financed by note payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IntangibleAssetsFinancedByNotePayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets Financed By Note Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IntangibleAssetsFinancedByNotePayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Intangible assets financed by note payable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from (Repayments of) Related Party Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">(Payments) Proceeds on related party loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AdditionalReceivablesFromOtherAffiliatesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Receivables From Other Affiliates [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AdditionalReceivablesFromOtherAffiliatesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Receivables From Other Affiliates [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AdditionalReceivablesFromOtherAffiliatesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional receivables from other affiliates.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_HazelPartnersHoldingsLlcLetterAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">HPH Letter Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_HazelPartnersHoldingsLlcLetterAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Hazel Partners Holdings LLC Letter Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_HazelPartnersHoldingsLlcLetterAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Hazel Partners Holdings LLC letter agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_OwnershipDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ownership [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringCostAndReserveAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from credit facility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Long-Term Lines of Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsCostRecoveryRightsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Claims Cost Recovery Rights [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsCostRecoveryRightsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Claims cost recovery rights.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Recent Accounting Pronouncements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvesteeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investee [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvesteeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Method Investee [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of claims</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Sold under Agreements to Repurchase, Market Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WarrantsIssuedToVirageMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Issued to Virage [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WarrantsIssuedToVirageMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrants issued to Virage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WorkingCapitalCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Working capital credit agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WorkingCapitalCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Working Capital Credit Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WorkingCapitalCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Working Capital Credit Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FixedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fixed price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FixedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fixed Price Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FixedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fixed price per share.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WorkingCapitalCreditFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Working Capital Credit Facility [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WorkingCapitalCreditFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Working capital credit facility.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WorkingCapitalCreditFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Working Capital Credit Facility [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BridgeLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Bridge Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BridgeLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Bridge loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfVwapOfSharesDuringPriorDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">VWAP of shares during prior date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfVwapOfSharesDuringPriorDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of VWAP of shares during Prior Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfVwapOfSharesDuringPriorDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of VWAP of shares during prior date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principal amount of unsecured promissory note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Principal amount of unsecured promissory note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Aggregate principal amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Numerator - basic and diluted:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MsoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">MSO [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MsoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">MSO.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MsoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">MSO [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ReductionInInterestAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reduction In Interest Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ReductionInInterestAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reduction In Interest Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ReductionInInterestAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reduction in interest amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Reduce Amended And Restated Nomura Promissory Note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments to reduce amended and restated nomura promissory note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments to reduce amended and restated nomura promissory note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in fair value of warrant and derivative liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Fair Value of Warrant And Derivative Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of warrant and derivative liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Change in fair value of warrant and derivative liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CODM Title</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Classification Of Common Stock Based On Voting Rights [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Classification of common stock based on voting rights.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, New Issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class A Issuances</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Committed to purchase shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WarrantConversionsOnACashlessBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant conversions on a cashless basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WarrantConversionsOnACashlessBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Conversions On A Cashless Basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WarrantConversionsOnACashlessBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant conversions on a cashless basis.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate202309Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASU 2023-09</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate202309Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2023-09 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfPaySellersToAmountOfTaxBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of pay sellers to amount of tax benefit.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfPaySellersToAmountOfTaxBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Pay Sellers to Amount of Tax Benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfPaySellersToAmountOfTaxBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of pay sellers to amount of tax benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MspRecoveryAviationLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">MSP Recovery Aviation, LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MspRecoveryAviationLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">MSP Recovery Aviation, LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MspRecoveryAviationLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">MSP recovery aviation, LLC.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SpecificContractMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Specific Contract [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SpecificContractMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Specific Contract.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassVShareholdersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class V Shareholders [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassVShareholdersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class V Shareholders [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at December 31, 2023</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at December 31, 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel">Balance at December 31, 2023</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel">Balance at December 31, 2024</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accounting policies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfRecoveryClaimsForTheControlling_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Recovery Claims For The Controlling Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfRecoveryClaimsForTheControlling_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of recovery claims for the controlling member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfRecoveryClaimsForTheControlling_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of recovery claims for the controlling member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FinancingObligationsAndNotesPayableAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing Obligations and Notes Payable Agreements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FinancingObligationsAndNotesPayableAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Financing obligations and notes payable agreements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FinancingObligationsAndNotesPayableAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financing Obligations and Notes Payable Agreements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Gross, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Gross, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Gross, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Property and Equipment, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Principles of Consolidation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility for acquiring additional Claims</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Facility Funded For Acquiring Additional Claims</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Line Of Credit Facility Funded For Acquiring Additional Claims</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Interest Entities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_StockIssuedDuringPeriodSharesConversionOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period shares conversion of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_StockIssuedDuringPeriodSharesConversionOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Conversion of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_StockIssuedDuringPeriodSharesConversionOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of Warrants, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Expected Term [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CommonClassVMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common class v.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CommonClassVMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Class V [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CommonClassVMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class V Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transferred New Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of New Warrant or Right Transferred During Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of new warrant or right transferred during period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TermSheetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Sheet [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TermSheetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term sheet.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Equity method ownership percentage for entities that track separate capital accounts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Ownership Percentage For Entities That Track Separate Capital Accounts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity method ownership percentage for entities that track separate capital accounts.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IssuanceOfSharesPurchaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of shares purchase term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IssuanceOfSharesPurchaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Shares Purchase Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IssuanceOfSharesPurchaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of shares purchase term.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Outstanding Ownership Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right outstanding ownership percentage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants to purchase shares of common stock, Owning percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCollateralAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional collateral, a pledge of proceeds from certain Claims</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCollateralAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Collateral Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Share Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business combination, share price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants or rights exercise price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants to purchase exercise price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance, (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MinimumFeePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Fee Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MinimumFeePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum fee paid.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MinimumFeePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum fee paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Reconciliation Statutory Income Tax Rate to the Company's Effective Tax Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_OwnershipAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ownership [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Note Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VRMFullPaymentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">VRM full payment description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VRMFullPaymentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">V R M Full Payment Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VRMFullPaymentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">VRM full payment description.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Credit Facility [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate202307Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2023-07 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate202307Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASU 2023-07</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible Assets, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit facility description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of Up C units issued in exchange of assets acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Up C Units Issued in Exchange of Assets Acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Up C units issued in exchange of assets acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Depreciation and amortization expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation, Depletion and Amortization, Nonproduction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Depletion and Amortization, Nonproduction, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DebtInstrumentsExtendedMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Extended maturity date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DebtInstrumentsExtendedMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instruments Extended Maturity Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DebtInstrumentsExtendedMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instruments extended maturity date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsFinancingObligationNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Claims financing obligation &amp; notes payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsFinancingObligationNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Claims Financing Obligation Notes Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsFinancingObligationNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Claims financing obligation&#160;&amp; notes payable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PublicWarrantsOutstandingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Public warrants outstanding.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PublicWarrantsOutstandingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Public Warrants Outstanding [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PublicWarrantsOutstandingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Public Warrants Outstanding [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PublicWarrantsOutstandingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Public Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Classification Of Common Stock Based On Voting Rights [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">classification of common stock based on voting rights.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Class A [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Class A Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class A [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective Income tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AffiliatePayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Affiliate payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AffiliatePayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Affiliate Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AffiliatePayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Affiliate Payable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive securities excluded from computation of earnings per share amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseDeceaseInAffiliatesReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Affiliate receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseDeceaseInAffiliatesReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decease In Affiliates Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseDeceaseInAffiliatesReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decease in affiliates receivable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Equity method investments ownership percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment, Ownership Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Company agreement to pay cash or warrant to purchase Class A common stock equal to percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion, Converted Instrument, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt converted into shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Derivative liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derivative liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income Tax Expense (Benefit), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provision for income tax benefit (expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Provision for income tax benefit (expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Provision for income tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RestructuringPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RestructuringPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restructuring plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingInformationProfitLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingInformationProfitLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at beginning of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MonthlyVirageWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Monthly Virage Warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MonthlyVirageWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Monthly virage warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfSharesExercisable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Shares Exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfSharesExercisable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of shares exercisable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfSharesExercisable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Premium and accrued and unpaid interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Debt Instrument To Monthly Payment Along With Premium And Accrued And Unpaid Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of debt instrument to monthly payment along with premium and accrued and unpaid interest.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TaxReceivableAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax receivable agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TaxReceivableAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Receivable Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable, commission payable and accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts payable, commission payable and accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) In Accounts Payable, Commission Payable And Accrued Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (decrease) in accounts payable, commission payable and accrued liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_HazelTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Hazel Transactions [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_HazelTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Hazel Transactions.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_HazelTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Hazel Transactions [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets organizational costs and startup expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Organizational Costs And Startup Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Start-up Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LegalAccountingAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal, Accounting, And Administrative Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LegalAccountingAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Legal, Accounting, And Administrative Expense.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Credit agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Credit Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amended and restated claims recovery and assignment agreement effective as of December 31, 2021, as amended to date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amended and Restated Claims Recovery and Assignment Agreement Effective as of December 31, 2021, as Amended to Date [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amended and Restated Claims Recovery and Assignment Agreement Effective as of December 31, 2021, as Amended to Date [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment of Intangible Assets, Finite-Lived</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Non-cash impairment charge</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Impairment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Impairement of intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Monthly payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Seventh trading day after the Trigger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Periodic Payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Instrument, Periodic Payment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants to purchase shares of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long-term liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Businesses, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of cash for assets purchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Number of Shares Issued in Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantsOrRightConvertedExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of warrants or right converted exercise price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantsOrRightConvertedExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrants or right converted exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantsOrRightConvertedExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Converted (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VrmMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">VRM [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VrmMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">VRM [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VrmMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">VRM.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of derivative liability at issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Issuance of note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Issuance of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adopted [true false]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adopted [true false]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtWeightedAverageInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtWeightedAverageInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt, Weighted Average Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SignificantExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SignificantExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Significant expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SignificantExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SignificantExpenses_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Significant Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SignificantExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Significant Expenses, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SignificantExpenses_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Significant Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NatureOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of the Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NatureOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nature of Operations [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Estimates and Assumptions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit borrowing amount accessible for each tranche</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility Borrowing, Available Amount For Each Tranche</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Line of credit facility borrowing, available amount for each tranche.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsFinancingObligationNotesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Claims financing obligation and notes payable, current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsFinancingObligationNotesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Claims Financing Obligation Notes Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsFinancingObligationNotesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Claims financing obligation notes payable, current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseInTaxReceivableAgreementLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase in Tax Receivable Agreement Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseInTaxReceivableAgreementLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase in tax receivable agreement liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseInTaxReceivableAgreementLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in TRA liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MaterialAgreementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Material Agreements Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MaterialAgreementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Material agreements disclosure.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MaterialAgreementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Material Agreements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseDecreaseInImpairmentCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Impairment Charges</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseDecreaseInImpairmentCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">increase decrease in impairment charges.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseDecreaseInImpairmentCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">increase (decrease) in impairment charges</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Volatility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Price Volatility [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCommitment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Commitment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCommitment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Commitment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCommitment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitment collateral</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfEquitySharesAcquiredToCoverTheShortPosition_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of equity shares acquired to cover the short position</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfEquitySharesAcquiredToCoverTheShortPosition_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Equity Shares Acquired To Cover The Short Position</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfEquitySharesAcquiredToCoverTheShortPosition_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of equity shares acquired to cover the short position.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LicenseFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License fee percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LicenseFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Fee Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LicenseFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License fee percentage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Acquiree [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Market Risk Spread</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Risk Free Interest Rate [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Purchase Agreement, Effective as of September 30, 2022, as Amended to Date [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase agreement, effective as of September 30, 2022, as amended to date.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Agreement, Effective as of September 30, 2022, as Amended to Date [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase Agreement, Effective as of September 30, 2022, as Amended to Date [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfConsecutiveTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Consecutive Trading Days</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfConsecutiveTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of consecutive trading days.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfConsecutiveTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of consecutive trading days</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EmbeddedDerivativeLiabilityMeasurementTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Embedded derivative liability term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EmbeddedDerivativeLiabilityMeasurementTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Embedded Derivative Liability Measurement Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EmbeddedDerivativeLiabilityMeasurementTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Embedded Derivative Liability Measurement Term.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfWarrantsIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Warrants Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfWarrantsIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of warrants issued.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfWarrantsIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of warrants issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: accumulated depreciation and amortization of software</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-controlling interest, Ownership percentage by non-controlling owners</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary, Ownership Percentage, Noncontrolling Owner</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Ownership percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ValueOfFullReturn_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Value of full return.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ValueOfFullReturn_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Value of Full Return</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ValueOfFullReturn_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Value of full return</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Right-of-use asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental cash flow information:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Embedded Derivative Liability Valuation Assumptions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Embedded Derivative Liability Valuation Assumptions [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of embedded derivative liability valuation assumptions.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Liabilities Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Financial Liabilities Fair Value Disclosure, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_InterestPeriodPlusAnApplicableMargin_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest period, plus an applicable margin.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_InterestPeriodPlusAnApplicableMargin_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Period, plus an Applicable Margin</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_InterestPeriodPlusAnApplicableMargin_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest period, plus an applicable margin</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earnings per share of common stock - diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Diluted net loss per common share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold improvements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AggregateAmountOutstandingUnderCashProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate amount outstanding under cash proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AggregateAmountOutstandingUnderCashProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Aggregate Amount Outstanding Under Cash Proceeds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AggregateAmountOutstandingUnderCashProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Aggregate amount outstanding under cash proceeds.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ReleaseOfTemporaryEquityDuringNonCash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Release of temporary equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ReleaseOfTemporaryEquityDuringNonCash_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Release Of Temporary Equity During Non Cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ReleaseOfTemporaryEquityDuringNonCash_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Release Of Temporary Equity During Non Cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure In Tabular Form Of Summarized Financial Information Of Equity Method Investees [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure in tabular form of summarized financial information of equity method investees.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash (used in) provided by investing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightCancellationDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cancellation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightCancellationDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right Cancellation During Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightCancellationDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right cancellation during period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightCancellationDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cancellation (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum VWAP of shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Minimum VWAP of Shares During Three Consecutive Days Commencing From Delivery Of Advance Notice</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of minimum VWAP of shares during three consecutive days commencing from delivery of Advance notice.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Forecast [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class A Issuances, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unrecognized Tax Benefits, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unrecognized Tax Benefits, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionPriceOfAcquisitionExpected_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Acquisition, Price of Acquisition, Expected</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionPriceOfAcquisitionExpected_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of claims</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Acquisition [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Warrant Liability Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective income tax rate reconciliation warrant liability percent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_Non-RecourseDebtSecondLienAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non-recourse Debt Second Lien Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_Non-RecourseDebtSecondLienAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-recourse debt second Lien amount.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_Non-RecourseDebtSecondLienAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-recourse debt second lien amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at beginning of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_UpCUnitHoldersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Up-C Unit Holders.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_UpCUnitHoldersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Up-C Unit Holders [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_UpCUnitHoldersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">UP-C Units [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Property and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-&#160;Controlling Interests [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DeferredTaxAssetsTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred Tax Assets Transaction Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DeferredTaxAssetsTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Transaction Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DeferredTaxAssetsTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NetGainOfTheAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net gain on sale of claims transactions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NetGainOfTheAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Gain Of The Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NetGainOfTheAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net gain of the asset.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Payment Arrangement, Noncash Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LegalFees_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal Fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LegalFees_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Professional fees - legal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LegalFees_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Professional fees - legal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DevelopmentCostsCapitalizedUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Development Costs Capitalized Useful Life.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DevelopmentCostsCapitalizedUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Development Costs Capitalized Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DevelopmentCostsCapitalizedUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Development costs capitalized useul life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accounting policies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WorkingCapitalCreditFacilityCollateralMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Working Capital Credit Facility Collateral [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WorkingCapitalCreditFacilityCollateralMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Working Capital Credit Facility Collateral [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WorkingCapitalCreditFacilityCollateralMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Working capital credit facility collateral.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LoansRepaymentPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loans Repayment Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LoansRepaymentPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Loans repayment percentage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LoansRepaymentPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loans repayment percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Future Amortization Expense [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Finite lived intangible assets future amortization expense.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SharesPledgedUnderAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares pledged under agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SharesPledgedUnderAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Pledged Under Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SharesPledgedUnderAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shares pledged under agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FloorPriceOfACommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Floor Price of a Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FloorPriceOfACommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Floor price of a common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FloorPriceOfACommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Floor price of a common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RealizedLossOnInvestmentsToCoverShortPosition_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized loss on investments to cover short position</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RealizedLossOnInvestmentsToCoverShortPosition_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Realized Loss On Investments To Cover Short Position</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RealizedLossOnInvestmentsToCoverShortPosition_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Realized loss on investments to cover short position.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Reportable Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of reportable segment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ForegoPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forego payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ForegoPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Forego Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ForegoPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Forego payments.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Common Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument maturity date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentToFundOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fund operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentToFundOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment To Fund Operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentToFundOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment to fund operations.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments and Joint Ventures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loan from related parties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Due to related party current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted average shares outstanding, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average shares of common stock outstanding - basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Equity Method Investments [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Equity Method Investments [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Maximum amount of common shares to be purchased</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Property, Plant and Equipment, Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from the issuance of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfProceedsFromGrantLien_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Proceeds From Grant Lien</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfProceedsFromGrantLien_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of proceeds from grant lien.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfProceedsFromGrantLien_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of proceeds from grant lien</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfHoldingInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of holding investments.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfHoldingInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Holding Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfHoldingInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of holding investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetInterestCarryforward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest Expense - 163j</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetInterestCarryforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Asset, Interest Carryforward</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Amortization expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Instruments, Gain (Loss) [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of intangible asset through issuance of Class A common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase of intangible asset through issuance of class A common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase of intangible asset through issuance of Class A common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ProceedsFromSaleOfStockMonthlyPaymentAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of stock monthly payment amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ProceedsFromSaleOfStockMonthlyPaymentAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale of Stock Monthly Payment Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ProceedsFromSaleOfStockMonthlyPaymentAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from sale of stock monthly payment amount.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WarrantLiabilityTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Liability [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WarrantLiabilityTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The entire disclosure for warrant liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_WarrantLiabilityTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative Expenses [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Claims Recovery</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Interest Payable, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Carrying value of claims</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Sold under Agreements to Repurchase, Carrying Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Impairment of Long-Lived Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due from related party current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Receivables, Net, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Receivables, Net, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VirageTermSheetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Virage Term Sheet [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VirageTermSheetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Virage Term Sheet.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VirageTermSheetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Virage Term Sheet</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Role of Management [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RelatedPartyLegalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related party legal expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RelatedPartyLegalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Legal Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RelatedPartyLegalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Related party legal expense.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NewClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">New Warrants outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NewClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Class of Warrant or Right Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NewClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">New class of warrant or right outstanding.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringPlanAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Plan [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Transfers of Claims Cost Recovery Rights to Others</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Transfer Of Claims Costs Recovery Right To Others [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Transfer of claims costs recovery right to others.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AffiliateReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Affiliate Receivable [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AffiliateReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Affiliate Receivable [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AffiliateReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Affiliate receivable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' Equity:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AmendedAndRestatedCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amended and restated credit agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AmendedAndRestatedCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amended and Restated Credit Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AmendedAndRestatedCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amended and Restated Credit Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfSharesObtainedThroughWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of shares obtained through warrant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfSharesObtainedThroughWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Shares Obtained Through Warrant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfSharesObtainedThroughWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of shares obtained through warrant.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of&#160;non-cash&#160;investing and financing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantsOrRightIssuedExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issued (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantsOrRightIssuedExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrants Or Right Issued Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantsOrRightIssuedExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrants or right issued exercise price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of Property and Equipment, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentsOfDeferredFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Deferred financing costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentsOfDeferredFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Deferred Financing Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentsOfDeferredFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments of deferred financing costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfPledge_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Pledge</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfPledge_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of pledge.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfPledge_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of pledge</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Warrants, Each Lot of 625 Warrants Exercisable for One Share of Class A Common Stock at an Exercise Price of $0.0625 Per Share [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Redeemable warrants, each lot of 625 warrants exercisable for one share of class a common stock at an exercise price of $0.0625 per share.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable Warrants, Each Lot of 625 Warrants Exercisable for One Share of Class A Common Stock at an Exercise Price of $0.0625 Per Share [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfTenWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Ten Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfTenWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Ten Warrant Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfTenWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of ten warrant.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_BrickellKeyInvestmentAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Brickell Key Investment Amendment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_BrickellKeyInvestmentAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Brickell Key Investment Amendment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_BrickellKeyInvestmentAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Brickell Key Investment Amendment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentsOnRelatedPartyLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments on Related Party Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentsOnRelatedPartyLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments on related party loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentsOnRelatedPartyLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments on related party loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentsOnRelatedPartyLoan_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payments on related party loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ExistingLegalServicesAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Existing Legal Services Agreements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ExistingLegalServicesAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Existing Legal Services Agreements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ExistingLegalServicesAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Existing legal services agreements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair value of warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Warrants decreased resulting in other income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants decreased resulting in other income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Change in fair value of warrant liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase (decrease) in cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PriceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Price of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PriceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Price Of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PriceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Price of common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MaomsoRecoveryLlcSeriesFhcpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">MAOMSO Recovery LLC Series FHCP [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MaomsoRecoveryLlcSeriesFhcpMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">MAO-MSO recovery LLC series FHCP.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants exercisable term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding, Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Operating and Nonoperating</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EarningsPerSharesBasicAndDilutedAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Earnings Per Shares Basic And Diluted [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EarningsPerSharesBasicAndDilutedAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Shares Basic And Diluted [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EarningsPerSharesBasicAndDilutedAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Denominator - basic and diluted:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Liabilities Measured at Fair Value on a Recurring Basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_InitialVirageWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Initial Virage Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_InitialVirageWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Initial virage warrant.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Internally developed software</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Software Development [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments to continuing equity owners and blocker shareholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Continuing Equity Owners and Blocker Shareholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments to continuing equity owners and blocker shareholders.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility, Interest rate during period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Interest Rate During Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfStockPurchasePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock purchased price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfStockPurchasePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Stock Purchase Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfStockPurchasePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of stock purchase price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adoption Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adoption date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Tranch Two [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Resale of the shares of common stock issuable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Tranche Two [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion, Converted Instrument, Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of debt obligation agreed to convert</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassifications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Related Party Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds on related party loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Warrants, each Lot of 25 Warrants is Exercisable for One Share of Class A Common Stock at an Exercise Price of $287.50 Per Share [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Redeemable warrants, each lot of 25 warrants is exercisable for one share of class a common stock at an exercise price of $287.50 per share.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable Warrants, each Lot of 25 Warrants is Exercisable for One Share of Class A Common Stock at an Exercise Price of $287.50 Per Share [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EntitledClaimsRecoverPercentageByNonControllingMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Entitled claims recover percentage by non-controlling members.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EntitledClaimsRecoverPercentageByNonControllingMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entitled Claims Recover Percentage by Non-Controlling Members</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EntitledClaimsRecoverPercentageByNonControllingMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entitled claims recover percentage by non-controlling member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal Statutory rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TotalClaimsRecovery_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Total Claims Recovery</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TotalClaimsRecovery_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Total claims recovery.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TotalClaimsRecovery_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total Revenues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TotalClaimsRecovery_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total Revenues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TotalClaimsRecovery_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Total Revenues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non-Cash Impairment Charge Would Decrease Estimated Recoveries</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-cash impairment charge would decrease estimated recoveries.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash impairment charge would decrease estimated recoveries</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments in Equity Securities and Obligations to Deliver Securities [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Investments in equity securities and obligations to deliver securities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Additional Paid in Capital, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ReservedSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reserved shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ReservedSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reserved Shares [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MaoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">MAO [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MaoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">MAO.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MaoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">MAO [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PartialRepaymentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Partial repayment of debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PartialRepaymentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Partial Repayment of Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PartialRepaymentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Partial Repayment of Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Second Amended and Restated First Lien Credit Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Second Amended and Restated First Lien Credit Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Second amended and restated first lien credit agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of proceeds used to pay amounts due under Convertible Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Aggregate Proceeds To Pay Amounts Due Under Convertible Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of aggregate proceeds to pay amounts due under convertible notes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Company's Deferred Tax Assets and Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassVCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Class V Common Stock Units [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassVCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class V Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassVCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class V common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassVCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class V Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfessionalFees_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Professional fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfessionalFees_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Professional Fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfessionalFees_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Professional fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseMoneyLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Purchase Money Loan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseMoneyLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase money loan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PurchaseMoneyLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Money Loan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ChangeInFairValueOfDerivatives_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in fair value of derivatives.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ChangeInFairValueOfDerivatives_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Fair Value of Derivatives</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ChangeInFairValueOfDerivatives_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of derivatives</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Stated Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LineOfCreditFundedInTranchesPerMonth_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Funded In Tranches per Month</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LineOfCreditFundedInTranchesPerMonth_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Line of credit funded in tranches per month</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_LineOfCreditFundedInTranchesPerMonth_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit funded in tranches per month</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Concentration of credit risk and&#160;Off-Balance&#160;Sheet Risk</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Firm Id</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VrmMspRecoveryPartnersLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">VRM MSP recovery partners LLC.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VrmMspRecoveryPartnersLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">VRM MSP Recovery Partners LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exchange Cap or the amount of shares of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Ownership Limitation Does Not Exceed The Exchange Cap Or The Amount Of Shares Of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of ownership limitation does not exceed the exchange cap or the amount of shares of common stock .</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfTwoWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Two warrant Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfTwoWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of two warrant.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NumberOfTwoWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Two Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Embedded Derivative Liabilities Measurement Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Embedded derivative liabilities measurement term.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Embedded derivative liability term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CanoHealthLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cano Health, LLC.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CanoHealthLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cano Health, LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CanoHealthLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cano Health, LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash lease expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmbeddedDerivativeLiabilityMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Embedded derivative liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmbeddedDerivativeLiabilityMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Embedded Derivative Liability, Measurement Input</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Claims Financing Obligations and Notes Payable [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Claims Financing Obligations and Notes Payable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AmountsReceivedToToTheMasterTransactionAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amounts received to to the master transaction agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AmountsReceivedToToTheMasterTransactionAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amounts Received to to the Master Transaction Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AmountsReceivedToToTheMasterTransactionAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amounts received to to the master transaction agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsRecoveryServiceIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Claims recovery service income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsRecoveryServiceIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Claims recovery service income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsRecoveryServiceIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Claims Recovery Service Income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsRecoveryServiceIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Claims recovery service income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of payment of aggregate purchase price of shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Payment of Aggregate Purchase Price of Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of payment of aggregate purchase price of shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaidInKindInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Paid-in-Kind Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaidInKindInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Paid-in-kind interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DebtInstrumentOriginalIssueDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument original issue discount.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DebtInstrumentOriginalIssueDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Original Issue Discount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DebtInstrumentOriginalIssueDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument original issue discount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CommissionPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commission Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CommissionPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commission payable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CommissionPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commission payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Warrants, Each Lot of 625 Warrants Exercisable for One Share of Class A Common Stock at an Exercise Price of $7,187.50 Per Share [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Redeemable warrants, each lot of 625 warrants exercisable for one share of class a common stock at an exercise price of $7,187.50 per share.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable Warrants, Each Lot of 625 Warrants Exercisable for One Share of Class A Common Stock at an Exercise Price of $7,187.50 Per Share [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure In Tabular Form Of Summarized Financial Information Of Equity Method Investees [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure in tabular form of summarized financial information of equity method investees.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MinimumCashAvailableForDistributionsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Budget percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MinimumCashAvailableForDistributionsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Cash Available For Distributions Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MinimumCashAvailableForDistributionsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum cash available for distributions percentage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OperationalCollectionFloorFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operational Collection Floor Facility [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OperationalCollectionFloorFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operational collection floor facility.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Stockholders' Equity Attributable to Noncontrolling Interest, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-controlling interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityListingsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Listings [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Basis of Presentation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">2023</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CODM Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Expense Information Used by CODM, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant and rights outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Acquisition [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NomuraPromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nomura Promissory Note [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NomuraPromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Nomura Promissory Note.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AggregateNumberOfSharesTransferredToEscrowAccount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Aggregate number of shares transferred to escrow account.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AggregateNumberOfSharesTransferredToEscrowAccount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Aggregate Number Of Shares Transferred To Escrow Account</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AggregateNumberOfSharesTransferredToEscrowAccount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate number of shares transferred to escrow account</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible assets held be certain specific subsidiaries</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets Held be Certain Specific Subsidiaries</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Intangible assets held be certain specific subsidiaries.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Expected Future Amortization Expense of Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RepaymentOfTheClaimsFinancingObligation_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Repayment of the Claims financing obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RepaymentOfTheClaimsFinancingObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayment Of The Claims Financing Obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RepaymentOfTheClaimsFinancingObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Repayment of the Claims financing obligation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OtherClaimsRecoveryRevenues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Claims Recovery Revenues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OtherClaimsRecoveryRevenues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other claims recovery revenues.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_OtherClaimsRecoveryRevenues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ServiceFeesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Service fees.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ServiceFeesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Service Fees [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ServiceFeesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Service fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseDeceaseInAffiliatesPayable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Affiliate payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseDeceaseInAffiliatesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decease In Affiliates Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseDeceaseInAffiliatesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">increase decease in affiliates payable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Converting Certain Debt Of Certain Creditors Into Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Converting certain debt of certain creditors into equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Converting certain debt of certain creditors into equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Operating Loss Carryforwards, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforward</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RecoveryRightsInterestExcessCashFlowPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Recovery Rights Interest Excess Cash Flow Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RecoveryRightsInterestExcessCashFlowPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Recovery rights interest excess cash flow percentage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_RecoveryRightsInterestExcessCashFlowPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recovery rights interest excess cash flow percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfProceedsFromRepaymentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of proceeds from repayment of debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfProceedsFromRepaymentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Proceeds from Repayment of Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfProceedsFromRepaymentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of proceeds from repayment of debt.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightOutstandingVotingPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Outstanding, Voting Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightOutstandingVotingPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right outstanding voting percentage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightOutstandingVotingPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Voting control from warrant exercise</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted average shares outstanding, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average shares of common stock outstanding - diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Other Segment Items</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NonEconomicVotingSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non economic voting shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NonEconomicVotingSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non Economic Voting Shares [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NonEconomicVotingSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non Economic Voting Shares [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Receivable, after Allowance for Credit Loss, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MSPRecoveryLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">MSP Recovery LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MSPRecoveryLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">M S P Recovery L L C [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MSPRecoveryLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">MSP Recovery, LLC.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding, Maturity Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants expire date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FundedForAdditionalClaims_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Funded For Additional Claims</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FundedForAdditionalClaims_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Funded for additional claims.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_FundedForAdditionalClaims_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Funded for additional claims</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NatureOfOperationsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nature Of Operations [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NatureOfOperationsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Nature of operations.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AmendedAndRestatedNomuraPromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amended and restated nomura promissory note.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AmendedAndRestatedNomuraPromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amended and Restated Nomura Promissory Note [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AmendedAndRestatedNomuraPromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amended and Restated Nomura Promissory Note [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentOfCertainCostsAndFees_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of certain costs and fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentOfCertainCostsAndFees_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment of Certain Costs and Fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentOfCertainCostsAndFees_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment of certain costs and fees.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SeriesMrcsLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series MRCS LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SeriesMrcsLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series MRCS LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SeriesMrcsLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series MRCS LLC.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CantorFitzgeraldMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cantor Fitzgerald.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CantorFitzgeraldMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cantor Fitzgerald [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CantorFitzgeraldMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cantor Fitzgerald [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Claims Financing Obligations and Notes Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VirageAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Virage Amendment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VirageAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Virage Amendment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_VirageAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Virage Amendment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant or Right, Reason for Issuance, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of warrants issued to counter party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdsAndLeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leaseholds and Leasehold Improvements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Revenues, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reverse stock ratio</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Derivative Liability, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derivative liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Credit Facility [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Investment in rights to claim recovery cash flows.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment in Rights to Claim Recovery Cash Flows [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Roll Forward Of Warrant Liability [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of roll forward of warrant liability text block</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Roll-forward of the Warrant Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfCostsAllocatedToNonControlling_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Costs Allocated To Non Controlling Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfCostsAllocatedToNonControlling_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of costs allocated to non controlling member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfCostsAllocatedToNonControlling_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of costs allocated to non controlling member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TermLoanAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan A.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TermLoanAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan A [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_TermLoanAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term Loan A [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsProceedsInvestmentAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Claims proceeds investment agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsProceedsInvestmentAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Claims Proceeds Investment Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsProceedsInvestmentAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Claims Proceeds Investment Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_StockIssuedDuringPeriodValueConversionOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period value conversion of warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_StockIssuedDuringPeriodValueConversionOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Conversion of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_StockIssuedDuringPeriodValueConversionOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Outstanding, Warrant Exercise Minimum Holding Percentage Of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right outstanding warrant exercise minimum holding percentage of common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum percentage of common stock held, Warrant Exercise</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SubsidiaryDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_SubsidiaryDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Subsidiary.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AffiliatePayableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Affiliate Payable [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AffiliatePayableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Affiliate Payable [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AffiliatePayableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Affiliate payable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of number of shares warrant purchased equal to quotient</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Number of Shares Warrant Purchased Equal to Quotient</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of number of shares warrant purchased equal to quotient.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CostOfClaimRecoveries_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost of claim recoveries</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CostOfClaimRecoveries_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cost of claim recoveries.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CostOfClaimRecoveries_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of Claim recoveries</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CostOfClaimRecoveries_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cost of revenues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AssignorConsistingNumberOfMedicareMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assignor Consisting Number Of Medicare Members</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AssignorConsistingNumberOfMedicareMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Assignor Consisting Number Of Medicare Members</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_AssignorConsistingNumberOfMedicareMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assignor consisting number of medicare members</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible assets, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets, Net (Excluding Goodwill)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Intangible Assets, Net (Excluding Goodwill), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsAmortizationExpensePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Claims amortization expense [Policy Text Block].</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsAmortizationExpensePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Claims Amortization Expense [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsAmortizationExpensePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Claims amortization expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsCostRecoveryAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Claims cost recovery agreements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsCostRecoveryAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Claims Cost Recovery Agreements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsCostRecoveryAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">CCRA [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClaimsCostRecoveryAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Claims Cost Recovery Agreements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseInProceedsFromLongTermLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase In Proceeds From Long Term Lines Of Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseInProceedsFromLongTermLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase in proceeds from long term lines of credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_IncreaseInProceedsFromLongTermLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in proceeds from credit facility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CommonUnitExchangeValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common unit exchange value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CommonUnitExchangeValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Unit Exchange Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CommonUnitExchangeValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common unit exchange value.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">New Warrants to purchase exercise price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Class of Warrant or Right Exercise Price of Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">New class of warrant or right exercise price of warrants or rights.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class A common stock subject to possible redemption, shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 3</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightIssuedDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Issued During Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightIssuedDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right issued during period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_ClassOfWarrantOrRightIssuedDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issued (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MspRecoveryLawFirmMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">MSP Recovery Law Firm [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MspRecoveryLawFirmMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">MSP Recovery Law Firm [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_MspRecoveryLawFirmMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">MSP recovery law firm.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Notes Payable, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Notes Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from promissory notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CostOfClaimsRecoveriesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cost of claims recoveries.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CostOfClaimsRecoveriesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost of Claims Recoveries [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_CostOfClaimsRecoveriesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of Claims Recoveries [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment of professional fees through issuance of Class A common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment of Professional fees Through Issuance of Class A Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of professional fees through issuance of Class A common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments in Equity Securities and Obligations to Deliver Securities [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Investments in equity securities and obligations to deliver securities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NatureOfOperationsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nature Of Operations [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="mspr_NatureOfOperationsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Nature of operations.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Liabilities at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Liabilities, Fair Value Disclosure, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Secured Overnight Financing Rate (SOFR) [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_DebtInstrumentPaymentInKindAnnualInterestRate" xlink:to="mspr_DebtInstrumentPaymentInKindAnnualInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_OriginalIssueDiscountOfNonCash" xlink:to="mspr_OriginalIssueDiscountOfNonCash_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AdditionalBridgeLoan" xlink:to="mspr_AdditionalBridgeLoan_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_GuarantyObligationNoncurrent" xlink:to="mspr_GuarantyObligationNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc" xlink:to="mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_CpiaWarrantMember" xlink:to="mspr_CpiaWarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AnnualCompoundedReturnOnContributionPercentage" xlink:to="mspr_AnnualCompoundedReturnOnContributionPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfNonControllingMemberAllocatedCost" xlink:to="mspr_PercentageOfNonControllingMemberAllocatedCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_StandbyEquityPurchaseAgreementMember" xlink:to="mspr_StandbyEquityPurchaseAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:to="us-gaap_ProceedsFromSaleOfIntangibleAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_RealizedClaimRecoveries" xlink:to="mspr_RealizedClaimRecoveries_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:to="us-gaap_GainLossOnDispositionOfIntangibleAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OpenTaxYear" xlink:to="us-gaap_OpenTaxYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingOtherItemAmount" xlink:to="us-gaap_SegmentReportingOtherItemAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AllowanceForCreditLosses" xlink:to="mspr_AllowanceForCreditLosses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ProfessionalFeesLegalMember" xlink:to="mspr_ProfessionalFeesLegalMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_GoodwillMeasurementInputIncreaseDecrease" xlink:to="mspr_GoodwillMeasurementInputIncreaseDecrease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PaymentToReduceAmountsOwedUnderNomuraNote" xlink:to="mspr_PaymentToReduceAmountsOwedUnderNomuraNote_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfPreferredReturnForTheControlling" xlink:to="mspr_PercentageOfPreferredReturnForTheControlling_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationDescription" xlink:to="us-gaap_IncomeTaxExaminationDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_MinimumRequiredPaymentMember" xlink:to="mspr_MinimumRequiredPaymentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers" xlink:to="mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ScheduleOfOwnershipInterestsTableTextBlock" xlink:to="mspr_ScheduleOfOwnershipInterestsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_MinimumVariablePricePerShare" xlink:to="mspr_MinimumVariablePricePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance" xlink:to="mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_OperationalFunding" xlink:to="mspr_OperationalFunding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_CommonStockPurchaseAgreementMember" xlink:to="mspr_CommonStockPurchaseAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_MspPrincipalsMember" xlink:to="mspr_MspPrincipalsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NumberOfTranches" xlink:to="mspr_NumberOfTranches_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NonControllingInterestsPolicyTextBlock" xlink:to="mspr_NonControllingInterestsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AnnualCostsAfterCurrentlyPlannedCostReductions" xlink:to="mspr_AnnualCostsAfterCurrentlyPlannedCostReductions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorOpinionTextBlock" xlink:to="dei_AuditorOpinionTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_OfficeAndComputerEquipmentMember" xlink:to="mspr_OfficeAndComputerEquipmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:to="us-gaap_DeferredCompensationShareBasedPaymentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ReductionInDebtPrincipalOwing" xlink:to="mspr_ReductionInDebtPrincipalOwing_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ParentMember" xlink:to="us-gaap_ParentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_SaleOfIntangibleAssets" xlink:to="mspr_SaleOfIntangibleAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClaimsAmortizationExpense" xlink:to="mspr_ClaimsAmortizationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_DebtInstrumentExtendedMaturityYear" xlink:to="mspr_DebtInstrumentExtendedMaturityYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ReleaseOfTemporaryEquityForPayments" xlink:to="mspr_ReleaseOfTemporaryEquityForPayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceIncrease" xlink:to="us-gaap_WarrantExercisePriceIncrease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeMember" xlink:to="us-gaap_OtherIncomeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_OperatingCostsAndExpenses1" xlink:to="mspr_OperatingCostsAndExpenses1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_EquityMethodInvestmentInvesteeMember" xlink:to="mspr_EquityMethodInvestmentInvesteeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_DebtInstrumentFloorPriceTrigger" xlink:to="mspr_DebtInstrumentFloorPriceTrigger_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_LoanFromRelatedPartiesNonCurrent" xlink:to="mspr_LoanFromRelatedPartiesNonCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_DescriptionOfCashPaymentsMadeToCounterParty" xlink:to="mspr_DescriptionOfCashPaymentsMadeToCounterParty_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_UnsecuredPromissoryNotesMember" xlink:to="mspr_UnsecuredPromissoryNotesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_OptionToSellMaximumSharesValueUnderPurchaseAgreement" xlink:to="mspr_OptionToSellMaximumSharesValueUnderPurchaseAgreement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:to="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAffiliatesMember" xlink:to="us-gaap_OtherAffiliatesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_VirageRecoveryParticipationLpMember" xlink:to="mspr_VirageRecoveryParticipationLpMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_FundsHeldForOtherEntitiesMember" xlink:to="mspr_FundsHeldForOtherEntitiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NumberOfMedicareMembers" xlink:to="mspr_NumberOfMedicareMembers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember" xlink:to="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:to="us-gaap_LineOfCreditFacilityExpirationPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion" xlink:to="mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_GuarantyObligationCurrent" xlink:to="mspr_GuarantyObligationCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClaimsFinancingObligationAndNotesPayableMember" xlink:to="mspr_ClaimsFinancingObligationAndNotesPayableMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_FinancialLiabilitiesFairValueWarrants" xlink:to="mspr_FinancialLiabilitiesFairValueWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock" xlink:to="mspr_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_TypeOfRestructuringDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_WarrantPaymentDescription" xlink:to="mspr_WarrantPaymentDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_IntangibleAssetsNetTable" xlink:to="mspr_IntangibleAssetsNetTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets" xlink:to="mspr_NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_VariableInterestEntityDisclosureAbstract" xlink:to="mspr_VariableInterestEntityDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_DividendComprisingNumberOfNewWarrantsPayableHolders" xlink:to="mspr_DividendComprisingNumberOfNewWarrantsPayableHolders_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClaimsRecoveryIncome" xlink:to="mspr_ClaimsRecoveryIncome_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="mspr_IntangibleAssetsNetLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:to="us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AccruedInterestPercentageInYearOne" xlink:to="mspr_AccruedInterestPercentageInYearOne_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations" xlink:to="mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PurchaseMoneyLoan" xlink:to="mspr_PurchaseMoneyLoan_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock" xlink:to="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PurchaseMoneyLoanAccruesInterest" xlink:to="mspr_PurchaseMoneyLoanAccruesInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClassOfWarrantConvertedDuringPeriod" xlink:to="mspr_ClassOfWarrantConvertedDuringPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_OtherSoftwareMember" xlink:to="mspr_OtherSoftwareMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfMinimumVariablePriceEqualingOfVwap" xlink:to="mspr_PercentageOfMinimumVariablePriceEqualingOfVwap_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_TermLoanBMember" xlink:to="mspr_TermLoanBMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfAggregateProceedsToPayOutstandingAmount" xlink:to="mspr_PercentageOfAggregateProceedsToPayOutstandingAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_CashPaidDuringThePeriodAbstract" xlink:to="mspr_CashPaidDuringThePeriodAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AffiliateReceivable" xlink:to="mspr_AffiliateReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringPlanDomain" xlink:to="us-gaap_RestructuringPlanDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="us-gaap_MinorityInterestLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_MarkToMarketGainOnLiabilityPayableInStock" xlink:to="mspr_MarkToMarketGainOnLiabilityPayableInStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ProfessionalFeesSettledInShares" xlink:to="mspr_ProfessionalFeesSettledInShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AdvancePaymentIncurredForExpenses" xlink:to="mspr_AdvancePaymentIncurredForExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration" xlink:to="us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsWarrantLiabilityPercent" xlink:to="mspr_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsWarrantLiabilityPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AdditionalFiniteLivedIntangibleAssetsAcquired" xlink:to="mspr_AdditionalFiniteLivedIntangibleAssetsAcquired_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ValueOfSharesToCoverShortPosition" xlink:to="mspr_ValueOfSharesToCoverShortPosition_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PmpiMember" xlink:to="mspr_PmpiMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="us-gaap_FinitelivedIntangibleAssetsAcquired1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ForcedExpiratoryFlowSharesMember" xlink:to="mspr_ForcedExpiratoryFlowSharesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_MembershipInterestPurchaseAgreementMember" xlink:to="mspr_MembershipInterestPurchaseAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_CostOfClaimRecoveriesPolicyTextBlock" xlink:to="mspr_CostOfClaimRecoveriesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfMinimumFixedPriceEqualingOfVwap" xlink:to="mspr_PercentageOfMinimumFixedPriceEqualingOfVwap_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid" xlink:to="mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries" xlink:to="mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AccruedInterestPercentageAfterOneYear" xlink:to="mspr_AccruedInterestPercentageAfterOneYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NumberOfWarrantsIssuedAndExercisable" xlink:to="mspr_NumberOfWarrantsIssuedAndExercisable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AgreementDate" xlink:to="mspr_AgreementDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_SubsidiaryAxis" xlink:to="mspr_SubsidiaryAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_WarrantLiabilityCurrent" xlink:to="mspr_WarrantLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_YaIiPnLtdMember" xlink:to="mspr_YaIiPnLtdMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalUseSoftwarePolicy" xlink:to="us-gaap_InternalUseSoftwarePolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsPolicy" xlink:to="us-gaap_EquityMethodInvestmentsPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_RecoveryRightsInterest" xlink:to="mspr_RecoveryRightsInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_InterestPayableNoncurrent" xlink:to="mspr_InterestPayableNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities" xlink:to="mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfCashProceedsFromSaleOfStock" xlink:to="mspr_PercentageOfCashProceedsFromSaleOfStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtMember" xlink:to="us-gaap_ConvertibleDebtMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_IntangibleAssetsFinancedByNotePayable" xlink:to="mspr_IntangibleAssetsFinancedByNotePayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AdditionalReceivablesFromOtherAffiliatesMember" xlink:to="mspr_AdditionalReceivablesFromOtherAffiliatesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_HazelPartnersHoldingsLlcLetterAgreementMember" xlink:to="mspr_HazelPartnersHoldingsLlcLetterAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipDomain" xlink:to="srt_OwnershipDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_RestructuringCostAndReserveAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="us-gaap_ProceedsFromLongTermLinesOfCredit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClaimsCostRecoveryRightsMember" xlink:to="mspr_ClaimsCostRecoveryRightsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvesteeMember" xlink:to="us-gaap_EquityMethodInvesteeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue" xlink:to="us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_WarrantsIssuedToVirageMember" xlink:to="mspr_WarrantsIssuedToVirageMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_WorkingCapitalCreditAgreementMember" xlink:to="mspr_WorkingCapitalCreditAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_FixedPricePerShare" xlink:to="mspr_FixedPricePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_WorkingCapitalCreditFacilityMember" xlink:to="mspr_WorkingCapitalCreditFacilityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BridgeLoan" xlink:to="us-gaap_BridgeLoan_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfVwapOfSharesDuringPriorDate" xlink:to="mspr_PercentageOfVwapOfSharesDuringPriorDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_MsoMember" xlink:to="mspr_MsoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ReductionInInterestAmount" xlink:to="mspr_ReductionInInterestAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote" xlink:to="mspr_PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities" xlink:to="mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis" xlink:to="mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_WarrantConversionsOnACashlessBasis" xlink:to="mspr_WarrantConversionsOnACashlessBasis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate202309Member" xlink:to="us-gaap_AccountingStandardsUpdate202309Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfPaySellersToAmountOfTaxBenefit" xlink:to="mspr_PercentageOfPaySellersToAmountOfTaxBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_MspRecoveryAviationLlcMember" xlink:to="mspr_MspRecoveryAviationLlcMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_SpecificContractMember" xlink:to="mspr_SpecificContractMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClassVShareholdersMember" xlink:to="mspr_ClassVShareholdersMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="mspr_AccountingPoliciesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfRecoveryClaimsForTheControlling" xlink:to="mspr_PercentageOfRecoveryClaimsForTheControlling_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_FinancingObligationsAndNotesPayableAgreementsMember" xlink:to="mspr_FinancingObligationsAndNotesPayableAgreementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims" xlink:to="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="us-gaap_VariableInterestEntityDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_StockIssuedDuringPeriodSharesConversionOfWarrants" xlink:to="mspr_StockIssuedDuringPeriodSharesConversionOfWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_CommonClassVMember" xlink:to="mspr_CommonClassVMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod" xlink:to="mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_TermSheetMember" xlink:to="mspr_TermSheetMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts" xlink:to="mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_IssuanceOfSharesPurchaseTerm" xlink:to="mspr_IssuanceOfSharesPurchaseTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage" xlink:to="mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCollateralAmount" xlink:to="us-gaap_DebtInstrumentCollateralAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_MinimumFeePaid" xlink:to="mspr_MinimumFeePaid_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_VRMFullPaymentDescription" xlink:to="mspr_VRMFullPaymentDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate202307Member" xlink:to="us-gaap_AccountingStandardsUpdate202307Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityDescription" xlink:to="us-gaap_LineOfCreditFacilityDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired" xlink:to="mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_DebtInstrumentsExtendedMaturityDate" xlink:to="mspr_DebtInstrumentsExtendedMaturityDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClaimsFinancingObligationNotesPayable" xlink:to="mspr_ClaimsFinancingObligationNotesPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PublicWarrantsOutstandingMember" xlink:to="mspr_PublicWarrantsOutstandingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain" xlink:to="mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AffiliatePayable" xlink:to="mspr_AffiliatePayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_IncreaseDeceaseInAffiliatesReceivable" xlink:to="mspr_IncreaseDeceaseInAffiliatesReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesCurrent" xlink:to="us-gaap_DerivativeLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_RestructuringPlanMember" xlink:to="mspr_RestructuringPlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="us-gaap_SegmentReportingInformationProfitLossAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_MonthlyVirageWarrantsMember" xlink:to="mspr_MonthlyVirageWarrantsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NumberOfSharesExercisable" xlink:to="mspr_NumberOfSharesExercisable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest" xlink:to="mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_TaxReceivableAgreementMember" xlink:to="mspr_TaxReceivableAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities" xlink:to="mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_HazelTransactionsMember" xlink:to="mspr_HazelTransactionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses" xlink:to="mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_LegalAccountingAndAdministrativeExpenseMember" xlink:to="mspr_LegalAccountingAndAdministrativeExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_CreditAgreementMember" xlink:to="mspr_CreditAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember" xlink:to="mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClassOfWarrantsOrRightConvertedExercisePrice" xlink:to="mspr_ClassOfWarrantsOrRightConvertedExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_VrmMember" xlink:to="mspr_VrmMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtWeightedAverageInterestRate" xlink:to="us-gaap_DebtWeightedAverageInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_SignificantExpenses" xlink:to="mspr_SignificantExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" xlink:to="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClaimsFinancingObligationNotesPayableCurrent" xlink:to="mspr_ClaimsFinancingObligationNotesPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_IncreaseInTaxReceivableAgreementLiability" xlink:to="mspr_IncreaseInTaxReceivableAgreementLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_MaterialAgreementsDisclosureTextBlock" xlink:to="mspr_MaterialAgreementsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_IncreaseDecreaseInImpairmentCharges" xlink:to="mspr_IncreaseDecreaseInImpairmentCharges_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitment" xlink:to="us-gaap_OtherCommitment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NumberOfEquitySharesAcquiredToCoverTheShortPosition" xlink:to="mspr_NumberOfEquitySharesAcquiredToCoverTheShortPosition_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_LicenseFeePercentage" xlink:to="mspr_LicenseFeePercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember" xlink:to="mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NumberOfConsecutiveTradingDays" xlink:to="mspr_NumberOfConsecutiveTradingDays_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_EmbeddedDerivativeLiabilityMeasurementTerm" xlink:to="mspr_EmbeddedDerivativeLiabilityMeasurementTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NumberOfWarrantsIssued" xlink:to="mspr_NumberOfWarrantsIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ValueOfFullReturn" xlink:to="mspr_ValueOfFullReturn_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock" xlink:to="mspr_ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_InterestPeriodPlusAnApplicableMargin" xlink:to="mspr_InterestPeriodPlusAnApplicableMargin_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AggregateAmountOutstandingUnderCashProceeds" xlink:to="mspr_AggregateAmountOutstandingUnderCashProceeds_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ReleaseOfTemporaryEquityDuringNonCash" xlink:to="mspr_ReleaseOfTemporaryEquityDuringNonCash_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:to="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClassOfWarrantOrRightCancellationDuringPeriod" xlink:to="mspr_ClassOfWarrantOrRightCancellationDuringPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice" xlink:to="mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionPriceOfAcquisitionExpected" xlink:to="us-gaap_AssetAcquisitionPriceOfAcquisitionExpected_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="us-gaap_AssetAcquisitionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent" xlink:to="mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_Non-RecourseDebtSecondLienAmount" xlink:to="mspr_Non-RecourseDebtSecondLienAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_UpCUnitHoldersMember" xlink:to="mspr_UpCUnitHoldersMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_DeferredTaxAssetsTransactionCosts" xlink:to="mspr_DeferredTaxAssetsTransactionCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NetGainOfTheAsset" xlink:to="mspr_NetGainOfTheAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_DevelopmentCostsCapitalizedUsefulLife" xlink:to="mspr_DevelopmentCostsCapitalizedUsefulLife_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AccountingPoliciesTable" xlink:to="mspr_AccountingPoliciesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_WorkingCapitalCreditFacilityCollateralMember" xlink:to="mspr_WorkingCapitalCreditFacilityCollateralMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_LoansRepaymentPercentage" xlink:to="mspr_LoansRepaymentPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable" xlink:to="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_SharesPledgedUnderAgreement" xlink:to="mspr_SharesPledgedUnderAgreement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_FloorPriceOfACommonStock" xlink:to="mspr_FloorPriceOfACommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_RealizedLossOnInvestmentsToCoverShortPosition" xlink:to="mspr_RealizedLossOnInvestmentsToCoverShortPosition_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ForegoPayments" xlink:to="mspr_ForegoPayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PaymentToFundOperations" xlink:to="mspr_PaymentToFundOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfProceedsFromGrantLien" xlink:to="mspr_PercentageOfProceedsFromGrantLien_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NumberOfHoldingInvestments" xlink:to="mspr_NumberOfHoldingInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetInterestCarryforward" xlink:to="us-gaap_DeferredTaxAssetInterestCarryforward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock" xlink:to="mspr_PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ProceedsFromSaleOfStockMonthlyPaymentAmount" xlink:to="mspr_ProceedsFromSaleOfStockMonthlyPaymentAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_WarrantLiabilityTextBlock" xlink:to="mspr_WarrantLiabilityTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts" xlink:to="us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_VirageTermSheetMember" xlink:to="mspr_VirageTermSheetMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_RelatedPartyLegalExpense" xlink:to="mspr_RelatedPartyLegalExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NewClassOfWarrantOrRightOutstanding" xlink:to="mspr_NewClassOfWarrantOrRightOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringPlanAxis" xlink:to="us-gaap_RestructuringPlanAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock" xlink:to="mspr_TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AffiliateReceivableMember" xlink:to="mspr_AffiliateReceivableMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AmendedAndRestatedCreditAgreementMember" xlink:to="mspr_AmendedAndRestatedCreditAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfSharesObtainedThroughWarrant" xlink:to="mspr_PercentageOfSharesObtainedThroughWarrant_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClassOfWarrantsOrRightIssuedExercisePrice" xlink:to="mspr_ClassOfWarrantsOrRightIssuedExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PaymentsOfDeferredFinancingCosts" xlink:to="mspr_PaymentsOfDeferredFinancingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfPledge" xlink:to="mspr_PercentageOfPledge_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember" xlink:to="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NumberOfTenWarrantMember" xlink:to="mspr_NumberOfTenWarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_BrickellKeyInvestmentAmendmentMember" xlink:to="mspr_BrickellKeyInvestmentAmendmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_VariableInterestEntityLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PaymentsOnRelatedPartyLoan" xlink:to="mspr_PaymentsOnRelatedPartyLoan_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ExistingLegalServicesAgreementsMember" xlink:to="mspr_ExistingLegalServicesAgreementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PriceOfCommonStock" xlink:to="mspr_PriceOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_MaomsoRecoveryLlcSeriesFhcpMember" xlink:to="mspr_MaomsoRecoveryLlcSeriesFhcpMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_EarningsPerSharesBasicAndDilutedAbstract" xlink:to="mspr_EarningsPerSharesBasicAndDilutedAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_InitialVirageWarrantMember" xlink:to="mspr_InitialVirageWarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders" xlink:to="mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfStockPurchasePrice" xlink:to="mspr_PercentageOfStockPurchasePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentRate" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember" xlink:to="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_EntitledClaimsRecoverPercentageByNonControllingMembers" xlink:to="mspr_EntitledClaimsRecoverPercentageByNonControllingMembers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestTable" xlink:to="us-gaap_MinorityInterestTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_TotalClaimsRecovery" xlink:to="mspr_TotalClaimsRecovery_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries" xlink:to="mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable" xlink:to="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ReservedSharesMember" xlink:to="mspr_ReservedSharesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_MaoMember" xlink:to="mspr_MaoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PartialRepaymentOfDebt" xlink:to="mspr_PartialRepaymentOfDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember" xlink:to="mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes" xlink:to="mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClassVCommonStockMember" xlink:to="mspr_ClassVCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PurchaseMoneyLoanMember" xlink:to="mspr_PurchaseMoneyLoanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ChangeInFairValueOfDerivatives" xlink:to="mspr_ChangeInFairValueOfDerivatives_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_LineOfCreditFundedInTranchesPerMonth" xlink:to="mspr_LineOfCreditFundedInTranchesPerMonth_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:to="us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_VrmMspRecoveryPartnersLlcMember" xlink:to="mspr_VrmMspRecoveryPartnersLlcMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock" xlink:to="mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NumberOfTwoWarrantMember" xlink:to="mspr_NumberOfTwoWarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm" xlink:to="mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_CanoHealthLlcMember" xlink:to="mspr_CanoHealthLlcMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeLiabilityMeasurementInput" xlink:to="us-gaap_EmbeddedDerivativeLiabilityMeasurementInput_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AmountsReceivedToToTheMasterTransactionAgreement" xlink:to="mspr_AmountsReceivedToToTheMasterTransactionAgreement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClaimsRecoveryServiceIncome" xlink:to="mspr_ClaimsRecoveryServiceIncome_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares" xlink:to="mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaidInKindInterest" xlink:to="us-gaap_PaidInKindInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_DebtInstrumentOriginalIssueDiscount" xlink:to="mspr_DebtInstrumentOriginalIssueDiscount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_CommissionPayable" xlink:to="mspr_CommissionPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember" xlink:to="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable" xlink:to="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_MinimumCashAvailableForDistributionsPercentage" xlink:to="mspr_MinimumCashAvailableForDistributionsPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_OperationalCollectionFloorFacilityMember" xlink:to="mspr_OperationalCollectionFloorFacilityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityListingsTable" xlink:to="dei_EntityListingsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription" xlink:to="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_AssetAcquisitionTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NomuraPromissoryNoteMember" xlink:to="mspr_NomuraPromissoryNoteMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AggregateNumberOfSharesTransferredToEscrowAccount" xlink:to="mspr_AggregateNumberOfSharesTransferredToEscrowAccount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries" xlink:to="mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_RepaymentOfTheClaimsFinancingObligation" xlink:to="mspr_RepaymentOfTheClaimsFinancingObligation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_OtherClaimsRecoveryRevenues" xlink:to="mspr_OtherClaimsRecoveryRevenues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ServiceFeesMember" xlink:to="mspr_ServiceFeesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_IncreaseDeceaseInAffiliatesPayable" xlink:to="mspr_IncreaseDeceaseInAffiliatesPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity" xlink:to="mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_RecoveryRightsInterestExcessCashFlowPercentage" xlink:to="mspr_RecoveryRightsInterestExcessCashFlowPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfProceedsFromRepaymentOfDebt" xlink:to="mspr_PercentageOfProceedsFromRepaymentOfDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClassOfWarrantOrRightOutstandingVotingPercentage" xlink:to="mspr_ClassOfWarrantOrRightOutstandingVotingPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NonEconomicVotingSharesMember" xlink:to="mspr_NonEconomicVotingSharesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_MSPRecoveryLLCMember" xlink:to="mspr_MSPRecoveryLLCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_FundedForAdditionalClaims" xlink:to="mspr_FundedForAdditionalClaims_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NatureOfOperationsTable" xlink:to="mspr_NatureOfOperationsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AmendedAndRestatedNomuraPromissoryNoteMember" xlink:to="mspr_AmendedAndRestatedNomuraPromissoryNoteMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PaymentOfCertainCostsAndFees" xlink:to="mspr_PaymentOfCertainCostsAndFees_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_SeriesMrcsLlcMember" xlink:to="mspr_SeriesMrcsLlcMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_CantorFitzgeraldMember" xlink:to="mspr_CantorFitzgeraldMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_VirageAmendmentMember" xlink:to="mspr_VirageAmendmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:to="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdsAndLeaseholdImprovementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember" xlink:to="mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock" xlink:to="mspr_ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfCostsAllocatedToNonControlling" xlink:to="mspr_PercentageOfCostsAllocatedToNonControlling_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_TermLoanAMember" xlink:to="mspr_TermLoanAMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClaimsProceedsInvestmentAgreementMember" xlink:to="mspr_ClaimsProceedsInvestmentAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_StockIssuedDuringPeriodValueConversionOfWarrants" xlink:to="mspr_StockIssuedDuringPeriodValueConversionOfWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock" xlink:to="mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_SubsidiaryDomain" xlink:to="mspr_SubsidiaryDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AffiliatePayableMember" xlink:to="mspr_AffiliatePayableMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient" xlink:to="mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_CostOfClaimRecoveries" xlink:to="mspr_CostOfClaimRecoveries_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_AssignorConsistingNumberOfMedicareMembers" xlink:to="mspr_AssignorConsistingNumberOfMedicareMembers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClaimsAmortizationExpensePolicyTextBlock" xlink:to="mspr_ClaimsAmortizationExpensePolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClaimsCostRecoveryAgreementsMember" xlink:to="mspr_ClaimsCostRecoveryAgreementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_IncreaseInProceedsFromLongTermLinesOfCredit" xlink:to="mspr_IncreaseInProceedsFromLongTermLinesOfCredit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_CommonUnitExchangeValue" xlink:to="mspr_CommonUnitExchangeValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_NoncontrollingInterestAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:to="mspr_NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:to="mspr_ClassOfWarrantOrRightIssuedDuringPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_MspRecoveryLawFirmMember" xlink:to="mspr_MspRecoveryLawFirmMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_CostOfClaimsRecoveriesMember" xlink:to="mspr_CostOfClaimsRecoveriesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock" xlink:to="mspr_PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" xlink:to="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_NatureOfOperationsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredOvernightFinancingRateSofrMember" xlink:to="us-gaap_SecuredOvernightFinancingRateSofrMember_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsLineItems" xlink:label="dei_EntityListingsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsTable" xlink:label="dei_EntityListingsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassVCommonStockMember" xlink:label="mspr_ClassVCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember" xlink:label="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember" xlink:label="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember" xlink:label="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember" xlink:label="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentType" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentAnnualReport" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_ClassVCommonStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsTable" xlink:to="dei_EntityListingsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentTransitionReport" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentPeriodEndDate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityFileNumber" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityRegistrantName" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityAddressCityOrTown" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_CityAreaCode" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_LocalPhoneNumber" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityAddressAddressLine1" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityAddressAddressLine2" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityVoluntaryFilers" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityFilerCategory" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntitySmallBusiness" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityExTransitionPeriod" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityShellCompany" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityCentralIndexKey" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_AmendmentFlag" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_Security12bTitle" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_TradingSymbol" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_SecurityExchangeName" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityPublicFloat" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_AuditorFirmId" order="37" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_AuditorName" order="38" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_AuditorLocation" order="39" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_AuditorOpinionTextBlock" order="40" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityListingsTable" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommonClassVMember" xlink:label="mspr_CommonClassVMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AffiliatePayable" xlink:label="mspr_AffiliatePayable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_GuarantyObligationNoncurrent" xlink:label="mspr_GuarantyObligationNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AffiliateReceivable" xlink:label="mspr_AffiliateReceivable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommissionPayable" xlink:label="mspr_CommissionPayable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationNotesPayable" xlink:label="mspr_ClaimsFinancingObligationNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="us-gaap_DerivativeLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WarrantLiabilityCurrent" xlink:label="mspr_WarrantLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LoanFromRelatedPartiesNonCurrent" xlink:label="mspr_LoanFromRelatedPartiesNonCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_GuarantyObligationCurrent" xlink:label="mspr_GuarantyObligationCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InterestPayableNoncurrent" xlink:label="mspr_InterestPayableNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationNotesPayableCurrent" xlink:label="mspr_ClaimsFinancingObligationNotesPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Cash" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_CommonClassVMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="mspr_AffiliatePayable" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="mspr_GuarantyObligationNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="mspr_AffiliateReceivable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="mspr_CommissionPayable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="mspr_ClaimsFinancingObligationNotesPayable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DerivativeLiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="mspr_WarrantLiabilityCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="mspr_LoanFromRelatedPartiesNonCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_MinorityInterest" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="mspr_GuarantyObligationCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="mspr_InterestPayableNoncurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="mspr_ClaimsFinancingObligationNotesPayableCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_InterestPayableCurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommonClassVMember" xlink:label="mspr_CommonClassVMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_CommonClassVMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsRecoveryIncome" xlink:label="mspr_ClaimsRecoveryIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CostOfClaimRecoveries" xlink:label="mspr_CostOfClaimRecoveries"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsRecoveryServiceIncome" xlink:label="mspr_ClaimsRecoveryServiceIncome"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsAmortizationExpense" xlink:label="mspr_ClaimsAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OtherClaimsRecoveryRevenues" xlink:label="mspr_OtherClaimsRecoveryRevenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TotalClaimsRecovery" xlink:label="mspr_TotalClaimsRecovery"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AllowanceForCreditLosses" xlink:label="mspr_AllowanceForCreditLosses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities" xlink:label="mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_ClaimsRecoveryIncome" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="mspr_CostOfClaimRecoveries" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_ClaimsRecoveryServiceIncome" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="mspr_ClaimsAmortizationExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_OtherClaimsRecoveryRevenues" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_TotalClaimsRecovery" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ProfessionalFees" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_LegalFees" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestExpense" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="mspr_AllowanceForCreditLosses" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsRecoveryServiceIncome" xlink:label="mspr_ClaimsRecoveryServiceIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MspRecoveryLawFirmMember" xlink:label="mspr_MspRecoveryLawFirmMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ProfessionalFeesLegalMember" xlink:label="mspr_ProfessionalFeesLegalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RelatedPartyLegalExpense" xlink:label="mspr_RelatedPartyLegalExpense"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_ClaimsRecoveryServiceIncome" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_VrmMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpenses" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_MspRecoveryLawFirmMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="mspr_ProfessionalFeesLegalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_RelatedPartyLegalExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassVCommonStockMember" xlink:label="mspr_ClassVCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_StockIssuedDuringPeriodValueConversionOfWarrants" xlink:label="mspr_StockIssuedDuringPeriodValueConversionOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ParentMember" xlink:label="us-gaap_ParentMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_StockIssuedDuringPeriodSharesConversionOfWarrants" xlink:label="mspr_StockIssuedDuringPeriodSharesConversionOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_7"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_ClassVCommonStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_StockIssuedDuringPeriodValueConversionOfWarrants" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_ParentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_StockIssuedDuringPeriodSharesConversionOfWarrants" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_NoncontrollingInterestMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_7" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CashPaidDuringThePeriodAbstract" xlink:label="mspr_CashPaidDuringThePeriodAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SaleOfIntangibleAssets" xlink:label="mspr_SaleOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IntangibleAssetsFinancedByNotePayable" xlink:label="mspr_IntangibleAssetsFinancedByNotePayable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsAmortizationExpense" xlink:label="mspr_ClaimsAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentsOfDeferredFinancingCosts" xlink:label="mspr_PaymentsOfDeferredFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseDeceaseInAffiliatesReceivable" xlink:label="mspr_IncreaseDeceaseInAffiliatesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReleaseOfTemporaryEquityDuringNonCash" xlink:label="mspr_ReleaseOfTemporaryEquityDuringNonCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseDeceaseInAffiliatesPayable" xlink:label="mspr_IncreaseDeceaseInAffiliatesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OriginalIssueDiscountOfNonCash" xlink:label="mspr_OriginalIssueDiscountOfNonCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentsOnRelatedPartyLoan" xlink:label="mspr_PaymentsOnRelatedPartyLoan"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities" xlink:label="mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock" xlink:label="mspr_PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AllowanceForCreditLosses" xlink:label="mspr_AllowanceForCreditLosses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock" xlink:label="mspr_PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ChangeInFairValueOfDerivatives" xlink:label="mspr_ChangeInFairValueOfDerivatives"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReleaseOfTemporaryEquityForPayments" xlink:label="mspr_ReleaseOfTemporaryEquityForPayments"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets" xlink:label="mspr_NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:label="us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RepaymentOfTheClaimsFinancingObligation" xlink:label="mspr_RepaymentOfTheClaimsFinancingObligation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WarrantConversionsOnACashlessBasis" xlink:label="mspr_WarrantConversionsOnACashlessBasis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MarkToMarketGainOnLiabilityPayableInStock" xlink:label="mspr_MarkToMarketGainOnLiabilityPayableInStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ProfessionalFeesSettledInShares" xlink:label="mspr_ProfessionalFeesSettledInShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_CashPaidDuringThePeriodAbstract" xlink:to="us-gaap_InterestPaidNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="mspr_SaleOfIntangibleAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="mspr_IntangibleAssetsFinancedByNotePayable" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="mspr_ClaimsAmortizationExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mspr_PaymentsOfDeferredFinancingCosts" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="mspr_IncreaseDeceaseInAffiliatesReceivable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfIntangibleAssets" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="mspr_ReleaseOfTemporaryEquityDuringNonCash" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_PaidInKindInterest" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="mspr_IncreaseDeceaseInAffiliatesPayable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="mspr_OriginalIssueDiscountOfNonCash" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mspr_PaymentsOnRelatedPartyLoan" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="mspr_PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="mspr_AllowanceForCreditLosses" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_StockIssued1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="mspr_PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="mspr_ChangeInFairValueOfDerivatives" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mspr_ReleaseOfTemporaryEquityForPayments" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="mspr_CashPaidDuringThePeriodAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="mspr_NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnDispositionOfIntangibleAssets" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="mspr_RepaymentOfTheClaimsFinancingObligation" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="mspr_WarrantConversionsOnACashlessBasis" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="mspr_MarkToMarketGainOnLiabilityPayableInStock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="mspr_ProfessionalFeesSettledInShares" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NatureOfOperations" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MaterialAgreementsDisclosureTextBlock" xlink:label="mspr_MaterialAgreementsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="mspr_MaterialAgreementsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvestees" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNet" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNet4" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTax" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntities" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VariableInterestEntityDisclosureAbstract" xlink:label="mspr_VariableInterestEntityDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_VariableInterestEntityDisclosureAbstract" xlink:to="us-gaap_VariableInterestEntityDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayable" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiability1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WarrantLiabilityTextBlock" xlink:label="mspr_WarrantLiabilityTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="mspr_WarrantLiabilityTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterest1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/CommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactions" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecurities" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShare1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiability" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEvents1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="us-gaap_EquityMethodInvestmentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalUseSoftwarePolicy" xlink:label="us-gaap_InternalUseSoftwarePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NonControllingInterestsPolicyTextBlock" xlink:label="mspr_NonControllingInterestsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock" xlink:label="mspr_TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CostOfClaimRecoveriesPolicyTextBlock" xlink:label="mspr_CostOfClaimRecoveriesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsAmortizationExpensePolicyTextBlock" xlink:label="mspr_ClaimsAmortizationExpensePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EquityMethodInvestmentsPolicy" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InternalUseSoftwarePolicy" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mspr_NonControllingInterestsPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mspr_TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mspr_CostOfClaimRecoveriesPolicyTextBlock" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mspr_ClaimsAmortizationExpensePolicyTextBlock" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentatonAndSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock" xlink:label="mspr_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mspr_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock" xlink:label="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryRightsMember" xlink:label="mspr_ClaimsCostRecoveryRightsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="mspr_ClaimsCostRecoveryRightsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock" xlink:label="mspr_ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="mspr_ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ScheduleOfOwnershipInterestsTableTextBlock" xlink:label="mspr_ScheduleOfOwnershipInterestsTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="mspr_ScheduleOfOwnershipInterestsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock" xlink:label="mspr_ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="mspr_ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassVCommonStockMember" xlink:label="mspr_ClassVCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis" xlink:label="mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain" xlink:label="mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NonEconomicVotingSharesMember" xlink:label="mspr_NonEconomicVotingSharesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MembershipInterestPurchaseAgreementMember" xlink:label="mspr_MembershipInterestPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NatureOfOperationsTable" xlink:label="mspr_NatureOfOperationsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NatureOfOperationsLineItems" xlink:label="mspr_NatureOfOperationsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TaxReceivableAgreementMember" xlink:label="mspr_TaxReceivableAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="us-gaap_BusinessAcquisitionSharePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantExercisePriceIncrease" xlink:label="us-gaap_WarrantExercisePriceIncrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DividendComprisingNumberOfNewWarrantsPayableHolders" xlink:label="mspr_DividendComprisingNumberOfNewWarrantsPayableHolders"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfPaySellersToAmountOfTaxBenefit" xlink:label="mspr_PercentageOfPaySellersToAmountOfTaxBenefit"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseInTaxReceivableAgreementLiability" xlink:label="mspr_IncreaseInTaxReceivableAgreementLiability"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders" xlink:label="mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_ClassVCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis" xlink:to="mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain" xlink:to="mspr_NonEconomicVotingSharesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_MembershipInterestPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="mspr_NatureOfOperationsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_TaxReceivableAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="mspr_NatureOfOperationsLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_WarrantExercisePriceIncrease" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_DividendComprisingNumberOfNewWarrantsPayableHolders" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_PercentageOfPaySellersToAmountOfTaxBenefit" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_IncreaseInTaxReceivableAgreementLiability" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness2024ReverseStockSplitAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NatureOfOperationsTable" xlink:label="mspr_NatureOfOperationsTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NatureOfOperationsLineItems" xlink:label="mspr_NatureOfOperationsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="mspr_NatureOfOperationsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="mspr_NatureOfOperationsLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember" xlink:label="us-gaap_ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_StandbyEquityPurchaseAgreementMember" xlink:label="mspr_StandbyEquityPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LegalAccountingAndAdministrativeExpenseMember" xlink:label="mspr_LegalAccountingAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AmendedAndRestatedNomuraPromissoryNoteMember" xlink:label="mspr_AmendedAndRestatedNomuraPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain" xlink:label="us-gaap_RestructuringPlanDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RestructuringPlanMember" xlink:label="mspr_RestructuringPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WorkingCapitalCreditAgreementMember" xlink:label="mspr_WorkingCapitalCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_YaIiPnLtdMember" xlink:label="mspr_YaIiPnLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanAxis" xlink:label="us-gaap_RestructuringPlanAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NatureOfOperationsTable" xlink:label="mspr_NatureOfOperationsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NatureOfOperationsLineItems" xlink:label="mspr_NatureOfOperationsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NomuraPromissoryNoteMember" xlink:label="mspr_NomuraPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OperationalCollectionFloorFacilityMember" xlink:label="mspr_OperationalCollectionFloorFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelPartnersHoldingsLlcLetterAgreementMember" xlink:label="mspr_HazelPartnersHoldingsLlcLetterAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:label="us-gaap_LineOfCreditFacilityExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfTranches" xlink:label="mspr_NumberOfTranches"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" xlink:label="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims" xlink:label="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitment" xlink:label="us-gaap_OtherCommitment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BridgeLoan" xlink:label="us-gaap_BridgeLoan"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AdditionalBridgeLoan" xlink:label="mspr_AdditionalBridgeLoan"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity" xlink:label="mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AggregateAmountOutstandingUnderCashProceeds" xlink:label="mspr_AggregateAmountOutstandingUnderCashProceeds"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfCashProceedsFromSaleOfStock" xlink:label="mspr_PercentageOfCashProceedsFromSaleOfStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfProceedsFromRepaymentOfDebt" xlink:label="mspr_PercentageOfProceedsFromRepaymentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentsExtendedMaturityDate" xlink:label="mspr_DebtInstrumentsExtendedMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_ConvertibleDebtMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_StandbyEquityPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="mspr_LegalAccountingAndAdministrativeExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mspr_AmendedAndRestatedNomuraPromissoryNoteMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringPlanDomain" xlink:to="mspr_RestructuringPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_VrmMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_WorkingCapitalCreditAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_YaIiPnLtdMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringPlanAxis" xlink:to="us-gaap_RestructuringPlanDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="mspr_NatureOfOperationsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_CreditFacilityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_Cash" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mspr_NomuraPromissoryNoteMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_OperationalCollectionFloorFacilityMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_HazelPartnersHoldingsLlcLetterAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="srt_CounterpartyNameAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_RestructuringPlanAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationPeriod" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="srt_StatementScenarioAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_NumberOfTranches" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_OtherCommitment" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsTable" xlink:to="mspr_NatureOfOperationsLineItems" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_BridgeLoan" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_AdditionalBridgeLoan" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_AggregateAmountOutstandingUnderCashProceeds" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_PercentageOfCashProceedsFromSaleOfStock" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_PercentageOfProceedsFromRepaymentOfDebt" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_DebtInstrumentsExtendedMaturityDate" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EquityMethodInvestmentInvesteeMember" xlink:label="mspr_EquityMethodInvestmentInvesteeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SpecificContractMember" xlink:label="mspr_SpecificContractMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryRightsMember" xlink:label="mspr_ClaimsCostRecoveryRightsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202307Member" xlink:label="us-gaap_AccountingStandardsUpdate202307Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_UpCUnitHoldersMember" xlink:label="mspr_UpCUnitHoldersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AccountingPoliciesLineItems" xlink:label="mspr_AccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AccountingPoliciesTable" xlink:label="mspr_AccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202309Member" xlink:label="us-gaap_AccountingStandardsUpdate202309Member"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassVShareholdersMember" xlink:label="mspr_ClassVShareholdersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription" xlink:label="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts" xlink:label="mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DevelopmentCostsCapitalizedUsefulLife" xlink:label="mspr_DevelopmentCostsCapitalizedUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsRecoveryServiceIncome" xlink:label="mspr_ClaimsRecoveryServiceIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="mspr_EquityMethodInvestmentInvesteeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_SpecificContractMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="mspr_ClaimsCostRecoveryRightsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202307Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipDomain" xlink:to="mspr_UpCUnitHoldersMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mspr_AccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202309Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipDomain" xlink:to="mspr_ClassVShareholdersMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesTable" xlink:to="srt_OwnershipAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="mspr_DevelopmentCostsCapitalizedUsefulLife" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesTable" xlink:to="mspr_AccountingPoliciesLineItems" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="mspr_ClaimsRecoveryServiceIncome" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OfficeAndComputerEquipmentMember" xlink:label="mspr_OfficeAndComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdsAndLeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mspr_OfficeAndComputerEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdsAndLeaseholdImprovementsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VirageAmendmentMember" xlink:label="mspr_VirageAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="us-gaap_AssetAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="us-gaap_AssetAcquisitionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired" xlink:label="mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CreditAgreementMember" xlink:label="mspr_CreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionTable" xlink:label="us-gaap_AssetAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseMoneyLoanMember" xlink:label="mspr_PurchaseMoneyLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_YaIiPnLtdMember" xlink:label="mspr_YaIiPnLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SeriesMrcsLlcMember" xlink:label="mspr_SeriesMrcsLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember" xlink:label="mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InitialVirageWarrantMember" xlink:label="mspr_InitialVirageWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_StandbyEquityPurchaseAgreementMember" xlink:label="mspr_StandbyEquityPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WorkingCapitalCreditAgreementMember" xlink:label="mspr_WorkingCapitalCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelPartnersHoldingsLlcLetterAgreementMember" xlink:label="mspr_HazelPartnersHoldingsLlcLetterAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMspRecoveryPartnersLlcMember" xlink:label="mspr_VrmMspRecoveryPartnersLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReservedSharesMember" xlink:label="mspr_ReservedSharesMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MonthlyVirageWarrantsMember" xlink:label="mspr_MonthlyVirageWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AnnualCompoundedReturnOnContributionPercentage" xlink:label="mspr_AnnualCompoundedReturnOnContributionPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TermLoanAMember" xlink:label="mspr_TermLoanAMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryAgreementsMember" xlink:label="mspr_ClaimsCostRecoveryAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DescriptionOfCashPaymentsMadeToCounterParty" xlink:label="mspr_DescriptionOfCashPaymentsMadeToCounterParty"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TermLoanBMember" xlink:label="mspr_TermLoanBMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelTransactionsMember" xlink:label="mspr_HazelTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WarrantPaymentDescription" xlink:label="mspr_WarrantPaymentDescription"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfProceedsFromRepaymentOfDebt" xlink:label="mspr_PercentageOfProceedsFromRepaymentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VRMFullPaymentDescription" xlink:label="mspr_VRMFullPaymentDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ValueOfFullReturn" xlink:label="mspr_ValueOfFullReturn"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MinimumCashAvailableForDistributionsPercentage" xlink:label="mspr_MinimumCashAvailableForDistributionsPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NetGainOfTheAsset" xlink:label="mspr_NetGainOfTheAsset"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims" xlink:label="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentOriginalIssueDiscount" xlink:label="mspr_DebtInstrumentOriginalIssueDiscount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfMedicareMembers" xlink:label="mspr_NumberOfMedicareMembers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionPriceOfAcquisitionExpected" xlink:label="us-gaap_AssetAcquisitionPriceOfAcquisitionExpected"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseMoneyLoan" xlink:label="mspr_PurchaseMoneyLoan"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AgreementDate" xlink:label="mspr_AgreementDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RealizedClaimRecoveries" xlink:label="mspr_RealizedClaimRecoveries"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfWarrantsIssued" xlink:label="mspr_NumberOfWarrantsIssued"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfWarrantsIssuedAndExercisable" xlink:label="mspr_NumberOfWarrantsIssuedAndExercisable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfSharesExercisable" xlink:label="mspr_NumberOfSharesExercisable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:label="us-gaap_LineOfCreditFacilityDescription"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" xlink:label="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AssignorConsistingNumberOfMedicareMembers" xlink:label="mspr_AssignorConsistingNumberOfMedicareMembers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:label="us-gaap_LineOfCreditFacilityExpirationPeriod"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_VirageAmendmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="mspr_CreditAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_AssetAcquisitionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_PurchaseMoneyLoanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_YaIiPnLtdMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_SeriesMrcsLlcMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="mspr_InitialVirageWarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_StandbyEquityPurchaseAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_WorkingCapitalCreditAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_HazelPartnersHoldingsLlcLetterAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_VrmMspRecoveryPartnersLlcMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mspr_ReservedSharesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="mspr_MonthlyVirageWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_AnnualCompoundedReturnOnContributionPercentage" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_TermLoanAMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_VrmMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mspr_ClaimsCostRecoveryAgreementsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_DescriptionOfCashPaymentsMadeToCounterParty" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_TermLoanBMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_HazelTransactionsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="srt_RangeAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_WarrantPaymentDescription" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_PercentageOfProceedsFromRepaymentOfDebt" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_AssetAcquisitionAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_VRMFullPaymentDescription" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_CreditFacilityAxis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="srt_CounterpartyNameAxis" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_ValueOfFullReturn" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_MinimumCashAvailableForDistributionsPercentage" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_NetGainOfTheAsset" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_DebtInstrumentOriginalIssueDiscount" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_NumberOfMedicareMembers" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionPriceOfAcquisitionExpected" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_PurchaseMoneyLoan" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_AgreementDate" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_RealizedClaimRecoveries" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_NumberOfWarrantsIssued" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_NumberOfWarrantsIssuedAndExercisable" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_NumberOfSharesExercisable" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_LineOfCreditFacilityDescription" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_AssignorConsistingNumberOfMedicareMembers" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ProceedsFromLongTermLinesOfCredit" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationPeriod" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PmpiMember" xlink:label="mspr_PmpiMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfHoldingInvestments" xlink:label="mspr_NumberOfHoldingInvestments"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MaoMember" xlink:label="mspr_MaoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MsoMember" xlink:label="mspr_MsoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfPreferredReturnForTheControlling" xlink:label="mspr_PercentageOfPreferredReturnForTheControlling"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfRecoveryClaimsForTheControlling" xlink:label="mspr_PercentageOfRecoveryClaimsForTheControlling"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfCostsAllocatedToNonControlling" xlink:label="mspr_PercentageOfCostsAllocatedToNonControlling"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="mspr_PmpiMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="mspr_NumberOfHoldingInvestments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="mspr_MaoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="mspr_MsoMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="mspr_PercentageOfPreferredReturnForTheControlling" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="mspr_PercentageOfRecoveryClaimsForTheControlling" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="mspr_PercentageOfCostsAllocatedToNonControlling" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvesteeMember" xlink:label="us-gaap_EquityMethodInvesteeMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:label="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable" xlink:label="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_EquityMethodInvesteeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:to="us-gaap_Revenues" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable" xlink:to="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:to="us-gaap_ProfitLoss" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:to="us-gaap_Assets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:to="us-gaap_Liabilities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OfficeAndComputerEquipmentMember" xlink:label="mspr_OfficeAndComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OtherSoftwareMember" xlink:label="mspr_OtherSoftwareMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mspr_OfficeAndComputerEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mspr_OtherSoftwareMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_DepreciationAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IntangibleAssetsNetTable" xlink:label="mspr_IntangibleAssetsNetTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IntangibleAssetsNetLineItems" xlink:label="mspr_IntangibleAssetsNetLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryRightsMember" xlink:label="mspr_ClaimsCostRecoveryRightsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SeriesMrcsLlcMember" xlink:label="mspr_SeriesMrcsLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AdditionalFiniteLivedIntangibleAssetsAcquired" xlink:label="mspr_AdditionalFiniteLivedIntangibleAssetsAcquired"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelTransactionsMember" xlink:label="mspr_HazelTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries" xlink:label="mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries" xlink:label="mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseDecreaseInImpairmentCharges" xlink:label="mspr_IncreaseDecreaseInImpairmentCharges"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_GoodwillMeasurementInputIncreaseDecrease" xlink:label="mspr_GoodwillMeasurementInputIncreaseDecrease"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_IntangibleAssetsNetTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="mspr_ClaimsCostRecoveryRightsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_SeriesMrcsLlcMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="mspr_IntangibleAssetsNetTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_IntangibleAssetsNetTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="mspr_AdditionalFiniteLivedIntangibleAssetsAcquired" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_HazelTransactionsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_IntangibleAssetsNetTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_IntangibleAssetsNetTable" xlink:to="mspr_IntangibleAssetsNetLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="mspr_IncreaseDecreaseInImpairmentCharges" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="mspr_GoodwillMeasurementInputIncreaseDecrease" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryRightsMember" xlink:label="mspr_ClaimsCostRecoveryRightsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="mspr_ClaimsCostRecoveryRightsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryRightsMember" xlink:label="mspr_ClaimsCostRecoveryRightsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:label="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable" xlink:label="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="mspr_ClaimsCostRecoveryRightsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable" xlink:to="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryRightsMember" xlink:label="mspr_ClaimsCostRecoveryRightsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SaleOfIntangibleAssets" xlink:label="mspr_SaleOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_5"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="mspr_ClaimsCostRecoveryRightsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FinitelivedIntangibleAssetsAcquired1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="mspr_SaleOfIntangibleAssets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_OperatingLossCarryforwardsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_IncomeTaxExaminationDescription" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OpenTaxYear" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsWarrantLiabilityPercent" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsWarrantLiabilityPercent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="mspr_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsWarrantLiabilityPercent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc" xlink:label="mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses" xlink:label="mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DeferredTaxAssetsTransactionCosts" xlink:label="mspr_DeferredTaxAssetsTransactionCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetInterestCarryforward" xlink:label="us-gaap_DeferredTaxAssetInterestCarryforward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="mspr_DeferredTaxAssetsTransactionCosts" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetInterestCarryforward" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VariableInterestEntityDisclosureAbstract" xlink:label="mspr_VariableInterestEntityDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="us-gaap_VariableInterestEntityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries" xlink:label="mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_VariableInterestEntityDisclosureAbstract" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_Assets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_Liabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_VariableInterestEntityLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_EquityMethodInvestments" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FinancingObligationsAndNotesPayableAgreementsMember" xlink:label="mspr_FinancingObligationsAndNotesPayableAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_YaIiPnLtdMember" xlink:label="mspr_YaIiPnLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MinimumRequiredPaymentMember" xlink:label="mspr_MinimumRequiredPaymentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelPartnersHoldingsLlcLetterAgreementMember" xlink:label="mspr_HazelPartnersHoldingsLlcLetterAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtWeightedAverageInterestRate" xlink:label="us-gaap_DebtWeightedAverageInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_FinancingObligationsAndNotesPayableAgreementsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_YaIiPnLtdMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_MinimumRequiredPaymentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_HazelPartnersHoldingsLlcLetterAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtWeightedAverageInterestRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="srt_CounterpartyNameAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_BrickellKeyInvestmentAmendmentMember" xlink:label="mspr_BrickellKeyInvestmentAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationAndNotesPayableMember" xlink:label="mspr_ClaimsFinancingObligationAndNotesPayableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsProceedsInvestmentAgreementMember" xlink:label="mspr_ClaimsProceedsInvestmentAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfSharesObtainedThroughWarrant" xlink:label="mspr_PercentageOfSharesObtainedThroughWarrant"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SharesPledgedUnderAgreement" xlink:label="mspr_SharesPledgedUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PriceOfCommonStock" xlink:label="mspr_PriceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_BrickellKeyInvestmentAmendmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="mspr_ClaimsFinancingObligationAndNotesPayableMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_ClaimsProceedsInvestmentAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfSharesObtainedThroughWarrant" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_SharesPledgedUnderAgreement" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_SharePrice" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PriceOfCommonStock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AmendedAndRestatedCreditAgreementMember" xlink:label="mspr_AmendedAndRestatedCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TermLoanAMember" xlink:label="mspr_TermLoanAMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelPartnersHoldingsLlcLetterAgreementMember" xlink:label="mspr_HazelPartnersHoldingsLlcLetterAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelTransactionsMember" xlink:label="mspr_HazelTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CreditAgreementMember" xlink:label="mspr_CreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TermLoanBMember" xlink:label="mspr_TermLoanBMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" xlink:label="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WorkingCapitalCreditFacilityMember" xlink:label="mspr_WorkingCapitalCreditFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseMoneyLoanMember" xlink:label="mspr_PurchaseMoneyLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims" xlink:label="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember" xlink:label="mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WorkingCapitalCreditAgreementMember" xlink:label="mspr_WorkingCapitalCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseInProceedsFromLongTermLinesOfCredit" xlink:label="mspr_IncreaseInProceedsFromLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:label="us-gaap_LineOfCreditFacilityExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:label="us-gaap_LineOfCreditFacilityDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseMoneyLoan" xlink:label="mspr_PurchaseMoneyLoan"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RealizedClaimRecoveries" xlink:label="mspr_RealizedClaimRecoveries"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AgreementDate" xlink:label="mspr_AgreementDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentOriginalIssueDiscount" xlink:label="mspr_DebtInstrumentOriginalIssueDiscount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AssignorConsistingNumberOfMedicareMembers" xlink:label="mspr_AssignorConsistingNumberOfMedicareMembers"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InterestPeriodPlusAnApplicableMargin" xlink:label="mspr_InterestPeriodPlusAnApplicableMargin"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseMoneyLoanAccruesInterest" xlink:label="mspr_PurchaseMoneyLoanAccruesInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentExtendedMaturityYear" xlink:label="mspr_DebtInstrumentExtendedMaturityYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCollateralAmount" xlink:label="us-gaap_DebtInstrumentCollateralAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentOfCertainCostsAndFees" xlink:label="mspr_PaymentOfCertainCostsAndFees"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="mspr_AmendedAndRestatedCreditAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_TermLoanAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_HazelPartnersHoldingsLlcLetterAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_HazelTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="mspr_CreditAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_TermLoanBMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="mspr_WorkingCapitalCreditFacilityMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_PurchaseMoneyLoanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_WorkingCapitalCreditAgreementMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_ProceedsFromLongTermLinesOfCredit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="srt_CounterpartyNameAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_IncreaseInProceedsFromLongTermLinesOfCredit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_CreditFacilityAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationPeriod" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityDescription" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PurchaseMoneyLoan" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_RealizedClaimRecoveries" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_AgreementDate" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_DebtInstrumentOriginalIssueDiscount" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_AssignorConsistingNumberOfMedicareMembers" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_InterestPeriodPlusAnApplicableMargin" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PurchaseMoneyLoanAccruesInterest" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_DebtInstrumentExtendedMaturityYear" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentCollateralAmount" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PaymentOfCertainCostsAndFees" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember" xlink:label="us-gaap_ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_StandbyEquityPurchaseAgreementMember" xlink:label="mspr_StandbyEquityPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NomuraPromissoryNoteMember" xlink:label="mspr_NomuraPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_YaIiPnLtdMember" xlink:label="mspr_YaIiPnLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AggregateAmountOutstandingUnderCashProceeds" xlink:label="mspr_AggregateAmountOutstandingUnderCashProceeds"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfCashProceedsFromSaleOfStock" xlink:label="mspr_PercentageOfCashProceedsFromSaleOfStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentsExtendedMaturityDate" xlink:label="mspr_DebtInstrumentsExtendedMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes" xlink:label="mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfAggregateProceedsToPayOutstandingAmount" xlink:label="mspr_PercentageOfAggregateProceedsToPayOutstandingAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ForegoPayments" xlink:label="mspr_ForegoPayments"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_ConvertibleDebtMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_StandbyEquityPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mspr_NomuraPromissoryNoteMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_YaIiPnLtdMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="srt_CounterpartyNameAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_AggregateAmountOutstandingUnderCashProceeds" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfCashProceedsFromSaleOfStock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_DebtInstrumentsExtendedMaturityDate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfAggregateProceedsToPayOutstandingAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_ForegoPayments" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember" xlink:label="us-gaap_ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommonStockPurchaseAgreementMember" xlink:label="mspr_CommonStockPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CantorFitzgeraldMember" xlink:label="mspr_CantorFitzgeraldMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OptionToSellMaximumSharesValueUnderPurchaseAgreement" xlink:label="mspr_OptionToSellMaximumSharesValueUnderPurchaseAgreement"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_StandbyEquityPurchaseAgreementMember" xlink:label="mspr_StandbyEquityPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_YaIiPnLtdMember" xlink:label="mspr_YaIiPnLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfStockPurchasePrice" xlink:label="mspr_PercentageOfStockPurchasePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice" xlink:label="mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NomuraPromissoryNoteMember" xlink:label="mspr_NomuraPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfMinimumFixedPriceEqualingOfVwap" xlink:label="mspr_PercentageOfMinimumFixedPriceEqualingOfVwap"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfVwapOfSharesDuringPriorDate" xlink:label="mspr_PercentageOfVwapOfSharesDuringPriorDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AggregateAmountOutstandingUnderCashProceeds" xlink:label="mspr_AggregateAmountOutstandingUnderCashProceeds"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion" xlink:label="mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfMinimumVariablePriceEqualingOfVwap" xlink:label="mspr_PercentageOfMinimumVariablePriceEqualingOfVwap"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MinimumVariablePricePerShare" xlink:label="mspr_MinimumVariablePricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentFloorPriceTrigger" xlink:label="mspr_DebtInstrumentFloorPriceTrigger"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FixedPricePerShare" xlink:label="mspr_FixedPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance" xlink:label="mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfAggregateProceedsToPayOutstandingAmount" xlink:label="mspr_PercentageOfAggregateProceedsToPayOutstandingAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes" xlink:label="mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfProceedsFromRepaymentOfDebt" xlink:label="mspr_PercentageOfProceedsFromRepaymentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares" xlink:label="mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest" xlink:label="mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock" xlink:label="mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations" xlink:label="mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReductionInDebtPrincipalOwing" xlink:label="mspr_ReductionInDebtPrincipalOwing"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReductionInInterestAmount" xlink:label="mspr_ReductionInInterestAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentToFundOperations" xlink:label="mspr_PaymentToFundOperations"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote" xlink:label="mspr_PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentToReduceAmountsOwedUnderNomuraNote" xlink:label="mspr_PaymentToReduceAmountsOwedUnderNomuraNote"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_ConvertibleDebtMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_CommonStockPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_CantorFitzgeraldMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_VrmMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_OptionToSellMaximumSharesValueUnderPurchaseAgreement" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_StandbyEquityPurchaseAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_YaIiPnLtdMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfStockPurchasePrice" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_DebtInstrumentAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="srt_RangeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mspr_NomuraPromissoryNoteMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfMinimumFixedPriceEqualingOfVwap" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfVwapOfSharesDuringPriorDate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_AggregateAmountOutstandingUnderCashProceeds" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="srt_CounterpartyNameAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfMinimumVariablePriceEqualingOfVwap" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_MinimumVariablePricePerShare" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_DebtInstrumentFloorPriceTrigger" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_FixedPricePerShare" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfAggregateProceedsToPayOutstandingAmount" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfProceedsFromRepaymentOfDebt" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPayment" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_ReductionInDebtPrincipalOwing" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_ReductionInInterestAmount" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PaymentToFundOperations" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PaymentToReduceAmountsOwedUnderNomuraNote" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfTenWarrantMember" xlink:label="mspr_NumberOfTenWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NewClassOfWarrantOrRightOutstanding" xlink:label="mspr_NewClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CpiaWarrantMember" xlink:label="mspr_CpiaWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfTwoWarrantMember" xlink:label="mspr_NumberOfTwoWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod" xlink:label="mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VirageRecoveryParticipationLpMember" xlink:label="mspr_VirageRecoveryParticipationLpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="mspr_NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_VrmMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="mspr_NumberOfTenWarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="mspr_NewClassOfWarrantOrRightOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_CpiaWarrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="mspr_NumberOfTwoWarrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_VirageRecoveryParticipationLpMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="mspr_NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilitySummaryOfActivityOfSharesUnderlyingWarrantsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:label="mspr_ClassOfWarrantOrRightIssuedDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantConvertedDuringPeriod" xlink:label="mspr_ClassOfWarrantConvertedDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantOrRightCancellationDuringPeriod" xlink:label="mspr_ClassOfWarrantOrRightCancellationDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_4"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantsOrRightIssuedExercisePrice" xlink:label="mspr_ClassOfWarrantsOrRightIssuedExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantsOrRightConvertedExercisePrice" xlink:label="mspr_ClassOfWarrantsOrRightConvertedExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="mspr_ClassOfWarrantOrRightIssuedDuringPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="mspr_ClassOfWarrantConvertedDuringPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="mspr_ClassOfWarrantOrRightCancellationDuringPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="mspr_ClassOfWarrantsOrRightIssuedExercisePrice" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="mspr_ClassOfWarrantsOrRightConvertedExercisePrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestLineItems" xlink:label="us-gaap_MinorityInterestLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_UpCUnitHoldersMember" xlink:label="mspr_UpCUnitHoldersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestTable" xlink:label="us-gaap_MinorityInterestTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommonClassVMember" xlink:label="mspr_CommonClassVMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipDomain" xlink:to="mspr_UpCUnitHoldersMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MinorityInterestTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_MinorityInterestTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_CommonClassVMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MinorityInterestTable" xlink:to="srt_OwnershipAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MinorityInterestTable" xlink:to="us-gaap_MinorityInterestLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestLineItems" xlink:label="us-gaap_MinorityInterestLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers" xlink:label="mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SubsidiaryAxis" xlink:label="mspr_SubsidiaryAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SubsidiaryDomain" xlink:label="mspr_SubsidiaryDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MSPRecoveryLLCMember" xlink:label="mspr_MSPRecoveryLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestTable" xlink:label="us-gaap_MinorityInterestTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MaomsoRecoveryLlcSeriesFhcpMember" xlink:label="mspr_MaomsoRecoveryLlcSeriesFhcpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EntitledClaimsRecoverPercentageByNonControllingMembers" xlink:label="mspr_EntitledClaimsRecoverPercentageByNonControllingMembers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_UpCUnitHoldersMember" xlink:label="mspr_UpCUnitHoldersMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfNonControllingMemberAllocatedCost" xlink:label="mspr_PercentageOfNonControllingMemberAllocatedCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommonUnitExchangeValue" xlink:label="mspr_CommonUnitExchangeValue"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_SubsidiaryAxis" xlink:to="mspr_SubsidiaryDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipDomain" xlink:to="mspr_MSPRecoveryLLCMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MinorityInterestTable" xlink:to="mspr_SubsidiaryAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_SubsidiaryDomain" xlink:to="mspr_MaomsoRecoveryLlcSeriesFhcpMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_MinorityInterestTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="mspr_EntitledClaimsRecoverPercentageByNonControllingMembers" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MinorityInterestTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_SubsidiaryDomain" xlink:to="mspr_UpCUnitHoldersMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="mspr_PercentageOfNonControllingMemberAllocatedCost" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MinorityInterestTable" xlink:to="srt_OwnershipAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="us-gaap_MinorityInterest" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MinorityInterestTable" xlink:to="us-gaap_MinorityInterestLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="mspr_CommonUnitExchangeValue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember" xlink:label="mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CanoHealthLlcMember" xlink:label="mspr_CanoHealthLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:label="us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:label="us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember" xlink:label="mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_CanoHealthLlcMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LossContingenciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:to="us-gaap_DeferredCompensationShareBasedPaymentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:to="us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="srt_CounterpartyNameAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FinancialLiabilitiesFairValueWarrants" xlink:label="mspr_FinancialLiabilitiesFairValueWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DerivativeLiabilities" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="mspr_FinancialLiabilitiesFairValueWarrants" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmbeddedDerivativeLiabilityMeasurementInput" xlink:label="us-gaap_EmbeddedDerivativeLiabilityMeasurementInput"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EmbeddedDerivativeLiabilityMeasurementTerm" xlink:label="mspr_EmbeddedDerivativeLiabilityMeasurementTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm" xlink:label="mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_EmbeddedDerivativeLiabilityMeasurementInput" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputSharePriceMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="mspr_EmbeddedDerivativeLiabilityMeasurementTerm" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_UnsecuredPromissoryNotesMember" xlink:label="mspr_UnsecuredPromissoryNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VirageAmendmentMember" xlink:label="mspr_VirageAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="us-gaap_AssetAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="us-gaap_AssetAcquisitionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ExistingLegalServicesAgreementsMember" xlink:label="mspr_ExistingLegalServicesAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MspPrincipalsMember" xlink:label="mspr_MspPrincipalsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AffiliatePayableMember" xlink:label="mspr_AffiliatePayableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WorkingCapitalCreditFacilityCollateralMember" xlink:label="mspr_WorkingCapitalCreditFacilityCollateralMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReservedSharesMember" xlink:label="mspr_ReservedSharesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InitialVirageWarrantMember" xlink:label="mspr_InitialVirageWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ProfessionalFeesLegalMember" xlink:label="mspr_ProfessionalFeesLegalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_BrickellKeyInvestmentAmendmentMember" xlink:label="mspr_BrickellKeyInvestmentAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentPaymentInKindAnnualInterestRate" xlink:label="mspr_DebtInstrumentPaymentInKindAnnualInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AdditionalReceivablesFromOtherAffiliatesMember" xlink:label="mspr_AdditionalReceivablesFromOtherAffiliatesMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MspRecoveryLawFirmMember" xlink:label="mspr_MspRecoveryLawFirmMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AffiliateReceivableMember" xlink:label="mspr_AffiliateReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CostOfClaimsRecoveriesMember" xlink:label="mspr_CostOfClaimsRecoveriesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FundsHeldForOtherEntitiesMember" xlink:label="mspr_FundsHeldForOtherEntitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MspRecoveryAviationLlcMember" xlink:label="mspr_MspRecoveryAviationLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationAndNotesPayableMember" xlink:label="mspr_ClaimsFinancingObligationAndNotesPayableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentOfCertainCostsAndFees" xlink:label="mspr_PaymentOfCertainCostsAndFees"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember" xlink:label="mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SeriesMrcsLlcMember" xlink:label="mspr_SeriesMrcsLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ServiceFeesMember" xlink:label="mspr_ServiceFeesMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PartialRepaymentOfDebt" xlink:label="mspr_PartialRepaymentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAffiliatesMember" xlink:label="us-gaap_OtherAffiliatesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OperatingCostsAndExpenses1" xlink:label="mspr_OperatingCostsAndExpenses1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AdvancePaymentIncurredForExpenses" xlink:label="mspr_AdvancePaymentIncurredForExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SharesPledgedUnderAgreement" xlink:label="mspr_SharesPledgedUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AnnualCompoundedReturnOnContributionPercentage" xlink:label="mspr_AnnualCompoundedReturnOnContributionPercentage"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mspr_UnsecuredPromissoryNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_VirageAmendmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mspr_ExistingLegalServicesAgreementsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_MspPrincipalsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="mspr_AffiliatePayableMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_WorkingCapitalCreditFacilityCollateralMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mspr_ReservedSharesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="mspr_InitialVirageWarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="mspr_ProfessionalFeesLegalMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_BrickellKeyInvestmentAmendmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mspr_DebtInstrumentPaymentInKindAnnualInterestRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mspr_AdditionalReceivablesFromOtherAffiliatesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_MspRecoveryLawFirmMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="mspr_AffiliateReceivableMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="mspr_CostOfClaimsRecoveriesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_InterestExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mspr_FundsHeldForOtherEntitiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_MspRecoveryAviationLlcMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="mspr_ClaimsFinancingObligationAndNotesPayableMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mspr_PaymentOfCertainCostsAndFees" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_CreditFacilityAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_SeriesMrcsLlcMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentTerm" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mspr_ServiceFeesMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_VrmMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mspr_PartialRepaymentOfDebt" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_OtherAffiliatesMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProceedsFromNotesPayable" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mspr_OperatingCostsAndExpenses1" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OperatingCostsAndExpenses" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_AssetAcquisitionAxis" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mspr_AdvancePaymentIncurredForExpenses" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_LongTermNotesPayable" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mspr_SharesPledgedUnderAgreement" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mspr_AnnualCompoundedReturnOnContributionPercentage" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable" xlink:label="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeMember" xlink:label="us-gaap_OtherIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" xlink:label="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfEquitySharesAcquiredToCoverTheShortPosition" xlink:label="mspr_NumberOfEquitySharesAcquiredToCoverTheShortPosition"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ValueOfSharesToCoverShortPosition" xlink:label="mspr_ValueOfSharesToCoverShortPosition"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RealizedLossOnInvestmentsToCoverShortPosition" xlink:label="mspr_RealizedLossOnInvestmentsToCoverShortPosition"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:label="us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_OtherIncomeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" xlink:to="mspr_NumberOfEquitySharesAcquiredToCoverTheShortPosition" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable" xlink:to="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" xlink:to="mspr_ValueOfSharesToCoverShortPosition" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" xlink:to="mspr_RealizedLossOnInvestmentsToCoverShortPosition" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription" xlink:label="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfOperatingSegments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfReportableSegments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TotalClaimsRecovery" xlink:label="mspr_TotalClaimsRecovery"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:label="us-gaap_SegmentReportingInformationProfitLossAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsAmortizationExpense" xlink:label="mspr_ClaimsAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SignificantExpenses" xlink:label="mspr_SignificantExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount" xlink:label="us-gaap_SegmentReportingOtherItemAmount"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="mspr_TotalClaimsRecovery" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="mspr_ClaimsAmortizationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_TotalClaimsRecovery" xlink:to="us-gaap_SegmentReportingInformationProfitLossAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="us-gaap_ProfessionalFees" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="us-gaap_LegalFees" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="us-gaap_InterestExpense" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="mspr_SignificantExpenses" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="us-gaap_ProfitLoss" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="us-gaap_SegmentReportingOtherItemAmount" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EarningsPerSharesBasicAndDilutedAbstract" xlink:label="mspr_EarningsPerSharesBasicAndDilutedAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_EarningsPerSharesBasicAndDilutedAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_EarningsPerSharesBasicAndDilutedAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_EarningsPerSharesBasicAndDilutedAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_EarningsPerSharesBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="mspr_EarningsPerSharesBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PublicWarrantsOutstandingMember" xlink:label="mspr_PublicWarrantsOutstandingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassVCommonStockMember" xlink:label="mspr_ClassVCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CpiaWarrantMember" xlink:label="mspr_CpiaWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WarrantsIssuedToVirageMember" xlink:label="mspr_WarrantsIssuedToVirageMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IssuanceOfSharesPurchaseTerm" xlink:label="mspr_IssuanceOfSharesPurchaseTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mspr_PublicWarrantsOutstandingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_ClassVCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_VrmMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mspr_CpiaWarrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mspr_WarrantsIssuedToVirageMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="mspr_IssuanceOfSharesPurchaseTerm" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="us-gaap_DerivativeLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ForcedExpiratoryFlowSharesMember" xlink:label="mspr_ForcedExpiratoryFlowSharesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AggregateNumberOfSharesTransferredToEscrowAccount" xlink:label="mspr_AggregateNumberOfSharesTransferredToEscrowAccount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeLiabilitiesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_ForcedExpiratoryFlowSharesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="mspr_AggregateNumberOfSharesTransferredToEscrowAccount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_RestrictedCashCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_DerivativeInstrumentsGainLossLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VirageTermSheetMember" xlink:label="mspr_VirageTermSheetMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity" xlink:label="mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LegalAccountingAndAdministrativeExpenseMember" xlink:label="mspr_LegalAccountingAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NomuraPromissoryNoteMember" xlink:label="mspr_NomuraPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain" xlink:label="us-gaap_RestructuringPlanDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RestructuringPlanMember" xlink:label="mspr_RestructuringPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredOvernightFinancingRateSofrMember" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MspPrincipalsMember" xlink:label="mspr_MspPrincipalsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OperationalCollectionFloorFacilityMember" xlink:label="mspr_OperationalCollectionFloorFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_YaIiPnLtdMember" xlink:label="mspr_YaIiPnLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanAxis" xlink:label="us-gaap_RestructuringPlanAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TermSheetMember" xlink:label="mspr_TermSheetMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelTransactionsMember" xlink:label="mspr_HazelTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitment" xlink:label="us-gaap_OtherCommitment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LicenseFeePercentage" xlink:label="mspr_LicenseFeePercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MinimumFeePaid" xlink:label="mspr_MinimumFeePaid"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FundedForAdditionalClaims" xlink:label="mspr_FundedForAdditionalClaims"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LoansRepaymentPercentage" xlink:label="mspr_LoansRepaymentPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AmountsReceivedToToTheMasterTransactionAgreement" xlink:label="mspr_AmountsReceivedToToTheMasterTransactionAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFundedInTranchesPerMonth" xlink:label="mspr_LineOfCreditFundedInTranchesPerMonth"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AccruedInterestPercentageInYearOne" xlink:label="mspr_AccruedInterestPercentageInYearOne"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AccruedInterestPercentageAfterOneYear" xlink:label="mspr_AccruedInterestPercentageAfterOneYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration" xlink:label="us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RecoveryRightsInterestExcessCashFlowPercentage" xlink:label="mspr_RecoveryRightsInterestExcessCashFlowPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RecoveryRightsInterest" xlink:label="mspr_RecoveryRightsInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BridgeLoan" xlink:label="us-gaap_BridgeLoan"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AdditionalBridgeLoan" xlink:label="mspr_AdditionalBridgeLoan"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AnnualCostsAfterCurrentlyPlannedCostReductions" xlink:label="mspr_AnnualCostsAfterCurrentlyPlannedCostReductions"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OperationalFunding" xlink:label="mspr_OperationalFunding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient" xlink:label="mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfWarrantsIssued" xlink:label="mspr_NumberOfWarrantsIssued"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid" xlink:label="mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_Non-RecourseDebtSecondLienAmount" xlink:label="mspr_Non-RecourseDebtSecondLienAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfProceedsFromGrantLien" xlink:label="mspr_PercentageOfProceedsFromGrantLien"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage" xlink:label="mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock" xlink:label="mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantOrRightOutstandingVotingPercentage" xlink:label="mspr_ClassOfWarrantOrRightOutstandingVotingPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentRate" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FloorPriceOfACommonStock" xlink:label="mspr_FloorPriceOfACommonStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfConsecutiveTradingDays" xlink:label="mspr_NumberOfConsecutiveTradingDays"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfCashProceedsFromSaleOfStock" xlink:label="mspr_PercentageOfCashProceedsFromSaleOfStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfPledge" xlink:label="mspr_PercentageOfPledge"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentsExtendedMaturityDate" xlink:label="mspr_DebtInstrumentsExtendedMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ProceedsFromSaleOfStockMonthlyPaymentAmount" xlink:label="mspr_ProceedsFromSaleOfStockMonthlyPaymentAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AggregateAmountOutstandingUnderCashProceeds" xlink:label="mspr_AggregateAmountOutstandingUnderCashProceeds"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="mspr_VirageTermSheetMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="mspr_LegalAccountingAndAdministrativeExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mspr_NomuraPromissoryNoteMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringPlanDomain" xlink:to="mspr_RestructuringPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_SecuredOvernightFinancingRateSofrMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_MspPrincipalsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_OperationalCollectionFloorFacilityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_YaIiPnLtdMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_VrmMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringPlanAxis" xlink:to="us-gaap_RestructuringPlanDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromLongTermLinesOfCredit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="mspr_TermSheetMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_HazelTransactionsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_CounterpartyNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_OtherCommitment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_DebtInstrumentAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_LicenseFeePercentage" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_StatementScenarioAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_MinimumFeePaid" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_RestructuringPlanAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_FundedForAdditionalClaims" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_LoansRepaymentPercentage" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_VariableRateAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_AmountsReceivedToToTheMasterTransactionAgreement" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_CreditFacilityAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_LineOfCreditFundedInTranchesPerMonth" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_AccruedInterestPercentageInYearOne" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_AccruedInterestPercentageAfterOneYear" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_RecoveryRightsInterestExcessCashFlowPercentage" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_RecoveryRightsInterest" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_BridgeLoan" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_AdditionalBridgeLoan" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_AnnualCostsAfterCurrentlyPlannedCostReductions" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_OperationalFunding" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_NumberOfWarrantsIssued" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_Non-RecourseDebtSecondLienAmount" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_PercentageOfProceedsFromGrantLien" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_ClassOfWarrantOrRightOutstandingVotingPercentage" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_FloorPriceOfACommonStock" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_NumberOfConsecutiveTradingDays" order="37" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="38" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_PercentageOfCashProceedsFromSaleOfStock" order="39" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_PercentageOfPledge" order="40" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_DebtInstrumentsExtendedMaturityDate" order="41" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="42" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_ProceedsFromSaleOfStockMonthlyPaymentAmount" order="43" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_AggregateAmountOutstandingUnderCashProceeds" order="44" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsLineItems" xlink:label="dei_EntityListingsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsTable" xlink:label="dei_EntityListingsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassVCommonStockMember" xlink:label="mspr_ClassVCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember" xlink:label="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember" xlink:label="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember" xlink:label="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember" xlink:label="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityListingsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentType" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_EntityListingsTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentAnnualReport" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_ClassVCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentTransitionReport" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentPeriodEndDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityFileNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityRegistrantName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityTaxIdentificationNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityAddressStateOrProvince" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityAddressCityOrTown" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityAddressPostalZipCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_CityAreaCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_LocalPhoneNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityAddressAddressLine1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityAddressAddressLine2" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityCurrentReportingStatus" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityInteractiveDataCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityVoluntaryFilers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityFilerCategory" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntitySmallBusiness" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityEmergingGrowthCompany" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityExTransitionPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityShellCompany" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityCentralIndexKey" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_CurrentFiscalYearEndDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentFiscalYearFocus" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_AmendmentFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_Security12bTitle" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_TradingSymbol" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="32" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_SecurityExchangeName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="33" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="34" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="35" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_EntityPublicFloat" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="36" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="37" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_AuditorFirmId" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="38" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_AuditorName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="39" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_AuditorLocation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="40" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityListingsLineItems" xlink:to="dei_AuditorOpinionTextBlock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommonClassVMember" xlink:label="mspr_CommonClassVMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AffiliatePayable" xlink:label="mspr_AffiliatePayable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_GuarantyObligationNoncurrent" xlink:label="mspr_GuarantyObligationNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AffiliateReceivable" xlink:label="mspr_AffiliateReceivable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommissionPayable" xlink:label="mspr_CommissionPayable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationNotesPayable" xlink:label="mspr_ClaimsFinancingObligationNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="us-gaap_DerivativeLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WarrantLiabilityCurrent" xlink:label="mspr_WarrantLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LoanFromRelatedPartiesNonCurrent" xlink:label="mspr_LoanFromRelatedPartiesNonCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_GuarantyObligationCurrent" xlink:label="mspr_GuarantyObligationCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InterestPayableNoncurrent" xlink:label="mspr_InterestPayableNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationNotesPayableCurrent" xlink:label="mspr_ClaimsFinancingObligationNotesPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Cash" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_CommonClassVMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="mspr_AffiliatePayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="mspr_GuarantyObligationNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="mspr_AffiliateReceivable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="mspr_CommissionPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="mspr_ClaimsFinancingObligationNotesPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DerivativeLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="mspr_WarrantLiabilityCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="mspr_LoanFromRelatedPartiesNonCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_MinorityInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="mspr_GuarantyObligationCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="mspr_InterestPayableNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="mspr_ClaimsFinancingObligationNotesPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_InterestPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommonClassVMember" xlink:label="mspr_CommonClassVMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_CommonClassVMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsRecoveryIncome" xlink:label="mspr_ClaimsRecoveryIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CostOfClaimRecoveries" xlink:label="mspr_CostOfClaimRecoveries"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsRecoveryServiceIncome" xlink:label="mspr_ClaimsRecoveryServiceIncome"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsAmortizationExpense" xlink:label="mspr_ClaimsAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OtherClaimsRecoveryRevenues" xlink:label="mspr_OtherClaimsRecoveryRevenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TotalClaimsRecovery" xlink:label="mspr_TotalClaimsRecovery"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AllowanceForCreditLosses" xlink:label="mspr_AllowanceForCreditLosses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities" xlink:label="mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_ClaimsRecoveryIncome" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="mspr_CostOfClaimRecoveries" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_ClaimsRecoveryServiceIncome" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="mspr_ClaimsAmortizationExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_OtherClaimsRecoveryRevenues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_TotalClaimsRecovery" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ProfessionalFees" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_LegalFees" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="mspr_AllowanceForCreditLosses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsRecoveryServiceIncome" xlink:label="mspr_ClaimsRecoveryServiceIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MspRecoveryLawFirmMember" xlink:label="mspr_MspRecoveryLawFirmMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ProfessionalFeesLegalMember" xlink:label="mspr_ProfessionalFeesLegalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RelatedPartyLegalExpense" xlink:label="mspr_RelatedPartyLegalExpense"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_ClaimsRecoveryServiceIncome" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_VrmMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingCostsAndExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_MspRecoveryLawFirmMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="mspr_ProfessionalFeesLegalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_RelatedPartyLegalExpense" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassVCommonStockMember" xlink:label="mspr_ClassVCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_StockIssuedDuringPeriodValueConversionOfWarrants" xlink:label="mspr_StockIssuedDuringPeriodValueConversionOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ParentMember" xlink:label="us-gaap_ParentMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_StockIssuedDuringPeriodSharesConversionOfWarrants" xlink:label="mspr_StockIssuedDuringPeriodSharesConversionOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_ClassVCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_StockIssuedDuringPeriodValueConversionOfWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_ParentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_StockIssuedDuringPeriodSharesConversionOfWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_NoncontrollingInterestMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryRightsMember" xlink:label="mspr_ClaimsCostRecoveryRightsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="mspr_ClaimsCostRecoveryRightsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NatureOfOperationsLineItems" xlink:label="mspr_NatureOfOperationsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NatureOfOperationsTable" xlink:label="mspr_NatureOfOperationsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassVCommonStockMember" xlink:label="mspr_ClassVCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis" xlink:label="mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain" xlink:label="mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain" xlink:label="mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NonEconomicVotingSharesMember" xlink:label="mspr_NonEconomicVotingSharesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MembershipInterestPurchaseAgreementMember" xlink:label="mspr_MembershipInterestPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TaxReceivableAgreementMember" xlink:label="mspr_TaxReceivableAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="us-gaap_BusinessAcquisitionSharePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantExercisePriceIncrease" xlink:label="us-gaap_WarrantExercisePriceIncrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DividendComprisingNumberOfNewWarrantsPayableHolders" xlink:label="mspr_DividendComprisingNumberOfNewWarrantsPayableHolders"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfPaySellersToAmountOfTaxBenefit" xlink:label="mspr_PercentageOfPaySellersToAmountOfTaxBenefit"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseInTaxReceivableAgreementLiability" xlink:label="mspr_IncreaseInTaxReceivableAgreementLiability"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders" xlink:label="mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_NatureOfOperationsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_ClassVCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis" xlink:to="mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis" xlink:to="mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain" xlink:to="mspr_NonEconomicVotingSharesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_MembershipInterestPurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_TaxReceivableAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_NatureOfOperationsTable" xlink:to="mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_WarrantExercisePriceIncrease" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_DividendComprisingNumberOfNewWarrantsPayableHolders" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_PercentageOfPaySellersToAmountOfTaxBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_IncreaseInTaxReceivableAgreementLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness2024ReverseStockSplitAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NatureOfOperationsLineItems" xlink:label="mspr_NatureOfOperationsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NatureOfOperationsTable" xlink:label="mspr_NatureOfOperationsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_NatureOfOperationsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NatureOfOperationsLineItems" xlink:label="mspr_NatureOfOperationsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NatureOfOperationsTable" xlink:label="mspr_NatureOfOperationsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember" xlink:label="us-gaap_ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_StandbyEquityPurchaseAgreementMember" xlink:label="mspr_StandbyEquityPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LegalAccountingAndAdministrativeExpenseMember" xlink:label="mspr_LegalAccountingAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AmendedAndRestatedNomuraPromissoryNoteMember" xlink:label="mspr_AmendedAndRestatedNomuraPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain" xlink:label="us-gaap_RestructuringPlanDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RestructuringPlanMember" xlink:label="mspr_RestructuringPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WorkingCapitalCreditAgreementMember" xlink:label="mspr_WorkingCapitalCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_YaIiPnLtdMember" xlink:label="mspr_YaIiPnLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanAxis" xlink:label="us-gaap_RestructuringPlanAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain" xlink:label="us-gaap_RestructuringPlanDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NomuraPromissoryNoteMember" xlink:label="mspr_NomuraPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OperationalCollectionFloorFacilityMember" xlink:label="mspr_OperationalCollectionFloorFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelPartnersHoldingsLlcLetterAgreementMember" xlink:label="mspr_HazelPartnersHoldingsLlcLetterAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:label="us-gaap_LineOfCreditFacilityExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfTranches" xlink:label="mspr_NumberOfTranches"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" xlink:label="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims" xlink:label="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitment" xlink:label="us-gaap_OtherCommitment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BridgeLoan" xlink:label="us-gaap_BridgeLoan"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AdditionalBridgeLoan" xlink:label="mspr_AdditionalBridgeLoan"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity" xlink:label="mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AggregateAmountOutstandingUnderCashProceeds" xlink:label="mspr_AggregateAmountOutstandingUnderCashProceeds"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfCashProceedsFromSaleOfStock" xlink:label="mspr_PercentageOfCashProceedsFromSaleOfStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfProceedsFromRepaymentOfDebt" xlink:label="mspr_PercentageOfProceedsFromRepaymentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentsExtendedMaturityDate" xlink:label="mspr_DebtInstrumentsExtendedMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_NatureOfOperationsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_ConvertibleDebtMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_StandbyEquityPurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="mspr_LegalAccountingAndAdministrativeExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mspr_AmendedAndRestatedNomuraPromissoryNoteMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringPlanDomain" xlink:to="mspr_RestructuringPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_VrmMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_WorkingCapitalCreditAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_YaIiPnLtdMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestructuringPlanAxis" xlink:to="us-gaap_RestructuringPlanDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RestructuringPlanAxis" xlink:to="us-gaap_RestructuringPlanDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_CreditFacilityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_Cash" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mspr_NomuraPromissoryNoteMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_OperationalCollectionFloorFacilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_HazelPartnersHoldingsLlcLetterAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_NatureOfOperationsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_NatureOfOperationsTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_RestructuringPlanAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_NatureOfOperationsTable" xlink:to="srt_StatementScenarioAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_NumberOfTranches" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_NatureOfOperationsTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_OtherCommitment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_BridgeLoan" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_AdditionalBridgeLoan" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_AggregateAmountOutstandingUnderCashProceeds" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_PercentageOfCashProceedsFromSaleOfStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_PercentageOfProceedsFromRepaymentOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="mspr_DebtInstrumentsExtendedMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_NatureOfOperationsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AccountingPoliciesLineItems" xlink:label="mspr_AccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AccountingPoliciesTable" xlink:label="mspr_AccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EquityMethodInvestmentInvesteeMember" xlink:label="mspr_EquityMethodInvestmentInvesteeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SpecificContractMember" xlink:label="mspr_SpecificContractMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryRightsMember" xlink:label="mspr_ClaimsCostRecoveryRightsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202307Member" xlink:label="us-gaap_AccountingStandardsUpdate202307Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_UpCUnitHoldersMember" xlink:label="mspr_UpCUnitHoldersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202309Member" xlink:label="us-gaap_AccountingStandardsUpdate202309Member"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassVShareholdersMember" xlink:label="mspr_ClassVShareholdersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription" xlink:label="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts" xlink:label="mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DevelopmentCostsCapitalizedUsefulLife" xlink:label="mspr_DevelopmentCostsCapitalizedUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsRecoveryServiceIncome" xlink:label="mspr_ClaimsRecoveryServiceIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="mspr_AccountingPoliciesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="mspr_EquityMethodInvestmentInvesteeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_SpecificContractMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="mspr_ClaimsCostRecoveryRightsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202307Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_OwnershipDomain" xlink:to="mspr_UpCUnitHoldersMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_AccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202309Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_OwnershipDomain" xlink:to="mspr_ClassVShareholdersMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_AccountingPoliciesTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_AccountingPoliciesTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfReportableSegments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_AccountingPoliciesTable" xlink:to="srt_OwnershipAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_AccountingPoliciesTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_AccountingPoliciesTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_AccountingPoliciesTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_AccountingPoliciesTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_AccountingPoliciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="mspr_DevelopmentCostsCapitalizedUsefulLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="mspr_ClaimsRecoveryServiceIncome" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_AccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OfficeAndComputerEquipmentMember" xlink:label="mspr_OfficeAndComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdsAndLeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mspr_OfficeAndComputerEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdsAndLeaseholdImprovementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionTable" xlink:label="us-gaap_AssetAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VirageAmendmentMember" xlink:label="mspr_VirageAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="us-gaap_AssetAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="us-gaap_AssetAcquisitionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="us-gaap_AssetAcquisitionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired" xlink:label="mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CreditAgreementMember" xlink:label="mspr_CreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseMoneyLoanMember" xlink:label="mspr_PurchaseMoneyLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_YaIiPnLtdMember" xlink:label="mspr_YaIiPnLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SeriesMrcsLlcMember" xlink:label="mspr_SeriesMrcsLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember" xlink:label="mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InitialVirageWarrantMember" xlink:label="mspr_InitialVirageWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_StandbyEquityPurchaseAgreementMember" xlink:label="mspr_StandbyEquityPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WorkingCapitalCreditAgreementMember" xlink:label="mspr_WorkingCapitalCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelPartnersHoldingsLlcLetterAgreementMember" xlink:label="mspr_HazelPartnersHoldingsLlcLetterAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMspRecoveryPartnersLlcMember" xlink:label="mspr_VrmMspRecoveryPartnersLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReservedSharesMember" xlink:label="mspr_ReservedSharesMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MonthlyVirageWarrantsMember" xlink:label="mspr_MonthlyVirageWarrantsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AnnualCompoundedReturnOnContributionPercentage" xlink:label="mspr_AnnualCompoundedReturnOnContributionPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TermLoanAMember" xlink:label="mspr_TermLoanAMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryAgreementsMember" xlink:label="mspr_ClaimsCostRecoveryAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DescriptionOfCashPaymentsMadeToCounterParty" xlink:label="mspr_DescriptionOfCashPaymentsMadeToCounterParty"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TermLoanBMember" xlink:label="mspr_TermLoanBMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelTransactionsMember" xlink:label="mspr_HazelTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WarrantPaymentDescription" xlink:label="mspr_WarrantPaymentDescription"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfProceedsFromRepaymentOfDebt" xlink:label="mspr_PercentageOfProceedsFromRepaymentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VRMFullPaymentDescription" xlink:label="mspr_VRMFullPaymentDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ValueOfFullReturn" xlink:label="mspr_ValueOfFullReturn"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MinimumCashAvailableForDistributionsPercentage" xlink:label="mspr_MinimumCashAvailableForDistributionsPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NetGainOfTheAsset" xlink:label="mspr_NetGainOfTheAsset"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims" xlink:label="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentOriginalIssueDiscount" xlink:label="mspr_DebtInstrumentOriginalIssueDiscount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfMedicareMembers" xlink:label="mspr_NumberOfMedicareMembers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionPriceOfAcquisitionExpected" xlink:label="us-gaap_AssetAcquisitionPriceOfAcquisitionExpected"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseMoneyLoan" xlink:label="mspr_PurchaseMoneyLoan"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AgreementDate" xlink:label="mspr_AgreementDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RealizedClaimRecoveries" xlink:label="mspr_RealizedClaimRecoveries"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts" xlink:label="us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfWarrantsIssued" xlink:label="mspr_NumberOfWarrantsIssued"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfWarrantsIssuedAndExercisable" xlink:label="mspr_NumberOfWarrantsIssuedAndExercisable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfSharesExercisable" xlink:label="mspr_NumberOfSharesExercisable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:label="us-gaap_LineOfCreditFacilityDescription"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" xlink:label="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AssignorConsistingNumberOfMedicareMembers" xlink:label="mspr_AssignorConsistingNumberOfMedicareMembers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:label="us-gaap_LineOfCreditFacilityExpirationPeriod"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_VirageAmendmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="mspr_CreditAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_PurchaseMoneyLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_YaIiPnLtdMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_SeriesMrcsLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="mspr_InitialVirageWarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_StandbyEquityPurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_WorkingCapitalCreditAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_HazelPartnersHoldingsLlcLetterAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_VrmMspRecoveryPartnersLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mspr_ReservedSharesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="mspr_MonthlyVirageWarrantsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_AnnualCompoundedReturnOnContributionPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_TermLoanAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_VrmMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mspr_ClaimsCostRecoveryAgreementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_DescriptionOfCashPaymentsMadeToCounterParty" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_TermLoanBMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_HazelTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_WarrantPaymentDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_PercentageOfProceedsFromRepaymentOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_AssetAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_VRMFullPaymentDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_CreditFacilityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_ValueOfFullReturn" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_MinimumCashAvailableForDistributionsPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_NetGainOfTheAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_DebtInstrumentOriginalIssueDiscount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_NumberOfMedicareMembers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionPriceOfAcquisitionExpected" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_PurchaseMoneyLoan" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_AgreementDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_RealizedClaimRecoveries" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_NumberOfWarrantsIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_NumberOfWarrantsIssuedAndExercisable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_NumberOfSharesExercisable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_LineOfCreditFacilityDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="mspr_AssignorConsistingNumberOfMedicareMembers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ProceedsFromLongTermLinesOfCredit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="32" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="33" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="34" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationPeriod" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PmpiMember" xlink:label="mspr_PmpiMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfHoldingInvestments" xlink:label="mspr_NumberOfHoldingInvestments"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MaoMember" xlink:label="mspr_MaoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MsoMember" xlink:label="mspr_MsoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfPreferredReturnForTheControlling" xlink:label="mspr_PercentageOfPreferredReturnForTheControlling"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfRecoveryClaimsForTheControlling" xlink:label="mspr_PercentageOfRecoveryClaimsForTheControlling"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfCostsAllocatedToNonControlling" xlink:label="mspr_PercentageOfCostsAllocatedToNonControlling"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="mspr_PmpiMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="mspr_NumberOfHoldingInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="mspr_MaoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="mspr_MsoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="mspr_PercentageOfPreferredReturnForTheControlling" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="mspr_PercentageOfRecoveryClaimsForTheControlling" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="mspr_PercentageOfCostsAllocatedToNonControlling" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:label="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable" xlink:label="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvesteeMember" xlink:label="us-gaap_EquityMethodInvesteeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:to="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_EquityMethodInvesteeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:to="us-gaap_Revenues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OfficeAndComputerEquipmentMember" xlink:label="mspr_OfficeAndComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OtherSoftwareMember" xlink:label="mspr_OtherSoftwareMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mspr_OfficeAndComputerEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="mspr_OtherSoftwareMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_DepreciationAndAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IntangibleAssetsNetLineItems" xlink:label="mspr_IntangibleAssetsNetLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IntangibleAssetsNetTable" xlink:label="mspr_IntangibleAssetsNetTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryRightsMember" xlink:label="mspr_ClaimsCostRecoveryRightsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SeriesMrcsLlcMember" xlink:label="mspr_SeriesMrcsLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AdditionalFiniteLivedIntangibleAssetsAcquired" xlink:label="mspr_AdditionalFiniteLivedIntangibleAssetsAcquired"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelTransactionsMember" xlink:label="mspr_HazelTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:label="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries" xlink:label="mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries" xlink:label="mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseDecreaseInImpairmentCharges" xlink:label="mspr_IncreaseDecreaseInImpairmentCharges"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_GoodwillMeasurementInputIncreaseDecrease" xlink:label="mspr_GoodwillMeasurementInputIncreaseDecrease"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="mspr_IntangibleAssetsNetTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_IntangibleAssetsNetTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="mspr_ClaimsCostRecoveryRightsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_SeriesMrcsLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_IntangibleAssetsNetTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="mspr_AdditionalFiniteLivedIntangibleAssetsAcquired" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_HazelTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_IntangibleAssetsNetTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="mspr_IncreaseDecreaseInImpairmentCharges" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_IntangibleAssetsNetLineItems" xlink:to="mspr_GoodwillMeasurementInputIncreaseDecrease" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryRightsMember" xlink:label="mspr_ClaimsCostRecoveryRightsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="mspr_ClaimsCostRecoveryRightsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:label="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable" xlink:label="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryRightsMember" xlink:label="mspr_ClaimsCostRecoveryRightsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="mspr_ClaimsCostRecoveryRightsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsCostRecoveryRightsMember" xlink:label="mspr_ClaimsCostRecoveryRightsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:label="us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SaleOfIntangibleAssets" xlink:label="mspr_SaleOfIntangibleAssets"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="mspr_ClaimsCostRecoveryRightsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FinitelivedIntangibleAssetsAcquired1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="mspr_SaleOfIntangibleAssets" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OpenTaxYear" xlink:label="us-gaap_OpenTaxYear"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_IncomeTaxExaminationDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OpenTaxYear" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="us-gaap_VariableInterestEntityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries" xlink:label="mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_EquityMethodInvestments" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FinancingObligationsAndNotesPayableAgreementsMember" xlink:label="mspr_FinancingObligationsAndNotesPayableAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_YaIiPnLtdMember" xlink:label="mspr_YaIiPnLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MinimumRequiredPaymentMember" xlink:label="mspr_MinimumRequiredPaymentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelPartnersHoldingsLlcLetterAgreementMember" xlink:label="mspr_HazelPartnersHoldingsLlcLetterAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtWeightedAverageInterestRate" xlink:label="us-gaap_DebtWeightedAverageInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_FinancingObligationsAndNotesPayableAgreementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_YaIiPnLtdMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_MinimumRequiredPaymentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_HazelPartnersHoldingsLlcLetterAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtWeightedAverageInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_BrickellKeyInvestmentAmendmentMember" xlink:label="mspr_BrickellKeyInvestmentAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationAndNotesPayableMember" xlink:label="mspr_ClaimsFinancingObligationAndNotesPayableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsProceedsInvestmentAgreementMember" xlink:label="mspr_ClaimsProceedsInvestmentAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfSharesObtainedThroughWarrant" xlink:label="mspr_PercentageOfSharesObtainedThroughWarrant"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SharesPledgedUnderAgreement" xlink:label="mspr_SharesPledgedUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PriceOfCommonStock" xlink:label="mspr_PriceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_BrickellKeyInvestmentAmendmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="mspr_ClaimsFinancingObligationAndNotesPayableMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_ClaimsProceedsInvestmentAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_CommonStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfSharesObtainedThroughWarrant" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_SharesPledgedUnderAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_SharePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PriceOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AmendedAndRestatedCreditAgreementMember" xlink:label="mspr_AmendedAndRestatedCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TermLoanAMember" xlink:label="mspr_TermLoanAMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelPartnersHoldingsLlcLetterAgreementMember" xlink:label="mspr_HazelPartnersHoldingsLlcLetterAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelTransactionsMember" xlink:label="mspr_HazelTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CreditAgreementMember" xlink:label="mspr_CreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TermLoanBMember" xlink:label="mspr_TermLoanBMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" xlink:label="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WorkingCapitalCreditFacilityMember" xlink:label="mspr_WorkingCapitalCreditFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseMoneyLoanMember" xlink:label="mspr_PurchaseMoneyLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims" xlink:label="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember" xlink:label="mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WorkingCapitalCreditAgreementMember" xlink:label="mspr_WorkingCapitalCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseInProceedsFromLongTermLinesOfCredit" xlink:label="mspr_IncreaseInProceedsFromLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:label="us-gaap_LineOfCreditFacilityExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:label="us-gaap_LineOfCreditFacilityDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseMoneyLoan" xlink:label="mspr_PurchaseMoneyLoan"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RealizedClaimRecoveries" xlink:label="mspr_RealizedClaimRecoveries"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AgreementDate" xlink:label="mspr_AgreementDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentOriginalIssueDiscount" xlink:label="mspr_DebtInstrumentOriginalIssueDiscount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AssignorConsistingNumberOfMedicareMembers" xlink:label="mspr_AssignorConsistingNumberOfMedicareMembers"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InterestPeriodPlusAnApplicableMargin" xlink:label="mspr_InterestPeriodPlusAnApplicableMargin"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseMoneyLoanAccruesInterest" xlink:label="mspr_PurchaseMoneyLoanAccruesInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentExtendedMaturityYear" xlink:label="mspr_DebtInstrumentExtendedMaturityYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCollateralAmount" xlink:label="us-gaap_DebtInstrumentCollateralAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentOfCertainCostsAndFees" xlink:label="mspr_PaymentOfCertainCostsAndFees"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="mspr_AmendedAndRestatedCreditAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_TermLoanAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_HazelPartnersHoldingsLlcLetterAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_HazelTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="mspr_CreditAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_TermLoanBMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="mspr_WorkingCapitalCreditFacilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_PurchaseMoneyLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_WorkingCapitalCreditAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_ProceedsFromLongTermLinesOfCredit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_IncreaseInProceedsFromLongTermLinesOfCredit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_CreditFacilityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PurchaseMoneyLoan" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_RealizedClaimRecoveries" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_AgreementDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_DebtInstrumentOriginalIssueDiscount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_AssignorConsistingNumberOfMedicareMembers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_InterestPeriodPlusAnApplicableMargin" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PurchaseMoneyLoanAccruesInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_DebtInstrumentExtendedMaturityYear" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentCollateralAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PaymentOfCertainCostsAndFees" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember" xlink:label="us-gaap_ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_StandbyEquityPurchaseAgreementMember" xlink:label="mspr_StandbyEquityPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NomuraPromissoryNoteMember" xlink:label="mspr_NomuraPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_YaIiPnLtdMember" xlink:label="mspr_YaIiPnLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AggregateAmountOutstandingUnderCashProceeds" xlink:label="mspr_AggregateAmountOutstandingUnderCashProceeds"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfCashProceedsFromSaleOfStock" xlink:label="mspr_PercentageOfCashProceedsFromSaleOfStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentsExtendedMaturityDate" xlink:label="mspr_DebtInstrumentsExtendedMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes" xlink:label="mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfAggregateProceedsToPayOutstandingAmount" xlink:label="mspr_PercentageOfAggregateProceedsToPayOutstandingAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ForegoPayments" xlink:label="mspr_ForegoPayments"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_ConvertibleDebtMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_StandbyEquityPurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mspr_NomuraPromissoryNoteMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_YaIiPnLtdMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_AggregateAmountOutstandingUnderCashProceeds" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfCashProceedsFromSaleOfStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_DebtInstrumentsExtendedMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfAggregateProceedsToPayOutstandingAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_ForegoPayments" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:label="mspr_ClaimsFinancingObligationsAndNotesPayableTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtMember" xlink:label="us-gaap_ConvertibleDebtMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommonStockPurchaseAgreementMember" xlink:label="mspr_CommonStockPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CantorFitzgeraldMember" xlink:label="mspr_CantorFitzgeraldMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OptionToSellMaximumSharesValueUnderPurchaseAgreement" xlink:label="mspr_OptionToSellMaximumSharesValueUnderPurchaseAgreement"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_StandbyEquityPurchaseAgreementMember" xlink:label="mspr_StandbyEquityPurchaseAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_YaIiPnLtdMember" xlink:label="mspr_YaIiPnLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfStockPurchasePrice" xlink:label="mspr_PercentageOfStockPurchasePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice" xlink:label="mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NomuraPromissoryNoteMember" xlink:label="mspr_NomuraPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfMinimumFixedPriceEqualingOfVwap" xlink:label="mspr_PercentageOfMinimumFixedPriceEqualingOfVwap"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfVwapOfSharesDuringPriorDate" xlink:label="mspr_PercentageOfVwapOfSharesDuringPriorDate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AggregateAmountOutstandingUnderCashProceeds" xlink:label="mspr_AggregateAmountOutstandingUnderCashProceeds"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion" xlink:label="mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfMinimumVariablePriceEqualingOfVwap" xlink:label="mspr_PercentageOfMinimumVariablePriceEqualingOfVwap"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MinimumVariablePricePerShare" xlink:label="mspr_MinimumVariablePricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentFloorPriceTrigger" xlink:label="mspr_DebtInstrumentFloorPriceTrigger"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FixedPricePerShare" xlink:label="mspr_FixedPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance" xlink:label="mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfAggregateProceedsToPayOutstandingAmount" xlink:label="mspr_PercentageOfAggregateProceedsToPayOutstandingAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes" xlink:label="mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfProceedsFromRepaymentOfDebt" xlink:label="mspr_PercentageOfProceedsFromRepaymentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares" xlink:label="mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest" xlink:label="mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock" xlink:label="mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations" xlink:label="mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReductionInDebtPrincipalOwing" xlink:label="mspr_ReductionInDebtPrincipalOwing"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReductionInInterestAmount" xlink:label="mspr_ReductionInInterestAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentToFundOperations" xlink:label="mspr_PaymentToFundOperations"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote" xlink:label="mspr_PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentToReduceAmountsOwedUnderNomuraNote" xlink:label="mspr_PaymentToReduceAmountsOwedUnderNomuraNote"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_ClaimsFinancingObligationsAndNotesPayableTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_ConvertibleDebtMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_CommonStockPurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_CantorFitzgeraldMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_VrmMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_OptionToSellMaximumSharesValueUnderPurchaseAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_StandbyEquityPurchaseAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_YaIiPnLtdMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfStockPurchasePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mspr_NomuraPromissoryNoteMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfMinimumFixedPriceEqualingOfVwap" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfVwapOfSharesDuringPriorDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_AggregateAmountOutstandingUnderCashProceeds" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfMinimumVariablePriceEqualingOfVwap" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_MinimumVariablePricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_DebtInstrumentFloorPriceTrigger" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_FixedPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfAggregateProceedsToPayOutstandingAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfProceedsFromRepaymentOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPayment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_ReductionInDebtPrincipalOwing" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_ReductionInInterestAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PaymentToFundOperations" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="mspr_PaymentToReduceAmountsOwedUnderNomuraNote" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfTenWarrantMember" xlink:label="mspr_NumberOfTenWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NewClassOfWarrantOrRightOutstanding" xlink:label="mspr_NewClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CpiaWarrantMember" xlink:label="mspr_CpiaWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfTwoWarrantMember" xlink:label="mspr_NumberOfTwoWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod" xlink:label="mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VirageRecoveryParticipationLpMember" xlink:label="mspr_VirageRecoveryParticipationLpMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="mspr_NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_VrmMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="mspr_NumberOfTenWarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="mspr_NewClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_CpiaWarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="mspr_NumberOfTwoWarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_VirageRecoveryParticipationLpMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="mspr_NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestLineItems" xlink:label="us-gaap_MinorityInterestLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestTable" xlink:label="us-gaap_MinorityInterestTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_UpCUnitHoldersMember" xlink:label="mspr_UpCUnitHoldersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommonClassVMember" xlink:label="mspr_CommonClassVMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="us-gaap_MinorityInterestTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_OwnershipDomain" xlink:to="mspr_UpCUnitHoldersMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_MinorityInterestTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_CommonClassVMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_MinorityInterestTable" xlink:to="srt_OwnershipAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestLineItems" xlink:label="us-gaap_MinorityInterestLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestTable" xlink:label="us-gaap_MinorityInterestTable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers" xlink:label="mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SubsidiaryAxis" xlink:label="mspr_SubsidiaryAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SubsidiaryDomain" xlink:label="mspr_SubsidiaryDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SubsidiaryDomain" xlink:label="mspr_SubsidiaryDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MSPRecoveryLLCMember" xlink:label="mspr_MSPRecoveryLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MaomsoRecoveryLlcSeriesFhcpMember" xlink:label="mspr_MaomsoRecoveryLlcSeriesFhcpMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EntitledClaimsRecoverPercentageByNonControllingMembers" xlink:label="mspr_EntitledClaimsRecoverPercentageByNonControllingMembers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_UpCUnitHoldersMember" xlink:label="mspr_UpCUnitHoldersMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfNonControllingMemberAllocatedCost" xlink:label="mspr_PercentageOfNonControllingMemberAllocatedCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommonUnitExchangeValue" xlink:label="mspr_CommonUnitExchangeValue"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="us-gaap_MinorityInterestTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="mspr_SubsidiaryAxis" xlink:to="mspr_SubsidiaryDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="mspr_SubsidiaryAxis" xlink:to="mspr_SubsidiaryDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_OwnershipDomain" xlink:to="mspr_MSPRecoveryLLCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_MinorityInterestTable" xlink:to="mspr_SubsidiaryAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_SubsidiaryDomain" xlink:to="mspr_MaomsoRecoveryLlcSeriesFhcpMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="mspr_EntitledClaimsRecoverPercentageByNonControllingMembers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_MinorityInterestTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_SubsidiaryDomain" xlink:to="mspr_UpCUnitHoldersMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="mspr_PercentageOfNonControllingMemberAllocatedCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_MinorityInterestTable" xlink:to="srt_OwnershipAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="us-gaap_MinorityInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="mspr_CommonUnitExchangeValue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember" xlink:label="mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CanoHealthLlcMember" xlink:label="mspr_CanoHealthLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:label="us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:label="us-gaap_DeferredCompensationShareBasedPaymentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:label="us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember" xlink:label="mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_CanoHealthLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" xlink:to="us-gaap_DeferredCompensationShareBasedPaymentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:to="us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:to="us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FinancialLiabilitiesFairValueWarrants" xlink:label="mspr_FinancialLiabilitiesFairValueWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DerivativeLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="mspr_FinancialLiabilitiesFairValueWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmbeddedDerivativeLiabilityMeasurementInput" xlink:label="us-gaap_EmbeddedDerivativeLiabilityMeasurementInput"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EmbeddedDerivativeLiabilityMeasurementTerm" xlink:label="mspr_EmbeddedDerivativeLiabilityMeasurementTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm" xlink:label="mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_EmbeddedDerivativeLiabilityMeasurementInput" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_MeasurementInputTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputSharePriceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="mspr_EmbeddedDerivativeLiabilityMeasurementTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_UnsecuredPromissoryNotesMember" xlink:label="mspr_UnsecuredPromissoryNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VirageAmendmentMember" xlink:label="mspr_VirageAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="us-gaap_AssetAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="us-gaap_AssetAcquisitionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ExistingLegalServicesAgreementsMember" xlink:label="mspr_ExistingLegalServicesAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MspPrincipalsMember" xlink:label="mspr_MspPrincipalsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AffiliatePayableMember" xlink:label="mspr_AffiliatePayableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WorkingCapitalCreditFacilityCollateralMember" xlink:label="mspr_WorkingCapitalCreditFacilityCollateralMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReservedSharesMember" xlink:label="mspr_ReservedSharesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InitialVirageWarrantMember" xlink:label="mspr_InitialVirageWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ProfessionalFeesLegalMember" xlink:label="mspr_ProfessionalFeesLegalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_BrickellKeyInvestmentAmendmentMember" xlink:label="mspr_BrickellKeyInvestmentAmendmentMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentPaymentInKindAnnualInterestRate" xlink:label="mspr_DebtInstrumentPaymentInKindAnnualInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AdditionalReceivablesFromOtherAffiliatesMember" xlink:label="mspr_AdditionalReceivablesFromOtherAffiliatesMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MspRecoveryLawFirmMember" xlink:label="mspr_MspRecoveryLawFirmMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AffiliateReceivableMember" xlink:label="mspr_AffiliateReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CostOfClaimsRecoveriesMember" xlink:label="mspr_CostOfClaimsRecoveriesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FundsHeldForOtherEntitiesMember" xlink:label="mspr_FundsHeldForOtherEntitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MspRecoveryAviationLlcMember" xlink:label="mspr_MspRecoveryAviationLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationAndNotesPayableMember" xlink:label="mspr_ClaimsFinancingObligationAndNotesPayableMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentOfCertainCostsAndFees" xlink:label="mspr_PaymentOfCertainCostsAndFees"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember" xlink:label="mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SeriesMrcsLlcMember" xlink:label="mspr_SeriesMrcsLlcMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ServiceFeesMember" xlink:label="mspr_ServiceFeesMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PartialRepaymentOfDebt" xlink:label="mspr_PartialRepaymentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAffiliatesMember" xlink:label="us-gaap_OtherAffiliatesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OperatingCostsAndExpenses1" xlink:label="mspr_OperatingCostsAndExpenses1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AdvancePaymentIncurredForExpenses" xlink:label="mspr_AdvancePaymentIncurredForExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SharesPledgedUnderAgreement" xlink:label="mspr_SharesPledgedUnderAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AnnualCompoundedReturnOnContributionPercentage" xlink:label="mspr_AnnualCompoundedReturnOnContributionPercentage"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="mspr_UnsecuredPromissoryNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_VirageAmendmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mspr_ExistingLegalServicesAgreementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_MspPrincipalsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="mspr_AffiliatePayableMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_WorkingCapitalCreditFacilityCollateralMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="mspr_ReservedSharesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="mspr_InitialVirageWarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="mspr_ProfessionalFeesLegalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="mspr_BrickellKeyInvestmentAmendmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mspr_DebtInstrumentPaymentInKindAnnualInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mspr_AdditionalReceivablesFromOtherAffiliatesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_MspRecoveryLawFirmMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="mspr_AffiliateReceivableMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="mspr_CostOfClaimsRecoveriesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_InterestExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mspr_FundsHeldForOtherEntitiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_MspRecoveryAviationLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="mspr_ClaimsFinancingObligationAndNotesPayableMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mspr_PaymentOfCertainCostsAndFees" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_CreditFacilityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_SeriesMrcsLlcMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="mspr_ServiceFeesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_VrmMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mspr_PartialRepaymentOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_OtherAffiliatesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProceedsFromNotesPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mspr_OperatingCostsAndExpenses1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OperatingCostsAndExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_AssetAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mspr_AdvancePaymentIncurredForExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherReceivablesNetCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_LongTermNotesPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mspr_SharesPledgedUnderAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="mspr_AnnualCompoundedReturnOnContributionPercentage" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" xlink:label="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable" xlink:label="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeMember" xlink:label="us-gaap_OtherIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfEquitySharesAcquiredToCoverTheShortPosition" xlink:label="mspr_NumberOfEquitySharesAcquiredToCoverTheShortPosition"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ValueOfSharesToCoverShortPosition" xlink:label="mspr_ValueOfSharesToCoverShortPosition"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RealizedLossOnInvestmentsToCoverShortPosition" xlink:label="mspr_RealizedLossOnInvestmentsToCoverShortPosition"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:label="us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" xlink:to="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_OtherIncomeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" xlink:to="mspr_NumberOfEquitySharesAcquiredToCoverTheShortPosition" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" xlink:to="mspr_ValueOfSharesToCoverShortPosition" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" xlink:to="mspr_RealizedLossOnInvestmentsToCoverShortPosition" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" xlink:to="us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EarningsPerSharesBasicAndDilutedAbstract" xlink:label="mspr_EarningsPerSharesBasicAndDilutedAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_EarningsPerSharesBasicAndDilutedAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="mspr_EarningsPerSharesBasicAndDilutedAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_EarningsPerSharesBasicAndDilutedAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_EarningsPerSharesBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mspr_EarningsPerSharesBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PublicWarrantsOutstandingMember" xlink:label="mspr_PublicWarrantsOutstandingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassVCommonStockMember" xlink:label="mspr_ClassVCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CpiaWarrantMember" xlink:label="mspr_CpiaWarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WarrantsIssuedToVirageMember" xlink:label="mspr_WarrantsIssuedToVirageMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IssuanceOfSharesPurchaseTerm" xlink:label="mspr_IssuanceOfSharesPurchaseTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mspr_PublicWarrantsOutstandingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="mspr_ClassVCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_VrmMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mspr_CpiaWarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="mspr_WarrantsIssuedToVirageMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="mspr_IssuanceOfSharesPurchaseTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="us-gaap_DerivativeLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ForcedExpiratoryFlowSharesMember" xlink:label="mspr_ForcedExpiratoryFlowSharesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AggregateNumberOfSharesTransferredToEscrowAccount" xlink:label="mspr_AggregateNumberOfSharesTransferredToEscrowAccount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_ForcedExpiratoryFlowSharesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="mspr_AggregateNumberOfSharesTransferredToEscrowAccount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_RestrictedCashCurrent" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VirageTermSheetMember" xlink:label="mspr_VirageTermSheetMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity" xlink:label="mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LegalAccountingAndAdministrativeExpenseMember" xlink:label="mspr_LegalAccountingAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NomuraPromissoryNoteMember" xlink:label="mspr_NomuraPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanDomain" xlink:label="us-gaap_RestructuringPlanDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RestructuringPlanMember" xlink:label="mspr_RestructuringPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredOvernightFinancingRateSofrMember" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MspPrincipalsMember" xlink:label="mspr_MspPrincipalsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OperationalCollectionFloorFacilityMember" xlink:label="mspr_OperationalCollectionFloorFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_YaIiPnLtdMember" xlink:label="mspr_YaIiPnLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_VrmMember" xlink:label="mspr_VrmMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringPlanAxis" xlink:label="us-gaap_RestructuringPlanAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TermSheetMember" xlink:label="mspr_TermSheetMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_HazelTransactionsMember" xlink:label="mspr_HazelTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitment" xlink:label="us-gaap_OtherCommitment"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LicenseFeePercentage" xlink:label="mspr_LicenseFeePercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MinimumFeePaid" xlink:label="mspr_MinimumFeePaid"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FundedForAdditionalClaims" xlink:label="mspr_FundedForAdditionalClaims"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LoansRepaymentPercentage" xlink:label="mspr_LoansRepaymentPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AmountsReceivedToToTheMasterTransactionAgreement" xlink:label="mspr_AmountsReceivedToToTheMasterTransactionAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LineOfCreditFundedInTranchesPerMonth" xlink:label="mspr_LineOfCreditFundedInTranchesPerMonth"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AccruedInterestPercentageInYearOne" xlink:label="mspr_AccruedInterestPercentageInYearOne"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AccruedInterestPercentageAfterOneYear" xlink:label="mspr_AccruedInterestPercentageAfterOneYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration" xlink:label="us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RecoveryRightsInterestExcessCashFlowPercentage" xlink:label="mspr_RecoveryRightsInterestExcessCashFlowPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RecoveryRightsInterest" xlink:label="mspr_RecoveryRightsInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BridgeLoan" xlink:label="us-gaap_BridgeLoan"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AdditionalBridgeLoan" xlink:label="mspr_AdditionalBridgeLoan"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AnnualCostsAfterCurrentlyPlannedCostReductions" xlink:label="mspr_AnnualCostsAfterCurrentlyPlannedCostReductions"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OperationalFunding" xlink:label="mspr_OperationalFunding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient" xlink:label="mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfWarrantsIssued" xlink:label="mspr_NumberOfWarrantsIssued"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid" xlink:label="mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_Non-RecourseDebtSecondLienAmount" xlink:label="mspr_Non-RecourseDebtSecondLienAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfProceedsFromGrantLien" xlink:label="mspr_PercentageOfProceedsFromGrantLien"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage" xlink:label="mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock" xlink:label="mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClassOfWarrantOrRightOutstandingVotingPercentage" xlink:label="mspr_ClassOfWarrantOrRightOutstandingVotingPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentRate" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_FloorPriceOfACommonStock" xlink:label="mspr_FloorPriceOfACommonStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_NumberOfConsecutiveTradingDays" xlink:label="mspr_NumberOfConsecutiveTradingDays"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfCashProceedsFromSaleOfStock" xlink:label="mspr_PercentageOfCashProceedsFromSaleOfStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PercentageOfPledge" xlink:label="mspr_PercentageOfPledge"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DebtInstrumentsExtendedMaturityDate" xlink:label="mspr_DebtInstrumentsExtendedMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ProceedsFromSaleOfStockMonthlyPaymentAmount" xlink:label="mspr_ProceedsFromSaleOfStockMonthlyPaymentAmount"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AggregateAmountOutstandingUnderCashProceeds" xlink:label="mspr_AggregateAmountOutstandingUnderCashProceeds"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="mspr_VirageTermSheetMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="mspr_LegalAccountingAndAdministrativeExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="mspr_NomuraPromissoryNoteMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringPlanDomain" xlink:to="mspr_RestructuringPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_SecuredOvernightFinancingRateSofrMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mspr_MspPrincipalsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="mspr_OperationalCollectionFloorFacilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="mspr_YaIiPnLtdMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_VrmMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestructuringPlanAxis" xlink:to="us-gaap_RestructuringPlanDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromLongTermLinesOfCredit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="mspr_TermSheetMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="mspr_HazelTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_OtherCommitment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_LicenseFeePercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_StatementScenarioAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_MinimumFeePaid" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_RestructuringPlanAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_FundedForAdditionalClaims" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_LoansRepaymentPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_VariableRateAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_AmountsReceivedToToTheMasterTransactionAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_CreditFacilityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_LineOfCreditFundedInTranchesPerMonth" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_AccruedInterestPercentageInYearOne" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_AccruedInterestPercentageAfterOneYear" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_RecoveryRightsInterestExcessCashFlowPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_RecoveryRightsInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_BridgeLoan" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_AdditionalBridgeLoan" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_AnnualCostsAfterCurrentlyPlannedCostReductions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_OperationalFunding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_NumberOfWarrantsIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_Non-RecourseDebtSecondLienAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_PercentageOfProceedsFromGrantLien" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="32" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_ClassOfWarrantOrRightOutstandingVotingPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="33" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="34" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="35" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="36" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_FloorPriceOfACommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="37" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_NumberOfConsecutiveTradingDays" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="38" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="39" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_PercentageOfCashProceedsFromSaleOfStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="40" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_PercentageOfPledge" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="41" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_DebtInstrumentsExtendedMaturityDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="42" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="43" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_ProceedsFromSaleOfStockMonthlyPaymentAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="44" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="mspr_AggregateAmountOutstandingUnderCashProceeds" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UsefulLifeDescriptionOfTermDomain" xlink:label="us-gaap_UsefulLifeDescriptionOfTermDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember" xlink:label="us-gaap_UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredOvernightFinancingRateSofrMember" xlink:label="us-gaap_SecuredOvernightFinancingRateSofrMember"/>
        </link:definitionLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_Cash" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquity" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_MinorityInterest" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="mspr_AffiliatePayable" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="mspr_InterestPayableNoncurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="mspr_CommissionPayable" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="mspr_AffiliateReceivable" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="mspr_LoanFromRelatedPartiesNonCurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="mspr_GuarantyObligationNoncurrent" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_InterestPayableCurrent" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DerivativeLiabilitiesCurrent" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="mspr_ClaimsFinancingObligationNotesPayable" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="mspr_WarrantLiabilityCurrent" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="mspr_ClaimsFinancingObligationNotesPayableCurrent" order="9" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="mspr_GuarantyObligationCurrent" order="10" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="11" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="11" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AffiliatePayable" xlink:label="mspr_AffiliatePayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_InterestPayableNoncurrent" xlink:label="mspr_InterestPayableNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CommissionPayable" xlink:label="mspr_CommissionPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AffiliateReceivable" xlink:label="mspr_AffiliateReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_LoanFromRelatedPartiesNonCurrent" xlink:label="mspr_LoanFromRelatedPartiesNonCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_GuarantyObligationNoncurrent" xlink:label="mspr_GuarantyObligationNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="us-gaap_DerivativeLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationNotesPayable" xlink:label="mspr_ClaimsFinancingObligationNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_WarrantLiabilityCurrent" xlink:label="mspr_WarrantLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsFinancingObligationNotesPayableCurrent" xlink:label="mspr_ClaimsFinancingObligationNotesPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_GuarantyObligationCurrent" xlink:label="mspr_GuarantyObligationCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="mspr_CostOfClaimRecoveries" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="mspr_TotalClaimsRecovery" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="mspr_TotalClaimsRecovery" xlink:to="mspr_ClaimsRecoveryIncome" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InterestExpense" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="mspr_ClaimsAmortizationExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="mspr_TotalClaimsRecovery" xlink:to="mspr_ClaimsRecoveryServiceIncome" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="mspr_TotalClaimsRecovery" xlink:to="mspr_OtherClaimsRecoveryRevenues" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ProfessionalFees" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_LegalFees" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="mspr_AllowanceForCreditLosses" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_DepreciationAndAmortization" order="8" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_CostOfClaimRecoveries" xlink:label="mspr_CostOfClaimRecoveries"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TotalClaimsRecovery" xlink:label="mspr_TotalClaimsRecovery"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsRecoveryIncome" xlink:label="mspr_ClaimsRecoveryIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsAmortizationExpense" xlink:label="mspr_ClaimsAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsRecoveryServiceIncome" xlink:label="mspr_ClaimsRecoveryServiceIncome"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities" xlink:label="mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_OtherClaimsRecoveryRevenues" xlink:label="mspr_OtherClaimsRecoveryRevenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AllowanceForCreditLosses" xlink:label="mspr_AllowanceForCreditLosses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="mspr_ClaimsAmortizationExpense" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="mspr_PaymentsOnRelatedPartyLoan" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfIntangibleAssets" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="mspr_PaymentsOfDeferredFinancingCosts" order="3" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="5" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_PaidInKindInterest" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="mspr_AllowanceForCreditLosses" order="8" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="mspr_ReleaseOfTemporaryEquityForPayments" order="8" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="9" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="mspr_RepaymentOfTheClaimsFinancingObligation" order="9" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnDispositionOfIntangibleAssets" order="10" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="mspr_MarkToMarketGainOnLiabilityPayableInStock" order="11" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="mspr_ProfessionalFeesSettledInShares" order="12" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="mspr_ChangeInFairValueOfDerivatives" order="13" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="14" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="14" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="16" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="20" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="22" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities" order="23" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet" order="24" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="mspr_IncreaseDeceaseInAffiliatesReceivable" order="25" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="mspr_IncreaseDeceaseInAffiliatesPayable" order="26" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsAmortizationExpense" xlink:label="mspr_ClaimsAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentsOnRelatedPartyLoan" xlink:label="mspr_PaymentsOnRelatedPartyLoan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:label="us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_PaymentsOfDeferredFinancingCosts" xlink:label="mspr_PaymentsOfDeferredFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_AllowanceForCreditLosses" xlink:label="mspr_AllowanceForCreditLosses"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ReleaseOfTemporaryEquityForPayments" xlink:label="mspr_ReleaseOfTemporaryEquityForPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_RepaymentOfTheClaimsFinancingObligation" xlink:label="mspr_RepaymentOfTheClaimsFinancingObligation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:label="us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_MarkToMarketGainOnLiabilityPayableInStock" xlink:label="mspr_MarkToMarketGainOnLiabilityPayableInStock"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ProfessionalFeesSettledInShares" xlink:label="mspr_ProfessionalFeesSettledInShares"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ChangeInFairValueOfDerivatives" xlink:label="mspr_ChangeInFairValueOfDerivatives"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities" xlink:label="mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseDeceaseInAffiliatesReceivable" xlink:label="mspr_IncreaseDeceaseInAffiliatesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_IncreaseDeceaseInAffiliatesPayable" xlink:label="mspr_IncreaseDeceaseInAffiliatesPayable"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent" xlink:label="mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetInterestCarryforward" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="mspr_DeferredTaxAssetsTransactionCosts" order="4" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc" xlink:label="mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses" xlink:label="mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetInterestCarryforward" xlink:label="us-gaap_DeferredTaxAssetInterestCarryforward"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_DeferredTaxAssetsTransactionCosts" xlink:label="mspr_DeferredTaxAssetsTransactionCosts"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_SegmentReportingOtherItemAmount" xlink:to="us-gaap_ProfitLoss" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="mspr_SignificantExpenses" xlink:to="mspr_ClaimsAmortizationExpense" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_SegmentReportingOtherItemAmount" xlink:to="mspr_SignificantExpenses" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="mspr_SignificantExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_SegmentReportingOtherItemAmount" xlink:to="mspr_TotalClaimsRecovery" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="mspr_SignificantExpenses" xlink:to="us-gaap_ProfessionalFees" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="mspr_SignificantExpenses" xlink:to="us-gaap_LegalFees" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="mspr_SignificantExpenses" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="mspr_SignificantExpenses" xlink:to="us-gaap_InterestExpense" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount" xlink:label="us-gaap_SegmentReportingOtherItemAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_SignificantExpenses" xlink:label="mspr_SignificantExpenses"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_ClaimsAmortizationExpense" xlink:label="mspr_ClaimsAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="mspr-20241231.xsd#mspr_TotalClaimsRecovery" xlink:label="mspr_TotalClaimsRecovery"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="2" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
        </link:calculationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="mspr_IncreaseInTaxReceivableAgreementLiability" name="IncreaseInTaxReceivableAgreementLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_PercentageOfNonControllingMemberAllocatedCost" name="PercentageOfNonControllingMemberAllocatedCost" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" name="FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_CreditAgreementMember" name="CreditAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm" name="EmbeddedDerivativeLiabilitiesMeasurementTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_PercentageOfCashProceedsFromSaleOfStock" name="PercentageOfCashProceedsFromSaleOfStock" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_UnsecuredPromissoryNotesMember" name="UnsecuredPromissoryNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries" name="Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities" name="EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient" name="PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_ProfessionalFeesSettledInShares" name="ProfessionalFeesSettledInShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember" name="AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_MembershipInterestPurchaseAgreementMember" name="MembershipInterestPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_AmountsReceivedToToTheMasterTransactionAgreement" name="AmountsReceivedToToTheMasterTransactionAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_MinimumVariablePricePerShare" name="MinimumVariablePricePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_ClassVCommonStockMember" name="ClassVCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_VariableInterestEntityDisclosureAbstract" name="VariableInterestEntityDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_NomuraPromissoryNoteMember" name="NomuraPromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_AffiliateReceivable" name="AffiliateReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_PaymentToFundOperations" name="PaymentToFundOperations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_PercentageOfMinimumVariablePriceEqualingOfVwap" name="PercentageOfMinimumVariablePriceEqualingOfVwap" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable" name="InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis" name="ClassificationOfCommonStockBasedOnVotingRightsAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock" name="ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember" name="RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ReleaseOfTemporaryEquityForPayments" name="ReleaseOfTemporaryEquityForPayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember" name="RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_NatureOfOperationsTable" name="NatureOfOperationsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember" name="RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_MinimumCashAvailableForDistributionsPercentage" name="MinimumCashAvailableForDistributionsPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_Non-RecourseDebtSecondLienAmount" name="Non-RecourseDebtSecondLienAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_PaymentsOnRelatedPartyLoan" name="PaymentsOnRelatedPartyLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_DescriptionOfCashPaymentsMadeToCounterParty" name="DescriptionOfCashPaymentsMadeToCounterParty" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_ClaimsFinancingObligationAndNotesPayableMember" name="ClaimsFinancingObligationAndNotesPayableMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_AdvancePaymentIncurredForExpenses" name="AdvancePaymentIncurredForExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_MonthlyVirageWarrantsMember" name="MonthlyVirageWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_WarrantPaymentDescription" name="WarrantPaymentDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_VrmMember" name="VrmMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity" name="ConvertingCertainDebtOfCertainCreditorsIntoEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_EmbeddedDerivativeLiabilityMeasurementTerm" name="EmbeddedDerivativeLiabilityMeasurementTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares" name="PercentageOfPaymentOfAggregatePurchasePriceOfShares" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_NumberOfTranches" name="NumberOfTranches" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_BrickellKeyInvestmentAmendmentMember" name="BrickellKeyInvestmentAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_EntitledClaimsRecoverPercentageByNonControllingMembers" name="EntitledClaimsRecoverPercentageByNonControllingMembers" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_StockIssuedDuringPeriodSharesConversionOfWarrants" name="StockIssuedDuringPeriodSharesConversionOfWarrants" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_PercentageOfCostsAllocatedToNonControlling" name="PercentageOfCostsAllocatedToNonControlling" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_ClaimsFinancingObligationNotesPayableCurrent" name="ClaimsFinancingObligationNotesPayableCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_ScheduleOfOwnershipInterestsTableTextBlock" name="ScheduleOfOwnershipInterestsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain" name="ClassificationOfCommonStockBasedOnVotingRightsDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock" name="ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_PartialRepaymentOfDebt" name="PartialRepaymentOfDebt" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_IntangibleAssetsFinancedByNotePayable" name="IntangibleAssetsFinancedByNotePayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_NatureOfOperationsLineItems" name="NatureOfOperationsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_AgreementDate" name="AgreementDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_ProceedsFromSaleOfStockMonthlyPaymentAmount" name="ProceedsFromSaleOfStockMonthlyPaymentAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_PaymentOfCertainCostsAndFees" name="PaymentOfCertainCostsAndFees" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_WorkingCapitalCreditAgreementMember" name="WorkingCapitalCreditAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_MaterialAgreementsDisclosureTextBlock" name="MaterialAgreementsDisclosureTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_CpiaWarrantMember" name="CpiaWarrantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_OriginalIssueDiscountOfNonCash" name="OriginalIssueDiscountOfNonCash" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations" name="PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries" name="IntangibleAssetsHeldBeCertainSpecificSubsidiaries" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_ClaimsCostRecoveryAgreementsMember" name="ClaimsCostRecoveryAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_HazelPartnersHoldingsLlcLetterAgreementMember" name="HazelPartnersHoldingsLlcLetterAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_PercentageOfPaySellersToAmountOfTaxBenefit" name="PercentageOfPaySellersToAmountOfTaxBenefit" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_PercentageOfMinimumFixedPriceEqualingOfVwap" name="PercentageOfMinimumFixedPriceEqualingOfVwap" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion" name="PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_CommonClassVMember" name="CommonClassVMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ClassOfWarrantOrRightOutstandingVotingPercentage" name="ClassOfWarrantOrRightOutstandingVotingPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_OperationalFunding" name="OperationalFunding" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember" name="RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_InterestPeriodPlusAnApplicableMargin" name="InterestPeriodPlusAnApplicableMargin" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_MSPRecoveryLLCMember" name="MSPRecoveryLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_PercentageOfPreferredReturnForTheControlling" name="PercentageOfPreferredReturnForTheControlling" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_PriceOfCommonStock" name="PriceOfCommonStock" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" name="NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_SharesPledgedUnderAgreement" name="SharesPledgedUnderAgreement" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_ClassVShareholdersMember" name="ClassVShareholdersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage" name="ClassOfWarrantOrRightOutstandingOwnershipPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember" name="InvestmentInRightsToClaimRecoveryCashFlowsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_MspRecoveryAviationLlcMember" name="MspRecoveryAviationLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ClassOfWarrantOrRightCancellationDuringPeriod" name="ClassOfWarrantOrRightCancellationDuringPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_WarrantsIssuedToVirageMember" name="WarrantsIssuedToVirageMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_PercentageOfStockPurchasePrice" name="PercentageOfStockPurchasePrice" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_AffiliateReceivableMember" name="AffiliateReceivableMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_VirageTermSheetMember" name="VirageTermSheetMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance" name="PercentageOfMandatoryMinimumAmountForAnyAdvance" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_StockIssuedDuringPeriodValueConversionOfWarrants" name="StockIssuedDuringPeriodValueConversionOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_ClaimsFinancingObligationsAndNotesPayableTable" name="ClaimsFinancingObligationsAndNotesPayableTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ServiceFeesMember" name="ServiceFeesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_PurchaseMoneyLoan" name="PurchaseMoneyLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_AccountingPoliciesTable" name="AccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ForcedExpiratoryFlowSharesMember" name="ForcedExpiratoryFlowSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_IncreaseDecreaseInImpairmentCharges" name="IncreaseDecreaseInImpairmentCharges" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_ClaimsAmortizationExpensePolicyTextBlock" name="ClaimsAmortizationExpensePolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_WorkingCapitalCreditFacilityCollateralMember" name="WorkingCapitalCreditFacilityCollateralMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_PercentageOfProceedsFromRepaymentOfDebt" name="PercentageOfProceedsFromRepaymentOfDebt" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_PercentageOfVwapOfSharesDuringPriorDate" name="PercentageOfVwapOfSharesDuringPriorDate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_FinancingObligationsAndNotesPayableAgreementsMember" name="FinancingObligationsAndNotesPayableAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ReservedSharesMember" name="ReservedSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ValueOfSharesToCoverShortPosition" name="ValueOfSharesToCoverShortPosition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_FundsHeldForOtherEntitiesMember" name="FundsHeldForOtherEntitiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_WarrantLiabilityTextBlock" name="WarrantLiabilityTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_FinancialLiabilitiesFairValueWarrants" name="FinancialLiabilitiesFairValueWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_RealizedClaimRecoveries" name="RealizedClaimRecoveries" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_NumberOfEquitySharesAcquiredToCoverTheShortPosition" name="NumberOfEquitySharesAcquiredToCoverTheShortPosition" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_OtherClaimsRecoveryRevenues" name="OtherClaimsRecoveryRevenues" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable" name="DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_DeferredTaxAssetsTransactionCosts" name="DeferredTaxAssetsTransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts" name="EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock" name="ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_LineOfCreditFundedInTranchesPerMonth" name="LineOfCreditFundedInTranchesPerMonth" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock" name="PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_EarningsPerSharesBasicAndDilutedAbstract" name="EarningsPerSharesBasicAndDilutedAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_WarrantLiabilityCurrent" name="WarrantLiabilityCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_PaymentToReduceAmountsOwedUnderNomuraNote" name="PaymentToReduceAmountsOwedUnderNomuraNote" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock" name="DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_NumberOfConsecutiveTradingDays" name="NumberOfConsecutiveTradingDays" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote" name="PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses" name="DeferredTaxAssetsOrganizationalCostsAndStartupExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" name="LineOfCreditFacilityBorrowingAvailableAmountForEachTranche" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_PercentageOfProceedsFromGrantLien" name="PercentageOfProceedsFromGrantLien" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_PercentageOfRecoveryClaimsForTheControlling" name="PercentageOfRecoveryClaimsForTheControlling" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_LicenseFeePercentage" name="LicenseFeePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_MspRecoveryLawFirmMember" name="MspRecoveryLawFirmMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_InitialVirageWarrantMember" name="InitialVirageWarrantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_CashPaidDuringThePeriodAbstract" name="CashPaidDuringThePeriodAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_MinimumFeePaid" name="MinimumFeePaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_ReductionInDebtPrincipalOwing" name="ReductionInDebtPrincipalOwing" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_ClaimsFinancingObligationNotesPayable" name="ClaimsFinancingObligationNotesPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_ClaimsRecoveryServiceIncome" name="ClaimsRecoveryServiceIncome" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_MaoMember" name="MaoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ForegoPayments" name="ForegoPayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_RelatedPartyLegalExpense" name="RelatedPartyLegalExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_SaleOfIntangibleAssets" name="SaleOfIntangibleAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_WorkingCapitalCreditFacilityMember" name="WorkingCapitalCreditFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_AccountingPoliciesLineItems" name="AccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_PmpiMember" name="PmpiMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_NumberOfWarrantsIssued" name="NumberOfWarrantsIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_PublicWarrantsOutstandingMember" name="PublicWarrantsOutstandingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_FloorPriceOfACommonStock" name="FloorPriceOfACommonStock" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_DebtInstrumentFloorPriceTrigger" name="DebtInstrumentFloorPriceTrigger" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_GuarantyObligationNoncurrent" name="GuarantyObligationNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries" name="Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_AffiliatePayableMember" name="AffiliatePayableMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_DividendComprisingNumberOfNewWarrantsPayableHolders" name="DividendComprisingNumberOfNewWarrantsPayableHolders" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_ReleaseOfTemporaryEquityDuringNonCash" name="ReleaseOfTemporaryEquityDuringNonCash" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_MspPrincipalsMember" name="MspPrincipalsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable" name="FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_IncreaseDeceaseInAffiliatesReceivable" name="IncreaseDeceaseInAffiliatesReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_PurchaseMoneyLoanAccruesInterest" name="PurchaseMoneyLoanAccruesInterest" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_YaIiPnLtdMember" name="YaIiPnLtdMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_CommonUnitExchangeValue" name="CommonUnitExchangeValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsWarrantLiabilityPercent" name="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsWarrantLiabilityPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_MarkToMarketGainOnLiabilityPayableInStock" name="MarkToMarketGainOnLiabilityPayableInStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_VRMFullPaymentDescription" name="VRMFullPaymentDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_TaxReceivableAgreementMember" name="TaxReceivableAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_SignificantExpenses" name="SignificantExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_AdditionalFiniteLivedIntangibleAssetsAcquired" name="AdditionalFiniteLivedIntangibleAssetsAcquired" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_TermLoanBMember" name="TermLoanBMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_VrmMspRecoveryPartnersLlcMember" name="VrmMspRecoveryPartnersLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_AmendedAndRestatedNomuraPromissoryNoteMember" name="AmendedAndRestatedNomuraPromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid" name="PercentageOfGrantProceedsToExtentFullReturnNotRepaid" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_DevelopmentCostsCapitalizedUsefulLife" name="DevelopmentCostsCapitalizedUsefulLife" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_LoanFromRelatedPartiesNonCurrent" name="LoanFromRelatedPartiesNonCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice" name="PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_MinimumRequiredPaymentMember" name="MinimumRequiredPaymentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_FixedPricePerShare" name="FixedPricePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_CanoHealthLlcMember" name="CanoHealthLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember" name="PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ClaimsFinancingObligationsAndNotesPayableLineItems" name="ClaimsFinancingObligationsAndNotesPayableLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_PurchaseMoneyLoanMember" name="PurchaseMoneyLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_AdditionalBridgeLoan" name="AdditionalBridgeLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_ClassOfWarrantOrRightIssuedDuringPeriod" name="ClassOfWarrantOrRightIssuedDuringPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_LoansRepaymentPercentage" name="LoansRepaymentPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_SubsidiaryAxis" name="SubsidiaryAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_AnnualCostsAfterCurrentlyPlannedCostReductions" name="AnnualCostsAfterCurrentlyPlannedCostReductions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_NumberOfWarrantsIssuedAndExercisable" name="NumberOfWarrantsIssuedAndExercisable" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired" name="NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock" name="DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_AccruedInterestPercentageInYearOne" name="AccruedInterestPercentageInYearOne" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_NetGainOfTheAsset" name="NetGainOfTheAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_NonEconomicVotingSharesMember" name="NonEconomicVotingSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_NewClassOfWarrantOrRightOutstanding" name="NewClassOfWarrantOrRightOutstanding" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_SubsidiaryDomain" name="SubsidiaryDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes" name="PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers" name="PercentageOfEntitledPreferredReturnByNonControllingMembers" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_ValueOfFullReturn" name="ValueOfFullReturn" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_GuarantyObligationCurrent" name="GuarantyObligationCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_NumberOfHoldingInvestments" name="NumberOfHoldingInvestments" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" name="DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_OfficeAndComputerEquipmentMember" name="OfficeAndComputerEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" name="InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_EquityMethodInvestmentInvesteeMember" name="EquityMethodInvestmentInvesteeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_HazelTransactionsMember" name="HazelTransactionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_AccruedInterestPercentageAfterOneYear" name="AccruedInterestPercentageAfterOneYear" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_RecoveryRightsInterestExcessCashFlowPercentage" name="RecoveryRightsInterestExcessCashFlowPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_FundedForAdditionalClaims" name="FundedForAdditionalClaims" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_ClaimsCostRecoveryRightsMember" name="ClaimsCostRecoveryRightsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent" name="EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_GoodwillMeasurementInputIncreaseDecrease" name="GoodwillMeasurementInputIncreaseDecrease" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_ClaimsAmortizationExpense" name="ClaimsAmortizationExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_DebtInstrumentExtendedMaturityYear" name="DebtInstrumentExtendedMaturityYear" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_OperationalCollectionFloorFacilityMember" name="OperationalCollectionFloorFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_LegalAccountingAndAdministrativeExpenseMember" name="LegalAccountingAndAdministrativeExpenseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_NumberOfTwoWarrantMember" name="NumberOfTwoWarrantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_AssignorConsistingNumberOfMedicareMembers" name="AssignorConsistingNumberOfMedicareMembers" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_NumberOfSharesExercisable" name="NumberOfSharesExercisable" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_DebtInstrumentsExtendedMaturityDate" name="DebtInstrumentsExtendedMaturityDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember" name="SecondAmendedAndRestatedFirstLienCreditAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_AggregateNumberOfSharesTransferredToEscrowAccount" name="AggregateNumberOfSharesTransferredToEscrowAccount" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_AdditionalReceivablesFromOtherAffiliatesMember" name="AdditionalReceivablesFromOtherAffiliatesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_CostOfClaimsRecoveriesMember" name="CostOfClaimsRecoveriesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_VirageAmendmentMember" name="VirageAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod" name="ClassOfNewWarrantOrRightTransferredDuringPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets" name="NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders" name="PaymentsToContinuingEquityOwnersAndBlockerShareholders" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_ReductionInInterestAmount" name="ReductionInInterestAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_AggregateAmountOutstandingUnderCashProceeds" name="AggregateAmountOutstandingUnderCashProceeds" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_AmendedAndRestatedCreditAgreementMember" name="AmendedAndRestatedCreditAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc" name="DeferredTaxAssetsInvestmentInMspRecoveryLlc" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_StandbyEquityPurchaseAgreementMember" name="StandbyEquityPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_DebtInstrumentPaymentInKindAnnualInterestRate" name="DebtInstrumentPaymentInKindAnnualInterestRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_CommonStockPurchaseAgreementMember" name="CommonStockPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ExistingLegalServicesAgreementsMember" name="ExistingLegalServicesAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_IncreaseInProceedsFromLongTermLinesOfCredit" name="IncreaseInProceedsFromLongTermLinesOfCredit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_ClaimsRecoveryIncome" name="ClaimsRecoveryIncome" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock" name="PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_OtherSoftwareMember" name="OtherSoftwareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities" name="ChangeInFairValueOfWarrantAndDerivativeLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_DebtInstrumentOriginalIssueDiscount" name="DebtInstrumentOriginalIssueDiscount" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_WarrantConversionsOnACashlessBasis" name="WarrantConversionsOnACashlessBasis" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_CantorFitzgeraldMember" name="CantorFitzgeraldMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock" name="PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_PercentageOfAggregateProceedsToPayOutstandingAmount" name="PercentageOfAggregateProceedsToPayOutstandingAmount" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_RealizedLossOnInvestmentsToCoverShortPosition" name="RealizedLossOnInvestmentsToCoverShortPosition" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_OperatingCostsAndExpenses1" name="OperatingCostsAndExpenses1" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_OptionToSellMaximumSharesValueUnderPurchaseAgreement" name="OptionToSellMaximumSharesValueUnderPurchaseAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_InterestPayableNoncurrent" name="InterestPayableNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_IssuanceOfSharesPurchaseTerm" name="IssuanceOfSharesPurchaseTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_NumberOfMedicareMembers" name="NumberOfMedicareMembers" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_CostOfClaimRecoveries" name="CostOfClaimRecoveries" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_RecoveryRightsInterest" name="RecoveryRightsInterest" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_TermSheetMember" name="TermSheetMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ChangeInFairValueOfDerivatives" name="ChangeInFairValueOfDerivatives" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_ClassOfWarrantsOrRightIssuedExercisePrice" name="ClassOfWarrantsOrRightIssuedExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims" name="LineOfCreditFacilityFundedForAcquiringAdditionalClaims" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_IntangibleAssetsNetTable" name="IntangibleAssetsNetTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ProfessionalFeesLegalMember" name="ProfessionalFeesLegalMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_AffiliatePayable" name="AffiliatePayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_PaymentsOfDeferredFinancingCosts" name="PaymentsOfDeferredFinancingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_UpCUnitHoldersMember" name="UpCUnitHoldersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_CommissionPayable" name="CommissionPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities" name="IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest" name="PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_NumberOfTenWarrantMember" name="NumberOfTenWarrantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock" name="TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_IntangibleAssetsNetLineItems" name="IntangibleAssetsNetLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_CostOfClaimRecoveriesPolicyTextBlock" name="CostOfClaimRecoveriesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_VirageRecoveryParticipationLpMember" name="VirageRecoveryParticipationLpMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_AllowanceForCreditLosses" name="AllowanceForCreditLosses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="mspr_AnnualCompoundedReturnOnContributionPercentage" name="AnnualCompoundedReturnOnContributionPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_PercentageOfSharesObtainedThroughWarrant" name="PercentageOfSharesObtainedThroughWarrant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="mspr_MsoMember" name="MsoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_NonControllingInterestsPolicyTextBlock" name="NonControllingInterestsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_ClaimsProceedsInvestmentAgreementMember" name="ClaimsProceedsInvestmentAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_PercentageOfPledge" name="PercentageOfPledge" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_ClassOfWarrantsOrRightConvertedExercisePrice" name="ClassOfWarrantsOrRightConvertedExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_SpecificContractMember" name="SpecificContractMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_IncreaseDeceaseInAffiliatesPayable" name="IncreaseDeceaseInAffiliatesPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_RepaymentOfTheClaimsFinancingObligation" name="RepaymentOfTheClaimsFinancingObligation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="mspr_TermLoanAMember" name="TermLoanAMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_SeriesMrcsLlcMember" name="SeriesMrcsLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_ClassOfWarrantConvertedDuringPeriod" name="ClassOfWarrantConvertedDuringPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="mspr_RestructuringPlanMember" name="RestructuringPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_MaomsoRecoveryLlcSeriesFhcpMember" name="MaomsoRecoveryLlcSeriesFhcpMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="mspr_TotalClaimsRecovery" name="TotalClaimsRecovery" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Apr. 10, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MSP Recovery, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-4117825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Miami<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">614-2222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3150 SW 38th Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001802450 <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,239,020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm Id</a></td>
<td class="text">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Deloitte & Touche LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Miami, Florida<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of MSP Recovery, Inc. and Subsidiaries (the "Company") as of December 31, 2024 and 2023, the related consolidated statements of operations, changes in equity, and cash flows, for each of the two years in the period ended December 31, 2024, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A common stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MSPR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,920,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mspr_ClassVCommonStockMember', window );">Class V Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,323,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember', window );">Redeemable Warrants, Each Lot of 625 Warrants Exercisable for One Share of Class A Common Stock at an Exercise Price of $7,187.50 Per Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Redeemable warrants, each lot of 625 warrants exercisable for one share of Class A common stock at an exercise price of $7,187.50 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MSPRW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember', window );">Redeemable Warrants, Each Lot of 625 Warrants Exercisable for One Share of Class A Common Stock at an Exercise Price of $0.0625 Per Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Redeemable warrants, each lot of 625 warrants exercisable for one share of Class A common stock at an exercise price of $0.0625 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MSPRZ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mspr_ClassVCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mspr_ClassVCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 12,328<span></span>
</td>
<td class="nump">$ 11,633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">295<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AffiliateReceivable', window );">Affiliate receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,204<span></span>
</td>
<td class="nump">1,188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,647<span></span>
</td>
<td class="nump">8,908<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,474<span></span>
</td>
<td class="nump">21,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,159<span></span>
</td>
<td class="nump">4,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">1,898,223<span></span>
</td>
<td class="nump">3,132,796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">227<span></span>
</td>
<td class="nump">342<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,919,083<span></span>
</td>
<td class="nump">3,159,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,971<span></span>
</td>
<td class="nump">6,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AffiliatePayable', window );">Affiliate payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">21,664<span></span>
</td>
<td class="nump">19,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_CommissionPayable', window );">Commission payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,342<span></span>
</td>
<td class="nump">821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">211<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_WarrantLiabilityCurrent', window );">Warrant liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">22,373<span></span>
</td>
<td class="nump">268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_GuarantyObligationCurrent', window );">Guaranty obligation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,126,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationNotesPayableCurrent', window );">Claims financing obligation and notes payable, current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">31,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Interest payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">33,298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">14,765<span></span>
</td>
<td class="nump">19,314<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,265,314<span></span>
</td>
<td class="nump">46,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_GuarantyObligationNoncurrent', window );">Guaranty obligation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">941,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationNotesPayable', window );">Claims financing obligation &amp; notes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">633,026<span></span>
</td>
<td class="nump">548,276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">102<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LoanFromRelatedPartiesNonCurrent', window );">Loan from related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">130,328<span></span>
</td>
<td class="nump">130,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_InterestPayableNoncurrent', window );">Interest payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">14,828<span></span>
</td>
<td class="nump">73,839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,047,492<span></span>
</td>
<td class="nump">1,740,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">546,635<span></span>
</td>
<td class="nump">357,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(446,050)<span></span>
</td>
<td class="num">(85,551)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100,585<span></span>
</td>
<td class="nump">272,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(228,994)<span></span>
</td>
<td class="nump">1,146,739<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(128,409)<span></span>
</td>
<td class="nump">1,419,129<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,919,083<span></span>
</td>
<td class="nump">$ 3,159,995<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of December 31, 2024 and 2023, total affiliate receivable, affiliate payable, warrant liability, guaranty obligation and loan from related parties balances are with related parties. In addition, the prepaid expenses and other current assets, claims financing obligation and notes payable, other current liabilities, and interest payable include balances with related parties. See Note 14, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Party Transactions, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for furthe</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">r details.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, intangible assets, net included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.2</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, related to a consolidated VIE. See Note 8,</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Variable Interest Entities</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for further details.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AffiliatePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Affiliate Payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AffiliatePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AffiliateReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Affiliate receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AffiliateReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClaimsFinancingObligationNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims financing obligation&#160;&amp; notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClaimsFinancingObligationNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClaimsFinancingObligationNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims financing obligation notes payable, current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClaimsFinancingObligationNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_CommissionPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_CommissionPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_GuarantyObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guaranty obligation current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_GuarantyObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_GuarantyObligationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guaranty obligation noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_GuarantyObligationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_InterestPayableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest payable noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_InterestPayableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_LoanFromRelatedPartiesNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loan From Related Parties Non Current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_LoanFromRelatedPartiesNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_WarrantLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant liability current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_WarrantLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,898,223<span></span>
</td>
<td class="nump">$ 3,132,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,500,000,000<span></span>
</td>
<td class="nump">5,500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,184,958<span></span>
</td>
<td class="nump">586,393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,184,958<span></span>
</td>
<td class="nump">586,393<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mspr_CommonClassVMember', window );">Class V Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,250,000,000<span></span>
</td>
<td class="nump">3,250,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,962,704<span></span>
</td>
<td class="nump">4,965,296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,962,704<span></span>
</td>
<td class="nump">4,965,296<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, intangible assets, net included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.2</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, related to a consolidated VIE. See Note 8,</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Variable Interest Entities</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for further details.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mspr_CommonClassVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mspr_CommonClassVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsRecoveryIncome', window );">Claims recovery income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 18,122<span></span>
</td>
<td class="nump">$ 7,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsRecoveryServiceIncome', window );">Claims recovery service income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_OtherClaimsRecoveryRevenues', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_TotalClaimsRecovery', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,249<span></span>
</td>
<td class="nump">7,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_CostOfClaimRecoveries', window );">Cost of revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,607<span></span>
</td>
<td class="nump">2,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsAmortizationExpense', window );">Claims amortization expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">484,076<span></span>
</td>
<td class="nump">476,492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">22,231<span></span>
</td>
<td class="nump">26,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,131<span></span>
</td>
<td class="nump">22,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Professional fees - legal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">9,519<span></span>
</td>
<td class="nump">34,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">752,697<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AllowanceForCreditLosses', window );">Allowance for credit losses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">277<span></span>
</td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,292,538<span></span>
</td>
<td class="nump">567,575<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,274,289)<span></span>
</td>
<td class="num">(559,870)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(420,032)<span></span>
</td>
<td class="num">(289,169)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">542<span></span>
</td>
<td class="nump">9,290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities', window );">Change in fair value of warrant and derivative liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">136,934<span></span>
</td>
<td class="nump">4,604<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before provision for income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,556,845)<span></span>
</td>
<td class="num">(835,145)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="num">(1,556,845)<span></span>
</td>
<td class="num">(835,145)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net loss attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,196,346<span></span>
</td>
<td class="nump">778,797<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to MSP Recovery, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (360,499)<span></span>
</td>
<td class="num">$ (56,348)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding, basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,001,525<span></span>
</td>
<td class="nump">356,591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding, diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,001,525<span></span>
</td>
<td class="nump">356,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (359.95)<span></span>
</td>
<td class="num">$ (158.02)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (359.95)<span></span>
</td>
<td class="num">$ (158.02)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding, basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,001,525<span></span>
</td>
<td class="nump">356,591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding, diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,001,525<span></span>
</td>
<td class="nump">356,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (359.95)<span></span>
</td>
<td class="num">$ (158.02)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (359.95)<span></span>
</td>
<td class="num">$ (158.02)<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, cost of Claim recoveries included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.4</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of related party expenses, respectively. This relates to contingent legal expenses earned from Claims recovery income pursuant to legal service agreements with the La Ley con John H. Ruiz P.A., d/b/a MSP Recovery Law Firm (the &#8220;Law Firm&#8221;). See Note 14, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for further details.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, general and administrative expenses included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of related party expenses, respectively</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024 and 2023, Professional Fees - Legal included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.7</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.2</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of related party expenses related to the Law Firm. See Note 14, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for further details.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024 and 2023, Interest expense included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">318.9</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">226.5</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of interest expense to related parties.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Balances include related party transactions.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> See Note 14,</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, f</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or further details.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AllowanceForCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AllowanceForCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrant and derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClaimsAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims amortization expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClaimsAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClaimsRecoveryIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims recovery income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClaimsRecoveryIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClaimsRecoveryServiceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims recovery service income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClaimsRecoveryServiceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_CostOfClaimRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of claim recoveries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_CostOfClaimRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_OtherClaimsRecoveryRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other claims recovery revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_OtherClaimsRecoveryRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_TotalClaimsRecovery">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total claims recovery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_TotalClaimsRecovery</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsRecoveryServiceIncome', window );">Claims recovery service income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 420,032<span></span>
</td>
<td class="nump">289,169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Related party expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">200<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">318,900<span></span>
</td>
<td class="nump">226,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryLawFirmMember', window );">MSP Recovery Law Firm [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Related party expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,700<span></span>
</td>
<td class="nump">19,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryLawFirmMember', window );">MSP Recovery Law Firm [Member] | Related Party [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Related party expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024 and 2023, Interest expense included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">318.9</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">226.5</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of interest expense to related parties.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClaimsRecoveryServiceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims recovery service income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClaimsRecoveryServiceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryLawFirmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryLawFirmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Total</div></th>
<th class="th">
<div>Common Stock [Member] </div>
<div>Class A Common Stock [Member]</div>
</th>
<th class="th">
<div>Common Stock [Member] </div>
<div>Class V Stock [Member]</div>
</th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Non-&#160;Controlling Interests [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2022</a></td>
<td class="nump">$ 2,185,465<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137,082<span></span>
</td>
<td class="num">$ (29,203)<span></span>
</td>
<td class="nump">$ 2,077,586<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning of period, shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">119,369<span></span>
</td>
<td class="nump">5,036,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_StockIssuedDuringPeriodValueConversionOfWarrants', window );">Conversion of Warrants</a></td>
<td class="nump">258<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_StockIssuedDuringPeriodSharesConversionOfWarrants', window );">Conversion of Warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Class A Issuances</a></td>
<td class="nump">68,551<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">220,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(151,850)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Class A Issuances, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">466,433<span></span>
</td>
<td class="num">(71,472)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(835,145)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56,348)<span></span>
</td>
<td class="num">(778,797)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period, shares at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">586,393<span></span>
</td>
<td class="nump">4,965,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Dec. 31, 2023</a></td>
<td class="nump">1,419,129<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">357,941<span></span>
</td>
<td class="num">(85,551)<span></span>
</td>
<td class="nump">1,146,739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Class A Issuances</a></td>
<td class="nump">9,307<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(179,387)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Class A Issuances, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,598,565<span></span>
</td>
<td class="num">(2,592)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(1,556,845)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(360,499)<span></span>
</td>
<td class="num">(1,196,346)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period, shares at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,184,958<span></span>
</td>
<td class="nump">4,962,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Dec. 31, 2024</a></td>
<td class="num">$ (128,409)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 546,635<span></span>
</td>
<td class="num">$ (446,050)<span></span>
</td>
<td class="num">$ (228,994)<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Balances include related party transactions.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> See Note 14,</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, f</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or further details.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_StockIssuedDuringPeriodSharesConversionOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares conversion of warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_StockIssuedDuringPeriodSharesConversionOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_StockIssuedDuringPeriodValueConversionOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value conversion of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_StockIssuedDuringPeriodValueConversionOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (1,556,845,000)<span></span>
</td>
<td class="num">$ (835,145,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">277,000<span></span>
</td>
<td class="nump">263,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsAmortizationExpense', window );">Claims amortization expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">484,076,000<span></span>
</td>
<td class="nump">476,492,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Paid-in-kind interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">278,800,000<span></span>
</td>
<td class="nump">214,380,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">752,697,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AllowanceForCreditLosses', window );">Allowance for credit losses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(137,095,000)<span></span>
</td>
<td class="num">(4,785,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ChangeInFairValueOfDerivatives', window );">Change in fair value of derivatives</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">161,000<span></span>
</td>
<td class="nump">181,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfIntangibleAssets', window );">Gain on sale of intangibles</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,599,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">830,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_MarkToMarketGainOnLiabilityPayableInStock', window );">Mark-to-market gain on liability payable in stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(545,000)<span></span>
</td>
<td class="num">(4,431,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ProfessionalFeesSettledInShares', window );">Professional fees settled in shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,072,000<span></span>
</td>
<td class="nump">2,745,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(78,000)<span></span>
</td>
<td class="nump">542,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,261,000<span></span>
</td>
<td class="nump">18,999,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_IncreaseDeceaseInAffiliatesReceivable', window );">Affiliate receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(17,000)<span></span>
</td>
<td class="nump">1,238,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_IncreaseDeceaseInAffiliatesPayable', window );">Affiliate payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,842,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities', window );">Accounts payable, commission payable and accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,100,000<span></span>
</td>
<td class="nump">13,513,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Interest Payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">141,167,000<span></span>
</td>
<td class="nump">74,752,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(16,121,000)<span></span>
</td>
<td class="num">(40,023,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(525,000)<span></span>
</td>
<td class="num">(1,742,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchases of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,200,000)<span></span>
</td>
<td class="num">(700,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfIntangibleAssets', window );">Proceeds from sale of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,725,000)<span></span>
</td>
<td class="nump">7,558,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from debt financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,500,000<span></span>
</td>
<td class="nump">39,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PaymentsOfDeferredFinancingCosts', window );">Deferred financing costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(250,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(708,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PaymentsOnRelatedPartyLoan', window );">Payments on related party loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(382,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds on related party loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,950,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ReleaseOfTemporaryEquityForPayments', window );">Release of temporary equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(11,420,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_RepaymentOfTheClaimsFinancingObligation', window );">Repayment of the Claims financing obligation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,640,000)<span></span>
</td>
<td class="num">(2,555,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from the issuance of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,063,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,541,000<span></span>
</td>
<td class="nump">29,017,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">695,000<span></span>
</td>
<td class="num">(3,448,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at beginning of year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,633,000<span></span>
</td>
<td class="nump">15,081,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,328,000<span></span>
</td>
<td class="nump">11,633,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of&#160;non-cash&#160;investing and financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_SaleOfIntangibleAssets', window );">Sale of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">30,987,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_IntangibleAssetsFinancedByNotePayable', window );">Purchase of intangible asset financed by note payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ReleaseOfTemporaryEquityDuringNonCash', window );">Release of temporary equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,807,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_OriginalIssueDiscountOfNonCash', window );">Original issue discount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,750,000<span></span>
</td>
<td class="nump">20,167,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock', window );">Purchase of intangible asset through issuance of Class A common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">833,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of shares in settlement of debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,063,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock', window );">Payment of professional fees through issuance of Class A common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,072,000<span></span>
</td>
<td class="nump">4,745,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets', window );">Non-cash lease liabilities arising from obtaining right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">376,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability', window );">Payment of Cano Health payment in shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">61,690,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_WarrantConversionsOnACashlessBasis', window );">Warrant conversions on a cashless basis</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">258,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_CashPaidDuringThePeriodAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,384,000<span></span>
</td>
<td class="nump">$ 37,000<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Balances include related party transactions.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> See Note 14,</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, f</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or further details.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AllowanceForCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AllowanceForCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_CashPaidDuringThePeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_CashPaidDuringThePeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ChangeInFairValueOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ChangeInFairValueOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClaimsAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims amortization expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClaimsAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_IncreaseDeceaseInAffiliatesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>increase decease in affiliates payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_IncreaseDeceaseInAffiliatesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_IncreaseDeceaseInAffiliatesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decease in affiliates receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_IncreaseDeceaseInAffiliatesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in accounts payable, commission payable and accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_IntangibleAssetsFinancedByNotePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible assets financed by note payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_IntangibleAssetsFinancedByNotePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_MarkToMarketGainOnLiabilityPayableInStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mark to market Gain on liability payable in stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_MarkToMarketGainOnLiabilityPayableInStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-cash lease liabilities arising from obtaining right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_OriginalIssueDiscountOfNonCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Original issue discount of non cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_OriginalIssueDiscountOfNonCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of professional fees through issuance of Class A common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PaymentsOfDeferredFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments of deferred financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PaymentsOfDeferredFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PaymentsOnRelatedPartyLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments on related party loan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PaymentsOnRelatedPartyLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ProfessionalFeesSettledInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Professional fees settled in shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ProfessionalFeesSettledInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase of intangible asset through issuance of class A common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ReleaseOfTemporaryEquityDuringNonCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Release Of Temporary Equity During Non Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ReleaseOfTemporaryEquityDuringNonCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ReleaseOfTemporaryEquityForPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Release of temporary equity for payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ReleaseOfTemporaryEquityForPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_RepaymentOfTheClaimsFinancingObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayment of the Claims financing obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_RepaymentOfTheClaimsFinancingObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_SaleOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_SaleOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_WarrantConversionsOnACashlessBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant conversions on a cashless basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_WarrantConversionsOnACashlessBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the liability as of the balance sheet date to an individual under a deferred compensation arrangement. This amount may be the result of periodic accruals made over the period of active employment, or reflect termination benefits resulting contractual terms or a death benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483043/710-10-30-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cyber Security Risk Management, Strategy, and Governance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p id="item1c" style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. Cybers</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ecurity.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company maintains robust processes for assessing, identifying, and managing material risks from cybersecurity threats. We are subject to federal and state laws and regulations governing privacy, security, and breaches of patient information and the conduct of certain electronic health care transactions, including, the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) and other health information privacy and security requirements. We rely on information technology networks and systems to process and store electronic information. We collect and store sensitive data, including PHI on our information technology networks. As we collect and manage large quantities of data, it is possible that hardware failures or errors in our systems could result in data loss or corruption or cause the information that we collect to be incomplete or contain inaccuracies that our partners regard as significant. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Increased global cybersecurity vulnerabilities, threats, computer viruses, ransomware and phishing attacks, and more sophisticated and targeted cyber-related attacks, as well as cybersecurity failures resulting from human error and technological errors, pose a risk to the security of the Company&#8217;s systems and networks and the confidentiality, availability, and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">integrity</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">data on these products, systems, and networks. We have implemented security measures designed to prevent disruptions and shutdowns of our information technology networks due to attacks by hackers or breaches due to malfeasance by contractors, employees and others who have access to our networks and systems. </span></span><span style=""></span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expect to continue to invest in long-term solutions to protect against cybersecurity risks and threats.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Except as otherwise provided herein, this Item 1C reflects the Company&#8217;s cybersecurity policies and procedures as of December 31, 2024.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2024, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we did not identify any cybersecurity threats that would have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or financial condition</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. However, despite our efforts, we cannot eliminate all risks from cybersecurity threats, or provide assurances that we have not experienced undetected cybersecurity incidents. For additional information about these risks, see Part I, Item 1A, &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors&#8201;&#8212;&#8201;Risks Related to IT Systems and Cybersecurity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; in this Annual Report.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risk Management and Strategy</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Company employs an IT Security Team that is responsible for assessing and managing cybersecurity risks.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has a designated IT Security Team to maintain its cybersecurity program and oversee third-party service providers that provide cybersecurity protection. The IT Security Team is tasked with the prevention, detection, mitigation, and remediation of cybersecurity incidents through a variety of technical and operational measures, and reports to our DevOPS/Security Manager. The team is comprised of personnel with a broad range of experience across the business and information technology industries, including our DevOPS/Security Manager, and employees in senior legal and administrative roles. The IT Security Team relies on the advice of the Manager DevOPS/Security related to the security of our data and any mitigation steps necessary.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our DevOPS/Security Manager leads our cybersecurity program and is tasked with supporting our security functions of identifying, preventing, detecting, responding to, and recovering from cybersecurity threats and incidents. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The DevOPS/Security Manager has 28 years of experience in IT networking, administration, and security related roles, including nine years at the Company. Prior to joining the Company, our DevOPS/Security Manager served for 15 years in a senior leadership role in the IT department of a large, publicly traded Fortune 500 company.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The DevOPS/Security Manager reports directly to the Company&#8217;s Chief Technology Officer, and provides quarterly updates to the Cybersecurity Subcommittee on the Company&#8217;s cybersecurity program, including cybersecurity risks, incidents, and mitigation strategies.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The identification of cybersecurity risks is a continuous and evolving assessment. As a data company, we are subject to cybersecurity risks. We have identified certain cybersecurity risks specific to our business, which are identified above in Part I, Item 1A, &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk Factors&#8201;&#8212;&#8201;Risks Related to IT Systems and Cybersecurity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; in this Annual Report.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Company has established processes for assessing, identifying, and managing material risks from cybersecurity threats.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company utilizes a hybrid platform consisting of a local and cloud environment. Our local environment connects to the cloud environment via an encrypted virtual private network (&#8220;VPN&#8221;) connection. Our Site-to-Site connection consists of a firewall in our local environment which responds to a connection from a firewall in our cloud. Our networks have segregated subnets, and only allow designated staff access to our cloud environment, which is only accessible from one of our local office segments. All firewalls are configured with intrusion detection systems and intrusion prevention systems, strict firewall rules, denial of service, spoof protection, advanced threat protection, and zero-day protection. Our firewalls are configured to receive definition updates as they are released, and firmware updates are automatically installed when available. We secure our local network by not utilizing any wireless access points connected to any of our networks or firewalls, enabling port security on switches, following a principle of least privilege policy, and implementing Security Information &amp; Event Management (&#8220;SIEM&#8221;) to capture all network traffic &amp; security events from both networking equipment, endpoints, and servers. We enforce a strict password policy with multi-factor authentication.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All computers and servers utilized by the Company are protected by endpoint protection, which provides real-time protection of local and network files, internet activity, and utilizes ransomware protection, application protection, malicious behavior protection, anti-malware scan interface protection, file integrity monitoring, and data loss prevention. Our endpoint protection software updates immediately upon definition releases. This endpoint has live protection and performs a deep system scan daily. Our endpoint protection products are managed by our IT Security Team via a dashboard that provides our team with immediate alerts, device isolation, and investigation features, and also contracted the use of a Managed Detection and Response (&#8220;MDR&#8221;) service. The MDR service monitors our protected endpoints, servers, and network equipment at all times. This service also investigates, eliminates, and mitigates any critical alerts, while notifying our IT Security Team issues identified. All endpoints and servers are updated with security patches and application updates to our systems from a Patch Management system.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our IT Security Team reviews security logs daily, and performs quarterly audits of device access, building access, outages, application access, and IT &amp; Development tickets. We employ data loss prevention policies to enforce HIPAA rules and also use stringent encryption controls. In addition, a Vulnerability Scanning system performs vulnerability detection on a quarterly basis. An independent third-party company conducts annual penetration and vulnerability detection as well.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our offices are physically secured with key card access controls for parking and floor access. In addition, security guards monitor building reception areas and parking garages, and receptionists are located in our lobbies to greet visitors.</span></p></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Company engages assessors, consultants, auditors, or other third parties in connection with its cybersecurity processes.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">engages</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> third </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">party vendors in connection with our cybersecurity processes, including penetration and vulnerability scanning, auditing of our information security management program (ISMP); and a provider of products and services to secure users, networks, and endpoints against ransomware, malware, exploits, phishing and the wide range of other cyberattacks. In addition, the Company engaged national accounting and advisory services firms to audit the operating effectiveness of our security program, which</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">incorporates </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cybersecurity in our processes. On an annual basis, the Company conducts a SOC 2 Type II audit and a HITRUST assessment.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SOC 2 Type II audits assess risks from interactions with the Company&#8217;s systems, particularly information about system controls that the Company has designed, implemented, and operated to provide reasonable assurance that its service commitments and system requirements were achieved based on the SOC 2 trust services criteria.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A HITRUST assessment address the need for a continuously relevant cybersecurity assessment that incorporates best practices and leverages the latest threat intelligence to maintain applicability with information security risks and emerging cyber threats, such as ransomware and phishing. HITRUST assessments also provide a level of assurance that delivers full transparency, accuracy, consistency, and integrity.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2023, the Company engaged a HITRUST Authorized External Assessor and AICPA member firm	`, which completed independent assessments of MSP Recovery&#8217;s system. These independent assessments verified that we met the healthcare industry&#8217;s highest standards in protecting healthcare information and mitigating this risk, including compliance with the HIPAA Security Rule. On October 13, 2023, HITRUST certified that the platforms, facilities, and supporting infrastructure of our organization meet the HITRUST CSF&#174; v11 Implemented, 1-year (i1) certification criteria. For our cloud computing services, we currently use Amazon Web Services (&#8220;AWS&#8221;) which is also HITRUST certified. On June 14, 2024, an Independent Service Auditor provided MSP Recovery a report opining that our data recovery system&#8217;s commitments and system requirements meet or exceed the stringent SOC 2 Type II applicable trust services criteria.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Company has processes to oversee and identify risks from cybersecurity threats associated with its use of third-party service providers.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company maintains specific policies and practices governing our third-party security risks, including our third-party assessment (&#8220;TPA&#8221;) process. Under our TPA process, we gather information from certain third parties who contract with the Company and share or receive data, or have access to or integrate with our systems, in order to help us assess potential risks associated with their security controls. We also generally require third parties to, among other things, utilize encrypted secure file transfer protocols to exchange data. We require counterparties to enter into Business Associate Agreements and Non-Disclosure Agreements that, among other things, require them to maintain security controls to protect our confidential information and data, and notify us of material data breaches that may impact our data.</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governance</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Board has established a Cybersecurity Subcommittee of the Audit Committee responsible for the oversight of risks from cybersecurity threats.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 7, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Board established the Cybersecurity Subcommittee of the Audit Committee (the &#8220;Cybersecurity Subcommittee&#8221;) to assist the Board in fulfilling its oversight responsibilities with respect to assessing and mitigating the Company&#8217;s cybersecurity risks.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s management, under the guidance of the IT Security Team, is responsible for the preparation, presentation, and self-assessment of the Company&#8217;s cybersecurity policies and practices.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Cybersecurity Subcommittee shall be comprised of at least one independent director, and is tasked with reviewing and providing high level guidance on cybersecurity-related issues of importance to the Company.</span></span></span></p><div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The IT Security Team reports to the Cybersecurity Subcommittee on a quarterly basis to inform the committee about and monitoring, prevention, detection, mitigation, and remediation of cybersecurity incidents</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and is tasked with notifying the Cybersecurity Subcommittee of a cybersecurity incident upon discovery. The Cybersecurity Subcommittee held three meetings during the year ended December 31, 2024.</span></p></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Increased global cybersecurity vulnerabilities, threats, computer viruses, ransomware and phishing attacks, and more sophisticated and targeted cyber-related attacks, as well as cybersecurity failures resulting from human error and technological errors, pose a risk to the security of the Company&#8217;s systems and networks and the confidentiality, availability, and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">integrity</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">data on these products, systems, and networks. We have implemented security measures designed to prevent disruptions and shutdowns of our information technology networks due to attacks by hackers or breaches due to malfeasance by contractors, employees and others who have access to our networks and systems. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expect to continue to invest in long-term solutions to protect against cybersecurity risks and threats.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Governance</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Board has established a Cybersecurity Subcommittee of the Audit Committee responsible for the oversight of risks from cybersecurity threats.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 7, 2024, </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Board established the Cybersecurity Subcommittee of the Audit Committee (the &#8220;Cybersecurity Subcommittee&#8221;) to assist the Board in fulfilling its oversight responsibilities with respect to assessing and mitigating the Company&#8217;s cybersecurity risks.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s management, under the guidance of the IT Security Team, is responsible for the preparation, presentation, and self-assessment of the Company&#8217;s cybersecurity policies and practices.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Cybersecurity Subcommittee shall be comprised of at least one independent director, and is tasked with reviewing and providing high level guidance on cybersecurity-related issues of importance to the Company.</span></span></span></p><div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The IT Security Team reports to the Cybersecurity Subcommittee on a quarterly basis to inform the committee about and monitoring, prevention, detection, mitigation, and remediation of cybersecurity incidents</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and is tasked with notifying the Cybersecurity Subcommittee of a cybersecurity incident upon discovery. The Cybersecurity Subcommittee held three meetings during the year ended December 31, 2024.</span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The IT Security Team reports to the Cybersecurity Subcommittee on a quarterly basis to inform the committee about and monitoring, prevention, detection, mitigation, and remediation of cybersecurity incidents</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and is tasked with notifying the Cybersecurity Subcommittee of a cybersecurity incident upon discovery. The Cybersecurity Subcommittee held three meetings during the year ended December 31, 2024.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s management, under the guidance of the IT Security Team, is responsible for the preparation, presentation, and self-assessment of the Company&#8217;s cybersecurity policies and practices.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Cybersecurity Subcommittee shall be comprised of at least one independent director, and is tasked with reviewing and providing high level guidance on cybersecurity-related issues of importance to the Company.</span></span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Company has established processes for assessing, identifying, and managing material risks from cybersecurity threats.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company utilizes a hybrid platform consisting of a local and cloud environment. Our local environment connects to the cloud environment via an encrypted virtual private network (&#8220;VPN&#8221;) connection. Our Site-to-Site connection consists of a firewall in our local environment which responds to a connection from a firewall in our cloud. Our networks have segregated subnets, and only allow designated staff access to our cloud environment, which is only accessible from one of our local office segments. All firewalls are configured with intrusion detection systems and intrusion prevention systems, strict firewall rules, denial of service, spoof protection, advanced threat protection, and zero-day protection. Our firewalls are configured to receive definition updates as they are released, and firmware updates are automatically installed when available. We secure our local network by not utilizing any wireless access points connected to any of our networks or firewalls, enabling port security on switches, following a principle of least privilege policy, and implementing Security Information &amp; Event Management (&#8220;SIEM&#8221;) to capture all network traffic &amp; security events from both networking equipment, endpoints, and servers. We enforce a strict password policy with multi-factor authentication.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All computers and servers utilized by the Company are protected by endpoint protection, which provides real-time protection of local and network files, internet activity, and utilizes ransomware protection, application protection, malicious behavior protection, anti-malware scan interface protection, file integrity monitoring, and data loss prevention. Our endpoint protection software updates immediately upon definition releases. This endpoint has live protection and performs a deep system scan daily. Our endpoint protection products are managed by our IT Security Team via a dashboard that provides our team with immediate alerts, device isolation, and investigation features, and also contracted the use of a Managed Detection and Response (&#8220;MDR&#8221;) service. The MDR service monitors our protected endpoints, servers, and network equipment at all times. This service also investigates, eliminates, and mitigates any critical alerts, while notifying our IT Security Team issues identified. All endpoints and servers are updated with security patches and application updates to our systems from a Patch Management system.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our IT Security Team reviews security logs daily, and performs quarterly audits of device access, building access, outages, application access, and IT &amp; Development tickets. We employ data loss prevention policies to enforce HIPAA rules and also use stringent encryption controls. In addition, a Vulnerability Scanning system performs vulnerability detection on a quarterly basis. An independent third-party company conducts annual penetration and vulnerability detection as well.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our offices are physically secured with key card access controls for parking and floor access. In addition, security guards monitor building reception areas and parking garages, and receptionists are located in our lobbies to greet visitors.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Cybersecurity Subcommittee shall be comprised of at least one independent director, and is tasked with reviewing and providing high level guidance on cybersecurity-related issues of importance to the Company.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The DevOPS/Security Manager has 28 years of experience in IT networking, administration, and security related roles, including nine years at the Company. Prior to joining the Company, our DevOPS/Security Manager served for 15 years in a senior leadership role in the IT department of a large, publicly traded Fortune 500 company.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The IT Security Team reports to the Cybersecurity Subcommittee on a quarterly basis to inform the committee about and monitoring, prevention, detection, mitigation, and remediation of cybersecurity incidents</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (360,499)<span></span>
</td>
<td class="num">$ (56,348)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of the Business</a></td>
<td class="text"><p id="footnotes" style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 1. DESCRIPTION OF THE BUSINESS</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 23, 2022 (the &#8220;Closing Date&#8221;), MSP Recovery, Inc., a Delaware corporation (formerly known as Lionheart Acquisition Corporation II (&#8220;LCAP&#8221;)) consummated the previously announced business combination pursuant to that certain Membership Interest Purchase Agreement, dated as of July 11, 2021, as amended (the &#8220;MIPA&#8221;), by and among the Company, Lionheart II Holdings, LLC, a wholly owned subsidiary of the Company, MSP Recovery, LLC and combined and consolidated subsidiaries (&#8220;Legacy MSP&#8221;), the members of Legacy MSP (the &#8220;Members&#8221;), and John H. Ruiz, in his capacity as the representative of the Members (the &#8220;Members&#8217; Representative&#8221;). Pursuant to the MIPA, the Members sold and assigned all of their membership interests in Legacy MSP to the Company in exchange for non-economic voting shares of Class V common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, of the Company (&#8220;Class V Common Stock&#8221;) and non-voting economic Class B Units of Opco (&#8220;Class B Units,&#8221; and each pair consisting of one share of Class V Common Stock and one Class B Unit, an &#8220;Up-C Unit&#8221;) (such transaction, the &#8220;Business Combination&#8221;).</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">T</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">he Company is organized in an &#8220;Up-C&#8221; structure in which all of the business of Legacy MSP and its subsidiaries is held directly or indirectly by the Company, the Company is the managing member, consolidates Legacy MSP and the Company owns all of the voting economic Class A Units and the Members and their designees own all of the non-voting economic Class B Units in accordance with the terms of the first amended and restated limited liability company agreement of the Company. Each Up-C Unit may be exchanged for either, at the Company&#8217;s option, (a) cash or (b) one share of Class A common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, of the Company (&#8220;Class A Common Stock&#8221;), subject to the provisions set forth in the LLC Agreement. The aggregate consideration paid to the Members (or their designees) at the Closing consisted of: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,200,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Units and (ii) rights to receive payments under the Tax Receivable Agreement (&#8220;TRA&#8221;), discussed in more detail below.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legacy MSP was organized in 2014 as a Medicaid and Medicare Secondary Payer Act recovery specialist. The Company utilizes its proprietary internal data analytics platform to review health Claims assigned by secondary payers such as health plans, MSOs, providers of medical services, and independent physicians associations. This platform allows the Company to identify Claims cost recovery rights with potential recovery paths where Claims either should not have been paid by the secondary payers or should have been reimbursed by third-party entities.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MSP Recovery is assigned recovery rights to Claims by secondary payers via CCRAs. Prior to executing a CCRA, MSP Recovery utilizes its proprietary internal data analytics platform to review the set of Claims of a prospective Assignor to identify Claims with probable recovery paths. MSP Recovery&#8217;s assets are these irrevocable broad assignments of health Claims recovery rights that are supported by federal and state laws and regulations. MSP Recovery&#8217;s offices are located in the U.S. and Puerto Rico.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Warrants</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Public Warrants</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the terms of the Existing Warrant Agreement, and after giving effect to the issuance of the New Warrants, as defined below, the exercise price of the Public Warrants increased to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0625</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share of Class A Common Stock, on a cashless basis, in lots of 625. During the period from the Closing Date to December 31, 2024, approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million war</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">rants of the orig</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inal </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">warrants had been exercised. For the years ended December 31, 2024 and 2023, the fair value of the remaining unexercised warrants decreased resulting in other income</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, which is recorded within change in fair value of warrant and derivative liabilities in the consolidated statements of operations.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">New Warrants</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, in connection with the Business Combination, the Company declared</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the New Warrant Dividend comprising approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,028</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million New Warrants payable to the holders of record of the Class A Common Stock as of the close of business on the Closing Date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The New Warrants expire on the fifth anniversary of the Closing Date or upon earlier redemption. The Company determined that the New Warrants instruments meet the equity scope exception in ASC 815 to be </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">classified in stockholders&#8217; equity, and as the repurchase right noted above has a mirrored value designed to offset the New Warrants, if exercised would be an equity only transaction. The New Warrants are each exercisable in lots of 625 for one whole share of Class A Common Stock at a reverse split adjusted exercise price $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,187.50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per whole share. The New Warrants are subject to certain anti-dilution adjustments.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Public Warrants and New Warrants are currently listed on Nasdaq under the symbols &#8220;MSPRZ&#8221; and &#8220;MSPRW,&#8221; respectively.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Tax Receivable Agreement</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Business Combination, the Company also entered into a Tax Receivable Agreement (the &#8220;TRA&#8221;). Pursuant to the TRA, the Company is required to pay the sellers </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the amount of tax benefits that the Company actually realizes as a result of (i) the Company&#8217;s direct and indirect allocable share of existing tax basis acquired in the Business Combination, (ii) increases in the Company&#8217;s allocable share of existing tax basis and tax basis adjustments that will increase the tax basis of the tangible and intangible assets of the Company as a result of the Business Combination and as a result of sales or exchanges of Up-C Units for cash or shares of Class A Common Stock, and (iii) certain other tax benefits related to entering into the TRA, including tax benefits attributable to payments under the TRA.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended December 31, 2024 and 2023, the Company&#8217;s TRA liability associated with the allocable share of existing tax basis acquired in the Business Combination would give rise to a TRA liability of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. The Company has not recognized such liabilities under the TRA after concluding it was not probable that the Company will be able to realize the remaining tax benefits based on estimates of future taxable income. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> payments were made to the Continuing Equity Owners and Blocker Shareholders (as defined in the TRA) pursuant to the TRA during the years ended December 31, 2024, or 2023. The estimation of liability under the tax receivable agreement is by its nature imprecise and subject to significant assumptions regarding the amount, character, and timing of the taxable income of MSP Recovery, Inc. in the future. We may incur additional liabilities under the TRA when Lionheart II Holdings, LLC are exchanged in the future. If the valuation allowance recorded against the deferred tax assets applicable to the tax attributes subject to the TRA is released in a future period, the relating TRA liability may be considered probable at that time and recorded within earnings.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has assessed the realizability of the net deferred tax assets and, in that analysis, has considered the relevant positive and negative evidence available to determine whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The Company has recorded a full valuation allowance against the deferred tax assets as of December 31, 2024 and 2023, which will be maintained until there is sufficient evidence to support the reversal of all or some portion of these allowances. As the tax benefits associated with the TRA have not be recognized, based on estimates of future taxable income, the Company has concluded it is not probable to recognize any tax receivable agreement liability. If the valuation allowance recorded against the deferred tax assets is released in a future period, the Tax Receivable Agreement liability may be considered probable at that time and recorded within earnings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Non-Controlling Interest</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company reflects non-controlling interests due to the Up-C structure. The Company holds all of the voting Class A Units of Opco, whereas the Members (or their designees) hold all of the non-voting economic Class B Units of Opco (these Class B Units represent the non-controlling interest in the Company). The ownership percentage of Class V Common Stock held in the Company by the Members (or their designees) will be equivalent to the number of Class B Units held in the Company, and as such, reflects non-controlling interest in the Company, which is equivalent to the Class V Common Stock ownership percentage. See Note 11, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Noncontrolling Interest</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for more information on ownership interests in the Company</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reverse Stock Splits</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective at 11:59 PM EDT on November 15, 2024, the Company amended its Charter filed with the Secretary of State of the State of Delaware to effect a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_51bd4aa3-2e94-4fa0-8f20-4260f6251be5;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1-for-25</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reverse stock split of the Company&#8217;s common stock (the &#8220;2024 Reverse Split&#8221;). The Company&#8217;s Class A Common Stock began trading post split on November 18, 2024. As a result of the 2024 </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reverse Split, every 25 shares of the Company&#8217;s old common stock were converted into one share of the Company&#8217;s new common stock. </span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fractional shares resulting from the 2024 Reverse Split were rounded up to the nearest whole number. The 2024 Reverse Split automatically and proportionately adjusted, based on the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_11cad189-e838-4ea3-9011-9fb880f04e08;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1-for-25</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> split ratio, all issued and outstanding shares of the Company&#8217;s common stock, as well as the terms of warrants and other derivative securities outstanding at the time of the effectiveness of the 2024 Reverse Split. Proportionate adjustments were made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options and warrants to purchase shares of common stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 12, 2023, we amended our Charter with the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Secretary of State of the State of Delaware to effect a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_6dbb5636-fa51-4f4c-bb43-bb758434c2c0;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1-for-25</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reverse stock split (the &#8220;2023 Reverse Split&#8221;) of the Company&#8217;s common stock, effective October 13, 2023.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise stated, all share and per shares numbers (except par value) in this Annual Report on Form 10-K have been adjusted to reflect the 2024 Reverse Split and 2023 Reverse Split.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Primary Market Change</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 6, 2024, the Company received notification from the Staff that the Company&#8217;s application to transfer the listing of its common stock from the Nasdaq Global Market to the Nasdaq Capital Market was approved. The Company&#8217;s securities transferred to the Nasdaq Capital Market at the opening of business on December 10, 2024, and continue to trade under the symbol &#8220;MSPR.&#8221; The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market, and listed companies must meet certain financial requirements and comply with Nasdaq&#8217;s corporate governance requirements.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Symbol Change</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective December 9, 2024, the Company rebranded all lines of business under the MSP Recovery brand, and the Company&#8217;s Class A Common Stock, New Warrants, and Public Warrants begin trading on Nasdaq under the ticker symbols &#8220;MSPR,&#8221; &#8220;MSPRW,&#8221; and &#8220;MSPRZ,&#8221; respectively. Prior to this change, the Company was known as LifeWallet.</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Going Concern</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As an early-stage growth company, the Company has incurred substantial net losses since inception. As of December 31, 2024, the Company had unrestricted cash and cash equivalents totaling </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company has incurred recurring losses and negative cash flows since inception and has an accumulated deficit of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_86dbe84b-548c-486d-9e3f-7db44ea29333;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">446.1 </span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of December 31, 2024. For the year ended December 31,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024, the Company used approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of cash in operations. The Company&#8217;s liquidity will depend on the ability to generate substantial Claims recovery income and Claims recovery services income in the near future, the timing and amount of which is uncertain, as well as its ability to secure funding from capital sources. The Company&#8217;s principal liquidity needs have been working capital, debt service, and Claims financing obligations.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company anticipates sources of liquidity to include up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in bridge loan funding to the Company under the existing Operational Collection Floor facility (in addition to the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million previously funded under the facility) in the amounts of: (i) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for March 2025, which was funded on February 28, 2025; (ii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for April 2025, which was funded on April 4, 2025; (iii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for May 2025, to be funded on or about April 30, 2025; (iv) up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to fund the legal, accounting, and administrative expenses associated with the reorganization, subject to certain terms and customary conditions acceptable to Hazel, and minimum license fees of (v) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.55</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for June 2025; and (vi) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.55</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for July 2025, as well as the Yorkville SEPA as disclosed in more detail in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Note 9,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Claims Financing Obligations and Notes Payable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and beyond July 2025, the MSP Principals&#8217; commitment to pledge $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of collateral to backstop additional working capital requirements of the Company. The Company </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">has taken several actions to address liquidity concerns, including actions enumerated below. However, as discussed further below, the Company has concluded management&#8217;s plans were not sufficient to alleviate the substantial doubt about the Company&#8217;s ability to continue as a going concern:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 29, 2023, the Company&#8217;s subsidiary, Subrogation Holdings, LLC and its parent, MSP Recovery, entered into the Working Capital Credit Facility consisting of commitments to fund up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in proceeds. Certain terms were amended to the Working Capital Credit Facility, which were memorialized in the Second Amended and Restated First Lien Credit Agreement dated November 10, 2023. See summary in &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hazel Working Capital Credit Facility and Hazel Purchase Money Loan</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; in Note 9,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Claims Financing Obligations and Notes Payable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements. On August 2, 2024, HPH agreed to, among other things, (i) extend the period for the Company draw up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for working capital, accessible in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">eight</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> tranches of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, that can be drawn at least one month apart, until September 2025 and (ii) provide for a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million loan to be funded by August 31, 2024 for the purpose of acquiring the New Claims. On January 30, 2025, the Company drew the final $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million tranche for working capital. Pursuant to the OCF Amendment, HPH may, at its sole discretion, increase the Operational Collection Floor by an amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, to be funded over a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_b0a040b1-eb30-4c2e-913a-8367a95bb387;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">six months</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 28, 2025 and April 4, 2025, HPH exercised that discretion and funded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, from the increase to the Operational Collection Floor; said payments are considered part of the bridge loan, as set forth in the proposed reorganization term sheet. An additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million remains available under the Operational Collection Floor, to be funded at HPH&#8217;s sole discretion.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 13, 2023, the Company entered into the MTA Amendment No. 2 and Amendment to the Amended and Restated Security Agreement (&#8220;Second Virage MTA Amendment&#8221;), which extended the due date for the payment obligations to Virage to December 31, 2024. See summary in Note 3,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Material Agreements </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements. On April 1, 2024, the Company entered into the MTA Amendment No. 3 and Amendment No. 2 to the Amended and Restated Security Agreement (&#8220;Third Virage MTA Amendment&#8221;), which: (i) extended the VRM Full Return payment due date to September 30, 2025, subject to acceleration upon certain triggering events; (ii) the Company agreed that, after the Yorkville Convertible Notes are fully satisfied, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the Company&#8217;s portion of any net proceeds from the Yorkville SEPA would be used to pay down the VRM Full Return; and (iii) commence the sale of certain reserved shares of Messrs. John H. Ruiz and Frank C. Quesada, and the delivery of the resulting net cash proceeds thereof to VRM. The VRM Full Return guaranty obligation became current on September 30, 2024, and the Company does not currently have available liquidity to satisfy said obligation.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 13, 2023, the Company entered into the Second Amended and Restated Nomura Note (defined in Note 3, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business Combination </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements), which extended the maturity date of the Nomura Note to December 31, 2024. See summary in Note 9, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Financing Obligations and Notes Payable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements. On March 26, 2024, the Company entered into the Third Amended and Restated Nomura Promissory Note, which extended the maturity date of the Nomura Note to September 30, 2025. The note became current on September 30, 2024, and the Company does not currently have available liquidity to satisfy said obligation. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to a letter agreement dated November 15, 2024, Nomura agreed to forego payments of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million due under the Third Amended and Restated Nomura Note from proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA until March 31, 2025.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 14, 2023, the Company entered into the Yorkville SEPA, which included the issuance of Yorkville </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes to Yorkville having aggregate principal amounts of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in connection with the purchase of Class A Common Stock. See summary in &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Committed Equity Facility</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; within Note 9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, Claims Financing Obligations and Notes Payable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements. On April 8, 2024, the maturity date of the Yorkville </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes was extended to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">September 30, 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. On April 12, 2024, Yorkville agreed that, to the extent that it holds Class A Common Stock in such quantities that would prevent the Company from utilizing the SEPA solely due to the Ownership Limitation, Yorkville commits to fund an additional advance in the principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">on the same terms and conditions as the previous </span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">advances </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pursuant to the Yorkville SEPA. On April 10, 2025, Yorkville further agreed to: (i) extend the due date for the first Monthly Payment to November 30, 2026, (ii) extend the maturity date of the Convertible Notes to November 30, 2026, and (iii) to waive Volume Threshold and Maximum Advance Amount limitations set forth in the Yorkville SEPA. As we have sold substantially all of the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares currently registered for resale to Yorkville, we need to file with the SEC one or more additional registration statements to register under the Securities Act the resale by Yorkville of any additional shares of our common stock, and the SEC would have to declare such registration statement or statements effective before we could sell additional shares. There can be no assurances of such events occurring or the timing of such events occurring.</span></div></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has concluded that, despite the aforementioned financing arrangements, there is substantial doubt about its ability to continue as a going concern. Unless we are successful in raising additional funds through the offering of debt or equity securities, we have concluded it is probable we will be unable to continue to operate as a going concern beyond the next twelve months. The Company has received a report from its independent registered public accounting firm with an emphasis of matter paragraph as to going concern in connection with the Company&#8217;s audited annual financial statements for the year ended December 31, 2024, which resulted in an event of default in the aforementioned debt agreement, which would have resulted in the debt becoming immediately due; however, the Company has received waivers from (i) Virage and VRM and (ii) HPH and Hazel as it pertains to the year ended December 31, 2024.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of presentation</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These statements have been prepared pursuant to the rules and regulations of the SEC and in accordance with GAAP. In the opinion of management, the consolidated financial statements reflect all adjustments, which consist only of normal recurring adjustments, necessary to state fairly the results of operations, financial condition and cash flows for the periods presented herein. Prior to the Business Combination, the consolidated financial statements reflect Legacy MSP. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All intercompany transactions and balances are eliminated from the consolidated financial statements.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Principles of consolidation</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company consolidates all entities that it controls through a majority voting interest or otherwise and the accompanying financial statements include the accounts of the Company&#8217;s wholly owned subsidiaries and these entities for which the Company has a controlling interest in. The Company also consolidates all entities that it controls as the primary beneficiary of a variable interest entity (&#8220;VIE&#8221;). Under the VIE model, management first assesses whether the Company has a variable interest in an entity, which would include an equity interest. If the Company has a variable interest in an entity, management further assesses whether that entity is a VIE, and if so, whether the Company is the primary beneficiary under the VIE model. Generally, entities that are organized similar to a limited partnership, in which a general partner (or managing member) make the most relevant decisions that affect the entity&#8217;s economic performance, are considered to be VIEs which would require consolidation, unless the limited partners have substantive kickout or participating rights. Entities that do not qualify as VIEs are assessed for consolidation under the voting interest model.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the VIE model, an entity is deemed to be the primary beneficiary of a VIE if it holds a controlling financial interest. A controlling financial interest is defined as (a) the power to direct the activities of a VIE that most significantly affect the entity&#8217;s economic performance and (b) the obligation to absorb losses of the entity or the right to receive benefits from the entity that could potentially be significant to the VIE. Management determines whether the Company is the primary beneficiary of a VIE at the time it becomes involved with a VIE and reconsiders that conclusion at each reporting date. This analysis includes an evaluation of the Company&#8217;s control rights, as well as the economic interests that the Company holds in the VIE, including indirectly through related parties. As a result of the Business Combination, the Company consolidates MSP Recovery under the VIE model.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Estimates and Assumptions</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting periods. Actual results could differ from the Company&#8217;s estimates. Estimates are periodically reviewed considering changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Significant estimates and assumptions reflected in these consolidated financial statements include but are not limited to recoverability of long-lived assets.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain reclassifications have been made to the prior year statement of cash flows to conform to classifications used in the current year. These reclassifications had no impact on net loss, shareholders&#8217; equity or total cash flows as previously reported.</span></p></div><div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Segments</span></p></div><div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are defined as components of an entity for which separate financial information (including profit and/or loss) is available and regularly reviewed by the chief operating decision maker (&#8220;CODM&#8221;). The Company manages its operations as a single segment for the purposes of assessing performance and making decisions. The Company&#8217;s CODM is its </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_8b390608-14b7-4bdf-8388-0311ecd33fec;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company has determined that it operates in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating segment and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. In addition, all of the Company&#8217;s revenues and long-lived assets are attributable primarily to operations in the United States and Puerto Rico for all periods presented.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Concentration of credit risk and Off-Balance Sheet Risk</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and affiliate receivable are financial instruments that are potentially subject to concentrations of credit risk. See Note 14,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, fo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">r disclosure of affiliate receivables. The Company&#8217;s cash and restricted cash are deposited in accounts at large financial institutions, and amounts may exceed federally insured limits. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash and cash equivalents are held. The Company has no other financial instruments with off-balance-sheet risk of loss.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers all highly liquid investments purchased with original maturities of three months or less to be cash equivalents. There are </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> cash equivalents as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 or 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company applies the provisions of ASC 820, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for fair value measurements of financial assets and financial liabilities and for fair value measurements of non-financial items that are recognized or disclosed at fair value in the financial statements on a recurring basis. The Company also applied the provisions of the subtopic to fair value measurements of non-financial assets and non-financial liabilities that are recognized or disclosed at fair value in the financial statements on a non-recurring basis. The subtopic defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The subtopic also establishes a framework for measuring fair value and expands disclosures about fair value measurements. The fair value framework requires the Company to categorize certain assets and liabilities into three levels, based upon the assumptions used to price those assets or liabilities. The three levels are defined as follows:</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1: Quoted prices in active markets for identical assets or liabilities.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2: Quoted prices for similar assets and liabilities in active markets or inputs that are observable.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3: Unobservable inputs reflecting management&#8217;s own assumptions about the inputs used in pricing the asset or liability.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has determined the estimated fair value of its financial instruments based on appropriate valuation methodologies; however, for Level 2 and Level 3 inputs considerable judgment is required to develop these estimates. Accordingly, these estimated fair values are not necessarily indicative of the amounts the Company could realize in a current market exchange. The estimated fair values can be materially affected by using different assumptions or methodologies. The methods and assumptions used in estimating the fair values of financial instruments are based on carrying values and future cash flows. As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t hold any Level 2 or Level 3 assets. See </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 13,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for additional information on Level 2 and Level 3 liabilities as of December 31, 2024.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash is stated at cost, which approximates their fair value. The carrying amounts reported in the consolidated balance sheets for affiliate receivable, accounts payable, affiliate payable and accrued liabilities approximate fair value, due to their short-term maturities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Outstanding borrowings that qualify as financial instruments are carried at cost, which approximates their fair value as of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, due to their short duration.</span></p></div><div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity Method Investments</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity investments that are not consolidated, but over which the Company exercises significant influence, are accounted for in accordance with ASC 323, &#8220;Investments&#8212;Equity Method and Joint Ventures&#8221; (&#8220;ASC 323&#8221;). Wh</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ether or not the Company exercises significant influence with respect to an investee company depends on an evaluation of several factors including, among others, representation on the investee company&#8217;s board of directors and ownership level. An entity is presumptively assumed to have significant influence in a corporation when it holds </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or more of the voting stock of the investee company, or at a lower level (e.g., </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%) for entities that track separate members capital accounts.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the equity method of accounting, an investee company&#8217;s accounts are not reflected within the Company&#8217;s consolidated balance sheets and statements of operations; however, the Company&#8217;s share of the earnings or losses of the investee company is reflected in the caption &#8220;Other income&#8221; in the consolidated statements of operations. The Company&#8217;s carrying value in equity method investee companies is not reflected in the Company&#8217;s consolidated balance sheets as of December 31, 2024 or 2023 as the carryin</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">g </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">value is de</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">minimis. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When the Company&#8217;s carrying value in an equity method investee company is reduced to zero, no further losses are recorded in the Company&#8217;s consolidated financial statements unless the Company has guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized.</span></p></div><div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and Equipment</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are stated at historical cost less accumulated depreciation and accumulated impairment losses, if any. Major expenditures for property and equipment and those that substantially increase useful lives are capitalized. When assets are sold or otherwise disposed of, costs and related accumulated depreciation are removed from the financial statements and any resulting gains or losses are included in general and administrative expenses within our consolidated statements of operations.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company provides for depreciation and amortization on property and equipment using the straight-line method to allocate the cost of depreciable assets over their estimated lives as follows:</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:67.54%;box-sizing:content-box;"></td>
           <td style="width:32.46%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:8.45pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office and Computer Equipment</span></p></td>
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
          </tr>
          <tr style="height:11.9pt;white-space:pre-wrap;word-break:break-word;">
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and Fixtures</span></p></td>
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
          </tr>
          <tr style="height:1pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold Improvements</span></p></td>
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="-sec-ix-hidden:F_d7c0ff4e-449b-40a5-8325-8ed41dfb3e58;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lesser of lease term or estimated life</span></span></span></p></td>
          </tr>
         </table></div></div><div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Internal Use Software</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Internal-use software development costs incurred in the preliminary project stage are expensed as incurred; costs incurred in the application and development stage, which meet the capitalization criteria, are capitalized and amortized on a straight-line basis over the estimated useful life of the asset and costs incurred in the post-implementation/operations stage are expensed as incurred. The estimated useful life for development costs capitalized as of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Further, internal and external costs incurred in connection with upgrades or enhancements are also evaluated for capitalization. If the software upgrade results in an additional functionality, costs are capitalized; if the upgrade only extends the useful life, it is expensed as occurred.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intangible assets</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In certain of its CCRAs, the Company makes up-front payments to acquire Claims recovery rights from secondary payers, such as health plans, managed service organizations, providers or medical services and independent physicians&#8217; associations. The Company recognizes intangible assets for costs incurred up front to acquire Claims recovery rights from various Assignors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CCRA assets are held at cost. Historically, the Company amortized capitalized costs associated with CCRAs over </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">eight years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, based on the expected timing to pursue recovery through litigation, including through potential appeals. As part of the annual reassessment of useful lives as of December 31, 2024, the Company updated the estimated useful life of the CCRAs to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seven years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> beginning January 1, 2025.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the Business Combination, the Company acquired rights to Claims recovery cash flows. As a result of this purchase and the guaranty obligation as noted in Note 8, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Variable Interest Entities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company consolidated the entity which holds these Claim rights. Upon consolidation, these Claims rights were accounted for under ASC 350. As such these assets are held at cost, net of amortization.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates these assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. If the estimated future cash flows (undiscounted and without interest charges) from the use of an asset group are less than the carrying value, a write-down would be recorded to reduce the related asset group to its estimated fair value.</span></p></div><div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Derivative Instruments</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates its convertible debt, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 480, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Distinguishing Liabilities from Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ASC 815, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Derivatives and Hedging</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The result of this accounting treatment is that the fair value of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability. The change in fair value is recorded in the statements of operations as a component of other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, combined derivative instrument.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">will </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">be classified in the consolidated balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Non-Controlling Interests</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the Business Combination and described in Note 1, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of the Business</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company became the managing member of MSP Recovery, which is consolidated as the Company controls the operating decisions of MSP Recovery. The non-controlling interest relates to the Up-C Units that are convertible into Class A Common Stock of the Company at the discretion of the holder of the Up-C Unit. The Up-C Unit holders retained approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.76</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the economic ownership percentage of the Company as of the Closing Date. The non-controlling interest is classified as permanent equity within</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the consolidated balance sheet of the Company. As of December 31, 2024, based on the Class A common stock issuances during the period, the non-controlling interest of Class V shareholders was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69.43</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in the Company&#8217;s ownership interest in MSP Recovery, due to Class V shareholders converting their shares to Class A, are accounted for as equity transactions. Each issuance of the Company&#8217;s Class A Common Stock requires a corresponding issuance of MSP Recovery units to the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company. The issuance would result in a change in ownership and would reduce the balance of non-controlling interest and increase the balance of additional paid-in capital.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates long-lived assets, such as property and equipment, including capitalized software costs, and finite-lived intangibles such as Claims recovery rights, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset or asset group may not be recoverable. If the estimated future cash flows (undiscounted and without interest charges) from the use of an asset group are less than the carrying value, a write-down would be recorded to reduce the related asset group to its estimated fair val</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ue.</span></p></div><div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims Recovery</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s primary income-producing activities are associated with the pursuit and recovery of proceeds related to Claims recovery rights that the Company obtains through CCRAs, in which it becomes the owner of those rights. As a result, such income is not generated from the transfer of control of goods or services to customers, but from the proceeds realized from perfection of Claims recoveries from rights the Company holds outright. The Company may also generate future revenue by providing Claims recovery services to other entities outside of the Company.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims recovery income</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes Claims recovery income based on a gain contingency model&#8212;that is, when the amounts are reasonably certain of collection. This typically occurs upon reaching a binding settlement or arbitration with the counterparty or when the legal proceedings, including any appellate process, are resolved.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, the Company owes an additional payment to the original Assignor in connection with the realized value of the recovery right. Claims recovery income is recognized on a gross basis, as the Company is entitled to the full value of recovery proceeds, and makes a payment to the original Assignor similar to a royalty arrangement. Such payments to prior owners are recognized as cost of Claims recovery in the same period the Claims recovery income is recognized.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When the Company becomes entitled to recovery proceeds from the settlement of a Claim recovery pursuit or proceeding that meets the requirements under ASC 450, it recognizes the amount in accounts receivable.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims recovery service income, ASC 606, Revenue from Contracts with Customers</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The guidance under ASC 606, Revenue from Contracts with Customers, provides that an entity should apply the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, the entity satisfies a performance obligation.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company derives revenues from contracts with customers primarily from Claims recovery services arrangements (&#8220;Claims recovery services&#8221;). Claims recovery services include services to related parties or third parties to assist those entities with pursuit of Claims recovery rights. The Company has determined it has a single performance obligation for the series of daily activities that comprise Claims recovery services, which are recognized over time using a time-based progress measure and are typically based on (1) budgeted expenses for the current month with an adjustment for the variance between budget and actual expenses from the prior month or (2) on a contingent basis dependent on actual settlements or resolved litigation. Amounts estimated and recognized, but not yet fully settled or resolved as part of litigation are recognized as contract assets. There were no contract assets as of December 31, 2024 or 2023, as amounts associated with unresolved litigation were fully constrained.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims recovery services are generally paid in advance on a monthly basis. The Company did not recognize any material revenue for the years ended December 31, 2024 or 2023 for performance obligations that were fully satisfied in previous periods. For the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company also recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of servicing income related to a specific contract where the performance obligations were completed during the year.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company does not have material unfulfilled performance obligation balances for contracts with an original length greater than one year in any years presented. Additionally, the Company does not have material costs related to obtaining a Claims recovery service contract with amortization periods greater than one year for any period presented.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company applies ASC 606 utilizing the following allowable exemptions or practical expedients:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exemption to not disclose the unfulfilled performance obligation balance for contracts with an original length of one year or less.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Practical expedient to recognize the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Election to present revenue net of sales taxes and other similar taxes, if any.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Practical expedient not requiring the entity to adjust the promised amount of consideration for the effects of a significant financing component if the entity expects, at contract inception, that the period between when the entity transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.</span></div></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfers of Claims Cost Recovery Rights to Others</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, the Company has entered into arrangements to transfer CCRAs or rights to proceeds from CCRAs to other parties. The Company evaluates whether such transfers are sales of nonfinancial assets, sales of future revenues treated as debt, in-kind contributions to equity method investees, or other types of arrangements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When they are treated as sales of nonfinancial assets, the Company recognizes a gain on the sale when control transfers to the counterparty based on the difference between the fair value of consideration (including cash) received and the recognized carrying value of the CCRAs. In some cases, such sales include variable consideration in the form of payments that will be made only upon achievement of certain recoveries or based on a percentage of actual recoveries. The Company estimates and constrains the amounts that will ultimately be realized based on these variable payment terms and includes those amounts in the determination of gain or loss; the gain or loss is subsequently updated based on changes in those estimates.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In other cases, such transfers are considered to be sales of future revenue that are debt-like in nature. These arrangements are recognized as debt based on the proceeds received, and are imputed an interest rate based on the expected timing and amount of payments to achieve contractual hurdles. These are subject to revisions of estimates of that timing and amount based on the contractual provisions and the Company&#8217;s assumptions from changes in facts and circumstances. Such changes are reflected through revision of the imputed interest rate on a cumulative catch-up basis.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cost of Claims Recoveries</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Costs of Claims recoveries consist of all directly attributable costs specifically associated with Claims processing activities, including contingent payments to Assignors (i.e., settlement expenses).</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims amortization expense</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims amortization expense includes amortization of CCRAs acquired as part of the business combination, shown as Intangibles, net in the consolidated balance sheets, and CCRA intangible assets for which the Company made up-front payments for Claims recovery rights. For further details on CCRAs see Note 6, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Intangible Assets, Net</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></div><div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our income tax expense, deferred tax assets and liabilities, and reserves for unrecognized tax benefits reflect management&#8217;s best assessment of estimated current and future taxes to be paid. As a result of the Business Combination, the Company became the sole managing member of MSP Recovery, which is treated as a partnership for U.S. federal, state and local income tax purposes. As a partnership, MSP Recovery is not subject to U.S. federal and certain state and local income taxes. Any taxable income or loss generated by MSP Recovery is passed through to and included in the taxable income or loss of its partners, including MSP Recovery, Inc. The Company is subject to U.S. federal income taxes, in addition to state and local income taxes, with respect to the Company&#8217;s allocable share of income of MSP Recovery, LLC.</span></p></div><div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s deferred tax balances reflect the impact of temporary differences between the carrying amount of assets and liabilities and the Company&#8217;s tax basis. The balances are stated at the tax rates in effect when the temporary differences are expected to be recovered or settled. The Company reviewed the anticipated future realization of the tax benefit of the Company&#8217;s existing deferred tax assets and concluded that it is more likely than not that all of the deferred tax assets will not be realized in the future and recorded a full valuation allowance at December 31, 2024 and 2023.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive Income (Loss)</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has no components of other comprehensive income (loss). As such, net loss equates to comprehensive income (loss) for all periods presented in this report.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New Accounting Pronouncements Recently Adopted</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2024, we </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-07, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, on a retrospective basis. The amendments are intended to increase reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. Refer to Note 15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, Segment Information</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for further information.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New Accounting Pronouncements Issued but Not Yet Adopted</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASU 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Among other requirements, this update adds specific disclosure requirements for income taxes, including: (1) disclosing specific categories in the rate reconciliation and (2) providing additional information for reconciling items that meet quantitative thresholds. The guidance is effective for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company is currently evaluating the provisions of this guidance and assessing the potential impact on the Company&#8217;s financial statement disclosures.</span></p><p style="text-indent:21.6pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU 2024-03, &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40) Disaggregation of Income Statement Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;. The guidance in ASU 2024-03 does not change the expense line items presented on the face of the financial statements, but instead, it requires additional disaggregation of specific expense captions</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the notes to the financial statements, among other things, specific information about certain costs and expenses including purchases of inventory; employee compensation; and depreciation, amortization and depletion expenses for each caption on the income statement where such expenses are included. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted, and the amendments may be applied prospectively to reporting periods after the effective date or retrospectively to all periods presented in the financial statements. The Company is currently evaluating the provisions of this guidance and assessing the potential impact on the Company&#8217;s financial statement disclosures.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_MaterialAgreementsDisclosureTextBlock', window );">Material Agreements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 3. MATERIAL AGREEMENTS</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Virage</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 23, 2022 as part of the Closing of the Business Combination, the Company acquired assets through the issuance of Up-C Units. In exchange for approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million Up-C Units, the Company acquired the rights to receive the distributable net proceeds (the &#8220;Proceeds&#8221;) of a portfolio of Claims owned by VRM MSP, a Delaware limited liability company and joint investment vehicle of VRM and Series MRCS. Under this asset acquisition structure, the Company determined that the arrangements to acquire the rights to proceeds from certain Claims recovery rights along with the guarantee of the VRM Full Return (noted and defined below) result in the Company consolidating the Series. Upon consolidation, the Company included the value of the Up-C Units provided and the value of the guarantee as Intangible Assets, net in the consolidated balance sheet. These are held at cost and treated as finite life intangible assets under ASC 350, and have a useful life of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seven years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with such transaction the Company agreed to pay Virage an amount equal to the contributions by Virage to VRM MSP plus an annual rate of return of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% (the &#8220;VRM Full Return&#8221;). Pursuant to the terms of the agreement with Virage, such amount is payable exclusively by any of the following means (or any combination thereof): (a) the Proceeds, net of expenses related to claim settlement, (b) a sale of certain reserved shares of Messrs. John H. Ruiz and Frank C. Quesada, and the delivery of the resulting net cash proceeds thereof to VRM, or (c) a sale of shares by the Company and delivery of the net cash proceeds thereof to VRM. The amount of the VRM Full Return was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,126.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">941.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the Company incurred debt related to the VRM Full Return as included in the guaranty obligation within the consolidated balance sheet, this value was included in the purchase price and is included in Intangible Assets, net, in the consolidated balance sheet for the full value of the VRM Full Return at the acquisition date. Any subsequent interest accrual is reflected within interest expense in the consolidated statement of operations.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Virage MTA dated March 9, 2022 (as amended on April 12, 2023, November 13, 2023, and April 1, 2024, the &#8220;Virage MTA&#8221;), the VRM Full Return payment due date is September 30, 2025. The payment methods for the VRM Full Return are as follows, and in the following order of priority: (a) a first priority lien on all sources of revenue of the Company not otherwise encumbered as of April 12, 2023 to the extent such revenues and liquidity exceed the amount of net of revenues necessary to establish and maintain an operating reserve (&#8220;Operating Reserve&#8221;) of to the budget of the Company (plus applicable taxes) plus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, (b) a sale of certain reserved shares of Messrs. John H. Ruiz and Frank C. Quesada, and the delivery of the resulting net cash proceeds thereof to VRM, (c) Parent&#8217;s sale of additional shares and delivery of proceeds to VRM, subject to certain anti-dilution provisions, and (d) if the VRM Full Return is not satisfied by the foregoing, a sale by Messrs. Ruiz and Quesada of other shares of Common Stock that they hold, and the delivery of the resulting net cash proceeds thereof to VRM; provided that if the VRM Full Return is not fully paid by September 30, 2025 the VRM Full Return shall be payable by any of such payment methods in any order of priority. In addition, Messrs. Quesada and Ruiz agreed to certain transfer restrictions applicable to their Common Stock.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Company agreed to make a one-time, lump sum payment to Virage for the period starting May 24, 2023 and ending December 31, 2023, in one or a combination of: (a)</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> cash, in an amount equal to 1.0% of each calendar month-end balance (which month-end balance shall be increased daily up to 20.0% per annum based on a formula set forth in the Virage MTA) of the amount owing to Virage as of each preceding calendar month end</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and/or (b) </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">issue to VRM a warrant to purchase a number of shares of Class A Common Stock of Parent equal to the quotient of 1.0% of each calendar month end balance of the Unpaid Base Amount (calculated on a cumulative basis) and the VWAP of a share of Class A Common Stock for the five-day period prior to the issuance, beginning with May 24, 2023 and ending December 31, 2023, which warrant will have an exercise price (payable in cash) of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share (the &#8220;Initial Virage Warrant&#8221;); provided that the Initial Virage Warrant will expire on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 1, 2026</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></span></p><div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Initial Virage Warrant, as amended, was issued effective January 1, 2024, entitling Virage to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,131,934</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock at an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, with an expiration date of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 1, 2026</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, for each calendar month-end beginning with January 31, 2024, and continuing until the VRM Full Return is paid in full, the Company agreed to issue to VRM a warrant to purchase a number of shares of Class A Common Stock of Parent equal to the quotient of 1% of the calendar month-end balance of the Unpaid Base Amount and the VWAP (each, a &#8220;Monthly Virage Warrant&#8221;), which warrant will have an exercise price (payable in cash) of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and expire on the second anniversary of its issuance.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Monthly Virage Warrants, entitling Virage to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,619,405</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock, each warrant expiring </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">two years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date of issuance, which are exercisable for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. Furthermore, on April 14, 2025, the Company issued two additional warrants for November 2024 and December 2024, each warrant exercisable for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,277,808</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,332,792</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, respectively, both which are exercisable for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and expiring two years from the date of issuance.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company also agreed that, after the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes are fully satisfied, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the Company&#8217;s portion of any net proceeds from the Yorkville SEPA would be used to pay down the VRM Full Return</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and that Messrs. John H. Ruiz and Frank C. Quesada would commence the sale of certain of their reserved shares, and deliver the resulting net cash proceeds thereof to VRM.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has received a report from its independent registered public accounting firm with an emphasis of matter paragraph as to going concern in connection with the Company&#8217;s audited annual financial statements for the year ended December 31, 2024; however on September 6, 2024, Virage agreed to waive a provision of the Virage MTA Amendment that would otherwise accelerate the payment of amounts due to Virage in such event.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hazel Purchase Money Loan</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 29, 2023, the Company acquired a controlling interest in nine legal entities, whose sole assets are CCRAs, from Hazel. This is referred to as the &#8220;Claims Purchase.&#8221; The purchase price for the Claims Purchase was funded by (i) a purchase money loan between Hazel, as a lender, and the Company, as a borrower, in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the &#8220;Purchase Money Loan&#8221;) and (ii) proceeds from the sale of certain, separate CCRAs in the Claims Sale (as defined below).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Also, on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 29, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company sold a controlling interest in three legal entities whose sole assets are CCRAs to Hazel. The agreement provided that the Company and Hazel would share in the recovery proceeds therefrom, in accordance with an agreed waterfall after Hazel had realized the first $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">150</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in claims recoveries. This transaction is referred to as the &#8220;Claims Sale,&#8221; and together with the Claims Purchase, the &#8220;Claims Transactions.&#8221;</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the Claims Transactions were negotiated together in contemplation of one another, they have been combined for accounting purposes. The Company analyzed the Claims Sale and determined that this transaction would be treated as the sale of in-substance nonfinancial assets, in exchange for noncash consideration in the form of the CCRAs from the Claims Purchase measured at fair value. The variable consideration related to future recoveries is fully constrained, because, at this time, it is not probable that any amounts will be owed above the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">150</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million recovery threshold that would trigger additional payments. The Company analyzed the Claims Purchase and determined it results in the initial consolidation of variable interest entities that are not businesses. The acquired CCRAs held by those entities are recognized at fair value.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of the assets sold in the Claims Sale was determined to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company&#8217;s carrying value of those CCRAs surrendered was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Because there are no other observable prices for such transactions, the Company determined the fair value by reference to the purchase price for those CCRAs in a recent transaction. The fair value of the acquired CCRAs was determined to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">285.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and the Company recognized the Purchase Money Loan recognized at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, as any implicit discount or premium to current market rates at the time of issuance were insignificant.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This resulted in a gain on the Claims Transactions of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which largely corresponds to the previously recognized amortization of the CCRAs that were sold in the Claims Sale.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, under the Operational Collection Floor, HPH agreed to extend up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (with a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% original issue discount) to fund the acquisition of additional Claims, which further collateralize the Working Capital Credit Facility. On October 2, 2024, the Company acquired the recovery rights to additional Medicare Secondary Payer Claims from an existing Assignor consisting of more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">450,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Medicare members, as documented by the Assignor.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts borrowed and obligations under the Purchase Money Loan and the Working Capital Credit Facility (See Note 9,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Claims Financing Obligations and Notes Payable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">are secured by a pledge of proceeds from specific Claims in the Company&#8217;s Claims portfolio, with the lien securing the Purchase Money Loan being subordinated and junior to the lien securing the Working Capital Credit Facility. Pursuant to the Purchase Money Loan and the Working Capital Credit Facility, the Company entered into a collateral administrative agreement between the Company and Hazel, which sets forth certain arrangements between the Company and Hazel in relation to Claims owned by the Company, the proceeds of which are due to the Company were pledged to Hazel to secure the Purchase Money Loan and the Working Capital Credit Facility.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hazel Working Capital Credit Facility</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 6, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, Subrogation Holdings entered into a credit agreement (as amended on March 29, 2023; November 10, 2023; and October 1, 2024; the &#8220;Working Capital Credit Facility&#8221;) with HPH providing for funding of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (with a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% original issue discount), consisting of a Term Loan A commitment to fund up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (in multiple installments) in proceeds and a Term Loan B Commitment to fund up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (in multiple installments) in proceeds. During fiscal year 2023, HPH disbursed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million under Term Loan A and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million under Term Loan B.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal year 2024, HPH disbursed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million under Term Loan B on January 25, 2024. On August 2, 2024, Subrogation Holdings entered into a letter agreement to amend the Working Capital Credit Facility (the &#8220;HPH Letter Agreement&#8221;) with HPH, which, among other things: (i) </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">extended the period to draw up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (with a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% original issue discount) remaining under Term Loan B for working capital, accessible in eight tranches of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, that can be drawn at least one month apart, until September 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and (ii) provided for a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million loan (subject to a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% original issue discount) funded by August 31, 2024 to acquire additional Claims (the &#8220;New Claims&#8221;) that collateralize the Working Capital Credit Facility (collectively, (i) and (ii) the &#8220;Operational Collection Floor&#8221;). The parties formalized the terms of the HPH Letter Agreement in Amendment No. 3 to the Working Capital Credit Facility dated October 1, 2024 (the &#8220;OCF Amendment&#8221;). On October 2, 2024, the Company acquired the recovery rights to additional Medicare Secondary Payer Claims from an existing Assignor consisting of more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">450,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Medicare members, as documented by the Assignor.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Operational Collection Floor, the Company received during 2024: (i) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for working capital, and (ii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the purpose of acquiring the New Claims. To date, the Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of working capital for 2025. Pursuant to the Working Capital Credit Facility, HPH may, at its sole discretion, increase the Operational Collection Floor by an amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, to be funded over a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_dcf042f9-2441-4111-b785-0c83a5affaab;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">six months</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. On February 28, 2025 and April 4, 2025, HPH exercised that discretion and funded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, from the increase to the Operational Collection Floor. An additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million remains available under the Operational Collection Floor, to be funded at HPH&#8217;s sole discretion.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_MaterialAgreementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Material agreements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_MaterialAgreementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment In Equity Method Investees<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Investment In Equity Method Investees</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 4. INVESTMENT IN EQUITY METHOD INVESTEES</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company holds </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">four</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> investments which are accounted for using the equity method</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: MAO-MSO Recovery II LLC Series PMPI (&#8220;Series PMPI&#8221;), MAO-MSO Recovery LLC, MAO-MSO Recovery II LLC (both collectively the &#8220;MAO-MSO entities&#8221;) and VRM MSP.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Series PMPI is a series of MAO-MSO Recovery II LLC. The Company exercises significant influence over the operating and financial activities of Series PMPI, but does not exercise control of the entity. In accordance with Series PMPI&#8217;s operating agreement, the controlling member is entitled to a preferred return of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Preferred Return&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Once the Preferred Return has been met, the controlling member is entitled to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of Claim</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s recoveries by PMPI. The noncontrolling member is allocated </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the costs of PMPI. Since the Preferred Return exceeds the total members&#8217; equity of PMPI as of both </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, the value of the equity method investment in the consolidated balance sheet is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The MAO-MSO entities are Delaware limited liability companies formed as master series entities whose central operations are to form other series legal entities that will hold and pursue Claims recovery rights. The MAO-MSO entities are not designed to hold or pursue Claims recoveries themselves. The Company holds a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">economic interest in both entities, and has significant influence through</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">its </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">equity investment, but does not control either entity. As equity method investments, the Company recognizes its proportionate share of net earnings or losses as equity earnings in Other income. The activity of these entities has been insignificant for the years ended December 31, 2024 and 2023. Since the Company did not make a contribution to the MAO-MSO entities and the entities have recorded losses, the value of the equity method investment in the consolidated balance sheets is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of both December 31, 2024 and 2023.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Summary financial information for equity accounted investees, not adjusted for the percentage ownership of the Company is as follows:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Year Ended December 31,</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">354</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,167</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,000</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">840</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,038</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.013%;box-sizing:content-box;"></td>
         <td style="width:1.04%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.403%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.543%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total Assets</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">928</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,403</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total Liabilities</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">762</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">399</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2023, in connection with an amendment to the VRM MSP structure, the Company became a direct investor in VRM MSP, which controls MSP Recovery Claims, Series LLC, and recognizes this investment as an equity method investment. However, the Company previously consolidated and continues to consolidate the underlying Series of MSP Recovery Claims, Series LLC, which hold investments in CCRAs that the Company controls as primary beneficiary under the VIE model. As such, other than the Series, which were already consolidated, the investment in VRM MSP includes only administrative activities that are not otherwise consolidated, and any costs are allocable to the other investors. As a result, the Company has no significant equity earnings or exposure to losses or obligations to fund this investment.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478156/740-323-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 323<br> -Publisher FASB<br> -URI https://asc.fasb.org/323/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 5. PROPERTY AND EQUIPMENT, NET</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment, net consist of the following:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:65.52%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.52%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.52%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office and computer equipment</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">459</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">434</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">701</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">113</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Internally developed software</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,588</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,789</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other software</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Property and equipment, gross</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">6,815</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">6,403</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: accumulated depreciation and amortization of software</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,656</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,492</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">5,159</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">4,911</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended December 31, 2024 and 2023, depreciation expense and amortization expense was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 6. INTANGIBLE ASSETS, NET</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company holds CCRAs held by Series MRCS, which were acquired through the issuance of equity as part of the Business Combination in 2022 and acquisitions of additional CCRAs from the Closing Date through 2024.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intangible assets, net consists of the following:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:65.987%;box-sizing:content-box;"></td>
         <td style="width:1.56%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.177%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.56%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.717%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets, gross</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,121,859</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,872,356</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated amortization</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,223,636</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">739,560</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">1,898,223</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">3,132,796</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, the Company purchased </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CCRAs included in Intangible assets, net, which were paid in cash. During the year ended December 31, 2023, the Company purchased $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">287.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of CCRAs included in Intangible assets, net, of whic</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">h </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">285.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was through the Hazel transaction (See Note 3,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Material Agreements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was through a Class A Common Stock and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was paid in cash.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended December 31, 2024 and 2023, Claims amortization expense was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">484.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">476.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future amortization for CCRAs is expected to be as follows:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:78.82%;box-sizing:content-box;"></td>
         <td style="width:1.86%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:17.32%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">CCRAs Amortization</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">474,556</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">474,556</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">474,556</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">474,555</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">1,898,223</span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company monitors intangible assets for potential impairment indicators, including, but not limited to, assumptions regarding the amount and timing of future collections derived from its CCRAs. The Company continues to pursue recoveries from various parties under rights held through its CCRAs; however, extended delays may result in future impairment of the Company&#8217;s intangible assets.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the Company&#8217;s fourth quarter review of its CCRAs, the Company identified potential impairment indicators, such as recurring operating losses, and a lack of substantial revenue generated from our Claims portfolio to date, which it considered in its evaluation of its definite-lived intangible assets. As a result, the Company performed a recoverability analysis on the definite-lived CCRA intangible assets in the fourth quarter of 2024. The recoverability analysis primarily included unobservable inputs, including internally developed assumptions about the estimated market share of insurance carriers that may not have paid claims due to Assignors, undiscounted cash flows of potential estimated recoveries from those carriers, the corresponding direct costs associated with those estimated recoveries, and the Company&#8217;s ability to successfully litigate or negotiate settlements.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An asset group is impaired if the estimated undiscounted cash flows are less than the asset group&#8217;s carrying value. Impairment is measured by the amount by which the carrying value exceeds fair value. The Company performed a probability-weighted undiscounted net cash flow analyses, taking into account various scenarios of expected cash flows, some of which rendered positive results, while others rendered negative results. Given that the probability-weighted average cash flows of all scenarios were below the carrying value, the Company performed a fair value assessment to measure impairment loss.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value assessment of the intangible assets was determined using the income approach. The significant inputs and assumptions used in the estimate of fair value were primarily Level 3 inputs, and include internally developed assumptions used in the undiscounted analysis, as well as the determination of an appropriate discount rate. The Company&#8217;s estimation of the fair value of its CCRA intangible assets resulted in a non-cash impairment charge amount of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">752.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> recorded during the fourth quarter of 2024 in Impairment of intangible assets in the consolidated statement of operations for the year ended December 31, 2024. The estimation of the fair value requires significant management judgment with respect to the estimates discussed above. The estimates of the fair value are based on the best information available as of the date of the assessment. Small changes in the significant inputs and assumptions would increase or decrease estimated discounted future operating cash flows and could increase or decrease an impairment charge by a material amount. For example, if estimated recoveries were accelerated by one year, the non-cash impairment charge would decrease by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">141.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, while if estimated recoveries were extended by a year, then the non-cash impairment charge would increase by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">128.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In addition, a hypothetical </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% change in the discount rate assumption would increase or decrease the impairment charge by approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. If actual results or future expectations are not consistent with the assumptions used in our estimate of fair value, it may result in the recording of additional impairment charges in the future which could be material.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the changes in the Company&#8217;s intangibles assets for </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:65.987%;box-sizing:content-box;"></td>
         <td style="width:1.6%;box-sizing:content-box;"></td>
         <td style="width:16.137%;box-sizing:content-box;"></td>
         <td style="width:1.56%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.717%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Intangible Assets</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2022</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,363,156</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquisitions of CCRAs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">287,029</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">476,492</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sale of CCRAs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,897</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,132,796</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquisitions of CCRAs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,200</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">484,076</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">752,697</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">1,898,223</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 7. INCOME TAX</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company holds an economic interest in MSP Recovery, LLC and consolidates its financial position and results. The remaining ownership of MSP Recovery, LLC not held by the Company is considered a noncontrolling interest. MSP Recovery, LLC is treated as a partnership for income tax reporting and its members, including the Company, are liable for federal, state, and local income taxes based on their share of the LLC&#8217;s taxable income.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> provision for income tax for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the United States statutory income tax rate to the Company&#8217;s effective tax rate for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 is as follows for the years indicated:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:56.249%;box-sizing:content-box;"></td>
         <td style="width:1.8%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:18.556%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.8%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:17.597%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Year Ended December 31,</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal Statutory rate</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.00</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.00</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncontrolling interests/effect of pass-through entities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">-</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16.14</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">-</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.59</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">-</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.47</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">-</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.73</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liability</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.85</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.00</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State Taxes</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.76</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.37</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.00</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">-</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.05</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Effective Income tax rate</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.00</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.00</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Details of the Company&#8217;s deferred tax assets and liabilities at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 are as follows for the years indicated:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:50.44%;box-sizing:content-box;"></td>
         <td style="width:2.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:20.14%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:20.14%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">in thousands</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforward</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,613</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,126</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment in MSP Recovery, LLC</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,668</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,385</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Start-up Costs</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">791</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">854</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Transaction Costs</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,699</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,962</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest Expense &#8212; 163j</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,863</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,065</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,634</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,392</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation Allowance</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,634</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,392</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets (liability)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has a deferred tax asset for the difference between the financial reporting and the tax basis of its investment in MSP Recovery, LLC. The deferred tax asset above does not consider the iterative impact of the TRA liability as the entire liability has not been recorded as of</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 the Company had </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of U.S. gross federal and state net operating loss carryovers available to offset future taxable income, respectively. As of December 31, 2023, the Company had </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of U.S. gross federal and state net operating loss carryovers available to offset future taxable income, respectively.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t recorded any unrecognized tax benefits. The Company files income tax returns in the U.S. federal jurisdiction and Florida which remain open and subject to examination by the various taxing authorities. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company&#8217;s federal and state and local income tax years </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2021</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> through </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> remain open and are subject to examination. </span></span><span style="font-size:10pt;font-family:Times New Roman;"></span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_VariableInterestEntityDisclosureAbstract', window );"><strong>Variable Interest Entity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable Interest Entities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 8. VARIABLE INTEREST ENTITIES</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments in consolidated Variable Interest Entities</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates its ownership, contractual, and other interests in entities to determine if they are VIEs, if the Company has a variable interest in those entities, and the nature and extent of those interests. These evaluations are highly complex and involve management judgment and the use of estimates and assumptions based on available historical information, among other factors. Based on its evaluations, if the Company determines it is the primary beneficiary of such VIEs, it consolidates such entities into its financial statements. VIEs information below is presented on aggregate basis based on similar risk and reward characteristics and the Company&#8217;s involvement with the VIEs.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company includes a number of entities that are determined to be VIEs and for which the common control group can direct the use of the entities&#8217; assets and resources for other purposes. The Company only consolidates those VIEs for which the Company is the primary beneficiary.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The assets of the consolidated VIEs may only be used to settle obligations of these VIEs and to settle any investors&#8217; ownership liquidation requests. There is no recourse to the Company for the consolidated VIEs&#8217; liabilities. The assets of the consolidated VIEs are not available to the Company&#8217;s creditors.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total assets and liabilities included in its consolidated balance sheets for these VIEs were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, at December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, at December 31, 2023. The assets at December 31, 2024 and 2023 include the Intangible Assets, net included in the Series of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments in unconsolidated Variable Interest Entities</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is involved with VIEs in which it has investments in equity but does not consolidate because it does not have the power to direct the activities that most significantly impact their economic performance and thus is not considered the primary beneficiary of the entities. Those VIEs are reflected as equity method investments and are reflected at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> on the Company&#8217;s consolidated balance sheet.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total assets and liabilities for these VIEs were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, at December 31, 2024 and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, at December 31, 2023.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Generally, MSP&#8217;s exposure is limited to its investment in those VIEs (see Note 4, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investment in Equity Method Investees</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">). For MAO-MSO Recovery II, LLC and Series PMPI, MSP may be exposed to providing additional recovery services at its own cost if recovery proceeds allocated to it are insufficient to recover the costs of those services. MSP does not have any other exposures or any obligation to provide additional funding.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VRM MSP</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 4,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Investment in Equity Method Investees</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company became a member of VRM MSP through the contribution of certain Series (holding certain CCRAs) by MSP Recovery into VRM MSP. The Company determined, based on analysis of the rights to cash flows from the Series and the related guaranty obligation, that the Company is the primary beneficiary of the Series entities, and therefore should consolidate as of the transaction date. The contribution is considered a common control transaction, as the Company controls and consolidated the Series before and after such contribution. The Company consolidates the Series held within VRM MSP, however does not consolidate VRM MSP itself.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to Note 4,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Investment in Equity Method Investees</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for additional information on this VRM MSP transaction.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_VariableInterestEntityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable interest entity disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_VariableInterestEntityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Claims Financing Obligations and Notes Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Claims Financing Obligations and Notes Payable</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 9. CLAIMS FINANCING OBLIGATIONS AND NOTES PAYABLE</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on claims financing obligations and notes payable agreements, as of December 31, 2024 and 2023, the present value of amounts owed under these obligations were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">673.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">556.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, including capitalized interest. In addition, as of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of advances from Yorkville, respectively. The weighted average interest rate is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> based on the current book value of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">685.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> with rates that range from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company is expected to repay these obligations from cash flows from claim recovery income or potentially for the renegotiated debt through class A common stock issuances.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the minimum required payments on these agreements are </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">818.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Certain of these agreements have priority of payment regarding any proceeds until full payment of the balance due is satisfied. The maturity of the commitments range from the date sufficient claims recoveries are received to cover the required return or in some cases by 2031.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Brickell Key Investments, LP</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2015, the Company entered into a Claims Proceeds Investment Agreement (as amended, the &#8220;CPIA&#8221;) with Brickell Key Investments LP (the &#8220;Holder&#8221;). On October 12, 2022, the Company entered into an Amendment to the CPIA (the &#8220;Amendment&#8221;) and a Warrant Agreement (the &#8220;Warrant Agreement&#8221;) with the Holder, pursuant to which the parties agreed to amend the original CPIA and required payment terms.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the CPIA, as amended, the Company granted to the Holder the right to purchase Class A common shares in the Company (the &#8220;Class A Shares&#8221;) up to a maximum amount of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,667</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;Amount&#8221;) for a purchase price equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,666.67</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ($</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0625</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per Class A Share), and is payable in cash. This Warrant (the &#8220;Warrant&#8221;) will expire at 5:00 p.m. (Eastern Time), on September 30, 2027 and may be exercised in whole or in part by Holder at any time prior to such date. The Holder can only sell a maximum of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per month of the Class A Shares obtained through the Warrant. In exchange for the Company issuing the Warrant, the amounts owed to the Holder pursuant to CPIA are amended to equal $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In exchange for the Company issuing the Warrant, the amounts owed to the Holder pursuant to CPIA was reduced from approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">143</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to equal $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the &#8220;Reduced Obligation&#8221;), and no further interest will accrue. The Holder has the right to receive the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">owed through (1) proceeds as outlined in the CPIA, (2) cash paid by the Company or (3) monetization of the Warrant (through the sale of the Warrant or sale of the underlying Class A Shares). If the Holder monetizes the Warrant, the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amount </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">owed will be reduced at a measure of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">750.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per Class A Share (five-day volume weighted average price as of September 30, 2022).</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Amendment and Warrant Agreement, the Holder also executed a Stock Pledge Agreement (the &#8220;Pledge Agreement&#8221;) with Legacy MSP founders, John H. Ruiz and Frank C. Quesada (the &#8220;Founders&#8221;). As part of the Pledge Agreement, the Founders agreed to pledge </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> thousand shares to secure payment of the original principal amount of the CPIA; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided, that if any any time prior to September 30, 2024, if the pledge agreement had not terminated, and the per share price of the pledged shares dropped below $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.60</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (before 2023 and 2024 Reverse stock splits), then additional shares were required to be pledged by the Founders to bring the number of pledged shares to a value based on the value on that date to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (minus amounts received in satisfaction of the obligation)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Holder has raised a dispute relating to the total number of shares that the Founders were required to pledge under the Pledge Agreement; however, before any pledged shares may be transacted upon, Holder must have monetized the CPIA Warrant. As of the date of this report, Holder has not monetized the CPIA Warrant.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As the Company has an obligation to pay this indebtedness through cash proceeds from certain purchased claims recovery rights, the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of amounts owed as of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> December 31, 2024 was included as Claims financing obligation and notes payable on the consolidated balance sheet.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Founders did not exercise the option to repurchase the CPIA Warrant on or before June 30, 2023. The Company recognizes the CPIA Warrant at fair value which, considering the price of the Company&#8217;s common stock was below $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">750.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, was determined to be </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">zero</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Hazel Working Capital Credit Facility and Purchase Money Loan</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Working Capital Credit Facility</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 6, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, Subrogation Holdings entered into a credit agreement (as amended on March 29, 2023; November 10, 2023; and October 1, 2024; the &#8220;Working Capital Credit Facility&#8221;) with HPH providing for funding of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (with a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% original issue discount), consisting of a Term Loan A commitment to fund up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (in multiple installments) in proceeds and a Term Loan B Commitment to fund up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (in multiple installments) in proceeds. During fiscal year 2023, HPH disbursed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million under Term Loan A and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million under Term Loan B.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During fiscal year 2024, HPH disbursed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million under Term Loan B on January 25, 2024. On August 2, 2024, Subrogation Holdings entered into a letter agreement to amend the Working Capital Credit Facility (the &#8220;HPH Letter Agreement&#8221;) with HPH, which, among other things: (i) </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">extended the period to draw up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (with a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% original issue discount) remaining under Term Loan B for working capital, accessible in eight tranches of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, that can be drawn at least one month apart, until September 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and (ii) provided for a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million loan (subject to a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% original issue discount) funded by August 31, 2024 to acquire additional Claims (the &#8220;New Claims&#8221;) that collateralize the Working Capital Credit Facility (collectively, (i) and (ii) the &#8220;Operational Collection Floor&#8221;). The parties formalized the terms of the HPH Letter Agreement in Amendment No. 3 to the Working Capital Credit Facility dated October 1, 2024 (the &#8220;OCF Amendment&#8221;). On October 2, 2024, the Company acquired the recovery rights to additional Medicare Secondary Payer Claims from an existing Assignor consisting of more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">450,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Medicare members, as documented by the Assignor.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Operational Collection Floor, the Company received during 2024: (i) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for working capital, and (ii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the purpose of acquiring the New Claims. To date, the Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of working capital for 2025. Pursuant to the Working Capital Credit Facility, HPH may, at its sole discretion, increase the Operational Collection Floor by an amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, to be funded over a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_339a811a-2d80-47ab-9bb0-fca6e26a7e13;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">six months</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. On February 28, 2025 and April 4, 2025, HPH exercised that discretion and funded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, from the increase to the Operational Collection Floor. An additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million remains available under the Operational Collection Floor, to be funded at HPH&#8217;s sole discretion.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Purchase Money Loan</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 29, 2023, the Company acquired a controlling interest in nine legal entities, whose sole assets are CCRAs, from Hazel. This is referred to as the &#8220;Claims Purchase.&#8221; The purchase price for the Claims Purchase was funded by (i) a purchase money loan between Hazel, as a lender, and the Company, as a borrower, in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the &#8220;Purchase Money Loan&#8221;) </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">as discussed in Note 3,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Material Agreements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and (ii) proceeds from the sale of certain, separate CCRAs in the Claims Sale (as defined below).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Also, on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 29, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company sold a controlling interest in three legal entities whose sole assets are CCRAs to Hazel. The agreement provided that the Company and Hazel would share in the recovery proceeds therefrom, in accordance with an agreed waterfall after Hazel had realized the first $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">150</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in claims recoveries. This transaction is referred to as the &#8220;Claims Sale,&#8221; and together with the Claims Purchase, the &#8220;Claims Transactions.&#8221;</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts borrowed and obligations under the Purchase Money Loan and the Working Capital Credit Facility are secured by a pledge of proceeds from specific Claims in the Company&#8217;s Claims portfolio, with the lien securing the Purchase Money Loan being subordinated and junior to the lien securing the Working Capital Credit Facility. Pursuant to the Second Amended and Restated First Lien Credit Agreement, and in order to secure those additional advances of Term Loan B beginning in January 2024, the following was provided as additional collateral: (i) a pledge of proceeds from certain Claims in the Company&#8217;s Claims portfolio, up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ii)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pledge of the equity interests in an Affiliate of Messrs. John H. Ruiz and Frank C. Quesada; and (iii) a personal guaranty by Messrs. John H. Ruiz and Frank C. Quesada, as primary obligors, guaranteeing those additional advances of Term Loan B beginning in January 2024. On December 22, 2023, our Board approved the Company's payment of certain costs and fees (including legal fees) on behalf of John H. Ruiz and Frank C. Quesada, associated with a mortgage granted in connection with said guaranty, totaling $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. On April 1, 2025, in connection with the increased funding under the Operational Collection Floor, the pledge and personal guaranty in (ii) and (iii) above was increased by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Loans under the Working Capital Credit Facility accrue interest at a Term Secured Overnight Financing Rate for 12-month interest period, plus an applicable margin of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum. Accrued interest on the Working Capital Credit Facility is payable in kind and are capitalized. The Working Capital Credit Facility has a stated maturity date of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2026</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and HPH may extend for up to one year in its sole discretion. The Purchase Money Loan accrues interest at a rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum, payable in kind or in cash at the Company&#8217;s discretion. The Purchase Money Loan has a maturity date of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2026</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, extendable up to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in Hazel&#8217;s sole discretion.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is permitted to prepay the loans under the Working Capital Credit Facility from time to time without prepayment premium. Prepayment of the Purchase Money Loan will be permitted after the prepayment or repayment of loans under the Working Capital Credit Facility, and such prepayment of the Purchase Money Loan may be subject to prepayment penalty, as applicable.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Purchase Money Loan and the Working Capital Credit Facility, the Company entered into a collateral administrative agreement between the Company and HPH, which sets forth certain arrangements between the Company and HPH in relation to the management of the litigation of certain Claims owned by the Company, the proceeds of which are due to the Company, and were pledged to Hazel and HPH to secure the Purchase Money Loan and the Working Capital Credit Facility, respectively.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Purchase Money Loan and the Working Capital Credit Facility contain certain representations, warranties, and covenants of the Company and its subsidiaries, including restrictions on debt incurrence, liens, investments, affiliate transactions, distributions and dividends, fundamental changes, certain debt prepayments, and Claim settlement.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Nomura Promissory Note</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 27, 2022, the Company issued an unsecured promissory note to Nomura (as amended on April 12, 2023, November 13, 2023, and March 26, 2024, the &#8220;Nomura Note&#8221;). The Nomura Note carries a principal amount of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million related to advisory fees and deferred underwriting fees and expenses that became due and payable by the Company to Nomura, in connection with the consummation of the Business Combination. The Nomura Note is payable in kind or in cash, at the Company&#8217;s discretion, accrues interest at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum, and matures on September 30, 2025. Upon two days prior written notice to Nomura, the Company may prepay all or any portion of the then outstanding principal amount under the Nomura Note together with all accrued and unpaid interest thereon. The balance of the unsecured Nomura Note and related interest are included within Claims financing obligations and notes payable in the consolidated balance sheet. The Nomura Note became current on September 30, 2024, and the Company does not currently have available liquidity to satisfy said obligation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Nomura Note, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the aggregate proceeds under the Yorkville SEPA will be used to pay amounts outstanding under the Amended and Restated Nomura Promissory Note (first towards accrued and unpaid interest, if any, then towards principal) and the remaining </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of such proceeds will be used to pay amounts due under the Convertible Notes, if any, or be paid to the Company after the Convertible Notes are fully repaid. Pursuant to a letter agreement dated November 15, 2024, Nomura agreed to forego payments of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million due under the Nomura Note from proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA until March 31, 2025.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Yorkville Standby Equity Purchase Agreement</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 14, 2023, the Company entered into a standby equity purchase agreement (the &#8220;Yorkville SEPA&#8221;) with YA II PN, Ltd., a Cayman Island exempted company (&#8220;Yorkville&#8221;), pursuant to which Yorkville committed to purchase up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in shares of Class A Common Stock, subject to certain limitations and conditions set forth therein, during the term thereof. Sales of Class A Common Stock under the Yorkville SEPA, and the timing of any such sales, are at the Company&#8217;s option, and the Company is under no obligation to sell any shares of Class A Common Stock to Yorkville under the Yorkville SEPA except in connection with notices that may be submitted by Yorkville, in certain circumstances as described below.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the terms and conditions set forth in the Yorkville SEPA, the Company has the right, but not the obligation, from time to time at its discretion until the Yorkville SEPA is terminated to direct Yorkville to purchase a specified number of shares of Class A Common Stock (&#8220;Advance&#8221;) by delivering written notice to Yorkville (&#8220;Advance Notice&#8221;). While there is no mandatory minimum amount for any Advance, it may not exceed an amount equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the average of the daily traded amount during the five consecutive trading days immediately preceding an Advance Notice.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The shares of Class A Common Stock purchased pursuant to an Advance Notice will be purchased at a price equal to: (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">98</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the VWAP of the shares of Class A Common Stock on the applicable date of delivery of the Advance Notice during regular trading hours on such date, or (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the lowest daily VWAP of the shares of Class A Common Stock during the three consecutive trading</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">days </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">commencing on the date of the delivery of the Advance Notice, other than the daily VWAP on a day in which the daily VWAP is less than a minimum acceptable price as stated by the Company in the Advance Notice or there is no VWAP on the subject trading day. The Company may establish a minimum acceptable price in each Advance Notice, below which the Company will not be obligated to make any sales to Yorkville.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Yorkville SEPA, and subject to the conditions set forth therein, Yorkville agreed to advance to the Company in the form of convertible promissory notes (the &#8220;Yorkville Convertible Notes&#8221;) an aggregate principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In 2023, the Company issued two Convertible Notes to Yorkville for a combined principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, resulting in net proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.48</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and in 2024 the Company issued a third Convertible Note to Yorkville in the principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, resulting in net proceeds to us of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Yorkville </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes, Yorkville has the option, subject to certain limitations, of exchanging on one or more occasions all or part of the then outstanding balance under a given note for shares of our Class A Common Stock at a conversion price equal to the lower of: (i) a fixed price equaling </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of VWAP the day prior to the date of the closing of each tranche (the &#8220;Fixed Price&#8221;), or (ii) a variable price equaling </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">95</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the lowest daily VWAP during the seven consecutive trading days immediately preceding the exchange (the &#8220;Variable Price&#8221;), but in no event may the variable price be lower than $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share (the &#8220;Floor Price&#8221;). With respect to the initial Convertible Note issued on November 15, 2023, the Fixed Price equals $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">200.5625</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, with respect to the second Convertible Note issued on December 11, 2023, the Fixed Price equals $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">92.84</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, and with respect to the third Convertible Note issued on April 8, 2024, the Fixed Price equals $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37.625</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As required pursuant to the Second Amended and Restated Nomura Promissory Note, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the aggregate proceeds under the Yorkville SEPA will be used to repay amounts outstanding under the Nomura Note (first towards accrued and unpaid interest, if any, then towards principal) and the remaining </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of such proceeds will be used to repay amounts due under the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville Convertible Notes, if any, or be paid to the Company after the Yorkville </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes are fully repaid. Pursuant to a letter agreement dated November 15, 2024, Nomura agreed to forego payments of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million due under the Nomura Note from proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA until March 31, 2025. Pursuant to the Third Virage MTA Amendment, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the Company&#8217;s portion of any net proceeds from the Yorkville SEPA would be used to pay down the VRM Full Return after the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville Convertible Notes are fully satisfied.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon the occurrence and during the continuation of an event of default, the Yorkville </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes shall become immediately due and payable, and the Company shall pay to Yorkville the principal and interest due thereunder. Events of default include, among others: (i) termination of quotation or listing of the Class A Common Stock on any primary market for a period of 10 consecutive trading days (the Company is currently quoted and listed for trading on Nasdaq) and (ii) failure to timely file any periodic report with the SEC on or before the due date of such filing as established by the SEC, including extensions under Rule 12b-25 under the Exchange Act. In no event shall Yorkville be allowed to effect a conversion if such conversion, along with all other shares of Common Stock beneficially owned by Yorkville and its affiliates would exceed </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding shares of the Common Stock of the Company. If any time on or after November 14, 2023: (i) the daily VWAP is less than the Floor Price for ten consecutive trading days (&#8220;Floor Price Trigger&#8221;), (ii) the Company has issued substantially all of the shares available under the Exchange Cap (as defined below) (&#8220;Exchange Cap Trigger&#8221;), or (iii) the Parent is in material breach of the Registration Rights Agreement, and such breach remains uncured for a period of twenty trading days, or the occurrence of an &#8220;Event&#8221; (as defined in the Registration Rights Agreement) (&#8220;Registration Event Trigger&#8221; and collectively with the Floor Price Trigger and the Exchange Cap Trigger, the &#8220;Trigger&#8221;), then the Company shall make monthly payments to Yorkville beginning on the seventh trading day after the Trigger and continuing monthly in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million plus a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% premium and accrued and unpaid interest. On December 6, 2024, stockholders holding at least a majority of our outstanding voting capital stock approved by written consent as required by Nasdaq Rule 5635(d), the issuance of shares of common stock of the Company in excess of the Exchange Cap set forth in the Yorkville SEPA. Effective January 8, 2025, the Exchange Cap was effectively lifted, allowing the Company to issue shares to Yorkville pursuant to the Yorkville SEPA and the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville Convertible Notes in excess of the Exchange Cap. In addition, on April 10, 2025, Yorkville agreed to waive Volume Threshold and Maximum Advance Amount limitations set forth in the Yorkville SEPA.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville, at its discretion and providing that there is a balance remaining outstanding under the Yorkville Convertible Notes, may deliver a notice under the Yorkville SEPA requiring the issuance and sale of shares of Class A Common Stock to Yorkville at the Conversion Price in consideration of an offset of the Yorkville </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes (&#8220;Investor Notice&#8221;). Yorkville, in its sole discretion, may select the amount of any Investor Notice, provided that the number of shares issued does not cause Yorkville to exceed the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% ownership limitation or the amount of shares of Class A Common Stock that are registered. As a result of an Investor Notice, the amounts payable under the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville Convertible Notes will be offset by such amount subject to each Investor Notice.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company will control the timing and amount of any sales of shares of Class A Common Stock to Yorkville, except with respect to the conversion of the Yorkville Convertible Notes. Actual sales of shares of Class A Common Stock to Yorkville as an Advance under the Yorkville SEPA will depend on a variety of factors to be determined by the Company from time to time, which may include, among other things, market conditions, the trading price of the Company&#8217;s Class A Common Stock, and determinations by the Company as to the appropriate sources of funding for our business and operations.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Yorkville SEPA will automatically terminate on the earliest to occur of: (i) the first day of the month following the 36-month anniversary of the date of the Yorkville SEPA, or (ii) the date on which Yorkville shall have made payment of Advances pursuant to the Yorkville SEPA for shares of Class A Common Stock equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company has the right to terminate the Yorkville SEPA at no cost or penalty upon five trading days&#8217; prior written notice to Yorkville, provided that there are no outstanding Advance Notices for which shares of Class A Common Stock need to be issued, and the Company has paid all amounts owed to Yorkville pursuant to the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville Convertible Notes. The Company and Yorkville may also agree to terminate the Yorkville SEPA by mutual written consent. Neither the Company nor Yorkville may assign or transfer the Company&#8217;s respective rights and obligations under the Yorkville SEPA, and no provision of the Yorkville SEPA may be modified or waived by the Company or Yorkville other than by an instrument in writing signed by both parties.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Yorkville SEPA contains customary representations, warranties, conditions and indemnification obligations of the parties. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The net proceeds under the Yorkville SEPA to the Company will depend on the frequency and prices at which the Company sells its shares of Class A Common Stock to Yorkville. The Company expects that any proceeds received from such sales to Yorkville will be used for working capital and general corporate purposes.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 12, 2024, Yorkville agreed that, to the extent that it holds Class A Common Stock in such quantities that would prevent the Company from utilizing the Yorkville SEPA solely due to the Ownership Limitation, Yorkville committed to fund an additional advance in the principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million on the same terms and conditions as the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yorkville Convertible Notes pursuant to the Yorkville SEPA.</span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During 2024, the Company sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,108,071</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock to Yorkville, respectively, pursuant to investor and/or advance notices delivered under the Yorkville SEPA at prices between $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.78</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.09</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. The proceeds therefrom were used to: (i) reduce amounts owed under Yorkville Note #1 by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of principal and interest, respectively for fiscal year 2024, (ii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to fund operations of the Company, and (iii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of payment to reduce amounts owed under the Nomura Note for fiscal year 2024. As we have sold substantially all of the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million shares currently registered for resale to Yorkville, we need to file with the SEC one or more additional registration statements to register under the Securities Act the resale by Yorkville of any additional shares of our common stock, and the SEC would have to declare such registration statement or statements effective before we could sell additional shares. </span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrant Liability<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_WarrantLiabilityTextBlock', window );">Warrant Liability</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 10. WARRANT LIABILITY</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When the Company issues warrants, it evaluates the proper balance sheet classification of the warrant to determine whether it should be classified as equity or as a derivative liability on the consolidated balance sheets. In accordance with ASC 815-40, &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Derivatives and Hedging-Contracts in the Entity&#8217;s Own Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; (&#8220;ASC 815-40&#8221;), the Company classifies a warrant as equity so long as it is &#8220;indexed to the Company&#8217;s equity&#8221; and several specific conditions for equity classification are met. A warrant is not considered indexed to the Company&#8217;s equity, in general, when it contains certain types of exercise contingencies or adjustments to the exercise price. If a warrant is not indexed to the Company&#8217;s own common stock or it has net cash settlement that results in the warrants to be accounted for under ASC 480, &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Distinguishing Liabilities from Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;, or ASC 815-40, it is classified as a derivative liability which is carried on the consolidated balance sheet at fair value with any changes in its fair value recognized currently in the consolidated statement of operations.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 17, 2022, the Company and CF Principal Investments LLC (&#8220;CF&#8221;) entered into an agreement for an OTC Equity Prepaid Forward Transaction (the &#8220;Prepaid Forward&#8221;). Pursuant to the terms of the Prepaid Forward, CF agreed to, among other things, transfer to MSP for cancellation any New Warrants received as a result of being the stockholder of record of any shares of Class A Common Stock as of the close of business on the closing date of the Business Combination, in connection with the New Warrant Dividend, On January 12, 2024, CF transferred </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">133,291,502</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> New Warrants to the Company, which were canceled upon receipt.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had recognized a warrant liability for the following securities which are convertible into, or allow the purchase of, our Class A Common Stock, including: (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,950,157</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Public Warrants outstanding, each exercisable to purchase </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_6dfc678e-53e4-4a49-b837-6bb6cde847d7;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1/625</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th of one share of our Class A Common Stock (but only exercisable in lots of 625 to purchase whole shares); (ii) the CPIA Warrant, exercisable to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,667</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock at a purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0625</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share; (iii) the VRM Warrants, of which 10 are exercisable to purchase a total of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,751,339</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock at a purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share; and (iv) warrants to Virage Recovery Participation, LP, exercisable to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock at a purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The warrant liability includes the mark-to-market fair value of the warrants discussed above. The fair value of the warrant liability is derived considering the potential shares issuable for each warrant and using the price of the Company&#8217;s Class A Common Stock as of the most recent balance sheet date, which is a quoted price in active markets.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The table below presents a roll-forward of the warrant liability from </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023 to December 31, 2024:</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:55.82%;box-sizing:content-box;"></td>
         <td style="width:2.26%;box-sizing:content-box;"></td>
         <td style="width:20.68%;box-sizing:content-box;"></td>
         <td style="width:2.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:17.02%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Warrant Liability</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">268</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">159,200</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of outstanding warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">137,095</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">22,373</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A summary of activity of the shares underlying the warrants from December 31, 2022 through December 31, 2024:</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:55.82%;box-sizing:content-box;"></td>
         <td style="width:1.74%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:19.2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:17.02%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"># of Shares</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise Price</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2022</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">111,978</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0625</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Converted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">590</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0625</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">111,388</span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0625</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issued</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,851,339</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0025</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">9,962,727</span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">0.0032</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to Note 1, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of the Business</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for discussion of the terms of the Public Warrants and New Warrants, to Note 3,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Material Agreements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for discussion of the terms of the VRM Warrants, and to Note 9, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims Financing Obligations and Notes Payable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for discussion of the terms of the CPIA Warrant.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_WarrantLiabilityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_WarrantLiabilityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Noncontrolling Interest<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Noncontrolling Interest</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 11. NONCONTROLLING INTEREST</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The non-controlling interest balance primarily represents the Up-C Units of the Company held by the Members. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the ownership of Units in the Company as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024:</span></span></p><div style="font-size:9pt;font-family:Times New Roman;">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.347%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.537%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:19.116%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Ownership Percentage</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Ownership of Class A Common Stock</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,184,958</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.6</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Ownership of Class V Common Stock</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,962,704</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69.4</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at end of period</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,147,662</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100.0</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The non-controlling interest holders have the right to exchange Up-C Units, at the Company&#8217;s option, for (i) cash or (ii) one share of Class A Common Stock, subject to the provisions set forth in the LLC Agreement. As such, future exchanges of Up-C Units by non-controlling interest holders will result in a change in ownership and reduce or increase the amount recorded as non-controlling interest and increase or decrease additional paid-in-capital or retained earnings when the Company has positive or negative net assets, respectively. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Up-C Units had been exchanged into Class A shares.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the non-controlling interest related to Up-C Units, the Company also has non-controlling interests related to the Series as noted in Note 8, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Variable Interest Entities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and MAO-MSO Recovery LLC Series FHCP (&#8220;FHCP&#8221;), which is a non-wholly owned subsidiary of MSP Recovery, LLC. In accordance with FHCP&#8217;s operating agreement, the noncontrolling member is entitled to a preferred return of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum (the &#8220;Preferred Return&#8221;). Once the Preferred Return has b</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">een met, the noncontrolling member is entitled to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of Claims recoveries by FHCP. The controlling member is allocated </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the costs of FHCP. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since the Preferred Return exceeds the total members&#8217; equity of FHCP as of both December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the non-controlling interest also includes $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million representing the entire members&#8217; equity of FHCP.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 12. COMMITMENTS AND CONTINGENCIES</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to certain legal proceedings, claims, investigations, and administrative proceedings in the ordinary course of its business. The Company records a provision for a liability when it is both probable that the liability has been incurred and the amount of the liability can be reasonably estimated. These provisions, if any, are reviewed and adjusted to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case. Depending on the nature and timing of any such proceedings that may arise, an unfavorable resolution of a matter could materially affect the Company&#8217;s future results of operations, cash flows or financial position in a particular period.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company pursues claims recoveries through settlement, arbitration and legal proceedings. The accounting policy for these activities is discussed under Claims recovery income in Note 2, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A significant majority of the Company&#8217;s expected recoveries arise from Claims brought pursuant to the private cause of action under the Medicare Secondary Payer Act (&#8220;MSP Act&#8221;). This law allows the Company to pursue recoveries against primary payers for reimbursement of medical expenses that the Company&#8217;s Assignors paid for when primary payers (i.e., liability insurers) were responsible for payment.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investigations</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 11, 2022, the Securities and Exchange Commission (the &#8220;SEC&#8221;) initiated an investigation of the Company, and requested documents relating to, among other matters, the Business Combination transaction with Lionheart Acquisition Corporation II consummated on May 23, 2022, certain historical and projected financial results, investor agreements, and data analytic platforms and Algorithms. The Company received a subpoena dated March 1, 2023 from the SEC regarding the aforementioned subject matter, and subsequently received a subpoena on May 10, 2023, in connection with the investigation relating to, among other matters, the Company&#8217;s projections and the accounting and valuation of certain assets that were the basis for the Company&#8217;s determination that its quarterly financial statements for the periods ended June 30, 2022 and September 30, 2022 require restatements and should no longer be relied upon, as disclosed in the Company&#8217;s Form 8-K on April 14, 2023. On August 16, 2023, the Company received an additional subpoena from the SEC regarding certain funding sources of the Company prior to the Business Combination, various statements and disclosures by the Company in connection with, and following, the Business Combination, certain historical and projected financial results, and data analytic platforms and Algorithms used to identify potential recoveries.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, on March 10, 2023, the Company received a subpoena from the U.S. Attorney&#8217;s Office (&#8220;USAO&#8221;) in connection with a grand jury investigation in the U.S. District Court for the Southern District of Florida requesting certain information concerning the Company, which subpoena requests documents relating to, among other matters, the Company&#8217;s proprietary Algorithms and other software used to identify potentially recoverable claims, the drop in the price of the Company&#8217;s common stock following the Business Combination, and certain marketing materials and investment agreements presented to potential investors. On July 18, 2024, the Company received an additional subpoena from the USAO, requesting documents related to a Company press release. To the best of the Company&#8217;s knowledge, the Department of Justice has not issued any target letters to anyone associated with the Company as a result of this investigation. (The United States Attorney&#8217;s Manual states that a &#8220;target&#8221; is a person as to whom the prosecutor or the grand jury has substantial evidence linking him or her to the commission of a crime and who, in the judgment of the prosecutor, is a putative defendant.)</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has cooperated, and will continue to cooperate, fully with these inquiries. On April 16, 2023, a special committee of the Board of Directors was formed, which along with external advisors retained thereby, reviewed matters related to the preparation and filing of the 2022 Annual Report on Form 10-K and the subject matter of information requests related to the foregoing subpoenas received prior to June 2023. Based on that review, and the nature of the documents requested in the subsequent subpoena, the Company believes that the investigations will be resolved without any material developments; however, there can be no assurance as to the outcome or future direction thereof.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cano Health, LLC</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 7, 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">318,401</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> unregistered shares of Class A Common Stock </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(after giving effect to the Reverse Split) </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to Cano Health, LLC (&#8220;Cano&#8221;) as payment for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in deferred compensation related to the following agreements, which the Company had the option to pay in cash or in stock and elected to pay in stock, of which (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">129,033</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock were issued as a deferred consideration for the assignment of certain claims pursuant to that certain Purchase Agreement, effective as of September 30, 2022, as amended to date, by and between MSP Recovery and Cano, and (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">189,368</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Common Stock were issued as deferred consideration for the assignment of certain claims pursuant to that certain Amended and Restated Claims Recovery and Assignment Agreement effective as of December 31, 2021, as amended to date, by and between MSP Recovery and Cano.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 10, 2023, the Company sued Cano in the Circuit Court of the Eleventh Judicial Circuit in and for Miami-Dade County, Florida for declaratory relief and anticipatory breach of the Cano CCRA, Cano Purchase Agreement, and a Service Agreement (collectively, the &#8220;Cano Agreements&#8221;) between the parties. On the same day, Cano sued the Company in the same court, alleging fraud in the inducement, breach of contract, tortious interference, and unjust enrichment relating to the Cano Agreements. The Company has a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million receivable outstanding from Cano; however, due to Cano&#8217;s Quarterly Report on Form 10-Q filings for the periods ending June 30, 2023 and September 30, 2023, which include a substantial doubt about Cano&#8217;s ability to continue as a going concern, and Cano&#8217;s subsequent filing of voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code on February 4, 2024, the Company established a reserve for the balance due under such receivable during 2023. These matters were automatically stayed as a result of Cano&#8217;s bankruptcy filing. As of June 28, 2024, the Debtors&#8217; Plan has been confirmed and declared effective. The automatic stay of litigation has been lifted and the parties anticipate the ongoing litigation to re-commence under a new scheduling order.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 4, 2024, Cano sued Simply Healthcare Plans, Inc. (&#8220;Simply&#8221;) and the Company and affiliated entities seeking a declaratory judgment to determine whether the Cano Purchase Agreement should be rescinded, and whether Cano or the Company have standing to recover on claims assigned to the Company against Simply under the Cano Purchase Agreement. Cano also seeks damages from Simply relating to the claims assigned to the Company under the Cano Purchase Agreement. Effective March 4, 2025, Cano voluntarily dismissed their case against Simply without prejudice.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company intends to vigorously assert its position in all Cano related litigation.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 13. FAIR VALUE MEASUREMENTS</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has no assets that are measured at fair value on a recurring basis as of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Liabilities measured at fair value on a recurring basis as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, are summarized as follows:</span></span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:47.359%;box-sizing:content-box;"></td>
         <td style="width:1.441%;box-sizing:content-box;"></td>
         <td style="width:1.681%;box-sizing:content-box;"></td>
         <td style="width:14.106%;box-sizing:content-box;"></td>
         <td style="width:1.441%;box-sizing:content-box;"></td>
         <td style="width:1.701%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.565%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.441%;box-sizing:content-box;"></td>
         <td style="width:1.701%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.565%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Level</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Derivative liability</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">211</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liability</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,373</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">268</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,584</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">305</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table details the roll-forward of the Level 3 liabilities during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:74.3%;box-sizing:content-box;"></td>
         <td style="width:2.26%;box-sizing:content-box;"></td>
         <td style="width:2.18%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:19.26%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Derivative liability</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of derivative liability</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">161</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of note</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">211</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the beneficial conversion feature within the Yorkville SEPA is treated as an embedded derivative liability and changes in the fair value were recognized in the change in fair value of warrant and derivative liabilities in the consolidated statements of operations. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The embedded derivative liability was valued at each of the respective issuance dates and at year-end using the following market-based inputs:</span></span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:57.563%;box-sizing:content-box;"></td>
         <td style="width:1.761%;box-sizing:content-box;"></td>
         <td style="width:1.581%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.587%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.761%;box-sizing:content-box;"></td>
         <td style="width:2.161%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.587%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Price of Common Stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.27</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56.75</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Volatility</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Market Risk Spread</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.56</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.37</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected Term (in years)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.75</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.25</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 14. RELATED PARTY TRANSACTIONS</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loans from Related Parties</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2022, the Company issued an unsecured promissory note in an aggregate principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">112.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the &#8220;Promissory Note&#8221;) to John H. Ruiz and Frank C. Quesada, the Company&#8217;s Chief Executive Officer and director and Chief Legal Officer and director, respectively (collectively, the &#8220;MSP Principals&#8221;), in exchange for the MSP Principals agreeing to provide cash to pay transaction costs related to the Merger, pay down affiliate payable balances, and provide operating cash to the Company. In addition to the amounts in the Promissory Note, at the merger date with LCAP, the MSP Principals contributed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million through funds that had been loaned to VRM MSP to cover related service fees. The Promissory Note as well as the amount contributed at the merger date bears interest at an annual rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, payable in kind, and will mature on the </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">four-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> anniversary of the issuance. The Promissory Note is payable by the Company at any time, without prepayment penalties, fees, or other expenses. The Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of interest expense related to the Promissory Note for each of the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A portion of the proceeds under the Promissory Note in an amount equal to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was advanced to the Law Firm, an affiliate of certain Members, for certain operating expenses pursuant to a legal services agreement. During the three months ended September 30, 2024, the Company amortized all remaining advances to the Law Firm. This amount is reflected in prepaid expenses and other current assets within the consolidated balance sheets and had a balance of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of December 31, 2024 and 2023, respectively. The advances of Law Firm expenses are reflected in Professional fees - legal within the consolidated statement of operations. The advances are expensed as incurred, as the Company does not have recourse to any amounts incurred should Law Firm fail to secure recoveries, although it does have recourse to any amounts advanced that have not been incurred as an expense.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the legal services agreement, Company shall advance certain of Law Firm&#8217;s monthly expenses, including payroll and overhead; however, should Law Firm earn fees under the legal service agreements (the &#8220;Existing LSAs&#8221;) noted below, net of pre-existing obligations including payments to co-counsel sufficient to cover its monthly expenses, Company is entitled to reimbursement of the advance of said monthly expenses. Further, to the extent that Law Firm earns a surplus of fees in excess of its monthly expenses, said surplus shall be used to reimburse past amounts of Law Firm&#8217;s monthly expenses that Company advanced. For the years ended December 31, 2024 and 2023, approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, of the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million advanced by the Company to the Law Firm has been incurred for expenses pursuant to the legal services agreement.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Founders&#8217; Pledge - Claims Proceeds Investment Agreement</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As disclosed in Note 9,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Claims Financing Obligations and Notes Payable </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements, the Founders pledged </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> thousand shares to secure payment of the original principal amount of the CPIA.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Services &#8211; Law Firm</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain Company entities have previously entered into the Existing LSAs with the Law Firm, an affiliate of certain Members, for the recovery of Claims. Pursuant to the terms of the Existing LSAs, the Law Firm provides the Company with investigation, case management, research and legal services in the pursuit of recovery of Claims in exchange for a portion of the recovered proceeds relating to such Claims. The Existing LSAs also provide that the Law Firm serves as lead counsel or co-lead counsel for any litigation relating to such Claims.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company has a payable to the Law Firm amounting to </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. For the years ended December 31, 2024 and 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, was included in Professional fees - legal for expenses related to the Law Firm in the consolidated statements of operations.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, during fiscal year 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company issued an unsecured promissory note in an aggregate principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.95</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to the Law Firm, to provide general operational funding (the &#8220;Law Firm Loan&#8221;). The aggregate unpaid principal amount of this promissory note is due </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months from the date of the last advance from the Second Amended and Restated First Lien Credit Agreement is made. This promissory note does not carry interest and is payable by the Company at any time, without prepayment penalties, fees, or other expenses. On March 4, 2024, the Board authorized the partial repayment of the Law Firm Loan in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which funds were to be used for the express purpose of paying property taxes on real property owned and pledged by the MSP Principals to HPH as collateral in connection with the Working Capital Credit Facility.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended December 31, 2024 and 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, were included in cost of Claims recoveries for expenses related to the Law Firm in the consolidated statements of operations.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Law Firm may also collect and/or hold cash on behalf of the Company in the ordinary course of business. As of December 31, 2024 and 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, was due from the Law Firm and included in the consolidated balance sheets in Affiliate Receivable. In addition, the Company rents office space from the Law Firm.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">MSP Recovery Aviation, LLC</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company may make payments related to operational expenses on behalf of its affiliate, MSP Recovery Aviation, LLC (&#8220;MSP Aviation&#8221;). The Company has made payments in the periods of the financial statements only related to specifically billed flights. As of both December 31, 2024 and 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was due from MSP Aviation and included in the consolidated balance sheets in Affiliate Receivable. For the years ended December 31, 2024 and 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, was included in General and Administrative expenses related to MSP Aviation in the consolidated statements of operations.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Funds Held for Other Entities</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company may collect and/or hold cash on behalf of its affiliates in the ordinary course of business. As of both December 31, 2024 and 2023, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was due to affiliates of the Company and included in the consolidated balance sheets in Affiliate Payable. These amounts were primarily due to Series MRCS, and will be repaid either through excess cash flows from operations or other financing. During the year ended December 31, 2021, the Company also entered into a note payable with Series MRCS as outlined in Note 6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, Intangible Assets, Net</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of both December 31, 2024 and 2023, the balance of the note payable was</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and included in the consolidated balance sheets in Claims financing obligation and notes payable.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, there were additional receivables from other affiliates of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. These were included in the consolidated balance sheets in Affiliate Receivable.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VRM MSP</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company concluded that VRM MSP is a related party due to ownership interests in the entity held by the MSP Recovery and Series MRCS. For the year ended December 31, 2024, the Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">188.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">124.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for interest expense related to the VRM Full Return and Virage MTA Amendment, and for the year ended December 31, 2023, the Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">156.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for interest expense related to the VRM Full Return and Virage MTA Amendment, respectively.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Virage</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in Note 3, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Material Agreements </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements, the Initial Virage Warrant, as amended, was issued effective January 1, 2024. Until our obligations to Virage are paid in full, the Company has the option every month to continue to pay Virage in one or a combination of: (a) cash, in an amount equal to 1.0% of each calendar month-end balance (which month-end balance shall be increased daily up to 20% per annum based on a formula set forth in the Virage MTA Amendment) of the amount owing to Virage as of each preceding calendar month end and/or (b) the issuance of subsequent Monthly Virage Warrants.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to Note 3, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Material Agreements </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements, for the listing of warrants issued during the year ended December 31, 2024.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to purchase agreements dated March 4, 2024 and August 22, 2024, and as disclosed on Form 4 filings by Mr. John H. Ruiz, the Company&#8217;s Chief Executive Officer, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,544</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,425</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, of unregistered shares of Class A Common Stock to Virage in satisfaction of certain obligations of the Company, which shares were subsequently purchased from Virage by Mr. Ruiz.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Founder&#8217;s Up-C Units &#8211; VRM Full Return</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As disclosed in Note 3, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Material Agreements </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the consolidated financial statements, in connection with the MTA Amendment, the Company agreed to pay Virage an amount equal to the contributions by Virage to VRM MSP plus an annual rate of return of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% (the &#8220;VRM Full Return&#8221;). Pursuant to the terms of the agreement with Virage, such amount may be payable by a sale of certain reserved shares of Messrs. John H. Ruiz and Frank C. Quesada, and the delivery of the resulting net cash proceeds thereof to VRM.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Working Capital Credit Facility Collateral</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Second Amended and Restated First Lien Credit Agreement, and in order to secure those additional advances of Term Loan B beginning in January 2024, the Company approved for Messrs. John H. Ruiz and Frank C. Quesada to provide, as additional collateral, the following: (i) a pledge of the equity interests in an Affiliate of Messrs. John H. Ruiz and Frank C. Quesada; (ii) a mortgage on real property owned by an Affiliate of Messrs. John H. Ruiz and Frank C. Quesada, and (iii) a personal guaranty by Messrs. John H. Ruiz and Frank C. Quesada, as primary obligors, guaranteeing those additional advances of Term Loan B beginning in January 2024. On December 22, 2023, our Board approved the Company's payment of certain costs and fees (including legal fees) on behalf of John H. Ruiz and Frank C. Quesada, associated with the mortgage granted in connection with said guaranty, totaling $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. On March 4, 2024, the Board authorized the partial repayment of the Law Firm Loan in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which funds were to be used for the express purpose of paying property taxes on real property owned and pledged by the MSP Principals to HPH as collateral in connection with the Working Capital Credit Facility.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 15. SEGMENT INFORMATION</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are defined as components of an entity for which separate financial information is available and regularly reviewed by the chief operating decision maker (&#8220;CODM&#8221;). The Company manages its operations, as described in Note 1, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of the Business</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, as a single reportable segment for the purposes of assessing performance and making decisions. The accounting policies of the reportable segment are those included in this Note 2, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company&#8217;s CODM is its </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_abbe20fe-8830-4413-8cd7-922975cc36b9;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has determined that it operates in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating segment and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment, as the CODM reviews financial information presented on a consolidated basis, using the operating expenses and interest expense, as presented on the face of the income statement, for purposes of making operating decisions, allocating resources, and evaluating financial performance.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The measure of segment assets is reported on the consolidated balance sheet as total consolidated assets. In addition, all of the Company&#8217;s revenues and long-lived assets are attributable primarily to operations in the United States and Puerto Rico for all periods presented.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant expenses regularly provided to the CODM are Claims Amortization Expense, Interest Expense, General &amp; Administrative, and Professional Fees as reported on the face of the income statement. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The table below presents the Company&#8217;s significant segment expenses and a reconciliation of Significant Segment expenses and other segment items to Net Loss, the CODM&#8217;s primary measure of performance:</span></span></p><div style="font-size:9pt;font-family:Times New Roman;">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:65.52%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.52%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.52%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total Revenues</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,249</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,705</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less:</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Significant Expenses:</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims amortization expense</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">484,076</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">476,492</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,231</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,131</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,766</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees &#8211; legal</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,519</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34,401</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment of intangible assets</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">752,697</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">420,032</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,169</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Significant Expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,702,686</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">849,336</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other Segment Items (1)</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">127,592</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,486</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net Loss</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">1,556,845</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">835,145</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes Cost of revenues, Allowance for credit losses, Depreciation and amortization, Change in fair value of warrant and derivative liabilities, and Other income (expense), net, as reported in our consolidated statements of operations.</span></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Common Share</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 16. N</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ET LOSS PER COMMON SHARE</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic earnings per share of Class A common stock is computed by dividing net income attributable to common shareholders by the weighted-average number of shares of Class A common stock outstanding during the period. Diluted earnings per share of Class A common stock is computed by dividing net income attributable to common shareholders adjusted for the assumed exchange of all potentially dilutive securities, by the weighted-average number of shares of Class A common stock outstanding adjusted to give effect to potentially dilutive elements. Diluted loss per share for all period presented is the same as basic loss per share as the inclusion of the potentially issuable shares would be anti-dilutive.
</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth the computation of basic and diluted earnings per share of Class A common stock:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.587%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.317%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.78%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.317%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Numerator - basic and diluted:</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,556,845</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">835,145</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Net loss attributable to the non-controlling interests</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,196,346</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">778,797</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss attributable to MSP Recovery, Inc.</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">360,499</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56,348</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Denominator &#8211; basic and diluted:</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares of Class A common stock outstanding &#8211; basic</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,001,525</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">356,591</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares of Class A common stock outstanding &#8211; dilutive</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,001,525</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">356,591</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Earnings per share of Class A common stock &#8211; basic</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">359.95</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">158.02</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Earnings per share of Class A common stock &#8211; diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">359.95</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">158.02</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Shares of the Company&#8217;s Class V common stock do not participate in the earnings or losses of the Company and are therefore not participating securities. As such, separate presentation of basic and diluted earnings per share of Class V common stock under the two-class method has not been presented.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the calculation for earnings per share for the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company excluded from the calculation of diluted earnings per share </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,962,704</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class V common stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,950,157</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Public Warrants outstanding, the CPIA Warrant exercisable for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,667</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">894,754,824</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> New Warrants outstanding and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,851,339</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants issued to Virage, as their effect would have been anti-dilutive.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the calculation for earnings per share for the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company excluded from the calculation of diluted earnings per share </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,965,296</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class V common stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,950,157</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Public Warrants outstanding, the CPIA Warrant exercisable for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,667</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">894,754,824</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> New Warrants outstanding because their effect would have been anti-dilutive.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liability<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Liability</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 17. DERIVATIVE LIABILITY</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes of determining whether certain instruments are derivatives for accounting treatment, the Company follows the accounting standard that provides guidance for determining whether an equity-linked financial instrument, or embedded feature, is indexed to an entity&#8217;s own stock. The standard applies to any freestanding financial instruments or embedded features that have the characteristics of a derivative, and to any freestanding financial instruments that are potentially settled in an entity&#8217;s own common stock.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Yorkville SEPA</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As disclosed previously, the beneficial conversion feature within the Yorkville SEPA is treated as an embedded derivative liability and changes in the fair value are recognized in the change in fair value of warrant and derivative liabilities in the consolidated statements of operations.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, the derivative liability associated with the beneficial conversion feature within the Yorkville SEPA amounted to </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.0 thousand</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Refer to Note 9,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Claims Financing Obligations and Notes Payable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for additional information on the Yorkville SEPA and Note 13, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for fair value measurements disclosures related to the embedded derivative in the Yorkville SEPA.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">OTC Equity Prepaid Forward Transaction</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and CF entered into an agreement for an OTC Equity Prepaid Forward Transaction (the &#8220;Transaction&#8221;). Pursuant to the terms of the Transaction, CF agreed to (a) transfer to the Company for cancellation any warrants to purchase shares received as a result of being the stockholder of record of a share as of the close of business on the closing date of the Business Combination, pursuant to the previously announced and declared LCAP dividend and (b) waive any redemption right that would require the redemption of the Subject Shares (as defined below) in exchange for a pro rata amount of the funds held in LCAP&#8217;s trust account.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At closing of the Business Combination, the Company transferred from the trust account to an escrow account an amount equal to (a) the aggregate number of such Subject Shares (approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> thousand shares), multiplied by (b) the per share redemption price for shares out of the trust account, as a prepayment to CF of the amount to be paid to CF in settlement of the Transaction for the number of shares owned by CF at the closing of the Business Combination (the &#8220;FEF Shares&#8221;). CF may sell the Subject Shares at its sole discretion in one or more transactions, publicly or privately. Any such sale shall constitute an optional early termination of the Transaction upon which (a) CF will receive from the escrow account an amount equal to the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">positive excess, if any, of (x) the product of the redemption price and the aggregate number of shares over (y) an amount equal to the proceeds received by CF in connection with sales of the shares, and (b) the Company will receive from the escrow account the amount set forth in (y) above.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company concluded that the instrument includes an embedded derivative for the change in value of the Company&#8217;s Class A common stock and as such, at the end of each period the Company will mark to market the shares through booking a derivative liability/asset. The calculation of the derivative liability/asset would be the difference between the restricted cash and current fair value of the outstanding FEF shares (number of FEF shares multiplied by market price of the Company&#8217;s Class A common stock as of period end).</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 6, 2023, the Company and CF entered into an Omnibus Fee Amendment Agreement (&#8220;Fee Amendment Agreement&#8221;). Pursuant to the terms of the Fee Amendment Agreement, in satisfaction of the deferred underwriting commissions under a previous agreement, the Company and CF agreed to release from escrow the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of restricted cash and release the FEF shares previously held as Class A Common Stock subject to possible redemption within temporary equity. Prior to the Fee Amendment Agreement, CF had not sold any FEF shares.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of the Fee Amendment Agreement and termination of the OTC Forward Transaction, as of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company no longer has any restricted cash, Class A Common Stock subject to possible redemption, or derivative liability in the consolidated balance sheets related to the OTC Forward Transaction.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/815/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 18. SUBSEQUENT EVENTS</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restructuring Plan</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described in our Current Report on Form 8-K filed with the SEC on April 10, 2025, on April 4, 2025, Virage Recovery Master, LP (&#8220;Virage&#8221;); Virage Capital Management, LP; Hazel Partners Holdings, LLC (&#8220;HPH&#8221;); Hazel Holdings I, LLC (and together with HPH, &#8220;Hazel&#8221;); La Ley con John H. Ruiz P.A. d/b/a MSP Recovery Law Firm; MSP Recovery, LLC; MSP Law Firm PLLC; MSP Recovery, Inc. (the &#8220;Company&#8221;), John H. Ruiz, and Frank C. Quesada (collectively, the &#8220;Parties&#8221;) entered into a term sheet (the &#8220;Term Sheet&#8221;) agreeing to certain terms and transactions that are designed to reduce costs of the Company through a servicer, deleverage the Company by converting certain debt of certain creditors into equity, provide access to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of bridge funding to the Company (of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million remains available through July 2025 pursuant to the Term Sheet, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of which remains available under the Operational Collection Floor at the sole discretion of HPH) and up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of working capital for New Servicer (as defined below), and focus the Company&#8217;s operations, through the New Servicer, on the core business model of pursuing recoveries under the MSP Laws so that it can achieve its long-term recovery goals. Beyond July 2025, the Company&#8217;s anticipated sources of funding include the MSP Principals&#8217; commitment to pledge $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of collateral to backstop additional working capital funding for the Company, potential distributions under our Standby Equity Purchase Agreement with YA II PN, Ltd. (the &#8220;Yorkville SEPA&#8221;), and claims recovery proceeds, subject to debt obligations on certain of the claims.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These proposed transactions are subject to, among other things, further negotiation and the execution of definitive agreements, regulatory approvals, certain third-party consents and approvals, and shareholder approvals if required by the Nasdaq Stock Market. The obligation of Hazel and its affiliates to enter into definitive documents is subject to the satisfaction of various conditions precedent, at their sole discretion, including, but not limited to, satisfactory finalization of due diligence and all required internal approvals, receipt of certain third-party consents required, and finalization of documentation. Consummation of the transactions contemplated by the Term Sheet are also subject to additional fundings by other parties and certain debt concessions by other stakeholders. As a result, there can be no guarantee that the transactions contemplated by the Term Sheet will be consummated.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The proposed transactions include, but are not limited to, the following transactions:</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Establishment of New Servicer</span></div></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company shall establish a new subsidiary (&#8220;New Servicer&#8221;) to provide and control recovery efforts, by way of litigation,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">demand </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">letters, settlements, or other means, in connection with existing claim recovery rights (to the extent assignable), and those acquired in the future, held in special purpose vehicles (&#8220;SPV&#8221;), wholly owned by New Servicer, to hold any new claims acquired. The Company will license its intellectual property to the New Servicer in exchange for a license fee of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of New Servicer&#8217;s excess cash flow, with a minimum fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.55</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million paid on May 30, 2025, and June 30, 2025. New Servicer will be funded by an affiliate of Hazel (hereinafter, &#8220;Funder&#8221;), up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in funding, as set forth below, with a right of first refusal for additional funding needs. New Servicer will be independently managed and be separately governed by an independent board of directors, including a chief executive officer chosen by Funder and consented to by the Company, one director chosen by the Company, and one independent director chosen by Funder and approved by the Company. Funder&#8217;s governance rights shall terminate once all Hazel loans have been repaid in full, and Funder&#8217;s Recovery Rights Interest (as defined below) in the New Servicer is less than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%. Virage shall have observer rights to the New Servicer board of directors until the amounts owed to Virage pursuant to the Master Transaction Agreement dated March 9, 2022, as amended (the &#8220;MTA&#8221;), which was approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the &#8220;VRM Full Return&#8221;) has been repaid and Virage&#8217;s equity interest in the Company is less than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Working Capital Funding for the New Servicer</span></div></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Funder has agreed to extend a line of credit to New Servicer of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, funded in tranches of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million per month, subject to the New Servicer meeting certain milestones (which are currently being negotiated and to be agreed in definitive documentation), beginning September 2025, with a maturity date of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">June 30, 2027</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. New Servicer funding will accrue interest at the Secured Overnight Financing Rate (&#8220;</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1094ec3c-3994-4e86-9062-4c0d05c077e7;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SOFR</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;) plus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum for one year, and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_d7edfda9-d03e-48a1-be13-3f45acb6f141;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SOFR</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> plus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% thereafter. Funder will establish a first lien on the New Servicer; the Company will not guaranty the loan to fund New Servicer.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, Funder or Hazel is entitled to receive to up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of New Servicer&#8217;s excess cash flow (the &#8220;Recovery Rights Interest&#8221;). At its option, Funder may convert, in whole or part, its Recovery Rights Interest for up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the then outstanding shares of Company&#8217;s equity, measured as of the Closing and subject to dilution for stock issuance thereafter.</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Additional Bridge Financing for the Company</span></div></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, Hazel agreed to provide up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in bridge loan funding to the Company under the existing Operational Collection Floor facility (in addition to the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million previously funded under the facility) in the amounts of: (i) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for March 2025, which was funded on February 28, 2025; (ii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for April 2025, which was funded on April 4, 2025; (iii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for May 2025, to be funded on or about April 30, 2025; (iv) up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to fund the legal, accounting, and administrative expenses associated with the reorganization, subject to certain terms and customary conditions acceptable to Hazel, and minimum license fees of (v) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.55</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for June 2025; and (vii) $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.55</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for July 2025. Funding is conditional, in part, on an increase in the pledge of collateral and personal guaranty by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million by Messrs. Ruiz and Quesada (the &#8220;MSP Principals&#8221;). Such minimum license fee payment will be paid from the Bridge Loan.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beyond July 2025, the MSP Principals have committed to pledge $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of collateral to backstop additional working capital requirements of the Company, in addition to other previous sources of funding, including cash proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA, and the proceeds from claims recoveries, subject to lien repayment on certain claims. In addition, the Company expects annual costs reductions due to New Servicer operations and shall be funded by the Funder (through New Servicer).</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Term Sheet requires (and is conditioned upon) La Ley con John H. Ruiz, P.A. d/b/a MSP Recovery Law Firm and MSP Law Firm, PLLC, collectively, raising $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for operational funding over two years, subject to similar milestones (to be agreed upon) as per the New Servicer funding, and to be entered into at completion of the proposed transaction.</span></p><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt Restructuring</span></div></div><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In exchange for a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest in the Company (inclusive of shares currently held and those shares acquired through warrant exercises pursuant to the Virage Term Sheet discussed below) Virage has agreed to waive all claims and release all liens against the Company relating to the VRM Full Return (approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), and the Parties agree that the VRM Full Return will be paid only from: (i) a junior lien against Subrogation Holdings proceeds, (ii) claims currently owned by Virage, (iii) liens over two tranches of claims currently owned by Hazel (which Hazel shall release as part of the reorganization transaction) and (iv) a non-recourse second lien up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million over </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the proceeds from the New Servicer and associated SPVs, to the extent that the VRM Full Return has not been repaid.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the MSP Principals have agreed to convert </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the Company&#8217;s debt obligation to them, totaling approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">144</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, into shares of the Company&#8217;s Class A Common Stock, the full and final amount of the debt-to-equity conversion is subject to tax analysis and approval of the MSP Principals and the Company&#8217;s Board of Directors.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Hazel&#8217;s existing loans to Subrogation Holdings and the amount of Company&#8217;s guaranty (currently approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million) remain unchanged except that such lien shall now exclude the Company&#8217;s intellectual property. Hazel agreed, subject to obtaining third-party consents, to extend the maturity date on all outstanding obligations to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">November 30, 2026</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To secure the repayment of the existing</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Hazel </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">loans to the extent such loans have not been repaid in full, the Company shall, for a principal amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">235</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million with an interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_4e424096-b0c4-45a8-94c2-f9386f78d00b;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SOFR</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> plus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum: (i) pledge to Hazel </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the New Servicer and associated SPV equity interests; and (ii) grant a lien over </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the proceeds from New Servicer and associated SPVs, once the New Servicer funding has been repaid. In addition, to the extent the VRM Full Return has not been repaid, Virage has second lien of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million over </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the proceeds from New Servicer and associated SPVs.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 13, 2025, the Board delegated to an independent committee of the Board of Directors (the &#8220;Independent Committee&#8221;) the power and authority to, among other things, determine on behalf of the Board and the Company whether, to the extent any conflicts or potential conflicts exist or arise in the future among the Company and Messrs. Ruiz and Quesada, certain Restructuring and Proposals are advisable and fair to, and in the best interests of, the Company and its stockholders. The Independent Committee reviewed the Term Sheet and engaged legal counsel and financial advisors that are familiar with the Company and restructuring transactions to determine if the Term Sheet is advisable and fair, and in the best interests of the Company and its stockholders. Although the Independent Committee identified material conflicts, those conflicts involve conditions precedent to the Term Sheet, and are resolvable to the satisfaction of the Independent Committee in furtherance of the Term Sheet and in the best interest of the Company; as such, the Independent Committee determined that it is advisable and in the best interests of the Company to approve the signing of the Term Sheet and subsequent entry into agreements consistent with the terms set forth therein.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Term Sheet, the parties are working to complete the definitive agreements by April 30, 2025.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">VRM Warrant Issuance and Restructuring</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the first Amendment to the Master Transaction Agreement, dated April 11, 2023 (the &#8220;First Amendment&#8221;), for each calendar month beginning with January 31, 2024 and ending when the VRM Full Return (as defined in the Master Transaction Agreement dated March 9, 2022 (as amended, the &#8220;MTA&#8221;)) is paid in full, the Company is required to either: (i) pay in cash or (ii) </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">issue a warrant to purchase a number of shares of Class A Common Stock of the Company, or some combination thereof, to Virage Recovery Master LP (&#8220;VRM&#8221;) equal to the quotient of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the calendar month-end balance of the Unpaid Base Amount (as defined in the MTA) (the &#8220;Required Monthly Issuance&#8221;).</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> On Apri</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">l 14,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 2025, the Company issued VRM Monthly Warrants for November 2024 and December 2024, for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,277,808</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,332,792</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares respectively, exercisable at a purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share for a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">two years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the original issuance date, exercisable on a cashless basis only. To date, the Company has issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> warrants to VRM pursuant to the First Amendment, entitling Virage to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,361,939</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A Common Stock.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with negotiations to restructure the Company&#8217;s obligations under the MTA, on February 18, 2025, the Company entered into a term sheet agreement with Virage (the &#8220;Virage Term Sheet&#8221;) to amend the MTA, whereby Virage and the Company agreed, subject to certain conditions, which have not been met as of the date of this Annual Report on Form 10-K, to enter into definitive documentation at a later date to: (i) exercise the VRM Warrants to purchase that number of shares that would result in Virage owning </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_6c011bf9-0559-4a17-8cc8-0125ab18a42f;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33 1/3</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the then issued and outstanding Common Stock (the &#8220;Warrant Exercise&#8221;), (ii) surrender to the Company any remaining unexercised VRM Warrants, or portions thereof, for termination, (iii) contemporaneous with the Warrant Exercise, terminate its agreement to hold no more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding Common Stock of the Company, (iv) subject to certain conditions, grant proxy voting rights to the MRCS Principals over an amount of shares of Common Stock issuable to Virage from the Warrant Exercise such that the MRCS Principals will have voting control over </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the total outstanding Parent Class A Common Stock, and (v) terminate any obligation of the Company to satisfy the Required Monthly Issuance. These proposed transactions under the Virage Term Sheet are subject to, among other things, further negotiation and the execution of definitive agreements, regulatory approvals, and shareholder approvals if required by the Nasdaq Stock Market; as a result, there can be no guarantee that the transactions thereby will be consummated.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Yorkville Amendments</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the close of Primary Market trading on October 18, 2024, the daily VWAP for MSP Recovery, Inc.&#8217;s (the &#8220;Company&#8221;) Class A Common Stock was below the Floor Price (which is $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.75</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">), as defined in the Exchangeable Promissory Notes (&#8220;Notes&#8221;) issued to YA II PN, Ltd. (&#8220;Yorkville&#8221;) pursuant to the Standby Equity Purchase Agreement dated November 14, 2023, as amended (the &#8220;SEPA&#8221;), by and between Yorkville and the Company, for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ten</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> consecutive Trading Days, resulting in a Floor Price Trigger pursuant to the Notes.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon the occurrence of a Trigger Event, the Company shall make monthly payments (&#8220;Monthly Payments&#8221;) beginning on the 7th Trading Day after the date of the Trigger Event and continuing on the same day of each successive month.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 10, 2025, Yorkville agreed: (i) that the first Monthly Payment, as set forth in Section (1)(c) of the Notes, would be due from the Company no sooner than November 30, 2026, (ii) the maturity date of the Convertible Notes is extended to November 30, 2026, and (iii) to waive Volume Threshold and Maximum Advance Amount limitations set forth in the Yorkville SEPA.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Capitalized but undefined terms have the same meaning as set forth in the Yorkville SEPA and the Notes.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">LSA Amendment</span></p><p style="text-indent:36pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 14, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2025, Lionheart II Holdings, LLC (&#8220;Lionheart&#8221;), a wholly owned subsidiary of the Company, entered into Amendment No. 1 to its Legal Services Agreement with La Ley con John H. Ruiz, P.A. d/b/a MSP Recovery Law Firm (&#8220;La Ley&#8221;), and MSP Law Firm, PLLC (collectively with La Ley, &#8220;Law Firm&#8221;), which: (i) terminates any obligation by the Company or its subsidiaries to provide further advances to fund the Law Firm, and provides that any Compensation earned by the Law Firm will be first used to repay the Advance Balance to Lionheart.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of presentation</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These statements have been prepared pursuant to the rules and regulations of the SEC and in accordance with GAAP. In the opinion of management, the consolidated financial statements reflect all adjustments, which consist only of normal recurring adjustments, necessary to state fairly the results of operations, financial condition and cash flows for the periods presented herein. Prior to the Business Combination, the consolidated financial statements reflect Legacy MSP. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All intercompany transactions and balances are eliminated from the consolidated financial statements.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Principles of consolidation</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company consolidates all entities that it controls through a majority voting interest or otherwise and the accompanying financial statements include the accounts of the Company&#8217;s wholly owned subsidiaries and these entities for which the Company has a controlling interest in. The Company also consolidates all entities that it controls as the primary beneficiary of a variable interest entity (&#8220;VIE&#8221;). Under the VIE model, management first assesses whether the Company has a variable interest in an entity, which would include an equity interest. If the Company has a variable interest in an entity, management further assesses whether that entity is a VIE, and if so, whether the Company is the primary beneficiary under the VIE model. Generally, entities that are organized similar to a limited partnership, in which a general partner (or managing member) make the most relevant decisions that affect the entity&#8217;s economic performance, are considered to be VIEs which would require consolidation, unless the limited partners have substantive kickout or participating rights. Entities that do not qualify as VIEs are assessed for consolidation under the voting interest model.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the VIE model, an entity is deemed to be the primary beneficiary of a VIE if it holds a controlling financial interest. A controlling financial interest is defined as (a) the power to direct the activities of a VIE that most significantly affect the entity&#8217;s economic performance and (b) the obligation to absorb losses of the entity or the right to receive benefits from the entity that could potentially be significant to the VIE. Management determines whether the Company is the primary beneficiary of a VIE at the time it becomes involved with a VIE and reconsiders that conclusion at each reporting date. This analysis includes an evaluation of the Company&#8217;s control rights, as well as the economic interests that the Company holds in the VIE, including indirectly through related parties. As a result of the Business Combination, the Company consolidates MSP Recovery under the VIE model.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Estimates and Assumptions</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Estimates and Assumptions</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting periods. Actual results could differ from the Company&#8217;s estimates. Estimates are periodically reviewed considering changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Significant estimates and assumptions reflected in these consolidated financial statements include but are not limited to recoverability of long-lived assets.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain reclassifications have been made to the prior year statement of cash flows to conform to classifications used in the current year. These reclassifications had no impact on net loss, shareholders&#8217; equity or total cash flows as previously reported.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Segments</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are defined as components of an entity for which separate financial information (including profit and/or loss) is available and regularly reviewed by the chief operating decision maker (&#8220;CODM&#8221;). The Company manages its operations as a single segment for the purposes of assessing performance and making decisions. The Company&#8217;s CODM is its </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_8b390608-14b7-4bdf-8388-0311ecd33fec;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company has determined that it operates in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating segment and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. In addition, all of the Company&#8217;s revenues and long-lived assets are attributable primarily to operations in the United States and Puerto Rico for all periods presented.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of credit risk and&#160;Off-Balance&#160;Sheet Risk</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Concentration of credit risk and Off-Balance Sheet Risk</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and affiliate receivable are financial instruments that are potentially subject to concentrations of credit risk. See Note 14,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, fo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">r disclosure of affiliate receivables. The Company&#8217;s cash and restricted cash are deposited in accounts at large financial institutions, and amounts may exceed federally insured limits. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash and cash equivalents are held. The Company has no other financial instruments with off-balance-sheet risk of loss.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers all highly liquid investments purchased with original maturities of three months or less to be cash equivalents. There are </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> cash equivalents as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 or 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company applies the provisions of ASC 820, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for fair value measurements of financial assets and financial liabilities and for fair value measurements of non-financial items that are recognized or disclosed at fair value in the financial statements on a recurring basis. The Company also applied the provisions of the subtopic to fair value measurements of non-financial assets and non-financial liabilities that are recognized or disclosed at fair value in the financial statements on a non-recurring basis. The subtopic defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The subtopic also establishes a framework for measuring fair value and expands disclosures about fair value measurements. The fair value framework requires the Company to categorize certain assets and liabilities into three levels, based upon the assumptions used to price those assets or liabilities. The three levels are defined as follows:</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1: Quoted prices in active markets for identical assets or liabilities.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2: Quoted prices for similar assets and liabilities in active markets or inputs that are observable.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3: Unobservable inputs reflecting management&#8217;s own assumptions about the inputs used in pricing the asset or liability.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has determined the estimated fair value of its financial instruments based on appropriate valuation methodologies; however, for Level 2 and Level 3 inputs considerable judgment is required to develop these estimates. Accordingly, these estimated fair values are not necessarily indicative of the amounts the Company could realize in a current market exchange. The estimated fair values can be materially affected by using different assumptions or methodologies. The methods and assumptions used in estimating the fair values of financial instruments are based on carrying values and future cash flows. As of December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t hold any Level 2 or Level 3 assets. See </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Note 13,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for additional information on Level 2 and Level 3 liabilities as of December 31, 2024.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash is stated at cost, which approximates their fair value. The carrying amounts reported in the consolidated balance sheets for affiliate receivable, accounts payable, affiliate payable and accrued liabilities approximate fair value, due to their short-term maturities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Outstanding borrowings that qualify as financial instruments are carried at cost, which approximates their fair value as of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, due to their short duration.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity Method Investments</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity investments that are not consolidated, but over which the Company exercises significant influence, are accounted for in accordance with ASC 323, &#8220;Investments&#8212;Equity Method and Joint Ventures&#8221; (&#8220;ASC 323&#8221;). Wh</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ether or not the Company exercises significant influence with respect to an investee company depends on an evaluation of several factors including, among others, representation on the investee company&#8217;s board of directors and ownership level. An entity is presumptively assumed to have significant influence in a corporation when it holds </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or more of the voting stock of the investee company, or at a lower level (e.g., </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%) for entities that track separate members capital accounts.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the equity method of accounting, an investee company&#8217;s accounts are not reflected within the Company&#8217;s consolidated balance sheets and statements of operations; however, the Company&#8217;s share of the earnings or losses of the investee company is reflected in the caption &#8220;Other income&#8221; in the consolidated statements of operations. The Company&#8217;s carrying value in equity method investee companies is not reflected in the Company&#8217;s consolidated balance sheets as of December 31, 2024 or 2023 as the carryin</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">g </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">value is de</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">minimis. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When the Company&#8217;s carrying value in an equity method investee company is reduced to zero, no further losses are recorded in the Company&#8217;s consolidated financial statements unless the Company has guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and Equipment</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are stated at historical cost less accumulated depreciation and accumulated impairment losses, if any. Major expenditures for property and equipment and those that substantially increase useful lives are capitalized. When assets are sold or otherwise disposed of, costs and related accumulated depreciation are removed from the financial statements and any resulting gains or losses are included in general and administrative expenses within our consolidated statements of operations.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company provides for depreciation and amortization on property and equipment using the straight-line method to allocate the cost of depreciable assets over their estimated lives as follows:</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:67.54%;box-sizing:content-box;"></td>
           <td style="width:32.46%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:8.45pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office and Computer Equipment</span></p></td>
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
          </tr>
          <tr style="height:11.9pt;white-space:pre-wrap;word-break:break-word;">
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and Fixtures</span></p></td>
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
          </tr>
          <tr style="height:1pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold Improvements</span></p></td>
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="-sec-ix-hidden:F_d7c0ff4e-449b-40a5-8325-8ed41dfb3e58;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lesser of lease term or estimated life</span></span></span></p></td>
          </tr>
         </table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Internal Use Software</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Internal Use Software</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Internal-use software development costs incurred in the preliminary project stage are expensed as incurred; costs incurred in the application and development stage, which meet the capitalization criteria, are capitalized and amortized on a straight-line basis over the estimated useful life of the asset and costs incurred in the post-implementation/operations stage are expensed as incurred. The estimated useful life for development costs capitalized as of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Further, internal and external costs incurred in connection with upgrades or enhancements are also evaluated for capitalization. If the software upgrade results in an additional functionality, costs are capitalized; if the upgrade only extends the useful life, it is expensed as occurred.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible assets</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intangible assets</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In certain of its CCRAs, the Company makes up-front payments to acquire Claims recovery rights from secondary payers, such as health plans, managed service organizations, providers or medical services and independent physicians&#8217; associations. The Company recognizes intangible assets for costs incurred up front to acquire Claims recovery rights from various Assignors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CCRA assets are held at cost. Historically, the Company amortized capitalized costs associated with CCRAs over </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">eight years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, based on the expected timing to pursue recovery through litigation, including through potential appeals. As part of the annual reassessment of useful lives as of December 31, 2024, the Company updated the estimated useful life of the CCRAs to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seven years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> beginning January 1, 2025.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the Business Combination, the Company acquired rights to Claims recovery cash flows. As a result of this purchase and the guaranty obligation as noted in Note 8, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Variable Interest Entities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company consolidated the entity which holds these Claim rights. Upon consolidation, these Claims rights were accounted for under ASC 350. As such these assets are held at cost, net of amortization.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates these assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. If the estimated future cash flows (undiscounted and without interest charges) from the use of an asset group are less than the carrying value, a write-down would be recorded to reduce the related asset group to its estimated fair value.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Instruments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Derivative Instruments</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates its convertible debt, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 480, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Distinguishing Liabilities from Equity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and ASC 815, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Derivatives and Hedging</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The result of this accounting treatment is that the fair value of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability. The change in fair value is recorded in the statements of operations as a component of other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, combined derivative instrument.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">will </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">be classified in the consolidated balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NonControllingInterestsPolicyTextBlock', window );">Non-controlling Interests</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Non-Controlling Interests</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the Business Combination and described in Note 1, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Description of the Business</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company became the managing member of MSP Recovery, which is consolidated as the Company controls the operating decisions of MSP Recovery. The non-controlling interest relates to the Up-C Units that are convertible into Class A Common Stock of the Company at the discretion of the holder of the Up-C Unit. The Up-C Unit holders retained approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.76</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the economic ownership percentage of the Company as of the Closing Date. The non-controlling interest is classified as permanent equity within</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the consolidated balance sheet of the Company. As of December 31, 2024, based on the Class A common stock issuances during the period, the non-controlling interest of Class V shareholders was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69.43</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in the Company&#8217;s ownership interest in MSP Recovery, due to Class V shareholders converting their shares to Class A, are accounted for as equity transactions. Each issuance of the Company&#8217;s Class A Common Stock requires a corresponding issuance of MSP Recovery units to the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company. The issuance would result in a change in ownership and would reduce the balance of non-controlling interest and increase the balance of additional paid-in capital.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates long-lived assets, such as property and equipment, including capitalized software costs, and finite-lived intangibles such as Claims recovery rights, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset or asset group may not be recoverable. If the estimated future cash flows (undiscounted and without interest charges) from the use of an asset group are less than the carrying value, a write-down would be recorded to reduce the related asset group to its estimated fair val</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ue.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Claims Recovery</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims Recovery</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s primary income-producing activities are associated with the pursuit and recovery of proceeds related to Claims recovery rights that the Company obtains through CCRAs, in which it becomes the owner of those rights. As a result, such income is not generated from the transfer of control of goods or services to customers, but from the proceeds realized from perfection of Claims recoveries from rights the Company holds outright. The Company may also generate future revenue by providing Claims recovery services to other entities outside of the Company.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims recovery income</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes Claims recovery income based on a gain contingency model&#8212;that is, when the amounts are reasonably certain of collection. This typically occurs upon reaching a binding settlement or arbitration with the counterparty or when the legal proceedings, including any appellate process, are resolved.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, the Company owes an additional payment to the original Assignor in connection with the realized value of the recovery right. Claims recovery income is recognized on a gross basis, as the Company is entitled to the full value of recovery proceeds, and makes a payment to the original Assignor similar to a royalty arrangement. Such payments to prior owners are recognized as cost of Claims recovery in the same period the Claims recovery income is recognized.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When the Company becomes entitled to recovery proceeds from the settlement of a Claim recovery pursuit or proceeding that meets the requirements under ASC 450, it recognizes the amount in accounts receivable.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Claims recovery service income, ASC 606, Revenue from Contracts with Customers</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The guidance under ASC 606, Revenue from Contracts with Customers, provides that an entity should apply the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, the entity satisfies a performance obligation.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company derives revenues from contracts with customers primarily from Claims recovery services arrangements (&#8220;Claims recovery services&#8221;). Claims recovery services include services to related parties or third parties to assist those entities with pursuit of Claims recovery rights. The Company has determined it has a single performance obligation for the series of daily activities that comprise Claims recovery services, which are recognized over time using a time-based progress measure and are typically based on (1) budgeted expenses for the current month with an adjustment for the variance between budget and actual expenses from the prior month or (2) on a contingent basis dependent on actual settlements or resolved litigation. Amounts estimated and recognized, but not yet fully settled or resolved as part of litigation are recognized as contract assets. There were no contract assets as of December 31, 2024 or 2023, as amounts associated with unresolved litigation were fully constrained.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims recovery services are generally paid in advance on a monthly basis. The Company did not recognize any material revenue for the years ended December 31, 2024 or 2023 for performance obligations that were fully satisfied in previous periods. For the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company also recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of servicing income related to a specific contract where the performance obligations were completed during the year.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company does not have material unfulfilled performance obligation balances for contracts with an original length greater than one year in any years presented. Additionally, the Company does not have material costs related to obtaining a Claims recovery service contract with amortization periods greater than one year for any period presented.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company applies ASC 606 utilizing the following allowable exemptions or practical expedients:</span></p><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exemption to not disclose the unfulfilled performance obligation balance for contracts with an original length of one year or less.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Practical expedient to recognize the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Election to present revenue net of sales taxes and other similar taxes, if any.</span></div></div><div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Practical expedient not requiring the entity to adjust the promised amount of consideration for the effects of a significant financing component if the entity expects, at contract inception, that the period between when the entity transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.</span></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock', window );">Transfers of Claims Cost Recovery Rights to Others</a></td>
<td class="text"><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfers of Claims Cost Recovery Rights to Others</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, the Company has entered into arrangements to transfer CCRAs or rights to proceeds from CCRAs to other parties. The Company evaluates whether such transfers are sales of nonfinancial assets, sales of future revenues treated as debt, in-kind contributions to equity method investees, or other types of arrangements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When they are treated as sales of nonfinancial assets, the Company recognizes a gain on the sale when control transfers to the counterparty based on the difference between the fair value of consideration (including cash) received and the recognized carrying value of the CCRAs. In some cases, such sales include variable consideration in the form of payments that will be made only upon achievement of certain recoveries or based on a percentage of actual recoveries. The Company estimates and constrains the amounts that will ultimately be realized based on these variable payment terms and includes those amounts in the determination of gain or loss; the gain or loss is subsequently updated based on changes in those estimates.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In other cases, such transfers are considered to be sales of future revenue that are debt-like in nature. These arrangements are recognized as debt based on the proceeds received, and are imputed an interest rate based on the expected timing and amount of payments to achieve contractual hurdles. These are subject to revisions of estimates of that timing and amount based on the contractual provisions and the Company&#8217;s assumptions from changes in facts and circumstances. Such changes are reflected through revision of the imputed interest rate on a cumulative catch-up basis.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_CostOfClaimRecoveriesPolicyTextBlock', window );">Cost of Claims Recoveries</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cost of Claims Recoveries</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Costs of Claims recoveries consist of all directly attributable costs specifically associated with Claims processing activities, including contingent payments to Assignors (i.e., settlement expenses).</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsAmortizationExpensePolicyTextBlock', window );">Claims amortization expense</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims amortization expense</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Claims amortization expense includes amortization of CCRAs acquired as part of the business combination, shown as Intangibles, net in the consolidated balance sheets, and CCRA intangible assets for which the Company made up-front payments for Claims recovery rights. For further details on CCRAs see Note 6, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Intangible Assets, Net</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our income tax expense, deferred tax assets and liabilities, and reserves for unrecognized tax benefits reflect management&#8217;s best assessment of estimated current and future taxes to be paid. As a result of the Business Combination, the Company became the sole managing member of MSP Recovery, which is treated as a partnership for U.S. federal, state and local income tax purposes. As a partnership, MSP Recovery is not subject to U.S. federal and certain state and local income taxes. Any taxable income or loss generated by MSP Recovery is passed through to and included in the taxable income or loss of its partners, including MSP Recovery, Inc. The Company is subject to U.S. federal income taxes, in addition to state and local income taxes, with respect to the Company&#8217;s allocable share of income of MSP Recovery, LLC.</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s deferred tax balances reflect the impact of temporary differences between the carrying amount of assets and liabilities and the Company&#8217;s tax basis. The balances are stated at the tax rates in effect when the temporary differences are expected to be recovered or settled. The Company reviewed the anticipated future realization of the tax benefit of the Company&#8217;s existing deferred tax assets and concluded that it is more likely than not that all of the deferred tax assets will not be realized in the future and recorded a full valuation allowance at December 31, 2024 and 2023.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive Income (Loss)</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has no components of other comprehensive income (loss). As such, net loss equates to comprehensive income (loss) for all periods presented in this report.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New Accounting Pronouncements Recently Adopted</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2024, we </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-07, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, on a retrospective basis. The amendments are intended to increase reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. Refer to Note 15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, Segment Information</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for further information.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New Accounting Pronouncements Issued but Not Yet Adopted</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASU 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Among other requirements, this update adds specific disclosure requirements for income taxes, including: (1) disclosing specific categories in the rate reconciliation and (2) providing additional information for reconciling items that meet quantitative thresholds. The guidance is effective for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company is currently evaluating the provisions of this guidance and assessing the potential impact on the Company&#8217;s financial statement disclosures.</span></p><p style="text-indent:21.6pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU 2024-03, &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40) Disaggregation of Income Statement Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;. The guidance in ASU 2024-03 does not change the expense line items presented on the face of the financial statements, but instead, it requires additional disaggregation of specific expense captions</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the notes to the financial statements, among other things, specific information about certain costs and expenses including purchases of inventory; employee compensation; and depreciation, amortization and depletion expenses for each caption on the income statement where such expenses are included. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted, and the amendments may be applied prospectively to reporting periods after the effective date or retrospectively to all periods presented in the financial statements. The Company is currently evaluating the provisions of this guidance and assessing the potential impact on the Company&#8217;s financial statement disclosures.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClaimsAmortizationExpensePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims amortization expense [Policy Text Block].</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClaimsAmortizationExpensePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_CostOfClaimRecoveriesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of claim recoveries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_CostOfClaimRecoveriesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_NonControllingInterestsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_NonControllingInterestsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfer of claims costs recovery right to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21D<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-21D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentaton and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock', window );">Summary of Depreciation and Amortization on Property and Equipment</a></td>
<td class="text"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company provides for depreciation and amortization on property and equipment using the straight-line method to allocate the cost of depreciable assets over their estimated lives as follows:</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:67.54%;box-sizing:content-box;"></td>
           <td style="width:32.46%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:8.45pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office and Computer Equipment</span></p></td>
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
          </tr>
          <tr style="height:11.9pt;white-space:pre-wrap;word-break:break-word;">
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and Fixtures</span></p></td>
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
          </tr>
          <tr style="height:1pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold Improvements</span></p></td>
           <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="-sec-ix-hidden:F_d7c0ff4e-449b-40a5-8325-8ed41dfb3e58;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lesser of lease term or estimated life</span></span></span></p></td>
          </tr>
         </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure in tabular form of useful lives of property plant and useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment In Equity Method Investees (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock', window );">Summarized Financial Information of Equity Method Investees</a></td>
<td class="text"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Summary financial information for equity accounted investees, not adjusted for the percentage ownership of the Company is as follows:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Year Ended December 31,</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">354</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,167</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,000</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">840</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,038</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.013%;box-sizing:content-box;"></td>
         <td style="width:1.04%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.403%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.543%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total Assets</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">928</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,403</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total Liabilities</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">762</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">399</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure in tabular form of summarized financial information of equity method investees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment, net consist of the following:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:65.52%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.52%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.52%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Office and computer equipment</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">459</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">434</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">701</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">113</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Internally developed software</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,588</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,789</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other software</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Property and equipment, gross</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">6,815</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">6,403</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: accumulated depreciation and amortization of software</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,656</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,492</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">5,159</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">4,911</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Summary of Intangible Assets Net</a></td>
<td class="text"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intangible assets, net consists of the following:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:65.987%;box-sizing:content-box;"></td>
         <td style="width:1.56%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.177%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.56%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.717%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets, gross</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,121,859</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,872,356</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated amortization</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,223,636</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">739,560</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">1,898,223</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">3,132,796</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Expected Future Amortization Expense of Intangible Assets</a></td>
<td class="text"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future amortization for CCRAs is expected to be as follows:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:78.82%;box-sizing:content-box;"></td>
         <td style="width:1.86%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:17.32%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">CCRAs Amortization</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">474,556</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">474,556</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">474,556</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">474,555</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">1,898,223</span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember', window );">Claims Cost Recovery Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Summary of Intangible Assets Net</a></td>
<td class="text"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the changes in the Company&#8217;s intangibles assets for </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:65.987%;box-sizing:content-box;"></td>
         <td style="width:1.6%;box-sizing:content-box;"></td>
         <td style="width:16.137%;box-sizing:content-box;"></td>
         <td style="width:1.56%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.717%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Intangible Assets</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2022</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,363,156</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquisitions of CCRAs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">287,029</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">476,492</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sale of CCRAs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,897</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,132,796</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquisitions of CCRAs</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,200</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization expense</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">484,076</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">752,697</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">1,898,223</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation Statutory Income Tax Rate to the Company's Effective Tax Rate</a></td>
<td class="text"><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the United States statutory income tax rate to the Company&#8217;s effective tax rate for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 is as follows for the years indicated:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:56.249%;box-sizing:content-box;"></td>
         <td style="width:1.8%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:18.556%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.8%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:17.597%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">For the Year Ended December 31,</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal Statutory rate</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.00</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.00</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncontrolling interests/effect of pass-through entities</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">-</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16.14</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">-</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.59</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">-</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.47</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">-</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.73</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liability</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.85</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.00</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State Taxes</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.76</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.37</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.00</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">-</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.05</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Effective Income tax rate</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.00</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.00</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Company's Deferred Tax Assets and Liabilities</a></td>
<td class="text"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Details of the Company&#8217;s deferred tax assets and liabilities at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 are as follows for the years indicated:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:50.44%;box-sizing:content-box;"></td>
         <td style="width:2.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:20.14%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.64%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:20.14%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">in thousands</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforward</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,613</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,126</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment in MSP Recovery, LLC</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,668</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,385</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Start-up Costs</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">791</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">854</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Transaction Costs</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,699</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,962</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest Expense &#8212; 163j</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,863</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,065</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,634</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,392</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation Allowance</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,634</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,392</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax assets (liability)</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has a deferred tax asset for the difference between the financial reporting and the tax basis of its investment in MSP Recovery, LLC. The deferred tax asset above does not consider the iterative impact of the TRA liability as the entire liability has not been recorded as of</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrant Liability (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock', window );">Schedule of Roll-forward of the Warrant Liability</a></td>
<td class="text"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The table below presents a roll-forward of the warrant liability from </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023 to December 31, 2024:</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:55.82%;box-sizing:content-box;"></td>
         <td style="width:2.26%;box-sizing:content-box;"></td>
         <td style="width:20.68%;box-sizing:content-box;"></td>
         <td style="width:2.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:17.02%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Warrant Liability</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">268</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">159,200</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of outstanding warrants</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">137,095</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">22,373</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Summary of Activity of Shares Underlying Warrants</a></td>
<td class="text"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A summary of activity of the shares underlying the warrants from December 31, 2022 through December 31, 2024:</span></p><p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:55.82%;box-sizing:content-box;"></td>
         <td style="width:1.74%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:19.2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:17.02%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"># of Shares</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise Price</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2022</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">111,978</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0625</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Converted</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">590</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0625</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">111,388</span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0625</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issued</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,851,339</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0025</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">9,962,727</span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">0.0032</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of roll forward of warrant liability text block</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Noncontrolling Interest (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ScheduleOfOwnershipInterestsTableTextBlock', window );">Summary of Ownership Units</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the ownership of Units in the Company as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024:</span>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.347%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.537%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:19.116%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Ownership Percentage</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Ownership of Class A Common Stock</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,184,958</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.6</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Ownership of Class V Common Stock</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,962,704</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69.4</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at end of period</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,147,662</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100.0</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ScheduleOfOwnershipInterestsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of ownership interests table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ScheduleOfOwnershipInterestsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Schedule of Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Liabilities measured at fair value on a recurring basis as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, are summarized as follows:</span>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:47.359%;box-sizing:content-box;"></td>
         <td style="width:1.441%;box-sizing:content-box;"></td>
         <td style="width:1.681%;box-sizing:content-box;"></td>
         <td style="width:14.106%;box-sizing:content-box;"></td>
         <td style="width:1.441%;box-sizing:content-box;"></td>
         <td style="width:1.701%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.565%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.441%;box-sizing:content-box;"></td>
         <td style="width:1.701%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.565%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Level</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Derivative liability</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">211</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrant liability</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,373</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">268</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,584</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">305</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value Measurements within the Fair Value Hierarchy of Derivative Liabilities Using Level 3 Inputs</a></td>
<td class="text"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table details the roll-forward of the Level 3 liabilities during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:74.3%;box-sizing:content-box;"></td>
         <td style="width:2.26%;box-sizing:content-box;"></td>
         <td style="width:2.18%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:19.26%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
         <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Derivative liability</span></p></td>
         <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2023</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of derivative liability</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">161</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of note</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at December 31, 2024</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">211</span></p></td>
         <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock', window );">Embedded Derivative Liability Valuation Assumptions</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The embedded derivative liability was valued at each of the respective issuance dates and at year-end using the following market-based inputs:</span>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:57.563%;box-sizing:content-box;"></td>
         <td style="width:1.761%;box-sizing:content-box;"></td>
         <td style="width:1.581%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.587%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.761%;box-sizing:content-box;"></td>
         <td style="width:2.161%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.587%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Price of Common Stock</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.27</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56.75</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Volatility</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cceeff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Market Risk Spread</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.56</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.37</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected Term (in years)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.75</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.25</span></span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of embedded derivative liability valuation assumptions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Other Segment Items</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The table below presents the Company&#8217;s significant segment expenses and a reconciliation of Significant Segment expenses and other segment items to Net Loss, the CODM&#8217;s primary measure of performance:</span>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:65.52%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.52%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:14.52%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands)</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total Revenues</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,249</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,705</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less:</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Significant Expenses:</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims amortization expense</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">484,076</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">476,492</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,231</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,508</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,131</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,766</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees &#8211; legal</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,519</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34,401</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Impairment of intangible assets</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">752,697</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">420,032</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">289,169</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Significant Expenses</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,702,686</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">849,336</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other Segment Items (1)</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">127,592</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,486</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net Loss</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">1,556,845</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">835,145</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes Cost of revenues, Allowance for credit losses, Depreciation and amortization, Change in fair value of warrant and derivative liabilities, and Other income (expense), net, as reported in our consolidated statements of operations.</span></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth the computation of basic and diluted earnings per share of Class A common stock:</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:63.587%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.317%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.78%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.317%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
         <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Numerator - basic and diluted:</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,556,845</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">835,145</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Net loss attributable to the non-controlling interests</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,196,346</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">778,797</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss attributable to MSP Recovery, Inc.</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">360,499</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56,348</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Denominator &#8211; basic and diluted:</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares of Class A common stock outstanding &#8211; basic</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,001,525</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">356,591</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares of Class A common stock outstanding &#8211; dilutive</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,001,525</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">356,591</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Earnings per share of Class A common stock &#8211; basic</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">359.95</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">158.02</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Earnings per share of Class A common stock &#8211; diluted</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">359.95</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">158.02</span></p></td>
         <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>May 23, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants exercised</a></td>
<td class="nump">9,962,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,962,727<span></span>
</td>
<td class="nump">111,388<span></span>
</td>
<td class="nump">111,978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Warrants decreased resulting in other income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137,095,000<span></span>
</td>
<td class="nump">$ 4,785,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants or rights exercise price</a></td>
<td class="nump">$ 0.0032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0032<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_IncreaseInTaxReceivableAgreementLiability', window );">Increase in TRA liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,800,000<span></span>
</td>
<td class="nump">$ 11,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_TaxReceivableAgreementMember', window );">Tax Receivable Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfPaySellersToAmountOfTaxBenefit', window );">Percentage of pay sellers to amount of tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders', window );">Payments to continuing equity owners and blocker shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mspr_ClassVCommonStockMember', window );">Class V Common Stock Units [Member] | Non Economic Voting Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par or stated value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Business combination units issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceIncrease', window );">Warrant, exercise price, increase per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued</a></td>
<td class="nump">8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants exercised</a></td>
<td class="nump">11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Warrants decreased resulting in other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DividendComprisingNumberOfNewWarrantsPayableHolders', window );">Dividend comprising number of new warrants payable holders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,028,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants or rights exercise price</a></td>
<td class="nump">$ 7,187.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,187.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member] | Membership interest purchase agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business combination, share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DividendComprisingNumberOfNewWarrantsPayableHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividend comprising number of new warrants payable holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DividendComprisingNumberOfNewWarrantsPayableHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_IncreaseInTaxReceivableAgreementLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase in tax receivable agreement liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_IncreaseInTaxReceivableAgreementLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_NatureOfOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nature of operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_NatureOfOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to continuing equity owners and blocker shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfPaySellersToAmountOfTaxBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of pay sellers to amount of tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfPaySellersToAmountOfTaxBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_TaxReceivableAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_TaxReceivableAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mspr_ClassVCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mspr_ClassVCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis=mspr_NonEconomicVotingSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis=mspr_NonEconomicVotingSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_MembershipInterestPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_MembershipInterestPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of the Business - 2024 Reverse Stock Split - Additional Information (Detail)<br></strong></div></th>
<th class="th"><div>Nov. 15, 2024</div></th>
<th class="th"><div>Oct. 12, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse stock ratio</a></td>
<td class="nump">0.0004<span></span>
</td>
<td class="nump">0.0004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split description</a></td>
<td class="text">Reverse Split, every 25 shares of the Company&#8217;s old common stock were converted into one share of the Company&#8217;s new common stock. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_NatureOfOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nature of operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_NatureOfOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business - Going Concern - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 10, 2025 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 04, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 15, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Apr. 08, 2024</div></th>
<th class="th"><div>Apr. 01, 2024</div></th>
<th class="th">
<div>Mar. 26, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 02, 2024 </div>
<div>USD ($) </div>
<div>Tranche</div>
</th>
<th class="th">
<div>Apr. 12, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 14, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 29, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Unrestricted cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,328,000<span></span>
</td>
<td class="nump">$ 11,633,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(446,050,000)<span></span>
</td>
<td class="num">(85,551,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash in operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,121,000)<span></span>
</td>
<td class="num">(40,023,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NumberOfTranches', window );">Number of tranches | Tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AdditionalBridgeLoan', window );">Additional bridge loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mspr_NomuraPromissoryNoteMember', window );">Nomura Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AggregateAmountOutstandingUnderCashProceeds', window );">Aggregate amount outstanding under cash proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate of promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mspr_RestructuringPlanMember', window );">Restructuring Plan [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BridgeLoan', window );">Bridge loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,550,000<span></span>
</td>
<td class="nump">$ 1,550,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity', window );">Converting certain debt of certain creditors into equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mspr_RestructuringPlanMember', window );">Restructuring Plan [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Commitment collateral</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BridgeLoan', window );">Bridge loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity', window );">Converting certain debt of certain creditors into equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember', window );">YA II PN, Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,200,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mspr_HazelPartnersHoldingsLlcLetterAgreementMember', window );">HPH Letter Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Increase in credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,250,000<span></span>
</td>
<td class="nump">$ 3,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member] | Nomura Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AggregateAmountOutstandingUnderCashProceeds', window );">Aggregate amount outstanding under cash proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member] | YA II PN, Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Stock sold | shares</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member] | YA II PN, Ltd [Member] | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000,000<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DebtInstrumentsExtendedMaturityDate', window );">Extended maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Stock sold | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member] | YA II PN, Ltd [Member] | VRM [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfProceedsFromRepaymentOfDebt', window );">Percentage of proceeds from repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=mspr_LegalAccountingAndAdministrativeExpenseMember', window );">Legal, Accounting, And Administrative Expense [Member] | Restructuring Plan [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BridgeLoan', window );">Bridge loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditAgreementMember', window );">Working Capital Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche', window );">Line of credit borrowing amount accessible for each tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims', window );">Line of credit facility for acquiring additional Claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditAgreementMember', window );">Working Capital Credit Agreement [Member] | HPH Letter Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche', window );">Line of credit borrowing amount accessible for each tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims', window );">Line of credit facility for acquiring additional Claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditAgreementMember', window );">Working Capital Credit Agreement [Member] | HPH Letter Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Increase in credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of credit facility, maximum remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditAgreementMember', window );">Working Capital Credit Agreement [Member] | Minimum [Member] | HPH Letter Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Increase in credit facility expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditAgreementMember', window );">Working Capital Credit Agreement [Member] | Maximum [Member] | HPH Letter Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Increase in credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Increase in credit facility expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_OperationalCollectionFloorFacilityMember', window );">Operational Collection Floor Facility [Member] | Restructuring Plan [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity', window );">Converting certain debt of certain creditors into equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_OperationalCollectionFloorFacilityMember', window );">Operational Collection Floor Facility [Member] | Restructuring Plan [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NatureOfOperationsLineItems', window );"><strong>Nature Of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BridgeLoan', window );">Bridge loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AdditionalBridgeLoan', window );">Additional bridge loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AdditionalBridgeLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Bridge Loan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AdditionalBridgeLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AggregateAmountOutstandingUnderCashProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount outstanding under cash proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AggregateAmountOutstandingUnderCashProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Converting certain debt of certain creditors into equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DebtInstrumentsExtendedMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instruments extended maturity date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DebtInstrumentsExtendedMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility borrowing, available amount for each tranche.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility Funded For Acquiring Additional Claims</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_NatureOfOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nature of operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_NatureOfOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_NumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_NumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfProceedsFromRepaymentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of proceeds from repayment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfProceedsFromRepaymentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BridgeLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-Term financing which is expected to be paid back relatively quickly, such as by a subsequent longer-term loan. Also called swing loan or bridge financing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BridgeLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mspr_NomuraPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mspr_NomuraPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mspr_RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mspr_RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mspr_HazelPartnersHoldingsLlcLetterAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mspr_HazelPartnersHoldingsLlcLetterAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mspr_StandbyEquityPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mspr_StandbyEquityPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_VrmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_VrmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mspr_LegalAccountingAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mspr_LegalAccountingAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mspr_OperationalCollectionFloorFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mspr_OperationalCollectionFloorFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Segment</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration', window );">CODM Title</a></td>
<td class="text">srt:ChiefExecutiveOfficerMember<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription', window );">CODM Description</a></td>
<td class="text">The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis, using the operating expenses and interest expense, as presented on the face of the income statement, for purposes of making operating decisions, allocating resources, and evaluating financial performance.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segment | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DevelopmentCostsCapitalizedUsefulLife', window );">Development costs capitalized useul life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite lived intangible assets useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsRecoveryServiceIncome', window );">Claims recovery service income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 498,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_SpecificContractMember', window );">Specific Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsRecoveryServiceIncome', window );">Claims recovery service income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember', window );">Claims Cost Recovery Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Finite life intangible assets acquired useful life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=mspr_UpCUnitHoldersMember', window );">Up-C Unit Holders [Member] | Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Non-controlling interests ownership percentage</a></td>
<td class="nump">99.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=mspr_ClassVShareholdersMember', window );">Class V Shareholders [Member] | Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Non-controlling interests ownership percentage</a></td>
<td class="nump">69.43%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts', window );">Equity method ownership percentage for entities that track separate capital accounts</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Equity Method Investment Investee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investments ownership percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts', window );">Equity method ownership percentage for entities that track separate capital accounts</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202307Member', window );">ASU 2023-07</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted', window );">Change in accounting principle, accounting standards update, adopted [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClaimsRecoveryServiceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims recovery service income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClaimsRecoveryServiceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DevelopmentCostsCapitalizedUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Development Costs Capitalized Useful Life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DevelopmentCostsCapitalizedUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity method ownership percentage for entities that track separate capital accounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether accounting standards update was adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-3<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of nature of expense information used by chief operating decision maker (CODM) to manage operation when segment expense information by category is not disclosed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mspr_SpecificContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mspr_SpecificContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mspr_UpCUnitHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mspr_UpCUnitHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mspr_ClassVShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mspr_ClassVShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mspr_EquityMethodInvestmentInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mspr_EquityMethodInvestmentInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202307Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202307Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Summary of Depreciation and Amortization on Property and Equipment (Detail)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mspr_OfficeAndComputerEquipmentMember', window );">Office And Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration', window );">Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]</a></td>
<td class="text">us-gaap:UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates description of term of useful life for property, plant, and equipment when not stated as numeric value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482190/360-10-35-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mspr_OfficeAndComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mspr_OfficeAndComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Agreements - Additional Information (Detail)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 04, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2024 </div>
<div>Members</div>
</th>
<th class="th">
<div>Oct. 01, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 02, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2024 </div>
<div>$ / shares</div>
</th>
<th class="th"><div>Jan. 31, 2024</div></th>
<th class="th">
<div>Mar. 29, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 23, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 14, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 01, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 01, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 25, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants to purchase shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,962,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,388<span></span>
</td>
<td class="nump">111,978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_VRMFullPaymentDescription', window );">VRM full payment description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company also agreed that, after the Yorkville Convertible Notes are fully satisfied, 25% of the Company&#8217;s portion of any net proceeds from the Yorkville SEPA would be used to pay down the VRM Full Return<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AgreementDate', window );">Credit facility, agreement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  06,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditAgreementMember', window );">Working Capital Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims', window );">Line of credit facility for acquiring additional Claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityDescription', window );">Credit facility description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">extended the period to draw up to $23.3 million (with a 40% original issue discount) remaining under Term Loan B for working capital, accessible in eight tranches of $1.75 million, that can be drawn at least one month apart, until September 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche', window );">Line of credit borrowing amount accessible for each tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditAgreementMember', window );">Working Capital Credit Agreement [Member] | HPH Letter Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims', window );">Line of credit facility for acquiring additional Claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DebtInstrumentOriginalIssueDiscount', window );">Debt instrument original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche', window );">Line of credit borrowing amount accessible for each tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_TermLoanAMember', window );">Term Loan A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_TermLoanBMember', window );">Term Loan B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_TermLoanBMember', window );">Term Loan B [Member] | HPH Letter Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=mspr_ClaimsCostRecoveryAgreementsMember', window );">Claims Cost Recovery Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NetGainOfTheAsset', window );">Net gain on sale of claims transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionPriceOfAcquisitionExpected', window );">Fair value of claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_RealizedClaimRecoveries', window );">Realized claim recoveries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts', window );">Carrying value of claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=mspr_ClaimsCostRecoveryAgreementsMember', window );">Claims Cost Recovery Agreements [Member] | Purchase Money Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionPriceOfAcquisitionExpected', window );">Fair value of claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | HPH Letter Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Increase in credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,250<span></span>
</td>
<td class="nump">$ 3,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Working Capital Credit Agreement [Member] | HPH Letter Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Increase in credit facility</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of credit facility, remaining borrowing capacity</a></td>
<td class="nump">$ 2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Working Capital Credit Agreement [Member] | HPH Letter Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AssignorConsistingNumberOfMedicareMembers', window );">Assignor consisting number of medicare members | Members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Subsequent Event [Member] | Working Capital Credit Agreement [Member] | HPH Letter Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Increase in credit facility expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Subsequent Event [Member] | Working Capital Credit Agreement [Member] | HPH Letter Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Increase in credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Increase in credit facility expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants to purchase shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,187.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_SeriesMrcsLlcMember', window );">Series MRCS LLC [Member] | Claims Cost Recovery Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Finite life intangible assets acquired useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_VrmMspRecoveryPartnersLlcMember', window );">VRM MSP Recovery Partners LLC [Member] | Investment in Rights to Claim Recovery Cash Flows [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired', window );">Number of Up C units issued in exchange of assets acquired | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_VrmMember', window );">VRM [Member] | Reserved Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AnnualCompoundedReturnOnContributionPercentage', window );">Annual compounded return percentage on contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ValueOfFullReturn', window );">Value of full return</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,126,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 941,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_VrmMember', window );">VRM [Member] | Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees', window );">Description of warrants issued to counter party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">issue a warrant to purchase a number of shares of Class A Common Stock of the Company, or some combination thereof, to Virage Recovery Master LP (&#8220;VRM&#8221;) equal to the quotient of 1% of the calendar month-end balance of the Unpaid Base Amount (as defined in the MTA) (the &#8220;Required Monthly Issuance&#8221;).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NumberOfWarrantsIssued', window );">Number of warrants issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,332,792<span></span>
</td>
<td class="nump">3,277,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_VrmMember', window );">VRM [Member] | Class A [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants to purchase shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,361,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NumberOfWarrantsIssued', window );">Number of warrants issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember', window );">Hazel Transactions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PurchaseMoneyLoan', window );">Purchase money loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AgreementDate', window );">Credit facility, agreement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 29,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_RealizedClaimRecoveries', window );">Realized claim recoveries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue', window );">Fair value of claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember', window );">Hazel Transactions [Member] | HPH Letter Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NumberOfMedicareMembers', window );">Number of Medicare Members | Members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember', window );">Hazel Transactions [Member] | Working Capital Credit Agreement [Member] | HPH Letter Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims', window );">Line of credit facility for acquiring additional Claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DebtInstrumentOriginalIssueDiscount', window );">Debt instrument original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember', window );">Hazel Transactions [Member] | Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DebtInstrumentOriginalIssueDiscount', window );">Debt instrument original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember', window );">Hazel Transactions [Member] | Credit Agreement [Member] | Term Loan A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember', window );">Hazel Transactions [Member] | Credit Agreement [Member] | Term Loan B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_VirageAmendmentMember', window );">Virage Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DescriptionOfCashPaymentsMadeToCounterParty', window );">Description of cash payments made to counter party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> cash, in an amount equal to 1.0% of each calendar month-end balance (which month-end balance shall be increased daily up to 20.0% per annum based on a formula set forth in the Virage MTA) of the amount owing to Virage as of each preceding calendar month end<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_WarrantPaymentDescription', window );">Virage warrants payment description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Furthermore, for each calendar month-end beginning with January 31, 2024, and continuing until the VRM Full Return is paid in full, the Company agreed to issue to VRM a warrant to purchase a number of shares of Class A Common Stock of Parent equal to the quotient of 1% of the calendar month-end balance of the Unpaid Base Amount and the VWAP (each, a &#8220;Monthly Virage Warrant&#8221;), which warrant will have an exercise price (payable in cash) of $0.0001 per share and expire on the second anniversary of its issuance.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_MinimumCashAvailableForDistributionsPercentage', window );">Budget percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_VirageAmendmentMember', window );">Virage Amendment [Member] | Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees', window );">Description of warrants issued to counter party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">issue to VRM a warrant to purchase a number of shares of Class A Common Stock of Parent equal to the quotient of 1.0% of each calendar month end balance of the Unpaid Base Amount (calculated on a cumulative basis) and the VWAP of a share of Class A Common Stock for the five-day period prior to the issuance, beginning with May 24, 2023 and ending December 31, 2023, which warrant will have an exercise price (payable in cash) of $0.0025 per share (the &#8220;Initial Virage Warrant&#8221;); provided that the Initial Virage Warrant will expire on January 1, 2026.The Initial Virage Warrant, as amended, was issued effective January 1, 2024, entitling Virage to purchase 1,131,934 shares of Class A Common Stock at an exercise price of $0.0025 per share, with an expiration date of January 1, 2026.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Warrants expire date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  01,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_VirageAmendmentMember', window );">Virage Amendment [Member] | Initial Virage Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants to purchase shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,131,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Warrants expire date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  01,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_VirageAmendmentMember', window );">Virage Amendment [Member] | Monthly Virage Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants to purchase shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,619,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NumberOfWarrantsIssued', window );">Number of warrants issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NumberOfSharesExercisable', window );">Number of shares exercisable | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,332,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_VirageAmendmentMember', window );">Virage Amendment [Member] | Monthly Virage Warrants [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NumberOfSharesExercisable', window );">Number of shares exercisable | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,277,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member] | VRM [Member] | YA II PN, Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfProceedsFromRepaymentOfDebt', window );">Percentage of proceeds from repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AgreementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreement date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AgreementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AnnualCompoundedReturnOnContributionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual compounded return on contribution percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AnnualCompoundedReturnOnContributionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AssignorConsistingNumberOfMedicareMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assignor Consisting Number Of Medicare Members</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AssignorConsistingNumberOfMedicareMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DebtInstrumentOriginalIssueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument original issue discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DebtInstrumentOriginalIssueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DescriptionOfCashPaymentsMadeToCounterParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of cash payments made to counter party</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DescriptionOfCashPaymentsMadeToCounterParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility borrowing, available amount for each tranche.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility Funded For Acquiring Additional Claims</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_MinimumCashAvailableForDistributionsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum cash available for distributions percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_MinimumCashAvailableForDistributionsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_NetGainOfTheAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net gain of the asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_NetGainOfTheAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_NumberOfMedicareMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of medicare members.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_NumberOfMedicareMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_NumberOfSharesExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_NumberOfSharesExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Up C units issued in exchange of assets acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_NumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_NumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfProceedsFromRepaymentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of proceeds from repayment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfProceedsFromRepaymentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PurchaseMoneyLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase money loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PurchaseMoneyLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_RealizedClaimRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Realized claim recoveries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_RealizedClaimRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_VRMFullPaymentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>VRM full payment description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_VRMFullPaymentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ValueOfFullReturn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of full return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ValueOfFullReturn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_WarrantPaymentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Payment description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_WarrantPaymentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionPriceOfAcquisitionExpected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of expected asset acquisition prior to consideration being transferred. Excludes business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionPriceOfAcquisitionExpected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of assets sold under agreements to repurchase when the carrying amount (or market value, if higher than the carrying amount) of securities or other assets sold under repurchase agreements exceeds 10 percent of total assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(m)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(m)(1)(ii)(A)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Market value of assets sold under agreements to repurchase when the carrying amount (or market value, if higher than the carrying amount) of securities or other assets sold under repurchase agreements exceeds 10 percent of total assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(m)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(m)(1)(ii)(A)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reason for issuing warrant or right.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mspr_HazelPartnersHoldingsLlcLetterAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mspr_HazelPartnersHoldingsLlcLetterAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mspr_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mspr_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mspr_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mspr_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=mspr_ClaimsCostRecoveryAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=mspr_ClaimsCostRecoveryAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mspr_PurchaseMoneyLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mspr_PurchaseMoneyLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_SeriesMrcsLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_SeriesMrcsLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_VrmMspRecoveryPartnersLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_VrmMspRecoveryPartnersLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_VrmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_VrmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=mspr_ReservedSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=mspr_ReservedSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=mspr_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=mspr_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mspr_VirageAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mspr_VirageAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=mspr_InitialVirageWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=mspr_InitialVirageWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=mspr_MonthlyVirageWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=mspr_MonthlyVirageWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mspr_StandbyEquityPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mspr_StandbyEquityPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment In Equity Method Investees - Additional Information (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Investment</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NumberOfHoldingInvestments', window );">Number of holding investments | Investment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mspr_PmpiMember', window );">PMPI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfPreferredReturnForTheControlling', window );">Percentage of preferred return for the controlling member</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfRecoveryClaimsForTheControlling', window );">Percentage of recovery claims for the controlling member</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfCostsAllocatedToNonControlling', window );">Percentage of costs allocated to non controlling member</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mspr_MaoMember', window );">MAO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investments ownership percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mspr_MsoMember', window );">MSO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investments ownership percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_NumberOfHoldingInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of holding investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_NumberOfHoldingInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfCostsAllocatedToNonControlling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of costs allocated to non controlling member</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfCostsAllocatedToNonControlling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfPreferredReturnForTheControlling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of preferred return for the controlling member.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfPreferredReturnForTheControlling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfRecoveryClaimsForTheControlling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of recovery claims for the controlling member.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfRecoveryClaimsForTheControlling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mspr_PmpiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mspr_PmpiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mspr_MaoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mspr_MaoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mspr_MsoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mspr_MsoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Investment In Equity Method Investees  - Summary of Financial Information For Equity Accounted Investees (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems', window );"><strong>Disclosure In Tabular Form Of Summarized Financial Information Of Equity Method Investees [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 542<span></span>
</td>
<td class="nump">$ 9,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,556,845)<span></span>
</td>
<td class="num">(835,145)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,919,083<span></span>
</td>
<td class="nump">3,159,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,047,492<span></span>
</td>
<td class="nump">1,740,866<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_EquityMethodInvesteeMember', window );">Equity Method Investee [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems', window );"><strong>Disclosure In Tabular Form Of Summarized Financial Information Of Equity Method Investees [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">354<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,167<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(840)<span></span>
</td>
<td class="num">(2,038)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">928<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 762<span></span>
</td>
<td class="nump">$ 399<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Balances include related party transactions.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> See Note 14,</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, f</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or further details.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure in tabular form of summarized financial information of equity method investees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
<td class="nump">$ 6,815<span></span>
</td>
<td class="nump">$ 6,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization of software</a></td>
<td class="num">(1,656)<span></span>
</td>
<td class="num">(1,492)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">5,159<span></span>
</td>
<td class="nump">4,911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mspr_OfficeAndComputerEquipmentMember', window );">Office and computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
<td class="nump">459<span></span>
</td>
<td class="nump">434<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
<td class="nump">701<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Internally developed software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
<td class="nump">5,588<span></span>
</td>
<td class="nump">5,789<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mspr_OtherSoftwareMember', window );">Other software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mspr_OfficeAndComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mspr_OfficeAndComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mspr_OtherSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mspr_OtherSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 277<span></span>
</td>
<td class="nump">$ 263<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_IntangibleAssetsNetLineItems', window );"><strong>Intangible Assets, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Non-cash impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 752,697<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries', window );">Non-cash impairment charge would decrease estimated recoveries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries', window );">Non-cash impairment charge would increase estimated recoveries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_IncreaseDecreaseInImpairmentCharges', window );">increase (decrease) in impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_GoodwillMeasurementInputIncreaseDecrease', window );">Goodwill measurement input increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember', window );">Claims Cost Recovery Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_IntangibleAssetsNetLineItems', window );"><strong>Intangible Assets, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, net</a></td>
<td class="nump">$ 1,898,223<span></span>
</td>
<td class="nump">$ 1,898,223<span></span>
</td>
<td class="nump">3,132,796<span></span>
</td>
<td class="nump">$ 3,363,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">484,076<span></span>
</td>
<td class="nump">476,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Non-cash impairment charge</a></td>
<td class="nump">$ 752,700<span></span>
</td>
<td class="nump">752,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember', window );">Claims Cost Recovery Rights [Member] | Series MRCS LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_IntangibleAssetsNetLineItems', window );"><strong>Intangible Assets, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payment of cash for assets purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AdditionalFiniteLivedIntangibleAssetsAcquired', window );">Additional purchase of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember', window );">Claims Cost Recovery Rights [Member] | Series MRCS LLC [Member] | Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_IntangibleAssetsNetLineItems', window );"><strong>Intangible Assets, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Issuance of stock value for purchase of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember', window );">Claims Cost Recovery Rights [Member] | Hazel Transactions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_IntangibleAssetsNetLineItems', window );"><strong>Intangible Assets, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible Assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 285,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AdditionalFiniteLivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional finite-Lived intangible assets acquired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AdditionalFiniteLivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_GoodwillMeasurementInputIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill measurement input increase (decrease).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_GoodwillMeasurementInputIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_IncreaseDecreaseInImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>increase decrease in impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_IncreaseDecreaseInImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_IntangibleAssetsNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible assets, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_IntangibleAssetsNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-cash impairment charge would decrease estimated recoveries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-cash impairment charge would increase estimated recoveries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_SeriesMrcsLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_SeriesMrcsLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net - Summary of Intangible Assets Net (Detail) - Claims Cost Recovery Rights [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 3,121,859<span></span>
</td>
<td class="nump">$ 3,872,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(1,223,636)<span></span>
</td>
<td class="num">(739,560)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 1,898,223<span></span>
</td>
<td class="nump">$ 3,132,796<span></span>
</td>
<td class="nump">$ 3,363,156<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net - Schedule of Expected Future Amortization Expense of Intangible Assets (Detail) - Claims Cost Recovery Rights [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems', window );"><strong>Finite Lived Intangible Assets Future Amortization Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 474,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">474,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="nump">474,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="nump">474,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 1,898,223<span></span>
</td>
<td class="nump">$ 3,132,796<span></span>
</td>
<td class="nump">$ 3,363,156<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite lived intangible assets future amortization expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net - Summary of Changes in the Company's Intangibles Assets (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (752,697)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_SaleOfIntangibleAssets', window );">Sale of CCRAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(30,987)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember', window );">Claims Cost Recovery Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,132,796<span></span>
</td>
<td class="nump">3,363,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Acquisitions of CCRAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="nump">287,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(484,076)<span></span>
</td>
<td class="num">(476,492)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment</a></td>
<td class="num">$ (752,700)<span></span>
</td>
<td class="num">(752,697)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_SaleOfIntangibleAssets', window );">Sale of CCRAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,897)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Ending Balance</a></td>
<td class="nump">$ 1,898,223<span></span>
</td>
<td class="nump">$ 1,898,223<span></span>
</td>
<td class="nump">$ 3,132,796<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_SaleOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_SaleOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mspr_ClaimsCostRecoveryRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationDescription', window );">Income tax examination, description</a></td>
<td class="text">As of December 31, 2024, the Company&#8217;s federal and state and local income tax years 2021 through 2023 remain open and are subject to examination. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryovers</a></td>
<td class="nump">$ 17,400,000<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open tax year</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryovers</a></td>
<td class="nump">$ 17,400,000<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OpenTaxYear', window );">Open tax year</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OpenTaxYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax year that remains open to examination under enacted tax laws, in YYYY format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OpenTaxYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax - Schedule of Reconciliation Statutory Income Tax Rate to the Company's Effective Tax Rate (Detail)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal Statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities', window );">Noncontrolling interests/effect of pass-through entities</a></td>
<td class="num">(16.14%)<span></span>
</td>
<td class="num">(19.59%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(8.47%)<span></span>
</td>
<td class="num">(1.73%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent', window );">Warrant liability</a></td>
<td class="nump">1.85%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State Taxes</a></td>
<td class="nump">1.76%<span></span>
</td>
<td class="nump">0.37%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.05%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation at noncontrolling interests effect of pass through entities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation warrant liability percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Tax - Schedule of Company's Deferred Tax Assets and Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Components of Deferred Tax Assets and Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">$ 4,613<span></span>
</td>
<td class="nump">$ 1,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc', window );">Investment in MSP Recovery, LLC</a></td>
<td class="nump">21,668<span></span>
</td>
<td class="nump">30,385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses', window );">Start-up Costs</a></td>
<td class="nump">791<span></span>
</td>
<td class="nump">854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DeferredTaxAssetsTransactionCosts', window );">Transaction Costs</a></td>
<td class="nump">2,699<span></span>
</td>
<td class="nump">2,962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetInterestCarryforward', window );">Interest Expense - 163j</a></td>
<td class="nump">16,863<span></span>
</td>
<td class="nump">5,065<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">46,634<span></span>
</td>
<td class="nump">40,392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation Allowance</a></td>
<td class="num">$ (46,634)<span></span>
</td>
<td class="num">$ (40,392)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets investment in MSP recovery, LLC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets organizational costs and startup expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DeferredTaxAssetsTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DeferredTaxAssetsTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetInterestCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetInterestCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable Interest Entities - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 1,919,083,000<span></span>
</td>
<td class="nump">$ 3,159,995,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="num">(2,047,492,000)<span></span>
</td>
<td class="num">(1,740,866,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">1,400,000,000<span></span>
</td>
<td class="nump">2,200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="num">(400,000)<span></span>
</td>
<td class="num">(400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries', window );">Intangible assets held be certain specific subsidiaries</a></td>
<td class="nump">1,200,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="num">(800,000)<span></span>
</td>
<td class="num">$ (400,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible assets held be certain specific subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Claims Financing Obligations and Notes Payable - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember', window );">YA II PN, Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 12.2<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_FinancingObligationsAndNotesPayableAgreementsMember', window );">Financing Obligations and Notes Payable Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, Maximum borrowing capacity</a></td>
<td class="nump">$ 673.6<span></span>
</td>
<td class="nump">$ 556.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of credit facility, Current borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 685.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_FinancingObligationsAndNotesPayableAgreementsMember', window );">Financing Obligations and Notes Payable Agreements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Line of credit facility, Interest rate during period</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_FinancingObligationsAndNotesPayableAgreementsMember', window );">Financing Obligations and Notes Payable Agreements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Line of credit facility, Interest rate during period</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_MinimumRequiredPaymentMember', window );">Minimum Required Payment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments of lines of credit</a></td>
<td class="nump">$ 818.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims Financing Obligations and Notes Payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClaimsFinancingObligationsAndNotesPayableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mspr_FinancingObligationsAndNotesPayableAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mspr_FinancingObligationsAndNotesPayableAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mspr_MinimumRequiredPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mspr_MinimumRequiredPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Claims Financing Obligations and Notes Payable - Brickell Key Investments, LP - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Nov. 15, 2024</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants or rights exercise price</a></td>
<td class="nump">$ 0.0032<span></span>
</td>
<td class="nump">$ 0.0032<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (137,095,000)<span></span>
</td>
<td class="num">$ (4,785,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Maximum amount of common shares to be purchased</a></td>
<td class="nump">5,500,000,000<span></span>
</td>
<td class="nump">5,500,000,000<span></span>
</td>
<td class="nump">5,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par or stated value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants or rights exercise price</a></td>
<td class="nump">7,187.5<span></span>
</td>
<td class="nump">$ 7,187.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (300,000)<span></span>
</td>
<td class="num">$ (4,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PriceOfCommonStock', window );">Price of common stock</a></td>
<td class="nump">750.00<span></span>
</td>
<td class="nump">$ 750.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants or rights exercise price</a></td>
<td class="nump">$ 0.0016<span></span>
</td>
<td class="nump">$ 0.0016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=mspr_ClaimsFinancingObligationAndNotesPayableMember', window );">Claims Financing Obligation and Notes Payable [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant and rights outstanding</a></td>
<td class="nump">$ 80,000,000<span></span>
</td>
<td class="nump">$ 80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_BrickellKeyInvestmentAmendmentMember', window );">Brickell Key Investment Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_SharesPledgedUnderAgreement', window );">Shares pledged under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_BrickellKeyInvestmentAmendmentMember', window );">Brickell Key Investment Amendment [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Maximum amount of common shares to be purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,666.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par or stated value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_BrickellKeyInvestmentAmendmentMember', window );">Brickell Key Investment Amendment [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_ClaimsProceedsInvestmentAgreementMember', window );">Claims Proceeds Investment Agreement [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants or rights exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfSharesObtainedThroughWarrant', window );">Percentage of shares obtained through warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims Financing Obligations and Notes Payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClaimsFinancingObligationsAndNotesPayableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfSharesObtainedThroughWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of shares obtained through warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfSharesObtainedThroughWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PriceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PriceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_SharesPledgedUnderAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares pledged under agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_SharesPledgedUnderAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mspr_ClaimsFinancingObligationAndNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mspr_ClaimsFinancingObligationAndNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mspr_BrickellKeyInvestmentAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mspr_BrickellKeyInvestmentAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mspr_ClaimsProceedsInvestmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mspr_ClaimsProceedsInvestmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Claims Financing Obligations and Notes Payable - Hazel Working Capital Credit Facility and Purchase Money Loan - Additional Information (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 04, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 02, 2024 </div>
<div>Members</div>
</th>
<th class="th">
<div>Oct. 01, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 02, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 22, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 29, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 25, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AgreementDate', window );">Credit facility, agreement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  06,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_TermLoanAMember', window );">Term Loan A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_TermLoanBMember', window );">Term Loan B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditAgreementMember', window );">Working Capital Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche', window );">Line of credit borrowing amount accessible for each tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims', window );">Line of credit facility for acquiring additional Claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityDescription', window );">Credit facility description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">extended the period to draw up to $23.3 million (with a 40% original issue discount) remaining under Term Loan B for working capital, accessible in eight tranches of $1.75 million, that can be drawn at least one month apart, until September 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mspr_HazelPartnersHoldingsLlcLetterAgreementMember', window );">Hazel Partners Holdings LLC Letter Agreement [Member] | Term Loan B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mspr_HazelPartnersHoldingsLlcLetterAgreementMember', window );">Hazel Partners Holdings LLC Letter Agreement [Member] | Working Capital Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche', window );">Line of credit borrowing amount accessible for each tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims', window );">Line of credit facility for acquiring additional Claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DebtInstrumentOriginalIssueDiscount', window );">Debt instrument original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember', window );">Hazel Transactions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PurchaseMoneyLoan', window );">Purchase money loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_RealizedClaimRecoveries', window );">Realized claim recoveries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AgreementDate', window );">Credit facility, agreement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 29,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PurchaseMoneyLoanAccruesInterest', window );">Purchase Money Loan accrues interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember', window );">Hazel Transactions [Member] | Purchase Money Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember', window );">Hazel Transactions [Member] | Hazel Partners Holdings LLC Letter Agreement [Member] | Working Capital Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims', window );">Line of credit facility for acquiring additional Claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DebtInstrumentOriginalIssueDiscount', window );">Debt instrument original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mspr_CreditAgreementMember', window );">Credit Agreement [Member] | Hazel Transactions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DebtInstrumentOriginalIssueDiscount', window );">Debt instrument original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mspr_CreditAgreementMember', window );">Credit Agreement [Member] | Hazel Transactions [Member] | Term Loan A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mspr_CreditAgreementMember', window );">Credit Agreement [Member] | Hazel Transactions [Member] | Term Loan B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mspr_WorkingCapitalCreditFacilityMember', window );">Working Capital Credit Facility [Member] | Hazel Transactions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_InterestPeriodPlusAnApplicableMargin', window );">Interest period, plus an applicable margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember', window );">Second Amended and Restated First Lien Credit Agreement [Member] | Term Loan B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PaymentOfCertainCostsAndFees', window );">Payment of certain costs and fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Hazel Partners Holdings LLC Letter Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Increase in credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,250<span></span>
</td>
<td class="nump">$ 3,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Hazel Partners Holdings LLC Letter Agreement [Member] | Working Capital Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Increase in credit facility</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of credit facility, remaining borrowing capacity</a></td>
<td class="nump">$ 2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Hazel Partners Holdings LLC Letter Agreement [Member] | Working Capital Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AssignorConsistingNumberOfMedicareMembers', window );">Assignor consisting number of medicare members | Members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Subsequent Event [Member] | Hazel Partners Holdings LLC Letter Agreement [Member] | Working Capital Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Increase in credit facility expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Hazel Transactions [Member] | Purchase Money Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DebtInstrumentExtendedMaturityYear', window );">Debt instrument extended maturity year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Second Amended and Restated First Lien Credit Agreement [Member] | Term Loan B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCollateralAmount', window );">Additional collateral, a pledge of proceeds from certain Claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Subsequent Event [Member] | Hazel Partners Holdings LLC Letter Agreement [Member] | Working Capital Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Increase in credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Increase in credit facility expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AgreementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreement date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AgreementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AssignorConsistingNumberOfMedicareMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assignor Consisting Number Of Medicare Members</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AssignorConsistingNumberOfMedicareMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims Financing Obligations and Notes Payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClaimsFinancingObligationsAndNotesPayableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DebtInstrumentExtendedMaturityYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument extended maturity year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DebtInstrumentExtendedMaturityYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DebtInstrumentOriginalIssueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument original issue discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DebtInstrumentOriginalIssueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_InterestPeriodPlusAnApplicableMargin">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest period, plus an applicable margin.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_InterestPeriodPlusAnApplicableMargin</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility borrowing, available amount for each tranche.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility Funded For Acquiring Additional Claims</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PaymentOfCertainCostsAndFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of certain costs and fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PaymentOfCertainCostsAndFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PurchaseMoneyLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase money loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PurchaseMoneyLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PurchaseMoneyLoanAccruesInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase Money Loan accrues interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PurchaseMoneyLoanAccruesInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_RealizedClaimRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Realized claim recoveries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_RealizedClaimRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCollateralAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets pledged to secure a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCollateralAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mspr_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mspr_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mspr_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mspr_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mspr_HazelPartnersHoldingsLlcLetterAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mspr_HazelPartnersHoldingsLlcLetterAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mspr_PurchaseMoneyLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mspr_PurchaseMoneyLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=mspr_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=mspr_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=mspr_WorkingCapitalCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=mspr_WorkingCapitalCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Claims Financing Obligations and Notes Payable - Nomura Promissory Note - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 15, 2024</div></th>
<th class="th"><div>Apr. 08, 2024</div></th>
<th class="th"><div>Mar. 26, 2024</div></th>
<th class="th"><div>Nov. 14, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Apr. 12, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember', window );">YA II PN, Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember', window );">YA II PN, Ltd [Member] | Standby Equity Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mspr_NomuraPromissoryNoteMember', window );">Nomura Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate of promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AggregateAmountOutstandingUnderCashProceeds', window );">Aggregate amount outstanding under cash proceeds</a></td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mspr_NomuraPromissoryNoteMember', window );">Nomura Promissory Note [Member] | Standby Equity Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AggregateAmountOutstandingUnderCashProceeds', window );">Aggregate amount outstanding under cash proceeds</a></td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt [Member] | Standby Equity Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes', window );">Percentage of proceeds used to pay amounts due under Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfAggregateProceedsToPayOutstandingAmount', window );">Percentag of aggregate proceeds used to pay amounts outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt [Member] | YA II PN, Ltd [Member] | Standby Equity Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DebtInstrumentsExtendedMaturityDate', window );">Extended maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes', window );">Percentage of proceeds used to pay amounts due under Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfAggregateProceedsToPayOutstandingAmount', window );">Percentag of aggregate proceeds used to pay amounts outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AggregateAmountOutstandingUnderCashProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount outstanding under cash proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AggregateAmountOutstandingUnderCashProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims Financing Obligations and Notes Payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClaimsFinancingObligationsAndNotesPayableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DebtInstrumentsExtendedMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instruments extended maturity date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DebtInstrumentsExtendedMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of aggregate proceeds to pay amounts due under convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfAggregateProceedsToPayOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of aggregate proceeds to pay outstanding amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfAggregateProceedsToPayOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mspr_StandbyEquityPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mspr_StandbyEquityPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mspr_NomuraPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mspr_NomuraPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Claims Financing Obligations and Notes Payable - Yorkville Standby Equity Purchase Agreement - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 10, 2025</div></th>
<th class="th"><div>Nov. 15, 2024</div></th>
<th class="th"><div>Apr. 08, 2024</div></th>
<th class="th"><div>Apr. 01, 2024</div></th>
<th class="th"><div>Mar. 26, 2024</div></th>
<th class="th"><div>Nov. 14, 2023</div></th>
<th class="th"><div>Nov. 14, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Apr. 12, 2024</div></th>
<th class="th"><div>Dec. 11, 2023</div></th>
<th class="th"><div>Nov. 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Committed to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,307<span></span>
</td>
<td class="nump">$ 68,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from debt financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,500<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember', window );">YA II PN, Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,200<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member] | YA II PN, Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from debt financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Stock sold</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member] | YA II PN, Ltd | VRM [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfProceedsFromRepaymentOfDebt', window );">Percentage of proceeds from repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt [Member] | Standby Equity Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfAggregateProceedsToPayOutstandingAmount', window );">Percentag of aggregate proceeds used to pay amounts outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes', window );">Percentage of proceeds used to pay amounts due under Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt [Member] | Standby Equity Purchase Agreement [Member] | YA II PN, Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfVwapOfSharesDuringPriorDate', window );">VWAP of shares during prior date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion', window );">VWAP seven consecutive trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_MinimumVariablePricePerShare', window );">Variable price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.75<span></span>
</td>
<td class="nump">$ 3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_FixedPricePerShare', window );">Fixed price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92.84<span></span>
</td>
<td class="nump">$ 200.5625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfAggregateProceedsToPayOutstandingAmount', window );">Percentag of aggregate proceeds used to pay amounts outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes', window );">Percentage of proceeds used to pay amounts due under Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares', window );">Percentage of payment of aggregate purchase price of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Seventh trading day after the Trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest', window );">Premium and accrued and unpaid interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock', window );">Exchange Cap or the amount of shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations', window );">Payment of advance for shares of common stock in event of termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Class A Issuances, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,108,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ReductionInDebtPrincipalOwing', window );">Reduction in principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ReductionInInterestAmount', window );">Reduction in interest amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PaymentToFundOperations', window );">Fund operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PaymentToReduceAmountsOwedUnderNomuraNote', window );">Payment to reduce nomura note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Stock sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Convertible Debt [Member] | Standby Equity Purchase Agreement [Member] | YA II PN, Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | YA II PN, Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Committed to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Convertible Debt [Member] | Standby Equity Purchase Agreement [Member] | YA II PN, Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mspr_NomuraPromissoryNoteMember', window );">Nomura Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AggregateAmountOutstandingUnderCashProceeds', window );">Aggregate amount outstanding under cash proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mspr_NomuraPromissoryNoteMember', window );">Nomura Promissory Note [Member] | Standby Equity Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AggregateAmountOutstandingUnderCashProceeds', window );">Aggregate amount outstanding under cash proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Standby Equity Purchase Agreement [Member] | YA II PN, Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfStockPurchasePrice', window );">Stock purchased price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice', window );">Minimum VWAP of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance', window );">Mandatory minimum amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems', window );"><strong>Claims Financing Obligations and Notes Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Class A Issuances, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,598,565<span></span>
</td>
<td class="nump">466,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AggregateAmountOutstandingUnderCashProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount outstanding under cash proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AggregateAmountOutstandingUnderCashProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClaimsFinancingObligationsAndNotesPayableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims Financing Obligations and Notes Payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClaimsFinancingObligationsAndNotesPayableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_FixedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_FixedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_MinimumVariablePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum variable price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_MinimumVariablePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of advance for shares of common stock in event of terminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PaymentToFundOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment to fund operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PaymentToFundOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PaymentToReduceAmountsOwedUnderNomuraNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment to reduce amounts owed under nomura note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PaymentToReduceAmountsOwedUnderNomuraNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of aggregate proceeds to pay amounts due under convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfAggregateProceedsToPayOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of aggregate proceeds to pay outstanding amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfAggregateProceedsToPayOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of debt instrument to monthly payment along with premium and accrued and unpaid interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of mandatory minimum amount for any advance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of minimum VWAP of shares during three consecutive days commencing from delivery of Advance notice.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of ownership limitation does not exceed the exchange cap or the amount of shares of common stock .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of payment of aggregate purchase price of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfProceedsFromRepaymentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of proceeds from repayment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfProceedsFromRepaymentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfStockPurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of stock purchase price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfStockPurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfVwapOfSharesDuringPriorDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of VWAP of shares during prior date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfVwapOfSharesDuringPriorDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of WAP of shares during seven consecutive trading days immediately preceding the conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ReductionInDebtPrincipalOwing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction in debt principal owing</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ReductionInDebtPrincipalOwing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ReductionInInterestAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction In Interest Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ReductionInInterestAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mspr_StandbyEquityPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mspr_StandbyEquityPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_VrmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_VrmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mspr_NomuraPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mspr_NomuraPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Warrant Liability - Additional Information (Detail) - $ / shares<br></strong></div></th>
<th class="th"><div>Jan. 12, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,962,727<span></span>
</td>
<td class="nump">111,388<span></span>
</td>
<td class="nump">111,978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod', window );">Transferred New Warrants</a></td>
<td class="nump">133,291,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0032<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,187.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member] | CPIA Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member] | VRP [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,950,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member] | Warrant [Member] | VRM [Member] | Number of Ten Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,751,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member] | Warrant [Member] | CPIA Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of new warrant or right transferred during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_CpiaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_CpiaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_VirageRecoveryParticipationLpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_VirageRecoveryParticipationLpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_VrmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_VrmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=mspr_NumberOfTenWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=mspr_NumberOfTenWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrant Liability - Schedule of Roll-forward of the Warrant Liability (Detail) - Warrant [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at December 31, 2023</a></td>
<td class="num">$ (268)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of warrants</a></td>
<td class="num">(159,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair value of outstanding warrants</a></td>
<td class="nump">137,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at December 31, 2024</a></td>
<td class="num">$ (22,373)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrant Liability - Summary of Activity of Shares Underlying Warrants (Detail) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning balance, shares</a></td>
<td class="nump">111,388<span></span>
</td>
<td class="nump">111,978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClassOfWarrantOrRightIssuedDuringPeriod', window );">Issued (in shares)</a></td>
<td class="nump">9,851,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClassOfWarrantConvertedDuringPeriod', window );">Converted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(590)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Ending Balance, shares</a></td>
<td class="nump">9,962,727<span></span>
</td>
<td class="nump">111,388<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 0.0625<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClassOfWarrantsOrRightIssuedExercisePrice', window );">Issued (in dollars per share)</a></td>
<td class="nump">0.0025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClassOfWarrantsOrRightConvertedExercisePrice', window );">Converted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Ending balance, (in dollars per share)</a></td>
<td class="nump">$ 0.0032<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClassOfWarrantConvertedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant converted during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClassOfWarrantConvertedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClassOfWarrantOrRightIssuedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right issued during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClassOfWarrantOrRightIssuedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClassOfWarrantsOrRightConvertedExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants or right converted exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClassOfWarrantsOrRightConvertedExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClassOfWarrantsOrRightIssuedExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrants or right issued exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClassOfWarrantsOrRightIssuedExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Noncontrolling Interest - Summary of Ownership Units (Detail) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=mspr_UpCUnitHoldersMember', window );">UP-C Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock Issued</a></td>
<td class="nump">7,147,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock Issued</a></td>
<td class="nump">2,184,958<span></span>
</td>
<td class="nump">586,393<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member] | UP-C Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock Issued</a></td>
<td class="nump">2,184,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage</a></td>
<td class="nump">30.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mspr_CommonClassVMember', window );">Class V Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock Issued</a></td>
<td class="nump">4,962,704<span></span>
</td>
<td class="nump">4,965,296<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mspr_CommonClassVMember', window );">Class V Common Stock [Member] | UP-C Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock Issued</a></td>
<td class="nump">4,962,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage</a></td>
<td class="nump">69.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mspr_UpCUnitHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mspr_UpCUnitHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mspr_CommonClassVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mspr_CommonClassVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Noncontrolling Interest - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="num">$ (228,994)<span></span>
</td>
<td class="nump">$ 1,146,739<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_SubsidiaryAxis=mspr_MaomsoRecoveryLlcSeriesFhcpMember', window );">MAOMSO Recovery LLC Series FHCP [Member] | MSP Recovery LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers', window );">Percentage of entitled preferred return by non-controlling member</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_EntitledClaimsRecoverPercentageByNonControllingMembers', window );">Entitled claims recover percentage by non-controlling member</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfNonControllingMemberAllocatedCost', window );">Percentage of non-controlling member allocated cost</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_SubsidiaryAxis=mspr_UpCUnitHoldersMember', window );">UP-C Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_CommonUnitExchangeValue', window );">Common unit exchange value</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_CommonUnitExchangeValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common unit exchange value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_CommonUnitExchangeValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_EntitledClaimsRecoverPercentageByNonControllingMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entitled claims recover percentage by non-controlling members.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_EntitledClaimsRecoverPercentageByNonControllingMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of entitled preferred return by non-controlling members.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfNonControllingMemberAllocatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of non-controlling member allocated cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfNonControllingMemberAllocatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_SubsidiaryAxis=mspr_MaomsoRecoveryLlcSeriesFhcpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_SubsidiaryAxis=mspr_MaomsoRecoveryLlcSeriesFhcpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mspr_MSPRecoveryLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mspr_MSPRecoveryLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_SubsidiaryAxis=mspr_UpCUnitHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_SubsidiaryAxis=mspr_UpCUnitHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jul. 07, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability', window );">Deferred compensation arrangement recorded liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 61,690<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mspr_CanoHealthLlcMember', window );">Cano Health, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member] | Option to Pay in Cash or in Stock and Elected to Pay in Stock [Member] | Cano Health, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued', window );">Deferred compensation arrangement shares issued</a></td>
<td class="nump">318,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability', window );">Deferred compensation arrangement recorded liability</a></td>
<td class="nump">$ 61,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member] | Purchase Agreement, Effective as of September 30, 2022, as Amended to Date [Member] | Option to Pay in Cash or in Stock and Elected to Pay in Stock [Member] | Cano Health, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued', window );">Deferred compensation arrangement shares issued</a></td>
<td class="nump">129,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member] | Amended and Restated Claims Recovery and Assignment Agreement Effective as of December 31, 2021, as Amended to Date [Member] | Option to Pay in Cash or in Stock and Elected to Pay in Stock [Member] | Cano Health, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued', window );">Deferred compensation arrangement shares issued</a></td>
<td class="nump">189,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the liability as of the balance sheet date to an individual under a deferred compensation arrangement. This amount may be the result of periodic accruals made over the period of active employment, or reflect termination benefits resulting contractual terms or a death benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483043/710-10-30-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued pursuant to the terms of a deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mspr_CanoHealthLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mspr_CanoHealthLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Liabilities Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure, Total</a></td>
<td class="nump">$ 22,584<span></span>
</td>
<td class="nump">$ 305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
<td class="nump">211<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_FinancialLiabilitiesFairValueWarrants', window );">Warrant liability</a></td>
<td class="nump">$ 22,373<span></span>
</td>
<td class="nump">$ 268<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_FinancialLiabilitiesFairValueWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial liabilities fair value warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_FinancialLiabilitiesFairValueWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Measurements within the Fair Value Hierarchy of Derivative Liabilities Using Level 3 Inputs (Details) - Level 3<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at December 31, 2023</a></td>
<td class="nump">$ 37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair value of derivative liability</a></td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of note</a></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at December 31, 2024</a></td>
<td class="nump">$ 211<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Embedded Derivative Liability Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Price of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeLiabilityMeasurementInput', window );">Embedded derivative liability</a></td>
<td class="nump">2.27<span></span>
</td>
<td class="nump">56.75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeLiabilityMeasurementInput', window );">Embedded derivative liability</a></td>
<td class="nump">0.60<span></span>
</td>
<td class="nump">0.40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Market Risk Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeLiabilityMeasurementInput', window );">Embedded derivative liability</a></td>
<td class="nump">0.0956<span></span>
</td>
<td class="nump">0.1237<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm', window );">Embedded derivative liability term</a></td>
<td class="text">9 months<span></span>
</td>
<td class="text">1 year 3 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Embedded derivative liabilities measurement term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure embedded derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 22, 2024</div></th>
<th class="th"><div>Mar. 04, 2024</div></th>
<th class="th"><div>Dec. 22, 2023</div></th>
<th class="th"><div>May 23, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420,032<span></span>
</td>
<td class="nump">$ 289,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Due to related party current</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,765<span></span>
</td>
<td class="nump">19,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,647<span></span>
</td>
<td class="nump">8,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditFacilityCollateralMember', window );">Working Capital Credit Facility Collateral [Member] | Second Amended and Restated First Lien Credit Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PaymentOfCertainCostsAndFees', window );">Payment of certain costs and fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspPrincipalsMember', window );">MSP Principals [Member] | Service fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspPrincipalsMember', window );">MSP Principals [Member] | Unsecured Promissory Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DebtInstrumentPaymentInKindAnnualInterestRate', window );">Interest rate, payable in kind</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, maturity term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryLawFirmMember', window );">MSP Recovery Law Firm [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Related party expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,700<span></span>
</td>
<td class="nump">19,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AdvancePaymentIncurredForExpenses', window );">Advance payment incurred for expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,700<span></span>
</td>
<td class="nump">19,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryLawFirmMember', window );">MSP Recovery Law Firm [Member] | Existing Legal Services Agreements [Member] | Professional Fees - Legal [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_OperatingCostsAndExpenses1', window );">Related party expenses 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,700<span></span>
</td>
<td class="nump">19,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryLawFirmMember', window );">MSP Recovery Law Firm [Member] | Existing Legal Services Agreements [Member] | Cost of Claims Recoveries [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_OperatingCostsAndExpenses1', window );">Related party expenses 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryLawFirmMember', window );">MSP Recovery Law Firm [Member] | Existing Legal Services Agreements [Member] | Affiliate Payable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Due to related party current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryLawFirmMember', window );">MSP Recovery Law Firm [Member] | Existing Legal Services Agreements [Member] | Affiliate Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Due from related party current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryLawFirmMember', window );">MSP Recovery Law Firm [Member] | Unsecured Promissory Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryLawFirmMember', window );">MSP Recovery Law Firm [Member] | Unsecured Promissory Notes [Member] | Existing Legal Services Agreements [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, maturity term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryLawFirmMember', window );">MSP Recovery Law Firm [Member] | Unsecured Promissory Notes [Member] | Working Capital Credit Facility Collateral [Member] | Existing Legal Services Agreements [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PartialRepaymentOfDebt', window );">Partial repayment of debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryAviationLlcMember', window );">MSP Recovery Aviation, LLC [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Related party expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryAviationLlcMember', window );">MSP Recovery Aviation, LLC [Member] | Affiliate Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Due from related party current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_SeriesMrcsLlcMember', window );">Series MRCS LLC [Member] | Claims Financing Obligation and Notes Payable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Note payable related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_VrmMember', window );">VRM [Member] | Reserved Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AnnualCompoundedReturnOnContributionPercentage', window );">Annual compounded return percentage on contribution</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_OtherAffiliatesMember', window );">Other Affiliates [Member] | Additional Receivables From Other Affiliates [Member] | Affiliate Receivable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Due from related party current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member] | Funds Held For Other Entities [Member] | Affiliate Payable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Due to related party current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,800<span></span>
</td>
<td class="nump">19,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member] | Unsecured Promissory Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_VirageAmendmentMember', window );">Virage Amendment [Member] | Class A Common Stock [Member] | Initial Virage Warrant [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,425<span></span>
</td>
<td class="nump">17,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_VirageAmendmentMember', window );">Virage Amendment [Member] | MSP Recovery Law Firm [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188,000<span></span>
</td>
<td class="nump">156,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_VirageAmendmentMember', window );">Virage Amendment [Member] | Series MRCS LLC [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124,700<span></span>
</td>
<td class="nump">$ 65,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=mspr_BrickellKeyInvestmentAmendmentMember', window );">Brickell Key Investment Amendment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_SharesPledgedUnderAgreement', window );">Shares pledged under agreement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024 and 2023, Interest expense included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">318.9</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">226.5</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of interest expense to related parties.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of December 31, 2024 and 2023, total affiliate receivable, affiliate payable, warrant liability, guaranty obligation and loan from related parties balances are with related parties. In addition, the prepaid expenses and other current assets, claims financing obligation and notes payable, other current liabilities, and interest payable include balances with related parties. See Note 14, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Party Transactions, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for furthe</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">r details.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AdvancePaymentIncurredForExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advance payment incurred for expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AdvancePaymentIncurredForExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AnnualCompoundedReturnOnContributionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual compounded return on contribution percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AnnualCompoundedReturnOnContributionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DebtInstrumentPaymentInKindAnnualInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument, payment in kind, annual interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DebtInstrumentPaymentInKindAnnualInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_OperatingCostsAndExpenses1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating costs and expenses 1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_OperatingCostsAndExpenses1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PartialRepaymentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Partial Repayment of Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PartialRepaymentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PaymentOfCertainCostsAndFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of certain costs and fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PaymentOfCertainCostsAndFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_SharesPledgedUnderAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares pledged under agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_SharesPledgedUnderAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditFacilityCollateralMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mspr_WorkingCapitalCreditFacilityCollateralMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspPrincipalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspPrincipalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mspr_ServiceFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mspr_ServiceFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=mspr_UnsecuredPromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=mspr_UnsecuredPromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryLawFirmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryLawFirmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mspr_ExistingLegalServicesAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mspr_ExistingLegalServicesAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mspr_ProfessionalFeesLegalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mspr_ProfessionalFeesLegalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mspr_CostOfClaimsRecoveriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mspr_CostOfClaimsRecoveriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mspr_AffiliatePayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mspr_AffiliatePayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mspr_AffiliateReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mspr_AffiliateReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryAviationLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspRecoveryAviationLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_SeriesMrcsLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_SeriesMrcsLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mspr_ClaimsFinancingObligationAndNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mspr_ClaimsFinancingObligationAndNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_VrmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_VrmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=mspr_ReservedSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=mspr_ReservedSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_OtherAffiliatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_OtherAffiliatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mspr_AdditionalReceivablesFromOtherAffiliatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mspr_AdditionalReceivablesFromOtherAffiliatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=mspr_FundsHeldForOtherEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=mspr_FundsHeldForOtherEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mspr_VirageAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mspr_VirageAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=mspr_InitialVirageWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=mspr_InitialVirageWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=mspr_BrickellKeyInvestmentAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=mspr_BrickellKeyInvestmentAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segment</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration', window );">CODM Title</a></td>
<td class="text">srt:ChiefExecutiveOfficerMember<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription', window );">CODM Description</a></td>
<td class="text">The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis, using the operating expenses and interest expense, as presented on the face of the income statement, for purposes of making operating decisions, allocating resources, and evaluating financial performance.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of nature of expense information used by chief operating decision maker (CODM) to manage operation when segment expense information by category is not disclosed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Other Segment Items (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_TotalClaimsRecovery', window );">Total Revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 18,249<span></span>
</td>
<td class="nump">$ 7,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Less:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClaimsAmortizationExpense', window );">Claims amortization expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(484,076)<span></span>
</td>
<td class="num">(476,492)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(22,231)<span></span>
</td>
<td class="num">(26,508)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(14,131)<span></span>
</td>
<td class="num">(22,766)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Professional fees - legal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(9,519)<span></span>
</td>
<td class="num">(34,401)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairement of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(752,697)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(420,032)<span></span>
</td>
<td class="num">(289,169)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_SignificantExpenses', window );">Significant Expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,702,686)<span></span>
</td>
<td class="num">(849,336)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">1,556,845<span></span>
</td>
<td class="nump">835,145<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other Segment Items</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (127,592)<span></span>
</td>
<td class="num">$ (6,486)<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, general and administrative expenses included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of related party expenses, respectively</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024 and 2023, Professional Fees - Legal included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.7</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.2</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of related party expenses related to the Law Firm. See Note 14, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for further details.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024 and 2023, Interest expense included </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">318.9</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">226.5</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of interest expense to related parties.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Balances include related party transactions.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> See Note 14,</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, f</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or further details.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClaimsAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims amortization expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClaimsAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_SignificantExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_SignificantExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_TotalClaimsRecovery">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total claims recovery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_TotalClaimsRecovery</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator - basic and diluted:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (1,556,845)<span></span>
</td>
<td class="num">$ (835,145)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net loss attributable to the non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,196,346<span></span>
</td>
<td class="nump">778,797<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to MSP Recovery, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (360,499)<span></span>
</td>
<td class="num">$ (56,348)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_EarningsPerSharesBasicAndDilutedAbstract', window );"><strong>Denominator - basic and diluted:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares of common stock outstanding - basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,001,525<span></span>
</td>
<td class="nump">356,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares of common stock outstanding - diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,001,525<span></span>
</td>
<td class="nump">356,591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share of common stock - basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (359.95)<span></span>
</td>
<td class="num">$ (158.02)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share of common stock - diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (359.95)<span></span>
</td>
<td class="num">$ (158.02)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_EarningsPerSharesBasicAndDilutedAbstract', window );"><strong>Denominator - basic and diluted:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares of common stock outstanding - basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,001,525<span></span>
</td>
<td class="nump">356,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares of common stock outstanding - diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,001,525<span></span>
</td>
<td class="nump">356,591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share of common stock - basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (359.95)<span></span>
</td>
<td class="num">$ (158.02)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share of common stock - diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (359.95)<span></span>
</td>
<td class="num">$ (158.02)<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Balances include related party transactions.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> See Note 14,</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, f</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or further details.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_EarningsPerSharesBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Shares Basic And Diluted [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_EarningsPerSharesBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share - Additional Information (Detail) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Apr. 14, 2025</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share</a></td>
<td class="nump">$ 0.0032<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mspr_PublicWarrantsOutstandingMember', window );">Public Warrants Outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount</a></td>
<td class="nump">2,950,157<span></span>
</td>
<td class="nump">2,950,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">New Warrants Outstanding [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount</a></td>
<td class="nump">894,754,824<span></span>
</td>
<td class="nump">894,754,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mspr_WarrantsIssuedToVirageMember', window );">Warrants Issued to Virage [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount</a></td>
<td class="nump">9,851,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mspr_ClassVCommonStockMember', window );">Class V Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount</a></td>
<td class="nump">4,962,704<span></span>
</td>
<td class="nump">4,965,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued</a></td>
<td class="nump">8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share</a></td>
<td class="nump">$ 7,187.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member] | VRM [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member] | CPIA Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount</a></td>
<td class="nump">106,667<span></span>
</td>
<td class="nump">106,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mspr_PublicWarrantsOutstandingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mspr_PublicWarrantsOutstandingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mspr_WarrantsIssuedToVirageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mspr_WarrantsIssuedToVirageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mspr_ClassVCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mspr_ClassVCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_VrmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_VrmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mspr_CpiaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=mspr_CpiaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liability - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jan. 06, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liability</a></td>
<td class="nump">$ 211<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mspr_ForcedExpiratoryFlowSharesMember', window );">FEF Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AggregateNumberOfSharesTransferredToEscrowAccount', window );">Aggregate number of shares transferred to escrow account</a></td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AggregateNumberOfSharesTransferredToEscrowAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of shares transferred to escrow account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AggregateNumberOfSharesTransferredToEscrowAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_ForcedExpiratoryFlowSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_ForcedExpiratoryFlowSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Detail)<br></strong></div></th>
<th class="th">
<div>Apr. 04, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 15, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 18, 2024 </div>
<div>Days </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 26, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jan. 31, 2024</div></th>
<th class="th">
<div>Jul. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 14, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Feb. 18, 2025</div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 01, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 01, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AdditionalBridgeLoan', window );">Additional bridge loan</a></td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants to purchase shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,962,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,388<span></span>
</td>
<td class="nump">111,978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
<td class="nump">$ 0.0625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants to purchase shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,187.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member] | VRM [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient', window );">Percentage of number of shares warrant purchased equal to quotient</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees', window );">Description of warrants issued to counter party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">issue a warrant to purchase a number of shares of Class A Common Stock of the Company, or some combination thereof, to Virage Recovery Master LP (&#8220;VRM&#8221;) equal to the quotient of 1% of the calendar month-end balance of the Unpaid Base Amount (as defined in the MTA) (the &#8220;Required Monthly Issuance&#8221;).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NumberOfWarrantsIssued', window );">Number of warrants issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,332,792<span></span>
</td>
<td class="nump">3,277,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mspr_RestructuringPlanMember', window );">Restructuring Plan [Member] | VRM [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AmountsReceivedToToTheMasterTransactionAgreement', window );">Amounts received to to the master transaction agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mspr_RestructuringPlanMember', window );">Restructuring Plan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LoansRepaymentPercentage', window );">Loans repayment percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity', window );">Converting certain debt of certain creditors into equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_MinimumFeePaid', window );">Minimum fee paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,550,000<span></span>
</td>
<td class="nump">$ 1,550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BridgeLoan', window );">Bridge loan</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,550,000<span></span>
</td>
<td class="nump">$ 1,550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member] | Restructuring Plan [Member] | Operational Collection Floor Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity', window );">Converting certain debt of certain creditors into equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mspr_NomuraPromissoryNoteMember', window );">Nomura Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate of promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AggregateAmountOutstandingUnderCashProceeds', window );">Aggregate amount outstanding under cash proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember', window );">YA II PN, Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NumberOfConsecutiveTradingDays', window );">Number of consecutive trading days | Days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember', window );">YA II PN, Ltd [Member] | Maximum [Member] | Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_FloorPriceOfACommonStock', window );">Floor price of a common stock | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Common Stock [Member] | VRM [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage', window );">Warrants to purchase shares of common stock, Owning percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock', window );">Minimum percentage of common stock held, Warrant Exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Class A Common Stock [Member] | VRM [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_NumberOfWarrantsIssued', window );">Number of warrants issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants to purchase shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,361,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ClassOfWarrantOrRightOutstandingVotingPercentage', window );">Voting control from warrant exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Restructuring Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity', window );">Converting certain debt of certain creditors into equity</a></td>
<td class="nump">9,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from credit facility</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Commitment collateral</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LicenseFeePercentage', window );">License fee percentage</a></td>
<td class="nump">17.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_FundedForAdditionalClaims', window );">Funded for additional claims</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LineOfCreditFundedInTranchesPerMonth', window );">Line of credit funded in tranches per month</a></td>
<td class="nump">$ 1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AccruedInterestPercentageInYearOne', window );">Accrued interest percentage in year one</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AccruedInterestPercentageAfterOneYear', window );">Accrued interest percentage after one year</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration', window );">Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]</a></td>
<td class="text">Secured Overnight Financing Rate (SOFR) [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_RecoveryRightsInterestExcessCashFlowPercentage', window );">Recovery rights interest excess cash flow percentage</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_RecoveryRightsInterest', window );">Recovery rights interest</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BridgeLoan', window );">Bridge loan</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_OperationalFunding', window );">Operational funding</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfProceedsFromGrantLien', window );">Percentage of proceeds from grant lien</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">Jun. 30,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Restructuring Plan [Member] | Virage Term Sheet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investments ownership percentage</a></td>
<td class="nump">43.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Restructuring Plan [Member] | VRM [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid', window );">Percentage of grant proceeds to extent full return not repaid.</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Restructuring Plan [Member] | Hazel Transactions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration', window );">Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]</a></td>
<td class="text">Secured Overnight Financing Rate (SOFR) [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_PercentageOfPledge', window );">Percentage of pledge</a></td>
<td class="nump">50.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_DebtInstrumentsExtendedMaturityDate', window );">Extended maturity date</a></td>
<td class="text">Nov. 30,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Restructuring Plan [Member] | MSP Principals [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Commitment collateral</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BridgeLoan', window );">Bridge loan</a></td>
<td class="nump">$ 9,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Percentage of debt obligation agreed to convert</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Restructuring Plan [Member] | MSP Principals [Member] | Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt converted into shares</a></td>
<td class="nump">$ 144,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Restructuring Plan [Member] | Legal, Accounting, And Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BridgeLoan', window );">Bridge loan</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Restructuring Plan [Member] | Operational Collection Floor Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BridgeLoan', window );">Bridge loan</a></td>
<td class="nump">9,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_AdditionalBridgeLoan', window );">Additional bridge loan</a></td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Restructuring Plan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_LoansRepaymentPercentage', window );">Loans repayment percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Restructuring Plan [Member] | Maximum [Member] | VRM [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mspr_Non-RecourseDebtSecondLienAmount', window );">Non-recourse debt second lien amount</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Restructuring Plan [Member] | Maximum [Member] | Hazel Transactions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 235,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AccruedInterestPercentageAfterOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued interest percentage after year one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AccruedInterestPercentageAfterOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AccruedInterestPercentageInYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued interest percentage in year one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AccruedInterestPercentageInYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AdditionalBridgeLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Bridge Loan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AdditionalBridgeLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AggregateAmountOutstandingUnderCashProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount outstanding under cash proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AggregateAmountOutstandingUnderCashProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_AmountsReceivedToToTheMasterTransactionAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts received to to the master transaction agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_AmountsReceivedToToTheMasterTransactionAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right outstanding ownership percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClassOfWarrantOrRightOutstandingVotingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right outstanding voting percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClassOfWarrantOrRightOutstandingVotingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right outstanding warrant exercise minimum holding percentage of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Converting certain debt of certain creditors into equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_DebtInstrumentsExtendedMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instruments extended maturity date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_DebtInstrumentsExtendedMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_FloorPriceOfACommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Floor price of a common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_FloorPriceOfACommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_FundedForAdditionalClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Funded for additional claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_FundedForAdditionalClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_LicenseFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License fee percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_LicenseFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_LineOfCreditFundedInTranchesPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of credit funded in tranches per month</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_LineOfCreditFundedInTranchesPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_LoansRepaymentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loans repayment percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_LoansRepaymentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_MinimumFeePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum fee paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_MinimumFeePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_Non-RecourseDebtSecondLienAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-recourse debt second Lien amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_Non-RecourseDebtSecondLienAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_NumberOfConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of consecutive trading days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_NumberOfConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_NumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_NumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_OperationalFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operational funding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_OperationalFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of grant proceeds to extent full return not repaid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of number of shares warrant purchased equal to quotient.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfPledge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of pledge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfPledge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_PercentageOfProceedsFromGrantLien">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of proceeds from grant lien.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_PercentageOfProceedsFromGrantLien</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_RecoveryRightsInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recovery rights interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_RecoveryRightsInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mspr_RecoveryRightsInterestExcessCashFlowPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recovery rights interest excess cash flow percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mspr_RecoveryRightsInterestExcessCashFlowPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mspr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BridgeLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-Term financing which is expected to be paid back relatively quickly, such as by a subsequent longer-term loan. Also called swing loan or bridge financing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BridgeLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reason for issuing warrant or right.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates type of variable interest rate on debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 470<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_VrmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_VrmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mspr_RestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mspr_RestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=mspr_OperationalCollectionFloorFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=mspr_OperationalCollectionFloorFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mspr_NomuraPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mspr_NomuraPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mspr_YaIiPnLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mspr_VirageTermSheetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mspr_VirageTermSheetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mspr_HazelTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspPrincipalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mspr_MspPrincipalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mspr_LegalAccountingAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mspr_LegalAccountingAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>99
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( +6DCUI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( +6DCUH#Y[LP\P   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DL%.PS ,AE\%Y=XZ;<= 4=<+TTX@(3$)Q"U*
MO"VB::+$J-W;DY:M \$#[!C[S^?/DFOEA7(!GX/S&,A@O!ELVT6A_(H=B+P
MB.J 5L8\);K4W+E@):5GV(.7ZD/N$4K.EV"1I)8D801F?B:RIM9*J("27#CA
MM9KQ_C.T$TPKP!8M=A2AR M@S3C1'X>VA@M@A!$&&[\+J&?B5/T7.W6 G9)#
M-'.J[_N\KZ9<VJ& MZ?'EVG=S'219*<P_8I&T-'CBITGOU8/Z^V&-24O;S.^
MR(KEEG-1W8GJ_GUT_>5W$;9.FYVY+N-%^</X+-C4\.<NFB]02P,$%     @
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M3@H\W/[O#;#"Q([A[8N_ 5!+ P04    " "UI(]:$9BP'D,+  "A3@  &
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MV\]79%PBB3X#<1(CA$?0=#L,,8H2RRQ KR<_SQE7+7-F?#W;E]2Q4EHO!XL
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MNOH&N?T +0FE>:O#S(S7]ZJ9GNZ@Y!;R%HC^-".:U^.*(XSB>H7^]/"QCQ8
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M2*N#'@G.**5,Y42!D/BM"=,KZ2IL=?"^&PM!Q(C,XS,!"+W9DIU2H*YGM'S
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ML]VL[:=IBBIK'V_CL_X%U[,OY4Z@+KTA$1"5SS3U4(9X8+M# 7(H0 X%R*$
M.10@?:S.?HQ@_,_%ZC[$P(D&-%^O>=@7!/+]M!RL[/^8E9WW5G;^I586L!A;
MD!SZ)'+^A;:WG\)#%OJWST+[++'_P9'QWM_^V&:)UTX.*V=USX/&M'^3P\L8
MAY<Q#B]C'%[&.+R,<7@9X_ RQN%EC,/+&(>7,0XO8QQ>QO@/>!EC7Y'6_X+B
M^ _]A*+S-OQT1M.W"OR@-[!["/+ U@\,>,;]:'_\AV;[OX>'AXK0_03\I[4
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M/K<K.E-ENZ%S Z*BMUF_,5DWX :X7V?60T,+T<KXY>7+<_JJ1C52VJXJVM*
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M$7 <'1C9:FNV2]/=A0\^,W-O+6"G W_N"M5V9<K:D=0S%*L5Z@I\CC'A>=X
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M=G_7 \@+:&+T;GQ)>)YI %D;3L)OZYX<@>!JK 8RAQ&.#E['O@' B:'J-3L
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M<5K#Y](HOY%K;RD&-KQ\R-@XO\5T,B;_3\>(<2]D'$C]?\288<@H5/$R,57
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M3^ WI2A01JCQ?9XZ*D*([QY.$2(\&1. XB\O4ES@0+E\=7;YG)KZ_MT;9E0
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M__!C>)S_?.:;HEMCRK@Q*WCU9/'=HSN<$=%?0&71GX%<VKZW6_IQ UK =/@
M?+^R<%#Y!3?P?Q?TIW\!4$L#!!0    ( +6DCUHT&A4/$A,  !DY   9
M>&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;-U;:V\;.9;]*X0G/; !199DQWD'
M4-S))(UVXK73:2P6^X&JHB1VZJ$N5EE1__H]]UZ2527)CV &@\%^26RIBKR/
M<\]]D'ZU+JMO;FE,K;[G6>%>'RSK>O7B^-@E2Y-K-RQ7IL W\[+*=8U?J\6Q
M6U5&I_Q2GAU/1J.SXUS;XN#-*_[LLGKSJFSJS!;FLE*NR7-=;=Z:K%R_/A@?
MA ^N[&)9TP?';UZM],)<F_JWU66%WX[C*JG-3>%L6:C*S%\?3,<OWI[2\_S
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M$;\52$, @:7,=Y18SE"T9.Q>R)Q0_, [=9VQI -U.#N"^YR6P ]QYG-)"O
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M4HBEJ4PX[8H"G(#4B"TKRTIE62X+Z5V,2%15;#SI:+'F.JU!C1A5D$51M=B
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MNB](DR;IPQP=T03=/7[8,(#ZPU7W;N>%4_MQUIOI>[*'*DZD-?Q"RZHO<C
M4.VYVR\ZQ#MBZA;8\;..:9\H3S'4BT/PBPN\LUN>N[G6L\!S";&[U1E-1]'0
M71)UK[S\D3J>SZ)!?'6V.'3P/Z<#?C2^BMG%V3W/Q7X;O@QP@I[APVD;.C=+
MQVR(XL'@J 7S<3283:&HU2'.J=5$TY_0/^Z<]0_=HEZV;L + 4S0/;]AKFC\
M97CSMOE3PL+?H.^7^[]#? :D<-C X+O"UD%_-NGY,W7]8-7&W:<OE;6J<#\S
MP3'7T0)\7RD<)L(#*6C^P'+S/U!+ P04    " "UI(]:,5:I/38'   ^$@
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M.)6QC&'-^:-"(^CC$U&SF?/655NK5Y6N,ZZEW9K$3?V;C?/^3D:K"OE'(,@
M"2>A)X@M-'[Z%$W^TFQUL<97'\4%6ZVX4T4B7\#PS08K/*X@GO<+.18K8H[O
M(TY$(R68U)]&[2:812"(-W40;V"P&)=E/I_T:# 5%2M@A7VMR$M1S: [2^"X
M2[K*M,M[0NFS>5S)! 6_B#X:D[QCV_J@_:2297"J5($CS;D1J_H1/$Q)Z8#0
M8?<)-P;"HNGLSQSI^P$8:8]@Q2UEMT%]"HBO$'V")F^XLV<ZD<*V+LMV!V"
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M5Q>N@'9Q2S'C=RQ54;F, G,<%&,1<!"-[53%&'&B%6R7-L]R7=,K 1V@H8-
MF\,"$ 4UI,+7U&R[@I #X3*]$34^:@_0HJ '/L]0U_)E&SJILQPA:)EAB@#V
M(R;[<;W<D 0?N@72M&$3R:I(&5 3FX)49PR1\ZZM-?92[G+ )@"D*):FE >
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MI+#^-*U'B5&+D^=V>XPF;#?3L*0N.[AG-BS7#4P*BAMRZ0T=VZ:=_L)=X.2
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MO #/YQKAU1?LH/T^>/%?4$L#!!0    ( +6DCUI4H2GV, 4  "H,   9
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M$5Z.0>FF5&>NB;99F::P)KPXBMB"7CPJDKC7(F[Z@+C)5%U!PCJHBZ8TY;Z
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M/>> [>7/=94%P0X:P!W5&R1?5*)FJ4.Q-1;9!Q':-$7"H'N\R3<?),D9)?/
MTWEZA?. 0:A)6\%MSK5#!1WFOR&1P7_872BRXK62Z'1886B4%),F0>S/!7ID
MS+7TB6H)*O=:7F_52MOK"?TG[I(L>U5YVE__9BO=6EE7 ITW)65LYDWVQ!EO
M)\?TZ@_:Q_W6HU$D) @8=.$[Z-&C=1-<PIUT3S +UQ+XJ=T?T'2<M--CLI@^
MLR(B=(^V!*YVUD"5WB50B-M)'_:=U9V=GEJB78:;@Z,<5-K7[77[=WLYF=0]
M^<V\OMD0QZ74#A0N:"F[C<#6MX5ZX,TJ=.BY\=3OPV=!2M"R <TO#&V09L .
MME>V\9]02P,$%     @ M:2/6D9Z,1&Y#@  62\  !D   !X;"]W;W)K<VAE
M971S+W-H965T,C4N>&UL[5I;4QM'%OXK7<3)XBHA)"%LXEN5C,W:*;!9($EM
M;>U#2].2NCP7I7L&H?SZ_<[IRUP0&!SG;5] ,].7<_W.I?O5NC!?[%*I4MQD
M:6Y?[RS+<O5B?]_.EBJ3ME^L5(XO\\)DLL2C6>S;E5$RX4E9NC\:#)[M9U+G
M.V]>\;MS\^95496ISM6Y$;;*,FDV;U5:K%_O#'?"BPN]6);T8O_-JY5<J$M5
M_KHZ-WC:CZLD.E.YU44NC)J_WID,7[P=TW@>\)M6:]OX+8B3:5%\H8>/R>N=
M 1&D4C4K:06)?]?J6*4I+00R_O!K[L0M:6+S=UC]A'D'+U-IU7&1_JZ3<OEZ
MYVA')&HNJ[2\*-8?E.?GD-:;%:GEOV+MQAY@\*RR99'YR: @T[G[+V^\'!H3
MC@9W3!CY"2.FVVW$5+Z3I7SSRA1K86@T5J,?S"K/!G$Z)Z5<E@9?->:5;RY4
M*DN5B'-IRHVX,C*WDN5E7^V76)]&[<_\6F_=6J,[UAJ.Q%F1ETLKWN>)2MH+
M[(.P2-TH4/=V=.^*[]2L+PZ&/3$:C,;WK'<0N3W@]0X>S:WXSV1J2X.G_VYC
MW"T[WKXL.<X+NY(S]7H'GF&5N58[;W[Z8?AL\/(>HL>1Z/%]JS]21?>O]:DH
ME1B.^^+B_>GDZOT[<3ZYN/JWN+J8?+J<'%]]_/SI4IP6V$',39&)YM9:6?&N
M,CI?B'*IQ$9)(Q3I64!+*ILJ$S0UZO&(XR);R7PCM+451LE<5+E5L\K@8875
M\;XP&Y$323JG[W*Q,&J!'?%=YS.]DJF065'EI2CFXHD8#D?](WA!FI)#[](F
M/_UP-!H-7I[7ZQ&+_';X\JDH"_%+L<S%!W!<Z3^Q22).(,$OXK@O_E4I*Q/9
MHI9F#I^_M.)XJ=5<O+\!P80;XO-\KF?@D59(M &H%.[!#3P%W>G603U@EUTI
M1I]T(W;AL6EX<EM['LXNS\5YX-L&%GHD&W4S6\I\H010F*>TQT)P1BG63$&B
MO=:)$C-IE_PL-Z*LC4;,"EM:T.0TBP&\GC(+!5)I<%*LH0IPDFI6A=S(::J
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MQ<*^C**$CI;S?-DN7Z1<&(^7C"9$F1.N80&PP7:BDYH)TH*S#@0 0_8CK56
M ;(L#P5P&UND.F'=>[@1G-JX^>2Z,G[@B##@#T_$\_[SJ TH ]_N-H0V(#LC
MC5QB9N"P0;Q1;?9@)7-E*3&%+LCZQ9Y7S%WLV!+_V&^P@U<ROG=VIXW\K@GQ
M 8PC:9'GVY:VD@*C$3DADVO%K@4C46PA3I<>8MUT"+&HTJ3F;"XUV[$+QSP?
MJ,&^#)]>,F;JTNUR[PZUU3MLQ5"BB@$V[D[>D0>^^N+7Z&QWV7(O\FF79(U^
ME]I):B7%>,W&CO@:E$9Q<Y96"=DP(,L4M X9(1A=HGIY*9;%6EU3T.M*!W"2
M.ZU6VTFM*;6M+.3]C;;LNZ>7DQC .<&AF(/ZIR=RQ18 _]A3870Q3?7"V4.;
M:+<#AZ4]R!]L@82*<@RM'!ZX>*7+;?S7^1<@H-1EZL#)*)U-29?!&LO: NG1
MDM]V5^N+D\J0^_8"#JB;DFD@O;<D!SV"2+-**_8FEJ-+8> Q#/=;J>5MPSRG
M]JD2E>T0#;%0R/3F]Q!#<"1&F/,&"X9\*O6PZ ''6"%<W&A$7DKC.I##(#3\
MN3^*K]HHTPN"[D2.Z#^=X-L!6WB6[3@5!\%M(>(^QR*NV::M%Y<XAU4@K]P3
MQZG4F25D<R'Q8WZ-D,PV,@G3Q<0BK;6SM+ .!SE$_MP+DT]T#F[(>#\W3)J$
M0P.QN,\T/)4M@)R[N41V@$KK(E0@6:R8UD0<#01AE*6%82G&!2>/92$]\?(N
MC%YH0NEM%05+_/SCI._3]\L@,);.\&4M_V.//$$_[% ZH".\^5J#H)0_*,/"
M\4RV,,%ELM^0'M 4C]*<V#F!]\5Y1_'8/+.!M=;6O;9!^?R]'568.LV*]]KK
M45J/3$+F<N&AF0I<:9!]D?@[AN8C'YNC9A'?)OI6/2.[:9F?X\I$9XV<$?H"
MQU;8/ C@ZI:(41+411#[?HMQKLXMQ:0444 $6*44K-AKO6+:()54!VG<3<9D
M>\[13K'(B65,M[LN[LS2+PXP:52ZCP>K1\/36H;8\[4,IP4\G4P],G-O"F2[
M.5"C2NR)Q*6Q<^ ,=N.JAG@2?U=38=S_N<;C6\E[HZ!>J!PDIS7E) Q $U';
MS *B$*B1$K( G^A%6JJ<\^/MJ$1%69<7(&^E!)3LLWKNS]"NB<<-QGT.CCZ6
MQQ&7\"=8P"1S=D/6<*%8&PD1BBFGR"?$,62HFVB//3.9*)_I=RF**>A,&KRK
MRUDL__=6E9\!CHQ XZ:7O2VD 7,5EC1<QS 24>.*RFK5B0LM)05S;9K%H#\.
M5@%"EWH6N@AKL$EF$;*3 ,^@SU"& _!;(3YREB<WG,D9,ID27,L;*C$(1S@B
M^=?%.O=J"1'."ZW3Z,"F'\X_$'11#PGJ(VO4U-')<]_DCO'E]\)\H;V/Y4J7
M&.:5>R)GB#3EYEL0Y:"6B$>40?_@;D A,341A?I.C2A0UQQ_!Z)<-:=F<N.B
M@F^]$?7[V'-9(.OGMA7HGRKDG/.8%028R7T6 2^GGHJO@C!J6EF=0]]W8G]+
M=H,&F@?9'=T+QN3MT8/K($'.U1#JU\IF#)G$Y.(").IK\LH.Y#8Y-EZ<U,@4
MW-2^34:?+?,BA/;)M?;)PNGI<:OG0Y+/Y!=5%S,-]39Q-*J_I0FJ%&)NU+MO
MT]U&#S5\:4-O,P@3JM4DA:0%QE@D,7G:EH^"NG339(&4IB$I5"L;,84V"0]2
M.@B*=C$%>GW5.$:M5E)4?9.;[Z?ZQWM^D\!@O0]/)?[IXR;-G"29SC4=M'!3
M?9O7MYA^G->?,$!_4*E#Y<\<-]Z'5+UKF ]#@Y8-VD< P@,4CXSLZ);FJ<-2
M[]?!H[]D!+[\8G^P=2.>D1J)2":-AAE[&BX=-I]='%\V^LY3)4)G3[-T0X?=
ME_<LOWE:K'V"4FNG#N3S4"7V'WB>-.QT*@G*6W66=!E)2#DX"#;HYXZ@.X^N
MJ]9GL-N/>8DJ1-.<"7<C>^*3*L6#-4A4-=J1]-@F!!N3KQRVO.>1^O/Q,DJM
MT2[BY7(NK5=!MU^/1J0$Y;0>0@!G2 $A@NI866U3?!P4!$.[E0I\,W2%DYJF
M*V,AOS(7>V$(]:8CK*SXZ-1;-J5;QB[U*N:LT:VYK$>,( 1IY& QZ!#'#<-J
M8^E=4-J-K_$89'ATU#@(\47::-PHW C%OG8Z0@R?5/#-"U56QJWSFS:HU\79
MU<1E_:YRIR_SKQ-\<#?!A\]NJ?_982,)_+[TMFW)C_$MJ,HV6U @^8SR80K7
MD[HW^[@^T\=<<ZW@-_H=98UDL=$I!XO*QS97>JKYW!$G?I%Y1;' ZYLZW*5&
MG5B95FN73AK=TI+[5)KIGT,4M]L$'&-6[..*+8^K/M?QI2:!LV0ZK?5+4E<\
MI[@$JY\5V11<^I;*"[$KGS(P]^XXS1KV!S^2=_.9&G(9\ KCX!WW\#MZYZXK
M@VY_B.U:.#E*&]),(BF65"M:?X3E5WPJGE<9WZ%)*,9*,I>L2J4 ]-)O;CXY
M&]EB#T]CK]I7:6O?*PE"M9&'%8%9X@ZEF]R0P8=POSM]VCH>Y=9W-;60"I6)
M9[Z+W#8&!/<+-:>P5WPGPPO^F(:S@#ELS.T5#"UY4) <MYN!J$)G2VK=-8XJ
M'!VMTMDE9=6B@K_2O0V'5_12-EN]T!;=@1)C0:B<+RRAXYGIMRY7/.H>Q=9N
MSO!Y[W#L:!J.>^/1X;8N>I4;M8"TE#O8XO:O*RN1?TQH2>A:7);%[$O#.F!8
M%AYAY_X61*/1VO31=KH5"G^_"\>QVD9@'4'*B0N9?B\O&Y));+A'>?RZVCL&
M0%!:&;K,743<VF7_RY9V1Z.@@[FM1(NV23I LP4_/ 'NR@.+<1J'-ZY7\,G.
M[9L.QC&-7Z.!^+'52>L(IB[H[FU[1XMW3#I">JY?ZTFG]'^JFCTJ@!"@HFD6
M_B)7T\;.D.(:VW_(E2)ZR]TYE>K0_W:];5NE[.ET$LCI<FQR<V)&XUAF_:_U
M<*"GV 7J"N0;6WX]GZ!2?>-0SI^JE$MJ:372Q>:!^94*?;2WD.I"YWQQ *N$
MP+CEM@$=IEW[[MF#Q=KHQKJP7--3=\1Z_DI,FG*$0/C33ZGM[@ZZO!I@NR3!
M5@(HFUGG8[3]$EOP'G2%8D%6?T>+C^SL6S=QJL%&CAMDL,SW @*&WC<,.H]8
MR_J*;^/@KZ"#)K^6OTGVES7.C=H8IGQT 8Q17N2;M<$*&J;Q#]L\P@O.Z"ZM
M<0)+9Q&[]3&Y/Y3 VZ?MPOU!4K#%3+-31#R,.ERP+))MN,EGU4'R=$8 [R1:
MJ!@:AF3X_WWJ[]&GWG9_=K]QW9GOU=&E;LOG=J6[^1S?QGOC$W==NA[N+IU#
M/[!>.@N<8^J@__QP1QAWD=L]E,6*+T]/B[(L,OY)MT>4H0'X/B\0G/T#;1!O
MT[_Y'U!+ P04    " "UI(]:6,3:>T(&   W#@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970R-BYX;6R-5]MNXS80??=7#+S%P@%4VY+ON0'.9;<&-A?$:8NB
MZ ,MT3:Q$JF25)STZSM#2K*\ZTW[8DL4YW#FG,.A=+Y3^JO9<F[A-4NEN6AO
MK<U/>ST3;WG&3%?E7.*3M=(9LWBK-SV3:\X2%Y2EO:C?'_<R)F3[\MR-/>K+
M<U785$C^J,$46<;TVQ5/U>ZB';:K@2>QV5H:Z%V>YVS#E]S^FC]JO.O5*(G(
MN#1"2=!\?=&>AZ=70YKO)OPF^,XTKH$J62GUE6X6R46[3PGQE,>6$!C^O?!K
MGJ8$A&G\76*VZR4IL'E=H7]RM6,M*V;XM4I_%XG=7K2G;4CXFA6I?5*[7WA9
MSXCP8I4:]PL[/S>:M2$NC%59&8P99$+Z?_9:\M (F/9_$!"5 9'+VR_DLKQA
MEEV>:[4#3;,1C2Y<J2X:DQ.21%E:C4\%QMG+)=\@Q186T@N,3)WW+ +3XUY<
M@EQYD.@'(&$$=TK:K8%;F?#D$*"'&=5I155:5]&[B#<\[L(@#"#J1\-W\ 9U
MF0.'-_B/,I]XKK05<@-_SE?&:C3%7\?J]6C#XVBT44Y-SF)^T<:=8+A^X>W+
MCQ_"<?_LG5R'=:[#]]#_KR3O@]PKRR$<=6%Y^_GN]OX9%O>?'I[NYL^+AWMX
MR+EFC@7CUS+ -"<S(TH"S$"LLEQ)]T2M@4G 2V'? #."W5;$6XS,&8)PP!@F
M8\%2$/N$02#D"Q,I6Z4<XQ/<P)LB93I]PZL7W%NXSNH-[)9#O!5\#:K.*>&Q
M<'L^8U^YAL['#],HZI]=/]S<N<OP[*0+SQAXC4DR^8;S)/8/ X*R]3!*FH#J
M2+B)M5CA8D*"YR2 &S>8NSRQ.LKAJC!8NC'@HAC@W083U\XNKH:2*<< 1>2%
MSI7AGA^#%Q0"N+KC0,:^:BRA69+QB;,X5H5TQ>8J%;'P, 1[9$62QFYQ+:PA
M3HO$%V.W2+&K* K@BAGA(![)CM)Z#2B!I6^V]&PI-E*L1<P0<[[/X+'*X(!4
M8CJ<G!D@VDE-(O?:*77[RN.">BD\K!$.)3J48^MXMUQGSDUVRRQ&E\J03,BZ
MY W!ZT(Q7WKR/0=.%:+'9>,-9'[@O-Q3P D+E8R1=:PP832R(IX"*)Q6A+=/
M@K_B.4=Z4A8"XQ'&5J-N_0-@"EYC!ZAT0VE4AODB]=QG3$9IFJ2TPO<^)Z>F
MJ8K]*"ZB"AUS&L5,^ M+"_]D7V[#99[ZC#-3:)=,329Z$B5#Y3R=^[2_821U
M9O5O ,2RLKC"P1P/U<6&!"Q)!+'L4JYJ_]8RJ ^714EEJN3FYQ3=4N$X/S-K
M<5L67N1<"_2HP-9@56,#>Y=S^%4*RF)IG7L(\['@&J<^B5@YFBD7#!,J::C4
M/3!\+>^^#^5:O0C:30A5>XN2NTZ9R S,,SHJ_O&NNJV,L*BL48]\YA)33N$C
MR_(SF"=H>T%'"VT1+^*C5FMJ$$KBM$^<JOA>EO?<Y%7V;*WH1:HJTQP5P#0*
MK_QPX&^&JZ/$L4@%J]I@DZWEL2"%2^D:#S7)R"UPC[[YH@SZM2*QSL,+^]:T
M9\.ZIZT_.-/^E0%[<LRS%>+CH=_J+(@251A<UIRX=P#Z&;2>G3F?*G_]!.$T
MB(8SO)@$D_ZH]059/FTU*RE5PM%25=94M:P/.C"<#H/^9 PG=#T9!\-9!">M
M2EK'V8&P."V*@F@0NHAH'(SZ4PPX4'I-2G<@' 9A-2\*)N/QT7F.M/ ,4K[!
MH0[,@E$X<T&#83#L8WQK@2H+[=A')K%',;D1[GSU&ZL#DU$4C&<3#'-PT5EK
M\4TGH_*B?M ?1#ZAZ2P(Q[C.4=(H>>05,:>>F>EP%@P&5,"#,T/]JN+,T EI
M3AA-@M',PR./%-FJ/()"$>1H- ZFPQ%.H?OI8!2$[HX %OZ,P\-&&5=GU4T"
MF&.7W+EN19L^UAQ[$?87.GSI4,<M$8O]R=<4.L"C"\FBC87[3&B@KNK\N&-:
ML_+L2;"%O'AU<5^L<'-84?5A7V^Y+SLEF2<!2.X/IWHWT^E6Z,,&6N]C=Q#L
M.USWV-MBK_$RGW&]<9\L]$:&Y[5_KZ]'ZZ^BN?\8V$_WGU1W3&\$-M*4KS&T
MWYV,VJ#]9XJ_L2IWGP8K9?%#PUUN\<N.:YJ S]<*7S#*&UJ@_E:\_!=02P,$
M%     @ M:2/6C/ VT!.!0  &0\  !D   !X;"]W;W)K<VAE971S+W-H965T
M,C<N>&ULU5=;;]LV%'[WKSAPAV(%%%N2+5_2Q(!S&1J@28VX:S$,>Z"E8XNK
M1&HD%3?_?H?4)7'B9$L1#-B++4KG?.<[5Y)'6ZF^Z131P/<\$_JXFQI3'/;[
M.DXQ9[HG"Q3T92U5S@PMU::O"X4L<4IYU@]]?]3/&1?=V9%[MU"S(UF:C M<
M*-!EGC-U>X*9W!YW@V[SXIIO4F-?]&='!=O@$LVOQ4+1JM^B)#Q'H;D4H'!]
MW)T'AR=#*^\$OG#<ZGO/8#U92?G-+BZ2XZYO"6&&L;$(C/YN\!2SS (1C;]J
MS&YKTBK>?V[0?W&^DR\KIO%49E]Y8M+C[J0+":Y9F9EKN?V M3^1Q8MEIMTO
M;"O9@=^%N-1&YK4R,<BYJ/[9]SH.]Q0F3RF$M4+H>%>&',LS9MCL2,DM*"M-
M:/;!N>JTB1P7-BE+H^@K)STSNZ*\?Y1:PP(5G,H\IT@M4Z;PJ&\(W@KUXQKJ
MI((*GX *0KB4PJ0:SD6"R2Y GWBUY,*&W$GX+.(9QCT8!!Z$?CA\!F_0.CMP
M>(,G\,Z9$EQL*F>=E_#[?*6-HMKX8Y_#%=QP/YSMET-=L!B/N]00&M4-=F=O
MWP0C__TS9(<MV>%SZ"_+S#] 28,0C'IP!>>?X>.GY1(6Y]=P^NGR\M,5+#_,
MK\_AA&D> S81*LBH=A&2:SC-&/&80URQH**,OP'7=EV4!A-8W4+";WA"JB"(
M-Q?T"8$9H_BJ-&R5(1C9ZEO<5&8)*FU538JP=>V#R0&[0473 $29KX@#67?B
M^DD>-&FT8<+93DIE_RP@.<!ETH,SGCF*_[UG+/F3^I<P:'0Z2F2JS"V5[W'*
MQ,818%D&!:5'&$Z/UAC1I3D%&F-RQG#4WNO&J*5%M#?6$J[7-"+M<B\1&J T
MA&GRMZ',;%7>A=&ZY]QP$0?7"L+*41PM;<ULP+0=GE1A#Y19)4-AS4HWZ,D%
ME[Y[5#C%S06Z]G(KRXPR0\HD<= 0[74^IY9,1ON,*X)*!8VV#$WJ8*N\,E-;
MJBA18"IW7U0FAYW?2+B:=4"3"ETN:%IU?KX09$R6FH I>Y1N+$SC+]FZ@TYH
M9+]ST\W^##I75!^*&0KHP6-NAQT[$ES\?H*?(?"B:.1-AA&\<^O)(/("N^I\
M1*T/H15^6*LV#D**@YB&M:)PV6!Q2AB%EF(5>,%TY V&(QB/)]YX.NX\"72Y
M7, UQI*J\=:#"T'#VA(9C'QO.)W6M"(+-B%69R@D;6#.N[=O)F$0O-_GX]>'
M1?Z"TMZ%#3S?IR"%$0R(1#0-7@6[[8O'\.?_?L3L,G51BZ:]:9/+()KT_)""
M]@.0324_"5KM(KKI--I:"B9NG?KXO:[!O^R")Y)*QD#!E.$Q+YBQ+>O4VX:A
MM-HJ>03LTFN)TSLZ<4F%#Z!L=.^F70_FFHZ(<>K12Q*RINJ1\H-M^\"5DAJV
MFL=F*P]B)Y(C]6L"*4TCRVV%*.[F6 \N*E=CEL5E5K&P0V^/T6;4W]K1@(]&
M0]7JWDYX:#QDI15<*YD_LD->/./CT)N.0F_L#Q]5\J[39-B;1KX71&-8E*N,
MHO>5*47S4]\O\IK8XF+>?"9VJ&*N7<M;YP)_Y(U&XSV=TQQ1*GN3Z= ;1T-O
M0OY>T=E\GSF7P:DWB0)O,)C"MA&Q\[[:G[YPVZ9>O4MPU>Q5U0Z04AM7N=K=
M"%XW7X-7SE?DA=/1_S-?*XQ9J?$EN=AW$.[?NZ[0?K=QES)[YBJ%J6XN[=OV
MWC>OKCMWXM6E\9*I#1<:,ER3JM\;1UU0U46L6AA9N,O/2AJZ2KG'E.ZNJ*P
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MY?L-,V8'OAT/W/Y!G-$I\1%?7ALQI5?^"(CC!Q7^&L%$YJ+W^=*=7/X4!?'
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M4P$O(601>$C]M!D^.HDU.&H]E-8_/32]9R,YZ+__^>GYV9/G#@B[K9&8;QI
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MQQ>O^D'"I@0M,;.V^1[LD\*B(6!+#E'@XP.Z]:3QTX.!?JPKH',4)"A.T#
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MU+0 2J$P[-CFN%72,@@HP74-!AD#8&G758/^IOE[#@>""_(FCPX.?'L]L9!
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MSR.J;FJU8&3I&LE2&FQ+;IGC?P"45<#S3$JS$ZR#YL\R^P=02P,$%     @
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M+81H\\$A]I2C&]-?TAWZ!GS)W(I+D>\I?WGW)@GZ\7NS?>2FJG9B7_\+4$G
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M"I2U)C0[<*&ZW42."YN4)Z-HE=,^,[P5J2P0)NP%3B9LFJ,^[?N&@.VRGVY
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MKI0EL]?+G*8K:I= \;52=K]Q!=IYG?P%4$L#!!0    ( +6DCUI4V&K0\ ,
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MHS0*=+X10A\$XZ![_N?_ %!+ P04    " "UI(]:27?QQ,H&   G,0  &0
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M:W-H965T<R]S:&5E=#0R+GAM;*U5:T_;,!3]*U=!0IO$FD=;0-!&@J)I2-M
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M[SZ=C<^DJ[*NR\W^X6V>+?.J?4+S\^NRK!^^: ?X7E:_[7?[\G\!4$L#!!0
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M6KYY1N>--YI/%JO_"E\W]SU])XR6BVH^W3RX7H)I,5O_;_;GYI78>8 HOO
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MYA+_8KJ<"K?SLD:;D!ME]7+4OSN8;;VC')UMI":AFHQJ"JJIJ*:AFK[1.F=
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MT5E':A*JR:BFH)J*:AJJZ:AFH)J):M9&V\VZ09UTS[..'-5!-1?5/%3S42U
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M.'/5WS@3Y-FD^'<^%D:3K)@*Y;H#LGCA-!BT3P;5)%2344U!-175-%334<U
M-1/5K(W6^8:F@[M]:%,,JKFHYJ&:CVH!JH6H%J%:C&H)JJ64ULVZMBGFJO=Z
M^X]*5I3"E^WW+JX"[W#,H>4PJ":AFHQJ"JJIJ*:AFHYJ!JJ9J&9MM-WS#,_.
MGWT-H8T.ZJ":BVH>JOFH%J!:B&H1JL6HEJ!:2FG=E&M;7Z[Z6U]Z3O@4_A(T
M3Q.LO&KZ_3\]37KVGA"*EK^@FH1J,JHIJ*:BFH9J.JH9J&:BFH5J-JHYJ.:B
MFH=J/JH%J!:B6H1J,:HEJ)926C<SVX*8J_4U]^P)H6@/#*I)J":CFH)J*JII
MJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!:C6H)J*:5UDO&Z;8NY[N]3
M:*^7M_-Q,6KZT=8[BXMZ9W)SZU X]K/'AB.J2:@FHYJ":NI&Z\[>/3](I:&C
MZJAFH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&JQ:B6H%I*:=W8:VMBKOMK8OHG
M4=-Y^7LQ^RS<9 ]%E4V$S?FDSR=4OV7"M7_)CDY.M&L&U6144U!-134-U714
M,U#-1#4+U6Q4<U#-134/U7Q4"U M1+4(U6)42U MI;1NOHIMOHK\A.LUVDV#
M:A*JR:BFH)J*:AJJZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%J(:A&JQ:B6H%I*
M:=UD;+MIKGNO\/^XRL#F]-3N-8K"W;P4LB8LRV;/,QN/5YG9['R^>!YK_TA'
MYR7:6(-J,JHIJ*:BFH9J.JH9J&:BFK71=B_7& Z?G<:*CNF@FHMJ'JKYJ!:@
M6HAJ$:K%J):@6DIIW1QLFVCJFWTY*.6WE5#,%E6Y7$V9SLOB<]'DW:JN6Q@7
MB]%\.:L.YEZO?'3ND9J$:C*J*:BFHIJ&:CJJ&:AFHIJUT:YW<N_T_=E^[)%#
M.JCFHIJ':CZJ!:@6HEJ$:C&J):B64EHW]MIJFNO^\HS^ X\O'F@\&(-H90VJ
M2:@FHYJ":BJJ::BFHYJ!:B:J6:AFHYJ#:BZJ>:CFHUJ :B&J1:@6HUJ":BFE
M=?.R[:^YOO@.!Q+1'AM4DU!-1C4%U514TU!-1S4#U4Q4LU#-1C4'U5Q4\U#-
M1[4 U4)4BU M1K4$U5)*ZR9CVW9SW=]V\Y],H*(%.*@FH9J,:@JJJ:BF;;3>
MB4 ='=) -1/5+%2S4<U!-1?5/%3S42U M1#5(E2+42U!M932NK'7UM]<]]??
MO'#^S(DPS?XLILNI<#LO:[0YB6:4U<M1_^Y@!**U-Z@FH9J,:@JJJ:BF;;3=
M<T"NGE\,J:.#&JAFHIJ%:C:J.:CFHIJ':CZJ!:@6HEJ$:C&J):B64EHW!-L^
MF^O>5H!O/8I8_R[*RZE@S;.9\*G_X"):?H-J$JK)J*:@FHIJ&JKIJ&:@FHEJ
M%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%J):@6DIIG1@=G+;M-\UM_/#B%H7"D>4D
MEI-93F$YE>4TEM-9SF YD^4LEK-9SF$YE^4\EO-9+F"YD.4BEHM9+F&Y%./V
M$G.PDYC]S3G0_.LKPQR?H6@/#LO)+*>PG,IRVI;;+:4;'IB&98<U6,YD.8OE
M;)9S6,YE.8_E?)8+6"YDN8CE8I9+6"[%N+UP%'?"L;<\ )F7_:UW7O:5)3@^
M-]&6'):364YA.97E-);36<Y@.9/E+):S6<YA.9?E/);S62Y@N9#E(I:+62YA
MN13C]N)UN!.OP^\Q6XO6Y+"<Q'(RRRDLI[*<QG(ZRQDL9[*<Q7(VRSDLY[*<
MQW(^RP4L%[)<Q'(QRR4LEV+<7F*>[23FV7]GMK9WF.,SE.0DEI-93F$YE>6T
M+=?YGONK0[.UY+ &RYDL9[&<S7(.R[DLY[&<SW(!RX4L%[%<S'()RZ48MQ>.
MYSOAV-_%DQ1E]CD7/DWSV?C5MIU7L.,C$.W;83F9Y1264UE.8SF=Y0R6,UG.
M8CF;Y1R6<UG.8SF?Y0*6"UDN8KF8Y1*62S%N+RDO=I+R.[3P;%$L,=$>'I:3
M64YA.97E-);36<Y@.9/E+):S6<YA.9?E/);S62Y@N9#E(I:+62YAN13C]A+S
M<B<Q7VOG68S*XF$5E,W\:[:X%QZRQV8W<R%,LW$N5'-A5="3E_4ORI?F7=&F
M'I:36$YF.87E5);36$YG.>.;N-4?^8E0S(2L_K]I\[<MY'\LLTGSISYX?_KW
MYHV09Z/[^HZ3?#;.2F$ZGU7W_ZQO"[?9))N-<N''K_=%?8_GOUC<9Y.)<)O7
M_JC,LT4^%L99,7D4E@^-+YXV SS4;Z9L-FN.:ZSN4;_YLN:;=:;+228L\JJY
M7=TWBUC=Y\)F_L>./OW4+%KSH\UBKX^(U.SF+MGB:=GKYSO*Q^L#)KO/0JAO
M']Y\0'N-6,YF.8?E7);S6,YGN8#E0I:+6"YFN83E4HS;VWRXVME\Z&\YVGSN
M?,W*,FNV&#:;#L*XW:PXO+V UAJQG,1R,LLI+*>RG,9R.LL9+&>RG,5R-LLY
M+.>^]LFB+.LMH+R<SLO\9/6E@R]ND>6?B]FLV=#Y6M2;-T8V6V;EHS <G-0;
M6^+92;VA-:[W8&95,5LV]ZJWFXK)>KLJL 5E66^M!7FU+&="T7Q^%>-FL^NN
M_O')ZDXW\^E#-GL4LN9JB'&SK;7N+6TVNNK'9]O/ON8'#\MR=%]OT-4_K;?M
M;NN-O'IKK-X@K%^.YM;-)&NF)ANR7GPAK.:CWYN?>_4==K=!FV'_6,ZK8E67
M>B<,_K[=[.O9(-W<(YZMGL)OS5)\6F\D-L]_]7333Y[P8_,RUJ^)\(^_78GB
MZ<]V ]5;IYL/\G3]9%:_'/S\TXFPWLS=/L>O1?UJW6=?\F;3.?\S+T=%/<Y#
M631;Q/5G?W8[:39\5UO8JVW5'^K-W=/3P6J#=_5"K)8F__.AJ&_.UYNWB[Q>
M.^-F>[CXDI>+9N75CRSJ-&E>Z>;)O3^\E82V7[%<P'(ART4L%[-<PG(IQNUM
M)5WO;"7UUV#]MAQ_KG?JZC?!J'Y+U^^SP]M$:)45RTDL)[.<PG(JRVDLI[.<
ML>6ZC<R#[GEU)CNHQ7(VRSDLY[*<QW(^RP4L%[)<Q'(QRR4LEV)<-_@&.[55
M@]Z:CY?/7&NN,MYL#?>>S-;O'YV)*">QG,QR"LNI+*>QG,YR!LN9+&>QG,UR
M#LNY+.>QG,]R <N%+!>Q7,QR"<NE&+<7GCL-5H/!=SB9;<#V5:&<Q'(RRRDL
MI[*<QG(ZRQDL9[*<Q7(VRSDLY[*<QW(^RP4L%[)<Q'(QRR4LEV+<7F**.XG9
M7VNU=S+;TU'IU1&;\=O.9.L?XOC\9'NK4$YF.87E5);36$YG.>.U/^W__D''
MET^$$]YVW/''^E&CY22KMB>XC9;-^6U5\25O3GLK%C]U#TW64K8Y2/C2<C?'
M@9O[W]7&/\?98W-(I9B/FR.0S6_6SV)[U/!D_]"P73^@.2 LGHK#]7'(V>H$
M.2D?K::@ML>,A\QA3_%\Y[#GC\V2;8ZYZK-Z6[Y^U0\?<_VYAN=?BG'S@76?
M5:NG=/@1Z^5J#Z9N#WVOG\7%^^C%1YXT9PIFS:Q</JZ?;/;T$9G?W>6CU1KJ
M8O6K5O]=%-6D>;TVUN[?WN!D4+]XU\.SU_[RLNK :WCH%3M9K[/5G>LGF*T^
MU,?U'U-S[_UG>G@3DJUN0SF;Y1R6<UG.8SF?Y0*6"UDN8KF8Y1*62S%N;Q-R
MI[IMT%MU\S'=;C-N/E:;3YS#VXEL6QO*22PGLYS"<BK+:2RGLYSQVM]OG8SO
M!>&T#L95,AX.1K:A#>5LEG-8SF4YC^5\E@M8+F2YB.5BEDM8+L6XO6#<:6BK
M;[\I&'<W^_>VX]O=G;^$'X0/FWV!P_'9.]KQ\4ER$LO)+*>PG,IR&LOI+&=L
MN<O.R6[-GN?^^6[HN!;+V2SGL)S+<A[+^2P7L%S(<A'+Q2R7L%R*<7LAN=/4
M-OC&IK8Z$%^8P^L__8WM<D,YB>5DEE-83F4YC>5TEC-8SF0YB^5LEG-8SF4Y
MC^5\E@M8+F2YB.5BEDM8+L6XO2S=Z7(;?(\NMP';Y89R$LO)+*>PG,IR&LOI
M+&>PG,ER%LO9+.>PG,MR'LOY+!>P7,AR$<O%+)>P7(IQ>XFYT^4VZ.]R.SA%
MVYZ/,5J?A[%8G8?Q5^_D+-OFAG(2R\DLI["<RG(:R^DL9["<R7(6R]DLY["<
MRW(>R_DL%[!<R'(1R\5;;O=KSP>#X>!Z>-8]!)*P Z<8MY>/.V5E@_Y*H;>?
MV\.VDZ&<Q'(RRRDLI[*<QG(ZRQDL9[*<Q7(VRSDLY[*<QW(^RP4L%[)<Q'+Q
M:R'Q^@ET";M$*<;M!>-./]6@OY^*/K>'+;)".8GE9)936$YE.8WE=)8S6,YD
M.8OE;)9S6,YE.8_E?)8+6"YDN8CEXBWWV@ET"3MNBG'=D!1WNJS$;^^R.MRB
MNN@_N:=_O*-C$N4DEI-93F$YE>4TEM-9SF YD^4LEK-9SF$YE^4\EO-9+F"Y
MD.4BEHM9+F&Y%./VPG2GVTK\'MU6(MMMA7(2R\DLI["<RG(:R^DL9["<R7(6
MR]DLY["<RW(>R_DL%[!<R'(1R\4LE[!<BG%[B2GN)&9_ 1!V<D__.,>'*%MP
MA7(RRRDLI[*<QG(ZRQDL9[*<Q7(VRSDLYVZYW5- KBX&UV>G>Y-X'CNPSW(!
MRX4L%[%<S'()RZ48MY>/.\4]XAN+>YACF/VC'9^2;+T/RLDLI["<RG(:R^DL
M9VRY_<,KI\^^CP<=UV(YF^4<EG-?>I'WCV%Y[+@^RP4L%[[U3R]BQXU9+F&Y
M%./V@FVG>*>^_:9@VX39JFRTRLOIX=SJQ8[/+9*36$YF.87E5);36$YG.8/E
M3):S6,YF.8?EW-<^3T3A,<_*0UN]'KLD/LL%+!>R7,1R,<LE+)=BW%XJ[C3M
MB/U-.\Y3U?E^RW__Y"=;J(-R$LO)+*>PG,IR&LOI+&>PG,ER%LO9+.>PG+OE
M=B<_KY_M][$M.2@7L%S(<A'+Q2R7L%R*<7LYN-.2(_:V"NSDX.98X.Y>8G\4
MLDTY*">QG,QR"LNI+*>QG,YR!LN9+&>QG,UR#LNY+.>QG,]R <N%6VYW,^)B
M.!0OK\5GTZ5L"0[*)2R78MQ>(.Z4X(C])3C_R64:]5W"Y>TB_V/9/%#^DK_6
MS]J_+,=G*%N4@W(RRRDLI[*<QG(ZRQDL9[*<Q7(VRSDLY[*<QW(^RP4L%[)<
MQ'(QRR4LEV+<7M#NM.F(ZUH"^!(.MEH'Y226DUE.83F5Y326TUG.8#F3Y2R6
MLUG.83F7Y3R6\UDN8+F0Y2*6BUDN8;D4X_82<Z=F1_ROUNSTCW9\E+(U.R@G
MLYS"<BK+:2RGLYS!<B;+62QGLYS#<B[+>5ONM3- ?7;<@.5"EHM8+F:YA.52
MC.N&Y'"G9F?87[/S[0<T^^&C\Q#E)):364YA.97E-);36<Y@.9/E+):S6<YA
M.9?EO"VW>XQO*%Y>7IU>[0<B.G# <B'+12P7LUS"<BG&[07B3E7.L+=:X&-8
M9;/Q[:,@_[$LJD?!V^XX?OI<YOG^$<XDL'?_^3^?!%T7/.=$L*IQ_Z',_J4X
M/CW9;AV4DUE.83F5Y326TUG.8#F3Y2R6LUG.83F7Y3R6\UDN8+F0Y2*6BUDN
M8;D4X_8B5MR)6/$[',H<LD4Z*">QG,QR"LNI+*>QG,YR!LN9+&>QG,UR#LNY
M+.>QG,]R <N%+!>Q7,QR"<NE&+>7F#MM.\/^MATO+T?UKF=S%NW\3G@HYZ,\
M'R^$NW(^%<K\(7M<[9C6OQKGM]7A]&0+=E!.8CF9Y1264UE.8SF=Y8PM=]TY
MQK7?_&*RHUHL9[.<PW(NRWDLY[-<P'(ART4L%[-<PG(IQJU3\</B/L\K*:NR
MC[],\_)S?I-/)@MA-%_.:KZ9OWWZ:1UY=TUH_NN3^.Y#_<CV[A]_>:@STL[*
MS\5L(4SRN_JAI^\OS]\)9?'Y_ND?U?RA(87;>57-IZN;]WDVSLOF#O7O[^;S
M:ON/9H"O\_+WU>)]_+]02P,$%     @ M:2/6G=P?4/> P  BA(  !D   !X
M;"]W;W)K<VAE971S+W-H965T-#<N>&ULO5C;CMLV$/T50@V*!&A7-]M[J2U@
M+PEJH$Z-N&D?@CYPI;$EA"(5DK*S0#\^I"3KXLK<M2'LBRU2G,-S9LCAB-,=
MXU]%#"#1]Y10,;-B*;,;VQ9A#"D6%RP#JMZL&4^Q5$V^L47& 4>%44ILSW$F
M=HH3:@73HF_)@RG+)4DH+#D2>9IB_G0'A.UFEFOM.SXEFUCJ#CN89G@#*Y"?
MLR57+;M&B9(4J$@811S6,^O6O;EWK[1!,>+O!':B]8RTE$?&ONK&/)I9CF8$
M!$*I(;#ZV\(]$**1%(]O%:A5SZD-V\][] ^%>"7F$0NX9^2?))+QS+JR4 1K
MG!/YB>U^ATK06..%C(CB%^VJL8Z%PEQ(EE;&BD&:T/(??Z\<T3+P_2,&7F7@
M'1AXWA$#OS+P"Z$ELT+6 Y8XF'*V0UR/5FCZH?!-8:W4)%2'<26Y>ILH.QG,
MZ1:$5'&1:$[1^V]Y(I_0 F3,(E2^ Q#H5W0;18GV.R:JNUP].@IO'T#BA+Q#
M;U!"T5\QRP6FD9C:4G'3,]AAQ>.NY.$=X>%Z:,&HC 5Z3R.(N@"V$E4K\_;*
M[CPCX@.$%\AW?T&>XXW0Y]4#>OOF'6KT]G"\?SFBOT<T,/7K&/@%KG\$=Z7V
M9I030&S=&P'-5J O?R@S-)>0BG_[_%O.,>J?0V>#&Y'A$&:6VNX"^!:LX.>?
MW(GS6Y\C!@+KN&-4NV-D0@\^YNDC<.V,F)$HH1NUM!HW_&<.X5V)/2FP=0[;
M!J.IO6UK,\Y^IK9QK6ULU+9<+.?HRP*TPMXH&LU/C>) 8!VEDUKIY!46]61(
M=PP$UG''9>V.2V/@C[J@3W4)-6ZM8>=@#9M&=/A=U?RNS L3>*CHJ)-;!TPY
M8 V<0Z1.:IESBE3&1S(&%*H<S1DA>E>FQ2KNXU].==UF=^$=*##2.3,8U[78
MZQ/$<@C9%O@3"@E.4G&BUNL>K>,#K48V9VIUG>:$=TY0&S*A]ATFA(58J@!+
MAJ@ZR%\FMIJIK=8]T&HF<Z[85CGC&L4N;O\TYE>S^:D992BTKEBO$>N]0HZM
M)AG*)0.A=5W2E%*NL30Y+<]66*9$6PV9/)]IW::^<<T%3L4Q+3FVBQNVH\!%
MG&0HJS=M+_'1"[*.F<6YD6@J'==<ZBQ6S^S$04N=H="Z8IMBQWV-:L<=M-P9
M"JWKDJ;@<0>L>-SG2Q[CD"['INAQS57/ #NQK];YWTX<M-BQ6U_[*?!-<0DB
MU F>4UE^^->]]47+;7&]8#?#RUN:!>:;A I$8*U,G8M+Y5U>7GR4#<FRXN[@
MD4G)TN(Q!AP!UP/4^S5C<M_0$]373\$/4$L#!!0    ( +6DCUJ*/I]$/@0
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MO9- 6K"J":H&@A:Z+9A0(9L,_3B7?2,P%2#7IY2*MX'J-)I.-/P/4$L#!!0
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M'6BQ15E&E1W%"UN)S+C2=8UM+G7IB<(8Z.]SSM5#QTQ0%[/Q#U!+ P04
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MT<Q<?-56(FT#9>T>\XU$4QJXS])4;Z#L!#.^E1(?&W:!OA[,_@-02P,$%
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M, V/T/HVHT'B!J,=&#T+]J"8T*RMPR?9:#]Q-$V/X!Q&*8W<=,..;OB333:
MQ]R0WQ^QUVG FA32^%\7X["W?$A']/@D]JT& 3VQMZ,.<G0^A=*PTO:;MHP8
M+".L*2,NS%$/(*$T3HXP'59!G)Y(9MIQIF<YO[%RPYJ-OBZQXS.1@XLP[5W6
M"Q>BR\S!Z!_T,_LM\86I%1>:E+!$Q^!RB JJ[<_MQ,BZ:7$+:;!A-L,U?M*
ML@;X?BFE>9[8KME])&7_ U!+ P04    " "UI(]:Y&S)CV@#   +#@  &0
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M>[S6*J'?\(4[;5%_8%2G4'9CV-C43)].]COXOJ>*AMY(G?3F!&^UZVH+K:Y
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M6>LH:@3U'461, \)\Y&P  FC2!A#PC@(IBEX>E#P]#USQ2E2Y4B8AX3Y2%B
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M;,W=6W.C2(*&X;]">'LWIB-JRQ8ZV-5;Y8CJX@P)%5T].Q<3>X&EM$VT)-2
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MX?"%JRI6$_BXK,\T3ILB?SY/H*8.+FXT2XAJ-JHYJ.8VVF9QZ]N5C08$42U
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M-,X>%T"FP)2!G)]1*EX'ZL:FO*$;_P-02P,$%     @ M:2/6E M2O-A P
MB T  !D   !X;"]W;W)K<VAE971S+W-H965T-C@N>&ULM5==;],P%/TK5P$A
MD-CRT>_11AH=B$DK5"N#!\2#F]RV%HY=;+?=)'X\=I)F31L"G<K+:L?W'I]S
M?./=]#="_E +1 WW">-JX"RT7EZXKHH6F!!U+I;(S<I,R(1H,Y5S5RTEDCA-
M2I@;>%[;30CE3MA/GXUEV!<KS2C'L02U2A(B']XB$YN!XSO;![=TOM#V@1OV
MEV2.$]1WR[$T,[= B6F"7%'!0>)LX%SZ%T,_L EIQ!>*&[4S!BME*L0/.[F.
M!XYG&2'#2%L(8G[6.$3&+)+A\3,'=8H];>+N>(O^/A5OQ$R)PJ%@7VFL%P.G
MZT",,[)B^E9L/F NJ&7Q(L%4^A<V>:SG0+126B1YLF&04)[]DOO<B)T$O_F'
MA"!/"/XUH9$G-%*A&;-4UA71).Q+L0%IHPV:':3>I-E&#>7V&"=:FE5J\G3X
M4?!(<"T%,RMSN.8:)2H-9W 9Q]0Z39AYFM6+]?WE%6I"V2L3<3>Y@I?/7\%S
MH!P^+\1*$1ZKOJL-+XON1CF'MQF'X \<KC ZAX;_&@(O:%:D#_\]O5%.=XT;
MA25!84F0XC6.M.3;C0F$:XV)^EXE,D-M5J/:U_%"+4F$ \>\;PKE&IWPQ3._
M[;VIDGPBL)(!C<* 1AVZ->!LUP&:.U E.D-JI4CVREB'9T'0[?7,.:YW]1S&
M^7ZSW6GTBK@2U69!M5E+=73Y:33Y!+<8B37*![BY&<($)44%[S\,Q_!MA,D4
MY7?X!:/)N!RW7:N25;OKL6=Y(K"20:W"H-9_*>;6*0TX$5C)@'9A0+NV0L8H
M(^3:_$L",0,SHIIA#&:G&4II1A+U2G*8/@#?J_LDK8\J=[(M>SO5[)T'>Q5?
M2^N)HCN%Z$ZMZ'=;F1$C-%%&8UKWL'PTXRB]G0J]W3V]M8R>J+=;Z.T><<C5
MNH P)B*BK2NB^C+K'LCT]T36TGBBR%XALG>R:[EW<-TVFYZW)^8O0262OO?8
M4'BU-._&9T.XXU2KVANV'N78&^94:&7-.TV4_U]NV1SV5":<"*ULPF/;Y-<V
M)>%0)(EI$%?FZ 'OHP7AYG5<$[;"2NG!84=P4*'U.QZKR-UID^TWRHC(.>4*
M&,X,O'?>,61DUO9G$RV6:><\%=KTX>EP83Z54-H LSX30F\GMADO/K["WU!+
M P04    " "UI(]:J6M&05@$  "(&   &0   'AL+W=O<FMS:&5E=',O<VAE
M970V.2YX;6S-F=%NVS84AE^%T(JA!=)(M&S9SFP#KM2A&5+4B-?MHM@%(QU;
M1"11(VF[ ?;P(RE%MAQ'C5=BVTTL2CP_R8_D3QUELF/\7J0 $GW-LT),G53*
M\LIU19Q"3L0E*Z%03U:,YT2J(E^[HN1 $A.49V[/\P(W)[1P9A-S;\%G$[:1
M&2U@P9'8Y#GA#^\@8[NI@YW'&[=TG4I]PYU-2K*&)<C/Y8*KDMNH)#2'0E!6
M( ZKJ3/'5Q$.=("I\1N%G3BX1GHH=XS=Z\)U,G4\W2/(()9:@JB?+82095I)
M]>//6M1IVM2!A]>/ZC^;P:O!W!$!(<M^IXE,I\[(00FLR":3MVSW >H!#;1>
MS#)A_J)=7==S4+P1DN5UL.I!3HOJEWRM01P$X/XS ;TZH/?2 +\.\%\:T*\#
M^H9,-13#(2*2S":<[1#7M96:OC P3;0:/BWTO"\E5T^IBI.SD.4YE6HBI4"D
M2%#("DF+-10Q!8'>HGF24#U!)$/71;7,]'2]CD 2FKU1-3XO(_3ZU1OT"M$"
M_9JRC5 Z8N)*U3O=AAO7/7E7]:3W3$]^V627R!M>H)[7\T^$A]WA$<27R,<F
MO'\B/'IY^%'KKD+:<.TU7'M&SW]&[X8)<03SRXVJ@ZXEY.*/4W@JP?YI0;W_
MKT1)8I@Z:H,+X%MP9C_^@ /OIU.P;(I%EL1:(/T&I-^EKB9F!9Q#@F*6*[,3
MU?HCG!,%5J];Y3XQXXFJD5%R1S,J'T[1[6SE7+J5V,"(:6?=SKR)NSU$]K1&
M@(/QOE:+1;]AT>]D$9*"H0] ,IE>H)N;$'WY"/D=\)/+J5/JW ';%(LLB;40
M#AJ$ ]O[<F 3I$VQR))8"V30@ PZU^)\O>:P)A)0R:D"6:H3@N1L4\A3##NU
MSF48/-E; \\[WH"66FRQ&39LAMW[5!VJRJ3"C*C%-F]V*?H+?2J-?4F&%N1!
M'Y@A$2EB7%\N)8OOS2'\7K\5*4/;5ZN>'0B=906=O3V7ODVQR))8:Y9&S2R-
M;%O!R"9(FV*1);$6R'$#<OR=1[1(B6H642$VD)P"6S40'&QI'X_Z'FYOZK"S
M'^<BLR360H:]_7NW]Z^\U]3-M-\TAL=V&';WYEQTMM3:[ YR%OP/_76QX7&J
MTD T5Z>3P7B!WJ]68+)+1 1B*[2$4IH Y'OF?;]WH9_,5>VD,MU('VO_N6MW
M0SC7;:RJ1;;4V@M@GUQAZ]D5MII>656+;*FU:>XS+/R]*=8W_;MNX=# <6_L
M^?ZQ#=E,PR);:FUN^VP,?R,=>]:&'KU$V\(M"$FT+ZAZ-!>J'+,M\ ?S<"X$
M71>&<>-83PPK@KCVJ^K[!/Z?^I75C-.J6F1+K;U2]DDGMIYU8JMIIU6UR)9:
MF^8^\\3=J:<-OPJ>^M5H[ >C8[^RF;A&MM0J;N[!5U_]C?XCX6M:")3!2LE[
MET,U2[SZ[%T5)"O-A^ [)B7+S64*) &N*ZCG*\;D8T%_6V[^^3#[&U!+ P04
M    " "UI(]:=!Q2A $#   ["P  &0   'AL+W=O<FMS:&5E=',O<VAE970W
M,"YX;6S-5EU/XD 4_2LW7;/1A+6EY=.%)BHQ:R(;(ZL^&!^&]@(3IQUV9@KZ
M[W>F+;7%RFK"@R_0:<\Y<\^92[F#-1=/<H&HX#EBL1Q:"Z66)[8M@P5&1![S
M)<;ZR8R+B"B]%'-;+@62,"5%S'8=IV-'A,:6/TCO70M_P!/%:(S7 F02142\
MG"'CZZ'5M#8W;NA\H<P-VQ\LR1PGJ&Z7UT*O[$(EI!'&DO(8!,Z&UFGSY+QO
M\"G@CN):EJ[!.)ER_F06E^'0<DQ!R#!01H'HKQ6>(V-&2)?Q-]>TBBT-L7R]
M4;](O6LO4R+QG+-[&JK%T.I9$.*,)$S=\/4OS/VTC5[ F4P_89UC'0N"1"H>
MY61=043C[)L\YSF4",W6.P0W)[@?)7@YP4N-9I6EMD9$$7\@^!J$06LU<Y%F
MD[*U&QJ;4YPHH9]2S5/^!:$"[@A+$,9(9")0'Y&2\ ,FNF'"A"'P&5Q1,J6,
M*HIR PN!*"BQS9' #0:)$#2>PQF15,+A"!6A3!YIO5=LHX1[&&,T1?&H ;>3
M$1P>',$!T!C&E#%]S')@*^W2U&H'N:.SS)'[CJ,1!L?@-1O@.FZKAG[^<;I7
MI=LZVR)@MPC83?6\_P;<@%,I46=+XK ^49WA:S(&]9O'8BO2ARN] 5PJC.1C
M73A9-:WZ:LP[X40N28!#2__H)8H56O[W;\V.\[,NJCV)58+SBN"\7>K^!8U)
M'%#"*EF5.FY$9<"X2:X!?[@BK"Z.;(]VNH=YHZU\UVWW=%^LRC[?HCRG76 J
MY;>*\EL[R[_"%3+PZFK:2?SL$>U)K.*Q77AL?ZG>;N\SN#V)58+K%,%U=C;'
M" 5=$?,'!BP/ZZ7.<*;2*7=OL[G5NV\Q7K>^=;M%==T/M*Y;5]!.XF=/8$]B
M%8^]PF/O2[5N;Y_![4FL$ER_"*Z_LSGNB1 D5KO[ME_SUO6ZWE;GUJ ZO:W6
MM4NCC1DKQT3,:2R!X4RSG..NIHML5,L6BB_3:6?*E9Z=TLN%GFY1&(!^/N-<
M;19F@"KF9?\?4$L#!!0    ( +6DCUH=75^<W0(  /8&   9    >&PO=V]R
M:W-H965T<R]S:&5E=#<Q+GAM;)U5;4_;,!#^*Z<,32 Q\M:7B:61*-U$)9 0
MK.S#M ]N<FTL'#NSG1;^_6PG#66$3MJ7QF??/??<X^LYV0KYJ I$#4\EXVKB
M%5I7Y[ZOL@)+HLY$A=R<K(0LB3:F7/NJDDAR%U0R/PJ"D5\2RKTT<7NW,DU$
MK1GE>"M!U65)Y/,4F=A.O-#;;=S1=:'MAI\F%5GC/>I%=2N-Y7<H.2V1*RHX
M2%Q-O(OP?#JV_L[A@>)6[:W!5K(4XM$:\WSB!980,LRT12#FL\%+9,P"&1J_
M6TRO2VD#]]<[]&^N=E/+DBB\%.P'S74Q\3Y[D..*U$S?B>T5MO4,+5XFF'*_
ML&U] P^R6FE1ML&&04EY\R5/K0Y[ 5'T3D#4!D2.=Y/(L9P13=)$BBU(ZVW0
M[,*5ZJ(-.<KMI=QK:4ZIB=/I-T(E/!!6(]P@4;5$H[A6\ G>.]E275 .NL!]
MERN*DLBL> :Q@AE*NB%6;KBF9$D9U105+!3E:[C&#3*(8<ZKVL =SU 3RM2)
M2;D[.@*3X'LA:D5XKA)?FT(M73]KBYHV147O%!5&<".X+A1\Y3GFKP%\HU G
M4[23:1H=1)QA=@9Q> I1$ U@<3^#XZ.3 [AQ)W_L<.-_RG_Z2JI6\1Q,X]YA
M5DMII9L21=4I++A8*I0;LF38R&A]!,],-'&]_O/:Y(&YQE+]ZI.O(37H)V7G
MP+FJ2(83S_S1;2;TTH\?PE'PY4#)@Z[DP2'T=$H8X1D"T:9/,BR7*'?*QGU<
M&[2A0[,C9I/&X\3?]# 8=@R&!QE<%H2OT?;8RLJ_<0ULVC9_:5O6WL5S'Z,&
M?;3'*!R%_91&':7104ISI6JGBJ'!A<:^M*.W:>/^K.,NZ_A_KV+0QV#\YBJB
M\._"_;U95*)<NXFK(!,UU\U8ZG:[H7[1S+(7]^9%N"%R3;D"ABL3&IR-36;9
M3-G&T*)RDVTIM)F3;EF8APFE=3#G*V&D; V;H'OJTC]02P,$%     @ M:2/
M6JS3Z<-K P  5P\  !D   !X;"]W;W)K<VAE971S+W-H965T-S(N>&ULQ5=M
M:]LP$/XKPH.QP1:_Y:7MDD";;JRP0FFW[L/8!\6^)"*6Y4IRTO[[G63'B3O'
MM&#HET22[QX]S^EDWXVW0J[5"D"31YZD:N*LM,[.7%=%*^!4]40&*3Y9",FI
MQJE<NBJ30&/KQ!,W\+RARRE+G>G8KMW(Z5CD.F$IW$BB<LZI?+J 1&PGCN_L
M%F[9<J7-@CL=9W0)=Z!_93<29VZ%$C,.J6(B)1(6$^?</YOY?>-@+>X9;-7!
MF!@I<R'69G(53QS/,(($(FT@*/YM8 9)8I"0QT,)ZE1[&L?#\0[]FQ6/8N94
MP4PDOUFL5Q/GQ"$Q+&B>Z%NQ_0ZEH('!BT2B["_9EK:>0Z)<:<%+9V3 65K\
MT\<R$ <._O"(0U Z!"]U"$N'T HMF%E9EU33Z5B*+9'&&M',P,;&>J,:EIIC
MO-,2GS+TT]-OE$ER3Y,<R#50E4O ,]**?"9?^1SB&&)R"9)MJ(DV^<'HG"5,
M/UD7:@_B7&$*9&:HR(=+T)0EZN/8U4C.;.%&)9&+@DAPA(@?D&N1ZI4B7U/<
MM0[@HJI*6K"3=A&T(EY"U".A_XD$7M!O(#1[N7O80B>L(AU:O/X1O!O)(B!B
M06:"<XS;G1;1NBE.K3#F6I^IC$8P<?#>*I ;<*;OW_E#[TN3QH[ :HK[E>*^
M10]?E5OD*LURS#":Q@=9]!.B5<H><E#DSP_$(5<:N/K;%)]^E_'I"*P6GT$5
MGT%K1E0W+-[?L&1WPYJ4%W#X2C)XY@6]F0:]8#1V-X>2&JP&P]YH4)G5R XK
MLL-6LO<B08;'F+7ZOO9,.@*KR1Q5,D=OD;.C+N/3$5@M/B=5?$ZZS=F3_[/1
MZPV?I6RC4;\Y84\KIJ>M3*^I7&,9=,O4FMS9$J>)7BO&:P^F([":7-_;?\F]
MMTC=<M>.0M056CU&!]6.WVWZEGB^7TM-[W3P/(6;#?T@'#6GL1_L.0?MG!\S
MK'F1\T^0O)%CJ_^K3Z@CM+K:?97DAV^2Q9U655VAU6.TKZO\UK*D/8N)/I8F
M[:"GA-OZNU%ONZM/GH!*$C8B%!K=@Q:%@US:SDV12.2I+DKZ:K7H#B],=VA:
MG&?KV#6>VU[)W<,4+2>^\)<,FY $%@CI8<7C$%ET<<5$B\PV0G.AL:VRPQ5^
M%D : WR^$$+O)F:#JI>>_@-02P,$%     @ M:2/6A@IRW.U$   @=L  !D
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MN_V)1'W%)!HE83(M*Y!?[^-H44TZJN/N-@W+(1<VL(^A<V:AA2)4HU"-0;4
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MI9FYTY7:R%ZI?<RBZ5<9Q^0_\IGPY%%%L)I"-"<3K8F$EFU0S8=J%*HQJ!9
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MGP!!<PQ0-%N -LL0N-,,5:R;'1'K(+?Y<U : :5%4#1;F38)$8Q/(]:!9BY
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MD@G30/^^XEP]GY@.FF+MZ?]02P,$%     @ M:2/6KIK\0H; P  J@L  !D
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M;[Y@&4_?\ 4\EOD7-J6M8T&02<63$JP]2"@K_N2AU&$'X Y> '@EP'L*Z+T
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M^9\B$35?6657Z49]89MZ'PZ]D +5-%334<U -1/5+%2S4<U!-1?5/%3S42U
MM1#5(E2+42VAM&&&]\6]YB%Z85OG47E,:AJJZ:AFH)J):A:JV:CFH)J+:AZJ
M^:@6H%J(:A&JQ:B64-HPC_OBWJFZN'=>;+?9[F9#8E5L-FDMRW0SFL.+)Y>N
M/;,^B'K$@S,6+>6AFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!:C6D)IPXSM
M2WFG_]&J=:=/E_,Z&UO.ZUP]S,'!BK;D4,U -1/5+%2S4<U!-1?5/%3S42U
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MHJCO/SAJ_&]%^>MNC __#U!+ P04    " "UI(]:;.U!>&$#  "R%@  #0
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MC3B".0 /&!)%YCZX=3\*FOM4L/XO]>@/4$L#!!0    ( +6DCUJ7BKL<P
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MM(=K2!EEH8S90L.8_WH(8U(6RI@M=+SVWL)B3,I"V:FV&G2W'F.2FZ!/L.$
M/9P8D[)0]M)[#XXF<AEEH:RUT+@]V;U[6ZB5-JKX A_AH#V793ZW(OQI=\)%
M<1)VPZV:LKR&MJ_F4RV+_:]B]K_H>?</4$L#!!0    ( +6DCUJ[2=+?8@(
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M_KK\.HDXKZXXU_<5P_-?4$L#!!0    ( +6DCUK=)VL+& (  (4M   3
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MQ\_/>G#=^)+/YG]?7_\&4$L! A0#%     @ M:2/6D;'34B5    S0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "U
MI(]: ^>[,/,    K @  $0              @ '#    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " "UI(]:F5R<(Q &  "<)P  $P
M@ 'E 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( +6DCUH1F+ >
M0PL  *%.   8              " @28(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " "UI(]:)4S>'*T'   8(P  &
M@(&?$P  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ M:2/
M6BG/K:P*!   00\  !@              ("!@AL  'AL+W=O<FMS:&5E=',O
M<VAE970S+GAM;%!+ 0(4 Q0    ( +6DCUK4UW]X]@<  & A   8
M      " @<(?  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M" "UI(]:9OG$!Z<#  #)#   &               @('N)P  >&PO=V]R:W-H
M965T<R]S:&5E=#4N>&UL4$L! A0#%     @ M:2/6O9D"UKF!0  M"   !@
M             ("!RRL  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4
M Q0    ( +6DCUKOCBL"V@D  $LO   8              " @><Q  !X;"]W
M;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "UI(]:AN6]N2,5  !Z
M7   &               @('W.P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL
M4$L! A0#%     @ M:2/6EH\3JY/ @  I04  !@              ("!4%$
M 'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( +6DCUHL=6B^
M0P(  (H&   9              " @=53  !X;"]W;W)K<VAE971S+W-H965T
M,3 N>&UL4$L! A0#%     @ M:2/6CRE,S@1 @  W00  !D
M ("!3U8  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "U
MI(]:/\/O^&X;   Z5   &0              @(&76   >&PO=V]R:W-H965T
M<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( +6DCUI#^L(/ R0  "-T   9
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M970Q-RYX;6Q02P$"% ,4    " "UI(]:,5:I/38'   ^$@  &0
M    @($TP   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (
M +6DCUJ$^!<K. <  "X3   9              " @:''  !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&UL4$L! A0#%     @ M:2/6@6:,(!['P  8V@  !D
M             ("!$,\  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"
M% ,4    " "UI(]:>^6+=0\(   K%   &0              @('"[@  >&PO
M=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( +6DCUI4H2GV, 4
M "H,   9              " @0CW  !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&UL4$L! A0#%     @ M:2/6I2!K0ZQ#0  )B,  !D              ("!
M;_P  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "UI(]:
MLAR"WBL$  "^"0  &0              @(%7"@$ >&PO=V]R:W-H965T<R]S
M:&5E=#(T+GAM;%!+ 0(4 Q0    ( +6DCUI&>C$1N0X  %DO   9
M      " @;D. 0!X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%
M  @ M:2/6EC$VGM"!@  -PX  !D              ("!J1T! 'AL+W=O<FMS
M:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " "UI(]:,\#;0$X%   9#P
M&0              @($B) $ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+
M 0(4 Q0    ( +6DCUJ^SEB$> @  "D6   9              " @:<I 0!X
M;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ M:2/6HV36V>>
M%@  OD(  !D              ("!5C(! 'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6Q02P$"% ,4    " "UI(]:UYM/,R E  !.?P  &0
M@($K20$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( +6D
MCUK!-I;<WP(  #\&   9              " @8)N 0!X;"]W;W)K<VAE971S
M+W-H965T,S$N>&UL4$L! A0#%     @ M:2/6@9528X# P  CP8  !D
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M=#,V+GAM;%!+ 0(4 Q0    ( +6DCUI8W@KOFP(  +L%   9
M  " @6.$ 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @
MM:2/6E38:M#P P  Z@D  !D              ("!-8<! 'AL+W=O<FMS:&5E
M=',O<VAE970S."YX;6Q02P$"% ,4    " "UI(]:!%5-I1X$  !\"   &0
M            @(%<BP$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4
M Q0    ( +6DCUH"]^*@9@,   H(   9              " @;&/ 0!X;"]W
M;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ M:2/6DEW\<3*!@
M)S$  !D              ("!3I,! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX
M;6Q02P$"% ,4    " "UI(]:?KQ=PI0"  "M!@  &0              @(%/
MF@$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( +6DCUJX
MNX?EPQD  )+N 0 9              " @1J= 0!X;"]W;W)K<VAE971S+W-H
M965T-#,N>&UL4$L! A0#%     @ M:2/6FU%>I,O!P  /B@  !D
M     ("!%+<! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +6DCUKN85UMJ0,  &81   9              "
M@:/[ 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ M:2/
M6B!A7*UX @  WP4  !D              ("!@_\! 'AL+W=O<FMS:&5E=',O
M<VAE970U,"YX;6Q02P$"% ,4    " "UI(]:9^RF!(\%  #P)   &0
M        @($R @( >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0
M   ( +6DCUIR1JR]Q0(  "4(   9              " @?@' @!X;"]W;W)K
M<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ M:2/6H$-H%#L @  E0H
M !D              ("!] H" 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q0
M2P$"% ,4    " "UI(]:V!>Y?N(#  !D$   &0              @($7#@(
M>&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( +6DCUIR>EA(
MQ ,  -@.   9              " @3 2 @!X;"]W;W)K<VAE971S+W-H965T
M-34N>&UL4$L! A0#%     @ M:2/6E>E*[]. P  &PH  !D
M ("!*Q8" 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " "U
MI(]:JLST!S<#   P"0  &0              @(&P&0( >&PO=V]R:W-H965T
M<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( +6DCUKD;,F/: ,   L.   9
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M970V,BYX;6Q02P$"% ,4    " "UI(]:.0ZG7J@0  !7_P  &0
M    @(%Q2@( >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    (
M +6DCUJRQO/L5@4  *DM   9              " @5!; @!X;"]W;W)K<VAE
M971S+W-H965T-C0N>&UL4$L! A0#%     @ M:2/6E8XP@^V @  EP8  !D
M             ("!W6 " 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"
M% ,4    " "UI(]:X%B] $8#  !$"P  &0              @('*8P( >&PO
M=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( +6DCUJ5&"BZA@,
M *T3   9              " @4=G @!X;"]W;W)K<VAE971S+W-H965T-C<N
M>&UL4$L! A0#%     @ M:2/6E M2O-A P  B T  !D              ("!
M!&L" 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " "UI(]:
MJ6M&05@$  "(&   &0              @(&<;@( >&PO=V]R:W-H965T<R]S
M:&5E=#8Y+GAM;%!+ 0(4 Q0    ( +6DCUIT'%*$ 0,  #L+   9
M      " @2MS @!X;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%
M  @ M:2/6AU=7YS= @  ]@8  !D              ("!8W8" 'AL+W=O<FMS
M:&5E=',O<VAE970W,2YX;6Q02P$"% ,4    " "UI(]:K-/IPVL#  !7#P
M&0              @(%W>0( >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+
M 0(4 Q0    ( +6DCUH8*<MSM1   (';   9              " @1E] @!X
M;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @ M:2/6II]M6\G
M P  T@<  !D              ("!!8X" 'AL+W=O<FMS:&5E=',O<VAE970W
M-"YX;6Q02P$"% ,4    " "UI(]:^0%-D-\$  ##$   &0
M@(%CD0( >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( +6D
MCUH@@6N"D00  "P2   9              " @7F6 @!X;"]W;W)K<VAE971S
M+W-H965T-S8N>&UL4$L! A0#%     @ M:2/6A;J85BJ!0  N"T  !D
M         ("!09L" 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"% ,4
M    " "UI(]:NFOQ"AL#  "J"P  &0              @($BH0( >&PO=V]R
M:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( +6DCUH/7FO_4B   +)/
M @ 9              " @72D @!X;"]W;W)K<VAE971S+W-H965T-SDN>&UL
M4$L! A0#%     @ M:2/6FSM07AA P  LA8   T              ( !_<0"
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "UI(]:EXJ[',     3 @  "P
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52P4&     %< 5P#8%P  =-0"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>318</ContextCount>
  <ElementCount>430</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>108</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040 - Statement - Condensed Consolidated Statements of Operations (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050 - Statement - Consolidated Statements of Changes in Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity</Role>
      <ShortName>Consolidated Statements of Changes in Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070 - Disclosure - Cyber Security Risk Management, Strategy, and Governance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance</Role>
      <ShortName>Cyber Security Risk Management, Strategy, and Governance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995457 - Disclosure - Description of the Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness1</Role>
      <ShortName>Description of the Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995467 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995477 - Disclosure - Material Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreements</Role>
      <ShortName>Material Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995487 - Disclosure - Investment In Equity Method Investees</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvestees</Role>
      <ShortName>Investment In Equity Method Investees</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995497 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995507 - Disclosure - Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNet4</Role>
      <ShortName>Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995517 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995527 - Disclosure - Variable Interest Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntities</Role>
      <ShortName>Variable Interest Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995537 - Disclosure - Claims Financing Obligations and Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayable</Role>
      <ShortName>Claims Financing Obligations and Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995547 - Disclosure - Warrant Liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiability1</Role>
      <ShortName>Warrant Liability</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995557 - Disclosure - Noncontrolling Interest</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterest1</Role>
      <ShortName>Noncontrolling Interest</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995567 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995577 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995587 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995607 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995617 - Disclosure - Net Loss Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShare1</Role>
      <ShortName>Net Loss Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995627 - Disclosure - Derivative Liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiability</Role>
      <ShortName>Derivative Liability</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995637 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEvents1</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995647 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995657 - Disclosure - Basis of Presentaton and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentatonAndSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentaton and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995667 - Disclosure - Investment In Equity Method Investees (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesTables</Role>
      <ShortName>Investment In Equity Method Investees (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvestees</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995677 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNet</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995687 - Disclosure - Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables</Role>
      <ShortName>Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNet4</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995697 - Disclosure - Income Tax (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxTables</Role>
      <ShortName>Income Tax (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTax</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995707 - Disclosure - Warrant Liability (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityTables</Role>
      <ShortName>Warrant Liability (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiability1</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995717 - Disclosure - Noncontrolling Interest (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestTables</Role>
      <ShortName>Noncontrolling Interest (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterest1</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995727 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurements</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995737 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformation</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995747 - Disclosure - Net Loss Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareTables</Role>
      <ShortName>Net Loss Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShare1</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995757 - Disclosure - Description of the Business - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail</Role>
      <ShortName>Description of the Business - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995767 - Disclosure - Description of the Business - 2024 Reverse Stock Split - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness2024ReverseStockSplitAdditionalInformationDetail</Role>
      <ShortName>Description of the Business - 2024 Reverse Stock Split - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995777 - Disclosure - Description of the Business - Going Concern - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail</Role>
      <ShortName>Description of the Business - Going Concern - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995787 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995797 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Summary of Depreciation and Amortization on Property and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Summary of Depreciation and Amortization on Property and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995807 - Disclosure - Material Agreements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail</Role>
      <ShortName>Material Agreements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995817 - Disclosure - Investment In Equity Method Investees - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail</Role>
      <ShortName>Investment In Equity Method Investees - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995827 - Disclosure - Investment In Equity Method Investees  - Summary of Financial Information For Equity Accounted Investees (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail</Role>
      <ShortName>Investment In Equity Method Investees  - Summary of Financial Information For Equity Accounted Investees (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995837 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail</Role>
      <ShortName>Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995847 - Disclosure - Property and Equipment, Net - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetail</Role>
      <ShortName>Property and Equipment, Net - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995857 - Disclosure - Intangible Assets, Net - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail</Role>
      <ShortName>Intangible Assets, Net - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995867 - Disclosure - Intangible Assets, Net - Summary of Intangible Assets Net (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail</Role>
      <ShortName>Intangible Assets, Net - Summary of Intangible Assets Net (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>995877 - Disclosure - Intangible Assets, Net - Schedule of Expected Future Amortization Expense of Intangible Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail</Role>
      <ShortName>Intangible Assets, Net - Schedule of Expected Future Amortization Expense of Intangible Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>995887 - Disclosure - Intangible Assets, Net - Summary of Changes in the Company's Intangibles Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail</Role>
      <ShortName>Intangible Assets, Net - Summary of Changes in the Company's Intangibles Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>995897 - Disclosure - Income Tax - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail</Role>
      <ShortName>Income Tax - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>995907 - Disclosure - Income Tax - Schedule of Reconciliation Statutory Income Tax Rate to the Company's Effective Tax Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail</Role>
      <ShortName>Income Tax - Schedule of Reconciliation Statutory Income Tax Rate to the Company's Effective Tax Rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>995917 - Disclosure - Income Tax - Schedule of Company's Deferred Tax Assets and Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail</Role>
      <ShortName>Income Tax - Schedule of Company's Deferred Tax Assets and Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>995927 - Disclosure - Variable Interest Entities - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail</Role>
      <ShortName>Variable Interest Entities - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>995937 - Disclosure - Claims Financing Obligations and Notes Payable - Additional Information (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail</Role>
      <ShortName>Claims Financing Obligations and Notes Payable - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>995947 - Disclosure - Claims Financing Obligations and Notes Payable - Brickell Key Investments, LP - Additional Information (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail</Role>
      <ShortName>Claims Financing Obligations and Notes Payable - Brickell Key Investments, LP - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>995957 - Disclosure - Claims Financing Obligations and Notes Payable - Hazel Working Capital Credit Facility and Purchase Money Loan - Additional Information (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail</Role>
      <ShortName>Claims Financing Obligations and Notes Payable - Hazel Working Capital Credit Facility and Purchase Money Loan - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>995967 - Disclosure - Claims Financing Obligations and Notes Payable - Nomura Promissory Note - Additional Information (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail</Role>
      <ShortName>Claims Financing Obligations and Notes Payable - Nomura Promissory Note - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>995977 - Disclosure - Claims Financing Obligations and Notes Payable - Yorkville Standby Equity Purchase Agreement - Additional Information (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail</Role>
      <ShortName>Claims Financing Obligations and Notes Payable - Yorkville Standby Equity Purchase Agreement - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>995987 - Disclosure - Warrant Liability - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail</Role>
      <ShortName>Warrant Liability - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>995997 - Disclosure - Warrant Liability - Schedule of Roll-forward of the Warrant Liability (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail</Role>
      <ShortName>Warrant Liability - Schedule of Roll-forward of the Warrant Liability (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>996007 - Disclosure - Warrant Liability - Summary of Activity of Shares Underlying Warrants (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilitySummaryOfActivityOfSharesUnderlyingWarrantsDetail</Role>
      <ShortName>Warrant Liability - Summary of Activity of Shares Underlying Warrants (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>996017 - Disclosure - Noncontrolling Interest - Summary of Ownership Units (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail</Role>
      <ShortName>Noncontrolling Interest - Summary of Ownership Units (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>996027 - Disclosure - Noncontrolling Interest - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail</Role>
      <ShortName>Noncontrolling Interest - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>996037 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>996047 - Disclosure - Fair Value Measurements - Schedule of Liabilities Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Liabilities Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>996057 - Disclosure - Fair Value Measurements - Fair Value Measurements within the Fair Value Hierarchy of Derivative Liabilities Using Level 3 Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value Measurements within the Fair Value Hierarchy of Derivative Liabilities Using Level 3 Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>996067 - Disclosure - Fair Value Measurements - Embedded Derivative Liability Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails</Role>
      <ShortName>Fair Value Measurements - Embedded Derivative Liability Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>996077 - Disclosure - Related Party Transactions - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail</Role>
      <ShortName>Related Party Transactions - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>996097 - Disclosure - Segment Information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetail</Role>
      <ShortName>Segment Information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>996107 - Disclosure - Segment Information - Schedule of Other Segment Items (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails</Role>
      <ShortName>Segment Information - Schedule of Other Segment Items (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>996117 - Disclosure - Net Loss Per Common Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail</Role>
      <ShortName>Net Loss Per Common Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>996127 - Disclosure - Net Loss Per Common Share - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail</Role>
      <ShortName>Net Loss Per Common Share - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>996137 - Disclosure - Derivative Liability - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail</Role>
      <ShortName>Derivative Liability - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="mspr-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>996147 - Disclosure - Subsequent Events - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail</Role>
      <ShortName>Subsequent Events - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="mspr-20241231.htm">mspr-20241231.htm</File>
    <File>mspr-20241231.xsd</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img214770500_0.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="624">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="48">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>106
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "mspr-20241231.htm": {
   "nsprefix": "mspr",
   "nsuri": "http://investor.msprecovery.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "mspr-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "mspr-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 274,
   "keyCustom": 156,
   "axisStandard": 32,
   "axisCustom": 2,
   "memberStandard": 30,
   "memberCustom": 71,
   "hidden": {
    "total": 24,
    "http://fasb.org/us-gaap/2024": 16,
    "http://xbrl.sec.gov/dei/2024": 7,
    "http://investor.msprecovery.com/20241231": 1
   },
   "contextCount": 318,
   "entityCount": 1,
   "segmentCount": 108,
   "elementCount": 850,
   "unitCount": 9,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 624,
    "http://xbrl.sec.gov/dei/2024": 48,
    "http://xbrl.sec.gov/cyd/2024": 15,
    "http://xbrl.sec.gov/ecd/2024": 5
   },
   "report": {
    "R1": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage",
     "longName": "100000 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
     "longName": "100010 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:Cash",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
     "longName": "100020 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_ea41718c-eb03-4364-a84c-37e5f43f1623",
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-8",
      "ancestors": [
       "span",
       "link:footnote",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations",
     "longName": "100030 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:ClaimsRecoveryIncome",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:ClaimsRecoveryIncome",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical",
     "longName": "100040 - Statement - Condensed Consolidated Statements of Operations (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Operations (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_e08e59d5-f389-4d0e-a508-50ce01da96aa",
      "name": "mspr:ClaimsRecoveryServiceIncome",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fe25ee78-67ec-4d53-967e-ac07893f4a6e",
      "name": "us-gaap:OperatingCostsAndExpenses",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "link:footnote",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity",
     "longName": "100050 - Statement - Consolidated Statements of Changes in Equity",
     "shortName": "Consolidated Statements of Changes in Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_8dbd5799-d76e-43f3-b963-830f8fd31b2e",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8dbd5799-d76e-43f3-b963-830f8fd31b2e",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
     "longName": "100060 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance",
     "longName": "100070 - Disclosure - Cyber Security Risk Management, Strategy, and Governance",
     "shortName": "Cyber Security Risk Management, Strategy, and Governance",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R10": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_6fc20ca9-1ab2-42c7-8e99-0cc58496a91f",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6fc20ca9-1ab2-42c7-8e99-0cc58496a91f",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness1",
     "longName": "995457 - Disclosure - Description of the Business",
     "shortName": "Description of the Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies",
     "longName": "995467 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreements",
     "longName": "995477 - Disclosure - Material Agreements",
     "shortName": "Material Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:MaterialAgreementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:MaterialAgreementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvestees",
     "longName": "995487 - Disclosure - Investment In Equity Method Investees",
     "shortName": "Investment In Equity Method Investees",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNet",
     "longName": "995497 - Disclosure - Property and Equipment, Net",
     "shortName": "Property and Equipment, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNet4",
     "longName": "995507 - Disclosure - Intangible Assets, Net",
     "shortName": "Intangible Assets, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTax",
     "longName": "995517 - Disclosure - Income Tax",
     "shortName": "Income Tax",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntities",
     "longName": "995527 - Disclosure - Variable Interest Entities",
     "shortName": "Variable Interest Entities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayable",
     "longName": "995537 - Disclosure - Claims Financing Obligations and Notes Payable",
     "shortName": "Claims Financing Obligations and Notes Payable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiability1",
     "longName": "995547 - Disclosure - Warrant Liability",
     "shortName": "Warrant Liability",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:WarrantLiabilityTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:WarrantLiabilityTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterest1",
     "longName": "995557 - Disclosure - Noncontrolling Interest",
     "shortName": "Noncontrolling Interest",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/CommitmentsAndContingencies",
     "longName": "995567 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurements",
     "longName": "995577 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactions",
     "longName": "995587 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformation",
     "longName": "995607 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShare1",
     "longName": "995617 - Disclosure - Net Loss Per Common Share",
     "shortName": "Net Loss Per Common Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiability",
     "longName": "995627 - Disclosure - Derivative Liability",
     "shortName": "Derivative Liability",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEvents1",
     "longName": "995637 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "995647 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentatonAndSummaryOfSignificantAccountingPoliciesTables",
     "longName": "995657 - Disclosure - Basis of Presentaton and Summary of Significant Accounting Policies (Tables)",
     "shortName": "Basis of Presentaton and Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesTables",
     "longName": "995667 - Disclosure - Investment In Equity Method Investees (Tables)",
     "shortName": "Investment In Equity Method Investees (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables",
     "longName": "995677 - Disclosure - Property and Equipment, Net (Tables)",
     "shortName": "Property and Equipment, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables",
     "longName": "995687 - Disclosure - Intangible Assets, Net (Tables)",
     "shortName": "Intangible Assets, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxTables",
     "longName": "995697 - Disclosure - Income Tax (Tables)",
     "shortName": "Income Tax (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityTables",
     "longName": "995707 - Disclosure - Warrant Liability (Tables)",
     "shortName": "Warrant Liability (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestTables",
     "longName": "995717 - Disclosure - Noncontrolling Interest (Tables)",
     "shortName": "Noncontrolling Interest (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:ScheduleOfOwnershipInterestsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:ScheduleOfOwnershipInterestsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables",
     "longName": "995727 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationTables",
     "longName": "995737 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareTables",
     "longName": "995747 - Disclosure - Net Loss Per Common Share (Tables)",
     "shortName": "Net Loss Per Common Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail",
     "longName": "995757 - Disclosure - Description of the Business - Additional Information (Detail)",
     "shortName": "Description of the Business - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:IncreaseInTaxReceivableAgreementLiability",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness2024ReverseStockSplitAdditionalInformationDetail",
     "longName": "995767 - Disclosure - Description of the Business - 2024 Reverse Stock Split - Additional Information (Detail)",
     "shortName": "Description of the Business - 2024 Reverse Stock Split - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_9565635a-4edf-48eb-b58e-a592cc2a6e49",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_9565635a-4edf-48eb-b58e-a592cc2a6e49",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
     "longName": "995777 - Disclosure - Description of the Business - Going Concern - Additional Information (Detail)",
     "shortName": "Description of the Business - Going Concern - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:Cash",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a9bac2b3-ff72-451c-87fe-ebf2bc6938a2",
      "name": "mspr:NumberOfTranches",
      "unitRef": "U_Tranche",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
     "longName": "995787 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:SegmentReportingExpenseInformationUsedByCodmDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail",
     "longName": "995797 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Summary of Depreciation and Amortization on Property and Equipment (Detail)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Summary of Depreciation and Amortization on Property and Equipment (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_66d1760e-3b4b-4a44-adcc-7a80bfabd72f",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "mspr:DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_66d1760e-3b4b-4a44-adcc-7a80bfabd72f",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "mspr:DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
     "longName": "995807 - Disclosure - Material Agreements - Additional Information (Detail)",
     "shortName": "Material Agreements - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:VRMFullPaymentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail",
     "longName": "995817 - Disclosure - Investment In Equity Method Investees - Additional Information (Detail)",
     "shortName": "Investment In Equity Method Investees - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "mspr:NumberOfHoldingInvestments",
      "unitRef": "U_Investment",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "mspr:NumberOfHoldingInvestments",
      "unitRef": "U_Investment",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail",
     "longName": "995827 - Disclosure - Investment In Equity Method Investees  - Summary of Financial Information For Equity Accounted Investees (Detail)",
     "shortName": "Investment In Equity Method Investees  - Summary of Financial Information For Equity Accounted Investees (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1fc207a6-b212-4da0-b588-3744dd9baaf9",
      "name": "us-gaap:Revenues",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "mspr:DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail",
     "longName": "995837 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail)",
     "shortName": "Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetail",
     "longName": "995847 - Disclosure - Property and Equipment, Net - Additional Information (Detail)",
     "shortName": "Property and Equipment, Net - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R51": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail",
     "longName": "995857 - Disclosure - Intangible Assets, Net - Additional Information (Detail)",
     "shortName": "Intangible Assets, Net - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsFinitelived",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail",
     "longName": "995867 - Disclosure - Intangible Assets, Net - Summary of Intangible Assets Net (Detail)",
     "shortName": "Intangible Assets, Net - Summary of Intangible Assets Net (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_d28da71e-2163-4433-89d2-79d811cad1b5",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_d28da71e-2163-4433-89d2-79d811cad1b5",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail",
     "longName": "995877 - Disclosure - Intangible Assets, Net - Schedule of Expected Future Amortization Expense of Intangible Assets (Detail)",
     "shortName": "Intangible Assets, Net - Schedule of Expected Future Amortization Expense of Intangible Assets (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_d28da71e-2163-4433-89d2-79d811cad1b5",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_d28da71e-2163-4433-89d2-79d811cad1b5",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail",
     "longName": "995887 - Disclosure - Intangible Assets, Net - Summary of Changes in the Company's Intangibles Assets (Detail)",
     "shortName": "Intangible Assets, Net - Summary of Changes in the Company's Intangibles Assets (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsFinitelived",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_4a8604ad-e380-417e-aa2c-4c0e29ad2d19",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail",
     "longName": "995897 - Disclosure - Income Tax - Additional Information (Detail)",
     "shortName": "Income Tax - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail",
     "longName": "995907 - Disclosure - Income Tax - Schedule of Reconciliation Statutory Income Tax Rate to the Company's Effective Tax Rate (Detail)",
     "shortName": "Income Tax - Schedule of Reconciliation Statutory Income Tax Rate to the Company's Effective Tax Rate (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail",
     "longName": "995917 - Disclosure - Income Tax - Schedule of Company's Deferred Tax Assets and Liabilities (Detail)",
     "shortName": "Income Tax - Schedule of Company's Deferred Tax Assets and Liabilities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail",
     "longName": "995927 - Disclosure - Variable Interest Entities - Additional Information (Detail)",
     "shortName": "Variable Interest Entities - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:Assets",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_ea41718c-eb03-4364-a84c-37e5f43f1623",
      "name": "us-gaap:Assets",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-8",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
     "longName": "995937 - Disclosure - Claims Financing Obligations and Notes Payable - Additional Information (Detail)",
     "shortName": "Claims Financing Obligations and Notes Payable - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "C_9f487c5a-0b48-49d0-b043-d8a27a0e661f",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c9b18bd8-324c-46e3-8afa-33926f895ed8",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
     "longName": "995947 - Disclosure - Claims Financing Obligations and Notes Payable - Brickell Key Investments, LP - Additional Information (Detail)",
     "shortName": "Claims Financing Obligations and Notes Payable - Brickell Key Investments, LP - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c30ed3e6-e67a-4d09-9360-8226e3fc395c",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
     "longName": "995957 - Disclosure - Claims Financing Obligations and Notes Payable - Hazel Working Capital Credit Facility and Purchase Money Loan - Additional Information (Detail)",
     "shortName": "Claims Financing Obligations and Notes Payable - Hazel Working Capital Credit Facility and Purchase Money Loan - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:AgreementDate",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e0dfe751-c423-4c59-83cb-f45bf2e04763",
      "name": "mspr:PurchaseMoneyLoanAccruesInterest",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
     "longName": "995967 - Disclosure - Claims Financing Obligations and Notes Payable - Nomura Promissory Note - Additional Information (Detail)",
     "shortName": "Claims Financing Obligations and Notes Payable - Nomura Promissory Note - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "C_9f487c5a-0b48-49d0-b043-d8a27a0e661f",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R63": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
     "longName": "995977 - Disclosure - Claims Financing Obligations and Notes Payable - Yorkville Standby Equity Purchase Agreement - Additional Information (Detail)",
     "shortName": "Claims Financing Obligations and Notes Payable - Yorkville Standby Equity Purchase Agreement - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_71aa315c-44f8-4147-b3c3-c4ea2d43f242",
      "name": "us-gaap:ProceedsFromIssuanceOfDebt",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-4",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail",
     "longName": "995987 - Disclosure - Warrant Liability - Additional Information (Detail)",
     "shortName": "Warrant Liability - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_90ec9698-713b-426c-b0bb-0ec128980a66",
      "name": "mspr:ClassOfNewWarrantOrRightTransferredDuringPeriod",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "mspr:WarrantLiabilityTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail",
     "longName": "995997 - Disclosure - Warrant Liability - Schedule of Roll-forward of the Warrant Liability (Detail)",
     "shortName": "Warrant Liability - Schedule of Roll-forward of the Warrant Liability (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "C_dc9a1a27-6e49-4cfa-9469-c027ab03a71a",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "mspr:ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_dc9a1a27-6e49-4cfa-9469-c027ab03a71a",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "mspr:ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilitySummaryOfActivityOfSharesUnderlyingWarrantsDetail",
     "longName": "996007 - Disclosure - Warrant Liability - Summary of Activity of Shares Underlying Warrants (Detail)",
     "shortName": "Warrant Liability - Summary of Activity of Shares Underlying Warrants (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "C_8f91f567-de42-4b1b-97c4-bc338e0704b9",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:ClassOfWarrantOrRightIssuedDuringPeriod",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail",
     "longName": "996017 - Disclosure - Noncontrolling Interest - Summary of Ownership Units (Detail)",
     "shortName": "Noncontrolling Interest - Summary of Ownership Units (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "C_4400c0b3-2cd1-40b7-ac05-f868dde9be3a",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_4400c0b3-2cd1-40b7-ac05-f868dde9be3a",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail",
     "longName": "996027 - Disclosure - Noncontrolling Interest - Additional Information (Detail)",
     "shortName": "Noncontrolling Interest - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:MinorityInterest",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_be8b70eb-d4ba-4f20-b375-143fdf4f8fe3",
      "name": "mspr:PercentageOfEntitledPreferredReturnByNonControllingMembers",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
     "longName": "996037 - Disclosure - Commitments and Contingencies - Additional Information (Detail)",
     "shortName": "Commitments and Contingencies - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_791e8b5c-e454-490f-af98-b274119fb0c5",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails",
     "longName": "996047 - Disclosure - Fair Value Measurements - Schedule of Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Schedule of Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "C_38dbca91-c3fa-4361-8e4e-ad3d415625fe",
      "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_38dbca91-c3fa-4361-8e4e-ad3d415625fe",
      "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails",
     "longName": "996057 - Disclosure - Fair Value Measurements - Fair Value Measurements within the Fair Value Hierarchy of Derivative Liabilities Using Level 3 Inputs (Details)",
     "shortName": "Fair Value Measurements - Fair Value Measurements within the Fair Value Hierarchy of Derivative Liabilities Using Level 3 Inputs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "C_c83119b4-f363-422f-942a-c73e79c98c94",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c83119b4-f363-422f-942a-c73e79c98c94",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails",
     "longName": "996067 - Disclosure - Fair Value Measurements - Embedded Derivative Liability Valuation Assumptions (Details)",
     "shortName": "Fair Value Measurements - Embedded Derivative Liability Valuation Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "C_9cad53be-d2bb-4e7e-a24f-2d039319090a",
      "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_9cad53be-d2bb-4e7e-a24f-2d039319090a",
      "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
     "longName": "996077 - Disclosure - Related Party Transactions - Additional Information (Detail)",
     "shortName": "Related Party Transactions - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:InterestExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_cf6558a6-9d3c-4663-9640-79620d1887bc",
      "name": "mspr:PaymentOfCertainCostsAndFees",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetail",
     "longName": "996097 - Disclosure - Segment Information - Additional Information (Detail)",
     "shortName": "Segment Information - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "U_Segment",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R75": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails",
     "longName": "996107 - Disclosure - Segment Information - Schedule of Other Segment Items (Details)",
     "shortName": "Segment Information - Schedule of Other Segment Items (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:TotalClaimsRecovery",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "mspr:SignificantExpenses",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail",
     "longName": "996117 - Disclosure - Net Loss Per Common Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Detail)",
     "shortName": "Net Loss Per Common Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R77": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
     "longName": "996127 - Disclosure - Net Loss Per Common Share - Additional Information (Detail)",
     "shortName": "Net Loss Per Common Share - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_cc1f9003-7531-46fc-b9f5-b111a3ad3adf",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail",
     "longName": "996137 - Disclosure - Derivative Liability - Additional Information (Detail)",
     "shortName": "Derivative Liability - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c",
      "name": "us-gaap:DerivativeLiabilitiesCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_490f215f-7665-40bb-8a57-3e0bba257f4f",
      "name": "mspr:AggregateNumberOfSharesTransferredToEscrowAccount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-2",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
     "longName": "996147 - Disclosure - Subsequent Events - Additional Information (Detail)",
     "shortName": "Subsequent Events - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "C_71d4c574-8d09-4451-b706-aecd0cddefa3",
      "name": "mspr:AdditionalBridgeLoan",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1bdb4676-b3b4-49b4-a184-8e7118c0d4af",
      "name": "mspr:PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees",
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mspr-20241231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AccountingPoliciesLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Line Items]",
        "documentation": "Accounting policies."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AccountingPoliciesTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Table]",
        "documentation": "Accounting policies."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingStandardsUpdate202307Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingStandardsUpdate202307Member",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update 2023-07 [Member]",
        "terseLabel": "ASU 2023-07",
        "documentation": "Accounting Standards Update 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures."
       }
      }
     },
     "auth_ref": [
      "r257",
      "r258"
     ]
    },
    "us-gaap_AccountingStandardsUpdate202309Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingStandardsUpdate202309Member",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASU 2023-09",
        "label": "Accounting Standards Update 2023-09 [Member]",
        "documentation": "Accounting Standards Update 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r472",
      "r473"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "totalLabel": "Accounts Payable, Current, Total",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r855"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Current, Total",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1026"
     ]
    },
    "mspr_AccruedInterestPercentageAfterOneYear": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AccruedInterestPercentageAfterOneYear",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued interest percentage after year one.",
        "label": "Accrued interest percentage after one year"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AccruedInterestPercentageInYearOne": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AccruedInterestPercentageInYearOne",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest percentage in year one",
        "label": "Accrued Interest Percentage in Year one",
        "documentation": "Accrued interest percentage in year one."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated depreciation and amortization of software",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total",
        "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance",
        "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r150",
      "r658"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Finite life intangible assets acquired useful life",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r801"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "mspr_AdditionalBridgeLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AdditionalBridgeLoan",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Bridge Loan",
        "documentation": "Additional Bridge Loan",
        "terseLabel": "Additional bridge loan"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AdditionalFiniteLivedIntangibleAssetsAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AdditionalFiniteLivedIntangibleAssetsAcquired",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional purchase of intangible assets",
        "label": "Additional Finite-Lived Intangible Assets Acquired",
        "documentation": "Additional finite-Lived intangible assets acquired."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Additional Paid in Capital, Total",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r855",
      "r1100"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r698",
      "r1013",
      "r1014",
      "r1015",
      "r1017",
      "r1068",
      "r1103"
     ]
    },
    "mspr_AdditionalReceivablesFromOtherAffiliatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AdditionalReceivablesFromOtherAffiliatesMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Receivables From Other Affiliates [Member]",
        "label": "Additional Receivables From Other Affiliates [Member]",
        "documentation": "Additional receivables from other affiliates."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Axis]",
        "documentation": "Information by amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r191",
      "r192",
      "r193",
      "r194",
      "r204",
      "r257",
      "r258",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r338",
      "r339",
      "r347",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r492",
      "r493",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r559",
      "r560",
      "r574",
      "r575",
      "r576",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r637",
      "r638",
      "r639",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AdvancePaymentIncurredForExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AdvancePaymentIncurredForExpenses",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advance payment incurred for expense",
        "label": "Advance Payment Incurred For Expenses",
        "documentation": "Advance payment incurred for expenses."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AffiliatePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AffiliatePayable",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Affiliate payable",
        "label": "Affiliate Payable",
        "documentation": "Affiliate Payable."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AffiliatePayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AffiliatePayableMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Affiliate Payable [Member]",
        "label": "Affiliate Payable [Member]",
        "documentation": "Affiliate payable."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AffiliateReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AffiliateReceivable",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliate receivable",
        "documentation": "Affiliate receivable."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AffiliateReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AffiliateReceivableMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Affiliate Receivable [Member]",
        "label": "Affiliate Receivable [Member]",
        "documentation": "Affiliate receivable."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AggregateAmountOutstandingUnderCashProceeds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AggregateAmountOutstandingUnderCashProceeds",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate amount outstanding under cash proceeds",
        "label": "Aggregate Amount Outstanding Under Cash Proceeds",
        "documentation": "Aggregate amount outstanding under cash proceeds."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AggregateNumberOfSharesTransferredToEscrowAccount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AggregateNumberOfSharesTransferredToEscrowAccount",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of shares transferred to escrow account.",
        "label": "Aggregate Number Of Shares Transferred To Escrow Account",
        "terseLabel": "Aggregate number of shares transferred to escrow account"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r903",
      "r913",
      "r946"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r895",
      "r906",
      "r916",
      "r949"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r980"
     ]
    },
    "mspr_AgreementDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AgreementDate",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement date.",
        "label": "Agreement Date",
        "terseLabel": "Credit facility, agreement date"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r907",
      "r917",
      "r941",
      "r950",
      "r954",
      "r962"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "mspr_AllowanceForCreditLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AllowanceForCreditLosses",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 7.0
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit losses",
        "label": "Allowance for Credit Losses",
        "documentation": "Allowance for credit losses."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended and restated claims recovery and assignment agreement effective as of December 31, 2021, as amended to date.",
        "label": "Amended and Restated Claims Recovery and Assignment Agreement Effective as of December 31, 2021, as Amended to Date [Member]",
        "terseLabel": "Amended and Restated Claims Recovery and Assignment Agreement Effective as of December 31, 2021, as Amended to Date [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AmendedAndRestatedCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AmendedAndRestatedCreditAgreementMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended and restated credit agreement.",
        "label": "Amended and Restated Credit Agreement [Member]",
        "terseLabel": "Amended and Restated Credit Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AmendedAndRestatedNomuraPromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AmendedAndRestatedNomuraPromissoryNoteMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended and restated nomura promissory note.",
        "label": "Amended and Restated Nomura Promissory Note [Member]",
        "terseLabel": "Amended and Restated Nomura Promissory Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization expense",
        "verboseLabel": "Amortization",
        "terseLabel": "Amortization expense",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r321",
      "r328",
      "r826"
     ]
    },
    "mspr_AmountsReceivedToToTheMasterTransactionAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AmountsReceivedToToTheMasterTransactionAgreement",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts received to to the master transaction agreement",
        "label": "Amounts Received to to the Master Transaction Agreement",
        "documentation": "Amounts received to to the master transaction agreement."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AnnualCompoundedReturnOnContributionPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AnnualCompoundedReturnOnContributionPercentage",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual compounded return on contribution percentage.",
        "label": "Annual Compounded Return on Contribution Percentage",
        "terseLabel": "Annual compounded return on contribution percentage",
        "verboseLabel": "Annual compounded return percentage on contribution"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_AnnualCostsAfterCurrentlyPlannedCostReductions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AnnualCostsAfterCurrentlyPlannedCostReductions",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Costs, After Currently Planned Cost Reductions",
        "documentation": "Annual costs, after currently planned cost reductions.",
        "terseLabel": "Annual costs, after currently planned cost reductions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "us-gaap_AssetAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition [Axis]",
        "documentation": "Information by asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r1066"
     ]
    },
    "us-gaap_AssetAcquisitionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition [Domain]",
        "documentation": "Asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r1066"
     ]
    },
    "us-gaap_AssetAcquisitionPriceOfAcquisitionExpected": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionPriceOfAcquisitionExpected",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition, Price of Acquisition, Expected",
        "terseLabel": "Fair value of claims",
        "documentation": "Purchase price of expected asset acquisition prior to consideration being transferred. Excludes business acquisition."
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "us-gaap_AssetAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition [Table]",
        "documentation": "Disclosure of information about asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "terseLabel": "Total assets",
        "verboseLabel": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r121",
      "r152",
      "r177",
      "r218",
      "r227",
      "r246",
      "r249",
      "r297",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r502",
      "r506",
      "r563",
      "r648",
      "r741",
      "r817",
      "r818",
      "r855",
      "r870",
      "r1050",
      "r1051",
      "r1085"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r158",
      "r177",
      "r297",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r502",
      "r506",
      "r563",
      "r855",
      "r1050",
      "r1051",
      "r1085"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Assets at fair value",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Assets, Fair Value Disclosure, Total",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r535",
      "r536",
      "r844"
     ]
    },
    "us-gaap_AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying value of claims",
        "label": "Assets Sold under Agreements to Repurchase, Carrying Amount",
        "documentation": "Carrying amount of assets sold under agreements to repurchase when the carrying amount (or market value, if higher than the carrying amount) of securities or other assets sold under repurchase agreements exceeds 10 percent of total assets."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r182"
     ]
    },
    "us-gaap_AssetsSoldUnderAgreementsToRepurchaseMarketValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsSoldUnderAgreementsToRepurchaseMarketValue",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of claims",
        "label": "Assets Sold under Agreements to Repurchase, Market Value",
        "documentation": "Market value of assets sold under agreements to repurchase when the carrying amount (or market value, if higher than the carrying amount) of securities or other assets sold under repurchase agreements exceeds 10 percent of total assets."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r182"
     ]
    },
    "mspr_AssignorConsistingNumberOfMedicareMembers": {
     "xbrltype": "integerItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "AssignorConsistingNumberOfMedicareMembers",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assignor Consisting Number Of Medicare Members",
        "documentation": "Assignor Consisting Number Of Medicare Members",
        "terseLabel": "Assignor consisting number of medicare members"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm Id",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r875",
      "r876",
      "r899"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r875",
      "r876",
      "r899"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r875",
      "r876",
      "r899"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]",
        "terseLabel": "Auditor Opinion"
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r957"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position Location, Balance [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r346",
      "r1095",
      "r1096"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position Location, Balance [Domain]",
        "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r50",
      "r346",
      "r1095",
      "r1096"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basis of Presentation and Summary of Significant Accounting Policies",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "mspr_BrickellKeyInvestmentAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "BrickellKeyInvestmentAmendmentMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Brickell Key Investment Amendment [Member]",
        "label": "Brickell Key Investment Amendment [Member]",
        "documentation": "Brickell Key Investment Amendment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BridgeLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BridgeLoan",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bridge Loan",
        "terseLabel": "Bridge loan",
        "documentation": "Short-Term financing which is expected to be paid back relatively quickly, such as by a subsequent longer-term loan. Also called swing loan or bridge financing."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r110"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r490",
      "r837",
      "r838"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r490",
      "r837",
      "r838"
     ]
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Issuance of stock value for purchase of assets",
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionSharePrice",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Business combination, share price per share",
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_CanoHealthLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "CanoHealthLlcMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cano Health, LLC.",
        "label": "Cano Health, LLC [Member]",
        "terseLabel": "Cano Health, LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_CantorFitzgeraldMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "CantorFitzgeraldMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cantor Fitzgerald.",
        "label": "Cantor Fitzgerald [Member]",
        "terseLabel": "Cantor Fitzgerald [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Cash",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "verboseLabel": "Cash in operations",
        "label": "Unrestricted cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r651",
      "r709",
      "r736",
      "r855",
      "r870",
      "r1002"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total",
        "periodEndLabel": "Cash at end of period",
        "periodStartLabel": "Cash at beginning of year",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r90",
      "r175"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r90"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash Equivalents, at Carrying Value",
        "totalLabel": "Cash Equivalents, at Carrying Value, Total",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r1002",
      "r1094"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of\u00a0non-cash\u00a0investing and financing activities:",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_CashPaidDuringThePeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "CashPaidDuringThePeriodAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid during the period for:",
        "label": "Cash Paid During The Period [Abstract]",
        "documentation": "Cash paid during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]",
        "terseLabel": "Change in accounting principle, accounting standards update, adopted [true false]",
        "documentation": "Indicates (true false) whether accounting standards update was adopted."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r134",
      "r145",
      "r190",
      "r257",
      "r299",
      "r300",
      "r301",
      "r306",
      "r307",
      "r338",
      "r347",
      "r471",
      "r481",
      "r482",
      "r491",
      "r492",
      "r495",
      "r511",
      "r512",
      "r523",
      "r524",
      "r559",
      "r560",
      "r575",
      "r581",
      "r582",
      "r637",
      "r638",
      "r672",
      "r673"
     ]
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Adoption Date",
        "terseLabel": "Change in accounting principle, accounting standards update, adoption date",
        "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r134",
      "r145",
      "r257",
      "r299",
      "r300",
      "r301",
      "r306",
      "r307",
      "r308",
      "r338",
      "r347",
      "r471",
      "r481",
      "r482",
      "r491",
      "r492",
      "r493",
      "r495",
      "r496",
      "r510",
      "r511",
      "r512",
      "r513",
      "r523",
      "r524",
      "r525",
      "r528",
      "r559",
      "r560",
      "r575",
      "r581",
      "r582",
      "r637",
      "r638",
      "r672",
      "r673",
      "r992"
     ]
    },
    "mspr_ChangeInFairValueOfDerivatives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ChangeInFairValueOfDerivatives",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in fair value of derivatives.",
        "label": "Change in Fair Value of Derivatives",
        "terseLabel": "Change in fair value of derivatives"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ChangeInFairValueOfWarrantAndDerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ChangeInFairValueOfWarrantAndDerivativeLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in fair value of warrant and derivative liabilities.",
        "label": "Change in Fair Value of Warrant And Derivative Liabilities",
        "terseLabel": "Change in fair value of warrant and derivative liabilities",
        "negatedLabel": "Change in fair value of warrant and derivative liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClaimsAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClaimsAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails": {
       "parentTag": "mspr_SignificantExpenses",
       "weight": 1.0,
       "order": 0.0
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Claims amortization expense.",
        "label": "Claims amortization expense",
        "terseLabel": "Claims amortization expense",
        "negatedLabel": "Claims amortization expense"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClaimsAmortizationExpensePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClaimsAmortizationExpensePolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Claims amortization expense [Policy Text Block].",
        "label": "Claims Amortization Expense [Policy Text Block]",
        "terseLabel": "Claims amortization expense"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClaimsCostRecoveryAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClaimsCostRecoveryAgreementsMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Claims cost recovery agreements.",
        "label": "Claims Cost Recovery Agreements [Member]",
        "verboseLabel": "CCRA [Member]",
        "terseLabel": "Claims Cost Recovery Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClaimsCostRecoveryRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClaimsCostRecoveryRightsMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Claims Cost Recovery Rights [Member]",
        "documentation": "Claims cost recovery rights."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClaimsFinancingObligationAndNotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClaimsFinancingObligationAndNotesPayableMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Claims Financing Obligation and Notes Payable [Member]",
        "label": "Claims Financing Obligation and Notes Payable [Member]",
        "documentation": "Claims financing obligation and notes payable."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClaimsFinancingObligationNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClaimsFinancingObligationNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Claims financing obligation &amp; notes payable",
        "label": "Claims Financing Obligation Notes Payable",
        "documentation": "Claims financing obligation\u00a0&amp; notes payable."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClaimsFinancingObligationNotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClaimsFinancingObligationNotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Claims financing obligation and notes payable, current portion",
        "label": "Claims Financing Obligation Notes Payable, Current",
        "documentation": "Claims financing obligation notes payable, current."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClaimsFinancingObligationsAndNotesPayableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClaimsFinancingObligationsAndNotesPayableLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Claims Financing Obligations and Notes Payable [Line Items]",
        "documentation": "Claims Financing Obligations and Notes Payable."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClaimsFinancingObligationsAndNotesPayableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClaimsFinancingObligationsAndNotesPayableTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Claims Financing Obligations and Notes Payable [Table]",
        "documentation": "Claims Financing Obligations and Notes Payable."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClaimsProceedsInvestmentAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClaimsProceedsInvestmentAgreementMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Claims proceeds investment agreement.",
        "terseLabel": "Claims Proceeds Investment Agreement [Member]",
        "label": "Claims Proceeds Investment Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClaimsRecoveryIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClaimsRecoveryIncome",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "mspr_TotalClaimsRecovery",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Claims recovery income",
        "label": "Claims recovery income",
        "documentation": "Claims recovery income."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClaimsRecoveryServiceIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClaimsRecoveryServiceIncome",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "mspr_TotalClaimsRecovery",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Claims recovery service income",
        "terseLabel": "Claims recovery service income",
        "label": "Claims Recovery Service Income",
        "documentation": "Claims recovery service income"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClassOfNewWarrantOrRightTransferredDuringPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClassOfNewWarrantOrRightTransferredDuringPeriod",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transferred New Warrants",
        "label": "Class of New Warrant or Right Transferred During Period",
        "documentation": "Class of new warrant or right transferred during period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r155",
      "r156",
      "r157",
      "r177",
      "r208",
      "r209",
      "r211",
      "r213",
      "r220",
      "r221",
      "r297",
      "r363",
      "r365",
      "r366",
      "r367",
      "r370",
      "r371",
      "r399",
      "r400",
      "r402",
      "r403",
      "r405",
      "r563",
      "r687",
      "r688",
      "r689",
      "r690",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r710",
      "r728",
      "r750",
      "r772",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r986",
      "r1009",
      "r1018"
     ]
    },
    "mspr_ClassOfWarrantConvertedDuringPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClassOfWarrantConvertedDuringPeriod",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilitySummaryOfActivityOfSharesUnderlyingWarrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant Converted During Period",
        "documentation": "Class of warrant converted during period.",
        "terseLabel": "Converted",
        "negatedLabel": "Converted (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "mspr_ClassOfWarrantOrRightCancellationDuringPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClassOfWarrantOrRightCancellationDuringPeriod",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilitySummaryOfActivityOfSharesUnderlyingWarrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancellation",
        "label": "Class of Warrant or Right Cancellation During Period",
        "documentation": "Class of warrant or right cancellation during period.",
        "negatedLabel": "Cancellation (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilitySummaryOfActivityOfSharesUnderlyingWarrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrants or rights exercise price",
        "verboseLabel": "Warrants to purchase exercise price per share",
        "periodStartLabel": "Beginning balance (in dollars per share)",
        "periodEndLabel": "Ending balance, (in dollars per share)",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "mspr_ClassOfWarrantOrRightIssuedDuringPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClassOfWarrantOrRightIssuedDuringPeriod",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilitySummaryOfActivityOfSharesUnderlyingWarrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right Issued During Period",
        "documentation": "Class of warrant or right issued during period.",
        "terseLabel": "Issued (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Company issued warrants",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Warrants issued",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilitySummaryOfActivityOfSharesUnderlyingWarrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrants to purchase shares of common stock",
        "terseLabel": "Warrants exercised",
        "label": "Warrants outstanding",
        "periodStartLabel": "Beginning balance, shares",
        "periodEndLabel": "Ending Balance, shares",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClassOfWarrantOrRightOutstandingOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClassOfWarrantOrRightOutstandingOwnershipPercentage",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right Outstanding Ownership Percentage",
        "documentation": "Class of warrant or right outstanding ownership percentage.",
        "terseLabel": "Warrants to purchase shares of common stock, Owning percentage"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClassOfWarrantOrRightOutstandingVotingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClassOfWarrantOrRightOutstandingVotingPercentage",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right Outstanding, Voting Percentage",
        "documentation": "Class of warrant or right outstanding voting percentage.",
        "terseLabel": "Voting control from warrant exercise"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right Outstanding, Warrant Exercise Minimum Holding Percentage Of Common Stock",
        "documentation": "Class of warrant or right outstanding warrant exercise minimum holding percentage of common stock.",
        "terseLabel": "Minimum percentage of common stock held, Warrant Exercise"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightReasonForIssuingToNonemployees",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant or Right, Reason for Issuance, Description",
        "terseLabel": "Description of warrants issued to counter party",
        "documentation": "Description of reason for issuing warrant or right."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "mspr_ClassOfWarrantsOrRightConvertedExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClassOfWarrantsOrRightConvertedExercisePrice",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilitySummaryOfActivityOfSharesUnderlyingWarrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of warrants or right converted exercise price",
        "documentation": "Class of warrants or right converted exercise price.",
        "terseLabel": "Converted (in dollars per share)"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClassOfWarrantsOrRightIssuedExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClassOfWarrantsOrRightIssuedExercisePrice",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilitySummaryOfActivityOfSharesUnderlyingWarrantsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued (in dollars per share)",
        "label": "Class Of Warrants Or Right Issued Exercise Price",
        "documentation": "Class of warrants or right issued exercise price."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClassVCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClassVCommonStockMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Class V Common Stock Units [Member]",
        "label": "Class V Common Stock [Member]",
        "documentation": "Class V common stock.",
        "terseLabel": "Class V Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClassVShareholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClassVShareholdersMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class V Shareholders [Member]",
        "label": "Class V Shareholders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClassificationOfCommonStockBasedOnVotingRightsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClassificationOfCommonStockBasedOnVotingRightsAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classification Of Common Stock Based On Voting Rights [Axis]",
        "documentation": "Classification of common stock based on voting rights."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ClassificationOfCommonStockBasedOnVotingRightsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ClassificationOfCommonStockBasedOnVotingRightsDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classification Of Common Stock Based On Voting Rights [Domain]",
        "documentation": "classification of common stock based on voting rights."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "mspr_CommissionPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "CommissionPayable",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commission Payable",
        "documentation": "Commission payable.",
        "terseLabel": "Commission payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r112",
      "r650",
      "r727"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r353",
      "r354",
      "r796",
      "r1039",
      "r1044"
     ]
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]",
        "verboseLabel": "Class A Common Stock [Member]",
        "terseLabel": "Class A [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r1103"
     ]
    },
    "mspr_CommonClassVMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "CommonClassVMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common class v.",
        "label": "Common Class V [Member]",
        "terseLabel": "Class V Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r860",
      "r861",
      "r862",
      "r864",
      "r865",
      "r866",
      "r867",
      "r1013",
      "r1014",
      "r1017",
      "r1068",
      "r1098",
      "r1103"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock par or stated value per share",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "mspr_CommonStockPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "CommonStockPurchaseAgreementMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock purchase agreement.",
        "label": "Common Stock Purchase Agreement [Member]",
        "terseLabel": "Common Stock Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Maximum amount of common shares to be purchased",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r728"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock Issued",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance",
        "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance",
        "label": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r76",
      "r728",
      "r747",
      "r1103",
      "r1104"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock issued",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r652",
      "r855"
     ]
    },
    "mspr_CommonUnitExchangeValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "CommonUnitExchangeValue",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common unit exchange value",
        "label": "Common Unit Exchange Value",
        "documentation": "Common unit exchange value."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income (Loss)",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Concentration of credit risk and\u00a0Off-Balance\u00a0Sheet Risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r127"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": [
      "r186",
      "r502",
      "r503",
      "r506",
      "r507",
      "r595",
      "r797",
      "r1049",
      "r1052",
      "r1053"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "auth_ref": [
      "r186",
      "r502",
      "r503",
      "r506",
      "r507",
      "r595",
      "r797",
      "r1049",
      "r1052",
      "r1053"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r806"
     ]
    },
    "us-gaap_ConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible Notes",
        "terseLabel": "Convertible Debt [Member]",
        "label": "Convertible Debt [Member]",
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r373",
      "r374",
      "r384",
      "r385",
      "r386",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832"
     ]
    },
    "mspr_ConvertingCertainDebtOfCertainCreditorsIntoEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ConvertingCertainDebtOfCertainCreditorsIntoEquity",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Converting Certain Debt Of Certain Creditors Into Equity",
        "documentation": "Converting certain debt of certain creditors into equity",
        "terseLabel": "Converting certain debt of certain creditors into equity"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_CostOfClaimRecoveries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "CostOfClaimRecoveries",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of claim recoveries",
        "documentation": "Cost of claim recoveries.",
        "terseLabel": "Cost of Claim recoveries",
        "verboseLabel": "Cost of revenues"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_CostOfClaimRecoveriesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "CostOfClaimRecoveriesPolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cost of Claims Recoveries",
        "label": "Cost Of Claim Recoveries [Policy Text Block]",
        "documentation": "Cost of claim recoveries."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_CostOfClaimsRecoveriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "CostOfClaimsRecoveriesMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of claims recoveries.",
        "label": "Cost of Claims Recoveries [Member]",
        "terseLabel": "Cost of Claims Recoveries [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r183",
      "r184",
      "r376",
      "r401",
      "r593",
      "r618",
      "r646",
      "r803",
      "r805"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_CpiaWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "CpiaWarrantMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CPIA warrant.",
        "label": "CPIA Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_CreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "CreditAgreementMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit agreement.",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r1047"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r1047",
      "r1048"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r884",
      "r973"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r884",
      "r973"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r886",
      "r975"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r886",
      "r975"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r888",
      "r977"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r886",
      "r975"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r879",
      "r968"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r880",
      "r969"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r880",
      "r969"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r878",
      "r967"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r878",
      "r967"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r878",
      "r967"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r881",
      "r970"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r883",
      "r972"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r883",
      "r972"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r884",
      "r973"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r887",
      "r976"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r885",
      "r974"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCyberSecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r882",
      "r971"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Debt converted into shares",
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r18"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentRate",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Converted Instrument, Rate",
        "terseLabel": "Percentage of debt obligation agreed to convert",
        "documentation": "Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r18"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Claims Financing Obligations and Notes Payable",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r176",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r361",
      "r362",
      "r372",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r388",
      "r395",
      "r396",
      "r398",
      "r572"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r65",
      "r66",
      "r110",
      "r111",
      "r186",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r379",
      "r384",
      "r385",
      "r386",
      "r387",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r854",
      "r1010",
      "r1040",
      "r1041",
      "r1042",
      "r1080",
      "r1081"
     ]
    },
    "us-gaap_DebtInstrumentCollateralAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCollateralAmount",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional collateral, a pledge of proceeds from certain Claims",
        "label": "Debt Instrument, Collateral Amount",
        "documentation": "Amount of assets pledged to secure a debt instrument."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "mspr_DebtInstrumentExtendedMaturityYear": {
     "xbrltype": "durationItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "DebtInstrumentExtendedMaturityYear",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument Extended Maturity Year",
        "terseLabel": "Debt instrument extended maturity year",
        "documentation": "Debt instrument extended maturity year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal amount of unsecured promissory note",
        "label": "Principal amount of unsecured promissory note",
        "verboseLabel": "Aggregate principal amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r373",
      "r572",
      "r573",
      "r829",
      "r830",
      "r854"
     ]
    },
    "mspr_DebtInstrumentFloorPriceTrigger": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "DebtInstrumentFloorPriceTrigger",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Floor price trigger",
        "label": "Debt Instrument Floor Price Trigger",
        "documentation": "Debt instrument floor price trigger."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Interest rate of promissory note",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r391",
      "r1080"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r374"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument maturity date",
        "label": "Debt Instrument, Maturity Date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r828",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r186",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r379",
      "r384",
      "r385",
      "r386",
      "r387",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r854",
      "r1010",
      "r1040",
      "r1041",
      "r1042",
      "r1080",
      "r1081"
     ]
    },
    "mspr_DebtInstrumentOriginalIssueDiscount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "DebtInstrumentOriginalIssueDiscount",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument original issue discount.",
        "label": "Debt Instrument Original Issue Discount",
        "terseLabel": "Debt instrument original issue discount"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_DebtInstrumentPaymentInKindAnnualInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "DebtInstrumentPaymentInKindAnnualInterestRate",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument, payment in kind, annual interest rate.",
        "label": "Debt Instrument, Payment in Kind, Annual Interest Rate",
        "terseLabel": "Interest rate, payable in kind"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Monthly payment",
        "terseLabel": "Seventh trading day after the Trigger",
        "label": "Debt Instrument, Periodic Payment",
        "totalLabel": "Debt Instrument, Periodic Payment, Total",
        "documentation": "Amount of the required periodic payments including both interest and principal payments."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r59"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, Term",
        "label": "Debt Instrument, Term",
        "verboseLabel": "Debt instrument, maturity term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentVariableInterestRateTypeExtensibleEnumeration",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]",
        "documentation": "Indicates type of variable interest rate on debt instrument."
       }
      }
     },
     "auth_ref": [
      "r645"
     ]
    },
    "mspr_DebtInstrumentsExtendedMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "DebtInstrumentsExtendedMaturityDate",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Extended maturity date",
        "label": "Debt Instruments Extended Maturity Date",
        "documentation": "Debt instruments extended maturity date"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtWeightedAverageInterestRate",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average interest rate",
        "label": "Debt, Weighted Average Interest Rate",
        "documentation": "Weighted average interest rate of debt outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationArrangementWithIndividualRecordedLiability",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Payment of Cano Health payment in shares",
        "label": "Deferred Compensation Arrangement with Individual, Recorded Liability",
        "terseLabel": "Deferred compensation arrangement recorded liability",
        "documentation": "The carrying amount of the liability as of the balance sheet date to an individual under a deferred compensation arrangement. This amount may be the result of periodic accruals made over the period of active employment, or reflect termination benefits resulting contractual terms or a death benefit."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]",
        "documentation": "Information by type of deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationArrangementWithIndividualSharesIssued",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Compensation Arrangement with Individual, Shares Issued",
        "terseLabel": "Deferred compensation arrangement shares issued",
        "documentation": "Number of shares issued pursuant to the terms of a deferred compensation arrangement."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_DeferredCompensationShareBasedPaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationShareBasedPaymentsMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred Compensation, Share-Based Payments [Member]",
        "label": "Deferred Compensation, Share-Based Payments [Member]",
        "terseLabel": "Option to Pay in Cash or in Stock and Elected to Pay in Stock [Member]",
        "documentation": "Deferred compensation arrangements (such as stock or unit options and share or unit awards) that are equity-based payments with individual employees. The arrangements are generally based on employment contracts between the entity and one or more selected officers or key employees, and contain a promise by the employer to pay certain amounts or benefits at designated future dates, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Other \"sub-members\" can be added as necessary."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetInterestCarryforward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetInterestCarryforward",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Expense - 163j",
        "label": "Deferred Tax Asset, Interest Carryforward",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward."
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "mspr_DeferredTaxAssetsInvestmentInMspRecoveryLlc": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "DeferredTaxAssetsInvestmentInMspRecoveryLlc",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets investment in MSP recovery, LLC.",
        "label": "Deferred Tax Assets Investment in MSP Recovery, LLC",
        "terseLabel": "Investment in MSP Recovery, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforward",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "mspr_DeferredTaxAssetsOrganizationalCostsAndStartupExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "DeferredTaxAssetsOrganizationalCostsAndStartupExpenses",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets organizational costs and startup expenses.",
        "label": "Deferred Tax Assets Organizational Costs And Startup Expenses",
        "terseLabel": "Start-up Costs"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_DeferredTaxAssetsTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "DeferredTaxAssetsTransactionCosts",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets Transaction Costs",
        "label": "Deferred Tax Assets Transaction Costs",
        "terseLabel": "Transaction Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfCompanysDeferredTaxAssetsAndLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r463"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation and amortization expense",
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "totalLabel": "Depreciation, Depletion and Amortization, Nonproduction, Total",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r26"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "totalLabel": "Depreciation, Depletion and Amortization, Total",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r218",
      "r231",
      "r249",
      "r817",
      "r818"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiability"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Liability",
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r509",
      "r522"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r49",
      "r51",
      "r52",
      "r54",
      "r55",
      "r508"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r508"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Liability",
        "totalLabel": "Derivative Liability, Total",
        "terseLabel": "Derivative liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r160",
      "r535",
      "r536",
      "r549",
      "r562",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r742",
      "r744",
      "r745",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r805",
      "r1072",
      "r1073",
      "r1074",
      "r1099"
     ]
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Liability, Current",
        "verboseLabel": "Derivative liability",
        "terseLabel": "Derivative liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments",
        "label": "Derivatives, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r45",
      "r46",
      "r47",
      "r53",
      "r185",
      "r203"
     ]
    },
    "mspr_DescriptionOfCashPaymentsMadeToCounterParty": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "DescriptionOfCashPaymentsMadeToCounterParty",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of cash payments made to counter party",
        "label": "Description of Cash Payments Made to Counter Party",
        "terseLabel": "Description of cash payments made to counter party"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_DevelopmentCostsCapitalizedUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "DevelopmentCostsCapitalizedUsefulLife",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development Costs Capitalized Useful Life.",
        "label": "Development Costs Capitalized Useful Life",
        "terseLabel": "Development costs capitalized useul life"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure In Tabular Form Of Summarized Financial Information Of Equity Method Investees [Line Items]",
        "documentation": "Disclosure in tabular form of summarized financial information of equity method investees."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure In Tabular Form Of Summarized Financial Information Of Equity Method Investees [Table]",
        "documentation": "Disclosure in tabular form of summarized financial information of equity method investees."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summarized Financial Information of Equity Method Investees",
        "label": "Disclosure In Tabular Form Of Summarized Financial Information Of Equity Method Investees [Table Text Block]",
        "documentation": "Disclosure in tabular form of summarized financial information of equity method investees."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentatonAndSummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Summary of Depreciation and Amortization on Property and Equipment",
        "label": "Disclosure In Tabular Form Of Useful Lives Of Property Plant And Useful Lives [Table Text Block]",
        "documentation": "Disclosure in tabular form of useful lives of property plant and useful lives."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_DividendComprisingNumberOfNewWarrantsPayableHolders": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "DividendComprisingNumberOfNewWarrantsPayableHolders",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividend comprising number of new warrants payable holders.",
        "label": "Dividend Comprising Number of New Warrants Payable Holders",
        "terseLabel": "Dividend comprising number of new warrants payable holders"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r875",
      "r876",
      "r899"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r875",
      "r876",
      "r899",
      "r942"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Jurisdiction [Member]",
        "terseLabel": "Federal [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Basic, Total",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings per share of common stock - basic",
        "verboseLabel": "Basic net loss per common share",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r206",
      "r208",
      "r211",
      "r212",
      "r213",
      "r217",
      "r488",
      "r499",
      "r532",
      "r533",
      "r642",
      "r666",
      "r808"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Diluted, Total",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings per share of common stock - diluted",
        "verboseLabel": "Diluted net loss per common share",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r208",
      "r211",
      "r212",
      "r213",
      "r217",
      "r488",
      "r499",
      "r532",
      "r533",
      "r642",
      "r666",
      "r808"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShare1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Common Share",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r214",
      "r215",
      "r216"
     ]
    },
    "mspr_EarningsPerSharesBasicAndDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "EarningsPerSharesBasicAndDilutedAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Shares Basic And Diluted [Abstract]",
        "label": "Earnings Per Shares Basic And Diluted [Abstract]",
        "terseLabel": "Denominator - basic and diluted:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective Income tax rate",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r450",
      "r841"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal Statutory rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r450",
      "r474",
      "r841"
     ]
    },
    "mspr_EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation at noncontrolling interests effect of pass through entities.",
        "label": "Effective Income Tax Rate Reconciliation at Noncontrolling Interests Effect of Pass Through Entities",
        "terseLabel": "Noncontrolling interests/effect of pass-through entities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Valuation allowance",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r454",
      "r841",
      "r1012",
      "r1055"
     ]
    },
    "mspr_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsWarrantLiabilityPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsWarrantLiabilityPercent",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liability",
        "label": "Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Warrant Liability Percent",
        "documentation": "Effective income tax rate reconciliation change in deferred tax assets warrant liability percent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r841",
      "r1012",
      "r1055",
      "r1056"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State Taxes",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r841",
      "r1012",
      "r1055"
     ]
    },
    "mspr_EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxScheduleOfReconciliationStatutoryIncomeTaxRateToTheCompanysEffectiveTaxRateDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation Warrant Liability Percent",
        "documentation": "Effective income tax rate reconciliation warrant liability percent.",
        "terseLabel": "Warrant liability"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_EmbeddedDerivativeLiabilitiesMeasurementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "EmbeddedDerivativeLiabilitiesMeasurementTerm",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Embedded Derivative Liabilities Measurement Term",
        "documentation": "Embedded derivative liabilities measurement term.",
        "terseLabel": "Embedded derivative liability term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmbeddedDerivativeLiabilityMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmbeddedDerivativeLiabilityMeasurementInput",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Embedded derivative liability",
        "label": "Embedded Derivative Liability, Measurement Input",
        "documentation": "Value of input used to measure embedded derivative liability."
       }
      }
     },
     "auth_ref": [
      "r537",
      "r538",
      "r539"
     ]
    },
    "mspr_EmbeddedDerivativeLiabilityMeasurementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "EmbeddedDerivativeLiabilityMeasurementTerm",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Embedded derivative liability term",
        "label": "Embedded Derivative Liability Measurement Term",
        "documentation": "Embedded Derivative Liability Measurement Term."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_EntitledClaimsRecoverPercentageByNonControllingMembers": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "EntitledClaimsRecoverPercentageByNonControllingMembers",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entitled claims recover percentage by non-controlling members.",
        "label": "Entitled Claims Recover Percentage by Non-Controlling Members",
        "terseLabel": "Entitled claims recover percentage by non-controlling member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "us-gaap_EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityBasedArrangementsIndividualContractsTypeOfDeferredCompensationDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]",
        "documentation": "Deferred compensation related to equity-based payment arrangements. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes broad group equity-based compensation plans, defined benefit pension plans, defined benefit other postretirement benefit plans and other deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r142",
      "r164",
      "r165",
      "r166",
      "r187",
      "r188",
      "r189",
      "r192",
      "r199",
      "r201",
      "r203",
      "r219",
      "r303",
      "r309",
      "r339",
      "r407",
      "r469",
      "r470",
      "r484",
      "r485",
      "r486",
      "r489",
      "r498",
      "r499",
      "r514",
      "r516",
      "r517",
      "r518",
      "r519",
      "r521",
      "r531",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r575",
      "r577",
      "r586",
      "r664",
      "r674",
      "r675",
      "r676",
      "r698",
      "r772"
     ]
    },
    "us-gaap_EquityMethodInvesteeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvesteeMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investee [Member]",
        "terseLabel": "Equity Method Investee [Member]",
        "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor."
       }
      }
     },
     "auth_ref": [
      "r1082",
      "r1083"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r293",
      "r294",
      "r296",
      "r480",
      "r988",
      "r989",
      "r990",
      "r1062",
      "r1063",
      "r1064",
      "r1065"
     ]
    },
    "mspr_EquityMethodInvestmentInvesteeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "EquityMethodInvestmentInvesteeMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Method Investment Investee [Member]",
        "label": "Equity Method Investment Investee [Member]",
        "documentation": "Equity method investment investee."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equity method investments ownership percentage",
        "label": "Equity Method Investment, Ownership Percentage",
        "negatedTerseLabel": "Company agreement to pay cash or warrant to purchase Class A common stock equal to percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equity Method Investments",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r234",
      "r249",
      "r292",
      "r1003",
      "r1031"
     ]
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvestees"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "verboseLabel": "Investment In Equity Method Investees",
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r295",
      "r298",
      "r990"
     ]
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsPolicy",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equity Method Investments",
        "label": "Equity Method Investments [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r56",
      "r294"
     ]
    },
    "mspr_EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equity method ownership percentage for entities that track separate capital accounts",
        "label": "Equity Method Ownership Percentage For Entities That Track Separate Capital Accounts",
        "documentation": "Equity method ownership percentage for entities that track separate capital accounts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNiCurrentAndNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in equity securities",
        "label": "Equity Securities, FV-NI",
        "totalLabel": "Equity Securities, FV-NI, Total",
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r535",
      "r561",
      "r646",
      "r647",
      "r844",
      "r858",
      "r859",
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r903",
      "r913",
      "r946"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r889",
      "r900",
      "r910",
      "r943"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "mspr_ExistingLegalServicesAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ExistingLegalServicesAgreementsMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Existing Legal Services Agreements [Member]",
        "label": "Existing Legal Services Agreements [Member]",
        "documentation": "Existing legal services agreements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of warrants",
        "negatedLabel": "Warrants decreased resulting in other income",
        "terseLabel": "Warrants decreased resulting in other income",
        "verboseLabel": "Change in fair value of warrant liability",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r6"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r535",
      "r536",
      "r549",
      "r844"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r535",
      "r536",
      "r549",
      "r844"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r537",
      "r538",
      "r539",
      "r847"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r537",
      "r538",
      "r539",
      "r847"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r534",
      "r536",
      "r537",
      "r538",
      "r539",
      "r548",
      "r549",
      "r551",
      "r602",
      "r603",
      "r604",
      "r829",
      "r830",
      "r834",
      "r835",
      "r836",
      "r844",
      "r847"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r535",
      "r536",
      "r537",
      "r539",
      "r844",
      "r1073",
      "r1078"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r544",
      "r546",
      "r547",
      "r548",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r641",
      "r844",
      "r848"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r409",
      "r414",
      "r536",
      "r537",
      "r549",
      "r603",
      "r829",
      "r830",
      "r834",
      "r835",
      "r836",
      "r844"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r536",
      "r537",
      "r538",
      "r539",
      "r549",
      "r604",
      "r829",
      "r830",
      "r834",
      "r835",
      "r836",
      "r844",
      "r847"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Liabilities Measured at Fair Value on a Recurring Basis",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset."
       }
      }
     },
     "auth_ref": [
      "r1070",
      "r1071"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input."
       }
      }
     },
     "auth_ref": [
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r550"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements within the Fair Value Hierarchy of Derivative Liabilities Using Level 3 Inputs",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r540",
      "r545",
      "r550"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r535",
      "r536",
      "r537",
      "r539",
      "r844",
      "r1073",
      "r1078"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of derivative liability at issuance",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "negatedLabel": "Issuance of note",
        "negatedTerseLabel": "Issuance of warrants",
        "verboseLabel": "Issuance of note",
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r550"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)",
        "totalLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total",
        "terseLabel": "Change in fair value of derivative liability",
        "verboseLabel": "Change in fair value of outstanding warrants",
        "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r1075",
      "r1077"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodStartLabel": "Balance at December 31, 2023",
        "periodEndLabel": "Balance at December 31, 2024",
        "negatedPeriodStartLabel": "Balance at December 31, 2023",
        "negatedPeriodEndLabel": "Balance at December 31, 2024",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r540",
      "r550"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsFairValueMeasurementsWithinTheFairValueHierarchyOfDerivativeLiabilitiesUsingLevel3InputsDetails",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r534",
      "r536",
      "r537",
      "r538",
      "r539",
      "r548",
      "r549",
      "r551",
      "r602",
      "r603",
      "r604",
      "r829",
      "r830",
      "r834",
      "r835",
      "r836",
      "r844",
      "r847"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring [Member]",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r844",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1078"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r397",
      "r404",
      "r522",
      "r556",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r616",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r665",
      "r825",
      "r844",
      "r845",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r856",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1069",
      "r1072",
      "r1073",
      "r1074",
      "r1076",
      "r1078"
     ]
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Liabilities Fair Value Disclosure",
        "totalLabel": "Financial Liabilities Fair Value Disclosure, Total",
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities."
       }
      }
     },
     "auth_ref": [
      "r1070",
      "r1071",
      "r1076"
     ]
    },
    "mspr_FinancialLiabilitiesFairValueWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "FinancialLiabilitiesFairValueWarrants",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Liabilities Fair Value Warrants",
        "documentation": "Financial liabilities fair value warrants",
        "terseLabel": "Warrant liability"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_FinancingObligationsAndNotesPayableAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "FinancingObligationsAndNotesPayableAgreementsMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Obligations and Notes Payable Agreements [Member]",
        "documentation": "Financing obligations and notes payable agreements.",
        "label": "Financing Obligations and Notes Payable Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Finite lived intangible assets useful lives",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r318",
      "r327",
      "r826"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1035",
      "r1105"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "verboseLabel": "2023",
        "terseLabel": "2025",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r801",
      "r826"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2029",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r801",
      "r826"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2028",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r801",
      "r826"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2027",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r801",
      "r826"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2026",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r801",
      "r826"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r330",
      "r331",
      "r636",
      "r640",
      "r801"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite Lived Intangible Assets Future Amortization Expense [Line Items]",
        "documentation": "Finite lived intangible assets future amortization expense."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite Lived Intangible Assets Future Amortization Expense [Table]",
        "documentation": "Finite lived intangible assets future amortization expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Gross",
        "totalLabel": "Finite-Lived Intangible Assets, Gross, Total",
        "terseLabel": "Intangible assets, gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r327",
      "r640",
      "r826"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r327",
      "r330",
      "r331",
      "r334",
      "r636",
      "r801",
      "r826"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r322",
      "r323",
      "r324",
      "r326",
      "r327",
      "r330",
      "r331",
      "r801"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfExpectedFutureAmortizationExpenseOfIntangibleAssetsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets, net",
        "totalLabel": "Total",
        "label": "Finite-Lived Intangible Assets, Net",
        "periodStartLabel": "Beginning Balance",
        "periodEndLabel": "Ending Balance",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r636",
      "r1034"
     ]
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Acquisitions of CCRAs",
        "label": "Finite-Lived Intangible Assets Acquired",
        "terseLabel": "Purchase of Intangible assets",
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition."
       }
      }
     },
     "auth_ref": [
      "r322"
     ]
    },
    "mspr_FixedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "FixedPricePerShare",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed price per share",
        "label": "Fixed Price Per Share",
        "documentation": "Fixed price per share."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_FloorPriceOfACommonStock": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "FloorPriceOfACommonStock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Floor Price of a Common Stock",
        "documentation": "Floor price of a common stock.",
        "terseLabel": "Floor price of a common stock"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ForcedExpiratoryFlowSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ForcedExpiratoryFlowSharesMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forced expiratory flow shares [Member].",
        "label": "Forced Expiratory Flow Shares [Member]",
        "terseLabel": "FEF Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ForegoPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ForegoPayments",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forego payments",
        "label": "Forego Payments",
        "documentation": "Forego payments."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r907",
      "r917",
      "r950"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r907",
      "r917",
      "r950"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r907",
      "r917",
      "r950"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r907",
      "r917",
      "r950"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r907",
      "r917",
      "r950"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "mspr_FundedForAdditionalClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "FundedForAdditionalClaims",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Funded For Additional Claims",
        "documentation": "Funded for additional claims.",
        "terseLabel": "Funded for additional claims"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_FundsHeldForOtherEntitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "FundsHeldForOtherEntitiesMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Funds Held For Other Entities Member",
        "terseLabel": "Funds Held For Other Entities [Member]",
        "label": "Funds Held For Other Entities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDispositionOfIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on sale of intangibles",
        "label": "Gain (Loss) on Disposition of Intangible Assets",
        "documentation": "Amount of gain (loss) on sale or disposal of intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails": {
       "parentTag": "mspr_SignificantExpenses",
       "weight": 1.0,
       "order": 1.0
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "totalLabel": "General and Administrative Expense, Total",
        "negatedLabel": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r752"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative Expenses [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "verboseLabel": "Intangible assets",
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r333",
      "r336"
     ]
    },
    "mspr_GoodwillMeasurementInputIncreaseDecrease": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "GoodwillMeasurementInputIncreaseDecrease",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill measurement input increase (decrease)",
        "label": "Goodwill, Measurement Input Increase (Decrease)",
        "documentation": "Goodwill measurement input increase (decrease)."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_GuarantyObligationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "GuarantyObligationCurrent",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guaranty obligation current.",
        "label": "Guaranty Obligation Current",
        "terseLabel": "Guaranty obligation"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_GuarantyObligationNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "GuarantyObligationNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guaranty obligation noncurrent.",
        "label": "Guaranty Obligation Noncurrent",
        "terseLabel": "Guaranty obligation"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_HazelPartnersHoldingsLlcLetterAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "HazelPartnersHoldingsLlcLetterAgreementMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "HPH Letter Agreement [Member]",
        "label": "Hazel Partners Holdings LLC Letter Agreement [Member]",
        "documentation": "Hazel Partners Holdings LLC letter agreement."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_HazelTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "HazelTransactionsMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hazel Transactions [Member]",
        "documentation": "Hazel Transactions.",
        "label": "Hazel Transactions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r875",
      "r876",
      "r899"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails": {
       "parentTag": "mspr_SignificantExpenses",
       "weight": 1.0,
       "order": 4.0
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "verboseLabel": "Non-cash impairment charge",
        "terseLabel": "Impairment of intangible assets",
        "negatedLabel": "Impairment",
        "negatedTerseLabel": "Impairement of intangible assets",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value."
       }
      }
     },
     "auth_ref": [
      "r321",
      "r1007",
      "r1037"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Impairment of Long-Lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r97"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Net loss before provision for income taxes",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r115",
      "r120",
      "r643",
      "r660",
      "r810",
      "r817",
      "r1020",
      "r1022",
      "r1023",
      "r1024",
      "r1025"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r346",
      "r350",
      "r541",
      "r545",
      "r550",
      "r669",
      "r671",
      "r757",
      "r801",
      "r846",
      "r1097"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r346",
      "r350",
      "r541",
      "r545",
      "r550",
      "r669",
      "r671",
      "r757",
      "r801",
      "r846",
      "r1097"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r450",
      "r451",
      "r458",
      "r466",
      "r841",
      "r1059"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r450",
      "r451",
      "r458",
      "r466",
      "r841",
      "r1059"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTax"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r445",
      "r450",
      "r455",
      "r456",
      "r457",
      "r460",
      "r465",
      "r475",
      "r477",
      "r478",
      "r479",
      "r692",
      "r841"
     ]
    },
    "us-gaap_IncomeTaxExaminationDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExaminationDescription",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Examination, Description",
        "terseLabel": "Income tax examination, description",
        "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings."
       }
      }
     },
     "auth_ref": [
      "r1057"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income Tax Expense (Benefit), Total",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income tax benefit (expense)",
        "negatedLabel": "Provision for income tax benefit (expense)",
        "verboseLabel": "Provision for income tax",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r135",
      "r202",
      "r203",
      "r218",
      "r232",
      "r249",
      "r449",
      "r450",
      "r476",
      "r667",
      "r841"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r447",
      "r448",
      "r460",
      "r461",
      "r464",
      "r468",
      "r686"
     ]
    },
    "mspr_IncreaseDeceaseInAffiliatesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "IncreaseDeceaseInAffiliatesPayable",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 26.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Affiliate payable",
        "label": "Increase Decease In Affiliates Payable",
        "documentation": "increase decease in affiliates payable."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_IncreaseDeceaseInAffiliatesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "IncreaseDeceaseInAffiliatesReceivable",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Affiliate receivable",
        "label": "Increase Decease In Affiliates Receivable",
        "documentation": "Increase decease in affiliates receivable."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable, commission payable and accrued liabilities",
        "negatedLabel": "Accounts payable, commission payable and accrued liabilities",
        "label": "Increase (Decrease) In Accounts Payable, Commission Payable And Accrued Liabilities",
        "documentation": "Increase (decrease) in accounts payable, commission payable and accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Receivable",
        "terseLabel": "Accounts receivable",
        "negatedTerseLabel": "Accounts receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "mspr_IncreaseDecreaseInImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "IncreaseDecreaseInImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Impairment Charges",
        "documentation": "increase decrease in impairment charges.",
        "terseLabel": "increase (decrease) in impairment charges"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInInterestPayableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInterestPayableNet",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Payable",
        "label": "Increase (Decrease) in Interest Payable, Net",
        "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "mspr_IncreaseInProceedsFromLongTermLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "IncreaseInProceedsFromLongTermLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase In Proceeds From Long Term Lines Of Credit",
        "documentation": "Increase in proceeds from long term lines of credit",
        "terseLabel": "Increase in proceeds from credit facility"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_IncreaseInTaxReceivableAgreementLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "IncreaseInTaxReceivableAgreementLiability",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in Tax Receivable Agreement Liability",
        "documentation": "Increase in tax receivable agreement liability.",
        "terseLabel": "Increase in TRA liability"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r907",
      "r917",
      "r941",
      "r950",
      "r954",
      "r962"
     ]
    },
    "mspr_InitialVirageWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "InitialVirageWarrantMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Virage Warrant [Member]",
        "documentation": "Initial virage warrant."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r877",
      "r966"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r877",
      "r966"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r877",
      "r966"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNet4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets, Net",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r332",
      "r335",
      "r800",
      "r801"
     ]
    },
    "mspr_IntangibleAssetsFinancedByNotePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "IntangibleAssetsFinancedByNotePayable",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of intangible asset financed by note payable",
        "label": "Intangible Assets Financed By Note Payable",
        "documentation": "Intangible assets financed by note payable."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_IntangibleAssetsHeldBeCertainSpecificSubsidiaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "IntangibleAssetsHeldBeCertainSpecificSubsidiaries",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets held be certain specific subsidiaries",
        "label": "Intangible Assets Held be Certain Specific Subsidiaries",
        "documentation": "Intangible assets held be certain specific subsidiaries."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "totalLabel": "Intangible Assets, Net (Excluding Goodwill), Total",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r1034",
      "r1036"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_IntangibleAssetsNetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "IntangibleAssetsNetLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net [Line Items]",
        "documentation": "Intangible assets, net."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_IntangibleAssetsNetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "IntangibleAssetsNetTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net [Table]",
        "documentation": "Intangible assets, net."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 1.0
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails": {
       "parentTag": "mspr_SignificantExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest expense",
        "negatedLabel": "Interest expense",
        "label": "Interest Expense, Operating and Nonoperating",
        "totalLabel": "Interest Expense, Total",
        "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r227",
      "r230",
      "r233",
      "r249",
      "r571",
      "r817",
      "r818"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r172",
      "r173"
     ]
    },
    "us-gaap_InterestPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Payable, Current",
        "terseLabel": "Interest payable",
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "mspr_InterestPayableNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "InterestPayableNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Payable Noncurrent",
        "documentation": "Interest payable noncurrent.",
        "terseLabel": "Interest payable"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_InterestPeriodPlusAnApplicableMargin": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "InterestPeriodPlusAnApplicableMargin",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest period, plus an applicable margin.",
        "label": "Interest Period, plus an Applicable Margin",
        "terseLabel": "Interest period, plus an applicable margin"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InternalUseSoftwarePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InternalUseSoftwarePolicy",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Internal Use Software",
        "label": "Internal Use Software, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally."
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "mspr_InvestmentInRightsToClaimRecoveryCashFlowsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "InvestmentInRightsToClaimRecoveryCashFlowsMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in rights to claim recovery cash flows.",
        "label": "Investment in Rights to Claim Recovery Cash Flows [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecurities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in Equity Securities and Obligations to Deliver Securities",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r139",
      "r260",
      "r261",
      "r557",
      "r558",
      "r1093"
     ]
    },
    "mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in Equity Securities and Obligations to Deliver Securities [Line Items]",
        "documentation": "Investments in equity securities and obligations to deliver securities."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in Equity Securities and Obligations to Deliver Securities [Table]",
        "documentation": "Investments in equity securities and obligations to deliver securities."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_IssuanceOfSharesPurchaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "IssuanceOfSharesPurchaseTerm",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares purchase term",
        "label": "Issuance Of Shares Purchase Term",
        "documentation": "Issuance of shares purchase term."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r580"
     ]
    },
    "us-gaap_LeaseholdsAndLeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdsAndLeaseholdImprovementsMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leaseholds and Leasehold Improvements [Member]",
        "documentation": "Asset held by lessee under finance lease and addition or improvement to asset held under lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "mspr_LegalAccountingAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "LegalAccountingAndAdministrativeExpenseMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal, Accounting, And Administrative Expense [Member]",
        "documentation": "Legal, Accounting, And Administrative Expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LegalFees",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails": {
       "parentTag": "mspr_SignificantExpenses",
       "weight": 1.0,
       "order": 3.0
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Fees",
        "terseLabel": "Professional fees - legal",
        "negatedLabel": "Professional fees - legal",
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings."
       }
      }
     },
     "auth_ref": [
      "r993"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total Liabilities",
        "totalLabel": "Total liabilities",
        "terseLabel": "Liabilities",
        "label": "Liability",
        "negatedLabel": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r65",
      "r66",
      "r67",
      "r70",
      "r71",
      "r72",
      "r73",
      "r177",
      "r297",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r503",
      "r506",
      "r507",
      "r563",
      "r726",
      "r809",
      "r870",
      "r1050",
      "r1085",
      "r1086"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r114",
      "r655",
      "r855",
      "r1011",
      "r1032",
      "r1079"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r148",
      "r177",
      "r297",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r503",
      "r506",
      "r507",
      "r563",
      "r855",
      "r1050",
      "r1085",
      "r1086"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liabilities at fair value",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Liabilities, Fair Value Disclosure, Total",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r536",
      "r1070"
     ]
    },
    "mspr_LicenseFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "LicenseFeePercentage",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License fee percentage",
        "label": "License Fee Percentage",
        "documentation": "License fee percentage."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_LineOfCreditFacilityBorrowingAvailableAmountForEachTranche": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "LineOfCreditFacilityBorrowingAvailableAmountForEachTranche",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit borrowing amount accessible for each tranche",
        "label": "Line of Credit Facility Borrowing, Available Amount For Each Tranche",
        "documentation": "Line of credit facility borrowing, available amount for each tranche."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit facility, Current borrowing capacity",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r69"
     ]
    },
    "us-gaap_LineOfCreditFacilityDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityDescription",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Description",
        "terseLabel": "Credit facility description",
        "documentation": "Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r69",
      "r362"
     ]
    },
    "us-gaap_LineOfCreditFacilityExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityExpirationPeriod",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in credit facility expiration period",
        "label": "Line of Credit Facility, Expiration Period",
        "documentation": "Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_LineOfCreditFacilityFundedForAcquiringAdditionalClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "LineOfCreditFacilityFundedForAcquiringAdditionalClaims",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit facility for acquiring additional Claims",
        "label": "Line Of Credit Facility Funded For Acquiring Additional Claims",
        "documentation": "Line Of Credit Facility Funded For Acquiring Additional Claims"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Increase (Decrease), Net",
        "totalLabel": "Line of Credit Facility, Increase (Decrease), Net, Total",
        "terseLabel": "Increase in credit facility",
        "documentation": "Amount of increase (decrease) of the credit facility."
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit facility, Interest rate during period",
        "label": "Line of Credit Facility, Interest Rate During Period",
        "documentation": "The effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r69"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Line of credit facility, Maximum borrowing capacity",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit facility, maximum borrowing capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r69"
     ]
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of credit facility, maximum remaining borrowing capacity",
        "verboseLabel": "Line of credit facility, remaining borrowing capacity",
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r69",
      "r362"
     ]
    },
    "mspr_LineOfCreditFundedInTranchesPerMonth": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "LineOfCreditFundedInTranchesPerMonth",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line Of Credit Funded In Tranches per Month",
        "documentation": "Line of credit funded in tranches per month",
        "terseLabel": "Line of credit funded in tranches per month"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_LoanFromRelatedPartiesNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "LoanFromRelatedPartiesNonCurrent",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan from related parties",
        "label": "Loan From Related Parties Non Current",
        "documentation": "Loan From Related Parties Non Current."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_LoansRepaymentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "LoansRepaymentPercentage",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans Repayment Percentage",
        "documentation": "Loans repayment percentage.",
        "terseLabel": "Loans repayment percentage"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Note payable related party",
        "label": "Notes Payable, Noncurrent",
        "totalLabel": "Notes Payable, Noncurrent, Total",
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r1040",
      "r1041",
      "r1042"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r28",
      "r1040",
      "r1041",
      "r1042"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r356",
      "r357",
      "r360",
      "r444",
      "r827",
      "r1045",
      "r1046"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingencies [Table]",
        "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r356",
      "r357",
      "r360",
      "r444",
      "r827",
      "r1045",
      "r1046"
     ]
    },
    "mspr_MSPRecoveryLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "MSPRecoveryLLCMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MSP Recovery LLC [Member]",
        "label": "M S P Recovery L L C [Member]",
        "documentation": "MSP Recovery, LLC."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_MaoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "MaoMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MAO [Member]",
        "documentation": "MAO.",
        "terseLabel": "MAO [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_MaomsoRecoveryLlcSeriesFhcpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "MaomsoRecoveryLlcSeriesFhcpMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MAOMSO Recovery LLC Series FHCP [Member]",
        "documentation": "MAO-MSO recovery LLC series FHCP."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_MarkToMarketGainOnLiabilityPayableInStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "MarkToMarketGainOnLiabilityPayableInStock",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mark to Market Gain on liability payable in stock",
        "documentation": "Mark to market Gain on liability payable in stock.",
        "negatedLabel": "Mark-to-market gain on liability payable in stock"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_MaterialAgreementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "MaterialAgreementsDisclosureTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Agreements Disclosure [Text Block]",
        "documentation": "Material agreements disclosure.",
        "terseLabel": "Material Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum [Member]",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r356",
      "r357",
      "r358",
      "r359",
      "r416",
      "r444",
      "r539",
      "r634",
      "r668",
      "r670",
      "r684",
      "r718",
      "r719",
      "r778",
      "r779",
      "r780",
      "r781",
      "r789",
      "r798",
      "r799",
      "r824",
      "r833",
      "r839",
      "r847",
      "r848",
      "r852",
      "r853",
      "r857",
      "r1054",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected Term",
        "label": "Measurement Input, Expected Term [Member]",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volatility",
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r847",
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Risk Spread",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputSharePriceMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price of Common Stock",
        "label": "Measurement Input, Share Price [Member]",
        "documentation": "Measurement input using share price of saleable stock."
       }
      }
     },
     "auth_ref": [
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r537",
      "r538",
      "r539",
      "r847"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsEmbeddedDerivativeLiabilityValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r537",
      "r538",
      "r539",
      "r847"
     ]
    },
    "mspr_MembershipInterestPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "MembershipInterestPurchaseAgreementMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Membership Interest Purchase Agreement [Member]",
        "documentation": "membership interest purchase agreement.",
        "terseLabel": "Membership interest purchase agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_MinimumCashAvailableForDistributionsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "MinimumCashAvailableForDistributionsPercentage",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Budget percentage",
        "label": "Minimum Cash Available For Distributions Percentage",
        "documentation": "Minimum cash available for distributions percentage."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_MinimumFeePaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "MinimumFeePaid",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum Fee Paid",
        "documentation": "Minimum fee paid.",
        "terseLabel": "Minimum fee paid"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum [Member]",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r356",
      "r357",
      "r358",
      "r359",
      "r416",
      "r444",
      "r539",
      "r634",
      "r668",
      "r670",
      "r684",
      "r718",
      "r719",
      "r778",
      "r779",
      "r780",
      "r781",
      "r789",
      "r798",
      "r799",
      "r824",
      "r833",
      "r839",
      "r847",
      "r848",
      "r852",
      "r857",
      "r1054",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092"
     ]
    },
    "mspr_MinimumRequiredPaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "MinimumRequiredPaymentMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum Required Payment [Member]",
        "label": "Minimum Required Payment [Member]",
        "documentation": "Minimum Required Payment Member"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_MinimumVariablePricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "MinimumVariablePricePerShare",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable price per share",
        "label": "Minimum Variable Price Per Share",
        "documentation": "Minimum variable price per share."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Total",
        "periodStartLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance",
        "periodEndLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r113",
      "r177",
      "r297",
      "r363",
      "r365",
      "r366",
      "r367",
      "r370",
      "r371",
      "r563",
      "r654",
      "r730"
     ]
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestDisclosureTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterest1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interest",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "us-gaap_MinorityInterestLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interest, Ownership percentage by non-controlling owners",
        "label": "Subsidiary, Ownership Percentage, Noncontrolling Owner",
        "verboseLabel": "Ownership percentage",
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Ownership interest",
        "label": "Subsidiary, Ownership Percentage, Parent",
        "terseLabel": "Non-controlling interests ownership percentage",
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Table]",
        "documentation": "Disclosure of information about noncontrolling interest, including, but not limited to, name of subsidiary, ownership percentage held by parent, ownership percentage held by noncontrolling owner, amount of noncontrolling interest and its location in statement of financial position, explanation of increase (decrease) in noncontrolling interest, noncontrolling interest share of net income (loss) of subsidiary and its location in statement of income, amount of noncontrolling interest represented by preferred stock, description and dividend requirement of preferred stock, and nature of noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r37",
      "r80",
      "r83"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "mspr_MonthlyVirageWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "MonthlyVirageWarrantsMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Monthly Virage Warrants [Member]",
        "documentation": "Monthly virage warrants."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_MsoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "MsoMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MSO [Member]",
        "documentation": "MSO.",
        "terseLabel": "MSO [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_MspPrincipalsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "MspPrincipalsMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MSP principals.",
        "label": "MSP Principals [Member]",
        "terseLabel": "MSP Principals [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_MspRecoveryAviationLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "MspRecoveryAviationLlcMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MSP Recovery Aviation, LLC [Member]",
        "label": "MSP Recovery Aviation, LLC [Member]",
        "documentation": "MSP recovery aviation, LLC."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_MspRecoveryLawFirmMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "MspRecoveryLawFirmMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MSP Recovery Law Firm [Member]",
        "label": "MSP Recovery Law Firm [Member]",
        "documentation": "MSP recovery law firm."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of the Business",
        "label": "Nature of Operations [Text Block]",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r136"
     ]
    },
    "mspr_NatureOfOperationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NatureOfOperationsLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness2024ReverseStockSplitAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature Of Operations [Line Items]",
        "documentation": "Nature of operations."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NatureOfOperationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NatureOfOperationsTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness2024ReverseStockSplitAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature Of Operations [Table]",
        "documentation": "Nature of operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "terseLabel": "Cash in operations",
        "totalLabel": "Net cash used in operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91",
      "r92"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NetGainOfTheAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NetGainOfTheAsset",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net gain on sale of claims transactions",
        "label": "Net Gain Of The Asset",
        "documentation": "Net gain of the asset."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "totalLabel": "Net loss attributable to MSP Recovery, Inc.",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r92",
      "r116",
      "r146",
      "r161",
      "r162",
      "r166",
      "r177",
      "r191",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r202",
      "r203",
      "r210",
      "r297",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r488",
      "r499",
      "r533",
      "r563",
      "r663",
      "r749",
      "r770",
      "r771",
      "r868",
      "r1050"
     ]
    },
    "us-gaap_NetIncomeLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "terseLabel": "Numerator - basic and diluted:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "totalLabel": "Net Income (Loss) Attributable to Noncontrolling Interest, Total",
        "negatedLabel": "Less: Net loss attributable to non-controlling interests",
        "negatedTerseLabel": "Less: Net loss attributable to the non-controlling interests",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r106",
      "r161",
      "r162",
      "r199",
      "r202",
      "r203",
      "r662",
      "r1005"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Recent Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NewClassOfWarrantOrRightExercisePriceOfWarrantsOrRights",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Warrants to purchase exercise price per share",
        "label": "New Class of Warrant or Right Exercise Price of Warrants or Rights",
        "documentation": "New class of warrant or right exercise price of warrants or rights."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NewClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NewClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Warrants outstanding",
        "label": "New Class of Warrant or Right Outstanding",
        "documentation": "New class of warrant or right outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NomuraPromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NomuraPromissoryNoteMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nomura Promissory Note [Member]",
        "documentation": "Nomura Promissory Note."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Cash Impairment Charge Would Decrease Estimated Recoveries",
        "documentation": "Non-cash impairment charge would decrease estimated recoveries.",
        "terseLabel": "Non-cash impairment charge would decrease estimated recoveries"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Cash Impairment Charge Would Increase Estimated Recoveries",
        "documentation": "Non-cash impairment charge would increase estimated recoveries.",
        "terseLabel": "Non-cash impairment charge would increase estimated recoveries"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_Non-RecourseDebtSecondLienAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "Non-RecourseDebtSecondLienAmount",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-recourse Debt Second Lien Amount",
        "documentation": "Non-recourse debt second Lien amount.",
        "terseLabel": "Non-recourse debt second lien amount"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash lease liabilities arising from obtaining right-of-use assets",
        "label": "Non-cash Lease Liabilities Arising from Obtaining Right-of-use Assets",
        "documentation": "Non-cash lease liabilities arising from obtaining right-of-use assets."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NonControllingInterestsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NonControllingInterestsPolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-controlling interests.",
        "label": "Non-controlling Interests [Policy Text Block]",
        "terseLabel": "Non-controlling Interests"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NonEconomicVotingSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NonEconomicVotingSharesMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non economic voting shares.",
        "label": "Non Economic Voting Shares [Member]",
        "terseLabel": "Non Economic Voting Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r907",
      "r917",
      "r941",
      "r950"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r923"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncontrollingInterestAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-\u00a0Controlling Interests [Member]",
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r407",
      "r1013",
      "r1014",
      "r1015",
      "r1017",
      "r1103"
     ]
    },
    "mspr_NumberOfConsecutiveTradingDays": {
     "xbrltype": "integerItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NumberOfConsecutiveTradingDays",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Consecutive Trading Days",
        "documentation": "Number of consecutive trading days.",
        "terseLabel": "Number of consecutive trading days"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NumberOfEquitySharesAcquiredToCoverTheShortPosition": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NumberOfEquitySharesAcquiredToCoverTheShortPosition",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of equity shares acquired to cover the short position",
        "label": "Number Of Equity Shares Acquired To Cover The Short Position",
        "documentation": "Number of equity shares acquired to cover the short position."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NumberOfHoldingInvestments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NumberOfHoldingInvestments",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of holding investments.",
        "label": "Number of Holding Investments",
        "terseLabel": "Number of holding investments"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NumberOfMedicareMembers": {
     "xbrltype": "integerItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NumberOfMedicareMembers",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Medicare Members",
        "documentation": "Number of medicare members.",
        "terseLabel": "Number of Medicare Members"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r818",
      "r1021"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segment",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r811",
      "r822",
      "r1021"
     ]
    },
    "mspr_NumberOfSharesExercisable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NumberOfSharesExercisable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Shares Exercisable",
        "documentation": "Number of shares exercisable.",
        "terseLabel": "Number of shares exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NumberOfTenWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NumberOfTenWarrantMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Ten Warrant [Member]",
        "label": "Number of Ten Warrant Member",
        "documentation": "Number of ten warrant."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NumberOfTranches": {
     "xbrltype": "integerItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NumberOfTranches",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Tranches",
        "documentation": "Number Of Tranches",
        "terseLabel": "Number of tranches"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NumberOfTwoWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NumberOfTwoWarrantMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Two warrant Member",
        "documentation": "Number of two warrant.",
        "terseLabel": "Number of Two Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Up C units issued in exchange of assets acquired",
        "label": "Number of Up C Units Issued in Exchange of Assets Acquired",
        "terseLabel": "Number of Up C units issued in exchange of assets acquired"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NumberOfWarrantsIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NumberOfWarrantsIssued",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Warrants Issued",
        "documentation": "Number of warrants issued.",
        "terseLabel": "Number of warrants issued"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_NumberOfWarrantsIssuedAndExercisable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "NumberOfWarrantsIssuedAndExercisable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Warrants Issued and Exercisable",
        "documentation": "Number of warrants issued and exercisable.",
        "terseLabel": "Number of warrants exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_OfficeAndComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "OfficeAndComputerEquipmentMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office and computer equipment",
        "label": "Office And Computer Equipment [Member]",
        "documentation": "Office And Computer Equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OpenTaxYear": {
     "xbrltype": "gYearListItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OpenTaxYear",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Open Tax Year",
        "terseLabel": "Open tax year",
        "documentation": "Tax year that remains open to examination under enacted tax laws, in YYYY format."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingCostsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related party expenses",
        "label": "Operating Costs and Expenses",
        "totalLabel": "Operating Costs and Expenses, Total",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_OperatingCostsAndExpenses1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "OperatingCostsAndExpenses1",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses 1",
        "documentation": "Operating costs and expenses 1.",
        "terseLabel": "Related party expenses 1"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating Loss",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r810",
      "r1020",
      "r1022",
      "r1023",
      "r1024",
      "r1025"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Operating lease liability, non-current",
        "verboseLabel": "Lease liabilities",
        "terseLabel": "Operating lease liability, non-current",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Right-of-use asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash lease expense",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryovers",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Disclosure of information about operating loss carryforward. Includes, but is not limited to, tax authority, amount and expiration date of operating loss carryforward, and likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "mspr_OperationalCollectionFloorFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "OperationalCollectionFloorFacilityMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operational Collection Floor Facility [Member]",
        "documentation": "Operational collection floor facility."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_OperationalFunding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "OperationalFunding",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operational funding.",
        "label": "Operational funding"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_OptionToSellMaximumSharesValueUnderPurchaseAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "OptionToSellMaximumSharesValueUnderPurchaseAgreement",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option to sell maximum shares value under purchase agreement.",
        "label": "Option to Sell Maximum Shares Value under Purchase Agreement",
        "terseLabel": "Option to sell maximum shares value under purchase agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_OriginalIssueDiscountOfNonCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "OriginalIssueDiscountOfNonCash",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Original issue discount",
        "label": "Original Issue Discount Of Non Cash",
        "documentation": "Original issue discount of non cash."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAffiliatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAffiliatesMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Affiliates [Member]",
        "label": "Other Affiliates [Member]",
        "documentation": "A category that identifies other affiliates."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_OtherClaimsRecoveryRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "OtherClaimsRecoveryRevenues",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "mspr_TotalClaimsRecovery",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Claims Recovery Revenues",
        "documentation": "Other claims recovery revenues.",
        "terseLabel": "Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitment",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitment",
        "totalLabel": "Other Commitment, Total",
        "terseLabel": "Commitment collateral",
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIncomeMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income [Member]",
        "documentation": "Primary financial statement caption encompassing other revenue."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan from related parties",
        "verboseLabel": "Due to related party current",
        "terseLabel": "Other current liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r855"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other expenses",
        "label": "Other Nonoperating Income (Expense)",
        "totalLabel": "Other Nonoperating Income (Expense), Total",
        "terseLabel": "Other income (expense), net",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due from related party current",
        "label": "Other Receivables, Net, Current",
        "totalLabel": "Other Receivables, Net, Current, Total",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_OtherSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "OtherSoftwareMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other software",
        "label": "Other Software [Member]",
        "documentation": "Other Software."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r894",
      "r905",
      "r915",
      "r948"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r897",
      "r908",
      "r918",
      "r951"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r897",
      "r908",
      "r918",
      "r951"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaidInKindInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaidInKindInterest",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Paid-in-Kind Interest",
        "terseLabel": "Paid-in-kind interest",
        "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ParentMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent [Member]",
        "terseLabel": "Members' Deficit [Member]",
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PartialRepaymentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PartialRepaymentOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Partial repayment of debt",
        "label": "Partial Repayment of Debt",
        "documentation": "Partial Repayment of Debt"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "mspr_PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment of advance for shares of common stock in event of termination",
        "label": "Payment Of Advance For Shares Of Common Stock In Event Of Terminations",
        "documentation": "Payment of advance for shares of common stock in event of terminations."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PaymentOfCertainCostsAndFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PaymentOfCertainCostsAndFees",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment of certain costs and fees",
        "label": "Payment of Certain Costs and Fees",
        "documentation": "Payment of certain costs and fees."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of professional fees through issuance of Class A common stock.",
        "label": "Payment of Professional fees Through Issuance of Class A Common Stock",
        "terseLabel": "Payment of professional fees through issuance of Class A common stock"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PaymentToFundOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PaymentToFundOperations",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fund operations",
        "label": "Payment To Fund Operations",
        "documentation": "Payment to fund operations."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PaymentToReduceAmountsOwedUnderNomuraNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PaymentToReduceAmountsOwedUnderNomuraNote",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment to Reduce Amounts Owed Under Nomura Note",
        "documentation": "Payment to reduce amounts owed under nomura note.",
        "terseLabel": "Payment to reduce nomura note"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Debt issuance costs",
        "label": "Payments of Debt Issuance Costs",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "mspr_PaymentsOfDeferredFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PaymentsOfDeferredFinancingCosts",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred financing costs",
        "label": "Payments of Deferred Financing Costs",
        "documentation": "Payments of deferred financing costs."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PaymentsOnRelatedPartyLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PaymentsOnRelatedPartyLoan",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments on Related Party Loan",
        "documentation": "Payments on related party loan",
        "terseLabel": "Payments on related party loan",
        "negatedLabel": "Payments on related party loan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payment of cash for assets purchase",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r494"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of intangible assets",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "mspr_PaymentsToContinuingEquityOwnersAndBlockerShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PaymentsToContinuingEquityOwnersAndBlockerShareholders",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to continuing equity owners and blocker shareholders",
        "label": "Payments To Continuing Equity Owners and Blocker Shareholders",
        "documentation": "Payments to continuing equity owners and blocker shareholders."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PaymentsToReduceAmendedAndRestatedNomuraPromissoryNote",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments To Reduce Amended And Restated Nomura Promissory Note",
        "documentation": "Payments to reduce amended and restated nomura promissory note",
        "terseLabel": "Payments to reduce amended and restated nomura promissory note"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r923"
     ]
    },
    "mspr_PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of proceeds used to pay amounts due under Convertible Notes",
        "label": "Percentage Of Aggregate Proceeds To Pay Amounts Due Under Convertible Notes",
        "documentation": "Percentage of aggregate proceeds to pay amounts due under convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfAggregateProceedsToPayOutstandingAmount": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfAggregateProceedsToPayOutstandingAmount",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentag of aggregate proceeds used to pay amounts outstanding",
        "label": "Percentage Of Aggregate Proceeds To Pay Outstanding Amount",
        "documentation": "Percentage of aggregate proceeds to pay outstanding amount."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfCashProceedsFromSaleOfStock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfCashProceedsFromSaleOfStock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage Of Cash Proceeds From Sale Of Stock",
        "documentation": "Percentage of cash proceeds from sale of stock.",
        "terseLabel": "Percentage of cash proceeds from sale of stock"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfCostsAllocatedToNonControlling": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfCostsAllocatedToNonControlling",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage Of Costs Allocated To Non Controlling Member",
        "terseLabel": "Percentage of costs allocated to non controlling member",
        "documentation": "Percentage of costs allocated to non controlling member"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Premium and accrued and unpaid interest",
        "label": "Percentage Of Debt Instrument To Monthly Payment Along With Premium And Accrued And Unpaid Interest",
        "documentation": "Percentage of debt instrument to monthly payment along with premium and accrued and unpaid interest."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfEntitledPreferredReturnByNonControllingMembers": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfEntitledPreferredReturnByNonControllingMembers",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of entitled preferred return by non-controlling members.",
        "label": "Percentage of Entitled Preferred Return by Non-Controlling Members",
        "terseLabel": "Percentage of entitled preferred return by non-controlling member"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfGrantProceedsToExtentFullReturnNotRepaid": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfGrantProceedsToExtentFullReturnNotRepaid",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage Of Grant Proceeds To Extent Full Return Not Repaid",
        "documentation": "Percentage of grant proceeds to extent full return not repaid.",
        "terseLabel": "Percentage of grant proceeds to extent full return not repaid."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfMandatoryMinimumAmountForAnyAdvance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfMandatoryMinimumAmountForAnyAdvance",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mandatory minimum amount",
        "label": "Percentage of Mandatory Minimum Amount For Any Advance",
        "documentation": "Percentage of mandatory minimum amount for any advance."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfMinimumFixedPriceEqualingOfVwap": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfMinimumFixedPriceEqualingOfVwap",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage Of Minimum Fixed Price Equaling Of Vwap",
        "documentation": "Percentage of minimum fixed price equaling of vwap.",
        "terseLabel": "Fixed price equaling"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfMinimumVariablePriceEqualingOfVwap": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfMinimumVariablePriceEqualingOfVwap",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable price equaling",
        "label": "Percentage of minimum Variable price equaling of vwap",
        "documentation": "Percentage of minimum variable price equaling of vwap."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum VWAP of shares",
        "label": "Percentage of Minimum VWAP of Shares During Three Consecutive Days Commencing From Delivery Of Advance Notice",
        "documentation": "Percentage of minimum VWAP of shares during three consecutive days commencing from delivery of Advance notice."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfNonControllingMemberAllocatedCost": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfNonControllingMemberAllocatedCost",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of non-controlling member allocated cost.",
        "label": "Percentage of Non-controlling Member Allocated Cost",
        "terseLabel": "Percentage of non-controlling member allocated cost"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of number of shares warrant purchased equal to quotient",
        "label": "Percentage of Number of Shares Warrant Purchased Equal to Quotient",
        "documentation": "Percentage of number of shares warrant purchased equal to quotient."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange Cap or the amount of shares of common stock",
        "label": "Percentage Of Ownership Limitation Does Not Exceed The Exchange Cap Or The Amount Of Shares Of Common Stock",
        "documentation": "Percentage of ownership limitation does not exceed the exchange cap or the amount of shares of common stock ."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfPaySellersToAmountOfTaxBenefit": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfPaySellersToAmountOfTaxBenefit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of pay sellers to amount of tax benefit.",
        "label": "Percentage of Pay Sellers to Amount of Tax Benefit",
        "terseLabel": "Percentage of pay sellers to amount of tax benefit"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfPaymentOfAggregatePurchasePriceOfShares": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfPaymentOfAggregatePurchasePriceOfShares",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of payment of aggregate purchase price of shares",
        "label": "Percentage of Payment of Aggregate Purchase Price of Shares",
        "documentation": "Percentage of payment of aggregate purchase price of shares."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfPledge": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfPledge",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of Pledge",
        "documentation": "Percentage of pledge.",
        "terseLabel": "Percentage of pledge"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfPreferredReturnForTheControlling": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfPreferredReturnForTheControlling",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage Of Preferred Return For The Controlling Member",
        "terseLabel": "Percentage of preferred return for the controlling member",
        "documentation": "Percentage of preferred return for the controlling member."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfProceedsFromGrantLien": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfProceedsFromGrantLien",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of Proceeds From Grant Lien",
        "documentation": "Percentage of proceeds from grant lien.",
        "terseLabel": "Percentage of proceeds from grant lien"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfProceedsFromRepaymentOfDebt": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfProceedsFromRepaymentOfDebt",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of proceeds from repayment of debt",
        "label": "Percentage of Proceeds from Repayment of Debt",
        "documentation": "Percentage of proceeds from repayment of debt."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfRecoveryClaimsForTheControlling": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfRecoveryClaimsForTheControlling",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage Of Recovery Claims For The Controlling Member",
        "terseLabel": "Percentage of recovery claims for the controlling member",
        "documentation": "Percentage of recovery claims for the controlling member."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfSharesObtainedThroughWarrant": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfSharesObtainedThroughWarrant",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of shares obtained through warrant",
        "label": "Percentage Of Shares Obtained Through Warrant",
        "documentation": "Percentage of shares obtained through warrant."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfStockPurchasePrice": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfStockPurchasePrice",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock purchased price",
        "label": "Percentage of Stock Purchase Price",
        "documentation": "Percentage of stock purchase price."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfVwapOfSharesDuringPriorDate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfVwapOfSharesDuringPriorDate",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VWAP of shares during prior date",
        "label": "Percentage of VWAP of shares during Prior Date",
        "documentation": "Percentage of VWAP of shares during prior date."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VWAP seven consecutive trading days",
        "label": "Percentage of WAP of Shares During Seven Consecutive Trading Days Immediately Preceding the Conversion",
        "documentation": "Percentage of WAP of shares during seven consecutive trading days immediately preceding the conversion."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PmpiMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PmpiMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PMPI [Member]",
        "documentation": "PMPI.",
        "terseLabel": "PMPI [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Remaining amount",
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1004"
     ]
    },
    "mspr_PriceOfCommonStock": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PriceOfCommonStock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price of common stock",
        "label": "Price Of Common Stock",
        "documentation": "Price of common stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from the issuance of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net proceeds from debt issuance amount",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from debt financing",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from credit facility",
        "label": "Proceeds from Long-Term Lines of Credit",
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromNotesPayable",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Proceeds from Notes Payable, Total",
        "label": "Proceeds from Notes Payable",
        "terseLabel": "Proceeds from promissory notes",
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Related Party Debt",
        "terseLabel": "Proceeds on related party loan",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from (Repayments of) Related Party Debt",
        "terseLabel": "(Payments) Proceeds on related party loan",
        "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of intangible assets",
        "label": "Proceeds from Sale of Intangible Assets",
        "documentation": "The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "mspr_ProceedsFromSaleOfStockMonthlyPaymentAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ProceedsFromSaleOfStockMonthlyPaymentAmount",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of stock monthly payment amount",
        "label": "Proceeds From Sale of Stock Monthly Payment Amount",
        "documentation": "Proceeds from sale of stock monthly payment amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails": {
       "parentTag": "mspr_SignificantExpenses",
       "weight": 1.0,
       "order": 2.0
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional fees",
        "label": "Professional Fees",
        "negatedLabel": "Professional fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r817",
      "r868",
      "r1101",
      "r1102"
     ]
    },
    "mspr_ProfessionalFeesLegalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ProfessionalFeesLegalMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Professional fees - legal.",
        "label": "Professional Fees - Legal [Member]",
        "terseLabel": "Professional Fees Legal [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ProfessionalFeesSettledInShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ProfessionalFeesSettledInShares",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional fees settled in shares",
        "label": "Professional Fees Settled In Shares",
        "documentation": "Professional fees settled in shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails": {
       "parentTag": "us-gaap_SegmentReportingOtherItemAmount",
       "weight": -1.0,
       "order": 0.0
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails",
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss (1)",
        "verboseLabel": "Net loss",
        "negatedTerseLabel": "Net Income",
        "negatedLabel": "Net Loss",
        "label": "Loss",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r161",
      "r162",
      "r170",
      "r177",
      "r191",
      "r199",
      "r202",
      "r203",
      "r297",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r488",
      "r499",
      "r501",
      "r504",
      "r505",
      "r533",
      "r563",
      "r643",
      "r661",
      "r697",
      "r749",
      "r770",
      "r771",
      "r842",
      "r843",
      "r869",
      "r1005",
      "r1050"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r580"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment, Net",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r128",
      "r131",
      "r132"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, Plant and Equipment, Gross, Total",
        "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance",
        "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance",
        "verboseLabel": "Property and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r149",
      "r659"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r580",
      "r644",
      "r659",
      "r855"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r128",
      "r131",
      "r657"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Property and Equipment, Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r580"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property, Plant and Equipment, Useful Life",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]",
        "documentation": "Indicates description of term of useful life for property, plant, and equipment when not stated as numeric value."
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "mspr_PublicWarrantsOutstandingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PublicWarrantsOutstandingMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public warrants outstanding.",
        "label": "Public Warrants Outstanding [Member]",
        "terseLabel": "Public Warrants Outstanding [Member]",
        "verboseLabel": "Public Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Purchase Agreement, Effective as of September 30, 2022, as Amended to Date [Member]",
        "documentation": "Purchase agreement, effective as of September 30, 2022, as amended to date.",
        "label": "Purchase Agreement, Effective as of September 30, 2022, as Amended to Date [Member]",
        "terseLabel": "Purchase Agreement, Effective as of September 30, 2022, as Amended to Date [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PurchaseMoneyLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PurchaseMoneyLoan",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase money loan.",
        "label": "Purchase Money Loan",
        "terseLabel": "Purchase money loan"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PurchaseMoneyLoanAccruesInterest": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PurchaseMoneyLoanAccruesInterest",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase Money Loan accrues interest.",
        "label": "Purchase Money Loan Accrues Interest",
        "terseLabel": "Purchase Money Loan accrues interest"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PurchaseMoneyLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PurchaseMoneyLoanMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Purchase Money Loan [Member]",
        "documentation": "Purchase money loan.",
        "label": "Purchase Money Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of intangible asset through issuance of Class A common stock",
        "documentation": "Purchase of intangible asset through issuance of class A common stock.",
        "label": "Purchase of intangible asset through issuance of Class A common stock"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r356",
      "r357",
      "r358",
      "r359",
      "r408",
      "r416",
      "r440",
      "r441",
      "r442",
      "r444",
      "r539",
      "r605",
      "r617",
      "r634",
      "r668",
      "r670",
      "r684",
      "r718",
      "r719",
      "r778",
      "r779",
      "r780",
      "r781",
      "r789",
      "r798",
      "r799",
      "r824",
      "r833",
      "r839",
      "r847",
      "r848",
      "r852",
      "r853",
      "r857",
      "r862",
      "r1043",
      "r1054",
      "r1073",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r356",
      "r357",
      "r358",
      "r359",
      "r408",
      "r416",
      "r440",
      "r441",
      "r442",
      "r444",
      "r539",
      "r605",
      "r617",
      "r634",
      "r668",
      "r670",
      "r684",
      "r718",
      "r719",
      "r778",
      "r779",
      "r780",
      "r781",
      "r789",
      "r798",
      "r799",
      "r824",
      "r833",
      "r839",
      "r847",
      "r848",
      "r852",
      "r853",
      "r857",
      "r862",
      "r1043",
      "r1054",
      "r1073",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092"
     ]
    },
    "mspr_RealizedClaimRecoveries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "RealizedClaimRecoveries",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Realized claim recoveries",
        "label": "Realized Claim Recoveries",
        "documentation": "Realized claim recoveries."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_RealizedLossOnInvestmentsToCoverShortPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "RealizedLossOnInvestmentsToCoverShortPosition",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Realized loss on investments to cover short position",
        "label": "Realized Loss On Investments To Cover Short Position",
        "documentation": "Realized loss on investments to cover short position."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r889",
      "r900",
      "r910",
      "r943"
     ]
    },
    "mspr_RecoveryRightsInterest": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "RecoveryRightsInterest",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery Rights Interest",
        "documentation": "Recovery rights interest.",
        "terseLabel": "Recovery rights interest"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_RecoveryRightsInterestExcessCashFlowPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "RecoveryRightsInterestExcessCashFlowPercentage",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery Rights Interest Excess Cash Flow Percentage",
        "documentation": "Recovery rights interest excess cash flow percentage.",
        "terseLabel": "Recovery rights interest excess cash flow percentage"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00025PerShareMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Warrants, Each Lot of 25 Warrants is Exercisable for One Share of Class A Common Stock at an Exercise Price of $0.0025 Per Share [Member]",
        "documentation": "Redeemable warrants, each lot of 25 warrants is exercisable for one share of class a common stock at an exercise price of $0.0025 per share.",
        "terseLabel": "Redeemable Warrants, each Lot of 25 Warrants is Exercisable for One Share of Class A Common Stock at an Exercise Price of $287.50 Per Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "RedeemableWarrantsEachLotOf25WarrantsIsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf28750PerShareMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Warrants, each Lot of 25 Warrants is Exercisable for One Share of Class A Common Stock at an Exercise Price of $287.50 Per Share [Member]",
        "documentation": "Redeemable warrants, each lot of 25 warrants is exercisable for one share of class a common stock at an exercise price of $287.50 per share.",
        "terseLabel": "Redeemable Warrants, each Lot of 25 Warrants is Exercisable for One Share of Class A Common Stock at an Exercise Price of $287.50 Per Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Warrants, Each Lot of 625 Warrants Exercisable for One Share of Class A Common Stock at an Exercise Price of $0.0625 Per Share [Member]",
        "documentation": "Redeemable warrants, each lot of 625 warrants exercisable for one share of class a common stock at an exercise price of $0.0625 per share.",
        "terseLabel": "Redeemable Warrants, Each Lot of 625 Warrants Exercisable for One Share of Class A Common Stock at an Exercise Price of $0.0625 Per Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Warrants, Each Lot of 625 Warrants Exercisable for One Share of Class A Common Stock at an Exercise Price of $7,187.50 Per Share [Member]",
        "documentation": "Redeemable warrants, each lot of 625 warrants exercisable for one share of class a common stock at an exercise price of $7,187.50 per share.",
        "terseLabel": "Redeemable Warrants, Each Lot of 625 Warrants Exercisable for One Share of Class A Common Stock at an Exercise Price of $7,187.50 Per Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ReductionInDebtPrincipalOwing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ReductionInDebtPrincipalOwing",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reduction in principal",
        "label": "Reduction In Debt Principal Owing",
        "documentation": "Reduction in debt principal owing"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ReductionInInterestAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ReductionInInterestAmount",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reduction In Interest Amount",
        "documentation": "Reduction In Interest Amount",
        "terseLabel": "Reduction in interest amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r415",
      "r590",
      "r591",
      "r649",
      "r656",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r746",
      "r748",
      "r777"
     ]
    },
    "mspr_RelatedPartyLegalExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "RelatedPartyLegalExpense",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related party legal expense",
        "label": "Related Party Legal Expense",
        "documentation": "Related party legal expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "terseLabel": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r180",
      "r590",
      "r591",
      "r592",
      "r593",
      "r649",
      "r656",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r746",
      "r748",
      "r777"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r590",
      "r591",
      "r1084"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r753",
      "r754",
      "r757"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r415",
      "r590",
      "r591",
      "r649",
      "r656",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r746",
      "r748",
      "r777",
      "r1084"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r587",
      "r588",
      "r589",
      "r591",
      "r594",
      "r693",
      "r694",
      "r695",
      "r755",
      "r756",
      "r757",
      "r775",
      "r776"
     ]
    },
    "mspr_ReleaseOfTemporaryEquityDuringNonCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ReleaseOfTemporaryEquityDuringNonCash",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Release of temporary equity",
        "label": "Release Of Temporary Equity During Non Cash",
        "documentation": "Release Of Temporary Equity During Non Cash"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ReleaseOfTemporaryEquityForPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ReleaseOfTemporaryEquityForPayments",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Release of temporary equity",
        "label": "Release Of Temporary Equity For Payments",
        "documentation": "Release of temporary equity for payments."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_RepaymentOfTheClaimsFinancingObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "RepaymentOfTheClaimsFinancingObligation",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of the Claims financing obligation",
        "label": "Repayment Of The Claims Financing Obligation",
        "documentation": "Repayment of the Claims financing obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfLinesOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayments of lines of credit",
        "label": "Repayments of Lines of Credit",
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r1010"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r183",
      "r184",
      "r376",
      "r401",
      "r593",
      "r618",
      "r646",
      "r804",
      "r805"
     ]
    },
    "mspr_ReservedSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ReservedSharesMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserved shares.",
        "label": "Reserved Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r890",
      "r901",
      "r911",
      "r944"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r891",
      "r902",
      "r912",
      "r945"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r898",
      "r909",
      "r919",
      "r952"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash",
        "verboseLabel": "Aggregate purchase price",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r1002",
      "r1008"
     ]
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Type [Axis]",
        "documentation": "Information by type of restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r348",
      "r349",
      "r351",
      "r352"
     ]
    },
    "us-gaap_RestructuringPlanAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringPlanAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Plan [Axis]",
        "documentation": "Information by individual restructuring plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringPlanDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringPlanDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Plan [Domain]",
        "documentation": "Identification of the individual restructuring plans."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_RestructuringPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "RestructuringPlanMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Plan [Member]",
        "documentation": "Restructuring plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r101",
      "r653",
      "r678",
      "r683",
      "r691",
      "r729",
      "r855"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r187",
      "r188",
      "r189",
      "r192",
      "r199",
      "r201",
      "r203",
      "r303",
      "r309",
      "r339",
      "r469",
      "r470",
      "r484",
      "r485",
      "r486",
      "r489",
      "r498",
      "r499",
      "r514",
      "r517",
      "r518",
      "r521",
      "r531",
      "r575",
      "r577",
      "r674",
      "r676",
      "r698",
      "r1103"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Claims Recovery",
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r751",
      "r802",
      "r807"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesSummaryOfFinancialInformationForEquityAccountedInvesteesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue",
        "label": "Revenues",
        "totalLabel": "Revenues, Total",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r119",
      "r167",
      "r177",
      "r218",
      "r228",
      "r229",
      "r245",
      "r249",
      "r253",
      "r255",
      "r256",
      "r297",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r563",
      "r643",
      "r817",
      "r1050"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "mspr_SaleOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "SaleOfIntangibleAssets",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of intangible assets",
        "negatedLabel": "Sale of CCRAs",
        "label": "Sale Of Intangible Assets",
        "documentation": "Sale of intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock sold",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of stock, price per share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]"
       }
      }
     },
     "auth_ref": [
      "r417",
      "r1016"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r204",
      "r417",
      "r987",
      "r1016"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Provision",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Company's Deferred Tax Assets and Liabilities",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1058"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Computation of Basic and Diluted Earnings Per Share",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1019"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation Statutory Income Tax Rate to the Company's Effective Tax Rate",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r841",
      "r1055"
     ]
    },
    "mspr_ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Embedded Derivative Liability Valuation Assumptions",
        "label": "Schedule Of Embedded Derivative Liability Valuation Assumptions [Table Text Block]",
        "documentation": "Schedule of embedded derivative liability valuation assumptions."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r293",
      "r294",
      "r296",
      "r480",
      "r988",
      "r989",
      "r990",
      "r1062",
      "r1063",
      "r1064",
      "r1065"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r293",
      "r294",
      "r296",
      "r297",
      "r563"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentInEquityMethodInvesteesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment [Table]",
        "documentation": "Disclosure of information about equity method investment. Includes, but is not limited to, name of investee or group of investees, percentage ownership, difference between investment and value of underlying equity in net assets."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r177",
      "r293",
      "r294",
      "r296",
      "r297",
      "r563"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfChangesInTheCompanysIntangiblesAssetsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetSummaryOfIntangibleAssetsNetDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r327",
      "r330",
      "r331",
      "r334",
      "r636",
      "r801",
      "r826"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Summary of Intangible Assets Net",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r826",
      "r1033"
     ]
    },
    "mspr_ScheduleOfOwnershipInterestsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ScheduleOfOwnershipInterestsTableTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of ownership interests table text block.",
        "label": "Schedule Of Ownership Interests Table Text Block",
        "terseLabel": "Summary of Ownership Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationAndAmortizationOnPropertyAndEquipmentDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r580"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r753",
      "r754",
      "r757"
     ]
    },
    "mspr_ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Roll Forward Of Warrant Liability [Table Text Block]",
        "documentation": "Schedule of roll forward of warrant liability text block",
        "terseLabel": "Schedule of Roll-forward of the Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Other Segment Items",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r25"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Summary of Activity of Shares Underlying Warrants",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity [Table]",
        "documentation": "Disclosure of information about variable interest held, whether or not such variable interest entity (VIE) is included in consolidated financial statements."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r502",
      "r503",
      "r506",
      "r507",
      "r613",
      "r614",
      "r615"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Expected Future Amortization Expense of Intangible Assets",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r826",
      "r1035"
     ]
    },
    "mspr_SecondAmendedAndRestatedFirstLienCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "SecondAmendedAndRestatedFirstLienCreditAgreementMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Second Amended and Restated First Lien Credit Agreement [Member]",
        "label": "Second Amended and Restated First Lien Credit Agreement [Member]",
        "documentation": "Second amended and restated first lien credit agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuredOvernightFinancingRateSofrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SecuredOvernightFinancingRateSofrMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Secured Overnight Financing Rate (SOFR) [Member]",
        "documentation": "Interest rate at which bank can borrow U.S. dollar overnight while posting U.S. Treasury bond as collateral."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "terseLabel": "CODM Title",
        "verboseLabel": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "documentation": "Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r816",
      "r823"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r218",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r235",
      "r236",
      "r237",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254",
      "r256",
      "r811",
      "r814",
      "r815",
      "r817",
      "r819",
      "r821",
      "r822"
     ]
    },
    "us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingExpenseInformationUsedByCodmDescription",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CODM Description",
        "label": "Segment Reporting, Expense Information Used by CODM, Description",
        "documentation": "Description of nature of expense information used by chief operating decision maker (CODM) to manage operation when segment expense information by category is not disclosed."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r237",
      "r249"
     ]
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less:",
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Other Segment Item, Amount",
        "totalLabel": "Other Segment Items",
        "negatedTotalLabel": "Other Segment Items",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r236",
      "r237",
      "r249",
      "r817"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Segments",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r252",
      "r255",
      "r812",
      "r813",
      "r820"
     ]
    },
    "mspr_SeriesMrcsLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "SeriesMrcsLlcMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series MRCS LLC [Member]",
        "label": "Series MRCS LLC [Member]",
        "documentation": "Series MRCS LLC."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ServiceFeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ServiceFeesMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service fees.",
        "label": "Service Fees [Member]",
        "terseLabel": "Service fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Share-Based Payment Arrangement, Noncash Expense, Total",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Tranch One [Member]",
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Tranche One [Member]",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Tranche Three [Member]",
        "verboseLabel": "Third Pre-Paid Advance [Member]",
        "terseLabel": "Trance Three [Member]",
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Tranch Two [Member]",
        "terseLabel": "Resale of the shares of common stock issuable",
        "label": "Share-Based Payment Arrangement, Tranche Two [Member]",
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares, Outstanding",
        "periodStartLabel": "Balance at beginning of period, shares",
        "periodEndLabel": "Balance at end of period, shares",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_SharesPledgedUnderAgreement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "SharesPledgedUnderAgreement",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares pledged under agreement",
        "label": "Shares Pledged Under Agreement",
        "documentation": "Shares pledged under agreement."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_SignificantExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "SignificantExpenses",
     "crdr": "debit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails": {
       "parentTag": "us-gaap_SegmentReportingOtherItemAmount",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Expenses",
        "documentation": "Significant expenses.",
        "terseLabel": "Significant Expenses",
        "negatedLabel": "Significant Expenses",
        "totalLabel": "Significant Expenses, Total",
        "negatedTotalLabel": "Significant Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SoftwareDevelopmentMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Internally developed software",
        "label": "Software Development [Member]",
        "documentation": "Internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_SpecificContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "SpecificContractMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Specific Contract [Member]",
        "documentation": "Specific Contract."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_StandbyEquityPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "StandbyEquityPurchaseAgreementMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Standby Equity Purchase Agreement [Member]",
        "label": "Standby Equity Purchase Agreement [Member]",
        "documentation": "Standby equity purchase agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDerivativeLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r155",
      "r156",
      "r157",
      "r177",
      "r208",
      "r209",
      "r211",
      "r213",
      "r220",
      "r221",
      "r297",
      "r363",
      "r365",
      "r366",
      "r367",
      "r370",
      "r371",
      "r399",
      "r400",
      "r402",
      "r403",
      "r405",
      "r563",
      "r687",
      "r688",
      "r689",
      "r690",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r710",
      "r728",
      "r750",
      "r772",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r986",
      "r1009",
      "r1018"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r76",
      "r79",
      "r80",
      "r142",
      "r164",
      "r165",
      "r166",
      "r187",
      "r188",
      "r189",
      "r192",
      "r199",
      "r201",
      "r203",
      "r219",
      "r303",
      "r309",
      "r339",
      "r407",
      "r469",
      "r470",
      "r484",
      "r485",
      "r486",
      "r489",
      "r498",
      "r499",
      "r514",
      "r516",
      "r517",
      "r518",
      "r519",
      "r521",
      "r531",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r575",
      "r577",
      "r586",
      "r664",
      "r674",
      "r675",
      "r676",
      "r698",
      "r772"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r219",
      "r577",
      "r635",
      "r685",
      "r710",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r728",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r737",
      "r738",
      "r739",
      "r740",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r748",
      "r751",
      "r752",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r772",
      "r863"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r204",
      "r417",
      "r987",
      "r991",
      "r1016"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r219",
      "r259",
      "r577",
      "r635",
      "r685",
      "r710",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r728",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r737",
      "r738",
      "r739",
      "r740",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r748",
      "r751",
      "r752",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r772",
      "r863"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r893",
      "r904",
      "r914",
      "r947"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued",
        "terseLabel": "Issuance of shares in settlement of debt",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r18"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Business combination units issued",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r76",
      "r101"
     ]
    },
    "mspr_StockIssuedDuringPeriodSharesConversionOfWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "StockIssuedDuringPeriodSharesConversionOfWarrants",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares conversion of warrants",
        "label": "Stock Issued During Period Shares Conversion of Warrants",
        "terseLabel": "Conversion of Warrants, shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Class A Issuances, shares",
        "verboseLabel": "Shares issued",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r75",
      "r76",
      "r101",
      "r687",
      "r772",
      "r791"
     ]
    },
    "mspr_StockIssuedDuringPeriodValueConversionOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "StockIssuedDuringPeriodValueConversionOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value conversion of warrants.",
        "label": "Stock Issued During Period Value Conversion of Warrants",
        "terseLabel": "Conversion of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Class A Issuances",
        "verboseLabel": "Committed to purchase shares",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r75",
      "r76",
      "r101",
      "r698",
      "r772",
      "r791",
      "r869"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Equity, Attributable to Parent",
        "totalLabel": "Total stockholders' equity",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r80",
      "r94",
      "r730",
      "r747",
      "r773",
      "r774",
      "r855",
      "r870",
      "r1011",
      "r1032",
      "r1079",
      "r1103"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total equity",
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r35",
      "r43",
      "r142",
      "r143",
      "r165",
      "r187",
      "r188",
      "r189",
      "r192",
      "r199",
      "r201",
      "r303",
      "r309",
      "r339",
      "r407",
      "r469",
      "r470",
      "r484",
      "r485",
      "r486",
      "r489",
      "r498",
      "r499",
      "r514",
      "r516",
      "r517",
      "r518",
      "r519",
      "r521",
      "r531",
      "r564",
      "r565",
      "r569",
      "r576",
      "r586",
      "r675",
      "r676",
      "r696",
      "r730",
      "r747",
      "r773",
      "r774",
      "r795",
      "r869",
      "r1011",
      "r1032",
      "r1079",
      "r1103"
     ]
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness2024ReverseStockSplitAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reverse stock ratio",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityReverseStockSplit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusiness2024ReverseStockSplitAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reverse stock split description",
        "label": "Stockholders' Equity, Reverse Stock Split",
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r570",
      "r597"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r570",
      "r597"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r570",
      "r597"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r570",
      "r597"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r570",
      "r597"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEvents1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r596",
      "r598"
     ]
    },
    "mspr_SubsidiaryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "SubsidiaryAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary [Axis]",
        "documentation": "Subsidiary."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_SubsidiaryDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "SubsidiaryDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary [Domain]",
        "documentation": "Subsidiary."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental cash flow information:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "mspr_TaxReceivableAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "TaxReceivableAgreementMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax receivable agreement.",
        "label": "Tax Receivable Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Shares Outstanding",
        "terseLabel": "Class A common stock subject to possible redemption, shares",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "mspr_TermLoanAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "TermLoanAMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan A.",
        "label": "Term Loan A [Member]",
        "terseLabel": "Term Loan A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_TermLoanBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "TermLoanBMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan B.",
        "label": "Term Loan B [Member]",
        "terseLabel": "Term Loan B [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_TermSheetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "TermSheetMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term Sheet [Member]",
        "documentation": "Term sheet."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_TotalClaimsRecovery": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "TotalClaimsRecovery",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      },
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails": {
       "parentTag": "us-gaap_SegmentReportingOtherItemAmount",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSegmentInformationScheduleOfOtherSegmentItemsDetails",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Claims Recovery",
        "documentation": "Total claims recovery.",
        "totalLabel": "Total Revenues",
        "terseLabel": "Total Revenues",
        "negatedLabel": "Total Revenues"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Transfers of Claims Cost Recovery Rights to Others",
        "label": "Transfer Of Claims Costs Recovery Right To Others [Policy Text Block]",
        "documentation": "Transfer of claims costs recovery right to others."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r397",
      "r404",
      "r522",
      "r556",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r616",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r665",
      "r844",
      "r845",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r856",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1069",
      "r1072",
      "r1073",
      "r1074",
      "r1076",
      "r1078"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r965"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "us-gaap_TypeOfAdoptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfAdoptionMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Domain]",
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r191",
      "r192",
      "r193",
      "r194",
      "r204",
      "r257",
      "r258",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r338",
      "r339",
      "r347",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r492",
      "r493",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r559",
      "r560",
      "r574",
      "r575",
      "r576",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r637",
      "r638",
      "r639",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfRestructuringDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Type of Restructuring [Domain]",
        "documentation": "Identification of the types of restructuring costs."
       }
      }
     },
     "auth_ref": [
      "r348",
      "r349",
      "r351",
      "r352"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureIncomeTaxAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unrecognized Tax Benefits, Beginning Balance",
        "periodEndLabel": "Unrecognized Tax Benefits, Ending Balance",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r446",
      "r459",
      "r840"
     ]
    },
    "mspr_UnsecuredPromissoryNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "UnsecuredPromissoryNotesMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory notes.",
        "label": "Unsecured Promissory Notes [Member]",
        "terseLabel": "Unsecured Promissory Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_UpCUnitHoldersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "UpCUnitHoldersMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNoncontrollingInterestSummaryOfOwnershipUnitsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Up-C Unit Holders.",
        "label": "Up-C Unit Holders [Member]",
        "terseLabel": "UP-C Units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Estimates and Assumptions",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r125",
      "r126",
      "r129",
      "r130"
     ]
    },
    "mspr_VRMFullPaymentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "VRMFullPaymentDescription",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VRM full payment description",
        "label": "V R M Full Payment Description",
        "documentation": "VRM full payment description."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ValueOfFullReturn": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ValueOfFullReturn",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of full return.",
        "label": "Value of Full Return",
        "terseLabel": "Value of full return"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_ValueOfSharesToCoverShortPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "ValueOfSharesToCoverShortPosition",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/InvestmentsInEquitySecuritiesAndObligationsToDeliverSecuritiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of securities to cover short position",
        "label": "Value Of Shares To Cover Short Position",
        "documentation": "Value of shares to cover short position."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_VariableInterestEntityDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "VariableInterestEntityDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity Disclosure [Abstract]",
        "documentation": "Variable interest entity disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entities",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r503",
      "r506",
      "r507",
      "r613",
      "r614",
      "r615"
     ]
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://investor.msprecovery.com/20241231/taxonomy/role/VariableInterestEntitiesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entities",
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r502",
      "r503",
      "r506",
      "r507"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_VirageAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "VirageAmendmentMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Virage Amendment [Member]",
        "documentation": "Virage Amendment.",
        "label": "Virage Amendment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_VirageRecoveryParticipationLpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "VirageRecoveryParticipationLpMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Virage Recovery Participation LP [Member]",
        "documentation": "Virage Recovery Participation LP [Member]",
        "terseLabel": "VRP [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_VirageTermSheetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "VirageTermSheetMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Virage Term Sheet [Member]",
        "documentation": "Virage Term Sheet.",
        "terseLabel": "Virage Term Sheet"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_VrmMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "VrmMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VRM [Member]",
        "label": "VRM [Member]",
        "documentation": "VRM."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_VrmMspRecoveryPartnersLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "VrmMspRecoveryPartnersLlcMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VRM MSP recovery partners LLC.",
        "label": "VRM MSP Recovery Partners LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "mspr_WarrantConversionsOnACashlessBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "WarrantConversionsOnACashlessBasis",
     "crdr": "debit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant conversions on a cashless basis",
        "label": "Warrant Conversions On A Cashless Basis",
        "documentation": "Warrant conversions on a cashless basis."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantExercisePriceIncrease": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantExercisePriceIncrease",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant, Exercise Price, Increase",
        "terseLabel": "Warrant, exercise price, increase per share",
        "documentation": "Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "mspr_WarrantLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "WarrantLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Liability Current",
        "documentation": "Warrant liability current.",
        "terseLabel": "Warrant liability"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_WarrantLiabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "WarrantLiabilityTextBlock",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiability1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Liability [Text Block]",
        "documentation": "The entire disclosure for warrant liability.",
        "terseLabel": "Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureWarrantLiabilityScheduleOfRollforwardOfTheWarrantLiabilityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "verboseLabel": "New Warrants Outstanding [Member]",
        "terseLabel": "Warrants [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r860",
      "r861",
      "r864",
      "r865",
      "r866",
      "r867"
     ]
    },
    "mspr_WarrantPaymentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "WarrantPaymentDescription",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Virage warrants payment description",
        "label": "Warrant Payment description",
        "documentation": "Warrant Payment description."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Note Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableBrickellKeyInvestmentsLpAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant and rights outstanding",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding, Maturity Date",
        "terseLabel": "Warrants expire date",
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants exercisable term",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "mspr_WarrantsIssuedToVirageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "WarrantsIssuedToVirageMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Issued to Virage [Member]",
        "documentation": "Warrants issued to Virage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "verboseLabel": "Weighted average shares outstanding, diluted",
        "terseLabel": "Weighted-average shares of common stock outstanding - diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r213"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Weighted average shares outstanding, basic",
        "terseLabel": "Weighted-average shares of common stock outstanding - basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r213"
     ]
    },
    "mspr_WorkingCapitalCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "WorkingCapitalCreditAgreementMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Working capital credit agreement.",
        "label": "Working Capital Credit Agreement [Member]",
        "terseLabel": "Working Capital Credit Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_WorkingCapitalCreditFacilityCollateralMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "WorkingCapitalCreditFacilityCollateralMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Working Capital Credit Facility Collateral [Member]",
        "label": "Working Capital Credit Facility Collateral [Member]",
        "documentation": "Working capital credit facility collateral."
       }
      }
     },
     "auth_ref": []
    },
    "mspr_WorkingCapitalCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "WorkingCapitalCreditFacilityMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableHazelWorkingCapitalCreditFacilityAndPurchaseMoneyLoanAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Working Capital Credit Facility [Member]",
        "documentation": "Working capital credit facility.",
        "label": "Working Capital Credit Facility [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mspr_YaIiPnLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://investor.msprecovery.com/20241231",
     "localname": "YaIiPnLtdMember",
     "presentation": [
      "http://investor.msprecovery.com/20241231/taxonomy/role/ClaimsFinancingObligationsAndNotesPayableAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableNomuraPromissoryNoteAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureClaimsFinancingObligationsAndNotesPayableYorkvilleStandbyEquityPurchaseAgreementAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureDescriptionOfTheBusinessGoingConcernAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureMaterialAgreementsAdditionalInformationDetail",
      "http://investor.msprecovery.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "YA II PN, Ltd",
        "documentation": "YA II PN, Ltd.",
        "label": "YA II PN, Ltd [Member]",
        "verboseLabel": "YA II PN, Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481766/480-10-25-13"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21D",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-21D"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-6"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-9"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "25",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-10"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483043/710-10-30-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/815/tableOfContent"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/942-320/tableOfContent"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "326",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-3"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "326",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-3"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "323",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/323/tableOfContent"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "b",
   "Publisher": "SEC"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-10"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-2"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-5"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-40/tableOfContent"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477123/405-50-65-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-5C"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-5"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-1A"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-5"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "470",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-14"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-9"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482190/360-10-35-3"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480123/805-50-15-3"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480682/815-20-25-6A"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/940-320/tableOfContent"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>107
<FILENAME>0000950170-25-054434-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-054434-xbrl.zip
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M,*HG41R93!:2^=+5CR+;)#-E&^7:WM&UX%R)LXTWV6&1=$T:,_[,V35L0#U
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MCX;2]?F B"[;/6S6H5\WF6X;"Q'10Q\' [\><NXM D-<L%1%,I+3X#&QRI.
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MR<:1ST![1 EAPI?^?/ ZTV;BP699&:/*4OXQ$16P'$!44 SU5^$#L$V-73?
M4,90*<3I )2K;,+%OADP2/1BGGW:8F^[BF# !NZ9,O?>I45L'T;K5OCRC@Q,
MN!RVL38=6JQ%[,B2D/9U7&F+2 C)4/@U]?B1L+=;_E"IT^",U$0B7!BL?%29
M[\&ZXN?S+$SHJ*Z-/&_APA 2T[^MKIJ;N_G.6?NW57IQUACJZ)75PUG.\*#;
MAO@BCC [&/-)D($/[$0KLJW1GC55-;B=6CKE3EV;?3@=ZU/(HE5:3,]9IDU7
M;?YHQXV^;+G:!Y:W9'7T?W%VR3=>>5O4LIN)L;^73"N$OADS>(095H<RWII\
M&1*H=N\F]MD5*<YO81"><"0[-,RVAS=!YAU$VXRR<BB,IVB#P3+C99B\TQ,^
ML'MLE;IDTGV/A=)X]Z6>2Z##M2G$)B%!U;G[PP$Z3Q73*VZH4_U6OG02%H?Z
ML9\84%N#%07OM3O\V$_L<],F#LP:W7;BC.0=-V,)FUN]Q@09D?S=^,DL3O$;
MWE?4H1!YMW>7^( D?%;^1@L2,B@BM0%AK/.$$>R=X(19@CL3U@&-OMTSHXE@
M"E-9^<;(HY_'Q]N%/W,,&\%[?DA6>LZ29_WK>F)5U-@(E;!4-KVB@%\6C875
MHA;[F+^/F3/&IRAM<!D*Q?J0]*9*VA1I+S%^SR"EY0EBS\3^7)ZHV%A/!#KW
M'%YNY(GPO/P-"9==M 9BZD5+ZL(@^&T(MT35B&01:4'G:M4Y4D=41RWA< T*
M@V+Z39!<5>K\5V1HL _6_\\&CD<F,Y]G+=.9S%;'&/&!H>(K!!U"76PKA-&]
M8O'>.G2>#QS+PQV]_\_N./UW)NPM^-]MX C"I>+LCW I$&8C\4>XI"$%X;+[
M.FGB%F2-1^0]3?D>!+MKP6L6%)(#"H*A?O/_JWB0XI0*8E K9<69#_@0V"H8
M58&RBPQY+_]^P^>;%W;YD:":%@ _[Z-BQ!W#O!*PT,]9[S>76A/ZIUB#%-=
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MSKH4O,(:&ME*A64[?]PC[C)_,_?J8)@>=4UCY]4:0YO./Z5)@X52LY=[CSN
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M>5(J^"):.'P2*\/WN5[=O_Y^5+V!HB0N*'9QMS)QC:U"/GSG,2HTYRJ+]TD
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M<_T\W=3MS7BJN*&#+3YF')I>#>VE3=)K_>>)=V0'L G:(GMJ\ :$H 1J%>_
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M8#L+U$S^?Q58R,>Q8 =0_FW9!TN8R*/\2'.N3ZP^^4'U(.4RRUV#YOXY)-+
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MWQBL62+T?10K8I3$W0P5LXO6LN@S?%.N+DO-_B[-=VA<A@.-)[#/];I4VO?
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M[9UK=A:1<9G_Z2J#K#]UR$Y) '\5(K/#ROD+$O',(?'>30G@K*(H5P)8JI
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M0MCK.[RLNADK2!*!+H'C*!7XYFXM!N66[EPH>+MW.^(9WYJS>-XPMV1B3*[
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M;SI/_9B=V7_2>8*EW#*6[?FCSM-B-[L\T.N/.D];%C%'[P__JO.$?U7>;7
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M4^+B6]_=*EN^"?CWKEKT>;EU>WX27Q6SQUK^*F[O AE_.,9VU'7C&G'XN=N
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M];)0L#<]9WVI'S76IJHZ$)+^<N!BG0WR4T4]HF(=#;KK'HF<JO-LRAT:;6E
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M*DC?NTV,NECE[,"GW]XNCHWG;I+]]G8A:VEPN,-=/?&4+_K3Z4LA/[VQWCU
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M0:90#W"; +?:B6\)Q*AR/3VB\&-/E&H2D[">D2\<8M<DZ)8%$S0H[Y<#\N]
M@_U<8^8E=1UZ\P9">-H/(8TBT/#7B9Z?(8&H6]Y20">;[LCSCS/S*K*\KO&
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M/"#)J2YQQ^7^-N.UR4<!1>8'L]A?,18OVBQ1O/I<R@4H)PGK:%62.0@\JQ$
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M_ 39.,-XCWO9LKG1O&FTG6VC9: .2=D.5MN,/N>6YVC_:Z-[>\-ZQ#EJUH5
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M<0).MM(FLX]XVOL$2LZ</3+2=6THRR]_#0_ODN;OVL2),8<S<:]$H!N1T1T
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M]B9L',[02=Y!3Q*[0]&YN,Y\;_R.A#.#MKNV%WR[48:W%:@5+8OS*_(M!)7
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M:9GA*Q_M#0X2DF;;W7YX%=XD[],:.7W!K#/TZ>*#4^K]@V0=D2U0.!Z\8AI
MO!Y1,.WZ%LF@PAB!VO;(?57[ ./ GM)\,,ZVN]JDF#8P63E6DT>;TG^?%Z2>
M.G^QVQ>>ARI3X+Y*&TL>FYL)*%9->I5@NZMM7ZE:)HGL$??;Z:P"$FPXC%QZ
M!'. G^';%J>XNR(28\46K/0XR#BJ.8[ 05_ZYJ*+E-.7?RZP1&I'ZA:DNURM
M"5&WWCQXM+^NLW5'1K<A>4Q;Q'8WY@LZ<41H'2U$_UJOM16:5M_30Q44N7UG
M:7R?OLM(N1OC4'PRX]R'M/0CE'+]I-9[_C<,#&),;S.U7$(TPI)@'YPHBO(?
M,')T@@3:H([J4!Y)C]OX.= RK/IX9I^&9D;\D\_6LBN.\3E4C=+*_JMNG'+.
M3QI5SZ.4Q=Z=4&UJ+9CKC-E0XQXD\FG6("K)S D1*?-<SHA%P%/OY/?\M.0D
MV%<&J)%YJ6.?I*T0QH&_9&D0X0@6@K!\A!!&YMP1;!%"NNW9R60OY!<S>=:;
M^;.K:EYRD]X,$=N9%$+"%_]-J 9J_-7^3TZ#Z.NW!'__1T<>>') +7PXE<9A
M\?%*&3M^\ /CO/2SVZL]/PQ,R%]I)=9>4S]TS;Y%FG5F7?/UA.-.!V(+L=L)
M';/@ >AJMB!""*DT7\T6T).PKB(ZE\[ZZ#]T7U6$^0S,X"WW;AOW,CG!^;JO
MB79+^/$?D0S 1(XK.,6BC;C<?U<R!"K5'UVJC$W;F2O=6ZWG1\"CLRBE)+\#
M=F-W_9^YU=E8RY9:BH\ZO:^(3.&O$4#!^3JRM.$V.B(B8WTWTY>V 6PSZ:PV
MH?.M.TXE:-087*R 1\#ON<QY/AWJ62I/V&:4-*HGZZ^^JUZRD3S&1'1*\+;B
M.6],MA1P=X!3ER,=5'JJ75A'X:&'4B_':^O.0D')@3"DE\RK*"&DB7IN[_9<
MEU?LZEX;[\R)\A[!>608YV$26AN;@.%,6<P((<PF G@MK6\7N&D@T2>;3\5)
MW#(BS]W"YT?!<@)%Y\KGSYE$\O>+Y,HO(4D!=?/\))(1[T!4"]?L$MN, I,4
M.=-Z+AQ4V?+0H?8#_?6.&T7&VD'/YF5B"]LO/K-%<!<_X!Y9BDW\Y(YT,T3
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MEX)3Z@,="BKM6QF$M6E<OB6%X1+*?#XP*=@5Q-3OK)?S_P#X#$FR7<)X 71
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M8_4=^R?@*V5.2,[ &'%T,8C+EU8)DC[)@U@0_=8$$0B^#ODU\B #+[ FG=>
MD:,\2.3ONR7> (YI_Z^&1W(/ E^YIWKO+K.@R8/,-@'+7ZP'VTGW8.LL*.<P
M?R+;)_Y_6BMJ8!^"?L53N1TQE&N=-M,]0Q8TI]@VM@_K>D8$7(VX6!JEZG@A
ML/J(G)%Y_J5>319K6\4O;2(C]D[D1-&A\V&<Y('%??^6>-R\D7CLUC6VP'%
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MH60"GS!I1,A(W]B-:#O1OK *,,?7%OC^[G3TG@WBPVG^WX4#;E#WKV>Y/>V
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M(?!)Y[I&0?MK2M8OB3=ZG'((L:P59PO#W/<#.=.74PW#IEC-,[A/*TM5_)U
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M2=]V4NF46=F-/;F2)[7VYLI]4<@H(IMX(YH_'4FYEG[O;04NM%3?Z]S[2_0
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M;AXV'"AUM,1;/<!ORQR!VK7W^<_UX9*X\4S;\KOQJ3F9N4[DF?W8=$]4X%7
MU4>\+Y66VFMJ4#B<W2LD)ZE-/'8NSO'3Z06Q+EU3J9)C"AT GYP5\\U:SWCK
MW&W A3*%<@5CZ,Z.4]E]W+WH6.X="\./P8FBH)!CO'>1_@^8RS4]GKLDL3(U
M2><3R9I$->(K'L0)5I)+2Z?+,!OHL6 H!1I^+<ZIN)A8S4 T=B"?OV)TWL]*
M?2>E%7G(0JFB6&?GU?(!WZ0501%:DFPXBV;H2D"<#'_=WZA7UFFV?BF\*\ 4
M)3F;.37T@>EQ+6_ %)$0]-,(G@VE09O]3.U)^5-\_U'W]#^]0,P_=GSK\?HW
M@XXC1[1\8.MP4@P-P47DM<<@?&RR*=*[R[6WQUCG;FKT ZT WU3M46O?)X.C
M-ZJ>E_;X3LN&!-X'_&\F]*]*"HFI ZDTP!M!YWM6CQHIJW.B#+/W4A4%*[!'
MZZW!=0>FX7()WTWHXA_-K0S?Z98*7(ZCQ0Z#9QK39(G'!XT'F+^VJ>5YTP4-
MYG_BRGI.W4([1/(IOM8%A-[I(YR!.#9<YGC\S&E8^];1 MR:T093JYS\0S=I
MP!T<W5PF%$\?9>[@I!+R(SS220RAAWY"CVQ+BW"[<3Y8G'"-:0'88U)9(VRN
MY]PN%+)2*'FAO%<Q*:>J1T5%ZFUIV+7B<JXDP4G&DK&[-&MJOP%Q2"OHMO6K
MKN5JN*X 4'9#-[77QD9[)*CWE>.IR4^=8LY^[S[42].6S _<> _K:J60@@L,
MI3!Z=,G&PB,901JO#07HQ&#"9/#'P=-,:?$/<[[*VB'O/CFEG$L>:= X6%Q5
M>>P'8:FP\(#(<7?1,EU-'B3Y5@IB+#*>!Z$;Z V]62Z98JTHDH_"0%$2E\S7
M6@TVHTX3:+L&%O,@KM!68/W)3-E$_#3P]Q[O"N6W:G0QD^;_O54%;!E2_ T6
MP%?\1]@/N%53THH)1A-/>_MUO_<\1QSVF3()8QJ[P=9K*#V@"_,>T)9,P;%.
M5NIP2VK<L#>[C,0Y7""Z_K^[RLKO,6M3)J\7UN1')'F0BE%NED/MW>8 V-\^
MP=Q1YDP*\R"(66"Z3:;"%;9XM!TVAPCF07IOG#(2L]GV_!_]7?XN;8F%XV/1
M4QXD-H"!XK8:"/$@YV_94AYB)WF0>@78YS0,W^\N[CS#@_0<B <GHQ&+7AK1
M+($V/F2Y/X1E8/E4>?$NVI_[^D0H#W+IZ?A*3K@2?DR6@_@O47]V%P\27,^#
MO-6%>42SLG#KM8;[;*?]OGK_C8&RWLMP2?R_Z(E1Q[-WCJ[,Y')C9$$_/K.>
M@S_[.T3N*AW#LV,Z'XPRS[/YSO*+\GCG)&?WKUQ^/TI8Z..Z][2Z3I$.980?
MV?5W&<.,:JZ $^MX!P//=.)!'N934M64.P]@.VT'L.JIU'N?>U'8O:.. JA'
M-L?4U0\W9\KMAT5YYU2Y1PV8TG-*#Q:XS8 JN!(MA_]4FXQ9XX(7?0_M%G8H
M>L\6(.)L$>I'>RXCWSXKCRUC&?2L:>+>\ %TI_(,?LB:>;,/N,Z#D,]0H?7M
M395Q9[I7- I H4N5F\N)8X(!677TVK6GOQ EM9D/"5[.=JT)5<SXEZ^?G4$<
M'?C8X//,Y41UBX]5Q'QRE:&WI4_<X_AGCA9WD(._^U@,/\*#@#_HT,QU?N$>
M ^.8SHR#<R1Z.-LM?*'9<*N)NV>0(M7_X3)2S>^<I?$;U0Q&=+!O7F9M346
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MMVW;2JIN7I6TH<87!4=4Y]OE.!#AX;!S7,_LO*Y"@115!)D Y7&J.D^V6Q2
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M-^R,Y%?S?]*K?QFKO?/-&=V[E),-+M#2RR4U3\K2O4L/4AQLPI)R\NPN%^Q
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M4\1X7?;.#]=J,;7LUDXSZ6W7OVRE\S;SQ3!B1G5-ZH5$8,GP6+E<R^+[#'9
MEB+OYMTYR6;Z)+E>@.(=[>L>[Q4A<E[/NC$F-WU'L(Y=OB^%N):L&:]D^"F/
M*'XG2BP-CW;]1##%= F10-UDH8+K1<@%(B+']H3IN$\ OYKM&W:UN1ZHTYW'
MS"X<.D%*K'SN,Z@(FPTU++]Y,_5 O]%P/2J*](K\,C.?MDA$&YY^Z3S$\O(*
M<4A990W[XG;,'-$FP6V\Y^?IAKJR:KRZ*A^=A:X<1)<>ZG8/5+6(LI&,D%5>
MDQ>&XQLM)-JX%@GXL9H!I VXA6SE[V<B?:(QR)LP\/[.5]SV!-E<6V2.@&KG
M<B,F!HX^W5(]'(B6/:AUI7<9TA.Z%OJ7A@/[OZ0BEE !]"OSM-Z<YK_T'-@?
MAQ>(?;)F5L[\WGF(C15>*=25@NQOJ4CP^Z5E>-@)7C"?^L."8=KT%8'+Q+'@
M,H'"PODTE]NW T9/<X)6<2K]"PPO;+=C$[W.ZFW>05BFE_"R^FEO+4DV_B98
MH#<]3Q/:6!8(?-MA>4FO(;'TX^W>6<J\MG(U =SMU<V$JR*#"6&&G<E9 KSX
ML<(@[2P]PY*W9?1#(3+W_=P!V(=U@+(15$7K"TOYD&^6KN"7EE3LJ(L&>357
M<=T:1GY7O3]F&X&3[4A+<\"T3-K&$0,2#?Q-7\'1;,XIX9%UP'6,N]!7&H";
M-'3GG?#<$G(@UHPZ1- AIJOR@R/"7"?=4&YR2[=H\W6NQ/12#,+N\\;HG=-'
M4-I8?_3\PW7 %BWQ8RI*<+TO3)V-#%/E&=RXSPS3XPE=O"E'TJ#6G[2YK4VN
M(]X2HW*%,W<[F4#*JT$#_3[F(N+=LB(6M3EKE^X7"+D@>E4^=?*#(A*T: T%
M9D[TVF25[G,].FBS!/FLW8>6DEP.R Z8;+$FY0H/9O](P8G?1;0B7DY@L"K*
MQC\ SQ/"3JT#:.A1G"5TKN?7.O/GN/B%5_BU%;E?/L]#A*T(WDOI=\Q]_5M8
MH]A0ZALM\)U6ZP OO+ 8O_9<<HB^JHQH)OZJY-SG-Q/BJ6PQ)DGRI A[*I@K
MM6*$QSH@=Z/ ]SMKP!(_R$EDC@B#K7FK['.(2FJS'?2MP)I[[UH]7G'6*0&M
M0TRR..RBWG"<O<3@,V9G?,U.C,_9W*[*E'^N8A->,B9(NE2;=+DRNAD:1'T!
MY$)[!(=OXBL7(WRI7HC[A,&QA&SYJE/[>1;UN<QA=6(D9>L AZG^.&P.FQ*>
M*YANX9\(P:D?W 8*"%=CXY5AH\Z(=4"3L7^@Z$=Z;>HXOZ4?L3(%6@A4$QWX
ME$I1"<',GU_>+X7?$XC0I#E0O31,*2]H.O]#Q997DK=  !DMM _SY$(:\8#F
M!%3K&J$YN*@;[>>?+_ Z4PWTIIM!2F0\0)J/G\_,&/<_K4('?U-#*QUAN@V?
MEV@@AL B^47^7OQ0\;A0Y"F(R;'UX-5,."5Y^.DDYGG)4@K&Y:)2;'P+/[HI
M>-Q9Y9NV/YB,[6JU.%[Y*KG/V? @EQZ]8G"P"\I-_4!_\O.;B\T._K0L-\XW
MJ^G8H-@!4?J5@.LOZE:4<)VK^<+S0MW1>8KOS9Y^XGWP#C*0"V8E_2A1P'S9
M"0=NPVQJ'M34Z+U1B_%HR%(W.C1QN7\Z0L;Y-BG!;64AT/7&TFE4 'D ='OA
MOGP($[9FK@3MJ!Y&;_RLHF>'/]U:[;/13DVVT:ZV\4[_16I9EG_9$6]M_[8)
MP"V=ER.Q56U-$A[!22VUO^ JT8A8'=T(Y+8O6;_Y\QRV/VS]>0[;/]/3]'_"
M.6Q_U5YQ M9;193_R*B))@W+H*&6]*HNL;I+W^(-19=9F%,ARB QYWJP3%C%
ML!L,8DSFF2A8:3T;'\Q40K\$3A<*89(>M=7Y<N$9T46!3IEQ=[^F(ET;+S,'
M/59D$F.F6'S0)TN.]X6W@X':]*5WMTND%(U5>7QXIFX95I;H@5R>B1!-(OI7
M1:H9?$0U;VOSXE>X 8I&^7 9YLO99M9J"]* \\&W&G.B12W^7E-HZWSO^=YF
M\8_LKJE>!7@4A(1ONHZ\[=F=F2LG>DFGC\^)W>5VI).3)PMI8['7QG#)RUX]
M-XY@U6C10U0C?-,*(JCP<[[4=@)^_DWS<K<Q[BUUJQ$B6];B'@'\2EVO&81E
M[F_# T4;%Q^Z0NXSYNR0C%WI,[8]'Q@ +Y8].\A<&'VL<:[\@,?WV[X)N-2'
MS"_+2C GS#>CDY9/B=-PIS^N ZJH\V)NY83G3[=NI+1)E&B+@6(3^S27T@#@
M'M@!&MF=]3YK7)SW_)W(#EF$'.P;*>H.1&YI8*D;RF>,S7WVD1K7#AP-_][M
M&]Y&RQS:O8L6YH_RX\FQ$C)[W^"YZ1]/7L@RZ@W@'T]7->VYS]G/4QC>9O$F
MC;ES8.$[[DC/)',=<)FTM*<."&VY4L#W[=[*5!B -Y#BPMD]SYH'^/WN8-)M
M%WRLJ<FG4<,W4ON8,OGCH!"Q>QT@.)K..64RWR'4QG1=YDH*53)YBNQ;Q5SJ
MZ^]2JD(3\L8>H TS6MP.O+QP=3H1L4O@-G:UOJH?DHIR+^M^IDV+BZL_C2TN
ML+_J<_8)[DB'58CK@BAML>.XE[&]PI/J6+2H#F12\0F<)GVC(V,<\#I UDX(
MDT* NN\DOC_@@%XL1'.\86L]=_K^BH8UA[D?K.^)$%PD0[!$3$0;/ X#&G_G
M6^5Z=,5L5-_]$U.Z+0MI"4?O% "CY!W<@N!4D_I/MS[7=O<_*3#X,(RWR(KS
MV!B(<3GPU\E'!-<2./28HB-Y!Z-SMI0-M^I&XC8Y5\'V0>4MS4+36Q![D'5I
MC_._C@A\Z :2_2A7@CITI] \L<8DRM?@IHL[",CJWVWG;W1R\%V7GY^?_ITS
MF^7)E1"C,JW8/3?B3W3H)W8^;(M]N]!X1>%;XF(.?[/X<0E8"L.'@ED]38N5
M+5D&]>4(-9%=PX7XNSY ^;"K*&0@43^WY+PWV=QW5\;XZ/%)#J?@5:_9B;SN
M8%^-B9%-TYZ!XD2-1C".-$[.*:C"^SNL)(?O>J,,0KK8B(PX)A(]8?$B]#/0
MH_<W9864_\ZA:*LJO]I9$/@]E<F5>FD>KL ")&82!?@K^ ./_B)$P/JGLO-_
M\-H7G43>--X3Z[:3!VSN>8#;1S.#CU-59E(V-,#YQ.U9[0[E3XHYZ(1]?/I)
M6KOL5/8+EV[?%TA"9$-93H$K;(PQ/&(EDMZJQO/@\33<27&R\>FQ!^N '<]X
M<BUR0X/LPV6&QEVD"&%+]LZ%#Z](%::(!$;3X%OU3,TE_H+\,TS18!-C@#R1
MB_IZ:&QX: PUQM!P&#!J. &G&6NHPF@E@>% :'E]WPI:]TI5#95F;'=<PK2U
M%9]V>%F?"(</JP^[>%375]7&PK$9(3>CO)DF'N;.UUR_TU\$ALI-Y#.3/R&Z
M=/J<EI"EN\+.:RI/>.72FXWKEL+IZ:.>>$*ILEC^?W[T! ;QO@Z=8B+Y)=1X
ML(:E(G0J92_^R#],F[/8'<%XBQVUA O"C0>6T[.TWTUY[Z-&7(_RW3UC<KD=
M&$6_UK>0<I$[]JD6X6 I;RN_Q?1N'8T LCFS#M!/MYXNPN8/%D0[/?K8E>8S
MFFUC.",)AV[T2\'W_M:LSF]>MIL_P>UDNZOZAD?@7?NXD,U)2N_L%&,.$O:Z
M'^5UJ1>1[VKIY;SPV/^#S]'#F_@H_K=2S_Q.\@[\18HE%]KF/2GXS*WN=$;+
M#M:$<<.@W*DTV@W+'$QG4*J9HW*LG5_@KI0);]"BKUF&@4I[*W-OW_4'P^L
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MKT)HO:.NP*E5G@R+GHA3%#1?XVYMP<N@-'?QDJ(6RXPX[F<&.3#& H/-1!Y
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MI=64Q[QP\;+;L]+P#Y,)[H>.5XR1Q.CZ!'$P9VB\[[YAIX*P"P83'DHS=NO
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M':]<VW<L+,J=N/"C6=/]@X#]>[9X:F1$OC!:ML-CFZTPQB5M@C?J>'IV75
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M=VBT#'%7<ZN//+\QP?Y0,O8FCO?<7P1XMK_]5(EP?P-4=8RYP 52H?N@X^/
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M<<_,0-2WT(R9P-B<H\Y!6 #*[P?(J6%R2Z6V*<_+OO);<FL,1&_W.^:!HZ!
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M)\J%VY<E65_M>7GA]UV_6']B$HJS5*T=\_&^$WIN SR#9D<#*?\D]!%4S1+
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ML?.^BLT(B-&B]3W2+(>+R5K>+#I=2%3N+?9)N\G>FFVKY3V $45HWPZXLB"
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MU@PYVW(>&JRA<4\WEJE2;C(%D'"?(4=BA[([2KQ?NZ"HC"QYS4\Z$_4L"-5
M96(F&#I>.O4<_"CT79KTT$TC=ZWP8G ?-MU]7"L\EBX&KU.4@-L^_:E%VT8F
M=GYACS.T!M;[5$I<IZDV[<3:F>"B)Z_W^%2E+B?GWB+E\(IX39, $R--NGM=
M:,7LXHZEM,NM^P).BX_TS$?<D1::LM*TS?IZR:._='XX=NO1U(7XG3^2?](/
M_ZP(%4 >!L-<HU$MR":D/*B-.N57[AW6U\#$0AMLXH=E;QP=A -Y'*^FW\P\
M7FLT8MQ2O(^UJ+_^5%F275WGQ9TR=E%OEM68T5G?)_;$BMLF+;Z]XB6N\*4
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M;+5EI_=;#*@4*!VU2 \/L6_?F&I11>C4D*U!TSB2]\A>TF4T;/$<O:LHL+6
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M%@^!T>+&XIZMK[80.M_5K?]JXBZ P*.$06COVJ]_5]/\%ID;>/KME;G/UXX
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MZ7P#+I3J&FG@X'N3J,-)]8_?,]9MJ,1YU=LYXV1G:ONX ^L_K*!75^72.C"
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MNVKDG3%2N1$^T8_2AL!]'+O -/W&#J>A-G:MD0T!#6WJ&C+9CJ<?+K*>0-2
M5X5@(XR&HNQX?ESY20<Z\N'7GIH="^]3,$W(S0UY,X X1JRIP:&?0D5IW+@#
MRO=JIMUOR.0D4.&DJAL'IDJHE%P*8J7%+J4].@L;=Y'TN<;HY50*._S5 -SE
ME1NE+;0X/]O#VDNLS!XYU=>!</=#'^&5UMW='G_AQ"VE:F9_Z)W3F=3RE\3&
MU!J;%94"Z\FTT;'*DVHC4];5\'[R:N;35'#)?ZW D($;+S<&;) 5-KR=$S1J
M'*F<%\ ]Y*%+%:VYH<6.S?9C5MJET"=H1)+?0<\$:OU*^^WNFA]\O.[U74C2
M7",]<I:TM77WQSS2;I553EY-X30Q873RK  RJD\5Y@>R!B+%6-&F)-AQ=TKC
MY19TP&89-#NZ<&IQ>#)X7]?>U[;+CJ*6W=[]RN)RCL>S7O$W0V6,)$B^6GX8
M<WNS0/RKQ6A4^T2\@_BZT#I[-J<\>G4IV/S3PJOUU8/_=/GI6U=M'!O@?!W%
M]5>/;GE U [4KXZB-@YO[3U BNV=LEL:\H*GZY7U!>H4-H;>2C9A2<?=#<B:
MWCQ\0>MZ936J5G>NU;*RK+:2]?'PQ2.F[TU/M&AW]6@ON<?H2;],2W'/J333
MSZF5!85)6QG0/+\1[!(2<DE6UKOCSN=9]Y^5.4X=OS8P.&THVU<4U[],%IW9
MW!]EDC]9%0)''5:3&WJG42[OK>M;T0E[T\>J%D8*;_X;9?X+\+AJ'531(]VF
M#A=K/XZ[GCA\;3 ;]X!X:"@:?:!A6-58$9U=\9SN Q<7X531;=&6)[*8[;5Y
M'KW^-H_F1FK #P5CK&>N884TO'+M-*8&B;"MA;8LG^;IN#BE)%.<9OM6$H;\
MX#Z+#NLC'_<4_FIW_=7N^JO=]5>[ZZ]VU_>7J<9@T.#M6!MV..<X2WX$'R,)
M'A9 (H)E:S_G5-M*C ?)6W[R)4)9*C$U^+U6'L$RK$TYR?33&JJ8_>4*FMWF
M^!U+F$4RJR^DQI1)?9^NQ@%&%4XY'FARVL;:@:<!.Z?*7(/22S*1B%QD/10"
MEQAT>!OB_<EFY[.)R)3#N^+63&P6UO&5QG\VSD0VD3>#7>E[.^GA]23I.^@:
M^='GC'W><$3DL%S9FT0XL5M%_;5(('(DU?9&%ZWR\8=%K+A3;6WBI^I'+3-?
M=5:/?'R$J[[J9?+QI365O829'MU=:<"K3]8^<%7#?4J35R0DTXP^CNX:]-=N
M8<HH,OJ]7%Y!_%&@51%'OBEX#ZLR#./2%6@Z(H#LG"0>9H)9&UKV]LI1PY?5
MT X7:\,N.!W.2NH%.X>QPX>=XQ5_^C#Y[B<!Y"RT/W64%": N ,/D&*@+O9:
MDU1R#.\T)B!OJN3CP: MC4F/UWRC#/3U)P+@&3/LE+ 7*CY6/MMW#I\W2(UX
M3FIGD[)(G'UX!EPWC0[]X^R%ITOS.YN"6/HTYT]D);N9*I_:\LI8WG%)J*YQ
MM&W'2!?/(F=@7WE7X6UAOAPU=\M=1\%?)[FUS2W@XK973GSYR@D1[6P!Y-=^
M>(N7K_YK*;\C"WISW=:.;_L:5J9K[6<!!,'".+"?\=T9*:!.93KA*??0 <W#
MF_E/#71>G5O3>G#G3K!2H&E(IZ\FJ-/'\+2JM]^1+]V]\/5SS7YO ].]-[)#
MQJ%[W;MT54O.0)?26,GTRM#@S3PUUGP35?X:/[4!*EYS/!^;:$693!P.BI)D
M:QQL_K0?:M5;OH70J?W&%.K6C2FZOO>#&F\1/,P[SU)M$D B#?4YV73N6TP@
MG+6AR7\B6B<R._&3B&_1M"15)YLH<8)6\MHTH=F<$')(XTZA1E&1A@:#\7O4
M'OZ=5^&GW:T35MS53-I?5@@@[YQ]QP81L)\*6LTL$?8IQ.FCP@#5DI:<8K97
M2@@CY[#_D7)LH0H@S$OS_<$#[ )^8:#HR/S.+_Q*&O5A#3D2*I&1, R/-C-J
M4)1Y4YY ;;"Y?OZF[K 6:U-[#*WVC/(;PG-O1Q/KZM+G>(W]88BY<=)> 60D
MBE2FRCN,Z?<0CTK?WP'6C9(I.Z8'WFMH?!! S"LYF%N)9Y@+79M5;-$^T? T
MD_=)[T5R9?R!R*6WFHX'*QT<$%\^K@9^)%4T7CP\O+OVP\!M<)!XKY-_Q>KT
MH)26B[%NT9%T[OSMVFZ^=,7D_\'>>X8UF6YMPYFQ,J@H""@(<2B"(L1"45K&
M0A.!H4B'#")2(D2D!0C)# H(""@(C%'(2!4I$6E2,T( $9%.)$A)4) 22"CA
MAK3W9N9XWN_;>WB^U[UG]KN?8W_^N'XD![FYK[+6.L]UK3)T$52WBV^?_;/>
MP2_Y;W_*S+5A3V*V W#.64 ?]Q7&&\#1YF^[2J99!^Q,K/(]6-M#O'C""50@
M0+A3:5JG"W/@F6I>9G]0DHB/X]4G:562$FW!SYS-I-?Z]_;Z^UCZG3"?RNNU
MJ$':\#;W>.>EK!<-6K[(OTBZU@G(;2./1B/\6*VSQ:$%7 3S?'A>/1#^M-V+
M)*ZN /=*'35>4 WDR;=J>]3Y*US5V9,'/#'S]_7UI/'\#4:RM]$D"G*GPP[E
M/_E4,Y 1D8.4,E@>22_TUL[-;8[.SYT.EA0%61XU(>J]OXL#PL'%0+5B./>-
MI;.3LX'"2<-D>64!Y,)3P)T-<H3(4.Q;1*5>5,=\$O<T+$9?(?>.9AB\F;@M
M@F#&2HT;S!BPK2$^W+'F&5>._I5S%!],\@C1:""HOM&6??QXQ$3B,6K6K<S!
ML(NL=.I3?0Y6G517F?[0-OW^0]UI8'OMZ_B/N%>C-3SI_I"R&L;KI+&:.-Y.
M7BEN# \M1\V&:+34$J?V8,X"YAY"GBRGEYHKDMIZ!??R%A@8EZSJ%'NF+S/Q
M5*9)Q?8Y72W=JN\=O5T5^V&BT\*XSB,KA_NB[ MZ'WE*EL77+$7@IS/PTTEJ
MU^\KC)]ZT1;H,PK7F"@'SV?1W3_K;R<R4OA"JIRKN"8;;*=$@R3+=Y[ NCF6
M4'F/)B+5KG(9)?I)5;Q/5IB5%:NFIG:HNJ^\6&.)M*=3?HY IIKG%JS:!N/K
MHXIPY.$(?XX(MB]L=/8FQQ"0I[,)$^^!( ^<,,:HVUWT&(4O@UR1B*6K*"8>
M_C8454ZI>,;2CXR^=),O:B'RJ0.=KFD:@(3+ZNQ<QHO&(>IB2&:KQ>-3&OE^
M?K9L[6,5]0DVHR]AP=B$^1E)8B[%F@=1+NJ0=.BI,\KVUO^VB\BH<!%Q[3VJ
MD2%M\_R^F6>!MV-ND1TUB)?3OM#N&^JMJ[7[0IW)WMOC-QV#%L+](K9R_B7>
MDI9M&S5@7)[D"T<(($JC=!'.(<(NW-)0".)N_S( 7W&&\\)B/F#82CPZ$7AG
M:2#>\\/G@$-L.FZC/@$TRL:Y:I@)?_ZB!;]NO=3J);U'M8 8J!.?"R ]!\&'
MA1JA_P<D/_T-6N3?0$C!/Y1B[ 60Y^GC)-Z%(,?%"TND/Q1(CBC7WRZ 1,.3
M]2^OEWP%D9;-P;_Z*FK#*/B-6]+Y7=HH66W-\U,!N/<BI\')G 0I1O_D+D(3
MM%R8?Y&R0P 9[&@C+:>.GUR\"EJ9^44N]M\=?K&A#3RKOPW7IL8D\5H$D&6Y
M_ID!E3;^WW\S7HJ8/Y4$VF#0@)@;\YI @'_/UD$ N<R5Y&=;@8]YIO<OOSLD
MOA=  (56;DIG/(Y]^A-NS3V9M&,C;M>J&P:"!>]'N'>N%@)(H>YAGMB2'?A-
M;Q.)_149OI;3"BU6MS3 ?06=_MQ"FAL.NXDDKH0(W[*;<QXWK !N_A3S-<FT
M<(,RR4XTW,AU<"WY2?Q'L:FX,5M01"_!EV*A3<4@#+R,&?N#D"00MN ^)*X7
M;G_N.0;G&90_77J]"/]#B63,^2HL<5$_4P=FL KJ*&.W?]9-A5#%4N%E&3$,
M.XXF]R)P4J?9MPA9 V<3;FKL?]0J\6 \XVN#_CJ5(-V;]TL)UI7Q9OVW=[0:
MD?KV0.[=2Y]V//+X\%G+1RZY0H<-V-[#6&6KN/L>^U4*#N$7?-X((!HNUA=)
MW4%Z1D;]OAZE?4L/9^I/6CW_^2N-7%X4.:TJK6S+T2RG\-LY<=_M^_'3=>.)
M)Y39*JX$B8VH!)0XYD8L9),$W(-IQ]CC^P1=,Z'L^R&18@8\R.O<+ NO,MGL
M"RJ\QC.J$^GC#AYI'TM*- A[9EBY%?6IJ04IK+R&EJA+CJG:I51_LY).AM&'
MN0:CCOZ\*9L,K3J7>MLI;J_%!*@G?;[[K W/Y4H!Q73B3R1QW2VLD)=:\*LL
M>-.\F'>#0J^63HXDX?+/$54F#0NO0GHUBO7FEA*L=AM1U6=FGHB(2BU>.*R>
M\VB]EW1FA\95PE,I7_7>,C/U@:EBZU7H)P8SG6X7TW "<PS L1"--U8S98!8
MVLY-+5)6Y5UF>KF5]7E#T]O,&I AR<K+>D<</O0&.?F.>&3F>@=YG\CI>A7_
MZ1)W!E1/FTG>;16C6[EG>*D8RZ?G5URWI/+EN$<C)T*T+&B^6+XQ-_270?*E
M@XFM9UD&;PET8_ESJA\[1A,UICXT%]^Y#/^4U0 7,Z#-].6P[]131D3L2=6%
M[! 7D:S'EVQSA8JIY>G>J@H-O-K"8Y]9X**)!8\-A&X!D&3]XRSS M\LM'MC
MF&PQ';%GQJZHW3/'2UL\JJ6@<#K]6MQ<Y8!41''S^]G;LW*QKPMW?R7J.ZA2
ME64:S-DZ1.B$<25KV01^&W.R"52L)YM2Z"O-\,M  >N(A_,J]D OBK@T_S40
M<47.&,%Q(DMHM]X.,L9USQ?!:?N9;YXL.""M0676S@@?9<!90ZZ\7*P>UPSH
M)[8%3 !#9$IZF%["0'^* ;,X<UBG,6Q[W.DYMWB.=%,EWO=6UOZ/)GYNF1]S
M\0X?4KFB#22A,V[,I:FAD2IU[J2JQXKW7HX"9DZNL-C6>BK<(#BN.X)#TFQ<
MST'?_3?JZRGI,FFP[!*O".XM$H/8=K1G0D_$IJ^E;+S#ZMUNJM*/ZA*)G&9)
M^@_?#+U_[[BENSSVBJP3DEJ2NHFE@2E$#"AQ=\>#$L$T:H2*\WM'Y$I;X_5A
MSL-HHY=6%BB%&U.X'=R3!4_ZU52O)I]R!B7"?5Q%$ODI\CVU@A#)/1WB?8,8
M%/[UC7$D#R%R.G^^HDV$97I> &'TAV(2F'WU%5[-7)41 G"II,&O>Y50'VQK
M&^:;D9>1[^@XM88E(%$>;FX>*/'BC-2,(I,MQ;FY14(') 8JNPSO#@TUQNX]
M+F<D=43YZXZ]=J\(9_^49^S+;=Y?,?98;-8ZUN$;L&.]N;G)9J:%U'IS\^C3
M;OC#F]:;F[<I^!4EWKGTT^8XK@:O3  9BQW=W@ S*D8OLGT(%X'#+%F$YFK=
M[C2D9"-,]&W:VZS&3M->N@E?QOG]VX.!]5T_].GJ?-VL^()YQ\JUH<";0S#P
M-:QW%)W,U9+L1^U7ZXGO)C8'>C_HRS4O"O4Q, F<(P2N6/1B\U<IW !>)O8D
MMB/S).%7G%3=IA(TU-7BA.FVOH-B7@T'R^Z<=[)F5MV^1AT_SU+[.0^=A5\Q
M(-7%O9UMRQ^5=C$<F>B!2A*7O(!:IAW-J)6X;100'A?YD:LW+H!\,[W'3'J*
MRB \T+A?1N[2X,<^'=)K**4-7U9^%^^"^JY/??AR&TLQ8TGTZ0L^ N<+ ^2T
MR*2HZ]-8."^M9#GICOZ6BCADQSG:,!"'BW<\H%RE)5H9A<H?=+3'G"F-W&>E
M4-[S^#GK5I661%H8+D:#K:7%Y+QS?IOJ=+:BP(8Z?^$&UHP4U-#36_ZP:P$Y
MYF-=5S"2(\G?)CZ1WCP#M4V&;_4JU*JTP_M^7._IY?S.1T+RY"#"?N2E:O''
MU(]%Q-];>AU@4S1[6YB=FU\E-QW1O2%7<U?%[LGUS_4S_K?<90#%W4UD%PD@
M43',&#*N3"1N&:;33-JJ.[H'+<8X,5_3KR\^LT98\W@4?J=*$LJ\B:[]7C/E
MO87"]2&O$35F9D+^KZI+!9K89<KJ-+8-4:Y?SSF*[<+MQ&I^0@8$;;NU_*JW
M64JU/"Z!;K%Y^M4:XHZNOH2GJ6%UG[IT8>=L+'%SY9I?O41JT79\A+8HZ1.4
MEB3Z25^=28FI<Z?Y6@TY,5OCU?64R T'!HH>X#OMNH*&A".LC?M5]_?+%!.7
M.(7A+_9W[VL^(G%)X:?%TYG003OV/=>/R';S%-M)A&9?_17*N:%?!]CWJZ57
M"@9#7_#2%P"L:76UP5X[_#]?[?\+#_S" [_PP"\\\/]//' =$/U*8EJ-#B:B
MJ 2V*7!SK&.3:;PUD$ [E07$,YLWB^@M\0\SG[8'!/PR52@MK[=R1U?K4#5-
M9?O'U*,4FX' F7;2\.!6!&TKJ8=.BID'5&"SI ".%G:@ =:G7@N5I\VW/,PP
MI1,B%2-'=,*%=3("+--P^]&71T[)QPV,\O>,BKYWKL@D7(N728_10.PJZ5_\
M3G;$TO4M.E1/  DUYRU9QZTJ*M3EK&6ZNIG2BM)7/*?83EQK;#QE40X4K\"%
MQL^]O0[G_:RO@QPMLVLE12.DRH74,*.; ?S;>?O2"FH/TE6\;C@?77;FN(E>
M^0D!Y!H0/&_U[+:9KHGXFR[GHF?MFV_DK^T&W,DU(@FZ&K3Y?8"33>4 ]SB]
M0\2$!8O1*#QTM:Q_22:X<=2F1\/4,,@(B>3I3X_,;0TT/'XA*M7D(.ZA#,Z9
MQ#PK@%!O0&^/?A4T.CA*ULXI UK'HI:H,=&T^@S%%PV .SU^U8\AT?W X T+
M[42F2*4]N/Z\[80WWJ^8%B\<$M?E2'5"KU;L\O$GBA=KM>NHTI2R<;0T GLQ
M0L0(5MA^V@IEPND60$2'@U>R!9"<'.Q4MX'XXF3)_QF)@_A[RUM>GC4M?Y:3
MQ>^L$2>7 H7C'0L=)::HHUTF>1AM)C8WWR?L[LFSW<]-Z681ZA'[OG,8:^C^
MEJ61T>>[]R<%7G,FVO<Q?F+"JYC!H">'3F:>C]OW;>R.Y [UY^+&] 3Q3!.9
MU#U[RW9_I<$5YH\BRCM 1N+&L<08 MGL6$2C;7K'&#':UD(Y64^'1HGR\V,$
M2MS>ENJ63I84\W$]T:^:_:(Z<M2)I5D@GDM.0_H99:=]SWX7I5G_6O/A8OH[
M!*Y^"GHR2<9NL-O?O*< 363R\E<<<$.M+>L4X33M[Y&!;"M''[.?I<009I71
M\E_BA%X>K6DEP\2GUK[%'S3N*;_NRB%G'GQ!#CA6RJ1$,S10NZ=A!R1%<Z,?
MW& YO3<N%!9 'B-^PHC32-%\868^2%2W>7=[RXHS[6+*DX2!<+,8Z:-+$:(M
M.[4;18&M#K8CPSL6&SQ>_-RF6]3S:A:7@0(.)H'"@I0DBU![R0,Z<GV^1*P$
MYIA3(7KH;:5I^\YSK5BE<N_LJTF2P=J>48&,L]T]YSZBF\Q2[U@9)_$.4SHF
M*GBY01=@PUEX;$#J(Q)S[_VPP<40O4=;U"[X9=NFFA&Y\:CZX=7?VD>Z.ORI
M^)XO3.VO1949I$I/KAB<C>:57INOJ$=<!+&Z/^M':GD8HIFTW>&\QOX\XY(M
MY2!H7B%XY*+'+SK%NJ4%A!\BT(,B>U1V*C7C-7+2CW=R[_,IB&<AK?/O*&2X
M.Y!"FV<@MOA(GFRE$6+Y^Q(G0.R"_V"B8X3:V3\8Y<&<JSYZ1B&E:8U.'1&]
M$J&WK*/<O$08-7 ';C91M\6KF]DUZ1_I6L*) BB7TA<]RR01X.;%YP.!9IX7
MZQ(>U_96N*A81DXT?5]:$XM7B3>M#2V>3'B@F'#_G@O@W%@IU8VKRVD@9Y8B
MWJ>5P&DA25<>5K<AMIE74)U3X0]4H4 VI=]AM;P(A^>)\]2P[PG,<Z.KPIB+
MO/@A3GI8_J\NX9<$D BU"0!)[[@ZR:^?2[K%1> $D#,.Y01Q >25=.,E[O#Z
MFPH@MY;K?WO5Y:2=Z)2S#?_UJO7=%?72UF7W_NM5P;^T:*A(=5Q_5[3?P7L.
MB@GV>Q &,>0><A/^$9';'68.*T^?)DIVU\KJ.6HHMZ?Y5["3!TXL85UL9YX>
M_Y05]_[5/WT_NS8D@$2*8WM3, : #!TW.-0LE6.GKPC(8S3@6W/)<]2HT2;H
MWN&.&Y6//6R3YV!"P%,SPS?#$;G)K284[LFL9J2WKYL/!=JF&'&3LQ7;789M
MAU; &SOCQ=I@7#GFS+;&T=V^HL'1.J2OT!7P4LPY]2>*D3H%@=OG5+D.N8/O
M+7;FK(W&E%?4X)4W)\,.:<8,'%N,M,,[+W$66VW2@=3Q1>UC_1$)7J_9\9@R
MQNL1D%O$F&"2YD?BXH1HU='2#[VS7E2]B#L]EBDD:N\9;2-JH'ZBQ4$A[KP'
M^H/AE< ?7AL?[*M8,.KZRT7C"^'Z0KB^$*XOA.L_E'!]A;B/8-JCUH.^(GDI
M%9W[IB3T0\@6/T*I4%%=F+KF@D5(."VJ*A)^FR^U57DR5;5"1&3P)=W 6'4$
MF8%\217/-O/UU/C0M!R<E;G=SPU/G=BW7ND^66@L4WV]TOV.&TWJ5EO7*]TG
M&P\[R.PK_%I(/%<J.=M6W+U.(7<Z;:;GPM2JIH'QD;OW%<M37#,(;8/$<]Q>
M96(%?.P74!DZCSXG,NQ8,%I&W@.UC+%:#FT<%WWTS8+3,$:/Y4S1<M2U#3 Y
M8-4A&3-/ZZ^3"3A:&JU-B)YO- D0;0WQ9[E$))QNR?G62HWUR"8]VXXST%FF
M?\/R^OUL14^)7E<O4!$\/_LYE*WA)>^F .(=2[K22<716IO;;ZH %U2F=%59
MLF_WN=*=B#$-2L>G^')X8?3]]\ZC7BILA+BWYG6330BDU%:"NV[CVXF/T/'I
M(Y[;^VX]5D2_53OA:N; Y>C?>=+6:'D_T-_'M%\GFZ<R2[RVK**SGG57T:?.
M.SLPPF[DOZ:K%.H,Z3Q)_CWMSEC-U^^'>X>J7D2-',X*3-:Z\H,9GAL-&O?C
M_%X!A%DO@'B$PV.DWO,]$]:!\:Q%3)4 HJ9/&=.)UR$!MF%)KS=[?_"6TL^E
M62B+R>,:%=F#6&0W@JC!ZB^XD.#0D\9,K;=EX4Z5\SV[>YX\[8TR*$_&)EUM
M,)]: \^:@\3_IQ$S!Y6E.]S[%1;";PL;O:GN8N4$TDMH;@T00@LLSW"K+V<^
M5RWN)->'(]4F2V\VI1]'7W!0S4U<Z+5A52:$[G*/#+:@YY% ^#E61"AOQX+<
ML6+TSEA/B=S#7TE;/]8#IF,#56G[&<M;F1,%Z$P5UMX038:"I#\2J^Q[?JKJ
M[@7F>P#;?O[>+L:L /(@=3DT0L0M.@XY6L!I6SVM^+K!\L+,ZJ/:S*UJQ(KB
M0PW[PN^MNLY/S"\\ \TT->!O3#_(+T2X.^G0V 9M9D@34<@QHI;,/\W2C*7I
M;>TKFC@=Y!)N6=5[M&[1=\L;UI"1WFN3(/7K%W^H-+FZ\,[0X(8XAR> ;);A
M/8#3U('B<0051:Z!$VBCM]C$L7G(B,N.(6>,,4OQQPB_N39,@2B2^ U:DR5?
M(V;R565*"U6O_ZFSF;2)1Z+<\\>&N79LNYK:MBGQE7I,28=R;Y#/63S'PHZJ
MX@!/)OD&PG,[?T1LU57AZ&+V P%,NY?> LA> :2I<\>@U_?#Y4*^^F4%5TU'
M=Z.3UT:4DI6#X'O1D?,V+-DG=[7NUB06!!ZTB;D,(UH:8 +\S%Z;51T:0@4/
MU:(ZZBVR3122;4T4TJ^4&RO_D_5F__?X4F'R+QX-,KQ2TAB!!,'Y[MQJ 5BH
M6P"&?$5[[V1[P(X^'\5@%-<ALJ^A]%^WV^\H]!V'[FBZ(8V+J9@_.5M)J:GB
MRCNF1P>9F?NZZ=.S2L0R3A_N3;F5-8</QC&MIS-Z'=6[3][RE-S?? $6V$_A
MPC,GF3#.97XC[@#I\KSX3AVZ6A*O>,S%W;JNC&G1++-KOR*3&"<7.W>EO*KZ
MAUYX--=,DW!MA:(OT7^5<\5$_'U-4 LQCYIA;A$_PU.H<Q_KW,X]QVPI'2/)
MHCW/L9)N8<[X'%TF[012+I8-!+I8#5Z-HY^:#YP!\BL)KZHCA0L]T6_2*-?/
M!&TR\M]AI?1;P#T($B.U@:HQ&_UO@6:.ND$1FC,V?,<./QI;)Q9R'1^3R-_O
M7:J0KE65YG=>2U:=Z?KSXR3J+W$X\4_:/\3Y!LO<:+<8P#@2SMQ\\]BQ;X::
M87:_\M9H)RUEEC? ]JX0>T4>RS5?S T]%R+S$<J_H(_/K>^YQCV:%:?2?^J?
MW3.1N4U\(7F.T?OUKH6EG9&]9*E\=GJ2_F[G#F9Z\_-.A:O\A:&FM,H4 .;P
M(B$?SQYG\+^I[YI%:13V3B!=Y7MT#6ZX3"9^,%KS1[1V<G=WLD&+%.7-^7YZ
M=.MRQKE9_CY@F?9@B:%_.'_!UPV(&7M7PCU#J\Z8K$GL@3%4MZ/+SL9I1)H.
MFSKTZ<(]_,;X$[A9J08+J-&[RSX&*F=Q=3$&WG[IR>GJ5K/WYFE'PAWWH.A)
MU3#[7,]I>B_V&BA0X]J?92L_=SW&-VW$H=86-\Q76^-".250?OVY!?UP,3[+
MCKO^0E/'/@OKFI(V*"/"G $5-$8 N1_/?RN K(#@;-F :T:<.](0<$H "<T7
M0%SE!9#\(YEO7;A" @AE$#>U&WQ:77;=OSO6^N^' '(:]@<B%8;X8[): Q6Z
M&=<$;8,>7T^^:8Q3?OI7%D']'<)NU/-YPU(B54?X\K@Q(GSAG@A5C#^EQ7\R
M'YW*.[ED VY]S".01NW_&62[BS$6M"3J%@'D$#(:-SOQ873M->O!:IG!7KN5
M53[\W^TWV]!A\!BZB?0A'8W@C^/6[ODLSXA_$$#^[AO6.^+*(R,>#N3S^0I8
MVGT!Y%7A45 I8(4%$,L"\"GVLC_^JUFYW1R.*^K.-YEL)G$.+,%YQ]L0T>(<
M B@4X+HGA[)0_%8]$0'DX@V[\4P]7%OY6_@L3 G<N\R]_-@U%0&D;8HVRH'0
MH3PK]Z0!O'(6Z<>D9<R?2B'8@$(A<OLWRE8K9I+F3^% 8KKN_CC_FL14P5&>
M$M;.)]$&0,Y=JG_]CR)BV/D'&A5*^&.N6H/<NMN!8"&3GL6-C%/..?8G^>LF
ME@A?.)8#>\]UXA'4+1(S]Y5RC.+AGC,9AHO.<=21DT$%F),L=7R@K%RRB7P2
M0PO.C)VVU78E?6WZ;45O8"C&*?AVLL5AW(==I)X ,E^J"^--(^X&=)JU72JK
M:$D27F%5T75&62.%&IG$7V8J):5<B;G#3T_H."&F5NPD4IYJ'X^S^^:UL3R7
M T="!P40>UXZS@L5!]U4$?JQP6(+.FJ\2R.TCJCES,26^J)* !U'PNQT95O$
M$\#3JF>RO]@WOBD?N>W[7JWR-'/DIQ-X;M_'F)25@G5>NYE01V(,Z@@@0^VE
M'Z[NK?:4:O>FGA! 1!TC6(A5%?U@T%J^TQW[W(5:TN(+Q7"L.C@J_'Z^$"7(
MM,T-"&!)V6/W<4UO!E3424G&HACR/747N[$L*\0V(%E/Q>5%=31UW!(ETD27
MD;>XE.)P%[YBAYA(0KQOY8I6L1\]9#_D)>M*%Z!OVL1; K',U[8 8GP@E&IF
M.#??-)!63!O=/9KS.J4-=KL.YI_K,CPMWU'10'&C6.WO:,[]6$^,>=@%'-^#
M6)K+;0!,^,=17.7E$VLD<<G)4SA&^P)R KO>%H.6^<M_*V*_7692;Z &W=<O
M,\?U-MG$7P02Z*^R@"!F,WE^RY+L8995NV\ T;M8JE9QY2972[::/B2D&#L[
M9--=/J-#&AZ)0C44 L,@VJ'P^R1&I4%NQ1<%+G,8KM_P,A@5(MO?M^\D)SM.
M(\0T#H\16E>$]MV[; $8?2SKX8H?M1I2[6\HHW5@SU>_>%Y?L8?]@U>$^Y[M
M%>AS*RFSXQ+U%/ZAOO#!AE;-(\3GV8<R\F'!,G,KR&Z7M:%J8+U@T(#L'_1[
M?M8G*O'V<H92$U4\ZFUA"9*:$9V0[1ULN9^HH6IG4Q/7:OZL/ KK[8=2FXP>
MV9[^0/'>[AM(WE<X=]@@O9/MP,,W2' E8HO]-' [O7S#QW=>&#@5.=V@Q=KY
M?FT^KH3?+:60GM;ELQ;5DI[C[)S^PFR;14_Q?G)PJ1P.1F(:B QBA\8]&:>5
MFHEB[WB%+Q%E]94$^HQ77E6RJ8LI_6JN+A/]]?"'XT4F LAV;F58?L+E-)74
MFJH!S.E?#-D4";LJ0_AL7-V.$9+Z>$Q\CP1H9YH5YXCW7000QL<A"R=8KM?K
MLA&[6[C&C _\&R:8.M!($O<M1?Y9N+/AK1263J%1N)(S_(LS-"+O$>DF:=F6
MZU%2),D9@?(;8'V3S0)(;3_(0Z>3/IP WZ-$_[/UZ\;YX?^!8Q/3D_\-J(,V
M_\@<;3G/@K?"!I,L2IF$9DJ\%85KQZ1NX<"C&U2FGYO)]'>P$Q162NW16BWI
M]R(J/MJK]C8U'.EW'3 SU!.VJ1W0-7J".ZQ_B-EY&R-)5T4UNJIV:\!W H2F
ML(R)!**7=L>C-6QACD\-9MXWW WG<>->IV^ KR[J0*GQC]$R+S<+(#D?L0C<
MR[.DL0<""$AEK\V+N*++&KL_8;_B904..05U-1PTV])<F4I_<?0'"39?"DC$
M>U3T=_!_'F@3+R'0C=4Y LANP->WJ!GOXZ@K*0MM6&:>3LGWL8_^:.'5%W(C
M>L"B,'+UM8Y*3O)BJ;VB3E].L=['G??K=4R96 L[[GE+UR06BJ9$AOU$V%UG
MRJRBIT<3ZPZ/H[Y!:"06YXP>N7O&4C7O<?XPV95BW;VL8Q?',>DO\LALLGJ6
M*5QK\C'ZDOND^))0@:)R>:])7H691F#O-+Y?]IR9)MX[_VIF@D8-,ON,P5[K
M?WB+J@%WUB97P)(E_2M.K ZF=8\.BQF!,>?O+-DI8LJ> "C;\O[BRQE7$KUR
M*U^D=?]0$^GE&4FGFOR0*?3X'AVW=(FI=*?<XO;(-B:*#-O1?I0OS1J-TM4;
MAXET:K>DF&6ALXW+!I8*KAI[9"JDF0K/A-R[G.G5WR9T-&Y3U>H+"AL)'@]C
M@*)$%D#>];3^2KT_<K6:J=6\-OJ3D)??^2K9??TN& 0MO,T/&O2HX>P,/C_&
MEU;I-5%5QOQ86EMAK:N5SM='F>)3M=N0YN8GYMOUB!]RDA%TO0,UN?G:OE/*
MBS#[^95\'">0M][8=++3^:\$]U\ZDOU%;/-+1[+_0>-+1[(_A2;^<SJ2_<W@
MA\#'Z@EE2NSYG[A;.#: I]&B!FR3BQ-7%\@(]3FNQ)636IXA12X7GSE_]B0R
M&UTR-]Y4'.C),7T/=!I7[+;P%7G@P=M#V<*RH'5&\V%<3=9HXZ@DU2"<1K@M
MNY>BJU1T[NCELVGX$8)>;&W5:C8:5:3P +8T\T(Q<OHUGTI=Z*&/3&S/2\)H
M>,84?_.4';^2/+,M)WVX"F]X:>I(7[[9'*6&8^)#&"6E( OXU^^#VL,#L/X]
M)2N<&=\R,/I[2I:/JW0?._NWE"Q>O&WI(N2WE"R&1H3:Y6WK*5D.K:+?+%[@
M;.Y+3@XQ.X0?S"O!+QN]5>_U_M1;YH('E^*SRBUMP9:!9_, W)L$?(^H2$P?
M&\;9\]\"X:R%@5[:!$G\90M!)'Z [L"71EH3-/>(]S=4AX32T'YY)X8<WP'M
M-FGH;7-SQ?!#1^R5\%0O/]^\M!'ZB/UD)%H!G1?I]<AD;U?[?KM$^^%+X_?V
MN\B<.[QYD\- KE1?_@7$#GKOPC1^T>Q077?@Q-3;DXDL[[45B[;"_ ^=2V59
M#3"0K>"P/0.X"L0LD=E)=Q_EE;5(2%UQW0H\/I DYN*$,69F9*02;JOY]6PV
M5A5 :(<B771:J!%%'AV5"?0(S?T$AM )(E6<57:KX.WWR>6/E?;#U!DKP1&V
M^=TM%_SO9,WEI+@FK)O9Y,B-5/W/(/A*HNYJ8KOP'F*/8#Q?I+5RG)I<9=,H
M+]E:<YAB1*OVA])/(WMZ#6I4.D/%D':556%W-%EE!ME4'[NR^OJ,W(X^Z"2C
M&*F]3G6<R-H,WN]4AU]6-)W^_,'O5">-8TFJ?=#P&]7!TT.=0*KS?@&Y0N(+
MMW',SXU;Q,ENY?W,/?[45#.>B5=BI9.552>-GM4"4707S7W<T^X!NVT[5F[I
M?AL4HFYM=-!&7[?O6GY29[D;=)&#,$OM8MOCO!7G!\JY??J-JS,P$[76V,1B
MQI$%)71O7<051L>*@U&_/@VT(CG^?WLR[*9(7%$D&U'-R\$A$=M]I'*3",R5
ML8JW#UD6+0N=*)GFJ(]O8YXTPV]BCOL?8+4C_040(<E87P9^T:+:,'&E"6]W
M.QT9>O[ =%_"D8 "6/2>&]C@P;"J*W6#W]\L./42=5BAKF1ER8DDOW8'W&DD
M_PV!V0Y_'M(TNG5Z#<XV(L,D')-NX\3H/^/(C5!)(&N$ZI\UO;EY?^),(_Z
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M%T"&>A"!UH.9AFYV>/^<RNCG LC>-$(@;FF]45+8Y*._/2>(L]C7A*\T$-0
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M=^ 4,.3UHA/@#CSYJ\,:-HZ1V;AKW?O"#=N5+W5V6_/-94'J<N6J.T@$WLK
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MWV]2'/4M2<NH(C.+#Y.JC^<<" :>KC/O D8# UN-5O4:#L6S'9;DOZQ Q,?
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MV1G".U5OJ&"F(.ZTBM*JTHK(H0IL)2Y-(>1+]Q<A.9EHOP1:BA+R\ZE3NWL
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M):7\47Y1W]8@""(4S3@.B2Y%5K*NL>\QDL]5)TTO#BW6^5:V%V6G?393KQ&
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ME;CR?.G2CHMS\+0!7?#6063DL_.<\SD"D(G;B/HF_N!6K30JO"_\6G*](O^
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MKN&Q83L-0)BI4O[& LX15&T2+^D9.Y\F"YZ2T^,]FR["7VWOBY^?1(6Q3#3
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M<+Q'L%4%(.[C. (@SNI4$O\IQ&UA8K7%P<4Q2IQN,)]@*0"UM\7)LR4)DWV
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M.YXD'3 X(85V>\/,(_HY:@5+,T$IUSB7*]#AU@Z,O(C$"Z]_.HK7+H0][QM
M1DUTG.4E8>9>\YX:&+![60[LEB%TK-R?4G7(]S4U4V9,4[[0>LV86O=N&9"*
MD0Z7M#[(F:G;= RX69M82[=[>3SO?88O*4N 5@_>14D'BG!.</<S$.]$PVV>
MVJ!#N2Y9Q.>]H0DVDZ:$RS4%;-3Y&)#[0NR:\U&3)IU#N]=68A,RC_S,-!6
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M2[GD+=:C5H1S6.[O]CW]#YP?&S_^P\Z/C1__.J3K!R =8),:97GIA*D<=I8
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MN+>_T8M:\+.#N@Q&"AD\:LT82$_HLSE1T9V5W6__H=OG@:'2M9\(74RQ!SZ
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ME/*DSZ=_E'KGZ0$XXSS_7<?_P]Y[AS6=Y_OB<:P(B(4B(*#21)I*DYJQ($U
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M=TVP]OB.EC"=2+1BA\T+9,9!%TB!O<E=_Y6T917CT(&&QH1390I_3SQX'B]
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M]MIHH73BH)-OQD$!K##H)AX6Q)&WQ.('=*03P8*&\5-<OCN]#1W6; 15%G]
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MO^!;  X/"N@.%N_((KS'3.WD"@BP(*:L,VQH)AG7+!S!,IQ$M>;DJ!LZOR>
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MZ\K:3IZK,XBQW[<'3QIVD"T<,^Q)XX+"Y9@[_<93GCFF#-O*N8A?QUZN'K)
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M<0TC(2CBE^7<N%<F"OXCJ"(82S5@-1#V2EYC*OXQH12^0.'^P$\&AR(5H4I
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MZPTXM%BHQU5P3,KY4%GY(7QX5V^&D_0Y?5Z>*%*:PT;?RI,:@:IS+%V.2T\
M3 )WLHK2:PP;)T8>="Y-8\*>/-4?*\VHKS.];3BLQ-+GQU9"VB=;![ 1#1SY
MEUL!Z^&1K\WNHPK7;KRE^.I.OBY,:31D-09MA&12\)<7W1'59P]4#3& ZS4G
M@@-=&9U!E>HCA%H'T;C(_QZH 4OCVV E]M72S:%WCU%9TTW@*,25V5/04^%7
M$V@. &&T\DNT2H;T,WDT6!J(&QHPMHV%1F:;X[['D(RM>%.=IB'68 FXN)7=
M:_*P+4%JL@^^YJR::7RR-Q=QUP]O <FLU.I=&OZZ+V/PXW\E4R1($S7TF6@
M7Q4_&V)4AWSOL"A1'!)O5[)"!C^&2>H7G0^ZWG<D.5 >64^00<[)'N2+_K;J
MWL7;G:?W#M5/]T<00F_%T>Q*.AE(00*:USF_=4#D@W<)M3<\ 4_/5[Q=_,(
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M9UH2?<MV#K^O9YT8@5A[]G)G1:7LXZ8*Q:&N@QU'WG>1C5"]MGL9V@_R^6!
M- *W=_*CJVZS$  3' 7>N525;7B_YCB+P%,95K)(51A &&F,1)0-:_0O,6,7
MBQ9C^MUDNEV+]17./U5P)"T5"D%Q)S6B7CN'YCVP\V?,6UN%=.(^(X^G?]_$
M/,KIZ4=E"T'2*%@:['/:6-EB-/<DS]72E[7,>0Q8,HT8;ZIFR*=Y/IFHFN/[
M-_M*ZU!5ZH5#J&$URI/!8;KSJ92S5X[W&^YG/+H=<&$M2400@FD_XTUXOL!5
MG_AZK1BD%!2<\]*6P6  1LT9QUF3F8A!Y.L\OUM]".L\- H2.YPCCW3[TB9&
M=W/52@_86VQA;->2PJLDK;R$<68H0E!VNO8G(B-G-:8(T!/)N2R^[ QIK/\W
MD<YS(#$V:I5<8*Q*ZIAF]SC7DN )C-=F[.[?:/,C;[Y'J_] 9AL%;??SP? K
M3C';M 9>[*-O5=;!6$@J_?&5, C/@Y4[FA*]3<:@M--M-M!-CU6<ZW?_VY/P
M-W,)8!DTW65E>+M.&^8U2EZ_T&'?(D;*7N!:B.MJ];5A#-!XNF@AZ'*,U7C\
MKQO3\84B#I9=QO>'%;5J;+:PEGF'=4?GB:6$.B>N)C;MX@"'L"!"$3/\213^
M.-=Z&;:(O"/H8AF&0NLG%DNYL&?\+ [1@*"[0/2,7X1=F@&SW.!?"IRJDOMM
M6-/-U-VUBB4=J7'44<QNEX'VDVU[T1X'L<Y,]<B ;_R.75[-:G>7_B6*?D-U
MT(]2I;O:]DU,W)J:$%0W#AUI4Q]976BWUY* Y#=/8T5>9 &FZ#E,=D2(1E2R
MB)H'S_6)!1'81$=68[VEBN?E?J@T[]H'ZL68GTO(&?*L^T_\2Z1^6XI1R^X&
M2:3O-0-MK<%8=A)?SC+E<N,Y:<"]/#V;3]%Z6XWDUH0C 9+.@RAM%^?6[[Y1
MT6T\W EU3]8+\#AD;'#,Z'-A-8HF!#W3N_:F.K\;GQB/?+%A*KUZ&%Q*7<#X
M[M5MYCKBV_,3&P]_+.']!'CZZ&0_4;S8UP]5BV(._RBW^TC&\:G(U</OL@J.
M=W?#T,L#N@@JI8M,H$=P GLI1K,7#1"!+]@E8T5\_F"#S'[Z !U(=8Z.O%QP
MX+!-Y=/=3=^\\<^'S+8[/ZA#3DY%34>L-@M!W[JYX='+9IUZ#B]$734+G!&"
M3#W'B +9#!$X31:!617X?81.)\!3" J;#J-NHBV3D6U:Y4*0J\.P4?'\LMEK
M&Z0!C>LA^"C3;>7CQ[7'MY=NR*RT;&/!V;2Q4+MS>M;NR8<R$QOWL-L4"E2>
M511DY=F#'FF(N? K"3=')!P-<@C<:SS0AS(G]]#F5SQ[EF?D<ENKN6V%0S@E
MQ/DJ]B&X*OT47>Z2/$IYFZ1;:P$]W4P(NFO)J^H?AI,C5D4\^%OD]%3-ZMR6
MQJBKGV!/+/=;;' M14$(HCO7WI>9/_73+VLFNDU*:E2M$T<OS[HIL(:+\JI^
MB!^^DNRS5UE<[TFVY(324=$8Z!+%&MB:4Q&S&Z\&D!I;C.$J95 EX,9XF]>=
M(:37HS&<0R;VYEC.4SQ;/%OVQ]"Q*;/-DWT*!R!O[/'XCD#NXDW78(U@<C^?
MJL#OA]E[D>JT) FU!*I'F]QEP'+,L!ESP"V''=94DHN5J)>_E;PGY1M2$<:G
MRI=IN:D:9/OEG$= EI-L68:3YX?2U"$?S\VLQA'63TU4/9KLST+0;7$PO"QJ
M:\:,P%R.[*]HZ-^Z'NA\ FS16:7PZO6SD&/;4N>D^RB56-=4^HG<79H3]#-X
M'6<;=(=M*.&,^H;RF9LL]G ^8<PV9>(%_ZP-LLDA#C;Z8:0,'GTLP62G+7"-
MU3C<1Q_R9,'J/Y(FHQRUY.><OS0WI".94FIS*]_JS3]//G2GK_W:(@02(-Z_
MR'9HP#!R.?7 6XQD,XP<T5ATOE7@I%;=Z4^4F5,ZR!IJ:\&GID96:8_M_%QU
MEHT8,9/:PNV\LN(_HK:+#"R^>B37G7GHTC'DX=ESP:VVW 1+(4A-.]G=%*?]
MLN:RQG(EX2%_"'<)&&&A1WG:-+8SL[D^/KQ%SU+_/3#=5'.81>Z//(8T/E;'
M0/3<6=*:_"!_.Q-RO20JJ#BC:<D(._D@Z!KA+%2#4.L-NT$*%X)0I2PA*-H8
MR29<*QLY]![P&1/KOEVF?/0 95G><I1_<.I+0CQD*OY!0=,SF15;YI@XA2#C
M]X?+^12W!IG(S=MF3T]*_4KE3&_H^<&UWPAV75+R*?^*VZ1JW:W]0)L(:430
M]ZZ(7P 'I%F>=4K?EA!.'L>=&^=;"T'-"/8Y3I9);VE23KS83+#KI[ %>SDM
M9$-?W[Q/<)=":0]$Q!&$(&6!OH!.I#@L2AXNI<KA3P/3C<$7!3;$^OUN#"RR
M-M%B>]G L0SD-N!\]P^LF!2-N[=BAJ!1=UT&72M;NUR'C$>T.EW7WOX2;. _
M>TZ?DSI%;+6M1*HE;1VF:$OGNUIGISYHA#KRQA745\^92CF<^]_6R?XK'G-A
M#+8;F]6,5^FL4ARE2LPKG60[/"&]ZM;3DO"2#^G(*_3N7TV<I'_YXM0,:6S(
MUC#:=EXY4B7Y_+M+2]3S^%;JNY$F(8@AUJPQNAR:(9_L8]#D[,Y<5IICNSH!
M"K4R#GMQY;QS1<T8/<+=\HLOUJ@27U2GJ 5%U8,5^'3]G+BL $]^%+X!S++^
MNI/K'3PBL_(SA#JF"U3GST:CF,M1]*%"L?R.LN]1BWDS;E+DBP-CQ%W05]?+
M?D+E0:8*[HF":G!?OL]"7W^T;%Q.F#5,T;Z:CEH,>3DRX(:4G"D*K/@)<.J_
M#Z!&G"B, .E>@5C!#,[H:UD1T?U,@ >CV1E*0#\7_@65H0G4HSGBGG5"T#[C
M+_K@W;P3?9#BVQEB?-L->,_=M7A%;$V7MJ<J^94ZJRR<HEK^H8LP=J3'AXP\
M^ 7/ZC3%]0:O^TH&G&Q=SD1<TB [F )E!3ZEM+M)QVVB0J53'"H3E]5%M[^5
M\'7FO.'S/V;!,-68ZH4!3AHN^'"-+KP90(.E3N&/ %VM)ZY MP&.RNP,DDD/
M2BPD@>OT+@EW]-?+5%18=C22+9,>>'.5WM6QXHSZU3G7.L?I7G=HKF:G%:.=
MX3%4J=J;>*8N=>KE<X? Q8W[:V8S/K@+7!')K3T'\]3ZLGPE0^()7B/:!8C4
MC^E'J-<1=EMB\H$^?GN%E;OF.Y_#X2.U6R;L5&5,H2B>[<+\ZERN9ZZ?%JT0
M;2KPA7G3  AA\2B[A&LIZOCM62*%A 5"?*<8(:3ZBL?>,&G]!_:M02D91BL0
MV)CL*NX#!C+*,@F/+9SUT^/8BJ0CV8<&=#]X$)3GYCIW-G:H7?"*X&>RN+Z^
ML#+DYC;L>GEUR'5HR'KE+[M0XO56/RV?ZJH4.?\[]?[Z29W Y&,N!03/'2^)
MSW/>+_0$$5%J0>LEVTCR)Y<W)\B;9O?G%F=HE; [5. XL7F9870M@]9()_&.
M4L6.5)1]Z,0?P")6)G':/I 7@90>W+F 8_5!S"'?0Y^(=/G\G/3L@1"%RUT'
M,@R DU$:C+#3ME%AI]^8WDD00<$C;EG@5DG;R\DS9ZRM;1^4+@E!8U6E>XYG
M%C[],S-.:\H<$=0\2L#A^3'Z8B'*/U!%<?\Q"X]^I4EB/6X,#FN=>7>JC/8@
MY,%HNHOI@Z!1DWN+Q5ITYR*#OHUSU,J:D L-4+G^I<4[*F1!&<Q#@K'!N<M_
MZ_\E92PWYE@7[MXS\ZWX.M(AJUPOXOZB[=45@VZNCEYU@DECBRSZJR$H9:PR
MW;:N]PHJ#TKT%P4]\&]#3N^KJ[HQ$'W%LTM3]3^^+7_$:=IJ#?+!G")!/"P6
M[RYJ_HJ=+BTOS=!+W3WFGWS(1B6VM^= ;53;#!.CRJT@+3:BM-A-LQ9KU3V5
MI0EFU_:Z7C:(;Y:8Q&!8U?VO"SZ*R.N6!L#BIPA!HV5(,JE.(TUQYWBH 96L
M_G/W J?=K\ D-P*O.L-Y9Z98T9(+4.%OT? #09<]JBL?-R&LBPKG9344*X"2
M2V$9-OQO\#08ZRKF"X,3&6']OE-PW)$'9><LV!RJVLV^8C;:[B:6=_ V5S6N
M)$0#>P&95-.N:R;SD FYM& ZH3^4_K+L^]^&I7$[U,(8CU_*,G*#+@W1R_1P
MFPFN:28(QPK].\^?WQ)\6KN_D$%K[5A^MZ7PM3) U__TE-@_:]G^_^KZ9RW;
MO[J0GR1XLI7->$-62N/(SX'#4NR4J"I=S'W6>$/)4.W8\OZYK5.&=NJ177JI
M3(C!RH!ZDN2$DZI] /SY_M-%K!XE-3+JQ/$S)Z"W27>O#O<[,\J3O/-C#6V:
M7Z@E)98N0A8XY7R8#7):50@2RQJ7Y4O'1Q( 5R!7"$HF$^IF@$:1FG)G(@6R
M^!-?U50PX4NW$$1D_\NBS833!+(H7$%SA*"')(%9_U8P(<M'6G /R:J :A,Z
M'0$1)H6-1!$VT68\S?@8Y)H]5'2?L?M,H@#1R8^%;8J&X-<4TN8105<\;RM%
ML(.Z"4;.S@IBR0Z;+;]S>_#?&N;H"4'3/,+7C-/$8^YEV.H<$I 7_1Y"R,W=
M,N@#/S&V&2/M'FA\ Q0T(&3#R9O%":TB:;7?NT]>_V5_@JD>FVX:\&;0^9QJ
MSU-GERO),U/V4<,HZ3T7)PD=&$<@G:W1<#:@(Y[$.\]N*L]V"X*AN];C9=!;
M&>D!G"!FQ>-% \.*4$[WINSW%_PDTB2#_.JE6DK-.R,DKK[WY+P#JUKF%KPI
MVM V;J. :PB9$7.$5Q(QL#O+ \J_P>@GF"-TY]' Q ?9_$3NA4NB9TH?$Q."
M#C#XU(77W8(3Z;KVU>QM-7<,D_L)'[I55A94!)\3/1(L?B*JX<Y]/4T1_YM@
M>QS[%/3X//5 @ :84I@*KU_^%IO/L<@I+=5ME,Z@,*U@=0+):J[_0Q^()J3J
M B1U\(-ABD%R&Z2!T! K7:@3O&=P_:1ER[U&DZKLQ9H.+CIG^-XG;VKX_OBB
M"2%(CRKQC _E60E!CT.-3]Q-9.#D^>E5%PJ,6ID,!)#&'#*L;\'L]7/2NP<?
M(^ZA8U\.MP7=#9!3DN,Y7T_U;_/P+YF+5.'X"M"XZU_;*QBD2L/(I]8(2EZ$
M77JBUZ!CT 65P7HW7ZF*8_"W_?:U/+)Z U[G77G80D:0EIXKP3R!Z7K!)ORB
MO!\=Q4$F^3MX&.\XF/[2J\DJ('V*[Z/6M?(>&40S=COVH <5&)L%--&6"0\_
M [F-PQKLCK('3(P"EM@ _9ZMEJ-!>P,\;CS;E\,4ORM J22@U*I[ ]!IE=R\
M6\E.'D'J'YX-6Z@$JJ9'3K_)K.BR<-)0S;2\57F8N_1?JD:S!J\ETAF<9'[&
MIP.\PT#O^,@V5-]*Y#AK,IFBEC7*^079G*?7#6@XN\+K''3:@A1,&E+.GBKR
M$V]<SZE-Z/ZQYM'XM/=)#[GV>QW:S]WF+"Q@B5;[=)Z[CJO+#D-R-XK@0_%A
M,!92@HZL&[E-!HI8XV/$QEBH8D; TLL*8CU1VLW_8! ]XR5=Q":5!T':_+3:
M[X/N=LFN/FT^3/B5L(\P6B,$E<">;,\I:R"&C<C4'!ZA2=UFSEO$U]>8L(9B
MVJYOR-JTOZG- S -NJ:<"0&M>XK"BJ'YJSY:XBAJ*O]4.M*B*MUL7+D;MAGP
MD5MG&S]V'\Q[/ANN>T#\S&8**D>KF<F#+Y%J8:QKQ"^2S3\V](')AA%DA2R9
M7_H1A%@R6 Y[$JT0:W.XZ&59A@J+0\P:MG17N7<N;W!6_G7.:\>*[!(D/YG9
MQ22\,3;A6@HZH)!PYG0=D;RS5DO2F7[YK2MM;#EJ>%O?*\J+[D_F=U6[ ^:?
MASO T]V?)0U K^^:HG9T14TFPTUYTOEFO,LZO.?&(E5#7S[<E GDU6Z=,5N=
M^D\MW_]/S#54*PADS9JTMC3 !X4@5B4;+@1!T.J)T%]"^2C]S:NWHW5<O:C/
ME^>K'.;^.%YV"9J(HI =+Q C\)X24&:"$$LAZ#LD+YZTMB8$7:)K\":H8_ZX
MFT)0YCNV*%**4:6$H)6^>, 5+$>=*<2)_KMNN1'&HV1QY0FK MC7\V]6SO%S
MP)OK6CQQP@J4VMW-5_ BK2:(VM#)CA9$-3=0>9H\.R&H#0'[/<L+*"&(!GQE
MG4)0RT[.<\)T#Y6E+P1]W!*"X/ UGTRJ-'4TM$:=K14-NX5Y4A$?A;M0C$WY
M,8(3QPYX;D@7%!$*ATT]P?5:H;K-*.F^+-^_S/3Z^>K\$'?,R3/5](>5<@P]
M=:6@R]^[(S%%]W&9CGU-Y.)]'VY&V GNY9_2BSXE4I;1FP-XD=:W-_VST_+@
M. (+01I(%,C"%RBP1KB$EQ"$84\O; ;XC4LG?R'DNN ,J\VO Q&HAY*G^BI,
M<DK3QRT3C3^+6<'JY;.3.U9=](M&V+G(6>0##\\\IZ%9>FQ.\:O<.9DR&0>.
M;"G;U6EX8.@BRQ7A2N](..>']ML6+]Y8]9%M)5EU3UEY/X'&Y3#X+_5A W:<
M9""%%3Y%=R2+PQQ37%G;Q],BXNV !\S=JCW&&G[2C9]*K (@28D&$7F?5J_4
M.W?IF\NCW&0"-U:B-F)8*\'U(V'#Q5H6J@)93]$C0)L3?[$E9SEI10\1T3E+
MU-0*(:@,_MPK,XH#U_M7-M/=Z>_CT!#<D3BVN*=N^EJ__J)U_:5.<N7QF/[4
MY()\5U/W7$?$>:I>F6&*7SUFF^6GA(]/SN@+?J:^2UE@>W)/"=J18GBQBWUE
M\M1PLD$U.SP'??A< %(!"%\*N=_H0/"*/6C9YJ4?<G[<LDM3TW)0[7'NK'T,
MT\CQ&2QE!#@6L4#U89=P7B8R^R,7\+VCI(%A!IP=0+9S;E$MSF'KVF9@C;^Y
MNR+7IR($A>*=3>R:WEE*MPXYST,/?U9^@([68&2!.:9N.S#(5-_ZQEDQ:P(S
M8<.A55,(XJPLYA:E=)$]G)8UZF!CUBN$,RHU;E\7^\8$__D%AM*\8$*M5XT*
M[B*+MEA+0KDIL)=CC4U>J]<3(TK4TEX!N2Y==V109&YIJD?)VYJR,B>/ZWL3
M=M67@]ZI.%C+[F-?"TE(?3QYK]*%H5>$+I[2GS^Y?]IWRJ7%R0@3$AA2RH,O
M:$8)06>T_M:+?P=B.O\=1#QK_,>Z=H?EWS; Z_?,OQ-12=CXO]0H4@'3;43L
MT58(^JU?"%*>YYO .DO+E_<#E77X ^'#TXUX==9&.&19%0M19^^CO)YY.V0E
M'Q0O7E61U/X>?E*]@]WP:8ZH#?)#3I\IQID#D4STCJXJB_$1>6S$E2#W%VN+
M?HUGIXJN=Y^WO*#K-#+BXDQ^IZUV9J_'N$K2D53F7/(509_R1)[_>H!TS93Z
MB\"L#=K:CWSXVCXV9K&=JX %=R /X$7\]KM?RRD]$YW+>D.Z3+-P8]/"+W/?
MAV2[.,_)JT?H*SHXO.6>2DZLO:\_^7P_8FC7HJ9JU!SV:.($38E0BZ)>)^QT
M-DXU; #+\BPKHQ<+U%Z,PB*@)\,G/4H2=G6I5+,7B0_)EO%EASS0&M&NB >&
M<5WW,Z:&;I48(AM5I<GW@L7&\^S=+)-%A'?B?> ::O-%FW:^0.X\M*J+ +'E
M=L->DZ+ K)_"4R,#4"QG3F!-N1_DX_M^P7%LZ7"+\D.U9Z<F*E@1H8OZWYTJ
M,Q!<V?B^?AQKVXK1Z3JQW.VSB/?BN8I>QF^"(:+,#6KW&/#*G55BVG,S]029
M&.H&)K.R/V=_[)RJ;TSIFL^ =7N$*3;H?L%6#-^Z5W)('OLJ&?;IK$9QQDXQ
M2\?.Z)#IH,KB@G0R,=/,F'UMFGTUP35KB<1+;N<Q]-=%%'M>H-&G576!&>OG
MR%:CYE\NF4-,4?.&Y^6;LG1,#Y_0Y^2^H?D]N'^R7LKF5(KDQWDIWZ9=%W_4
M.9Y9P?DR_7>MU<:)#P63D<W(G\\^[1&(XQS9M/H6J[9AER_ ?;?JLL\!1BD/
M(:E6F'K;%L.(@.7!YCVA??Z50&_1XJVK!^F,*KR6Z8E+.M8Z45^9F![?KL+=
MJG'(('7@=3>WD^O!RA6(E7-=L88+?<2#_N!P@MS:V@"G<LCL?$JMTLD/ S_C
MTN&UW4[8FXQ/VV/2JB3]5A>T@\Q)AZE9!'&1BU&I):65$\X\.'".[3 V.2@$
M>=B7LQ:;(Z!'9PSNP>A6X\-N+4&CU9B%OC'(]JIDZ"%J>24ZLB$Y$.T='\![
M8>-R36=!U2HD17G9Z@-AHF!(Y++6O[AK[Q>"4EZVD;M2F/SE9C:L?$0DCFL1
ML.M@><:I4I'P\J?M<RUZ[S*$RM!CE<56:?FAILP[HP.K>ZJ,E")"[F7?Q9)#
MG&T'%#1*MK> ?\2Z<_+XOU2AJ[!FG"A D>ETLS1\A<DP!8I&72^M=-''OSVA
M55A$&=!<N*^]TNIV;EOD<:];IDE..S?';%RZ6F8J5WKSE 9;=<H&L_AXHV;M
M-S4G?\+'V? &X]?RN_6M=!%O*;W^/I>:[;N6,R4'O!$>0]7\L F5)$G$,.+K
M#L:+!=^HV)X]N&OGD=XYD2P)7O/":^-<2L,U'A"B" >*%A>9<7)'(IH$:E%R
M-R*W^5Z0LIGS?M8H?S+;-S/_V/%K()"&[+\1L/L\<9E;%9V$$R/]6%*/$&1V
M\@^3IYS_%M7:^8?U./BOY+C$XG$1;N<11M%"T+-U009QAF&*UR#4[L;!F4@9
M_,>1 P%@*2#"A:WY2F)1D3E_'$/A(X0@IZJH#E@X<I=G7)=&T27F%'8Q*V.*
M>>OAX8OO:7I1#R?OC5#T)QVR9WK3U34]=]Z]510B25]B;)CLL>,\'S-R?J&.
M'NY??<_[FG>)_@]=\??KU5'="E9D17%+"%)3)@E! U< /R$H5XP^4T>HOB$$
MS:_#^! Y)NRALZ":)@19>+(?BR+X%_#9?]-;=!P4\!L?B5:"=%7M9G77*1UE
M]\<$E+N9:-5GR'4MK8?83ER,U6^O+2/'77K4U#2D\K7D=J)X>)K'WHW^#8.^
MIU8Z(6>XDH(&L#3,AQHI/@;>3F@T'&T76]A [J]1GT/<Z=^2>*PW_UA]@&EY
MM?RM8(AMD#?Q*54V'+(N=F9]1SAS;FG#LG.! D&T<<WYR51W(>@A];W$(W=6
M1!UX-WW 6[:T5(PI!"EZ6R@NQ_+\"!YWGX54-IR=B)SFI]"XII,I$>3E=UCT
MI0_5-8EF77<R..RET]J_;&&=:[50B)85M]83"U-;J/RHWMD':B_Z(^JLJ54C
MJGH"-4I2F8UK2"#<"N$EP E!GD3@"*81)EF?BQXAIS14@\?"0MFF?K"?>;L5
MRV*-O1_VW4JQ[JTR7VD<K?YV:]AF+W/\(N:)O>Q^F5 +C,:+(_R;7V?*M_GP
M'T,5S="B85AO<I\96("J;.N#JF&[77LF$C^5IO8A*5Y0!6)=C7CE<"(YFD/<
MV\9!/P^?HRUTUTM%;R698J_Y OE%PX69Q('<)97*!Z6)2&:B"0*+D.*\SN;2
MAN]OSM18@+4&\ W(=\5$3]2-G0NON*=;MB<556=K/6 YC/7E8-G.%Y\V;03'
M98TQBB[\6''KA[M:F*5BC&:.EDEO0_?'%7TB<'/DR[P@UI CHA[U!U@BMO("
ML>46-<VA$*8GX;Q]R.F)FG&DI\1$A.!;:EM+2/,T)EH$N<]A;R5B"AN+1A;6
M7\WX-:+?. ]X0_>SU6.KU(,\(3R;9DY7JGHD1(]O.]<R%O5@6W^A_@,CE/T/
M$"6Q@H]WH7I?]X9LV\5_P?M!<PFO@+,!**PI 39;AE-!SE!D+X<OW';>5D9)
M4#P;HEN//YJJ5:;."7\EWA_]^L&K4YQD.Y2O0F I?RB3$JXK#1\CV779^B']
M-U/&1BJ/.08?''YN<O6J6X9O"0\^D<7TY.T'<Q)8:RD.8#'!2=Q)(.EU;=G'
MLKXF*FNU8:/&X]/W\<J6"6V->,7XUG"+NTOXWG&-D+>,JL"1.^78ZXFKB2(+
MDM.<'L!4L4=@R$\3J%WP<"</S]4<ZCH*/,P<:.)\'MJ]1*%%;+@=[SI"<5Q2
MCK/,P]C2-:@Z=4ZVG$-%XP+>F^**H%*ULU9V^964-JT:@WB!I<#,>&5+!W 9
MY1%UN-EI/((E(?46R\I'KZ__^S:,+^;44_@V=M6_KIUXJM%\ZFYAPJ6YXK@<
MQV]WO2G@'Q1HX-N))4)0LQZ8558CSCL-A 4<MMQ>0V)B=L]L"(Z^"[M-3G_5
M;6S>5T":];W",8CT4TK/0^0,51WKFK#RIHGA;_R%R$CC/RH9QEG&AR-2&K0>
M!3\=XCP( 2,_L&GA.^;1CH2N-:JB93X0-7ZKK\LU=X#GX<Z=Y\Z,?"J5Q\G?
M#S@U'%J87^<_$H!J7K9/&9*Y1]/*IX1FP=2Q92OWD9O:/*P-\@-85C1B'A,I
MR$==*R(Q[A -/8Q#==](RB)WW^BY#3P8MVS01<KE^J@W7A'L*WU"/W>]NX!W
M/BBSIB:AZWBQSRF&7=I*/7-Y@<8]A]M>GB 1@]P)/8J#/M1$="BZ-R@=ZGG%
MZGAU[QF]1248%GTTG+ 7C?^QFF)!-.M=S@I')>QV5?_D_CDW\I4S$'!#G5?5
M(HI%WP2FN#%FRUO.ZJ-X_I/2P_WQ@FW%5,GZ-YE17_Y+&^?^_%63P_^%X ZG
M[^14L96]D#MPAS2S7CN.()RP*<V(05(6(%;W[?)>M?YUSJ.Q5,>BEJJST$C/
M0B!AJE/)%7:Q^LB)%];?1S^?R)(N>)YJ@?LR?LCB3>,9PTP+UY+)?'X'/Y0P
M&D,\"-5KR<%=YK]>#*"%4O=D,X)R@!.UW=#CP,#1<HHVO\2JLC0!^1WV]M;1
M$$FWN=F=4<5=NZ:Z]8Q\=&V[JRR0)81W6KR#B:.PA?1]2>,2DO0OO!L PP<2
M_CKC#%LIZ3LOP;Y>']LS5W'&+#Z-?K0KIZ1Z!QHCB4PC'22_,_-%^65=7,QM
MWB*Z*6GIWUUC]5MZ7N/!>6*Y0 [I%MDS+^(W1#>)=,WJ#K5!))/"4$/5\2:
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M_&".7ABDS]M:B5YR0;+6U(M0]H?($(HT_8 E^SXA?B;D')O$Z>'G4[U^F:0
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M0#;!M@KPX@Y+$%PRC+]$!80@3D_(/@7^< JPW\94^N/=/]L,Z:]5T+<S^+_
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MBAMKUFF9R.PF:-N<'# ^=^+L6P"P(SYS2>\D;3UWN>="T5L].41H3TZ[!SG
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M5RY@'C'],+6@U"<:@._I<(I#66!- /)OG^!NJ0J&-PH!]#@X6H=X[XJ<WM>
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M *6&*,>W+HFJ?Q]79;2A-0N6]S]7I_3"S#MM3*XQ@(F4'I<M[,SR42I,3?/
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M>BIZ)9Z]E*'NHK%6TEKMT1:2S-J;K[?>["]\L%-FLW& B8K2MSN$O2GGE]>
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M3_>)]#M:E$R/NX*^F=75*[<_IR(>:I,WFF;62_E=)77(+E[=<][K8K1^1%#
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MRNM(6YZ\^*=OV :0JE&12#&C#:"+$*CL@O+830P_OB*2AOB*8.<8^#&P*X6
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M!U6Y/)$8+/^,(+R@1/UJ7P-G13_U/C8MC]U9C5$_8F[:,K="J;JP3X:3%6W
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M.>=KVF0J!!0@2J]\,=,M>6KB_V1)^]7"G0^?WD[;!$HS!ZVC40BZU63:9]'
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M4]%@E[D[K/*^2*W5BH)LVV%'YZ946^WU2BX4]U%9"7(?(J?]HOD2<-U-CRZ
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M-TQW]'Z6Q*H/_J>56+ GA* ]9_CIFWW4((XED,) +X^C>8BI)F4;((757ZY
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MR^@BT)Z+M$6%\&\%X(!>Y=_)9F@RRF7'Z;S.Q'[UAH:LLW<?*(_#EW_&Z'H
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M4UG!^7D+-*R+HF&CMKB;7+$<A\#)+.8T],$^"\5N8FCNXT8QL#N)"20A_0/
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M&;!!E5_''=:H+4&TD8B",24-2F5+(1GSJ-U8!SA,&.BXV3]AJ_J@:05Z".O
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M>! JP(/,UN6'.7("^?\4X&;OP>!OLV.W6H?^:U4X3(H/:FL=W")XD 7U +]
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M4Z!!.P$=3T6!-K6$=)4/Z3D2#]R'5?$A#*/H#46,.!\R[_F-#UEM50BZ-#;
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M:W=99N$;%=21=L+RVD$S!X'9ORKC[7^;$2?'HQ!%8:.@VW1C&P#+ ND5Q!(
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MAEBM^9$Z(>LB;/TQE(L$+44V'36!'@/7$;8<NEKUMT*@'S8XXDDC?A3@CO^
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M]MX[KJEU6Q?.6E9$145 0(F%(D*("HC2LBP(B! !!:E1$2D1(BH0!)*U5+J
M@H""$J6(U @DH+2(-!&03B24D" @/:&$"4EF[L1]SOV^[^YU?W=_=Z]S;CGG
MC_D'D(0YWXQWC.<9XQWC$<'Z2"O>OT"6Z/-%2K@1^MXW&FH)=@,G1; MT O%
MW=BM-:@0)N<Q9/^QX$<( $4,T\3Q*OP[?!408A@\,@\E4"PK>"[,$D(7Q(G=
M@Z-:^3*\D%A&$(U:/4HTZ+(Y'JFV_>Q=5Q4I0P=*/#;1,C&IT]E!SO+MCZ[H
M,_$^5;%N^/?@>1'L%!SP0GZ;!&.:>.Z0+YI=+48EYZ!8E-6JDAZR%X*@$K1/
M3- S5[#TEJS#5T@2K-80?F]8F14B HD4-X@YL99HD[0%*LCW;04.$J?T6).\
M3@B5>J(>),F([[PCJX62N0RD?LQXE2"> [A/,!R^P(3?Q?"=IVX5&\ONA:>L
M)HW7O17^7J%]0X.""1]$ B$G2KI4=/T?&NX"&%^XKL61)Q!340#_',>0Q'MY
M:>#5.Y^@F\.)LENS_=]\O)J,8<=%OAW9Y<N]F(N@6&Q'5PI[I@3)V _((WF\
M$.TQ#QT1+%,)T%R) IZ+8!LV )LZ]-X:;B6T.B/IF<'9KCF"\]RST:R#T_->
MXI5U/7^PW 6>]$#DEKHBQFFV _)8[[Y*G7=-:M^,EH.YN:"X%/]6T!4SH9XY
M%WS.":Q98GI$4T@/[8]S>*\2.QU.8G<8#R,LQARXE2^;Q7?2U0+2@3#3QTR,
MDT7$SL/C?@S<2+Y4-_J7D$PWN2/Q3FX!Y4L4\D[ACL.IARK-]YR-'Y<WYIJB
M*L%UT^B+78NY_'S;RUTXJI?%BK7V3'KV0#^&.=#\F[5V]TA77+_CN4L7996>
M]/^^_M8ZR[3(J3Z7%P?)[XC05_+M *](F'6W'+5=L!<XG8=UWEI1]:$0+3\I
M%Q/&0HNMN1KHD341W^<YJ-1%H?;L[YC1X#E5LP!JX%*@@<7@UZ\SLV:TTE*A
M&X 0P=:#^"7K8$UK0 3CEM8,2A7ATS]TZ:MR&LZ5<PU+SK0ERMU-5>6NO:<1
MFXFQ__Q#8P9Q%[[SF]9C<YR;4O/1NFRDMJ.S7'3WN38K^^-9+8K\X_73J(O1
MV:S)B\4A)[2F9[6;Y U+_<RQ'6/S9 P>;"9RS)F,<M[;%+,N?5G.'/\3 =:5
M=I]K>%!PII3&*;V?U:GL=XG6YJUQ\WN7X*KDLQ&3OD_VWH7>Q5E) 7>NIV2B
M)R6&D((=?!Y"2%)HLN0P/SG Y? Y7P]*@I*HR%(X)Q5[VQRW^7'4-ZWIL[LJ
M]J5C3,?0ZG3#W9RJR#G3_3'[2XMCF L[*KXLT\X;H/B$++2)D;"E"1S0RW8=
M\&P%!\(FE:MLS-I)3S&%I8(=.CR\,''FK@@F!^2C6/Y!SL5S*A2N6]3=;_F"
M(ZQ :HRE&J!7C7*O[)R>,6N45RYERT<3[:G)'>(O=XR=U'0^B9J8WFD;:Y-_
MKF,L]X2%$].H5^EZ4IPIQKH]RV)G6OK&MYE]_J.#T\OO_B%QI/^%X_$CU1;)
M/'W(X9X3G!&^ \6_"=PY]#K:.D#/K)*[E<8::?=MD72LHL5XK<>_2F85J.]V
M>%:P^77Z!9VW:W6.YTWT9)W57[S^6O[MP)M%_Z)VG?9E&8L7$TV)+P(R;TS?
MI=C0;9(N$LY98MK"!*>'N;%@C"2+!$HJJ(I@PT^)M8:H72+8#Y:AK C&.L(F
M@2<@7\S8A5H6P>""]41!+&FL-R48+0FY*Q*X3@(T 0-_D'^<!O=Q@081S%B,
M [ELL=B=D(U_0;'A\$?$A5NDS2(8YQD7#:'@=/YI:)%0PY#C@U[W9%[ /[R2
MJ@(&HP2;X((G@J7V?_2FC'FA$B 1^H^_D$2P V/+O*N+^FC!"A'8B5H^L#R;
MMCJH+JQA&"[<K5*#$BCK0]2]X: (%AY$@&);^Z<@32@DN-2A!+=CIS?#!2)8
M++@&!1JOGC.8P).6%Z ;/DB<,YYG&A'Z@"QPHQK?Q3T[T >BD[N"Q+C1%;:M
M6TD>5]E,&0^Y@8$_GO>(3Z8X!7[TDT,\JOHM!MNDQ=TS7OJ$(6\W^RF@E>-?
MCP149J>?</8SEJR :(YXP[&RK2_G!_&D&IN25%U.77ZQ26%- +$ 4)ZME2,D
M>.E5F,I[SE\V*3:7RFNO\V-OZMF5IWWVJ9JUU]2'N/@%BQ::FN/7BVHGG2^^
M22+8="QZC@>UQKC_/)N_D@5%SB#4]QBPC<:S$B!%L+<4JB#/=A%:_?4 L7&/
M\#5Q*A/ B&"6'MC6%E3_!#&2!";&-&_@UQ)K4)_!A]#G+-_I_V?GSQA"!G(_
MQ;GW&Z&:2.E:HOOU7##E+$V9:O=S'<XL)2=6IGLP?--,-=.T6\#7OE@75YBR
M0V[3,\054Y5D+=S0U]7)17\GN$'<2EVPTQ7!W-[R>[ S(:AY_: ZD"=.U0*7
M30E_0# @+V"U +AA?$RPO>$\C0;=0IA O*R8FLAF&A4"Y.R)HOI?S.3%"!+X
M>>.8B9N/SZ"S)QA>CP_M6J;[;/92"N,M8^HW"+9O -&T&@@>F*^V79=TT(I7
MEBMZF5+P0X?-1+!?4X1H+!)<6S$!_6!Z?S757?R7I;K_1Q=H@!JJ6!D)S>=[
MX.T_M61B8S<'P3B&83D1!XZD8?KQK6QTA,OE77'*X>.$?9V.G]__>B-Y]XW]
M:'8"H1J"1SYY9 31^Z5%8*Y9KKLV,@0C@;P[7H 8"46<^GJ<ZG5B9BKCB91&
MOO6%SMDI!?8:1;, 5W]/1[37497AD6""N+!30@1S3E_& B2#2!$,GPOJ ! 2
M=U+^65;]T_-*A$K;[TC!]C7@>6/H3T7/N?(BF(7TI95%S+Y'(MB]6B*]%W1K
MAW#+'\9@);3FIJN\XLB[?R3M $!/M*Z?,[NJ$Y<Q@;GY+SIQ8FSD@2GP;SIQ
MPR0Q86SS//MO.G$4P_:1_AF^1&]0"!_-\!+!8CS_>YH?2:I>+$R"1^9XTX;E
M$OSS^^=H^<=+)P.0C:L]^YW'5V=.2/1C@+U(02JRELP_%@NYIXD.0!M#?TG<
M1^+\AEG6QT1@>%X*D+?ISN1XTLBZRX\ZA3.8(6A_9J0.KA$R06;2C]7>IX:_
M8JC8+]RL:3[_^&F^->$+:6>53%^?F0_[V]T ?5?.T,>+CA+ASMM#@VUK2HX\
M=XT9V,_=9T;>R#2_I>3@I%.K4WK+F/<9D1$+R*2*Y;])9HS*>LT@1N+$AE)U
M(MV5(YIOUVA9K<./1'?'F0Q<:N_*A9V4 A-]!2:0/3G3;I  MU8&ORYY-.KJ
M':\A5 S&$\AG?7#2]%A?F8\YQ]QVUPP;<D<^.*PNSLF38Z=XK"G3O>I N]9"
M""M4/B46=Y#L@990R: %2%QR5:R\]+(B1;_Y4T(75JFT'&7,H<67+1<TC.3O
MM'0>'_F96^DG"7:0>! 3"(T3/J[8?B>7R>@'YEDVS!##8Y$Z??Z*5;*%Q9C-
M6/]C4T\:13#)6;&6#$=TH%RCFW^^PZ2/0\N8W4"?/1A'YT)Q8^U%8>8^0)5_
M*:L&M<W3T@,4%Z:IW]3?KF>1@^AD2R=H3]-K3*^GW/L2-Z&SDE@\-+DK+<:7
M9,4-?IQ\G'VVO 1L5ALYLF 0JNRA=HI8$88UNTNK4<OU*YX(!,Y5]3QR %[/
MF($#]JCDXL7WED92M7?_*UTF2!"K\2CW;'TQSH%J6C$OQ'\$2Y*CUN3AT[\D
MCYZXPMGPQPP":9ZNN/^X",8.9C=2S&.U:Y]4IC[(M:<^JA_1@-@L'@M 4>S^
M$T([CTG=,.W+U6Q@*&<+\X>\?IV AQ&W(@_$F:K/!,D.C7OG(Q;--8/F0SKU
MS?+[L:F(HHTE=6QZ;:==GY.9S[:%VU\4Z)*RVC/MSNU5+QKYD<+ERI&!DR_P
M$U5?HR*!',-+XQ6D@:QFP*)4_P@K/[ ^58FS]* "D3F ):AP;WS( + UR8BX
MW$'/%5XY$9<Y+N>45KY?NQMR[#@/[[P?;^PN:!Y4?*0K3(%N]P"A999[AY=%
MC+HW2E*'5IQTUX^K=;L)NWDE>*G6*4!#B[C.(_[Y1U6-Y]X,$>S1M+>7.-HU
M%X\YNR.G#I_'-'+.23^;:4O9SZ#9>4%T$V>:.:]_[X*OYZEDOM4Y89+MG*W;
MXE7(%^QL1[FA_L"(@V( P:1 W5 !L&DZ^YX6.:AWL7OQ@[V362V#6QJQ_5H2
MAJO$R\VWR)#5GUS>W&&F&H#I<T^K.F9U._[IRQ'E[WT#)3-]BV[M&6E/;=I-
MD6?R_LI1(G^]L!0LK>JA,('F5NG&RP86A]"_5\&Y6Y^SG# -1,[3X'A,#\*;
M?+=/ C 2R+*1LH[!;QB?H[(-N[&LWKS7<[&-!LU6J)GV29[FGP&ZL=S(FK:X
M$/O('3Y6IMDHWY+X#H0WJ7]%WOJU39YC=G6CRI<!-M54SY-^-G:L*A)\^&<(
M\,\^N/7O8.%1,"M"!"-![_@U3 13)!HLV"[L$\&V 0(7$2S](0!QLX<-D41@
M!,Z5B*U'K1Q'AQ*!\WC(N\98"E]#B)O$A18(>M7GG_7&?U>\FM"*#P.WK C3
M\U^7XC8%80&E?$>M/ TV=R.7&7HU=-MS4\189Y :FUZ60!IQOUY".8-^83&V
M=%>]9OU 907!TR-X1A7Y+-CZYSTSX:")8%L:S1K<1ZR60^%PORJUU(75H"6"
MC-]1DB[8D0D*P&2-?T$/S]I(JG*D));M0!/'QZT@[%RQT8:,!J,/71V[7,'.
M=YVN<^SX^2SVAAIX.'.3]G@%DJOWD8 $@MD'CV*,N*0P7]R6"66#PL_%==A<
M>WLS'R]UZ]-:,A?4$^G;T&LY9HJ:9V8K=;L\1;"M>2H][7%>]S)FJMSK[^98
M ZR#R^\I54+2X*TN2R//DPNT*0<13"6*KRR"]38)-JZ&0):]"'9*3@0SF/WS
MYM@A-U3M:U!,!!LW69R;975!-% $ZUB=$S&L$/Z_Z?GL59W:/&$6\08MC/0.
M\S%V \3L>2' GB&<C#MD0<6K0@V(88DHPU\YK>$+M&F)1[1MBV82TWLD[>E3
M5#UDR7A2B7UT%L/K&M\\>B"_7V]Z9O^3552BEB(5&G/HA<<7BTV:UA56WN/G
MCM&_H$=QI\I?ZVA+*;.';S#:WY>/@_)!K:N;(K1C]>CT%.U&K,!0!!,G+N>D
M@_)FJR>CTXN$R2@.7X 0P49S:*WW(H? ADS(GG.(0T? <NA1G,G3$*5J?1\\
MNYJ&(E:TN(&;O/CKW6WH2[9,"KVFE]T9Q*1H1 LKV7K/]9_KE_+7D<(H7E:S
MEYKNR/ <95*#B)5AS5%CY)0@CY_C'!\*U)>PKR=1.PT5$14EA34J]\$]3M\R
M5QQ/[RXV=S?<[^G\ZY/]A?Y8[.N@Q#OZ;9][+@PZ/'-+ NK2"DZ<E0VRSD5J
MN&<"IR!"AGF./)S'BSXNR& .JQ'@FBMG "AD;]B(G?_$HZV#2( 7_/S[N3]B
M'0$2NV_@-OS$XQLZ''((0E^??=!QAS)&5N;#65BUNS5R&<T=!C=9\EW!-NZ$
M+NX1>'2R;,/#Q3WM34/$L'WZZUBAQ7&]TUF=R*3?CJTPPRE-?Z@7M;JR6W"8
M2-.7IK_J88]/5TFFE:M>X5"H(;LPRYD!Y4L6WC:$Q!-C$61KTXL)J>/VJLO:
M.^.75P=KC!_>I+;P@"4AV('C_0 ^KEQJR:I>#EK#FK9!Z+*"++G&]IWZ\*MN
M'MDUZUJH SVA\Q@\VR2NQ\>@^9[_0_),_OG;C%;OI&HOS*+U4*E ?C;-ONIY
M-MA&VC-+O;8_QMRZFKEQP60A]U+9MD1WA""8_6VV@)Q'Z+JDB.+\[KYTQ_X,
M>+''5L94*4G)T4\Z83G7B,J[.DM#^XVC;&+"KV*[ (]&C;DE6W+E#="4U/SP
M'VW?(_<@>^^ &R?YMD%!%>V^M#T_X)S7X*[!X#C>9"W!\)$1FR_4,/5KA8>"
M"D8J D4X@V#1.-WZZ  G](D!)6V4;EUQ7;I(!+M$@A&OD7L?\*Z'?D(_8&[4
M5X,BVK9OWQJO!/D3;^B?Y&Z:4<M0>_M<@,U/F2;LHIZ]$3B@9U%1V/[EV;07
MI0\KCS6[;)A)/EJ%4\&SQN?(8]ENR$OK9K(FOI.N^ULUL?,FS5+X3\HP)[SI
M:5&3A+ Z8A%F:@/_!*&>)VG&H7WJF' ^WG73JL81>#TLAE@D[YZP^2!A$/UR
MA=%GA\<9ESUW29PUX73')'B\I1:0E-]IF^7K?AU%4B&6%_'55W',RNI%ZEQ\
M>:<1S:C]9NRIPX_VIV]\6W<S#GJTL&"'[E5%AU?_TX(._T.PT(P"#L5.V4I,
M^_!13A/.DNTCE0"3$X<X72N";9%K?(+3/^UQZ+?!0YRUC2HS!6E<I9 7.O=T
MX8<FX#O'Y?:?#/3*&IRT882-CTAE'HI+MY+:.WU0B^XV@%*F8'.N7WSH>>I"
M7,7U//ZR]NC?M+C1:WLZS;WN;"Y9DIYK7,M!R]=I29X9/7$U6?77BMOU$XV*
MWCD_)B[]OC<RDN:/&J(PWWT)@@,/:92E&G,Y-5PH24H[M)0[$Y_9VUPR* $D
M^14-H//.'9# 8=.!A;RE+\RR2&8MU_-6::)VL,8@;>/DY%N;T/U/#]5X(&PO
M-P99$CR$$ZTW@A;M;Z=;71PINV<8;9 \AYWQ1U_\%'DP_]$GVBLBL!\^#1&X
MC1*/9HC7R1%RBVT<8JWY^0G4!M=*G&YK#6F;]^F2?-;E D5EARV:#4>,I7I>
MWB +7TI$Y;OR$3F>A,-=WMXH4F2Q:V# FT%[3UW?@9\=T.NFHQ>?SOVM SJ>
M,<!P^HW[LP/:0TORT[CZT313^=RW!W8;;62K6CSEQ;4O/DHLC%L(7+)U./93
MXSS:9.%> 7>"E,-_23HMW%.E'&3"<?LD <.7LXFU!MY]-57B$&L/9L.W32R=
M>8)S<=E.5.Y9V[RT\E(PN@=ETI'7X77:MML[;Z%2=W 4G!L40_W.9-!X\5S2
MM NWJ1XC*W 'SY<-M+WC](3)PETYY =:C<JQ-01Y*BP!]Z[W\XTNC;-;T_,&
M/.TS(HN8NK'O:#=)@.IL+9+1R@L 5#E6*SW\4V4<X2/=K 8#"Q4'+#I\4+M-
M@TQABCO:RSN=M=/0U[_K2^%Z4[,\_1(?Z\3B:.WJ6\@/%Q V2W.?WA<))&NR
MNW*2J/$^-MUGQ19^UF)8(_.Z/L\2[.JW$=CGT%_-?5?%-!9QG]46QT"Q#7Q)
M8HVYX#8F8O!$>Q6=XS)$R,K WJ/H\*IN) VC%,2VIK.(ZY_-3-_H7(P^VC(M
MZ<1]\Z(>7_]$F)#A63*)99?;$IMC'T+AK<*-2V8;/R#L##+H1)7HNPY7WN[\
MK2W/_N3:]:/?BUO\@V]?2FP]W^EUX'T7U8QN$]-D02DK?[PS)(1(P!2U3DT.
MM?9BAG!_$,2!0QV]7@*=-\8ZX8O/KAX9P)?6^W,;4)'Z=MEF^[#/9WR#S9J/
M/>DW.]A!<=>J7-_0V$%Y:=@S,'J9?-6LMYJ1?['#8W*CEZI_.> RYD_T:ZZ^
MP*.>^%[YQ7N6DI'717"@]AE_6%#::8DY&OB/3+KZMVUG_4]%O/]4Q+L=0GA(
M^ 3GH&-E"0,00*6B6#N $!;I%Q%L51CL(9Q_&MQA@+S41:,26<>A7]1,D5S
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M\>3*+*1<DSK#)GM]YJL)9XO"C(EC)2+8CT#,<Q+'FOG-N8;7 *@@QD+4U:\
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M QW#]56[;LC,>@_* V%>N&&OHSU?YRVC-;1W4;3IKIR!%E;<K%]6.J:O,3C
MH**35AK?U4.5Z3Z;07">HAT/;I[7W.5AD?:C']YZ&;0R5(- VH#^:E_RFD49
M<"-S.(-C.[W$2>U@X_/S] ,R\$L?2XM;]-M>!4*4:8(Q& LS*2H]R@3B:U8T
M2&LE'VQ,GCD!VEV)H//OD.<SA:0J)5,.;CBK>C:R$='L$Z0'/!\B[<(@,NB'
MF_PSW0WW=RYN<;'PH^!G%*G=6F^16GU]UV\ZVPV@/?976.OJK!RJUM<Y7'/'
M2\M6>FF[L;YD]7ZSS9PO]TW>A%YN4GQB\HB\.[PYYI&LZ5JYY2FV=/ZY+--.
MG^5/ML2'[9,C'96ZCR=EYX,RX@3L1@A.S$G\0RKIX!GB4)6AECF.5P@$#O4Y
MO,VB<E#5B.VS5Z2+3VLGA>NCV:TRGCKO3.]H^63V6_V0KI(N>]BGU<,QJ.7*
M5G5IO'K Z:'])H(-9=.VQ;.-IZ?Y9R9ZEHZV7&7-2HV+8!(W7WF=\CHU6 WN
M!NZ<Y3@7>MUPC5Q7%(G;_J.L)_-.5O7&T$YK&@US;,XF<65L?JZJ1FSK><3&
M*>%3>:<729H"!T/_[1J>BZY"7E)&<#>P.F7J5:W:G1J%/=U!5]D8";S9J0?3
M]LQ([1:5FC+M@LO!69=Z9J<76G0WYY1+Z,Y,[)I[.Z5S*^_6UCV$5Y!_@%>)
MF7%C>4. #_&.&X^T5:!0TE6%G)S3LKEMO!;<M<T.T']-B\03.JKTNP5'_.5.
M;DZ.Z[-S=O:8=M-^WC6EF6MIE6F5SMCVM-+>'IE2M)QDL373Y&1P]L$5Y46B
M$ODSV&&H "#/ ;@A^!J!?EOH@.1'YVT<^OT%U[D>1)EM",4!(6&A8)5XF>OA
MLG&N^[GUS/W?UI>M'"0_\BKIZR[UXY<$'[*Q<4!L@QSC[W\=_(=<Z_TEL&6<
M18."XU;("6Y9@X[<HLDV> 3?6D'4IN9]4>2VADQY:P0A<R=TKNOOP&"KQ$J"
MMP[NX11=#D)%IT=:>2NA)V*J7(1%*+<F"484SPO(YEQCJ\&G5\=L.Y W,#&O
MYRBQNW_<;L@#C*UD-C8:O##+M[-G>&HZ?,[7B/7/MK-(DO;W/U:\>&52B-EN
MD>X7%52\.B<D9=D#>?%J1.;TVZ_B[%(M8BT50RA<'4ILJ'NH93IA-"7 /\OS
M6-(QN9"09IYMC\X[,VR :P!6K=K7PQ^K:VQ ;:%P*S2KCRJ^^Q*[.[P@8U/W
M8D/KSSS.%;":1+G)+&J81G.*V;5S9B+8Q@K=:DYIK?R9EZ]C9C\Z(]!3F&TM
MA\2NQ$PX_:H7193V\/.7K/$P+&5-([S?1/ZB&"5</OF/;DG(Y7X!&<2AQRA*
M$]A&*U()I>RYS5;5]^7L=T _K-J'.0:G>!K"VQ?*;8%@MDK)V8#AR/E/HQ(2
M_<[.>HZ>@WLYY'!?Y7W>4K9U+3^<#]<:8>$#70O>'*+*W24@O5TA%6/S]:)#
M.Y^[>*X#HQ5?&H^R_I$6R4%?C Q@E81B4YZGE9:61IJ.I0;L.'@E5/&HF5;'
MYTL'(K5L A3]+IZQ:OYM+9TCSP\ VXL)72(8%56'BMIFBA3LG\>N^<24R%?P
M2]9#_X(W114&&6B9N*;JV?D"TS/Z=CEV?:W:&7+,<%\C:O+ES;=U%E<%#5R%
MZ2A6*M&%I$"\[@EQY%1=@!K[$-S"UVZ-SX%0E9AV?JM *9F:E+23#A&D7D.)
MTIZ*2AMD,?'&Q%*93CS1(]O)HPK'F72>L3SUY<V^? ?>+9JKFW*E4X(@63^O
M/K]?5:64AK3-L&UT$K39SI $VV)Y_NAP%$4GRM!@,O%HTZN@39RE7GT=M8BT
M4A(;&9OONT>AX^* N+VGI7OJUK ZJT&&V-J5&UEY> =K89_P:2-@AQE$"20=
M>/[$WG0>"G 8RK>H5Y/8!:3652D)?HO6CS\*E-:WV6.THZ?>G=YA'LP2_KIG
MPR?ZT0UEYBLR2;A 7X\]%2W=S^F\RVX[IW4'V;--%4QPS8P(UE>_ZY!S1U$\
MX,&?%=@NV3+)PK+6BM5YD0_^Z7F1?W<)VJ'-7"V"?=%%N<?R,T@KE8:RMN.^
M?WK^/@C)_PH':= [.I\<)0LV,1<GLL G!P!?R(U.H5_\Q,UFM*%8TMP38B\3
M_"_LO7=8D^FZ+IY9=E%1$1 04 $!$6*A*"UC 42$""C5D$&DA!@R2@L0DK'0
M!480&%&(TB(@A(Y 2*2+BDA+)$!"@M)+0@F!M!-F[;//[YP]>Y_]VVO6.7N=
M:__QY0^NBR_?^^5YG^>^GW*_TPS1:W)<M;#-F3WS3]W*":+_WJUL(; ES!\G
M!4IX;!A>#/!0$P/PQ[,_0P0[Q #J('9JK^1NQ%SBOW ^WQ>&G$=%!,X"UY['
M83]OJ8^L*6%AY=!F QV/EI^_7:Y)N,[!1'MR-!\M]^/<2'U!68;C$J(8;OX,
MYETR+<^MH>W^]@7N<"6G!??:K^C1"TV%#M25T\XT#JQ8\"7O:0Z+FP);-_#!
M'F)4R@OV5W*7>6'\*YAN#Q GYEWR+'8[3VDLN1EY$(67+"(*QX9?$WUD3T2C
M(U["W>BYW-U EO(\/H*K>_K#],1L9G#:B+ [[1O-;?BFZ5T0]XR%+$E3WE%6
MZT.>I_SFWF\.5[H8'C ;=GG:SKVO%"SWV%J/+.F/S"%.;/2+?[KSGW5PM@W;
MI J2&$8E63A EAB&#)P7O#'>LGWM]WI&EA@P+T&@T\N\YQY.=T5S8!&Y0\*+
M!DP6%\:Z18T2MVES?QUB<<#YL\K[_S[<)1O!W2D&1-?RKF:;\2+P:V05T?ZI
MC R5 ]6/$$@5WO5N[AS\W9F3H$49R>,D0IM2ZB\_])"93(E,HK;69A;@UKLM
M8)9O)OL374RNZ(EL@Q/F\TIQJ;W=#L<=$R]?D7%^G(8+'B3HKWCX_O\26WF)
MY>EJSNY0;4G>!\%0&-L%("X6P",[UB:,J23FN[M?Q*.,VL-?<.LQ6:P9N)*2
M25#%%P'R]95?9T*-I+7 RE#UWIOZ))WJFEH11F>F;(49FZ]8-CBE03GMWK9&
M:--?QYDY/7W=U>Q>XCBESH53V:&0O_Q5<:4"R%,WFN.HSNFRZS!2:#NJJ63A
MJCN#VA+U%K(']3!'!2;5*%U]W/Z6[Q:("7BVTM(<T83UVDV[5,\KV8)S8G65
M6L\MD7LF"*"^1LOSVL88OT!EB*H<)+.@7"^1)7&Y,W*T4IQ6^MR=ZH.W?@8N
MZP9(F11K5TM+PRF6D3J0/O.^G?Z*D)&N8FO5W]0];OHHGBW24]0FA+_ 68<@
MU[PKU\QZC5JH0<>UD?+S7:&)JQ[PX"5W0VRNA*@FS^+YMKQ-W+<\72;A,5DZ
M;U&WVG;=.4Y@9-;O'(Y[@/;%-\'U&IBZ'BYC#R,_X[@?W1MT:FJJ%$DQKV&*
MWPS+W/U_MC1/(J0^]=YQ9;_=Z82[*1$%69GF#TX[7+&'M147U!=(+/'RWWL0
M]E\;@,5(WEX3AOR-@Y'$Z,$JE(2F.V6TNPF,":5-V'I/,6"&)@3CVL0 X@TQ
M0'[R]XS-B_\T@L%_RB7RQHZ^4ET,9<ACY\^+ 0.>HT6BS.(_3@O+3 Z* 1H4
MA!AP.UORJIP5]@F>+$O(=2KT5\GKBY#\SXQ9FV:[OKT%-D!U_.>_P\$Y_S#7
M'V1[HV7Y&P*JOXD!*6$<I*C#3%H,N'K/>2S;#-M9]1DT"]24O/[L Z*X=1TQ
MH'.*R> #6*I"!Z]D2J96#OF7Y!7TO\G6)%'^?^U+WI ;V28)%%V2[QUY)P8L
M[">,)Y&*=<6 >[EBP%W0\MS%IG:)<0^( ;6@Y6')3BD=>ZKSO_8G_S65K"2Y
ME]%],2!$* 8TUKP-!*X>9ZQ*5F#79UP&7= GSXD!0J,SZS<W:AM@U/\@&+LD
MAM2Q<9 $.\<4"YQ38[?8+(KV"1RIZF+ HUJKBH=[49M8EGB-[]^I3^"^>/?!
M*=)>CMO+AEZCX<]W!!>%A'Q<A>OPI%P%UB.X!7U5PI^Z$T0 3FB+=&RX1FTL
M47XL<0^_A7ZD5^_^7UCMZT>S@]],Q<T:F.QH-8Y^4C1(W/BD#4YG!K=5"[.(
MG&7FJ=,M3H[.=S%SES=:<@A=2'F&S6#E+HOMU +6<@IE_T9Y"P0\(QC5(A2+
M 7<8@R;MY')RQ^Y0IE$\'>)H[1?=."HM_QREBQ# 1HL_%A<CC-S=W2,:OO<1
M<M]6-O0%)QZ'?>(:9Z6U=QLWPZ6&R$]U9CS/]C_VW9JOH*%5/0":N=$SV8U[
M>O/VF'I_*@Q?OR$\\4IED&^"1G,F9C]R'C8Q%$2'1BSD8XD:Z-Y.O(?9UXT2
MYX@EA4:.7ID\,:_K4]^S$J&M7EL7=RS)Q7L16'([FMM+09%)X,&EL>Y?0##D
M(X_=O$[VD#W?-\844F 1J/%T;N\ VJCD4H)*+1."V9Y]J9IJ:O8ZC!:Y;KE(
MNZEO/ZWHW<5-#?.,#!0%KZQ+/-[F'"$1RK7FD274"-2J[.9B#D [DZ*[VTH.
M1Y4(I%G4)"4S*=;1@*C2+8EOXW5EVLK<1]S5>)@9/H+93R">RI^BF@=X/>(N
M"_-DI_O %D1F0_)SM[>KH1#[H8>M$=J+UJ)YI!CP0VJ%PW*$S;=U5PGW[+]^
M#;S[T\GA(5O9ML96^^[-[,LI+::G7Z9HOTH_W:GNH*;3<?2,6NY6A_-;\PG/
MS,K^[';(WT=(-P"TA1CP5P2=(U)P'D_$9&#_:'*0U"$EFHL1 P@'L,O#X!<$
M03ACA8L796RD(@(/$V;YHNV2#7-,[25V\.J&7 1>ZKCH))QO+OF2P]C.V$E5
MKN.&6GKS!^*G(>$ EOH5XV!2(0:,D==7@<+CFC,#!^RA^A'G_ZZUJAT;Q^:9
M;^KD7Q2UXQ30"@53#)KYB2_ZISA*[]CMM:<]C.*(FR>@<L:WY3JUW_8++%X-
MS6 .5#SPNQUM'<R6<K^LUEC#KXBO#PR:V/F$]TJK,[P-OVH"_W:5A5>XX'Y%
M#]A3'"DD=B]9Y9#HDG7'B;H6^+HB"DY&I.PRM?B5![Q!2NY@['Y!:X'!0/>)
MM_H8@VY3O[[;#RKC>;G8(IN.6L1O29EI7K4]I+WO,2X6/EOXV>#(SB>4,_$I
MR_Y<#-RGWDSZ^=.;&EJ=KFU50L<R"=J^'85A2U:U&6-@Q92FJ;(TFVROB &S
MZ]AVX*9CY:_</@;>*1_A=3.)M6XO#--K^GX,4!G';IM1.=FO&:'S_GS-EZ;&
M<M)E1&D5KFEZ9>$7D/S&AR)& >W-'OQ<S%YJ6[>*C2JW0*V8&=-'+4K]4HM-
MK6;KN7&&N;F0@^.U60C"=WA$L6MKZ#YF7/[<Y(U\RL]H,LMC&?C]4UJ77S_W
MAJ=CWFV"2#Z/O.C4O>R64R8XQ8)L:\]69*\^1NL6N<,Q!SD^,7F\C);,@=0S
MKM/K>QH\D44PQ?Q<X]SJ:A$N&!FZR5CM8/Z%#WF_&NF,U0ROFW'_S\&%C3 C
M\0D T+=D3%^F!4ZPS#,8@[%4N0<YR/MZXXD!H-G \K<DOJKPA]E2 O:; @+:
M^QT]Q(>B-Y=M- O[,!*P6P)Z@;4\<G.M+=/]&=ZP'"8Z]^5[3*O*MG[-NNMA
M1\MK.$[/\K)<C^ZD9IKXR^V:D1U^-M7LQ#T8'PST*W3#CJ:GK%2$>L 0=4E'
M<=6Y9X.KQT0:17SNLN_:;(];."6QB!?H^ON$],TIM_&'A8S?)Z3W12_9#@0U
M%/YU0GH\?OSS_(Z2B;BZ))<1Z:.5.C.K7]>^_%Z\7*@5[9CC($1&F'90Y41R
M0,#1N@'W=T[F!ZC?D\[^%&9ZGBT:GWE7W_:)6S-UP#!EVHBDDGI=CMV$##A"
MBK8YJU:9,@+G[2=,2XEV"WE3PE=,:"*H,JDXLGZB)3,KIHVPE=8=.6&W;O@V
M/?L@IZ0Q[>G;E+ZK$H>NNH->5@/3A=IS$,.];?# GWNG57S@-KC=<_LI3_O)
M<X,1%4LC;61;N]DM=FZ?=:<<=($<76=F\!(HUU\KA^3'??"_0\)U.$5>K25;
M^B':?8R\SY:+E.;IM!BO)@0/)9^FJ%9.T@_UEJXDVB&-U\<_?P >__ YS/3C
MQX\VUX?J6>/;+W[(,L!X;J02S,^H/F24=;2^UM5,9[CQZB)S!0H]MQ\S<DYR
M[C'\5;0?A.FO'0Z*GWBGHLJ)+),WVN<"UB^CT3LB-R\4T*<L]Y2X!5&'7G@M
M(HZ);!R.VSH^&A=]<J?6NP&??Q$=1\-8([X=]%,<WR2B!8B&/C\&EH'3=:D!
MZ(^%I)XWO.3K]12#<X*9F><?!]%#0YW?EH! O=*\$<DCAB5\$'0=<*:IIUC[
MI51 4LQA#37T!:??JS+"G[%-VS8*#[P?-SX5!"A*E80/M*HJH:_J+TC;FJHV
M)C G?LE>L*O*I%C/W7I;(QKB!$_$T==-8 45_7>6H7L@E43*=+H8\!'_CO$H
M^PAOB1/#)#>1=^)T;O(264+Y9@JU!&'V3=&L)C<DKI#W8)TV)#P*.=-2[T"?
MJ2>D7$K PZAV>;*$92#O[JCJ;L'QC2;9:(\]->G=S61I@?9+E$D+975_0D)>
MC^!<@3O,<'=$8,69T$C=QB*;R/#)"CJ$2'48=[V)4S,D?+RB+[-:9 X+NZ W
MLY!&9LN%*T3J^:<447YU2N9]%]F3Z4F]\5J$;+-?_O08*8%R#[Z(NK#L/!!<
M20R(#3<@I(XR:"HT,8 E&Y?4-\NET UKZFJK>8EX]?(6V<:!3^LEXSC63.>-
M[%'KL<WR/]59SX..%/.C)#>JPG3-\2^).C &""5P.K]#=;L&2-[T<'I(6?=K
M.CZZBL\CNKYZ9S?4F3-@JA%6/-R6/VAB6SA3[_&@G$:'N--^9+0,1-I!H$.>
M.<]7"S'S$%K\S>0))9T56/:>TQD5)3K $(P@$MI*<B#GP/_:\'Z![(P=32)7
MU0JT0+29']FEM5BX[ZAJLERY0)]S*(/P_;PGZYQWRA)SO%*IR'<.RDY=P\B:
MHWM<F@IX9$=2G;1N5K'%FH5#DRFE[V(@0G\C]]!A*M.DMI%[8&UD?S]LY!X(
MAV(_3$XK7#ZL^+GD+ 5O[,#SE9?_MFXP(>]#[ D:G_I\)HD#6U\%=Q;COW4O
M5^:0K(31(#\>UI\P^) 9TS8X?\>'<X.;1%+EQ2%^VG_V#>8(ZN=CSUD_W>G5
MRK!-N/$V";AO:OUG9W=;-?>^W*2(US4WNZ95JYS;([=Q43PECM68<RQ]B ]B
M3CPRL VA]\Z'U"2X4HGEWDSD[KS)I%MU'*NX^>7D/:[G(,5A13]"GA@9"P+Q
M!O:]L*7"Q7LKXV1=$M)KLI\U6@0=N3M!7D5$D-,G%C>T5NJ$>:JLB3D[W Y]
MLPNN GF^^>0,\]G1^&F%9?Y";/VB^XR*0?_HWKT.D-,C5=);(>Z0Z.R/3FQ2
MQ2WO>$X:64$GL%6D027"6-"]O(XVXWQ*+0LK!\^LC4-;E7A4-(X3"/#:5<4"
M0A&DXK@:!#HM[RP?NNMUO'?:AZ('@!9"V2MK^WR[%/X^:](B'SP^+_+]//!Z
MNC_+ZO>C)M$I-M\BQ0 )?&T79GD)\[%WD%&B P.Z&.HH8PO$F@/MX.@;4J_9
M,I/_ G&AN\-"*1F7K (+4,_;,CP.LM-?QSW+[:OF%_]V'P4@S(^3=V-'HW"5
M$6A#83;:FC,![?M>RS'J2+REM:P6 =\5*D?>0Y0)+H357^<^YA-*;G$T8P."
MYRQ'C09'!ZI&0"V*CW\>=M>(^D:NN['T+ V+B'OJ2-0B^)!;249BP/T(,G?:
M[+$LT-?"L.1X<M;J=[[./%5$][0XX)P=\J>?_/B/H\+RCR(Z^"?G3C<D)#[Q
MNIOH!WDQ3%49E'1[IADAUE1M3%G:D<V(T[=I.3WDGZE7Z:L;G>NMGK[8%+@-
MAS"-S3"L; I%''%/<!U]FW3.D6<C)(D!7MC]F#:RB@$2,"QLN,Z+8)W-XX":
M<?+#;K^]HJ)U[YZSKFJ(2XEXC64>82?.&,:4#IGV>%R-*T#%O3D1U+T?)@5<
MK88>$@V3*^2CL'<6[ALOM.A"YH((\E-T;"SF(*_FM@5R-XI&^< R.TL?+DEZ
MA2(I4!0M^DQOP'R1&FWM:3HWW0X/G @:?#G_[A9=L22/49[UE+I(2K4AAJ\F
M#CRWKST&E)YCH@CTBRZDF3?0U)$0S!O1)K]2<H=H$\>Y60Q00A4S&4GZ"5E2
M;?1=5 /5/;R'5QH2Q]+['/KT5.@_10V8SL!JI!)TWC8]X'YV >IFVX2QGM3M
M7'_:9XT/ZH659(;CETR/92(,?*I@\S@?R4]V$G09-)JI6JLAX0*>G(IS1.O0
M2%"3=&SOU+I1F^U1RK"'-3Z_O"[A(N<S#JE<W2;(H._/N-:0N=AAVTK['!?X
M^FM"1.-Y_>AJ$:NJT?$J9;G+Q*TG6$D9:C4PBS"PU73JG9];6.YRO$JN39IO
ML>\CS*FG4[CM7(I+*4)O+C^=/DYW&8^V2AQ(7BNB+G^4N"A[(>E; ]]H]BX'
MVZJ0+N6+&U6-#4YX_LS[;1(#G9G1W)!U87[1&USIMKD?H^J: (_P>S.[0MB3
M/Y%IJIUG.S;^FQV*:&NPT ;T3^'EO'DJ_*DJ@FXXE &UVA3['=..'$E=586!
M*J?T</054+ZQ!"*B5_XKT?I?B=;_MZ[_2K3^\Y/Q3$0[]_$/\)!<"N](!!-2
M8^S;!MYJ4<1[."H&).C]>A26K9Y- 5:C J_77XJ(16N/G??T+$#]TISZ7+ND
M*GF?1E)N,)-OHR &1(%E4+ZMYE(<N5HF4&XR$Q<M #,;[98LJ57*/I\C03=Z
M#2#FH36-9>2*NLL3-74UV49)+GD_7MPS^@#;>X^<A>7I.L]NDXZKLKW([>"!
M\]JDXTP-O!0%P5]*U"3(X%%,2\C=(=<I\MXYM1_Q?*\6.4XICI7?RJ"9*\DI
MEAGJ,K.L5W#0$^T1YTZ86?'KR".UW&.B[J<^HBMNPL(SGSL\U_I*MBQ81,RL
MY=2OMT7.]*A^C#Q@#[T0MI'4VK:RT3IW0]CHV$&7EV".V]+QX?U6[?3M/=]4
MMP3K3/D88738AHF(P+"PT3J]@/EQ>>..^_IOKV9N2<N[!A0<=HMP;[GS*\]N
M?'QL?1=A"<'V?8P&LY?:Z J<B0<K"01I7D,3;?P9"[Q[)N267%WO2HGBHH[0
MF'MV_F@V#7MT?/O(7.G+[-[QD]S5:V"D^A/0*HS_%\R@BI*PBK1IRMR\AK\G
M@R/5DM+!3(ZG[ZVMW]_U"E5 !["GT]E$N4ILLQEK1@,2>*'NLG=E%,.1/<U@
M^&.4!FC WQ69D/ML,?-(AHV?[<KB8S%@![3>YNL[UKFQ61_A)#"87"V;W^C%
MZ^BIG)O6RB$^_/)G>K!_F#[:?]9Y&,-52;<O;!-]QFXSQ7)P'4:GK%ZAY%NH
MM(JOU?V&H1Y'*'+'$LZS2S-.3'/$@#LHG$N$KLQ5>N)^"+U#M_VC7\$3LR1R
M*IFGISF7BN#HL(ZE\G50TM?X5H\P^_T1)>@KY)KL\UL)'(NY^3LE K/OL91S
M"/2./(A=AM&.N\?!+-V(ZWT3U;5OV9^,Y"%GKYJT4A--S*^O%9E_L85Z) IT
MNGZ[I7-</]_L7,V#R-L25^0O>+(FQ=G$Q?'6.#KMHN.<U5C1<1Y+-[!M?3R7
M,'W-CZ1%K8(H4B;LWX;1^JQ[3P0??+,\<KK+%?'F1,D7*P3\@/U?VFQJ5V7Y
MN]!J'& 3<-!Y=.$^&EDHH5?)\BW:+/ A.B]%#+C6'YS'<4XH]>4<*\RC#_O[
M9SP4[:OI'V-W$?>W)V\I2-Y\;ZWR1.5'@:\D:IN:;\7/2?%O"?;R(B-ALA,Q
MASDWS?4Y3XUVGW8#,X$_M&G&KT0:S]MX&^V0CY6WB6FQK]IJQ'>J###O\\DG
M'!:MZ?1TX0_RC^^U3\PP3;&&L9M@8@ 2-OG9E'0ZHZKX&)T8/[\^^4T,6$Y;
M?2EQ:FUF_]&3XC9QI$52<7S@L,!=B-,')V4?+.=;)8!\9[(LEV[&T^AG@@O1
M9SCZF4$J1U.LU9+GC$#LN&DG8P_R7VR.5/<%A:'=0V)3P-K8;WO(O<77>Y>[
MD%?[@R!PN_*!Y4B/]@6;@:HLAUZZ))8,Z'_DA^D"E^<LF^?/(9!WD CO=-I\
M[[@V8A[Q/44A%S7R5$*4&>QKP$'S):ZI,$\ 97_^"KF)DG;N>"R2\\_0T;$.
M'34+F5_@F]C6U:6[9BXXLJM'&A>BJFTZ@E(=ZGI!-;8E+XSSY'KX:W::F:=;
MK&>D/N->N*_FSBB8E$Z#\\":)W-AQS_"W,XLIC@E+,/<!\)P,I(=,9N]<33F
M#\)0;-,>D+\+1@N]90#KF[S/XQ(:QC[N"(IY,B@WYLSS8BFMS=\Y9L'$9S33
MA&WS"1%'2S\B#,6 YIY3,)\04-T-$7I#PF[N% '3J5JE>A^C/\E=-<[&Y0QW
MY_,Z6FJH4@%T3;9=U8.^5F.M,-!=+D[M0_]R]-NM=(9'7U!QW7V;>SK\Q0W/
M>8HCW6S^5\\)W8NR:C=6^2?/Z5TSH _Q^?Q/GO/!N+0Y#;7A.1_,TRY(/.?Y
MNX>>:'X:1V&](/WQPA%XI[LWJ(98RCB] KO3C=SD3G/XEKHZQ2<%J'H+2/*3
MA+H^R?+'L_X]LE_;S%@,.13R'4:>LRW1U.O-5UYH,TFV9V4WMM5X'@]\XIDW
MN0ZIRLA8I3IX_F:!1,K477=.O[#YKI5Z:2SCO6I;,N^$&#"G$<9WA(/D,'OA
MBQ*FO"VHTRI* &0_;*TIA_*@K:3M?<&:;Q.<. 'I2I_ZB#"6+W1.9P39LLH-
M'[^/,%61K:16[U9L#QDP<Q1)*4FL11J<L"[*Y1\7*%&/UO&<F<H>:IR+K;0;
MPUT(SK9V-^5I6^GHGY!'#\ZC=49+;G4%9+.T%X+$@+VH[(V!1Y WFYN&?8VY
MAVE2K3"LY=_&?"$=Y-T]%$K)_DNO1BW'J@VYE[;CJ+'5_2K^>U#5B3<+HJY@
M)(RENC]%7W6//OMS.72D!J];TI64@4F8'V4'37[)5I,]2/(SS#4(WAG22,,&
MN+D7.5D7T$S?V!T-/MZ>N,-,/4,?4H?'B $?50B^Q>'JW7/N7!O>4B&F#R3!
M1BW=B?7XEJY 9F)WDG[G@G.+VRP;HG"TAOBV' *WK ,?6YQI,1YR-Q,#8I#5
MMD:7B?U!A8CJ@V]N]P4L"RW%@,GI3SU!")V63,-4YMS.YJ$K7Y:53[=8]E0U
M:#TR# ](RZ>U>>%=W"Z03SA10GZ]B-QLTWK7,O:L+-Y#??AF'E/%I<[HX C)
MA6$1&C);U3"\<C3S\?6L;RFVJS!_$?):3OQQR_]P'D$5Q'8'#1Y?&EV= X#\
M@+MI\[Q@CFC:I@O\8<D%%<$JP/FJ"M1K9.:MKE=S$'FG4.2KF39UQ^H'?#B1
M>4[I;IAD[PG1,>KZ'LQ7:*55M!@ AP[R.W!;JM>.EC=2WF"K! J$]PUDICQG
M/BEEF.<,N7/^KHY+&P;31' ?.@IA\)#7*$%#\ 17@L,X<-3F;Z+,I.<G6OG^
MQU_@%K3RY4=:_&P^?QS!P(SJ6%Y^$<>)4Q%I2O /4%@89)I(0#Q[+]EB4X?.
M0^](PH(D$OM!>3Y8V@Q3M=7LXHV:7E/5U_ G*'F6[@A/#(@+4MG$R2N;7*?D
MOS9FH4J(!J;I*GK[W<N>^+(%/[ ::L]\'4';6EQE*OZ:=0Y]YG&.4+UDE;MT
M?/_/3WUJ'S_-* H%];+B-R8W'ES#])>)^E0K8J(0U1'O\WF)['LZTM'FYQ[>
MDTIX'92P?8R-C<L\$GT*%=/R\U!^V\?C^1VQ^H2];ZZH_;)3>(:06&QWO<CN
M!4G+NFUMR(>86>EQ==TX\,81A0Z8.C5MU:-P4O!%LJYGGO]FG;0S0R"/'Q,#
M!,= R@(IOCE,/MOG"3NPY10OH>WDJZ%D%?2/M37]B-F)Q)(!'!_8M)=W3]3+
MU,M+)#.U&W]IVI4^I\[HEV^'QM-E>4IL0@=9'HT(Y")WH<W9G_-9MF!X#CB,
MJP7^6O5<]>2C2+!;OTK?Y5ZF>F2N/:GZE\##A*5^7C5'IQ6D8*XI^)%'8'6B
MN_>A+W&PL::>145=IE_<;L[0TMI?";-N4:75RZ<R;SIV%$R%#!$;S(PIE%[9
MRYZ)\I0/?H&4-!@P),4?*,JV 6?E1G#O)9@*F@FZ9WO!K@T?!:?$@'-N]$25
M"(L#SCTJ9^TM(L_SE3&?/(X+2TD@E,XH-9HR3@7W!UA6CG7O&VI>Q#\4J<",
M#&/:5-32HAH_[1ONV/))T>Z^\G2;]VM>L=.7H(2$Y]?[,3V'/ML_\CYG8JG]
MP7;9&I)TZE[*XQO#F=:AB$'5C5G)"\!!J=G,D$:^%Z^]6V::/$26%DF[0=PC
M1XQIJ#M$^%BQS8-/B=S&"U*,OTQU'TQ"@2I-/;<T5\G7E#)Z;>^1MK"=HT5*
M/& S3EJ@C+?(0SDW>:CTF@*9<X:'[E3V+-L<U)_9;C.JX.T>$73F\UHZRTM]
ML=)&K7RZ^-LI@^^Q)<:$2R,YY'0I9G*G/[^&X3CYVN$ZK%TJB*!)MXWH7N@)
ML=ZHZ&^Z]B>74@"$T0S13DV^$7FVEN^&!O."O? ?O48;G=9!JFC#0/CN_#S1
M5DX"&.L-+[@(N"QJ829Z&I WQ\EIR=D0I$;T?\ZS/(UM+!*<E.R1*4P7B%T!
MDN U:=$7Q2U17=WQF"W3MZA0N;@)@^X6K#S=]:N_L\R[TF,9HGV,?7IQKT^4
M66B5]Q*(%R-""KUW49U(2:[0KZSK[JLZ0!^^M@<;0Z0OY#WK2,J?TZH#QN.(
M1"H-&D)66Y.3O(JI[EV_"U6()-^\1]2'94<)G#B$V4X6Q.L]>Z$MP9F3_,N=
M^23=$I$Z*N#=L5K8;?H=V&YJO$#))P6BD/MBN',T2X4R,#?^)+=QE< #=LS)
M*J<_9!.XT"_S2Z$E-W'Q(G.7@AISNS2\P7S,:**>7[]-H!@@HVQ-M"@>SHON
M\A2U]7Q_#-4=>@X<%P.8N%:H+/HH+V:4$*^RC2SZQ G]!6V;RR.TK-Y1N2SO
MT(/T;'P@-1.4 JR!963;5P[HKQTZ_WJ**N]D=&1N7L-RA4";X<920/XXFA(+
MW#[GH#.C!)6#[U"-#C+A_U;JS9YXN!SA$H3;Y??3D+K3W8_P?#?WCZ^5SJ;H
ME'B,V???AB<4#R44"M9^ZNNPDO'N?/^-@FM+S)5'ZJ\1!#T-PS,NZ645N:&?
MOJ5$%I+#"(WNO4[FB T1'G9N*T[9?$.$YSSS8'XJE!?%*M%L<;K7@>2^PK=$
MWLNUIP0<7BII^3KI=LL#;AP'C]UO(B7U3,4O;5?"]Q7A=FS3)C' %\2SQAP3
M6 D+!.?SPFA6+9"3 C->)#886;]IK%O.]8U(IS^H./^IOALNFKA/W=ALV:&U
MIQ./MG:Z^KXA9ZJ5XA(N>WSE<>0 '7F9T%B\=FS]X!?\G'^SLM(J,:<ZHR!A
M 83'Q="WLE=;5/_",V%2'Y68MS"3-Z%\+[&S'_H[_:#NYO00[SZ5;AF(V%*U
M'V*]I<(F6#^$_685>(+N]FQ[*2E>9VP(4;."&"'-X2ZE6&OD7.D,N2RQGXM_
M>HKM'ZP!_G^>Q'D@>7:Z:(C&XS!B0-[(*!4MBBE(_I?OE9R,-D1HB]OW^;2(
M2%:6XU4O)G;K\ZSC[C9/R[_HZUK:1KA6I\Q/=SL,&(SL]JZJ(K-S.D'S'7,9
M?# *R;THQ!%AG.<0=Z4Y1[MX79EW)*7&!KZF0$-D1MD?_$5_^Y6RM^D:<JN9
M]+(:S_DYHE$N//S1%8O4?8(=J.YV<TU>#&M!!K74GME&C36%C"D'.G(TXPP:
MFG8.3V=2*L-T1;D1ZB&<\XAMN$#3I'1*V7D80L$]PN5P;=+95.J',GIO )'U
M0IM^$NQK/^1^I__6NK#P6/75I?*5M:.%%C0'BM.(Q1U"3R>7TKGL+P;48MF7
M;)58M6T,6K&SA)+'26B[E L;V03>Y$\K^5Z#9T'W^Z_KKL83@Q$1HPM[8(I9
MC?0\[J;//:5$K])!I=_F5><P2HES<S;MU'0HI1%C+?GEY<VWDIM!7QM:Z#K]
M<QHU',T.U;W3#!E@.O,5[!5[:<U#F0VI0@"^GD#J[Y8#'J"IIX#O*O%R1L'J
MM@DZ8,J'[Y^.'_^MZ$6-?51A.Z6VCH.@VUE9[M]SX$C(4.9$J&C1":J5MY&P
M5LO[6T:Q1,K8/Y"ASV?\8<FJ7 +W&C:RYFVJ0B.9"1TQ0*56&%DH!N2_E]QK
M^+W.'ZG(L&>@P\X;$D+V/?\L(33%,22^&1/2<$)LLNAY4>AW1@=.&)XARMBT
M7!^O17AA]NO_EU^S(T121OQ-'9R'34;0:J/F+NE/O'PVXZ(:RS(#KU$%',-&
MTS0:NX9ILSW$,MV)..(.OXK.0^\KIC,[HFXL)U(37Z*0=LEK6H3EMX0QD&CG
M"/\'S=EJCK&JY&FE],_]Q-O!<5B?1IVHXN_(L.5YC64\F0^6WMK0M*.LC,TM
MEU&&OBNOJOE4PX%G*S]HTR6>0D041M1YG)[R+#)S9KM/U_>MN'?4$\,M0#K*
M,95<MAN(I5X3H2W@9F3AG)$=X5HYC96?=O;U!&<YMV1^3F4I[Q1-7*'J*]NU
MN/94VVA?-<H,*,X?L8C$0VE7R?K.AJ$_7[R[N?C3O?:D<[+/+)3FMZW:2K;^
MD+!V&3ED,HJ($I5'P)$< E-8BGN)AGQ)0R!H"_:G/NYY-M:HUTO1\9.YR,F3
M2V$\CX";N.C;AIO!6]AM&NE9^&GCC,DT;/;J;#+?CL?@6O"^,Z&/23N1U5C?
M,!HP 6VB3]WG@FII4JQ*'_-@C[^L696C^S[CPFW=K5)"TAEV'+W45].+[A"L
MKRX11Z<V Q-4MO(FV'U-##F2$OP4G+Z#\SE9I?S5]'99[QWC73#)@MX1CE10
M]"$.E%5+RO+4H:Z"&3EY&IJ72?O1''JR2>B&-Y6?]S<<$W8&C KJ.X@!U7?O
MK)Y$)2/VN(+HYW56GX8XK)!2EBJGPS?4-,.^_EW+M$=P;"AAS10:3>8B5/9L
M2#]QTLE[BE?E_["R%!DB)>R3ECA=ZC1:!!2R"#SR)<EM@@\Q_UB3Y?LM<A&6
M9]0BNKPP)R4&> ,E6VD]P<8# Q--. JNBP'+52$_@>AJ(@61U;*:! A_S![]
MOUWC^+W.L239Y5NVBP&I)%Z#&'!/6E0LO<5Y>> /9,:_X"R[U_0JD7QU#F/]
M[?OD;\D%OH),08SHXS!!#'"=US8_)0ER_)_%@#/_VY:Q_Y>O/]8./TD8%@-X
MZAV"U.X$+/?<)';=*X5\B#,CLBVX*P9XAH%$;]CX97 /5 0&2ZSSZ[:]8L!T
MZB%,58^%K& SMICY;V6>EJS^H%!$SB7SSL);3P[S*KFN[)RA#[6*P!C2"5ZT
M>\6D9[:JS+0'X'<YT,\5-/*C .]G0]^"B+]HGNJ$?M:(='(K>9"+74>)UBOA
M;--#2'X7E!_(?G3A[U-A.JX]&CVN4%+J&<^BL[0/9^\8L_;,5KC6<>*,Q>';
M*=K[GJDG#CSIB2\[_,2AYT?5UEJ!K EW3[TP6712^@!/U3K-'(!V)#42V8<H
MX_/SC*;,X5/YG\O9"]<;ZC.G6=J(S<F%**?("]@SKNRU3"4880%]CK5#EWQ"
M1RAY97Z,P27FQ-QY=D(;=)NYQM=(_'F.1NF,F0--2MN L'.&,J/)!<>CC0(C
MX:&RT75Y']6CI>Y+G>"FTJ<RX(99KSV&P(*]F"_8'P18OKX PLEH(L098[\*
MK)C*=NY^"S^YVJ6Q;.6<8/I@63^9#[&K;JJQ04M[<G]:5'<.F=&96L^J3BKQ
MQ7HAE@=#@#,'A"\8"X4E2.)HE>,2W )D JKV9HZ=%+6COT ;LADC&2YK>K^+
MBFTHF#]IE^4:S1KP/7C%W%.\N5=HV][]$S?82;G?4*&LT$>O0CU9T,TC]*'.
M0BD='U+?G%(KS;B=AHL*6-!3JZT=N.4>46L,X>;O$@,.]3B>M<S3V%'JUVF@
MOHX7^JV"'7*U+URQ#WGJ!ELCS-P8\,/F:;808CVD>>6C2"FT%7MKG1<+O W5
M855-65;VLGL;S:*/]WZWF\SSN_WD)U+Y6^LW!C8[7""P^JP2.B[LD%%(96M6
M/E89R[XLV05:X9A/) /0)@P0?M==L)F7\$:=ZR8BA)YV0VMPGK)M%6>TIC:S
M@#MYI:,N,+IV_/>793T!N16<6R.P&HI(4_15U#*:K?2;9UU-IDY"1&SNABJ-
M1C3*^_SOJC0IE_,LG9,N^5A9[LI[L!N=#90RU77>%KHMU"Y20QFTZ$?OA:P,
MYC):J(GA_C;6NIHJA:O+$?C%$7T;B5O6?OLG>=8_^6 @;J0$(_PH<=/[OH!F
M"]"6$GX1E88]:/ OSRCU\$&(ILDSLR!MY4$LAR&,R!"ER:Q,2V!7IMG+?SUO
MP/S;3T97M*U*0=2DV(30XX"&356IB$%=]PB-$9PJMLF2?"?R#-=0F+U"/C"U
M6@YL0RI9O$:!1T4O*)355EZ!NQE51;.ALMX:X=TC4((;P^430C=S0S,F+O<$
M'/4L+@4]$CI>[U]I!-M3JDLL^<X4@XB91D>G@6J;A@0A^'K_PKQZ [D_6(E?
MIU'?2&JL3W=_WM#PS/MMW=MTZX(GWT*\5ISG*G^7W_O(X[!4$\P/1T,T6S@6
MJC'FRBB+/&LU=O+]JL%2]3[]J=N/R^HI!E()S[M"6YW;K9W&W/L7;I4;T@QJ
MTO N@F3HC?O-0K?$O(SJ0MCUR*I>^>G<T!G-8U5^[%,W1L*3&)L#7C:L9KPA
M;TX!X<$\(_[H(8H;J!U*\W*N3I>CY-?P3$;CU"T?=15,+4Z1=#C?67$E30WE
M]?T=#V9/!,SI83[7KLN1?7].&78G#&+SKJS!N9H\15QE\BR![<@\4//$=6:#
M6$2M)HS%%?QJE(2^NLC#M>/(=5*!IM=X&<[]<W?H05&Y9;55M4FTWNV>50^G
MW=:&(4AD;+&]2=N'+Q(KBOPJG((.9']6P57DVBF'.6;P\HOYSVMS)&RR+O$_
M'+G)9I*HEX<K]\'Q?04_D+_H)T2X8$ZBS45?.- FH8>]EXQ-B4'516>V[=S*
MS%!)0<S81Q,3B.&T$[F\JHSZAGB*I7Q^OD1_QPD],>""5C'>X7J199YR_M8\
MW"2_H I>A @^]G/BY2O[-P9UUP@&]9$J^+6BZ4P/?(Y_>%)""8Q*LRS/@T*F
MPFM2B]QNNOB'>^ ][VKDB[)>?X5TR ZDK:3U.PQ!:#?;9-NJ6QTNZL..GHXW
M$)Z4[%$_[&AV\E$)3:P!-V5M/:S+,@*IHH%Y0RTR%?J4="[C0%#)\?8FE7'(
MTF>,!L3@4^4)'5_65$E4(SDAV$\,>#:]/FMX]&"F?>&>^BMFGOII+!$?/Z"_
M_G5MNC_?,O=1XZWU*V:*0F>KH']J\%/ -AT@(Y^RQ_'>_$,"%XJ&J(VZ4*K)
M4R#X&YVQ44EC2<T\REQ@QMVH>GK>BR451Z@F[+DYXC'D[C9SBV^1&*#)V9JV
MNW;I^;^_5;AEWX6#F0[Y9L WMVL?I_=Z9#G?".ZG)+K:O\:K9!KTVD>TK:_[
M]4;D"D],$EJ3>1JA@@,35L*<H-W;N!@>M=@B7Q#)IB=OS6)V[_4/K2""%*HB
M5=X?(<O7]MF<05M55=0:>1SK*\BV1E]Z,LS+O:R'=^L+ @V%KQGW^U_;T.;*
MJXE4K[\"+,(^K ^!Y3+P#K(_X;<%K<[CK@NH MF7$@_WY.6_"5)'8P2R2Z*=
MEQG;@B*A7#>><HG-MC:LC!^W@P5,UC=S.CB/44!A[3,B4+Y7,MM#&\HY"['+
M7^,:WV8A]$Q/,2.=AJ[U2<'#*<\+4=C!#>D8!MM!]PSW!CMRHAGTR.-P>;TP
M#^WLM4=1*2+2237*0ZG?\P3:YDU>:F2ZM*R_7,4)TIX>Y.%&6E*V&N4$J,(R
M#4G *M47%!;.A&?GEL#=$KF$-_ZKU/""DF+_C%#Y]>S"0L:P=2CV];31ZCV;
MX(C(B. 3M4:AH:<_W@V\>R+55NW];,?7CV7F/1W[7"/BZ"\4>;1*1^PPV)N;
M+9I>)<[ZZ*09ZS.(RR\R!L&S>$$WP669"@N"*-W@J%3F\2(NE-4-!'=%.);U
M5"'T/J@9C.<736?8NTQ1Y'XE=.EV?1]F#S7M7U*O.+K'%AO$8-N!OI*ZN;J\
M3=Y,,S<;Q$46(7'^)TYH6^*M_C;=HIENQ#<87;8W0,UAR0^SI^_K%&6)V*>7
M_Z:;,,.=\4:46!2XB"#8)CG)>\M>R&O)QPR"#BZ[9*[:EX?R=C!+SGO^YNKB
M\=HF.;ZVYL-G+Q*Q=FFY>W-3:-F0"[@0]730VF B*M@&.+4_'9; 35EO-$*=
MI^="_>&SZQ<)8=BHD^^8:_(UF:MYC:WK%D*":]"<*D<_?J/+I.=OZXL+PXY6
M,\ILNY.JX+@A&:;=DPD4OFE=\3RGXV)9U>-AU,.F3-DB*SS:XK%[>ZW,-&9'
M[TMC9+QWG9$/=//@E'/AL6?>HQ_S^\FOBN)11^JBX?#?;KVM?1M_6?,!JM?%
M-_KZJ8^[>BXKJ,=?\K%6"[X==.O-=G6GK^%++0.)+@%5*5-:Y'@@%>^3.J)F
M7)7KMF?_X#3.I;K2 Q=?/XW-])9=7Y+0+E<QX$&X!^:#ZCY-7C&;>G6$;XJ^
M0M50U"TILE%#G^;<&*@C-;#M<N@N<4$F4U[]2.+N$*5PF-.JBBI).BS'H@A.
M_G5@I=^_N?%L?\&"@LX:G@*L!%N29HK/3!0YIFE_D'&ZBSU6;_"-4KRA@5>R
M?:-7-0-:_0U4 9XSR)GVT.[7J.*!.<8Z4 #ZJM=1*;.CO>M<0_9J8JF#M=IC
MB]&16Q8-_?/.7?4/FZFD8S92\.*/L8A\T;=_-_J2+!4+8; M04-%JHG079["
M3'.-F2=&;;A'X:9[44?G>7E&YJ8\UY_B$)Z[ L.B@,2+;)'!0XO^W$6$'M)4
MCZX\<  NS\T^,: KN$G=^2W]V,YY;<LB]T7A,P%)(>Q>8ZIO_B\$G\G.0>O:
MK6+ \S>8"(+)BN_\#0D\WC'SKS>N.S=!V=>P0Z'-Y')H$\*J]4+DF>N\.M:,
MNU")J?I0S\=:G4Q-K+/B6)9['HH+$>UEI]IN?55BZC,2K)/>1S3:+<*%E0PQ
MW"'&@<5G^Q[<>YJ5 GT>N7^D-L>MPO=LWV.\IE\;A#Q3/*A'N+BA:HWGWQ[R
M7T]/Y1]"R5];*JE2RE)MQRD09B=^O43K.Z\Q\8BXZ?1ON:[D2EV].P*O-VOW
M;M(B*U9;]IYXXN]FB4=L6\)"I!/0KBRP,B^W546?DU09R0+*HHI=^@W$@+TS
M]2_:(X3N+@-ZMXED4GWJSEVU\OL;TBPNYVZV.G"W-3:AVYGJ^=I*VO) ;O&5
M16R7$<>FIS'C4LHD>L6_M-KZ>J1'0I537.30:JBGQ0&G<8LYH,T&TK+K"8(8
M_Q5IV0*M>X,:;/X)::E5E?55S4A=_OY7I*4#M['QR]] 6F<]$[\%.PJ;)3'U
M#-8S O2U=K2R@^57@C0W%-B(NJ@8K>E?P;+#BD:#/Z7RI9FB)X%W%F"&SY@6
M1%+$$-]7 AQ:W9((J RJL:G;[AK<VIH$K" E6^0>;OM7/VCU:OO<?C46PK]M
M ;.#=\:Y;V&TD9W]_)YO#32VOK%Z8C 'X04M\TUMXG;[!F_%O80,H;*E:ONK
M;4WX,NM:!-PG3G8/T4P392%:M)XZIYGGC&J:7C^G@8PRFADM&TX8NNZQQ)/A
MGX*S5C+L/E(E3)=P:/G"WR,_4(=31%T\SWLXNB"'DFHSQ-)4#G+(T<$+VU%)
M+9_\2",O>1DV#3W5$2 #<Y2H#T\?OC@._/1\%7C8V=9"GP8K40P%5YXG3:P-
M2%CG5K0UWPQ]A_>,#6W[U4:NG+W:%IX4>^SI7@/(H:<D-B-6=^G0B3MH&V9#
MHV:K<6#G%B+!LW#(M(:[>.9"]CEH;ZA OH\+SU02 Z)!U> 8_<[;U<0$D:QS
MZTRLZX@N4K=UO;:ER\/]MI4?J[%6#'B$N]!??<Y#R<6G@EV0M03Q/QDCN@.?
M85>G'XTRSA@HM@UY$9213R_N+$#/A7NTOV'VF+2M)@Q$#H'T)?ZG].'&"31_
M<3F<.>Z'*'F5SF*Q7$8?;%<+\\F&W;0Z<++MH&^*JW*:6J)LULB#U^KWH0S&
MK [?7'.VC7\"K<ZS#3Q@S;(%M?3,B,ZE:#R[1#K'<:QI9/D%_MSN>JN7L.!^
MH2IKK 8VJU]L[?:Y*ZLD1V1+'DV!5D;5SDGSO5"Z@O/Y8@ ,)<W<\H8A)W#?
MQ:DK)]:QOP_DJ4CUE*K[:5:\Y6,3D4$F0UV*RV'AU!C]Y'WN!U!>;R48[ZTB
M.S"<FF:\0P BXHI[I0;T?*?4P^N"=;0ID9'OUW7.@2QG21O*U1SPU;^+GO(_
MU%D _^,2[)5\3S>&H<TN;EK%5B0W-]YRV9"^ZFD17*-4#3TKF4?O&U6V.ZBB
M*JW^X$OK>D>KTH[2(_5\,T&HFU54KV_VL.I^F/,UQ(7''%FO*TJ=T^N6.F$@
M#5Z#1O&98B=]V(>\&G>]"N1M(F.TE'M5L%&=*!,-@=@#8H#*/!HXFN@[1]XD
MDK[)0(6^6QR$A&4B'QLLC)QG):NRZ-/C[>M#UT@/;,\TAW),WM!E*BKZ638F
MB:$.U=!NY$.05/5"(D[.7%F@SN[^6(J^Q,%$,4V4'BIV*2=S&P6&5.,\CBFW
M6*,FS6]5,:U7Z3<C=[</FU__W-*ELPH6;3=@&PC@?&M4WUA(+DQG4N+)B/*Z
MZ<E!B@=[3 ,YQTR$?WG_@Q8LX&A"4TCVV:2I$P-N-/C(J?E2SR14"4&4$W#0
M5/V%W--"FM&,9M[-ACK; F&0J=;2K;O[Q@?Z,\<7XP?ROQ_$(R^NM[*3HZK
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M^"_0Z6[5I;^]LLXU'(>O*M3-GBZK^L@(J&(<6I\P5C\VY$^P6-% =:P:3(I
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M4;9D+O^21*>?"]!B%QRCC8W#)NZ,M^TKIASM6O2\U) 67)9@?339X=;&L](
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MC(V;:0_/LF>'RO81BHLK#ZIN&1A<_O!7R]YS:[V:1<&%1B#L%R+O-T#9EV^
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M/[UXHLBP0>7C4"SN@XWV.N >38"4Y-1Z"<!S"\+S-EO$>GPU 9YA,R0 <FF
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MZ=3?T7?(IUN!V"*(6_/M5[\P(^FA-:0#/J@'K*EC/"([XJ[-#JPY#RU;O^H
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MKC?5ON[>..2U*@?56^<D3PB=N)UB59'[G#I?RX/M1Z']PA=M9_N4\ZQ2&UY
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M_29]_8BLT=Y>T]HZ.7D2B-+63M6*Z5XQDWC;(G<:_8?9<6$I[+D.[U+FYY
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MQ2;].G"QY_GU0Y?V<IYO?]D9Z0^+7D>NH?Y+";&]/.' 7S<H;Y*,T^(>ODA
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MR/XNL"]2;]T@PN,!9WBH>"2^7QHQY.88_WSU$&R")%;UD%YT$%R3 >K@P3)
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MB-$2,*1)7I:NJCKY%C44:>53G$'+H/)M*C$/)URMIA8+^7N#.-X 9!T>ETW
M>,.D;CGV,NA/#-RXMDT8']@9BT9E5'5_>,V-BI8*+?[Q40E]#M4B<%=:+;L
M&U381?%>,X:MQL)E 8N&0#P5N>[X(7-&4(O$I>XY].G,:YB#?%,)?9P&:K$M
M4O>"!]E!QNT/$>CWWP859&KTV,I(SU?#5Q8#'RR/?A.\=C76(PUJRYS(&L,I
M&S[L,*%RLR:6+QS1U7(WDYJA&I':E/%K&N;?@1UZ*/\O1>C7<P'>LB;6'8D)
M(;$L8>O:DD/QPL[\=.%+@KIP5PEO %A>'TQG#/H3G&-YBK0R462?]!+S:[H@
M7 0:5@XY%,3V%(%<Z<+4?0N;HG@HSO^Q5@T+XVKV-NNP8/.AN?QK%36I]XQU
MP\Y]"0R_-&-Q(B"SK5$,SKVXJG;40IX9IX'<-8W>_BR?]#Q!MY]L]*M]:#QN
M3I-T'C+VFL2"A1MR5OL:91V@[+-"F?MX5HLM^^9 (D >=]P5ZO/064R>RQZP
M+538 Y?C&M"HGVI9H]@@SC3N>A:Z\[L3N,I_Y!#OM,QX=&N[?SI8_]"E^ST_
M!@9C]02K\BGGRP/R'9_FR@07'C)U =M6#E2EU]'A2F>%.]9%(+4?FV-<%DI%
MH)D5;B8\?V )/P?GZ?G *\SG! SX'U2Z%(;AZ<B%V+)-![%,1:[)[RQX4@$W
ML]4@.G:"3*JX30V#*I,\!E;#[:;FJ8YM_<OAE9TW:P@UU37Q,\4=4FJ?&[S;
MELT"?:PT>US/9"8_\M;-'<I#7-74*6J_2DXX9UHJGQ$'NT$;";AMNM_NQ,]<
MJ5B/8G4Z_P5UWET$\NACTS>K->)*^&LE@AT87ZWULWA:M[ G=YPD+*;+V*\O
MVG^Y"\# S9R:K# 9JWJ&.XV)@F=LIN8>]T"^1'/ F_KD@A3,',UX*V:FE%4:
MK@770;>1ECSA%4A!IOD'K.!FHPP^?Y99C)$NY$Z(0/EGIP&;V(/C*HE >:]R
MXM3%-Y,N1NGCI";23O07N)CP:)@<N^VMO?%AM@@471: 2$]3?3E-G5:VW]C3
M@-P=I(=568O6Y5TX"Z<\=_X@(<STK3-UIJY/ "RUCMZ".\SM9BS&YL1)2J/V
MM;D>8R%CCD;FH6X/\K5+1KTRWEXG]EW4:),7)#2;D9MV/XT3;SLL_5B@5,+%
M :>WEW\^^H-B#19+T(">O_>V\037ODE1JG3<BVP8[$$D2T;JAG:?>=M[RKX.
ML.I 1/T+%9H(1/.'YZA%'N^M3!GPR;\*YE5@JZ!5.>1'R\]=20SSK+\H5GO?
MI)6G:RQZGZ!^HPJO\7N[0H#U6_YHW"[X$^,ECALJY)1S(6QU2RA/OT4:E='=
M#-GKZO1^;@[^04'K_6-3MDI[SK+2197JZ&VMKFI1)Y]:9UV^5.[O[W7=Y;)@
MW7X]E[JA(NQ1T.P7'D5_WBSJQNH6IEFZM=.W-LJ@ZNV20TOBIW&V;-4_=>0]
M!),-]9YUQ-0RO+NW9IG+@N:1%QX>25]QXN<*GK\9<"*H07O,R-B18+184;HE
M+=\XC@*_H+)NPJ&IY1 O]_^OI-7^]_/_\"/<A1G+AR^%TZL6!<^[12"!_O2
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M>O<^&3']5E.:"=8C,[C+ZHG9TOE9+[]YXWG!H_!U]62#!]>G6LUXEY8QG'F
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M)Z.S/UOSOR=>0T EK(W+=H8LMPDM<!' OPVW8&S#^,%9YKWKYN9SP&$+1(I
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M:^B'"'2?V'CEKZN#SZXI=<^+"?9I-'^^6_N./9/J +$XI\)MRRYSS"J!YCZ
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M5&8/(D+CG;KE81VR0FDR 6%8+M_0GA3^QLSEN_9PKZ#/?ADO FWG\96@DM%
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M4&\O6+2#FVWR\M;N:[*Q6<R7]H^&6F)R56-:!IXXK>44.]Q[GIK'?TM#5D
MT\\AMKS_I[18/!<[OBC!5^=BQI&QC=JU:;W-)$G^23RWHU7_ %L\/J^/?[[
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M3\FN%_Y(8@5N8NU)Q6_V?&E_SG/ !!,$6**4H#1P"D4?$X&26(_;%<+I-"2
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MBSH=M)FGL='Z]SR-+*N+I(.8>T!:^(K9V-Q.R];U_[XA?9<0.#+_?  T9 3
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M1KCI$%]'U.$DPW?GQFVTQ=ST[_$F%[X_5^V1KX3>',%U:1[;QB64_"/>U)Q
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MK<+,<TZ]N)>B+Q]Q'15D^V<TKZZ@ )B[5_*J44V8"  YC\P%<=/S4:*S E?
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M \J'1>VGC5+"-!94T1IJ',EZK0B%DWHV5]*=&U":.<P9E_2;EFFCD2D]1O=
MX]7ZZ*/E> 3BI2NE@I)DJA:"'C[^&J]VNG5WIZG<:)*>K=D1/ZB)=>%/FVU+
M%P4[>T_=NN!YU;SWLRW.[^G$TR;[]NOR<UODB_O+L!W7A85QYKP&#I%%:%Y0
MFH9(8T^C^^PX$S$ZIAD4@ET/GJY27DR!.PU<Z_*MT1]N-?E:&@17JT@:,.G4
M%D+,*1L*/,@C2>/^":V3F55=5E=/FZD4QINI)+6H9IH7GW= E@\@IP?\D:O(
M>5Q.DZP5;&_PN;\-(RL"S^6ZP%IT2EA#A:?=7KB/HM.:.]%VED3#,PX?T[>R
MQT-'7LYF>RA?EJ??QX(=#6Y>N:L=F$8:]#\N5]^J@ '_N*9G=E+37M:ZWSJW
M=E(%TV/29IT5[*ZVVO*6U+';0S[])$<KO%J#:([<D\%R]#'[>M*M)L"Y)&KI
M-I5"([E6Q6_W<H^EGY^WFD C)Q+O[>EL4'\4$_ZOJI8DE;D#.I46Y/BC)Q:C
M@G03UDK^T:?[\=2/A.__\T!Q6USCNG BVM"<!9:=/NUP*0^=?*>GC#_YSQ O
M:EY',8]T)!V1,EH>&Y1L*HV('+,+.9EP=:0*ESWV5PW,F3[I=?*]V@U-J19E
M)\![:^+FU40;50M!X4G!P$+9S/DZ:WB)_X>H-4DA_G,O5PS:+SA4=.7PLT86
ML(KT&AKQ-OM "=*>@1:I;6"SC-N'[LFU@!E(W!8(VP*V9K30'RWZ[!HN2EU1
M$*T43)3$C0)KD0SC8Z@MP<WODG$[<2M+8A R C"1WY4?_; 8>"WO?U7Q>B/,
M' ->M*L]B>LWYS!$.?JDH("S?7NKWEC.^T&^+)W5R*/J$^+4UI3AQK+0R@"3
M/O!;2(0;NWF.S%?WO.'0Y+L*.5BKB [(3!F2NLM!12X#-OW.G9]?I=R?6\GW
M8EY:--.6RGYYQ1DV^1-LHN:OM!66J(6ZH1C\,V0%CK:E?@VKWLW40ABO^'ZO
MO6J/O;^RN,#L%H/ (CIU8U>4$W?Y;T48/"$CP',I"=R/E<?V*(-I+*C9/9X)
M9Y^Y^>WJ*=O+/3H+/R,H<R"$M]Q[ *F JWJTI,^G%&'4LU/SG_OR$;CQ0&JG
M%O<9[W@FMI/P<^TQC QG\W.';YC?V*3Y&!1.I]K?+!OAK6V?'.;'1)W0;]7\
MDV5^4-T^]%?I@%ZIERY1-^*):].\JGHZX\]J* NWF8?_[*C7F"[)V5/&1.V%
MT[*?M]TE\7#6[[O\'(YGI1S&GT>BYC1_>:X:=5YJ],3DTYUQV9\+^%?W)&!7
MY%T9\?;-\_Y.9D>:FKN^OWFC.M\-#7Z1F,#O(:12W7QZ %>ZW4B-ES!";M("
M8>S9CQO357A!K!K%)GOK.Q*]%!NXWO,[+<3A8YO+8G.\2N"KGRK\2]^G6"5&
MW)V0A>9VQ7M[3N7B@[1[\-@\ED4N_B$\%S^D\P9W1 @6'< 8L\E-C/#TG;R,
MD2  BVAMY_$;]"%1 LC#.FD?(L+VQG##EN4=*E3G[MGJWN(>WS65LU/TQ)J>
MT$\.T0%607C!5H#V2&)ISW@T)O@IU0TB[1G?QB(_Z>LS.L/6EO<IJ&$T@*6'
M!YK?V$UQML"?.NWEE'73/&7N7 5FS?AC5U=PHONIN-7Q6@,IXZ\DZP3^F548
MNN:>"%ZP-KA^0D?._@:>;P;[;&ZFE4#]_.6?36GSIO%I8=&YGOKM!7YRL<G9
MWX:F Q-GOT?<GSVI\;VRNO)EWKW#%$J4F<LAL^U/'ED"5I$!6$4<Q.-)6 -3
M;?9]!NPJ1;Z8^A$<<:/>+7)+Z/MNP5DV_UH2Z\ 3/6]'I[C]T^M)"7Y2NC2X
MDVR/G%E2[V61>V$A64>]U<+@>NE[:K?6_._%[]X5AS@4M ZTYEOO<C WMY,V
MF_?R<G]^*&2[U1@>:CIZY2%(*,.'88*H&W6_<*UH@D+1,.PMFMKD;\YT@+_>
M5SPEVOIU-/I7MA'A0K%!D]P*)=2W3<6S0^I6=:_B#:J?]% +H1APD3' 3"\D
M*.'NHW;QR#:E2QA%]IY^K/J,=:M$2\AH(]VO^R& ;BJ\7A\V0%H8WM:A1".[
M)DX-PVLE>C78C@E@Z)73=;\GQ)>$ZED'#YFI5P!#6EPT:E'>8F9X7<V"J+-]
M[:('8? 5?GXH;GJ&>YKWDSO_-/8+8T?MGB;WC=3=H ;=U=JS^,'+;;C1MN!4
M!T[H8)_5'<?H(?S02D]H8C-]_DC<U6+:[.RPP2X'TT/K85'J8\3CUZU?I8V=
M/V^VBAP2G5S-DMO_4=TC1VXR\:^MQOS]_XG&P4\BCV4 J]4M,F$TK5F 6F])
M%2:+?L*VP;9A)7C-'W#**UHR@@OLT-H_23 > D"JDBAMQ8)/7O,3<-\JD@TK
M*2;/XKXU\^>:X637X[]_J ?M9GSI"6*$45UA],<?\7N2681MV#8Q2%EPFQGC
MU8_RA4GQ$"-B4*.&_\6>V?Z4?0OF/<O4/4/P5>Z7R<D2^AUS*1?7/5>?G>=H
M'^M[ZNQ(/P%U6E6K<:/,9 4JWBBP??$J7[V\4-BGH9G>6F4&IC7_$&""-QCN
MMQE1)'E.2PQZXE_/$&'*-I2V&_:)OE&7X=12JFA_7!1,\!GX;+<#_YX8U)DK
MZA*#>/>,CN.6U._ ^M=P@$,8<]V(_NXAD  G SBAXU2MF8E)G#GA!\.7XAI$
M5&?R^M&-L:48NW!KBWU+)C\<W>2'T!?\'W]RTPR:.@; 0=0&' 1W77\'/!DQ
M2/CB-<W+=:.3.8XN8]/3U\)7C7V7B3GWM;1_U5)Z,)AXJYB7R%(O@)WH;M,V
MLHT+F.A0LNW@HL>#\HR0/ #.;]OA^8 ^:(_Y19@Z>Y]\[79IGTB%QQJ]61;K
M5EIIJ3E:;[2_<SG -6H7MYC0'OV17=.3K6>;;ORJS\J)CCWHB2N6G'//_.;H
M6=DQ6\._/*7O^/1*T)"Y#4^-<Z*^OGWO;RE%9,WJLW(UU;\6/U8I/OSSKVHJ
MT+"9=.4^P6DL'1JI?<&Y@8XW5IHC(O"N\PG8MU]VA+F54$.&F?=>_.S\[*/4
M!U4S4.^+18'$POXW20NW6C0JKYA!TGIKGU@>B"HGQPM?)XJ0$$?(D4D"W9G;
M+'P-X(7@0(8=CS9:D(:PI&EZ:6(,1N8T-W=B9)AA%3"-]FCFS*7OP<1/356>
MZZ\JDVJ\O3;K!9+J0>ICZ\>*>/6GHIX>SI++?&IMAGG><ORJQ6>+EIH!)&7)
M?17 RYLQ  3WQ;:+0:NV8M!*(,:"W#6],8E"C'"?]2'N.'X!;KW&Z&C?E!\F
M3%TX :!TV QNJ@5L?&FC!K@'(CQ\R%C6=FO&WR4@_Y\7P?M$KH?P-%%-N">$
MG=C]@N.TVBT"PQX /H3!)#'R;&Z#;0U'/O*7ZIZ3 GEFC5[#P\J8P5.'0A0+
MOFEWOZ^(DKX7>]OQR!JH:'Q5M&<WCZF:1H<S0+5R]M.22'V[(:>9=$UJ27FU
MQRO[#G_G+;VI%^9*S[Z(#S+U4]SA=0\:9C  ]3;$G36DR!]O>>-=\@*/[5+4
MHS9A:\A9BU3*;B_E4U$^_E91B'B'[&3G]7>9U%BP+. ['D*0'7LO;;:WB*N#
M;#*T<C)1;0ZMWD)R;'NP>GQG@_;,*.P KW[(E?8%I?JR/&18/B@R5*#WZ:T*
M>(_@MK!:#+H/BV$/]0M,A1FU1Z;QMAGR"7F\H$L]F6R]T++]#^U.-.3Q;#X\
M'%9@#V=(ZZ; O97\\7>FY$8J:I]JC,W-KLKOSI(Z^G[B^JZB(FM^/$!V1TQ3
MW&2M5YW/0XSE5LL9HJL=LP1N'# -PD0MC.*Y\OQMC991"FZD40F]+Q$8;;:,
M X_:O"K?:69H2;3([G<T)O(>3CGUCBG #GB*%&BC2>###MT5>/H!:A)X@"C:
MF< A<AOCE^H"3>BU<A@)\Q1#:OBZ<OX?]/"GA\+&<MY5\>(*+W)Q<PRM^_)6
M:,_M+'93S+)NGP7\C2?>+^DM(;D;FA_6FG>7GEYV0H-H8*]5?:_4\@WRLWF6
MB<1]5_N69M.+"_L9MX03?5TM 5ODEJEUU&\,;H[P-;95KU[K3]S>:H<<I[60
MOB;PM[C7O*.W#_&/QTORK@NNK6L]MAZSYO:BBEN*<EHHR7/J4A0S%4LZH[]!
MM%VJT+$-623J <O>Z[J_^<HE-I\I^]QQ1OJ+$TS##W40L>Y"=WQR(X*I9ZL/
M"2M+KHT:MYLK$YYPN(D?]?Q6?6&S,,=N*/AE+9Q!.>G55U"\=(883K(=?/80
M!R^R ^ZYI<EDD2#N _4Q=8M(#1/,F8]CTYAJCU?B%-#4VTF']A%R' S?3O5:
M^"/<C2A%C&<G2\&2\"6G 1Q\IK*0BW=*3[C2!SV]]CQ,!/BLD5=4]C7(5NQ'
M/)H7/AI=<[:94;KO?:X)P&+W%W[Z*E+ZQK!KQ%/"JB6Y2?%!J:DIWRM+>@1P
M0UV%L'>YVY=G-/0NTX@]I!5<#78KM@.R%>?6L?7B""2D]J>O HG7Q&15_E3O
M.!+1*/\\Y>HT]CA';O0.(EVUN]ORY(WA&>AJ?#]]_S)?!D%T&+"_-"?'=#Y[
M@"5#M-#W35_G Q9?QOZ8&.3G)'2PUX)*/([91]0EVA 7Z];\<<,X%<K?5RW]
MW^._SZ'..PX8A$1<RRJ61N7: *A@F4&$KI)^F"E<<Y\@9!&% ;CU.Y*0TR)9
MR P +[I<, 8 ^^M4/O]# 3W1$\3:_ _:@PJW][6,@Q<2Q: FL/"PVM>[D*$I
M7/C*76"H U__9=O "E?G:7@Q( O[ 295.F-'<GG<E'Z*Y\P4&L]+VR8I&J 4
MX4XGS.[CSV>:SL=F,%.W.TZ8OXQYU><=81MPJ((B.JZ^+@"N<X5'Y<MP?V7#
M0N<6-)RK.>1F\&Z'.]]:E?FII&T7V<08OX*9:&MT]&S@H/(!L[%M_LGH0SMM
MW5U$O\Y,/7C1*T<=+]"M[LD MY_DG-T6R!79&4,T7+5:-I0J:.?BIF1$$JRO
MLYHZ8A"]JK'X)/%FER_NL?W!U,CMH?<-+P5QSHA!UK</?51)+#(\G;/?167_
M<[4;VU/>"?6A2QPQ:.L:[](L;+,1!+TZ^S!?#-JAU>2XJQZ,,CL;Y /0.Y,G
MR#+"NT%CP;YR"/LM9L8,,I9=&3HM!K6>$/TY,W96'N/J5GE.J_*5C,#F@D"A
M7(& 3^"/':7NVO)W*84_"?3_N1OS/^4!4LVI/V@,ZQPJ!CW<B)M&0=:]U-JA
MH@NH=3[PR,V?_;C1ZYH=^8<IXKIPT82-8*-2IA3U2 Q"Q_'<U\!?8V2M8)I!
M?_X7&>S;'F&_XHH7/I#I<?76/,@HK$$(;BJ/EM%,(,DB#9IJ#U1HEJA.A&%L
M?O^]MS3 UC?6(1H11)UML]K;C[!52$K5:7O!:(7./0= DA-OAGU QU)1L#N>
M/]I7/V :,]03FW;OG0#*;J*^^C1JQ4[#%Z-K/PZIE+:31CJ]\VM1"SJ2VR?Q
MU]..9FEQCQO[,=\ELCL&D[6U2.<1\L-#]P1]B;2KS1?NZYR8&;9--FLV"X"M
MQ<]R)WLZEJZE[R#EXNGC!S8D$>-WC*3K;4@B?GG0H&V]94,2,=YTZ%9G=P'H
MHIP<S@]7MBJ0T>/"A>1#/7YS/@W/,4:\JB!9K$E3QV9ZLVO1X."OSTUDT%57
M8AV0\LU2VGL=;IOY%/V*N80B.ER\FXT.-Z/\6B8HPGZ#L"TLZ9>X1N]K>ZLO
M 9BS/HB--W@1;LDK&_FF,&.\ZZ3;34M9CVB=C^]'6E\HWDUR=).</3#_S7Y*
M7U3P"[)6I'@J(Z(4-3M-7?-7JQ)]+[5>M#?GEW<O(NZ>Z*RB&.ZKYCAH+6B,
MSKQ9@ER8S(R:/_];)7@'C]*DO)ES-&84O(7WV(Y-CJHV"-Y#S$"'_]JMZ5OC
M;$9]1-"<_BAJ-RW2&/LI97_6GRJ6*M9;HTRN3.1E9-,L'"\H!.GTAPV >\0@
M@4R6:)<\@I-LQU[XP*#'.X*!Z2?C![_757V(8]TU3/N-38DM.R*76!,6S0K6
MEU%.978H(/S=YF;)VI]\&3L1T'B'2:Z"4VA>"_&VIQA$U1%YK/QEI7[!C>0$
M=C3=]J7V0T?G:X0YHZT29TQ%4NC5F^G3P;!FA8?/W76&^AYC+!Y\;3W8$5EJ
M<;@]:$B]48_R1P=+0[/+0>/R(#JJRX"Q%WT^S.EU&L80*4>ZBG"I_+PK4^0Q
MFU1@GC/-/!UK8?UFX>C<CEK2W(& VKBB#D?8\A' P$4%_F@S8QM[YH=9^T(
M5H1TH0,/RHMV_L31LXYBW68TU<KQ[K(47WZ_>;,4/_ A4"UTW_#/U=46*&:$
M9JO94F11[L7%P]"Q"\&Q<L30A@$1QAJFLYW(RYHXO>/-"ED,@KB)KEN0ZT)E
MK1Q2P)/];*C(=*(>Q3^*W008;8>KY&MD:2'>\))D-,X=W ^8Z(>]BW0''F$D
MN9ZPMPYN<*0-L:=LQ&*;==2P>]SW@-_-$V.O6#Y/,W/:3D:2(^,]K2W]CA+>
MN-.:AD\CW!($/_\79/X',<L%[+_$EY</D4>J1#OO,DW8J+E1_G6X9&Y3=ME$
M8U"<7+2=:YA+HJ%_-MSI7)RUUF;:Z^3;<8WFA98R^FV;^[HN^4C4-#X8:)KY
M/A?D65"0@XM_92/HG'!37_5EP,M6FZB=A-U6QG++:L\"876XM9.P'6(08,9D
M '.==H+:64YM.[-CO!ROF K/V=@'.#^2OD-Y8Q] VEC[S,=;HTEZM]#?KT!-
M;GR^".I;MYX*3 LKRX73VQ/]Y+C)!79TST#D[.:7J)-:<Z.5)95/WEK?VQC$
M6?7BL9%GDG),=_4[!O-OR.]IN!@Q:%-/JU,BU'W;ZI)6/2,R,.H8>>_R#^/:
MU! "[SA40/"?,Q"#7 '/(@99K/OA GM$&%QY]=(=;#^X[$E"V\EY:FER\W:Y
M\>??_<(&6.Z1)%+&[K&(J.'A8Z]#3CTTWNW=M/^FL=7,]YG5%9BG+7]"?EWY
M(<#[_2W\4W&^]D++E\#"7I?YI+WL"+;B["G)GE2X0!G0"?:Q>=NY7&6IOPM7
MYJF?UFUKJSL<W/W6X>+$8(>LD]^7KW7*<TOF2I[MD*XD:H<6]RH[6:!&*-.:
M'1V9"+=)[VN$*6'WP?')7$.L6PXRRW(4*<-'W2AO*_O^!\ IX;N"\MK\+Q1R
MRV_8M_K['R@/L1>#+EUE^R0OW!VEZX!%FT>H7%I/*[3*UG%LR^IQB'"CCPO'
M\MK?HIPU &>$K&/;?"[AV,W<?/9XRLDDRG-<_1M>FO<N@QS26 7!EA=0T'H_
M8DX)6BX&L1,F[9.(Z@V(W;U.LK1:!.G*7C&(=@MM.7>>?<E$F&WT$^8F3Y6T
M/XL"..Y0S>4AH^D U:B#>HU)9QUFG*1ZW=!W*Y(_=V)NY7K02R.2EE*D/WW\
M_<7YF,H_$H?!4M=SA .+'>W274[E3HM+ILU2Y@/6K_3+T&)0).)@H.,DPZUC
MJ2:38FC)) 75854YDH^K;7*&/-+5V.GO"]"(QD"-Z3=.< 5N*,X[9WK=D9ZE
MK]$3EH'PAO_Q9C[3[I7Z*= K_?5E&O3ZU#2^OVBB?>[]-'435H,7/J+W$1PF
M!ATP/&$XY,/LB%Z&R0[<UOG"_0.QC^Y'-R(R^3.IJ.6(T@XIN$50AF>MZ1G=
MM+RAPR'VU*\TYFHLY@+'X$/M'EXT4YU*03LW&QWH-+S]>FC?HQ;-1#*\=SWM
MV2L'2Y_-_E9U#YX[7CK8V+KEL[GDRX]G$(*A@O4NX E(B6A:H\"KTTEA*N:2
MMU2?:#L,Y\73&;:S';7F^8TB;:RHE:6F_CI#@[4RG*?X9S74%X5[X;4:[/*$
M^U%)$+WGJ3<F<A0X]EV8XH66HX5BT%P_5AJ5,>FZ$N!Y-2'0P@F !!.*@BZ3
M!1T 3Q@&_03;@ZN[@O/HX+F!^^59Q$8)/:CH$Z>V+!=77\-SU]8#NW93F8:<
M;*B"7UA6UJ=[2;K= K7LHY31O,R4RP_JF(@GJB\+4:L'<4<9;"<(_:*A-R?K
M Z,D.;QL._&KT9[)!1;J@$9.]Y<2@3'GE=2%HI0\A^]T,ZU0S,&MJ3[$P<9K
M[+919&#]]R,.H0?1)XP8,M<EG$YCNX+?_T*#KYG1(5Q.1U3!;%Z[&=WB00-5
MN[1R*:JZUF0D% <%)N%%7'\]>+M D4.=TR(-7 5P932^"7!*"HMRIP8$%]C7
M7W/I92M9)L><M2(P?GN(1,]30_5M/Z/!U_#ME\UGRI+7T#QW]DP33!Y[B*?.
MQ/TY"RD5.(XNR'B(9-G"+/G8K=UE!=_NOTY?9QY)G@UT)>!1.A:_73X%I_O5
M]*RTF <%..*^\IE:#3!)C"+O+H#DF"9/6(L" _9"O<*VQ\NY'K^'!54AMUE0
M:.TYF/(I)6O/P,*W9OF>% -,:]O5^>EYMX#<YP-];06+5C&RPNFB10!W*>">
MDF;<RKJ7%M?O]*A:D7XII#9K+4+72CM^ V#TA.7O_Q5E^>_6<E(=#&-S_V35
M*/,;AH]]7<9)>RB\,M^3DS&S[IKT+FOZ5/:[]F<,./ZIO"[4^V2G\9EF[\T1
MQ<U*C[89'[D7I?M-L@$\$"W:3F5'LXH>LR3!V%;ZT11V*JN-1!HFRC]:;I&W
MX+F.MC9YC.D[UJ88$OJIDF7G25GQ?2;)#5,YO,N.I5*>=(L7_GKV*X1%*Y('
MG1RND^;00)\+;4\L\M!/$\443OF_VX_2'H*:5R8U6[VM"JWU*+H_/X(?1J>^
M'(OYNJ@N/([@?0.6)0NC5,;SYKO$'83KOG.8@BEBMKQ&MT\Z-, 1*'"TKYEF
M]0'6L2/E(<SQ *^3I5J2O!  Z..[VG0D+!OE"R6&ONNM:LV/H2L34AMZ$O!C
M#XC'#5H>T-FU<_9S,(1.^;"3@>3V)MLG-_VNPM75@F5)Q?Z= T&,( K?X0?Z
MCM@:Z'>M?WT>ZRM.3F>%,QLQ2_>UM&^XO\KN :?1=0/PX%_N_UWBF1R _$3)
M&W_G71A+@&?_ [=Z?&P<MC@A8N'F-_K5#AJ6< =&] 12)BRUN9_8,";A8YP$
MQH?M%)TCN,(F$2-HQGV&QXMV"0_#YS5)XS0ZJ^%&-:4V2L9+P6!$0]G[D(3K
M3Y:$7BH+#'Z*6_Z#L)&L^G(C656)/ CC'24*7H;/-HE!+EVMP'78)P8WPW2@
MIYOJ2:9OHCKSSY&'&ER/QO."U/TOO$$;&N;77]^S^,1A=:PJ"D7VX7T0%E-'
MGA'D("YQ(4DPA5]X?^9BH#3MFFMTS-6W7PU/ZSZ6_U-[8&;25PR21/2NTL,C
MM%#5%KFPX4'ZM^F/&I)FA-^JJ\N<]V7E!I-OE@C"R,NO.9+ARY;[/!0F0C$6
M.78SM8H<S;A\'JY1X6@^ZN!P:N$DONW%^L."'$_=!'5C/^<\NSN#]HX#GTE*
MW"4SF7S;P]0P'._8Q*QQH:B)JD3VM3@A87F#IS.*@S2"=P@L_22ZWU3ZM*29
MU]F79W)2;U=;C/!S]R4K.WZA3=OO7M\6,7^D.-4^V>+=\AF!;\&2-4EE>N;8
MU<^&G!E%E61M?QIZN=H!\_++B1S/%WWSR]905.*R/[+*G!WH9RI8W2BV/]9K
M*,.*D^11?\4?TR%+(!2PE%PS[\W0A[D+U]_'3A\CWY^ 4FK?O6K^#K.[DYU$
MZ8VW@/LH/;,XK'?!.)!T%.\Y-4GK+_HR,N#,YPO#Q2!/QE: +X$PISDF]=RD
MRCWO7,4@67)<M1PJ$;:%UV%:7LY_F.!I-%MY<"R;:]\7YI45L+ER3X[SEI&R
M7@T_"_WF&;IH%W6$0"AWCX#<6XA3,(FYQ( )SG"NE1LI\:C,(!5*$M*YWL(P
MY +L>M2X[K9&H[T5E0E.G=+'EU>[TQ6IDI;Y=E/T,6$][J&R-,<]3!# Q$GR
M:'7TMKB(:G46"6S9)[A0-!6_QE4HCWOC8!)P-QAQ5.XI=-]B5JB?F;-*\TGO
MS['1BQ6"(PVW5FVXMQ1]&5YL5#4J9\6[I&=P]6UBCV=@_\W0%\E^768/@X.T
MU^TF/?ZNJOC_K[ZFE<"M]A=)BT'[>9;UN/NB=C'H258C73(<5VK4P:6^%8.0
MTTF5J &CUHF!8.(L [XDZN"FX@S<DR>:JKXX>?ZH+VIVJE6"0UYYC?6Y>PDO
M;/I;U";[^8D0@2*#X^>6@J1ZQ(5+#Q06;U<EU#NI4?"FEY[+)EP\V//YHGIN
M;[SL^PK3P1>WQW:J>/QH64]G1JW%S1FZ"P1QHEW '#HB=%QS&%R/55P#B[9!
MEB"/.P8&N-LY$[,:HQV2'O8?J6(0<%*/,.ZY9OXCC,B]'E8\3PF8-<VY=$,3
M_F(->WU&I$HPZ5X^OU XM'G]%=L3[S>7L_*JUJ/[?NE"2(%P)]6SHS_A [BL
MN0XE+5#@/08_1[ZYWX,YS3+5N%?5+9 9O6"T*Z]4:]^4E)F*XCQ@#<H=[9WH
M&FVO>Y8O7()^':\,&;!)ORC8J&0T&&4\@LE4WV4GL)SB-&-8 /6<D=>WS9"*
MFKM?MO_>@_LZ0])!K0['RR0!BW)% OI;MZAMIZ>"XU!95S/XI3/,6>MCL%OJ
M4SJW6Z21;!AHH>I:&V]VV^!^]O-Q%EM4C^F$51$:2&LPN_*5I>C LI[2_K&5
ME>99$[ZUH^@3H53R"5;#*%0^JOHLZG@7!LZDA/0&%2Q(,"I5A[@A*">#($NY
MR2>:^<R!WO2OBA5@B_?5%)K?A5\IGY:AODR%YR^.D@\<Q=.GUDC0-SU*G0E/
MLHY57=70%O12(3HE_82I@R,H);0Y"_98H ?@S9\1O49J;/_HY2"-H 8\%S_?
MBT]*QNUL0^F?S)=KJGY].FJZ?5XQ:$ Q;[RDMIQ2%>)Q9+I@#>!5(9HBAI1
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MIK"'%L.%AW"7/]Y-LQBJ7(S77/_H>^M#A'[1Y(<0^+VD<8^(Z5,9G>['1($
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M7 3WHEQO-N< >&,!"R0>R8E5V7/M7PWMSV!&+'<E!]__+3FXLBLYV'H#"!T
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M3HG=+Q,ZS[&GW$B=F;W4YZ!C$KIR#.EKY=_D<+3SC%-9<>G\4!JZ_OTA4I-
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M@26-CH_Y]G#,O>D+Z=HM/>8E+-,6YKY;0P2ELI;'D@(V9@2*O%=.](W>V;Y
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M1=]%B %M6!D#4WJS4P+[&CWL1X7/Q$'"[8=%#%;]QZ'D<WV%6=2#/I9HEEF
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M-/_I%038A]C>L-\!F25R]'BGEJGT==^N.M+?&DG(D&Y.,WH4P6UY] K!(>Z
M:M'LOWCH3^^^]D_9.3YK!^2-(<LVD=ZW?\3(<N ,;^[;D:9'=V&Y7N6?X@*I
M-J+>0^=@X1)T;DYEC%P8"5)7K??T&S_4JB>[?R/FE ]<;Q(_9<,1FF6RN>_!
M]]%DV6MT;(LAXN,*O;W1Z+=!@BMUHQ<EZID'A=[L4BN,YFCG.7N?-6Q)W3SO
MO?U^437ORG%R^..BEKZH@)K:N<*H8KMXB\44^WS&19VRI<S<W/H!]?1*=SUZ
MI)E=L']6A\JPVU!JG1(^3'B5M*[-H[,7W_UG/X-5<=H4?0\@Z<ZT9373R[YV
MT[*4"/2N]F<$/B',. ECP,,%4;[():J_W_V_>&3&6TR%PHZ+D9ZJJ1A8OH=4
M_S5$" U*V97RN,3;'&?2O8LD3S!YHI6<FIC?>IN^,O5'#5;$0&CP@99>(&X<
M']0U!17\/2/]("P (6(9''PXTV>:_-W+>3 BE>[BTB%*<!NW=?M:($V*V_QK
MPUP9[Y 4GNCYZF5O7>3UZDV%N8VX+7V\0^)6]#^\$]=Y_'3O;ZSIVQ0\CU6*
MA__B(_ZP)5R)%6K.*'R29*SF/7Z"SL=\[0QD\E]VUJ=!FQ]-#ARTDJCQL>'[
M@O6*F!QI#.,Z0+8&PKNQ$@1SMB'J/@O&R&WR[Q0KIV^V/@JOOOWL+VW7XVGE
M#*7HY7/RJO=1EI3Z!I=F<JRI(0%_NW@T#R*VJOD%.P>9A$JR$%33"(XR8T\C
M^;DS*1+E0Z')M<K(]&>W=7;)NI0_L7WWLL \UJ&F]I*!8 Q\1NC2F=+R.LSK
MKJ):R(VT9F>]+6M^8[Q*>TK92D;YTO3&]6(].+M_!(8.<L;704AP_<P;O#O$
M]E_8B4-CH71;$DOE0'B'K!!!F(ZE_!9/L7F6I=.[4EJU WKNX#S:9Y4W!XC7
MQU+U$7M'H'-UE;IU2IC T\Z&#\:@O&"/1-O #RS/F@V='+SW+MI9RQN27FAA
M\'^P]Z913:71MBA590LJ" (*"BH@(@(V-$J7LD'$"!%0F@1(*=*$&%(47>B2
M$@4$1$H04!!2TDH3(I 0FI!(+R(B 1();8*B](E V)"&%^N<=\8[]WC.N7>\
M]^ZO^V/#8 P&[.R]OK7F_+ZYUF0@:%TZ@TUI0Y[385G.YADWKU@NA;F"&U$"
MSZCU "RSSTM7>";Z-HZM-!'>BDXQF, KB"P@#\8T(+NA +A]YXYL<MS]U?!K
M"%9W<.!C&US!K$ !ADEHS<YN#@B%[)II<,D7A*%#F*^$/GY'Z]XZII'R1Z!]
M0R6^E96YV=,O$*4ZV@N%Z9"&@.G9RM'_H'(EWL5-%--K1L9)J7,H/JS%W/ZY
M:]Y)7LI#^![J=G7WII4!FC9O?[AY;L>SHF9%*6L<UM#E4?.T>?%/>:0HM.4%
MU;QY_\##Z8MEQZ9[^I\?L^7>+]"95<&/S!,?GTYZKK,=I=V_AI]*M<'>QS7;
MTWU P.U%=D&'AMH'TO@KT4F^8$/FP8:,G.6#6K<A3#"<VB#YP"NBO>Z3+H5M
MK@\.#8A ?K>7>K"69]&<41>@ +D[4+1*K"YQ,D&T%&+WM=N%#]X1,7MKKJ[5
M-_<_?V' 9>,,::FAGY3_.1+XB7:2#=R;\&M/C56E.!Y <NBIO_'STG>D0R\8
MTQ2EA.S<G0]0]T[TSIX1J&UBM%&%9X#YPYIQ2R-NC&&'LY],?P%^[5<B P]H
M?YG?*3^W*O2-!M4S0_>2%K>(;B2A[VL8YLU<3^H8TU3UFOZ&05YKR'3S36+H
MRZLAQ@Y$$>S8?7="ZDV.U--J^S_1C'I2B^9?D6]E?%;NU5B]UTC)26&]&Y9S
M'F+="WP+2?-*Z^>%X;2$J?E)^I]Z__ZA9!8_#ABMMG\, <72MV)EW>%MV26I
MHJB8R9A;[_<]KJ1SU'DJZ:9XE/)*0XVEJ7DFG=MM47[6YZ+0<SQ^085IJV+V
MAO[6'ILO?3!PG/]EK*5D*._4JSZB3CTOH3E''7<?NATV4%?=,$ %1<1$3%I!
MQ\9&/]7$PU)59LR+_S(L2$.F7 !_"(FH]$F^;1Z3\'DPQO?GK.H61C+#R8OA
M53,8TU>]I@E*?EGF^CR]P=XFTL9=O#"G3P*")C05HV\ =R?P\=A=Y*2E=KB"
MY8V_,1:MS*5N090KT]*V=!AANC,BN-J&5)7$G=:A-86<=&=KLYRX1Y\_,J2_
M@ .'S.9RS)(L8[AP-KW#W+*@=5R>V\A+;>ELJ@VE#%HBR]E6]$3JA5N,O^VX
MO-J[OZ\;!Q],VS(@LCN;=)'6I^VVTL9TBSQ=MII$<HVP.DQ="<?:T>X[%L\,
MWE>>8T\A"UW;)&!^]0SN*F@[5@V(FAAOE4_8D)&UU%7-XHPG8!4^6&H6G;ZP
MZ?3HL+\YBI87JO^9<IF;[CSH$VL/OE$_/.45X!KN&GRZQ_C16)P4TLW7#@=*
MKX4Q OYBFIU.OITV-5-*QIS^2VM)V^O]QTT(IQW[R# W(JD)VO%]9[5D4VO$
M31SZGYW5*^G*[=1JFX,[MML>5(@@+LV)7]']1ET%<'&A]3'1W@&#REO]T:>Y
MR,;4+6,>];GD5!FDO9@XD7)]],%D_,S49"LE4V%F:OS=HVXORF (Y:^1CP[E
MDOLFH@5<<Q3(%S(__@L@)RCEO4^="O#:TD !(OCFWP9N08"+)K,LW.99:.R#
M^[ZL2WS/T<X$Z-=>058]/^]QP,$\MN:I[OZWL\+CMC7HT8HGN/GEQ:U+U()9
M[=\G2X,97\!CQ8L;,H&->C%LT,7>SV5)1XE%ELZK=,FV"\*K]+NT4P!=@.!O
M;@-SZ _#3F$*FK_9'S^I+O^ MKO_<^:WM[NUFFE&RICS^JU_@$<=*!*E#X0*
MU&[TRO;.%1@7I_C56H['>A#MS<UU&K[(Z[R_; 5KHVDQB>Z9O9<_A.C+I3B[
M#AH.*8^B*HR%L.3ZH=T?;90R7 [^(OGCGZ&J7$B<-!B5^*>;68[N0+F4F2:1
MY/<"D5P,34JV.Q-,+%#09K0!I8,2=FH$6NC*=.#J=]MF,SW:]>^)(;AF*2 *
MU)2?&>=!</$L_,Z5;05-XNH[(=U1QA1:';))]37;BI9;*7*H ;_YC?)H2NC
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MPD6'-:SZ&&$?3(#SI75)1U15LX^\8OH8+D2;5<Q&1E_=//N+:">P(?,:>PR
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M_KI^_?33XR'=^C&24!%KE8)]MW;JG9DV%-/0[6X0X=)3/E-PX+IAEO&B/M3
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M>RC#!55U ^NV/WJE>">P'^!R$']2? ;N5[-CKH*4:U4\PS=3O2I^\@.VC%X
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MJ @KJ1G?/;A$<61]%@$<A5_8FBTXN<9/XT<&O=\C+U0K0Z_4U3P#4;29B,4
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MYK_AE8+J5U &_+$(H+*1_=N8JAV2*05AK,24356=NW;W?;P(8,]>2=#$S_G
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MY8QM87O)-RM0K('4E2IBX3/B_'F;W8.PI4+A3YK_3Q0M#HM7APM\1,SG?40
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MDP@P*F8?KU%BO-XI GQXB;O7*<1VBP _P?F9I/5J$> BB.L@ ARA_DCCVXH
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MI%N]8NY<\E"(CC_WM>3Q_*NW4_LM0P+1RAX-HJLW2Y9%^4*YG(O; .)YU.]
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M(E6^?D^Q9G=M[Y,US'-7J2%0IX=7]9R^7$/<UQ72ZV1Q9.QGT.YTWCZV.$=
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M])E=6)X N2'+.QO-_"G1FZ1=2>VS9H)>W4Q0ZF-Q>O>\9W=&W#@C(Q[G/_W
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MZ[2>>9@SF46/9T.90SGZQ).<6<I=G0YG[([?'=XIVJNJ155&$9IP1J244:2
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M/QAYS7'0P_*;_8GJ=?Q>'V%@5:.OU^_)R=CO-7NCSKC9[\+=XT[@-WU?3B;
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MJD/&<."'@O',*S">G=#"+W/$W>7,WL"7ASW"XRF'<I>S/HL#3$55PEL+?Z%
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M8EGU*E:(CDASN>+$ KUKY0E(- FC2]PUWH 6D>T+=S*AKEBM82^;JP00?H;
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M82&XFYM0ZZ&/2 _M/A(]=--%>;KA/ZO5TIO73Y\@5" !Q1J)0F[=0PI,3-H
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MX4+?-. D=:HN$'F&,MVJ&J[M*'<!JG4;$F>#=0%09T2H^&RMSLU+<XN5F49
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M KB]44'X)Z@OV0:Y5='=P&;C:I4S$H,ZEY.TG*D M0:GJ#K6G 2!H1G4](1
M26!/ETQ5FL?J8X\;HIHSP,1V</Z[6F,A/"J7W# "-50/+B8Z(9E(5.9@W!SY
MPJ_9]8J-3"_^\"-0!;Z(2VJ3LLT?W!"FV#T=;)B+M;4)S!B%L, !NOBPK#T5
MBU_K==LSNUV/-&D=\ R?!Q_^38F]6"5)4@\+AB^4B'I\NB[:CR"UT!SMU\H
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M[N+7RW=B6H#ZG,)$ _'R _!/S-D/<&8D[%6:GIV<3\62=:A9B-XJH[1QLE]
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M%R8J\(J"NS_J%0.N<.+!=9&4JJ?$&#4W^'UU(.-D XF]X3@^.;F8LC]54F4
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MR34J#^>FY9.;BTVQ ]/SA]JDH65,?@Q=CL&\2,,**%N:<KUAWQI.:[:DFND
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M$Q 8(Z+B0*;O61Y1=-@Y2AK5!< %U-*?RO]N#<9IXX)Y<3!]7TLUQG4X)1=
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MT.*H'2M )26D1"0C0L:QCTYB*'G%XJZ]*!-FT[RG7G@YDW AKR>"7A8&I9A
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MW&^"PHT&W\(2MN$G/H%1H\_4&YYR:N@1Y,?##&IMZ@X9OA%@H I +@>+;%Z
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M2>_+>YNSKBU7X/E!YK2Z#!ETW)4Z6H(,IKSY8,IO,Y@R@RG_>O30?U:]7N"
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M@+4$3S]0L=_C:@U>6,G9]\7V$$#0O9/;$G=O]ZWWJG\ZDW>FPEMFLH^4Y]Z
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MJ9AJ)5OVQ>,?GSXK?I#I&O)1"#V8TN;NUV&"[N<7/YR&V;85-L?.+WFD,B!
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M\+%205=IH'?&@1-W4R_GQ./Z-)?JXW:=79#/*+G"A$!.NL<R2H$[KI<,9=.
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MC&>('H9#W"/+^R/OC_>U/_[SR/*,&<:(C:+]$:26_.ZQ+5,BED:10H,6IDW
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M,J1Q,KANUYN]/1.8Y#^MYH+."\"6#5-1D%5K!F9MPJ&]LJ*2S3*;Y37PZ?&
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MECE+S<#HOKTAE\H;1#8*4G_.W&9D$>&(6;FBC[KH=I&L'9?M][J$5SP_+ 1
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M=.V9ZO<[*!!WD<;-NK+6IX@-.P$)GGFJZ^D5,7.1W-9DP$T74=NS\7<U3A/
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M:N!(#,!>=@6EO*6Q=H*//7<'OJU/V3%\E"D:6E[8/(^LG6M_$BM]G,1PTC"
M3>-,ZU36;>B/%3V,1H'!"MQQ<D)2;]F'IHTZ5HL#2K#0-JKG1W+>)A.Z,N_Y
MBZ8][R'_;S$T$=Z$GL:NWD]>LFNV[-!L%YO?TG D3-76!Z,&H>^<5UW;2$]#
MXA>I$# ]@_0VMJ7PP#P#&H+\ )P.!5B(^="P%D.Y:+N7)N B:$/^B4J:?"".
MY8Y7:*8PKVK/27VO4RYJO3:-R-Y<-@(&,W=<W=(>8%@-C_T7ZZ:3@L$!KA$I
M<'3490@2\;\\)]-(3*OVOESO$?F"[.G\K&*'>)U;/K;"GH]65E. RL&NXX_Z
M8T1HY.5TY](GCZM:G==7 W3:OM7582TK,L$-[<O^T$,E9F&'0(]<M@Y+Q<7L
MR=/X4W'N?BS*'GOK9QG(UW;]Q=1_S%XF106DKVEF('0ZQ/_.7<Q?M;3R_O12
MN)!/1L[N8\5CLH.L&(?_0]F_U!&>[QVVL26=?^<I,_[3#VO36D/R OVE:D#O
MX9:F6-__\O<?-+NZK;R.)66@/%9=6A[VSY*13_\LR=(7EHO%9LRU.IO<E>!C
M@;:[B4Z49Z, GC?^SC""@&*X'I6;KMSUL<\S":F3 K?(SVMW+XD0>S&-@T$%
M@D%SW71Z8P.RN @_(N:W1C_%-@PFAUY*;QK\_E6/LURB0L^&TJPR#COCL-\*
MAWTOX[ S#OLSQ6'+T'+MSF72RS&7LT3)YE+5^_86.PF@H&LE4Y=&D!9S^>2(
M(8,R8TDA+9<:N%2@#7_!DM$AN9.435%K_L>L6@:X612616'490?7E'%#[VW:
MP)J2,VKI3QGOXCPO[;]=*ZN+^EM_O=#J(R3]/X;<WL<GZWK$?+&^H[Y")N6C
M"NT11#6!%85"@IKEEZ)TZAQOB,%[FAI$/2C?+4U=R&S(]TNES*CJ2;&VC!"V
M:]0_N U7_BMP);';N:+(P&:#$N"=5<?4C.^OJI!#_C>'C83DS*+8!$;OH3XA
M8XNYEM$$FJU*[3F=&XK ]1:U)[QSM#>O-*9PO$;@R"IJ44*MM _'OV;F*#8>
MN>S)Q]6DY>Z2[Z3%!G@V:0[KKQ^L5@WV8=0(K#1O18Z8!$++#/8/T>^[IFOK
M6FH/R;Y@K&B/B>)5NX_A'$G>_.\V><M;U-@LP,CLY;;YG],"T87SU7CT'&?*
M@6?N6"M*2W_'J<[#>/=DP=QWLB6S8.Y,,#=[UO& ^]L<>+WO-EDIDR>GO3.)
M=*&CRPH5BK22VO#5VFVJ7H)K\6I3B;YI!@]FCA"4AE@_:T[G+?3^MQ!'8 EC
MD@_N]A1_P2Y[A_,,=AKJ8S,G9E_<6L<MY97.& GIJR^_R:B#,#=;!](JR+>S
M]6?K_Y#6SW.47=D$(-^172^5X$72?D<+TG9WU&#1X1+[9I3^G3,.YO@OLR5G
M2_[0EAPG!I$=BY'*^$= \J$D56T88B-'P%GMLM5FJ_V@5LLEHU[P6*NH'#I?
M-$I!!\XWX8KG!E$\I7\<BL>M<.Y1-&*-Q.>GCWT?42M;C^+>6;;W;.\?PM[;
M"\XR2P9$_B8U%*V1 Y>H$;<X[TBXRG,7"\^=-WQDM/*':G5EG[HX78&.DN+N
MDSF3W\^9LU8XXZ+GG0<G7W[S]=]\8U8_]^!SJ82>-H< FU\A7V_WTK[)1>F;
MURQYNKYDD@QEYQW3:& 2ET&JJNA6160OB;1ZM;8:D2#2(HI/^+/EEL%<,;N>
MJK)@M+9IB[IM-@+@=Z@,6?_0H_[[^?&SF'?B+4?+/DLK>W\3E2;B+B^.U2O0
MG[IZTM*PLI</L7+1?A&S/"]LQB(:6^<Q[&;#%/&<KP+D*0T!+:4(:)Z;PJ$=
M')G7(IIPT@G/X_G*1$:!B<UU?%,<GH &R$2VU9YGA)84H;$(HS8-TG%B0_']
M:4.T,?=HLCU-8!@&[^7@#G*P8O4:)5%G5%?\(/.#Q('?Z:1XHMT;K\$Q+P+L
M6T'2-YEB(6460UM @3W*(U(]O>V,] 4/P2I_"7!HH?,F(T,/;RS@*T?..7)^
MC_4-"H\!>HY&61;*8M"(-*AU.).N:*YI9$O]X)4X&3FM9&3NC>T66 *7@JZR
M]6;K_9#6FV _#-5#YL1IRRK5U6*5> /S!+2/3(94-I[FYU.R*6=3_M"F'"MS
M2;E& 5L\Y-$=LJ/-UOGQK-.2R-4$-XDQ0:9):AS^&W;*6'4>T!/JC)A/QBQ;
M&.P8[,3<2A'(KPU./1MZ-O0/'0_W'G_*$KR8C8U2-9L3SI:9+?-#6J8!,JLF
MKKQ#M7H1Z_4)JPTX?/O<,\Y6^C'\IZ=RB2@8CD@)KN[L?J8-G&>1+A:/OSU^
M?AK)+Z8\S!."A^6V;87-@L7 M> ?4_!,ROWTN+ZY8,*/"VUA**LTK++BL[!2
MFF%I+%5!?5B$M5=82/L!95KM(TK!3J3HNK1_Z2^B[+\8@Q]416]5C/O6!E:X
M2T4QICLI3D,G4:]Z=DB;G=K>B1H9,IK($SC:&+/;T.Z7-#IY/$V:0AS/<N]J
M5_6]L1P*XU/4IQ(>)>Z;M$MA%UA.Q\6..FO2GHH;63;< \)BND!=>_*VR7V6
M8<56K1,F?KIV^U*6L^TJ,G3T6 ,_FV_F1<93^G&?T-#%85)UN!C+_RV2GR8C
M09N'H_C>=Q6UM==;1R\FZ9T3&J$GC1N'? OQ _>3)^ZY'0U=;/JIZI(139$=
M7KD@!/>^.#?^HDWHCP-UB"G<9O$-?7 %*;SAPM//0QA$6 E%-9)346D E\.Q
M!)&9Z+^SFDW!\K<KJ;60@;4'^8"1"K9, ^ZE4I)+QB+NT-4<2J;9A7;*;E]6
M1S+KD>+1_*U-=) ^D=>8Z3,^ ?J,^YD^(]-GS-!G?"*GT_N5;]9VT..6@M<
MRPZ!HP&R$8=[1#;" *]9>&KXI;FO?7=ZFO)!I1E0\>;A/BO#"!AO2R$[!7H
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MFG59M0 T22F61,;8XQQ')+MQ69=:=9DUIV4J/'D85S#TO:']SJ\G-T[CAS0
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MFH3#C+Q6M LY=<O($K'(_3[\8L6Z,OR$$8^@\NMV/P(_K-LB[%#2!&W+8>;
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MU_9[Q8C9WY[@:H-[SI'FYP>+\F@OD;-8#4[!Z97%:PK9WP,* 4S'$KM-R;
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M:8JP6,\EQR>M;(AR5T3/UXH#IPJ:GNW,<RFF)\J"&N1=21(]]GVP]-!:3L/
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M*_9\"1DW9IDB%T$85G"4?_1SN$P /4[X_VL0J@\?!7U#0+LG_7S'ICWQYBW
M]N\_)FI38J,J[1A47B7N*FEW U= 6S:M0Y"/;M,#CIJ2JD5KC^/3 M[K$=[I
MH3<NQ@XRHTM.W6CJJ.^,F)>4>\(6+;O8!YD,1G-\*F;3.&D:;9U1^$5]#9(
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MQ/_OA#4&U=EV(A;HVZEXX"%[NE^*I,+//E)>KF[GMDY8S\+0(Y-3LUPJEMR
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M@FX,!?C'\8J,#.$N[>H)<0U='QE;F7$R)(.,6D=H5FLXE.J 9-1Y+'Y$H##
M#1\&)>*+L(/"#)6.C#H9I(.L=U-F,)J^APV/_(3*)TROM%%%SYA"Q4[7<_SY
ML_SET[/;3IEPP-#I@#U1A-VT\BR9/Z"I@9;<FVU1"Z?2S==KN>#.;N$@,CAZ
M99U\P&;*,/J5'LL(\;5CF%U&"4\;1AU0V4D>J9!;D15UM@4=MYVRCJAX/$F:
MDOY"1J@@!,)N4VW#FSP)PQA_1[LD!TB0'I$(*.EC1*6AS0TU-:KUNU)@AG7-
MR7"\@%<J;0B*$68,  D>D+<D77CVU5=\$-AG1>7DXH+X60X>C"XO[&$18N0_
M8#H]@:>.%8$8ZKHOG&)U>+&_%#4?@R!D(\?,]+W(S:!:PVXG(#!89OL"CLUG
M3&@B$4:MPJ5:7/2??7;V."O_!<&H1MH NP[OS%%+,1X$^[@[]1H"JXX^R=2M
MU+(\?2 *GU]8U0?2+=.K18K4=470%7[GL#81T4P\$>32O"8,:M9-F(R4XBRL
M BB0QK9!YKX1X#M2:$*G7Q-?T"Y[]^1K-YT1 $%2SM+M!>Z<VS8I;:SXY6%\
MZ77"S3^^Y8H3RV_*@)RKKHB]SK%7IB0Z,?@PB8Z:!@/J@'V1ME%]04+63@%!
M'M31"/&(X;;'[F94P$;_-C0^S;ZLQ?3,QY('D:>BT&*<HY*"DP#.589^?8?@
MTJWS_]>T[R^)%2Q[]Z<WY^8=Q5^_=@OX;\VAE/2CI4_#A MQTMWSIV%50?\@
MWH7.6U,VEA<X]I"@/D!# LC&MH11A]@S40MCQZ^3L^LD>X>A"?>/%PJ6(YQ/
MPRTU&(T4T#Z9SI,O3D MG/C4L2&10U\R[45RAY'ENV5H[=$Y@Z5LBN+@8H.*
M#@(GP,%T30-)MI'4YXDP$[P$-##A@AA=\E /2"+SOYZHJI,S<2G4$)$U:$SA
M"B/.QM(PFFU*U+I,?_C/1LA)Z*#$0\Y68."<3E1CA'SNKEL^3.&5CR&%)@8=
MA3B<B7/35HDL$G1MY:.2"=4^"IP/H^K)'9Z$UL65"Z^UJ#)@A.'@3[4[Y(&A
MO2,NN40\^B'L5GE@^/"\T#YHG7_\JEX%7]:SVX&O9Q'<[5)*8F"+JS9-LY+O
M2' ]*![$-$05)^P(!_9=*U</>C=]&?@>TP9>WQ$-)]J\F).R0/Y&_%L)Z;<B
MLP9W&($#0IZB&_0$)^4DI3E"5?6N\+K(/)*P[287%A:J\*"E^[Q"R9-7K&9;
MG"R-=PV:=6GF8G*+A#UDOA.XEK;:& 3 E_UI3V_*+6*8HG:=TKGBQ'",BQB1
ME; E^?9AZS-Z4H/U*!DH^.DGGP#X%I4C;+!2'.!HS":0>D)=PVMXD!"[^M"M
M>G0H;&MRTLZZ*](8_J#<73)HF=-QC2Z-?$(.&-J_&F'[=Y=GI4VDICV"0@S]
M'15FXJ./S4FX'+_/MQ8Y-YP,5OZ?*;M!J87J0.E#&J46R>:NV8(^%LW[XP>3
MJDS%-TG([#[B:@.VC",0:?PZ65_Y),@QRI2$IV@_$-28?2F@SHRFG-&4'X2F
M?#&C*6<TY6\43?FY0(WO2O-L/J299^JD^E3=.^(AS-YYFBFYXZS0+*@/4<7A
MU[#?E%(HST>J]+UHIR,;(-D" ^51I5C!)#YO^=>_OG9ZEH:J29]%(+"U>!]6
M?;=< /EV"2:JM7:;<;<-TAEP>6ZL*:#<)M4F*NQ[:*RG//3*.;?ZUN&)66+N
MAH"CWPJ7,?O,P% LRLQS[T+EX5H'HNE*7V6<CJN3..8A[X@O)-,Z[%IW2CN4
MF5=9@U0;))(:%%H^E@7QH*?@$V(+;'RCP)-J*K$QFAYHSO5Y[2,=<)*?:(M5
MW(II$;1*Q##]6>F0+10.=DB5<N #<!%EL$9*ST()Y+.D%-B<9#_:P]D;3K_)
MBJ#Q6LCF0TYI3;;7)N]"%Z7<M/)? -_GUE=5>N*OY+U"_ &I<^)FXZ$CY@3H
MMJM<!_)=M2=4<2HN,*;(\TKI?U5>-M(7S[EFH91E>C0RFJ(]I3:39=SI"HN2
M+IY>P,\CR'+;YHI!JT/@4R(6;VG ,-?_ZL$A,>84=]GGR/EB:C1>347$5)18
M7;7OEDL:!\[%;(F[/!QL>])Y8IDOQ\DN9T#'?0V>Y$=7CQETHIB;7*M@5*<7
M%6)]&Q.3 ;+J%3U=DCJ-#Q#Y[0?$-D!<L/Z:@!UD1-QKQFOZQSVZN:0>R+D=
MYMJ",,R0:>LD^P$KCJL56P?.2O3*!L=>^+9J2BKA"R%'N>+ X@!1\STJ%M#&
M%OI^:+0YJ;QN9)ASOV8-A>*^1^DVO%A8$^+L"(79@[;I7^98O8G-11.Y3LHA
M]7N\]N4-^;X'/2V?0F-MVML==$2P 4R\:L1XQKU%(P[\D XSD5V*T[DJZ:_=
M#>T@H[L%TY3<C$,!04XTS)AE'.L ]Q4A\!#*8 ([3V9]D?Y6?LRDPL.GX[I8
M)E75,0VYZT/J7!.+7U,N3Q&F<?>$GN))R08:4[EWJ0I9*I1S^>;TY.G+5U^_
M.(O_5PWR@X,U.)D(1/KJ6ZRV)W3_[ANRB93 &JW+N"K"K2D#=9\6ZK.3KUX$
MS^C9R]/3ER^?OWI^^OSWWUXU[8H3;]^\+\M]>-2M#9 DZ3!.-PP,I9A"\/7"
MT@ N6\<W/CL]_?W@JO=ENT:]M*&D@52V_]4W"@$UGGWS/6/F@U)J\M]YM<ZK
M]1.M5M64B/"[>4W.:_)+6U %0Q<1Q75@ULPI''&LD._+FN#"]'M#L?APEH.<
M1=N\)W]"717-CA[!(!8K.+T'Z?PA6=C@T%"Z@=)^+,+",=%UDF6TK:4QFM[/
M]%NB:$M#OL^U?2+**<U;<=Z*]\.9L71275Y)1QC))7=4HB*"]8L2*(IY@<X+
M]#.?%4H4/VIK<ZDEE]TEH\J4*N[ODNWCTX!S1"=32_FWGHSX&64J&3373O2C
MJ(W]L ,1,=*>YTR6<_;JU0N2&+=$.U$R$OF^D,UT0CQ#9;9.!(>4<P;Y?*UV
M:IU;4:-Q3C4#6* C:EVVDGTLNEC?NT1G3_R.EIJSGQNI3!Y0A_@/LRW#' OP
M7]=2;!\]0W:^)87,BXUF@P_2E2CC05V1-XQ$ZAP(*4@ZS-FJH4L:]X?<@_8(
MZ,VAQN1*$-5:^G'A5W5]MZ^6DK!>MT7/,@7YX&-K:637#P7'B-+>XN?D7!!U
M=Z<$HKP26MD619O.\&BDV*6BMF1"NA<M*KR,:  L7J:9:'^S[Z"@EST)_QCG
MF\;YQP3Y:"G(4=GX@*2^?ND&8#J];D\Y_(M"N N9W5DG[_:>(EI8DU]O!KKK
M!572G1434.E_ XKB"R2W[_-R,<+_3[=H'O)J^014'G_IZS)[B7;DKU(6#Y)M
MJ)OPN!7#IF0%_%7F^G\!W:Y4PRZ8O/4Z>^2P)N_H-P8F'Y?1<'G"SNWVVZI0
M*A"^BY6B_U"M"&X3EL;;N"!5C&*Y;5 #7E0K1\KF;F*7F5Q*FX+2[-LM4"QT
M</SN[.3TU!'=T-6>G7*B74K^)JZT*JZ[[!'351'_"8U?N'6+4PZ#^H)_^?@D
M'*FQ4U%&D1V)X&G2FU&7^_.OSTX?+1\_>O;XT?GC\42P.G:YXD%B\#:-VA*%
MC])QW)Q]?1J[T.DI4<&@HNDV^V.Y!/@H^\HF'+W1W)QB5[0JUN3HGV1AV;PK
MPZF-2^G+YVD5@_X768 #"79TAPD.8=\G('T$2;N AX'=: ^.T &S6 36[E5+
MX':C4>$FA$99W?K@G+3,^F<=Z?20?[1^CX299K2X&$2>NT9(NCY7:? F68@I
MJD.R.[!>WLJ'WM&?;:L<T6D9<R!-W0,%Y/#?&N2+\*K.OGD&WHMOGIWFRB&O
M[UQ.WFIZ!*QW/\\*+E@3T6-;1OS_(431L7\JHNT5%@GA]C5)M.(IY7/CH< 2
M^QLYV+3"SIYZ\\3/YG@$F,EB6>KFF+ZDC)C>]^P;6K>2-0O[B^>M+\2IM<;V
M\%';\HU_)B8^^FH^3M+CQ"S,LZDC1<B8T-%"=&$-#=%2! S%,I+OS#NQF%9E
MH7B*"$I(,C*LORWHA>(1P%IH4+XF [\H:=L'$RG*8Z-SB#[$)E# (MX(ZF''
M)OJKYZ>/BL>/SAXG()_1(<.2H[(KHV<5UNG" B?!\*S2&,H3/]GWAL_D.%..
MM4%A_]A4O+AQ*OB(YV,\PEQQ>!^? WD&ZZ(GS/9ZT.!$?4.'+AT-N[X\^9]9
M!)-/0X59R=]>RUD@?[QB"AB8].GQ=V&4/E ;P5O35Y7WH[TNS^RWNPWAV:F.
MH0*85+0'D^@PL]WU+CCSKK/N;8S 9_;UN5_H _N%7L[]0G._T&^T7VC:8C/8
MD5-E:2L0I]8 _P7)F$2)4T>-2*+R61RS@KLP )P4T>2KA\>ZA B? A'R-XA:
M)QMV_VOZ''[M>?ZA!AE:[AP/RSMXEX6*<BYAH/[0W3(&E,1./^A]NY$N[Z:X
MI+\1=IOPX%LE)>,XFR(8H*6[;T.@>U5"93V$F3^%6 DQ,2=4GN5W]S2IC\UY
M=F.7;EXQ;L6L!Q0O5Q ZW0Z1N*-M>5.6<]AU]M;P\/#^:07]6-75KM]AC;G5
M=9Q=?(I*T-*E:*!'309B!%>ED=72\E>P\=%+5YUU*; ARTW6"RMZ3P'R07@,
MJ/A,V%%JB[-T;8H_28E,.9\'_M[ORX*P(%WVIJC++="TQ]]7,"2+TAXKY@YO
M&B=M"7$#Q:_!72 [8I%-*IV@#=(.AT&ZNA;PRQ/J60%!ST:X@M)2DA!)QJLN
M^N"JD.CUCEEK0=<SN!:/4S>X)R?&3?FB''X+D8_0]-$"\TRO57TCRUB8:!Z>
MD4JSYU  30.5NB1;PX')S41.QZ]Z:R)>.9[6!>>'A&8J[+"V6E!![M"(D#G"
M<E$V+] !W 7K4*R,IHEB=P MNO?Z884$'2=>&Q4=QG&FK&1Y2RJ?3<I<)R04
MU+YR,+-BY?(';7V_0(U)3(3CGS5KX*>&9ET8+ <\+0[BQG8 Q(&>#7? "9:L
M>.$.?,B3]BD0#>_^])K)&D4IV!E8*U,G9LMUD$TU.@]LF)NS8%G?N)^P EA"
MF1SU,6&;5#6L9LR->-27];OG)Z>GN7&#%QX/X;E,B<-&?/:Z&*-AM$&#Y:(U
M^<UDS(94]Q<1FM7PD?CG[KHC7%4>JS$8.^D\D:>G-2V$QU4=+K\KXHB)1(*E
MS-S@,7V? P*XFH^<S-9D0@RL>!2<Q41@U\!39=5Q[  SCK7?:Y42]]Y6FJ>6
MR^$4Q/T'PCQ*8OHI9[,\VK<&1RW2I45B\.L&OW=#(?@'=Q%ZKTC.Q%WJFD8D
MET",@_A5U-%8F-.,&6X)*R&)8K+IJV;9(R20X!M>-M<E(%E@4S;!;W3\[6@A
MV"O%8QZ]C+_"ZPT&3P)58D<L^.'#:M<:UQ%4L;^K@%Z"66=J8W(;F.9 N1J%
M$*&5OF*XI<R#E?S97&N]>;'4IE5M=SYLQ*_=2_?S<$*,;=CHK^QB7I=@L&'"
M%D.$YHU.RF\%4@7V+%8%Q_G[:WX$O0$/ 1__]ACJV;A'3#P]SS[AQ-* @];8
MX78,] #[?%QS OBC-4.R!P2#> H[ J^-/H([H?\+#L$OPQ\IW>.^O_= 6XU6
M3?EDU5S5.$7XQV:]Y@H[,9"T_3+XC17I'1$PI6HE.E3&F[!IV@L]<IWL7MH'
MK_ 66UQLTF,JBM:06"7.6##-C'4/YVEC(=M[H<9S7"&W._XN4GK(R^C7]J7^
M@=Y@,MUH#"ZSZZ:/P3K1S:R"3;DH.;D3CLSP(?1S4I+'^C@!WDVU"O8D$E$?
M-"#44A1/7<*$0#>/+>I-UM< $QZY Z-2BN"I=.35D"2*X=R3Q\5:U9".\!G5
MJHP!%C/T\1*B)RZ()S A=12#'^-"M+G*VP4CMN3M%'=2LI&$P2EW>XG]>;^T
M066P)-8EVV$W;K"(58L$!\2,0]'_GRY)!6@],6W!'2-N@G4/601:X.0?1*5T
M.L3"PY#2#_,&\&_BL/"<N5HUG8NU^Y3.$F$P*J;61-9:J%P[<FQK1S(5+D5-
M"C7-'HY0[DNH]#4BP)9Z@V4<9.21-BVZ38:^ ,;0&2M%&(%=\.9 /<%P.K4X
MUBTGD-L"-J*05!5H"_1&F/>P/(/7T0,#/,X&F%E3ZF,CL Y/M B+C5)5HU:@
M@1=VY'Z1UI[376'0$<W45#@.S[EQ2R3LDUKIJP4 8DO4*WZDJYIV.L M9%K*
M7RR#MC@8$^QEU1ZB[63PO7TH(N\)KT( 7X1"_&N'*XM+?2C?,.X1[_KU&@XO
M? ]U,!,KGK@"V3L$&?Y"%)CUM=*K-'H<D:^SXB9)D8=P-\#%'_2!\ 7\BK_7
M1NM/KJ@$HT3D9=(=A^*7C$M;%*-*EW_8%Y3NZ&0I&JBK_*4P'U]67#"+E!BQ
ME8[KE6%_U-VQ$_^(7R%>_X1K\:"G_1/X 1/Y?>U,@'S8 5:5)R;,1^2F)_70
ML!#>22\$NBM%)GF+<('G\)_!#':K:BD6@4@RE,=N8MTL)[+HEV0))47<CE8
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M5E'G-W/';V)M#UM=YHW<*GV<H_:V?C6T95M5<PZ+2L#/]L_.;.*BB8H,[RA
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MN_U[_3CXZ5-&MO2UI%_S7L-D6 (GA'6K%3=9]Y$ EA^/IPEJDJB.6%$VXD_
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ML$,U0U)&(@NBCX*?I[)*XD--HR6Y?3[N7""Z:BM1%*V-]>IXGJU\8PT[&^L
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MA1 1[C"ST0(5D@7<H5C?>T6%NRNV_<,(L!)OHG^HHV4^#+EX!KIF@9P3TDJ
M?D>5(:C(%GZVPE"NJ=\T,#O(<+RVOJ>I^BML2X:!@J2K+&SL CCQ4*Q&K, =
MFL"'5TV'Q;&U0:C_X(D>6@ *(%,GO+U*%F5],Q[Z<<I#XBODZ&D]C48<I=*&
MTA6I,KA2<&%9M%T0,]GICM#%-RZ,RV4L'6(AHJYBQY7-5@3-TPW7Q#RW6,=1
M! E-HHYD+U[RNN$!&'@!]CN^..^I_O#.WA-92_W0(INCDB -73>"QZ?\#%5
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M1!T"&$/6>5/:[]0(%5QN&#U,K0/:7DA24/]&,@IFP@Q.##L> H/6FW=M5)\
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M"?MR8B+G?)G]$^[QJYO!K,A1HLG6\U\O+-EJ8"?2#EN30Y/X=P3[3X]2H47
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MW24R&+L7?(D$BP%$U7+ V$:ZGQGH./""$'*R"$!T3UP4H6TUZ'PR*6CYTLS
M3 P13.[:4(][?3K-WN1<H?(D".,,U1NR,BJ@Z%NS^2CI)+X%_G-6*/!<.13
M<:&*%@(R!D<,B,>NWZD)IU]=G&6J>$TFPP5('*D':>DE%B[MR=(^-YOD'\G
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M5$Q^=:$4T4[Z))KVI)$-#9CNF;J^JAZJ'2U<X!,2F?II,-("(0EI=,$X-JS
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M5N8@+ 5&),[KMIU4;V*8&,E";7^:4+ &_TA)'[,-B1^,"\!S**Q:!(.7&!+
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M2^VVFX8Y0V<T8)&$D,9/$3Q&"P'2Y&/=W,;,&W(+&]G1P6"@/S;^V#S8L?E
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MB6^7M<U;C70(^OTWV_O!\<?@[:]?$4CW">0'H>#ZV[KIGVN&R4B1X$AQ!DU
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MS:%U?7]AN)/5!0T\B#=HELGW,<L5BJ%0@P>,5:,3#&*)U+!E(-$$6T;*:P7
MS&*33,+@4KC6-!KSI*)7L17V^J$O^CM.E?$<AWYE50'FB]A/]F7Z,<99-J[K
ME#'7=:N*J@#))16CQ?B:\F1<GQKE%69E!EQ+N'W %3H87*H]B%&DJQ]40YD>
M2$'.TE,P.B4@K,R).R'T()<Y5_P@':_")YV_-M:E0R@7!IX@FC[4PWE,E\%H
M@B&SHN06H#0F(2U4V^PIG&K@=L6JV:'+.,HQL'HVDX)G#1E!N.*\U W3B.EX
M&3INYT0!26^].G_=".(AB<B$Y$^GRJ9S3<CF98)GZQE7)W80+$@.[!U&2ID@
M0'8"A3"/8-3JN#2"T:N\(#XVQMQHT3@F\(>/8%L@)H- MWB;0;FZL8XEK!S;
M%B<XC*Z%+KH.T03T*&9ARLQ$#GZ H]GK;%;KN0O>=L!EG1,X=,>828F.WA5D
MLC;FNUF6TQ"_@D@2D=L"_'1#OV1':YRCY<DB2N@0M19.8_VR05$V(XIU?*5M
MC%I_1QUI25T+'-E$[AG5JC!6P0(L!5D9K&Y*2%-CBH!<1FS\2)AO H"S0),1
M@75/WPX;$IQ?,X% %>*LLUYI/+#[B-?>^;NL9:2#2#-CF*@PPI7N:!7,L_3U
M#Q2*M1>$A4&]1"&/XH(;H=2U3^98.]I&HIX;Y45&08<ZEQ8QW!SEM8!-+0[#
M7P,&Q5PMA^N<')*)W]0+)$H:Y)(8$'RY JOF';VGY.AM/1%'[U=$O]:JX[P_
MURHI&UGUK>'+JW)7KV(>YDUY6AU9L@%B0F19X);\;O!;6GU=1#G:P9CTS<<Q
M>A!-52XY0T=XV^%WDM^42^H!=FY70'/J!+A%_8L2G@Y'" 1L5JX[&;F?Q@@-
MZYLV$H#4P/F&"<77U@8YUBAM7*H%5#=?4C/3LQ2=5K!9V!F-@K^J-(:=(AM%
M?\))-<HS ?:; D!;/4+.I]#"[I,!OS$10W$OI9.[UCMNEF'U(P30P#XL_X.M
M&$/V@MPFK4?JCJ&K35Y+ZXGSUS(H$FTT;) ?%#B%:,(?KO,=F]9UI15OVQ#H
MLE%94W\RH%"[K"?'?Q2AF;;(2,25&X3LAG%Y)P7L[:_+[*\V/\6>5XE\!ZA?
M5@W;:50]R4[-0MM6KGDRM[9LTHP,&AL";WM!FZ<A('O<>5/TX4PHI6X\L"[8
MO0T1F?PI!06]ZA4RT7<[SMRM[=$/:I!HU73N7S3HXE<-NO"<YW">*6>67(W$
M$1EE ]O0*B@UK>W.-JEN8C:OK.QK\IL51:^E!#6H4E:M$\H:S46B%!BF(2G&
M(C+-+O!W4PK9?'DK1JY7"\#6_()LA*XJ-PA<+F0*G11T2\<@G@KB9H[<4L.V
M7D&]X"N./L 4JXAVXS=/Z]%<%_%4E[1,$@N%:@A7"X=R=351+Q2S9:Z/CK.+
M.KXYM&X6IYA3:]KDDF.N9W)-SI>5KD11=  2M$RO;R35%5JE:4P5![JWTNO@
ME R@2-+!E^JOJW57)NFW]OQX ['4C& T]-ZU5%[H6E^N<G;P"-?6SU=]7\]#
MW+L/<>][B+N'N+= W)^I,?(Y#?XG2BD1V!^&3MB>C3CL\G$:2:"^@9?607S3
MPV_9[JNEA-X[]Q[I>VW]%XK;[$)+U@H<<U+YJ\K=)XKQRF0/C!3HV6E]'0WK
M%+LXXP.:B@1_PK[K23SFT>JVP8+],YD'E*G,8YM'T]-D:77NJRC$NB)+9DOJ
MZVV1\))CBER2:8W/G9S'!8^\1\,>I[,3,>S P1$'/D1IP^<W)S9PU3S!7TPI
M-9;LM6Y%@-D0=2%=W]U*;WB.2D\)44\)5QSE#I::]3A2*FNC!>.NFP8SQ)YQ
ME-MLJ[NVO$: >HN:S-G@>-I<$?HG2]2YG#37H$QMT'8[B<R NXF98F_9))1H
MDN4;[H.M6OL+M'6+(=;/E<RQ=*>P-CL77++$5+>"B*0E;,MVME&I0:0#*MRH
ML.7;ZI>939J8!BU+>W.M'4'QPO4+_+D@*LFP;UT]UI2"R8I+@?_-%Y(,L&.T
MJ!MY49I>)P0WHR2^K40IN;+%NZ:.-CB^I),1"6@)#G(&L=&# V&G&<)YJ;-4
M2X\1#,+501[WVT7OSKJ^=:2/'OH[?TI$^KT&,^)Y:$\A/$A'G6YWUFOR,R.;
M;6?.:U3XA%+B(_WU.& ^K!DV[^I/M34^Z/93.^MQE,"/D6#='7@Y22=M@)GR
M'E:XC!D_4^F**/]2N_6;%BK1,Z10J=:4SBE4PH;LP>KX1FR;SI TH+&K$I"(
M%E1HC^ )H ,%$ZBY.S93%2Y&](=N3Q4%:45!&YNO606N:(([$.*;S51MI 6)
M=[*(LA6=#VN-#[]\M"WX_JX8=(+O^+O*>(@B5F^:N$!]/]$9#$;2)%2N^'=*
M1/N%&F]QM*=MQ[X>OFZ LX68NE>W/N<60=72T[:^(]0_']E%/T-D!H_TM2-2
M-*>9;!!/%,"+AN%@=S?<V]RC"W;"X7 0[NX/]+[@1 T+%9#D&.M[#!69+363
M@UYL]N#@]REF1<_0$3&PH#)R&0Q\P*9"P/X_I6BV 6XC#]??E\D@L3,J5!M%
M&+G&;!0%_/ARES@8!1("]0>:"\G:1'HU<WN-<QT*(!^/I7"4R[_]_7"XTP_W
MA_M7L*_O>>8F89J-.)SV97JDN^BV]LBS&_IU.@=^/0QK*%>9F-$X+*N[;39&
M;LE^U^HNFYE?MY4)256[$IH@9+*82ZYI2X#<@+F,YZ#1M_7@\PS7:JQIVU$?
MSL$AH[L:'63[FQO_"J_NGB;]XRCRBXX./[K,6+;K?+C13'\Z1\F<"/((EH0Z
M_96'"7!#+Q2&0ICL@K3B<!CT?Q[6"T7DV%)9M!/YK^D%=WNTH?16EFJU,FFB
M@G(DQ"YUA#=GV&>2G:A2_:F3VG>&'"G(=4-5T34\[X/+J"EHS>EJ:4 &YF.J
M$&YH?)+F(D.G")OZW;D3T:G=2YJQ@4TUN?N]_7U#I954:6I+REM?P6H<]<?D
MT2(XSR@S4J^R_OCEZ,3-!?+<I=3);-2J>>QJ2)B+8RN[;B1^DQR<<S$I[N8[
M"8- QT&6J)L&<1C?JFO*O]8(=!Q1=^7VA"JCKYU&YLT^YLN^*[OGC(%<J<,I
M]K*RQZ,57LN8DL?K__BC/1TIBG#[UGVE",ZK>O3Y;$LWLRT#GVWQV99[;"C4
M"#_<<DX>O>^"&6($<NY^#L._U")X%W%>Y)"':&#Y6)5C_ :D8_M,O'L)TSP6
MG6X9^$(:'3&N[QALKFF6Q)D/<SDM,+"=$'!4SJ84-@%'6+PJN<?^2(VC"F=M
M*\'=T!7-%H<:\QJ#87R>C=F=ISZ'9"#T@C_1#(=G4&ZJT),#R*+A1X3X*[;M
MU6T#\KCXYN")9 NQD)S]%[T&?!<\GQ_M5KV31XZA(3&U><CP8FGMS;J^)NXI
MW-ZW&%CX_E^P^&9B S,:ZV9O&>YMNC<<8S"'+S>]>[3T6[IW;[>WNW3S'U%2
M\71'G5^$2[_8[Q?JA*L@NH8^Y6*.(TJ318U2&I?8I(P;TZ"Y(D=?#@MNV$O6
M<D20K<28MT)WV"*!P9SF6>$6(6D'X) X(,L)I6-<"'#[F W(+->>X,3RI;ZM
M$ ;1/H6+J]3?T M^61"<FEZ-92!_XZ? P3,U(=3F,Y;TZVDT-T,9ZSM,R56[
MA1PV2N"$@UF-L3Q:\D@E-%5 6%PK,*;(J4H5X; P]U1&G""6^BE+<[@]K2@*
M=@9?AH8^'-2 10F'WY &YO <V4HMMY<I7H,9%B WC0^>F;$K ?<XQ11LJ:)9
M82N:"]V91!]\,N]Q@%$)]^+AC3%<5N5V]@(W27%/,B_('"KLVUP$,OT!3=UX
MQ,7,U%\A)V<$:W#-TKF(U.%O0S4D!_60($H8#M$5JMD<#WB%);OQF,-X(4>=
M75;#*ZOY!O 2^J;U(*/4Q1M9],!!MF[K!Q,+U0>3&K;(WDQJ+*U9V!Q8$=IS
MK7>E,QW\TICF$6-T6V>(44[3D Z>[>$\DT)3<H<+HX!3,-5'KTIUA$!/=,;K
M5FZ]#A\TSE4@K1+B]%P5)6<@-0%FT80RY2WS1["5B<2G& ..($0$3"L9?49%
MZU4NISN2,T&M!H4BGOD:QIO%U!PUQH?$Z1@S-S3\]A1D5JIS J:QXPS6Z#3N
M=P#0_*@+#5SAX3=)J?4P&P\,>+%12+F+HY#F5F3>G%ZOFR<Z#Y?..WH(DK&)
M:"Q!TR"BZ)S6Y1<<ZY"7.,\E7(0976YKFBT;4@8#M( ^;48(CBA9AG]E6Z[Y
MPGG"O9=BK(LDI4%MN+$7@CH5!2Y0:/S!*&0=G7*NI#W0$W B?#+(@'Q&T>-)
M-4;!;G?6:G9NYZ"M4(HYSB(JU=;/'EOA,9?I86?QO'"GV\P4:.><[:$+A=4-
MA6[B38$E]W%(K<\UXX).+I@N%RF+A^' ^1&(-MCL;Y-)A,(%_%[7+F%AV2Z/
M9'0Q_7=4DOE4IZ*VLS2M0A9X8Y(G(D<0F,^21!!D-4GBA4=[E4Z]; ")KIF>
M;"IKFD@A,XII!ZZE#QXS)B@$$A-P7E%BS!,>./Q-+?0&MFY-T 04Z E5;09D
MBR.#;3BRU""C;#<1Y&.<Z4TQ8%., %JYK#@BBU?CP4^B"X'B@+C" \BN'>E;
MHE)]>M8AT&&.8>R2K3C6=R6/@ZEP'9-H!@9BP4 #JE&@!9$4F49Q4A_)B5D/
M?86NH)"@,/P=UY.K>#;"6CB6D(T-K+\T#*9J0BT>X+,$$DA!:$'*\4M!".8H
M*5Q,J":HI9!!L=%Y=Q:)DPG)RES4&K[Z8U:?0&EC]!>*7'2A<(--R.E:)KK$
M%(3E-BCFIR8U=?8G5D>J;PVKKK"]C)AS&4)2\P.URR*=KSBWF.$8<R-F>\$[
MEY-P+)&P3;*PTV$_'GYVDF_<?!H%QAEY@G)97I@F6W4GDD_(>$Q"Q7QB$FO1
M0\<6/O18EL^ 0V?*%#MNA1[]ZP#CR!JIM6M I()9J6W5@"MK/$:6+0@>.]Q6
M,JQLO!#4 G,#T:FJ9\6.ZO,NI,,3W:PU?PL+."8+F/Q1@JA ?Z+:0Y9+X0%0
M-#:(@[^>IC1,'7MAH(H8GW'#\5$L?1'-+!.&H(_BDH&(UN>O\"!R$1U<8D!C
MS"I2Q<1I0J>C>4J9/D5]=OBB NTM@S_&*2*'X-35NT>A40BWD_%&?7JJG$,X
MG#/F,_U7-3F5O"(V3J?:?;F_UJ8'^1E[SG,$!['3&$&B@2U.A6#CB00=<I>U
MV@!HW"MVV.5^G39-0P?:;G+CXOYR%Q3R&RET#_;GU+7O'<,#J\J=D(@3\@QK
MI?ST$4WIPN18$1(,&X''O9W>WDNG!IXGM &5)@M+?'=L8V% )=0^5UP>2M&V
MB6&YQ];I41H9UTD@R<C^(#L@> U8WO@,+\IRYBQ.14NC!#/@$-UQ?L--8<%W
MFG#K<!X$,TB@75#A$1[N/3#E&%/V[:FC9SM0&SWG\RBI" U5.]%DX"/P!P$/
M<?&MD.,LX<>2XC]SK!UEV_\OA@P4Y,$JQW\%\1,7_ NQ.#>F9=?/[A!G1,!+
M_ 9"_)SL$UR!<P565,D>&C#JOX[?.QWSP#9S7&DZ8PO%TQ9E#"X52TSA*6FI
M=8PM&*>P1DX"A%'[9);)12*+:T](0%X$X!VA/S/-2!FPVA+4AHD;AFY@&HYT
M KM8!+AX6ER!%1C2 WQ,WC_0\S1G'4-S.<A;XAH3OHU\[4)-*XH-RA;JZ+Y+
M-/B8^KXVV[NA V>$M\AHO:^$OL6.D?F$'D9*]+?#PV,.%9F5?"7[R$D;A#?,
MY(CY>.WK+3Y9?%(FU#$07"O\$S2]"WZ8!&37VNRZ]Z3[TB9VJ7OD&V(X0IVZ
MV:EX"2?^6Y(5!?JSL/%?I8Z)W?UH!"RC Y%N=(I#AR2 [(AK2?SR><;P&'"^
M#K3"T8RP9X03Q%^RK$PG4>L_N NG%\*Y0GQX1K:KGG9_LX,C)IW).?2"CU;2
M&+G!F00X&B".L>A,BPXMBVF]&/JGF"0WTK/2A607E9@1BA\SY0PA9#'K2ALG
M?RYQYEI+U1H%"DI6%YQ_,[(=_QZ707%&YJ<.;+@80N/KK:+V32A(PWTEU!BZ
MMO*%?O^DPM(A,,&H3R[Y&ZP=:@#'&[W3BZ'+"I%N0$EC!QS_<?SE2!L"795;
MN,;;2"Q$,V"OH7]4:YJQGB%9X4#INRIJ54E9DN040X1GLX(=P=G(Y&U 6N 9
M'Z-#C+LA]Y+CPE "JHV:UDK W0"6^=3(FGO..1$)0*$<XPAQ#CMS8DMQJLMG
M^&XL&+[\\RZ5?KP.$^%RA"#)Q55?PP@0KM9-LTXI13\H= UPO4./Z_6XWH?#
M]78LOK"D !A%I[$)I (PA6(1CAJ8J$4_JH1+A;X.S*$ZQ7)?>9S@J# +0+U2
M1H2N(S@;9AE420IWRBAC<@NP/27U2(ZMLWLBJKC?[V.?+,164BC3"<Q2SAJ+
M8D"4CBE2B29]$>,*[2V4XD2DP*LO7]Z^#D#1PI\Q%(F90\[T4/$9T"C.[3.,
MA4M!E49"L3B0_ O5%F.^5**+%$:4<0<9"(FT5GILVX4PX1J+E%)E^Q&T.$E5
M6NS)97O"& /'/C?H-LD5K\*V% PUO,*WBL;C2H:47M?NT:8-/DGL&+"HP-DK
MFE@8G7$S(?%KF!8W<*SNU)TB,^M^'*D5.T0Q0(QW7U#1V1G"'MD[]E[-I0,?
M;A3@,G[-+]WU:VAI*#M 5$AF%N<*SBK6=8V,,'SR5:;[W;LY]^GBO*/4VBSZ
MBW$6$F;5&LD]9D98Q.SM-$Z<EC<\$5M2A4U7:;2P^,OE=#LUNC0  _I7(Q$M
MHX_GH-NX7"&)+NX:0Z-0\.0TGS'#C@\+A!W CRZP!C.)%WK.\(.@:OZT8",7
M07-3R .G4AE6\X\2DK"C2A6\&)@W. /GKI;X.9T3^EF XV9^5<3TQD_GJFF7
M%G,X!.-%[8.R:RA9KV-_3,?^XG7LNNC8I:10MQ0F!@+/HZ)<4AI.Q1!5K^,A
M*I=GJPM^\B  AE TM(\Z^;3?S0*%P]>E15Z%E.$H<]C)T/*9@5W122BL>&<U
MY[SABK51#H7%4&)@Y0:U=IF&.Z!,!BU&*J-(I.*YTPMFB;CT0=QDJ*Z5*%$#
M9[2D3AP6"L\+FG#V<HE="&U4P\WC";;%'RN.*\-O+.S>M!=*71\6_Z*!M04+
M(G''FKK>Q#JU+:AZI[T0FPAHWXL%^UF$4Z<;=V*/9LQCO!AN;CI0-4&XB:T&
MOR]_/-P\_/Z:=YR%,E +FR_PKN*S0&]CHEFY'1A:'D2:3JI'^+:5Q LM>B8W
M_20)B3>GS]$ML03Z90H;>8AA(: ]W=_(HHJNI4E$C]3T!WG:*4'_C.9P=]4T
MTVE3(>WT<"+.3BRDH6X=C;B$A>,JK>"PY=F4(0CZWS4,,0';CX 7K6MN>=]U
MSB8%1R1NX\@"VE\*W2<Q&'<26Y!&4D[$'6U>?05A'V %:,>Y)C@5LL W_JY%
MV^RJ.+[D8ND$4ET'_(!2&'=T(FU2L9H%U!<VL*+N8X6@*6CVWG*3=&NP4PVB
MC<F8JJ]S5]RNM3*^!UAT.^[.)2QR@I&6%JJI@73MQP='J")0DQA\I"[EU+#V
MU(A4!HT68H,=+XSD0E,2>XTEC*-4JK"!6<=58JNGI9H7=3F+'P> RD>!';Y"
MU5XF<.$E, Z/3Y3@7L@!2?P3-6F=R#@Y!YC*N2E<FW,$+5B:.U )PNC42);&
M8.1:T86U)606$?@>,5K_TT+$"!;S9'FJ%H7 N29\A'7:3KI&.4Z;<]"-?\V8
M)X%UT7O3,8-;920']RIF1\:XEHR[U)-S:Y5;9 8DX+7#,\ <+Y0!O.L)#>>O
MI4F:]!D69"IWYLNL"M)88OPR(;CK[)C%N.5Q+CFS"Q(>DXC\Z)\-0+=H5'&N
ML_BX?Q3 Y4BN;EGV5RQVA070IJ&-TE=3;+U,?8!++@CDQGML^$BLC0]*45+\
MQ.UH8(LW]1SC6A2M7- #"7)H'%2GSHNJ!J7[I&DTP%*O7BW$AC2CFYRJB490
MT#XY.@79A*T3ZN_0 LDVRVQ6)>%"*5=1,[#I[^0$%;I:PS9$."P:UC@#L(N6
M&E)+;BWUW**-VDK:Q\.292*%LXZ#;^M$EW9(%XRPVGG5?WU]_/BKP>MK8\A?
M#5_7XI?70933GIHI[@4;7F;PD)[_B[@YV5=VFMJWU@(WEC948F@T_TA'','$
MQ']41$0X**0@Y('$J1=G4L'N,(%NN(\>9*HYMI7LMW8+;A]6BDM[_.&3**H8
MV8%)YFC43IM\,?>)1V^1\Z*CA0W6-EF7 H/.CN"\UZC0321EBUD47,4.K+3J
MB436OK"1N1-I)*2R>=REJ3U7V_T_01#\-P^!;YD<2R ' 1R@^$;YNWE EV\D
MT2*KY!(SQ+2W^5)?3Y.PYX5Z4R!\&0BAE2#Y4'S?3_1^6(!!8)S'.M'Z1C]
M7P673>I34[<&O=VM_9<N.D)C 0@>\?.J&_NWN6>[M[<U?*B7]?9V_'=U];O^
M^^<R7^)<0?#L@RV#8]]/P8!-)QMB"$WI?]H-(6>V,$.)\ ]M3%_'$&WVX_0
MASNB,2^6)-N72^@QA!3)GW*!&='=[1"8_4>!#]T6%%1.'$(!M?&G__-3?_.G
MNZ":P5H)"F][7O+LA$";MJUT;2'"/=+YQS!V2][#M3;B/^#<!6^Q W\MSK!Z
M9^YW,_AX;0Z[NQWWQ_B=%4:S>#))5(>%T>T=[-O50;Y LT\:[!77$&*#&\BP
MU<3V,FS%=F!,] X$UJTH_YP%UA.3(@]ETGAI<-_28.BEP?I*@S5F;"]!GHH$
M&7@)L@X.T'BL%#I /^#KM'[.NIDNUST/UZ\5KC<KN,DI<-^>9D^ G#?P"W^4
M7G?$@*UG^!YI2"^_5YX<[FWV;N7C/0%N? CK[$E(P4>S;9\ DWF1USF1M[/?
MVWNFW.A%GA=Y7N0]/Y&WN^5%WN.D$+T'?=<>]#6KTJ\&W>*W;FSU!@/LR7(%
M G>GMSF$JY:;I%Q_\:\&K_T17">KX^GI 1Q@YWEPG7C06[[K1+LU9;(G*.CV
M>ON>!]>)![V@6R?:K2F3/4%!M]_;\3SH4^-K[MC?K.&<9W@O=!\WG+K=NQ44
MTC/A\Y&/WKQ\=DSV%"7=L+?MF7"=F-!+NG6BW9HRV5.4=+L^1?XX*7)?97N'
M?'R+MK(/G0?O7Y('O^-2G&<BO.##;B6[G@ =NU]WUQ$ILUXU=-UEN#L]N)]^
M/O3G=IW.[7.@G3_*_BAW@QU]=JX3/L4UV]MZK]F';AX% ['S;",WMRVU>=D1
M9GQR;M"3YC8O\;S$>VP>]!+/2SPO\9Z?Q-OV$N].))YQJ>$_$%+Y?]UA\4"K
MV482%^6&XD$UM$US9U[\)"[F2;1X,TW4=_>+<6"+3&G12Z!K-HHRRLL#^KH-
M?'SQ!D>;)W&JENA@/V2SMUWGXD>?'[73V]G9?>G&%;XI-8?5)0>:)'&*7[5!
ME+F$%#_]W[X9+X"DUU):#PAXV7C@XWUSG9U^M6/*%MC;6BWUMFZ9H<43[^"Z
MTSPK"G=B$TW_V^OU@QFW^PWQ+W9JRO)8JVE]MJ.9S+5JNB.-XNKWAH.@I&]>
M&KY%LV56OLH<'MBCVO^%L^/NVS\T_^C[F\$![?$DSA5-=<3A#-4L/:@=F*:0
MZ0V!S9'@$M-BOF]E'B!W2];5:<-O>M]]7R&CFO.8=JY@C7MK'GC7G+E3;V"E
M-^G,1 SE2^2 TC'DZ1KU'X#$_.=Y=*KXE&]$4_C0-U%R$2T*F6[@[GY=X^#F
M67Y8VM>[W;X'LA'YW7>V5RUFDGNH1 _-X&CKF^C_XU&W2DC3>+N%I#]YA783
MA>9,DSD#0TBE=Z/BUE'!7:5<<+ZA'1ULIAHZ(W]I;G@ZC>(\*/-H@@.C<,3O
MF";3XV!:T$A@1FZU:Z1>T%"QQ0H=.Z0783/5T-6(%SB;"Z<KVMFB,C@2UQ[,
MG+G!,N-ITFO3<O[X/+ ].%A+>_!S&AQ6I\CV_<U0N!$Y]]\IC?;$/!$\^2BK
M<IJ-? AL$R5P"-XFZAR><!8<Q?FXBLO@3"43F?L%EE>5;Y!Y66">J:1B,)H6
M2MFG0F;O!L"$2<QSW62HJ4S;#$:Y.U*<#$(] O,$YW9.<*S;,8YU"P['I1V0
MG,?G.(JL,9M;6XDR-+-E)<[XW2K5<U4G9JI9V[SO:#S.9:XWG,5L'J?XUUF$
MYC*M6G^2#"<C C7&=5>I.^63!^DM[.A?*IS+U:0"V7/\Q_&7([KD%_ZOPAD,
M2Y,'<;HSCU\C&3*-L18/%C^)IU-%4QM98,E<.3U__2\05P7.+4=Z,*6 C%DN
MDY6=>6PT#"\*)FH*'XCB]$+1C#:45O0!/"RRPB%HL'"S/)XZ!]^3*QY /XEF
M-"4/)R_&TWA,-\J<<?-TF@ N4W#MHQH3</'),=!R+"/,82?RBD:ZTJ[A<'7X
M9F?&<W,T\$3-DVQ!HX%Q&Y(@4:?P?WF@]2DRYRNK(UH&WQ9*T:1,_ (0K1,[
M+ ^5!1P,&CN(1$Q3XF2<D4=CA6%SLPO-[S0DECX0D^':"9KR=%KBPPBW-4EH
M.GU18/"#WIKPQ^:G%4_Y13$\$0;.M(LVS:-J4B7( CCS%DXP7OR:5\-#CO$H
MTE1>_4B:KXCG<TQ;VW9ZD5V!ZV=D^M*P>9P#F.-</@4LAWO"!XDX'-8N,R/U
M2'!8&=*'2& FCK^WTXEYMY8DS028IJ 3*.(C2WGI(&%QGB(1."_-O,?F V@@
MX\*Y**-I\+5SP(/&^043N4!D6=$49K)9*V6/PS]9GF<7FKKE6:[4I6+2H;^\
MY!1)F>+N&9G7>!]/'K9OFN8RO/(=R&TS*=$5FD7\G5?!^\JS.&<9J 3T^U.'
MX+*=<8%SF\V#?]5D-UKB(W!H-#ZK</PTB!1TQ-7W",<FAU;FX^#JB,>HMGY[
ML;1Q/'E:?<=!KP5L.>PWS9TN[$#9YBUV##V3DB2W#+S$WP:;!R3'HX3^U3]
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M!9O@'JIQ$A4%;EB<ZIOH_\._5?Y3\\QMMY#T)Y]#;Z/[^]D\ FV$7@T(Q_=
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MN*I<< )@RI;J2!/]O&4U9[ <GB #NI60-YRCYQPZ*2(:(>R72/_BDO#F^XN
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MNP(3(T==>&J]'8A5(F%V*JR5FVVA4T3PJZ<<)!N0-MQ H=2C;QS%LW4D5T4
M?.6 $<B1WE=-N[0^ JM0RQX=-YRHU2KHB4\ &3*97*&+^%-8$-G(*4E^> =>
M@-=[F?93=I(B<NUM(FS$DU] :0:V"^()5KVP/H(:O$\"E6#NOM%TE_T&OW4[
MW>6A%+$;[5V2(5(Z)DH254AS%&U@)*13X0T!1G6T.@8&;'G*O?"7+W^Q&)(4
MDO,$317D%"3HER>"*Z') L*'2RT>!&15%Z3>ZCI T;!SQ4O<8* %;UC1J(.W
M+77%!00A[YX%ZO\\/Q$J]\! 0F;*EO#E.9HB^!HPSI9@3# X!\ %=.4Y6 <,
M&":P2S0L9L !%DO!%5"/$QHZ6CK ULZJ0K3V8D-#A0S)@;F372AH*6],=^C%
MJEF JHY[93FJ;"IXA/<G4(F@_3]L3F:;LI,F:R"#I\EBK% 9')J%$AYC )PB
M];<K)M0G7.#SV_>"?YZ2S,!+/67 >0%.*$L +SAI<@T79A-H@2"I6Z%Q76D3
M9Q?DZ2(+%H\K;UBSA=>-1!!4 %N)):3# G:1IZ;Z(>Y*P&;#IJ5K&ABHXB3\
M!V_R"E500H3^'/0%^=HA\/ #W:J=@&;=+O!@9WP&<"$O$9Z]!T1]+2S>6"W.
M3^P"B""@A7@M2"0C_BF=77-.D!;=\B5>Y/)$R3Q Q 79>D.#UOH.4M;Z=L+Y
M4M.\%1-UDWVW $&M:<&$0>G\[@R!M$]\<FH=S77C"\A?0QFPND#-@5L] YN;
M>'SOT;D**];0'Q 4<+;7^8:4USL$,<PE__DP)@DZ!XU1<A>CQ#M4HZ17C?T1
MNV33EOCM^U$O1>#;4\L3/+G[FWQP5%7_AHYX5%)[#?V55+VEAO^WJL& T> U
M4E'\65D)0M'@0M4HP)Y'?::7NX+WZCYVW)-<&'X:";.L60/$2?U]9Z2_H=\(
MU;<.F.T!ZYPDTT<C6C? 07\-!P5>WA$3OY]4S8T0\;6F]DIL_-O7WZSWJQF&
MSY>K9MXA8X>EL*=>\>Q5/LU'C8KO3,H24*7@'YW7NJF.CSGID9PDI_3PZ\!2
M>CIH0:!58"K*FBOY;3VGC$*47L)>810:F\TN0'=95FU9\0*V%?ZTYESL'74X
M<4YX+_&-&*95KH!>:5KS79_7JQGZ#D5X$KVA#'3;^GP^!K4W2AF'LZ$W@F-T
ME?Q^;$;ZM ((*&R\.<.P\0D<@LR"W\!H: "E_J<^F5M_F5I?5]5_:+GWH"O_
M;KV=6O^[XBTKF'#G$@<!049A2'E>6&DU(V\('HUBI=WYT.CA^%R-FQ;^UO4[
M/P:-%?3N"XT#P<ES=@JT@(%EY$WS32P(^AUURG\-AT)GJ/S>[$+$'7O]8Q -
M$]=W(530_N5&H3A A<)_+@K%59Z]3_7IJF%"'+_"[(FY9NGLO7S^9=7"AML6
MSYZ!W"-&<(@">ESQ.F5+(4%)KDG>J=_8S56M)Q:U/,A+)BU,ABBB&ZEA0D^Z
MBG"_@#90M6T-5XT NC,:;6I,0O+.\?-'%:T#+QNS9GR)&A>[-/X0JOW($W9N
M531?^''=>XYZ/UJ@>2!1C^Q]#M?? $&0E+)-%4UI4V]1#;".$#2G"+UEG?^.
M+^Y5N,6:*W%-N1/^5($[DM!#HW0<H-(1'+[2$=Q(Z1@BL.)+78T(>7U;1/F<
M*.0JZVE *,!"*&WB&,CZ&/E9GT#8)WAU$9!0(VQ,4:WG<^DU['*9%BJ$=PF=
M'F8@\RV%F)%-O0,>"QQ6!2_W27"J\"3>A0E1[IFB(MQ%B:ZGC"H25U$N9CWV
MJLBXEM%[IKIH:+_DP-<BMT\++D44JEI:)_4,1.ZHA 6<:E? =<8$I2D;V\NR
ML=@Q96.F;*PO&S/Z[,[TV;.JK43FYNN3JBCX?#L:[B'JM_]&TXO:V0JQ(GSI
M6%T@)$VOYY)IMP)CC"A=N-?00,,(,QBX:#RJ'(9S0//VI%I8'RM0Q62F?"_:
M1!)@GP#(!E%Q5IPQ4?$D$Q6&2JY(S_$U[5:6#+5HJ&NY]UK&?2M7$B43Z@WM
M-::G+J"[6$K_B$I'[JSLU^N)2AO1PY*2"7_#%!2 V!<9OH&7=R:&5 ZBB0B^
M:(N-:B"C%L/(8GW( SX_9UCE\#<4[&CE-[Q%18*>^8W]H!*$(WD'1P+DL^X:
M1S))UH%VU(HZ.7A'B^MJ^=1P:/B'VKR>_"1C++V_!$P<X'=D6"'TX$,F"B:Z
MUU$YWEPY."KXM#-LOKU[2XE9\$6J8]"P2ZPK V"]WH=KJ%=J/A 9R$/J.,J7
M*H"#.\DNM(/+8)7VFCYF5*\:0GAZ':AFO;<(=RG(C8 %.R@X,/R&"]5M?*=X
M)FW;O"Q%4I&5<73R($QR6K.E6H_U'9%K"].&1#+;O,8BEU4CR %V2V\6\3^K
MSE6%HD3?OD)N]+'I/BG\HYKOW2K@[J%A/KKTN[P";E@R(<R,@K>+2I9!,$0G
M1#) G]Y80O\#]D47Y17M1,0LL5;RLK*)M6K)*\HDIM9?YS,,:0 .2RK +,UR
M115(#0.AC:_O41J%![+VIEX="\*O@1P:B:-4*0F8RX47H.U(>=+QI_[\8$U5
M6)%99V2ZGG-1E(HQY;DJU>JV#C^+XM:Q4Z@B'E%C^@.8QCF?G?$N\7#]#L#0
MXA6&F1G\B-%O(6@1;(B@6!2+9*_QP\4*S.Y<JV)#N7(JN!^61I\N8-V*R!F$
M!C*T!6M 2K'%"8G">FW#EWB'-FI=5@!X\@3/5PC\$>NY$W175Q0+AYB(A(N8
M&VZ;% ZZMY+!!UWMXA /Z58[%WB7VM^S47U9$8"'+V0<6#">N3H]Y44E*I=!
M/+\!&UJ6&JV7$W7W0N*RD:YME/ R>0/9.$;GN]Q>RF3N\N.I4!BS4)>4U2<U
MC!OW=GFJ32/NFM?9U^AV'25VV#OBD9CX'8%S3='&_6O [X5I>R8#NT!DI)SY
M8Z500Z\^4V.X^]C;*^3\,C96KY=?O=DL"A)I1Y_S94U_%13_AGB"]*I?<XLJ
M/4PP:.0UHI: ^#_6CLL2]#X$D/3J]2LA'*S ^0E$8G5,Z?X8A!"YP2A'?IZL
ME6HQD0N.A3W6T5JYJ5ZWY6NOP<)A3&]:4&$%"(;93 3Y]9(N47.MK?Z+]?;2
MU=WDEJN;E@=Z]YT:RUY[>^;:\JX\;U:\[UG&ENJBR!("7/]\AN_%>ID^#/!5
MV;BN9XM:F&X!484QL1:SE>A8LE@ ;R.-2L 1,<T%K%R@)0V:Q2D8D+2)HE]$
M&OC7;1X5.!EZ@'7A46'34I6$^ H6_0D-[+JUJ,&*)</=&Z;W(!HMS6M9\J),
M=@2'0&$T1$GLPZ9&:F'$?D:JZ>1EM&NWT<@]>#K0)ALGKYN^,<UX[?)-MB#
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MB9BKN7J8"F.[70^WJIH[ [ZTRITKJU)5 '230+MQ2J(74#> I_>8".R@90A
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M&E8+5X)FTJUU%NE< 46OZ8VK$E3N>74?$@6Z@?^S\WJ2X[)S5-^HO$T [$H
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ME]Q0GQ$Q3PC+C8C9JH@IZWI)+1H?4ZR(IK<X]$F7+V/)F$98;$M8A%?3$?R
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M_OK/OW[[%502N"YXR']A%3RO3MFL_>,+&W[#PFVV_..+ZL?R]7QU:A<U35;
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MD6\=$;O:KA/7G43!X[MQ[]Q?PY"TD2Q&LNPE&AK)<AO)4A0!"_(XL<NH3.R
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MSPF9'Y; D%TOL@.'<?B)>7:4)$7A!W'HYN'#],[8DJB/?'_B>(_OPC34>%B
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MQZ ,6=OOS,/R=-.]*BQD8P$/  \&@@?'9]F7F ,> !X '@ >@'\ > !X '@
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M>+S/(L,<M'5">(RH8A9Q93TRP1&$*8VTG%0K]$:&^2$%^WORL>^79B:"C+2
M8GW(,P,# 0,-CX$.4]"7@I0"!4$(XM1R9 EU*%(712*.T<AW*=8_1,Y%ZI$0
MD'(Y=)T^='<_=)W^NSBOQM,&RO,'QN8N6TB<77Y2!%0UTW$=JK5B]$:^_>?[
M+84)>;C'4.<E1V &"@W8>G!E!&P%; 5L?=8*W1M1 ;8^=U4$; 5L?5(*W1M1
M ;8^=U4$; 5L?5(*W1M1 ;8^=U4$; 5L?5(*W1M1 ;8^=U7<,[9"?>7N]96>
M)YF(1UHQC+@.&-F$/8J&:>J8=";BC?I*99-Q@B-K;4 \1HULX!0Y*UV^F>8D
MN=OU-!]FTSR<7Z=-YT640HX8/WR7RT&1&-19 IL!FP&;/34V8X%(GV1$3E"/
MN$\1644IDHQY@UE,E&]4AVZS6V!_;*:4'BFC@,Z SH#.@,Z SIXSG?DDHJ9$
M(BF$S<$9U<AHRA#GQ#(I/2=^HWOQ-IL=]D=GFHD1X0+H['!T=I #"_:Y\:%O
M6QN^+F7IIN/P@,GZQ8[+4025G5>OHH]G+LXJ1D85Q92!6S(LMZ0WTNN_T]%C
MEV);@M_._K^3CI6.F*@T(LH1Q)6*2"?BD*')4^9Q4&GC'&B2HM?88<2TS[X!
M80398#5B-@EMF!5$D(WMC6UWU/>+>3.WDS(A.Q]-(+0<,0-'$PS=%@'TAR:]
M.]S%[2#I/WJB@@,KK=A.V-!C"N 1X!$4#7SBW_.)LT,<=8@2!6$CXBYEGY@)
MCS#FWC,3K.3^MD^<W6')M8O(.Q(0UX0BXU) GF)));>2W''(0.<^,1\9*4;4
M2/"*!VZ- /M#DQYXQ> 5#T]K 1X!'@$>P5_>Q5].C#/'K$0,1X$X3QY9J@5*
MRFE* U6*;I;T&LR8Y!P9'HN/'50IZ56(T*@$\\XG?W?+U-,\XCAK7O]K4<\O
MWD[\>%&FYL-T5@9T/)_/:K>86S>.GZ;OII/RT-ET/,Y?>5OF*#;SCGKH,:%&
MAD,3/6 28!)@DB? )%LSQ^$KGKHD,Q$CHU1SA'6TB#.#D<5*(DD,P43&P 7;
M*(%B)C(N/<J$%Q#W@2!G,<YDIIEFB261Q*')[)[E4P(ZP^X%:Z#R%^@.Z*Y'
M=-<'KN'!>XD)0S1&C[@A%#DM% I244^",PIO%-\(F0,FA16B!!O$15)(LT"1
M-C$HRG/P).FAN>;'9U",")<CQ0RP#(1.P"7 )< E77")I\HGDA*2SI*R=2,A
M;8-!0J:HK<T<$3:X1"=#DI"9<"*GB+M2]ZD\1\XSIB-6F+N[SP;M#Y=P8D:$
M I? 618/FHV54)_2618G8]LTU7%53HHI&SW@4 OP$IZ5.SIL7V"G/1S">LT\
MDC+ITE*'(*<B0RX2C&U@CD=YF_J-T))9C9$S#B,NDT,.Q^(S)$TC]YI;?L\C
MJI9E;'>?4;5-$1L9":-'0AY^$R=8Y/!$!=#_#!5M8*5J4)GV=%41,&]HTANH
MHO7#W7T6;5%H4HHR[E%(7B+NI$5::(6D]E$DKK25&P5NW AE%3=(NV01)\(A
MXU1 "EOA$DXTB;O7:3IQL.^WVD^SITW!R_Y!=AS6]H%Z@'K W095[*DJ N8-
M37H#5;1^N-L'<'Z)88H8PU!J'5F; K+&>N04#2[0(#4S&P6Q+C'&*$%<1(.X
M83&[P22BP'#$,;O3K<-\+^?W;W:\B'?[OCNL&VL]DH:#ZSMPHP3T'YKT!JIH
MX/&"*O9$%0'SAB:]@2I:/SS>9Y%@QLH%&Y-"./F4?6P<D&/1HQ@%#E(9R^6&
MC\V("\9S@G0, 7%)&-(R2J2%$SARHY+2>_:Q[Y=E)LJ,F#[\"1.]P0/(,P,#
M 0,-AH$.D7,),9%H.#):9&SGVB*7G$>::Y8T<=1(>YL/5"IGX7F,B!$4\8@%
M,HR*S <QJ(2%Q?[N8OY'RKED$L!  H>NT^_@J 6HT]_)XM_%>36>-E">/S R
MAZ.@AG,4%*3A=IF!_AU0U'^%[HVH %N?NRH"M@*V/BF%[HVH %N?NRH"M@*V
M/BF%[HVH %N?NRH"M@*V/BF%[HVH %N?NRH"M@*V/BF%[HVH %N?NRKN&5NA
MO'+G<AJML97"$R2L8(@+5TIC@D;4>"Y%,-0EOE%>&4AB/G"$L8Z(:\>0%L&B
M)+!T7I/\WW2[G.;#;)J'\^NTZ;R&DDD\XN;P;2X'Q6)09PET!G0&=/;4Z"Q(
M3Y.F&/GD=:D.E<A(A5&07-E$>9)^HSITF]T"^Z,S,B)&CA@__#G%0&A :$!H
M0&A : <D-&Y+AXD<:U'/;28T;)&E2B,3!#64!*(EZ6*[PSX)30@YTOSP/8N?
M,:$=Y-2"?>Y^Z-O^ANW.*_G%CLMY!)6=5Z^BCV<NSBI&1A7%E(-C,F3'A![1
M B]ANG#C"*[)KJ[) \39#^=D6U>ARW./I A*\$11P*2<O6HBLCPF%((7PGGB
MDU8;YQY%KR1U!B5)LN\@LP/A3#G\*'AMC;+,>+6Q5;)MM/I^,6_F=E(F9.=S
M#NB(:#XR0O?,9[BEAOWS&OIOU[T1%9 ,'*EW0/KI25W(=A/2BT(1 &, 8P#C
MIZ.,X/'O[/%'R:-S7I26L@)Q'CURG"N4>##!<14H=QNG,>3_LT0SY'.T@+A@
M"6D:%3+Y5CB8Z(/=;([2N<>?O7U)1PH?OO$LD R0#) ,>/S@\8/'#V ,8 Q@
M_!3!^.G' C*$$(5U*"49$:=4(>U9]O"C3 %+D]W]C5A "Y$C!VQ+BUV*.'$1
MZ4@E,MI22CFFF(0[&R6>YA''6?/Z7XMZ?O%VXL>+,C4?IK,RH./Y?%:[Q=SF
MV?LT?3>=E(?.IN-Q_LK;,D>QF7?425%P.9*L;Z4&P%O 6\!;P%N]YZVM>>KP
M-79=4B=AAGL<2\4<-HAC%9##*J+$J;9<*A%HW#C7B2C/K27(8J(09\0CJ[5#
M(A OJ>8:.WYHZKQ?P1[/'(H%!@X]$&Q!23JPZP#4%-@5V'6[/5J!!\^Q1 (7
M=DU$YW!31Q2ELT&%I />*&D71";M<O2*R^9D[IE!AC",+&5.62,LM7(8[$JI
M'ID>G*\([ KL"NS:6S4%=@5VW8I=G0Y:6*,0UL$B3D,J:5^%'%6,:*O*$3FW
MV37IE)12 E&7,.*<$J235TAH2[AT-!KLA\&N)+,KQWUK!O+<V?5R]UG^H6C#
MO=!!KNWQX:]XA4+W8[^KY__H@;L0Y2'>]T'[8\U]7KZ]\8MZGI_J'R".3Z>Q
MLMY/S_+@+O*WJ\ETGF]N9_GC#%OY:Y]G=ER=V]F\FJ9J?AJ;6!"JW9MIYS%4
MJ9[8B:_SEYIY_N LW[<YNJ%JH?Y2-.S_Y'_7[__O]C2D;R_HRS2.WU"H9[$%
M@Q=9,(NSR<M0-^=C>_&B_'7#AH]$-L7R0JM-DLL/_F?1S.MTL7ZW]E(4)^'E
M^;2IVWO/XMC.ZR\Q(\"W(MDBG$LP^'9/8B3TH+K0H25H>N<LG5[N05V]23W)
MK)"'-,\Z\,(NYM.7-_^09;S\^-Q^CLO]J,BF_*(O[/BKO6A>_O2GV]-_$]'+
M[%TIQ,;$=CM_C^2T+Y^]1]2Z855^;)NF3%B^?'51^V_^/<Y^NFUTX@Z1[EEX
MNVG^W6YAAZ;PEX\?JM]>G[S_V^O?_C&JWKX[.<KH%ZJ/"]?4H;:S.C8/9(R=
M)=6ZC%>(.DW>-J=I//W:]%6()]=9X>/ER MMG-SED?=FX%FPU9LBV<>>X][X
M0*W_U[I_M["_/<&P!?<5T);AE?OG]RE?1YFDIXO55Y:/(C@[RW]8?S]/\MB>
M-_%%$[,/D75B+9>E7]U>]]-&]X,O=5.[>IP#EQ?K&]S5UV#Y0"F/C&%_N,X*
M:PQL:>%/W[N0' F]S67;7$./#-UJC,_VO7[4%L/\L"W&77:T2Z^,?203S6#[
M8E3;Q.M#$^&>L[%YALJ?_OR3_*D+H>W>*FHM@SV*N6,7\%[S\(]H9]7K[/2&
M&SU<]JK!6W<RZL-T[$_O <[W#>=;9H!^?CNIYJ?319,CGF:K%;BA"?2QP)T"
MN.\3W+=MQ 5(OM?U9$ #0(/#H $#-!B"7^>SJ)('OVZ_]G!2LIIMOKA*L^E9
M-3V/,SLO*WQEV?U+/:]C\P+PO6_XOE,13U=BO+.&9Z .!<@.C!6,=2 *]\1E
MMWT.; >WJ'W=LO _F;\H=6I[KI>^OG!8'G?]\?AEOSRK>\WGNSBOQM.FJ7XF
M_:Y/'S N[Z?0LR>RV_:T@ .4F3^!$O*;%9-=U(N;QSE-1"ILN T*1<$=XEA$
M9+#+_Z%4.:(5MEK#:2+/PO*!9X!G@&> 9_;",XYI'"7#B"?/RH:BA)PE DFK
M!=54:<[91@,-K*,P0:#$M$$\X(BLP!H)[",FP1II[>/QC&9B1(!E]L,R_<GG
MWPY<(4;][E0>A[+[95EN/9]6LYC_Y.MQK";KX#5_6GXN1>35HHFAJB>P) !9
MQKYFRB#+V%/9@;&"PH&Q/J$E ?+(:P+D23A<KV*^R->VC:O*5D%[5AHK_+O]
MH"?Q]).#ZB<=Q3VVF)Y4TN;1DRA!2>-TTL@Y&A"W5B"MDD?&$1]HB%R(U$6R
M_CK.Y)_'L6W>,@G'U^"FH_;<5"G(J S:%@'PAR2[@2K9,P5\H4GR(9B"UJD
M?D F.(82)R(D[EU,&ZV[MLF:/R;@2P: WZ$M;I\YAU#N@*'<R=C69\V- *Z*
MW\[CI(D]@5S@]2')#GA]2+PNL>-&28^4R?$8ET2AS,L,"8T5=8)BHW8*Y,Z:
M\]F+)<1<I_#72X#IB,FYYB.L)+#YH"T08'Y(LANHDCU3F%=1E)Q<1,1AB[C/
M:&V)=$CG($A[E6A(<I?P[7%@7LD1-Q1@_J!!&ZR_]2!H^V#KD%\ _3._1-NE
MN#0LAQTZP.7 Y4^?RVW*;!XE8C$':MQKET,VKI",E$9G=;+&=[)1)F/,V\G_
MEQ&FXX-PJ=(CC0]_B!]8W[ $!1#_[)3LF4*\$4809S.Z:Y+_$WA VNN F(\D
M!(9U*&>==[!'96\03_B(:8!X6%][]J':V[-S6\_*WI1R$D".U>SD<UTZS=NF
MB?.F)T +;#XDV0&;#XG-8TA),^=1$$XBCBU'SFF*&%,T:"D8E;:+@.T*:=ZG
MMY<X<]S"S)LZTWH<UU]BZ(CBE: C::!F<M@F";@_)-D-5,F>*>[[J"-72J'D
M=:FMR/]QGDDD,^;''*O%(&,74=Q><3_5WV) _XZS:5$J30E]"9 /"W#//:H[
M'H^G7^W$QV(LE9_%4"\[#42(Z(#9@=F?-K,;823C.3J3+*@<T3&:F5TP1*SA
MS&'MA,$[5TU>0LR;Z>RD!9A?6WP!'@?; X ?FNP&JF3/%.")H4Y1IA!V%",N
M"$,ZN%!07@:*%:%XI^UN>P#XC02=&&$HLH 5.(C53D[MY',L'=^2K6?5%SM>
MQ+(6]]7.9G:2P[;:+@];[@GF K$/279 [-!M]ON.A TYR'.V.!)"(.X\038)
MCCC'3AN"1:0;&R^V6?M[DY'M;P78KEIAOD]_7P)<]XW.F1IA PUH[U3B^VL,
M%.L#WP#? -]TVJ>%L)"2UR@0G[E#,9[YAF-DO5':4ZM#V,A,;K/F^*A\PT=*
M ]OLA6U@^?%)A;0ASNHO=EY_@65(<"[ N7CB66H6F)18Y9!2)5..S))(*Z.0
MELHP23CF;J/ Z.'-6UJH>3NY9/SWZ=45RG24JR:2 +\/V@0!YX<DNX$JV3/%
M^:25EU1GI*;<9YQO(3YA%$(@U$J1L7MC \'#N[<\"LYKP'E8D7SVX=O_:\OQ
M4_G>V81N[@J$L WH'.C\:=.Y458P'S@2-A8Z=Q@9D7_E!B>N7$BDFS7!@C*E
MHNC]Y%7=G$^;NHQA<XL(U)."-0+D#TUV U6R?D#^DU\&)#@F&3) \Q0=XD(8
MI#'QR DA4LK_4\)TL0RX5XJY8QU0& ,L ^N $$BN)O/CJ9W%RMERHK&?GI5N
MNW $'[@4X%(\_2B2*H6](A%)S7&.""U#COF$E$X^*N,PD[R+*+*%F%\*PIQ<
M Q@(&L'X .&')KN!*MDS17BM# [".J2P)HA;3I&3C""G,O;KH (-&PB_31#7
M)<)OQ&R:P1Y$6/%[]H':7^SLGWF(*(_AGW%>?5XM %YN/:S.[84M74'K\ORI
M_V=/H!?X?4BR WZ'I/#W_0GE";=.<:1BC(CKR)!6U" JI C8^.B8V+E<M #=
MI^E?6I@KV>'WDU_7&/=A"7%O)Q\+P'75Y8##SA#8APA< UP#7-,CKK&<86JH
M1U)3AKBA&#F""<(<"YJ,#][O?N#@8W,-'W$&]:NP_@AA[>4YA+-IBDV3S<".
MJQ3SN)HXGX]C:./8DE>"@E9P+L"Y>-J):L6E3])A)'PYLXHECIQW'$GL/$G,
M$$QW;X=Z'6K>9*3YN 2:S/ MS'1U<-4(*SAA>-A6"% _)-D-5,F>+=0SITA&
M>:I*82E-!#EA%2+8)2-\#N["[EL1'POJ%>0.86T2@KAWTPGRMCFMQM$VL8K?
M2@U [ G. ID/279 YD,B<ZVL(4YZ1%1I24HE1L8(C*@,(=#DA+*=E)"^/X\S
M.\^#_+4 S&_EW=^GOS;+S2''9],\=?]N:XY>+Z&G(X*70.Z#MDJ _B');J!*
M]DRAG\<8O9 .28DEXD)JY'BT* IIF:,$2[%1"[)-;>F!H!]2>(>-Z]:+<W>I
M;J?!'L1U]VD2.EU;X>K0^<I.PF7M:1V;%]M8Q]!,8<_DGJ>N_.G//]&?]B:T
M^Y)55V*\DZL.YB2![ XE.S!64#@PUNYD=_!$.<6/FRAOGS=XA^K8^SPGV7V:
M11_K+Z7 L"=1[),#: C*(%7R3$NG,=744RL0]=P@SIU%QAN"*"5$><9"9!M+
M[-MDY=]._*PD95[%Y;]O)VM\^^T2WCI*QR@-^1C8HP-$ T0S(*)Y_-HJ*XST
M&?@5T1QQY31R06"48N3)FT!2W.G0Z?T __V.\!(<4O+]2,E#!'G0_3+QW-9A
M76.U3,1/YZ=QMLK,]P2!@>:')#N@^2'1?,(T>!XEXCF60UP+AES4#)EH??(B
M>*SV%-^MT.=53'$VBV&UY'X\">\+ CVT5>_]B%^-*)SM-7!#!388DNP&JF3/
ME U$H)))X1%)+ =](6*DC1)(6AY<$M1PO-.&FGZQ =$C RW<G]:F&X@$MUI+
M3*D>UW8>KRTF5C\3R/,"Y0/EPX)BI^>-)>F3X09I%DHO)BF1M4PC(X-R-CL@
MFKN=VS-<\R]6.>4UP'6_G$@4>!"PG @T S0S()IY_#H2X@3FE**HE4)<8HP,
M<0IAR2)A/O$<7N[<JJ%CV+]G%#FB#"I*8#D1@LC+('+=/AXB2*!VH/:G3NTV
M8),44TC0$M'IS-46&XHR7ROCK?'<[=[)_0?4ONJNVSVO:R@3&KA% NP/278#
M5;)G"OO$6,6P\BB:C-Z<48T<Q08%K5AB0FG&-A)Y749T#X9]./NQSR$<K /V
M(81;[RE<17"C<H[S6=UVO[R,ZDJ5J/5^MH@WVC;T!(V!\H<D.Z#\(5&^%(EZ
MQBP2P@7$N>%(:ZD0\U)BIPFS-G49Z=W:$+)B_)-+2%I]<#P)QTL\^O4*CKI:
MW<,C@N'0T&&;*W#"D&0W4"5[IIR@"771B82\HQ)QI1VR 2>DO;2:2JXCW^"$
M7<+ /G "&PG"@!-@R>^YQXMO"\[%9EZMK*XG4 Q\/R39 =\/B>^E=$8+1Y!+
MQ".NO4.N;!%QQF>NC]@KWDF;]DW*7X/-"FO>Q7E7?,[)B$@HXQRV/0+H#TEV
M U6R9PKZ1!"N!5<YJE,Y8$N:(!TI1CX13361A&&_GWV!>P-]Q4=*0'W'TUKT
M>^03MVC?.[-_70K?3<?A(4=PQ7G5'L&U:)9G)U_KV)ZMY LL]^V?]5VV@#A;
M"2^K6=5,QW6HUE/>,0JMGK;^Y </? HXU9V<'Z[$6TJZ'W['UK!SV-V*VZ'@
MW9Z0HS$'K=GU,=KS',K:A)S&'%G&A'542:UV6@)=>T(9@T\R!'^83;_4(89?
M+O[:E#-'+T^P.;X$XL[K7N6(T"V:Y'S/DI:)6LP>$;,V'MF_C9';Z21LIP#6
M!=8%UGUNK"L)U<)8C73I2,N=LLBD() +DGK%##4Q=)%_.!SK<CS"=(LU96#=
M0[%N/\^A8W><0Y>_NG.J@SW-5$<%QU?MS.EP?!4<7_5490?&"@H'QMJ'L^:Z
M=IJ&A@O[]8-*U%.E\?1K4Z79]*RJ)U]B<VO%!\[E!?CM 80 _/94=F"LH'!@
MK(?TE3K>$_'(U31]SS#=[TREQ<R?VG*8TC15Y[-2.3._:+?,QW\MZO.S_"U8
MPX-ZV<,OP3VG>MDGWU1;$2.($AP1ET@YRHDA(QU!PAM9ULV,Q*:+JI0/]J(@
M6/-I>NPSG,WBAQ7"?1C;R?QX$EZO0:ZC*EU!!93H?G<Y"VI&@&^ ;X!O'IUO
MF,')1TF05K345GB&K)$)>2("L=R8N,DWV]1C/#K?D)&"II_[89R#[PZ!<';'
M<+:>S.WD<]WV@(/S@<&S ,\"/(O.FXE'J;&+&)DH0XYD-4%&,(4<(SDZ=2(D
M3_82R;Z]!+>''C;Y0X>"CBBTCX,0%H@&B :(ID]$(RAV5&=F"<PEQ!4MO4PS
M?6 2@^?"2$_U7D+8/1&- IKI2]P*R["'CUMG4Q]C6%6S-=F>(( %OP+\BH/[
M%8_.\]AXPJ6.R"B%$4^4(5..H!2<"1X"=5[:3@+*%>*\R8#S,>/-^]0-T<-)
M)4_-$ 'MAR2[@2K9,T5[$JF4@1$D*5$YJF/M,<,4$4&))DDR$3?2AUM%=7M"
M^[O.G\ 0V75JC =?B(0V==VVJ?MYU:?NCZ7@MFW<4+F+.[<P]02<GZH' .US
MH'U.[WP0:)_SWR)ZDGQ,B :18V!F M(J>*2$,XX(1RCKI#SX.^USWJZ1>'_M
M<^A(;5,I#-USH&<=D"Z0+I!N+P+_+CG/L$AHU!8%$3)_29J0+75%U!(CA?*!
M\DY*E/?!>3]>Z!T)H8'J^@85_6P'Q_%^VL'QOA]?!NW@H&O"8'?^0]>$GLH.
MC!44#HP5VL$='A<>MQU<JB=VXFMH!P?PVS<( ?CMJ>S 6$'AP%BA'1SL0[C<
MAQ"BFU_Y4K N!N6HAU_6@G+4/9:C1LP-2UHCID) 7)B$C(X8,1>4#9HIFD37
MFP_>-LTB TQ\GUYEN.EJ&SL;"2A#';@1 M(/278#5;)GBO1,>.^MT,CS#-V<
M)X:<8A1%YC*$*^>#85UO/-@+TC,#&PX.7AH G<\.'KF]BBG.9C%<RWW[:0-;
MQH'+@<N?.)<[+:16.>[2/CG$DW'().,1(9EYI?5$^+A+U';6G,\N^\(4\EXB
MS9LUT)P4G('=XF"# /1#D]U E:P?0/_D>XZY1'B*)B"B!$%<J(0TEAPI'ZU*
M1LJ(=PH2]T@LFQE! 4'B][=*0;^QYQ8MNGE5K_(Q$"B"_P#^PS,(%(655(1D
M$<;<(JX#199YEP-%RKT+%IN(NVQ6O4STKM.^$":"!0+,#U)V U6R?L#\DP\3
MF79<&\H0TSB5,Q 2LE$3E+0+%">O.79=MJ;NC%;N:$J]Q4[EIVGRAPX284GQ
MX$'BVMZJ;.FS.+;S&*IS6\X''D_S(W\FT"H%G EP)L"9Z-*9, S;*'-X*B,K
M_:^S1^$BY\CGP#413A,V.Y6@WLPY3WY;XMJ' FN_9E3KJBI)PZF,>W$D@%R
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MJIH\]?FGWZV[YAS.E7LZFZR>!"EVB@[%XBH[KUS,0RA?+[NE+J*=]80.P.>
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ME?L/B?&ZPWA(XO4M;(,%OH.';1_LQ3HZ.Y]-4VR:; 9V7*68AP@+?,#WP/?
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MMOIY-8!?3XX_K!_\Q]:K69R=M4Y-NX ^BU_JZ:+)M[>3R70Q\?D/;I&'7+:
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M^!(4UWK)<92'YG&#\%^UG["$T;27?&6T$WQLJHRM(;"2A%,PW]7%=GR#"#%
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M$-;=0L-8D4*?[9J!8S-4-?CE??U/B,JLMBUYKQ(IE9=8830/VRFE*<#30Z<
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MY9N7OWRX>&1*Y4A*#I_I]/Q6M_SRU $U@M2OO#>@CS%*!VT>3KN97I@ [L%
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MU(XVT'XJ981S5/&WQ!C+O6VGJNU2_P[6_75J[S+.RBQ7$4L*<,UB/PB9"(*
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MKYPGN**+W#=2@R4<Y3#G3RF2608GR9BN\]U/&4']4/F.*.4XBPRY-"R5EU0
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MQ_7(>Q$IY=#[S]^ZD#SV=>6AO.A]KQ-[?>#__?-LNI5EVK1,%E9KW.^?IB!
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M%.$80C)/D.1.(&X"03HHCI05AN)@P"1U>D;N$YGUSDYQ_6A3=P8[-9PK/76
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MH7/R?Y_)6>M)I2NYI&OUG=C0=^4-^@X?7W_HWP=F*.#Z$;Q4K]XIB5*?7N@
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MS-9^O>5) *'WAUI^&-3'KO<RY<O7]FZQ2V?+TJ5V)=5X!-('[I>9MH"FFW\
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M'NV\GWXRX^H_N:'=C+*^.!G[K$#F%Z^_7H1Q'7:53I2:#-:TER(WZ.N^TND
MF.=[U==&:UE*C:PU$/7P8)%50J R"-#DVE/L.P-E'Q[U/*:^5B4?]/5P^'-H
MT<_'J1G7K:@. =!@4 >#>A@&59?1BE)P)$0H$:=<( WQ#2)@&,'2*N5*N_L
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MO=+F?>+@CF7IT\MM&)1<62!?;HM7TD^C"82/ZT)U&<STP1;H&JXV-! M0T#
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MZ=5R.LM$_"0JK7Z.5P1ZZE16N"#)D -0/BQWE<TK09A2!FTB'#"@*^(*,*E
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M=74&^[1XS'R"3EDW:>CR+XN5R_CD"RWQ$^4]R#(03%,015WM0[-/F[I9)3=
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M]TF<O(8K.0"O0>;2%U[6I&)%380O<8R,!/_!P@9RSTTA1G5&GM7,R@I<"UV
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ML8GRCU2T-:0ZY<-96YDQSH?#04U:*@I5T*MX>,#]F!;?'7'L!-*_T#*91N&
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MBOUM389_>A5_-L_>J)LLKT(1%]N4KRC[7K[*NCA^:HB.XN/GGU]V@OKEJU9
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M7:_:!-DF'WR)D(M)+(7:[:7$ZN]-A*Z 4.^KT8#BA6"QPP06%?,4<$T"JN"
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M)5P@NDBU%2GG)CU(ENK]"4R9B1$=Q&7_Q.6:+0N_: #$?_^7*S\F=JPK.&.
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M+0)C5*N#6W.'%I)9GHZX>LA)M=\L"Q@B94=IC/4$?H/@&03/#05/SH0O>.K
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M5.KW+]Z>#MRC YK3*G&U  /$@E=]+*>+:GQ5$[WQ$Q_*B)QPQT<_JZ*OJ::
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M:N#GV'*S;BV-(<&;M*,5S!Y0)3L(K[N?Z)'GCZ5( S=*QW Z$SR8D0S<?C@
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MLU('W_;AK.%.-MD'!?O"FYE<HBO3@+"M91-L*+<V /,FV*O[_+5K4.8X5Q,
M352I0#V%N_"0(><_R$51$FC]&SA<CN^Y?^=J;5P[K]P*LB5%3%G:[((ELX%:
M _#0=<$>>8W&:>()OULRU8A&"N*NN83IKY?%<D8Q^^6,@$,588I+BF4\<*7#
M,/9\/THGKC<83-Q0^"-W',?802D8B,@?BS!(=^6$]/N._ZR_N[4.QE=:8WA)
MZ5?(WW:Q?\OU;Y\A'834=E83\*(@3T6 &72FV_V=&81UK@ )EKGFQZ3%C#W.
MP"F5+-'A!&K*3HD&JM<<0R+2FN;PN,@E]JDPL?[52?;,VY+R/AI1 ;/$_ \X
MG<Z\('D%&[3["D)_$@91* >NAYC(X7""S1*%</MQ*L5P,@@3SU_+Y9\,4P\+
MPE(QC#$O%12$?C!Q$\^3P_XD&,23=LSA2]J!^D$3^9B;%BF<%3M@P<Q$O'33
M<,27&T)-=ENE,*=LZZE:#:@1MN87[A.N#T DFBOGHB"PFY*L7!/-_G!T9B,+
M42XM4*.I8K14'7LV9+6IA",EVHUIMWJ<N+[28.NM?I-P4NG.4U-$JI3%;%\2
M>Z-0#).1/W%];S+&RV8,ARN9N*D_2OK^9#1(_?'JX>K[H2_3R= =>V,?V[F#
MXCT<C]U8Q-C!,0V2.+[5X?HGD>[^ZZP&N^V7:BXGQ']K'9Y345+RV4;H+FX
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M!24V5AJ]+Y8)\/F64.*WU6>_!97NZ-=X?2%F2Y.5U\B';>3\>K'Q>$"M?L<
M5T87KY,TE(MMRBT,Y5:133XL0;_Q^\+U!T_D4WK8'R3J7TTRH\XQ :%>-V".
M8!8#01364UYQ=0]B_N6<28#[:>-!82R/9\@F\Y)NDY)J6W1-"=K,,*4MGR:
MJ1C5UZ3'JZHJ+KJ9PYY1@(AQ)'%(_$?E8#4]XS.J&-#9ZR.3RE7"\IE$.&/=
M"51W8GS0=8@X7LXQ5U/-&<%3ESG(?X6M6BQ+V-@<=&6.G68Y]H&D(#;\<C3-
M9(KIURKCX21-#;PM_];<M^HW*A@2,TI# VZ;75'R1T7AR%*>BY(&-^ML>.G
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MI@DM_7;R\HQ299 M5#4C[!V2]-PY+XO+>MK$E Y4?>/C+?JZ<^+;YHJO'2]
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MD='B:3K"J981J%MJ&AA\F!4BT<D)TZ):D%RO,;Z1@(0 ;?/;967NN\?@FG8
MG7C?3X?!RI:ROX"E^;%Q%EB'EZ4R1OMA9A>80#'CE+2CJ8"S*?(>G'F5$\/]
M7[?D;V*F)5 ?S-NR!N7HCV7&#CS3,!;_^^U;CK.#TGID(CI GGB* N0#"*98
MS#&_8+&,0#;B5$J1F!"?2E!HK4Z%_BG]] OSHVR?9V\PF_"= ,.S3,0,)*O
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M*QY*02!6H,<93:^!*6;7N_/F\,U3UD(;1Z$7X"??R*C4WKA1*R-:'G$6.X>
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MK5JRDGE&R'L;4M%$;:>A;3Z@#$VNTAI74OUL0T]YAG#:%'@@XT/Y>[1$J+9
M;>[8)6!-Y_ZCP7OIL?DXA1<JYW?DK\M/8#=VU_O^>VS.*!W#%%.!J%/;K/;8
M]N!>FSF"N?-/5HL+GFJIKXL,FA)&6[JTS U)Z?V(=8D9: CG"TH&UE>C80**
M/!G27"TEL"X:[B2858[>',9=YFJ7P@K$]!!;%161^,K83U3"LYBA 8=01/0+
MV-E3:4$HS5OEE_$*C-$'S*;"H4CK;5)<6/QK^EDUFHT;0BCSB%2*H\;HPXOU
M^/6K]X?_LK.@+$<#IRS9F46CGBJ]H[HZUM-76L71)/EJA0TJ)97AT<B'H&',
MR"F PYK$13]HE8T+I2[I)2%LK*JG(*9#^TC78&K8*75+:Q"JU>PE<@]HKD.7
MQ.&R+MZKS:*5"T3NH%MKW9H],K?>JU58VV,P\A%KOD4FMK/_F0G8PF;XIN1H
MY0LT4).AI&UK/32G<KU$2PN4323]:U2/,'*L]K.IGMVVBM[J'BFCOKT]I@QN
M,B:/1'M.;3[;!A6R^;22 H@)1EDK"JM^:9N\Z-3-SK%R:PIW3X.;T)2N?2RE
MH,12I7XN*Q.EH5I?I3@T26#J.S2W]C(P-II=*)/]-Q FE?.JH)B12@@LZ^FE
M:E-A39--\*'!JCT\>'F ?SPUZ [:Y-]BU^M%JI&ZTI[':+MJ)ON2\6JLT2:9
M6&&IV'KPJBFJ1_\ROK6R#DF%;GQ:YJO2%B?;;6;V+=?H.:W$#*.=AS8@7Z*U
M[[;POG4QD8F0TC/*DFA\Q]P+ _W)C/=2-!FXVTIQL"F4*6U9^88NPK<IR*DA
MBCQ/FU"LZ@6A(PSZ D17<$%I&K;4ZW"FNTS,W<K$''>9F%TF9I>)^0-D8GYW
MU\V' D-QQW)6_]ENO-MIMOOIMD&-3FVG:4S"&,F@=[UZ=^B<9@OLB_GNU$3D
M1RJU9):0*HJ-LS!1HGKN_(VKPXX*U^"Y/ D\?V!\*0@'H_ _&S.3$*K5XZ\Q
M?:)>5B]T(D6U-EJ_/=H+A6W54R5;!N.*JHGP!7_;"VJZ*E8 *QNO/FE]N\<U
MCA8TC#%"KYW5=6\!*5?>0LJL4[%G.2JT#7RJN\BLCN,/GEI.E_\6''1M;67O
M^FT_$E,PPYR_P94,*C ;8Q\DGNE9PPC^9#12R0TC57 X51U05]Q=FQ9O1>_-
MQ#'W!19MA\_A'8,^#I3YE37ZEB^H-0CZ9YB]5I\)6Q\Z:!%@F\?CD,V>JP8E
M50?8$>20(^54XHAKY5<89+T):3M/T-F#FT+>ON#%*?=U4UO=@F#]6*(3"$TY
M@_]EN1:L3SZQB]Y\?^/(Z]Y"-<.&D]K+ZZEF3<4"K;L>Y=A?-4D-^M-VX:#Z
ML.U$#)Z:OE);9[#1D?2\A4=#LT3:*6^RK]UF"%WS=!6[9M/#3>TT/O^KN)J+
M3P1FW@:G.Z !GEB.47Y=U5_2RS';T(1&F269*%4COO=P/L :/=3=8K7C\HE%
M$#49Y1VEX3X:-CG,$N>LB,F8?V(7I)(3M:$TR<Q?<0I'<H;9?_#NWSAOD*LK
MK0^R0]1>#[YLLM*XOS$%QH6]F;YGUP:';!M_)';)\CGV<=)U";93LO7A=AWI
MT_81,\%+XY;;4&,Q+?)"P8^:IJV"$L-G5TWW5B## N23R/% +[!@&1_!(Z).
M.'9Q;*#YVO/8[A54A:&9PB8E'^&&8ZC. ?>65D%\=A+2*UI ''&G*LJS;#%7
M6_2B=%:!\LWNU6L8-\38ATI$P&9@H,VVH<!T,(3J\14HE0T2B-X0!-E#YQ!E
MG5&,F,')J.:D22:TL9%47T\5->9_N*1!(\2@SK R?I28DI:TF^JK"?*/*,,E
M"NP%3 28HQ0 Q6VID_;34AA\P@8[DH#^KA3TU:V^V.ZNP<$4V-WBDJ 3MX%E
MD5]I.R@FRAV:E#HPMY[5(0Q;@+1F/SHV1B9>!!5HEM%.Z)X,]!5+&M[R.Z^!
M?C6P^.;PVT:LK]M3IT$ZVPHJ1N&Q\DIBW02BQ3EGRX@W XG8B,K^;>GX]I6F
M8H47CU[0ZWR68<Y0 X]A7);P WE914P=Q74>=*EPD\L:") 5#:H9W.RG?S.W
MP[N#T[5#<-M)_WTFJ5*NK*8]SOG0&I9*(N4P%N;0<!?"!>(B$+!'EH*9PQ$,
MW!(\^<OE?%N]#C./OKUN.\VCJ\_8QK#)!"0_M<[!-TA1*I?J3]6I!&VAV*[E
M@S%@HCD[48U0Z35P(T4-,^2 7M-==^AQRA4[ZRAIGP!;L.FNE02OA,)MET:Z
MTA'J.@+Q( X5<C5JSW@OG!XYR;/HF7@&-_UG6%==T-5+FV4RNCA0L+Y^[*^-
M39 7:,#HY79AI$<81M+LMCF,=&Y!P-D1) UJHQ*P5J-'>M"[QV=,]VD*GZBB
MEP(+1LZG+D@[[ /=TT#[RIK'V)3+3EQ,N*@UCOP*<%F#<@:<3MF07#U+U7IM
M\-E6XL6!\XJ;LN)X0,,E(J4T-BV:G:">_Q=6A>L1K>J_=L(C* C93.5F]PPT
MK28:VZ_J9!+B#2@88 M3F0ZCPK7#5JJ+E 9Z4N4.<V-M<GX)S@"((N)/WS!E
M;9.O]BZ.QML>@#NV7%D#;JWN*\GM&RW >?Q;>R,ZV$V?=TGF.BZHER;CUMWQ
M!D3M3/'U/CV[1-D#I25W!V!C,\YOU>OJ1I/K#L&C.03['DP\!/41]A4LQ-.9
MJ+ QTK[VK?U6Y%E!S%M-S]WLK3*QH C^/D<E>BUE%-$M5CYBL!A7FZXR5**%
MK&.@$A&$QD07U-@'*V.K,G[]U(K?07> HOIR]EM6A..G8U2.\FMBAR_C60)M
M/J]$K*KWD8#TM,;'7NE#:YL55%FN%[(Z55!&L:\)3P ?*^54X6%;0T:@U*-U
MD).1Q47RK0Y9Z,=P$/?:E'"U>YI95=UF15E5+66U!4.TU<&G89+++?G:S998
M2<$PZE&17V07@L&4SK0#%3TS5I6:<>':5+,KU/N>U\.@PP)^03NQ9WOA^_B#
MVCDV!\?P%\8(S=@E99[58(P4>( UL7N&S"=5AM_:')4Z3GCZ,]6_3+4ZRZJM
MKIN>AHM53]BKLD"YK?Z]"A4&%RPN]:ZE6%K52KFT_.Y5;TNA/KLC"EVCUMM8
M<]6SFR);SW),CQV-/:#V%:9CTA^MFB[#^*NLC.&4;6CNVG0U!P1YU26$5U&6
MV')AOM+_S3 C45WQT=H&;9%15)EP=/36E/I2)$M%D*NFCS*APS.]:RGFK6W8
M5$31'*B5 ZXWLG$A8(F><B&LDBE/,.E6IS5P=Q;5FL--BME,E"M;W>RAP9?G
M?6D!WJ-CXYS!W/78S;XU)X0JXY$XL']%53NY:0_=FJ;QS\!P1,J,VXU@\BZ5
M^S/NL^HI<T647&07!;J?:=]4*,>$27IVKT;ESY$FD7^SH%"RA7\RD,6\FZOL
M9P&RMF)NY'UY>:BZ;/G;4^KA*NU9+-*.)!+.*XQBWFYB=#I\O>D\8'./HM2Q
M!3H\6;2LU8!UQGVJ_@[3K3,"/Y,]%>(WWJQWN#!DJ2.%ZT)]=QE[X^]9HGQU
M5+F YXT3B<_J Z!"(KL\XBZ/>+?RB"=='G&71]SE$7=YQ-\@CQAQ.9*"2SX[
MJW\K92R#O]6B ,$NK.:FZT8_!K74$%8P6]ND6=X"SO=5TN1*O2K^H""R=#Z<
M2M>Q)]<X"FB"I.& A71 :!Q<X2DP]V2@&J58[Z,:1GG$%H@$+/3D1-E*1V].
M-*H$J<RFQY1)06LW(-G8P/*E3#$I0"?"MJQG:RZ7:U^FE$ST+-28;);%SFEQ
M"2MZ@Z9^XYGLF4PDG1YXM>U-DV<";QRLT@$KN;$:U>H2VH9&LG!.R- EG1<>
MLOY^G?Z\/U@9WUTXH?\^SJJ8#J&HW'_^O[\$P>!%]<=2_MF)JIO1:3VIVHBP
M!EWP1B(,!Q8\YF9)9F7.!OT5)$<%ELUV;:6/]?K'>AN^UDBWCXV#L<F:/M.N
ML6.=QO#*H!+7SLM7)\X_S@XI7YX[E6#RW:9%-9]Y)0F]6XUO1B-K\O3X;W81
MAJ]@$3&?3QAY5#Y3& &Z%%]N?-D;\,O8U_K-"JCCX'I*,$(%?^49R7DM?S3J
MQ.LR!VG/4O3?\ ,F)YYN6K>QW[7D6\'3,^/&5]L$V_NB!LG^BMJ&LTA4T'Q&
MB#99O;>$Y]MCF?DP9YU[4WV0"@$,&X1WLM#&-$+G%'K(\D(UW75*FUA.).M+
MRFCGG-!B6=HIA>4ZBNJ>@H _"'G?<O8_R7&J@^"2#%-N$TM)JE7'D@W-E+O;
M:."^:E78<W(%SHL\J+&.K1@)0GSF4F$(6W\OFJ?7F;4IV; K-9#9V3._,)ND
MJQ"R%L">_R3=A*['[;F+)1@)D3103A1JRQU)^' VX(R(."<;ILH^=R7.<1YZ
M)3T';*@*WJ%U"M73C(*CTDZ.W'0F376AJBOH3JCFMB;,^#<3S$)=##2]Q4SJ
M<$%"?/>:$&N[L]I0[P1.(J>W9%0IH< =,6V70LN;0H5H#]O4-7$DBIQR*BXB
MGF&_%E+#24&KIWSLZ1LD3_&9(B>L9?REU0'#$3$"I3< G/@$Y@$#P12F9JOG
ML,8BYCXULRPF)^-,7%9VK)M#9X59LTB*!5>5;."AORT)GQPQ1*TA8=*M&[2W
M2201D/]\,2NNI$[4Y7BL*FFBHUPN-0%M@%/4+JEG(6*^QL7"W-E?FB,:'1<B
MF[%W-5?$UN]<R@@T3 KC3^MZ43U_]@S$I:P(6&9> 9.Q57)  &/*MZ&2M5X5
M\9)"L=I',14EYEFKO"/J]ZR:!5EO;9JO?J,6$?>KMY&!U)SU3*LIYC_G18WR
M-Y%P!:/4-BLB -)2IJ#]F.8G")N5YTL0TQ\DAM@.T!#@H-U< "$CNKMQ S#P
M'T\I]UL0.]<$><34;E>K;J9VA'R=<PC>N2SQU"!0+1@8%3+V\Y:IMY[WTO<'
MGG/VN],? S,<7LA\*7O.V1+7[?N>U].A1YV<T._[X; 3^D9L;<_(ZX0ZV02-
M9%3E>9@XLJ)$D-6@LS BTET:'&$3]=4OO62HNX^F4"2S(?M0O!54[,D-['-5
MB[^W]4,/MC%,//(^#X%(U--  W$KL:;E"5:YXD6I)9;0SZ.L'#I%'(N*+HVD
MT;A1TW88Y]D42??]'KIL0KJ?\3_@TL+2:J6.6KB;EA:*M30T#%P9<).#6!L-
M?M',4%-.1[[4< MF'>JR4M<K52EK&(.X 4\$(0S7]=2A3"BK#7,GX58DG &N
MZ.2;19O395DM58L1Y+9#!6RN$4.JFA2$EU>H_]GZ'FH!^&LTRZHI=XHIN733
M,&?5DG?.M+A$O !00"H@! [+?D_0 R1"K[-!>,6X] V'4SD6IEXN* !C#]G3
MY7;X.VH+E!]7XV%LD-5AXIW@7!&<I/@K8$5KKYK=;6XCW:P$(1+:T,8]YZA5
ME7>VC.)54-?U5VS0>NOO.LGJ/=OS.D*V47>TP)5?H^QM()GU6DK265>J,46U
MREJH"I-%4A:@N.I<9A4*;=A<Z:)\8?/MG''I8;*LJ1Z:+0_5NB93U9$\K:HU
M,<K/K%1Y??6\X\LV7Z[FJ6\TF<\M8](TD&,SRKB0B.WBAKU:O1+B-MOE;9;;
M^,TUQE[7FGEO;;-Q4^:],LEZ.V4Z:B66[43=$TZ)8Z79M$V]GK-<%,9*8RB
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MG.3.X0(>=/R 1@UI"2\+42;8'^^5[H4*8];<#*^460X;7$OSO:;%JEY:719
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MU*[ /<KC.'0!_,%5&0LR7'[X[,^SM.L#I(V1[7!S_'%U44JXN\_O<)L*D&H
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M,GNI29 +I%]._<S,PDO27V8.O9(AH:M6.NRS(25B-STW2L1>#_:9+V, 90D
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M"-6+HWIQ>M6+:U*].*H71_7B"JX7E]?Q=J6V,1U?<*I_X7V2VE<W[.R/UZM
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M12[/VO-^M.0T]5H,8Y4<;U5G!!0AMK5JP?V#@ 9!-DTH:50I^73EHB&S<I&
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M;@8#;KUY;-N!7Y+LD3O!KD?#81 6DU),9\D$]W2C(<&]@E3B?HIZ@GN'OE#
MVRV">P3W-@/WMM[[]E,0WO/0>217Y#E +ZD"0]DB!/!THR$!O(*4X'X*=P)X
MA[Y06 .3>NP2PEL5X=E5JVZ8)K;WL,TC?VPB4S;-VH-A?XULC@#OA[C]^5\?
MM@SS9(^/<W?@(J@[=WG'];"(2X;W\.<OPVY R(V0FQ8T).16E';;3ZE-T.W0
M%PJ9FYI\$'1;%;JU+,.LF:91-VW3/')J5LVHUAQTS&V]A%\;()D#0 T]:E<B
MBJ4K[M&Z?H3;"I HU$V7ZK/H0TDJP_=BDEWPK+ 5(3=]ETEV'R3D1LBM<.2V
M]0)\-_P!@%I7N'<<^^<2/B-\IA<-"9]1_3S"9[1,3^$SZI!!^&S3AZ)_VR92
M2VL<$T2CHT^]:$A'GT7IL/V4S73T>>@+A<Q-;2P(H!7O0-MZ:>./@Z$7C&5(
M6BX90>H+X3#7CP/&(XQ6D[:D2DLP9[,2?@OZ/ONUPJY&[G?YPSD,JB]X&+.S
M,_9KX.&R15-M:U\XX>=/B(J;D.M/#QJ2ZX_*)Y/KCY:)D"4AR]='EELOG%P(
MLOP4<O\;.ZVP?XQ$Q!U.Z'(?]#FA2T*7^E"2:B@3NMS/94)T27W9"%T6CRZW
M7CWY8]0-@_L7(,NLE H?!/XMN[B^Q,#! %9P7&)G?K=28KVC;T><_?A#TS2K
M)Q.0V>[^.7(C5^:!G ;A,!D\@,^2O-8X>021EJ:<HR4<&-9P"070)((AJ\)_
M,%;\]D(,.B*,Y#!/8:I &+C"8]=QT/W&;@ +1ST1LA_Y8'@"'[%23%(,ID*X
ME'"I%C0D7$IUG0F7TC(]A4NI9QSATC5QJ5FU6\WFD6-9MMU$7-IJ&=O&I?.X
M4ODUOPQ\MS.*\!NX$#'?I<=]@FT$V_2@H6599;->MQH43[HN*5NMBK&?0GMC
M)/MMY %P:Q)PTWR=$+A13S8";L4[%+=>F_D\Z'XK_SZD_!2"9IK1D#QJ5%F9
M/&JT3$\!,VJ41L"L>& &G+5M9"9N\0Q4A'=N5T2K'/FFT82/'=.><W8NQ@Q>
M.YW.<EEI5TK,.>H<\:E#8[CAGGURPX%\ _Z2?D%./4*.>M"0D"-5=B;H2,OT
M)&M3TS6"CDN@H_OP?T[0_;FX*C2?MUJ%QG4$X+P8],430%(>21B&%%_&'))\
M).-Y>;C@;/)*94GV"N%&PHV$&_>"DK)IPGXJ#<*-A[U,P-HFM7(CW/A:N/'+
M-G'C'V[(;P5; A]5[]['<*-*.IE.!9G-;2ZM!")G,"0Y'PE$ZD%# I&%]F_8
M3PU"(/*PEPE!)#65(Q"YZ=+7EUL%CU<7[-/(\]B5B$>AS_XVX@#]\NV ";05
M($NH%C;5PM:"B%*I[:>PWAC-J!;VCBP4,C<UDR/$MBYBJS9;+2./V.I?,=RP
M;)K;CC=L1Y&(I9OM3!X+1_&D]$J&V)CKLU!XRBL7![)\R[4(7:#EQ=7I-5,/
MR;GQJ#3A3NAN I$$(K4@HM2S^ZD_"$0>^D(A<U/'.P*1&P.1UK9!Y/,0(WH&
M,75D*5HD+$=8CK#<KA-1JKO]%..$Y0Y]H9"YJ84)8;F-83E[VUCN@D<8\"<A
M'>]*_$:HCE#=#M.04%U1BF\_!;H6J [^X!U/P$^.>X??_ 3_IJ/Z7G9!GC\<
MFR<]3SR4'3<44C(?PW!' __$<:.AQ\?'^.L<=2LU("4.,0&+ZHO_C*+8[8W3
MT<I;R\)W3H:!$M_'2M#?B9-.\("4Q^EV "2*$![]L!V67KX@D[<_]L)U$(R^
M&[CHN1O6M+Q,.;*?V1W)5%P?(48YBGD8'_-1')Q,_P#\I+X>\ENAK(TR[\%,
MC[EWS\?1R9NC65:?EB#(J1/FGV-B37AU%AG^$ ?=KSCE#>&XHM?[!B4/IG.<
MJJ^B6>BFC_6Q^6T^)7^['H\B9'>X/;E)_@N?1?AF5CS7%C"DLJA_DL)]9O?@
MS-7V2%@5)XPC!OK@Y640Z<$HN40-WJB":GR;7@_\Y/%A)(XC,>3 ,"*EL]*B
M\KXW<SZ#.\#G'==SX_%Q^H!%=K]Z8?-M?DNE))![ZFC9/<8*]]2L56ZJU.U5
MQE==X:;&*B^J5:SZD_>18T<'K(;XEKJ'D6-G-<=.M57#J'S3@C\;IG4TB(9A
M&1TZ7[?>H^$T& P"/^FJ=3F">?!(S.=S_L;]$0_'K"Z-%:N4%?]8T.,!H\7^
MW<9LS,O/)78>.Y2'680(HCQ,RL/4AY*8A[F?<GYC)$MEJ&$J(4KG>-HN%<(]
M:LI%<*]HN+?U>/XK<>M&<5) XPK)&FT*[%%PO]8*G. DP4E]*(D*=S_U",%)
M6BKD;FH51G!RO8X45M4PC5KMR+'-AFVICA1F8]N(\AH> ABP#0#2P<)O\/>5
MB&())$\][@XB=AD&72$<;/@*LXQEJ-A2T&G:*,Z,UA3J;*>/,F1A-_F67T*W
M^TUX'ON[&.>>'+'S2P*(A<26&4=M C:%]))MUHTZD;((+;J?VF'C(-&L$DC4
M?*F0O:EM&8'$#8#$YK9!HD2'$O?%@8)RSP.%UV(8BT%'A,RJ9GW,'G=&$BPD
M6*@_%0D6%JLW]U,?$"RDI4+VII9D! O7A(6( BT38&'+J-I-U<UVVZCPXJ;-
M)LA0@C?71RJS&Q$.V'5?B'BNVUC2?2)K/9LDI)Y?EO(UYTJ,LTA]Q$:X']K9
MK[+![5/-)Y*7G/*A&W,/WN'#1SE*?,\T\GRL8^[LM1E*?:S[KH*^*CML[G"'
MH"L=>=.1]SY0DB(H5\R8-1H$6C5?*.!MB_JA$6@M'K1N/8)RX4'WM>B.L&?N
M91@,W"@* )=^#F)1VD:F[*J-Z)#P3Z]!\]NV%V 1/)XU$K#RS&DP@"&J[S\'
M@U'(:34V$OXQ"MT8+2M9(=R7#^2>LG7(;"&S10L:DME"D;IDMM!"/6VV4 <^
M,EO63?NR[*;5RJ5]6=MWM<LHBJCO#B>-7)9G^U]P^"6M3&;--&[.>[25PWKJ
M&Q6HF[K;)^&ZO_+OPELG-^Q>2<-.X#D%$H:M.*3B1I!Z_]D9TJHH"E$ZW6O#
M(D+IA-*UH:1$,ONIH3<7%#/RLC[9A-+U72?D;>JZ2"B]<)2^];.%=5#Z<I!>
M6HK2TY@8VUYT30),TXNJQ@R89XN1*\%(@I$$(_>#DE+5[J<*(1AYX.N$O$U]
M%PE&%@XCM]YO\304CKL@FVXQ8$QC)JY'G3"X597!,F0WAPJ7@\E\A#4KIQ^,
M6KG:*ENF\2S<N+'-S@@*$#+=/A$)F1:JO?=3*Q$R/?!U0MZF+I*$3 M'IEOO
M'KFX2MC.PE72W@0F"4SN/B6EPMU/14)@\L#7"7F;.E<1F%P/3-I5VS9:C2//
M[=TG8+*F)YC$GH6@+[C'V@[<.>EV\-PHUQ1@*O!WR</8%V$T@S$7H<_)\?AL
MB"QA1L*,>A"1,&.A>G4_]<6F$Z%J4N(N!MP$&G58*&1NZG]%H'%=#V3=:MJU
M'&C<>B':Z9)CGX,*,R5BFRI0B]4#EI=Y<./Q!$LF4/(S0#U9IM:P%GLKGUNU
M3./"9 1BBP&Q_R#H12!6$TJ"GJ]2[=R7T6PBZVUR?FJ^5HACJ?$6X=BB<6QK
MVSCVT:Y;2\[3)X*K6L"1^F]7G_XQ6[G6KE<-=AJ@\_5OO.,)V?IK""R2WO2(
M3W7><?JL<WI"I81*]2 BH=(B46EK/[41H5):*XE*J=,7H=*B42GPU;9A:0PH
M#E#EQS]'Z":=SUV?@Z+V8BCZ[S;Z'R\_ VZ\^5"9PX94792PGTY$).Q79%>$
MZG[*?,)^M%82^U$[+\)^A6._K9<8O1*WDV#+*Z1K1+A/9T5+N(]PGS:41-Q'
M!2L)]^WK6@%_V]01BW!?T6DX]M9]?@O/H&<:84UGW-15_/>BIDU+HA)5_R9&
MS88HRV87B$BPL%"UN9_J@+)L#GVAD+FIW1!APL(QX=9]@?-I-M9,FHU*O5DI
MV>9Q%/G<3!O.(O4QZ+&+#^U\F.$::3CKM.^A;CV$<G>)B(1R"P4"^ZG@M$"Y
M\ >&H\-/CGN'W_P$_Z:C^EYV0?D\')LG/4\\E!TW%%VI_F"XHX%_XKC1T./C
M8_QUCKJ5&I 2AYB 9_7%?T91[/;&Z6CEK650<2?#('+ELT/A@8Z]$R>=X $I
MC]/M &@6(3SZ83LLO7Q!)F]_[(7K(#I]-W#1<S=F^G*E'-G/[+!D*JZ/T*L,
M:"B,C_DH#DZF?P!^4E\/ 7LHZZO,>S#38^[=\W%T\N9HEM6G)0ARZH3YYYA8
M$UZ=1<H_Q$'W*TYY0_BVZ/6^0<F#(/-4?15MHPN]+MM\2OYV/1Y%R.YP>W*3
M_!<^B_#-K'BN+6!(Y6'X20KWF=V#,U?;(V%5G#".&.B#EY=!I >CY!(U>*,*
MJO%M>GT7"TD-(W$<B2$'AA$IG946E?>]F?.AW+F1VW$],%N.TP<L\H.H%S;?
MYK=42@*YIXZ6W6.L<$_-6N6F2MU>97S5%6YJK/*B6L6J/WG?_CFZIL3"+FW]
MUX6T1*9M(_\]=6WM8YT5VCA$)B(3D6EU,NT?SMI%GQCZ$:DSLO[;?0=05\W*
M)Q=L&W3].PB_W;D>6/G7'R_;[-IU!,"M& _VU)F@\@8W9YS!=$2V^B9IT@D9
MG9!I0TE,#]A/@;WI S*3PL T7RA$;=2(F%!;X;XR<T=@VYR,(MQ&H4T$W/:"
MDM(EL9]"6XO0)D)N6T9NU*B7D-NZR*UF-ANUG?*W7? Q(]1&WC:=:$B@C;QM
M6X,"*! M FR:KQ("-FJ&2X!M7<#6M&L-<Z< FVS738XV@FQ:T9 @&T&VK8$!
M)1)G8T8(M.FV3@C:J!DM@;9U05O+:C9;.H&V!*!-ZEL\HQ^73!$XF<] .%G0
MD.ODJ89<)RLTW#J10US2R$L^-3W;'=V.HIB\A 0YM:(A04Z"G-L[V54RD3"G
M[@N%F),:QQ+F7!MS-HR:G<><UK9!YR.>0O$@NJ,<=#-F#S0(NU&_!0)O>T%)
M!&^+^P7LO.#>-'I+NBT0?--WI1"^48=5@F]KPC>C6C-:MH8N0YYW&2ZM>"L]
M=4M+U>(%3E)I=QBK1C)U GSDK-.(AH3WR%FW-1 Q$8M&E1"?YHN%B(_ZJA+B
M6Q?Q&99I:G5(/-M&(0ZP,T*0-E.8[9IP&@K'C>=Z)GSIQ@%*,CJ-)8"G$PT)
MX!' VQIF6"84"=WIME+ W#7JGDKH;EUT9S:J5MZ?U]@VNGO.:6S6YKE!X(V.
M8W4B(J&W A5<8S_E]L9(EHE%.H_5?JT0OU&G4\)OZ^.W5EVKPL1)8_JY3 [E
M=9N(*/*[D=]-)QH2<B._FP;(C1(A=%\K1&[44H*0VWK(#?YO5!O5HT$T##5!
M;A//VQ+P]AOW1SP<,U.9ES7";H3=M* A83?";MLKFI)(1:LZ(Q4)NNFV5 C=
MJ*\$0;=UH5O-;%7K.P7=D@+JLR**@!L!-P)N^T!) FZK-I4@V*;[0B%LL_^Z
M_]Q-L.U)V#;!7#5[VZ#K_+K-;D0(/\LG'2JHVD6N)<(1X?923KX.F0@6:0&+
M[(I!J.B0=_LL*K*W[XDZ#1S!@A[[&/?=;D28:'=XE@A'A"/"$4K:OL8O%B6U
M""5INO^WA)):VT=)9W[DPKWL)N1(%G8)]W?'A)9VAW>)<$0X(ARAI>UK_D+1
MDFD06M)T_V\'+9G&]M'2]:@#<,GELNU2T&-Q7[#38 ##(<BT0PQ,A"/"$>$(
M,FU?_1<+F2R"3)KN_RU!)FO[D.DT\".,_@:T]$%X@1O'@OW(!\,3=A.,NH"?
MSL\O"3OM#B<3X8AP1#C"3MO' 85B)^LPW$V%THSM)[UF0)2E@=_I%(G6 [+)
M?N, I2Y#U^^Z0^ZQC[(4J7LGV)<>7"%"=CD*HQ$'R!4'[&J$C<4-BY<-^QU_
M+^O1&S4G^20'))U8U_"0T(W1K?7QH=OG_JU@[:Y$;4;+LDN,1ZSM!$/,X,L_
M'^Z30[*J9NH/N^9AA_LB*G]Y\,0X?8I9K9H5PGFD=8EP1+B#)!SA/!TP"^ \
MDW >X;R%.,_4&.=]<GT.?\)?A/,.3WD0X8AP1+B=(!SA/!TPBV56C!_V$[<0
MSEL/YYD[[,\SFNSWRG7EM)(A,L.J59^$;:UJG6 ;*5$B'!&."$>P35\( K#-
M)-A&L&TA;-M=]QS!MIW2!40X(AP1;B<(1[!-!PC2:AR$MVT7]_]VT%JKL7TG
MV[PG[<Q'\83?8-*F\",%Y*[@;4#A,16_V#GN)L(1X8APA*>VCPT*KC-O5,X^
M7U.@&GG"-DFO?_UR=0Z@*(HY "/V(>B.L%$/"5321$0X(MS!$8ZPCPY*";'/
M]>FO!X!]=E$$[#IWG?G2ER21SPU_"/Q@,&8?'^#7"%U!U]V^&'#V3S?NLX^#
MCG <X;!SU__6X=$$(44D=W>#6XEP1#@B'$&D/5-B1I6:$.JY_7>=LT[Q((Q=
M\EO!SE"R\*X\+OO 8\X^N9Y@[WI!.. Q1BSQB.71%*8<XH,X?.,PUP=4U7<[
M;LP T+\G*;P;_$N$(\(1X38!F. /WO%$;G8S%#)@AD5-N ,P2H39YTJC-HR3
M^(GD4K4&S7JE7F^\75T3R['6TY$O&=TZA,RH)8?H^@Y<>%RV*PV[]39C*!SS
ML5VI6=;;PDA8D-:=C*08"OWUOU -.ZPO0G'OQOT*$6LYL7[XKT\CN"SJ$\&>
M1[#_^:_+4-RYP2CRQJR'C#9%KB/'O4-A]A/\FP[UNR3;P[%YTO/$0]EQ0Q6\
M?@QS& W\$\>-AAX?'^.O<TJA4@,-@(-)3$CUQ7]&4>SVQNFXY*UEX3LGPR!R
MY;-#X7$$IB#H'I (.+%,YCWHID.*7J5'I.2KS79;'&I8YD*.[&?>B&0JKC1-
MRE',P_B8C^+@9/H'X"?U]1",'>6#*/,>S/28>_=\')V\.9IE]6G@@YPZ8?XY
M)M:$5V?C,W^(@^Y7G/*&(C.+7N\;!$V8ZG*JOIIKY*J/5V+SVWQ*_G8]'D7(
M[G![<E,YM;_#-[/BN;: (9_'>D^ANR?IQUSGYS= M(%17U&(W*N-U0F\#7'9
M&8R.&?64UEJ.L<(^!2&,LEK^.[L>#8#LXR>AC%5I/(Y:UEC<1$OKHA@^!S'C
MPZ$'9BA(C#V&+8:Y^IKIILLMTN6DRTF7%ZS+\QK@2;MU#0V02A.IX"/XAL>C
M4$2Z*OGKL[]];M_\?O7Q^K7U)EZMK^;,9YYCJGDH_AR!.I2!+KA;)RGK+ B9
M47OGO,^RTI\J)XD778E;-XI#?$.?1\P9>6/6Y:-(./"S&\'OPR"4;^^ ^ $"
MP0_P.A?>WA%][O589RP?)(64ND ^.10C'^Z2#P3QWP]"H(RC-XC+L9[T"DNG
M\(RZDPXGJ<\2W8)#Q4?#[L/+RP!,@E%RB7J+4:U6JF_3ZV&Z'A]&XC@20PX2
M7DQ[?>5];^:.\>_<R.VXGAN/C],'+#J*5R^T:Q6[_C:O!U.Y)17AT;+[S!7N
ML5:XQVY5:O:3]U$XPX8=E',;ZM7R.-1,B(8+: @OQI]^?F.^(7H^EYX7UY=9
MHG ),XDK.Q8@-7 =QQ/[L( D0XAD1++](IF^<O/ EJ<]#%T/K+P2,ZMFC=B;
M<I W2Z]?QL<;9;+94"@S"X5BZ0STC4LKE-)'T1'[+>C[[-<*NQJYWTD.Z[PO
M"%ELA63[8R7MC.MEIR3M:E0EL:O!AM"5_XED^T0R$KOZB-W3OBMZ\QU5=B-R
M=K4IOWNDD\SB++R%JH?4C?9IJ40IHM26*:6%"CG$8@?Z<S3YI ]2(NPZI_TR
M?E5G]"0M5U_Y6K@/^E.(G7*B;L"NW#L>E?_X\0?3K)U$?XX$.4=(CA"EB%+[
MBU8W:_V3:*5M0)0B2I%HW9 O>:[-XX'XDN?;6V*YM\GO[6X7=$0,CR1G,\D#
MHA11:C]US%8*Q5%FZI+,U&>FH$YR3#'_M".$GZ:9=H07W*?II;W @T^HPH8B
MC (_PBS4) ,U>5DNE=7UY3==CKF9\O6H$0/UK<-C^ *6#'M%SQ31TF>[;SS)
M?:<S7*WJ"FFGM55N,I^^Z4D[_050:9Y?B@M1GW9P&T\YN/?03OC,!V)S*0!$
MWQLW]HC &R3P!Y"FS[?=#CP/7A<L360B,JT5RO+:^*&P,W*M)7!Q>5D;IRY+
MG&Y5Z_7H/(79X3W55L.<^F_:['^%M5@2,2QMN],^=T.81FH,_A+PT,$/'V3Q
MP"",-FKFZ4>LE\<:[[(K[14(^HPXM\<$>5,K.?Z"-6JB&-)@D3:4W+5_7*\+
MGCML6JUKD.DC '9V"8A61"NRUP[/7GMQH!W9;Z]HORV-TMG8>]GAFGY%A0;M
MGWH@VW#[MN&K;IU7"MK>OYU"H%,'6I$]N?4E(%H1K<B>W+8]J1_>3FW.;^RT
MPOXQ$A%W.-F9VUN/],CO0 0363)DR3S3DGDU":7/[B"(HP.MR'HI4$X02^O
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MGH\CU03PIZ-.X(S_][]_.NK' ^]__S]02P,$%     @ M:2/6O.-/EL6$@(
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MCD<_9SXB_$T9$^6#(C'JVW'I>%QNR:V9!%XX6R68/:7E0Z!IT;"U/U:V5M!
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M?"\GD4+@"MQGIP'1!ZL,I-4M(+V5Z_/TPW=LRGI*]5,6\^V=XP<M[KP5+C(
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MK "<2#!_LT#6V&="R2@RL([C>S:\0!T(C'\_6[#UMPD_MC7,) )C(94+U%=
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MYJ#K/N1L^Q>T/M3\7!C$L&Y]1S05\#0H%@5Q%<8O38)E;9=!<1]YE,86HC0
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M'M=!PJQOLM()4:"O?7+FJ#42I 2)*M/VO>A.= +X.PT5=8E$&R?98TQ+QQR
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MUB0L<P![1-7D^AK#:A/;.<1*]*(&  NJ=_!,W<>U!\NR^.T!;SW0Z7AL"Q=
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M$4[I$#(H50&'.$%\G*^%;?6F'(.U;L7Q_HJA .CNT,UE@YW2T2IO&ERV6[P
M-5$=^03!H A&_3K60MWQC^\__M&IQ'F/V9-50B7I,V=!$BV IG!X.WSW;#(2
MEGB@Y-#]4?%0DOB-^^%<TJ^Z P%)E)R4''&SWT&CQ% *U% *Y)"?EWD\0NZD
M-EIU^(*MB+%+_XHH_4'>-34%O<^CG1)I.*<T^:EO:?X!49>3C)^W,R^$Y$;D
M9>@)KX(H JD1T@IHRQ.4TB&/A+'+R*^RA2-_>(9^]H((BD7-HXL@W?+LXQ[Z
M<C'0D3,)@X OJFH0.#K^2B&"P-BW0/]WP)\RQ"AV :7<F?SG+P%1L9+%>D]1
M('KDP>26<R1I,L/Y[(OCI!BP)L]VM"#=)V]SL)N<44! 8J(S+?BV!YAN'6#(
MQ_XJ$Z6#/A[1[#5>(D;T!'%F!M/] #6++.8&\L\ 4Y'A2QW($! [!0PN!.2(
MGDX(HK\QDLXY^>(E ;C39'$\ZKGY%&=W20!A9&<XPLM@ <BFO79-C),G5K*1
M3B!>#_'!D#+:8'OI? 74KVZZRS GJOFC]PJZ^:%);X0"C7<&&A.>;B'C$.8,
M8>G[ >9<KI1'B_@"+L!L P[10U4(1A5)LD2; ,+";$N1!TX0&^/(6,SBS O%
M5E68<J]16.*FE&$T#E,L"$Y@P%W%"<-Z! &YGUE+TJ1!6@M*%864[%'P$NK8
M8 31S?&P40ZW->^*XZBQ$@+2#3GUH14/O4H9+0EI=(I"H'XT#/&C5F#DBC%"
MJ0X33&&1H5* 08FK 7D2^,P*^BM5#LJ9HKTR]/@8:),/@@(8A?Q?D>WKBVS?
MHV0W+')Z@I0!F+:%-(G-1\EJ.4&VT^8ZOG&8^_8QOL?^;H&9M)'.7[!/TW=8
MJ4Q((#KT_N'NX2Q&; 0N':8(QF Y0HB-0M.ICI/9\NN1,YTPICW.= Q,[RC3
M$6,:0'".=(L+-W*%986_P<*H[Q*>?,HR+HB8\[C&2F!U_\CQ^1+)041^#1D&
MD7'0>26<_&@9-X>/;R7W/,\$9#ZB6J!J3/G1<E^;+=%A 9P[=R'J>8,?O=?+
M5V\31'2^%[GW]7 \$4*5VE<4NB?H8CB_KF7&BJ&.E#NPQ&"5NP&]UBP/251F
M@8-*S@R.%H6J+%8R=)61J).F,-9QLQFVX!#EXPR2R%5Q1=1GM= TEL]1_)3B
MY)D9AHD0"$$GT8)6UB)GT<HQ4)QVBFR;HI<@6P<1O;VT?CW ?Y/UA)#"#/H,
M%;FY,^1[[ASY=UA5C6=(718Q'7 #YWE%=$8G2)T3UW"*LQH!-R#?WK14^Z;/
M>5,.C5*%ZGAX"<MLT&QY((G^QO\[Y&UB#GD\V]]Z_X@3AO3=PZE?%_.9HJ<]
MHL,@.HYC+W^:9']GX5:W.%O'/@-ZP1@<X+V<GSEBS GUI@_F^+S 1&9<!%R(
MV8:8!B9'OAJOVN]KR^G3-]!3"!\C<V&5+Y ^.7'*XNS(653=36WY/$'4G^-4
MK>*U7N\A-2V1]1S[6VPY720(R[R!04RV-KD*OS:&2MJND;&!31HT6B$DO!65
M^[.]+E>^KPNKJ.)C/G15UW_:&_+G77NZ!EN8JLF++(@8LFK[>MI3)(6JZ<NM
M)W.X]3!;P@XX)6X3ER4$V/PE(K->!UL1^L.P$@X6A\OIRPHN6BR&DM474I11
M)28# ?D)AG/[:;ACFW\*DMWY$LDA9%15BLHZVY%R:P!VRSF&DI+.=3@EC3!E
MH!]>_AO(O4L]6E,V[0=?2+Y*[XFB11 551F3R5S*SRQJ)EM[@*&E=G*M/*C/
MO CEH[4CR25$TP^LQ 9N@2+D&K \@Z-AIB2$27XH40 X8R"$1\./009[-NR3
MLQLU!VRY846W\X)5_5!H!+E!2A2)R^0>AQ %=^<EV5ZY._JRQ,DB2A<IA =A
MKJET(&!30.@5/ NKA.&,6\=3R\=#<D"4CS@.:AJ9E \EQO;\\V&>[JLXF47[
MF?\,$6J]5%A!'FWXY^DY#70=@C^MM)\S*NXA-A)U=).Q$!_LF!FOU?\VAIVF
MKEZ/+(#'!G4KV,JB@5YXM3LHR[!<324GB):,XM0YX.=3,W/GSDM=6>(>)G9F
M.B>'2Z!F"[1HQ^9TI28\35IV@VC%!N!9X /B63GB3O$M$ZY8LO=8>&3VN2L'
M"(S.XFVZ)=)SM BV7GB@8E<6H!_N0&;F)-T>/PNS%^H,F75.ZFC6OB DC<""
M *;BT#P]\:CF2P%?Y-:$V7?6I1-_9+-7STP.!)8YGGI>S3B"^M@T4^7*@_@+
M  X!>P[$C\1)$K^0?YQ[6_*W;']HLBWH@H0IGM\CQ@$0$3X2DD,A,=9Q<U[(
M^N;L\WR@I61_X[U2F3J1R_ DEV'Q52Q#$0+.N!!C+ #[> N.$6D_[ADT4[Z0
M2AX0Z1]P^QJ[X4T\$26><B? @&%!#MDLW,HF7L<+=_J<XN4NO F6/6LFL!%0
M2,.=*K"T:$>'H7\^2F9#E4LCD!^CCV" 8T![GSVE1#I8')JZK@9L\J@V</4T
MQVY6,.'I;(C2SN?C]C,7E43(9S=;DN_OG!7_"_=WA%S$2@/0M![J$^M;."8%
M@!,Z#I(#(3X2_3/*QSIBMDW5@BC['F5_(=G?<O;ASRRUB8XY3+T@-_QK2^=T
M8?X8[@OHST.]%^LH^.<.]W9EZ:/H>? [O2CDH"@?=1"G4.ZW.R=32KSP.O+Q
MZU_PH;H+]]IQ8HA20X3<Y.>O*0TQ&!/2=.RE:XA@?O9"&L:0G7M) G7PZ-GI
M9:TCE&G5 $[ZN#@)%284JB> >B@(L^_KN/A28WE;,.<XC%?P:*/,Y] 5/GO-
MN824CU_RRIP*4N=Q\*)^])(+US-74 OG6Z(\]$^3$N"%G-P@80$6N=#A,'*:
M;OVFRV6PP#1G<D-D"YS A;*UX_!AM*FTLN#4Z8M"R1\55V&!H1G-_>0,2<K#
M."!L<U;VV]=Q.$2.>0'\Y#J2Y3IXN95#5?."9+.&D$LHY9T7-O%R/3W,Y?\_
M'2_#_,1J8&V \;P*"A]F ".#B]1:2V7YK*?5.E]$M=[4=9KN($1HO@2DU;ZB
M3(:VA9)3/J&) CZ$XS T^]SQS2Y6T1(D6<[YTQ&Q8ZY\1K=I&42$]A 12WF@
M",.G![:P;RTZA)$[$B["*@,G2)1 ."I.BG>!&F@EB@/0F\ ]/Q<\RTDMKY07
M7>)9@@>&D!29%",A=2B^?<6R4^Z5HB&X#_\]V2ZB(].7.HN!19"&J"&%Z%N!
MN'Y #+P,6>VIO!G[VV"%N-P8INV(3-V,TFY%(EY*B3L,KB-X5V58V/RE)R*9
M) PG0(;Y'0\O89F-ZXC*/'GD'*)TCX>C2KDK98.H%"1W"<4N.3/K<'<)WGJ!
M+^XS7A^.?* TP\]&>1L^ L*,-/OX8IH_.$R]6\=,MU)BQ2+PH>@:L!S*H6KB
M KH;+?\-Y[&_I@Y8<9+< !IY[@F;^3YID]+!YPG1+)Z#PS-\N"^,TU0*I NZ
MQ\*/QL''"7.>YNYY*AXVP% '+9(AS^T O%^DJZ1G>!DG6*(9XO3RE1R?./&)
M4ICLJ4^8" B+:B17OP/+:U%1)32?%LKGA9[HQ% .]0AZ47$J,N+KWV@955<>
MF%T Q5ZLU19.%6".TS2P0,)(N@\2N_.2OE9R1F(P0;G/C OI! RTXS^(> 15
M:H9C0)O^U4=.K\G_&L8Z";6?H/03(#VG1'LZA)=B?"BY;+>,#DIX2O064J*/
M@9,P9R)%G :[ %GPTS'P4+BL3(P, 1I&:^6F5\+0.7\*@Q6[N*D"G'/8\P,B
M@R Y"E*&X5&:RA(,HN"ZY;N<8MF)?^=N07BN"UB[??86B)60>X?8OP</@'3Z
M%@$M .=42ILZUOUL\*'59@4GY^?WLTG/O@36Y#&@IL&*KEIDH0RS93I+SK_M
M*OPJM?+: ^UF R V E*&H!?9?\>$9?2%_+Q+QL/P=K<(16='3AO,@+J5P6.F
MH:0J BFWZD IQ,=U@AUEIL HU,Q?!#^%41$=]BM9#?7A^/C^XX\#R"J:Z=L1
M2U3(86$!=8SZ8(NAHGRI8^0X^"@X[H^6&:TP,A8[X!C) >PO7S,<^=B_]3(*
MA=6C@"WU]N24D2"-!&VGE6T=\5;$)(<(I9Q!+!C<" 9=EL%UQ&#IZFO'H]M;
M\!Z'X'N9+Q_Q9ALG7K)G$L15G CG?+]/CP] T1G$$#1@V'&.NDW&*O!]E".
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M\0<1;-[KT<LG*VM G2"8+R(3AJ7[^$->'"I(D3)KFAM)YLT,.U3/I<AM,U0
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MT'0"EJ?AE*+S.,W G<HMZ;V\)B*%E:'_8D[Q:%BIR,^4(,N,.C9>U&-7Q]!
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MAS%#7>-:-_4.:#N7U<YDF=$134O7Y*=" S5(T4!X4F5/FL&T$"=4QW.BN03
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MPR"(IV_&=$.\8G7R0I,N@\6!3;).KV=2ZW7,OT4&R09"0?*OP6;['S:CX/3
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M?1/3XI8&X"&-( X-Z-%9:^"X5?3C,C5280V=1"J%? 6,EOG&PQ!2$A#5##R
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M$+I._Q:GT3Q-=T$B V]@!$Q0;W][4+!F#1_=8K-YIN^F:?2.>W.$("'E^G5
M*D=\J,8W&@C/,F3;O8AS&I997BR03HRM#<JC8R([4<3P7^$BC]=LK4O0[P?+
M.IB+%BM@7 V*I]IG=_CQX>'H\MAG>1RM*5!SUD T/32*KT<&(U]0&?LL[7?W
M-*3Q,UCPFKZG8]X;?FQ^V@7@MM[K.Q!$6G)S9&V,#CT\/)1::);)76^ZZ9*P
M8><Z^MWA@9YOXT"$&_"S3PU.[8E1?$F:.[VYL$PU7K)Q4>\L;-"NT.7JV7K'
M#@S%75:PD_K_B[?G660M(X>?''X2\@,=L+FP-2VBT3UE%^)TP3G!X\<=K Z:
M9J>^W+_I]9&>1)1_<)$_[!Y#^2_33YGEIYY13A0^_,RP2)TLDGB^%BD.>7!'
MU";&F]X>Q;*FKO=\YX!<;WU#%WD^T2*]AP'.>0EK!BR7_SP+BKA8MITB>A,^
MDF6/G8JR'$)RX0/'&_ YG(GR??OZ=_"5X:?[ X02/XH 8\E75B$)K\WR8UX:
MQ>0V(TX> MANJ^P43;/V];=& 4[>VN^"./I"RR8DE4=&T6Q)7B.LVNGZ@:[1
MK] $H/7A44#1Q'4601T4N%FRXQL[XRU26O^&3GA]%'"OXC0NZ4W\#%R^]@?1
M0+[P7S3(K[)=(_+3) V_6M[3((G_R<;+YD^K+9 MSXUB%.L7#E&;4U?&;+;W
MOOK:..!5DV1:O[Q:)LW03?\IB-.;K"@6Z47,CLD\E.^X+>O(5T<!4QT*S_;J
MQY]CMKZS<\0>\UK:C+S'O3GX67&^B^(RR[\$F]J9T/C3N,;"2%;ZW+YC'7A\
M%'" RP%H)< ; -RMG)"@"4GSDZ, \2W(8[CSR,,;OT=\R<J[/-X$^?Z,IG05
MA\"IWCY2;Q8R"NCLF)<N@^^PX3>!,OX\BN:*P^@]W<*9)5TORB>:@R^4'6)V
M:?,V>OB5X8\X*F_W*LLY%PKL*PUGG+8'AX=0C;>[H>L@:;G*'GAV>""2R-"@
M6\&%M^J<J;LZCGQQ>(C"S;[,[FFT"RG_"HK%"XV^INRH^27;[/( +.+UD3OV
MS1& -*R"=[EPUG";,?MXED_4L!,>-"F^]O(H5D6P>&TH6Z<OOP>;.,6;W 4M
MPCS&+/(6;^.A5T8!BUNT)=DT=#KK<)J&%M'T0:?/VR2, K0Z\!VVVZ*A]FN:
M/18T?^;'#K;:P,4W#;%H!QO$@UWC0L\H.E!3AQ<5-LKF*):VIT<!YH#9YFQ_
M&_R='00PDKWM^G;\ZX/"+?+RO[F)XY:63UG$O>F4PJVM?J-X_>E1C-T%W>8T
MC,72NDTHVAK3R+2W-4_)U]\;?H<5Q=_N(2X]5W5$6LY\AQX>'HJYW^.M+6%-
MM/?]LWV3;[%^1#]=U/#=H",D%B\I:]%3O)5WV<*N3U]W3QW]ZBB^3+,0#7>
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M.#-,7W,I04!74Q>T/ST*,,9%F >G<M;D-C=RPZ.C@-%4L+U>WKU]=WC+^Z,
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MS)'F3Z@9.T8B&XO+C/*V3P<TOX4G]*G2<E5VC!6B +HXQYF;YLFW@<.)?:0
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M'1-?LP_E\(I^R.U_:'9&)N4B^T^O18&HLB,IE ?+BX:QC-SSK<"\T"JT*6[
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ME&('U/ ,Q3FLV#CCH94M;+@#C"M9>8KF;U!4+(P^PU=\$E&(#5"H&<K(#F8
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M^/N''W[XZ6]6\#=M)6<]ZA>TA=+3>"?02XUYW!VPB^/N'W[XKQ-/?,2%G/7
MH8=*# \V<$,3I>P:/'LQU)AEGS]_U%DW\.9\*W)A_;R1D4!2L>#/NNB5YV&K
M."&86\<DBK;Q5-A;,P/<Q)*O\1_7\5OTV37U>) F%OH<):D3_'_^@4O(5. S
M+1<0M(J1PUA@Z^<S+8D$83WOHI!]W_= 3!QN\1_PROPH.ML6K.'%_J2PV)_.
MN]CB#:<JW03")F,[QAC@9[Z[4@2Q,/X'PD:&TWFOHEQ:5/"S+EG0C;.W9A;\
M61?]-0KPY>[$1,N/V331A3N[D1)?XPMR&\5'YA+;4&==(+7>3F^!;:BS+O!V
MCV*(%?\ECC[3'43\.R$;DW3H\R[X6^U<:@>Y]%?;!SWOX>\P(XM0V@(ZK_#'
M@C"&KDL>^O:_B+W"+MRY-*5<5-_Y"=8]_HF<F.U^8H*>V4U6+^ ._PN-WUF0
M1A::\X3<4INP9U\LMC;WZ6T<0\H'/NFBC50=CT-=-7/0F99?5:9AK+3]^YD6
M5<0R''_\Z?T-7FHIZ^J!G&EI6%9#J.CK<?\>!91UM7\_,[[*V'*&@XP*=J8E
MWKN;>)61*N:K-"55XMCLP0$^[]TCT:FT?Q'Q!IUU^<_9>^"[=T'DL"V/)LR9
M)692N^H@3?L%(L]1Z/8K<% $IWCLN>1G3J80!GM/T_':OY]W40PQT/SUO LJ
M&[JS%U5!G'=AZX,?0ILE#N6Q(,^E9T((4S<GIZE<MGZG+*H9ZZ0ENNS@@#;[
M'^[.#RK"9[5\?*!%_37Y.8\EBF(/Q?_W+S_\Y?\<L!X'5]7__<M/?_D_68+7
M$QWR0K7P6Y&C\I!OG[E2LLP48I\)I&&LB".3^OW+VJ% 8Z '4\U[9 >"^F3#
M[(_&">D9 TF!E=@1,E4[?JA S(\S9BY^2-,8"+*3<B0Z\#:(:SYX$5]3O>"R
M CD_S9VK3,6ZS0+_P@A62D'>UF&56/INN19[88(%;OXZ:0HZC8-'#5R<-/X5
MR+,?T%A@YC^GQK-V72O4$,LQ4'^Y1-D-O2RP\[=)8L<JD4F-!ITT^I6)4Q F
M6B#KOQ9D<4-2"S3]?4$3+PBVP-(_%BPQXFX+!/V\((@=[UOZ4Z;IYE9 4CO*
MN$3+-!V4"FCI1SJ7J)FFEV,H6[4CK4L<+78D.\"[Q-%BUG#CRDLT+0HV-Y:]
M1-.B6O/CYTL\+;HU/62_Q,^B5=.R!4KL+"HU+56A?-B8O2Y]R\N3*+$T>]7Z
MEIF<4:)H4;$I22$E<A;=FIZ24N)G]GHU.QNF1-'L=6IF%DZ)H=FKTYSTGQ)'
MLU>E9;*.2F3-7J_NY#B5>)F]1MU/LRIC,6:O3G?2O$J\S%Z!IF>:E>B9O?+,
MRW(KD;0HT1*Y=26R9J]1W_8S^4K<:%6E;8@+&Z#_2.00ENB:O5[=254L\3)[
M7;J5+5EB95&:NRF;)69FKS8S<T;+H-'I:L_4+%1Z E&18U3BY.>14P^*M@+=
MBO[GZ"Y09V=$81(%OD?N(B> MB6O.X0:C>7.WG;@I'KI/0XH\HTY@,:*O.?-
MZA@)T@P@PXLMG*52:^["FFM1X"0[QDK)3TO#AXMJ^#!DT8VV-G(DS!E@C@6Y
M#<6Z/$@'MN$$5J%'*'D7!?BB3?)F4?+GP1]NL&6'XI9LW$3#P]%J"DQE[0:8
M^48IM+8N#"#SB[6CJ\M)6UAOBN993E!V9!32N\10X\+U!;G(_P Z>4*IG(BE
M#M'=U*:^3+]R^MGTH32O8[798#&,#[+3I+2YBAZ,YC7\DCF0I':L6PI"<V_J
M48GAS1&<Y_FY(?GL^-Y]>.T<_-3IUN<301M;_G,<'5"<'I^QS9CB*QENL -P
M-^8!QAZX0\:BTYHYN:3: !N!<WW2))3#,GT@_4VQ_'U2]3MLLD*_XW!K95(#
MC9'A"TJQ-82\6R<.P86#97*VSP)P9]R@C>_Z+&*4&&AL4_=AZH1;:&:<6]*8
M/VZ_N4$&[TR_1)'WZ0<L.2$UU*#00 <LOFZ_'5"8(.@*F^Y0W'(7,&6'>*2Q
M;=V@&,L.2#;HFXV,_7"'&-M(T<<VW#X@)ZE6=F1>K_+C+#++I,TQ6\[A!5K5
MKC=?DIRGI<Z@.\8.OZ&,OU#WS5>4-*B(DKX4+JCF%3U$3G@71_L71*Z;9R<&
MYL?,PEF:<(RQ W[T0_) 0E*N4,(ZXQZ888KDDN+X%@OGJ-G FE=5'D6AQ/&-
M*#:P1:+]/BQ4G6?(CHS"59K&_GN6PHK?(EAS%*9Q%.!5; 7TJFER$VH\A[:4
MQIN[_D"W:^A%8OV#/<"D$M]D&/X-R "VP5LO=LC;0RA\)+.@C7K;_93$A&&+
MYAJ+#\R3"',F$^N\$380"_\ ;,*]Z$%IX#N4)87 V/$0S;*;W0"$6=0RYP8R
MM(J2DK"!6>!DJ>\N0) X?J#%5XR'^EG0DNI#?Q-Q/#3/ GEJZ.J_UL\$2;0W
M_YGW6ACR0$]%63L(=K)XH@=?]K6CN<HA&?U17M1/M1^#LE+)#S-9^ITPXUCF
M@1LY/9,1B3,W#$FKEQ)10[/ G9IVR0Q0F@FNI)7,QATYCWN.1S7\N+!9D(Y0
M&6!'J(W1&L@F^E&XWRAQ<[-HG#3X@I,,\9L%$I?N4YJ5 9DXRUE0EO@&E(O>
MG!&R),QBJ<#027?=&O;2P(\\G1O"E-\;).)=Q\"AA0]<:GBC/9>/0FP1-CAM
M0I-8^@M"=V?!DO+>4*J UUM RS824C"!F*'+DV[U=[(A)(ZOG@7^U$1Z/XQ[
M%DB2?09<A)/8G]YEKVG6S3Y9/''"[F>!N%-5S6%!_J.@]H+95RV38-(=2;58
MDIR4A;DA3T+Q9R5'3+JEJ^8(R9&P=9DR39@1,NDVN#HHBYN,,@;V;'H,42,R
M#GWIK31K,2\JTY=$>. TR_1J%ON,;*5Q.C13"=#JNK7/Y!QV*/7=NIC24L1V
MM$6_H3V4LH^/.2%2^B)0MR <MA1EO<RBK$F<-A:,_U8O%O_E]R;?WD+Q;9!H
M_0J(7%#C"Z:2A0#8&&E\=6(?;*S2Y+K-NW/$_AYSWQ4*2?0&_B.7;!0G,5^>
M<BD'NI0#U50(%VL4ZYBLUB-9=L\H)M<55\+R1UYZ<5"=Z,VO_E66[K#2^B?R
MQ&CMC;!G&Z1_NO06"FA[EB_6V[A#YE0PT=JD/+%"/HL,QJ6D 0-!,EHXH$BD
M_$XU05A.Z6\2D:J&/0O^6Y+TER3],]UX4KKZ&)EG%DGU);GZ%)'$OQ.GGM2I
MS&5]DVT6V2Q+4MFX6=.3S7H=R&"E,V$V*2B#L$0S;;4&Z5XLJI02$<\0<VK;
MNW'UCUA.%VD[^-?ES7BH%YI$E+X4IP%-SO><CC(=.(.N0_A^A1W!HP4+VOP#
MS"4\>%6Y<46>KZCW+1M>^P-*@DUQ0I@%7?9+,', EUB%RXQ5N*BW6BFI^XKB
M#]]%LL*W#3[*RE9[R-+XD]R?!1NSUT4#UKPJ$B#<QL(+^D!A1F=X'K@Q8OP%
MA5@P!JO06WE[/_1!*$(- #I^94=I1O0;Q ZV,4=#, W,9%/##2(UAYS@#C&K
M\/? S%6Q1UON2NO?S5_ZN91YB!+68FF0YO3"_<'QX]Q'WS6D[C#WI"C O,-Z
MZI<=;;P["5]D=*%T-^D,@N@30G?OHO@:VY9^"F=.%\1,6+/-1YZPD=DF6SY&
M!8,,MC $.]K/G1CXAFA<Q(R=\$;HUB1VF(&PEG*'>8H\ZZPW16D$_&%J"1RJ
MBJ$^BWFA65H^LA:2:4,:F!)J+^3Y0QEDEE:>E2NTB>)"V7QSOJ'D]AM60:+8
M\T,G/A*?A%*+KC&_:%0%R64;1_DH (PM\@FE-?)/:+*F/H\=6Y;9CKFE_H:@
MZA#R5EB9=K;H*0/3&9N@77?YE9/X+F,K:G/8MM4;/\C P2L9U*@ZB['MEM47
MR[ &W@G28:U9>H%<R<67T)?P_,)QAL\B\DO@49]S/)/0 =X(TJ%ZI"<>F[H$
M[R[1E0;$<\=K/HM@. 51Q/;CSP)32R>(@4S&?6J91<2@%)-)O^K, F5+D*4.
MUJ,^OLVB0K,2R_7?^V91GUDN?)"#R5F4AE6BI,9#["R0HTA"3=?I+"IQ*A&/
M]%OS3.K#2@8WMQ^PM5;9_#G'38BY.BU@+<&.O-W&?EV?14%220DE>,2?14%2
M)6'%C128!;ID_$L#(A:TUMB\< '&B8,8I9"K;>J#[!TX8LC%+ J:RN&Y&9-Q
MQCJ;UN-E0!A(B3X]?E%[I=P !-;(T>OANTS:4@QB*5&W),D."HLIT;<DSG+"
M;$HD:36_)X.D*J"G1)-6\Y*%)DMRBCU03CUQ<O%2G7HB.6]+WO$%Y1TW&@$>
MW[ 1GF#482;C9LSRQUBQ%6[R+ 70BD5+(_U$3#-$Q]=XSZZ06_]HBUAX@(_
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MIT[+72QTG\PB')KM=&DBB^;EF,D#[$ O;!6L)O+*3)4IE7TY%<:H3I59,*/
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M6'K-WA/?P[AB1)"J3V(N!NK?&::#1Y3N(J_V&C #GAC0%K0.4%52Z(7N!"K
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MBS]@O-65 HFM&+&!Q^'5M^@N"[WU <5"/NR!CK,BK"81)&#!10*YL31_P5C
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M_X7T4<-6!122XR92J<ZB^Q$@BS&=)FBUC5%>;'BS05#%#:T@A@H=4O+9O_Z
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MM(W^E_=^ENY9^\3[77CM]AG;TF>[JF/.S02+A"5.4:2:I%RE_O4'X"8N6"F
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M24Y:WS*2@(1*>B"LX<^H@&R-TK(P=.&&=3*(D\# 0_GMU?NUEX4^EOANP^B
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M"O+:M=?OH054009 CA.PP\38:Y\1%QB_?.<YP*@"&D5XFZ-9FY6?5Z9^3)D
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M.&2\Z,IFZ<R81T<7/RJO1X/&(-[241248S(;!*C!D:!1D!.A1?&3%(6[(VF
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M&H$)H"0KGU32"")0Q596\DHC($"75/D9,XU  E!L%27F-((#0!%U7(Y/(^@
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MZ6 2Z5ESM*Z_'G8[+SUV$M4V5G;RPEMTNO(+!W!TZG>> 9Y5]CW,"*T<4O1
M(GT.D9?B*>Q6[^4LB;LE;9JT;<=3'&QZIU2\H4]I-@/HG2;-8&_L,Y-:J<DS
M?!*% 3FX=W&.3Q;*&!9H9E/K$V:^0W : [)G(D0UP$ITL+:(%_2!X@-BF:Z;
MG^V5C=\E:1[^7IVV?@I4QK0%G:PM9I5O48HOU62/R+,U,1+@JPN1X)$X8]F]
M!9ULUOQ]#_/')&/M0JN!/?+ADHEE<G@,O2_$CR%DGK]V"^?LU%-(-*?H/1-R
M@MMF.Y%(<(H>9]_$H!'@VV#$ @;?](!<K\HVU?D;RA*0 1.^GIA6.WC'SF#B
MAOG1FT@T=-24.C6,(J'444OKU#"VQ6%'C:Z3'V"#!W4"X^O4<'74!0=-L2>H
M\%G!S"8_D@ ]#,.>Z!O/*#]9L1D-+#L]U[-:1UZ<MZ?&,K0J= 3@Y,R<I9R;
MLZ"[33L%?5X_IUS;!:\3O,5<'T\Y(]56U.H);UED:E2KL$I/S4\2J_?WT$?X
M6Z12Q"%':?--MO^ML(\]"YGO'W;XVL):R"TB?#RLXDOV$2HNV3AH"]I,O%DV
M-EW#V[/2D=BT;1(%#[M]BB^Y3AT$NM6.TP/>$2NB[=3.%NEB[\)*WO-O7HIN
MT0>*$O:Y$[?7S1>((E5_C<,**,V<L^VJBT1TWV.1S '9DB3AES$.'I'$ AH4
MJ9*@"F*,%#!M,0$R.B-<M^6D<BF4VN!"1NF<@S44&)LG(K'<YJCA]3QNHT\
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MBFH[\[*ZC@@9,[FLKN,L&6V3&4/1A R-S!L=6QVM'QT4-$'08/!?(2C*80U
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MNK0M$S).4TGL;+X-&9W)#UEE.(;L/3D5Q0A4(<@034XV;/,]9+_2R2EI* =
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MT(M<TK2=0_MLS^PAX7==H4$O7'A'#GRFFXNQ?2I K]%4 CJ69[>C8"B[?3=
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MBI'G1I!RPSH@#F0W HX;2J],D+P1>!Q2Z,#4*OG!41T&4(F<'QR5Q[G9!HP
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M9UO\ORUZPG<12EM'K/$?H,U5>0QK!Y6P]YJ[-R:-\GGB.DG3Y!LQBWE[_,O
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M;2"TQ-!&'LR!Z?C=,%RI---&8(&HTYZ1P=H(1D#5NU&)KHT !$RUX6;.-@(
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MD=X4#%=96;=ZK5L;H,?/OG#U^#J?^2Z@QVXFYM3V0F%WP93-_SW*?1KD3!V
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MGOA@6;T&B(2(^I(6' BJ9_A[>BID69-3W%]?GLNPV<AC((!OI(G^,9-ONF.
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MP>J]=&L;A;-0N%1^@S+XY,ADU,H, Z/>=4U>BP[<0QVRUFL"^[-T9K<(TY
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M-FGB/X!T2[GHX^]A%%9H^(*2 [ E-KZ;9<Y\5\NJ!&D"!\$]6GI:T_AQ.*,
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ML"ZR:2[96B#D00A@. @:A$(O,S2R'";(AHH)'#FUO P3.'$ '1(I+KG/3,"
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MW9D6(*B$Y$#1-&R1"2AB;';%,%T1;S>FN$0'9<;R\D&FM$<A25% DP,0L^?
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M%24;=R[E H(W<3Y6*ZTXPBI_ZID51B"Z<Y@\)!NHXAJF4^8 =>T1-^UD!_N
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M_SW>]7I%3N!NK]?@J#X\1_7@'AW5[[^<EMGZAW_[_LM%O<Q_^/]02P,$%
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M7OU^K_6D)5+^H'B__A+V@PE"(=3]5,X_S!/L59RKGP30;W<K /0;GZ7A)CA
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M[4(6 !D@ V01,N.070>R=<B,L0#( %F$S#AD"4#FG1Y !L@B9,8A2P R*UD
M9( L0F8<LM- [MO]F[H1HY !,D 6(3,.60*060P9( -D$3+CD)T&<M-EP4H6
M !D@BY 9A^PXD.WJ]'0APV-X+$)F#++K/!X9'C,,&2 #9!$R8Y"=!G+3A<S,
M:8 ,D$7(?#<@FU_B::K,H41?VD^.S,]-?C[Z>I&HZW$TF:?JVD]TKF:ES@S\
MLG1UL9@DNEBF\7ILCU;Y:) >'/:,?A]61:GGZTV6JK-\M4@FRZS0U6URD\52
M7RJKPTWZYS<-1*.>7J1Z880HX[P<QZLRF]P^8&Y9?[R,SU3=+OCQW,!Y'*=7
M\;JH6X;M[W4[5&Q>/WW3+[[&E[F=9M<V%FP)3$W+HW)3P-=?"9<PN,^FX.LA
M4B<>F<3_*KV[1].OOX3]8'(KEK8#9I;&16%+S%S>7%3]-'^K_.#S>.KM#($J
M'*MH_"P ;%6I2[B1VWYAFV,CD#W=-S&8K9I3ZLR'@:G$CS;GFW!-XV6AQH5:
MQKGASD;HNKY7UQU\X4\N=:&G.M7E>KRYP2Z342?8&3W:CHN-!DU@[ 16D]/O
MO*[;.QSTOS?-[F'4O=.U/$FWW;C5*]XP%@O?AF\3(3,/TD[S>.@'/7_(?%Z
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M[#B0P\#O]%E;"" #9!$RXY!=![(=ALS:0@ 9((N0&8?L-)#[UB'W E[J 62
M+$)F'++C0+:+O47,G ;( %F$S#ADUX'<\[N] 7$/D &R!)EQR*X#N6N 3)<%
M0 ;((F3&(;L.9+L^/5T6 !D@BY 9A^PTD =^,/#[78:] 62 +$)F'++30*[6
M%HI8ZPT>PV,1,F.0G>9Q/7,Z9*(>0 ;((F3&(#L-Y*$%\C#$(0-D@"Q"9ARR
MTT#NV<7>.D,<,D &R")DQB$[#>2^70ZYVV6+4X ,D$7(C$-V'<BV#QD@ V2
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MO(QNQ;R)]4L]VY]H_T'M?OTE[ <3A$*H^ZF;+\R]=!*+-K2.%]$V/A^#36B
M4 ]>)W\N-G&=]X/-9\T3EA?"37" 4 ]?*;&;K2^B6T_KV=Q[MS)J9-Z)GF5
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MT/7REAEDY@Y=<PPSG?5 6HO2!5UFYTNJX4SK#6LN]H =E>% _ &%<:W]AE4
M>1O+X0(SK%)T,!ZV;%[V_D]!_JJ_7_7WGSSOUWU.067(>X07LK(QK,PFXQR]
MNKI-4C=Y2MGX\R[3-;&%8[AD=,KESQB!3[?L+]XA'UP21W&A<"=R<IBU5T6F
MOZETG%-ME6RB(/V\?_EK4WLJF@Z]G25XNW[\QGF/7[H._A!3THJOKH+/$.?;
M[BO^5, F][^M7*-('<H/0A8>72355C9UVX8E_=#639YQFQ<:PK\!4$L#!!0
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M@[+NF?%Q-D;<X70MRUJD,N5[GNL]:N21AYSF!00%Y!2# PTJ=NM>Z=E#BW%
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M#ARR:L[I JHUSZ$)4BV@?$G7A5WU!FWS_8.7#P9M^\V%?P%02P,$%     @
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M"2HKJ+-3Y]Z$'2,W$=F[&])^# 2F^";H1G<$O0M_WE2V<;X!RVWM\G[8BMV
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M%MGYDU,A*R5%E]Z.A6W,^[M1<ORS*()[D%DJC P28\*1LT+ (AUVHI,F*/]
M8H$!3RY]EI$RB0MO&6<Y7S.M]96MVG5='^,T0I%<I>4AA2WJY!*/6#B;<T?>
M/4Q9SIN?U1^01S0BL'VYS.Q8X=?HO,+P:79<Z5.IP:E:^KR2NF/I<;1 IVYD
M%*]E)^-#K\H5.Z305<F:H]69:9O% ND<I# 8U4N*B\N@'1\$J'+F(>S%INNC
M;<I46Y%0]%O+ILA;/E0\W6!H,7_L'1Y[&!N71YZ<.@X'$CT>AB]!A\*-TLB(
M[,C <,5D*HV+L9@O@4PANX1S?6P'>?DR)L9E/<B;48]Z-;U*/EKK8_,BS[A/
M:EB*U"P7KIHW4G2BZ3BSC>;(A$FR25IU1&L2[:-1[)XP!8%AUVU*^]CQ(B>=
MH-GCL >!EIG4:F%A37VAPVH48J4A80I_3<PH%2=&.D2L+B+)G$K:Y!%@IL=8
M"7QBGK,VRDD;B5FQW76WD*9QH[UI4''FZ2@E+B(["2*X<W,SBV%3J[E=Q#?)
M&<%DU>9:1Z.M2#E)7L#C'$^.G?&4I2WNC+8Z3VZK(@ M#!"]DT=)]T9_OZ"I
M1A?#^T)5B(>&NOODAD_0QJ"]LM/2[/\+S'R3I-0TQ#A$6A1II6%;24Y8)B'E
M$V%C(50YD[\H<QL%,Z3@%H 7&"M%-HJU?+!E4QJZ3+#H=MD:]2-O44: ZDJI
M,6"*;ZWQLQ4V]2+[D5M-2S2ZCL40+:*,US8GU;2D*1@IU"-EU;HYB,,#+3#3
M\XS4O U"CU)3L@P:. S2R>1Q?=O$<47$N9\#-:$8#,$4Q,--E8@S7CLO(F$?
M:,Q#K;&]0%V(K';?7K;U\UGJAA8U?_+F28M5=GZ6X<8&L)<#L4E'VH2I@&E]
MQ^;MF7R2!H J/H-Q&[DZ5*H=.0<8AH$8KTQ F&<]W(H)PI)9%#8_"+:13^3[
M5@@*U!:\%48GQ3"]3.QKR/M8Y8K#TG='^K&& R#S3A2A45(YSACY07#A_I!2
M)<Y)%2WD/?*T=%N;G(B8/9X\W"GTPT'O")IA:23,*9S;K7/S4E!WZLK7-6:E
MQJRLU,*]&K-28U9JS$J-6:D*9N4[XU/6J>IUKN"9=9Q&$>I&5P(1ZJA@OD==
M=7_KORTPU<TJ'";9_>*L@4BXJ2-3!@)ETFZ :N>")F='\::U@=4&X8L@E&I9
MII0CT<UFG@K']=# $C+[&)VN2\@0\M$H:@IIA# 4:<S..4Q^P2=<@D[*29''
M.?5_ XPV5XR95$> [KFI[G['-[[S;>?+UL!!NK8,D_^9<!?S-S,/UIL(AN4Z
M_@+G[3,&<-9ZG'-+JDIFM(XVHAN.S;>L8GV6E5<6'2ZST4I-YQ&Y=&2,OWRK
M?0Q=X9-E:J,]/H7K>Q,!D@ $R#$SX,&=88A>R1OKO1?8 54?^DB6+FSD-[(;
M90^KN$) [.7*MY!+4W)V*$\!'PT-"]WDRNFUJW.==+4J(WO+_D+):U11UI$W
M=U@H3U6B%"6VE7-+Y-+ [M!T-P)+H'I@^ C/0"/,-,WRKXI)=W%VM9M&RD&!
MI08WVJW-'#<2J"Y>Z"I.I1+RI+Q+-9^6LV"C0->[FPHXEF*T#'H$H^MG$639
MTX,6O</X69/&<=(\^F@^7UOC-)#I?>;V,<K49&10BXF?C'ZX=H9M"P*8+B?'
M^#C?(8J?;><[%7GQEZTQ+ 6<=T&$'A&."O<0=AQ\-0TSUH]/S0&<N"J?,%+Y
M5K:> U.UX PZFCK![CG#(]5\&X?V C6GBD)#'BM&7#WOF)W:'LWSLD"H9 J-
MN9IUS,%:'5"AE94%N5-'4K!FT>*Y3.,LJ!MPG(*B, CRC(O/>^A1G-7:L*;0
ML%(95'VI0RGZCX3/VGX<FD1"&N&\,*\;9H\+*U/,IPB EH@%/CNR+-<L7;F8
M[EJ"H694L!EEH1\\J:;G"VW1A<9#^$VRUC@B;:GV'1L;Z,#W&%N7&Y>XB/Z+
M%3PHGL/_Q8P8,H)]"MX7$PY=VTM$?C)G!1FV%[0ILZF2'#(\6Y]$ZJ2Q(@N(
MJ5^<*:G.+WF-_))5$TPPP\1,*T&V)(;W)QC4'%( JKH))GF6!!>/0-5THZ1?
ME<[";^1 0<R [Y,$N5'8[-D":=M0Y!Q&%-&86U:T*=*=(;3&3"=C (]RE7#Q
M ;[/YPC2];V1!($3#Y'8%8< ;_)2D<K#$C4$9SW)0^B+]U 5UB6KHL!Q+\/5
M]/H,6V-;[=;/%*HE!4GJ&>]M+Y*6^$*?F3KI\Y61,P1NP8] )M_<'#6>]^22
M1]?+5@A:>GC-5PWZ[N?7?G.WN[.SVSGH;'=:K?WV<U7KVNBM6CD(UD>>W\\+
MAJS:#K6A6A$W_!(W]N($B[EESLI@GAS'U ,SYXAAR8-^+<E]9LJ$>(:6Y$B"
M&D1<G]R:!$$9N-'T3\!>)L]^6WER0O3:YYCMBXW-'4$G#!:^,/![)3[\?.,S
M0M.(4?H2&3(OG4KQPH\?%&GM*3>5+FZ>-VTSVU #F M0%44:DX2(/C(XC-@:
M4ARY"_.NELOS!T[Y1J[V@,FL5#ZC#TVAFNKGH&(J789JN!=.YR*JKL=/[%$-
M'JK!0S5X:*46[M?@H1H\5(.':O#0]P</U6;=:YIU[U8M78EF75;L*\?7'@^E
M([M"9MU"0M"\SSWG@RDG^30IS@FN)1^=BV,NK09VJ#%36BT?:Q#44ZP^G<,U
MKW+GF6(54.J1H[!P!)ZBC=-[O3)P&$>@*%<:H]W%\-%&L2S7.B7=%*)8WJ;A
M.*G"7MC,UWBJ'7%K)[&/5RVR ?MIJ. _*+-Q9P]E)'6X/80K/*\B$KN(5%IS
MFF2O6D3)#1T#>L!KIV$@?/(A&*3<Y951G9O)=*:OB)%*3)<,YP=FPB,KD$06
MVM8X]?W9EHNG"!Y9F@!)M73.;[2H;>W6%B(IL))>$?R4@2CF3JLZJ/X6@NIW
MJ\74[X9# G<,<V44AL,AXWF&N&J'265CZA<$3#DQVUXE:=.T3A@6Q>G:L@[0
MTHBYEZ>NX!WN(HXGHO@ 47W@+W-5,@J5,;C\A21(0?(!29A!>-6_4@\Q-_J"
MS0*2;5&,WJP_D:118)9XR%7KR,C)N+@X]-'RO0E<J-A)9G/MS3@&X4E3IGG+
M7FCK'C>L>.H1<4BCA-Y,T7.@KDUC?$-""VYR;N$O>E3VM<&RQD@J1CEQU&BS
M6))\.>6]BCP;:?WK>VY7ZM16;*,;;P;"D2V;*HUS ;VA@#X9#859>M$48XR1
M:.A:+@K,*I;E9FE7PC<&@!D\;92T\+Y*KH 5BUJ8T[.LV,S"JBZ*E4U"9X.Y
M)J+H@<<ARG84(O_E7,68DD(V/*C%1RN61_ULB;44#%LQ8#2H1LK"R8R^1-[>
MXMU22Y3U8;*@KN:#%23]'$F&Y(H1S""5](W#3!QBQS*P+L9T@Q).FT6@XCPV
M@%)O0CNB 3JA@&48$8;W)@Q=[%9R6[WJ-Z>P9CV-SIXC6S'(Q6('ADRR8UA$
M.D4'DZ9CD2O\0XY)TYB?^:F)'YJ;4(:K$4X,;\\1:LW/6RERJVD-ED*?[V'Q
M(96B>6X:NPI&D"Y[<IF8);NH-F3>@"&SFAT#9DPD% <3FB]I@&)PJ!72;ZJC
M^O)VS%76^"KI TWK$XVCH=AK:6GF-M1J[O.HN<EM%*8WMP164_1_WOC)J&O3
M@!22D1__-E:94MCRA$9YJD+\)KOE,5GV+X3P*[JPLD8]L13@ACT?>_I6]-=C
M6DF -8D"*RAP)1I027)4_H6@J[H&^#!/8CGVHC@IIZ;R*/4)%QLQO_*(T]F<
M6QF28&#$[>W)W,=+>T;'?$]R*)3@I!]?]M"<@#]>80*X2X]Z#:6)971^-'5_
MKL?4D=9I\IY]:_2W1A76J,(:5;A2"P]J5&&-*JQ1A36J\/NC"FM*LA4IC[3*
MZ@4.DGAD%HY2JA:DE) .ME#QDC[-#">W&@)NL;H;RQA5'O\& Y%[O&&?H>O1
M0;^:S.&2J8WEJBN5,T+<P!RI#MZC:W2Q]JG"->56A 8R2')_+.J4*'2?V9\"
MT"&OB&=,,&HXYFT:Q2!1GO&DR3P6*-8Y.(;Q?8$KA&ST+'S(>4Z1QX-#>QE7
M4'9!G*N'M:PTE62-49=ROZ$K=J+"DPO##@^RX[#;VVQ5CI(/^R1YQHDB?8YM
MO':[O@6WZVJ<#'?>< BK07"T?IB$PRP@,$2[DN'0E?6[]G7;<:WWLF#&)[2)
M3XUH9W5K@IZ'"8K/#&X6S)"\7)='S/CN8)-',_DUB>?(\.$%9A&"XCFW*FA:
MYHGFSITR6=]'?B0\L%X-E-;N-O=W#UY)J,#+NMUNM01+!QK9WMWN[NQT]W:[
MG<[+R!5W);'B#H<!*$<.A7)4)'$^F_X9C(+O$H(XY[Y52XS\K@*V<QM6;N*"
M!,"8<&DP"/>SIJY:;P1SE68H']:1"K'M^05\@&WQSL$T$LXSH522#'\ L_68
MV<7J,]8(E->Q@4E0.K[M4'TW1!%F!)KZ\" W-/F3B1]LOMF:,H61C$;%6QF5
MXNAM[D[0>R5B (F@\:W:3,FXDZC9NNJ2R1"=U4I]+-]T0\8QY-ND.QYM$>RM
MT>:RB;E!  /:$PB&^F"4:)+)8KFJ8O M-!]9\^34*0O&>,F+GX>[S8/N]BL=
MAQ5,6=EN=G9V#@[V=@]V=G;W6_O;+W(<[C17.0V'0\6\9Z0;KNO9=RV[8NB4
M59*R"&O2Z%UI/G-[C=K3D8 O(O8&R:I)OKA!2##\/XRH7C%&[TDT&-JPJBZF
M2Q=&@HO%X5FJ7H1:=8-K"(9<L-4+9#$ZZ3B2\D3!JD':13<B?PPT5,E-E&X:
M-F8T15ZM*R0F\H1P,3&%W U2 5O7),1VJTK+BD/DUH:@$YNKU\?I&*L*P@6;
MLGAB5I5* C%D_-E-N5"5P\!*.-)N CJ/S7)>6=IHN%XSIESH[RHU8:J<I$RM
M")T41]Q697$GMJ2VLN,P@"T[(W5(<)4RQ6,M=U>3O0FRJ"M,K,=<3-GNI$E6
M=9-MS'#PQE*_PAIV=.>4/:=EVD96G%D_!O5 Z+9AA^O:ZW+1!/8D(]:E)254
M&4SZFY4I>;$&<I#\0],=E!=V'#.#50"&6:ITQ&R%-@R )[H,LL*#=$E8;*=$
ML"J$A(%RS:/-%4$5""D$;,@VNQFC;MZ%#_MJ,DV8C<S!P?=]X=8JU5M0J797
M5*DX"0#=#$.N[SRTAT9VP'"(V4KKJF1)#>$<=H?,;+79<\F=.[+.="I6C,?%
MF6>/B(R_2B*X:5T8V5<F+X+R8.9"83HUI10O7S!O=;E:XTHOYHR)LK00#9%R
MT\4D&0WS:2QX4#X5ZO#>A5QNV"@L?FN6\342BF5B7;PP(H2>%HZ_Y6IN$SV?
M_57'YC914*HF:?>PBD"[NMBK&J01A\= HG.3X0-JP'H0E(YILS',V7Q</5YV
ML,$6<,A:*G:.GB@R#U&6IB<M_XW[6RXDS83N)DMY0YX=*H%G/NW/^"E'8M[0
M]>6)97"F6!8UGGF3J>)YEC/S>R($.D\84:<(#>FX>6#HM#L]&T 8)6\RY<@<
M]LV7FXWB@N: YJ*!!2KDC0?][/DNS156SB\?=&[P:-/Q;3:)_'IQ+"*CV+M:
M=+AL8>I *?$H!R?_T-(#M88+UG#![XY_JSY<\#G,U1HO^ (+N<8+UGC!'PLO
M>-#<WNV^-*75$L.U;,>]G@VRU^SN=O>W6^V#O8-NJ]UY+NZJO17MU$C UURK
M;!@&0S^,X^$0X7T8UY(54"8O;Z=:ZFDOLBNNLDZ2.0J=/+).9"=EK93)2/J?
M*F6CUC"5-P%3L5>M\)#;GAD7J-ZI"();5R]2;E=F"#"Y02NU#=G#3G;\E!JK
M62H,#WT,8Q<C=B&,9L4 F+1D<=+(C3-.&DC- !:\AO).TL3S[3)_-$DH,M"U
M$Q^]X %Q,$P"+'*YI!D>%J1.9%"()A;L]M!E)HH,&R"?I3T>MBY)BN;^>.RY
M]IU'?<=.J [EO%'(N6*$G;+F;<J@0\!D%>@ T9TM"R62TT!U'KU-TJG.+<L/
M;3Y@@0Q)2%9QC\Z,J0ABL22&40AI0O-\3Z0Z,[H0XH".(ZH%QBKDB$JQB 1,
M"(94[FP?.[\0VFC'.8]A'.* (G]4$OH(3I%#PS0:M$;"F7"/-&$'ER!JJ-!)
MV8@&H;$TC"QJ#O@P!YB9WPVSCZ(-)E]U9L)$4W).LL0$TSUH3DI]4+V-@VJT
M*F=U4654VI1Y:JWK0;5(4UP'C$D6$,X ;08%3TD-4'WHQ#H_0V-J%)F=@1'@
M.(>,5WO!7>C?&8%;M2RX_*<>N0)P1=ZMLHK"R"2.R!'CQ:7A6BI;^E<*S6%L
MPXA\Y]1?;J\*3C>R(,-B[(H9S)['L>#QPLQ7D1<XWM169PL%)/#L(_:+\(;]
MWQ)Y44#@<81;DU5@K#R61Y,9"">4#@ZO<1"Q!QW:->*8% 7P.3HMO>D2^X[M
M^: H%PF$Z<'$W1 ]%%7% P4A$#-HK.V'"N^X")*@::O42."4S:,37G3I/<>B
M*T(;2O2%)Z,==+K2N(!U-:^+P]QQ6I(1QTE]M#XD^=6B=^H3/:^3R+5JOJ;L
M;I,2*Z?#2(4BRV%;7:E9O>?/JD?4KJ:7<#7MK^AJRN3!$*>=\BW 3%EWY])Q
MB9CK.=72"&KM_$UHY]_@1L+$)M()A@PE'G*9&85&&LW65CN_ROIFG5'?7B"T
M^)S:>94DP[7A_T"N,P?S5<L9>,DA%&O%;D8G.7&3DKH99]*O1+-;)\"P@G@_
M0^&^9P8,2^U>+W>9%2 =.Y+YU<1IRVRJ>4 //FV<1FS,R8F]57R]<Q SRL/G
M:NMY&G84.&$Y7@AU['E4G#9:"HF]DH";<[W92VDY7@0F2)QPK75J'I7_Q19Q
MG2/FM+WS0M-O2J=OT[HNRXPHR3*>:TJQ+QLR6PR48C@A28?E]LE7;1H,RHD]
MF;+CSIN@?9@H,]16<T4VR@@[E7APUTP"[)6QBZZWP[+3>KI O\T!@(M![@?7
MW]*#=Z^YM]VNUC%;1B?N'%U_.!U8O_>NKGKGUU;O_,2Z_M"W!OWC3U>GUZ?]
M@74Z&'SJO3OK6Y\N+\ZM_A_]J^/30=^Z>&_E[OS0^]RWSB^NK7?]_KEUU?_M
M='#=O^J?6)_.3_I7Q8?VCJ_Q">V#;K=A]>#SQSY<=F)MX'6:EN3XVN \O[BR
M_OFI=W;Z_E0_M'?^IS6X[EWW\<?W%U?]T]_.S;><]7X?4)<^]OZ4;8.WOJ=F
MP>76H'?6;UB#B[.3AG5YUC_YK0]_?/CS\@):<0R//<'GXH>KW['+U]#1 =Q]
MQ3_T!@-X'S7FK#\86!NGFU9/]ORJ=WT*HT6-@ZY=6\<7G_M7I^>_68-/QQ_R
MPVOUH4G'UZ<P?ME8X0!AR^'GN5Y?7IZ='M.4<.?Q.M5[Z#*V;>,4&H//H3;#
MP[ U^*H_^A\OKZWW5Q<?Z>=<:_$YEU<7@TMHS:>!==(_@S9=_0D7_?/3Z17U
M8U#21/Q;MO&8'E0IR;\0QU'#'6NX8PUW+,7OM6NX8PUWK.&.-=SQN>".M?Y=
MXGF9UZH>U.S@<\,Z?4\JU_'%QTM4@/$Y_<'U /3H<^OB\O2<%$]0Q ;O04.[
M /WM^B)W WPD)9353E#<!TIGQT: FOGN3[CVT_F@?]94^K>Y/&K7Y]JY/E<&
M)D1B$M[9/N(0%GI!U]?U27U#_:+V@GZC%U2'^,D;)H$",JQ=0+LA+2E2FR89
M78+ ^A6AE5#U1!]S*L4T-@/D@7!$'-L,R=/YXI(/E/UZ>BXY0W'.S:?S_@UR
M'WP'%GM%]%9P4_1OR7CT* R_;&&2:$0>7JJO4$39\1U9G:M\F'PD[,AB:J68
MBSJ&CL=TH^BYNZ<261@UCERNYS+6"8#<-QY&594)@8!A$$@_JW20Q;:?SYUL
M,#:.*]SF@'K0A.($4&?QAU$4PIPKM-P\@L,8/<FU(*_P17"#7M,QUT'A4/K<
M"%FW-LS(2(C NA6^*XFL\L_48(DL\Q=]EIAF/$:Z)X-45U,X7,^-N1,B60=>
MJQWK61YG^<(QF&+,DBZ<@RG]C]@6&E7T_$Z1$23"!M5L!6^!K>!@Q="\0N@I
M'_>Z'HAJKU[)?E3ID"G;XSCO)$(T,P]:*6B9*&32$I09R?58HXYX[J)<)"07
M_S#@5#'+[7"<;Q0"JI T@$\!I'^FIUS"#5A3CSBC8DGM8C[>RT5'LJ*1_%5>
M?*LW,[H(R5,DB\"BLT=R'-@D\1CEAC]*)%V!?;:A0D@DZPV>&(4):YB(L S0
MF.',\@,GU%L74)@O!K'5 O4M"-1V:R6)VM($L^LJ22O)(=MC<< 06ZE4Q@U%
M_8%_^;8WB3&U!A[MPA_W-N(W&?3(.QVV_R0-I*IFDN09U1@(KLO88P,KJ>A4
M0D,'1!J2X) *OR&/L *,LIBZI>)>)"L4_A>I3KQHHH6T3"G:/*)Z:/0(R1:B
MX;R2-$\(S-L@BA,J2L<2C$+(6+/T)H#1AC[>X4@B4PJH^9$'W=I064N:0 Q?
MYFPJ> #5-%"/%5M$($=4HI<G[S4(6/:BV'J2FI(#%9X*TG3#U0\&84B%5,WJ
MJEQ6%5Z!J&6D^F"]F4/FQA&"ES14#?BY#C0L.# 2#$+ @L/2"A(O6YC:"6QL
MBLJ+C)#0P$8CYR$1DN2X"8F1T"7;RE6L>H26YC--PM\-'D.;'C0CLAJ- S )
MS#1C+JV5\H-D31$RU2)!W"P]<E_'<5L9T&]^2$['!?OW\&\?!Y>@'CLH*$!;
M.@V<9FGL)Z=\((YZ;]EX/2V\D-,UNIUFJULEV'1^!+OMG98U^-WJ[L-&[<$&
M3D4]7LM$0PIOLMJ@&]7#M&28/GKPA(;U'M[NN;;5[;:W=U]]P"HZ-CW4E.@P
M^UL/='%0HB+01L!J0N9.NQXE&?HD5>WP;_94C<S_GL1818LD>Q-TH0='2@Z4
M:2)MP>AU#O9_UC@A'M+6RT4Y.\T.AL\J.LK9 <K>B\._78<YD&R!V5JYU=6O
ML84FOM!$M\RUB+,$NC'[;Q:1W#USG+)V%[R&NZ"]DKN@/1R"G94RV@ CEL+U
MUM=U<*R[ HHF=Z5*9D+3XJI<:F/#$*&!*+YB'"WV9YIH8=ZW2!8DD^O;A+OG
MWF5W%.DZ,54WFUEVPT9$!(I^2C^-V9W;T+]X&1THI\"Z=+%"C7M)2C^-,44Z
MR]65;2(;6C;)OH/3@=(Z04+Y]CWQ16">0#++!=EJ-^6;D#N=E>1.9SBD)8'K
M!,2.[XGQN@J=ONH'R!SL1\4D#M;I*3 LJVB'4A6<+T%X[POW1B6[8'TD*O!#
M 1XJQDE9_OSE:*9X^]'[)%$#\!]*9Q_!XI=>,)6K8DBE^S#U7690CC#C!4F"
M(O2D47$0Z]:.)DKVL7SA=Z"K%+Y&IY?,OX=.)PAI<.V)C<WF!ZN #8HR6%[H
M\JN9>VLH>PUE7PV;W:FA[$\9KAK*7D/9:RC[BS#W2NW^^ZORC]-QJZ'\D47&
MVAXJ4*-9+M_:,RM94M@UT_GLQVI]')G,=+[&(M6- I2->2-SIA.D<_9DSL:E
MYDK&I<RX9'Y)+] %EY4#C-O;*%8GT>:&Q>:&63G39M KK&7\1&*AP2R7_TH#
M60I31E8=Q']BKC0%4?.UM/C!"]I+&%J;@N/45J0R$&3__RL%7=CUZFJ8;\<H
M[JYD%'?!*(85&XFAID!=6Z.8^F'U5#^J911?YVL;Y1CS4("9=7MU%R3<ASQA
M@G&%,=:Q)$)6[J[!7,L6MT)ZD$UKVL&%2O$,^6;^NHF=)%R54U;B446A"!*4
MPEZ/!<++N?R;)REAJ7L3+#P4B#"-%=TN_(35?EA0&3V!'9Q!@PBB%-D@GXOM
M(H&:;UBA!K(\"$"6PMA@P"%P4/ E]XA1XKB#K+&LZ_.-0G=62@MBT!4OFH$G
M/%%79$ZBT*_EZIN0J]LKR=7MX1 6,F;!A!&QQ,K$C745K@/5&=HU/>Y,=25L
M1B#$RIUB,-=JJ4:OC3P25YP!9=37#-)(XZU'H)2.O3D)*_5,]2H]W\4H9]D5
M!(.?S^HQ,Z\DSB]_TR\EZ5@+^<DS#">1E<N?BU#T#!5:2ZPW(;%6*XR^@RCN
M(>%8AV1'#7G9.YX=K7%\]CQ$P0"#?$FVX3NS3Q667UZ6ZD(:7T$$+0JK\$<O
M,J&_>0$R1Z5OYAK.2Q89DZ5"C4HIE,%C2?P%]B<^%!6C!&EO2=[H IEFM<O,
M:I4Y-E3 4=S8Q+-F&,NX9!I9EV6@5WL  CM!X7P/-F\<@DJ(!=H#F:HZ4D3-
M=8;*FY1MJU4HWAT.;X5-9LFZRK$/LOU5DUG(9L@M*\6#C&GW@@B@^C%AX,\,
M)8ORA+/<7A0@$;0X*:T+4V_@-[&!5RO=MC<<VC"G+I6&0G-J$KHZ!1TS>C$/
M:5VW=D_UC+;&1Z-G1[#XL6?5VO0246;'!C>J!H4I)6&NY 7M?;1#)J0E-"R>
M0LZ&BM/IE'>MRGDU'%M&BEI6^X$"!*:_OVF!JL<+H:32LDEH,3:]/D9.JTS5
MS<H%D&BBBN5,B@J*CP^Z(W)99,2SQ02Z7'4*;F#,#8-+"HVDFN-\";U4<2!P
M1?-<U6M;W98//U!Y(MOS02%J&-$45XQMI(QE[)W"^JFZ1]P^<K0I?QP_/*MD
M3=&9V(.U8I->!5-%0CRQG%L[LIV$PQ5N=H/CI%&$HS 2,#"""VEQ*AQRV=+S
MJ?NRN10@D32T#6XS['LN,4'?PK.,8NB4 XE:(.;#W4M>D@@&%:D>X*BAZQ5K
MR)Q+[C$#*U.UC_+EW2U\+G-UD-W/N>F:/%>W;VGSLKQ+Q*S[J2L,91BN5.3$
M^LDJ;5RNW.(;C<#5LO?61^:;.#)7*T&Q/QS&:!QQ,?K9NAZ. Z,/U3H&3WDO
M@HB;\*X+RRLVL6U\!VL6[61?&[QI( *0E(Y0]6CP:69@ML$B6MX+_=>W2URS
M\00:GWFU.A,6#S<3S7E^E924LF)4OIW4I/F'>:9Y7T>7WYP,6HUKYV XO.$D
M_>!FZ-OWZRJ$?E.=L,[L^VI)H>MY90<T'!YUI4N[AL:S@-J%;.\ !!/,DHXG
M#!))WG4"JMD]FO-X?9@F"*?&T5#$7 RK<6Y#S/RG.F3!&#1EKB-JWYM"!\1*
M"F)DPU TRU\EJRK,2Y1-J5$2_-JQ4U:75+$UY3I0_2@*524.;VWT5H29#W2N
M!:62J\9QUSCN[XY+7@,<=[?&<=<X[AK'7>.XJX+CKDV&5S89.BN3R<7I2-)L
M#9-P:"IOZVH_#'2/4%?^/T:/JF5,]'1 /DX]K(+G*.)(T. =(1BY+GVM: >P
MBQ++Q;JJV'3>HT#<:!FP,E:@49\HQR082Y<VEDA732 Q%C YML\(=FV6? H\
MO(84=OJR-Q$1J/[J?<>W:-M$,^M8 =_++0QT-:._G) 0?L@L: H=X7'&P>^>
M#\-UDX02#&N$'3"+]"YTB/":EFQ603M+=\^;'C)=0'9'^DPDX'71>#>M@8CN
M/"YK1U_',7J&)A-*?I!T:YK;4Y/8/4 XIZ&VU!FN&W!P%&MNCRS P1&=LK!(
M/-<P645Y-M<?F9^1K:)1%*;(W&<. HT+!Y45QLX<9!S_%$&_G,U!;(#DNV=#
MD1##<HL1-[1-)<>A<41DE>6/Y%M&,9BL7:JLMIPC?*?9!O4^"6TF7QMRG/O"
MIE$F3L;Y3LD<YX=G>_&X6+=VS#2,N4L8!@T]]'#28?C32>UR>Q/GY\KL*AS/
MPAH0('UFPR3R;']=3TZ.?^/>A5-S9EUC7ZIU9O:S$R'':J!E1)QM?LX,0([6
MF6(50,90XB4HH2[P8JIX[U,9!2^X"_T[P?5H)64GO@,CLYY#]4&QP*<$^5$
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MH3O[QW_\^LMM,O'_\?\!4$L#!!0    ( +6DCUK^T1DG]U,  -;Q @ /
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M+$H8(.M61P[EAE15^0I-5KY)E=+0,.K$9B4[K5P=M]J8>!O&A+N2,>'FC8E
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MH,SQ"D]"'?0G,9?K%YQB4@6GK%:,BJ5>?&LBT93J3U<N>1+"[D*JX6<2[1J
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M7)2SR-^MZX:;.[@JM?.8#FP>N2Q,=M9Y-I"Y&&DLDL07!4SB"&'4,_(:1RJ
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M$#[Y$ Q2[O+*J,[-9#K35\1():9+AO,#,^&1%4@B"VUKG/K^;,O%4P2/+$V
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MXH&"$(@9--;V0X5W7 1)T+15:B1PRN;1"2^Z])YCT16A#27ZPI/1#CI=:5S
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MTTVK)WM^U;L^A=&BQD'7KJWCB\_]J]/SWZS!I^,/^>&U^M"DX^M3&+]LK'"
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MXAMCZ&P\ME^G*'%]Q+W*$>?\&$?<J5[VE3[9,"Y&6P\/,=AX,")8NV0LRWJ
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M0L_=3LVPXK'<J$H 33)ILY-)KYID4I-,^@OJ4D^-@8994&-&"%NE9>[',0"
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MSV_&3V%.-K'=9Q7;/6QBN^N+[;Y[.4S#V0]_>_=RG$_B'_X+4$L! A0#%
M  @ M:2/6K;%K]*#,0< O68+ !(              ( !     &EM9S(Q-#<W
M,#4P,%\P+FIP9U!+ 0(4 Q0    ( +6DCUKXU K+)W4% '$Y-P 1
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M,2YH=&U02P$"% ,4    " "UI(]:E0,F!_T2  #Q] , #P
M@ 'S+ \ ;7-P<BUE>#(Q7S$N:'1M4$L! A0#%     @ M:2/6@42?COT @
M%PX   \              ( !'4 / &US<'(M97@R,U\Q+FAT;5!+ 0(4 Q0
M   ( +6DCUH=$;*7[ @  $DZ   /              "  3Y##P!M<W!R+65X
M,S%?,2YH=&U02P$"% ,4    " "UI(]:R5)$&N4(  "2.@  #P
M    @ %73 \ ;7-P<BUE>#,Q7S(N:'1M4$L! A0#%     @ M:2/6B>W$3(R
M!0  P"    \              ( !:54/ &US<'(M97@S,E\Q+FAT;5!+ 0(4
M Q0    ( +6DCUI%G&!T0P4  .<@   /              "  <A:#P!M<W!R
M+65X,S)?,BYH=&U02P$"% ,4    " "UI(]:Y[ES5_53  #6\0( #P
M        @ $X8 \ ;7-P<BUE>#1?,3@N:'1M4$L! A0#%     @ M:2/6O[1
M&2?W4P  UO$"  \              ( !6K0/ &US<'(M97@T7S$Y+FAT;5!+
M 0(4 Q0    ( +6DCUJ8@QJ..1@  *7/   /              "  7X($ !M
D<W!R+65X.3=?,2YH=&U02P4&      \ #P"; P  Y" 0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>mspr-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mspr="http://investor.msprecovery.com/20241231"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mspr-20241231.xsd" xlink:type="simple"/>
    <context id="C_80f27fb1-52e9-4cda-90cc-c5c855c8fd29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mspr:ClassificationOfCommonStockBasedOnVotingRightsAxis">mspr:NonEconomicVotingSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-23</instant>
        </period>
    </context>
    <context id="C_82042595-d2ec-46bd-8d33-1d9c1c5fcd8a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-31</instant>
        </period>
    </context>
    <context id="C_83481840-3ca0-4d32-ba67-06de37b1459f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliatePayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:FundsHeldForOtherEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8396e5b3-8975-41b1-a3c5-b71482629bc6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ReservedSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8553900b-1ff0-43df-9d09-bab541f91e7e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_8558b10a-b3e2-41be-8e26-98a22240201d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_859ecd69-4f84-40b2-9e61-c5f7ca8a44e9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_867693d0-bbf0-446d-b67d-8df69e448e9a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_86c39d9b-6f64-4386-b8c0-33b19e6166a7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_87af9b54-aaad-4ee8-ad42-ba6bf6f841fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_87f7ef45-9817-4e4f-b4b2-29e0e91e875b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mspr:MSPRecoveryLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mspr:SubsidiaryAxis">mspr:MaomsoRecoveryLlcSeriesFhcpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_88fe5d42-7072-4d23-aaf0-bcc6834ff66f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="C_89033644-94ee-4bd7-ad47-12e753cbcfce">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_89133fd7-659a-4cd9-9d0e-e1da45db1b8f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_8c271ab2-9939-4c4b-a48c-af64c4e19688">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-04</instant>
        </period>
    </context>
    <context id="C_8d558395-7c90-405f-a7c4-dc8b67120549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:OperationalCollectionFloorFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-04</instant>
        </period>
    </context>
    <context id="C_8dbd5799-d76e-43f3-b963-830f8fd31b2e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_8df417e8-0685-446e-aae3-3e40048d4ae7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-12</instant>
        </period>
    </context>
    <context id="C_8ec762b9-f612-4652-b91b-9dc8a97a39c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8f91f567-de42-4b1b-97c4-bc338e0704b9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_8faa5dec-aa23-45d8-bc7c-a3721aed1c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_903ea2ae-ea75-475e-a44b-a70d6056fa63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-14</startDate>
            <endDate>2023-11-14</endDate>
        </period>
    </context>
    <context id="C_909336c6-c224-484c-94a5-23ceb49463c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_90d84360-6d32-4efa-ad4a-6a919e209aa9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_90ec9698-713b-426c-b0bb-0ec128980a66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
        </entity>
        <period>
            <startDate>2025-01-12</startDate>
            <endDate>2025-01-12</endDate>
        </period>
    </context>
    <context id="C_9268077d-b92b-434c-8a1c-d085e2f473a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:BrickellKeyInvestmentAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="C_92683e84-cc53-487c-a7c4-f4dbdc1db394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mspr:ProfessionalFeesLegalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_9269574f-8058-4390-81dd-e7ec4e7ed960">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_936c5ddb-0e12-496d-8f55-6b4fe1ea6f11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:CanoHealthLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:PurchaseAgreementEffectiveAsOfSeptember302022AsAmendedToDateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-07</startDate>
            <endDate>2023-07-07</endDate>
        </period>
    </context>
    <context id="C_93c831d9-6dfd-4340-ab2a-da4af19391f3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-04</startDate>
            <endDate>2025-04-04</endDate>
        </period>
    </context>
    <context id="C_948dc2cf-d2dd-4834-9c8e-109e2968c0dd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:PmpiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_94909e83-2e9e-40db-b644-8523c07ddb09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_94b11fc0-301a-40ea-b25e-f4fc6d4b8a9f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-23</startDate>
            <endDate>2022-05-23</endDate>
        </period>
    </context>
    <context id="C_94f5cc8c-3b7d-43d7-abe9-3622bcd0a570">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_9565635a-4edf-48eb-b58e-a592cc2a6e49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
        </entity>
        <period>
            <startDate>2024-11-15</startDate>
            <endDate>2024-11-15</endDate>
        </period>
    </context>
    <context id="C_95863a80-b9b0-46fb-b0ef-8af82e4c84a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_96faf7e0-a707-4cd1-84ae-926008d6d5e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_97164373-b267-4695-841a-94d63fab565c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_98ae30fc-b820-4fbe-b5f9-592ed60a472d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-01</endDate>
        </period>
    </context>
    <context id="C_998a064a-3957-4126-8109-a66c5f9a5542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:NumberOfTenWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9996cf94-6a99-485b-acb5-c26104f11cc7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9a2ac67d-cd44-4f9e-84d7-12c88681d46c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-14</startDate>
            <endDate>2023-11-14</endDate>
        </period>
    </context>
    <context id="C_9a7a94af-f271-43a1-89d2-fb92e5b46edd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspPrincipalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-04</startDate>
            <endDate>2025-04-04</endDate>
        </period>
    </context>
    <context id="C_9c8844ba-74b8-4891-9bac-96c2d880ebdd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-01</instant>
        </period>
    </context>
    <context id="C_9c92dc8a-3a85-4931-89ec-6e28019c163f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:ClaimsFinancingObligationAndNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_9cad53be-d2bb-4e7e-a24f-2d039319090a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9dbaa8ae-8f9d-4755-91f8-724dee794a36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9dda51d6-a0f5-455b-8398-c575ec62a1c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_9f0551af-5ff4-4726-988b-01f1ae60bf7d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ReservedSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:VrmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-23</startDate>
            <endDate>2022-05-23</endDate>
        </period>
    </context>
    <context id="C_9f05eae4-c2b6-4611-89ab-2c023d2bae90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-10</instant>
        </period>
    </context>
    <context id="C_9f487c5a-0b48-49d0-b043-d8a27a0e661f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9fe75ae4-df32-424c-8f99-45879b90c2fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_a1020e10-75c6-4d02-b1f3-a22f7c0f5c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:PurchaseMoneyLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="C_a14a72e7-94f0-4886-8c83-bd32c3ffe4e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-04</instant>
        </period>
    </context>
    <context id="C_a20e98f1-f378-4fc2-9d07-1d9c65d339f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mspr:NomuraPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-26</startDate>
            <endDate>2024-03-26</endDate>
        </period>
    </context>
    <context id="C_a5e2c7d9-9acb-499e-b27d-26fe7e7dce15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_a64e596b-3d3c-475c-aff9-9243dbb55747">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:InvestmentInRightsToClaimRecoveryCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMspRecoveryPartnersLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-23</startDate>
            <endDate>2022-05-23</endDate>
        </period>
    </context>
    <context id="C_a6a99836-7eb5-486a-9687-cdb21bc04965">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:CommonClassVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_a819d26b-6742-4f37-b1c0-79825dc5c770">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:MonthlyVirageWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-30</instant>
        </period>
    </context>
    <context id="C_a81ca7d1-03d7-4254-97b6-cef1cc580eba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ClaimsCostRecoveryAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-29</instant>
        </period>
    </context>
    <context id="C_a848591b-1adb-44bc-b891-a50be4491f02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_a9bac2b3-ff72-451c-87fe-ebf2bc6938a2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
        </entity>
        <period>
            <instant>2024-08-02</instant>
        </period>
    </context>
    <context id="C_ac30e5d6-58b4-4221-bd9f-24cd5b3365b0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-29</instant>
        </period>
    </context>
    <context id="C_acacf35c-6921-4d48-ad39-e840756fabcf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-01</endDate>
        </period>
    </context>
    <context id="C_ade22552-6404-4c28-b71c-a1780541b8a5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-14</startDate>
            <endDate>2023-11-14</endDate>
        </period>
    </context>
    <context id="C_aeef635c-511c-48e7-bd31-2303d3add962">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:CpiaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b1695415-e4a5-4136-8a0b-0977ddf9fef4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b2b2ecfa-79d0-47aa-8ded-ad13037b27b6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-01</instant>
        </period>
    </context>
    <context id="C_b3db7d99-631c-4482-beca-74fc892d1e93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mspr:CostOfClaimsRecoveriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_b40da480-7051-433e-99a9-7c5f5dd5ea4b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mspr:CostOfClaimsRecoveriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b46cfbc4-b098-4d9a-a0eb-4d949d390497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="C_b4bab880-e77f-42ec-81c9-310c18bf1482">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b4d69b9f-ab9d-46c5-9d48-786f9a6c9133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_b56a07ac-ec0a-4021-a488-5ef64b5339af">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-28</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="C_b7e7a2a7-5fd8-4f91-9fd5-9427aec0dbef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b8a984e0-7f94-40c6-bd5c-e7d950cd2591">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-11</instant>
        </period>
    </context>
    <context id="C_ba17b4e4-2add-4b5b-8fa4-ea5edfe1120f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ba6d251e-46b0-4175-8e53-534f56cc7116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-02</startDate>
            <endDate>2024-10-02</endDate>
        </period>
    </context>
    <context id="C_ba798111-eacc-4c32-969b-07c6da1f0336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-04</startDate>
            <endDate>2025-04-04</endDate>
        </period>
    </context>
    <context id="C_bc381c59-088d-4d05-9d41-0901345815e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:MonthlyVirageWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-01</instant>
        </period>
    </context>
    <context id="C_bdb33403-9b1e-41b7-92e4-eb7991db7d0f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-04</instant>
        </period>
    </context>
    <context id="C_be1531d0-0b2e-4de3-957e-6199271373d6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_be8b70eb-d4ba-4f20-b375-143fdf4f8fe3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mspr:MSPRecoveryLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mspr:SubsidiaryAxis">mspr:MaomsoRecoveryLlcSeriesFhcpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_bee1feb7-080c-486a-81cc-c38168970e45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-23</instant>
        </period>
    </context>
    <context id="C_bf132eff-e862-4432-9a3c-8ea0d6d97f66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:TaxReceivableAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_bf775bb4-df03-4ad8-b1ef-bfc5c2f6dc53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspPrincipalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_c070ff64-2fdb-45a2-8448-0062a4c61eaf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c1e89a5f-129c-4943-a1a7-f314ec636657">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:ClaimsFinancingObligationAndNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c23753ff-91ab-40d0-869b-679d87defcd8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_c30ed3e6-e67a-4d09-9360-8226e3fc395c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-30</instant>
        </period>
    </context>
    <context id="C_c452056c-aa10-4243-85df-a94afbf6101c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_c4d052d7-2f78-44e5-bfef-1e0596f96bbb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:CanoHealthLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-07</instant>
        </period>
    </context>
    <context id="C_c4e77341-1e9b-4ba5-8f65-82e4691d35db">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:OperationalCollectionFloorFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-31</instant>
        </period>
    </context>
    <context id="C_c51278ee-8240-44e0-840b-5a8e9271f685">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:TaxReceivableAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c5742b65-c220-4c54-a9c1-2dcf8313f948">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mspr:NomuraPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-15</startDate>
            <endDate>2024-11-15</endDate>
        </period>
    </context>
    <context id="C_c74b5044-7416-44a5-9669-00e2ec8bac52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_c83119b4-f363-422f-942a-c73e79c98c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c8abebaf-3c7e-4eab-8f91-5ad82e71af2b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c8ac68ca-b4ac-40c0-8ee5-21c155beaa2e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliatePayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:FundsHeldForOtherEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c8e18be5-39a5-489d-80ce-12c6054c1c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:BrickellKeyInvestmentAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="C_c92dc1fa-2679-4e97-b7ad-ad332c3af75f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:SpecificContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c9b18bd8-324c-46e3-8afa-33926f895ed8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:FinancingObligationsAndNotesPayableAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_cacd009a-fa05-475a-b5fd-20053ae0307f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_cb300f73-f574-4a36-a626-d7af3d2c40eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:CommonClassVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_cb90e83b-7cd0-4ffd-8a4c-cfdf4d8ff256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_cbc261d2-d131-4653-99be-97e07cea361a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:InitialVirageWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-01</instant>
        </period>
    </context>
    <context id="C_cc1f9003-7531-46fc-b9f5-b111a3ad3adf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mspr:PublicWarrantsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_cc4d14e4-5132-4152-bdd4-d68740ba0480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-04</instant>
        </period>
    </context>
    <context id="C_cecba122-eda2-4c0b-a407-e208dd46ea06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mspr:ClassVShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_cf6558a6-9d3c-4663-9640-79620d1887bc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditFacilityCollateralMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:SecondAmendedAndRestatedFirstLienCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-22</startDate>
            <endDate>2023-12-22</endDate>
        </period>
    </context>
    <context id="C_cfa5832c-9e4b-41f3-8998-fe2d8ab4f357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mspr:WorkingCapitalCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="C_cff61f62-d448-43e7-ae71-41198608a96b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-30</startDate>
            <endDate>2025-01-30</endDate>
        </period>
    </context>
    <context id="C_d0089042-c0e3-454a-8c16-1481457cdcac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-04</instant>
        </period>
    </context>
    <context id="C_d105a18b-9d1a-4643-bb7c-ac6ea1c98248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_d114e753-e2e8-448e-8e31-cdfe137f7707">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d1561d98-416b-4bbe-bf56-1bedb1ab84d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditFacilityCollateralMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-04</startDate>
            <endDate>2024-03-04</endDate>
        </period>
    </context>
    <context id="C_d1d4678d-582f-4815-8271-9022cf27ca70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_d28da71e-2163-4433-89d2-79d811cad1b5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d3663b7d-96ee-43d9-aad4-51ec8fb8fe14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:CanoHealthLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-07</startDate>
            <endDate>2023-07-07</endDate>
        </period>
    </context>
    <context id="C_d60db90f-4a37-413a-9383-5f9638a7dac4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d6608e57-e2af-4392-9108-161e0284de3a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:ClaimsProceedsInvestmentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="C_d6c4c28a-22a2-40b1-9778-e6b573c72de1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_d7d3c349-08d9-4eaf-a899-c3399e98c5cb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_d84f5212-815c-411b-b1b6-254a05c04b96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ReservedSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-23</startDate>
            <endDate>2022-05-23</endDate>
        </period>
    </context>
    <context id="C_d8874f5c-dad1-443d-9908-5daf18c46c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:PmpiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_d91eca92-81d8-4e73-a6df-71357a7bccc1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:CanoHealthLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:AmendedAndRestatedClaimsRecoveryAndAssignmentAgreementEffectiveAsOfDecember312021AsAmendedToDateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-07</startDate>
            <endDate>2023-07-07</endDate>
        </period>
    </context>
    <context id="C_d9cc9699-1810-4465-8001-abc8935d5526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_dba0c8eb-4e7d-4101-939e-a66a07a72a4a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-02</startDate>
            <endDate>2024-10-02</endDate>
        </period>
    </context>
    <context id="C_dbbed700-6dd7-4ab4-a4d1-5d2840f9852a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:InitialVirageWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-04</startDate>
            <endDate>2024-03-04</endDate>
        </period>
    </context>
    <context id="C_dc851705-b338-480f-8b51-035da6fa3959">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_dc9a1a27-6e49-4cfa-9469-c027ab03a71a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_df38630e-a571-42c3-ade6-4ab4217b9d08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-08</instant>
        </period>
    </context>
    <context id="C_e08e59d5-f389-4d0e-a508-50ce01da96aa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_e0dfe751-c423-4c59-83cb-f45bf2e04763">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="C_e0f110ef-52d0-4fa6-963b-0050628d41b6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:FinancingObligationsAndNotesPayableAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_e17c4aa1-a017-431c-a88b-5d1c628480b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e29473fa-863b-4122-a9a4-eac7411b776e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mspr:SubsidiaryAxis">mspr:UpCUnitHoldersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e330bbbd-adcb-4879-b62e-75b820d5a126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-14</instant>
        </period>
    </context>
    <context id="C_e3728ea4-48fd-4ffc-a2ed-312c25de71eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:InitialVirageWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-22</startDate>
            <endDate>2024-08-22</endDate>
        </period>
    </context>
    <context id="C_e39e346c-7b8d-4cd1-ba00-128383f3f5f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_e47e8e78-3f7a-483f-be52-5d827c62b8cf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:BrickellKeyInvestmentAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="C_e69f5703-ad7e-4186-a291-683b533d05a3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e701c51b-571e-4acd-bab5-e8a71bb9884c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:MaoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_e76601ce-3711-4870-9e0a-3ab905ebdac4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_e8640518-f241-41b6-ae14-29e050a44e3f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-26</startDate>
            <endDate>2024-03-26</endDate>
        </period>
    </context>
    <context id="C_e9e16be1-82df-4b4d-8077-c5113b5f1637">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ea41718c-eb03-4364-a84c-37e5f43f1623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_eb9380b7-557e-4277-b64d-8fa02512fa54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-14</instant>
        </period>
    </context>
    <context id="C_ebf33321-45e9-493e-8b1e-d30e0e2f7a60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_ec4285f4-9b93-43aa-ab90-0409cd42c969">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mspr:UpCUnitHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ecb1b45b-fbaa-4bf2-92d9-318171959c6a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliateReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryAviationLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ecedb469-0a15-457a-8825-173264a5730b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ed1639a1-0034-449c-ad1f-a852134441a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ef3c75c0-7dd9-4529-8a9a-8a70309613f8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-30</startDate>
            <endDate>2025-01-30</endDate>
        </period>
    </context>
    <context id="C_ef3df522-36ab-46ff-ba3a-3539524a7ffe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspPrincipalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_f07a439f-c693-42c4-98e6-3d9e006b5525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f0fc5e6c-97d0-40e9-841d-33b02270183d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliateReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f1707b98-eb20-432a-b96a-1452ac5f9a6f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:FinancingObligationsAndNotesPayableAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f22fac30-7861-497e-b1e5-adc45046f525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-02</instant>
        </period>
    </context>
    <context id="C_f282d974-0b54-4d2a-8885-b9170aeb1b0e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mspr:SecondAmendedAndRestatedFirstLienCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-22</startDate>
            <endDate>2023-12-22</endDate>
        </period>
    </context>
    <context id="C_f39537ea-1309-4548-918f-2247de76b5db">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:BrickellKeyInvestmentAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-15</instant>
        </period>
    </context>
    <context id="C_f47d4941-5e9a-4b10-9ef9-c0cd1e17b7a2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f5366bf8-0f82-48ee-a516-2669d00a2346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:TermLoanAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mspr:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-01</instant>
        </period>
    </context>
    <context id="C_f7fd3f49-71c3-435f-9615-5ad600a0128e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-29</instant>
        </period>
    </context>
    <context id="C_f861f31f-886c-4e73-9be4-15fe686df5d1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f926d350-ede4-483e-9655-21fee4b1788c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-10</instant>
        </period>
    </context>
    <context id="C_fc307584-aef8-4d18-a952-2cc14880dd3f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-31</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_fc6dbd33-7019-4991-ae2a-4323861f1f73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mspr:PublicWarrantsOutstandingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_fcb3bfd4-b997-46bd-95a6-c338562ed04e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_fd924673-3ac8-4110-8c0f-caed5b9b9417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_fe25ee78-67ec-4d53-967e-ac07893f4a6e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_0056d899-051b-43a5-b6bd-b84abe56a57e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ServiceFeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspPrincipalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_00bf460d-a55a-43dc-b3bf-96f35be4b164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:FinancingObligationsAndNotesPayableAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_019f56fe-b87d-4bf1-9a97-950481da89e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-04</instant>
        </period>
    </context>
    <context id="C_044f7093-020d-4a2c-8402-0be8ff0eb918">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:FinancingObligationsAndNotesPayableAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_045a7ff1-2fb5-4c22-bc5d-29ba574f00d7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_04ac6ccd-aacd-4024-ae81-e73dcdcaa130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mspr:OfficeAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_056857a2-ae2a-45f6-a0e9-2f2918ae0478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_0583270c-f1a4-4ea8-9ef4-57cca824c658">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mspr:SecondAmendedAndRestatedFirstLienCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-25</instant>
        </period>
    </context>
    <context id="C_05d37fc5-14e3-4592-b1a0-f0a3bb0acc27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ReservedSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_065c4f1b-82bd-4f57-8208-a41a3b157055">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mspr:ProfessionalFeesLegalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_0788ee7d-2d90-4bf2-ae7b-9ebb1d14ae84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_07df6a83-0af1-46c6-adcf-ff855b251aa5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mspr:CpiaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_08ce17f4-9500-467c-ac13-d6286aef1dd5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mspr:OtherSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_096f06bd-fa6c-4347-b329-d00e63925c9f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-18</instant>
        </period>
    </context>
    <context id="C_0acb2411-d354-4e47-8f87-facfc960c807">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0b0648be-cb1d-4812-9bfd-c206264a6106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_0bbf18dd-84b1-4a9c-8590-5c60d8a4eac1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_0d4a0973-f818-41cd-a1c5-5c03e254d884">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mspr:LegalAccountingAndAdministrativeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-04</instant>
        </period>
    </context>
    <context id="C_0d6f7737-1475-425e-8764-bcd96bc150b3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_0db234ba-3e48-4d00-9318-17c9b2c2ecdc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0de33523-97c8-4b01-8a64-4dc4bc66ca27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf00625PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_0e019663-7988-47f0-9493-92a40c3ae831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_0fff79a6-2fca-469c-b4ba-d88fff8a1879">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-04</startDate>
            <endDate>2025-04-04</endDate>
        </period>
    </context>
    <context id="C_1065a761-b9fe-4aae-899f-8f897411b778">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_108cf1ce-e085-4fcf-bec5-40d0b2f1648c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_124c16cb-bff6-4d6a-83be-6bf4a76f2445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_125dfb7b-a596-48e9-aa73-d42dc93faea2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_12cd0c5c-e9e0-4c6d-873d-d9f0a4031377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mspr:WarrantsIssuedToVirageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_13748221-3ec6-4846-a96d-b183a19ab473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mspr:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-01</endDate>
        </period>
    </context>
    <context id="C_13c3ccb9-b33e-456f-b270-960ccbced512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_1590504a-c1dc-4f29-92cb-3b6c727c0ce3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliateReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:AdditionalReceivablesFromOtherAffiliatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:OtherAffiliatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_16e00acb-17ef-4f0e-b8a3-32f37c07b09f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:EquityMethodInvestmentInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_16f268f8-c0e0-4f58-8d27-bfb1180e5347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-30</instant>
        </period>
    </context>
    <context id="C_171901d1-c52f-41fe-91df-db360c126e4e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_1720b370-71e8-404f-b2ba-d747e1f96522">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_18297503-8f58-43a0-b62e-2f8147de332e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_19dd057d-164d-4d09-aca4-862b4fbf7c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-02</startDate>
            <endDate>2024-08-02</endDate>
        </period>
    </context>
    <context id="C_1bdb4676-b3b4-49b4-a184-8e7118c0d4af">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-31</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="C_1be14025-3d59-42c6-81ac-3d450aba88f4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:MonthlyVirageWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-01</instant>
        </period>
    </context>
    <context id="C_1d7e8bd6-06e5-4825-92f8-4bcc96d6e304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-14</startDate>
            <endDate>2023-11-14</endDate>
        </period>
    </context>
    <context id="C_1e01a200-c2e8-4634-9efe-10da04e93fb6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-04</startDate>
            <endDate>2025-04-04</endDate>
        </period>
    </context>
    <context id="C_1fc207a6-b212-4da0-b588-3744dd9baaf9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_1fec80b0-38c3-4131-ada8-3af5893a5151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_2007c22d-ce55-459e-b965-217365e43f85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspPrincipalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-04</startDate>
            <endDate>2025-04-04</endDate>
        </period>
    </context>
    <context id="C_21918913-de21-41f4-bb8a-ff60365fc94c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-04</startDate>
            <endDate>2025-04-04</endDate>
        </period>
    </context>
    <context id="C_21fdfacf-60d9-461c-b409-b9c8d8d5e297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">mspr:MonthlyVirageWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_22a3e60b-719b-4f54-9b60-4ff2fca68d03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_23a8a03a-394f-4c24-88aa-cfe8564c686c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-30</instant>
        </period>
    </context>
    <context id="C_23f0d6a2-3c2c-4e89-aa10-98a9a94f129d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_240c3aca-617e-45d0-80e7-144cd05885bc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mspr:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-01</instant>
        </period>
    </context>
    <context id="C_2430ad04-c84e-49df-bcbe-0fa2ab3fc260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_24ac4204-0641-451a-87a3-70ba142b0f90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliateReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryAviationLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_24c05dee-37c3-47dd-b886-8f4b407eef55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_26717c14-ec44-4c6a-8117-50449ba3aaaa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:MsoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_28b71e0a-7e6d-429a-b008-1ff060441f3d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-29</instant>
        </period>
    </context>
    <context id="C_297dbcdf-6f51-4f4f-9dc8-a5ae170c5102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-15</instant>
        </period>
    </context>
    <context id="C_29a25c58-bd49-4813-98cf-174eff897359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2a65b7e7-25a4-4784-a0df-3b3fc40b9b39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspPrincipalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-04</instant>
        </period>
    </context>
    <context id="C_2b6ff688-5733-44c4-adef-6460a88c6577">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-02</instant>
        </period>
    </context>
    <context id="C_2c439b10-3157-4c98-b8f8-371831d66f6f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-10</startDate>
            <endDate>2025-04-10</endDate>
        </period>
    </context>
    <context id="C_2cfffa07-7d0f-4494-b8a7-e7489ea1d410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-01</endDate>
        </period>
    </context>
    <context id="C_2f3b6385-dd5e-478a-98d6-86c7576434f0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliateReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_305dc9b3-22e0-4f75-b7ee-85c8627cae64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3141ef96-8081-408d-8688-cac679df2dcc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-18</instant>
        </period>
    </context>
    <context id="C_3190b9d6-2f05-4406-add2-4c8346e46faf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_31bd9c41-8edd-4613-86e6-85b50e497f78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_32b282eb-1b22-41ce-afda-7322605f66e8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mspr:UpCUnitHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:CommonClassVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_32d5fd3f-18ff-44f6-bea9-54478be0fe12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-18</instant>
        </period>
    </context>
    <context id="C_343a98c3-3718-4240-81dc-cca99ff09156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_349d4676-24fa-4ed0-8d02-0ac0acbd44a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mspr:NomuraPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-26</instant>
        </period>
    </context>
    <context id="C_34c224df-e4d4-4363-a01b-1fcb9b2acaa2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">mspr:CpiaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_3597e466-ae9e-44f5-b5bc-782036376b71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:ForcedExpiratoryFlowSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-06</instant>
        </period>
    </context>
    <context id="C_35dae5c1-7aae-4e29-bd11-991504d30ddb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-14</instant>
        </period>
    </context>
    <context id="C_3895f47c-684e-4e66-8154-738062424885">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mspr:NomuraPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-15</startDate>
            <endDate>2024-11-15</endDate>
        </period>
    </context>
    <context id="C_38dbca91-c3fa-4361-8e4e-ad3d415625fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3c7a8126-415b-4641-9233-e1ab41a700c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:PmpiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3d1f3cd4-008e-48b3-85da-f506bc8106bf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_3d4f1e16-3314-456a-9834-b6faa08ca709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_3e8969f2-ae97-4d3c-b1d0-74bbfc712aea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:CpiaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3f1e810b-70ff-4880-b849-ee3f4452b2d0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_3f274e94-4af0-46e3-87d2-ba8533edbab8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:MinimumRequiredPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_3f5e2295-148f-48ae-a6d0-b63e048ebdc3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3f7d2988-c276-41f2-9ddb-13cdccfa0680">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-25</instant>
        </period>
    </context>
    <context id="C_40198a04-59e0-4db6-b71b-2e2d515a739c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:RedeemableWarrantsEachLotOf625WarrantsExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf718750PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_4275f40d-714d-47ab-97d1-4eba6db92ac7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VirageRecoveryParticipationLpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_428035f8-2a73-4bf3-bd07-7c486a2b2984">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4400c0b3-2cd1-40b7-ac05-f868dde9be3a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mspr:UpCUnitHoldersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_440a05a3-a996-4acf-b096-ffc25257e6de">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4444a183-cd75-453f-82e7-94eb0d9ecda9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_47aa4785-b887-4bdc-9f4f-5f764a502283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ClaimsCostRecoveryAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="C_490f215f-7665-40bb-8a57-3e0bba257f4f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:ForcedExpiratoryFlowSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_4957a749-8bfa-415b-9b7d-70a5bf0f2f52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_4a8604ad-e380-417e-aa2c-4c0e29ad2d19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_4a8f2f53-79e9-446a-aa64-4ca7f9c8dff2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4c7596be-feb0-407b-896b-01187ad8e8fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ClaimsCostRecoveryAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-23</startDate>
            <endDate>2022-05-23</endDate>
        </period>
    </context>
    <context id="C_4cf329ce-5aca-4da4-8888-8728533d3e78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4d43bce3-acbe-4666-82a1-1d40c94afa24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:MaoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_50aeca4c-0cc0-40a9-95d1-4f6f9ca8d58b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:VrmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-01</instant>
        </period>
    </context>
    <context id="C_516f8b35-03d8-4c39-9130-a23b7a95a2a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_51823262-9427-432d-a0b9-aa056efd7162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_5247622b-3115-44c8-972e-3aa6f0834d88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:ClaimsProceedsInvestmentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="C_5252ca49-cd7d-42f1-90d0-31e55fce0385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliatePayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:ExistingLegalServicesAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_540b65a1-9fe2-4515-b78b-8e298f79fa7e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-01</endDate>
        </period>
    </context>
    <context id="C_54d701f3-9c51-4703-a1c1-2c01604c2e0d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_564ee707-2109-45f7-83d2-89ed72475362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_56b72099-7c42-4ac1-9909-043db62ef97f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_57297e08-daf9-4ea8-9f0a-e30feb80ee20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryAviationLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_57d602bd-2d0a-4e61-888a-2ec5eb79b28f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_58441ed6-59f7-4eb3-8ebb-2144c6210c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mspr:OtherSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_59b01d67-342b-4678-bb64-aa2875d5d3be">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-08</startDate>
            <endDate>2024-04-08</endDate>
        </period>
    </context>
    <context id="C_5b46d7fc-7b57-43b1-9b41-9ab104ade8c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:PurchaseMoneyLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="C_5be07310-661f-4b62-876e-7ad045ede894">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_5cbb4b4f-b96f-4942-a566-a9743e895772">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202307Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_5d819013-3703-4830-ab07-b1f1c7119714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_5e551576-1454-4e6e-8860-e330e9e8fef2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_609a7cf7-e71f-4260-af06-3fa43d842a79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:FinancingObligationsAndNotesPayableAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_61507485-2d9f-40ad-8b7b-fd6cc068d0c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_61e6579c-7403-4590-b421-ac4ffdad7513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:SeriesMrcsLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_62435c4d-78b1-4259-85bd-74e491eb2245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-18</startDate>
            <endDate>2024-10-18</endDate>
        </period>
    </context>
    <context id="C_6416e867-3e37-4d6c-9be5-842500520199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mspr:HazelTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mspr:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-01</instant>
        </period>
    </context>
    <context id="C_6607a34a-616c-4068-a1b4-1252fffde914">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_66a14f4e-f9d4-4b7a-8ceb-e5a34a3dad44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryAviationLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_66d1760e-3b4b-4a44-adcc-7a80bfabd72f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mspr:OfficeAndComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6839411a-9365-4c82-94be-9667ed37b849">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_6914b62b-8ebd-492e-9751-a059c6e34653">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:VirageTermSheetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mspr:RestructuringPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-04</instant>
        </period>
    </context>
    <context id="C_6965b820-31a4-444e-ba96-f6ea5d589a06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mspr:ClassVCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_6d36e1f0-9fa4-464e-bcc8-ec43920a4389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_6fc20ca9-1ab2-42c7-8e99-0cc58496a91f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_71aa315c-44f8-4147-b3c3-c4ea2d43f242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-08</startDate>
            <endDate>2024-04-08</endDate>
        </period>
    </context>
    <context id="C_71d4c574-8d09-4451-b706-aecd0cddefa3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
        </entity>
        <period>
            <instant>2025-04-04</instant>
        </period>
    </context>
    <context id="C_72b0b910-c912-487c-9f21-114be2b29359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="C_72c17608-1d12-4578-9b1c-a1ccd7d443c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:YaIiPnLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:VrmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-01</endDate>
        </period>
    </context>
    <context id="C_747655f3-412e-461f-8786-a873c027b7d0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_75501a7c-fddd-4767-9d6b-6669aaf3d334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:ClaimsFinancingObligationAndNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_77a7af59-7ae1-4d3d-a7f3-5e0380c71c5d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_77c0175e-530a-4d31-b2a4-dbf10318bced">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mspr:MsoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_786664b5-9979-4e35-9243-6bdb750f8536">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_788dd740-ae7d-4599-bfa0-5e03d87f6792">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:HazelPartnersHoldingsLlcLetterAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:WorkingCapitalCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-30</instant>
        </period>
    </context>
    <context id="C_791e8b5c-e454-490f-af98-b274119fb0c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mspr:CanoHealthLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_79d9f285-5c8d-4c0b-8618-a9851a277fcc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">mspr:ClaimsCostRecoveryAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">mspr:PurchaseMoneyLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="C_7a02de5d-b9d8-4bf8-9ce7-036a7202e220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_7b14a4eb-0fed-4c10-be9c-613f3475755b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mspr:MspRecoveryLawFirmMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">mspr:VirageAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_7ec4a520-4502-411f-9714-8faecac859f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mspr:AffiliateReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">mspr:AdditionalReceivablesFromOtherAffiliatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:OtherAffiliatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_7fafbd14-3e05-4ab0-b8db-3c7d640f612b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mspr:UnsecuredPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_7fe3a456-0271-47b2-9277-1147387966fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001802450</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mspr:ClaimsCostRecoveryRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Days">
        <measure>mspr:Days</measure>
    </unit>
    <unit id="U_Segment">
        <measure>mspr:Segment</measure>
    </unit>
    <unit id="U_Members">
        <measure>mspr:Members</measure>
    </unit>
    <unit id="U_Tranche">
        <measure>mspr:Tranche</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U_Investment">
        <measure>mspr:Investment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_b323380d-1dd9-4878-be80-aabdb6a065ce">0001802450</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_fb03b66b-bf08-4fce-b90f-9c48a92c3f83">FY</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_ea0775f7-3f76-484b-a25e-9c209fe1e197">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_95ee2598-9ded-487a-b450-fb16e8eeb8a9">false</dei:AmendmentFlag>
    <dei:SecurityExchangeName
      contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156"
      id="F_45f62b44-7ce5-42b4-833b-a2684d21b27e">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="C_40198a04-59e0-4db6-b71b-2e2d515a739c"
      id="F_8d6c5f74-9ddf-4376-bd12-11eb7e1ff425">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="C_0de33523-97c8-4b01-8a64-4dc4bc66ca27"
      id="F_ee6b036a-077a-4fbc-a8ae-9fdf6d065041">NASDAQ</dei:SecurityExchangeName>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      id="F_40f7ef7b-5eb0-4c7b-ad84-9efbd7cf34d6"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      id="F_b4dccdf0-8391-4f47-a8d8-62f8ba636738"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="C_9565635a-4edf-48eb-b58e-a592cc2a6e49"
      decimals="4"
      id="F_51bd4aa3-2e94-4fa0-8f20-4260f6251be5"
      unitRef="U_pure">0.0004</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="C_9565635a-4edf-48eb-b58e-a592cc2a6e49"
      decimals="4"
      id="F_11cad189-e838-4ea3-9011-9fb880f04e08"
      unitRef="U_pure">0.0004</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="C_72b0b910-c912-487c-9f21-114be2b29359"
      decimals="4"
      id="F_6dbb5636-fa51-4f4c-bb43-bb758434c2c0"
      unitRef="U_pure">0.0004</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-4"
      id="F_86dbe84b-548c-486d-9e3f-7db44ea29333"
      unitRef="U_USD">-446050000.00</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="C_ef3c75c0-7dd9-4529-8a9a-8a70309613f8"
      id="F_b0a040b1-eb30-4c2e-913a-8367a95bb387">P3M</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_8b390608-14b7-4bdf-8388-0311ecd33fec">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration
      contextRef="C_5e551576-1454-4e6e-8860-e330e9e8fef2"
      id="F_d7c0ff4e-449b-40a5-8325-8ed41dfb3e58">http://fasb.org/us-gaap/2024#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember</us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="C_90d84360-6d32-4efa-ad4a-6a919e209aa9"
      id="F_dcf042f9-2441-4111-b785-0c83a5affaab">P3M</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="C_90d84360-6d32-4efa-ad4a-6a919e209aa9"
      id="F_339a811a-2d80-47ab-9bb0-fca6e26a7e13">P3M</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_77a7af59-7ae1-4d3d-a7f3-5e0380c71c5d"
      decimals="4"
      id="F_6dfc678e-53e4-4a49-b837-6bb6cde847d7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0016</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_abbe20fe-8830-4413-8cd7-922975cc36b9">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
      contextRef="C_1e01a200-c2e8-4634-9efe-10da04e93fb6"
      id="F_1094ec3c-3994-4e86-9062-4c0d05c077e7">http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember</us-gaap:DebtInstrumentVariableInterestRateTypeExtensibleEnumeration>
    <us-gaap:DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
      contextRef="C_1e01a200-c2e8-4634-9efe-10da04e93fb6"
      id="F_d7edfda9-d03e-48a1-be13-3f45acb6f141">http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember</us-gaap:DebtInstrumentVariableInterestRateTypeExtensibleEnumeration>
    <us-gaap:DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
      contextRef="C_0fff79a6-2fca-469c-b4ba-d88fff8a1879"
      id="F_4e424096-b0c4-45a8-94c2-f9386f78d00b">http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember</us-gaap:DebtInstrumentVariableInterestRateTypeExtensibleEnumeration>
    <mspr:ClassOfWarrantOrRightOutstandingOwnershipPercentage
      contextRef="C_096f06bd-fa6c-4347-b329-d00e63925c9f"
      decimals="2"
      id="F_6c011bf9-0559-4a17-8cc8-0125ab18a42f"
      unitRef="U_pure">0.11</mspr:ClassOfWarrantOrRightOutstandingOwnershipPercentage>
    <dei:DocumentType
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_f3d663ee-b685-4222-9894-4fcaee711feb">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_cb7d5489-dab2-4169-a591-5b340cb7fa32">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_99bc00a5-fcae-49c7-9d1c-7044e07e6ad0">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_17d1a794-9f3f-4037-9dd0-e24d7d0a8324">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_8b9c2f16-a804-4a2e-b757-7b3f9d9a1747">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_dd17172a-1644-4bd3-802b-eee3eba37943">001-39445</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_96896f80-4a22-42fd-b0bd-5baa981c9534">MSP Recovery, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_c8e20ba6-1f5a-41b6-a628-981fb2d9236b">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_9519c9dc-b6db-412f-b690-416c3039e978">84-4117825</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_3fb11ad3-5d21-4697-bef5-0dd7df92d8e8">3150 SW 38th Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_ce2735c6-6dd5-4027-9cd0-21e672e7b0f0">Suite 1100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_ed5a956d-aa20-45b7-b15c-74448d66dca9">Miami</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_a95e7f9a-f3c5-4ab0-98f1-1fc897967b8d">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_dd228b8b-f011-4f44-84c2-1ae36f54ddd2">33146</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_cd075438-e706-425d-b198-ff3c8a172793">305</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_3b843241-d6fa-4e01-b014-bf1c14a2e058">614-2222</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156"
      id="F_cc7dee40-b866-4d7b-8d34-0749e31c34de">Class A common stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156"
      id="F_2f9d620b-84f4-4138-985f-b97809bbec0c">MSPR</dei:TradingSymbol>
    <dei:Security12bTitle
      contextRef="C_40198a04-59e0-4db6-b71b-2e2d515a739c"
      id="F_3d6bf331-c765-4850-8509-e164248f4344">Redeemable warrants, each lot of 625 warrants exercisable for one share of Class A common stock at an exercise price of $7,187.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_40198a04-59e0-4db6-b71b-2e2d515a739c"
      id="F_10f2ff23-a66d-4474-bde4-d320aeccba08">MSPRW</dei:TradingSymbol>
    <dei:Security12bTitle
      contextRef="C_0de33523-97c8-4b01-8a64-4dc4bc66ca27"
      id="F_85a7219f-4348-4ca4-9739-ed8e70dee4ce">Redeemable warrants, each lot of 625 warrants exercisable for one share of Class A common stock at an exercise price of $0.0625 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_0de33523-97c8-4b01-8a64-4dc4bc66ca27"
      id="F_71ddbecf-6be7-47b8-b076-3d22ac31a6a4">MSPRZ</dei:TradingSymbol>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_82a68bdc-1b20-4c0d-9abc-e53cc57d2a83">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_29c42d04-909a-4a84-bf7b-d4b3359b6a4d">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_d04a222e-4bb3-459a-adac-a1eaf299c54c">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_0578d400-befe-42d1-b144-3aa16d345872">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_e3613af7-1c25-406b-8db0-e62f330775f5">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_d3e65866-b2da-4d0f-88ad-99012131c52c">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_65784cd3-190f-4d14-96c7-b40c4361a8b8">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_73a33479-2360-44d3-85bb-3f40d840e226">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_02b0b585-cc6a-4d39-baf4-87635b068288">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_ad326926-19c7-4f28-8398-d320e1b8c506">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_057cdbda-0c7c-42be-ae2f-ec7aa04ba35b">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_c74b5044-7416-44a5-9669-00e2ec8bac52"
      decimals="0"
      id="F_fa62216a-609d-440a-8f30-8c7b823acb1d"
      unitRef="U_USD">7239020</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_f926d350-ede4-483e-9655-21fee4b1788c"
      decimals="INF"
      id="F_ec184cd0-4c1a-4677-bf09-bca3f63d2597"
      unitRef="U_shares">4920520</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_9f05eae4-c2b6-4611-89ab-2c023d2bae90"
      decimals="INF"
      id="F_2ca172b0-34dc-411c-8a64-7823342cbdee"
      unitRef="U_shares">3323146</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_20ea3b33-d280-492f-98b7-2ab08ba78d25">&lt;p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;DOCUMENTS INCORPORATED BY REFERENCE&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;None.&lt;/span&gt;&lt;/p&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_b03677fd-f244-426b-bbb0-2ae5c76caf93">&lt;p id="item1c" style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Item 1C. Cybers&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ecurity.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Overview&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company maintains robust processes for assessing, identifying, and managing material risks from cybersecurity threats. We are subject to federal and state laws and regulations governing privacy, security, and breaches of patient information and the conduct of certain electronic health care transactions, including, the Health Insurance Portability and Accountability Act of 1996 (&#x201c;HIPAA&#x201d;) and other health information privacy and security requirements. We rely on information technology networks and systems to process and store electronic information. We collect and store sensitive data, including PHI on our information technology networks. As we collect and manage large quantities of data, it is possible that hardware failures or errors in our systems could result in data loss or corruption or cause the information that we collect to be incomplete or contain inaccuracies that our partners regard as significant. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Increased global cybersecurity vulnerabilities, threats, computer viruses, ransomware and phishing attacks, and more sophisticated and targeted cyber-related attacks, as well as cybersecurity failures resulting from human error and technological errors, pose a risk to the security of the Company&#x2019;s systems and networks and the confidentiality, availability, and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;integrity&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;data on these products, systems, and networks. We have implemented security measures designed to prevent disruptions and shutdowns of our information technology networks due to attacks by hackers or breaches due to malfeasance by contractors, employees and others who have access to our networks and systems. &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;expect to continue to invest in long-term solutions to protect against cybersecurity risks and threats.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Except as otherwise provided herein, this Item 1C reflects the Company&#x2019;s cybersecurity policies and procedures as of December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In 2024, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;we did not identify any cybersecurity threats that would have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or financial condition&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. However, despite our efforts, we cannot eliminate all risks from cybersecurity threats, or provide assurances that we have not experienced undetected cybersecurity incidents. For additional information about these risks, see Part I, Item 1A, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risk Factors&#x2009;&#x2014;&#x2009;Risks Related to IT Systems and Cybersecurity&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d; in this Annual Report.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Risk Management and Strategy&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;The Company employs an IT Security Team that is responsible for assessing and managing cybersecurity risks.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has a designated IT Security Team to maintain its cybersecurity program and oversee third-party service providers that provide cybersecurity protection. The IT Security Team is tasked with the prevention, detection, mitigation, and remediation of cybersecurity incidents through a variety of technical and operational measures, and reports to our DevOPS/Security Manager. The team is comprised of personnel with a broad range of experience across the business and information technology industries, including our DevOPS/Security Manager, and employees in senior legal and administrative roles. The IT Security Team relies on the advice of the Manager DevOPS/Security related to the security of our data and any mitigation steps necessary.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our DevOPS/Security Manager leads our cybersecurity program and is tasked with supporting our security functions of identifying, preventing, detecting, responding to, and recovering from cybersecurity threats and incidents. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The DevOPS/Security Manager has 28 years of experience in IT networking, administration, and security related roles, including nine years at the Company. Prior to joining the Company, our DevOPS/Security Manager served for 15 years in a senior leadership role in the IT department of a large, publicly traded Fortune 500 company.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The DevOPS/Security Manager reports directly to the Company&#x2019;s Chief Technology Officer, and provides quarterly updates to the Cybersecurity Subcommittee on the Company&#x2019;s cybersecurity program, including cybersecurity risks, incidents, and mitigation strategies.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The identification of cybersecurity risks is a continuous and evolving assessment. As a data company, we are subject to cybersecurity risks. We have identified certain cybersecurity risks specific to our business, which are identified above in Part I, Item 1A, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risk Factors&#x2009;&#x2014;&#x2009;Risks Related to IT Systems and Cybersecurity&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d; in this Annual Report.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;The Company has established processes for assessing, identifying, and managing material risks from cybersecurity threats.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company utilizes a hybrid platform consisting of a local and cloud environment. Our local environment connects to the cloud environment via an encrypted virtual private network (&#x201c;VPN&#x201d;) connection. Our Site-to-Site connection consists of a firewall in our local environment which responds to a connection from a firewall in our cloud. Our networks have segregated subnets, and only allow designated staff access to our cloud environment, which is only accessible from one of our local office segments. All firewalls are configured with intrusion detection systems and intrusion prevention systems, strict firewall rules, denial of service, spoof protection, advanced threat protection, and zero-day protection. Our firewalls are configured to receive definition updates as they are released, and firmware updates are automatically installed when available. We secure our local network by not utilizing any wireless access points connected to any of our networks or firewalls, enabling port security on switches, following a principle of least privilege policy, and implementing Security Information &amp;amp; Event Management (&#x201c;SIEM&#x201d;) to capture all network traffic &amp;amp; security events from both networking equipment, endpoints, and servers. We enforce a strict password policy with multi-factor authentication.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;All computers and servers utilized by the Company are protected by endpoint protection, which provides real-time protection of local and network files, internet activity, and utilizes ransomware protection, application protection, malicious behavior protection, anti-malware scan interface protection, file integrity monitoring, and data loss prevention. Our endpoint protection software updates immediately upon definition releases. This endpoint has live protection and performs a deep system scan daily. Our endpoint protection products are managed by our IT Security Team via a dashboard that provides our team with immediate alerts, device isolation, and investigation features, and also contracted the use of a Managed Detection and Response (&#x201c;MDR&#x201d;) service. The MDR service monitors our protected endpoints, servers, and network equipment at all times. This service also investigates, eliminates, and mitigates any critical alerts, while notifying our IT Security Team issues identified. All endpoints and servers are updated with security patches and application updates to our systems from a Patch Management system.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our IT Security Team reviews security logs daily, and performs quarterly audits of device access, building access, outages, application access, and IT &amp;amp; Development tickets. We employ data loss prevention policies to enforce HIPAA rules and also use stringent encryption controls. In addition, a Vulnerability Scanning system performs vulnerability detection on a quarterly basis. An independent third-party company conducts annual penetration and vulnerability detection as well.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our offices are physically secured with key card access controls for parking and floor access. In addition, security guards monitor building reception areas and parking garages, and receptionists are located in our lobbies to greet visitors.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;The Company engages assessors, consultants, auditors, or other third parties in connection with its cybersecurity processes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;engages&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; third &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;party vendors in connection with our cybersecurity processes, including penetration and vulnerability scanning, auditing of our information security management program (ISMP); and a provider of products and services to secure users, networks, and endpoints against ransomware, malware, exploits, phishing and the wide range of other cyberattacks. In addition, the Company engaged national accounting and advisory services firms to audit the operating effectiveness of our security program, which&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;incorporates &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;cybersecurity in our processes. On an annual basis, the Company conducts a SOC 2 Type II audit and a HITRUST assessment.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;SOC 2 Type II audits assess risks from interactions with the Company&#x2019;s systems, particularly information about system controls that the Company has designed, implemented, and operated to provide reasonable assurance that its service commitments and system requirements were achieved based on the SOC 2 trust services criteria.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A HITRUST assessment address the need for a continuously relevant cybersecurity assessment that incorporates best practices and leverages the latest threat intelligence to maintain applicability with information security risks and emerging cyber threats, such as ransomware and phishing. HITRUST assessments also provide a level of assurance that delivers full transparency, accuracy, consistency, and integrity.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In 2023, the Company engaged a HITRUST Authorized External Assessor and AICPA member firm	`, which completed independent assessments of MSP Recovery&#x2019;s system. These independent assessments verified that we met the healthcare industry&#x2019;s highest standards in protecting healthcare information and mitigating this risk, including compliance with the HIPAA Security Rule. On October 13, 2023, HITRUST certified that the platforms, facilities, and supporting infrastructure of our organization meet the HITRUST CSF&#xae; v11 Implemented, 1-year (i1) certification criteria. For our cloud computing services, we currently use Amazon Web Services (&#x201c;AWS&#x201d;) which is also HITRUST certified. On June 14, 2024, an Independent Service Auditor provided MSP Recovery a report opining that our data recovery system&#x2019;s commitments and system requirements meet or exceed the stringent SOC 2 Type II applicable trust services criteria.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;The Company has processes to oversee and identify risks from cybersecurity threats associated with its use of third-party service providers.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company maintains specific policies and practices governing our third-party security risks, including our third-party assessment (&#x201c;TPA&#x201d;) process. Under our TPA process, we gather information from certain third parties who contract with the Company and share or receive data, or have access to or integrate with our systems, in order to help us assess potential risks associated with their security controls. We also generally require third parties to, among other things, utilize encrypted secure file transfer protocols to exchange data. We require counterparties to enter into Business Associate Agreements and Non-Disclosure Agreements that, among other things, require them to maintain security controls to protect our confidential information and data, and notify us of material data breaches that may impact our data.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Governance&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;The Board has established a Cybersecurity Subcommittee of the Audit Committee responsible for the oversight of risks from cybersecurity threats.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 7, 2024, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the Board established the Cybersecurity Subcommittee of the Audit Committee (the &#x201c;Cybersecurity Subcommittee&#x201d;) to assist the Board in fulfilling its oversight responsibilities with respect to assessing and mitigating the Company&#x2019;s cybersecurity risks.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s management, under the guidance of the IT Security Team, is responsible for the preparation, presentation, and self-assessment of the Company&#x2019;s cybersecurity policies and practices.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Cybersecurity Subcommittee shall be comprised of at least one independent director, and is tasked with reviewing and providing high level guidance on cybersecurity-related issues of importance to the Company.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The IT Security Team reports to the Cybersecurity Subcommittee on a quarterly basis to inform the committee about and monitoring, prevention, detection, mitigation, and remediation of cybersecurity incidents&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and is tasked with notifying the Cybersecurity Subcommittee of a cybersecurity incident upon discovery. The Cybersecurity Subcommittee held three meetings during the year ended December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_2047d019-e6e6-4128-8615-64dd122ef92f">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Increased global cybersecurity vulnerabilities, threats, computer viruses, ransomware and phishing attacks, and more sophisticated and targeted cyber-related attacks, as well as cybersecurity failures resulting from human error and technological errors, pose a risk to the security of the Company&#x2019;s systems and networks and the confidentiality, availability, and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;integrity&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;data on these products, systems, and networks. We have implemented security measures designed to prevent disruptions and shutdowns of our information technology networks due to attacks by hackers or breaches due to malfeasance by contractors, employees and others who have access to our networks and systems. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;expect to continue to invest in long-term solutions to protect against cybersecurity risks and threats.&lt;/span&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_028ae83e-f8ae-4766-97a2-136e39dea512">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_2bb15d9f-3849-4231-a6ba-1d34d37f7e70">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_91d9de8b-cef6-4bd8-8649-345cb1c3cbf7">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The DevOPS/Security Manager has 28 years of experience in IT networking, administration, and security related roles, including nine years at the Company. Prior to joining the Company, our DevOPS/Security Manager served for 15 years in a senior leadership role in the IT department of a large, publicly traded Fortune 500 company.&lt;/span&gt;</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_b64e5ecf-f544-476c-9bb6-515df06cd735">&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;The Company has established processes for assessing, identifying, and managing material risks from cybersecurity threats.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company utilizes a hybrid platform consisting of a local and cloud environment. Our local environment connects to the cloud environment via an encrypted virtual private network (&#x201c;VPN&#x201d;) connection. Our Site-to-Site connection consists of a firewall in our local environment which responds to a connection from a firewall in our cloud. Our networks have segregated subnets, and only allow designated staff access to our cloud environment, which is only accessible from one of our local office segments. All firewalls are configured with intrusion detection systems and intrusion prevention systems, strict firewall rules, denial of service, spoof protection, advanced threat protection, and zero-day protection. Our firewalls are configured to receive definition updates as they are released, and firmware updates are automatically installed when available. We secure our local network by not utilizing any wireless access points connected to any of our networks or firewalls, enabling port security on switches, following a principle of least privilege policy, and implementing Security Information &amp;amp; Event Management (&#x201c;SIEM&#x201d;) to capture all network traffic &amp;amp; security events from both networking equipment, endpoints, and servers. We enforce a strict password policy with multi-factor authentication.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;All computers and servers utilized by the Company are protected by endpoint protection, which provides real-time protection of local and network files, internet activity, and utilizes ransomware protection, application protection, malicious behavior protection, anti-malware scan interface protection, file integrity monitoring, and data loss prevention. Our endpoint protection software updates immediately upon definition releases. This endpoint has live protection and performs a deep system scan daily. Our endpoint protection products are managed by our IT Security Team via a dashboard that provides our team with immediate alerts, device isolation, and investigation features, and also contracted the use of a Managed Detection and Response (&#x201c;MDR&#x201d;) service. The MDR service monitors our protected endpoints, servers, and network equipment at all times. This service also investigates, eliminates, and mitigates any critical alerts, while notifying our IT Security Team issues identified. All endpoints and servers are updated with security patches and application updates to our systems from a Patch Management system.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our IT Security Team reviews security logs daily, and performs quarterly audits of device access, building access, outages, application access, and IT &amp;amp; Development tickets. We employ data loss prevention policies to enforce HIPAA rules and also use stringent encryption controls. In addition, a Vulnerability Scanning system performs vulnerability detection on a quarterly basis. An independent third-party company conducts annual penetration and vulnerability detection as well.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our offices are physically secured with key card access controls for parking and floor access. In addition, security guards monitor building reception areas and parking garages, and receptionists are located in our lobbies to greet visitors.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_9a7b7174-e788-41f4-b760-f6274b12c1a2">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_06e903a0-e3b0-4203-942c-ccb8ae9f5b38">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_45e7c49c-0272-467d-870a-4bc397316b46">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Governance&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;The Board has established a Cybersecurity Subcommittee of the Audit Committee responsible for the oversight of risks from cybersecurity threats.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 7, 2024, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the Board established the Cybersecurity Subcommittee of the Audit Committee (the &#x201c;Cybersecurity Subcommittee&#x201d;) to assist the Board in fulfilling its oversight responsibilities with respect to assessing and mitigating the Company&#x2019;s cybersecurity risks.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s management, under the guidance of the IT Security Team, is responsible for the preparation, presentation, and self-assessment of the Company&#x2019;s cybersecurity policies and practices.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Cybersecurity Subcommittee shall be comprised of at least one independent director, and is tasked with reviewing and providing high level guidance on cybersecurity-related issues of importance to the Company.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The IT Security Team reports to the Cybersecurity Subcommittee on a quarterly basis to inform the committee about and monitoring, prevention, detection, mitigation, and remediation of cybersecurity incidents&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and is tasked with notifying the Cybersecurity Subcommittee of a cybersecurity incident upon discovery. The Cybersecurity Subcommittee held three meetings during the year ended December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_090581bf-dbf0-4937-b7fa-a4545451c4d8">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_bb7d453e-0bd9-4a80-b4b7-aa5e18c4ddb7">&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s management, under the guidance of the IT Security Team, is responsible for the preparation, presentation, and self-assessment of the Company&#x2019;s cybersecurity policies and practices.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Cybersecurity Subcommittee shall be comprised of at least one independent director, and is tasked with reviewing and providing high level guidance on cybersecurity-related issues of importance to the Company.&lt;/span&gt;&lt;/span&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_0d4c15e6-3d5d-42ca-9fcc-3672b3aa84ca">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_a9940c0a-b665-4456-b32d-db7a72c891c0">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Cybersecurity Subcommittee shall be comprised of at least one independent director, and is tasked with reviewing and providing high level guidance on cybersecurity-related issues of importance to the Company.&lt;/span&gt;</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_deedd04a-cf4a-4f6b-a044-a096f74b4621">&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The IT Security Team reports to the Cybersecurity Subcommittee on a quarterly basis to inform the committee about and monitoring, prevention, detection, mitigation, and remediation of cybersecurity incidents&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and is tasked with notifying the Cybersecurity Subcommittee of a cybersecurity incident upon discovery. The Cybersecurity Subcommittee held three meetings during the year ended December 31, 2024.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_206b514a-7f83-493b-8b2f-bc3310fe49a5">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The IT Security Team reports to the Cybersecurity Subcommittee on a quarterly basis to inform the committee about and monitoring, prevention, detection, mitigation, and remediation of cybersecurity incidents&lt;/span&gt;</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <dei:AuditorFirmId
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_0d5e7f36-5e0b-47f1-a5f8-67b7691b7ac6">34</dei:AuditorFirmId>
    <dei:AuditorOpinionTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_a08b4f9f-d8fc-4768-be0f-908ba397cc93">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Opinion on the Financial Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have audited the accompanying consolidated balance sheets of MSP Recovery, Inc. and Subsidiaries (the "Company") as of December 31, 2024 and 2023, the related consolidated statements of operations, changes in equity, and cash flows, for each of the two years in the period ended December 31, 2024, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.&lt;/span&gt;&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_a3d8eb9a-f2dd-4aef-9397-db8eba8403b2">Deloitte &amp; Touche LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_c7efe285-37de-426e-b1d5-c4478d7a4583">Miami, Florida</dei:AuditorLocation>
    <us-gaap:Cash
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_bda987b0-f554-4743-b164-f481d8abeaef"
      unitRef="U_USD">12328000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_e599351a-be0d-4a7a-8f4b-6e2219374d56"
      unitRef="U_USD">11633000</us-gaap:Cash>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_f9c59423-a860-4945-9c2a-1a88cf8cffd5"
      unitRef="U_USD">295000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_b24ca8d5-cc12-4022-bc5b-12c486323b4b"
      unitRef="U_USD">217000</us-gaap:AccountsReceivableNetCurrent>
    <mspr:AffiliateReceivable
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_ea8949b7-b3fb-4122-a17b-a12fec3eba2b"
      unitRef="U_USD">1204000</mspr:AffiliateReceivable>
    <mspr:AffiliateReceivable
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_127e888e-7ffb-4b96-9379-154fbd63a074"
      unitRef="U_USD">1188000</mspr:AffiliateReceivable>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_5f85d3ca-1713-492b-bc89-518782029d0a"
      unitRef="U_USD">1647000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_dd4a4c78-f6f8-4e11-aab0-11a7a18e2318"
      unitRef="U_USD">8908000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_71d1d8bb-e701-480f-8898-7afb573ab77c"
      unitRef="U_USD">15474000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_b6810b38-31b5-4670-aa9b-a07f67970f96"
      unitRef="U_USD">21946000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_036a0355-9236-40d5-aae1-d391c56cea19"
      unitRef="U_USD">5159000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_524966d4-4541-4cf2-97fb-b05cf9a868da"
      unitRef="U_USD">4911000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_0e5f8c74-a7f3-4607-8eb1-009f6f2e19e6"
      unitRef="U_USD">1898223000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_049581b0-85bf-4cc1-856e-c1f12e8a3f2b"
      unitRef="U_USD">3132796000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_2b1f690a-9b80-4541-bebd-d9420bc3deea"
      unitRef="U_USD">227000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_de0f27e5-3fbd-430d-8b25-c0138ce07b55"
      unitRef="U_USD">342000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Assets
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_cd476432-8f15-4710-ac9a-e389de9761d3"
      unitRef="U_USD">1919083000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_4315a12d-c77b-4587-8d79-7bd75143f9bd"
      unitRef="U_USD">3159995000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_b8e13ac0-c8a7-4830-bb66-b6bfca1dc13e"
      unitRef="U_USD">13971000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_9ac85195-8bb5-43f6-8814-a7106fce2274"
      unitRef="U_USD">6244000</us-gaap:AccountsPayableCurrent>
    <mspr:AffiliatePayable
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_7349faec-67c3-4457-b111-13aa8b59814b"
      unitRef="U_USD">21664000</mspr:AffiliatePayable>
    <mspr:AffiliatePayable
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_a895c9d8-b77b-49fc-bed7-f6f09c5117a3"
      unitRef="U_USD">19822000</mspr:AffiliatePayable>
    <mspr:CommissionPayable
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_0d55a56d-9335-49c7-a5e3-be726408b6f4"
      unitRef="U_USD">1342000</mspr:CommissionPayable>
    <mspr:CommissionPayable
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_d789c86d-6905-42b9-8b2b-e0116b51f33a"
      unitRef="U_USD">821000</mspr:CommissionPayable>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_412c3429-23c5-4d01-96c7-59b9f33c9466"
      unitRef="U_USD">211000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_379bef79-b669-432d-b2ef-b7281b917d73"
      unitRef="U_USD">37000</us-gaap:DerivativeLiabilitiesCurrent>
    <mspr:WarrantLiabilityCurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_b250df4c-8239-48d4-aaf6-48db038dc64f"
      unitRef="U_USD">22373000</mspr:WarrantLiabilityCurrent>
    <mspr:WarrantLiabilityCurrent
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_3922abe0-69f6-4492-9c8a-1a5a120731ec"
      unitRef="U_USD">268000</mspr:WarrantLiabilityCurrent>
    <mspr:GuarantyObligationCurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_c7ce0478-2b86-4765-abfd-d0a23db5c0b7"
      unitRef="U_USD">1126490000</mspr:GuarantyObligationCurrent>
    <mspr:ClaimsFinancingObligationNotesPayableCurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_6a867877-52a0-4e7f-a2ee-387043ab5ed6"
      unitRef="U_USD">31200000</mspr:ClaimsFinancingObligationNotesPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_97dfeaba-1e75-43a0-ac86-c2ba64165dc6"
      unitRef="U_USD">33298000</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_ea20dce6-d3f9-471b-9aee-3f6f144ce678"
      unitRef="U_USD">14765000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_6bdb6d2b-db69-4134-b692-902a552fd027"
      unitRef="U_USD">19314000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_b6ad9eda-0ac3-4ff8-876f-146a86504eb6"
      unitRef="U_USD">1265314000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_44781b55-45f4-42ca-9540-2df23f41f4b1"
      unitRef="U_USD">46506000</us-gaap:LiabilitiesCurrent>
    <mspr:GuarantyObligationNoncurrent
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_f9f90372-fc27-416e-aab7-d587cf41cece"
      unitRef="U_USD">941301000</mspr:GuarantyObligationNoncurrent>
    <mspr:ClaimsFinancingObligationNotesPayable
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_205a35fd-b126-40ae-b1a2-688dd34751c5"
      unitRef="U_USD">633026000</mspr:ClaimsFinancingObligationNotesPayable>
    <mspr:ClaimsFinancingObligationNotesPayable
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_9315e270-47e0-4e4e-a1cc-3186e954fd9c"
      unitRef="U_USD">548276000</mspr:ClaimsFinancingObligationNotesPayable>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_5fda4b9b-e925-405b-88da-51da2f21f7fa"
      unitRef="U_USD">102000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_3144712f-c1e9-47cd-b212-52cbd61c9692"
      unitRef="U_USD">235000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <mspr:LoanFromRelatedPartiesNonCurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_8e88b3c9-7da4-4078-bfd3-a81f7b588a00"
      unitRef="U_USD">130328000</mspr:LoanFromRelatedPartiesNonCurrent>
    <mspr:LoanFromRelatedPartiesNonCurrent
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_ff9b0771-e0bd-4028-8ea2-970ffa0de6cd"
      unitRef="U_USD">130709000</mspr:LoanFromRelatedPartiesNonCurrent>
    <mspr:InterestPayableNoncurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_621c8126-d89e-4874-9bdd-c9eebd642153"
      unitRef="U_USD">14828000</mspr:InterestPayableNoncurrent>
    <mspr:InterestPayableNoncurrent
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_0a108fb9-2063-4b2f-a76e-eee9593bb7db"
      unitRef="U_USD">73839000</mspr:InterestPayableNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_c7e2d0e8-95b4-4f61-9aac-9f651017cdcb"
      unitRef="U_USD">3894000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_4cf53cfc-c544-4024-9ac2-78be92713b02"
      unitRef="U_USD">2047492000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_5ac74836-4594-4de5-bfa0-c0b21e1d09ac"
      unitRef="U_USD">1740866000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_9996cf94-6a99-485b-acb5-c26104f11cc7"
      decimals="INF"
      id="F_78ac3d88-3247-4a50-947a-097068fef34d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_056857a2-ae2a-45f6-a0e9-2f2918ae0478"
      decimals="INF"
      id="F_9cb2d57f-2052-40b7-98e5-0257017df878"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_9996cf94-6a99-485b-acb5-c26104f11cc7"
      decimals="INF"
      id="F_03b8ed82-5799-4d69-a53e-2d31e40a0179"
      unitRef="U_shares">5500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_056857a2-ae2a-45f6-a0e9-2f2918ae0478"
      decimals="INF"
      id="F_ed5c82cc-3d53-4ec7-a82d-db4b920336d7"
      unitRef="U_shares">5500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_9996cf94-6a99-485b-acb5-c26104f11cc7"
      decimals="INF"
      id="F_b6c449ac-b7f0-4ffa-a84a-aa014b0d2c75"
      unitRef="U_shares">2184958</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_9996cf94-6a99-485b-acb5-c26104f11cc7"
      decimals="INF"
      id="F_50917e60-cdac-49e6-a468-4702e3f43892"
      unitRef="U_shares">2184958</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_056857a2-ae2a-45f6-a0e9-2f2918ae0478"
      decimals="INF"
      id="F_3edb958d-9e7b-4630-ad39-82a31a2621fa"
      unitRef="U_shares">586393</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_056857a2-ae2a-45f6-a0e9-2f2918ae0478"
      decimals="INF"
      id="F_6117dd02-2989-4572-a4bc-4c9548b0b4d1"
      unitRef="U_shares">586393</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_cb300f73-f574-4a36-a626-d7af3d2c40eb"
      decimals="INF"
      id="F_601ddd58-54f2-4e79-b2c4-13698076069c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_a6a99836-7eb5-486a-9687-cdb21bc04965"
      decimals="INF"
      id="F_3d54d126-a6f1-434d-b1a1-cf98252b584d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_cb300f73-f574-4a36-a626-d7af3d2c40eb"
      decimals="INF"
      id="F_eb331d80-3e93-45ea-9f84-7739bad74f6e"
      unitRef="U_shares">3250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_a6a99836-7eb5-486a-9687-cdb21bc04965"
      decimals="INF"
      id="F_a6fa1160-583c-4aaa-b2b7-241d09ddb3b4"
      unitRef="U_shares">3250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_cb300f73-f574-4a36-a626-d7af3d2c40eb"
      decimals="INF"
      id="F_945c245c-c314-4542-a539-9153cd930f80"
      unitRef="U_shares">4962704</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_cb300f73-f574-4a36-a626-d7af3d2c40eb"
      decimals="INF"
      id="F_b2f06aed-fbde-4e6a-946d-af75a54d55e3"
      unitRef="U_shares">4962704</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_a6a99836-7eb5-486a-9687-cdb21bc04965"
      decimals="INF"
      id="F_b9a13ac5-f3f2-453e-8d86-e75eb1153936"
      unitRef="U_shares">4965296</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_a6a99836-7eb5-486a-9687-cdb21bc04965"
      decimals="INF"
      id="F_3608c88f-73e4-4e44-a56c-0ea90ac14046"
      unitRef="U_shares">4965296</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_7cccfd6f-cd3c-4ebc-b69e-7453d51c9699"
      unitRef="U_USD">546635000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_ee1c88c8-5ef6-4dfb-bee4-3e6f9aeb734c"
      unitRef="U_USD">357941000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_1d7b3ef7-3712-4cfb-bbea-4d42d2a433ef"
      unitRef="U_USD">-446050000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_9384447a-14c4-464b-9c23-f876790ab466"
      unitRef="U_USD">-85551000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_51d0bd27-56fb-44cd-9989-09fe2cdb0e89"
      unitRef="U_USD">100585000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_0fedd86d-3f99-4827-88d7-a911005a0d77"
      unitRef="U_USD">272390000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_91ba0355-461c-4f46-acbe-8169fc2aa9f3"
      unitRef="U_USD">-228994000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_8e2fa33f-aaf8-4e5d-b40b-259e977f2ab4"
      unitRef="U_USD">1146739000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_d0155496-8374-468c-98cf-9d8e0761610c"
      unitRef="U_USD">-128409000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_a48d69a3-7934-48cb-8acc-bc49c1493110"
      unitRef="U_USD">1419129000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_e3f31d3a-ff80-4d36-a6e6-c992df27d38f"
      unitRef="U_USD">1919083000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_5147e9b4-144e-4e53-99b6-aae07804b455"
      unitRef="U_USD">3159995000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_ea41718c-eb03-4364-a84c-37e5f43f1623"
      decimals="-8"
      id="F_36c91bc8-c5e9-4489-9823-2cda6a1fe2af"
      unitRef="U_USD">1400000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_ba17b4e4-2add-4b5b-8fa4-ea5edfe1120f"
      decimals="-8"
      id="F_7a64d663-7010-4670-9eeb-1bb6839c3024"
      unitRef="U_USD">2200000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <mspr:ClaimsRecoveryIncome
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_94b8d356-3a27-4492-aa41-6b8d871b0d44"
      unitRef="U_USD">18122000</mspr:ClaimsRecoveryIncome>
    <mspr:ClaimsRecoveryIncome
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_244de9e0-7790-4280-95e7-c57d5abf208a"
      unitRef="U_USD">7207000</mspr:ClaimsRecoveryIncome>
    <mspr:ClaimsRecoveryServiceIncome
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_468371b6-a944-4c4d-a66a-40f0f01253df"
      unitRef="U_USD">498000</mspr:ClaimsRecoveryServiceIncome>
    <mspr:OtherClaimsRecoveryRevenues
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_40ee0357-3c37-43fb-8c1b-b31245e165f7"
      unitRef="U_USD">127000</mspr:OtherClaimsRecoveryRevenues>
    <mspr:TotalClaimsRecovery
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_c1c9f722-f78e-496f-805b-9cf1fb530474"
      unitRef="U_USD">18249000</mspr:TotalClaimsRecovery>
    <mspr:TotalClaimsRecovery
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_ca5e14a1-d0c8-4a39-8cfa-f54902b39e21"
      unitRef="U_USD">7705000</mspr:TotalClaimsRecovery>
    <mspr:CostOfClaimRecoveries
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_11eab42e-5feb-4b3f-b742-4d5fa7feb23c"
      unitRef="U_USD">9607000</mspr:CostOfClaimRecoveries>
    <mspr:CostOfClaimRecoveries
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_ada24831-ea2f-471f-80bc-c5d0bb37a5a9"
      unitRef="U_USD">2145000</mspr:CostOfClaimRecoveries>
    <mspr:ClaimsAmortizationExpense
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_23a74459-6685-4fc1-a5c8-06a285c45345"
      unitRef="U_USD">484076000</mspr:ClaimsAmortizationExpense>
    <mspr:ClaimsAmortizationExpense
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_21cd5fa4-faba-455f-b6f7-f88dc4864da6"
      unitRef="U_USD">476492000</mspr:ClaimsAmortizationExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_23f3c66e-3461-429c-9a94-0719426712a9"
      unitRef="U_USD">22231000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_89672a83-8db0-4a03-8baa-589e45240c0f"
      unitRef="U_USD">26508000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ProfessionalFees
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_a4c42070-b3b6-4a0e-9455-78490b6eef55"
      unitRef="U_USD">14131000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_952dd24c-f9aa-4afc-b0cb-ef2981386621"
      unitRef="U_USD">22766000</us-gaap:ProfessionalFees>
    <us-gaap:LegalFees
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_694112ad-309c-4458-b030-ad8125036e89"
      unitRef="U_USD">9519000</us-gaap:LegalFees>
    <us-gaap:LegalFees
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_ffdd38b8-f4e4-4330-9852-d7d6ac99a536"
      unitRef="U_USD">34401000</us-gaap:LegalFees>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_bed12f23-a898-4bce-b62c-13f87396b0bc"
      unitRef="U_USD">752697000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <mspr:AllowanceForCreditLosses
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_04683025-ea1a-4e69-beb7-0e6d435c6423"
      unitRef="U_USD">5000000</mspr:AllowanceForCreditLosses>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_1012f7ac-e265-4afa-b4eb-f41d7c1eaeea"
      unitRef="U_USD">277000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_70ec9fe3-a255-430b-b697-d8f6aaf72491"
      unitRef="U_USD">263000</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingExpenses
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_777c43df-4de3-43b6-a578-f117be4b4a7b"
      unitRef="U_USD">1292538000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_0081aba8-371c-4f83-b25b-f18d999caa5c"
      unitRef="U_USD">567575000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_d342194c-3f49-4d54-a117-3830fa065cf2"
      unitRef="U_USD">-1274289000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_054d9bde-9a41-4fd3-a09a-5e57f47e1a60"
      unitRef="U_USD">-559870000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_1f2aa437-b4da-460d-bf52-7edcbb42a12a"
      unitRef="U_USD">420032000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_516c8fa1-698f-44b9-91be-4fb706ccd763"
      unitRef="U_USD">289169000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_3202478b-2efd-46f7-8041-a359ee0c9646"
      unitRef="U_USD">542000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_4bb1a7f8-3d06-425a-8b7a-d814e1979f66"
      unitRef="U_USD">9290000</us-gaap:OtherNonoperatingIncomeExpense>
    <mspr:ChangeInFairValueOfWarrantAndDerivativeLiabilities
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_fd54a7f7-fcd9-4aa4-9e1f-1ac8a1c76eee"
      unitRef="U_USD">-136934000</mspr:ChangeInFairValueOfWarrantAndDerivativeLiabilities>
    <mspr:ChangeInFairValueOfWarrantAndDerivativeLiabilities
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_9e2b895f-a7cd-4970-8d28-a4d1a5d2a02b"
      unitRef="U_USD">-4604000</mspr:ChangeInFairValueOfWarrantAndDerivativeLiabilities>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_a6b7e3cb-ef1d-4144-91eb-b1fed618dbca"
      unitRef="U_USD">-1556845000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_38ad261b-c970-4ed7-ac05-5ad47477f37d"
      unitRef="U_USD">-835145000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_d1c11b6b-01ae-49a1-9652-d114ac7d76a5"
      unitRef="U_USD">-1556845000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_5f257151-a134-43a1-ad28-9597abeaf0bd"
      unitRef="U_USD">-835145000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_6984eabf-8b14-4ecd-a988-396d2023b0f7"
      unitRef="U_USD">-1196346000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_abd7fd90-a0ae-4f89-b9c2-51cc6300b14f"
      unitRef="U_USD">-778797000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_e759957d-9ebe-4def-a0e3-811bcf4c1680"
      unitRef="U_USD">-360499000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_82f41da1-51e8-4344-a8e8-4e63a72b8fd8"
      unitRef="U_USD">-56348000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156"
      decimals="0"
      id="F_1654bf83-caea-47da-9288-d43c15badebb"
      unitRef="U_shares">1001525</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156"
      decimals="0"
      id="F_4c48d164-22c8-4f6b-afd4-a427dbb46d70"
      unitRef="U_shares">1001525</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_1720b370-71e8-404f-b2ba-d747e1f96522"
      decimals="0"
      id="F_8652c3dd-6477-4b92-8492-b8881866a79c"
      unitRef="U_shares">356591</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_1720b370-71e8-404f-b2ba-d747e1f96522"
      decimals="0"
      id="F_5026c220-35ea-43a6-ad29-2937c96ff8bb"
      unitRef="U_shares">356591</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156"
      decimals="2"
      id="F_29e11530-007e-4115-85f5-5d10b9370acf"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-359.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156"
      decimals="2"
      id="F_220506d7-50fb-4327-ae05-5daf1fdb4a8f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-359.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_1720b370-71e8-404f-b2ba-d747e1f96522"
      decimals="2"
      id="F_e9664009-d1bd-4d7e-a52f-22d535782b91"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-158.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_1720b370-71e8-404f-b2ba-d747e1f96522"
      decimals="2"
      id="F_6ea52bb7-e3f3-4d72-aa48-bd0b9d809282"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-158.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="C_b7e7a2a7-5fd8-4f91-9fd5-9427aec0dbef"
      decimals="-5"
      id="F_92917827-7757-4e9a-bfbd-12685c6a429a"
      unitRef="U_USD">3400000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="C_5d819013-3703-4830-ab07-b1f1c7119714"
      decimals="-5"
      id="F_dec14e83-d033-44b9-ba26-210adfe46403"
      unitRef="U_USD">300000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="C_fe25ee78-67ec-4d53-967e-ac07893f4a6e"
      decimals="-5"
      id="F_88478178-c219-4e68-b995-563014fb16ce"
      unitRef="U_USD">200000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="C_5be07310-661f-4b62-876e-7ad045ede894"
      decimals="-5"
      id="F_1e55f5c6-3d79-4c36-b323-2ba82d337bff"
      unitRef="U_USD">200000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="C_c452056c-aa10-4243-85df-a94afbf6101c"
      decimals="-5"
      id="F_11035ae1-0aca-461f-aa66-0d71863ed7e2"
      unitRef="U_USD">7700000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="C_94909e83-2e9e-40db-b644-8523c07ddb09"
      decimals="-5"
      id="F_2cb27973-b952-4220-b55b-a09f745dfe11"
      unitRef="U_USD">19200000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:InterestExpense
      contextRef="C_fe25ee78-67ec-4d53-967e-ac07893f4a6e"
      decimals="-5"
      id="F_9508de49-0fd8-4f10-b86d-a4e7715861c9"
      unitRef="U_USD">318900000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_5be07310-661f-4b62-876e-7ad045ede894"
      decimals="-5"
      id="F_93ebfcf7-3243-4db0-9e4d-c2080b82362b"
      unitRef="U_USD">226500000</us-gaap:InterestExpense>
    <us-gaap:SharesOutstanding
      contextRef="C_d1d4678d-582f-4815-8271-9022cf27ca70"
      decimals="INF"
      id="F_172c2378-ad5c-4409-8734-a173e540677d"
      unitRef="U_shares">119369</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="C_89133fd7-659a-4cd9-9d0e-e1da45db1b8f"
      decimals="INF"
      id="F_45c83dea-835e-478a-8abd-0a2071753827"
      unitRef="U_shares">5036768</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_d9cc9699-1810-4465-8001-abc8935d5526"
      decimals="-3"
      id="F_68823bd3-dce5-4e61-af5d-bc751afe5b8c"
      unitRef="U_USD">137082000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_867693d0-bbf0-446d-b67d-8df69e448e9a"
      decimals="-3"
      id="F_49c4b944-a389-4360-861b-cec22fca8808"
      unitRef="U_USD">-29203000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_fcb3bfd4-b997-46bd-95a6-c338562ed04e"
      decimals="-3"
      id="F_7d1e728a-6aa0-4f43-84ff-69c04ff02ba8"
      unitRef="U_USD">2077586000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_8dbd5799-d76e-43f3-b963-830f8fd31b2e"
      decimals="-3"
      id="F_f02bf800-1274-49f1-a3c9-328fc2f71e42"
      unitRef="U_USD">2185465000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <mspr:StockIssuedDuringPeriodSharesConversionOfWarrants
      contextRef="C_13c3ccb9-b33e-456f-b270-960ccbced512"
      decimals="INF"
      id="F_e2d91421-10a2-41c5-a065-8abd52c5ba19"
      unitRef="U_shares">591</mspr:StockIssuedDuringPeriodSharesConversionOfWarrants>
    <mspr:StockIssuedDuringPeriodValueConversionOfWarrants
      contextRef="C_6839411a-9365-4c82-94be-9667ed37b849"
      decimals="-3"
      id="F_adc2eb04-c108-4a69-a0ae-1fc142fd44e2"
      unitRef="U_USD">458000</mspr:StockIssuedDuringPeriodValueConversionOfWarrants>
    <mspr:StockIssuedDuringPeriodValueConversionOfWarrants
      contextRef="C_8553900b-1ff0-43df-9d09-bab541f91e7e"
      decimals="-3"
      id="F_fa9241c7-fa6f-4575-834b-b93928d3851b"
      unitRef="U_USD">-200000</mspr:StockIssuedDuringPeriodValueConversionOfWarrants>
    <mspr:StockIssuedDuringPeriodValueConversionOfWarrants
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_ce2ae544-15e3-4943-b7f4-3680a2fa3c2b"
      unitRef="U_USD">258000</mspr:StockIssuedDuringPeriodValueConversionOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_13c3ccb9-b33e-456f-b270-960ccbced512"
      decimals="INF"
      id="F_b258f7fe-e14b-497e-b7c0-5fa338abee61"
      unitRef="U_shares">466433</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_6965b820-31a4-444e-ba96-f6ea5d589a06"
      decimals="INF"
      id="F_b4510ea1-9251-4fdd-ad98-8c3177876b0a"
      unitRef="U_shares">-71472</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_6839411a-9365-4c82-94be-9667ed37b849"
      decimals="-3"
      id="F_09768ef0-96c7-4152-99a2-1a3adc7c0927"
      unitRef="U_USD">220401000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_8553900b-1ff0-43df-9d09-bab541f91e7e"
      decimals="-3"
      id="F_d8ab55c0-273a-47ac-9db1-022e2207158a"
      unitRef="U_USD">-151850000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_b25fd665-d511-42a4-a12b-e2be5f1b32e4"
      unitRef="U_USD">68551000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ProfitLoss
      contextRef="C_87af9b54-aaad-4ee8-ad42-ba6bf6f841fb"
      decimals="-3"
      id="F_dc4f6f1c-8730-48d0-af0c-e9382b36b9e0"
      unitRef="U_USD">-56348000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_8553900b-1ff0-43df-9d09-bab541f91e7e"
      decimals="-3"
      id="F_3d16cf6e-b52c-4cfe-a722-633c903ef244"
      unitRef="U_USD">-778797000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_cf5e8216-655a-4828-9823-441a366c41c1"
      unitRef="U_USD">-835145000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_1fec80b0-38c3-4131-ada8-3af5893a5151"
      decimals="INF"
      id="F_d6b19e78-17b1-477e-8f1b-92fc23c0d7f2"
      unitRef="U_shares">586393</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="C_0b0648be-cb1d-4812-9bfd-c206264a6106"
      decimals="INF"
      id="F_19ee8de6-d5ae-4bfe-835c-004cc39da64c"
      unitRef="U_shares">4965296</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_89033644-94ee-4bd7-ad47-12e753cbcfce"
      decimals="-3"
      id="F_f343b3a6-30e5-44fc-a285-f7b822d27720"
      unitRef="U_USD">357941000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_e39e346c-7b8d-4cd1-ba00-128383f3f5f5"
      decimals="-3"
      id="F_5ee32284-08ea-4390-a076-6191016ed453"
      unitRef="U_USD">-85551000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_564ee707-2109-45f7-83d2-89ed72475362"
      decimals="-3"
      id="F_4dcc6013-2eec-4912-b857-d672c1db9702"
      unitRef="U_USD">1146739000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_c27cf1ff-6ba1-482f-8ad9-56fe8aa83dd2"
      unitRef="U_USD">1419129000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_95863a80-b9b0-46fb-b0ef-8af82e4c84a4"
      decimals="INF"
      id="F_d65ac83c-66f8-48d1-b7e3-be100ad3b4e6"
      unitRef="U_shares">1598565</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_4957a749-8bfa-415b-9b7d-70a5bf0f2f52"
      decimals="INF"
      id="F_2f77234c-dfc6-4b6a-8587-68ce5f478a60"
      unitRef="U_shares">-2592</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_ebf33321-45e9-493e-8b1e-d30e0e2f7a60"
      decimals="-3"
      id="F_19371993-fbfa-4afd-a9ac-b72dbd2d6839"
      unitRef="U_USD">188694000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_31bd9c41-8edd-4613-86e6-85b50e497f78"
      decimals="-3"
      id="F_07bdaef7-0fcf-4a0d-b3ec-ee50d679a469"
      unitRef="U_USD">-179387000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_1def1e94-985d-448a-bfbc-8483f81b296a"
      unitRef="U_USD">9307000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ProfitLoss
      contextRef="C_3d1f3cd4-008e-48b3-85da-f506bc8106bf"
      decimals="-3"
      id="F_880a65c1-5a53-45b5-93d8-29c465d92bf4"
      unitRef="U_USD">-360499000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_31bd9c41-8edd-4613-86e6-85b50e497f78"
      decimals="-3"
      id="F_d6c2f820-cfc8-4486-9670-d647af24f6ca"
      unitRef="U_USD">-1196346000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_4a7199d4-2c4a-440a-a278-9d52921d1861"
      unitRef="U_USD">-1556845000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_8ec762b9-f612-4652-b91b-9dc8a97a39c7"
      decimals="INF"
      id="F_65d754f2-d01d-4c9e-a4ef-ddc55bc1cf87"
      unitRef="U_shares">2184958</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="C_4444a183-cd75-453f-82e7-94eb0d9ecda9"
      decimals="INF"
      id="F_e64ebbc5-8b15-44ec-b447-f4d9db47d24b"
      unitRef="U_shares">4962704</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_8558b10a-b3e2-41be-8e26-98a22240201d"
      decimals="-3"
      id="F_6ddde5ab-ff6e-4227-8c35-4e6fd069cd7b"
      unitRef="U_USD">546635000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_e17c4aa1-a017-431c-a88b-5d1c628480b4"
      decimals="-3"
      id="F_1394c0e5-8509-407d-b07e-f428a4675d2e"
      unitRef="U_USD">-446050000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_516f8b35-03d8-4c39-9130-a23b7a95a2a6"
      decimals="-3"
      id="F_dd4dc406-5009-4f18-b38e-e6bad7df8d01"
      unitRef="U_USD">-228994000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_b8d85a97-08da-42df-8c37-b27318a781b2"
      unitRef="U_USD">-128409000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_67094ad7-e54b-405e-90be-9227b1870a88"
      unitRef="U_USD">-1556845000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_b380e630-4fc3-442f-ba15-6a8528278443"
      unitRef="U_USD">-835145000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_d769b8f8-bb2d-4aa5-87fc-9b1cd2de455f"
      unitRef="U_USD">277000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_581fcdd9-85ef-4aad-9db3-f415df4cbef2"
      unitRef="U_USD">263000</us-gaap:DepreciationDepletionAndAmortization>
    <mspr:ClaimsAmortizationExpense
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_60b4976c-7905-4617-a963-58072b52097f"
      unitRef="U_USD">484076000</mspr:ClaimsAmortizationExpense>
    <mspr:ClaimsAmortizationExpense
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_7e5e455e-1b0a-4c25-a16b-82638c7f2df6"
      unitRef="U_USD">476492000</mspr:ClaimsAmortizationExpense>
    <us-gaap:PaidInKindInterest
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_7afe5ee6-3e63-4c8b-a947-6e22eba8fa9c"
      unitRef="U_USD">278800000</us-gaap:PaidInKindInterest>
    <us-gaap:PaidInKindInterest
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_95951ba3-4813-4d4d-8c8d-3ce1dd308d1d"
      unitRef="U_USD">214380000</us-gaap:PaidInKindInterest>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_edff83bc-d5b6-40a4-bb82-3372d865326a"
      unitRef="U_USD">752697000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_ce8e4777-fc85-4685-bc36-6865ee59ed6e"
      unitRef="U_USD">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <mspr:AllowanceForCreditLosses
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_959634c0-63d7-4032-bc53-1a943b08b590"
      unitRef="U_USD">0</mspr:AllowanceForCreditLosses>
    <mspr:AllowanceForCreditLosses
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_192b7237-0b20-4513-8dbd-bc56d2071202"
      unitRef="U_USD">5000000</mspr:AllowanceForCreditLosses>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_ad932ba7-0b55-4bc1-af54-440b89105e26"
      unitRef="U_USD">-137095000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_513dffc8-d1c2-4734-af40-ac978c2a8dd0"
      unitRef="U_USD">-4785000</us-gaap:FairValueAdjustmentOfWarrants>
    <mspr:ChangeInFairValueOfDerivatives
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_3d366071-a7f9-4056-8797-8679361404be"
      unitRef="U_USD">161000</mspr:ChangeInFairValueOfDerivatives>
    <mspr:ChangeInFairValueOfDerivatives
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_f87c6285-924c-4097-86f0-ddd12a6585ea"
      unitRef="U_USD">181000</mspr:ChangeInFairValueOfDerivatives>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_97a53cd4-5aec-40b0-95d4-490f47bdf126"
      unitRef="U_USD">0</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_10ef6ded-4feb-4559-801c-b555ff55f759"
      unitRef="U_USD">4599000</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:ShareBasedCompensation
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_2770c71e-6840-4ea3-b3cf-78fce79b0364"
      unitRef="U_USD">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_8790d5ab-7081-4a42-b631-b72778d7d2d4"
      unitRef="U_USD">830000</us-gaap:ShareBasedCompensation>
    <mspr:MarkToMarketGainOnLiabilityPayableInStock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_7c14ab74-7eee-48e3-8729-2565d09ceb35"
      unitRef="U_USD">545000</mspr:MarkToMarketGainOnLiabilityPayableInStock>
    <mspr:MarkToMarketGainOnLiabilityPayableInStock
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_a430292c-6823-4920-b101-04052f9cdcc6"
      unitRef="U_USD">4431000</mspr:MarkToMarketGainOnLiabilityPayableInStock>
    <mspr:ProfessionalFeesSettledInShares
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_746cf6b0-5ca3-43f4-bcb4-60bc1f391020"
      unitRef="U_USD">2072000</mspr:ProfessionalFeesSettledInShares>
    <mspr:ProfessionalFeesSettledInShares
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_743b71a3-27eb-42f1-b5a7-10bf95c052da"
      unitRef="U_USD">2745000</mspr:ProfessionalFeesSettledInShares>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_87a91b6c-1754-4260-9950-26ddd2fb57a4"
      unitRef="U_USD">6000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_4eeec56b-6606-4568-b4ea-e56a3b210655"
      unitRef="U_USD">2000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_0282c2a5-2c49-44ba-9c91-22117c33de3a"
      unitRef="U_USD">78000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_7a596ca5-7184-47b8-bd50-fee4fc9d1fe2"
      unitRef="U_USD">-542000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_f02dc4e6-433d-4853-be83-9eacfc5dc07a"
      unitRef="U_USD">-7261000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_5d26365c-1f34-4de0-8975-6a4dbf52940a"
      unitRef="U_USD">-18999000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <mspr:IncreaseDeceaseInAffiliatesReceivable
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_9f6cf949-83d3-4966-aa38-96d7ba5d284b"
      unitRef="U_USD">17000</mspr:IncreaseDeceaseInAffiliatesReceivable>
    <mspr:IncreaseDeceaseInAffiliatesReceivable
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_01b50422-e877-4600-91b7-063e13cf4bf5"
      unitRef="U_USD">-1238000</mspr:IncreaseDeceaseInAffiliatesReceivable>
    <mspr:IncreaseDeceaseInAffiliatesPayable
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_ad09f737-52d3-4889-a092-d0e79ca9c4b5"
      unitRef="U_USD">-1842000</mspr:IncreaseDeceaseInAffiliatesPayable>
    <mspr:IncreaseDeceaseInAffiliatesPayable
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_19a7307c-e905-4328-b209-d873f357833b"
      unitRef="U_USD">0</mspr:IncreaseDeceaseInAffiliatesPayable>
    <mspr:IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_65f2c33a-55bd-4494-8867-3c660b813aaf"
      unitRef="U_USD">10100000</mspr:IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities>
    <mspr:IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_812beb5f-cb26-478b-ad0f-8c6a82648e4f"
      unitRef="U_USD">13513000</mspr:IncreaseDecreaseInAccountsPayableCommissionPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_66b985b1-bf1c-48cb-b975-b9c48ee0c744"
      unitRef="U_USD">141167000</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_15148547-8c79-4f81-8e20-cf182816130c"
      unitRef="U_USD">74752000</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_b2e5ed20-98c4-4eaf-b804-a335ab27687f"
      unitRef="U_USD">-16121000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_612859a8-8ca5-4b7a-9fd5-bd62c73929ed"
      unitRef="U_USD">-40023000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_71951754-1bf1-4333-96b1-5c9659a89609"
      unitRef="U_USD">525000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_390fce61-8729-4dc3-a96f-c15d1a499e09"
      unitRef="U_USD">1742000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_ae680be0-9e6d-4381-9537-b31932b5dfc1"
      unitRef="U_USD">2200000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_520b2837-d3bf-4724-8852-01edc4596c28"
      unitRef="U_USD">700000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfIntangibleAssets
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_09c1468e-9770-4f23-9877-54354dd2bc6a"
      unitRef="U_USD">0</us-gaap:ProceedsFromSaleOfIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfIntangibleAssets
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_1e266d31-6217-4730-91b2-152181f635e1"
      unitRef="U_USD">10000000</us-gaap:ProceedsFromSaleOfIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_5ec1fcef-2d50-439d-87dc-75b9b15b1239"
      unitRef="U_USD">-2725000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_93e12e8a-d5d2-462f-abe0-2a19657cd249"
      unitRef="U_USD">7558000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_e0493f88-37dd-459f-98e0-3bd7ad8372f5"
      unitRef="U_USD">23500000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_35ccca58-c4c0-44f3-b732-e3b4e07bcd93"
      unitRef="U_USD">39000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <mspr:PaymentsOfDeferredFinancingCosts
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_b8568705-8cfb-4f9b-9f9c-11eed6ac15ce"
      unitRef="U_USD">0</mspr:PaymentsOfDeferredFinancingCosts>
    <mspr:PaymentsOfDeferredFinancingCosts
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_bf14fe9d-1751-457f-8064-7cea7f966e03"
      unitRef="U_USD">250000</mspr:PaymentsOfDeferredFinancingCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_5a625dfa-004a-48d2-a3cb-1124cbda09e0"
      unitRef="U_USD">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_38b48923-380f-438f-ae81-f8bd20fc840b"
      unitRef="U_USD">708000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <mspr:PaymentsOnRelatedPartyLoan
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_930ae64a-6e30-4f0f-be44-c5dff142f095"
      unitRef="U_USD">382000</mspr:PaymentsOnRelatedPartyLoan>
    <mspr:PaymentsOnRelatedPartyLoan
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_8815d523-67e4-437e-965d-caa19cf4a4e1"
      unitRef="U_USD">0</mspr:PaymentsOnRelatedPartyLoan>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_9a66c039-75ba-48a3-af8a-e15632e557f6"
      unitRef="U_USD">0</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_c284a7e8-84d6-404e-8590-3871ab408ad3"
      unitRef="U_USD">4950000</us-gaap:ProceedsFromRelatedPartyDebt>
    <mspr:ReleaseOfTemporaryEquityForPayments
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_e153c2fa-f8fb-485c-a8b2-e10e1e3fb819"
      unitRef="U_USD">0</mspr:ReleaseOfTemporaryEquityForPayments>
    <mspr:ReleaseOfTemporaryEquityForPayments
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_63f0835b-cbc2-4079-8bbf-9b5431653a16"
      unitRef="U_USD">11420000</mspr:ReleaseOfTemporaryEquityForPayments>
    <mspr:RepaymentOfTheClaimsFinancingObligation
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_9de4fe0a-6f6f-4385-8a59-d924f5c18041"
      unitRef="U_USD">6640000</mspr:RepaymentOfTheClaimsFinancingObligation>
    <mspr:RepaymentOfTheClaimsFinancingObligation
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_85b1c1d5-5001-401c-8384-6d5ae4527fac"
      unitRef="U_USD">2555000</mspr:RepaymentOfTheClaimsFinancingObligation>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_8154c682-b649-4f68-b006-dab8b63de37a"
      unitRef="U_USD">3063000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_058c0697-639d-457c-9de9-4f7435e8d783"
      unitRef="U_USD">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_18ae87f2-d704-4949-9400-90f649e6c23b"
      unitRef="U_USD">19541000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_388303c4-427d-47dd-83d7-079072e33c22"
      unitRef="U_USD">29017000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_18326b3b-1fae-4c67-9ba0-92dcb754a147"
      unitRef="U_USD">695000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_1e3fc2ff-3963-4157-8dbb-1e1e3f0b89cb"
      unitRef="U_USD">-3448000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_d7214458-23aa-429c-b2b8-21208179b15e"
      unitRef="U_USD">11633000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_8dbd5799-d76e-43f3-b963-830f8fd31b2e"
      decimals="-3"
      id="F_a2590ac1-62a4-4d60-a1be-3d138b711f12"
      unitRef="U_USD">15081000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_f6bf50eb-0420-47df-add3-b6f60e9fa71c"
      unitRef="U_USD">12328000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_4c73a54c-0ef3-4d3e-9782-7b7d9d6673f7"
      unitRef="U_USD">11633000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <mspr:SaleOfIntangibleAssets
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_560147cb-0dcf-4b18-8ac1-47d50ea14627"
      unitRef="U_USD">0</mspr:SaleOfIntangibleAssets>
    <mspr:SaleOfIntangibleAssets
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_34b11072-b00e-41fc-9dfd-dff8b29c710d"
      unitRef="U_USD">30987000</mspr:SaleOfIntangibleAssets>
    <mspr:IntangibleAssetsFinancedByNotePayable
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_c566f6d6-425f-4008-9a89-20e0e09c6e42"
      unitRef="U_USD">0</mspr:IntangibleAssetsFinancedByNotePayable>
    <mspr:IntangibleAssetsFinancedByNotePayable
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_a75c6acf-6f4b-4f93-b6bc-e8d9e0ce6d67"
      unitRef="U_USD">250000000</mspr:IntangibleAssetsFinancedByNotePayable>
    <mspr:ReleaseOfTemporaryEquityDuringNonCash
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_942f816f-88ba-4b43-8359-fd9394fe5f8e"
      unitRef="U_USD">0</mspr:ReleaseOfTemporaryEquityDuringNonCash>
    <mspr:ReleaseOfTemporaryEquityDuringNonCash
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_eb3427da-9055-4074-a4ed-439b030e5406"
      unitRef="U_USD">1807000</mspr:ReleaseOfTemporaryEquityDuringNonCash>
    <mspr:OriginalIssueDiscountOfNonCash
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_c51734bd-59e6-486f-ae13-c766a057f141"
      unitRef="U_USD">12750000</mspr:OriginalIssueDiscountOfNonCash>
    <mspr:OriginalIssueDiscountOfNonCash
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_63eb2886-5bc5-4a90-9218-71e33e198f06"
      unitRef="U_USD">20167000</mspr:OriginalIssueDiscountOfNonCash>
    <mspr:PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_a9650a3b-d511-40c3-8e53-75c295fd00ad"
      unitRef="U_USD">0</mspr:PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock>
    <mspr:PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_08945d0b-e2d9-4c83-a611-94135a9f9fa8"
      unitRef="U_USD">833000</mspr:PurchaseOfIntangibleAssetThroughIssuanceOfClassACommonStock>
    <us-gaap:StockIssued1
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_01ff08c6-fe0b-4cec-9d6a-290c4572074c"
      unitRef="U_USD">3063000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_8e75061a-0482-4047-b97d-4d78a5f6f97e"
      unitRef="U_USD">0</us-gaap:StockIssued1>
    <mspr:PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_d31e469b-66bc-4b87-87fa-38907c5f3ebb"
      unitRef="U_USD">2072000</mspr:PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock>
    <mspr:PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_aba1fe40-f49e-41a1-9ff9-4b713052b208"
      unitRef="U_USD">4745000</mspr:PaymentOfProfessionalFeesThroughIssuanceOfClassACommonStock>
    <mspr:NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_ebf2abd1-966d-49f4-824e-c3567df0a7ab"
      unitRef="U_USD">0</mspr:NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets>
    <mspr:NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_dd5c4001-abbf-4593-9a63-56ebe70367fa"
      unitRef="U_USD">376000</mspr:NonCashLeaseLiabilitiesArisingFromObtainingRightOfUseAssets>
    <us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_15f1e09c-262e-4502-b1da-7f6c2486f073"
      unitRef="U_USD">0</us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability>
    <us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_2cff6a2c-301f-44f7-ada7-c18e3dd6093b"
      unitRef="U_USD">61690000</us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability>
    <mspr:WarrantConversionsOnACashlessBasis
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_e2f099a0-965f-4e49-b316-0036707af240"
      unitRef="U_USD">0</mspr:WarrantConversionsOnACashlessBasis>
    <mspr:WarrantConversionsOnACashlessBasis
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_b99866bf-0374-436d-8031-8cf106d92764"
      unitRef="U_USD">258000</mspr:WarrantConversionsOnACashlessBasis>
    <us-gaap:InterestPaidNet
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_00e897fd-6bc2-4663-bff2-0477da7912e7"
      unitRef="U_USD">6384000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_88e9c93e-3224-4e7a-b540-d89c195e30ab"
      unitRef="U_USD">37000</us-gaap:InterestPaidNet>
    <us-gaap:NatureOfOperations
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_73e07322-c9ea-4374-b248-8be27a3a4015">&lt;p id="footnotes" style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 1. DESCRIPTION OF THE BUSINESS&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On May 23, 2022 (the &#x201c;Closing Date&#x201d;), MSP Recovery, Inc., a Delaware corporation (formerly known as Lionheart Acquisition Corporation II (&#x201c;LCAP&#x201d;)) consummated the previously announced business combination pursuant to that certain Membership Interest Purchase Agreement, dated as of July 11, 2021, as amended (the &#x201c;MIPA&#x201d;), by and among the Company, Lionheart II Holdings, LLC, a wholly owned subsidiary of the Company, MSP Recovery, LLC and combined and consolidated subsidiaries (&#x201c;Legacy MSP&#x201d;), the members of Legacy MSP (the &#x201c;Members&#x201d;), and John H. Ruiz, in his capacity as the representative of the Members (the &#x201c;Members&#x2019; Representative&#x201d;). Pursuant to the MIPA, the Members sold and assigned all of their membership interests in Legacy MSP to the Company in exchange for non-economic voting shares of Class V common stock, par value $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, of the Company (&#x201c;Class V Common Stock&#x201d;) and non-voting economic Class B Units of Opco (&#x201c;Class B Units,&#x201d; and each pair consisting of one share of Class V Common Stock and one Class B Unit, an &#x201c;Up-C Unit&#x201d;) (such transaction, the &#x201c;Business Combination&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;T&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;he Company is organized in an &#x201c;Up-C&#x201d; structure in which all of the business of Legacy MSP and its subsidiaries is held directly or indirectly by the Company, the Company is the managing member, consolidates Legacy MSP and the Company owns all of the voting economic Class A Units and the Members and their designees own all of the non-voting economic Class B Units in accordance with the terms of the first amended and restated limited liability company agreement of the Company. Each Up-C Unit may be exchanged for either, at the Company&#x2019;s option, (a) cash or (b) one share of Class A common stock, par value $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, of the Company (&#x201c;Class A Common Stock&#x201d;), subject to the provisions set forth in the LLC Agreement. The aggregate consideration paid to the Members (or their designees) at the Closing consisted of: &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,200,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Units and (ii) rights to receive payments under the Tax Receivable Agreement (&#x201c;TRA&#x201d;), discussed in more detail below.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Legacy MSP was organized in 2014 as a Medicaid and Medicare Secondary Payer Act recovery specialist. The Company utilizes its proprietary internal data analytics platform to review health Claims assigned by secondary payers such as health plans, MSOs, providers of medical services, and independent physicians associations. This platform allows the Company to identify Claims cost recovery rights with potential recovery paths where Claims either should not have been paid by the secondary payers or should have been reimbursed by third-party entities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;MSP Recovery is assigned recovery rights to Claims by secondary payers via CCRAs. Prior to executing a CCRA, MSP Recovery utilizes its proprietary internal data analytics platform to review the set of Claims of a prospective Assignor to identify Claims with probable recovery paths. MSP Recovery&#x2019;s assets are these irrevocable broad assignments of health Claims recovery rights that are supported by federal and state laws and regulations. MSP Recovery&#x2019;s offices are located in the U.S. and Puerto Rico.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Public Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to the terms of the Existing Warrant Agreement, and after giving effect to the issuance of the New Warrants, as defined below, the exercise price of the Public Warrants increased to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0625&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share of Class A Common Stock, on a cashless basis, in lots of 625. During the period from the Closing Date to December 31, 2024, approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million war&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;rants of the orig&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;inal &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;warrants had been exercised. For the years ended December 31, 2024 and 2023, the fair value of the remaining unexercised warrants decreased resulting in other income&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, which is recorded within change in fair value of warrant and derivative liabilities in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;New Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Additionally, in connection with the Business Combination, the Company declared&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; the New Warrant Dividend comprising approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,028&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million New Warrants payable to the holders of record of the Class A Common Stock as of the close of business on the Closing Date.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The New Warrants expire on the fifth anniversary of the Closing Date or upon earlier redemption. The Company determined that the New Warrants instruments meet the equity scope exception in ASC 815 to be &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;classified in stockholders&#x2019; equity, and as the repurchase right noted above has a mirrored value designed to offset the New Warrants, if exercised would be an equity only transaction. The New Warrants are each exercisable in lots of 625 for one whole share of Class A Common Stock at a reverse split adjusted exercise price $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,187.50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per whole share. The New Warrants are subject to certain anti-dilution adjustments.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Public Warrants and New Warrants are currently listed on Nasdaq under the symbols &#x201c;MSPRZ&#x201d; and &#x201c;MSPRW,&#x201d; respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Tax Receivable Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with the Business Combination, the Company also entered into a Tax Receivable Agreement (the &#x201c;TRA&#x201d;). Pursuant to the TRA, the Company is required to pay the sellers &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the amount of tax benefits that the Company actually realizes as a result of (i) the Company&#x2019;s direct and indirect allocable share of existing tax basis acquired in the Business Combination, (ii) increases in the Company&#x2019;s allocable share of existing tax basis and tax basis adjustments that will increase the tax basis of the tangible and intangible assets of the Company as a result of the Business Combination and as a result of sales or exchanges of Up-C Units for cash or shares of Class A Common Stock, and (iii) certain other tax benefits related to entering into the TRA, including tax benefits attributable to payments under the TRA.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the years ended December 31, 2024 and 2023, the Company&#x2019;s TRA liability associated with the allocable share of existing tax basis acquired in the Business Combination would give rise to a TRA liability of&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively. The Company has not recognized such liabilities under the TRA after concluding it was not probable that the Company will be able to realize the remaining tax benefits based on estimates of future taxable income. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; payments were made to the Continuing Equity Owners and Blocker Shareholders (as defined in the TRA) pursuant to the TRA during the years ended December 31, 2024, or 2023. The estimation of liability under the tax receivable agreement is by its nature imprecise and subject to significant assumptions regarding the amount, character, and timing of the taxable income of MSP Recovery, Inc. in the future. We may incur additional liabilities under the TRA when Lionheart II Holdings, LLC are exchanged in the future. If the valuation allowance recorded against the deferred tax assets applicable to the tax attributes subject to the TRA is released in a future period, the relating TRA liability may be considered probable at that time and recorded within earnings.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has assessed the realizability of the net deferred tax assets and, in that analysis, has considered the relevant positive and negative evidence available to determine whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The Company has recorded a full valuation allowance against the deferred tax assets as of December 31, 2024 and 2023, which will be maintained until there is sufficient evidence to support the reversal of all or some portion of these allowances. As the tax benefits associated with the TRA have not be recognized, based on estimates of future taxable income, the Company has concluded it is not probable to recognize any tax receivable agreement liability. If the valuation allowance recorded against the deferred tax assets is released in a future period, the Tax Receivable Agreement liability may be considered probable at that time and recorded within earnings.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Non-Controlling Interest&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company reflects non-controlling interests due to the Up-C structure. The Company holds all of the voting Class A Units of Opco, whereas the Members (or their designees) hold all of the non-voting economic Class B Units of Opco (these Class B Units represent the non-controlling interest in the Company). The ownership percentage of Class V Common Stock held in the Company by the Members (or their designees) will be equivalent to the number of Class B Units held in the Company, and as such, reflects non-controlling interest in the Company, which is equivalent to the Class V Common Stock ownership percentage. See Note 11, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Noncontrolling Interest&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, for more information on ownership interests in the Company&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Reverse Stock Splits&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Effective at 11:59 PM EDT on November 15, 2024, the Company amended its Charter filed with the Secretary of State of the State of Delaware to effect a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_51bd4aa3-2e94-4fa0-8f20-4260f6251be5;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1-for-25&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reverse stock split of the Company&#x2019;s common stock (the &#x201c;2024 Reverse Split&#x201d;). The Company&#x2019;s Class A Common Stock began trading post split on November 18, 2024. As a result of the 2024 &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Reverse Split, every 25 shares of the Company&#x2019;s old common stock were converted into one share of the Company&#x2019;s new common stock. &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Fractional shares resulting from the 2024 Reverse Split were rounded up to the nearest whole number. The 2024 Reverse Split automatically and proportionately adjusted, based on the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_11cad189-e838-4ea3-9011-9fb880f04e08;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1-for-25&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; split ratio, all issued and outstanding shares of the Company&#x2019;s common stock, as well as the terms of warrants and other derivative securities outstanding at the time of the effectiveness of the 2024 Reverse Split. Proportionate adjustments were made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options and warrants to purchase shares of common stock.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On October 12, 2023, we amended our Charter with the&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Secretary of State of the State of Delaware to effect a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_6dbb5636-fa51-4f4c-bb43-bb758434c2c0;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1-for-25&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reverse stock split (the &#x201c;2023 Reverse Split&#x201d;) of the Company&#x2019;s common stock, effective October 13, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Unless otherwise stated, all share and per shares numbers (except par value) in this Annual Report on Form 10-K have been adjusted to reflect the 2024 Reverse Split and 2023 Reverse Split.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Primary Market Change&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On December 6, 2024, the Company received notification from the Staff that the Company&#x2019;s application to transfer the listing of its common stock from the Nasdaq Global Market to the Nasdaq Capital Market was approved. The Company&#x2019;s securities transferred to the Nasdaq Capital Market at the opening of business on December 10, 2024, and continue to trade under the symbol &#x201c;MSPR.&#x201d; The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market, and listed companies must meet certain financial requirements and comply with Nasdaq&#x2019;s corporate governance requirements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Symbol Change&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Effective December 9, 2024, the Company rebranded all lines of business under the MSP Recovery brand, and the Company&#x2019;s Class A Common Stock, New Warrants, and Public Warrants begin trading on Nasdaq under the ticker symbols &#x201c;MSPR,&#x201d; &#x201c;MSPRW,&#x201d; and &#x201c;MSPRZ,&#x201d; respectively. Prior to this change, the Company was known as LifeWallet.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Going Concern&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As an early-stage growth company, the Company has incurred substantial net losses since inception. As of December 31, 2024, the Company had unrestricted cash and cash equivalents totaling &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company has incurred recurring losses and negative cash flows since inception and has an accumulated deficit of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_86dbe84b-548c-486d-9e3f-7db44ea29333;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;446.1 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as of December 31, 2024. For the year ended December 31,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2024, the Company used approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of cash in operations. The Company&#x2019;s liquidity will depend on the ability to generate substantial Claims recovery income and Claims recovery services income in the near future, the timing and amount of which is uncertain, as well as its ability to secure funding from capital sources. The Company&#x2019;s principal liquidity needs have been working capital, debt service, and Claims financing obligations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company anticipates sources of liquidity to include up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in bridge loan funding to the Company under the existing Operational Collection Floor facility (in addition to the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million previously funded under the facility) in the amounts of: (i) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for March 2025, which was funded on February 28, 2025; (ii) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for April 2025, which was funded on April 4, 2025; (iii) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for May 2025, to be funded on or about April 30, 2025; (iv) up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to fund the legal, accounting, and administrative expenses associated with the reorganization, subject to certain terms and customary conditions acceptable to Hazel, and minimum license fees of (v) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.55&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for June 2025; and (vi) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.55&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for July 2025, as well as the Yorkville SEPA as disclosed in more detail in&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Note 9,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Claims Financing Obligations and Notes Payable&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and beyond July 2025, the MSP Principals&#x2019; commitment to pledge $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of collateral to backstop additional working capital requirements of the Company. The Company &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;has taken several actions to address liquidity concerns, including actions enumerated below. However, as discussed further below, the Company has concluded management&#x2019;s plans were not sufficient to alleviate the substantial doubt about the Company&#x2019;s ability to continue as a going concern:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;1.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 29, 2023, the Company&#x2019;s subsidiary, Subrogation Holdings, LLC and its parent, MSP Recovery, entered into the Working Capital Credit Facility consisting of commitments to fund up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in proceeds. Certain terms were amended to the Working Capital Credit Facility, which were memorialized in the Second Amended and Restated First Lien Credit Agreement dated November 10, 2023. See summary in &#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Hazel Working Capital Credit Facility and Hazel Purchase Money Loan&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d; in Note 9,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Claims Financing Obligations and Notes Payable &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to the consolidated financial statements. On August 2, 2024, HPH agreed to, among other things, (i) extend the period for the Company draw up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for working capital, accessible in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;eight&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; tranches of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, that can be drawn at least one month apart, until September 2025 and (ii) provide for a $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million loan to be funded by August 31, 2024 for the purpose of acquiring the New Claims. On January 30, 2025, the Company drew the final $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million tranche for working capital. Pursuant to the OCF Amendment, HPH may, at its sole discretion, increase the Operational Collection Floor by an amount of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, to be funded over a period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_b0a040b1-eb30-4c2e-913a-8367a95bb387;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;six months&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 28, 2025 and April 4, 2025, HPH exercised that discretion and funded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, from the increase to the Operational Collection Floor; said payments are considered part of the bridge loan, as set forth in the proposed reorganization term sheet. An additional $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million remains available under the Operational Collection Floor, to be funded at HPH&#x2019;s sole discretion.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;2.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On November 13, 2023, the Company entered into the MTA Amendment No. 2 and Amendment to the Amended and Restated Security Agreement (&#x201c;Second Virage MTA Amendment&#x201d;), which extended the due date for the payment obligations to Virage to December 31, 2024. See summary in Note 3,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Material Agreements &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to the consolidated financial statements. On April 1, 2024, the Company entered into the MTA Amendment No. 3 and Amendment No. 2 to the Amended and Restated Security Agreement (&#x201c;Third Virage MTA Amendment&#x201d;), which: (i) extended the VRM Full Return payment due date to September 30, 2025, subject to acceleration upon certain triggering events; (ii) the Company agreed that, after the Yorkville Convertible Notes are fully satisfied, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the Company&#x2019;s portion of any net proceeds from the Yorkville SEPA would be used to pay down the VRM Full Return; and (iii) commence the sale of certain reserved shares of Messrs. John H. Ruiz and Frank C. Quesada, and the delivery of the resulting net cash proceeds thereof to VRM. The VRM Full Return guaranty obligation became current on September 30, 2024, and the Company does not currently have available liquidity to satisfy said obligation.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;3.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On November 13, 2023, the Company entered into the Second Amended and Restated Nomura Note (defined in Note 3, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Business Combination &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to the consolidated financial statements), which extended the maturity date of the Nomura Note to December 31, 2024. See summary in Note 9, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Claims Financing Obligations and Notes Payable &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to the consolidated financial statements. On March 26, 2024, the Company entered into the Third Amended and Restated Nomura Promissory Note, which extended the maturity date of the Nomura Note to September 30, 2025. The note became current on September 30, 2024, and the Company does not currently have available liquidity to satisfy said obligation. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to a letter agreement dated November 15, 2024, Nomura agreed to forego payments of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million due under the Third Amended and Restated Nomura Note from proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA until March 31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;4.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On November 14, 2023, the Company entered into the Yorkville SEPA, which included the issuance of Yorkville &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Convertible Notes to Yorkville having aggregate principal amounts of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in connection with the purchase of Class A Common Stock. See summary in &#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Committed Equity Facility&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d; within Note 9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, Claims Financing Obligations and Notes Payable &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to the consolidated financial statements. On April 8, 2024, the maturity date of the Yorkville &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Convertible Notes was extended to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;September 30, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. On April 12, 2024, Yorkville agreed that, to the extent that it holds Class A Common Stock in such quantities that would prevent the Company from utilizing the SEPA solely due to the Ownership Limitation, Yorkville commits to fund an additional advance in the principal amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;on the same terms and conditions as the previous &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;advances &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;pursuant to the Yorkville SEPA. On April 10, 2025, Yorkville further agreed to: (i) extend the due date for the first Monthly Payment to November 30, 2026, (ii) extend the maturity date of the Convertible Notes to November 30, 2026, and (iii) to waive Volume Threshold and Maximum Advance Amount limitations set forth in the Yorkville SEPA. As we have sold substantially all of the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares currently registered for resale to Yorkville, we need to file with the SEC one or more additional registration statements to register under the Securities Act the resale by Yorkville of any additional shares of our common stock, and the SEC would have to declare such registration statement or statements effective before we could sell additional shares. There can be no assurances of such events occurring or the timing of such events occurring.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has concluded that, despite the aforementioned financing arrangements, there is substantial doubt about its ability to continue as a going concern. Unless we are successful in raising additional funds through the offering of debt or equity securities, we have concluded it is probable we will be unable to continue to operate as a going concern beyond the next twelve months. The Company has received a report from its independent registered public accounting firm with an emphasis of matter paragraph as to going concern in connection with the Company&#x2019;s audited annual financial statements for the year ended December 31, 2024, which resulted in an event of default in the aforementioned debt agreement, which would have resulted in the debt becoming immediately due; however, the Company has received waivers from (i) Virage and VRM and (ii) HPH and Hazel as it pertains to the year ended December 31, 2024.&lt;/span&gt;&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_80f27fb1-52e9-4cda-90cc-c5c855c8fd29"
      decimals="INF"
      id="F_acaab098-c78d-4152-8a98-0ebd3afa2741"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="C_bee1feb7-080c-486a-81cc-c38168970e45"
      decimals="INF"
      id="F_2dc528af-6cf2-4905-b80d-3e0aa02b957a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="C_94b11fc0-301a-40ea-b25e-f4fc6d4b8a9f"
      decimals="INF"
      id="F_94396d02-31b7-4dab-9a45-092d2db205c5"
      unitRef="U_shares">5200000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:WarrantExercisePriceIncrease
      contextRef="C_94b11fc0-301a-40ea-b25e-f4fc6d4b8a9f"
      decimals="INF"
      id="F_8ccd686a-708c-4cfc-9ac5-8e30aadf481f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0625</us-gaap:WarrantExercisePriceIncrease>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_9996cf94-6a99-485b-acb5-c26104f11cc7"
      decimals="-5"
      id="F_87265a44-8a8e-46c7-ac82-f0e9862c36c4"
      unitRef="U_shares">8900000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_9996cf94-6a99-485b-acb5-c26104f11cc7"
      decimals="-5"
      id="F_5ac6ac58-e160-45b5-88b1-562545de5821"
      unitRef="U_shares">11800000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156"
      decimals="-5"
      id="F_695b1feb-9354-4a67-b792-45031db45043"
      unitRef="U_USD">-300000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_1720b370-71e8-404f-b2ba-d747e1f96522"
      decimals="-5"
      id="F_f9f8e7f3-7f58-4a1f-b13b-2db3bf01779e"
      unitRef="U_USD">-4800000</us-gaap:FairValueAdjustmentOfWarrants>
    <mspr:DividendComprisingNumberOfNewWarrantsPayableHolders
      contextRef="C_343a98c3-3718-4240-81dc-cca99ff09156"
      decimals="-6"
      id="F_86e1f928-4b80-4bf3-a6f1-d72f9a4d4fa1"
      unitRef="U_shares">1028000000</mspr:DividendComprisingNumberOfNewWarrantsPayableHolders>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_9996cf94-6a99-485b-acb5-c26104f11cc7"
      decimals="2"
      id="F_1bbc35bf-52b3-420a-9ab3-7e878731b898"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">7187.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <mspr:PercentageOfPaySellersToAmountOfTaxBenefit
      contextRef="C_bf132eff-e862-4432-9a3c-8ea0d6d97f66"
      decimals="2"
      id="F_44cc443d-49fc-4523-94df-3f4f791597b5"
      unitRef="U_pure">0.85</mspr:PercentageOfPaySellersToAmountOfTaxBenefit>
    <mspr:IncreaseInTaxReceivableAgreementLiability
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-5"
      id="F_3224a2a8-4059-4ec0-8962-4bb3e6e45ad5"
      unitRef="U_USD">12800000</mspr:IncreaseInTaxReceivableAgreementLiability>
    <mspr:IncreaseInTaxReceivableAgreementLiability
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-5"
      id="F_deb6d26f-f3af-4af2-bfc1-c70b31445641"
      unitRef="U_USD">11300000</mspr:IncreaseInTaxReceivableAgreementLiability>
    <mspr:PaymentsToContinuingEquityOwnersAndBlockerShareholders
      contextRef="C_bf132eff-e862-4432-9a3c-8ea0d6d97f66"
      decimals="INF"
      id="F_78b3ae5b-c39b-4606-8d68-d759dfb1adde"
      unitRef="U_USD">0</mspr:PaymentsToContinuingEquityOwnersAndBlockerShareholders>
    <mspr:PaymentsToContinuingEquityOwnersAndBlockerShareholders
      contextRef="C_c51278ee-8240-44e0-840b-5a8e9271f685"
      decimals="INF"
      id="F_5596e581-750d-4692-bfef-a3943c4981cc"
      unitRef="U_USD">0</mspr:PaymentsToContinuingEquityOwnersAndBlockerShareholders>
    <us-gaap:StockholdersEquityReverseStockSplit
      contextRef="C_9565635a-4edf-48eb-b58e-a592cc2a6e49"
      id="F_acd4b75b-e7f9-4f7b-b139-5fc7a5bb115c">Reverse Split, every 25 shares of the Company&#x2019;s old common stock were converted into one share of the Company&#x2019;s new common stock. </us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:Cash
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-5"
      id="F_b3af1293-227c-4487-b63c-9c2388ac34a6"
      unitRef="U_USD">12300000</us-gaap:Cash>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-5"
      id="F_2c8d0850-a4c9-4d86-bf99-eedee68005b6"
      unitRef="U_USD">-16100000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:BridgeLoan
      contextRef="C_8d558395-7c90-405f-a7c4-dc8b67120549"
      decimals="-4"
      id="F_940b9948-c171-44ed-8c5d-e1fb7abbb964"
      unitRef="U_USD">9750000</us-gaap:BridgeLoan>
    <mspr:AdditionalBridgeLoan
      contextRef="C_71d4c574-8d09-4451-b706-aecd0cddefa3"
      decimals="-5"
      id="F_45e7fdc0-9844-4eea-9af4-cdf102cd743f"
      unitRef="U_USD">16000000</mspr:AdditionalBridgeLoan>
    <us-gaap:BridgeLoan
      contextRef="C_88fe5d42-7072-4d23-aaf0-bcc6834ff66f"
      decimals="-4"
      id="F_8a93180b-8092-458a-90d5-de68b08f31ef"
      unitRef="U_USD">1750000</us-gaap:BridgeLoan>
    <us-gaap:BridgeLoan
      contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688"
      decimals="-5"
      id="F_627cbc70-110e-467e-98d5-a2a22c628328"
      unitRef="U_USD">1500000</us-gaap:BridgeLoan>
    <us-gaap:BridgeLoan
      contextRef="C_a14a72e7-94f0-4886-8c83-bd32c3ffe4e1"
      decimals="-5"
      id="F_51e32426-d6ad-40bd-a56b-0cc55bd817d6"
      unitRef="U_USD">1500000</us-gaap:BridgeLoan>
    <us-gaap:BridgeLoan
      contextRef="C_0d4a0973-f818-41cd-a1c5-5c03e254d884"
      decimals="-5"
      id="F_7e518435-551d-4b2a-85ca-a278f5292dc9"
      unitRef="U_USD">2000000</us-gaap:BridgeLoan>
    <us-gaap:BridgeLoan
      contextRef="C_c23753ff-91ab-40d0-869b-679d87defcd8"
      decimals="-4"
      id="F_9f3b6415-d208-4edf-aea5-75ca269bcc5c"
      unitRef="U_USD">1550000</us-gaap:BridgeLoan>
    <us-gaap:BridgeLoan
      contextRef="C_82042595-d2ec-46bd-8d33-1d9c1c5fcd8a"
      decimals="-4"
      id="F_90055722-3d4a-42e4-a738-7567a05b0e8f"
      unitRef="U_USD">1550000</us-gaap:BridgeLoan>
    <us-gaap:OtherCommitment
      contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688"
      decimals="-6"
      id="F_28df29dd-3f64-40d8-913e-46077daaea00"
      unitRef="U_USD">25000000</us-gaap:OtherCommitment>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_f7fd3f49-71c3-435f-9615-5ad600a0128e"
      decimals="-6"
      id="F_beb2f9de-56a1-4344-9ea6-304c0994f20a"
      unitRef="U_USD">48000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_f22fac30-7861-497e-b1e5-adc45046f525"
      decimals="-6"
      id="F_f28af631-0a60-4270-953d-04662a61a084"
      unitRef="U_USD">14000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <mspr:NumberOfTranches
      contextRef="C_a9bac2b3-ff72-451c-87fe-ebf2bc6938a2"
      decimals="INF"
      id="F_bdd1897c-4a9e-4478-a80d-64b548e23f73"
      unitRef="U_Tranche">8</mspr:NumberOfTranches>
    <mspr:LineOfCreditFacilityBorrowingAvailableAmountForEachTranche
      contextRef="C_f22fac30-7861-497e-b1e5-adc45046f525"
      decimals="-4"
      id="F_8ee334f8-167a-43c3-9916-af9b3480a50b"
      unitRef="U_USD">1750000</mspr:LineOfCreditFacilityBorrowingAvailableAmountForEachTranche>
    <mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims
      contextRef="C_f22fac30-7861-497e-b1e5-adc45046f525"
      decimals="-5"
      id="F_5587596b-7f2c-40a1-be4f-bed5814da5bc"
      unitRef="U_USD">2000000</mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_788dd740-ae7d-4599-bfa0-5e03d87f6792"
      decimals="-4"
      id="F_58f43b07-a839-408f-849b-631f2a011f60"
      unitRef="U_USD">1750000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="C_cff61f62-d448-43e7-ae71-41198608a96b"
      decimals="-5"
      id="F_037c831d-837c-4939-abd2-650b1a75ad88"
      unitRef="U_USD">6000000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="C_cff61f62-d448-43e7-ae71-41198608a96b"
      id="F_3ba70a15-dfd6-4cf3-92ec-f9390251ddbf">P6M</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="C_b56a07ac-ec0a-4021-a488-5ef64b5339af"
      decimals="-4"
      id="F_e832759e-dbf6-4f70-bab6-b30af4394821"
      unitRef="U_USD">1750000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="C_21918913-de21-41f4-bb8a-ff60365fc94c"
      decimals="-5"
      id="F_6c581579-97e1-469f-a6d9-138dd823d894"
      unitRef="U_USD">1500000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="C_bdb33403-9b1e-41b7-92e4-eb7991db7d0f"
      decimals="-4"
      id="F_3cab4dad-f327-47ee-a156-da180eb3f82a"
      unitRef="U_USD">2750000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <mspr:PercentageOfProceedsFromRepaymentOfDebt
      contextRef="C_72c17608-1d12-4578-9b1c-a1ccd7d443c7"
      decimals="2"
      id="F_d8de2df1-eaf8-4278-906d-45258dd5afaf"
      unitRef="U_pure">0.25</mspr:PercentageOfProceedsFromRepaymentOfDebt>
    <mspr:AggregateAmountOutstandingUnderCashProceeds
      contextRef="C_3895f47c-684e-4e66-8154-738062424885"
      decimals="-5"
      id="F_738f056b-9d5c-46b3-8208-0b705abbef6e"
      unitRef="U_USD">4000000</mspr:AggregateAmountOutstandingUnderCashProceeds>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_35dae5c1-7aae-4e29-bd11-991504d30ddb"
      decimals="-5"
      id="F_5c77af1a-6532-4fd9-9d64-432c93cc9b44"
      unitRef="U_USD">15000000</us-gaap:DebtInstrumentFaceAmount>
    <mspr:DebtInstrumentsExtendedMaturityDate
      contextRef="C_59b01d67-342b-4678-bb64-aa2875d5d3be"
      id="F_01396f50-ecc3-4d1d-aeb4-e462b33a3f4e">2025-09-30</mspr:DebtInstrumentsExtendedMaturityDate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_8df417e8-0685-446e-aae3-3e40048d4ae7"
      decimals="-5"
      id="F_c8b38c58-7ad6-479b-a4bd-44a7a70d4520"
      unitRef="U_USD">13000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_2c439b10-3157-4c98-b8f8-371831d66f6f"
      decimals="1"
      id="F_5d105f09-6a3b-4fef-bcdd-404192373138"
      unitRef="U_shares">2</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_2bc3053c-8495-4a41-b4b6-723d3baa0f92">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;These statements have been prepared pursuant to the rules and regulations of the SEC and in accordance with GAAP. In the opinion of management, the consolidated financial statements reflect all adjustments, which consist only of normal recurring adjustments, necessary to state fairly the results of operations, financial condition and cash flows for the periods presented herein. Prior to the Business Combination, the consolidated financial statements reflect Legacy MSP. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;All intercompany transactions and balances are eliminated from the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Principles of consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company consolidates all entities that it controls through a majority voting interest or otherwise and the accompanying financial statements include the accounts of the Company&#x2019;s wholly owned subsidiaries and these entities for which the Company has a controlling interest in. The Company also consolidates all entities that it controls as the primary beneficiary of a variable interest entity (&#x201c;VIE&#x201d;). Under the VIE model, management first assesses whether the Company has a variable interest in an entity, which would include an equity interest. If the Company has a variable interest in an entity, management further assesses whether that entity is a VIE, and if so, whether the Company is the primary beneficiary under the VIE model. Generally, entities that are organized similar to a limited partnership, in which a general partner (or managing member) make the most relevant decisions that affect the entity&#x2019;s economic performance, are considered to be VIEs which would require consolidation, unless the limited partners have substantive kickout or participating rights. Entities that do not qualify as VIEs are assessed for consolidation under the voting interest model.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under the VIE model, an entity is deemed to be the primary beneficiary of a VIE if it holds a controlling financial interest. A controlling financial interest is defined as (a) the power to direct the activities of a VIE that most significantly affect the entity&#x2019;s economic performance and (b) the obligation to absorb losses of the entity or the right to receive benefits from the entity that could potentially be significant to the VIE. Management determines whether the Company is the primary beneficiary of a VIE at the time it becomes involved with a VIE and reconsiders that conclusion at each reporting date. This analysis includes an evaluation of the Company&#x2019;s control rights, as well as the economic interests that the Company holds in the VIE, including indirectly through related parties. As a result of the Business Combination, the Company consolidates MSP Recovery under the VIE model.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Estimates and Assumptions&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting periods. Actual results could differ from the Company&#x2019;s estimates. Estimates are periodically reviewed considering changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Significant estimates and assumptions reflected in these consolidated financial statements include but are not limited to recoverability of long-lived assets.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Reclassifications&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain reclassifications have been made to the prior year statement of cash flows to conform to classifications used in the current year. These reclassifications had no impact on net loss, shareholders&#x2019; equity or total cash flows as previously reported.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Segments&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments are defined as components of an entity for which separate financial information (including profit and/or loss) is available and regularly reviewed by the chief operating decision maker (&#x201c;CODM&#x201d;). The Company manages its operations as a single segment for the purposes of assessing performance and making decisions. The Company&#x2019;s CODM is its &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_8b390608-14b7-4bdf-8388-0311ecd33fec;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Executive Officer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company has determined that it operates in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; operating segment and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. In addition, all of the Company&#x2019;s revenues and long-lived assets are attributable primarily to operations in the United States and Puerto Rico for all periods presented.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Concentration of credit risk and Off-Balance Sheet Risk&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash and affiliate receivable are financial instruments that are potentially subject to concentrations of credit risk. See Note 14,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Related Party Transactions&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, fo&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;r disclosure of affiliate receivables. The Company&#x2019;s cash and restricted cash are deposited in accounts at large financial institutions, and amounts may exceed federally insured limits. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash and cash equivalents are held. The Company has no other financial instruments with off-balance-sheet risk of loss.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company considers all highly liquid investments purchased with original maturities of three months or less to be cash equivalents. There are &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; cash equivalents as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 or 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company applies the provisions of ASC 820, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, for fair value measurements of financial assets and financial liabilities and for fair value measurements of non-financial items that are recognized or disclosed at fair value in the financial statements on a recurring basis. The Company also applied the provisions of the subtopic to fair value measurements of non-financial assets and non-financial liabilities that are recognized or disclosed at fair value in the financial statements on a non-recurring basis. The subtopic defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The subtopic also establishes a framework for measuring fair value and expands disclosures about fair value measurements. The fair value framework requires the Company to categorize certain assets and liabilities into three levels, based upon the assumptions used to price those assets or liabilities. The three levels are defined as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 1: Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 2: Quoted prices for similar assets and liabilities in active markets or inputs that are observable.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 3: Unobservable inputs reflecting management&#x2019;s own assumptions about the inputs used in pricing the asset or liability.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has determined the estimated fair value of its financial instruments based on appropriate valuation methodologies; however, for Level 2 and Level 3 inputs considerable judgment is required to develop these estimates. Accordingly, these estimated fair values are not necessarily indicative of the amounts the Company could realize in a current market exchange. The estimated fair values can be materially affected by using different assumptions or methodologies. The methods and assumptions used in estimating the fair values of financial instruments are based on carrying values and future cash flows. As of December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t hold any Level 2 or Level 3 assets. See &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 13,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, for additional information on Level 2 and Level 3 liabilities as of December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash is stated at cost, which approximates their fair value. The carrying amounts reported in the consolidated balance sheets for affiliate receivable, accounts payable, affiliate payable and accrued liabilities approximate fair value, due to their short-term maturities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Outstanding borrowings that qualify as financial instruments are carried at cost, which approximates their fair value as of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, due to their short duration.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Equity Method Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Equity investments that are not consolidated, but over which the Company exercises significant influence, are accounted for in accordance with ASC 323, &#x201c;Investments&#x2014;Equity Method and Joint Ventures&#x201d; (&#x201c;ASC 323&#x201d;). Wh&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ether or not the Company exercises significant influence with respect to an investee company depends on an evaluation of several factors including, among others, representation on the investee company&#x2019;s board of directors and ownership level. An entity is presumptively assumed to have significant influence in a corporation when it holds &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% or more of the voting stock of the investee company, or at a lower level (e.g., &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%) for entities that track separate members capital accounts.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under the equity method of accounting, an investee company&#x2019;s accounts are not reflected within the Company&#x2019;s consolidated balance sheets and statements of operations; however, the Company&#x2019;s share of the earnings or losses of the investee company is reflected in the caption &#x201c;Other income&#x201d; in the consolidated statements of operations. The Company&#x2019;s carrying value in equity method investee companies is not reflected in the Company&#x2019;s consolidated balance sheets as of December 31, 2024 or 2023 as the carryin&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;g &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;value is de&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;minimis. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;When the Company&#x2019;s carrying value in an equity method investee company is reduced to zero, no further losses are recorded in the Company&#x2019;s consolidated financial statements unless the Company has guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are stated at historical cost less accumulated depreciation and accumulated impairment losses, if any. Major expenditures for property and equipment and those that substantially increase useful lives are capitalized. When assets are sold or otherwise disposed of, costs and related accumulated depreciation are removed from the financial statements and any resulting gains or losses are included in general and administrative expenses within our consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company provides for depreciation and amortization on property and equipment using the straight-line method to allocate the cost of depreciable assets over their estimated lives as follows:&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:67.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:32.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8.45pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Office and Computer Equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:11.9pt;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and Fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:1pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold Improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_d7c0ff4e-449b-40a5-8325-8ed41dfb3e58;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lesser of lease term or estimated life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Internal Use Software&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Internal-use software development costs incurred in the preliminary project stage are expensed as incurred; costs incurred in the application and development stage, which meet the capitalization criteria, are capitalized and amortized on a straight-line basis over the estimated useful life of the asset and costs incurred in the post-implementation/operations stage are expensed as incurred. The estimated useful life for development costs capitalized as of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Further, internal and external costs incurred in connection with upgrades or enhancements are also evaluated for capitalization. If the software upgrade results in an additional functionality, costs are capitalized; if the upgrade only extends the useful life, it is expensed as occurred.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Intangible assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In certain of its CCRAs, the Company makes up-front payments to acquire Claims recovery rights from secondary payers, such as health plans, managed service organizations, providers or medical services and independent physicians&#x2019; associations. The Company recognizes intangible assets for costs incurred up front to acquire Claims recovery rights from various Assignors.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The CCRA assets are held at cost. Historically, the Company amortized capitalized costs associated with CCRAs over &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;eight years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, based on the expected timing to pursue recovery through litigation, including through potential appeals. As part of the annual reassessment of useful lives as of December 31, 2024, the Company updated the estimated useful life of the CCRAs to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;seven years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; beginning January 1, 2025.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As part of the Business Combination, the Company acquired rights to Claims recovery cash flows. As a result of this purchase and the guaranty obligation as noted in Note 8, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Variable Interest Entities&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company consolidated the entity which holds these Claim rights. Upon consolidation, these Claims rights were accounted for under ASC 350. As such these assets are held at cost, net of amortization.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates these assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. If the estimated future cash flows (undiscounted and without interest charges) from the use of an asset group are less than the carrying value, a write-down would be recorded to reduce the related asset group to its estimated fair value.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Derivative Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates its convertible debt, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 480, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and ASC 815, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The result of this accounting treatment is that the fair value of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability. The change in fair value is recorded in the statements of operations as a component of other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, combined derivative instrument.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;will &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;be classified in the consolidated balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Non-Controlling Interests&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As part of the Business Combination and described in Note 1, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Description of the Business&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company became the managing member of MSP Recovery, which is consolidated as the Company controls the operating decisions of MSP Recovery. The non-controlling interest relates to the Up-C Units that are convertible into Class A Common Stock of the Company at the discretion of the holder of the Up-C Unit. The Up-C Unit holders retained approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;99.76&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the economic ownership percentage of the Company as of the Closing Date. The non-controlling interest is classified as permanent equity within&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; the consolidated balance sheet of the Company. As of December 31, 2024, based on the Class A common stock issuances during the period, the non-controlling interest of Class V shareholders was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69.43&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Changes in the Company&#x2019;s ownership interest in MSP Recovery, due to Class V shareholders converting their shares to Class A, are accounted for as equity transactions. Each issuance of the Company&#x2019;s Class A Common Stock requires a corresponding issuance of MSP Recovery units to the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Company. The issuance would result in a change in ownership and would reduce the balance of non-controlling interest and increase the balance of additional paid-in capital.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates long-lived assets, such as property and equipment, including capitalized software costs, and finite-lived intangibles such as Claims recovery rights, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset or asset group may not be recoverable. If the estimated future cash flows (undiscounted and without interest charges) from the use of an asset group are less than the carrying value, a write-down would be recorded to reduce the related asset group to its estimated fair val&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ue.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Claims Recovery&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s primary income-producing activities are associated with the pursuit and recovery of proceeds related to Claims recovery rights that the Company obtains through CCRAs, in which it becomes the owner of those rights. As a result, such income is not generated from the transfer of control of goods or services to customers, but from the proceeds realized from perfection of Claims recoveries from rights the Company holds outright. The Company may also generate future revenue by providing Claims recovery services to other entities outside of the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Claims recovery income&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes Claims recovery income based on a gain contingency model&#x2014;that is, when the amounts are reasonably certain of collection. This typically occurs upon reaching a binding settlement or arbitration with the counterparty or when the legal proceedings, including any appellate process, are resolved.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In some cases, the Company owes an additional payment to the original Assignor in connection with the realized value of the recovery right. Claims recovery income is recognized on a gross basis, as the Company is entitled to the full value of recovery proceeds, and makes a payment to the original Assignor similar to a royalty arrangement. Such payments to prior owners are recognized as cost of Claims recovery in the same period the Claims recovery income is recognized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;When the Company becomes entitled to recovery proceeds from the settlement of a Claim recovery pursuit or proceeding that meets the requirements under ASC 450, it recognizes the amount in accounts receivable.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Claims recovery service income, ASC 606, Revenue from Contracts with Customers&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The guidance under ASC 606, Revenue from Contracts with Customers, provides that an entity should apply the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, the entity satisfies a performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company derives revenues from contracts with customers primarily from Claims recovery services arrangements (&#x201c;Claims recovery services&#x201d;). Claims recovery services include services to related parties or third parties to assist those entities with pursuit of Claims recovery rights. The Company has determined it has a single performance obligation for the series of daily activities that comprise Claims recovery services, which are recognized over time using a time-based progress measure and are typically based on (1) budgeted expenses for the current month with an adjustment for the variance between budget and actual expenses from the prior month or (2) on a contingent basis dependent on actual settlements or resolved litigation. Amounts estimated and recognized, but not yet fully settled or resolved as part of litigation are recognized as contract assets. There were no contract assets as of December 31, 2024 or 2023, as amounts associated with unresolved litigation were fully constrained.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Claims recovery services are generally paid in advance on a monthly basis. The Company did not recognize any material revenue for the years ended December 31, 2024 or 2023 for performance obligations that were fully satisfied in previous periods. For the year ended December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company also recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of servicing income related to a specific contract where the performance obligations were completed during the year.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company does not have material unfulfilled performance obligation balances for contracts with an original length greater than one year in any years presented. Additionally, the Company does not have material costs related to obtaining a Claims recovery service contract with amortization periods greater than one year for any period presented.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company applies ASC 606 utilizing the following allowable exemptions or practical expedients:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Exemption to not disclose the unfulfilled performance obligation balance for contracts with an original length of one year or less.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Practical expedient to recognize the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Election to present revenue net of sales taxes and other similar taxes, if any.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Practical expedient not requiring the entity to adjust the promised amount of consideration for the effects of a significant financing component if the entity expects, at contract inception, that the period between when the entity transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Transfers of Claims Cost Recovery Rights to Others&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In some cases, the Company has entered into arrangements to transfer CCRAs or rights to proceeds from CCRAs to other parties. The Company evaluates whether such transfers are sales of nonfinancial assets, sales of future revenues treated as debt, in-kind contributions to equity method investees, or other types of arrangements.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;When they are treated as sales of nonfinancial assets, the Company recognizes a gain on the sale when control transfers to the counterparty based on the difference between the fair value of consideration (including cash) received and the recognized carrying value of the CCRAs. In some cases, such sales include variable consideration in the form of payments that will be made only upon achievement of certain recoveries or based on a percentage of actual recoveries. The Company estimates and constrains the amounts that will ultimately be realized based on these variable payment terms and includes those amounts in the determination of gain or loss; the gain or loss is subsequently updated based on changes in those estimates.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In other cases, such transfers are considered to be sales of future revenue that are debt-like in nature. These arrangements are recognized as debt based on the proceeds received, and are imputed an interest rate based on the expected timing and amount of payments to achieve contractual hurdles. These are subject to revisions of estimates of that timing and amount based on the contractual provisions and the Company&#x2019;s assumptions from changes in facts and circumstances. Such changes are reflected through revision of the imputed interest rate on a cumulative catch-up basis.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cost of Claims Recoveries&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Costs of Claims recoveries consist of all directly attributable costs specifically associated with Claims processing activities, including contingent payments to Assignors (i.e., settlement expenses).&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Claims amortization expense&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Claims amortization expense includes amortization of CCRAs acquired as part of the business combination, shown as Intangibles, net in the consolidated balance sheets, and CCRA intangible assets for which the Company made up-front payments for Claims recovery rights. For further details on CCRAs see Note 6, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Intangible Assets, Net&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our income tax expense, deferred tax assets and liabilities, and reserves for unrecognized tax benefits reflect management&#x2019;s best assessment of estimated current and future taxes to be paid. As a result of the Business Combination, the Company became the sole managing member of MSP Recovery, which is treated as a partnership for U.S. federal, state and local income tax purposes. As a partnership, MSP Recovery is not subject to U.S. federal and certain state and local income taxes. Any taxable income or loss generated by MSP Recovery is passed through to and included in the taxable income or loss of its partners, including MSP Recovery, Inc. The Company is subject to U.S. federal income taxes, in addition to state and local income taxes, with respect to the Company&#x2019;s allocable share of income of MSP Recovery, LLC.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s deferred tax balances reflect the impact of temporary differences between the carrying amount of assets and liabilities and the Company&#x2019;s tax basis. The balances are stated at the tax rates in effect when the temporary differences are expected to be recovered or settled. The Company reviewed the anticipated future realization of the tax benefit of the Company&#x2019;s existing deferred tax assets and concluded that it is more likely than not that all of the deferred tax assets will not be realized in the future and recorded a full valuation allowance at December 31, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has no components of other comprehensive income (loss). As such, net loss equates to comprehensive income (loss) for all periods presented in this report.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;New Accounting Pronouncements Recently Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In 2024, we &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;adopted&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2023-07, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, on a retrospective basis. The amendments are intended to increase reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. Refer to Note 15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, Segment Information&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for further information.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;New Accounting Pronouncements Issued but Not Yet Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Among other requirements, this update adds specific disclosure requirements for income taxes, including: (1) disclosing specific categories in the rate reconciliation and (2) providing additional information for reconciling items that meet quantitative thresholds. The guidance is effective for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company is currently evaluating the provisions of this guidance and assessing the potential impact on the Company&#x2019;s financial statement disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:21.6pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU 2024-03, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40) Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d;. The guidance in ASU 2024-03 does not change the expense line items presented on the face of the financial statements, but instead, it requires additional disaggregation of specific expense captions&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in the notes to the financial statements, among other things, specific information about certain costs and expenses including purchases of inventory; employee compensation; and depreciation, amortization and depletion expenses for each caption on the income statement where such expenses are included. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted, and the amendments may be applied prospectively to reporting periods after the effective date or retrospectively to all periods presented in the financial statements. The Company is currently evaluating the provisions of this guidance and assessing the potential impact on the Company&#x2019;s financial statement disclosures.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_a41683c3-5401-42f6-b4da-7eff32aa3233">&lt;p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;These statements have been prepared pursuant to the rules and regulations of the SEC and in accordance with GAAP. In the opinion of management, the consolidated financial statements reflect all adjustments, which consist only of normal recurring adjustments, necessary to state fairly the results of operations, financial condition and cash flows for the periods presented herein. Prior to the Business Combination, the consolidated financial statements reflect Legacy MSP. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;All intercompany transactions and balances are eliminated from the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_80ba22bd-9bc5-46b8-9c74-ac1ccc7aedcf">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Principles of consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company consolidates all entities that it controls through a majority voting interest or otherwise and the accompanying financial statements include the accounts of the Company&#x2019;s wholly owned subsidiaries and these entities for which the Company has a controlling interest in. The Company also consolidates all entities that it controls as the primary beneficiary of a variable interest entity (&#x201c;VIE&#x201d;). Under the VIE model, management first assesses whether the Company has a variable interest in an entity, which would include an equity interest. If the Company has a variable interest in an entity, management further assesses whether that entity is a VIE, and if so, whether the Company is the primary beneficiary under the VIE model. Generally, entities that are organized similar to a limited partnership, in which a general partner (or managing member) make the most relevant decisions that affect the entity&#x2019;s economic performance, are considered to be VIEs which would require consolidation, unless the limited partners have substantive kickout or participating rights. Entities that do not qualify as VIEs are assessed for consolidation under the voting interest model.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under the VIE model, an entity is deemed to be the primary beneficiary of a VIE if it holds a controlling financial interest. A controlling financial interest is defined as (a) the power to direct the activities of a VIE that most significantly affect the entity&#x2019;s economic performance and (b) the obligation to absorb losses of the entity or the right to receive benefits from the entity that could potentially be significant to the VIE. Management determines whether the Company is the primary beneficiary of a VIE at the time it becomes involved with a VIE and reconsiders that conclusion at each reporting date. This analysis includes an evaluation of the Company&#x2019;s control rights, as well as the economic interests that the Company holds in the VIE, including indirectly through related parties. As a result of the Business Combination, the Company consolidates MSP Recovery under the VIE model.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_9f164af0-313d-4c19-a1e0-af3a5b8afe86">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Estimates and Assumptions&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting periods. Actual results could differ from the Company&#x2019;s estimates. Estimates are periodically reviewed considering changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Significant estimates and assumptions reflected in these consolidated financial statements include but are not limited to recoverability of long-lived assets.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_08dd13fc-175f-46bd-a373-5b777be1bb15">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Reclassifications&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain reclassifications have been made to the prior year statement of cash flows to conform to classifications used in the current year. These reclassifications had no impact on net loss, shareholders&#x2019; equity or total cash flows as previously reported.&lt;/span&gt;&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_e667066a-9eb5-4e5d-a9ec-7441825ff997">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Segments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments are defined as components of an entity for which separate financial information (including profit and/or loss) is available and regularly reviewed by the chief operating decision maker (&#x201c;CODM&#x201d;). The Company manages its operations as a single segment for the purposes of assessing performance and making decisions. The Company&#x2019;s CODM is its &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_8b390608-14b7-4bdf-8388-0311ecd33fec;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Executive Officer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company has determined that it operates in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; operating segment and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. In addition, all of the Company&#x2019;s revenues and long-lived assets are attributable primarily to operations in the United States and Puerto Rico for all periods presented.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="INF"
      id="F_002a03ca-eed4-4409-a369-94762ead54fb"
      unitRef="U_Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="INF"
      id="F_8f2ca362-8748-4619-afcc-46fc1f976cb2"
      unitRef="U_Segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_4128e570-c514-43ed-a534-d23ccad03f1b">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Concentration of credit risk and Off-Balance Sheet Risk&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash and affiliate receivable are financial instruments that are potentially subject to concentrations of credit risk. See Note 14,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Related Party Transactions&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, fo&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;r disclosure of affiliate receivables. The Company&#x2019;s cash and restricted cash are deposited in accounts at large financial institutions, and amounts may exceed federally insured limits. The Company believes it is not exposed to significant credit risk due to the financial strength of the depository institutions in which the cash and cash equivalents are held. The Company has no other financial instruments with off-balance-sheet risk of loss.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_41e455a9-8b77-436b-9a50-91f28ccd89c0">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company considers all highly liquid investments purchased with original maturities of three months or less to be cash equivalents. There are &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; cash equivalents as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 or 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="INF"
      id="F_adb03ff9-1c13-456d-b62d-573d316a085f"
      unitRef="U_USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="INF"
      id="F_5ebf5d55-4f7a-4026-bfa3-dc3d3e914e06"
      unitRef="U_USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_871e37b5-118c-4e55-9d9c-01136c923366">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company applies the provisions of ASC 820, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, for fair value measurements of financial assets and financial liabilities and for fair value measurements of non-financial items that are recognized or disclosed at fair value in the financial statements on a recurring basis. The Company also applied the provisions of the subtopic to fair value measurements of non-financial assets and non-financial liabilities that are recognized or disclosed at fair value in the financial statements on a non-recurring basis. The subtopic defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The subtopic also establishes a framework for measuring fair value and expands disclosures about fair value measurements. The fair value framework requires the Company to categorize certain assets and liabilities into three levels, based upon the assumptions used to price those assets or liabilities. The three levels are defined as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 1: Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 2: Quoted prices for similar assets and liabilities in active markets or inputs that are observable.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 3: Unobservable inputs reflecting management&#x2019;s own assumptions about the inputs used in pricing the asset or liability.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has determined the estimated fair value of its financial instruments based on appropriate valuation methodologies; however, for Level 2 and Level 3 inputs considerable judgment is required to develop these estimates. Accordingly, these estimated fair values are not necessarily indicative of the amounts the Company could realize in a current market exchange. The estimated fair values can be materially affected by using different assumptions or methodologies. The methods and assumptions used in estimating the fair values of financial instruments are based on carrying values and future cash flows. As of December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t hold any Level 2 or Level 3 assets. See &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 13,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, for additional information on Level 2 and Level 3 liabilities as of December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash is stated at cost, which approximates their fair value. The carrying amounts reported in the consolidated balance sheets for affiliate receivable, accounts payable, affiliate payable and accrued liabilities approximate fair value, due to their short-term maturities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Outstanding borrowings that qualify as financial instruments are carried at cost, which approximates their fair value as of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, due to their short duration.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_e9e16be1-82df-4b4d-8077-c5113b5f1637"
      decimals="0"
      id="F_20ad384c-87e8-454e-b526-e23ab06df68f"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_1e2506b0-ca87-4064-856c-3517da6369a1">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Equity Method Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Equity investments that are not consolidated, but over which the Company exercises significant influence, are accounted for in accordance with ASC 323, &#x201c;Investments&#x2014;Equity Method and Joint Ventures&#x201d; (&#x201c;ASC 323&#x201d;). Wh&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ether or not the Company exercises significant influence with respect to an investee company depends on an evaluation of several factors including, among others, representation on the investee company&#x2019;s board of directors and ownership level. An entity is presumptively assumed to have significant influence in a corporation when it holds &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% or more of the voting stock of the investee company, or at a lower level (e.g., &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%) for entities that track separate members capital accounts.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under the equity method of accounting, an investee company&#x2019;s accounts are not reflected within the Company&#x2019;s consolidated balance sheets and statements of operations; however, the Company&#x2019;s share of the earnings or losses of the investee company is reflected in the caption &#x201c;Other income&#x201d; in the consolidated statements of operations. The Company&#x2019;s carrying value in equity method investee companies is not reflected in the Company&#x2019;s consolidated balance sheets as of December 31, 2024 or 2023 as the carryin&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;g &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;value is de&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;minimis. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;When the Company&#x2019;s carrying value in an equity method investee company is reduced to zero, no further losses are recorded in the Company&#x2019;s consolidated financial statements unless the Company has guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized.&lt;/span&gt;&lt;/p&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_16e00acb-17ef-4f0e-b8a3-32f37c07b09f"
      decimals="2"
      id="F_4a0080e2-0228-45de-b77b-017f8a12305f"
      unitRef="U_pure">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mspr:EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts
      contextRef="C_0788ee7d-2d90-4bf2-ae7b-9ebb1d14ae84"
      decimals="2"
      id="F_78259e20-392e-4c16-9343-5e1bcda72692"
      unitRef="U_pure">0.03</mspr:EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts>
    <mspr:EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts
      contextRef="C_3f5e2295-148f-48ae-a6d0-b63e048ebdc3"
      decimals="2"
      id="F_b416822d-b561-4b48-8719-6a1331316612"
      unitRef="U_pure">0.05</mspr:EquityMethodOwnershipPercentageForEntitiesThatTrackSeparateCapitalAccounts>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_ba52adc6-fa2a-4848-9303-7700c5ca061a">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are stated at historical cost less accumulated depreciation and accumulated impairment losses, if any. Major expenditures for property and equipment and those that substantially increase useful lives are capitalized. When assets are sold or otherwise disposed of, costs and related accumulated depreciation are removed from the financial statements and any resulting gains or losses are included in general and administrative expenses within our consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company provides for depreciation and amortization on property and equipment using the straight-line method to allocate the cost of depreciable assets over their estimated lives as follows:&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:67.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:32.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8.45pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Office and Computer Equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:11.9pt;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and Fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:1pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold Improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_d7c0ff4e-449b-40a5-8325-8ed41dfb3e58;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lesser of lease term or estimated life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <mspr:DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_4cbcdbbc-7082-417b-9188-be3f9783cca0">&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company provides for depreciation and amortization on property and equipment using the straight-line method to allocate the cost of depreciable assets over their estimated lives as follows:&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:67.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:32.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:8.45pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Office and Computer Equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:11.9pt;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and Fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:1pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold Improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_d7c0ff4e-449b-40a5-8325-8ed41dfb3e58;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lesser of lease term or estimated life&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;</mspr:DisclosureInTabularFormOfUsefulLivesOfPropertyPlantAndUsefulLivesTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_66d1760e-3b4b-4a44-adcc-7a80bfabd72f"
      id="F_0ddedd76-7c62-460a-b5af-7eb149c9aae7">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_9dbaa8ae-8f9d-4755-91f8-724dee794a36"
      id="F_dda656a3-f2ff-4813-935c-d23e9b021a05">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:InternalUseSoftwarePolicy
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_cda1621b-13f7-4e87-9455-a47a63f52589">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Internal Use Software&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Internal-use software development costs incurred in the preliminary project stage are expensed as incurred; costs incurred in the application and development stage, which meet the capitalization criteria, are capitalized and amortized on a straight-line basis over the estimated useful life of the asset and costs incurred in the post-implementation/operations stage are expensed as incurred. The estimated useful life for development costs capitalized as of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Further, internal and external costs incurred in connection with upgrades or enhancements are also evaluated for capitalization. If the software upgrade results in an additional functionality, costs are capitalized; if the upgrade only extends the useful life, it is expensed as occurred.&lt;/span&gt;&lt;/p&gt;</us-gaap:InternalUseSoftwarePolicy>
    <mspr:DevelopmentCostsCapitalizedUsefulLife
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_29b8dde9-7560-4287-8300-8e96d3ef6afe">P5Y</mspr:DevelopmentCostsCapitalizedUsefulLife>
    <mspr:DevelopmentCostsCapitalizedUsefulLife
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      id="F_3b5ea9ae-a1d1-4906-a6ce-d0ad30f909ed">P5Y</mspr:DevelopmentCostsCapitalizedUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_a4c9737e-797d-4407-9498-46eb58ae4219">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Intangible assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In certain of its CCRAs, the Company makes up-front payments to acquire Claims recovery rights from secondary payers, such as health plans, managed service organizations, providers or medical services and independent physicians&#x2019; associations. The Company recognizes intangible assets for costs incurred up front to acquire Claims recovery rights from various Assignors.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The CCRA assets are held at cost. Historically, the Company amortized capitalized costs associated with CCRAs over &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;eight years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, based on the expected timing to pursue recovery through litigation, including through potential appeals. As part of the annual reassessment of useful lives as of December 31, 2024, the Company updated the estimated useful life of the CCRAs to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;seven years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; beginning January 1, 2025.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As part of the Business Combination, the Company acquired rights to Claims recovery cash flows. As a result of this purchase and the guaranty obligation as noted in Note 8, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Variable Interest Entities&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company consolidated the entity which holds these Claim rights. Upon consolidation, these Claims rights were accounted for under ASC 350. As such these assets are held at cost, net of amortization.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates these assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. If the estimated future cash flows (undiscounted and without interest charges) from the use of an asset group are less than the carrying value, a write-down would be recorded to reduce the related asset group to its estimated fair value.&lt;/span&gt;&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      id="F_11275084-7385-4f31-a71c-a18d07e3d50e">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="C_4a8604ad-e380-417e-aa2c-4c0e29ad2d19"
      id="F_7cc78fdd-429d-4066-804e-557136b0eddd">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_c003c5f7-0205-4360-a699-ada048b1fd34">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Derivative Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates its convertible debt, warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 480, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and ASC 815, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The result of this accounting treatment is that the fair value of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability. The change in fair value is recorded in the statements of operations as a component of other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, combined derivative instrument.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;will &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;be classified in the consolidated balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.&lt;/span&gt;&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <mspr:NonControllingInterestsPolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_85287e80-3d76-46be-bd01-ed5785d81caa">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Non-Controlling Interests&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As part of the Business Combination and described in Note 1, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Description of the Business&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company became the managing member of MSP Recovery, which is consolidated as the Company controls the operating decisions of MSP Recovery. The non-controlling interest relates to the Up-C Units that are convertible into Class A Common Stock of the Company at the discretion of the holder of the Up-C Unit. The Up-C Unit holders retained approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;99.76&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the economic ownership percentage of the Company as of the Closing Date. The non-controlling interest is classified as permanent equity within&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; the consolidated balance sheet of the Company. As of December 31, 2024, based on the Class A common stock issuances during the period, the non-controlling interest of Class V shareholders was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69.43&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Changes in the Company&#x2019;s ownership interest in MSP Recovery, due to Class V shareholders converting their shares to Class A, are accounted for as equity transactions. Each issuance of the Company&#x2019;s Class A Common Stock requires a corresponding issuance of MSP Recovery units to the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Company. The issuance would result in a change in ownership and would reduce the balance of non-controlling interest and increase the balance of additional paid-in capital.&lt;/span&gt;&lt;/p&gt;</mspr:NonControllingInterestsPolicyTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="C_ec4285f4-9b93-43aa-ab90-0409cd42c969"
      decimals="4"
      id="F_c258b911-120a-4980-a8a2-49dd1e7dfb2b"
      unitRef="U_pure">0.9976</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="C_cecba122-eda2-4c0b-a407-e208dd46ea06"
      decimals="4"
      id="F_59b255d7-389a-4dae-97b8-c5a439fe04d5"
      unitRef="U_pure">0.6943</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_35deb694-43ea-4761-8d66-63b53de796ba">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates long-lived assets, such as property and equipment, including capitalized software costs, and finite-lived intangibles such as Claims recovery rights, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset or asset group may not be recoverable. If the estimated future cash flows (undiscounted and without interest charges) from the use of an asset group are less than the carrying value, a write-down would be recorded to reduce the related asset group to its estimated fair val&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ue.&lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_7501e508-1912-406f-ba59-a492c6b16e0f">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Claims Recovery&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s primary income-producing activities are associated with the pursuit and recovery of proceeds related to Claims recovery rights that the Company obtains through CCRAs, in which it becomes the owner of those rights. As a result, such income is not generated from the transfer of control of goods or services to customers, but from the proceeds realized from perfection of Claims recoveries from rights the Company holds outright. The Company may also generate future revenue by providing Claims recovery services to other entities outside of the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Claims recovery income&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes Claims recovery income based on a gain contingency model&#x2014;that is, when the amounts are reasonably certain of collection. This typically occurs upon reaching a binding settlement or arbitration with the counterparty or when the legal proceedings, including any appellate process, are resolved.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In some cases, the Company owes an additional payment to the original Assignor in connection with the realized value of the recovery right. Claims recovery income is recognized on a gross basis, as the Company is entitled to the full value of recovery proceeds, and makes a payment to the original Assignor similar to a royalty arrangement. Such payments to prior owners are recognized as cost of Claims recovery in the same period the Claims recovery income is recognized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;When the Company becomes entitled to recovery proceeds from the settlement of a Claim recovery pursuit or proceeding that meets the requirements under ASC 450, it recognizes the amount in accounts receivable.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Claims recovery service income, ASC 606, Revenue from Contracts with Customers&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The guidance under ASC 606, Revenue from Contracts with Customers, provides that an entity should apply the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, the entity satisfies a performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company derives revenues from contracts with customers primarily from Claims recovery services arrangements (&#x201c;Claims recovery services&#x201d;). Claims recovery services include services to related parties or third parties to assist those entities with pursuit of Claims recovery rights. The Company has determined it has a single performance obligation for the series of daily activities that comprise Claims recovery services, which are recognized over time using a time-based progress measure and are typically based on (1) budgeted expenses for the current month with an adjustment for the variance between budget and actual expenses from the prior month or (2) on a contingent basis dependent on actual settlements or resolved litigation. Amounts estimated and recognized, but not yet fully settled or resolved as part of litigation are recognized as contract assets. There were no contract assets as of December 31, 2024 or 2023, as amounts associated with unresolved litigation were fully constrained.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Claims recovery services are generally paid in advance on a monthly basis. The Company did not recognize any material revenue for the years ended December 31, 2024 or 2023 for performance obligations that were fully satisfied in previous periods. For the year ended December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company also recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of servicing income related to a specific contract where the performance obligations were completed during the year.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company does not have material unfulfilled performance obligation balances for contracts with an original length greater than one year in any years presented. Additionally, the Company does not have material costs related to obtaining a Claims recovery service contract with amortization periods greater than one year for any period presented.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company applies ASC 606 utilizing the following allowable exemptions or practical expedients:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Exemption to not disclose the unfulfilled performance obligation balance for contracts with an original length of one year or less.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Practical expedient to recognize the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Election to present revenue net of sales taxes and other similar taxes, if any.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.2798611111111111in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.25in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.4621737007759505%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Practical expedient not requiring the entity to adjust the promised amount of consideration for the effects of a significant financing component if the entity expects, at contract inception, that the period between when the entity transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <mspr:ClaimsRecoveryServiceIncome
      contextRef="C_c92dc1fa-2679-4e97-b7ad-ad332c3af75f"
      decimals="-5"
      id="F_d1224e06-09c2-4944-a995-5a5e2528bedb"
      unitRef="U_USD">500000</mspr:ClaimsRecoveryServiceIncome>
    <mspr:TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_d55b46a3-d243-46ef-ba9d-0646b3595a03">&lt;p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Transfers of Claims Cost Recovery Rights to Others&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In some cases, the Company has entered into arrangements to transfer CCRAs or rights to proceeds from CCRAs to other parties. The Company evaluates whether such transfers are sales of nonfinancial assets, sales of future revenues treated as debt, in-kind contributions to equity method investees, or other types of arrangements.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;When they are treated as sales of nonfinancial assets, the Company recognizes a gain on the sale when control transfers to the counterparty based on the difference between the fair value of consideration (including cash) received and the recognized carrying value of the CCRAs. In some cases, such sales include variable consideration in the form of payments that will be made only upon achievement of certain recoveries or based on a percentage of actual recoveries. The Company estimates and constrains the amounts that will ultimately be realized based on these variable payment terms and includes those amounts in the determination of gain or loss; the gain or loss is subsequently updated based on changes in those estimates.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In other cases, such transfers are considered to be sales of future revenue that are debt-like in nature. These arrangements are recognized as debt based on the proceeds received, and are imputed an interest rate based on the expected timing and amount of payments to achieve contractual hurdles. These are subject to revisions of estimates of that timing and amount based on the contractual provisions and the Company&#x2019;s assumptions from changes in facts and circumstances. Such changes are reflected through revision of the imputed interest rate on a cumulative catch-up basis.&lt;/span&gt;&lt;/p&gt;</mspr:TransferOfClaimsCostsRecoveryRightToOthersPolicyTextBlock>
    <mspr:CostOfClaimRecoveriesPolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_6f12421b-26b4-496f-a50a-045213b1e4b3">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cost of Claims Recoveries&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Costs of Claims recoveries consist of all directly attributable costs specifically associated with Claims processing activities, including contingent payments to Assignors (i.e., settlement expenses).&lt;/span&gt;&lt;/p&gt;</mspr:CostOfClaimRecoveriesPolicyTextBlock>
    <mspr:ClaimsAmortizationExpensePolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_e997aecf-15b9-4cab-90f3-8aacbb73a8f5">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Claims amortization expense&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Claims amortization expense includes amortization of CCRAs acquired as part of the business combination, shown as Intangibles, net in the consolidated balance sheets, and CCRA intangible assets for which the Company made up-front payments for Claims recovery rights. For further details on CCRAs see Note 6, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Intangible Assets, Net&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</mspr:ClaimsAmortizationExpensePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_59ea7cf9-9b46-4bd3-b3b1-628260d56389">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our income tax expense, deferred tax assets and liabilities, and reserves for unrecognized tax benefits reflect management&#x2019;s best assessment of estimated current and future taxes to be paid. As a result of the Business Combination, the Company became the sole managing member of MSP Recovery, which is treated as a partnership for U.S. federal, state and local income tax purposes. As a partnership, MSP Recovery is not subject to U.S. federal and certain state and local income taxes. Any taxable income or loss generated by MSP Recovery is passed through to and included in the taxable income or loss of its partners, including MSP Recovery, Inc. The Company is subject to U.S. federal income taxes, in addition to state and local income taxes, with respect to the Company&#x2019;s allocable share of income of MSP Recovery, LLC.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s deferred tax balances reflect the impact of temporary differences between the carrying amount of assets and liabilities and the Company&#x2019;s tax basis. The balances are stated at the tax rates in effect when the temporary differences are expected to be recovered or settled. The Company reviewed the anticipated future realization of the tax benefit of the Company&#x2019;s existing deferred tax assets and concluded that it is more likely than not that all of the deferred tax assets will not be realized in the future and recorded a full valuation allowance at December 31, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_4968d868-b57d-44b0-b1b7-bdd06a6601a8">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has no components of other comprehensive income (loss). As such, net loss equates to comprehensive income (loss) for all periods presented in this report.&lt;/span&gt;&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_74801a7b-e712-4ec3-b9f4-542c58af08fd">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;New Accounting Pronouncements Recently Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In 2024, we &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;adopted&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2023-07, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, on a retrospective basis. The amendments are intended to increase reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. Refer to Note 15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, Segment Information&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for further information.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;New Accounting Pronouncements Issued but Not Yet Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Among other requirements, this update adds specific disclosure requirements for income taxes, including: (1) disclosing specific categories in the rate reconciliation and (2) providing additional information for reconciling items that meet quantitative thresholds. The guidance is effective for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company is currently evaluating the provisions of this guidance and assessing the potential impact on the Company&#x2019;s financial statement disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:21.6pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU 2024-03, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40) Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d;. The guidance in ASU 2024-03 does not change the expense line items presented on the face of the financial statements, but instead, it requires additional disaggregation of specific expense captions&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in the notes to the financial statements, among other things, specific information about certain costs and expenses including purchases of inventory; employee compensation; and depreciation, amortization and depletion expenses for each caption on the income statement where such expenses are included. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted, and the amendments may be applied prospectively to reporting periods after the effective date or retrospectively to all periods presented in the financial statements. The Company is currently evaluating the provisions of this guidance and assessing the potential impact on the Company&#x2019;s financial statement disclosures.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
      contextRef="C_5cbb4b4f-b96f-4942-a566-a9743e895772"
      id="F_5999613d-4d57-4137-92d8-cbec97b25f0e">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted>
    <mspr:MaterialAgreementsDisclosureTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_f0d35edd-e822-4075-a7ae-9f92fc21f045">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 3. MATERIAL AGREEMENTS&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Virage&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On May 23, 2022 as part of the Closing of the Business Combination, the Company acquired assets through the issuance of Up-C Units. In exchange for approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million Up-C Units, the Company acquired the rights to receive the distributable net proceeds (the &#x201c;Proceeds&#x201d;) of a portfolio of Claims owned by VRM MSP, a Delaware limited liability company and joint investment vehicle of VRM and Series MRCS. Under this asset acquisition structure, the Company determined that the arrangements to acquire the rights to proceeds from certain Claims recovery rights along with the guarantee of the VRM Full Return (noted and defined below) result in the Company consolidating the Series. Upon consolidation, the Company included the value of the Up-C Units provided and the value of the guarantee as Intangible Assets, net in the consolidated balance sheet. These are held at cost and treated as finite life intangible assets under ASC 350, and have a useful life of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;seven years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with such transaction the Company agreed to pay Virage an amount equal to the contributions by Virage to VRM MSP plus an annual rate of return of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% (the &#x201c;VRM Full Return&#x201d;). Pursuant to the terms of the agreement with Virage, such amount is payable exclusively by any of the following means (or any combination thereof): (a) the Proceeds, net of expenses related to claim settlement, (b) a sale of certain reserved shares of Messrs. John H. Ruiz and Frank C. Quesada, and the delivery of the resulting net cash proceeds thereof to VRM, or (c) a sale of shares by the Company and delivery of the net cash proceeds thereof to VRM. The amount of the VRM Full Return was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,126.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;941.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As the Company incurred debt related to the VRM Full Return as included in the guaranty obligation within the consolidated balance sheet, this value was included in the purchase price and is included in Intangible Assets, net, in the consolidated balance sheet for the full value of the VRM Full Return at the acquisition date. Any subsequent interest accrual is reflected within interest expense in the consolidated statement of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to the Virage MTA dated March 9, 2022 (as amended on April 12, 2023, November 13, 2023, and April 1, 2024, the &#x201c;Virage MTA&#x201d;), the VRM Full Return payment due date is September 30, 2025. The payment methods for the VRM Full Return are as follows, and in the following order of priority: (a) a first priority lien on all sources of revenue of the Company not otherwise encumbered as of April 12, 2023 to the extent such revenues and liquidity exceed the amount of net of revenues necessary to establish and maintain an operating reserve (&#x201c;Operating Reserve&#x201d;) of to the budget of the Company (plus applicable taxes) plus &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, (b) a sale of certain reserved shares of Messrs. John H. Ruiz and Frank C. Quesada, and the delivery of the resulting net cash proceeds thereof to VRM, (c) Parent&#x2019;s sale of additional shares and delivery of proceeds to VRM, subject to certain anti-dilution provisions, and (d) if the VRM Full Return is not satisfied by the foregoing, a sale by Messrs. Ruiz and Quesada of other shares of Common Stock that they hold, and the delivery of the resulting net cash proceeds thereof to VRM; provided that if the VRM Full Return is not fully paid by September 30, 2025 the VRM Full Return shall be payable by any of such payment methods in any order of priority. In addition, Messrs. Quesada and Ruiz agreed to certain transfer restrictions applicable to their Common Stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, the Company agreed to make a one-time, lump sum payment to Virage for the period starting May 24, 2023 and ending December 31, 2023, in one or a combination of: (a)&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; cash, in an amount equal to 1.0% of each calendar month-end balance (which month-end balance shall be increased daily up to 20.0% per annum based on a formula set forth in the Virage MTA) of the amount owing to Virage as of each preceding calendar month end&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and/or (b) &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;issue to VRM a warrant to purchase a number of shares of Class A Common Stock of Parent equal to the quotient of 1.0% of each calendar month end balance of the Unpaid Base Amount (calculated on a cumulative basis) and the VWAP of a share of Class A Common Stock for the five-day period prior to the issuance, beginning with May 24, 2023 and ending December 31, 2023, which warrant will have an exercise price (payable in cash) of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share (the &#x201c;Initial Virage Warrant&#x201d;); provided that the Initial Virage Warrant will expire on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;January 1, 2026&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Initial Virage Warrant, as amended, was issued effective January 1, 2024, entitling Virage to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,131,934&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Class A Common Stock at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, with an expiration date of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;January 1, 2026&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Furthermore, for each calendar month-end beginning with January 31, 2024, and continuing until the VRM Full Return is paid in full, the Company agreed to issue to VRM a warrant to purchase a number of shares of Class A Common Stock of Parent equal to the quotient of 1% of the calendar month-end balance of the Unpaid Base Amount and the VWAP (each, a &#x201c;Monthly Virage Warrant&#x201d;), which warrant will have an exercise price (payable in cash) of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share and expire on the second anniversary of its issuance.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Monthly Virage Warrants, entitling Virage to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,619,405&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Class A Common Stock, each warrant expiring &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;two years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; from the date of issuance, which are exercisable for $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. Furthermore, on April 14, 2025, the Company issued two additional warrants for November 2024 and December 2024, each warrant exercisable for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,277,808&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,332,792&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares, respectively, both which are exercisable for $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share and expiring two years from the date of issuance.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company also agreed that, after the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Yorkville &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Convertible Notes are fully satisfied, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the Company&#x2019;s portion of any net proceeds from the Yorkville SEPA would be used to pay down the VRM Full Return&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and that Messrs. John H. Ruiz and Frank C. Quesada would commence the sale of certain of their reserved shares, and deliver the resulting net cash proceeds thereof to VRM.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has received a report from its independent registered public accounting firm with an emphasis of matter paragraph as to going concern in connection with the Company&#x2019;s audited annual financial statements for the year ended December 31, 2024; however on September 6, 2024, Virage agreed to waive a provision of the Virage MTA Amendment that would otherwise accelerate the payment of amounts due to Virage in such event.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Hazel Purchase Money Loan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 29, 2023, the Company acquired a controlling interest in nine legal entities, whose sole assets are CCRAs, from Hazel. This is referred to as the &#x201c;Claims Purchase.&#x201d; The purchase price for the Claims Purchase was funded by (i) a purchase money loan between Hazel, as a lender, and the Company, as a borrower, in the amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (the &#x201c;Purchase Money Loan&#x201d;) and (ii) proceeds from the sale of certain, separate CCRAs in the Claims Sale (as defined below).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Also, on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 29, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company sold a controlling interest in three legal entities whose sole assets are CCRAs to Hazel. The agreement provided that the Company and Hazel would share in the recovery proceeds therefrom, in accordance with an agreed waterfall after Hazel had realized the first $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;150&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in claims recoveries. This transaction is referred to as the &#x201c;Claims Sale,&#x201d; and together with the Claims Purchase, the &#x201c;Claims Transactions.&#x201d;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As the Claims Transactions were negotiated together in contemplation of one another, they have been combined for accounting purposes. The Company analyzed the Claims Sale and determined that this transaction would be treated as the sale of in-substance nonfinancial assets, in exchange for noncash consideration in the form of the CCRAs from the Claims Purchase measured at fair value. The variable consideration related to future recoveries is fully constrained, because, at this time, it is not probable that any amounts will be owed above the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;150&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million recovery threshold that would trigger additional payments. The Company analyzed the Claims Purchase and determined it results in the initial consolidation of variable interest entities that are not businesses. The acquired CCRAs held by those entities are recognized at fair value.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of the assets sold in the Claims Sale was determined to be $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;45.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Company&#x2019;s carrying value of those CCRAs surrendered was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. Because there are no other observable prices for such transactions, the Company determined the fair value by reference to the purchase price for those CCRAs in a recent transaction. The fair value of the acquired CCRAs was determined to be $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;285.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, and the Company recognized the Purchase Money Loan recognized at $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, as any implicit discount or premium to current market rates at the time of issuance were insignificant.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;This resulted in a gain on the Claims Transactions of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which largely corresponds to the previously recognized amortization of the CCRAs that were sold in the Claims Sale.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, under the Operational Collection Floor, HPH agreed to extend up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (with a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% original issue discount) to fund the acquisition of additional Claims, which further collateralize the Working Capital Credit Facility. On October 2, 2024, the Company acquired the recovery rights to additional Medicare Secondary Payer Claims from an existing Assignor consisting of more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;450,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Medicare members, as documented by the Assignor.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Amounts borrowed and obligations under the Purchase Money Loan and the Working Capital Credit Facility (See Note 9,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Claims Financing Obligations and Notes Payable&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;are secured by a pledge of proceeds from specific Claims in the Company&#x2019;s Claims portfolio, with the lien securing the Purchase Money Loan being subordinated and junior to the lien securing the Working Capital Credit Facility. Pursuant to the Purchase Money Loan and the Working Capital Credit Facility, the Company entered into a collateral administrative agreement between the Company and Hazel, which sets forth certain arrangements between the Company and Hazel in relation to Claims owned by the Company, the proceeds of which are due to the Company were pledged to Hazel to secure the Purchase Money Loan and the Working Capital Credit Facility.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Hazel Working Capital Credit Facility&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 6, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, Subrogation Holdings entered into a credit agreement (as amended on March 29, 2023; November 10, 2023; and October 1, 2024; the &#x201c;Working Capital Credit Facility&#x201d;) with HPH providing for funding of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (with a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% original issue discount), consisting of a Term Loan A commitment to fund up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (in multiple installments) in proceeds and a Term Loan B Commitment to fund up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (in multiple installments) in proceeds. During fiscal year 2023, HPH disbursed $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million under Term Loan A and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million under Term Loan B.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During fiscal year 2024, HPH disbursed $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million under Term Loan B on January 25, 2024. On August 2, 2024, Subrogation Holdings entered into a letter agreement to amend the Working Capital Credit Facility (the &#x201c;HPH Letter Agreement&#x201d;) with HPH, which, among other things: (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;extended the period to draw up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (with a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% original issue discount) remaining under Term Loan B for working capital, accessible in eight tranches of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, that can be drawn at least one month apart, until September 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and (ii) provided for a $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million loan (subject to a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% original issue discount) funded by August 31, 2024 to acquire additional Claims (the &#x201c;New Claims&#x201d;) that collateralize the Working Capital Credit Facility (collectively, (i) and (ii) the &#x201c;Operational Collection Floor&#x201d;). The parties formalized the terms of the HPH Letter Agreement in Amendment No. 3 to the Working Capital Credit Facility dated October 1, 2024 (the &#x201c;OCF Amendment&#x201d;). On October 2, 2024, the Company acquired the recovery rights to additional Medicare Secondary Payer Claims from an existing Assignor consisting of more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;450,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Medicare members, as documented by the Assignor.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under the Operational Collection Floor, the Company received during 2024: (i) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for working capital, and (ii) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the purpose of acquiring the New Claims. To date, the Company received $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of working capital for 2025. Pursuant to the Working Capital Credit Facility, HPH may, at its sole discretion, increase the Operational Collection Floor by an amount of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, to be funded over a period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_dcf042f9-2441-4111-b785-0c83a5affaab;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;six months&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. On February 28, 2025 and April 4, 2025, HPH exercised that discretion and funded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, from the increase to the Operational Collection Floor. An additional $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million remains available under the Operational Collection Floor, to be funded at HPH&#x2019;s sole discretion.&lt;/span&gt;&lt;/p&gt;</mspr:MaterialAgreementsDisclosureTextBlock>
    <mspr:NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired
      contextRef="C_a64e596b-3d3c-475c-aff9-9243dbb55747"
      decimals="-5"
      id="F_f246f7c5-6bc2-49c1-a822-043d4f5599de"
      unitRef="U_shares">600000</mspr:NumberOfUpCUnitsIssuedInExchangeOfAssetsAcquired>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="C_4c7596be-feb0-407b-896b-01187ad8e8fd"
      id="F_d47c78e3-59ae-4012-b111-5ccc1b16cbd4">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <mspr:AnnualCompoundedReturnOnContributionPercentage
      contextRef="C_d84f5212-815c-411b-b1b6-254a05c04b96"
      decimals="2"
      id="F_e249bc34-d9b7-4816-bc10-fd0e1b78e9f1"
      unitRef="U_pure">0.20</mspr:AnnualCompoundedReturnOnContributionPercentage>
    <mspr:ValueOfFullReturn
      contextRef="C_8396e5b3-8975-41b1-a3c5-b71482629bc6"
      decimals="-5"
      id="F_481979ae-2906-4aa4-ab6f-443cbcd2d46f"
      unitRef="U_USD">1126500000</mspr:ValueOfFullReturn>
    <mspr:ValueOfFullReturn
      contextRef="C_05d37fc5-14e3-4592-b1a0-f0a3bb0acc27"
      decimals="-5"
      id="F_c3be63cd-743b-4a17-a336-badcbc48b8e7"
      unitRef="U_USD">941300000</mspr:ValueOfFullReturn>
    <mspr:MinimumCashAvailableForDistributionsPercentage
      contextRef="C_acacf35c-6921-4d48-ad39-e840756fabcf"
      decimals="2"
      id="F_b3e1f698-2be1-496d-a339-fe3bf2e6bd95"
      unitRef="U_pure">0.10</mspr:MinimumCashAvailableForDistributionsPercentage>
    <mspr:DescriptionOfCashPaymentsMadeToCounterParty
      contextRef="C_acacf35c-6921-4d48-ad39-e840756fabcf"
      id="F_99cb377f-9bcb-442d-b273-9c6aff19f9e9"> cash, in an amount equal to 1.0% of each calendar month-end balance (which month-end balance shall be increased daily up to 20.0% per annum based on a formula set forth in the Virage MTA) of the amount owing to Virage as of each preceding calendar month end</mspr:DescriptionOfCashPaymentsMadeToCounterParty>
    <us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees
      contextRef="C_540b65a1-9fe2-4515-b78b-8e298f79fa7e"
      id="F_941bf0e4-9e87-490c-977e-399e1049876e">issue to VRM a warrant to purchase a number of shares of Class A Common Stock of Parent equal to the quotient of 1.0% of each calendar month end balance of the Unpaid Base Amount (calculated on a cumulative basis) and the VWAP of a share of Class A Common Stock for the five-day period prior to the issuance, beginning with May 24, 2023 and ending December 31, 2023, which warrant will have an exercise price (payable in cash) of $0.0025 per share (the &#x201c;Initial Virage Warrant&#x201d;); provided that the Initial Virage Warrant will expire on January 1, 2026.The Initial Virage Warrant, as amended, was issued effective January 1, 2024, entitling Virage to purchase 1,131,934 shares of Class A Common Stock at an exercise price of $0.0025 per share, with an expiration date of January 1, 2026.</us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_9c8844ba-74b8-4891-9bac-96c2d880ebdd"
      decimals="4"
      id="F_01238f20-5400-4da7-b323-eec6f1e9ff1f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0025</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_9c8844ba-74b8-4891-9bac-96c2d880ebdd"
      id="F_0d0c6319-8394-4f07-90a5-dbfe4279e842">2026-01-01</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_cbc261d2-d131-4653-99be-97e07cea361a"
      decimals="INF"
      id="F_806bc548-275c-4fd8-b363-b8b7a01fcb48"
      unitRef="U_shares">1131934</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_cbc261d2-d131-4653-99be-97e07cea361a"
      decimals="4"
      id="F_023a825f-b37c-491b-8dc6-e33c29e04287"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0025</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_cbc261d2-d131-4653-99be-97e07cea361a"
      id="F_ca0a25b5-d384-4e0a-b5d2-ff221c2e3806">2026-01-01</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <mspr:WarrantPaymentDescription
      contextRef="C_fd924673-3ac8-4110-8c0f-caed5b9b9417"
      id="F_fea741a1-7670-4354-acf3-807912d4662d">Furthermore, for each calendar month-end beginning with January 31, 2024, and continuing until the VRM Full Return is paid in full, the Company agreed to issue to VRM a warrant to purchase a number of shares of Class A Common Stock of Parent equal to the quotient of 1% of the calendar month-end balance of the Unpaid Base Amount and the VWAP (each, a &#x201c;Monthly Virage Warrant&#x201d;), which warrant will have an exercise price (payable in cash) of $0.0001 per share and expire on the second anniversary of its issuance.</mspr:WarrantPaymentDescription>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_bc381c59-088d-4d05-9d41-0901345815e7"
      decimals="4"
      id="F_afe57484-a602-4046-baf9-16d71ab46ba9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <mspr:NumberOfWarrantsIssued
      contextRef="C_21fdfacf-60d9-461c-b409-b9c8d8d5e297"
      decimals="INF"
      id="F_bcb3d576-ac32-472f-a448-489f2cf7a4f8"
      unitRef="U_shares">9</mspr:NumberOfWarrantsIssued>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_21fdfacf-60d9-461c-b409-b9c8d8d5e297"
      decimals="INF"
      id="F_d4fe7138-e370-42b4-bdfc-b9a826ff150c"
      unitRef="U_shares">8619405</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="C_21fdfacf-60d9-461c-b409-b9c8d8d5e297"
      id="F_8fcca2dd-9802-4b82-82d6-83f89adc4a95">P2Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_21fdfacf-60d9-461c-b409-b9c8d8d5e297"
      decimals="4"
      id="F_70c6088f-23f8-4d8e-9e01-2dba9c8df879"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0025</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <mspr:NumberOfSharesExercisable
      contextRef="C_a819d26b-6742-4f37-b1c0-79825dc5c770"
      decimals="INF"
      id="F_6a04e865-60df-4588-8812-8298925b199c"
      unitRef="U_shares">3277808</mspr:NumberOfSharesExercisable>
    <mspr:NumberOfSharesExercisable
      contextRef="C_1be14025-3d59-42c6-81ac-3d450aba88f4"
      decimals="INF"
      id="F_5ff75c05-c40d-4955-98cc-4106a2f48846"
      unitRef="U_shares">6332792</mspr:NumberOfSharesExercisable>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_a819d26b-6742-4f37-b1c0-79825dc5c770"
      decimals="4"
      id="F_a8b0af90-db0c-4486-8e0c-6d6213086e8e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_1be14025-3d59-42c6-81ac-3d450aba88f4"
      decimals="4"
      id="F_a50fad66-1db9-4136-be8a-c64592e001f5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <mspr:VRMFullPaymentDescription
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_fda161e6-85b8-4357-9f2b-70af3a08999b">The Company also agreed that, after the Yorkville Convertible Notes are fully satisfied, 25% of the Company&#x2019;s portion of any net proceeds from the Yorkville SEPA would be used to pay down the VRM Full Return</mspr:VRMFullPaymentDescription>
    <mspr:PercentageOfProceedsFromRepaymentOfDebt
      contextRef="C_98ae30fc-b820-4fbe-b5f9-592ed60a472d"
      decimals="2"
      id="F_12cfa4ab-39f4-43b7-93a9-83bcaace255a"
      unitRef="U_pure">0.25</mspr:PercentageOfProceedsFromRepaymentOfDebt>
    <mspr:PurchaseMoneyLoan
      contextRef="C_28b71e0a-7e6d-429a-b008-1ff060441f3d"
      decimals="-6"
      id="F_c08b1db2-bac5-4873-82ed-e514c8e522aa"
      unitRef="U_USD">250000000</mspr:PurchaseMoneyLoan>
    <mspr:AgreementDate
      contextRef="C_e0dfe751-c423-4c59-83cb-f45bf2e04763"
      id="F_f40ea2e0-81b0-4fb5-8e6a-53aa2bccbc7b">2023-03-29</mspr:AgreementDate>
    <mspr:RealizedClaimRecoveries
      contextRef="C_e0dfe751-c423-4c59-83cb-f45bf2e04763"
      decimals="-6"
      id="F_62f9be89-8122-4349-9868-d862bf00b618"
      unitRef="U_USD">150000000</mspr:RealizedClaimRecoveries>
    <mspr:RealizedClaimRecoveries
      contextRef="C_47aa4785-b887-4bdc-9f4f-5f764a502283"
      decimals="-6"
      id="F_fa676569-350e-4723-9df1-e40176b801fd"
      unitRef="U_USD">150000000</mspr:RealizedClaimRecoveries>
    <us-gaap:AssetsSoldUnderAgreementsToRepurchaseMarketValue
      contextRef="C_28b71e0a-7e6d-429a-b008-1ff060441f3d"
      decimals="-5"
      id="F_81e3ebf6-1dbd-4d70-bd83-9b4ef0bcc762"
      unitRef="U_USD">45500000</us-gaap:AssetsSoldUnderAgreementsToRepurchaseMarketValue>
    <us-gaap:AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts
      contextRef="C_a81ca7d1-03d7-4254-97b6-cef1cc580eba"
      decimals="-5"
      id="F_2fd08d59-9e9c-4b5c-8375-63af41d88fad"
      unitRef="U_USD">40900000</us-gaap:AssetsSoldUnderAgreementsToRepurchaseCarryingAmounts>
    <us-gaap:AssetAcquisitionPriceOfAcquisitionExpected
      contextRef="C_47aa4785-b887-4bdc-9f4f-5f764a502283"
      decimals="-5"
      id="F_2a3330a8-2a6f-4fab-800d-0a3b84368a6a"
      unitRef="U_USD">285500000</us-gaap:AssetAcquisitionPriceOfAcquisitionExpected>
    <us-gaap:AssetAcquisitionPriceOfAcquisitionExpected
      contextRef="C_79d9f285-5c8d-4c0b-8618-a9851a277fcc"
      decimals="-6"
      id="F_58cf3ae4-df06-49ae-a040-75d2225139a5"
      unitRef="U_USD">250000000</us-gaap:AssetAcquisitionPriceOfAcquisitionExpected>
    <mspr:NetGainOfTheAsset
      contextRef="C_47aa4785-b887-4bdc-9f4f-5f764a502283"
      decimals="-5"
      id="F_8f572531-50be-445f-98a1-9b00f9727c7e"
      unitRef="U_USD">4600000</mspr:NetGainOfTheAsset>
    <mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims
      contextRef="C_ac30e5d6-58b4-4221-bd9f-24cd5b3365b0"
      decimals="-5"
      id="F_7b818dc3-d04a-44a0-8f1a-05b8e19139ab"
      unitRef="U_USD">3300000</mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims>
    <mspr:DebtInstrumentOriginalIssueDiscount
      contextRef="C_b46cfbc4-b098-4d9a-a0eb-4d949d390497"
      decimals="2"
      id="F_89dc0580-d344-4dee-9fef-63576b69afca"
      unitRef="U_pure">0.40</mspr:DebtInstrumentOriginalIssueDiscount>
    <mspr:NumberOfMedicareMembers
      contextRef="C_dba0c8eb-4e7d-4101-939e-a66a07a72a4a"
      decimals="INF"
      id="F_d4ba74d7-f3b9-4225-bbea-958178bae3b9"
      unitRef="U_Members">450000</mspr:NumberOfMedicareMembers>
    <mspr:AgreementDate
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_5cc00db7-c300-47ec-9f96-d110f54248ca">2023-03-06</mspr:AgreementDate>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_6416e867-3e37-4d6c-9be5-842500520199"
      decimals="-6"
      id="F_660b9db3-1221-43bd-b957-34d7910e0f3c"
      unitRef="U_USD">80000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <mspr:DebtInstrumentOriginalIssueDiscount
      contextRef="C_13748221-3ec6-4846-a96d-b183a19ab473"
      decimals="2"
      id="F_fdda453a-27b2-4849-bd71-516e642cc8dd"
      unitRef="U_pure">0.40</mspr:DebtInstrumentOriginalIssueDiscount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_f5366bf8-0f82-48ee-a516-2669d00a2346"
      decimals="-6"
      id="F_213516d8-3d36-4261-8a0e-8701e5f29f30"
      unitRef="U_USD">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_240c3aca-617e-45d0-80e7-144cd05885bc"
      decimals="-6"
      id="F_188c43f3-c0a5-4526-8a80-ba60d7a3b503"
      unitRef="U_USD">18000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_94f5cc8c-3b7d-43d7-abe9-3622bcd0a570"
      decimals="-5"
      id="F_6bc38299-a024-4e7b-ae68-b92b7312126a"
      unitRef="U_USD">20500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_6d36e1f0-9fa4-464e-bcc8-ec43920a4389"
      decimals="-5"
      id="F_94a2c504-7164-4bc8-8e55-eba3172e460e"
      unitRef="U_USD">9000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_3f7d2988-c276-41f2-9ddb-13cdccfa0680"
      decimals="-5"
      id="F_c90c8aa8-05ba-4c6b-a400-fa8f2fde21ff"
      unitRef="U_USD">4500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityDescription
      contextRef="C_d114e753-e2e8-448e-8e31-cdfe137f7707"
      id="F_891b4274-3919-403d-bc20-ce4b18b645f0">extended the period to draw up to $23.3 million (with a 40% original issue discount) remaining under Term Loan B for working capital, accessible in eight tranches of $1.75 million, that can be drawn at least one month apart, until September 2025</us-gaap:LineOfCreditFacilityDescription>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_2b6ff688-5733-44c4-adef-6460a88c6577"
      decimals="-5"
      id="F_834c8a94-0fa5-41c7-867a-7f165bbcdd2f"
      unitRef="U_USD">23300000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <mspr:DebtInstrumentOriginalIssueDiscount
      contextRef="C_19dd057d-164d-4d09-aca4-862b4fbf7c68"
      decimals="2"
      id="F_4d0c8f86-99e5-4d08-992e-f6381ed7bf4e"
      unitRef="U_pure">0.40</mspr:DebtInstrumentOriginalIssueDiscount>
    <mspr:LineOfCreditFacilityBorrowingAvailableAmountForEachTranche
      contextRef="C_2b6ff688-5733-44c4-adef-6460a88c6577"
      decimals="-4"
      id="F_2e9e4362-308f-422a-abc9-4ab8bfc18692"
      unitRef="U_USD">1750000</mspr:LineOfCreditFacilityBorrowingAvailableAmountForEachTranche>
    <mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims
      contextRef="C_2b6ff688-5733-44c4-adef-6460a88c6577"
      decimals="-5"
      id="F_a1175668-3b25-468d-b26f-32e1a2e11b11"
      unitRef="U_USD">3300000</mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims>
    <mspr:DebtInstrumentOriginalIssueDiscount
      contextRef="C_19dd057d-164d-4d09-aca4-862b4fbf7c68"
      decimals="2"
      id="F_7c46dbef-76aa-4391-82ea-023cd3cfc1a6"
      unitRef="U_pure">0.40</mspr:DebtInstrumentOriginalIssueDiscount>
    <mspr:AssignorConsistingNumberOfMedicareMembers
      contextRef="C_ba6d251e-46b0-4175-8e53-534f56cc7116"
      decimals="INF"
      id="F_d146a150-9bb4-4d1d-aa27-3854dd23648d"
      unitRef="U_Members">450000</mspr:AssignorConsistingNumberOfMedicareMembers>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="C_f47d4941-5e9a-4b10-9ef9-c0cd1e17b7a2"
      decimals="-5"
      id="F_7b0e7221-0d07-4ecc-99e0-c1cbbf7937dc"
      unitRef="U_USD">12300000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims
      contextRef="C_e69f5703-ad7e-4186-a291-683b533d05a3"
      decimals="-5"
      id="F_d2ca59df-b0b1-4126-940f-21e90e912553"
      unitRef="U_USD">2000000</mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="C_859ecd69-4f84-40b2-9e61-c5f7ca8a44e9"
      decimals="-5"
      id="F_bf0752df-083b-467e-878c-e67e87b18c39"
      unitRef="U_USD">3500000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="C_0bbf18dd-84b1-4a9c-8590-5c60d8a4eac1"
      decimals="-5"
      id="F_9807bfc1-a32a-44fe-b117-fa3b04939d42"
      unitRef="U_USD">6000000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="C_0bbf18dd-84b1-4a9c-8590-5c60d8a4eac1"
      id="F_e363690d-f5b1-4a01-ae7f-9e9ab4ccd13e">P6M</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="C_b56a07ac-ec0a-4021-a488-5ef64b5339af"
      decimals="-4"
      id="F_860ec9a3-7e90-4318-af2b-59433b62327b"
      unitRef="U_USD">1750000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="C_21918913-de21-41f4-bb8a-ff60365fc94c"
      decimals="-5"
      id="F_eb1f8288-9cbd-4fef-a4e1-6864ec1ed16b"
      unitRef="U_USD">1500000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="C_bdb33403-9b1e-41b7-92e4-eb7991db7d0f"
      decimals="-4"
      id="F_643be868-3487-48ad-b6f4-5cf52c01a7ca"
      unitRef="U_USD">2750000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_5caad33f-1cfc-4f65-9da6-18428c5fc7fb">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 4. INVESTMENT IN EQUITY METHOD INVESTEES&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company holds &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;four&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; investments which are accounted for using the equity method&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;: MAO-MSO Recovery II LLC Series PMPI (&#x201c;Series PMPI&#x201d;), MAO-MSO Recovery LLC, MAO-MSO Recovery II LLC (both collectively the &#x201c;MAO-MSO entities&#x201d;) and VRM MSP.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Series PMPI is a series of MAO-MSO Recovery II LLC. The Company exercises significant influence over the operating and financial activities of Series PMPI, but does not exercise control of the entity. In accordance with Series PMPI&#x2019;s operating agreement, the controlling member is entitled to a preferred return of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per annum&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (the &#x201c;Preferred Return&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Once the Preferred Return has been met, the controlling member is entitled to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of Claim&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;s recoveries by PMPI. The noncontrolling member is allocated &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the costs of PMPI. Since the Preferred Return exceeds the total members&#x2019; equity of PMPI as of both &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023, the value of the equity method investment in the consolidated balance sheet is &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The MAO-MSO entities are Delaware limited liability companies formed as master series entities whose central operations are to form other series legal entities that will hold and pursue Claims recovery rights. The MAO-MSO entities are not designed to hold or pursue Claims recoveries themselves. The Company holds a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;economic interest in both entities, and has significant influence through&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;its &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;equity investment, but does not control either entity. As equity method investments, the Company recognizes its proportionate share of net earnings or losses as equity earnings in Other income. The activity of these entities has been insignificant for the years ended December 31, 2024 and 2023. Since the Company did not make a contribution to the MAO-MSO entities and the entities have recorded losses, the value of the equity method investment in the consolidated balance sheets is &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as of both December 31, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Summary financial information for equity accounted investees, not adjusted for the percentage ownership of the Company is as follows:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;354&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,167&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,038&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.013%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.04%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.403%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.543%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;928&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,403&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;762&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;399&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In 2023, in connection with an amendment to the VRM MSP structure, the Company became a direct investor in VRM MSP, which controls MSP Recovery Claims, Series LLC, and recognizes this investment as an equity method investment. However, the Company previously consolidated and continues to consolidate the underlying Series of MSP Recovery Claims, Series LLC, which hold investments in CCRAs that the Company controls as primary beneficiary under the VIE model. As such, other than the Series, which were already consolidated, the investment in VRM MSP includes only administrative activities that are not otherwise consolidated, and any costs are allocable to the other investors. As a result, the Company has no significant equity earnings or exposure to losses or obligations to fund this investment.&lt;/span&gt;&lt;/p&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <mspr:NumberOfHoldingInvestments
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="INF"
      id="F_5c7c31a3-5dc4-444e-a3a1-8cde84f2f90c"
      unitRef="U_Investment">4</mspr:NumberOfHoldingInvestments>
    <mspr:PercentageOfPreferredReturnForTheControlling
      contextRef="C_948dc2cf-d2dd-4834-9c8e-109e2968c0dd"
      decimals="2"
      id="F_41b34a39-f3a2-4cf3-8930-31fd0accd9ec"
      unitRef="U_pure">0.20</mspr:PercentageOfPreferredReturnForTheControlling>
    <mspr:PercentageOfRecoveryClaimsForTheControlling
      contextRef="C_948dc2cf-d2dd-4834-9c8e-109e2968c0dd"
      decimals="2"
      id="F_b4f5b3b0-25ba-4ed2-8d21-449e360df778"
      unitRef="U_pure">0.50</mspr:PercentageOfRecoveryClaimsForTheControlling>
    <mspr:PercentageOfCostsAllocatedToNonControlling
      contextRef="C_948dc2cf-d2dd-4834-9c8e-109e2968c0dd"
      decimals="2"
      id="F_b27ee73e-827d-4822-9fd7-9149d9434604"
      unitRef="U_pure">1</mspr:PercentageOfCostsAllocatedToNonControlling>
    <us-gaap:EquityMethodInvestments
      contextRef="C_3c7a8126-415b-4641-9233-e1ab41a700c5"
      decimals="-3"
      id="F_67b173cf-fab2-4572-9514-25be84b5eafa"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="C_d8874f5c-dad1-443d-9908-5daf18c46c70"
      decimals="-3"
      id="F_b9275708-4496-44db-850a-876c8bbd7910"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_4d43bce3-acbe-4666-82a1-1d40c94afa24"
      decimals="2"
      id="F_83a1e637-da3f-4aaa-8ec4-29644a691454"
      unitRef="U_pure">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_26717c14-ec44-4c6a-8117-50449ba3aaaa"
      decimals="2"
      id="F_330b819a-38ed-4628-b202-1d5efa0f095d"
      unitRef="U_pure">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="C_26717c14-ec44-4c6a-8117-50449ba3aaaa"
      decimals="-3"
      id="F_7f03c279-a126-4e17-b257-927a6c920262"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="C_77c0175e-530a-4d31-b2a4-dbf10318bced"
      decimals="-3"
      id="F_d639a4b8-4025-4e15-b307-17de55d19f86"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="C_4d43bce3-acbe-4666-82a1-1d40c94afa24"
      decimals="-3"
      id="F_c9cdbaf4-245f-4990-9323-500f7b475280"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="C_e701c51b-571e-4acd-bab5-e8a71bb9884c"
      decimals="-3"
      id="F_81c42503-c3f5-405a-82d7-3a0e4feca0e5"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestments>
    <mspr:DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_928db263-b006-409f-b9fe-27e1184c6a4f">&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Summary financial information for equity accounted investees, not adjusted for the percentage ownership of the Company is as follows:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;354&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,167&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,038&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.013%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.04%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.403%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.543%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;928&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,403&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;762&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;399&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</mspr:DisclosureInTabularFormOfSummarizedFinancialInformationOfEquityMethodInvesteesTableTextBlock>
    <us-gaap:Revenues
      contextRef="C_1fc207a6-b212-4da0-b588-3744dd9baaf9"
      decimals="-3"
      id="F_32dd08c3-f402-455e-9c31-b6504fc4b24b"
      unitRef="U_USD">354000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_8faa5dec-aa23-45d8-bc7c-a3721aed1c52"
      decimals="-3"
      id="F_e759e584-3221-47d8-bce5-a34090ba03ec"
      unitRef="U_USD">-8000</us-gaap:Revenues>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_1fc207a6-b212-4da0-b588-3744dd9baaf9"
      decimals="-3"
      id="F_bd235a17-eef8-425b-9bc2-3bc643ea2cc9"
      unitRef="U_USD">1167000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_8faa5dec-aa23-45d8-bc7c-a3721aed1c52"
      decimals="-3"
      id="F_1877a3af-dd6b-4a01-8f82-ff20a1e10bd9"
      unitRef="U_USD">2000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_1fc207a6-b212-4da0-b588-3744dd9baaf9"
      decimals="-3"
      id="F_e40f8b27-daf0-42dc-af53-ca13370d8834"
      unitRef="U_USD">27000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_8faa5dec-aa23-45d8-bc7c-a3721aed1c52"
      decimals="-3"
      id="F_5b61cde7-ccd7-4ee3-9979-04a797906cec"
      unitRef="U_USD">30000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ProfitLoss
      contextRef="C_1fc207a6-b212-4da0-b588-3744dd9baaf9"
      decimals="-3"
      id="F_a0d1106c-ff73-43eb-815a-d829fc7de1b2"
      unitRef="U_USD">-840000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_8faa5dec-aa23-45d8-bc7c-a3721aed1c52"
      decimals="-3"
      id="F_107cfb98-0f8b-4528-9a4d-7d6fe7e821c5"
      unitRef="U_USD">-2038000</us-gaap:ProfitLoss>
    <us-gaap:Assets
      contextRef="C_b4bab880-e77f-42ec-81c9-310c18bf1482"
      decimals="-3"
      id="F_7b4bcacf-2ed7-4cb5-9cd0-02f8ab8d0b9b"
      unitRef="U_USD">928000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_56b72099-7c42-4ac1-9909-043db62ef97f"
      decimals="-3"
      id="F_1dd687a6-0805-4bbe-bf9a-37ce3827d7ef"
      unitRef="U_USD">1403000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="C_b4bab880-e77f-42ec-81c9-310c18bf1482"
      decimals="-3"
      id="F_4c1ee48a-ccfe-4bdc-be49-a3b2d06cd6cd"
      unitRef="U_USD">762000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_56b72099-7c42-4ac1-9909-043db62ef97f"
      decimals="-3"
      id="F_6baa9a98-3faf-458b-8629-f10fa808c52b"
      unitRef="U_USD">399000</us-gaap:Liabilities>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_a9875462-2255-4341-930f-49be712eebff">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 5. PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net consist of the following:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:65.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Office and computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;434&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;701&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;113&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Internally developed software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,588&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;6,815&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;6,403&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: accumulated depreciation and amortization of software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,656&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;5,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;4,911&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the years ended December 31, 2024 and 2023, depreciation expense and amortization expense was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_c73f46ba-b263-44d8-be28-1897f21af753">&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net consist of the following:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:65.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Office and computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;434&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;701&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;113&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Internally developed software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,588&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,789&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;6,815&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;6,403&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: accumulated depreciation and amortization of software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,656&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;5,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;4,911&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_66d1760e-3b4b-4a44-adcc-7a80bfabd72f"
      decimals="-3"
      id="F_6e9930fc-9ed2-4d9b-a930-0dffbfaac968"
      unitRef="U_USD">459000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_04ac6ccd-aacd-4024-ae81-e73dcdcaa130"
      decimals="-3"
      id="F_1f59eec1-5a17-40ba-8a17-601d9e122ffb"
      unitRef="U_USD">434000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_5e551576-1454-4e6e-8860-e330e9e8fef2"
      decimals="-3"
      id="F_84184696-8cf0-474b-8a05-89284b777fa8"
      unitRef="U_USD">701000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_ecedb469-0a15-457a-8825-173264a5730b"
      decimals="-3"
      id="F_5fab5ef0-b165-4d80-a464-a7c3367f19e3"
      unitRef="U_USD">113000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_29a25c58-bd49-4813-98cf-174eff897359"
      decimals="-3"
      id="F_4d3cbf6c-b5e5-4cab-8897-5425b709961c"
      unitRef="U_USD">5588000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_b4d69b9f-ab9d-46c5-9d48-786f9a6c9133"
      decimals="-3"
      id="F_799f6f36-d9fb-4854-a2d5-b7c75c434665"
      unitRef="U_USD">5789000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_58441ed6-59f7-4eb3-8ebb-2144c6210c69"
      decimals="-3"
      id="F_c8530920-e15c-4ad6-a493-5d13366d74c9"
      unitRef="U_USD">67000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_08ce17f4-9500-467c-ac13-d6286aef1dd5"
      decimals="-3"
      id="F_9caec4d9-f433-4211-b987-79640f910d26"
      unitRef="U_USD">67000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_e1288763-3026-4599-8e8c-3dbc48ebe30c"
      unitRef="U_USD">6815000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_281cc5e4-54f9-4c3e-8276-d30b0a82ced0"
      unitRef="U_USD">6403000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_67c72925-afd9-43b3-a0be-d9cdf23697fc"
      unitRef="U_USD">1656000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_1404f9d1-74c6-4ae1-9e84-8b6a20ea8ff3"
      unitRef="U_USD">1492000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_84d8e9e8-686b-4b64-b978-641d4242bf33"
      unitRef="U_USD">5159000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_fd75d65c-1e51-4172-8b52-f6630f7ef2cb"
      unitRef="U_USD">4911000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-5"
      id="F_2e176d83-9af7-4d82-87d9-3f42027842e0"
      unitRef="U_USD">300000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-5"
      id="F_a7217235-78ae-45b6-ac2d-4cee86fb78db"
      unitRef="U_USD">300000</us-gaap:DepreciationAndAmortization>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_a7c2de14-36d7-4554-a49f-911004230564">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 6. INTANGIBLE ASSETS, NET&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company holds CCRAs held by Series MRCS, which were acquired through the issuance of equity as part of the Business Combination in 2022 and acquisitions of additional CCRAs from the Closing Date through 2024.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Intangible assets, net consists of the following:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:65.987%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.177%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.717%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intangible assets, gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,121,859&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,872,356&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accumulated amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,223,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;739,560&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;1,898,223&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;3,132,796&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024, the Company purchased &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;CCRAs included in Intangible assets, net, which were paid in cash. During the year ended December 31, 2023, the Company purchased $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;287.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of CCRAs included in Intangible assets, net, of whic&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;h &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;285.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was through the Hazel transaction (See Note 3,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Material Agreements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;), &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was through a Class A Common Stock and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was paid in cash.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the years ended December 31, 2024 and 2023, Claims amortization expense was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;484.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;476.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Future amortization for CCRAs is expected to be as follows:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:78.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:17.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;CCRAs Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;474,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;474,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;474,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;474,555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;1,898,223&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company monitors intangible assets for potential impairment indicators, including, but not limited to, assumptions regarding the amount and timing of future collections derived from its CCRAs. The Company continues to pursue recoveries from various parties under rights held through its CCRAs; however, extended delays may result in future impairment of the Company&#x2019;s intangible assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the Company&#x2019;s fourth quarter review of its CCRAs, the Company identified potential impairment indicators, such as recurring operating losses, and a lack of substantial revenue generated from our Claims portfolio to date, which it considered in its evaluation of its definite-lived intangible assets. As a result, the Company performed a recoverability analysis on the definite-lived CCRA intangible assets in the fourth quarter of 2024. The recoverability analysis primarily included unobservable inputs, including internally developed assumptions about the estimated market share of insurance carriers that may not have paid claims due to Assignors, undiscounted cash flows of potential estimated recoveries from those carriers, the corresponding direct costs associated with those estimated recoveries, and the Company&#x2019;s ability to successfully litigate or negotiate settlements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;An asset group is impaired if the estimated undiscounted cash flows are less than the asset group&#x2019;s carrying value. Impairment is measured by the amount by which the carrying value exceeds fair value. The Company performed a probability-weighted undiscounted net cash flow analyses, taking into account various scenarios of expected cash flows, some of which rendered positive results, while others rendered negative results. Given that the probability-weighted average cash flows of all scenarios were below the carrying value, the Company performed a fair value assessment to measure impairment loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value assessment of the intangible assets was determined using the income approach. The significant inputs and assumptions used in the estimate of fair value were primarily Level 3 inputs, and include internally developed assumptions used in the undiscounted analysis, as well as the determination of an appropriate discount rate. The Company&#x2019;s estimation of the fair value of its CCRA intangible assets resulted in a non-cash impairment charge amount of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;752.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; recorded during the fourth quarter of 2024 in Impairment of intangible assets in the consolidated statement of operations for the year ended December 31, 2024. The estimation of the fair value requires significant management judgment with respect to the estimates discussed above. The estimates of the fair value are based on the best information available as of the date of the assessment. Small changes in the significant inputs and assumptions would increase or decrease estimated discounted future operating cash flows and could increase or decrease an impairment charge by a material amount. For example, if estimated recoveries were accelerated by one year, the non-cash impairment charge would decrease by $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;141.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, while if estimated recoveries were extended by a year, then the non-cash impairment charge would increase by $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;128.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. In addition, a hypothetical &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% change in the discount rate assumption would increase or decrease the impairment charge by approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. If actual results or future expectations are not consistent with the assumptions used in our estimate of fair value, it may result in the recording of additional impairment charges in the future which could be material.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents the changes in the Company&#x2019;s intangibles assets for &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;year ended December 31, 2024:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:65.987%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.6%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.137%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.717%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Intangible Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,363,156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Acquisitions of CCRAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;287,029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;476,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Sale of CCRAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,897&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,132,796&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Acquisitions of CCRAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;484,076&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Impairment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;752,697&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;1,898,223&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_ae12e070-87f3-4312-86e4-9431b0063817">&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Intangible assets, net consists of the following:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:65.987%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.177%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.717%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intangible assets, gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,121,859&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,872,356&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accumulated amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,223,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;739,560&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;1,898,223&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;3,132,796&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5"
      decimals="-3"
      id="F_54d992de-8248-4374-83fc-d9220ab97f60"
      unitRef="U_USD">3121859000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_125dfb7b-a596-48e9-aa73-d42dc93faea2"
      decimals="-3"
      id="F_f003419a-aa6d-4038-9ecb-6db04d902b3b"
      unitRef="U_USD">3872356000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5"
      decimals="-3"
      id="F_4b168000-401e-47a5-a359-cd273d08b5a2"
      unitRef="U_USD">1223636000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_125dfb7b-a596-48e9-aa73-d42dc93faea2"
      decimals="-3"
      id="F_cd064645-2397-47b2-b120-1dac5ebaa276"
      unitRef="U_USD">739560000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5"
      decimals="-3"
      id="F_4e64bc70-dbc8-492d-8859-eaa9bd1f382d"
      unitRef="U_USD">1898223000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_125dfb7b-a596-48e9-aa73-d42dc93faea2"
      decimals="-3"
      id="F_06d82de1-02c4-431a-a573-95ac4ec3f5b2"
      unitRef="U_USD">3132796000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="C_e76601ce-3711-4870-9e0a-3ab905ebdac4"
      decimals="-5"
      id="F_f522baee-e3fd-4cc8-864b-3308472e89ee"
      unitRef="U_USD">2200000</us-gaap:PaymentsToAcquireBusinessesGross>
    <mspr:AdditionalFiniteLivedIntangibleAssetsAcquired
      contextRef="C_23f0d6a2-3c2c-4e89-aa10-98a9a94f129d"
      decimals="-5"
      id="F_4bafacd3-81fc-4ab4-8c33-1c08f61cbd20"
      unitRef="U_USD">287000000</mspr:AdditionalFiniteLivedIntangibleAssetsAcquired>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_d6c4c28a-22a2-40b1-9778-e6b573c72de1"
      decimals="-5"
      id="F_67a81912-9623-45b2-80f4-d25179044e04"
      unitRef="U_USD">285500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="C_51823262-9427-432d-a0b9-aa056efd7162"
      decimals="-5"
      id="F_9c55e33e-26c5-4719-930f-52281ed4b695"
      unitRef="U_USD">800000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="C_23f0d6a2-3c2c-4e89-aa10-98a9a94f129d"
      decimals="-5"
      id="F_e22444f8-b332-4dbb-9bf4-3ea73cd12ed2"
      unitRef="U_USD">700000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_4a8604ad-e380-417e-aa2c-4c0e29ad2d19"
      decimals="-5"
      id="F_50923188-2f50-40e0-ad4f-e2014dca3052"
      unitRef="U_USD">484100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_a5e2c7d9-9acb-499e-b27d-26fe7e7dce15"
      decimals="-5"
      id="F_a375adf7-a850-4b9e-b29b-e8a2e4c00290"
      unitRef="U_USD">476500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_8a54746e-a04f-4cd6-9a15-2109f1495334">&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Future amortization for CCRAs is expected to be as follows:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:78.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.86%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:17.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;CCRAs Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;474,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;474,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;474,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;474,555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;1,898,223&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5"
      decimals="-3"
      id="F_79c90ef7-6d0c-4386-9241-88faec77f83c"
      unitRef="U_USD">474556000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5"
      decimals="-3"
      id="F_d9fe16a0-c962-464b-acda-e510b5503159"
      unitRef="U_USD">474556000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5"
      decimals="-3"
      id="F_be5bc9a3-ab2b-4ab7-9e28-f6967e9a0d49"
      unitRef="U_USD">474556000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5"
      decimals="-3"
      id="F_c7e59f19-1e86-4593-a960-9f2f284bba6d"
      unitRef="U_USD">474555000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5"
      decimals="-3"
      id="F_dc3b0458-7ed6-4ec6-a740-920c32a2eca7"
      unitRef="U_USD">1898223000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="C_7fe3a456-0271-47b2-9277-1147387966fe"
      decimals="-5"
      id="F_de1f8726-fef0-44d0-94d1-70b7a513b66e"
      unitRef="U_USD">752700000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <mspr:Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-5"
      id="F_ab678c3c-d583-460a-a465-91e6000109b2"
      unitRef="U_USD">141600000</mspr:Non-CashImpairmentChargeWouldDecreaseEstimatedRecoveries>
    <mspr:Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-5"
      id="F_ae17066b-bd05-4ff1-bc3e-6f5d840a0d01"
      unitRef="U_USD">128300000</mspr:Non-CashImpairmentChargeWouldIncreaseEstimatedRecoveries>
    <mspr:GoodwillMeasurementInputIncreaseDecrease
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="2"
      id="F_ad53a73a-b1f7-44b0-9073-8ebe5881d408"
      unitRef="U_pure">0.01</mspr:GoodwillMeasurementInputIncreaseDecrease>
    <mspr:IncreaseDecreaseInImpairmentCharges
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-5"
      id="F_fe4117cc-b5be-4611-baf5-1d5d04235116"
      unitRef="U_USD">39000000</mspr:IncreaseDecreaseInImpairmentCharges>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="C_4a8604ad-e380-417e-aa2c-4c0e29ad2d19"
      id="F_f442e20b-7792-45c1-8b49-ee30347f3c8c">&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents the changes in the Company&#x2019;s intangibles assets for &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;year ended December 31, 2024:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:65.987%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.6%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.137%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.717%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Intangible Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,363,156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Acquisitions of CCRAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;287,029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;476,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Sale of CCRAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,897&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,132,796&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Acquisitions of CCRAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;484,076&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Impairment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;752,697&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;1,898,223&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_124c16cb-bff6-4d6a-83be-6bf4a76f2445"
      decimals="-3"
      id="F_e8fbdbd2-c65a-4c7f-aa47-9022e248b624"
      unitRef="U_USD">3363156000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="C_a5e2c7d9-9acb-499e-b27d-26fe7e7dce15"
      decimals="-3"
      id="F_98a7a192-340e-4b1d-b8da-2d77bae0709d"
      unitRef="U_USD">287029000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_a5e2c7d9-9acb-499e-b27d-26fe7e7dce15"
      decimals="-3"
      id="F_b8cc1f43-bb4e-45cf-b7a6-98786c18506d"
      unitRef="U_USD">476492000</us-gaap:AmortizationOfIntangibleAssets>
    <mspr:SaleOfIntangibleAssets
      contextRef="C_a5e2c7d9-9acb-499e-b27d-26fe7e7dce15"
      decimals="-3"
      id="F_85756e9d-59e5-487c-a3a1-8bedbea3118a"
      unitRef="U_USD">40897000</mspr:SaleOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_125dfb7b-a596-48e9-aa73-d42dc93faea2"
      decimals="-3"
      id="F_d9fb1233-7a2d-4036-a98d-a2c7cd86524b"
      unitRef="U_USD">3132796000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="C_4a8604ad-e380-417e-aa2c-4c0e29ad2d19"
      decimals="-3"
      id="F_cff9ec14-9fe6-4cce-8d64-dba42c509112"
      unitRef="U_USD">2200000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_4a8604ad-e380-417e-aa2c-4c0e29ad2d19"
      decimals="-3"
      id="F_eec4078d-78d2-4f8f-90fe-29f7936282dc"
      unitRef="U_USD">484076000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="C_4a8604ad-e380-417e-aa2c-4c0e29ad2d19"
      decimals="-3"
      id="F_96c19d0f-4312-43a3-a79f-72d5f122f625"
      unitRef="U_USD">752697000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_d28da71e-2163-4433-89d2-79d811cad1b5"
      decimals="-3"
      id="F_17a50813-5967-43a0-b354-96ef380fe616"
      unitRef="U_USD">1898223000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_eb31242e-acf9-4930-af83-4f744adacb52">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 7. INCOME TAX&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company holds an economic interest in MSP Recovery, LLC and consolidates its financial position and results. The remaining ownership of MSP Recovery, LLC not held by the Company is considered a noncontrolling interest. MSP Recovery, LLC is treated as a partnership for income tax reporting and its members, including the Company, are liable for federal, state, and local income taxes based on their share of the LLC&#x2019;s taxable income.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;There was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; provision for income tax for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the United States statutory income tax rate to the Company&#x2019;s effective tax rate for the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 is as follows for the years indicated:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:56.249%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:18.556%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:17.597%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal Statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Noncontrolling interests/effect of pass-through entities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16.14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.73&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.85&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State Taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.76&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.05&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Effective Income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Details of the Company&#x2019;s deferred tax assets and liabilities at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 are as follows for the years indicated:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:50.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:20.14%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:20.14%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;in thousands&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforward&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,613&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investment in MSP Recovery, LLC&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,385&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Start-up Costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;791&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;854&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Transaction Costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,699&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,962&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest Expense &#x2014; 163j&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,863&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,065&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Valuation Allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets (liability)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has a deferred tax asset for the difference between the financial reporting and the tax basis of its investment in MSP Recovery, LLC. The deferred tax asset above does not consider the iterative impact of the TRA liability as the entire liability has not been recorded as of&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 the Company had &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of U.S. gross federal and state net operating loss carryovers available to offset future taxable income, respectively. As of December 31, 2023, the Company had &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of U.S. gross federal and state net operating loss carryovers available to offset future taxable income, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t recorded any unrecognized tax benefits. The Company files income tax returns in the U.S. federal jurisdiction and Florida which remain open and subject to examination by the various taxing authorities. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company&#x2019;s federal and state and local income tax years &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; through &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; remain open and are subject to examination. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="INF"
      id="F_659e69c4-68bb-478f-909b-ea9c17255aae"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="INF"
      id="F_b20fb039-83dc-4aab-a7a2-2e685aaeb4fc"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_5016e1df-5984-4ce8-b23d-36dc532d8e2c">&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the United States statutory income tax rate to the Company&#x2019;s effective tax rate for the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 is as follows for the years indicated:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:56.249%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:18.556%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:17.597%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;For the Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal Statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Noncontrolling interests/effect of pass-through entities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16.14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.73&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.85&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State Taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.76&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.05&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Effective Income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="INF"
      id="F_d63a4d08-f972-4ac9-9609-281c2d279f92"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="INF"
      id="F_33b322a3-bde4-44d8-a680-20ae06625b43"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <mspr:EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="4"
      id="F_9977a8b0-0026-4a93-9cc2-f4fd158a0b64"
      unitRef="U_pure">-0.1614</mspr:EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities>
    <mspr:EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="4"
      id="F_92fea579-d819-4009-b01b-00fcf2be93ce"
      unitRef="U_pure">-0.1959</mspr:EffectiveIncomeTaxRateReconciliationAtNoncontrollingInterestsEffectOfPassThroughEntities>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="4"
      id="F_afedeb5b-1f87-47e6-a445-200ca121dab5"
      unitRef="U_pure">-0.0847</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="4"
      id="F_c073ed2a-bb1e-4ba1-8b57-164a5882af24"
      unitRef="U_pure">-0.0173</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <mspr:EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="4"
      id="F_6744dc0b-4e5d-4751-8cc8-5e8030e2e812"
      unitRef="U_pure">0.0185</mspr:EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent>
    <mspr:EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="4"
      id="F_660c7891-9682-4a92-80e0-517fc9cc7cc8"
      unitRef="U_pure">0</mspr:EffectiveIncomeTaxRateReconciliationWarrantLiabilityPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="4"
      id="F_fadcedd0-85de-4e44-8cee-93467cc982fa"
      unitRef="U_pure">0.0176</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="4"
      id="F_ddb92287-61b7-4b49-ac0b-6558e805f8aa"
      unitRef="U_pure">0.0037</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="4"
      id="F_6885a70f-f824-4e65-9674-ac9bcf32c7c1"
      unitRef="U_pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="4"
      id="F_64d99560-52f5-4aac-aa87-0ab9a1c4be79"
      unitRef="U_pure">-0.0005</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="4"
      id="F_eb0e5f4e-9413-4738-9b38-302abf9614a8"
      unitRef="U_pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="4"
      id="F_762f7145-fa13-46d4-9433-c4b43b9e763a"
      unitRef="U_pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_e457e5d9-5c4b-4cb6-b301-cbf63b0765cc">&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Details of the Company&#x2019;s deferred tax assets and liabilities at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 are as follows for the years indicated:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:50.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:20.14%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.64%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:20.14%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;in thousands&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforward&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,613&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investment in MSP Recovery, LLC&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,385&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Start-up Costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;791&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;854&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Transaction Costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,699&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,962&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest Expense &#x2014; 163j&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,863&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,065&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Valuation Allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax assets (liability)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has a deferred tax asset for the difference between the financial reporting and the tax basis of its investment in MSP Recovery, LLC. The deferred tax asset above does not consider the iterative impact of the TRA liability as the entire liability has not been recorded as of&lt;/span&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_12055e2a-73fc-4e0c-9499-a617201b3cc7"
      unitRef="U_USD">4613000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_1526eade-9946-4c5b-9d5d-02b650abd687"
      unitRef="U_USD">1126000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <mspr:DeferredTaxAssetsInvestmentInMspRecoveryLlc
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_9c25bb46-d219-4c12-a086-25b7292a46ee"
      unitRef="U_USD">21668000</mspr:DeferredTaxAssetsInvestmentInMspRecoveryLlc>
    <mspr:DeferredTaxAssetsInvestmentInMspRecoveryLlc
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_bbdabde5-2e2d-4ec2-b316-cec7cf999a00"
      unitRef="U_USD">30385000</mspr:DeferredTaxAssetsInvestmentInMspRecoveryLlc>
    <mspr:DeferredTaxAssetsOrganizationalCostsAndStartupExpenses
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_b17082ef-6e92-4bd8-bae9-1a2a65bace9c"
      unitRef="U_USD">791000</mspr:DeferredTaxAssetsOrganizationalCostsAndStartupExpenses>
    <mspr:DeferredTaxAssetsOrganizationalCostsAndStartupExpenses
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_ba997579-bbad-44eb-b866-5e61709d20d2"
      unitRef="U_USD">854000</mspr:DeferredTaxAssetsOrganizationalCostsAndStartupExpenses>
    <mspr:DeferredTaxAssetsTransactionCosts
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_95fb6564-66e5-4246-98ff-1e0797588c5b"
      unitRef="U_USD">2699000</mspr:DeferredTaxAssetsTransactionCosts>
    <mspr:DeferredTaxAssetsTransactionCosts
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_e658d1ac-f429-4275-b2e9-93aa905451cd"
      unitRef="U_USD">2962000</mspr:DeferredTaxAssetsTransactionCosts>
    <us-gaap:DeferredTaxAssetInterestCarryforward
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_3afe63b0-96c2-49d3-84b0-fffdcb43fad2"
      unitRef="U_USD">16863000</us-gaap:DeferredTaxAssetInterestCarryforward>
    <us-gaap:DeferredTaxAssetInterestCarryforward
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_3e99fd9f-58b4-44a0-9a25-11183bdf546c"
      unitRef="U_USD">5065000</us-gaap:DeferredTaxAssetInterestCarryforward>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_03748bcb-1c3e-4e48-b81b-8628fc20ea27"
      unitRef="U_USD">46634000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_db513d06-a6dc-4139-95a4-83d370a1de70"
      unitRef="U_USD">40392000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-3"
      id="F_62d63ceb-dd37-4d50-bbb6-5ed8bc5012e1"
      unitRef="U_USD">46634000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_1b01d0e0-3179-478a-a8b1-df3d8b989b95"
      unitRef="U_USD">40392000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0db234ba-3e48-4d00-9318-17c9b2c2ecdc"
      decimals="-5"
      id="F_04e8565f-f855-44af-a5f3-2000e5fd7bd4"
      unitRef="U_USD">17400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_f07a439f-c693-42c4-98e6-3d9e006b5525"
      decimals="-5"
      id="F_ad817bfe-70c0-4367-a2dd-226bd3722510"
      unitRef="U_USD">17400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_d105a18b-9d1a-4643-bb7c-ac6ea1c98248"
      decimals="-5"
      id="F_a7b2fcac-d97c-4703-a6b3-2ce1ce4801ec"
      unitRef="U_USD">4300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_045a7ff1-2fb5-4c22-bc5d-29ba574f00d7"
      decimals="-5"
      id="F_0de07c75-7f5e-449d-9976-6d58023661d1"
      unitRef="U_USD">4200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="INF"
      id="F_e57da7ad-0d8c-41e3-9277-3e753a715706"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="INF"
      id="F_9326c398-add0-467e-8bbf-0d96b772fe1d"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:IncomeTaxExaminationDescription
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_124e6392-d4c2-47c8-be83-9a085b7ae7a6">As of December 31, 2024, the Company&#x2019;s federal and state and local income tax years 2021 through 2023 remain open and are subject to examination. </us-gaap:IncomeTaxExaminationDescription>
    <us-gaap:OpenTaxYear
      contextRef="C_54d701f3-9c51-4703-a1c1-2c01604c2e0d"
      id="F_a2e197ee-5a0a-4070-8e0f-73271dcdeee8">2021</us-gaap:OpenTaxYear>
    <us-gaap:OpenTaxYear
      contextRef="C_7a02de5d-b9d8-4bf8-9ce7-036a7202e220"
      id="F_82e43e61-7615-4007-bc0a-b45c24beadc3">2023</us-gaap:OpenTaxYear>
    <us-gaap:VariableInterestEntityDisclosureTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_21fa6d91-d1b6-4a8b-8deb-e1381766e191">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 8. VARIABLE INTEREST ENTITIES&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Investments in consolidated Variable Interest Entities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates its ownership, contractual, and other interests in entities to determine if they are VIEs, if the Company has a variable interest in those entities, and the nature and extent of those interests. These evaluations are highly complex and involve management judgment and the use of estimates and assumptions based on available historical information, among other factors. Based on its evaluations, if the Company determines it is the primary beneficiary of such VIEs, it consolidates such entities into its financial statements. VIEs information below is presented on aggregate basis based on similar risk and reward characteristics and the Company&#x2019;s involvement with the VIEs.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company includes a number of entities that are determined to be VIEs and for which the common control group can direct the use of the entities&#x2019; assets and resources for other purposes. The Company only consolidates those VIEs for which the Company is the primary beneficiary.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The assets of the consolidated VIEs may only be used to settle obligations of these VIEs and to settle any investors&#x2019; ownership liquidation requests. There is no recourse to the Company for the consolidated VIEs&#x2019; liabilities. The assets of the consolidated VIEs are not available to the Company&#x2019;s creditors.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Total assets and liabilities included in its consolidated balance sheets for these VIEs were &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; billion&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, at December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; billion&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, at December 31, 2023. The assets at December 31, 2024 and 2023 include the Intangible Assets, net included in the Series of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; billion&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; billion&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Investments in unconsolidated Variable Interest Entities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is involved with VIEs in which it has investments in equity but does not consolidate because it does not have the power to direct the activities that most significantly impact their economic performance and thus is not considered the primary beneficiary of the entities. Those VIEs are reflected as equity method investments and are reflected at $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; on the Company&#x2019;s consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Total assets and liabilities for these VIEs were &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, at December 31, 2024 and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, at December 31, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Generally, MSP&#x2019;s exposure is limited to its investment in those VIEs (see Note 4, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Investment in Equity Method Investees&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;). For MAO-MSO Recovery II, LLC and Series PMPI, MSP may be exposed to providing additional recovery services at its own cost if recovery proceeds allocated to it are insufficient to recover the costs of those services. MSP does not have any other exposures or any obligation to provide additional funding.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;VRM MSP&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As discussed in&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 4,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Investment in Equity Method Investees&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company became a member of VRM MSP through the contribution of certain Series (holding certain CCRAs) by MSP Recovery into VRM MSP. The Company determined, based on analysis of the rights to cash flows from the Series and the related guaranty obligation, that the Company is the primary beneficiary of the Series entities, and therefore should consolidate as of the transaction date. The contribution is considered a common control transaction, as the Company controls and consolidated the Series before and after such contribution. The Company consolidates the Series held within VRM MSP, however does not consolidate VRM MSP itself.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Refer to Note 4,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Investment in Equity Method Investees&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, for additional information on this VRM MSP transaction.&lt;/span&gt;&lt;/p&gt;</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:Assets
      contextRef="C_ea41718c-eb03-4364-a84c-37e5f43f1623"
      decimals="-8"
      id="F_2dda366d-2505-494e-93fe-9c86f6679fa4"
      unitRef="U_USD">1400000000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="C_ea41718c-eb03-4364-a84c-37e5f43f1623"
      decimals="-5"
      id="F_31d6173c-f3f0-4d3a-9c27-661b18fcabf3"
      unitRef="U_USD">400000</us-gaap:Liabilities>
    <us-gaap:Assets
      contextRef="C_ba17b4e4-2add-4b5b-8fa4-ea5edfe1120f"
      decimals="-8"
      id="F_59712ec3-043b-41eb-bc71-9bfec29dae79"
      unitRef="U_USD">2200000000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="C_ba17b4e4-2add-4b5b-8fa4-ea5edfe1120f"
      decimals="-5"
      id="F_f01c5339-b955-4046-abd6-70f16ef7ddee"
      unitRef="U_USD">400000</us-gaap:Liabilities>
    <mspr:IntangibleAssetsHeldBeCertainSpecificSubsidiaries
      contextRef="C_ea41718c-eb03-4364-a84c-37e5f43f1623"
      decimals="-8"
      id="F_2aff6da5-0bba-4e8b-9e47-0f798fc6a08f"
      unitRef="U_USD">1200000000</mspr:IntangibleAssetsHeldBeCertainSpecificSubsidiaries>
    <mspr:IntangibleAssetsHeldBeCertainSpecificSubsidiaries
      contextRef="C_ba17b4e4-2add-4b5b-8fa4-ea5edfe1120f"
      decimals="-8"
      id="F_06cd4233-6943-40c4-abfb-707dc6f2887d"
      unitRef="U_USD">2000000000</mspr:IntangibleAssetsHeldBeCertainSpecificSubsidiaries>
    <us-gaap:EquityMethodInvestments
      contextRef="C_305dc9b3-22e0-4f75-b7ee-85c8627cae64"
      decimals="0"
      id="F_15e2ab1c-3982-4a95-9cf9-192569f778ec"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestments>
    <us-gaap:Assets
      contextRef="C_305dc9b3-22e0-4f75-b7ee-85c8627cae64"
      decimals="-5"
      id="F_c0d13b51-bad5-4f58-a289-852e43ced142"
      unitRef="U_USD">900000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="C_305dc9b3-22e0-4f75-b7ee-85c8627cae64"
      decimals="-5"
      id="F_80fcd8cb-36e2-49ee-a498-7dde88a7d8df"
      unitRef="U_USD">800000</us-gaap:Liabilities>
    <us-gaap:Assets
      contextRef="C_96faf7e0-a707-4cd1-84ae-926008d6d5e3"
      decimals="-5"
      id="F_e7aebe43-136e-4976-baa4-9800f376c03e"
      unitRef="U_USD">1400000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="C_96faf7e0-a707-4cd1-84ae-926008d6d5e3"
      decimals="-5"
      id="F_5f3b31cc-1643-4c02-82db-511849e201b5"
      unitRef="U_USD">400000</us-gaap:Liabilities>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_53f7c84d-6ceb-4653-8f30-00d293b81ffa">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 9. CLAIMS FINANCING OBLIGATIONS AND NOTES PAYABLE&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Based on claims financing obligations and notes payable agreements, as of December 31, 2024 and 2023, the present value of amounts owed under these obligations were &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;673.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;556.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, including capitalized interest. In addition, as of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of advances from Yorkville, respectively. The weighted average interest rate is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; based on the current book value of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;685.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; with rates that range from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company is expected to repay these obligations from cash flows from claim recovery income or potentially for the renegotiated debt through class A common stock issuances.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, the minimum required payments on these agreements are &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;818.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Certain of these agreements have priority of payment regarding any proceeds until full payment of the balance due is satisfied. The maturity of the commitments range from the date sufficient claims recoveries are received to cover the required return or in some cases by 2031.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Brickell Key Investments, LP&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In 2015, the Company entered into a Claims Proceeds Investment Agreement (as amended, the &#x201c;CPIA&#x201d;) with Brickell Key Investments LP (the &#x201c;Holder&#x201d;). On October 12, 2022, the Company entered into an Amendment to the CPIA (the &#x201c;Amendment&#x201d;) and a Warrant Agreement (the &#x201c;Warrant Agreement&#x201d;) with the Holder, pursuant to which the parties agreed to amend the original CPIA and required payment terms.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to the CPIA, as amended, the Company granted to the Holder the right to purchase Class A common shares in the Company (the &#x201c;Class A Shares&#x201d;) up to a maximum amount of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,667&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (the &#x201c;Amount&#x201d;) for a purchase price equal to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,666.67&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; ($&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0625&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per Class A Share), and is payable in cash. This Warrant (the &#x201c;Warrant&#x201d;) will expire at 5:00 p.m. (Eastern Time), on September 30, 2027 and may be exercised in whole or in part by Holder at any time prior to such date. The Holder can only sell a maximum of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per month of the Class A Shares obtained through the Warrant. In exchange for the Company issuing the Warrant, the amounts owed to the Holder pursuant to CPIA are amended to equal $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In exchange for the Company issuing the Warrant, the amounts owed to the Holder pursuant to CPIA was reduced from approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;143&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to equal $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (the &#x201c;Reduced Obligation&#x201d;), and no further interest will accrue. The Holder has the right to receive the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;owed through (1) proceeds as outlined in the CPIA, (2) cash paid by the Company or (3) monetization of the Warrant (through the sale of the Warrant or sale of the underlying Class A Shares). If the Holder monetizes the Warrant, the&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;amount &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;owed will be reduced at a measure of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;750.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per Class A Share (five-day volume weighted average price as of September 30, 2022).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with the Amendment and Warrant Agreement, the Holder also executed a Stock Pledge Agreement (the &#x201c;Pledge Agreement&#x201d;) with Legacy MSP founders, John H. Ruiz and Frank C. Quesada (the &#x201c;Founders&#x201d;). As part of the Pledge Agreement, the Founders agreed to pledge &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; thousand shares to secure payment of the original principal amount of the CPIA; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;provided, that if any any time prior to September 30, 2024, if the pledge agreement had not terminated, and the per share price of the pledged shares dropped below $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.60&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (before 2023 and 2024 Reverse stock splits), then additional shares were required to be pledged by the Founders to bring the number of pledged shares to a value based on the value on that date to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (minus amounts received in satisfaction of the obligation)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Holder has raised a dispute relating to the total number of shares that the Founders were required to pledge under the Pledge Agreement; however, before any pledged shares may be transacted upon, Holder must have monetized the CPIA Warrant. As of the date of this report, Holder has not monetized the CPIA Warrant.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; As the Company has an obligation to pay this indebtedness through cash proceeds from certain purchased claims recovery rights, the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of amounts owed as of&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; December 31, 2024 was included as Claims financing obligation and notes payable on the consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Founders did not exercise the option to repurchase the CPIA Warrant on or before June 30, 2023. The Company recognizes the CPIA Warrant at fair value which, considering the price of the Company&#x2019;s common stock was below $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;750.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, was determined to be &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Hazel Working Capital Credit Facility and Purchase Money Loan&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Working Capital Credit Facility&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 6, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, Subrogation Holdings entered into a credit agreement (as amended on March 29, 2023; November 10, 2023; and October 1, 2024; the &#x201c;Working Capital Credit Facility&#x201d;) with HPH providing for funding of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (with a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% original issue discount), consisting of a Term Loan A commitment to fund up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (in multiple installments) in proceeds and a Term Loan B Commitment to fund up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (in multiple installments) in proceeds. During fiscal year 2023, HPH disbursed $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million under Term Loan A and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million under Term Loan B.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During fiscal year 2024, HPH disbursed $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million under Term Loan B on January 25, 2024. On August 2, 2024, Subrogation Holdings entered into a letter agreement to amend the Working Capital Credit Facility (the &#x201c;HPH Letter Agreement&#x201d;) with HPH, which, among other things: (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;extended the period to draw up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (with a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% original issue discount) remaining under Term Loan B for working capital, accessible in eight tranches of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, that can be drawn at least one month apart, until September 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and (ii) provided for a $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million loan (subject to a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% original issue discount) funded by August 31, 2024 to acquire additional Claims (the &#x201c;New Claims&#x201d;) that collateralize the Working Capital Credit Facility (collectively, (i) and (ii) the &#x201c;Operational Collection Floor&#x201d;). The parties formalized the terms of the HPH Letter Agreement in Amendment No. 3 to the Working Capital Credit Facility dated October 1, 2024 (the &#x201c;OCF Amendment&#x201d;). On October 2, 2024, the Company acquired the recovery rights to additional Medicare Secondary Payer Claims from an existing Assignor consisting of more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;450,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Medicare members, as documented by the Assignor.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under the Operational Collection Floor, the Company received during 2024: (i) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for working capital, and (ii) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the purpose of acquiring the New Claims. To date, the Company received $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of working capital for 2025. Pursuant to the Working Capital Credit Facility, HPH may, at its sole discretion, increase the Operational Collection Floor by an amount of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, to be funded over a period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_339a811a-2d80-47ab-9bb0-fca6e26a7e13;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;six months&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. On February 28, 2025 and April 4, 2025, HPH exercised that discretion and funded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, from the increase to the Operational Collection Floor. An additional $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million remains available under the Operational Collection Floor, to be funded at HPH&#x2019;s sole discretion.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Purchase Money Loan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 29, 2023, the Company acquired a controlling interest in nine legal entities, whose sole assets are CCRAs, from Hazel. This is referred to as the &#x201c;Claims Purchase.&#x201d; The purchase price for the Claims Purchase was funded by (i) a purchase money loan between Hazel, as a lender, and the Company, as a borrower, in the amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (the &#x201c;Purchase Money Loan&#x201d;) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;as discussed in Note 3,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Material Agreements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and (ii) proceeds from the sale of certain, separate CCRAs in the Claims Sale (as defined below).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Also, on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 29, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company sold a controlling interest in three legal entities whose sole assets are CCRAs to Hazel. The agreement provided that the Company and Hazel would share in the recovery proceeds therefrom, in accordance with an agreed waterfall after Hazel had realized the first $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;150&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in claims recoveries. This transaction is referred to as the &#x201c;Claims Sale,&#x201d; and together with the Claims Purchase, the &#x201c;Claims Transactions.&#x201d;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Amounts borrowed and obligations under the Purchase Money Loan and the Working Capital Credit Facility are secured by a pledge of proceeds from specific Claims in the Company&#x2019;s Claims portfolio, with the lien securing the Purchase Money Loan being subordinated and junior to the lien securing the Working Capital Credit Facility. Pursuant to the Second Amended and Restated First Lien Credit Agreement, and in order to secure those additional advances of Term Loan B beginning in January 2024, the following was provided as additional collateral: (i) a pledge of proceeds from certain Claims in the Company&#x2019;s Claims portfolio, up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;a &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;pledge of the equity interests in an Affiliate of Messrs. John H. Ruiz and Frank C. Quesada; and (iii) a personal guaranty by Messrs. John H. Ruiz and Frank C. Quesada, as primary obligors, guaranteeing those additional advances of Term Loan B beginning in January 2024. On December 22, 2023, our Board approved the Company's payment of certain costs and fees (including legal fees) on behalf of John H. Ruiz and Frank C. Quesada, associated with a mortgage granted in connection with said guaranty, totaling $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. On April 1, 2025, in connection with the increased funding under the Operational Collection Floor, the pledge and personal guaranty in (ii) and (iii) above was increased by $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Loans under the Working Capital Credit Facility accrue interest at a Term Secured Overnight Financing Rate for 12-month interest period, plus an applicable margin of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per annum. Accrued interest on the Working Capital Credit Facility is payable in kind and are capitalized. The Working Capital Credit Facility has a stated maturity date of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2026&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and HPH may extend for up to one year in its sole discretion. The Purchase Money Loan accrues interest at a rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per annum, payable in kind or in cash at the Company&#x2019;s discretion. The Purchase Money Loan has a maturity date of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2026&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, extendable up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in Hazel&#x2019;s sole discretion.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is permitted to prepay the loans under the Working Capital Credit Facility from time to time without prepayment premium. Prepayment of the Purchase Money Loan will be permitted after the prepayment or repayment of loans under the Working Capital Credit Facility, and such prepayment of the Purchase Money Loan may be subject to prepayment penalty, as applicable.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to the Purchase Money Loan and the Working Capital Credit Facility, the Company entered into a collateral administrative agreement between the Company and HPH, which sets forth certain arrangements between the Company and HPH in relation to the management of the litigation of certain Claims owned by the Company, the proceeds of which are due to the Company, and were pledged to Hazel and HPH to secure the Purchase Money Loan and the Working Capital Credit Facility, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Purchase Money Loan and the Working Capital Credit Facility contain certain representations, warranties, and covenants of the Company and its subsidiaries, including restrictions on debt incurrence, liens, investments, affiliate transactions, distributions and dividends, fundamental changes, certain debt prepayments, and Claim settlement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Nomura Promissory Note&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On May 27, 2022, the Company issued an unsecured promissory note to Nomura (as amended on April 12, 2023, November 13, 2023, and March 26, 2024, the &#x201c;Nomura Note&#x201d;). The Nomura Note carries a principal amount of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million related to advisory fees and deferred underwriting fees and expenses that became due and payable by the Company to Nomura, in connection with the consummation of the Business Combination. The Nomura Note is payable in kind or in cash, at the Company&#x2019;s discretion, accrues interest at &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per annum, and matures on September 30, 2025. Upon two days prior written notice to Nomura, the Company may prepay all or any portion of the then outstanding principal amount under the Nomura Note together with all accrued and unpaid interest thereon. The balance of the unsecured Nomura Note and related interest are included within Claims financing obligations and notes payable in the consolidated balance sheet. The Nomura Note became current on September 30, 2024, and the Company does not currently have available liquidity to satisfy said obligation.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under the Nomura Note, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the aggregate proceeds under the Yorkville SEPA will be used to pay amounts outstanding under the Amended and Restated Nomura Promissory Note (first towards accrued and unpaid interest, if any, then towards principal) and the remaining &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of such proceeds will be used to pay amounts due under the Convertible Notes, if any, or be paid to the Company after the Convertible Notes are fully repaid. Pursuant to a letter agreement dated November 15, 2024, Nomura agreed to forego payments of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million due under the Nomura Note from proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA until March 31, 2025.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Yorkville Standby Equity Purchase Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On November 14, 2023, the Company entered into a standby equity purchase agreement (the &#x201c;Yorkville SEPA&#x201d;) with YA II PN, Ltd., a Cayman Island exempted company (&#x201c;Yorkville&#x201d;), pursuant to which Yorkville committed to purchase up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in shares of Class A Common Stock, subject to certain limitations and conditions set forth therein, during the term thereof. Sales of Class A Common Stock under the Yorkville SEPA, and the timing of any such sales, are at the Company&#x2019;s option, and the Company is under no obligation to sell any shares of Class A Common Stock to Yorkville under the Yorkville SEPA except in connection with notices that may be submitted by Yorkville, in certain circumstances as described below.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to the terms and conditions set forth in the Yorkville SEPA, the Company has the right, but not the obligation, from time to time at its discretion until the Yorkville SEPA is terminated to direct Yorkville to purchase a specified number of shares of Class A Common Stock (&#x201c;Advance&#x201d;) by delivering written notice to Yorkville (&#x201c;Advance Notice&#x201d;). While there is no mandatory minimum amount for any Advance, it may not exceed an amount equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the average of the daily traded amount during the five consecutive trading days immediately preceding an Advance Notice.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The shares of Class A Common Stock purchased pursuant to an Advance Notice will be purchased at a price equal to: (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;98&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the VWAP of the shares of Class A Common Stock on the applicable date of delivery of the Advance Notice during regular trading hours on such date, or (ii) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;97&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of the lowest daily VWAP of the shares of Class A Common Stock during the three consecutive trading&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;days &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;commencing on the date of the delivery of the Advance Notice, other than the daily VWAP on a day in which the daily VWAP is less than a minimum acceptable price as stated by the Company in the Advance Notice or there is no VWAP on the subject trading day. The Company may establish a minimum acceptable price in each Advance Notice, below which the Company will not be obligated to make any sales to Yorkville.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with the Yorkville SEPA, and subject to the conditions set forth therein, Yorkville agreed to advance to the Company in the form of convertible promissory notes (the &#x201c;Yorkville Convertible Notes&#x201d;) an aggregate principal amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. In 2023, the Company issued two Convertible Notes to Yorkville for a combined principal amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, resulting in net proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.48&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, and in 2024 the Company issued a third Convertible Note to Yorkville in the principal amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, resulting in net proceeds to us of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to the Yorkville &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Convertible Notes, Yorkville has the option, subject to certain limitations, of exchanging on one or more occasions all or part of the then outstanding balance under a given note for shares of our Class A Common Stock at a conversion price equal to the lower of: (i) a fixed price equaling &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;120&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of VWAP the day prior to the date of the closing of each tranche (the &#x201c;Fixed Price&#x201d;), or (ii) a variable price equaling &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;95&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the lowest daily VWAP during the seven consecutive trading days immediately preceding the exchange (the &#x201c;Variable Price&#x201d;), but in no event may the variable price be lower than $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share (the &#x201c;Floor Price&#x201d;). With respect to the initial Convertible Note issued on November 15, 2023, the Fixed Price equals $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;200.5625&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, with respect to the second Convertible Note issued on December 11, 2023, the Fixed Price equals $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;92.84&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, and with respect to the third Convertible Note issued on April 8, 2024, the Fixed Price equals $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37.625&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As required pursuant to the Second Amended and Restated Nomura Promissory Note, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the aggregate proceeds under the Yorkville SEPA will be used to repay amounts outstanding under the Nomura Note (first towards accrued and unpaid interest, if any, then towards principal) and the remaining &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of such proceeds will be used to repay amounts due under the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Yorkville Convertible Notes, if any, or be paid to the Company after the Yorkville &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Convertible Notes are fully repaid. Pursuant to a letter agreement dated November 15, 2024, Nomura agreed to forego payments of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million due under the Nomura Note from proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA until March 31, 2025. Pursuant to the Third Virage MTA Amendment, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the Company&#x2019;s portion of any net proceeds from the Yorkville SEPA would be used to pay down the VRM Full Return after the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Yorkville Convertible Notes are fully satisfied.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Upon the occurrence and during the continuation of an event of default, the Yorkville &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Convertible Notes shall become immediately due and payable, and the Company shall pay to Yorkville the principal and interest due thereunder. Events of default include, among others: (i) termination of quotation or listing of the Class A Common Stock on any primary market for a period of 10 consecutive trading days (the Company is currently quoted and listed for trading on Nasdaq) and (ii) failure to timely file any periodic report with the SEC on or before the due date of such filing as established by the SEC, including extensions under Rule 12b-25 under the Exchange Act. In no event shall Yorkville be allowed to effect a conversion if such conversion, along with all other shares of Common Stock beneficially owned by Yorkville and its affiliates would exceed &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the outstanding shares of the Common Stock of the Company. If any time on or after November 14, 2023: (i) the daily VWAP is less than the Floor Price for ten consecutive trading days (&#x201c;Floor Price Trigger&#x201d;), (ii) the Company has issued substantially all of the shares available under the Exchange Cap (as defined below) (&#x201c;Exchange Cap Trigger&#x201d;), or (iii) the Parent is in material breach of the Registration Rights Agreement, and such breach remains uncured for a period of twenty trading days, or the occurrence of an &#x201c;Event&#x201d; (as defined in the Registration Rights Agreement) (&#x201c;Registration Event Trigger&#x201d; and collectively with the Floor Price Trigger and the Exchange Cap Trigger, the &#x201c;Trigger&#x201d;), then the Company shall make monthly payments to Yorkville beginning on the seventh trading day after the Trigger and continuing monthly in the amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million plus a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% premium and accrued and unpaid interest. On December 6, 2024, stockholders holding at least a majority of our outstanding voting capital stock approved by written consent as required by Nasdaq Rule 5635(d), the issuance of shares of common stock of the Company in excess of the Exchange Cap set forth in the Yorkville SEPA. Effective January 8, 2025, the Exchange Cap was effectively lifted, allowing the Company to issue shares to Yorkville pursuant to the Yorkville SEPA and the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Yorkville Convertible Notes in excess of the Exchange Cap. In addition, on April 10, 2025, Yorkville agreed to waive Volume Threshold and Maximum Advance Amount limitations set forth in the Yorkville SEPA.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Yorkville, at its discretion and providing that there is a balance remaining outstanding under the Yorkville Convertible Notes, may deliver a notice under the Yorkville SEPA requiring the issuance and sale of shares of Class A Common Stock to Yorkville at the Conversion Price in consideration of an offset of the Yorkville &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Convertible Notes (&#x201c;Investor Notice&#x201d;). Yorkville, in its sole discretion, may select the amount of any Investor Notice, provided that the number of shares issued does not cause Yorkville to exceed the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% ownership limitation or the amount of shares of Class A Common Stock that are registered. As a result of an Investor Notice, the amounts payable under the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Yorkville Convertible Notes will be offset by such amount subject to each Investor Notice.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company will control the timing and amount of any sales of shares of Class A Common Stock to Yorkville, except with respect to the conversion of the Yorkville Convertible Notes. Actual sales of shares of Class A Common Stock to Yorkville as an Advance under the Yorkville SEPA will depend on a variety of factors to be determined by the Company from time to time, which may include, among other things, market conditions, the trading price of the Company&#x2019;s Class A Common Stock, and determinations by the Company as to the appropriate sources of funding for our business and operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Yorkville SEPA will automatically terminate on the earliest to occur of: (i) the first day of the month following the 36-month anniversary of the date of the Yorkville SEPA, or (ii) the date on which Yorkville shall have made payment of Advances pursuant to the Yorkville SEPA for shares of Class A Common Stock equal to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Company has the right to terminate the Yorkville SEPA at no cost or penalty upon five trading days&#x2019; prior written notice to Yorkville, provided that there are no outstanding Advance Notices for which shares of Class A Common Stock need to be issued, and the Company has paid all amounts owed to Yorkville pursuant to the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Yorkville Convertible Notes. The Company and Yorkville may also agree to terminate the Yorkville SEPA by mutual written consent. Neither the Company nor Yorkville may assign or transfer the Company&#x2019;s respective rights and obligations under the Yorkville SEPA, and no provision of the Yorkville SEPA may be modified or waived by the Company or Yorkville other than by an instrument in writing signed by both parties.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Yorkville SEPA contains customary representations, warranties, conditions and indemnification obligations of the parties. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The net proceeds under the Yorkville SEPA to the Company will depend on the frequency and prices at which the Company sells its shares of Class A Common Stock to Yorkville. The Company expects that any proceeds received from such sales to Yorkville will be used for working capital and general corporate purposes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On April 12, 2024, Yorkville agreed that, to the extent that it holds Class A Common Stock in such quantities that would prevent the Company from utilizing the Yorkville SEPA solely due to the Ownership Limitation, Yorkville committed to fund an additional advance in the principal amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million on the same terms and conditions as the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Yorkville Convertible Notes pursuant to the Yorkville SEPA.&lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During 2024, the Company sold &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,108,071&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Class A Common Stock to Yorkville, respectively, pursuant to investor and/or advance notices delivered under the Yorkville SEPA at prices between $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.78&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.09&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. The proceeds therefrom were used to: (i) reduce amounts owed under Yorkville Note #1 by $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of principal and interest, respectively for fiscal year 2024, (ii) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to fund operations of the Company, and (iii) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of payment to reduce amounts owed under the Nomura Note for fiscal year 2024. As we have sold substantially all of the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million shares currently registered for resale to Yorkville, we need to file with the SEC one or more additional registration statements to register under the Securities Act the resale by Yorkville of any additional shares of our common stock, and the SEC would have to declare such registration statement or statements effective before we could sell additional shares. &lt;/span&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_c9b18bd8-324c-46e3-8afa-33926f895ed8"
      decimals="-5"
      id="F_16be53b0-b745-498a-9484-dacd0d387afa"
      unitRef="U_USD">673600000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_f1707b98-eb20-432a-b96a-1452ac5f9a6f"
      decimals="-5"
      id="F_061f10bb-48aa-4a92-ab0d-84a260a782ee"
      unitRef="U_USD">556300000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_9f487c5a-0b48-49d0-b043-d8a27a0e661f"
      decimals="-5"
      id="F_6913da0f-361c-4749-8c82-d223a6af8581"
      unitRef="U_USD">12200000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_428035f8-2a73-4bf3-bd07-7c486a2b2984"
      decimals="-5"
      id="F_004eaceb-e44f-4672-b377-053daa5e61be"
      unitRef="U_USD">10000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="C_c9b18bd8-324c-46e3-8afa-33926f895ed8"
      decimals="3"
      id="F_575a18a9-e1da-46a6-a40f-0751fff9f401"
      unitRef="U_pure">0.15</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="C_f1707b98-eb20-432a-b96a-1452ac5f9a6f"
      decimals="3"
      id="F_082cc81e-e356-4031-8930-58253716b649"
      unitRef="U_pure">0.15</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="C_f1707b98-eb20-432a-b96a-1452ac5f9a6f"
      decimals="-5"
      id="F_e13da600-59f7-4026-a751-6bf63ead028e"
      unitRef="U_USD">685700000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="C_f1707b98-eb20-432a-b96a-1452ac5f9a6f"
      decimals="-5"
      id="F_e6287a8a-13f9-48b6-92db-915bfbd6006c"
      unitRef="U_USD">685700000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="C_609a7cf7-e71f-4260-af06-3fa43d842a79"
      decimals="3"
      id="F_16cad5f8-6ea3-4f61-8daa-593aa7ce3f89"
      unitRef="U_pure">0</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="C_e0f110ef-52d0-4fa6-963b-0050628d41b6"
      decimals="3"
      id="F_4d82d33d-217f-48bc-b6b2-eb77e4ea1a7d"
      unitRef="U_pure">0</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="C_044f7093-020d-4a2c-8402-0be8ff0eb918"
      decimals="3"
      id="F_2f21e6e5-7ab5-429d-81e7-2c500c7d9281"
      unitRef="U_pure">0.20</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="C_00bf460d-a55a-43dc-b3bf-96f35be4b164"
      decimals="3"
      id="F_28640c9a-6f76-4853-b83e-63ece78e3c38"
      unitRef="U_pure">0.20</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="C_3f274e94-4af0-46e3-87d2-ba8533edbab8"
      decimals="-5"
      id="F_d714133f-903d-4538-8d6a-efadd4f87ce3"
      unitRef="U_USD">818700000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_c8e18be5-39a5-489d-80ce-12c6054c1c18"
      decimals="INF"
      id="F_88790463-8780-42c7-a1ac-1e5e0c1675e7"
      unitRef="U_shares">106667</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockValue
      contextRef="C_c8e18be5-39a5-489d-80ce-12c6054c1c18"
      decimals="2"
      id="F_25f14334-aaf7-4836-92d1-690f0f87fdee"
      unitRef="U_USD">6666.67</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_c8e18be5-39a5-489d-80ce-12c6054c1c18"
      decimals="INF"
      id="F_cb4e3794-f9fb-43e1-8190-52dce2426958"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0625</us-gaap:CommonStockParOrStatedValuePerShare>
    <mspr:PercentageOfSharesObtainedThroughWarrant
      contextRef="C_5247622b-3115-44c8-972e-3aa6f0834d88"
      decimals="INF"
      id="F_ce3a7ca4-f7ad-45cc-84e9-53ac2a1e1b58"
      unitRef="U_pure">0.15</mspr:PercentageOfSharesObtainedThroughWarrant>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_9268077d-b92b-434c-8a1c-d085e2f473a4"
      decimals="-6"
      id="F_2b81ad0e-7dff-4055-a749-79aa29853d0a"
      unitRef="U_USD">80000000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_c30ed3e6-e67a-4d09-9360-8226e3fc395c"
      decimals="-6"
      id="F_371a265a-2d98-4f20-8119-75b5ae856a86"
      unitRef="U_USD">143000000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_5247622b-3115-44c8-972e-3aa6f0834d88"
      decimals="-6"
      id="F_65a9f82d-178b-4eb8-8aa7-70d90e9b1095"
      unitRef="U_USD">80000000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_5247622b-3115-44c8-972e-3aa6f0834d88"
      decimals="-6"
      id="F_c2f9d108-25ba-48cb-9c76-1f4536e07ed0"
      unitRef="U_USD">80000000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_d6608e57-e2af-4392-9108-161e0284de3a"
      decimals="INF"
      id="F_a7f83b8d-267e-48ce-9274-8d5eb8222541"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">750</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <mspr:SharesPledgedUnderAgreement
      contextRef="C_e47e8e78-3f7a-483f-be52-5d827c62b8cf"
      decimals="-3"
      id="F_5cb2cdb5-9baf-4107-a15f-9e6bdea58cf6"
      unitRef="U_shares">80000</mspr:SharesPledgedUnderAgreement>
    <us-gaap:SharePrice
      contextRef="C_f39537ea-1309-4548-918f-2247de76b5db"
      decimals="INF"
      id="F_07a69ed3-967e-4bba-8fa0-5aeb3a33abd0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.6</us-gaap:SharePrice>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_f39537ea-1309-4548-918f-2247de76b5db"
      decimals="-5"
      id="F_ac70ea8b-0b2f-43df-a40d-d4ddd1f35561"
      unitRef="U_USD">36000000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_75501a7c-fddd-4767-9d6b-6669aaf3d334"
      decimals="-5"
      id="F_ca88bb0d-1c4c-4880-aac6-7e52b90ac44b"
      unitRef="U_USD">80000000</us-gaap:WarrantsAndRightsOutstanding>
    <mspr:PriceOfCommonStock
      contextRef="C_4cf329ce-5aca-4da4-8888-8728533d3e78"
      decimals="INF"
      id="F_768ab56c-eedb-452f-912e-c076e4e5af4b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">750.00</mspr:PriceOfCommonStock>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_22a3e60b-719b-4f54-9b60-4ff2fca68d03"
      decimals="INF"
      id="F_09a4f21f-0e0d-4ba1-954b-1bd091ed9163"
      unitRef="U_USD">0</us-gaap:FairValueAdjustmentOfWarrants>
    <mspr:AgreementDate
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_9d62fec9-4bee-4675-b7aa-f29320c91b04">2023-03-06</mspr:AgreementDate>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_6416e867-3e37-4d6c-9be5-842500520199"
      decimals="-6"
      id="F_ad0d7913-647a-4f93-8e6a-8e61321b5681"
      unitRef="U_USD">80000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <mspr:DebtInstrumentOriginalIssueDiscount
      contextRef="C_13748221-3ec6-4846-a96d-b183a19ab473"
      decimals="2"
      id="F_ef8cae7a-c9fb-4388-a0e9-81943561d5d0"
      unitRef="U_pure">0.40</mspr:DebtInstrumentOriginalIssueDiscount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_f5366bf8-0f82-48ee-a516-2669d00a2346"
      decimals="-6"
      id="F_8c5ab2be-7c10-4270-838c-0aec38bb0ade"
      unitRef="U_USD">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_240c3aca-617e-45d0-80e7-144cd05885bc"
      decimals="-6"
      id="F_bc02f9c7-7829-43bd-b216-8ee47ef0b6bf"
      unitRef="U_USD">18000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_94f5cc8c-3b7d-43d7-abe9-3622bcd0a570"
      decimals="-5"
      id="F_8fe79457-5f33-486b-b5e3-bd34ec08474d"
      unitRef="U_USD">20500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_6d36e1f0-9fa4-464e-bcc8-ec43920a4389"
      decimals="-5"
      id="F_4f7d0c67-37f1-4fd1-a901-eb7b530a2520"
      unitRef="U_USD">9000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_3f7d2988-c276-41f2-9ddb-13cdccfa0680"
      decimals="-5"
      id="F_b0e7bbdd-add8-46b6-a65f-7c52bead0f02"
      unitRef="U_USD">4500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityDescription
      contextRef="C_d114e753-e2e8-448e-8e31-cdfe137f7707"
      id="F_35852166-a7e8-461c-83d7-d4a6d8e2175b">extended the period to draw up to $23.3 million (with a 40% original issue discount) remaining under Term Loan B for working capital, accessible in eight tranches of $1.75 million, that can be drawn at least one month apart, until September 2025</us-gaap:LineOfCreditFacilityDescription>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_2b6ff688-5733-44c4-adef-6460a88c6577"
      decimals="-5"
      id="F_d3f2d6f9-f518-4b8e-8533-3ba2b352aaeb"
      unitRef="U_USD">23300000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <mspr:DebtInstrumentOriginalIssueDiscount
      contextRef="C_19dd057d-164d-4d09-aca4-862b4fbf7c68"
      decimals="2"
      id="F_cef429fd-116e-46db-b7db-7655bdfff3b1"
      unitRef="U_pure">0.40</mspr:DebtInstrumentOriginalIssueDiscount>
    <mspr:LineOfCreditFacilityBorrowingAvailableAmountForEachTranche
      contextRef="C_2b6ff688-5733-44c4-adef-6460a88c6577"
      decimals="-4"
      id="F_d6863c05-9183-4618-a339-01054ffa44e3"
      unitRef="U_USD">1750000</mspr:LineOfCreditFacilityBorrowingAvailableAmountForEachTranche>
    <mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims
      contextRef="C_2b6ff688-5733-44c4-adef-6460a88c6577"
      decimals="-5"
      id="F_6ecaef37-4ca8-4ec7-bd75-7f69ca77adc9"
      unitRef="U_USD">3300000</mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims>
    <mspr:DebtInstrumentOriginalIssueDiscount
      contextRef="C_19dd057d-164d-4d09-aca4-862b4fbf7c68"
      decimals="2"
      id="F_fd39b72d-9516-497e-8fa8-b59aa79586d7"
      unitRef="U_pure">0.40</mspr:DebtInstrumentOriginalIssueDiscount>
    <mspr:AssignorConsistingNumberOfMedicareMembers
      contextRef="C_ba6d251e-46b0-4175-8e53-534f56cc7116"
      decimals="INF"
      id="F_9cfa7c23-392c-4bfc-a9f6-adb65a49038a"
      unitRef="U_Members">450000</mspr:AssignorConsistingNumberOfMedicareMembers>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="C_f47d4941-5e9a-4b10-9ef9-c0cd1e17b7a2"
      decimals="-5"
      id="F_6d8a0c4a-7bc7-4e84-b175-e48790984038"
      unitRef="U_USD">12300000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims
      contextRef="C_e69f5703-ad7e-4186-a291-683b533d05a3"
      decimals="-5"
      id="F_3cc8b1d6-3afa-47bf-b885-f7f237629324"
      unitRef="U_USD">2000000</mspr:LineOfCreditFacilityFundedForAcquiringAdditionalClaims>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="C_859ecd69-4f84-40b2-9e61-c5f7ca8a44e9"
      decimals="-5"
      id="F_cd824c34-5ee9-42d2-a27b-ebaf186654d7"
      unitRef="U_USD">3500000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="C_0bbf18dd-84b1-4a9c-8590-5c60d8a4eac1"
      decimals="-5"
      id="F_fa95743f-45a9-49d4-a8f7-10f9152a889c"
      unitRef="U_USD">6000000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="C_0bbf18dd-84b1-4a9c-8590-5c60d8a4eac1"
      id="F_932af136-b7f1-4cf1-98b1-dd8698efc64f">P6M</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="C_b56a07ac-ec0a-4021-a488-5ef64b5339af"
      decimals="-4"
      id="F_21e7d174-2aac-40bb-9cb7-e52d2d80a66f"
      unitRef="U_USD">1750000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="C_21918913-de21-41f4-bb8a-ff60365fc94c"
      decimals="-5"
      id="F_4c5c75f7-3cd0-421c-91c3-c39df969c322"
      unitRef="U_USD">1500000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="C_bdb33403-9b1e-41b7-92e4-eb7991db7d0f"
      decimals="-4"
      id="F_6a9a83c5-0fcd-403b-878b-d8b93f235519"
      unitRef="U_USD">2750000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <mspr:PurchaseMoneyLoan
      contextRef="C_28b71e0a-7e6d-429a-b008-1ff060441f3d"
      decimals="-5"
      id="F_17c47db5-0bcd-4a07-9d8e-cf98c8d6b1f3"
      unitRef="U_USD">250000000</mspr:PurchaseMoneyLoan>
    <mspr:AgreementDate
      contextRef="C_e0dfe751-c423-4c59-83cb-f45bf2e04763"
      id="F_5fbc6244-96f7-4dbf-9582-01abddf7bf91">2023-03-29</mspr:AgreementDate>
    <mspr:RealizedClaimRecoveries
      contextRef="C_e0dfe751-c423-4c59-83cb-f45bf2e04763"
      decimals="-6"
      id="F_ea102158-24d8-46d8-add5-d3093291bb4c"
      unitRef="U_USD">150000000</mspr:RealizedClaimRecoveries>
    <us-gaap:DebtInstrumentCollateralAmount
      contextRef="C_0583270c-f1a4-4ea8-9ef4-57cca824c658"
      decimals="-6"
      id="F_09ca6628-1ee3-498d-b7b4-09dd01d73be7"
      unitRef="U_USD">14000000</us-gaap:DebtInstrumentCollateralAmount>
    <mspr:PaymentOfCertainCostsAndFees
      contextRef="C_f282d974-0b54-4d2a-8885-b9170aeb1b0e"
      decimals="-5"
      id="F_919f5f98-7258-4f6f-9193-4dfee3f3c542"
      unitRef="U_USD">100000</mspr:PaymentOfCertainCostsAndFees>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="C_fc307584-aef8-4d18-a952-2cc14880dd3f"
      decimals="-4"
      id="F_ef9c9dbd-504f-4cd3-b907-66e05a01afab"
      unitRef="U_USD">3250000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="C_2cfffa07-7d0f-4494-b8a7-e7489ea1d410"
      decimals="-4"
      id="F_80de4159-277e-47e7-8145-ebb6f299fcda"
      unitRef="U_USD">17250000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <mspr:InterestPeriodPlusAnApplicableMargin
      contextRef="C_cfa5832c-9e4b-41f3-8998-fe2d8ab4f357"
      decimals="2"
      id="F_8fb0bb7e-a188-414e-86ff-d2d288cd1c04"
      unitRef="U_pure">0.10</mspr:InterestPeriodPlusAnApplicableMargin>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_cfa5832c-9e4b-41f3-8998-fe2d8ab4f357"
      id="F_c7dc4813-f1c4-43f5-b42f-e06890a7e31f">2026-03-31</us-gaap:DebtInstrumentMaturityDate>
    <mspr:PurchaseMoneyLoanAccruesInterest
      contextRef="C_e0dfe751-c423-4c59-83cb-f45bf2e04763"
      decimals="2"
      id="F_7f724279-0057-4108-bb54-6d14855ec8ff"
      unitRef="U_pure">0.20</mspr:PurchaseMoneyLoanAccruesInterest>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_5b46d7fc-7b57-43b1-9b41-9ab104ade8c7"
      id="F_233b327e-610f-47c3-bd23-8f5d408fcc79">2026-03-31</us-gaap:DebtInstrumentMaturityDate>
    <mspr:DebtInstrumentExtendedMaturityYear
      contextRef="C_a1020e10-75c6-4d02-b1f3-a22f7c0f5c36"
      id="F_fec88da3-12d5-4b3a-8972-8978905dcbfe">P1Y</mspr:DebtInstrumentExtendedMaturityYear>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_349d4676-24fa-4ed0-8d02-0ac0acbd44a4"
      decimals="-5"
      id="F_38ec8f3c-5dc1-4e42-a0be-ec961aab421e"
      unitRef="U_USD">30000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="C_a20e98f1-f378-4fc2-9d07-1d9c65d339f5"
      decimals="2"
      id="F_7275b831-e84e-48ab-be6a-c1179bc061b9"
      unitRef="U_pure">0.16</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <mspr:PercentageOfAggregateProceedsToPayOutstandingAmount
      contextRef="C_e8640518-f241-41b6-ae14-29e050a44e3f"
      decimals="2"
      id="F_2a3f00ef-68f7-497a-8df1-7b25853136d0"
      unitRef="U_pure">0.50</mspr:PercentageOfAggregateProceedsToPayOutstandingAmount>
    <mspr:PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes
      contextRef="C_e8640518-f241-41b6-ae14-29e050a44e3f"
      decimals="2"
      id="F_a29314fb-573e-42da-8939-56a6a10729bb"
      unitRef="U_pure">0.50</mspr:PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes>
    <mspr:AggregateAmountOutstandingUnderCashProceeds
      contextRef="C_c5742b65-c220-4c54-a9c1-2dcf8313f948"
      decimals="-5"
      id="F_eb384b03-8ccc-49ae-968f-da4a89c5c1a6"
      unitRef="U_USD">4000000</mspr:AggregateAmountOutstandingUnderCashProceeds>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_903ea2ae-ea75-475e-a44b-a70d6056fa63"
      decimals="-5"
      id="F_12a9be84-2c10-4c93-97b2-09357c3aa8a5"
      unitRef="U_USD">250000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <mspr:PercentageOfMandatoryMinimumAmountForAnyAdvance
      contextRef="C_ade22552-6404-4c28-b71c-a1780541b8a5"
      decimals="2"
      id="F_45b64dc3-2561-46ca-993a-914b04d10999"
      unitRef="U_pure">1</mspr:PercentageOfMandatoryMinimumAmountForAnyAdvance>
    <mspr:PercentageOfStockPurchasePrice
      contextRef="C_ade22552-6404-4c28-b71c-a1780541b8a5"
      decimals="2"
      id="F_8be27245-6f26-4c53-956f-e7543ec5012a"
      unitRef="U_pure">0.98</mspr:PercentageOfStockPurchasePrice>
    <mspr:PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice
      contextRef="C_ade22552-6404-4c28-b71c-a1780541b8a5"
      decimals="2"
      id="F_9d868363-d3f6-49c8-be8b-5541fa7cbf15"
      unitRef="U_pure">0.97</mspr:PercentageOfMinimumVwapOfSharesDuringThreeConsecutiveDaysCommencingFromDeliveryOfAdvanceNotice>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_e330bbbd-adcb-4879-b62e-75b820d5a126"
      decimals="-5"
      id="F_516af340-1a83-4747-940c-c3896d7df5c1"
      unitRef="U_USD">15000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_a848591b-1adb-44bc-b891-a50be4491f02"
      decimals="-6"
      id="F_392e82f9-10ad-4cc3-aa04-ca63def9714a"
      unitRef="U_USD">10000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="C_86c39d9b-6f64-4386-b8c0-33b19e6166a7"
      decimals="-4"
      id="F_48338401-3968-48fd-b58b-ae418dae2185"
      unitRef="U_USD">9480000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0acb2411-d354-4e47-8f87-facfc960c807"
      decimals="-5"
      id="F_a40fef93-12cf-45f5-aa71-425ff7660b2e"
      unitRef="U_USD">5000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="C_71aa315c-44f8-4147-b3c3-c4ea2d43f242"
      decimals="-4"
      id="F_49aff1fb-f553-44fa-b038-bd6a4c253025"
      unitRef="U_USD">4750000</us-gaap:ProceedsFromIssuanceOfDebt>
    <mspr:PercentageOfVwapOfSharesDuringPriorDate
      contextRef="C_9a2ac67d-cd44-4f9e-84d7-12c88681d46c"
      decimals="2"
      id="F_92bc3cad-51dc-4306-8e1a-fdffd48559a7"
      unitRef="U_pure">1.20</mspr:PercentageOfVwapOfSharesDuringPriorDate>
    <mspr:PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion
      contextRef="C_9a2ac67d-cd44-4f9e-84d7-12c88681d46c"
      decimals="2"
      id="F_ed503fee-0f5e-42cd-810d-f154cf2cd1fe"
      unitRef="U_pure">0.95</mspr:PercentageOfWAPOfSharesDuringSevenConsecutiveTradingDaysImmediatelyPrecedingTheConversion>
    <mspr:MinimumVariablePricePerShare
      contextRef="C_35dae5c1-7aae-4e29-bd11-991504d30ddb"
      decimals="INF"
      id="F_82d93742-c6b5-403f-9528-fabe72e8c60e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.75</mspr:MinimumVariablePricePerShare>
    <mspr:FixedPricePerShare
      contextRef="C_297dbcdf-6f51-4f4f-9dc8-a5ae170c5102"
      decimals="INF"
      id="F_121d0b29-f890-43cc-84d4-df449222fd18"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">200.5625</mspr:FixedPricePerShare>
    <mspr:FixedPricePerShare
      contextRef="C_b8a984e0-7f94-40c6-bd5c-e7d950cd2591"
      decimals="INF"
      id="F_b6126cac-fc56-4ada-8039-81a2842bf492"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">92.84</mspr:FixedPricePerShare>
    <mspr:FixedPricePerShare
      contextRef="C_df38630e-a571-42c3-ade6-4ab4217b9d08"
      decimals="INF"
      id="F_6279cb65-3f53-48c4-a284-4294c90db7af"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">37.625</mspr:FixedPricePerShare>
    <mspr:PercentageOfAggregateProceedsToPayOutstandingAmount
      contextRef="C_1d7e8bd6-06e5-4825-92f8-4bcc96d6e304"
      decimals="2"
      id="F_fea5d85d-4bea-468f-9405-c90ce54b5a20"
      unitRef="U_pure">0.50</mspr:PercentageOfAggregateProceedsToPayOutstandingAmount>
    <mspr:PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes
      contextRef="C_1d7e8bd6-06e5-4825-92f8-4bcc96d6e304"
      decimals="2"
      id="F_49d079d5-ca34-4d8f-ab2a-5e5f271f484a"
      unitRef="U_pure">0.50</mspr:PercentageOfAggregateProceedsToPayAmountsDueUnderConvertibleNotes>
    <mspr:AggregateAmountOutstandingUnderCashProceeds
      contextRef="C_c5742b65-c220-4c54-a9c1-2dcf8313f948"
      decimals="-5"
      id="F_b42bcd8d-d0d2-4426-b225-4c8abf332a62"
      unitRef="U_USD">4000000</mspr:AggregateAmountOutstandingUnderCashProceeds>
    <mspr:PercentageOfProceedsFromRepaymentOfDebt
      contextRef="C_98ae30fc-b820-4fbe-b5f9-592ed60a472d"
      decimals="2"
      id="F_cf4ac771-09f7-461a-8008-f1f4a6f69495"
      unitRef="U_pure">0.25</mspr:PercentageOfProceedsFromRepaymentOfDebt>
    <mspr:PercentageOfPaymentOfAggregatePurchasePriceOfShares
      contextRef="C_9a2ac67d-cd44-4f9e-84d7-12c88681d46c"
      decimals="4"
      id="F_869b293c-d10d-4062-bcef-6e7ddbe347df"
      unitRef="U_pure">0.0999</mspr:PercentageOfPaymentOfAggregatePurchasePriceOfShares>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="C_9a2ac67d-cd44-4f9e-84d7-12c88681d46c"
      decimals="-5"
      id="F_828f82b0-fce6-49e1-82be-ae113a58d657"
      unitRef="U_USD">1500000</us-gaap:DebtInstrumentPeriodicPayment>
    <mspr:PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest
      contextRef="C_9a2ac67d-cd44-4f9e-84d7-12c88681d46c"
      decimals="3"
      id="F_c2d407e7-d70c-49ac-8b52-78e6480b5d27"
      unitRef="U_pure">0.05</mspr:PercentageOfDebtInstrumentToMonthlyPaymentAlongWithPremiumAndAccruedAndUnpaidInterest>
    <mspr:PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock
      contextRef="C_9a2ac67d-cd44-4f9e-84d7-12c88681d46c"
      decimals="4"
      id="F_8d776b38-4b98-4715-a825-dddbd5a473c4"
      unitRef="U_pure">0.0999</mspr:PercentageOfOwnershipLimitationDoesNotExceedTheExchangeCapOrTheAmountOfSharesOfCommonStock>
    <mspr:PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations
      contextRef="C_35dae5c1-7aae-4e29-bd11-991504d30ddb"
      decimals="-5"
      id="F_73be5f06-4315-474d-a60f-5d927955907d"
      unitRef="U_USD">250000000</mspr:PaymentOfAdvanceForSharesOfCommonStockInEventOfTerminations>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_8df417e8-0685-446e-aae3-3e40048d4ae7"
      decimals="-5"
      id="F_083f3630-7965-40a9-ae53-085cda522f91"
      unitRef="U_USD">13000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_6607a34a-616c-4068-a1b4-1252fffde914"
      decimals="INF"
      id="F_98a26bd2-81d1-49ac-b040-4f435b25af05"
      unitRef="U_shares">1108071</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_cacd009a-fa05-475a-b5fd-20053ae0307f"
      decimals="INF"
      id="F_059c6fd7-14dd-4c12-9e15-de50f5bf77b6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.78</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_61507485-2d9f-40ad-8b7b-fd6cc068d0c8"
      decimals="INF"
      id="F_dbff0342-5cdb-46d2-8b7b-159e18a06e69"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">21.09</us-gaap:SaleOfStockPricePerShare>
    <mspr:ReductionInDebtPrincipalOwing
      contextRef="C_6607a34a-616c-4068-a1b4-1252fffde914"
      decimals="-5"
      id="F_d4b5a1d6-73b2-4130-be0a-efbd5b2fdcde"
      unitRef="U_USD">2800000</mspr:ReductionInDebtPrincipalOwing>
    <mspr:ReductionInInterestAmount
      contextRef="C_6607a34a-616c-4068-a1b4-1252fffde914"
      decimals="-5"
      id="F_6af7094c-3ba2-41db-bb3a-eba3b563b12b"
      unitRef="U_USD">200000</mspr:ReductionInInterestAmount>
    <mspr:PaymentToFundOperations
      contextRef="C_6607a34a-616c-4068-a1b4-1252fffde914"
      decimals="-5"
      id="F_ae31fbf7-7008-4650-94ff-a0244a7d8443"
      unitRef="U_USD">500000</mspr:PaymentToFundOperations>
    <mspr:PaymentToReduceAmountsOwedUnderNomuraNote
      contextRef="C_6607a34a-616c-4068-a1b4-1252fffde914"
      decimals="-5"
      id="F_a0a47917-e7e5-489d-9068-62cfbb5259d8"
      unitRef="U_USD">2600000</mspr:PaymentToReduceAmountsOwedUnderNomuraNote>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_6607a34a-616c-4068-a1b4-1252fffde914"
      decimals="INF"
      id="F_2ccade26-580c-41a0-bc80-c098c5925d9e"
      unitRef="U_shares">2</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <mspr:WarrantLiabilityTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_efcf43d7-b107-43a4-b78c-e6f62f283c62">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 10. WARRANT LIABILITY&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;When the Company issues warrants, it evaluates the proper balance sheet classification of the warrant to determine whether it should be classified as equity or as a derivative liability on the consolidated balance sheets. In accordance with ASC 815-40, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Derivatives and Hedging-Contracts in the Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d; (&#x201c;ASC 815-40&#x201d;), the Company classifies a warrant as equity so long as it is &#x201c;indexed to the Company&#x2019;s equity&#x201d; and several specific conditions for equity classification are met. A warrant is not considered indexed to the Company&#x2019;s equity, in general, when it contains certain types of exercise contingencies or adjustments to the exercise price. If a warrant is not indexed to the Company&#x2019;s own common stock or it has net cash settlement that results in the warrants to be accounted for under ASC 480, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d;, or ASC 815-40, it is classified as a derivative liability which is carried on the consolidated balance sheet at fair value with any changes in its fair value recognized currently in the consolidated statement of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On May 17, 2022, the Company and CF Principal Investments LLC (&#x201c;CF&#x201d;) entered into an agreement for an OTC Equity Prepaid Forward Transaction (the &#x201c;Prepaid Forward&#x201d;). Pursuant to the terms of the Prepaid Forward, CF agreed to, among other things, transfer to MSP for cancellation any New Warrants received as a result of being the stockholder of record of any shares of Class A Common Stock as of the close of business on the closing date of the Business Combination, in connection with the New Warrant Dividend, On January 12, 2024, CF transferred &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;133,291,502&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; New Warrants to the Company, which were canceled upon receipt.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had recognized a warrant liability for the following securities which are convertible into, or allow the purchase of, our Class A Common Stock, including: (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,950,157&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Public Warrants outstanding, each exercisable to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_6dfc678e-53e4-4a49-b837-6bb6cde847d7;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1/625&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;th of one share of our Class A Common Stock (but only exercisable in lots of 625 to purchase whole shares); (ii) the CPIA Warrant, exercisable to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,667&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Class A Common Stock at a purchase price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0625&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share; (iii) the VRM Warrants, of which 10 are exercisable to purchase a total of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,751,339&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Class A Common Stock at a purchase price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share; and (iv) warrants to Virage Recovery Participation, LP, exercisable to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Class A Common Stock at a purchase price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The warrant liability includes the mark-to-market fair value of the warrants discussed above. The fair value of the warrant liability is derived considering the potential shares issuable for each warrant and using the price of the Company&#x2019;s Class A Common Stock as of the most recent balance sheet date, which is a quoted price in active markets.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The table below presents a roll-forward of the warrant liability from &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023 to December 31, 2024:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:55.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:20.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:17.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Warrant Liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;268&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Issuance of warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;159,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of outstanding warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;137,095&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;22,373&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A summary of activity of the shares underlying the warrants from December 31, 2022 through December 31, 2024:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:55.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:19.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:17.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;# of Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;111,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Converted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;590&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;111,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Issued&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,851,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;9,962,727&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;0.0032&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Refer to Note 1, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Description of the Business&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, for discussion of the terms of the Public Warrants and New Warrants, to Note 3,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Material Agreements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, for discussion of the terms of the VRM Warrants, and to Note 9, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Claims Financing Obligations and Notes Payable &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;for discussion of the terms of the CPIA Warrant.&lt;/span&gt;&lt;/p&gt;</mspr:WarrantLiabilityTextBlock>
    <mspr:ClassOfNewWarrantOrRightTransferredDuringPeriod
      contextRef="C_90ec9698-713b-426c-b0bb-0ec128980a66"
      decimals="INF"
      id="F_6e98b6ea-f11b-4620-a77e-542a58983013"
      unitRef="U_shares">133291502</mspr:ClassOfNewWarrantOrRightTransferredDuringPeriod>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_77a7af59-7ae1-4d3d-a7f3-5e0380c71c5d"
      decimals="0"
      id="F_12e2d015-ea89-4e2f-8ef8-0755ad6b3021"
      unitRef="U_shares">2950157</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_aeef635c-511c-48e7-bd31-2303d3add962"
      decimals="0"
      id="F_d8bd6607-be80-43c2-9d38-aeb36de0f151"
      unitRef="U_shares">106667</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_3e8969f2-ae97-4d3c-b1d0-74bbfc712aea"
      decimals="4"
      id="F_decc36c7-2aa8-44c6-b7d4-19d4be086601"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0625</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_998a064a-3957-4126-8109-a66c5f9a5542"
      decimals="0"
      id="F_ddec5226-c13e-4d89-8b42-802a39ae71a8"
      unitRef="U_shares">9751339</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_998a064a-3957-4126-8109-a66c5f9a5542"
      decimals="4"
      id="F_83b748ae-b00f-45d5-8e42-e948320b19c3"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0025</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_4275f40d-714d-47ab-97d1-4eba6db92ac7"
      decimals="0"
      id="F_7a4df70b-26de-4ed8-919f-3a4dc06500a3"
      unitRef="U_shares">100000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_4275f40d-714d-47ab-97d1-4eba6db92ac7"
      decimals="4"
      id="F_c94020a8-e972-4df9-bfd8-26376bf249bd"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0025</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <mspr:ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_240cc23c-0093-4009-ad77-a8139dc62510">&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The table below presents a roll-forward of the warrant liability from &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023 to December 31, 2024:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:55.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:20.68%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:17.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Warrant Liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;268&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Issuance of warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;159,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of outstanding warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;137,095&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td colspan="4" style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;22,373&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</mspr:ScheduleOfRollForwardOfWarrantLiabilityTableTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="C_dc9a1a27-6e49-4cfa-9469-c027ab03a71a"
      decimals="-3"
      id="F_9c0425b8-2009-460a-ba63-cf52b92a13a5"
      unitRef="U_USD">268000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="C_786664b5-9979-4e35-9243-6bdb750f8536"
      decimals="-3"
      id="F_97edf9c4-dcea-4095-8eff-6ff3b2779507"
      unitRef="U_USD">159200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="C_786664b5-9979-4e35-9243-6bdb750f8536"
      decimals="-3"
      id="F_8f13516d-69ec-4823-9f30-7aa9484cbc19"
      unitRef="U_USD">137095000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="C_4cf329ce-5aca-4da4-8888-8728533d3e78"
      decimals="-3"
      id="F_4dff5cd2-c7fa-435e-9f82-62de1207e740"
      unitRef="U_USD">22373000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_6dd00bd4-4d30-41ce-a05e-331750bee466">&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A summary of activity of the shares underlying the warrants from December 31, 2022 through December 31, 2024:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:55.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:19.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:17.02%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;# of Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;111,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Converted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;590&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;111,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Issued&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,851,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;9,962,727&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;0.0032&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_8dbd5799-d76e-43f3-b963-830f8fd31b2e"
      decimals="0"
      id="F_ec45dc93-4745-423d-92db-64a958df9756"
      unitRef="U_shares">111978</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_8dbd5799-d76e-43f3-b963-830f8fd31b2e"
      decimals="4"
      id="F_072487f0-3524-477e-adad-c1a58bb3a172"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0625</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <mspr:ClassOfWarrantConvertedDuringPeriod
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="0"
      id="F_5f988c6d-5d23-438a-9b47-d4a7ece015a1"
      unitRef="U_shares">590</mspr:ClassOfWarrantConvertedDuringPeriod>
    <mspr:ClassOfWarrantsOrRightConvertedExercisePrice
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="4"
      id="F_f8b1a4fd-4285-497c-8009-e2cfec828e14"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0625</mspr:ClassOfWarrantsOrRightConvertedExercisePrice>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="0"
      id="F_1a0c9a45-3dec-4caa-9bc7-a9cafdbfd5c2"
      unitRef="U_shares">111388</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="4"
      id="F_0fa23a7c-6d9d-4e02-9c2a-c3b3476ea00a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0625</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <mspr:ClassOfWarrantOrRightIssuedDuringPeriod
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="0"
      id="F_9c1dd6c0-d534-4c02-a11f-aaa96814f1ba"
      unitRef="U_shares">9851339</mspr:ClassOfWarrantOrRightIssuedDuringPeriod>
    <mspr:ClassOfWarrantsOrRightIssuedExercisePrice
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="4"
      id="F_4485b32d-38f0-4337-948c-fd405f243eea"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0025</mspr:ClassOfWarrantsOrRightIssuedExercisePrice>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="0"
      id="F_96f34709-bc93-422a-a740-cf4ce335cce4"
      unitRef="U_shares">9962727</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="4"
      id="F_9ba48ca1-7c71-4a4a-a9ee-32058631e49e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0032</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_7124f71f-5e6e-44bf-9088-4cdb1f2c80bd">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 11. NONCONTROLLING INTEREST&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The non-controlling interest balance primarily represents the Up-C Units of the Company held by the Members. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the ownership of Units in the Company as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:9pt;font-family:Times New Roman;"&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64.347%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.537%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:19.116%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Ownership Percentage&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Ownership of Class A Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,184,958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Ownership of Class V Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,962,704&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at end of period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,147,662&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The non-controlling interest holders have the right to exchange Up-C Units, at the Company&#x2019;s option, for (i) cash or (ii) one share of Class A Common Stock, subject to the provisions set forth in the LLC Agreement. As such, future exchanges of Up-C Units by non-controlling interest holders will result in a change in ownership and reduce or increase the amount recorded as non-controlling interest and increase or decrease additional paid-in-capital or retained earnings when the Company has positive or negative net assets, respectively. As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Up-C Units had been exchanged into Class A shares.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition to the non-controlling interest related to Up-C Units, the Company also has non-controlling interests related to the Series as noted in Note 8, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Variable Interest Entities&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and MAO-MSO Recovery LLC Series FHCP (&#x201c;FHCP&#x201d;), which is a non-wholly owned subsidiary of MSP Recovery, LLC. In accordance with FHCP&#x2019;s operating agreement, the noncontrolling member is entitled to a preferred return of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per annum (the &#x201c;Preferred Return&#x201d;). Once the Preferred Return has b&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;een met, the noncontrolling member is entitled to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of Claims recoveries by FHCP. The controlling member is allocated &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the costs of FHCP. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Since the Preferred Return exceeds the total members&#x2019; equity of FHCP as of both December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the non-controlling interest also includes $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million representing the entire members&#x2019; equity of FHCP.&lt;/span&gt;&lt;/p&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <mspr:ScheduleOfOwnershipInterestsTableTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_27f4035a-1581-4a83-ba5d-d307ee9a5a2e">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the ownership of Units in the Company as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024:&lt;/span&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64.347%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.537%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:19.116%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Ownership Percentage&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Ownership of Class A Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,184,958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Ownership of Class V Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,962,704&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at end of period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,147,662&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</mspr:ScheduleOfOwnershipInterestsTableTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_ec4285f4-9b93-43aa-ab90-0409cd42c969"
      decimals="INF"
      id="F_d4bf6494-4e5d-4acf-83b7-a5a68e659cda"
      unitRef="U_shares">2184958</us-gaap:CommonStockSharesIssued>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="C_ec4285f4-9b93-43aa-ab90-0409cd42c969"
      decimals="3"
      id="F_b18e6241-54bf-45de-8c31-db5dc3f40528"
      unitRef="U_pure">0.306</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_32b282eb-1b22-41ce-afda-7322605f66e8"
      decimals="INF"
      id="F_45e399bf-7529-45bd-9ac4-59298baf3dea"
      unitRef="U_shares">4962704</us-gaap:CommonStockSharesIssued>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="C_32b282eb-1b22-41ce-afda-7322605f66e8"
      decimals="3"
      id="F_58f60cc0-f3ea-48a7-8887-0d8b0307b09e"
      unitRef="U_pure">0.694</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_4400c0b3-2cd1-40b7-ac05-f868dde9be3a"
      decimals="INF"
      id="F_0dc1a7b4-9872-44e6-89f6-6bffe05e42c9"
      unitRef="U_shares">7147662</us-gaap:CommonStockSharesIssued>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="C_4400c0b3-2cd1-40b7-ac05-f868dde9be3a"
      decimals="3"
      id="F_dd4cb926-0cd7-4a61-9514-5c84d160e947"
      unitRef="U_pure">1</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <mspr:CommonUnitExchangeValue
      contextRef="C_e29473fa-863b-4122-a9a4-eac7411b776e"
      decimals="-5"
      id="F_4b31eeda-bdd9-4589-bdea-4507cb793b79"
      unitRef="U_USD">100000</mspr:CommonUnitExchangeValue>
    <mspr:PercentageOfEntitledPreferredReturnByNonControllingMembers
      contextRef="C_be8b70eb-d4ba-4f20-b375-143fdf4f8fe3"
      decimals="2"
      id="F_51466ba1-06d3-4c45-9d2d-964b3d89ef35"
      unitRef="U_pure">0.20</mspr:PercentageOfEntitledPreferredReturnByNonControllingMembers>
    <mspr:EntitledClaimsRecoverPercentageByNonControllingMembers
      contextRef="C_be8b70eb-d4ba-4f20-b375-143fdf4f8fe3"
      decimals="2"
      id="F_e348c267-f1b5-4d95-90f0-007be47442a8"
      unitRef="U_pure">0.80</mspr:EntitledClaimsRecoverPercentageByNonControllingMembers>
    <mspr:PercentageOfNonControllingMemberAllocatedCost
      contextRef="C_be8b70eb-d4ba-4f20-b375-143fdf4f8fe3"
      decimals="2"
      id="F_cc79e47c-29e9-4b00-a6ed-0a8fa8cfce4e"
      unitRef="U_pure">1</mspr:PercentageOfNonControllingMemberAllocatedCost>
    <us-gaap:MinorityInterest
      contextRef="C_be8b70eb-d4ba-4f20-b375-143fdf4f8fe3"
      decimals="-5"
      id="F_9a65d7d6-a807-4210-8005-7d262cf13286"
      unitRef="U_USD">4400000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="C_87f7ef45-9817-4e4f-b4b2-29e0e91e875b"
      decimals="-5"
      id="F_df11dd7d-0859-4b1b-a9a7-89f2d6d2f73e"
      unitRef="U_USD">4400000</us-gaap:MinorityInterest>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_25a06344-be2c-473f-b56b-704e99e8e51c">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 12. COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is subject to certain legal proceedings, claims, investigations, and administrative proceedings in the ordinary course of its business. The Company records a provision for a liability when it is both probable that the liability has been incurred and the amount of the liability can be reasonably estimated. These provisions, if any, are reviewed and adjusted to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case. Depending on the nature and timing of any such proceedings that may arise, an unfavorable resolution of a matter could materially affect the Company&#x2019;s future results of operations, cash flows or financial position in a particular period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company pursues claims recoveries through settlement, arbitration and legal proceedings. The accounting policy for these activities is discussed under Claims recovery income in Note 2, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A significant majority of the Company&#x2019;s expected recoveries arise from Claims brought pursuant to the private cause of action under the Medicare Secondary Payer Act (&#x201c;MSP Act&#x201d;). This law allows the Company to pursue recoveries against primary payers for reimbursement of medical expenses that the Company&#x2019;s Assignors paid for when primary payers (i.e., liability insurers) were responsible for payment.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Investigations&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On August 11, 2022, the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) initiated an investigation of the Company, and requested documents relating to, among other matters, the Business Combination transaction with Lionheart Acquisition Corporation II consummated on May 23, 2022, certain historical and projected financial results, investor agreements, and data analytic platforms and Algorithms. The Company received a subpoena dated March 1, 2023 from the SEC regarding the aforementioned subject matter, and subsequently received a subpoena on May 10, 2023, in connection with the investigation relating to, among other matters, the Company&#x2019;s projections and the accounting and valuation of certain assets that were the basis for the Company&#x2019;s determination that its quarterly financial statements for the periods ended June 30, 2022 and September 30, 2022 require restatements and should no longer be relied upon, as disclosed in the Company&#x2019;s Form 8-K on April 14, 2023. On August 16, 2023, the Company received an additional subpoena from the SEC regarding certain funding sources of the Company prior to the Business Combination, various statements and disclosures by the Company in connection with, and following, the Business Combination, certain historical and projected financial results, and data analytic platforms and Algorithms used to identify potential recoveries.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, on March 10, 2023, the Company received a subpoena from the U.S. Attorney&#x2019;s Office (&#x201c;USAO&#x201d;) in connection with a grand jury investigation in the U.S. District Court for the Southern District of Florida requesting certain information concerning the Company, which subpoena requests documents relating to, among other matters, the Company&#x2019;s proprietary Algorithms and other software used to identify potentially recoverable claims, the drop in the price of the Company&#x2019;s common stock following the Business Combination, and certain marketing materials and investment agreements presented to potential investors. On July 18, 2024, the Company received an additional subpoena from the USAO, requesting documents related to a Company press release. To the best of the Company&#x2019;s knowledge, the Department of Justice has not issued any target letters to anyone associated with the Company as a result of this investigation. (The United States Attorney&#x2019;s Manual states that a &#x201c;target&#x201d; is a person as to whom the prosecutor or the grand jury has substantial evidence linking him or her to the commission of a crime and who, in the judgment of the prosecutor, is a putative defendant.)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has cooperated, and will continue to cooperate, fully with these inquiries. On April 16, 2023, a special committee of the Board of Directors was formed, which along with external advisors retained thereby, reviewed matters related to the preparation and filing of the 2022 Annual Report on Form 10-K and the subject matter of information requests related to the foregoing subpoenas received prior to June 2023. Based on that review, and the nature of the documents requested in the subsequent subpoena, the Company believes that the investigations will be resolved without any material developments; however, there can be no assurance as to the outcome or future direction thereof.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cano Health, LLC&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 7, 2023, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;318,401&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; unregistered shares of Class A Common Stock &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(after giving effect to the Reverse Split) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to Cano Health, LLC (&#x201c;Cano&#x201d;) as payment for $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;61.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in deferred compensation related to the following agreements, which the Company had the option to pay in cash or in stock and elected to pay in stock, of which (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;129,033&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock were issued as a deferred consideration for the assignment of certain claims pursuant to that certain Purchase Agreement, effective as of September 30, 2022, as amended to date, by and between MSP Recovery and Cano, and (ii) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;189,368&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Common Stock were issued as deferred consideration for the assignment of certain claims pursuant to that certain Amended and Restated Claims Recovery and Assignment Agreement effective as of December 31, 2021, as amended to date, by and between MSP Recovery and Cano.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On August 10, 2023, the Company sued Cano in the Circuit Court of the Eleventh Judicial Circuit in and for Miami-Dade County, Florida for declaratory relief and anticipatory breach of the Cano CCRA, Cano Purchase Agreement, and a Service Agreement (collectively, the &#x201c;Cano Agreements&#x201d;) between the parties. On the same day, Cano sued the Company in the same court, alleging fraud in the inducement, breach of contract, tortious interference, and unjust enrichment relating to the Cano Agreements. The Company has a $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million receivable outstanding from Cano; however, due to Cano&#x2019;s Quarterly Report on Form 10-Q filings for the periods ending June 30, 2023 and September 30, 2023, which include a substantial doubt about Cano&#x2019;s ability to continue as a going concern, and Cano&#x2019;s subsequent filing of voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code on February 4, 2024, the Company established a reserve for the balance due under such receivable during 2023. These matters were automatically stayed as a result of Cano&#x2019;s bankruptcy filing. As of June 28, 2024, the Debtors&#x2019; Plan has been confirmed and declared effective. The automatic stay of litigation has been lifted and the parties anticipate the ongoing litigation to re-commence under a new scheduling order.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On January 4, 2024, Cano sued Simply Healthcare Plans, Inc. (&#x201c;Simply&#x201d;) and the Company and affiliated entities seeking a declaratory judgment to determine whether the Cano Purchase Agreement should be rescinded, and whether Cano or the Company have standing to recover on claims assigned to the Company against Simply under the Cano Purchase Agreement. Cano also seeks damages from Simply relating to the claims assigned to the Company under the Cano Purchase Agreement. Effective March 4, 2025, Cano voluntarily dismissed their case against Simply without prejudice.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company intends to vigorously assert its position in all Cano related litigation.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued
      contextRef="C_d3663b7d-96ee-43d9-aad4-51ec8fb8fe14"
      decimals="INF"
      id="F_1a67efc7-ee82-41d7-b430-5e17940c069f"
      unitRef="U_shares">318401</us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued>
    <us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability
      contextRef="C_c4d052d7-2f78-44e5-bfef-1e0596f96bbb"
      decimals="-5"
      id="F_e83e7e49-eff5-4f0d-a8d6-a1e59b2c7c22"
      unitRef="U_USD">61700000</us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability>
    <us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued
      contextRef="C_936c5ddb-0e12-496d-8f55-6b4fe1ea6f11"
      decimals="INF"
      id="F_39cbce9a-8ee0-4c3d-a963-d168b834b17f"
      unitRef="U_shares">129033</us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued>
    <us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued
      contextRef="C_d91eca92-81d8-4e73-a6df-71357a7bccc1"
      decimals="INF"
      id="F_2b0ab7bb-319f-4659-aaf5-13dc3a1f128e"
      unitRef="U_shares">189368</us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_791e8b5c-e454-490f-af98-b274119fb0c5"
      decimals="-5"
      id="F_6adfd698-2708-4530-a9d4-ee66c72977cf"
      unitRef="U_USD">5000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_d87506d1-7e19-4b59-a62c-787c3ec1541a">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 13. FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has no assets that are measured at fair value on a recurring basis as of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Liabilities measured at fair value on a recurring basis as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023, are summarized as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:47.359%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.441%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.681%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.106%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.441%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.701%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.565%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.441%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.701%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.565%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Level&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Derivative liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,373&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;268&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,584&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;305&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table details the roll-forward of the Level 3 liabilities during the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:74.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:19.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Derivative liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of derivative liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;161&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Issuance of note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the beneficial conversion feature within the Yorkville SEPA is treated as an embedded derivative liability and changes in the fair value were recognized in the change in fair value of warrant and derivative liabilities in the consolidated statements of operations. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The embedded derivative liability was valued at each of the respective issuance dates and at year-end using the following market-based inputs:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:57.563%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.761%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.581%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.587%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.761%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.161%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.587%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Price of Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;56.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Market Risk Spread&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.56&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected Term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.75&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.25&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_7180efaf-82fa-4e90-899e-9de59d3f097f">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Liabilities measured at fair value on a recurring basis as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023, are summarized as follows:&lt;/span&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:47.359%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.441%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.681%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.106%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.441%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.701%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.565%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.441%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.701%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.565%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Level&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Derivative liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrant liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,373&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;268&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,584&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;305&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:DerivativeLiabilities
      contextRef="C_dc851705-b338-480f-8b51-035da6fa3959"
      decimals="-6"
      id="F_74b0c95e-ecbd-4017-98b3-1a20e97252c1"
      unitRef="U_USD">211000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="C_171901d1-c52f-41fe-91df-db360c126e4e"
      decimals="-6"
      id="F_99c5f241-69cb-498c-9055-c6c510bd19c4"
      unitRef="U_USD">37000000</us-gaap:DerivativeLiabilities>
    <mspr:FinancialLiabilitiesFairValueWarrants
      contextRef="C_cb90e83b-7cd0-4ffd-8a4c-cfdf4d8ff256"
      decimals="-6"
      id="F_bc21b7cc-015e-45da-8a4e-6ba583648bba"
      unitRef="U_USD">22373000000</mspr:FinancialLiabilitiesFairValueWarrants>
    <mspr:FinancialLiabilitiesFairValueWarrants
      contextRef="C_1065a761-b9fe-4aae-899f-8f897411b778"
      decimals="-6"
      id="F_c7f97c04-a8b3-499b-bcb0-41e103b9a899"
      unitRef="U_USD">268000000</mspr:FinancialLiabilitiesFairValueWarrants>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_38dbca91-c3fa-4361-8e4e-ad3d415625fe"
      decimals="-6"
      id="F_7a8f389e-b5a7-46c9-8e48-6c1c8ccbc78f"
      unitRef="U_USD">22584000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_0e019663-7988-47f0-9493-92a40c3ae831"
      decimals="-6"
      id="F_1497a238-99b2-4ec7-85b7-07e35ad2656d"
      unitRef="U_USD">305000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_cdbd1b28-163f-4017-ad4c-e0e6def45339">&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table details the roll-forward of the Level 3 liabilities during the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:74.3%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:19.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Derivative liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of derivative liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;161&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Issuance of note&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;211&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="C_c83119b4-f363-422f-942a-c73e79c98c94"
      decimals="-3"
      id="F_cec0e35b-36d9-43af-88e1-d4124dc389c7"
      unitRef="U_USD">37000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="C_9dda51d6-a0f5-455b-8398-c575ec62a1c3"
      decimals="-3"
      id="F_71f27aa5-e0ce-4266-9aeb-38aa1b85fcda"
      unitRef="U_USD">161000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="C_9dda51d6-a0f5-455b-8398-c575ec62a1c3"
      decimals="-3"
      id="F_a230ff63-1aba-4802-855f-d6b3eea8be87"
      unitRef="U_USD">13000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="C_ed1639a1-0034-449c-ad1f-a852134441a4"
      decimals="-3"
      id="F_f7eea90b-5857-44f1-b10c-ee356fd4e419"
      unitRef="U_USD">211000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <mspr:ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_05014204-c4d7-4fb0-9d3a-1bfaa4ba79e5">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The embedded derivative liability was valued at each of the respective issuance dates and at year-end using the following market-based inputs:&lt;/span&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:57.563%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.761%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.581%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.587%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.761%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.161%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.587%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="3" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Price of Common Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;56.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cceeff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Market Risk Spread&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.56&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected Term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.75&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.25&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</mspr:ScheduleOfEmbeddedDerivativeLiabilityValuationAssumptionsTableTextBlock>
    <us-gaap:EmbeddedDerivativeLiabilityMeasurementInput
      contextRef="C_9cad53be-d2bb-4e7e-a24f-2d039319090a"
      decimals="2"
      id="F_7128d925-71d7-458c-ba1d-e47a2f60d769"
      unitRef="U_pure">2.27</us-gaap:EmbeddedDerivativeLiabilityMeasurementInput>
    <us-gaap:EmbeddedDerivativeLiabilityMeasurementInput
      contextRef="C_440a05a3-a996-4acf-b096-ffc25257e6de"
      decimals="2"
      id="F_620aa17f-62e6-4b31-9a6d-ae2f2093c42b"
      unitRef="U_pure">56.75</us-gaap:EmbeddedDerivativeLiabilityMeasurementInput>
    <us-gaap:EmbeddedDerivativeLiabilityMeasurementInput
      contextRef="C_c070ff64-2fdb-45a2-8448-0062a4c61eaf"
      decimals="2"
      id="F_af0f6579-5b8b-4f2c-82ff-3b605f1ca079"
      unitRef="U_pure">0.60</us-gaap:EmbeddedDerivativeLiabilityMeasurementInput>
    <us-gaap:EmbeddedDerivativeLiabilityMeasurementInput
      contextRef="C_d7d3c349-08d9-4eaf-a899-c3399e98c5cb"
      decimals="2"
      id="F_8f0a55d7-ef89-433f-ad84-4e747633cbf9"
      unitRef="U_pure">0.40</us-gaap:EmbeddedDerivativeLiabilityMeasurementInput>
    <us-gaap:EmbeddedDerivativeLiabilityMeasurementInput
      contextRef="C_108cf1ce-e085-4fcf-bec5-40d0b2f1648c"
      decimals="4"
      id="F_626b5ea8-ed10-42b5-9d2c-0b431e5b8b04"
      unitRef="U_pure">0.0956</us-gaap:EmbeddedDerivativeLiabilityMeasurementInput>
    <us-gaap:EmbeddedDerivativeLiabilityMeasurementInput
      contextRef="C_4a8f2f53-79e9-446a-aa64-4ca7f9c8dff2"
      decimals="4"
      id="F_b1159f98-fdf6-4b0d-9edf-6fe6b1ef9a62"
      unitRef="U_pure">0.1237</us-gaap:EmbeddedDerivativeLiabilityMeasurementInput>
    <mspr:EmbeddedDerivativeLiabilitiesMeasurementTerm
      contextRef="C_9fe75ae4-df32-424c-8f99-45879b90c2fd"
      id="F_8aac89bd-f875-4f04-9c7d-5a6f68b2d4c5">P0Y9M</mspr:EmbeddedDerivativeLiabilitiesMeasurementTerm>
    <mspr:EmbeddedDerivativeLiabilitiesMeasurementTerm
      contextRef="C_18297503-8f58-43a0-b62e-2f8147de332e"
      id="F_152e60ff-908a-4dc0-957d-a05d28c77420">P1Y3M</mspr:EmbeddedDerivativeLiabilitiesMeasurementTerm>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_af42b370-447a-49ec-a508-b45361ab81fe">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 14. RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Loans from Related Parties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2022, the Company issued an unsecured promissory note in an aggregate principal amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;112.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (the &#x201c;Promissory Note&#x201d;) to John H. Ruiz and Frank C. Quesada, the Company&#x2019;s Chief Executive Officer and director and Chief Legal Officer and director, respectively (collectively, the &#x201c;MSP Principals&#x201d;), in exchange for the MSP Principals agreeing to provide cash to pay transaction costs related to the Merger, pay down affiliate payable balances, and provide operating cash to the Company. In addition to the amounts in the Promissory Note, at the merger date with LCAP, the MSP Principals contributed $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million through funds that had been loaned to VRM MSP to cover related service fees. The Promissory Note as well as the amount contributed at the merger date bears interest at an annual rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, payable in kind, and will mature on the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;four-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; anniversary of the issuance. The Promissory Note is payable by the Company at any time, without prepayment penalties, fees, or other expenses. The Company recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of interest expense related to the Promissory Note for each of the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A portion of the proceeds under the Promissory Note in an amount equal to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million was advanced to the Law Firm, an affiliate of certain Members, for certain operating expenses pursuant to a legal services agreement. During the three months ended September 30, 2024, the Company amortized all remaining advances to the Law Firm. This amount is reflected in prepaid expenses and other current assets within the consolidated balance sheets and had a balance of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as of December 31, 2024 and 2023, respectively. The advances of Law Firm expenses are reflected in Professional fees - legal within the consolidated statement of operations. The advances are expensed as incurred, as the Company does not have recourse to any amounts incurred should Law Firm fail to secure recoveries, although it does have recourse to any amounts advanced that have not been incurred as an expense.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under the legal services agreement, Company shall advance certain of Law Firm&#x2019;s monthly expenses, including payroll and overhead; however, should Law Firm earn fees under the legal service agreements (the &#x201c;Existing LSAs&#x201d;) noted below, net of pre-existing obligations including payments to co-counsel sufficient to cover its monthly expenses, Company is entitled to reimbursement of the advance of said monthly expenses. Further, to the extent that Law Firm earns a surplus of fees in excess of its monthly expenses, said surplus shall be used to reimburse past amounts of Law Firm&#x2019;s monthly expenses that Company advanced. For the years ended December 31, 2024 and 2023, approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, of the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million advanced by the Company to the Law Firm has been incurred for expenses pursuant to the legal services agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Founders&#x2019; Pledge - Claims Proceeds Investment Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As disclosed in Note 9,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Claims Financing Obligations and Notes Payable &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to the consolidated financial statements, the Founders pledged &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; thousand shares to secure payment of the original principal amount of the CPIA.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Legal Services &#x2013; Law Firm&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain Company entities have previously entered into the Existing LSAs with the Law Firm, an affiliate of certain Members, for the recovery of Claims. Pursuant to the terms of the Existing LSAs, the Law Firm provides the Company with investigation, case management, research and legal services in the pursuit of recovery of Claims in exchange for a portion of the recovered proceeds relating to such Claims. The Existing LSAs also provide that the Law Firm serves as lead counsel or co-lead counsel for any litigation relating to such Claims.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, the Company has a payable to the Law Firm amounting to &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. For the years ended December 31, 2024 and 2023, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, was included in Professional fees - legal for expenses related to the Law Firm in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, during fiscal year 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company issued an unsecured promissory note in an aggregate principal amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.95&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to the Law Firm, to provide general operational funding (the &#x201c;Law Firm Loan&#x201d;). The aggregate unpaid principal amount of this promissory note is due &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; months from the date of the last advance from the Second Amended and Restated First Lien Credit Agreement is made. This promissory note does not carry interest and is payable by the Company at any time, without prepayment penalties, fees, or other expenses. On March 4, 2024, the Board authorized the partial repayment of the Law Firm Loan in the amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which funds were to be used for the express purpose of paying property taxes on real property owned and pledged by the MSP Principals to HPH as collateral in connection with the Working Capital Credit Facility.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the years ended December 31, 2024 and 2023, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, were included in cost of Claims recoveries for expenses related to the Law Firm in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Law Firm may also collect and/or hold cash on behalf of the Company in the ordinary course of business. As of December 31, 2024 and 2023, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, was due from the Law Firm and included in the consolidated balance sheets in Affiliate Receivable. In addition, the Company rents office space from the Law Firm.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;MSP Recovery Aviation, LLC&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company may make payments related to operational expenses on behalf of its affiliate, MSP Recovery Aviation, LLC (&#x201c;MSP Aviation&#x201d;). The Company has made payments in the periods of the financial statements only related to specifically billed flights. As of both December 31, 2024 and 2023, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was due from MSP Aviation and included in the consolidated balance sheets in Affiliate Receivable. For the years ended December 31, 2024 and 2023, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, was included in General and Administrative expenses related to MSP Aviation in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Funds Held for Other Entities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company may collect and/or hold cash on behalf of its affiliates in the ordinary course of business. As of both December 31, 2024 and 2023, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was due to affiliates of the Company and included in the consolidated balance sheets in Affiliate Payable. These amounts were primarily due to Series MRCS, and will be repaid either through excess cash flows from operations or other financing. During the year ended December 31, 2021, the Company also entered into a note payable with Series MRCS as outlined in Note 6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;, Intangible Assets, Net&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. As of both December 31, 2024 and 2023, the balance of the note payable was&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and included in the consolidated balance sheets in Claims financing obligation and notes payable.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, there were additional receivables from other affiliates of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. These were included in the consolidated balance sheets in Affiliate Receivable.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;VRM MSP&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company concluded that VRM MSP is a related party due to ownership interests in the entity held by the MSP Recovery and Series MRCS. For the year ended December 31, 2024, the Company recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;188.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;124.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for interest expense related to the VRM Full Return and Virage MTA Amendment, and for the year ended December 31, 2023, the Company recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;156.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for interest expense related to the VRM Full Return and Virage MTA Amendment, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Virage&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As discussed in Note 3, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Material Agreements &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to the consolidated financial statements, the Initial Virage Warrant, as amended, was issued effective January 1, 2024. Until our obligations to Virage are paid in full, the Company has the option every month to continue to pay Virage in one or a combination of: (a) cash, in an amount equal to 1.0% of each calendar month-end balance (which month-end balance shall be increased daily up to 20% per annum based on a formula set forth in the Virage MTA Amendment) of the amount owing to Virage as of each preceding calendar month end and/or (b) the issuance of subsequent Monthly Virage Warrants.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Refer to Note 3, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Material Agreements &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to the consolidated financial statements, for the listing of warrants issued during the year ended December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to purchase agreements dated March 4, 2024 and August 22, 2024, and as disclosed on Form 4 filings by Mr. John H. Ruiz, the Company&#x2019;s Chief Executive Officer, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,544&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,425&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, of unregistered shares of Class A Common Stock to Virage in satisfaction of certain obligations of the Company, which shares were subsequently purchased from Virage by Mr. Ruiz.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Founder&#x2019;s Up-C Units &#x2013; VRM Full Return&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As disclosed in Note 3, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Material Agreements &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to the consolidated financial statements, in connection with the MTA Amendment, the Company agreed to pay Virage an amount equal to the contributions by Virage to VRM MSP plus an annual rate of return of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% (the &#x201c;VRM Full Return&#x201d;). Pursuant to the terms of the agreement with Virage, such amount may be payable by a sale of certain reserved shares of Messrs. John H. Ruiz and Frank C. Quesada, and the delivery of the resulting net cash proceeds thereof to VRM.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Working Capital Credit Facility Collateral&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to the Second Amended and Restated First Lien Credit Agreement, and in order to secure those additional advances of Term Loan B beginning in January 2024, the Company approved for Messrs. John H. Ruiz and Frank C. Quesada to provide, as additional collateral, the following: (i) a pledge of the equity interests in an Affiliate of Messrs. John H. Ruiz and Frank C. Quesada; (ii) a mortgage on real property owned by an Affiliate of Messrs. John H. Ruiz and Frank C. Quesada, and (iii) a personal guaranty by Messrs. John H. Ruiz and Frank C. Quesada, as primary obligors, guaranteeing those additional advances of Term Loan B beginning in January 2024. On December 22, 2023, our Board approved the Company's payment of certain costs and fees (including legal fees) on behalf of John H. Ruiz and Frank C. Quesada, associated with the mortgage granted in connection with said guaranty, totaling $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. On March 4, 2024, the Board authorized the partial repayment of the Law Firm Loan in the amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which funds were to be used for the express purpose of paying property taxes on real property owned and pledged by the MSP Principals to HPH as collateral in connection with the Working Capital Credit Facility.&lt;/span&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_ef3df522-36ab-46ff-ba3a-3539524a7ffe"
      decimals="-5"
      id="F_f3dba98f-9815-477a-8ef7-422b44f88493"
      unitRef="U_USD">112800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0056d899-051b-43a5-b6bd-b84abe56a57e"
      decimals="-5"
      id="F_8d76245f-96e3-4c79-ac59-6231e8dafbdd"
      unitRef="U_USD">13000000</us-gaap:DebtInstrumentFaceAmount>
    <mspr:DebtInstrumentPaymentInKindAnnualInterestRate
      contextRef="C_ef3df522-36ab-46ff-ba3a-3539524a7ffe"
      decimals="2"
      id="F_9c9d19ac-73b1-4a24-8d64-48279c2e2e3a"
      unitRef="U_pure">0.04</mspr:DebtInstrumentPaymentInKindAnnualInterestRate>
    <us-gaap:DebtInstrumentTerm
      contextRef="C_bf775bb4-df03-4ad8-b1ef-bfc5c2f6dc53"
      id="F_ff0a7a37-522c-4c6b-b366-1cf9aec9dcd8">P4Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:InterestExpense
      contextRef="C_3190b9d6-2f05-4406-add2-4c8346e46faf"
      decimals="-5"
      id="F_e3a9bdb5-984b-4b3b-83ec-b77d425ec4e9"
      unitRef="U_USD">5000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_7fafbd14-3e05-4ab0-b8db-3c7d640f612b"
      decimals="-5"
      id="F_d8cd389c-3efe-40fc-8bfd-5ab4f606dc75"
      unitRef="U_USD">5000000</us-gaap:InterestExpense>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="C_f861f31f-886c-4e73-9be4-15fe686df5d1"
      decimals="-5"
      id="F_a4e38b9b-c75f-4736-a7f5-2185f66253fe"
      unitRef="U_USD">36500000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_2430ad04-c84e-49df-bcbe-0fa2ab3fc260"
      decimals="-6"
      id="F_3f6add1b-6582-4d9d-b378-1f221ee4c641"
      unitRef="U_USD">0</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_c8abebaf-3c7e-4eab-8f91-5ad82e71af2b"
      decimals="-5"
      id="F_0007e669-e265-47d8-8745-c9789af7bc84"
      unitRef="U_USD">7700000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <mspr:AdvancePaymentIncurredForExpenses
      contextRef="C_747655f3-412e-461f-8786-a873c027b7d0"
      decimals="-5"
      id="F_d2f5c13e-b95d-46c2-961b-231f26d6a5f4"
      unitRef="U_USD">7700000</mspr:AdvancePaymentIncurredForExpenses>
    <mspr:AdvancePaymentIncurredForExpenses
      contextRef="C_57d602bd-2d0a-4e61-888a-2ec5eb79b28f"
      decimals="-5"
      id="F_e9c0895a-9fe5-4d7a-a6b6-97aaa31f52aa"
      unitRef="U_USD">19200000</mspr:AdvancePaymentIncurredForExpenses>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="C_f861f31f-886c-4e73-9be4-15fe686df5d1"
      decimals="-5"
      id="F_7a178293-d82c-4ff8-ad93-18286e0fb969"
      unitRef="U_USD">36500000</us-gaap:ProceedsFromNotesPayable>
    <mspr:SharesPledgedUnderAgreement
      contextRef="C_e47e8e78-3f7a-483f-be52-5d827c62b8cf"
      decimals="-3"
      id="F_4e57ad81-6a64-429e-acdc-e7d339ef0e52"
      unitRef="U_shares">80000</mspr:SharesPledgedUnderAgreement>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_5252ca49-cd7d-42f1-90d0-31e55fce0385"
      decimals="-5"
      id="F_7aaa9c4f-7d33-4f38-9eae-392c4431a815"
      unitRef="U_USD">1800000</us-gaap:OtherLiabilitiesCurrent>
    <mspr:OperatingCostsAndExpenses1
      contextRef="C_92683e84-cc53-487c-a7c4-f4dbdc1db394"
      decimals="-5"
      id="F_6f109ca4-4593-41f3-90d9-d08840d94f43"
      unitRef="U_USD">7700000</mspr:OperatingCostsAndExpenses1>
    <mspr:OperatingCostsAndExpenses1
      contextRef="C_065c4f1b-82bd-4f57-8208-a41a3b157055"
      decimals="-5"
      id="F_dab5ac58-9d5c-416f-be79-90d0fb7cf4ed"
      unitRef="U_USD">19200000</mspr:OperatingCostsAndExpenses1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_9269574f-8058-4390-81dd-e7ec4e7ed960"
      decimals="-4"
      id="F_4d797262-fcf1-4a04-869f-e19e798d891e"
      unitRef="U_USD">4950000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentTerm
      contextRef="C_b1695415-e4a5-4136-8a0b-0977ddf9fef4"
      id="F_947529ac-7d14-40f1-84e7-e08f738543da">P24M</us-gaap:DebtInstrumentTerm>
    <mspr:PartialRepaymentOfDebt
      contextRef="C_d1561d98-416b-4bbe-bf56-1bedb1ab84d5"
      decimals="-5"
      id="F_42786803-1aa1-4ba6-bb5b-2a2a1a09ffcf"
      unitRef="U_USD">400000</mspr:PartialRepaymentOfDebt>
    <mspr:OperatingCostsAndExpenses1
      contextRef="C_b40da480-7051-433e-99a9-7c5f5dd5ea4b"
      decimals="-5"
      id="F_c0fd61de-6c7c-428f-b202-3f4b1bf35db8"
      unitRef="U_USD">3400000</mspr:OperatingCostsAndExpenses1>
    <mspr:OperatingCostsAndExpenses1
      contextRef="C_b3db7d99-631c-4482-beca-74fc892d1e93"
      decimals="-5"
      id="F_e5e62d9a-0c60-45ff-9e8f-e2d955c33862"
      unitRef="U_USD">300000</mspr:OperatingCostsAndExpenses1>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_2f3b6385-dd5e-478a-98d6-86c7576434f0"
      decimals="-5"
      id="F_2b48cf71-2ec0-46a4-8b4e-238993fe7139"
      unitRef="U_USD">800000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_f0fc5e6c-97d0-40e9-841d-33b02270183d"
      decimals="-5"
      id="F_fd5b0a86-ce6a-40d6-99ac-c70f70418a2c"
      unitRef="U_USD">800000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_ecb1b45b-fbaa-4bf2-92d9-318171959c6a"
      decimals="-5"
      id="F_2ae13e08-2aeb-400a-a350-3e1a9398fd05"
      unitRef="U_USD">200000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_24ac4204-0641-451a-87a3-70ba142b0f90"
      decimals="-5"
      id="F_309ce0a3-adfe-4caf-a179-cb1a036678da"
      unitRef="U_USD">200000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="C_57297e08-daf9-4ea8-9f0a-e30feb80ee20"
      decimals="-5"
      id="F_c5b47643-15cc-49f7-a754-872cad109f72"
      unitRef="U_USD">200000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="C_66a14f4e-f9d4-4b7a-8ceb-e5a34a3dad44"
      decimals="-5"
      id="F_bda61174-14a3-4157-b044-b3c577b4f17a"
      unitRef="U_USD">200000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_83481840-3ca0-4d32-ba67-06de37b1459f"
      decimals="-5"
      id="F_ca6dc896-1940-4787-9d30-223d30d1f434"
      unitRef="U_USD">19800000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_c8ac68ca-b4ac-40c0-8ee5-21c155beaa2e"
      decimals="-5"
      id="F_ba1325de-3320-4992-92a5-ba33f83221e8"
      unitRef="U_USD">19800000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="C_c1e89a5f-129c-4943-a1a7-f314ec636657"
      decimals="-5"
      id="F_74c3f7c6-2aeb-49c4-841f-2c080e79e01f"
      unitRef="U_USD">500000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="C_9c92dc8a-3a85-4931-89ec-6e28019c163f"
      decimals="-5"
      id="F_0f17969f-0d75-469b-9b4e-b91f5f18d42e"
      unitRef="U_USD">500000</us-gaap:LongTermNotesPayable>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_7ec4a520-4502-411f-9714-8faecac859f6"
      decimals="-5"
      id="F_94d92676-c9a8-4205-9253-5497d251cbc2"
      unitRef="U_USD">200000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_1590504a-c1dc-4f29-92cb-3b6c727c0ce3"
      decimals="-5"
      id="F_6fec9d4f-ecab-40f7-b213-4853322be3c3"
      unitRef="U_USD">200000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:InterestExpense
      contextRef="C_7b14a4eb-0fed-4c10-be9c-613f3475755b"
      decimals="-5"
      id="F_8860abda-2f54-4f19-95ad-1a3f2261ff0a"
      unitRef="U_USD">188000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_3d4f1e16-3314-456a-9834-b6faa08ca709"
      decimals="-5"
      id="F_003fbced-c82f-4621-a760-b783bbb82cc7"
      unitRef="U_USD">124700000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_be1531d0-0b2e-4de3-957e-6199271373d6"
      decimals="-5"
      id="F_128d68aa-fa20-46ab-8233-b669ab9f47c7"
      unitRef="U_USD">156200000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_61e6579c-7403-4590-b421-ac4ffdad7513"
      decimals="-5"
      id="F_07c5b987-28bf-4adf-9ca6-d76d37bef480"
      unitRef="U_USD">65300000</us-gaap:InterestExpense>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_dbbed700-6dd7-4ab4-a4d1-5d2840f9852a"
      decimals="0"
      id="F_fecc0c97-699f-4eb4-90a9-bb96d25bc7f6"
      unitRef="U_shares">17544</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_e3728ea4-48fd-4ffc-a2ed-312c25de71eb"
      decimals="0"
      id="F_e31408bd-fe8d-4c61-a732-65a192fa5d63"
      unitRef="U_shares">14425</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <mspr:AnnualCompoundedReturnOnContributionPercentage
      contextRef="C_9f0551af-5ff4-4726-988b-01f1ae60bf7d"
      decimals="2"
      id="F_e49829ee-8f0a-42d1-9417-54244331c830"
      unitRef="U_pure">0.20</mspr:AnnualCompoundedReturnOnContributionPercentage>
    <mspr:PaymentOfCertainCostsAndFees
      contextRef="C_cf6558a6-9d3c-4663-9640-79620d1887bc"
      decimals="-5"
      id="F_567c67da-7e28-4a6c-a3e2-4db3d42ea124"
      unitRef="U_USD">100000</mspr:PaymentOfCertainCostsAndFees>
    <mspr:PartialRepaymentOfDebt
      contextRef="C_d1561d98-416b-4bbe-bf56-1bedb1ab84d5"
      decimals="-5"
      id="F_3afa240d-3a74-4201-b956-b954c5bf0b09"
      unitRef="U_USD">400000</mspr:PartialRepaymentOfDebt>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_edcbda42-9549-460f-818a-74449180df80">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 15. SEGMENT INFORMATION&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments are defined as components of an entity for which separate financial information is available and regularly reviewed by the chief operating decision maker (&#x201c;CODM&#x201d;). The Company manages its operations, as described in Note 1, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Description of the Business&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, as a single reportable segment for the purposes of assessing performance and making decisions. The accounting policies of the reportable segment are those included in this Note 2, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company&#x2019;s CODM is its &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_abbe20fe-8830-4413-8cd7-922975cc36b9;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Chief Executive Officer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has determined that it operates in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; operating segment and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reportable segment, as the CODM reviews financial information presented on a consolidated basis, using the operating expenses and interest expense, as presented on the face of the income statement, for purposes of making operating decisions, allocating resources, and evaluating financial performance.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The measure of segment assets is reported on the consolidated balance sheet as total consolidated assets. In addition, all of the Company&#x2019;s revenues and long-lived assets are attributable primarily to operations in the United States and Puerto Rico for all periods presented.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant expenses regularly provided to the CODM are Claims Amortization Expense, Interest Expense, General &amp;amp; Administrative, and Professional Fees as reported on the face of the income statement. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The table below presents the Company&#x2019;s significant segment expenses and a reconciliation of Significant Segment expenses and other segment items to Net Loss, the CODM&#x2019;s primary measure of performance:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:9pt;font-family:Times New Roman;"&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:65.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total Revenues&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,249&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,705&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Significant Expenses:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Claims amortization expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;484,076&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;476,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,231&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,131&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,766&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Professional fees &#x2013; legal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,519&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;34,401&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Impairment of intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;752,697&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;420,032&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,169&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Significant Expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,702,686&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;849,336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other Segment Items (1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;127,592&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;1,556,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;835,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(1)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Includes Cost of revenues, Allowance for credit losses, Depreciation and amortization, Change in fair value of warrant and derivative liabilities, and Other income (expense), net, as reported in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingExpenseInformationUsedByCodmDescription
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_6b88191d-f40d-4764-9bc5-b2813148e90c">The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis, using the operating expenses and interest expense, as presented on the face of the income statement, for purposes of making operating decisions, allocating resources, and evaluating financial performance.</us-gaap:SegmentReportingExpenseInformationUsedByCodmDescription>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="INF"
      id="F_774c616a-6e79-46ac-9591-c38dacf88157"
      unitRef="U_Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="INF"
      id="F_d74de64f-7cae-4888-80db-4a11405293db"
      unitRef="U_Segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_1ec21296-09be-4ee6-a424-ef5a28c73e13">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The table below presents the Company&#x2019;s significant segment expenses and a reconciliation of Significant Segment expenses and other segment items to Net Loss, the CODM&#x2019;s primary measure of performance:&lt;/span&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:65.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:14.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total Revenues&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,249&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,705&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Significant Expenses:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Claims amortization expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;484,076&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;476,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,231&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,508&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,131&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,766&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Professional fees &#x2013; legal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,519&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;34,401&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Impairment of intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;752,697&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;420,032&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;289,169&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Significant Expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,702,686&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;849,336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other Segment Items (1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;127,592&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net Loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;1,556,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;835,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(1)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Includes Cost of revenues, Allowance for credit losses, Depreciation and amortization, Change in fair value of warrant and derivative liabilities, and Other income (expense), net, as reported in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <mspr:TotalClaimsRecovery
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_375d5ef2-f8ee-4bfe-8322-21ea1de1e929"
      unitRef="U_USD">18249000</mspr:TotalClaimsRecovery>
    <mspr:TotalClaimsRecovery
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_df2538fc-1c86-4a16-b51d-a722f7c73394"
      unitRef="U_USD">7705000</mspr:TotalClaimsRecovery>
    <mspr:ClaimsAmortizationExpense
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_5565d19f-7d71-44ed-a427-474f5f0106aa"
      unitRef="U_USD">484076000</mspr:ClaimsAmortizationExpense>
    <mspr:ClaimsAmortizationExpense
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_72bcf323-9df6-450b-bdc3-93fdaa77c32c"
      unitRef="U_USD">476492000</mspr:ClaimsAmortizationExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_ca1a0ed3-e4f8-4efe-a22a-6a6a01f0b139"
      unitRef="U_USD">22231000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_e0e480b3-f6e9-4d89-92c4-02cea1825e95"
      unitRef="U_USD">26508000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ProfessionalFees
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_c1047646-2664-482b-961c-ae6425196c2e"
      unitRef="U_USD">14131000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_70816971-00f3-414b-be38-f2c3957528cd"
      unitRef="U_USD">22766000</us-gaap:ProfessionalFees>
    <us-gaap:LegalFees
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_8283251e-e531-4c4d-928b-52d3e8988d93"
      unitRef="U_USD">9519000</us-gaap:LegalFees>
    <us-gaap:LegalFees
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_f53b3e4c-6410-4913-94b5-25f717171e55"
      unitRef="U_USD">34401000</us-gaap:LegalFees>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_0a54cdf2-68e1-4c47-8b7a-df26a23949e8"
      unitRef="U_USD">752697000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:InterestExpense
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_4fb56340-ad75-46c3-97de-c16302b9b7f0"
      unitRef="U_USD">420032000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_5ce5249f-5b6c-4f58-8f40-b5ee68e4de56"
      unitRef="U_USD">289169000</us-gaap:InterestExpense>
    <mspr:SignificantExpenses
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_8862fc78-066f-45cf-a4f6-85cc7bb6f0e2"
      unitRef="U_USD">1702686000</mspr:SignificantExpenses>
    <mspr:SignificantExpenses
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_47c43b89-8ae1-49f0-bb04-fcbc7f74d97f"
      unitRef="U_USD">849336000</mspr:SignificantExpenses>
    <us-gaap:SegmentReportingOtherItemAmount
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_dff60589-bc3a-46a2-b9d3-b986d22eeb78"
      unitRef="U_USD">-127592000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_51d18894-4a00-48af-9882-6574aff6e215"
      unitRef="U_USD">-6486000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:ProfitLoss
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_2aed189d-63ba-4872-a0b6-f3d918294f8d"
      unitRef="U_USD">-1556845000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_277361e9-53e9-476e-95df-a70ac5044b06"
      unitRef="U_USD">-835145000</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_93d47858-57cb-409a-bf28-a69abf4695d0">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 16. N&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ET LOSS PER COMMON SHARE&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic earnings per share of Class A common stock is computed by dividing net income attributable to common shareholders by the weighted-average number of shares of Class A common stock outstanding during the period. Diluted earnings per share of Class A common stock is computed by dividing net income attributable to common shareholders adjusted for the assumed exchange of all potentially dilutive securities, by the weighted-average number of shares of Class A common stock outstanding adjusted to give effect to potentially dilutive elements. Diluted loss per share for all period presented is the same as basic loss per share as the inclusion of the potentially issuable shares would be anti-dilutive.
&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table sets forth the computation of basic and diluted earnings per share of Class A common stock:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.587%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.317%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.317%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(In thousands, except share and per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Numerator - basic and diluted:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,556,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;835,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: Net loss attributable to the non-controlling interests&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,196,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;778,797&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss attributable to MSP Recovery, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;360,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;56,348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Denominator &#x2013; basic and diluted:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares of Class A common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,001,525&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;356,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares of Class A common stock outstanding &#x2013; dilutive&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,001,525&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;356,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Earnings per share of Class A common stock &#x2013; basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;359.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;158.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Earnings per share of Class A common stock &#x2013; diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;359.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;158.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Shares of the Company&#x2019;s Class V common stock do not participate in the earnings or losses of the Company and are therefore not participating securities. As such, separate presentation of basic and diluted earnings per share of Class V common stock under the two-class method has not been presented.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In the calculation for earnings per share for the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company excluded from the calculation of diluted earnings per share &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,962,704&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Class V common stock, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,950,157&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Public Warrants outstanding, the CPIA Warrant exercisable for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,667&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Class A Common Stock, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;894,754,824&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; New Warrants outstanding and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,851,339&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; warrants issued to Virage, as their effect would have been anti-dilutive.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In the calculation for earnings per share for the year ended December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company excluded from the calculation of diluted earnings per share &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,965,296&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Class V common stock, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,950,157&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Public Warrants outstanding, the CPIA Warrant exercisable for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,667&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Class A Common Stock, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;894,754,824&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; New Warrants outstanding because their effect would have been anti-dilutive.&lt;/span&gt;&lt;/p&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_dbf74cb8-d272-49e1-ae85-40e2fa149b56">&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table sets forth the computation of basic and diluted earnings per share of Class A common stock:&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:63.587%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.317%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.78%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.317%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(In thousands, except share and per share data)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Numerator - basic and diluted:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,556,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;835,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: Net loss attributable to the non-controlling interests&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,196,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;778,797&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss attributable to MSP Recovery, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;360,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;56,348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Denominator &#x2013; basic and diluted:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares of Class A common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,001,525&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;356,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average shares of Class A common stock outstanding &#x2013; dilutive&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,001,525&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;356,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Earnings per share of Class A common stock &#x2013; basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;359.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;158.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Earnings per share of Class A common stock &#x2013; diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;359.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;158.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_e5ef4efb-b5d8-4ec6-8710-cce029971c1f"
      unitRef="U_USD">-1556845000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_3066991a-69f8-48cf-899a-ee3cc88cd81e"
      unitRef="U_USD">-835145000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_25076080-1974-4465-9392-bd342016497d"
      unitRef="U_USD">-1196346000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_3b4300c2-147b-4cd8-9e92-ad935cafccdc"
      unitRef="U_USD">-778797000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="-3"
      id="F_a13837fc-f8be-404c-957f-6c80a5f221a9"
      unitRef="U_USD">-360499000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="-3"
      id="F_625e740d-4c0c-4af2-8d63-2b067fcf2c6f"
      unitRef="U_USD">-56348000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="0"
      id="F_2960f945-71a3-4ad0-b244-f5117f736af6"
      unitRef="U_shares">1001525</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="0"
      id="F_6df5c2c2-4e58-4050-a166-3739759d6bf2"
      unitRef="U_shares">356591</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="0"
      id="F_bcd9e6a5-be9b-4ce5-b880-1b33992f7601"
      unitRef="U_shares">1001525</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="0"
      id="F_d9c0117d-ec81-49f1-bfc0-fa8438d5ac58"
      unitRef="U_shares">356591</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="2"
      id="F_8641101b-76af-4954-b4c9-b58585cda6bd"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-359.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="2"
      id="F_149448c5-9dc1-4a84-93e0-b95d869a8f4a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-158.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      decimals="2"
      id="F_b0c9f18d-86b6-4688-9e4a-cb964c31b92e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-359.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_e08e59d5-f389-4d0e-a508-50ce01da96aa"
      decimals="2"
      id="F_18eee7e8-469e-41a5-bba7-7ac0c9072283"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-158.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_d60db90f-4a37-413a-9383-5f9638a7dac4"
      decimals="0"
      id="F_4dd4a197-24cc-4be7-92c4-3b58664949e6"
      unitRef="U_shares">4962704</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_cc1f9003-7531-46fc-b9f5-b111a3ad3adf"
      decimals="0"
      id="F_b484b591-9df5-4bbe-a295-6a4cce38b7d5"
      unitRef="U_shares">2950157</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_34c224df-e4d4-4363-a01b-1fcb9b2acaa2"
      decimals="0"
      id="F_49045f5c-cc6b-45a1-b83b-65c415693907"
      unitRef="U_shares">106667</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_909336c6-c224-484c-94a5-23ceb49463c4"
      decimals="0"
      id="F_6cbc4c8e-7052-442d-950b-47ef59d58540"
      unitRef="U_shares">894754824</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_12cd0c5c-e9e0-4c6d-873d-d9f0a4031377"
      decimals="0"
      id="F_32f084cf-1b1c-4f56-8ddf-422d8f51feac"
      unitRef="U_shares">9851339</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0d6f7737-1475-425e-8764-bcd96bc150b3"
      decimals="0"
      id="F_8890c9c5-edc3-4016-b620-4417b5512f05"
      unitRef="U_shares">4965296</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_fc6dbd33-7019-4991-ae2a-4323861f1f73"
      decimals="0"
      id="F_1e6eb46b-9631-4a99-bb07-9fa107fa9258"
      unitRef="U_shares">2950157</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_07df6a83-0af1-46c6-adcf-ff855b251aa5"
      decimals="0"
      id="F_fec875d8-7861-4dfc-a033-1305f6112585"
      unitRef="U_shares">106667</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_3f1e810b-70ff-4880-b849-ee3f4452b2d0"
      decimals="0"
      id="F_42a43462-dd17-4749-ba8f-3e83e8c51dda"
      unitRef="U_shares">894754824</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_40d6c5cf-7469-4c5b-97da-8c5b867319a1">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 17. DERIVATIVE LIABILITY&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For purposes of determining whether certain instruments are derivatives for accounting treatment, the Company follows the accounting standard that provides guidance for determining whether an equity-linked financial instrument, or embedded feature, is indexed to an entity&#x2019;s own stock. The standard applies to any freestanding financial instruments or embedded features that have the characteristics of a derivative, and to any freestanding financial instruments that are potentially settled in an entity&#x2019;s own common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Yorkville SEPA&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As disclosed previously, the beneficial conversion feature within the Yorkville SEPA is treated as an embedded derivative liability and changes in the fair value are recognized in the change in fair value of warrant and derivative liabilities in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, the derivative liability associated with the beneficial conversion feature within the Yorkville SEPA amounted to &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.0 thousand&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Refer to Note 9,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Claims Financing Obligations and Notes Payable&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for additional information on the Yorkville SEPA and Note 13, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for fair value measurements disclosures related to the embedded derivative in the Yorkville SEPA.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;OTC Equity Prepaid Forward Transaction&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company and CF entered into an agreement for an OTC Equity Prepaid Forward Transaction (the &#x201c;Transaction&#x201d;). Pursuant to the terms of the Transaction, CF agreed to (a) transfer to the Company for cancellation any warrants to purchase shares received as a result of being the stockholder of record of a share as of the close of business on the closing date of the Business Combination, pursuant to the previously announced and declared LCAP dividend and (b) waive any redemption right that would require the redemption of the Subject Shares (as defined below) in exchange for a pro rata amount of the funds held in LCAP&#x2019;s trust account.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At closing of the Business Combination, the Company transferred from the trust account to an escrow account an amount equal to (a) the aggregate number of such Subject Shares (approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; thousand shares), multiplied by (b) the per share redemption price for shares out of the trust account, as a prepayment to CF of the amount to be paid to CF in settlement of the Transaction for the number of shares owned by CF at the closing of the Business Combination (the &#x201c;FEF Shares&#x201d;). CF may sell the Subject Shares at its sole discretion in one or more transactions, publicly or privately. Any such sale shall constitute an optional early termination of the Transaction upon which (a) CF will receive from the escrow account an amount equal to the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;positive excess, if any, of (x) the product of the redemption price and the aggregate number of shares over (y) an amount equal to the proceeds received by CF in connection with sales of the shares, and (b) the Company will receive from the escrow account the amount set forth in (y) above.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company concluded that the instrument includes an embedded derivative for the change in value of the Company&#x2019;s Class A common stock and as such, at the end of each period the Company will mark to market the shares through booking a derivative liability/asset. The calculation of the derivative liability/asset would be the difference between the restricted cash and current fair value of the outstanding FEF shares (number of FEF shares multiplied by market price of the Company&#x2019;s Class A common stock as of period end).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On January 6, 2023, the Company and CF entered into an Omnibus Fee Amendment Agreement (&#x201c;Fee Amendment Agreement&#x201d;). Pursuant to the terms of the Fee Amendment Agreement, in satisfaction of the deferred underwriting commissions under a previous agreement, the Company and CF agreed to release from escrow the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of restricted cash and release the FEF shares previously held as Class A Common Stock subject to possible redemption within temporary equity. Prior to the Fee Amendment Agreement, CF had not sold any FEF shares.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As a result of the Fee Amendment Agreement and termination of the OTC Forward Transaction, as of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company no longer has any restricted cash, Class A Common Stock subject to possible redemption, or derivative liability in the consolidated balance sheets related to the OTC Forward Transaction.&lt;/span&gt;&lt;/p&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="C_f8ff7775-2bf0-4421-8fc7-58a146b2e90c"
      decimals="-5"
      id="F_35d3072d-b960-48a0-bece-f2918157e59b"
      unitRef="U_USD">200000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="C_8f91f567-de42-4b1b-97c4-bc338e0704b9"
      decimals="-3"
      id="F_1fdf7420-a775-4092-9223-983be90d4406"
      unitRef="U_USD">37000</us-gaap:DerivativeLiabilitiesCurrent>
    <mspr:AggregateNumberOfSharesTransferredToEscrowAccount
      contextRef="C_490f215f-7665-40bb-8a57-3e0bba257f4f"
      decimals="-2"
      id="F_259cbcd2-51f4-44d4-9a14-ff189262627b"
      unitRef="U_shares">1800</mspr:AggregateNumberOfSharesTransferredToEscrowAccount>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_3597e466-ae9e-44f5-b5bc-782036376b71"
      decimals="-5"
      id="F_b17e5552-7687-46da-8b48-0add63891905"
      unitRef="U_USD">11400000</us-gaap:RestrictedCashCurrent>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_d41d7044-890b-4eea-b914-30ed7406c2da">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Note 18. SUBSEQUENT EVENTS&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Restructuring Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As described in our Current Report on Form 8-K filed with the SEC on April 10, 2025, on April 4, 2025, Virage Recovery Master, LP (&#x201c;Virage&#x201d;); Virage Capital Management, LP; Hazel Partners Holdings, LLC (&#x201c;HPH&#x201d;); Hazel Holdings I, LLC (and together with HPH, &#x201c;Hazel&#x201d;); La Ley con John H. Ruiz P.A. d/b/a MSP Recovery Law Firm; MSP Recovery, LLC; MSP Law Firm PLLC; MSP Recovery, Inc. (the &#x201c;Company&#x201d;), John H. Ruiz, and Frank C. Quesada (collectively, the &#x201c;Parties&#x201d;) entered into a term sheet (the &#x201c;Term Sheet&#x201d;) agreeing to certain terms and transactions that are designed to reduce costs of the Company through a servicer, deleverage the Company by converting certain debt of certain creditors into equity, provide access to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of bridge funding to the Company (of which $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million remains available through July 2025 pursuant to the Term Sheet, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of which remains available under the Operational Collection Floor at the sole discretion of HPH) and up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of working capital for New Servicer (as defined below), and focus the Company&#x2019;s operations, through the New Servicer, on the core business model of pursuing recoveries under the MSP Laws so that it can achieve its long-term recovery goals. Beyond July 2025, the Company&#x2019;s anticipated sources of funding include the MSP Principals&#x2019; commitment to pledge $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of collateral to backstop additional working capital funding for the Company, potential distributions under our Standby Equity Purchase Agreement with YA II PN, Ltd. (the &#x201c;Yorkville SEPA&#x201d;), and claims recovery proceeds, subject to debt obligations on certain of the claims.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;These proposed transactions are subject to, among other things, further negotiation and the execution of definitive agreements, regulatory approvals, certain third-party consents and approvals, and shareholder approvals if required by the Nasdaq Stock Market. The obligation of Hazel and its affiliates to enter into definitive documents is subject to the satisfaction of various conditions precedent, at their sole discretion, including, but not limited to, satisfactory finalization of due diligence and all required internal approvals, receipt of certain third-party consents required, and finalization of documentation. Consummation of the transactions contemplated by the Term Sheet are also subject to additional fundings by other parties and certain debt concessions by other stakeholders. As a result, there can be no guarantee that the transactions contemplated by the Term Sheet will be consummated.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The proposed transactions include, but are not limited to, the following transactions:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;1.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Establishment of New Servicer&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Company shall establish a new subsidiary (&#x201c;New Servicer&#x201d;) to provide and control recovery efforts, by way of litigation,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;demand &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;letters, settlements, or other means, in connection with existing claim recovery rights (to the extent assignable), and those acquired in the future, held in special purpose vehicles (&#x201c;SPV&#x201d;), wholly owned by New Servicer, to hold any new claims acquired. The Company will license its intellectual property to the New Servicer in exchange for a license fee of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of New Servicer&#x2019;s excess cash flow, with a minimum fee of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.55&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million paid on May 30, 2025, and June 30, 2025. New Servicer will be funded by an affiliate of Hazel (hereinafter, &#x201c;Funder&#x201d;), up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in funding, as set forth below, with a right of first refusal for additional funding needs. New Servicer will be independently managed and be separately governed by an independent board of directors, including a chief executive officer chosen by Funder and consented to by the Company, one director chosen by the Company, and one independent director chosen by Funder and approved by the Company. Funder&#x2019;s governance rights shall terminate once all Hazel loans have been repaid in full, and Funder&#x2019;s Recovery Rights Interest (as defined below) in the New Servicer is less than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%. Virage shall have observer rights to the New Servicer board of directors until the amounts owed to Virage pursuant to the Master Transaction Agreement dated March 9, 2022, as amended (the &#x201c;MTA&#x201d;), which was approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; billion&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (the &#x201c;VRM Full Return&#x201d;) has been repaid and Virage&#x2019;s equity interest in the Company is less than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;2.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Working Capital Funding for the New Servicer&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Funder has agreed to extend a line of credit to New Servicer of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, funded in tranches of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million per month, subject to the New Servicer meeting certain milestones (which are currently being negotiated and to be agreed in definitive documentation), beginning September 2025, with a maturity date of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;June 30, 2027&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. New Servicer funding will accrue interest at the Secured Overnight Financing Rate (&#x201c;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_1094ec3c-3994-4e86-9062-4c0d05c077e7;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;SOFR&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201d;) plus &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per annum for one year, and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_d7edfda9-d03e-48a1-be13-3f45acb6f141;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;SOFR&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; plus &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% thereafter. Funder will establish a first lien on the New Servicer; the Company will not guaranty the loan to fund New Servicer.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, Funder or Hazel is entitled to receive to up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of New Servicer&#x2019;s excess cash flow (the &#x201c;Recovery Rights Interest&#x201d;). At its option, Funder may convert, in whole or part, its Recovery Rights Interest for up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the then outstanding shares of Company&#x2019;s equity, measured as of the Closing and subject to dilution for stock issuance thereafter.&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;3.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Additional Bridge Financing for the Company&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Moreover, Hazel agreed to provide up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in bridge loan funding to the Company under the existing Operational Collection Floor facility (in addition to the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million previously funded under the facility) in the amounts of: (i) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for March 2025, which was funded on February 28, 2025; (ii) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for April 2025, which was funded on April 4, 2025; (iii) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for May 2025, to be funded on or about April 30, 2025; (iv) up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to fund the legal, accounting, and administrative expenses associated with the reorganization, subject to certain terms and customary conditions acceptable to Hazel, and minimum license fees of (v) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.55&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for June 2025; and (vii) $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.55&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for July 2025. Funding is conditional, in part, on an increase in the pledge of collateral and personal guaranty by $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million by Messrs. Ruiz and Quesada (the &#x201c;MSP Principals&#x201d;). Such minimum license fee payment will be paid from the Bridge Loan.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Beyond July 2025, the MSP Principals have committed to pledge $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of collateral to backstop additional working capital requirements of the Company, in addition to other previous sources of funding, including cash proceeds from the sale of Class A Common Stock to Yorkville pursuant to the Yorkville SEPA, and the proceeds from claims recoveries, subject to lien repayment on certain claims. In addition, the Company expects annual costs reductions due to New Servicer operations and shall be funded by the Funder (through New Servicer).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, the Term Sheet requires (and is conditioned upon) La Ley con John H. Ruiz, P.A. d/b/a MSP Recovery Law Firm and MSP Law Firm, PLLC, collectively, raising $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for operational funding over two years, subject to similar milestones (to be agreed upon) as per the New Servicer funding, and to be entered into at completion of the proposed transaction.&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:0.33958333333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;4.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Debt Restructuring&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In exchange for a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% equity interest in the Company (inclusive of shares currently held and those shares acquired through warrant exercises pursuant to the Virage Term Sheet discussed below) Virage has agreed to waive all claims and release all liens against the Company relating to the VRM Full Return (approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; billion&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;), and the Parties agree that the VRM Full Return will be paid only from: (i) a junior lien against Subrogation Holdings proceeds, (ii) claims currently owned by Virage, (iii) liens over two tranches of claims currently owned by Hazel (which Hazel shall release as part of the reorganization transaction) and (iv) a non-recourse second lien up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million over &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the proceeds from the New Servicer and associated SPVs, to the extent that the VRM Full Return has not been repaid.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, the MSP Principals have agreed to convert &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the Company&#x2019;s debt obligation to them, totaling approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;144&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, into shares of the Company&#x2019;s Class A Common Stock, the full and final amount of the debt-to-equity conversion is subject to tax analysis and approval of the MSP Principals and the Company&#x2019;s Board of Directors.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Hazel&#x2019;s existing loans to Subrogation Holdings and the amount of Company&#x2019;s guaranty (currently approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million) remain unchanged except that such lien shall now exclude the Company&#x2019;s intellectual property. Hazel agreed, subject to obtaining third-party consents, to extend the maturity date on all outstanding obligations to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;November 30, 2026&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;To secure the repayment of the existing&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Hazel &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;loans to the extent such loans have not been repaid in full, the Company shall, for a principal amount of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;235&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million with an interest rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_4e424096-b0c4-45a8-94c2-f9386f78d00b;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;SOFR&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; plus &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per annum: (i) pledge to Hazel &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the New Servicer and associated SPV equity interests; and (ii) grant a lien over &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the proceeds from New Servicer and associated SPVs, once the New Servicer funding has been repaid. In addition, to the extent the VRM Full Return has not been repaid, Virage has second lien of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million over &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the proceeds from New Servicer and associated SPVs.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On January 13, 2025, the Board delegated to an independent committee of the Board of Directors (the &#x201c;Independent Committee&#x201d;) the power and authority to, among other things, determine on behalf of the Board and the Company whether, to the extent any conflicts or potential conflicts exist or arise in the future among the Company and Messrs. Ruiz and Quesada, certain Restructuring and Proposals are advisable and fair to, and in the best interests of, the Company and its stockholders. The Independent Committee reviewed the Term Sheet and engaged legal counsel and financial advisors that are familiar with the Company and restructuring transactions to determine if the Term Sheet is advisable and fair, and in the best interests of the Company and its stockholders. Although the Independent Committee identified material conflicts, those conflicts involve conditions precedent to the Term Sheet, and are resolvable to the satisfaction of the Independent Committee in furtherance of the Term Sheet and in the best interest of the Company; as such, the Independent Committee determined that it is advisable and in the best interests of the Company to approve the signing of the Term Sheet and subsequent entry into agreements consistent with the terms set forth therein.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to the Term Sheet, the parties are working to complete the definitive agreements by April 30, 2025.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;VRM Warrant Issuance and Restructuring&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to the first Amendment to the Master Transaction Agreement, dated April 11, 2023 (the &#x201c;First Amendment&#x201d;), for each calendar month beginning with January 31, 2024 and ending when the VRM Full Return (as defined in the Master Transaction Agreement dated March 9, 2022 (as amended, the &#x201c;MTA&#x201d;)) is paid in full, the Company is required to either: (i) pay in cash or (ii) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;issue a warrant to purchase a number of shares of Class A Common Stock of the Company, or some combination thereof, to Virage Recovery Master LP (&#x201c;VRM&#x201d;) equal to the quotient of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the calendar month-end balance of the Unpaid Base Amount (as defined in the MTA) (the &#x201c;Required Monthly Issuance&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; On Apri&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;l 14,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; 2025, the Company issued VRM Monthly Warrants for November 2024 and December 2024, for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,277,808&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,332,792&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares respectively, exercisable at a purchase price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share for a period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;two years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; from the original issuance date, exercisable on a cashless basis only. To date, the Company has issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; warrants to VRM pursuant to the First Amendment, entitling Virage to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,361,939&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Class A Common Stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In connection with negotiations to restructure the Company&#x2019;s obligations under the MTA, on February 18, 2025, the Company entered into a term sheet agreement with Virage (the &#x201c;Virage Term Sheet&#x201d;) to amend the MTA, whereby Virage and the Company agreed, subject to certain conditions, which have not been met as of the date of this Annual Report on Form 10-K, to enter into definitive documentation at a later date to: (i) exercise the VRM Warrants to purchase that number of shares that would result in Virage owning &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_6c011bf9-0559-4a17-8cc8-0125ab18a42f;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;33 1/3&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the then issued and outstanding Common Stock (the &#x201c;Warrant Exercise&#x201d;), (ii) surrender to the Company any remaining unexercised VRM Warrants, or portions thereof, for termination, (iii) contemporaneous with the Warrant Exercise, terminate its agreement to hold no more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the outstanding Common Stock of the Company, (iv) subject to certain conditions, grant proxy voting rights to the MRCS Principals over an amount of shares of Common Stock issuable to Virage from the Warrant Exercise such that the MRCS Principals will have voting control over &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the total outstanding Parent Class A Common Stock, and (v) terminate any obligation of the Company to satisfy the Required Monthly Issuance. These proposed transactions under the Virage Term Sheet are subject to, among other things, further negotiation and the execution of definitive agreements, regulatory approvals, and shareholder approvals if required by the Nasdaq Stock Market; as a result, there can be no guarantee that the transactions thereby will be consummated.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Yorkville Amendments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At the close of Primary Market trading on October 18, 2024, the daily VWAP for MSP Recovery, Inc.&#x2019;s (the &#x201c;Company&#x201d;) Class A Common Stock was below the Floor Price (which is $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;), as defined in the Exchangeable Promissory Notes (&#x201c;Notes&#x201d;) issued to YA II PN, Ltd. (&#x201c;Yorkville&#x201d;) pursuant to the Standby Equity Purchase Agreement dated November 14, 2023, as amended (the &#x201c;SEPA&#x201d;), by and between Yorkville and the Company, for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;ten&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; consecutive Trading Days, resulting in a Floor Price Trigger pursuant to the Notes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Upon the occurrence of a Trigger Event, the Company shall make monthly payments (&#x201c;Monthly Payments&#x201d;) beginning on the 7th Trading Day after the date of the Trigger Event and continuing on the same day of each successive month.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On April 10, 2025, Yorkville agreed: (i) that the first Monthly Payment, as set forth in Section (1)(c) of the Notes, would be due from the Company no sooner than November 30, 2026, (ii) the maturity date of the Convertible Notes is extended to November 30, 2026, and (iii) to waive Volume Threshold and Maximum Advance Amount limitations set forth in the Yorkville SEPA.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:20.15pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Capitalized but undefined terms have the same meaning as set forth in the Yorkville SEPA and the Notes.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;LSA Amendment&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:36pt;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On April 14, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2025, Lionheart II Holdings, LLC (&#x201c;Lionheart&#x201d;), a wholly owned subsidiary of the Company, entered into Amendment No. 1 to its Legal Services Agreement with La Ley con John H. Ruiz, P.A. d/b/a MSP Recovery Law Firm (&#x201c;La Ley&#x201d;), and MSP Law Firm, PLLC (collectively with La Ley, &#x201c;Law Firm&#x201d;), which: (i) terminates any obligation by the Company or its subsidiaries to provide further advances to fund the Law Firm, and provides that any Compensation earned by the Law Firm will be first used to repay the Advance Balance to Lionheart.&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <mspr:ConvertingCertainDebtOfCertainCreditorsIntoEquity
      contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688"
      decimals="-4"
      id="F_35bf780f-c04c-41d7-ace8-bbc1ecbe4296"
      unitRef="U_USD">9750000</mspr:ConvertingCertainDebtOfCertainCreditorsIntoEquity>
    <mspr:ConvertingCertainDebtOfCertainCreditorsIntoEquity
      contextRef="C_82042595-d2ec-46bd-8d33-1d9c1c5fcd8a"
      decimals="-5"
      id="F_26f14b12-4071-45ca-b314-06f437a82670"
      unitRef="U_USD">6500000</mspr:ConvertingCertainDebtOfCertainCreditorsIntoEquity>
    <mspr:ConvertingCertainDebtOfCertainCreditorsIntoEquity
      contextRef="C_c4e77341-1e9b-4ba5-8f65-82e4691d35db"
      decimals="-4"
      id="F_424680a5-4f7c-4ff3-b31c-a45a4bcb2965"
      unitRef="U_USD">2750000</mspr:ConvertingCertainDebtOfCertainCreditorsIntoEquity>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="C_1e01a200-c2e8-4634-9efe-10da04e93fb6"
      decimals="-6"
      id="F_97267c4c-c680-4286-96ef-11301d0caa6a"
      unitRef="U_USD">25000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:OtherCommitment
      contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688"
      decimals="-6"
      id="F_e3b37006-b035-4350-8e62-958ac11e2205"
      unitRef="U_USD">25000000</us-gaap:OtherCommitment>
    <mspr:LicenseFeePercentage
      contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688"
      decimals="3"
      id="F_c5c461bc-17f1-453f-9ce1-050fc9e3eb9f"
      unitRef="U_pure">0.175</mspr:LicenseFeePercentage>
    <mspr:MinimumFeePaid
      contextRef="C_16f268f8-c0e0-4f58-8d27-bfb1180e5347"
      decimals="-4"
      id="F_3d2f1ea4-0d6c-47d0-afb3-4f0e343f85dd"
      unitRef="U_USD">1550000</mspr:MinimumFeePaid>
    <mspr:MinimumFeePaid
      contextRef="C_c23753ff-91ab-40d0-869b-679d87defcd8"
      decimals="-4"
      id="F_195d1308-bb2d-4972-bc68-5ea91b5ded17"
      unitRef="U_USD">1550000</mspr:MinimumFeePaid>
    <mspr:FundedForAdditionalClaims
      contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688"
      decimals="-6"
      id="F_68c824a6-2edd-4e42-b426-4432956986fb"
      unitRef="U_USD">25000000</mspr:FundedForAdditionalClaims>
    <mspr:LoansRepaymentPercentage
      contextRef="C_d0089042-c0e3-454a-8c16-1481457cdcac"
      decimals="2"
      id="F_d4fb79c0-8b7a-43dc-8a2b-d3b09e30bdd8"
      unitRef="U_pure">0.10</mspr:LoansRepaymentPercentage>
    <mspr:AmountsReceivedToToTheMasterTransactionAgreement
      contextRef="C_24c05dee-37c3-47dd-b886-8f4b407eef55"
      decimals="-8"
      id="F_6c53c4c8-4a3e-42cd-aa69-45694d267a7c"
      unitRef="U_USD">1100000000</mspr:AmountsReceivedToToTheMasterTransactionAgreement>
    <mspr:LoansRepaymentPercentage
      contextRef="C_97164373-b267-4695-841a-94d63fab565c"
      decimals="2"
      id="F_f2452483-eca0-47a7-9a3f-dc72c3c78449"
      unitRef="U_pure">0.10</mspr:LoansRepaymentPercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688"
      decimals="INF"
      id="F_1c0600fd-fbb6-4656-9017-3b8fda5aef8d"
      unitRef="U_USD">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <mspr:LineOfCreditFundedInTranchesPerMonth
      contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688"
      decimals="-4"
      id="F_46356be8-5271-4f7e-bed1-fbbe9ac0da2c"
      unitRef="U_USD">1750000</mspr:LineOfCreditFundedInTranchesPerMonth>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_1e01a200-c2e8-4634-9efe-10da04e93fb6"
      id="F_2d897482-fb94-40a5-a5c5-4ad01541f079">2027-06-30</us-gaap:DebtInstrumentMaturityDate>
    <mspr:AccruedInterestPercentageInYearOne
      contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688"
      decimals="2"
      id="F_8b48d703-ed95-43c1-932a-ec7ab76eac30"
      unitRef="U_pure">0.05</mspr:AccruedInterestPercentageInYearOne>
    <mspr:AccruedInterestPercentageAfterOneYear
      contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688"
      decimals="2"
      id="F_dcc4fe97-8bd0-4207-9aee-3a9101f18792"
      unitRef="U_pure">0.10</mspr:AccruedInterestPercentageAfterOneYear>
    <mspr:RecoveryRightsInterestExcessCashFlowPercentage
      contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688"
      decimals="2"
      id="F_313aa4a2-c997-4976-ae4c-7a0a1f0592c2"
      unitRef="U_pure">0.35</mspr:RecoveryRightsInterestExcessCashFlowPercentage>
    <mspr:RecoveryRightsInterest
      contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688"
      decimals="2"
      id="F_6ee09995-2dc9-40ca-b726-bdc5b1ec52dc"
      unitRef="U_pure">0.30</mspr:RecoveryRightsInterest>
    <us-gaap:BridgeLoan
      contextRef="C_8d558395-7c90-405f-a7c4-dc8b67120549"
      decimals="-4"
      id="F_dd2c3bfa-431b-4f16-88a5-9e22b0aca234"
      unitRef="U_USD">9750000</us-gaap:BridgeLoan>
    <mspr:AdditionalBridgeLoan
      contextRef="C_8d558395-7c90-405f-a7c4-dc8b67120549"
      decimals="-5"
      id="F_8bdfaa9e-e024-4086-a4c0-c9962df5c96c"
      unitRef="U_USD">16000000</mspr:AdditionalBridgeLoan>
    <us-gaap:BridgeLoan
      contextRef="C_88fe5d42-7072-4d23-aaf0-bcc6834ff66f"
      decimals="-4"
      id="F_383718bd-1384-4cd1-89d8-8aaf82bac955"
      unitRef="U_USD">1750000</us-gaap:BridgeLoan>
    <us-gaap:BridgeLoan
      contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688"
      decimals="-5"
      id="F_6b697473-88b5-4394-bf50-66aa6d957477"
      unitRef="U_USD">1500000</us-gaap:BridgeLoan>
    <us-gaap:BridgeLoan
      contextRef="C_23a8a03a-394f-4c24-88aa-cfe8564c686c"
      decimals="-5"
      id="F_a3c6d451-9f87-473d-ae19-7c4557c1b0e4"
      unitRef="U_USD">1500000</us-gaap:BridgeLoan>
    <us-gaap:BridgeLoan
      contextRef="C_0d4a0973-f818-41cd-a1c5-5c03e254d884"
      decimals="-5"
      id="F_3e757fbc-2296-473f-83e8-bddab94ba74a"
      unitRef="U_USD">2000000</us-gaap:BridgeLoan>
    <us-gaap:BridgeLoan
      contextRef="C_c23753ff-91ab-40d0-869b-679d87defcd8"
      decimals="-4"
      id="F_107b0200-a9a4-4d47-9c1f-5f8e49fb275b"
      unitRef="U_USD">1550000</us-gaap:BridgeLoan>
    <us-gaap:BridgeLoan
      contextRef="C_82042595-d2ec-46bd-8d33-1d9c1c5fcd8a"
      decimals="-4"
      id="F_37fe2928-01ca-4274-9524-a3f9bf52b7af"
      unitRef="U_USD">1550000</us-gaap:BridgeLoan>
    <us-gaap:BridgeLoan
      contextRef="C_2a65b7e7-25a4-4784-a0df-3b3fc40b9b39"
      decimals="-4"
      id="F_4e80918e-95f4-428d-850d-c9ca44b5f08a"
      unitRef="U_USD">9750000</us-gaap:BridgeLoan>
    <us-gaap:OtherCommitment
      contextRef="C_2a65b7e7-25a4-4784-a0df-3b3fc40b9b39"
      decimals="-6"
      id="F_394b1780-5ff6-4702-a34b-46051454ef6c"
      unitRef="U_USD">25000000</us-gaap:OtherCommitment>
    <mspr:OperationalFunding
      contextRef="C_8c271ab2-9939-4c4b-a48c-af64c4e19688"
      decimals="-6"
      id="F_91ba6499-7ac5-429b-80f5-54f8f2ba67a0"
      unitRef="U_USD">25000000</mspr:OperationalFunding>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_6914b62b-8ebd-492e-9751-a059c6e34653"
      decimals="2"
      id="F_fe643977-af12-4ea7-90c2-23e587f5041b"
      unitRef="U_pure">0.43</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mspr:AmountsReceivedToToTheMasterTransactionAgreement
      contextRef="C_24c05dee-37c3-47dd-b886-8f4b407eef55"
      decimals="-8"
      id="F_7018eaf2-bf8d-4d51-abe2-345b393a3789"
      unitRef="U_USD">1100000000</mspr:AmountsReceivedToToTheMasterTransactionAgreement>
    <mspr:Non-RecourseDebtSecondLienAmount
      contextRef="C_93c831d9-6dfd-4340-ab2a-da4af19391f3"
      decimals="-6"
      id="F_c7ad43cd-b555-48fe-a872-f39686e26ab5"
      unitRef="U_USD">100000000</mspr:Non-RecourseDebtSecondLienAmount>
    <mspr:PercentageOfGrantProceedsToExtentFullReturnNotRepaid
      contextRef="C_ba798111-eacc-4c32-969b-07c6da1f0336"
      decimals="2"
      id="F_437ed781-28f8-4894-a542-de15134f386c"
      unitRef="U_pure">0.50</mspr:PercentageOfGrantProceedsToExtentFullReturnNotRepaid>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="C_9a7a94af-f271-43a1-89d2-fb92e5b46edd"
      decimals="2"
      id="F_3c6fba2d-7c49-4de8-82ae-3cb02a865437"
      unitRef="U_pure">1</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="C_2007c22d-ce55-459e-b965-217365e43f85"
      decimals="-6"
      id="F_5d16e745-1dbb-45ac-bf0d-270620f81b2d"
      unitRef="U_USD">144000000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_cc4d14e4-5132-4152-bdd4-d68740ba0480"
      decimals="-6"
      id="F_4938ebf3-5bb1-421a-8408-a687c104832b"
      unitRef="U_USD">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <mspr:DebtInstrumentsExtendedMaturityDate
      contextRef="C_0fff79a6-2fca-469c-b4ba-d88fff8a1879"
      id="F_8a551566-3ad5-43d4-bf18-443c01743cef">2026-11-30</mspr:DebtInstrumentsExtendedMaturityDate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_019f56fe-b87d-4bf1-9a97-950481da89e1"
      decimals="-6"
      id="F_912ff67c-66bd-4b1b-a985-1d3fc05b418e"
      unitRef="U_USD">235000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_cc4d14e4-5132-4152-bdd4-d68740ba0480"
      decimals="2"
      id="F_0d9ac644-9561-4616-bb13-624c2c9e406c"
      unitRef="U_pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <mspr:PercentageOfPledge
      contextRef="C_0fff79a6-2fca-469c-b4ba-d88fff8a1879"
      decimals="3"
      id="F_2518ebad-92f1-4a60-a27c-1d2ae9c6e609"
      unitRef="U_pure">0.501</mspr:PercentageOfPledge>
    <mspr:PercentageOfProceedsFromGrantLien
      contextRef="C_1e01a200-c2e8-4634-9efe-10da04e93fb6"
      decimals="2"
      id="F_ed2eb785-3afe-4d13-aa71-8adeec82009a"
      unitRef="U_pure">0.50</mspr:PercentageOfProceedsFromGrantLien>
    <mspr:Non-RecourseDebtSecondLienAmount
      contextRef="C_93c831d9-6dfd-4340-ab2a-da4af19391f3"
      decimals="-6"
      id="F_7d5f2859-505d-43cb-bcdb-e25f2bef1e07"
      unitRef="U_USD">100000000</mspr:Non-RecourseDebtSecondLienAmount>
    <mspr:PercentageOfGrantProceedsToExtentFullReturnNotRepaid
      contextRef="C_ba798111-eacc-4c32-969b-07c6da1f0336"
      decimals="2"
      id="F_8f96c8e7-8879-4550-b4f2-20e4ef011ff7"
      unitRef="U_pure">0.50</mspr:PercentageOfGrantProceedsToExtentFullReturnNotRepaid>
    <us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees
      contextRef="C_1bdb4676-b3b4-49b4-a184-8e7118c0d4af"
      id="F_4469199e-744e-4ec9-9e70-879d98bc8912">issue a warrant to purchase a number of shares of Class A Common Stock of the Company, or some combination thereof, to Virage Recovery Master LP (&#x201c;VRM&#x201d;) equal to the quotient of 1% of the calendar month-end balance of the Unpaid Base Amount (as defined in the MTA) (the &#x201c;Required Monthly Issuance&#x201d;).</us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees>
    <mspr:PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient
      contextRef="C_1bdb4676-b3b4-49b4-a184-8e7118c0d4af"
      decimals="2"
      id="F_d07d47c4-768a-416a-8e0e-309c9ace6a57"
      unitRef="U_pure">0.01</mspr:PercentageOfNumberOfSharesWarrantPurchasedEqualToQuotient>
    <mspr:NumberOfWarrantsIssued
      contextRef="C_b2b2ecfa-79d0-47aa-8ded-ad13037b27b6"
      decimals="INF"
      id="F_e64cf72d-eb3d-41f6-9f06-bd98c1aafba3"
      unitRef="U_shares">3277808</mspr:NumberOfWarrantsIssued>
    <mspr:NumberOfWarrantsIssued
      contextRef="C_50aeca4c-0cc0-40a9-95d1-4f6f9ca8d58b"
      decimals="INF"
      id="F_2383030c-f3ac-4d66-919c-f650f1da1086"
      unitRef="U_shares">6332792</mspr:NumberOfWarrantsIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_eb9380b7-557e-4277-b64d-8fa02512fa54"
      decimals="4"
      id="F_24e7cec7-1e8d-475b-aa13-93443024eef0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="C_eb9380b7-557e-4277-b64d-8fa02512fa54"
      id="F_82a81d4e-732e-4940-9689-f0d46c9b4bbf">P2Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <mspr:NumberOfWarrantsIssued
      contextRef="C_eb9380b7-557e-4277-b64d-8fa02512fa54"
      decimals="INF"
      id="F_c19c3814-7f9c-4cba-b7cf-9f8f38691853"
      unitRef="U_shares">12</mspr:NumberOfWarrantsIssued>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_eb9380b7-557e-4277-b64d-8fa02512fa54"
      decimals="INF"
      id="F_98dbb897-30c5-46e9-96ae-cfdcaf6fcdd2"
      unitRef="U_shares">19361939</us-gaap:ClassOfWarrantOrRightOutstanding>
    <mspr:ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock
      contextRef="C_096f06bd-fa6c-4347-b329-d00e63925c9f"
      decimals="4"
      id="F_3942b4e5-062b-469f-83aa-3cfea6954d01"
      unitRef="U_pure">0.0999</mspr:ClassOfWarrantOrRightOutstandingWarrantExerciseMinimumHoldingPercentageOfCommonStock>
    <mspr:ClassOfWarrantOrRightOutstandingVotingPercentage
      contextRef="C_3141ef96-8081-408d-8688-cac679df2dcc"
      decimals="2"
      id="F_b4a6d719-1098-4a18-83d9-f17d31975f18"
      unitRef="U_pure">0.51</mspr:ClassOfWarrantOrRightOutstandingVotingPercentage>
    <mspr:FloorPriceOfACommonStock
      contextRef="C_32d5fd3f-18ff-44f6-bea9-54478be0fe12"
      decimals="2"
      id="F_f07a6886-b0fc-4cea-bbe6-140b64a22599"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.75</mspr:FloorPriceOfACommonStock>
    <mspr:NumberOfConsecutiveTradingDays
      contextRef="C_62435c4d-78b1-4259-85bd-74e491eb2245"
      decimals="0"
      id="F_542a1eba-99bc-4882-acf5-7dc8c5c3ba38"
      unitRef="U_Days">10</mspr:NumberOfConsecutiveTradingDays>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_6fc20ca9-1ab2-42c7-8e99-0cc58496a91f"
      id="F_757dabb5-ba0e-403a-bd7a-e3bc38d93a3a">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="C_6fc20ca9-1ab2-42c7-8e99-0cc58496a91f"
      id="F_91a3288a-abbc-424e-b5fd-9a31078a3e34">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="C_6fc20ca9-1ab2-42c7-8e99-0cc58496a91f"
      id="F_b0ba318a-f959-4484-8a3f-7ee92cb749b6">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="C_6fc20ca9-1ab2-42c7-8e99-0cc58496a91f"
      id="F_34ba0c4a-9a11-4e36-811b-1ddbec5a3abb">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag
      contextRef="C_7fbf6fc0-1952-4e05-9325-85ed7f05a0c9"
      id="F_9d1a96bb-f757-48c0-92bc-2d2686d2bd11">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#F_205a35fd-b126-40ae-b1a2-688dd34751c5"
          xlink:label="F_205a35fd-b126-40ae-b1a2-688dd34751c5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_a895c9d8-b77b-49fc-bed7-f6f09c5117a3"
          xlink:label="F_a895c9d8-b77b-49fc-bed7-f6f09c5117a3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_ea20dce6-d3f9-471b-9aee-3f6f144ce678"
          xlink:label="F_ea20dce6-d3f9-471b-9aee-3f6f144ce678"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_6a867877-52a0-4e7f-a2ee-387043ab5ed6"
          xlink:label="F_6a867877-52a0-4e7f-a2ee-387043ab5ed6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_dd4a4c78-f6f8-4e11-aab0-11a7a18e2318"
          xlink:label="F_dd4a4c78-f6f8-4e11-aab0-11a7a18e2318"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_0a108fb9-2063-4b2f-a76e-eee9593bb7db"
          xlink:label="F_0a108fb9-2063-4b2f-a76e-eee9593bb7db"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_8e88b3c9-7da4-4078-bfd3-a81f7b588a00"
          xlink:label="F_8e88b3c9-7da4-4078-bfd3-a81f7b588a00"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_7349faec-67c3-4457-b111-13aa8b59814b"
          xlink:label="F_7349faec-67c3-4457-b111-13aa8b59814b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_c7ce0478-2b86-4765-abfd-d0a23db5c0b7"
          xlink:label="F_c7ce0478-2b86-4765-abfd-d0a23db5c0b7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_6bdb6d2b-db69-4134-b692-902a552fd027"
          xlink:label="F_6bdb6d2b-db69-4134-b692-902a552fd027"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_127e888e-7ffb-4b96-9379-154fbd63a074"
          xlink:label="F_127e888e-7ffb-4b96-9379-154fbd63a074"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_5f85d3ca-1713-492b-bc89-518782029d0a"
          xlink:label="F_5f85d3ca-1713-492b-bc89-518782029d0a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_97dfeaba-1e75-43a0-ac86-c2ba64165dc6"
          xlink:label="F_97dfeaba-1e75-43a0-ac86-c2ba64165dc6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_ff9b0771-e0bd-4028-8ea2-970ffa0de6cd"
          xlink:label="F_ff9b0771-e0bd-4028-8ea2-970ffa0de6cd"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_b250df4c-8239-48d4-aaf6-48db038dc64f"
          xlink:label="F_b250df4c-8239-48d4-aaf6-48db038dc64f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_ea8949b7-b3fb-4122-a17b-a12fec3eba2b"
          xlink:label="F_ea8949b7-b3fb-4122-a17b-a12fec3eba2b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_3922abe0-69f6-4492-9c8a-1a5a120731ec"
          xlink:label="F_3922abe0-69f6-4492-9c8a-1a5a120731ec"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_621c8126-d89e-4874-9bdd-c9eebd642153"
          xlink:label="F_621c8126-d89e-4874-9bdd-c9eebd642153"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_9315e270-47e0-4e4e-a1cc-3186e954fd9c"
          xlink:label="F_9315e270-47e0-4e4e-a1cc-3186e954fd9c"
          xlink:type="locator"/>
        <link:footnote id="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f" xlink:label="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of December 31, 2024 and 2023, total affiliate receivable, affiliate payable, warrant liability, guaranty obligation and loan from related parties balances are with related parties. In addition, the prepaid expenses and other current assets, claims financing obligation and notes payable, other current liabilities, and interest payable include balances with related parties. See Note 14, </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Party Transactions, </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for furthe</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">r details.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_205a35fd-b126-40ae-b1a2-688dd34751c5"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_a895c9d8-b77b-49fc-bed7-f6f09c5117a3"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_ea20dce6-d3f9-471b-9aee-3f6f144ce678"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_6a867877-52a0-4e7f-a2ee-387043ab5ed6"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_dd4a4c78-f6f8-4e11-aab0-11a7a18e2318"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_0a108fb9-2063-4b2f-a76e-eee9593bb7db"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_8e88b3c9-7da4-4078-bfd3-a81f7b588a00"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_7349faec-67c3-4457-b111-13aa8b59814b"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_c7ce0478-2b86-4765-abfd-d0a23db5c0b7"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_6bdb6d2b-db69-4134-b692-902a552fd027"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_127e888e-7ffb-4b96-9379-154fbd63a074"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_5f85d3ca-1713-492b-bc89-518782029d0a"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_97dfeaba-1e75-43a0-ac86-c2ba64165dc6"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_ff9b0771-e0bd-4028-8ea2-970ffa0de6cd"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_b250df4c-8239-48d4-aaf6-48db038dc64f"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_ea8949b7-b3fb-4122-a17b-a12fec3eba2b"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_3922abe0-69f6-4492-9c8a-1a5a120731ec"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_621c8126-d89e-4874-9bdd-c9eebd642153"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_9315e270-47e0-4e4e-a1cc-3186e954fd9c"
          xlink:to="FNT_a9fb295c-695c-4bea-8a5e-17895d0bac3f"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_049581b0-85bf-4cc1-856e-c1f12e8a3f2b"
          xlink:label="F_049581b0-85bf-4cc1-856e-c1f12e8a3f2b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_0e5f8c74-a7f3-4607-8eb1-009f6f2e19e6"
          xlink:label="F_0e5f8c74-a7f3-4607-8eb1-009f6f2e19e6"
          xlink:type="locator"/>
        <link:footnote id="FNT_85277ec4-535a-4590-b3e1-ed9c8021c99f" xlink:label="FNT_85277ec4-535a-4590-b3e1-ed9c8021c99f" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, intangible assets, net included </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.2</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> billion</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, related to a consolidated VIE. See Note 8,</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Variable Interest Entities</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for further details.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_049581b0-85bf-4cc1-856e-c1f12e8a3f2b"
          xlink:to="FNT_85277ec4-535a-4590-b3e1-ed9c8021c99f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_0e5f8c74-a7f3-4607-8eb1-009f6f2e19e6"
          xlink:to="FNT_85277ec4-535a-4590-b3e1-ed9c8021c99f"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_ada24831-ea2f-471f-80bc-c5d0bb37a5a9"
          xlink:label="F_ada24831-ea2f-471f-80bc-c5d0bb37a5a9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_11eab42e-5feb-4b3f-b742-4d5fa7feb23c"
          xlink:label="F_11eab42e-5feb-4b3f-b742-4d5fa7feb23c"
          xlink:type="locator"/>
        <link:footnote id="FNT_071ffd73-77db-4a34-b2a1-f3867369fb2f" xlink:label="FNT_071ffd73-77db-4a34-b2a1-f3867369fb2f" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, cost of Claim recoveries included </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.4</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of related party expenses, respectively. This relates to contingent legal expenses earned from Claims recovery income pursuant to legal service agreements with the La Ley con John H. Ruiz P.A., d/b/a MSP Recovery Law Firm (the &#x201c;Law Firm&#x201d;). See Note 14, </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Party Transactions</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for further details.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_ada24831-ea2f-471f-80bc-c5d0bb37a5a9"
          xlink:to="FNT_071ffd73-77db-4a34-b2a1-f3867369fb2f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_11eab42e-5feb-4b3f-b742-4d5fa7feb23c"
          xlink:to="FNT_071ffd73-77db-4a34-b2a1-f3867369fb2f"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_23f3c66e-3461-429c-9a94-0719426712a9"
          xlink:label="F_23f3c66e-3461-429c-9a94-0719426712a9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_89672a83-8db0-4a03-8baa-589e45240c0f"
          xlink:label="F_89672a83-8db0-4a03-8baa-589e45240c0f"
          xlink:type="locator"/>
        <link:footnote id="FNT_35ea91e8-3c49-4990-ba5b-48a3392a1f92" xlink:label="FNT_35ea91e8-3c49-4990-ba5b-48a3392a1f92" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, general and administrative expenses included </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of related party expenses, respectively</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_23f3c66e-3461-429c-9a94-0719426712a9"
          xlink:to="FNT_35ea91e8-3c49-4990-ba5b-48a3392a1f92"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_89672a83-8db0-4a03-8baa-589e45240c0f"
          xlink:to="FNT_35ea91e8-3c49-4990-ba5b-48a3392a1f92"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_694112ad-309c-4458-b030-ad8125036e89"
          xlink:label="F_694112ad-309c-4458-b030-ad8125036e89"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_ffdd38b8-f4e4-4330-9852-d7d6ac99a536"
          xlink:label="F_ffdd38b8-f4e4-4330-9852-d7d6ac99a536"
          xlink:type="locator"/>
        <link:footnote id="FNT_9039f59d-d74a-45c2-87f9-6463d50e70ba" xlink:label="FNT_9039f59d-d74a-45c2-87f9-6463d50e70ba" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024 and 2023, Professional Fees - Legal included </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.7</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.2</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of related party expenses related to the Law Firm. See Note 14, </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Related Party Transactions</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for further details.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_694112ad-309c-4458-b030-ad8125036e89"
          xlink:to="FNT_9039f59d-d74a-45c2-87f9-6463d50e70ba"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_ffdd38b8-f4e4-4330-9852-d7d6ac99a536"
          xlink:to="FNT_9039f59d-d74a-45c2-87f9-6463d50e70ba"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_1f2aa437-b4da-460d-bf52-7edcbb42a12a"
          xlink:label="F_1f2aa437-b4da-460d-bf52-7edcbb42a12a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_516c8fa1-698f-44b9-91be-4fb706ccd763"
          xlink:label="F_516c8fa1-698f-44b9-91be-4fb706ccd763"
          xlink:type="locator"/>
        <link:footnote id="FNT_cd459352-1f75-44db-a821-c46b5ea066c0" xlink:label="FNT_cd459352-1f75-44db-a821-c46b5ea066c0" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">year ended December 31, 2024 and 2023, Interest expense included </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">318.9</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">226.5</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of interest expense to related parties.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_1f2aa437-b4da-460d-bf52-7edcbb42a12a"
          xlink:to="FNT_cd459352-1f75-44db-a821-c46b5ea066c0"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_516c8fa1-698f-44b9-91be-4fb706ccd763"
          xlink:to="FNT_cd459352-1f75-44db-a821-c46b5ea066c0"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_01b50422-e877-4600-91b7-063e13cf4bf5"
          xlink:label="F_01b50422-e877-4600-91b7-063e13cf4bf5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_9f6cf949-83d3-4966-aa38-96d7ba5d284b"
          xlink:label="F_9f6cf949-83d3-4966-aa38-96d7ba5d284b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_67094ad7-e54b-405e-90be-9227b1870a88"
          xlink:label="F_67094ad7-e54b-405e-90be-9227b1870a88"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_95951ba3-4813-4d4d-8c8d-3ce1dd308d1d"
          xlink:label="F_95951ba3-4813-4d4d-8c8d-3ce1dd308d1d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_7afe5ee6-3e63-4c8b-a947-6e22eba8fa9c"
          xlink:label="F_7afe5ee6-3e63-4c8b-a947-6e22eba8fa9c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_930ae64a-6e30-4f0f-be44-c5dff142f095"
          xlink:label="F_930ae64a-6e30-4f0f-be44-c5dff142f095"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_8815d523-67e4-437e-965d-caa19cf4a4e1"
          xlink:label="F_8815d523-67e4-437e-965d-caa19cf4a4e1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_ad09f737-52d3-4889-a092-d0e79ca9c4b5"
          xlink:label="F_ad09f737-52d3-4889-a092-d0e79ca9c4b5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_19a7307c-e905-4328-b209-d873f357833b"
          xlink:label="F_19a7307c-e905-4328-b209-d873f357833b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_c284a7e8-84d6-404e-8590-3871ab408ad3"
          xlink:label="F_c284a7e8-84d6-404e-8590-3871ab408ad3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_9a66c039-75ba-48a3-af8a-e15632e557f6"
          xlink:label="F_9a66c039-75ba-48a3-af8a-e15632e557f6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_b380e630-4fc3-442f-ba15-6a8528278443"
          xlink:label="F_b380e630-4fc3-442f-ba15-6a8528278443"
          xlink:type="locator"/>
        <link:footnote id="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6" xlink:label="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Balances include related party transactions.</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> See Note 14,</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Related Party Transactions</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, f</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or further details.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_01b50422-e877-4600-91b7-063e13cf4bf5"
          xlink:to="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_9f6cf949-83d3-4966-aa38-96d7ba5d284b"
          xlink:to="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_67094ad7-e54b-405e-90be-9227b1870a88"
          xlink:to="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_95951ba3-4813-4d4d-8c8d-3ce1dd308d1d"
          xlink:to="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_7afe5ee6-3e63-4c8b-a947-6e22eba8fa9c"
          xlink:to="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_930ae64a-6e30-4f0f-be44-c5dff142f095"
          xlink:to="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_8815d523-67e4-437e-965d-caa19cf4a4e1"
          xlink:to="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_ad09f737-52d3-4889-a092-d0e79ca9c4b5"
          xlink:to="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_19a7307c-e905-4328-b209-d873f357833b"
          xlink:to="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_c284a7e8-84d6-404e-8590-3871ab408ad3"
          xlink:to="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_9a66c039-75ba-48a3-af8a-e15632e557f6"
          xlink:to="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_b380e630-4fc3-442f-ba15-6a8528278443"
          xlink:to="FNT_3729ecfb-9394-48e0-abf2-382d35c865c6"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
